Citrus Sinensis ID: 004994

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720
Protein Sequence
MGYVNYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTAIPPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAILCALGCSLFMWRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNSPLQPSGQVEEVSKEPVVKSQDGHGVDSRRMVSSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI
Secondary Structure (PSIPRED)
cccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccccccccccccccccccEEEEEccEEEEEEEccccccccccccccccccccEEEcccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccEEEEcccccEEEEHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccccccEEccccccEEEEEEEccccEEEEEEcccccccccccHHHHHHHHHHHccccccccccEEEEccccEEEEEEEEcccccHHHHccccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHccHHHcccccccEEEccccccccccccHHcccccEEEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccccccccccEEEEccccccccccHcHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEccccccccccccccccccccccccccccccccccHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHccccHHHHHHHHccccHHcEEEcccccEEEEEEcccccEEEEEEccccccccccccHHHHHHHHHcccccccHHHHHEEEcccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEEccccccHHHHccHHHHcccccccccHEHHccccccccccHcEEEEcccccHHHHHHHHHHHHccccccccccccccccHHHHHHHHHcccccHHHHccHHHcccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHc
Coil and Loop (DISEMBL)
MGYVNYGMCVGLTMALAVLtapfcagvtdprdvMALNSLYislnfpplekwlsfggdpcgdswqgVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVInidlsnnhiggsipsnlpvtvrnfslsgnqltgsipeSLSRLTQLLDLSlnnnhlnggipdafhqFTGLINfdlsannltgqlppstrnlSSLYSLHLqnnklsgtlnvleDLHLIDlniennlfsgpipekllsipnfrkdgnpfnttvialpptaippsiapaptfqapgdqadapsafemtnsakakkfwTTKRVIWVALSAAAILCALGCSLFMWRYCktrrvnrdaekntgtykghgekpnyknsplqpsgqveevskepvvksqdghgvdsrrmvssprpqdeklplpplplplvekvtvkplapaevtrrsspstnvissSVSVFTIASLQQYTnsfsegnfigegllgsvykaelpggklLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLvydyggnctlhdllhsDEEAHKKFSWNIRIRVALGAARALQYLQEvceppivhgnfkssnilldekLIVRVSdcglapllfsgstnelSEGLltahgsgapefesgsyscqsdvYSLGVVMLELltgrkpydrsrprgeqsLVRWaiprlhdidalsrmvdpsldgAYLAKSLSRFADIISRcvqwepgfrppmsEIVQDLLCMI
Flexible Loop (DISEMBL)
MGYVNYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTAIPPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAILCALGCSLFMWRYCKTrrvnrdaekntgtykghgekpnyknsplqpsgqveevskepvvksqdghgvdsrrmvssprpqdeklplpplplplVEKVTVKPLapaevtrrsspstnvisSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSntvsqrqtdEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTgrkpydrsrprgeqslvrwaiprlhDIDALSRMVDPSLDGAYLAKSLSRFADIISRCvqwepgfrppmseiVQDLLCMI
Low Complexity Region (SEG)
MGYVNYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPEslsrltqlldlslnnnhlnGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVialpptaippsiapapTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAILCALGCSLFMWRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNSPLQPSGQveevskepvvksQDGHGVDSRRMVSSPRPQDEklplpplplplvekvtvkplAPAEVTRRsspstnvisssvsvFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI
Disordered region (IsUnstruct)
**YVNYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL*****NLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPP*********************************AKKFWTTKRVIWVALSAAAILCALGCSLFMWRYCKTRRV***************************************************************************************************SSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTV******EEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL**GLL*************SYSCQSDVYSLGVVMLELLTGRK***********SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC**
Disordered Region (DISOPRED)
****NYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGN*******************************************************WVALSAAAILCALGCSLFMWR**************************************************************************************************************VFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSN******T***FLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI
Disordered Region (DISEMBL)
MGYVNYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTAIPPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAILCALGCSLFMWRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNS***************************************KLPLPPLPLPLVEKVTVKPLAPA***********VISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI
Disordered Region (DISPRO)
*GYVNYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTAIPPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAILCALGCSLFMWRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNSPLQPSGQVEEVSKEPVVKSQDGHGVDSRRMVSSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAE*TRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI
Transmembrane Helix (TMHMM)
oooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGYVNYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTAIPPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAILCALGCSLFMWRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNSPLQPSGQVEEVSKEPVVKSQDGHGVDSRRMVSSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	720	2.2.26 [Sep-21-2011]
Q8RWZ1	768	Protein STRUBBELIG OS=Ara	yes	no	0.977	0.916	0.496	0.0
Q6R2K3	776	Protein STRUBBELIG-RECEPT	no	no	0.963	0.894	0.524	0.0
Q06BH3	775	Protein STRUBBELIG-RECEPT	no	no	0.988	0.918	0.493	0.0
Q6R2J8	703	Protein STRUBBELIG-RECEPT	no	no	0.886	0.907	0.431	1e-142
Q9C8M9	719	Protein STRUBBELIG-RECEPT	no	no	0.937	0.938	0.423	1e-139
Q6R2K1	699	Protein STRUBBELIG-RECEPT	no	no	0.925	0.952	0.392	1e-130
Q9LUL4	717	Protein STRUBBELIG-RECEPT	no	no	0.918	0.921	0.399	1e-122
Q6R2K2	687	Protein STRUBBELIG-RECEPT	no	no	0.931	0.976	0.385	1e-121
Q9FG24	735	Protein STRUBBELIG-RECEPT	no	no	0.477	0.468	0.436	1e-71
Q41328	354	Pto-interacting protein 1	N/A	no	0.419	0.853	0.403	1e-56

>sp|Q8RWZ1|SUB_ARATH Protein STRUBBELIG OS=Arabidopsis thaliana GN=SUB PE=1 SV=1

 Score =  710 bits (1832), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 389/784 (49%), Positives = 505/784 (64%), Gaps = 80/784 (10%)

Query: 1   MGYVNYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCG 60
           M +  + +  GL+  +  LT PF AGVT+ RDV A+N+LYI+L  P L  WL+FGGDPCG
Sbjct: 1   MSFTRWEVFFGLS--VLALTMPFSAGVTNLRDVSAINNLYITLGAPSLHHWLAFGGDPCG 58

Query: 61  DSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVR 120
           + WQGV C  SN+TEIR+ GM +GG L+DTL D  S+  +D S+NHI G+IP  LP ++R
Sbjct: 59  EKWQGVVCDSSNITEIRIPGMKVGGGLSDTLADFSSIQVMDFSSNHISGTIPQALPSSIR 118

Query: 121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
           N SLS N+ TG+IP +LS L+ L +LSL +N L+G IPD F Q + L   DLS+N L G 
Sbjct: 119 NLSLSSNRFTGNIPFTLSFLSDLSELSLGSNLLSGEIPDYFQQLSKLTKLDLSSNILEGH 178

Query: 181 LPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKD 240
           LP S  +L+SL  L+LQ+NKL+GTL+V+EDL L DLN+ENNLFSGPIP  LL IPNF+KD
Sbjct: 179 LPSSMGDLASLKILYLQDNKLTGTLDVIEDLFLTDLNVENNLFSGPIPPNLLKIPNFKKD 238

Query: 241 GNPFNTTVI----------------ALPPTAIPPS------------------------- 259
           G PFNT++I                A P   IPP                          
Sbjct: 239 GTPFNTSIITPPPPPVVDPPPATHRAPPVPRIPPVSGVPPAPFAPFAPLQPQQHPPPSPP 298

Query: 260 --IAPAPTFQAPGDQADAPSA-----FEMTNSAKAKKFWTTKRVIWVALSAAAILCALGC 312
              +P  +    GD  ++ S          + + + KFW+T+R+I V  S A I+   G 
Sbjct: 299 LVWSPPSSDNGGGDPWNSVSGQPTLQISPPSGSGSGKFWSTQRIILVVSSVAIIVLVSGL 358

Query: 313 SLFMWRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNSPLQPSGQVEEVSKEPVVKSQDGHG 372
            + +WR C+++  NR     +G  K   ++P +   P QP+  + +VS+EP+VK  DG+G
Sbjct: 359 CVTLWRCCRSKIYNR---YYSGARKDL-QRPYFNKPPSQPTPTMGKVSREPMVKPFDGYG 414

Query: 373 VDSRRMVSSPRPQ---DEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVIS----- 424
              R+    P PQ   + +  +PP       K    P  P +   R   S +  S     
Sbjct: 415 AGDRKY-GYPMPQRAEESRRAMPPTSY--YNKDVNTPQKPLQQPPRQFQSNDTASKRAAH 471

Query: 425 --------SSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTV 476
                   SS +VFTIASLQQYTN+FSE N IGEG +G+VY+AEL  GK LAVKKLSNT+
Sbjct: 472 FPPGLNSSSSATVFTIASLQQYTNNFSEENIIGEGSIGNVYRAELRHGKFLAVKKLSNTI 531

Query: 477 SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAH 536
           ++ Q+D EFL L S + +L+ G+I+EL+GYCNE GQ LLVY+Y  N +L D LH D + H
Sbjct: 532 NRTQSDGEFLNLVSNVLKLKRGHILELLGYCNEFGQRLLVYEYCPNGSLQDALHLDRKLH 591

Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
           KK +WN+RI +ALGA++ALQ+L EVC+PP+VH NFKSS +LLD KL VRV+D GLA +L 
Sbjct: 592 KKLTWNVRINIALGASKALQFLHEVCQPPVVHQNFKSSKVLLDGKLSVRVADSGLAYMLP 651

Query: 597 SGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS 656
              T++++       G  APE E GSY+CQSDV+SLGVVMLELLTGR+P+DR+RPRG Q+
Sbjct: 652 PRPTSQMA-------GYAAPEVEYGSYTCQSDVFSLGVVMLELLTGRRPFDRTRPRGHQT 704

Query: 657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           L +WAIPRLHDIDAL+RMVDPSL GAY  KSLSRFADIISR +Q EPGFRPP+SEIVQDL
Sbjct: 705 LAQWAIPRLHDIDALTRMVDPSLHGAYPMKSLSRFADIISRSLQMEPGFRPPISEIVQDL 764

Query: 717 LCMI 720
             MI
Sbjct: 765 QHMI 768

Regulates the expression of transcription factors that define the cell fates. Seems to be required for the regulation of cell shape and the orientation of the mitotic division plane. Involved in root hair specification, in the formation of the outer integument and the shape of organs such as carpels and petals and is necessary for the shape and height of the stem.
Arabidopsis thaliana (taxid: 3702)

>sp|Q6R2K3|SRF3_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 3 OS=Arabidopsis thaliana GN=SRF3 PE=1 SV=1

 Score =  692 bits (1785), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 386/736 (52%), Positives = 486/736 (66%), Gaps = 42/736 (5%)

Query: 26  GVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGG 85
             T+P DV A+N L+ +L  P L  W++ GGDPCG++WQG+ C  S++  I +   NL G
Sbjct: 29  AATNPDDVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISITVNAANLQG 88

Query: 86  VLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLD 145
            L D L    S+  ID SNN IGGSIPS LPVT+++F LS NQ TGSIPESL  L+ L D
Sbjct: 89  ELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESLGTLSFLND 148

Query: 146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL 205
           +SLN+N L+G +PD F    GLIN D+S+NN++G LPPS  NL +L +L +QNN+LSGTL
Sbjct: 149 MSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRVQNNQLSGTL 208

Query: 206 NVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVI-----------ALPPT 254
           +VL+ L L DLNIENNLFSGPIP+KLLSIP F  +GNPFN T+I           +L PT
Sbjct: 209 DVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNPFNATMINSTSTAPSLSPSLSPT 268

Query: 255 AIPPS-----IAPAPTFQAPGDQADAPSAFEMTNS--AKAKKFWTTKRVIWVALSAAAIL 307
              P+     + P P  +  G  AD PS  E ++S  +K K    TK++I +A +   + 
Sbjct: 269 KPAPTRPFSGVPPPPNERNRGKVADGPSDSEGSSSENSKGKNSSHTKKIILIAFAGVLVF 328

Query: 308 CALGCSLFMWR-YCKTRR--VNRDAE-KNTGTYKGHGEKPNYKNSP-LQPSGQVEEVSKE 362
             L  ++ +    C  RR   NR  +    G  +G  E      +P L P G+ E+V +E
Sbjct: 329 IILVLAILLLLPKCARRREHANRVFKPHQVGADRGSRENALENGTPVLPPPGRSEKVQRE 388

Query: 363 PVVKSQDG----HGVDS-RRMVSSPRPQDEKLPLPPL------------PLPLVEKVTVK 405
           P  K+ +     H ++  RR     R + + +    L            P PL EKVTV 
Sbjct: 389 PFKKAGEEPKVLHDLERLRRPAPISRQESQDIDFSMLMPPPPPPPPPPPPPPLDEKVTVM 448

Query: 406 PL-APAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGG 464
           P+ +P    +++SP   +  +SV  ++IASLQQYT SF++ N IG G+LGSVY+A LP G
Sbjct: 449 PIISPERPVKKTSPK-RLPLTSVKHYSIASLQQYTESFAQENLIGSGMLGSVYRARLPNG 507

Query: 465 KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCT 524
           KL AVKKL    S++Q D EF+EL + I  +RH NIVEL+GYC EH Q LLVY+Y  N T
Sbjct: 508 KLFAVKKLDKRASEQQQDHEFIELVNNIDMIRHSNIVELVGYCAEHDQRLLVYEYCSNGT 567

Query: 525 LHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIV 584
           L D LHSD+E  KK SWN R+ +ALGAARAL+YL EVCEPPI+H NFKS+N+LLD+ L V
Sbjct: 568 LQDGLHSDDEFKKKLSWNTRVSMALGAARALEYLHEVCEPPIIHRNFKSANVLLDDDLSV 627

Query: 585 RVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRK 644
            VSDCGLAPL+ SGS ++LS  LL A+G GAPEF+SG Y+ QSDVYS GVVMLELLTGR 
Sbjct: 628 LVSDCGLAPLISSGSVSQLSGQLLAAYGYGAPEFDSGIYTWQSDVYSFGVVMLELLTGRM 687

Query: 645 PYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPG 704
            YDR R RGEQ LVRWAIP+LHDIDAL +MVDPSL+G Y AKSLS FADIISRCVQ EP 
Sbjct: 688 SYDRDRSRGEQFLVRWAIPQLHDIDALGKMVDPSLNGQYPAKSLSHFADIISRCVQSEPE 747

Query: 705 FRPPMSEIVQDLLCMI 720
           FRP MSE+VQDLL MI
Sbjct: 748 FRPLMSEVVQDLLDMI 763

Not essential for epidermal patterning and not redundant with STRUBBELIG.

Arabidopsis thaliana (taxid: 3702)

>sp|Q06BH3|SRF1_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 1 OS=Arabidopsis thaliana GN=SRF1 PE=2 SV=2

 Score =  642 bits (1656), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/746 (49%), Positives = 485/746 (65%), Gaps = 34/746 (4%)

Query: 8   MCVGLTMALAVLTAP-FCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGV 66
           +C    ++ A+++ P     +T+P DV A+NSL+++L  P L  W++ GGDPCG+SWQGV
Sbjct: 12  ICFLGFLSFALISLPSLSLALTNPDDVAAINSLFLALESPLLPGWVASGGDPCGESWQGV 71

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSG 126
            C  S V  I L   NLGG L   L    S+  +D SNNHIGGSIPS LPV+++N  LSG
Sbjct: 72  LCNASQVETIILISANLGGELGVGLNMFTSLKAMDFSNNHIGGSIPSTLPVSLQNLFLSG 131

Query: 127 NQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTR 186
           N  TG+IPESLS L  L  +SLNNN L+G IPD F     +IN DLS+NNL+G LPPS +
Sbjct: 132 NNFTGTIPESLSSLKSLSVMSLNNNLLSGKIPDVFQDLGLMINIDLSSNNLSGPLPPSMQ 191

Query: 187 NLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNT 246
           NLS+L SL LQNN LSG L+VL+DL L DLN+ENNLF+GPIPEKLLSIPNF K GN FN 
Sbjct: 192 NLSTLTSLLLQNNHLSGELDVLQDLPLKDLNVENNLFNGPIPEKLLSIPNFIKGGNLFNV 251

Query: 247 TVIALPPTAI---------PPSIAPAPTFQAPGDQADA---PSAFEMTNSAKAKK--FWT 292
           T+   P             P    P+P   A   QA     PS    +      K   +T
Sbjct: 252 TIAPSPSPETPPSPTSPKRPFFGPPSPNASAGHGQAHVRSPPSDHHPSRPTPQGKEDSFT 311

Query: 293 TKRVIWVALSAAA--ILCALGCSLFMWRYCKTRRVNRD--AEKNTGTYKGHGEKPNYKNS 348
           +KR+IW+++  A   ++ AL C L   R C  +R + +  ++ +  +  G   + +  N+
Sbjct: 312 SKRIIWISILGAFSFVVLALVC-LLCGRKCLRKREDSEQLSKPHLTSEYGRAREGSRSNA 370

Query: 349 PLQPSGQVEEVSKEPVVKSQDG-----HGVDSRRMVSSPRPQDEKLPL--------PPLP 395
            + P        KE   K + G     HG   R + S  + +  ++ +         P  
Sbjct: 371 SMLPPSNTFNKDKEARPKERVGGASKLHGGAERSVGSESKQESHEIDMNGNAMDLMHPSS 430

Query: 396 LPLVEKVTVKPLAPAEVT-RRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLG 454
           +P +++V  K   PAE + +R++  ++   ++V  FT+ASLQQ+TNSFS  N IG G+LG
Sbjct: 431 IPPIKRVIAKATEPAEASLKRTTSKSHGPLTAVKHFTVASLQQHTNSFSHENLIGTGMLG 490

Query: 455 SVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL 514
           SVY+AELPGGKL AV+KL       + + +FLEL + I R+RH NIV+L+G+C+EH Q L
Sbjct: 491 SVYRAELPGGKLFAVRKLDKKSPNHEEEGKFLELVNNIDRIRHANIVQLVGFCSEHSQRL 550

Query: 515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSS 574
           L+++Y  N TLHDLLH D+    + SWN+R+R+AL AA+AL+YL E+C+PP +H NFKS+
Sbjct: 551 LIHEYCRNGTLHDLLHIDDRLKIELSWNVRVRIALEAAKALEYLHEICDPPSIHRNFKSA 610

Query: 575 NILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGV 634
           NILLD+ + V VSDCGLAPL+ SG+ ++LS  LL A+G GAPEFE G Y+ + DVYS GV
Sbjct: 611 NILLDDDIRVHVSDCGLAPLISSGAVSQLSGQLLAAYGYGAPEFEYGIYTMKCDVYSFGV 670

Query: 635 VMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADI 694
           VMLELLTGRK YD+ R RGEQ LVRWAIP+LHDIDAL++MVDPSL G Y AKSLS FAD+
Sbjct: 671 VMLELLTGRKSYDKKRDRGEQFLVRWAIPQLHDIDALAKMVDPSLKGDYPAKSLSHFADV 730

Query: 695 ISRCVQWEPGFRPPMSEIVQDLLCMI 720
           ISRCVQ EP +RP MSE+VQDL  MI
Sbjct: 731 ISRCVQSEPEYRPLMSEVVQDLSDMI 756

Not essential for epidermal patterning and not redundant with STRUBBELIG.

Arabidopsis thaliana (taxid: 3702)

>sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1

 Score =  504 bits (1299), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 303/702 (43%), Positives = 414/702 (58%), Gaps = 64/702 (9%)

Query: 27  VTDPRDVMALNSLYISLNFPP-LEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGG 85
           VTDP DV AL  LY SLN P  L  W + GGDPCG+SW+G+ C  S V  I ++ + + G
Sbjct: 28  VTDPSDVQALQVLYTSLNSPSQLTNWKNGGGDPCGESWKGITCEGSAVVTIDISDLGVSG 87

Query: 86  VLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLD 145
            L   L DL+S+  +D+S N I  ++P  LP  + + +L+ N L+G++P S+S +  L  
Sbjct: 88  TLGYLLSDLKSLRKLDVSGNSIHDTLPYQLPPNLTSLNLARNNLSGNLPYSISAMGSLSY 147

Query: 146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL 205
           ++++ N L   I D F     L   DLS NN +G LP S   +S+L  L++QNN+L+G++
Sbjct: 148 MNVSGNSLTMSIGDIFADHKSLATLDLSHNNFSGDLPSSLSTVSTLSVLYVQNNQLTGSI 207

Query: 206 NVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTAIP-----PSI 260
           +VL  L L  LN+ NN F+G IP++L SI     DGN F+  V A P    P     PS 
Sbjct: 208 DVLSGLPLKTLNVANNHFNGSIPKELSSIQTLIYDGNSFDN-VPASPQPERPGKKETPSG 266

Query: 261 APAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAILCALGCSLFMWRYC 320
           +  P   +    +D         S K         +++ +L  A I+  +   L++  + 
Sbjct: 267 SKKPKIGSEEKSSD---------SGKGLSGGVVTGIVFGSLFVAGIIALV---LYLCLHK 314

Query: 321 KTRRVNRDAEKNTGTYKGHGEKPNYKNSPLQPSGQVEEVSKEPVVKSQDGHGVDSRRMVS 380
           K R+V                + + ++ PL  + +V+E   + V    D        + S
Sbjct: 315 KKRKVRGST------------RASQRSLPLSGTPEVQEQRVKSVASVAD--------LKS 354

Query: 381 SPRPQDEKLPLPPLPLPLVEKVTV-KPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYT 439
           SP                 EKVTV + +    ++R  SP T       S +T++SLQ  T
Sbjct: 355 SP----------------AEKVTVDRVMKNGSISRIRSPIT------ASQYTVSSLQVAT 392

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           NSFS+ N IGEG LG VY+AE P GK++A+KK+ N     Q ++ FLE  S +SRLRH N
Sbjct: 393 NSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNFLEAVSNMSRLRHPN 452

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV L GYC EHGQ LLVY+Y GN  L D LH++++     +WN R++VALG A+AL+YL 
Sbjct: 453 IVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNARVKVALGTAKALEYLH 512

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           EVC P IVH NFKS+NILLDE+L   +SD GLA L    +  ++S  ++ + G  APEF 
Sbjct: 513 EVCLPSIVHRNFKSANILLDEELNPHLSDSGLAALT-PNTERQVSTQVVGSFGYSAPEFA 571

Query: 620 -SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            SG Y+ +SDVY+ GVVMLELLTGRKP D SR R EQSLVRWA P+LHDIDALS+MVDPS
Sbjct: 572 LSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVRWATPQLHDIDALSKMVDPS 631

Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           L+G Y AKSLSRFADII+ C+Q EP FRPPMSE+VQ L+ ++
Sbjct: 632 LNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQLVRLV 673

Arabidopsis thaliana (taxid: 3702)

>sp|Q9C8M9|SRF6_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 6 OS=Arabidopsis thaliana GN=SRF6 PE=1 SV=1

 Score =  496 bits (1276), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 301/711 (42%), Positives = 412/711 (57%), Gaps = 36/711 (5%)

Query: 5   NYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPP-LEKWLSFGGDPCGDSW 63
           N+ +    T+ +      F  G TD  D  ALN+L+  ++ P  L +W +  GDPCG +W
Sbjct: 4   NWAVVALFTLCIVGFELRFIHGATDASDTSALNTLFSGMHSPAQLTQWTAAAGDPCGQNW 63

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGD-LESVINIDLSNNHIGGSIPSNLPVTVRNF 122
           +GV C  S VT+I+L+G+ L G L   + D L S+  +DLS+N++GG +P   P  ++  
Sbjct: 64  RGVTCSGSRVTQIKLSGLELSGTLGGYMLDKLTSLTELDLSSNNLGGDLPYQFPPNLQRL 123

Query: 123 SLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP 182
           +L+ NQ TG+   SLS++T L  L+L +N   G I   F +   L   D S N+ T  LP
Sbjct: 124 NLANNQFTGAASYSLSQITPLKYLNLGHNQFKGQIAIDFSKLDSLTTLDFSFNSFTNSLP 183

Query: 183 PSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGN 242
            +  +L+SL SL+LQNN+ SGT++VL  L L  LNI NN F+G IP  L  I    KDGN
Sbjct: 184 ATFSSLTSLKSLYLQNNQFSGTVDVLAGLPLETLNIANNDFTGWIPSSLKGI-TLIKDGN 242

Query: 243 PFNTTVIALPPTAIPPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALS 302
            FNT     PP   P  I  +P+ ++ G ++   S+ E T +  +KK       I   + 
Sbjct: 243 SFNTGPAPPPPPGTP-PIRGSPSRKSGGRESR--SSDESTRNGDSKKSGIGAGAIAGIII 299

Query: 303 AAAILCALGCSLFMWRYCKTRRVN-RDAEKNTGTYKGHGEKPNYKNSPLQPSGQVEEVSK 361
           +  ++ AL  + F++R  K++R +  D EK             ++N+ +Q S  VE    
Sbjct: 300 SLLVVTALLVAFFLFRRKKSKRSSPMDIEKTDNQPFTLASNDFHENNSIQSSSSVE---- 355

Query: 362 EPVVKSQDGHGVDSRRMVSSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTN 421
               K      ++ R     P P D             E  T KP+A  +       ST 
Sbjct: 356 --TKKLDTSLSINLR-----PPPIDRNKSFDD------EDSTRKPIAVKK-------STV 395

Query: 422 VISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQT 481
           V+ S+V ++++A LQ  T SFS  N +GEG  G VY+AE   GK+LAVKK+ ++      
Sbjct: 396 VVPSNVRLYSVADLQIATGSFSVDNLLGEGTFGRVYRAEFDDGKVLAVKKIDSSALPHGM 455

Query: 482 DEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSW 541
            ++F+E+ S I+ L H N+ +L+GYC EHGQHL+VY++  N +LHD LH  EE  K   W
Sbjct: 456 TDDFIEMVSKIANLDHPNVTKLVGYCAEHGQHLVVYEFHKNGSLHDFLHLSEEESKALVW 515

Query: 542 NIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN 601
           N R+++ALG ARAL+YL EVC P IV  N KS+NILLD +L   +SD GLA  L   + N
Sbjct: 516 NSRVKIALGTARALEYLHEVCSPSIVDKNIKSANILLDSELNPHLSDSGLASFL--PTAN 573

Query: 602 ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW 660
           EL     T  G  APE   SG YS +SD+YS GVVMLELLTGRKP+D +R R EQSLVRW
Sbjct: 574 ELLNQ--TDEGYSAPEVSMSGQYSLKSDIYSFGVVMLELLTGRKPFDSTRSRSEQSLVRW 631

Query: 661 AIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSE 711
           A P+LHDIDAL++MVDP+L G Y  KSLSRFAD+I+ CVQ EP FRPPMSE
Sbjct: 632 ATPQLHDIDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSE 682

Arabidopsis thaliana (taxid: 3702)

>sp|Q6R2K1|SRF5_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 5 OS=Arabidopsis thaliana GN=SRF5 PE=2 SV=1

 Score =  466 bits (1199), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 281/716 (39%), Positives = 392/716 (54%), Gaps = 50/716 (6%)

Query: 10  VGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFP-PLEKWLSFGGDPCGDSWQGVFC 68
           V L +    +T       TD ++V ALN ++ SLN P  L+ W + GGDPC DSW+GV C
Sbjct: 6   VRLVIVSLAITVTLLQAKTDNQEVSALNVMFTSLNSPSKLKGWKANGGDPCEDSWEGVKC 65

Query: 69  VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQ 128
             S+VTE++L+G  LGG     L +L+S+   DLS N++ G+IP  LP  + N   S N+
Sbjct: 66  KGSSVTELQLSGFELGGSRGYLLSNLKSLTTFDLSKNNLKGNIPYQLPPNIANLDFSENE 125

Query: 129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNL 188
           L G++P SLS++  L  ++L  N LNG +PD F + + L   D S N L+G+LP S  NL
Sbjct: 126 LDGNVPYSLSQMKNLQSINLGQNKLNGELPDMFQKLSKLETLDFSLNKLSGKLPQSFANL 185

Query: 189 SSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTV 248
           +SL  LHLQ+N+ +G +NVL +L + DLN+E+N F G IP +L  I +    GN ++T  
Sbjct: 186 TSLKKLHLQDNRFTGDINVLRNLAIDDLNVEDNQFEGWIPNELKDIDSLLTGGNDWSTET 245

Query: 249 IALPPTAIPPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAILC 308
            A PP   PP +          D     +   M              VI  A     +L 
Sbjct: 246 -APPP---PPGVKYGRKSSGSKDGGGITAGTGM--------------VIAGACLGVLVLI 287

Query: 309 ALGCSLFMWRYCKT--RRVNRDAEKNTGTYKGHGEKPNYKNSPLQPSGQVEEVSKEPVVK 366
            +  +L   +        ++ D   +T         P +K+  L   G  +E+  +    
Sbjct: 288 IVLIALVSKKKSSLSPHFIDEDNSHHT---------PKFKS--LTSHGSAQELRVDFGND 336

Query: 367 SQDGHGVDSRRMVSSPRPQDEKL-PLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVISS 425
            +DG   DS          DE +  +    L       V      E   + +      + 
Sbjct: 337 YKDGKSGDS---------GDENIHRIGSKGLKHYVSSRVMSFTDTEFANKLNAKRTTSTR 387

Query: 426 SVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEF 485
           S   F ++ LQ  T +FS GN +GEG +G VY+A+   G+ LAVKK+ +T+      E  
Sbjct: 388 SAVEFELSDLQSATANFSPGNLLGEGSIGRVYRAKYSDGRTLAVKKIDSTLFDSGKSEGI 447

Query: 486 LELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRI 545
             +  ++S++RH NI EL+GYC+E G ++LVY+Y  N +LH+ LH  +   K  +WN R+
Sbjct: 448 TPIVMSLSKIRHQNIAELVGYCSEQGHNMLVYEYFRNGSLHEFLHLSDCFSKPLTWNTRV 507

Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
           R+ALG ARA++YL E C P ++H N KSSNILLD  L  R+SD GL+      S N    
Sbjct: 508 RIALGTARAVEYLHEACSPSVMHKNIKSSNILLDADLNPRLSDYGLSKFYLRTSQN---- 563

Query: 606 GLLTAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR 664
                 G  APE    S Y+ +SDVYS GVVMLELLTGR P+D  +PR E+SLVRWA P+
Sbjct: 564 ---LGEGYNAPEARDPSAYTPKSDVYSFGVVMLELLTGRVPFDGEKPRPERSLVRWATPQ 620

Query: 665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           LHDIDALS + DP+L G Y  KSLSRFADII+ CVQ EP FRPPMSE+V+ L+ M+
Sbjct: 621 LHDIDALSNIADPALHGLYPPKSLSRFADIIALCVQVEPEFRPPMSEVVEALVRMV 676

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LUL4|SRF7_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 7 OS=Arabidopsis thaliana GN=SRF7 PE=1 SV=1

 Score =  439 bits (1128), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 285/714 (39%), Positives = 388/714 (54%), Gaps = 53/714 (7%)

Query: 12  LTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFP-PLEKWLSFGGDPCGDSWQGVFCVF 70
           L + +      F  G TD  D  ALN ++ S+N P  L +W + GGDPCG +W+G+ C  
Sbjct: 11  LILCIVGFEPSFIHGATDSSDTSALNIMFSSMNSPGQLSQWTASGGDPCGQNWKGITCSG 70

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLT 130
           S VT+I+L  + L G L   L  L SV   D+SNN++GG +P  LP  +   +L+ NQ T
Sbjct: 71  SRVTQIKLPSLGLSGSLGFMLDKLTSVTEFDMSNNNLGGDLPYQLPPNLERLNLANNQFT 130

Query: 131 GSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSS 190
           GS   S+S +  L  L+L +N L     D F + T L   DLS+N   G LP +  +L+S
Sbjct: 131 GSAQYSISMMAPLKYLNLAHNQLKQLAID-FTKLTSLSILDLSSNAFIGSLPNTCSSLTS 189

Query: 191 LYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIA 250
             S++LQNN+ SGT+++L  L L +LNI NN F+G IP+ L  I N +KDGN  N+    
Sbjct: 190 AKSIYLQNNQFSGTIDILATLPLENLNIANNRFTGWIPDSLKGI-NLQKDGNLLNSGPAP 248

Query: 251 LPPTAIPPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAILCAL 310
            PP   PP    +PT ++ G++ +  +     +   +K       V  + +S   ++ A+
Sbjct: 249 PPPPGTPPISKSSPTPKS-GNRGNRSNGDSSNSKDSSKSGLGAGGVAGIVIS-LIVVTAV 306

Query: 311 GCSLFMWRYCKTRRVNRDAEKNTGTYKG---------HGEKPNYKNSPLQPSGQVEEVSK 361
                + R    R  + D EK                H E  + +N PL  + +++    
Sbjct: 307 IAFFLIKRKRSKRSSSTDIEKTDNNINQPIILASNDFHQENKSVQNPPLVETKKLDT--- 363

Query: 362 EPVVKSQDGHGVDSRRMVSSPRPQDEKLPLPPLPLPLVEKVTVKPLA---PAEVTRRSSP 418
                        S  M   P P +           + + +  K  A   P+ V   +  
Sbjct: 364 -------------SLSMNLRPPPSERHKSFDDDDSTMRKPIVAKKAAVVVPSNVNTYTVS 410

Query: 419 STNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQ 478
              V ++S SV          N   EG F      G VY+A+   GK+LAVKK+ ++   
Sbjct: 411 DLQVATNSFSV---------DNLLGEGTF------GRVYRAQFEDGKVLAVKKIDSSALP 455

Query: 479 RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK 538
             T ++F E+ S I+ L H N+ +L GYC+EHGQHL+VY++  N +LHD LH  EE  K 
Sbjct: 456 TDTADDFTEIVSKIAHLDHENVTKLDGYCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKP 515

Query: 539 FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG 598
             WN R+++ALG ARAL+YL EVC P IVH N KS+NILLD +L   +SD GLA  L   
Sbjct: 516 LIWNPRVKIALGTARALEYLHEVCSPSIVHKNIKSANILLDSELNPHLSDSGLASFL--P 573

Query: 599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL 657
           + NEL        G  APE   SG YS +SDVYS GVVMLELLTGRKP+D +R R EQSL
Sbjct: 574 TANELLNQ--NDEGYSAPETSMSGQYSLKSDVYSFGVVMLELLTGRKPFDSTRSRSEQSL 631

Query: 658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSE 711
           VRWA P+LHDIDAL +MVDP+L G Y  KSLSRFAD+I+ CVQ EP FRPPMSE
Sbjct: 632 VRWATPQLHDIDALGKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSE 685

Arabidopsis thaliana (taxid: 3702)

>sp|Q6R2K2|SRF4_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 4 OS=Arabidopsis thaliana GN=SRF4 PE=2 SV=1

 Score =  435 bits (1119), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 280/727 (38%), Positives = 398/727 (54%), Gaps = 56/727 (7%)

Query: 10  VGLTMALAVLTAPFCAGV--------TDPRDVMALNSLYISLNFP-PLEKWLSFGGDPCG 60
           +G  +   VL    C G+        TD +DV ALN  Y S+N P  L+ W S GGDPCG
Sbjct: 1   MGPNLQRIVLVFIACFGIFTSVVLAKTDSQDVSALNDAYKSMNSPSKLKGWSSSGGDPCG 60

Query: 61  DSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVR 120
           DSW G+ C  S+VTEI+++G  L G L   LG+L+S+  +D+S N++ G++P  LP  + 
Sbjct: 61  DSWDGITCKGSSVTEIKVSGRGLSGSLGYQLGNLKSLTYLDVSKNNLNGNLPYQLPDKLT 120

Query: 121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
               S N   G++P S+S +  L  L+L  N+LNG + D F +   L   DLS+N LTG+
Sbjct: 121 YLDGSENDFNGNVPYSVSLMNDLSYLNLGRNNLNGELSDMFQKLPKLETIDLSSNQLTGK 180

Query: 181 LPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSGPIPEKLLSIPNFRK 239
           LP S  NL+ L +LHLQ N+  G++N L DL  + D+N+ NN F+G IP +L +I N   
Sbjct: 181 LPQSFANLTGLKTLHLQENQFKGSINALRDLPQIDDVNVANNQFTGWIPNELKNIGNLET 240

Query: 240 DGNPFNTTVIALPPTAIPPSIAPAPTFQAPGDQ-ADAPSAFEMTNSAKAKKFWTTKRVIW 298
            GN +++     PP               PG +  D  S+     S+KA    T   +I 
Sbjct: 241 GGNKWSSGRAPSPP---------------PGTRHIDRNSSGGGGGSSKA---LTLGVIIA 282

Query: 299 VALSAAAILCALGCSLFMWRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNSPLQPSGQVEE 358
           V+     IL A   +L          ++R    N  ++    EK   ++ PL      + 
Sbjct: 283 VSSIGGLILFAGLIAL----------ISRRKNSNDSSHFFDDEKGTNRSKPLFTPQSSQM 332

Query: 359 VSKEPVVKSQDGHGVDSRRMV----SSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTR 414
           +  + + + ++   VDS   +    S  R         P    L+    V        T 
Sbjct: 333 LQFDNMEEFKNQKTVDSNTSLETKPSVKRTSSVSFKNSPT-FHLIPSTQVAATPDRSSTS 391

Query: 415 RSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSN 474
           + SP T      V  F++A LQ   + FS    +GEG +G VYKA+   G+  AVK++ +
Sbjct: 392 QDSPDTR----GVKAFSLADLQNTASCFSPNRLLGEGTIGRVYKAKFQDGRKFAVKEIDS 447

Query: 475 TVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEE 534
           ++  +   EEF  + S+IS + H N+ EL+GYC+E G+++LVY+Y  + +LH  LH  ++
Sbjct: 448 SLLGKGNPEEFSHIVSSISSIHHKNMAELVGYCSEQGRNMLVYEYFTSGSLHRFLHLSDD 507

Query: 535 AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL 594
             K  +WN RIR+ALG A+A++YL E C PP+VH N KSSNILLD +L  R+SD GLA  
Sbjct: 508 FSKPLTWNTRIRIALGTAKAIEYLHETCSPPLVHKNIKSSNILLDNELNPRLSDYGLANF 567

Query: 595 LFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRG 653
               S N          G  APE  +  +Y+ +SDVYS GVVMLELLTGRKPYD  RP+ 
Sbjct: 568 HHRTSQN-------LGVGYNAPECTDPSAYTQKSDVYSFGVVMLELLTGRKPYDSGRPKA 620

Query: 654 EQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIV 713
           EQSLVRWA P+L D+D L  MVDP+L G Y  +S+S FADI+S CV  EPG RPP+S +V
Sbjct: 621 EQSLVRWAKPQLKDMDTLDEMVDPALCGLYAPESVSSFADIVSICVMTEPGLRPPVSNVV 680

Query: 714 QDLLCMI 720
           + L  ++
Sbjct: 681 EALKRLV 687

Acts as a direct positive regulator of leaf size but not leaf shape.

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FG24|SRF2_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 2 OS=Arabidopsis thaliana GN=SRF2 PE=2 SV=1

 Score =  271 bits (694), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 159/364 (43%), Positives = 225/364 (61%), Gaps = 20/364 (5%)

Query: 361 KEPVVKSQDGHGVDSRRMVSSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPST 420
           +E  V ++D   +  +R    P PQ   LP PP+    ++K            R+S  +T
Sbjct: 348 REYPVATEDNPQI--KRFQPPPAPQLRHLPSPPV---RIDK---------SARRKSFSAT 393

Query: 421 NVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQ 480
               S   +F+ A LQ  TN FSE N +GEG LGSVY+A+LP G+   V+ +  +     
Sbjct: 394 CQYPSFAKLFSAAELQLATNCFSEENLLGEGPLGSVYRAKLPDGQFAVVRNIPMSSLSLH 453

Query: 481 TDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFS 540
            +E+F E+  T S+LRH NIV L+G+C E+G+HLLVY+Y G+ +L++ +H  +E +K  S
Sbjct: 454 EEEQFTEVLQTASKLRHPNIVTLLGFCIENGEHLLVYEYVGHLSLYNAMH--DEVYKPLS 511

Query: 541 WNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA---PLLFS 597
           W +R+R+A+G ARAL YL     PPI H + K++NILLDE+L  R++DCGLA   PL  +
Sbjct: 512 WGLRLRIAIGVARALDYLHSSFCPPIAHSDLKATNILLDEELTPRIADCGLASLRPLTSN 571

Query: 598 GSTNELSEGLLTAHGSGAPEF-ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS 656
                 SE  +   G  APE  + GS   +SD Y+LGV++LELLTGRK +D SRPRGEQ 
Sbjct: 572 SVKLRASEIAIQNTGYIAPEHGQPGSSGTKSDTYALGVLLLELLTGRKAFDSSRPRGEQL 631

Query: 657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           LV+WA  RLHD  +L +M+D  + G + ++  S++ADIIS C Q E  FRPP+SEIV+ L
Sbjct: 632 LVKWASTRLHDRRSLEQMIDGGIAGTFSSRVASQYADIISLCTQAEKEFRPPVSEIVEAL 691

Query: 717 LCMI 720
             +I
Sbjct: 692 TALI 695

Arabidopsis thaliana (taxid: 3702)

>sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2

 Score =  221 bits (564), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 126/312 (40%), Positives = 184/312 (58%), Gaps = 10/312 (3%)

Query: 411 EVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVK 470
           E  +R + + N+   +V    +  L+  T++F     IGEG  G VY   L  G+  A+K
Sbjct: 37  ESAQRETQTVNIQPIAVPSIAVDELKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIK 96

Query: 471 KLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLH 530
           KL    S +Q D EFL   S +SRL+  N+VEL+GYC + G  +L Y+Y  N +LHD+LH
Sbjct: 97  KLD---SSKQPDREFLAQVSMVSRLKDENVVELLGYCVDGGFRVLAYEYAPNGSLHDILH 153

Query: 531 SDEEAHKK-----FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR 585
             +           SW  R+++A+GAA+ L+YL E  +P I+H + KSSNILL +  + +
Sbjct: 154 GRKGVKGAQPGPVLSWAQRVKIAVGAAKGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAK 213

Query: 586 VSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRK 644
           ++D  L+      +    S  +L   G  APE+  +G  S +SDVYS GVV+LELLTGRK
Sbjct: 214 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRK 273

Query: 645 PYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPG 704
           P D + PRG+QSLV WA PRL + D + + VD  L+  Y  K++++ A + + CVQ+E  
Sbjct: 274 PVDHTLPRGQQSLVTWATPRLSE-DKVKQCVDARLNTDYPPKAIAKMAAVAALCVQYEAD 332

Query: 705 FRPPMSEIVQDL 716
           FRP MS +V+ L
Sbjct: 333 FRPNMSIVVKAL 344

A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	720
255560796	672	lrr receptor-linked protein kinase, puta	0.926	0.992	0.607	0.0
224078900	667	predicted protein [Populus trichocarpa]	0.883	0.953	0.561	0.0
356542131	784	PREDICTED: protein STRUBBELIG-RECEPTOR F	0.979	0.899	0.534	0.0
356547026	784	PREDICTED: protein STRUBBELIG-RECEPTOR F	0.988	0.908	0.537	0.0
449479358	752	PREDICTED: protein STRUBBELIG-RECEPTOR F	0.977	0.936	0.535	0.0
449433876	752	PREDICTED: protein STRUBBELIG-RECEPTOR F	0.977	0.936	0.535	0.0
255553857	709	lrr receptor-linked protein kinase, puta	0.904	0.918	0.550	0.0
449479018	791	PREDICTED: LOW QUALITY PROTEIN: protein	0.990	0.901	0.525	0.0
356519546	699	PREDICTED: protein STRUBBELIG-RECEPTOR F	0.938	0.967	0.545	0.0
297739262	781	unnamed protein product [Vitis vinifera]	0.963	0.888	0.530	0.0

>gi|255560796|ref|XP_002521411.1| lrr receptor-linked protein kinase, putative [Ricinus communis] gi|223539310|gb|EEF40901.1| lrr receptor-linked protein kinase, putative [Ricinus communis]

 Score =  797 bits (2058), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 440/724 (60%), Positives = 522/724 (72%), Gaps = 57/724 (7%)

Query: 1   MGYVNYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCG 60
           +G +  G   GL   L   TA FC  +TDPRDV+A+NSL++SLNFPPL  WL  GGDPCG
Sbjct: 2   LGCIKIGTLSGLV--LVAFTASFCVAITDPRDVVAMNSLWVSLNFPPLLGWLP-GGDPCG 58

Query: 61  DSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVR 120
           + WQGV CVFSN+T ++L+GMNLGG LAD L   ES+I IDLSNNHIGGSIPS+LP T+R
Sbjct: 59  EEWQGVSCVFSNITALKLSGMNLGGTLADDLALFESIIEIDLSNNHIGGSIPSSLPPTLR 118

Query: 121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
            FSL+GNQ  GSIP++LS LTQL  LS+N+NHL+G +PDAF Q T L N DLS NNL+GQ
Sbjct: 119 IFSLAGNQFNGSIPDTLSTLTQLSHLSINDNHLSGEMPDAFQQLTSLTNLDLSGNNLSGQ 178

Query: 181 LPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKD 240
           LPPS  NLSSL SLHLQ+NK  G L+VL+DL L DLN+ENNLFSGPIP KLL+IPNFRKD
Sbjct: 179 LPPSLGNLSSLSSLHLQSNKFVGVLDVLQDLPLQDLNVENNLFSGPIPAKLLNIPNFRKD 238

Query: 241 GNPFNTTVIALPPTAIPPSIAPAPTF-QAPGDQADAPSAFEM--TNSAKAKKFWTTKRVI 297
           GNPFNTT+IA PP A+ PS A  P+  +AP  Q   PS  +     +  ++ F TTKR I
Sbjct: 239 GNPFNTTIIASPPLALSPSPAMPPSSAEAPEKQGYWPSISQTPKAEAESSRAFLTTKRAI 298

Query: 298 WVALSAAAILCALGCSLFMWRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNSPLQPSGQVE 357
            V ++   I+  L   + +    K ++V  DAE++   YKGH EKPN K S       ++
Sbjct: 299 LVTVAVVVIVIILVLCVLVSSCSKRKKVKEDAERHVVPYKGHIEKPNSKAS-------LQ 351

Query: 358 EVSKEPVVKSQDGHGVDSRRMVSSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSS 417
           + ++E VV                                           PAE+  RSS
Sbjct: 352 QTNEEKVV-------------------------------------------PAEIYTRSS 368

Query: 418 PSTNVISSS-VSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTV 476
            + N+ SSS + VFTIA+LQQYTNSFSE NF+GEG LGSVYKAELP  KLLAVKKL++  
Sbjct: 369 STKNLKSSSSLRVFTIATLQQYTNSFSEENFVGEGTLGSVYKAELPDRKLLAVKKLNSMA 428

Query: 477 SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAH 536
           +++QT++EFL+L ST+S++RH NIVEL+GYCNEHGQ LLVY++    TL+D LH D+E H
Sbjct: 429 TRQQTEKEFLDLVSTVSKIRHPNIVELLGYCNEHGQRLLVYEFCETGTLNDALHMDDEIH 488

Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
           KK SWN RIR+ALGAARALQYL EVCEP IVH NF+SSNILLDEKL   VSDCGLAPL  
Sbjct: 489 KKLSWNARIRLALGAARALQYLHEVCEPSIVHQNFRSSNILLDEKLAACVSDCGLAPLQS 548

Query: 597 SGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS 656
           S S NELS  LL+  G GAPEFE GSY+C+SDVYS GVVMLELLTGRK YDRSR RGEQS
Sbjct: 549 SSSANELSGRLLSTSGYGAPEFELGSYTCKSDVYSFGVVMLELLTGRKSYDRSRSRGEQS 608

Query: 657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           LVRWAIPRLHDID+L  MVDPSL+G+Y AKSLSRFADII+RCVQWEP FRP MSEIVQDL
Sbjct: 609 LVRWAIPRLHDIDSLCGMVDPSLNGSYPAKSLSRFADIIARCVQWEPEFRPAMSEIVQDL 668

Query: 717 LCMI 720
           L M+
Sbjct: 669 LRML 672

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224078900|ref|XP_002305672.1| predicted protein [Populus trichocarpa] gi|222848636|gb|EEE86183.1| predicted protein [Populus trichocarpa]

 Score =  783 bits (2022), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 402/716 (56%), Positives = 491/716 (68%), Gaps = 80/716 (11%)

Query: 36  LNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLE 95
           +NSLY+S+ +P L  W++ GGDPC D WQGV CV SN+T ++L G+NLGG L    G   
Sbjct: 1   MNSLYVSMEYPNLIGWIALGGDPCLDGWQGVSCVLSNITSLKLNGLNLGGTLNSDFGLFT 60

Query: 96  SVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNG 155
           S++ ID+S+NHIGG IP +LP T+RNFSL+ NQ +G IP++L  LTQLLDLS +NN L G
Sbjct: 61  SIVEIDISDNHIGGDIPLSLPSTMRNFSLARNQFSGRIPDTLYSLTQLLDLSFHNNQLTG 120

Query: 156 GIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLID 215
            IPD F + T LIN DLS NNL+GQLPPS   LSSL +LHLQNN+L+GTL+V++DL L  
Sbjct: 121 EIPDVFPEMTSLINLDLSGNNLSGQLPPSMGILSSLTTLHLQNNRLTGTLDVVQDLPLEY 180

Query: 216 LNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTAIPPSIAPAPTFQAPGDQADA 275
           LN+ENNLFSGPIPEKLL IPNFRKDGNPFNT++I  PP A+ P     P  +AP  QA+ 
Sbjct: 181 LNVENNLFSGPIPEKLLGIPNFRKDGNPFNTSIILSPPPALSPFPGSLPAAEAPWKQANG 240

Query: 276 PSAFEMTNSAKAKKFWTTKRVIWVALSAAAILCALGCSLFMWRYCKTRRVNRDAEKNTGT 335
            SA E     ++K F+T+ RV+W+A++   ++  LG                        
Sbjct: 241 TSASETPKYERSKGFFTSNRVVWIAVTGVVVIIILGS----------------------- 277

Query: 336 YKGHGEKPNYKNSPLQPSGQVEEVSKEPVVKSQDGHGVDSRRMVSSPRPQDEK------- 388
                                   +KE + K QD +G D+RR  + P+ Q E+       
Sbjct: 278 -----------------------FTKESIAKLQDQYGPDNRRQEAYPKAQGEQDMDLKRM 314

Query: 389 -----------------------LPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVISS 425
                                  LP PP  +P  + +   P+     + + S ST  +SS
Sbjct: 315 AAYSKKKMDQGIIMTGVVANFMPLPAPPSSVP-TDNIIANPIG--HTSHKKSHSTETLSS 371

Query: 426 -SVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEE 484
            SV +FTIA+LQ+YT+SFSE NF+GEG LGSVY+AELPGGKLLAVKKL+   S++QTDEE
Sbjct: 372 YSVKIFTIATLQKYTSSFSEENFVGEGTLGSVYRAELPGGKLLAVKKLNGAASKQQTDEE 431

Query: 485 FLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR 544
           FL+L S+IS+L+H NI+E +GYCNEHGQ LLVY Y  N TL+D LH+DEE H+K +WN R
Sbjct: 432 FLQLVSSISKLQHDNILEFVGYCNEHGQRLLVYKYCENGTLYDALHADEEIHRKLTWNAR 491

Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
           IR+ALGAARALQYL EVC+PPIVH NFKSSNILLD+KL+ RVSDCGL+PL  SGS  ELS
Sbjct: 492 IRLALGAARALQYLHEVCQPPIVHWNFKSSNILLDDKLVARVSDCGLSPLKSSGSATELS 551

Query: 605 EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR 664
              LT+HG GAPE E GSY+C SDVYS GVVMLELLTGRK YDRS  RGEQSLVRWAI +
Sbjct: 552 GRFLTSHGYGAPELELGSYTCSSDVYSFGVVMLELLTGRKSYDRSLSRGEQSLVRWAIHQ 611

Query: 665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           LHDIDALSRMVDPSL GAY  KSLSRFADIISRC+Q EP FRPP+SEIVQDLL M+
Sbjct: 612 LHDIDALSRMVDPSLHGAYPVKSLSRFADIISRCIQGEPEFRPPVSEIVQDLLHML 667

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356542131|ref|XP_003539524.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Glycine max]

 Score =  744 bits (1922), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 402/752 (53%), Positives = 506/752 (67%), Gaps = 47/752 (6%)

Query: 14  MALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNV 73
           + + + T  F    TDP DV A+N LY +L  P L  W+S  GDPCG  WQGV C  S +
Sbjct: 24  IIMLICTIQFSVADTDPVDVAAINRLYTALGNPVLPGWVSSAGDPCGQGWQGVQCNGSVI 83

Query: 74  TEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSI 133
            EI L G NLGG L D+LG   S+  I L+NNHIGGSIPS+LPVT+++F LS NQ TGSI
Sbjct: 84  QEIILNGANLGGELGDSLGSFVSIRAIVLNNNHIGGSIPSSLPVTLQHFFLSDNQFTGSI 143

Query: 134 PESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYS 193
           P SLS LT+L D+SLN+N L G +PDAF     LIN DLS NNL+G+LPPS  NLS+L S
Sbjct: 144 PASLSTLTELTDMSLNDNLLTGEVPDAFQSLMQLINLDLSNNNLSGELPPSMENLSALTS 203

Query: 194 LHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFN----TTVI 249
           +HLQNNKLSGTL+VL+DL L DLN+ENN F+GPIP KLLSIP+FRKDGNPFN    +T+ 
Sbjct: 204 VHLQNNKLSGTLDVLQDLPLQDLNVENNQFAGPIPPKLLSIPSFRKDGNPFNLNDNSTIA 263

Query: 250 ALPPTAIPPSIAPAPTF--------QAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVAL 301
              P   P + +P  T         + P      P+A + +NS K+KK   TK+V+W+++
Sbjct: 264 PAHPPHSPVTASPTGTVVSVTPSSGRVPTKPTKGPTAAKESNSGKSKK--NTKKVVWISI 321

Query: 302 SA--AAILCALGCSLFMWRYCKTRRVNRDAEKN-TGTYKGHGEKPNYKNSPLQPSGQVEE 358
           S     I+  LG  LF+ R  +  RVNR ++++  G Y G  + P    + +QP  Q E+
Sbjct: 322 SGILVFIILVLGLLLFVPRCSRRERVNRSSKQHQVGAYGGERQNPRDYGAFVQPPSQTEK 381

Query: 359 VSKEPVVKSQDGHGVDSRRMVSSPRPQDEKLP----LPPLPLPL---------------- 398
           V K  VV+ +  H  ++RR+ + P+PQ E+      +  +P  L                
Sbjct: 382 VPKGAVVRLKGDHQEEARRLRTIPKPQGEQEKDEQRMETIPKLLEHEIDMSSLDVFSMPS 441

Query: 399 ---------VEKVTVKPLAPAEVTRRSSPSTNVISSS-VSVFTIASLQQYTNSFSEGNFI 448
                     E+V V+  +  +    + P  + +  + V  FTIASLQQYTNSFS+ N I
Sbjct: 442 PPPPPPPLPAERVIVESASFHKEANINPPKKSPVPPTFVKTFTIASLQQYTNSFSQDNLI 501

Query: 449 GEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN 508
           G G+LGSVY+AELP GK+LAVKKL   VS  QTD+EFLEL ++I R+RH NIVELIGYC 
Sbjct: 502 GLGMLGSVYRAELPDGKILAVKKLDKRVSDHQTDDEFLELINSIDRIRHPNIVELIGYCA 561

Query: 509 EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVH 568
           EHGQ LL+Y+Y  N +L D LHS +E   + SWN RIR+ALGAAR+L+YL E  +PP+VH
Sbjct: 562 EHGQRLLIYEYCSNGSLQDALHSHDEFKTRLSWNARIRIALGAARSLEYLHEQFQPPVVH 621

Query: 569 GNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSD 628
            NFKS++ILL + + VRVSDCGL+PL+  GS ++LS  LLTA+G GAPEFESG Y+ QSD
Sbjct: 622 RNFKSASILLYDDVSVRVSDCGLSPLITKGSVSQLSGQLLTAYGYGAPEFESGIYTYQSD 681

Query: 629 VYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSL 688
           VYS GVVMLELLTGR+ YDR+RPRGEQ LVRWAIP+LHDIDALS+MVDPSL G Y AKSL
Sbjct: 682 VYSFGVVMLELLTGRQSYDRTRPRGEQFLVRWAIPQLHDIDALSKMVDPSLKGNYPAKSL 741

Query: 689 SRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           S FADIISRCVQ EP FRP MSE+V  L+ MI
Sbjct: 742 SNFADIISRCVQSEPEFRPAMSEVVLYLINMI 773

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356547026|ref|XP_003541919.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Glycine max]

 Score =  744 bits (1920), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 409/761 (53%), Positives = 509/761 (66%), Gaps = 49/761 (6%)

Query: 6   YGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQG 65
           YG  +   + + + T  F    TDP DV A+N LY +L  P L  W+S  GDPCG+ WQG
Sbjct: 16  YGEVLLGFIIMLICTVQFSLADTDPIDVAAINRLYTALGNPVLPGWVSSAGDPCGEGWQG 75

Query: 66  VFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLS 125
           V C  S + EI L G NLGG L D+LG   S+  I L+NNHIGG+IPS+LPVT+++F LS
Sbjct: 76  VQCNGSVIQEIILNGANLGGELGDSLGSFVSIRAIVLNNNHIGGNIPSSLPVTLQHFFLS 135

Query: 126 GNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST 185
            NQ TGSIP SLS LT+L D+SLN N L G IPDAF   T LIN DLS NNL+G+LPPS 
Sbjct: 136 DNQFTGSIPASLSTLTELTDMSLNGNLLTGEIPDAFQSLTQLINLDLSNNNLSGELPPSM 195

Query: 186 RNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFN 245
            NLS+L S+HLQNN LSGTL+VL+ L L DLN+ENN F+GPIP KLLSIP+FRKDGNPFN
Sbjct: 196 ENLSALTSVHLQNNNLSGTLDVLQGLPLQDLNVENNQFAGPIPPKLLSIPSFRKDGNPFN 255

Query: 246 -----TTVIALPPTAIPP--------SIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWT 292
                T   A PP +  P        S+ P+ + + P    + P+A + +NS K+KK   
Sbjct: 256 LNGNSTIAPAHPPRSPVPATPSGTVASVTPS-SGRIPTKPTEGPTAAKESNSEKSKK--N 312

Query: 293 TKRVIWVALSA--AAILCALGCSLFMWRYCKTRRVNRDAEKN-TGTYKGHGEKPNYKNSP 349
           TK+V+W+++S     I+  LG  LF+ R  K   VNR ++++  G Y    + P    + 
Sbjct: 313 TKKVVWISVSGILVFIILVLGLLLFVPRCSKREWVNRSSKQHQVGAYGVERQNPREYGAF 372

Query: 350 LQPSGQVEEVSKEPVVKSQDGHGVDSRRMVSSPRPQDEKLP----LPPLPLPL------- 398
           +QP  Q E+V K  +V+ +  H  ++RR+ + P PQ E+      +  +P  L       
Sbjct: 373 VQPPNQTEKVPKGAIVRPKGDHQEEARRVRAIPNPQGEQEKDEQRMETIPKLLEHEIDMS 432

Query: 399 ------------------VEKVTVKP-LAPAEVTRRSSPSTNVISSSVSVFTIASLQQYT 439
                             VE+V V+P L   E        + V  +    FTIASLQQYT
Sbjct: 433 SLDVFSMPSPPPPPPPLPVERVIVEPTLFHKEANINPPKKSPVPPTFAKTFTIASLQQYT 492

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           NSFS+ N IG G+LGSVY+AELP GK+LAVKKL   VS +QTD+EFLEL ++I R+RH N
Sbjct: 493 NSFSQDNLIGLGMLGSVYRAELPDGKILAVKKLDKRVSDQQTDDEFLELINSIDRIRHPN 552

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IVELIGYC EHGQ LL+Y+Y  N +L D LHSD+E   + SWN RIR+ALGAARAL+YL 
Sbjct: 553 IVELIGYCAEHGQRLLIYEYCSNGSLQDALHSDDEFKTRLSWNARIRIALGAARALEYLH 612

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           E  +P +VH NFKS+NILLD+ + VRVSDCGLAPL+  GS ++LS  LLTA+G GAPEFE
Sbjct: 613 EQFQPSVVHRNFKSANILLDDDVSVRVSDCGLAPLITKGSVSQLSGQLLTAYGYGAPEFE 672

Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
           SG Y+ QSD+YS GVVMLELLTGR+ YDR+RPRGEQ LVRWAIP+LHDIDALS+MVDPSL
Sbjct: 673 SGIYTYQSDIYSFGVVMLELLTGRQSYDRTRPRGEQFLVRWAIPQLHDIDALSKMVDPSL 732

Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
            G Y AKSLS FADIISRCVQ EP FRP MSE+V  L+ MI
Sbjct: 733 KGNYPAKSLSNFADIISRCVQSEPEFRPAMSEVVLYLINMI 773

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449479358|ref|XP_004155578.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Cucumis sativus]

 Score =  740 bits (1910), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/768 (53%), Positives = 514/768 (66%), Gaps = 64/768 (8%)

Query: 1   MGYVNYGMCVGLTMALA-VLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPC 59
           MG  N+ + + + + L  V   PFC G TD RDV A+N+L+ISL +PPL  W+  GGDPC
Sbjct: 1   MGCANWNLLMKILIGLLLVFINPFCFGDTDLRDVAAINALFISLGYPPLRGWILVGGDPC 60

Query: 60  GDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTV 119
           G+ WQGV CVFSN+T ++L+G+NLGG L  +L   ES+I++DLSNNHIGG+IPS LP T+
Sbjct: 61  GEKWQGVECVFSNITSLQLSGLNLGGELGTSLDQFESIISMDLSNNHIGGNIPSTLPPTL 120

Query: 120 RNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG 179
           R+ SLS NQ TGSIP +L+ L QL+DLSLNNN L G IPD F    GL N D+S+NNL+G
Sbjct: 121 RSLSLSANQFTGSIPPALASLAQLMDLSLNNNLLTGAIPDVFQLLNGLNNLDMSSNNLSG 180

Query: 180 QLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRK 239
           QLPPS  +L SL +LHLQNN+LSG L+ L+DL L DLNIENNLFSGPIP KLL IPNFRK
Sbjct: 181 QLPPSVADLLSLTTLHLQNNQLSGLLDPLQDLPLSDLNIENNLFSGPIPAKLLGIPNFRK 240

Query: 240 DGNPFNTTVI------ALPPTAIPPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTT 293
           DGNPFNTT+I      A  P A+ P     PT QA G Q   P   E ++ A++  F++ 
Sbjct: 241 DGNPFNTTIIPSAPALAPSPFAVAPVTVGPPTRQAGGGQPLWPGTPESSDGARS--FFSA 298

Query: 294 KRVIWVALSAAAILCALGCSLFM---WRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNSPL 350
           KR+IW+ +    IL ALG  L +    +  K R+ N+    NT           YK  P+
Sbjct: 299 KRIIWIVIIGTVILVALGFCLLVSICLKRSKRRKDNKIVRDNTDMAS------KYKPKPM 352

Query: 351 QPSGQ---VEEVSKEPVVKSQDGHGVDSRRM-VSSPRPQDEK------------------ 388
           +PS +   +E+  KE  +K  D   +  R M  ++PR  D +                  
Sbjct: 353 KPSVEGVDMEKGPKETTLKPLDRDRMKDRTMDFTTPRLHDRQDTNGKRKDASNTSFRRDH 412

Query: 389 -------------LPLPPLPLPLVEKVTVKPLA---PAEVTRRSSPSTNVISSSVSVFTI 432
                         P PP    L  +   KP+A   P++V R+      + +SS+ VFTI
Sbjct: 413 TESSSISMDDFPPPPPPPPFPLLSTQEIAKPMAAEVPSKVPRK------LKTSSLKVFTI 466

Query: 433 ASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI 492
           ASLQQYTNSFSE N +G G+LGSVY AELP G+LLAVKKL  + S    D++F +L S+I
Sbjct: 467 ASLQQYTNSFSEDNLLGRGMLGSVYSAELPSGRLLAVKKLDGSSSTHWNDDDFHDLVSSI 526

Query: 493 SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
            ++RH NIVEL+GYC EHGQ+LL+Y+Y  N TL+D LH D+E H+K SWN+R+R+ALGAA
Sbjct: 527 CQIRHDNIVELVGYCAEHGQYLLIYEYCKNGTLYDALHVDKEMHQKLSWNVRVRIALGAA 586

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           RAL+YL E C+PPI+H NFKS+NILLD +L  RVSD GLA LL S + +  S   L A G
Sbjct: 587 RALEYLHEACQPPIMHQNFKSANILLDNELKPRVSDSGLARLLPSATQS--SARSLPAQG 644

Query: 613 SGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
             APEFE G+Y+ QSD+YS GVVMLELLTGRK  DRS PRGEQ LVRWA+PRLHDIDALS
Sbjct: 645 YSAPEFELGTYTYQSDLYSFGVVMLELLTGRKSCDRSLPRGEQFLVRWAVPRLHDIDALS 704

Query: 673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           RMVDPSL+G Y AKSLSRFADIIS C+  EP FRPP+SEIVQ+LL M+
Sbjct: 705 RMVDPSLNGMYPAKSLSRFADIISSCIMREPEFRPPISEIVQELLQML 752

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449433876|ref|XP_004134722.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Cucumis sativus]

 Score =  739 bits (1909), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/768 (53%), Positives = 514/768 (66%), Gaps = 64/768 (8%)

Query: 1   MGYVNYGMCVGLTMALA-VLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPC 59
           MG  N+ + + + + L  V   PFC G TD RDV A+N+L+ISL +PPL  W+  GGDPC
Sbjct: 1   MGCANWNLLMKILIGLLLVFINPFCFGDTDLRDVAAINALFISLGYPPLRGWILVGGDPC 60

Query: 60  GDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTV 119
           G+ WQGV CVFSN+T ++L+G+NLGG L  +L   ES+I++DLSNNHIGG+IPS LP T+
Sbjct: 61  GEKWQGVECVFSNITSLQLSGLNLGGELGTSLDQFESIISMDLSNNHIGGNIPSTLPPTL 120

Query: 120 RNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG 179
           R+ SLS NQ TGSIP +L+ L QL+DLSLNNN L G IPD F    GL N D+S+NNL+G
Sbjct: 121 RSLSLSANQFTGSIPPALASLAQLMDLSLNNNLLTGAIPDVFQLLNGLNNLDMSSNNLSG 180

Query: 180 QLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRK 239
           QLPPS  +L SL +LHLQNN+LSG L+ L+DL L DLNIENNLFSGPIP KLL IPNFRK
Sbjct: 181 QLPPSVADLLSLTTLHLQNNQLSGLLDPLQDLPLSDLNIENNLFSGPIPAKLLGIPNFRK 240

Query: 240 DGNPFNTTVI------ALPPTAIPPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTT 293
           DGNPFNTT+I      A  P A+ P     PT QA G Q   P   E ++ A++  F++ 
Sbjct: 241 DGNPFNTTIIPSAPALAPSPFAVAPVTVGPPTRQAGGGQPLWPGTPESSDGARS--FFSA 298

Query: 294 KRVIWVALSAAAILCALGCSLFM---WRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNSPL 350
           KR+IW+ +    IL ALG  L +    +  K R+ N+    NT           YK  P+
Sbjct: 299 KRIIWIVIIGTVILVALGFCLLVSICLKRSKRRKDNKIVRDNTDMAS------KYKPKPM 352

Query: 351 QPSGQ---VEEVSKEPVVKSQDGHGVDSRRM-VSSPRPQDEK------------------ 388
           +PS +   +E+  KE  +K  D   +  R M  ++PR  D +                  
Sbjct: 353 KPSVEGVDMEKGPKETTLKPLDRDRMKDRTMDFTTPRLHDRQDTNGKRKDASNTSFRRDH 412

Query: 389 -------------LPLPPLPLPLVEKVTVKPLA---PAEVTRRSSPSTNVISSSVSVFTI 432
                         P PP    L  +   KP+A   P++V R+      + +SS+ VFTI
Sbjct: 413 TESSSISMDDFPPPPPPPPFPLLSTQEIAKPMAAEVPSKVPRK------LKTSSLKVFTI 466

Query: 433 ASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI 492
           ASLQQYTNSFSE N +G G+LGSVY AELP G+LLAVKKL  + S    D++F +L S+I
Sbjct: 467 ASLQQYTNSFSEDNLLGRGMLGSVYSAELPSGRLLAVKKLDGSSSTHWNDDDFHDLVSSI 526

Query: 493 SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
            ++RH NIVEL+GYC EHGQ+LL+Y+Y  N TL+D LH D+E H+K SWN+R+R+ALGAA
Sbjct: 527 CQIRHDNIVELVGYCAEHGQYLLIYEYCKNGTLYDALHVDKEMHQKLSWNVRVRIALGAA 586

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           RAL+YL E C+PPI+H NFKS+NILLD +L  RVSD GLA LL S + +  S   L A G
Sbjct: 587 RALEYLHEACQPPIMHQNFKSANILLDNELKPRVSDSGLARLLPSATQS--SAPSLPAQG 644

Query: 613 SGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
             APEFE G+Y+ QSD+YS GVVMLELLTGRK  DRS PRGEQ LVRWA+PRLHDIDALS
Sbjct: 645 YSAPEFELGTYTYQSDLYSFGVVMLELLTGRKSCDRSLPRGEQFLVRWAVPRLHDIDALS 704

Query: 673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           RMVDPSL+G Y AKSLSRFADIIS C+  EP FRPP+SEIVQ+LL M+
Sbjct: 705 RMVDPSLNGMYPAKSLSRFADIISSCIMREPEFRPPISEIVQELLQML 752

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255553857|ref|XP_002517969.1| lrr receptor-linked protein kinase, putative [Ricinus communis] gi|223542951|gb|EEF44487.1| lrr receptor-linked protein kinase, putative [Ricinus communis]

 Score =  733 bits (1893), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 398/723 (55%), Positives = 481/723 (66%), Gaps = 72/723 (9%)

Query: 18  VLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIR 77
           + +A    GVT+P DV A+NSLY SL  P L  W++ GGDPCG+ WQGV C  S++T   
Sbjct: 27  IYSATISYGVTNPSDVAAINSLYSSLGSPILPGWVASGGDPCGELWQGVACEASDIT--- 83

Query: 78  LTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESL 137
                                +IDLS+N IGGSIPSNLPVT++NF L+ N  TGSIP+S+
Sbjct: 84  ---------------------SIDLSSNRIGGSIPSNLPVTMQNFFLAANNFTGSIPDSI 122

Query: 138 SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQ 197
           S LT L  +SLNNN L+G IPD+F    GLIN DLS+NN +GQLPPS  NL  L +L LQ
Sbjct: 123 SSLTLLTAMSLNNNFLSGEIPDSFQFLAGLINLDLSSNNFSGQLPPSFENLIHLTTLRLQ 182

Query: 198 NNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTAIP 257
            N+LSGTLNVLEDL L DLNIENNLFSGPIPEKLL+IP+FRKDGNPFN +   LP    P
Sbjct: 183 ENQLSGTLNVLEDLPLKDLNIENNLFSGPIPEKLLAIPDFRKDGNPFNNSTAPLPAPTSP 242

Query: 258 PSIAPAPTF-------------QAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAA 304
            +  PAP               + PG Q D   +    +S+  KKF TTKRV+W++++  
Sbjct: 243 LTPPPAPGLSGAPSSPSSPSSGKTPGKQIDG-PSSPEESSSGEKKFLTTKRVVWISIAGV 301

Query: 305 A--ILCALGCSLFMWRYCKTRRVNRD---AEKNTGTYKGHGEKPNYKNSPLQPSGQVEEV 359
              ++ A+   LFM R C  RR            G  KG+ E P    S  QP+ + E+V
Sbjct: 302 LLFVILAIALVLFMPR-CSRRREEAGRIFKRHQVGADKGNRENPRDHGSLDQPTNETEKV 360

Query: 360 SKEPVVKSQDGHGVDSRRMVSSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSP- 418
           SKE +   ++ H          P+PQ                V V P  P E +    P 
Sbjct: 361 SKEALALPKEDH----------PKPQ---------------TVIVTPTVPTEASTAKPPI 395

Query: 419 -STNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVS 477
            + N ++S+ S FTIASLQQYTNSFS+ N IG G+LG+VY+AELP GKLLAVKKL    S
Sbjct: 396 KAQNPLTSARS-FTIASLQQYTNSFSQENLIGGGMLGNVYRAELPNGKLLAVKKLDQKAS 454

Query: 478 QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHK 537
            +Q D+EF+EL + I R+RH N+VEL+GYC EHGQ LL+Y+Y  N TL D LHSD+E  K
Sbjct: 455 SQQKDDEFIELVNNIDRIRHANVVELMGYCAEHGQRLLIYEYCSNGTLQDALHSDDELKK 514

Query: 538 KFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS 597
           K SWN RIR+ALGAARAL+YL EVC+PP+VH NFKS NILLD+ L VRVSDCGLAPL+ S
Sbjct: 515 KLSWNTRIRMALGAARALEYLHEVCQPPVVHRNFKSVNILLDDDLDVRVSDCGLAPLISS 574

Query: 598 GSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL 657
           GS ++LS  LLTA+G GAPEFESG Y+  SDV+S GVVMLELLTGR  YDR+R R EQ L
Sbjct: 575 GSVSQLSGHLLTAYGYGAPEFESGIYTVHSDVFSFGVVMLELLTGRTSYDRTRTRNEQFL 634

Query: 658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
           VRWAIP+LHDIDALS+MVDPSL+G Y AKSLS FADIISRCVQ +P FRPPMSE+VQDL 
Sbjct: 635 VRWAIPQLHDIDALSKMVDPSLNGEYPAKSLSHFADIISRCVQNQPEFRPPMSEVVQDLT 694

Query: 718 CMI 720
            MI
Sbjct: 695 DMI 697

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449479018|ref|XP_004155482.1| PREDICTED: LOW QUALITY PROTEIN: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Cucumis sativus]

 Score =  730 bits (1884), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 406/772 (52%), Positives = 505/772 (65%), Gaps = 59/772 (7%)

Query: 5   NYGMCVGLTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQ 64
           N  + V + +   V  A    G+T+P D  A++SL+ +L  P L  W   G DPCGD+WQ
Sbjct: 11  NLRIWVQVLVGFVVCAAQVLLGITNPGDFSAISSLHTALGLPSLPGW-GIGQDPCGDAWQ 69

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSL 124
           GV C  S++  I +   NLGG L D LG   S+  IDLSNNHIGGSIPSNLPVT++NF L
Sbjct: 70  GVVCNDSSIIRIIINAANLGGELGDNLGLFSSIQTIDLSNNHIGGSIPSNLPVTLQNFFL 129

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS 184
           S NQ TGSIP SLS LTQL  +SLN+N L+G IPD+F   + L+NFDLS NNL+G LPPS
Sbjct: 130 SANQFTGSIPSSLSSLTQLTAMSLNDNKLSGEIPDSFQVISQLVNFDLSNNNLSGPLPPS 189

Query: 185 TRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPF 244
             NL +L +LHLQNN+LSGTL+VL+DL L DLNIENNLFSGPIPEK+LSIPNFRKDGNPF
Sbjct: 190 VSNLLALTTLHLQNNQLSGTLDVLQDLPLKDLNIENNLFSGPIPEKVLSIPNFRKDGNPF 249

Query: 245 NTTVIALPPTAI-----------------PPSIAPAPTFQAPGDQADAPSAFEMTNSAKA 287
           N++V    P                    P S AP  + Q P  QAD PSA E ++S K 
Sbjct: 250 NSSVSPTSPPVSPSPPSKPAPAPPVSGGPPVSGAPPSSQQRPKKQADGPSASEESSSGKN 309

Query: 288 KKFWTTKRVIWVALSA--AAILCALGCSLFM-WRYCKTRRVNRDAEKNTGTYKGHGEKPN 344
           KK  +TKRV+ + ++   + I+  L C LFM     + R  +       G Y+G  E   
Sbjct: 310 KK--STKRVVLITIAVVLSFIILVLACVLFMPRCRRRRRSDSVSKRHQIGAYRGERENVG 367

Query: 345 YKNSPLQPSGQVEEVSKEPVVKSQDGHGVDSR--------------RMVSSPRPQDEKLP 390
            + +  Q + Q+ +V KEPVV+ +     + +              RM + P+    ++ 
Sbjct: 368 NQGAMPQTNDQIPKVPKEPVVRMKQETQTEVQKVPKDNVEREKNMPRMSAIPKKDHHEVD 427

Query: 391 LPPLPLPL---------------------VEKVTVKPLAPAEVTRRSSPSTNVISSSVSV 429
           +  L + L                     VE+VT  P  PAEV      + N I+   + 
Sbjct: 428 MSTLDVYLMPPPPPPPPPPPPPPPPPPPPVEEVTAVPTVPAEVPPLKPLTKNKITLPFAR 487

Query: 430 -FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLEL 488
            +TIASLQQYTNSFS+ N +GEG+LG+VY+A LP GK+LAVKKL       Q D+EFLEL
Sbjct: 488 PYTIASLQQYTNSFSQENLLGEGMLGNVYRAHLPSGKVLAVKKLDKRAFSLQKDDEFLEL 547

Query: 489 ASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
            + I R+RH N+VEL GYC EHG+ LL+++Y    TL D LHSDEE  KK SWN RIR+A
Sbjct: 548 VNNIDRIRHANVVELSGYCAEHGERLLIFEYCSGGTLQDALHSDEEFRKKLSWNARIRMA 607

Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
           LGAARAL+YL EVC+PP++H NFKS+NILLD+ L VRVSDCGLAPL+  G+ ++LS  LL
Sbjct: 608 LGAARALEYLHEVCQPPVIHRNFKSANILLDDDLSVRVSDCGLAPLISKGAVSQLSGQLL 667

Query: 609 TAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI 668
           TA+G GAPEFESG Y+ +SDVYS GVVMLELLTGR  YDR+R RGEQ LVRWAIP+LHDI
Sbjct: 668 TAYGYGAPEFESGVYTLESDVYSFGVVMLELLTGRMSYDRTRIRGEQFLVRWAIPQLHDI 727

Query: 669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           +AL+ MVDPSL+G Y AKSLS FADIIS+CVQ EP FRPPMS +VQDLL MI
Sbjct: 728 EALTSMVDPSLNGRYPAKSLSYFADIISKCVQSEPEFRPPMSSVVQDLLNMI 779

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356519546|ref|XP_003528433.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Glycine max]

 Score =  717 bits (1852), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/720 (54%), Positives = 490/720 (68%), Gaps = 44/720 (6%)

Query: 12  LTMALAVLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFS 71
             +++ + TA  C G TDP DV A+NSLY++L  PPLE W + GGDPC + W+GV CVFS
Sbjct: 13  FILSMLIFTASLCVGDTDPLDVAAINSLYVALGSPPLEGWKAIGGDPCLEQWEGVSCVFS 72

Query: 72  NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTG 131
           N+T +RL GMNL G L   L D  S+I++DLSNN IGG+IPS L  T+RN SLS N L G
Sbjct: 73  NITALRLGGMNLSGQLGSNL-DFPSIIDMDLSNNQIGGTIPSTLSPTLRNLSLSANHLNG 131

Query: 132 SIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSL 191
           SIP++LS LTQL DLSL +NHLNG IP+ F Q TGL+N DLS NNL+GQLPPS  NLSSL
Sbjct: 132 SIPDALSSLTQLSDLSLKDNHLNGQIPNVFLQLTGLMNMDLSGNNLSGQLPPSMGNLSSL 191

Query: 192 YSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIAL 251
             LHLQNN+LSG L VL+DL L DLNIENN+FSGPIP +LLSIPNFRKDGNPFNTT+I  
Sbjct: 192 IILHLQNNQLSGILFVLQDLPLQDLNIENNIFSGPIPPELLSIPNFRKDGNPFNTTIIPS 251

Query: 252 PPTAI--------PPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSA 303
           PP A          P  +P      P D   AP        A A + + T +++W+  + 
Sbjct: 252 PPAASPEPAAMAPSPEKSPWKVTHNPSDTIKAPIP------AIAGRSFKTTKLVWIVGAG 305

Query: 304 AAILCALGCSLFMWRYCKTRRVNRDAEK-NTGTYKGHGEKPNYKNSPLQPSGQVEEVSKE 362
             I  ALG  L M    K R+ N+  +K NT  Y     K    +SP + +         
Sbjct: 306 FLIFIALGVCLLMLWCFKRRQENKKYKKHNTNVYTRSLHKRTSSDSPFEAT--------- 356

Query: 363 PVVKSQDGHGVDSRRMVSSPRPQDEKLPLPPLPLPLV--EKVTVKPLAPAEVTRRSSPST 420
                      D  +  SS  P  +  P PP  +P++  E + +        T+R     
Sbjct: 357 ----------TDKEKGWSSKLPPLQ--PAPPHHIPIIPGENLIINQAISTTATKR----- 399

Query: 421 NVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQ 480
            ++++S+ V+T+ASLQQYTNSFS+ N+IGEG+LG VY+AELP GKLLAV+KL+ T S  Q
Sbjct: 400 QIVTNSIKVYTVASLQQYTNSFSQENYIGEGMLGPVYRAELPDGKLLAVRKLNATASMGQ 459

Query: 481 TDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFS 540
             E+FL+LA +IS+++H NIV+L+GYC E+ Q LLV++Y  N TLHD LH+D++   K S
Sbjct: 460 NHEQFLQLAFSISKIQHANIVKLMGYCAEYSQRLLVHEYCSNGTLHDALHTDDKLQIKLS 519

Query: 541 WNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST 600
           W+ RI V+LGAARAL+YL E C+PPIVH NF+S+N+LL++ L VRVSDCGL  LL SGS 
Sbjct: 520 WDNRIWVSLGAARALEYLHEHCQPPIVHQNFRSANVLLNDNLEVRVSDCGLGSLLSSGSA 579

Query: 601 NELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW 660
           ++L    LTA+G  APEFE GSY+ QSDV+S GVVMLELLTGRK YD S PRGEQ LVRW
Sbjct: 580 SQLVGCHLTANGYSAPEFEYGSYTLQSDVFSFGVVMLELLTGRKSYDSSLPRGEQFLVRW 639

Query: 661 AIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           A+P+LHDIDALS+MVDPSL+G Y  KSLSRFADIIS C+Q EP FRP MSEIVQDLL M+
Sbjct: 640 AVPQLHDIDALSKMVDPSLNGEYPKKSLSRFADIISSCIQHEPEFRPVMSEIVQDLLRMM 699

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297739262|emb|CBI28913.3| unnamed protein product [Vitis vinifera]

 Score =  710 bits (1833), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 400/754 (53%), Positives = 498/754 (66%), Gaps = 60/754 (7%)

Query: 18  VLTAPFCAGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIR 77
           +  A    G T P DV A+N+LY +L  P L  W+S GGDPC D+WQGV C  S +  I 
Sbjct: 26  IFAAQVLLGYTSPGDVTAINNLYAALGSPLLPGWVSTGGDPCADAWQGVSCNGSEINSII 85

Query: 78  LTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESL 137
           L G NLGG L D+LG   S+  IDLSNN IGGSIPS+LP+T++NF LS NQ TGSIP SL
Sbjct: 86  LNGANLGGELGDSLGTFASIKVIDLSNNQIGGSIPSSLPLTLQNFFLSANQFTGSIPTSL 145

Query: 138 SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQ 197
           S L+ L D+SLNNN L G IPDAF    GLIN DLS+N+L+GQLPPS  NLSSL +L LQ
Sbjct: 146 SSLSLLTDMSLNNNLLTGEIPDAFQALVGLINLDLSSNHLSGQLPPSMENLSSLTTLRLQ 205

Query: 198 NNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTAIP 257
            N+LSGTL+VL+DL L DLN+ENNLFSG IP+KLLSIPNFRKDGNPF      L     P
Sbjct: 206 INQLSGTLDVLQDLPLKDLNVENNLFSGTIPDKLLSIPNFRKDGNPFGNVTAPLLAPTSP 265

Query: 258 PSIAPAPTF--------QAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAI-LC 308
            ++   P          Q P   AD PSA E +NS    K  +TKR++W++++   + + 
Sbjct: 266 LTLPSPPPPLSGPPSSNQPPVKPADGPSATEESNSGGKGKGLSTKRIVWISITVVLVFII 325

Query: 309 ALGCSLFMWRYCKTRRVNRD--AEKN-TGTYKGHGEKPNYKNSPLQPSGQVE-EVSKEPV 364
            +   + + ++C   R   D  +++N TG YKG           L+ +G +E +V KE V
Sbjct: 326 LVLALVLLVKWCCGERQESDWISKRNETGAYKG-------SRLNLRDNGSLEQQVPKEAV 378

Query: 365 VKSQDGHGVDSRRMVSSPRPQDEK-------LPLPP------------------------ 393
              ++ H    RR+  +P+PQ+E+         +P                         
Sbjct: 379 GTPKEEHQEVVRRIGVAPKPQNEQDRNVERMFTIPKQDSHEIDISGLDVMMPPPPPPPPP 438

Query: 394 -----LPLPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSV--FTIASLQQYTNSFSEGN 446
                 P PLVE V V P+ P EV     PS   ++  +S   FTIASLQQYTNSFS+ N
Sbjct: 439 PPPPPPPPPLVETVIVNPIVPVEVNAE-KPSMKTLNPPISARSFTIASLQQYTNSFSQEN 497

Query: 447 FIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
            IG G+LG+VY+A+LPGGKLLAVKKL   +  +Q D+EF +L ++I  +RH N+VEL+GY
Sbjct: 498 LIGSGMLGTVYRAQLPGGKLLAVKKLDKKICNQQKDDEFFDLVNSIDGIRHANVVELMGY 557

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C EHG+ LL+Y+Y  + TLHD LHSD+E  KK SW+ R+R+ALGAARALQYL EVC PPI
Sbjct: 558 CAEHGERLLIYEYCSDGTLHDALHSDDEFKKKLSWSARVRMALGAARALQYLHEVCRPPI 617

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQ 626
           VH NFKS+N+LLD++L VRVSDCGLAPL+   S ++LS G L+A+G  APE ESG Y+ +
Sbjct: 618 VHRNFKSANVLLDDELTVRVSDCGLAPLISRCSVSQLS-GRLSAYGCEAPEHESGIYTLK 676

Query: 627 SDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAK 686
           SDVYS G VMLELLTGRK YD  R RGE+ LVRWAI +LHDIDALSRMVDPSL+G Y AK
Sbjct: 677 SDVYSFGAVMLELLTGRKSYDSKRNRGEKLLVRWAIHQLHDIDALSRMVDPSLNGEYPAK 736

Query: 687 SLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           SLSRFADIISRCVQ EP FRP MSE+V DL+ MI
Sbjct: 737 SLSRFADIISRCVQDEPEFRPQMSEVVDDLIDMI 770

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	720
TAIR|locus:2202084	768	SUB "STRUBBELIG" [Arabidopsis	0.583	0.546	0.504	1.7e-174
TAIR|locus:2125566	776	SRF3 "STRUBBELIG-receptor fami	0.404	0.375	0.694	5e-173
TAIR|locus:2051404	775	SRF1 "STRUBBELIG-receptor fami	0.433	0.402	0.610	1.2e-164
TAIR|locus:2120683	703	SRF8 "STRUBBELIG-receptor fami	0.402	0.412	0.599	6.9e-130
TAIR|locus:2091015	717	SRF7 "STRUBBELIG-receptor fami	0.398	0.400	0.565	4e-123
TAIR|locus:2024837	720	SRF6 "STRUBBELIG-receptor fami	0.398	0.398	0.559	1.7e-122
TAIR|locus:2207280	699	SRF5 "STRUBBELIG-receptor fami	0.394	0.406	0.520	2e-119
TAIR|locus:2089210	687	SRF4 "STRUBBELIG-receptor fami	0.388	0.407	0.5	2.9e-114
TAIR|locus:2170219	735	SRF2 "STRUBBELIG-receptor fami	0.401	0.393	0.491	5.7e-107
TAIR|locus:2051628	1008	PSKR1 "phytosulfokin receptor	0.376	0.268	0.394	4e-59

TAIR|locus:2202084 SUB "STRUBBELIG" [Arabidopsis thaliana (taxid:3702)]

 Score = 1045 (372.9 bits), Expect = 1.7e-174, Sum P(2) = 1.7e-174
 Identities = 225/446 (50%), Positives = 286/446 (64%)

Query:   289 KFWTTKRVIWVALSAAAILCALGCSLFMWRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNS 348
             KFW+T+R+I V  S A I+   G  + +WR C+++  NR     +G  K   ++P +   
Sbjct:   335 KFWSTQRIILVVSSVAIIVLVSGLCVTLWRCCRSKIYNR---YYSGARKDL-QRPYFNKP 390

Query:   349 PLQPSGQXXXXXXXXXXXXQDGHGVDSRRMVSSPRPQD-EXXXXXXXXXXXXXXXXXXXX 407
             P QP+               DG+G   R+    P PQ  E                    
Sbjct:   391 PSQPTPTMGKVSREPMVKPFDGYGAGDRKY-GYPMPQRAEESRRAMPPTSYYNKDVNTPQ 449

Query:   408 APAE-----------VTRRXXXX--XXXXXXXXXXFTIASLQQYTNSFSEGNFIGEGLLG 454
              P +            ++R                FTIASLQQYTN+FSE N IGEG +G
Sbjct:   450 KPLQQPPRQFQSNDTASKRAAHFPPGLNSSSSATVFTIASLQQYTNNFSEENIIGEGSIG 509

Query:   455 SVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL 514
             +VY+AEL  GK LAVKKLSNT+++ Q+D EFL L S + +L+ G+I+EL+GYCNE GQ L
Sbjct:   510 NVYRAELRHGKFLAVKKLSNTINRTQSDGEFLNLVSNVLKLKRGHILELLGYCNEFGQRL 569

Query:   515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSS 574
             LVY+Y  N +L D LH D + HKK +WN+RI +ALGA++ALQ+L EVC+PP+VH NFKSS
Sbjct:   570 LVYEYCPNGSLQDALHLDRKLHKKLTWNVRINIALGASKALQFLHEVCQPPVVHQNFKSS 629

Query:   575 NILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGV 634
              +LLD KL VRV+D GLA +L    T++++       G  APE E GSY+CQSDV+SLGV
Sbjct:   630 KVLLDGKLSVRVADSGLAYMLPPRPTSQMA-------GYAAPEVEYGSYTCQSDVFSLGV 682

Query:   635 VMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADI 694
             VMLELLTGR+P+DR+RPRG Q+L +WAIPRLHDIDAL+RMVDPSL GAY  KSLSRFADI
Sbjct:   683 VMLELLTGRRPFDRTRPRGHQTLAQWAIPRLHDIDALTRMVDPSLHGAYPMKSLSRFADI 742

Query:   695 ISRCVQWEPGFRPPMSEIVQDLLCMI 720
             ISR +Q EPGFRPP+SEIVQDL  MI
Sbjct:   743 ISRSLQMEPGFRPPISEIVQDLQHMI 768

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISS;IDA

GO:0010059 "positive regulation of atrichoblast fate specification" evidence=IMP

GO:0010063 "positive regulation of trichoblast fate specification" evidence=IMP

GO:0048437 "floral organ development" evidence=IEP;IMP

GO:0048481 "ovule development" evidence=IMP

GO:0000902 "cell morphogenesis" evidence=IEP;IMP

GO:0010071 "root meristem specification" evidence=IMP

GO:0048367 "shoot system development" evidence=TAS

GO:0009506 "plasmodesma" evidence=IDA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0042127 "regulation of cell proliferation" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

TAIR|locus:2125566 SRF3 "STRUBBELIG-receptor family 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1037 (370.1 bits), Expect = 5.0e-173, Sum P(3) = 5.0e-173
 Identities = 202/291 (69%), Positives = 233/291 (80%)

Query:   430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
             ++IASLQQYT SF++ N IG G+LGSVY+A LP GKL AVKKL    S++Q D EF+EL 
Sbjct:   473 YSIASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELV 532

Query:   490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
             + I  +RH NIVEL+GYC EH Q LLVY+Y  N TL D LHSD+E  KK SWN R+ +AL
Sbjct:   533 NNIDMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMAL 592

Query:   550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             GAARAL+YL EVCEPPI+H NFKS+N+LLD+ L V VSDCGLAPL+ SGS ++LS  LL 
Sbjct:   593 GAARALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQLLA 652

Query:   610 AHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID 669
             A+G GAPEF+SG Y+ QSDVYS GVVMLELLTGR  YDR R RGEQ LVRWAIP+LHDID
Sbjct:   653 AYGYGAPEFDSGIYTWQSDVYSFGVVMLELLTGRMSYDRDRSRGEQFLVRWAIPQLHDID 712

Query:   670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
             AL +MVDPSL+G Y AKSLS FADIISRCVQ EP FRP MSE+VQDLL MI
Sbjct:   713 ALGKMVDPSLNGQYPAKSLSHFADIISRCVQSEPEFRPLMSEVVQDLLDMI 763

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007623 "circadian rhythm" evidence=IEP

TAIR|locus:2051404 SRF1 "STRUBBELIG-receptor family 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 994 (355.0 bits), Expect = 1.2e-164, Sum P(2) = 1.2e-164
 Identities = 191/313 (61%), Positives = 237/313 (75%)

Query:   409 PAEVT-RRXXXXXXXXXXXXXXFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLL 467
             PAE + +R              FT+ASLQQ+TNSFS  N IG G+LGSVY+AELPGGKL 
Sbjct:   444 PAEASLKRTTSKSHGPLTAVKHFTVASLQQHTNSFSHENLIGTGMLGSVYRAELPGGKLF 503

Query:   468 AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHD 527
             AV+KL       + + +FLEL + I R+RH NIV+L+G+C+EH Q LL+++Y  N TLHD
Sbjct:   504 AVRKLDKKSPNHEEEGKFLELVNNIDRIRHANIVQLVGFCSEHSQRLLIHEYCRNGTLHD 563

Query:   528 LLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVS 587
             LLH D+    + SWN+R+R+AL AA+AL+YL E+C+PP +H NFKS+NILLD+ + V VS
Sbjct:   564 LLHIDDRLKIELSWNVRVRIALEAAKALEYLHEICDPPSIHRNFKSANILLDDDIRVHVS 623

Query:   588 DCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
             DCGLAPL+ SG+ ++LS  LL A+G GAPEFE G Y+ + DVYS GVVMLELLTGRK YD
Sbjct:   624 DCGLAPLISSGAVSQLSGQLLAAYGYGAPEFEYGIYTMKCDVYSFGVVMLELLTGRKSYD 683

Query:   648 RSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP 707
             + R RGEQ LVRWAIP+LHDIDAL++MVDPSL G Y AKSLS FAD+ISRCVQ EP +RP
Sbjct:   684 KKRDRGEQFLVRWAIPQLHDIDALAKMVDPSLKGDYPAKSLSHFADVISRCVQSEPEYRP 743

Query:   708 PMSEIVQDLLCMI 720
              MSE+VQDL  MI
Sbjct:   744 LMSEVVQDLSDMI 756

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2120683 SRF8 "STRUBBELIG-receptor family 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 889 (318.0 bits), Expect = 6.9e-130, Sum P(2) = 6.9e-130
 Identities = 175/292 (59%), Positives = 218/292 (74%)

Query:   430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
             +T++SLQ  TNSFS+ N IGEG LG VY+AE P GK++A+KK+ N     Q ++ FLE  
Sbjct:   383 YTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNFLEAV 442

Query:   490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
             S +SRLRH NIV L GYC EHGQ LLVY+Y GN  L D LH++++     +WN R++VAL
Sbjct:   443 SNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNARVKVAL 502

Query:   550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             G A+AL+YL EVC P IVH NFKS+NILLDE+L   +SD GLA L    +  ++S  ++ 
Sbjct:   503 GTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAALT-PNTERQVSTQVVG 561

Query:   610 AHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI 668
             + G  APEF  SG Y+ +SDVY+ GVVMLELLTGRKP D SR R EQSLVRWA P+LHDI
Sbjct:   562 SFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVRWATPQLHDI 621

Query:   669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
             DALS+MVDPSL+G Y AKSLSRFADII+ C+Q EP FRPPMSE+VQ L+ ++
Sbjct:   622 DALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQLVRLV 673

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009624 "response to nematode" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2091015 SRF7 "STRUBBELIG-receptor family 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 824 (295.1 bits), Expect = 4.0e-123, Sum P(2) = 4.0e-123
 Identities = 165/292 (56%), Positives = 206/292 (70%)

Query:   430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
             +T++ LQ  TNSFS  N +GEG  G VY+A+   GK+LAVKK+ ++     T ++F E+ 
Sbjct:   407 YTVSDLQVATNSFSVDNLLGEGTFGRVYRAQFEDGKVLAVKKIDSSALPTDTADDFTEIV 466

Query:   490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
             S I+ L H N+ +L GYC+EHGQHL+VY++  N +LHD LH  EE  K   WN R+++AL
Sbjct:   467 SKIAHLDHENVTKLDGYCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKPLIWNPRVKIAL 526

Query:   550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             G ARAL+YL EVC P IVH N KS+NILLD +L   +SD GLA  L   + NEL      
Sbjct:   527 GTARALEYLHEVCSPSIVHKNIKSANILLDSELNPHLSDSGLASFL--PTANELLNQ--N 582

Query:   610 AHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI 668
               G  APE   SG YS +SDVYS GVVMLELLTGRKP+D +R R EQSLVRWA P+LHDI
Sbjct:   583 DEGYSAPETSMSGQYSLKSDVYSFGVVMLELLTGRKPFDSTRSRSEQSLVRWATPQLHDI 642

Query:   669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
             DAL +MVDP+L G Y  KSLSRFAD+I+ CVQ EP FRPPMSE+VQ L+ ++
Sbjct:   643 DALGKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVVLV 694

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2024837 SRF6 "STRUBBELIG-receptor family 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 813 (291.2 bits), Expect = 1.7e-122, Sum P(2) = 1.7e-122
 Identities = 164/293 (55%), Positives = 206/293 (70%)

Query:   430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
             +++A LQ  T SFS  N +GEG  G VY+AE   GK+LAVKK+ ++       ++F+E+ 
Sbjct:   404 YSVADLQIATGSFSVDNLLGEGTFGRVYRAEFDDGKVLAVKKIDSSALPHGMTDDFIEMV 463

Query:   490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
             S I+ L H N+ +L+GYC EHGQHL+VY++  N +LHD LH  EE  K   WN R+++AL
Sbjct:   464 SKIANLDHPNVTKLVGYCAEHGQHLVVYEFHKNGSLHDFLHLSEEESKALVWNSRVKIAL 523

Query:   550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             G ARAL+YL EVC P IV  N KS+NILLD +L   +SD GLA  L   + NEL     T
Sbjct:   524 GTARALEYLHEVCSPSIVDKNIKSANILLDSELNPHLSDSGLASFL--PTANELLNQ--T 579

Query:   610 AHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRS-RPRGEQSLVRWAIPRLHD 667
               G  APE   SG YS +SD+YS GVVMLELLTGRKP+D S R R EQSLVRWA P+LHD
Sbjct:   580 DEGYSAPEVSMSGQYSLKSDIYSFGVVMLELLTGRKPFDSSTRSRSEQSLVRWATPQLHD 639

Query:   668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
             IDAL++MVDP+L G Y  KSLSRFAD+I+ CVQ EP FRPPMSE+VQ L+ ++
Sbjct:   640 IDALAKMVDPALKGLYPVKSLSRFADVIALCVQPEPEFRPPMSEVVQALVVLV 692

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2207280 SRF5 "STRUBBELIG-receptor family 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 750 (269.1 bits), Expect = 2.0e-119, Sum P(2) = 2.0e-119
 Identities = 152/292 (52%), Positives = 198/292 (67%)

Query:   430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
             F ++ LQ  T +FS GN +GEG +G VY+A+   G+ LAVKK+ +T+      E    + 
Sbjct:   392 FELSDLQSATANFSPGNLLGEGSIGRVYRAKYSDGRTLAVKKIDSTLFDSGKSEGITPIV 451

Query:   490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
              ++S++RH NI EL+GYC+E G ++LVY+Y  N +LH+ LH  +   K  +WN R+R+AL
Sbjct:   452 MSLSKIRHQNIAELVGYCSEQGHNMLVYEYFRNGSLHEFLHLSDCFSKPLTWNTRVRIAL 511

Query:   550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             G ARA++YL E C P ++H N KSSNILLD  L  R+SD GL+      S N L EG   
Sbjct:   512 GTARAVEYLHEACSPSVMHKNIKSSNILLDADLNPRLSDYGLSKFYLRTSQN-LGEGY-- 568

Query:   610 AHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI 668
                  APE    S Y+ +SDVYS GVVMLELLTGR P+D  +PR E+SLVRWA P+LHDI
Sbjct:   569 ----NAPEARDPSAYTPKSDVYSFGVVMLELLTGRVPFDGEKPRPERSLVRWATPQLHDI 624

Query:   669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
             DALS + DP+L G Y  KSLSRFADII+ CVQ EP FRPPMSE+V+ L+ M+
Sbjct:   625 DALSNIADPALHGLYPPKSLSRFADIIALCVQVEPEFRPPMSEVVEALVRMV 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2089210 SRF4 "STRUBBELIG-receptor family 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 721 (258.9 bits), Expect = 2.9e-114, Sum P(2) = 2.9e-114
 Identities = 144/288 (50%), Positives = 197/288 (68%)

Query:   430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
             F++A LQ   + FS    +GEG +G VYKA+   G+  AVK++ +++  +   EEF  + 
Sbjct:   403 FSLADLQNTASCFSPNRLLGEGTIGRVYKAKFQDGRKFAVKEIDSSLLGKGNPEEFSHIV 462

Query:   490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
             S+IS + H N+ EL+GYC+E G+++LVY+Y  + +LH  LH  ++  K  +WN RIR+AL
Sbjct:   463 SSISSIHHKNMAELVGYCSEQGRNMLVYEYFTSGSLHRFLHLSDDFSKPLTWNTRIRIAL 522

Query:   550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             G A+A++YL E C PP+VH N KSSNILLD +L  R+SD GLA   F   T++ + G+  
Sbjct:   523 GTAKAIEYLHETCSPPLVHKNIKSSNILLDNELNPRLSDYGLAN--FHHRTSQ-NLGV-- 577

Query:   610 AHGSGAPEF-ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI 668
               G  APE  +  +Y+ +SDVYS GVVMLELLTGRKPYD  RP+ EQSLVRWA P+L D+
Sbjct:   578 --GYNAPECTDPSAYTQKSDVYSFGVVMLELLTGRKPYDSGRPKAEQSLVRWAKPQLKDM 635

Query:   669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
             D L  MVDP+L G Y  +S+S FADI+S CV  EPG RPP+S +V+ L
Sbjct:   636 DTLDEMVDPALCGLYAPESVSSFADIVSICVMTEPGLRPPVSNVVEAL 683

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170219 SRF2 "STRUBBELIG-receptor family 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 705 (253.2 bits), Expect = 5.7e-107, Sum P(2) = 5.7e-107
 Identities = 145/295 (49%), Positives = 199/295 (67%)

Query:   430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
             F+ A LQ  TN FSE N +GEG LGSVY+A+LP G+   V+ +  +      +E+F E+ 
Sbjct:   403 FSAAELQLATNCFSEENLLGEGPLGSVYRAKLPDGQFAVVRNIPMSSLSLHEEEQFTEVL 462

Query:   490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
              T S+LRH NIV L+G+C E+G+HLLVY+Y G+ +L++ +H  +E +K  SW +R+R+A+
Sbjct:   463 QTASKLRHPNIVTLLGFCIENGEHLLVYEYVGHLSLYNAMH--DEVYKPLSWGLRLRIAI 520

Query:   550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL--LFSGSTN-ELSEG 606
             G ARAL YL     PPI H + K++NILLDE+L  R++DCGLA L  L S S     SE 
Sbjct:   521 GVARALDYLHSSFCPPIAHSDLKATNILLDEELTPRIADCGLASLRPLTSNSVKLRASEI 580

Query:   607 LLTAHGSGAPEF-ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL 665
              +   G  APE  + GS   +SD Y+LGV++LELLTGRK +D SRPRGEQ LV+WA  RL
Sbjct:   581 AIQNTGYIAPEHGQPGSSGTKSDTYALGVLLLELLTGRKAFDSSRPRGEQLLVKWASTRL 640

Query:   666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
             HD  +L +M+D  + G + ++  S++ADIIS C Q E  FRPP+SEIV+ L  +I
Sbjct:   641 HDRRSLEQMIDGGIAGTFSSRVASQYADIISLCTQAEKEFRPPVSEIVEALTALI 695

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 470 (170.5 bits), Expect = 4.0e-59, Sum P(2) = 4.0e-59
 Identities = 109/276 (39%), Positives = 151/276 (54%)

Query:   439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
             TNSF + N IG G  G VYKA LP GK +A+KKLS    Q   + EF     T+SR +H 
Sbjct:   731 TNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQ--IEREFEAEVETLSRAQHP 788

Query:   499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
             N+V L G+C      LL+Y Y  N +L   LH   +      W  R+R+A GAA+ L YL
Sbjct:   789 NLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLYL 848

Query:   559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF 618
              E C+P I+H + KSSNILLDE     ++D GLA L+    T+ +S  L+   G   PE+
Sbjct:   849 HEGCDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETH-VSTDLVGTLGYIPPEY 907

Query:   619 ESGSYSC-QSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP 677
                S +  + DVYS GVV+LELLT ++P D  +P+G + L+ W +   H+  A S + DP
Sbjct:   908 GQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGCRDLISWVVKMKHESRA-SEVFDP 966

Query:   678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIV 713
              +      K + R  +I   C+   P  RP   ++V
Sbjct:   967 LIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLV 1002

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP;IDA

GO:0009611 "response to wounding" evidence=IGI

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0031347 "regulation of defense response" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8RWZ1	SUB_ARATH	No assigned EC number	0.4961	0.9777	0.9166	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.IV.2305.1 hypothetical protein (697 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	720
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-38
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-36
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-35
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-35
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-32
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-24
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-22
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-19
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-13
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-13
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-11
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-11
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-10
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-09
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-09
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-08
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-08
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-08
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-08
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-08
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-07
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-06
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-06
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-06
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	4e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-06
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-05
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-05
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-05
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-04
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-04
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.001
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.001
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.001
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	0.002
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	0.002
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	0.002
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	0.002
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.002
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	0.002
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.002
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.003
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.003
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.003
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	0.003
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.004

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  141 bits (358), Expect = 7e-38
 Identities = 85/288 (29%), Positives = 134/288 (46%), Gaps = 55/288 (19%)

Query: 448 IGEGLLGSVYKAELPGGKLL-----AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +GEG  G VYK  L G         AVK L    S+ +  EEFLE AS + +L H NIV 
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER-EEFLEEASIMKKLSHPNIVR 65

Query: 503 LIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           L+G C +     +V +Y  GG+  L D L    E   K +    +++AL  A+ ++YL+ 
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGD--LLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLES 120

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------ 614
                 VH +  + N L+ E L+V++SD GL+  ++               G G      
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY-------YRKRGGGKLPIKW 170

Query: 615 -APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL 671
            APE  + G ++ +SDV+S GV++ E+ T G +PY                P + + + L
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVL 214

Query: 672 SRMVDPSLDGAYLAKSL---SRFADIISRCVQWEPGFRPPMSEIVQDL 716
             +     DG  L +         +++ +C  ++P  RP  SE+V+DL
Sbjct: 215 ELLE----DGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  139 bits (353), Expect = 1e-37
 Identities = 75/273 (27%), Positives = 111/273 (40%), Gaps = 62/273 (22%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +GEG  G+VY A     GK +A+K +    S     EE L     + +L H NIV+L G 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL-EELLREIEILKKLNHPNIVKLYGV 59

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
             +     LV +Y    +L DLL  +E    K S +  +R+ L     L+YL       I
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GI 113

Query: 567 VHGNFKSSNILLDEK-LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE--FESGSY 623
           +H + K  NILLD     V+++D GL+  L +   + L   + T     APE     G Y
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLS-KLLTSDKSLLKTIVGTPAYM-APEVLLGKGYY 171

Query: 624 SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAY 683
           S +SD++SLGV++ E                                             
Sbjct: 172 SEKSDIWSLGVILYE--------------------------------------------- 186

Query: 684 LAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
               L    D+I + +Q +P  RP   EI++ L
Sbjct: 187 ----LPELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  136 bits (344), Expect = 5e-36
 Identities = 82/285 (28%), Positives = 131/285 (45%), Gaps = 50/285 (17%)

Query: 448 IGEGLLGSVYKAELPGGK-----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +GEG  G VYK +L G        +AVK L    +  Q  EEFL  A  + +L H N+V+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED-ASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 503 LIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           L+G C E     +V +Y  GG+  L   L    +   K S +  +  AL  AR ++YL+ 
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGD--LLSYLR---KNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL----TAHGSGAP 616
                 +H +  + N L+ E L+V++SD GL+  L+         G L          AP
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-----AP 172

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM 674
           E  + G ++ +SDV+S GV++ E+ T G +PY                P + + + L  +
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLEYL 216

Query: 675 VDPSLDGAYLAKSLS---RFADIISRCVQWEPGFRPPMSEIVQDL 716
                +G  L +  +      D++ +C   +P  RP  SE+V+ L
Sbjct: 217 K----NGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  135 bits (342), Expect = 1e-35
 Identities = 84/287 (29%), Positives = 134/287 (46%), Gaps = 53/287 (18%)

Query: 448 IGEGLLGSVYKAELPGGKLL-----AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +GEG  G VYK  L G         AVK L    S++Q  EEFL  A  + +L H NIV+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI-EEFLREARIMRKLDHPNIVK 65

Query: 503 LIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           L+G C E    ++V +Y  GG+  L D L  +    K+ S +  +  AL  AR ++YL+ 
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGD--LLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES 121

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG------LLTAHGSG 614
                 +H +  + N L+ E L+V++SD GL+  L+     ++  G      +       
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM------- 171

Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
           APE  + G ++ +SDV+S GV++ E+ T G +PY                P + + + L 
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY----------------PGMSNAEVLE 215

Query: 673 RMVDPSLDGAYLAKSLS---RFADIISRCVQWEPGFRPPMSEIVQDL 716
            +      G  L K  +       ++ +C   +P  RP  SE+V+ L
Sbjct: 216 YLK----KGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  135 bits (342), Expect = 1e-35
 Identities = 78/290 (26%), Positives = 120/290 (41%), Gaps = 52/290 (17%)

Query: 448 IGEGLLGSVYKAEL---PGGKLL-AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +GEG  G VYK +L    G     AVK L    S  +  ++FL+ A  + +L H N+V L
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-EEERKDFLKEARVMKKLGHPNVVRL 61

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHS-----DEEAHKKFSWNIRIRVALGAARALQYL 558
           +G C E     LV +Y     L D L               S    +  A+  A+ ++YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---- 614
                   VH +  + N L+ E L+V++SD GL+  ++                 G    
Sbjct: 122 ASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-------RKKTGGKLPI 171

Query: 615 ---APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDID 669
              APE  + G ++ +SDV+S GV++ E+ T G  PY                P L + +
Sbjct: 172 RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY----------------PGLSNEE 215

Query: 670 ALSRMVDPSLDGAYLAKSL---SRFADIISRCVQWEPGFRPPMSEIVQDL 716
            L  +      G  L K         +++  C Q +P  RP  SE+V+ L
Sbjct: 216 VLEYL----RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  124 bits (314), Expect = 5e-32
 Identities = 73/286 (25%), Positives = 114/286 (39%), Gaps = 47/286 (16%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           +     +GEG  G VY A +   GKL+A+K +     ++  +    E+   + +L+H NI
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREI-KILKKLKHPNI 59

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAARALQ 556
           V L     +  +  LV +Y     L DLL       E+  + +   I          AL+
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQI--------LSALE 111

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           YL       IVH + K  NILLDE   V+++D GLA         +L  G       G  
Sbjct: 112 YLHSKG---IVHRDLKPENILLDEDGHVKLADFGLA--------RQLDPGEKLTTFVGTP 160

Query: 615 ---APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
              APE      Y    D++SLGV++ ELLTG+ P+                     ++ 
Sbjct: 161 EYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPG---------------DDQLLEL 205

Query: 671 LSRMVDPSLDGAYLAKSLSR-FADIISRCVQWEPGFRPPMSEIVQD 715
             ++  P          +S    D+I + +  +P  R    E +Q 
Sbjct: 206 FKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  124 bits (313), Expect = 9e-32
 Identities = 79/271 (29%), Positives = 117/271 (43%), Gaps = 23/271 (8%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G+VYKA+  G GK++AVK L     + + D+        + RL H NIV LI  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
             +     LV +Y     L D L          S +   ++AL   R L+YL       I
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN---GI 119

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE--FESGSYS 624
           +H + K  NILLDE  +V+++D GLA  L    ++      +      APE       Y 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 625 CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
            + DV+SLGV++ ELLTG+ P+       +  L+R                    D    
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR-----------RILGPPLEFDEPKW 226

Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           +       D+I +C+  +P  RP   EI+Q 
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEILQH 257

Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 16/206 (7%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG+G  G V   +  G K+ AVK L +  +  Q    FL  AS ++ LRH N+V+L+
Sbjct: 11  GATIGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLL 66

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           G   +     +V +Y    +L D L S   A    +   ++  AL     ++YL+   E 
Sbjct: 67  GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLE---EK 121

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSY 623
             VH +  + N+L+ E L+ +VSD GLA      ++     G L    + APE      +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLA----KEASQGQDSGKLPVKWT-APEALREKKF 176

Query: 624 SCQSDVYSLGVVMLELLT-GRKPYDR 648
           S +SDV+S G+++ E+ + GR PY R
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPR 202

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  101 bits (255), Expect = 4e-24
 Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 46/289 (15%)

Query: 441 SFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTI---SRLR 496
            ++ G  +G G  GSVY A     G+L+AVK +        ++EE   L   I   S L+
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV---ELSGDSEEELEALEREIRILSSLQ 57

Query: 497 HGNIVELIGYC--NEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALG 550
           H NIV   G     E     +  +Y    +L  LL       E   +K++  I       
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI------- 110

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
               L YL       IVH + K +NIL+D   +V+++D G A  L      E  EG  + 
Sbjct: 111 -LEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRL---GDIETGEGTGSV 163

Query: 611 HGS---GAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH 666
            G+    APE   G  Y   +D++SLG  ++E+ TG+ P+      G      + I    
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL---GNPMAALYKIGSSG 220

Query: 667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           +   +           +L++    F   + +C++ +P  RP   E++Q 
Sbjct: 221 EPPEIP---------EHLSEEAKDF---LRKCLRRDPKKRPTADELLQH 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  102 bits (254), Expect = 2e-23
 Identities = 81/288 (28%), Positives = 125/288 (43%), Gaps = 22/288 (7%)

Query: 441 SFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRH-G 498
           S+     +GEG  G VY A     KL+A+K L+    S+ +  E FL     ++ L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L  +  + G   LV +Y    +L DLL          S +  + +      AL+YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGR-KGPLSESEALFILAQILSALEYL 117

Query: 559 QEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPLL-FSGSTNELSEGLLTAHGS--- 613
                  I+H + K  NILLD    +V++ D GLA LL   GST+ +     T+ G+   
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 614 GAPE----FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID 669
            APE          S  SD++SLG+ + ELLTG  P++  +     S     I       
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-LKIILELPTP 233

Query: 670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
           +L+  + PS             +D++ + +  +P  R   S  +   L
Sbjct: 234 SLASPLSPSNPE----LISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 96.0 bits (240), Expect = 4e-22
 Identities = 66/279 (23%), Positives = 121/279 (43%), Gaps = 44/279 (15%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKK--LSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG+G  G VY       GKL  +K+  LSN +S+++ ++   E    + +L H NI++  
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNE-VKILKKLNHPNIIKYY 65

Query: 505 GYCNEHGQHLL-VYDYGGNCTLHDLLHSDEEAHKKFS----WNIRIRVALGAARALQYLQ 559
               E    L  V +Y     L   +   ++  K F      +  +++ L    AL+YL 
Sbjct: 66  E-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLH 120

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---AP 616
                 I+H + K  NI L    +V++ D G++ +L     +   +   T  G+    +P
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----SSTVDLAKTVVGTPYYLSP 172

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
           E  ++  Y+ +SD++SLG V+ EL T + P++         L    I +      +    
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLELA-LKILKGQ-YPPIPSQY 227

Query: 676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
              L             +++S  +Q +P  RP +++I+Q
Sbjct: 228 SSEL------------RNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 95.7 bits (239), Expect = 5e-22
 Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 58/283 (20%)

Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F     IG+G  G VYKA     GK +A+K +    S+ + ++   E+   + + +H NI
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQ-ILKKCKHPNI 59

Query: 501 VELIG--YCNEHGQHLLVYDYGGNCTLHDLL----HSDEEAHKKFSWNIRIRVALGAARA 554
           V+  G     +    ++ +  GG  +L DLL     +  E+   +       V     + 
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGG--SLKDLLKSTNQTLTESQIAY-------VCKELLKG 110

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+YL       I+H + K++NILL     V++ D GL+         +LS+        G
Sbjct: 111 LEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLS--------AQLSDTKARNTMVG 159

Query: 615 -----APEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI 668
                APE  +G  Y  ++D++SLG+  +EL  G+ PY                    ++
Sbjct: 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY-------------------SEL 200

Query: 669 DALSRMVDPSLDGAYLAKSLSR----FADIISRCVQWEPGFRP 707
             +  +   + +G    ++  +    F D + +C+Q  P  RP
Sbjct: 201 PPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 68/273 (24%), Positives = 122/273 (44%), Gaps = 30/273 (10%)

Query: 446 NFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           N IG+G  G V+K       ++ A+K++  +   R+  EE ++ A  +++L    I+   
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAH--KKFSWNIRIRVALGAARALQYLQEVC 562
               + G+  +V +Y  N  LH LL         +   W   I++ LG    L +L    
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLHS-- 119

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF-ESG 621
              I+H + KS N+ LD    V++ D G+A LL        +  ++      +PE  E  
Sbjct: 120 -KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCEDK 176

Query: 622 SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG 681
            Y+ +SDV++LGVV+ E  TG+ P+D      + +L+            + R V P +  
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALIL----------KIIRGVFPPVSQ 223

Query: 682 AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            Y  +     A +I +C+  +   RP   ++++
Sbjct: 224 MYSQQ----LAQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =   99 bits (249), Expect = 1e-21
 Identities = 69/177 (38%), Positives = 95/177 (53%), Gaps = 12/177 (6%)

Query: 63  WQGVFCV-FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVT--- 118
           WQG+ C   S V  I L+G N+ G ++  +  L  +  I+LSNN + G IP ++  T   
Sbjct: 60  WQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSS 119

Query: 119 VRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT 178
           +R  +LS N  TGSIP       + LDLS  NN L+G IP+    F+ L   DL  N L 
Sbjct: 120 LRYLNLSNNNFTGSIPRGSIPNLETLDLS--NNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177

Query: 179 GQLPPSTRNLSSLYSLHLQNNKLSG----TLNVLEDLHLIDLNIENNLFSGPIPEKL 231
           G++P S  NL+SL  L L +N+L G     L  ++ L  I L   NNL SG IP ++
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY-NNL-SGEIPYEI 232

Length = 968

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 25/211 (11%)

Query: 448 IGEGLLGSVYKA--ELPGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IG G  G V +   +LPG K   +A+K L    S +Q  + FL  AS + +  H NI+ L
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIRL 70

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    +++ +Y  N +L   L  ++    KF+    + +  G A  ++YL E+  
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMN- 126

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS------GAPE 617
              VH +  + NIL++  L+ +VSD GL+  L      E SE   T  G        APE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRL------EDSEATYTTKGGKIPIRWTAPE 178

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+VM E+++ G +PY
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPY 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 92.9 bits (231), Expect = 8e-21
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 28/221 (12%)

Query: 448 IGEGLLGSVYKAEL--PGGKL----LAVKKL--SNTVSQRQTDEEFLELASTISRLRHGN 499
           +GEG  G VYK EL  P  +L    +A+K L  +     +Q   EF + A  +S L+H N
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDLQHPN 69

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLL-----HSD-------EEAHKKFSWNIRIRV 547
           IV L+G C +     ++++Y  +  LH+ L     HSD       E        +  + +
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 548 ALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS-TNELSEG 606
           A+  A  ++YL        VH +  + N L+ E L V++SD GL+  ++S       S+ 
Sbjct: 130 AIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 607 LLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           LL            G ++ +SD++S GVV+ E+ + G +PY
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 78/289 (26%), Positives = 126/289 (43%), Gaps = 50/289 (17%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           GN IG G  G VY A  L  G+L+AVK++    +  +T +E  +    +  L+H N+V+ 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRV-ALGAARALQYLQEVC 562
            G      +  +  +Y    TL +LL      H +      IRV  L     L YL    
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLE-----HGRILDEHVIRVYTLQLLEGLAYLHS-- 117

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APEFE 619
              IVH + K +NI LD   ++++ D G A  L + +T  + E + +  G+    APE  
Sbjct: 118 -HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT-TMGEEVQSLAGTPAYMAPEVI 175

Query: 620 SGS----YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI---------PRLH 666
           +G     +   +D++SLG V+LE+ TG++P+        +    + I         P + 
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPW-------SELDNEFQIMFHVGAGHKPPIP 228

Query: 667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           D   LS                    D + RC++ +P  RP  SE++Q 
Sbjct: 229 DSLQLSPEG----------------KDFLDRCLESDPKKRPTASELLQH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 41/277 (14%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG G  G V+       + +A+K +        ++E+F+E A  + +L H  +V+L G C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            E     LV+++  +  L D L +      KFS    + + L     + YL+      ++
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS------GAPE-FES 620
           H +  + N L+ E  +V+VSD G+   +       L +   ++ G+       +PE F  
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFV-------LDDQYTSSTGTKFPVKWSSPEVFSF 175

Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
             YS +SDV+S GV+M E+ + G+ PY+ +R   E          +  I+A  R+  P L
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEV---------VETINAGFRLYKPRL 225

Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
               +        +++  C +  P  RP  S ++  L
Sbjct: 226 ASQSV-------YELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 95.7 bits (238), Expect = 3e-20
 Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 30/201 (14%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP------SNL-- 115
             +F   S++  + L+  N  G +    G + ++  +DLSNN + G IP      S+L  
Sbjct: 111 DDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKV 168

Query: 116 ------------PVTVRN------FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGI 157
                       P ++ N       +L+ NQL G IP  L ++  L  + L  N+L+G I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228

Query: 158 PDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL--NVLEDLHLID 215
           P      T L + DL  NNLTG +P S  NL +L  L L  NKLSG +  ++     LI 
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288

Query: 216 LNIENNLFSGPIPEKLLSIPN 236
           L++ +N  SG IPE ++ + N
Sbjct: 289 LDLSDNSLSGEIPELVIQLQN 309

Length = 968

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 69/280 (24%), Positives = 124/280 (44%), Gaps = 29/280 (10%)

Query: 444 EGNFIGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHG 498
           +G  +G G   S Y+A ++  G L+AVK+++     +  Q +  E   +    ++RL H 
Sbjct: 4   KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           +I+ ++G   E     L  ++    ++  LL      +  F   + I       R L YL
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYL 119

Query: 559 QEVCEPPIVHGNFKSSNILLDEK-LIVRVSDCGLAPLLFSGST--NELSEGLLTAHGSGA 615
            E     I+H + K +N+L+D     +R++D G A  L +  T   E    LL      A
Sbjct: 120 HE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 616 PEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM 674
           PE   G  Y    DV+S+G V++E+ T + P++  +     +L+ + I       ++   
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-FKIASATTAPSIPEH 235

Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           + P L             D+  RC++ +P  RPP  E+++
Sbjct: 236 LSPGL------------RDVTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 91.8 bits (228), Expect = 5e-19
 Identities = 52/154 (33%), Positives = 81/154 (52%), Gaps = 3/154 (1%)

Query: 78  LTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQLTGSIPES 136
           ++  NL G +     D+ S+  + L+ N   G +P S     + N  LS NQ +G++P  
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK 494

Query: 137 LSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHL 196
           L  L++L+ L L+ N L+G IPD       L++ DLS N L+GQ+P S   +  L  L L
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554

Query: 197 QNNKLSGTL--NVLEDLHLIDLNIENNLFSGPIP 228
             N+LSG +  N+     L+ +NI +N   G +P
Sbjct: 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588

Length = 968

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.4 bits (214), Expect = 8e-19
 Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 56/286 (19%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG+G  G VYK  L G   +AVK   +T+       +FL+ A  + +  H NIV+LIG C
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 508 NEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP 565
            +     +V +   GG+  L   L   +           ++++L AA  ++YL+      
Sbjct: 62  VQKQPIYIVMELVPGGS--LLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESKN--- 113

Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS--------GAPE 617
            +H +  + N L+ E  ++++SD G+        + E   G+ T             APE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGM--------SREEEGGIYTVSDGLKQIPIKWTAPE 165

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLVRWAIPRLHDIDA 670
               G Y+ +SDV+S G+++ E  + G  PY      ++R R               I++
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---------------IES 210

Query: 671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
             RM  P L    + +       ++ +C  ++P  RP  SEI  +L
Sbjct: 211 GYRMPAPQLCPEEIYR-------LMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 42/275 (15%)

Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           +  G+ IG G  G VYK   L  G  +A+K++S    + +  +  ++    +  L+H NI
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           V+ IG         ++ +Y  N +L  ++         F  ++         + L YL E
Sbjct: 62  VKYIGSIETSDSLYIILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHE 117

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE 617
                ++H + K++NIL  +  +V+++D G+A  L     N++S+   +  G+    APE
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVATKL-----NDVSKDDASVVGTPYWMAPE 169

Query: 618 FESGSYSCQ-SDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID---ALSR 673
               S +   SD++SLG  ++ELLTG  PY                   +D++   AL R
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPY-------------------YDLNPMAALFR 210

Query: 674 MVDPSLDGAYLAKSLS-RFADIISRCVQWEPGFRP 707
           +V    D   L + +S    D + +C Q +P  RP
Sbjct: 211 IV--QDDHPPLPEGISPELKDFLMQCFQKDPNLRP 243

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 84.6 bits (209), Expect = 4e-18
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 49/281 (17%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IGEG  G+V + E  G K+ AVK +   V    T + FLE  + +++L H N+V L+
Sbjct: 11  GEIIGEGEFGAVLQGEYTGQKV-AVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLL 65

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE- 563
           G    +G ++ V +      L + L +            R R  +   + LQ+  +V E 
Sbjct: 66  GVILHNGLYI-VMELMSKGNLVNFLRT------------RGRALVSVIQLLQFSLDVAEG 112

Query: 564 ------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
                   +VH +  + NIL+ E  + +VSD GLA +   G  N       T     APE
Sbjct: 113 MEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT-----APE 167

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
             +   +S +SDV+S GV++ E+ + GR PY    P+     V+  + + +      RM 
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY----PKMSLKEVKECVEKGY------RME 217

Query: 676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            P  +G       +    +++ C + EP  RP   ++ + L
Sbjct: 218 PP--EGC-----PADVYVLMTSCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 72/282 (25%), Positives = 110/282 (39%), Gaps = 49/282 (17%)

Query: 448 IGEGLLGSVYKA--ELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  GSV K    +  GK +  AVK L          E FL  AS +++L H  IV L
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE-FLREASVMAQLDHPCIVRL 61

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLL--HSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           IG C      +LV +      L   L    +               A   A  + YL+  
Sbjct: 62  IGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK 114

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------- 614
                VH +  + N+LL  +   ++SD G++  L +GS          A  +G       
Sbjct: 115 ---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD------YYRATTAGRWPLKWY 165

Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
           APE    G +S +SDV+S GV + E  + G KPY     +G + +          +++  
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY--GEMKGAEVIAM--------LESGE 215

Query: 673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           R+  P      +         I+  C ++ P  RP  SE+  
Sbjct: 216 RLPRPEECPQEI-------YSIMLSCWKYRPEDRPTFSELES 250

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 38/270 (14%)

Query: 447 FIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIG 505
            +G+G  G VYK    P GK+ A+KK+ +     +  ++ L    T+       +V+  G
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 506 -YCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
            +  E G+  +V +Y  GG  +L DLL    +   K    +   +A    + L YL    
Sbjct: 67  AFYKE-GEISIVLEYMDGG--SLADLL----KKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA---PE-F 618
              I+H + K SN+L++ K  V+++D G++ +L +           T  G+     PE  
Sbjct: 120 H--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN-----TFVGTVTYMSPERI 172

Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
           +  SYS  +D++SLG+ +LE   G+ P+    P G+ S   + +     + A+     PS
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFL---PPGQPSF--FEL-----MQAICDGPPPS 222

Query: 679 L-DGAYLAKSLSRFADIISRCVQWEPGFRP 707
           L    +  +    F D IS C+Q +P  RP
Sbjct: 223 LPAEEFSPE----FRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 68/268 (25%), Positives = 115/268 (42%), Gaps = 35/268 (13%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKL---SNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V K    P GK++AVK +    N   Q+Q   E       + +     IV  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILREL----DILHKCNSPYIVGF 64

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G    +G   +  +Y    +L  +L   +E   +    I  ++A+   + L YL E  +
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGS 622
             I+H + K SNIL++ +  +++ D G++  L     N L++  +      APE  +   
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVSGQL----VNSLAKTFVGTSSYMAPERIQGND 175

Query: 623 YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD---PSL 679
           YS +SD++SLG+ ++EL TGR PY                P     + L  +V+   P L
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYP-----------PENDPPDGIFELLQYIVNEPPPRL 224

Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRP 707
                +     F   ++ C+  +P  RP
Sbjct: 225 PSGKFSPDFQDF---VNLCLIKDPRERP 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 86.4 bits (214), Expect = 2e-17
 Identities = 81/297 (27%), Positives = 137/297 (46%), Gaps = 30/297 (10%)

Query: 423 ISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTD 482
           +S S+++  I S      S  E N I  G  G+ YK +     +  V K  N V+   + 
Sbjct: 679 VSKSITINDILS------SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS 732

Query: 483 EEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWN 542
           E      + + +L+H NIV+LIG C       L+++Y     L ++L +        SW 
Sbjct: 733 E-----IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWE 780

Query: 543 IRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE 602
            R ++A+G A+AL++L   C P +V GN     I++D K    +    L  LL + +   
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCF 839

Query: 603 LSEGLLTAHGSGAPEF-ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA 661
           +S   +      APE  E+   + +SD+Y  G++++ELLTG+ P D +      S+V WA
Sbjct: 840 ISSAYV------APETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWA 892

Query: 662 IPRLHDIDALSRMVDPSLDGAYLA--KSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                D   L   +DPS+ G        +    ++   C   +P  RP  +++++ L
Sbjct: 893 RYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 66/245 (26%), Positives = 109/245 (44%), Gaps = 25/245 (10%)

Query: 445 GNFIGEGLLGSVYKA----ELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
              +G G  G+VYK     E    K+ +A+K L    +  + ++E L+ A  ++ + H +
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-TSPKANKEILDEAYVMASVDHPH 70

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLL--HSDE-EAHKKFSWNIRIRVALGAARALQ 556
           +V L+G C    Q  L+        L D +  H D   +    +W ++I      A+ + 
Sbjct: 71  VVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMS 123

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
           YL+E     +VH +  + N+L+     V+++D GLA LL        +EG        A 
Sbjct: 124 YLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLV----RWAIPRLHDIDA 670
           E      Y+ +SDV+S GV + EL+T G KPY+         L+    R   P +  ID 
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240

Query: 671 LSRMV 675
              +V
Sbjct: 241 YMVLV 245

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 12/203 (5%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+  +  G   +A+K +        ++++F+E A  + +L H N+V+L G C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     +V +Y  N  L + L    E   K      + +      A++YL+       +
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122

Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQ 626
           H +  + N L+ E  +V+VSD GLA  +        S+G         PE F+   +S +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSK 181

Query: 627 SDVYSLGVVMLELLT-GRKPYDR 648
           SDV+S GV+M E+ + G+ PY+R
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 52/292 (17%)

Query: 448 IGEGLLGSVYKA--ELPGGK---LLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIV 501
           +GEG  G V     +  G      +AVK L+ +   Q ++D  F      +  L H NIV
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD--FEREIEILRTLDHENIV 69

Query: 502 ELIGYCNEHGQ--HLLVYDYGGNCTLHDLL--HSDEEAHKKFSWNIRIRVALGAARALQY 557
           +  G C + G     L+ +Y  + +L D L  H D+   K+      +  +    + + Y
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMDY 124

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG--- 614
           L        +H +  + NIL++ + +V++SD GLA +L         +        G   
Sbjct: 125 LGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL------PEDKDYYYVKEPGESP 175

Query: 615 ----APEFESGS-YSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDI 668
               APE    S +S  SDV+S GV + EL T G        P  E   +   I      
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS---PPAEFLRM---IGIAQGQ 229

Query: 669 DALSRMVDPSLDGAYLAKSLSRFA-------DIISRCVQWEPGFRPPMSEIV 713
             ++R+++   +G    + L R         D++  C + EP  RP  ++++
Sbjct: 230 MIVTRLLELLKEG----ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 68/298 (22%), Positives = 120/298 (40%), Gaps = 52/298 (17%)

Query: 442 FSEGNFIGEGLLGSVYKAEL--PGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRH 497
              G  +GEG  GSV + +L    G  L  AVK +   +      EEFL  A+ +    H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 498 GNIVELIGYC------NEHGQHLLVYDYGGNCTLHDLLHSD--EEAHKKFSWNIRIRVAL 549
            N+++LIG C       +  + +++  +  +  LH  L         +K      ++  +
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             A  ++YL        +H +  + N +L E + V V+D GL+  ++SG           
Sbjct: 121 DIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR------Q 171

Query: 610 AHGSGAP----EFESGS---YSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWA 661
              +  P      ES +   Y+ +SDV++ GV M E+ T G+ PY      G ++     
Sbjct: 172 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP-----GVEN----- 221

Query: 662 IPRLHDIDALSRMVDPSLDGAYLAKS---LSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                       + D    G  L +    L    D++  C + +P  RP  +++ + L
Sbjct: 222 ----------HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 31/219 (14%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKL-SNTVSQRQTDEEFLELASTISRLRHG 498
            S      +G G  G V+     G   +AVK L   T+S     E FL+ A  + +LRH 
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP----EAFLQEAQIMKKLRHD 61

Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRI--RVALGAARALQ 556
            +V+L   C+E     +V +Y    +L D L S E    +    + +  ++A G A    
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA---- 117

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           YL+       +H +  + NIL+ E L+ +++D GLA L+      E  E   TA      
Sbjct: 118 YLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI------EDDE--YTAREGAKF 166

Query: 615 -----APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                APE    G ++ +SDV+S G+++ E++T GR PY
Sbjct: 167 PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 73/252 (28%), Positives = 115/252 (45%), Gaps = 27/252 (10%)

Query: 439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTIS 493
                +   +G G+ G+V+K   +P G  +    A+K + +  S RQT +E  +    + 
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMG 64

Query: 494 RLRHGNIVELIGYCNEHGQHL-LVYDYGGNCTLHDLLHSDEEA---HKKFSWNIRIRVAL 549
            L H  IV L+G C   G  L LV       +L D +    ++    +  +W ++I    
Sbjct: 65  SLDHAYIVRLLGICP--GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI---- 118

Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             A+ + YL+E     +VH N  + NILL    IV+++D G+A LL+            T
Sbjct: 119 --AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173

Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLV----RWAIP 663
                A E    G Y+ QSDV+S GV + E+++ G +PY   RP     L+    R A P
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP 233

Query: 664 RLHDIDALSRMV 675
           ++  ID    MV
Sbjct: 234 QICTIDVYMVMV 245

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 77/289 (26%), Positives = 116/289 (40%), Gaps = 52/289 (17%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKL----SNTVSQRQTDEEFLELASTISRL 495
               E + +GEG  GSV K  L    ++   K      N   Q+Q   E LE+  +    
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRE-LEINKSCK-- 57

Query: 496 RHGNIVELIG-YCNEHGQHL-LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
               IV+  G + +E    + +  +Y    +L  +    ++   +    +  ++A    +
Sbjct: 58  -SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL-LTAHG 612
            L YL       I+H + K SNILL  K  V++ D G+     SG   EL   L  T  G
Sbjct: 117 GLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGV-----SG---ELVNSLAGTFTG 165

Query: 613 SG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL---------VR 659
           +    APE  +   YS  SDV+SLG+ +LE+   R P+    P GE  L         V 
Sbjct: 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELLSYIVN 222

Query: 660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSR-FADIISRCVQWEPGFRP 707
              P L D        +P           S  F D I +C++ +P  RP
Sbjct: 223 MPNPELKD--------EPGNG-----IKWSEEFKDFIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 24/219 (10%)

Query: 448 IGEGLLGSVYKAEL--PG---GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +GE   G +YK  L  PG    +L+A+K L + ++  Q   EF + AS ++ L H NIV 
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD-INNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLL-----------HSDEEAHKKFSWNIR--IRVAL 549
           L+G   +     ++++Y     LH+ L            SDE+   K S +    + +A+
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             A  ++YL        VH +  + NIL+ E+L V++SD GL+  ++S     +    L 
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 PE    G +S  SD++S GVV+ E+ + G +PY
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.9 bits (197), Expect = 2e-15
 Identities = 58/175 (33%), Positives = 84/175 (48%), Gaps = 11/175 (6%)

Query: 68  CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN---LPVTVRNFSL 124
           C   N+ ++ L   +L G +  +LG   S+  + L +N   G +PS    LP+ V    +
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL-VYFLDI 435

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS 184
           S N L G I      +  L  LSL  N   GG+PD+F     L N DLS N  +G +P  
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRK 494

Query: 185 TRNLSSLYSLHLQNNKLSGTLNVLEDL----HLIDLNIENNLFSGPIPEKLLSIP 235
             +LS L  L L  NKLSG   + ++L     L+ L++ +N  SG IP     +P
Sbjct: 495 LGSLSELMQLKLSENKLSG--EIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMP 547

Length = 968

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 69/277 (24%), Positives = 127/277 (45%), Gaps = 34/277 (12%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKK---LSNTVSQRQTDEEFLELASTISRLRHGNI 500
           G  +G G  GSVY+   L  G   AVK+     +  + ++  ++  +  + +S+L+H NI
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           V+ +G   E     +  +     +L  LL       KK+       + L   + L  L+ 
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLL-------KKYGSFPEPVIRLYTRQILLGLEY 117

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF-- 618
           + +   VH + K +NIL+D   +V+++D G+A  +   S  +  +G  + +   APE   
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKG--SPYWM-APEVIA 174

Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
           + G Y   +D++SLG  +LE+ TG+ P+ +     E     + I R  ++          
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQL----EGVAAVFKIGRSKELPP-------- 222

Query: 679 LDGAYLAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQ 714
                +   LS  A D I +C+Q +P  RP  +E+++
Sbjct: 223 -----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 38/214 (17%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY- 506
           IG+G  G V   +  G K+ AVK + N      T + FL  AS +++LRH N+V+L+G  
Sbjct: 14  IGKGEFGDVMLGDYRGNKV-AVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP-- 564
             E G   +V +Y    +L D L S            R R  LG    L++  +VCE   
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRS------------RGRSVLGGDCLLKFSLDVCEAME 116

Query: 565 -----PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH---GSGAP 616
                  VH +  + N+L+ E  + +VSD GL        T E S    T        AP
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQDTGKLPVKWTAP 168

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDR 648
           E      +S +SDV+S G+++ E+ + GR PY R
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 29/208 (13%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA----STISRLRHGNIVE 502
           +GEG  G V K      G+++A+KK      + + DE+  + A      + +LRH NIV 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFK----ESEDDEDVKKTALREVKVLRQLRHENIVN 64

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHS-----DEEAHKKFSWNIRIRVALGAARALQY 557
           L       G+  LV++Y    TL +LL +       +A + + W +         +A+ Y
Sbjct: 65  LKEAFRRKGRLYLVFEYVE-RTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAY 115

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
                   I+H + K  NIL+ E  ++++ D G A  L +   + L++ + T     APE
Sbjct: 116 CHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVAT-RWYRAPE 171

Query: 618 FESGS--YSCQSDVYSLGVVMLELLTGR 643
              G   Y    DV+++G +M ELL G 
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 24/219 (10%)

Query: 440 NSFSEGNFIGEGLLGSVYKA--ELPGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRL 495
           +  ++   IG G  G V++   ++PG K   +A+K L    +++Q  ++FL  AS + + 
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-QDFLSEASIMGQF 63

Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            H NI+ L G   +    +++ +Y  N  L   L    +   +FS    + +  G A  +
Sbjct: 64  SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGM 120

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG- 614
           +YL ++     VH +  + NIL++  L  +VSD GL+ +L      +  EG  T  G   
Sbjct: 121 KYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL-----EDDPEGTYTTSGGKI 172

Query: 615 -----APEFES-GSYSCQSDVYSLGVVMLELLT-GRKPY 646
                APE  +   ++  SDV+S G+VM E+++ G +PY
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 38/225 (16%)

Query: 448 IGEGLLGSVYKAEL----PGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +GEG  G V+  E     P     L+AVK L  T +     ++F   A  ++  +H NIV
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKET-ASNDARKDFEREAELLTNFQHENIV 71

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----------EEAHKKFSWNIRIRVALGA 551
           +  G C E    ++V++Y  +  L+  L S           +    + + +  +++A+  
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 552 ARALQYL--QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS-------GSTNE 602
           A  + YL  Q       VH +  + N L+   L+V++ D G++  +++       G T  
Sbjct: 132 ASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT-- 184

Query: 603 LSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
               +L              ++ +SDV+S GVV+ E+ T G++P+
Sbjct: 185 ----MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 78.7 bits (194), Expect = 5e-15
 Identities = 53/160 (33%), Positives = 84/160 (52%), Gaps = 10/160 (6%)

Query: 83  LGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFS---LSGNQLTGSIPESLSR 139
           L G +  ++  L+ +I++DLS+N + G IP  L + ++N     L  N  TG IP +L+ 
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPE-LVIQLQNLEILHLFSNNFTGKIPVALTS 330

Query: 140 LTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNN 199
           L +L  L L +N  +G IP    +   L   DLS NNLTG++P    +  +L+ L L +N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390

Query: 200 KLSG----TLNVLEDLHLIDLNIENNLFSGPIPEKLLSIP 235
            L G    +L     L  + L  ++N FSG +P +   +P
Sbjct: 391 SLEGEIPKSLGACRSLRRVRL--QDNSFSGELPSEFTKLP 428

Length = 968

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.3 bits (185), Expect = 6e-15
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 16/208 (7%)

Query: 448 IGEGLLGSVYKAEL--PGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IG G  G V +  L  PG +   +A+K L +  +++Q   +FL  AS + +  H NI+ L
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHPNIIHL 70

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    +++ ++  N  L   L  ++    +F+    + +  G A  ++YL E+  
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM-- 125

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS---GAPE-FE 619
              VH +  + NIL++  L+ +VSD GL+  L   +++      L         APE   
Sbjct: 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              ++  SDV+S G+VM E+++ G +PY
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPY 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 78.0 bits (192), Expect = 9e-15
 Identities = 58/158 (36%), Positives = 82/158 (51%), Gaps = 4/158 (2%)

Query: 78  LTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPE 135
           L    L G +   LG ++S+  I L  N++ G IP  +    ++ +  L  N LTG IP 
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254

Query: 136 SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLH 195
           SL  L  L  L L  N L+G IP +      LI+ DLS N+L+G++P     L +L  LH
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILH 314

Query: 196 LQNNKLSGTLNV-LEDL-HLIDLNIENNLFSGPIPEKL 231
           L +N  +G + V L  L  L  L + +N FSG IP+ L
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352

Length = 968

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 71/315 (22%)

Query: 445 GNFIGEGLLGSVYKAE------LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-- 496
           G  +GEG  G V KA         G   +AVK L    S      E  +L S  + L+  
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS----SELRDLLSEFNLLKQV 60

Query: 497 -HGNIVELIGYCNEHGQHLLVYDY-----------------------GGNCTLHDLLHSD 532
            H ++++L G C++ G  LL+ +Y                        GN     L + D
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 533 EEAHK-----KFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVS 587
           E A        F+W I        +R +QYL E+    +VH +  + N+L+ E   +++S
Sbjct: 121 ERALTMGDLISFAWQI--------SRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKIS 169

Query: 588 DCGLAPLLFS-GSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKP 645
           D GL+  ++   S  + S+G +              Y+ QSDV+S GV++ E++T G  P
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229

Query: 646 YDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGF 705
           Y    P    +L++             RM  P               +++  C + EP  
Sbjct: 230 YPGIAPERLFNLLKTG----------YRMERPE-------NCSEEMYNLMLTCWKQEPDK 272

Query: 706 RPPMSEIVQDLLCMI 720
           RP  ++I ++L  M+
Sbjct: 273 RPTFADISKELEKMM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 73/286 (25%), Positives = 115/286 (40%), Gaps = 53/286 (18%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG G  G V+   L      +AVK    T+      + FL+ A  + +  H NIV LIG 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C +     +V +          L + E    K      I++   AA  ++YL+       
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRT-EGPRLKV--KELIQMVENAAAGMEYLESKH---C 115

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS--------GAPE- 617
           +H +  + N L+ EK ++++SD G+        + E  +G+  + G          APE 
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGM--------SREEEDGVYASTGGMKQIPVKWTAPEA 167

Query: 618 FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLVRWAIPRLHDIDAL 671
              G YS +SDV+S G+++ E  + G  PY      ++R   EQ  VR   P L      
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPELCPDAVY 226

Query: 672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
             M                      RC +++PG RP  S + Q+L 
Sbjct: 227 RLM---------------------ERCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 62/251 (24%), Positives = 108/251 (43%), Gaps = 48/251 (19%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG G  G+V K    P G ++AVK++ +TV +++     ++L   +       IV+  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 507 C-NEHGQHLLVYDYGGNC------------TLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
              E           G+C              +  ++   ++       I  ++A+   +
Sbjct: 72  LFRE-----------GDCWICMELMDISLDKFYKYVYEVLKSV--IPEEILGKIAVATVK 118

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL YL+E  E  I+H + K SNILLD    +++ D G+     SG   +L + +     +
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGI-----SG---QLVDSIAKTRDA 168

Query: 614 G-----APE----FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ--SLVRWAI 662
           G     APE         Y  +SDV+SLG+ + E+ TG+ PY +     +Q   +V+   
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP 228

Query: 663 PRLHDIDALSR 673
           P L + +    
Sbjct: 229 PILSNSEEREF 239

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 53/290 (18%)

Query: 446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDE------EFLELASTISRLRHGN 499
           + +G G  G VY+           KK S TV+ +   E      EFL+ A+ +  ++H N
Sbjct: 12  HKLGGGQYGEVYEG--------VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 63

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           +V+L+G C       ++ ++     L D L       ++ +  + + +A   + A++YL+
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLE 121

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----- 614
              +   +H +  + N L+ E  +V+V+D GL+ L        ++    TAH        
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFPIK 170

Query: 615 --APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
             APE      +S +SDV++ GV++ E+ T G  PY    P  + S V         ++ 
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----PGIDLSQV------YELLEK 220

Query: 671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
             RM  P            +  +++  C QW P  RP  +EI Q    M 
Sbjct: 221 GYRMERPE-------GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 30/225 (13%)

Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           IG+G  G V++A  PG        ++AVK L    S      +F   A+ ++   H NIV
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDHPNIV 71

Query: 502 ELIGYCNEHGQHLLVYDYGG----------NC--TLHDLLHSDEEAHK------KFSWNI 543
           +L+G C       L+++Y                    L HS   A K        S   
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
           ++ +A   A  + YL    E   VH +  + N L+ E ++V+++D GL+  ++S    + 
Sbjct: 132 QLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 604 SEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           SE          PE      Y+ +SDV++ GVV+ E+ + G +PY
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 59/286 (20%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL---RHGNIVEL 503
           +GEG  GSVYKA     G+++A+K +         +E+  E+   IS L       IV+ 
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVP-------VEEDLQEIIKEISILKQCDSPYIVKY 63

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHS-----DEEAHKKFSWNIRIRVAL-GAARALQY 557
            G   ++    +V +Y G  ++ D++        EE          I   L    + L+Y
Sbjct: 64  YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE---------EIAAILYQTLKGLEY 114

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG--- 614
           L        +H + K+ NILL+E+   +++D G++  L    T      ++   G+    
Sbjct: 115 LHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVI---GTPFWM 166

Query: 615 APEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
           APE   E G Y+ ++D++SLG+  +E+  G+ PY    P        + IP         
Sbjct: 167 APEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHP----MRAIFMIP--------- 212

Query: 673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC 718
               P+L      K    F D + +C+  +P  RP        LL 
Sbjct: 213 NKPPPTLSDP--EKWSPEFNDFVKKCLVKDPEERPS----AIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 68/284 (23%), Positives = 131/284 (46%), Gaps = 47/284 (16%)

Query: 448 IGEGLLGSVYKAEL--PGGKLLAVKKLSNT-----VSQRQTDEEFLELASTIS----RLR 496
           +G G  G VYK      G  LLA+K+++         +R+ D+   ++ S ++    +LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFS----WNIRIRVALGAA 552
           H NIV       E+ +  +V D      L +  +S +E  ++F+    WNI +++ L   
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
            AL+YL +  E  IVH +   +NI+L E   V ++D GLA         +    L +  G
Sbjct: 125 -ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA------KQKQPESKLTSVVG 175

Query: 613 S---GAPEF-ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI 668
           +     PE  ++  Y  ++DV++ G ++ ++ T + P+  +      +++  A      +
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST------NMLSLA---TKIV 226

Query: 669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
           +A+    +P  +G Y         D+I+ C+  +   RP + ++
Sbjct: 227 EAV---YEPLPEGMY----SEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 36/224 (16%)

Query: 444 EGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-------L 495
           +G  IG G  GSVY       G+L+AVK++        + +    +   ++R       L
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 496 RHGNIVELIGYCNEHGQHL---LVYDYGGNC-TLHDLLHSDEEAH-KKFSWNIRIRVALG 550
           +H NIV+ +G  +    HL   L Y  GG+   L +   + EE   + F     +R  L 
Sbjct: 64  QHENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF-----VRQIL- 116

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
             + L YL       I+H + K +NIL+D K  +++SD G++  L     N LS     A
Sbjct: 117 --KGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGA 168

Query: 611 HGS-------GAPEF-ESGSYSCQSDVYSLGVVMLELLTGRKPY 646
             S        APE  +  SY+ ++D++SLG +++E+LTG+ P+
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.9 bits (179), Expect = 3e-13
 Identities = 54/164 (32%), Positives = 78/164 (47%), Gaps = 30/164 (18%)

Query: 28  TDPRDVMALNSLYISLNFPPLEKWLSFG--GDPCGDS---WQGVFCVFSNVTEIRLTGMN 82
           T   +V AL +L  SL  P     L FG  GDPC      W G  C F +          
Sbjct: 369 TLLEEVSALQTLKSSLGLP-----LRFGWNGDPCVPQQHPWSGADCQFDSTK-------- 415

Query: 83  LGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVT--VRNFSLSGNQLTGSIPESLSRL 140
            G    D LG         L N  + G IP+++     +++ +LSGN + G+IP SL  +
Sbjct: 416 -GKWFIDGLG---------LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI 465

Query: 141 TQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS 184
           T L  L L+ N  NG IP++  Q T L   +L+ N+L+G++P +
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509

Length = 623

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 70.3 bits (173), Expect = 3e-13
 Identities = 75/293 (25%), Positives = 116/293 (39%), Gaps = 62/293 (21%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           +     IGEG  G VYKA +   GK +A+KK+      +Q  E  +     +   +H NI
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR---KQNKELIINEILIMKDCKHPNI 77

Query: 501 VELIGYCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRI--RVALGAARAL 555
           V+        G  L +V +Y  GG+ T  D++            N      V     + L
Sbjct: 78  VDYYD-SYLVGDELWVVMEYMDGGSLT--DII-----TQNFVRMNEPQIAYVCREVLQGL 129

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS-- 613
           +YL       ++H + KS NILL +   V+++D G A               LT   S  
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFA-------------AQLTKEKSKR 173

Query: 614 ----G-----APEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAI 662
               G     APE      Y  + D++SLG++ +E+  G  PY R  P R    +    I
Sbjct: 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI 233

Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           P L + +  S                  F D +++C+  +P  RP   E++Q 
Sbjct: 234 PPLKNPEKWS----------------PEFKDFLNKCLVKDPEKRPSAEELLQH 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 45/281 (16%)

Query: 447 FIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
            +G+G  G V+K  L     +AVK     + Q +   +FL  A  + +  H NIV+LIG 
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 507 CNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           C +     +V +   GG+         DE   K+      ++ AL AA  + YL+     
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLE---SK 112

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE 617
             +H +  + N L+ E  ++++SD G+        + +  +G+ ++ G         APE
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGM--------SRQEDDGIYSSSGLKQIPIKWTAPE 164

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
               G YS +SDV+S G+++ E  + G  PY    P       R  + + +      RM 
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFSLGVCPY----PGMTNQQAREQVEKGY------RMS 214

Query: 676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            P        K       ++ RC  ++P  RP  SE+ ++L
Sbjct: 215 CPQ-------KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 21/204 (10%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IGEG  G V+KA +   G+ +A+KK++    +     + L     +   +H  +V+L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 507 CNEHGQHL-LVYDYGGNCTLHDLLHSDE----EAHKKFSWNIRIRVALGAARALQYLQEV 561
              HG    LV +Y  +  L ++L  +E    EA  K              + + Y+   
Sbjct: 68  FP-HGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVK-------SYMRMLLKGVAYMHAN 118

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG 621
               I+H + K +N+L+    +++++D GLA L         S  + T     APE   G
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT-RWYRAPELLYG 174

Query: 622 S--YSCQSDVYSLGVVMLELLTGR 643
           +  Y    D++++G +  ELL G 
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 16/203 (7%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L          E FL+ A  + +LRH  +V L    
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V ++ G  +L D L   +  + K      + +A   A  + Y++ +     +
Sbjct: 71  SEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQ--LVDMAAQIADGMAYIERM---NYI 124

Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ + L+ +++D GLA L+     NE +  +G        APE    G ++
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL+T GR PY
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V+     G   +AVK L   T+S     E FLE A  + +LRH  +V+L   
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
            +E   ++ V +Y    +L D L   E    K    + +   + A  A  Y++ +     
Sbjct: 70  VSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA--YIERM---NY 123

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSY 623
           +H + +S+NIL+ + L+ +++D GLA L+     NE +  +G        APE    G +
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 624 SCQSDVYSLGVVMLELLT-GRKPY 646
           + +SDV+S G+++ EL+T GR PY
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 73/273 (26%), Positives = 116/273 (42%), Gaps = 28/273 (10%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTD-EEFLELASTISRLRHGNIVELIG 505
           IG G    VY A  LP  + +A+K++   + + QT  +E  +    +S+  H N+V+   
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRID--LEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 506 YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP 565
                 +  LV  Y    +L D++ S           I   V     + L+YL    +  
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKS-SYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APEF--ES 620
            +H + K+ NILL E   V+++D G++  L  G      +   T  G+    APE   + 
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT-RKVRKTFVGTPCWMAPEVMEQV 181

Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD 680
             Y  ++D++S G+  +EL TG  PY +  P     L     P             PSL+
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-------------PSLE 228

Query: 681 -GAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
            GA   K    F  +IS C+Q +P  RP   E+
Sbjct: 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 23/213 (10%)

Query: 442 FSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           F+    +G G  G V++        +A+K L +    +Q D  F +    + RLRH +++
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLI 65

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
            L   C+      ++ +     +L   L S E      +  I +  A   A  + YL+E 
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDM--ACQVAEGMAYLEE- 122

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------A 615
                +H +  + NIL+ E L+ +V+D GLA L        + E +  +          A
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARL--------IKEDVYLSSDKKIPYKWTA 172

Query: 616 PEFES-GSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE  S G++S +SDV+S G+++ E+ T G+ PY
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 80/283 (28%), Positives = 128/283 (45%), Gaps = 55/283 (19%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTIS---RLRHGNIVEL 503
           IG G  G+VY A      +++AVKK+S   S +QT+E++ ++   +    +L+H N +E 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMS--YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 504 IG-YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIR-VALGAARALQYLQEV 561
            G Y  EH   L++    G+ +  DLL    E HKK    + I  +  GA + L YL   
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSAS--DLL----EVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE---- 617
               ++H + K+ NILL E   V+++D G      S S +  +   +      APE    
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFG------SASKSSPANSFVGTPYWMAPEVILA 191

Query: 618 FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV-- 675
            + G Y  + DV+SLG+  +E L  RK                  P L +++A+S +   
Sbjct: 192 MDEGQYDGKVDVWSLGITCIE-LAERK------------------PPLFNMNAMSALYHI 232

Query: 676 ----DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                P+L       S   F D    C+Q  P  RP  +E+++
Sbjct: 233 AQNDSPTLQSNEWTDSFRGFVDY---CLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 69.7 bits (170), Expect = 8e-13
 Identities = 77/283 (27%), Positives = 133/283 (46%), Gaps = 57/283 (20%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI---SRLRH 497
           FS+   IG G  G+VY A ++   +++A+KK+S   S +Q++E++ ++   +    +LRH
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 498 GNIVELIG-YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIR-VALGAARAL 555
            N ++  G Y  EH   L++    G+ +  DLL    E HKK    + I  V  GA + L
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSAS--DLL----EVHKKPLQEVEIAAVTHGALQGL 128

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGSTNELSEGLLTA 610
            YL       ++H + K+ NILL E  +V++ D G A ++     F G+   ++  ++ A
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILA 185

Query: 611 HGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
                   + G Y  + DV+SLG+  +EL              E+       P L +++A
Sbjct: 186 -------MDEGQYDGKVDVWSLGITCIEL-------------AERK------PPLFNMNA 219

Query: 671 LSRMV------DPSLDGAYLAKSLSRFADIISRCVQWEPGFRP 707
           +S +        P+L   + ++    F D    C+Q  P  RP
Sbjct: 220 MSALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 71.4 bits (175), Expect = 1e-12
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 5/170 (2%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPV--TVRNFSLSGNQ 128
           +N+T + L+  NL G + + L    ++  + L +N + G IP +L    ++R   L  N 
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415

Query: 129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNL 188
            +G +P   ++L  +  L ++NN+L G I         L    L+ N   G LP S  + 
Sbjct: 416 FSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS- 474

Query: 189 SSLYSLHLQNNKLSGTL-NVLEDL-HLIDLNIENNLFSGPIPEKLLSIPN 236
             L +L L  N+ SG +   L  L  L+ L +  N  SG IP++L S   
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524

Length = 968

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 70/294 (23%), Positives = 127/294 (43%), Gaps = 55/294 (18%)

Query: 442 FSEGNFIGEGLLGSVYKAELPGGKLLAVKKL----SNTVSQRQTDEEFLELASTISRLRH 497
           +++G  +G+G  G+VY      G+L+AVK++    SN ++  +  E+  E    +  L+H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLH-----SDEEAHKKFSWNIRIRVALGAA 552
            NIV+ +G C +            + T+   +      S      +F             
Sbjct: 62  VNIVQYLGTCLD------------DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK 109

Query: 553 RALQ---YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP-LLFSGSTNELSEGLL 608
           + L    YL   C   +VH + K +N++L    I+++ D G A  L + G     S  L 
Sbjct: 110 QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 609 TAHGSG---APEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA-I 662
           + HG+    APE   ESG Y  +SD++S+G  + E+ TG+ P               A +
Sbjct: 167 SMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPP--------------LASM 211

Query: 663 PRLHDIDALS--RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            RL  +  +   R + P L  ++ A +     D ++ C+  +   RP   ++++
Sbjct: 212 DRLAAMFYIGAHRGLMPRLPDSFSAAA----IDFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 17/204 (8%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKL-SNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V++        +AVK L   T+      ++FL  A  + +LRH  +++L   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP----KDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRI--RVALGAARALQYLQEVCEP 564
           C       +V +     +L + L        K    I +  +VA G A    YL+     
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA----YLEA---Q 122

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSY 623
             +H +  + N+L+ E  I +V+D GLA  +      E  EG        APE      +
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAALYNRF 181

Query: 624 SCQSDVYSLGVVMLELLT-GRKPY 646
           S +SDV+S G+++ E++T GR PY
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 31/223 (13%)

Query: 446 NFIGEGLLGSVYKAEL-------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           NF+G G  G VY+           G   +AVK L    +  Q  +EFL+ A  +S   H 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHP 59

Query: 499 NIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKK------FSWNIRIRVALG 550
           NIV+L+G C  +    ++ +   GG     DLL    +A  +       +    + + L 
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGG-----DLLSYLRDARVERFGPPLLTLKELLDICLD 114

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEK-----LIVRVSDCGLAPLLFSGST-NELS 604
            A+   YL+++     +H +  + N L+ EK      +V++ D GLA  ++      +  
Sbjct: 115 VAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171

Query: 605 EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           EGLL            G ++ QSDV+S GV+M E+LT G++PY
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 38/276 (13%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKL-SNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V+     G   +A+K L   ++S     E FL  A+ + +L+H  +V L   
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP----EAFLAEANLMKQLQHPRLVRLYAV 69

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
             +     ++ +Y  N +L D L + E    K + N  I +A   A  + +++       
Sbjct: 70  VTQE-PIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIER---KNY 123

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSY 623
           +H + +++NIL+ E L  +++D GLA L+     NE +  EG        APE    G++
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTF 180

Query: 624 SCQSDVYSLGVVMLELLT-GRKPY-DRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG 681
           + +SDV+S G+++ E++T GR PY   + P   Q+L R             RM  P    
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-----------GYRMPRPDNCP 229

Query: 682 AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
             L        +++  C + +P  RP   E ++ +L
Sbjct: 230 EEL-------YELMRLCWKEKPEERPTF-EYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 63/279 (22%), Positives = 119/279 (42%), Gaps = 32/279 (11%)

Query: 443 SEGNFI---GEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           SE  F+   G G  G V+  +      +A+K ++       ++E+F+E A  + +L H  
Sbjct: 4   SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPK 60

Query: 500 IVELIGYCNEHGQHLLVYDYGGN-CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           +V+L G C +     +V ++  N C L+ L     +   K S ++ + +       ++YL
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLLSMCQDVCEGMEYL 116

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF 618
           +       +H +  + N L+    +V+VSD G+   +        S        S    F
Sbjct: 117 ER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVF 173

Query: 619 ESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP 677
               YS +SDV+S GV+M E+ T G+ P+++        +V   I R        R+  P
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK---SNYEVVE-MISRGF------RLYRP 223

Query: 678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            L    + +       ++  C   +P  RP  +E+++ +
Sbjct: 224 KLASMTVYE-------VMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 24/219 (10%)

Query: 448 IGEGLLGSVYKAEL----PG--GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +GE   G VYK  L    PG   + +A+K L +   +    EEF   A   SRL+H NIV
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIV 71

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLL-----HSD---EEAHKKFSWNIR----IRVAL 549
            L+G   +     +++ Y  +  LH+ L     HSD    +  K     +     + +  
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             A  +++L       +VH +  + N+L+ +KL V++SD GL   +++    +L    L 
Sbjct: 132 QIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                +PE    G +S  SD++S GVV+ E+ + G +PY
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G+G  G V+     G   +A+K L   T+S     E FL+ A  + +LRH  +V+L   
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
            +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     
Sbjct: 70  VSEEPIYI-VTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERM---NY 123

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSY 623
           VH + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G +
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 624 SCQSDVYSLGVVMLELLT-GRKPY 646
           + +SDV+S G+++ EL T GR PY
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 76/287 (26%), Positives = 122/287 (42%), Gaps = 60/287 (20%)

Query: 447 FIGEGLLGSVYKAE-LPGGKLLAVKK--LSNTVSQRQTDEEFLE---LASTISRLRHGNI 500
            +G+G  GSVYK + L   +  A+K+  L + +SQ++ ++   E   LAS    + H NI
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGS-MSQKEREDAVNEIRILAS----VNHPNI 61

Query: 501 VELIGYCNEH---GQHL-LVYDYGGNCTLHDLLHSDEEAHKKFS----WNIRIRVALGAA 552
              I Y  E    G  L +V +Y     L   +   ++  K       W I I++  G  
Sbjct: 62  ---ISY-KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG-- 115

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
                LQ + E  I+H + KS+NILL    +V++ D G++ +L             T  G
Sbjct: 116 -----LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-------TQIG 163

Query: 613 S---GAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYD-RSRPRGEQSLVRWAIPRLHD 667
           +    APE   G  YS +SD++SLG ++ E+ T   P++ RS       + R   P +  
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI-- 221

Query: 668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                    P +    L          I   +Q +P  RP   +I+ 
Sbjct: 222 ---------PPIYSQDLQN-------FIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 62/215 (28%), Positives = 93/215 (43%), Gaps = 41/215 (19%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-------LRHGN 499
           IGEG  G VYKA     G+L+A+KK+          E F     T  R       LRH N
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME----NEKEGF---PITAIREIKLLQKLRHPN 59

Query: 500 IVELIGYCNEH--GQHLLVYDYGGNCTLHDL---LHSDE----EAHKKFSWNIRIRVALG 550
           IV L         G   +V++Y      HDL   L S E    E+  K            
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEY----MDHDLTGLLDSPEVKFTESQIKC-------YMKQ 108

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
               LQYL       I+H + K SNIL++   +++++D GLA      ++ + +  ++T 
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT- 164

Query: 611 HGSGAPEFESGS--YSCQSDVYSLGVVMLELLTGR 643
                PE   G+  Y  + D++S+G ++ EL  G+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 41/216 (18%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTIS---RLRHGNIVEL 503
           IG G  G+VY A ++   +++A+KK+S   S +Q++E++ ++   +    +LRH N +E 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 504 IG-YCNEHGQHLLVYDYGGNC--TLHDLLHSDEEAHKKFSWNIRIR-VALGAARALQYLQ 559
            G Y  EH    LV +Y   C  +  D+L    E HKK    + I  +  GA + L YL 
Sbjct: 81  KGCYLREH-TAWLVMEY---CLGSASDIL----EVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGSTNELSEGLLTAHGSG 614
                  +H + K+ NILL E   V+++D G A L+     F G+   +           
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWM----------- 178

Query: 615 APE----FESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           APE     + G Y  + DV+SLG+  +EL   + P 
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)

Query: 446 NFIGEGLLGSVYKAEL--PGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
             IG+G  G VY   L    G+ +  AVK L N ++  +  E+FL+    +    H N++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 502 ELIGYC-NEHGQHLLVYDYGGNCTLH-DLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
            L+G C    G  L+V  Y      H DL +         +    I   L  A+ ++YL 
Sbjct: 60  SLLGICLPSEGSPLVVLPY----MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL- 114

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAP 616
                  VH +  + N +LDE   V+V+D GLA  ++     S +  +   L        
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++  ++ +SDV+S GV++ EL+T G  PY
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 69.5 bits (170), Expect = 4e-12
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 19/133 (14%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRNFS 123
               S + +++L+   L G + D L   + ++++DLS+N + G IP   S +PV +    
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV-LSQLD 553

Query: 124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLI----------NFDLS 173
           LS NQL+G IP++L  +  L+ +++++NHL+G +P      TG            N DL 
Sbjct: 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP-----STGAFLAINASAVAGNIDLC 608

Query: 174 ANNLTGQLPPSTR 186
             + T  LPP  R
Sbjct: 609 GGDTTSGLPPCKR 621

Length = 968

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 43/290 (14%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLL---AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           G  +GEG  GSV + +L     +   AVK +   +  R   E+FL  A  +    H N++
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 502 ELIGYCNEHGQH------LLVYDYGGNCTLHD-LLHSDEEAHKKF-SWNIRIRVALGAAR 553
            LIG C +  +       +++  +  +  LH  LL+S      ++    + ++     A 
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
            ++YL        +H +  + N +L+E + V V+D GL+  +++G  +   +G +     
Sbjct: 124 GMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG--DYYRQGRIAKMPV 178

Query: 614 GAPEFESGS---YSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHD-I 668
                ES +   Y+ +SDV+S GV M E+ T G+ PY    P  E S        ++D +
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY----PGVENS-------EIYDYL 227

Query: 669 DALSRMVDPS--LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
              +R+  P   LDG Y          ++S C    P  RP    +  +L
Sbjct: 228 RQGNRLKQPPDCLDGLY---------SLMSSCWLLNPKDRPSFETLRCEL 268

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V   +  G   +A+K +        +++EF+E A  + +L H  +V+L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     +V +Y  N  L + L    E  K+F  +  + +       + YL+       +
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFI 122

Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS------GAPE-FES 620
           H +  + N L+D++  V+VSD GL       S   L +   ++ GS        PE    
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGL-------SRYVLDDEYTSSVGSKFPVRWSPPEVLLY 175

Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPYDR 648
             +S +SDV++ GV+M E+ + G+ PY+R
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 69.5 bits (170), Expect = 5e-12
 Identities = 57/184 (30%), Positives = 80/184 (43%), Gaps = 33/184 (17%)

Query: 82  NLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL----PVTVRNFSLSGNQLTGSIPESL 137
           N  G +   L  L  +  + L +N   G IP NL     +TV    LS N LTG IPE L
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV--LDLSTNNLTGEIPEGL 376

Query: 138 ---SRLTQLLDLS---------------------LNNNHLNGGIPDAFHQFTGLINF-DL 172
                L +L+  S                     L +N  +G +P  F +   L+ F D+
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLP-LVYFLDI 435

Query: 173 SANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL-NVLEDLHLIDLNIENNLFSGPIPEKL 231
           S NNL G++     ++ SL  L L  NK  G L +      L +L++  N FSG +P KL
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKL 495

Query: 232 LSIP 235
            S+ 
Sbjct: 496 GSLS 499

Length = 968

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 66.4 bits (163), Expect = 7e-12
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 38/212 (17%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA----STISRLRHGNIVE 502
           +GEG  G VYKA +   G+++A+KK    +     +E     A    S +  L+H NIV+
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKK----IRLDNEEEGIPSTALREISLLKELKHPNIVK 62

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHS-----DEEAHKKFSWNIRIRVALGAARALQY 557
           L+   +   +  LV++Y  +  L   L            K   + +     L   R L Y
Sbjct: 63  LLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQL-----L---RGLAY 113

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG--- 614
                   I+H + K  NIL++   +++++D GLA   F       +  ++T        
Sbjct: 114 CHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLRTYTHEVVT-----LWY 164

Query: 615 -APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
            APE    S  YS   D++S+G +  E++TG+
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 66.7 bits (162), Expect = 7e-12
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 57/295 (19%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI---SRLRH 497
           F++   IG G  G+VY A ++   +++A+KK+S   S +Q++E++ ++   +    R++H
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 498 GNIVELIG-YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIR-VALGAARAL 555
            N +E  G Y  EH   L++    G+ +  DLL    E HKK    + I  +  GA + L
Sbjct: 85  PNSIEYKGCYLREHTAWLVMEYCLGSAS--DLL----EVHKKPLQEVEIAAITHGALQGL 138

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGSTNELSEGLLTA 610
            YL       ++H + K+ NILL E   V+++D G A +      F G+   ++  ++ A
Sbjct: 139 AYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILA 195

Query: 611 HGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
                   + G Y  + DV+SLG+  +EL   + P                   L +++A
Sbjct: 196 -------MDEGQYDGKVDVWSLGITCIELAERKPP-------------------LFNMNA 229

Query: 671 LSRMV------DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM 719
           +S +        P+L     +     F D    C+Q  P  RP   E+++ +  +
Sbjct: 230 MSALYHIAQNESPTLQSNEWSDYFRNFVD---SCLQKIPQDRPTSEELLKHMFVL 281

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 68.7 bits (168), Expect = 8e-12
 Identities = 37/116 (31%), Positives = 56/116 (48%), Gaps = 2/116 (1%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVR--NFSLSGNQ 128
             +  + L+     G +   LG L  ++ + LS N + G IP  L    +  +  LS NQ
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534

Query: 129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS 184
           L+G IP S S +  L  L L+ N L+G IP        L+  ++S N+L G LP +
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590

Length = 968

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 74/285 (25%), Positives = 116/285 (40%), Gaps = 40/285 (14%)

Query: 448 IGEGLLGSVYKAELPGG------KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G V+ A+  G        L+ VK L           EF        +L H N+V
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKAL-QKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLH------SDEEAHKKFSWNIRIRVALGA--AR 553
            L+G C E   H ++ +Y     L DL        S +E  K    + + +VAL    A 
Sbjct: 72  RLLGLCREAEPHYMILEY---TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
            + +L        VH +  + N L+  +  V+VS   L+  +++    +L   L+     
Sbjct: 129 GMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185

Query: 614 GAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL 671
            APE  +   +S +SDV+S GV+M E+ T G  P+                  L D + L
Sbjct: 186 -APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF----------------YGLSDEEVL 228

Query: 672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           +R+    L+        SR   +++RC    P  RP  SE+V  L
Sbjct: 229 NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 31/222 (13%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKK--LSNTVSQRQTD------EEFLELASTISRL 495
           G  IG+G  G VY A  +  G+++AVK+  L  T++ R         +       T+  L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            H NIV+ +G+        +  +Y    ++   L +    + +F   +           L
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGL 121

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL---LFSGSTNELSEGLLTAHG 612
            YL       I+H + K+ N+L+D   I ++SD G++     ++    N      ++  G
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN------MSMQG 172

Query: 613 S---GAPEF---ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
           S    APE     S  YS + D++SLG V+LE+  GR+P+  
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 26/215 (12%)

Query: 448 IGEGLLGSVYKA---ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           +G G  G+V K         K +AVK L N  +     +E L  A+ + +L +  IV +I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           G C E    +LV +      L+  L  ++   +K    +  +V++G    ++YL+   E 
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLE---ET 114

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE 617
             VH +  + N+LL  +   ++SD GL+  L +       E    A   G       APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA------DENYYKAKTHGKWPVKWYAPE 168

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSR 650
                 +S +SDV+S GV+M E  + G+KPY   +
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 56/193 (29%), Positives = 94/193 (48%), Gaps = 23/193 (11%)

Query: 464 GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-HGQHLLVYDYGGN 522
           GK   +KKL+   + R+  +   + A  +S+L+H NIV    Y     G+  L+Y   G 
Sbjct: 25  GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV---AYRESWEGEDGLLYIVMGF 81

Query: 523 CTLHDLLHSDEEAHKKF-------SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSN 575
           C   DL H  +E   K         W ++I      A ALQYL E     I+H + K+ N
Sbjct: 82  CEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLHE---KHILHRDLKTQN 132

Query: 576 ILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGV 634
           + L    I++V D G+A +L   +  +++  L+      +PE F +  Y+ +SDV++LG 
Sbjct: 133 VFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGC 190

Query: 635 VMLELLTGRKPYD 647
            + E+ T +  ++
Sbjct: 191 CVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 17/204 (8%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V+         +AVK L   T+S     + FLE A+ +  L+H  +V L   
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV----QAFLEEANLMKTLQHDKLVRLYAV 69

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
             +     ++ +Y    +L D L SDE         I     +  A  + Y++       
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE---RKNY 124

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSY 623
           +H + +++N+L+ E L+ +++D GLA ++     NE +  EG        APE    GS+
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSF 181

Query: 624 SCQSDVYSLGVVMLELLT-GRKPY 646
           + +SDV+S G+++ E++T G+ PY
Sbjct: 182 TIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 32/220 (14%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G+G  G V   ++   GK+ A KKL     +++  E+       I        +  + Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 507 CNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC- 562
             E    L LV     GG+   H + +  E                  ARA+ Y  ++  
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYH-IYNVGEPG-------------FPEARAIFYAAQIIC 106

Query: 563 ------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
                 +  IV+ + K  N+LLD+   VR+SD GLA  L  G   +   G     G  AP
Sbjct: 107 GLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG---TPGYMAP 163

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ 655
           E  +   Y    D ++LG  + E++ GR P+   R R E+
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSPF---RQRKEK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 26/218 (11%)

Query: 448 IGEGLLGSVYKAEL-PGGKLLAVKKLSNT--VSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG+G  G V   +     K+ A+K ++    V +        E    +  L H  +V L 
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNER-RILQELNHPFLVNLW 66

Query: 505 GYCNEHGQHL-LVYDY--GGNCTLH--DLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
            Y  +  +++ LV D   GG+   H    +   EE  K +   I          AL+YL 
Sbjct: 67  -YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI--------VLALEYLH 117

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-F 618
                 I+H + K  NILLDE+  V ++D  +A  +   + + L+       G  APE  
Sbjct: 118 S---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVL 171

Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYD-RSRPRGEQ 655
               YS   D +SLGV   E L G++PY   SR   +Q
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 27/225 (12%)

Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G           +AVK L +  +++   +   E+       +
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C + G   ++ +Y     L + L +      ++S++I             
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 545 IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS-GSTNE 602
           +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  + +     +
Sbjct: 140 VSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 603 LSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
            + G L              Y+ QSDV+S GV+M E+ T G  PY
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 77/312 (24%), Positives = 128/312 (41%), Gaps = 72/312 (23%)

Query: 445 GNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL--- 495
           G  +GEG  G V KAE            +AVK L +      T+++  +L S +  +   
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMI 72

Query: 496 -RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------------DEEAHKKFSWN 542
            +H NI+ L+G C + G   +V +Y  +  L D L +                 +  +  
Sbjct: 73  GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 543 IRIRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----F 596
             +  A   AR +++L  + C    +H +  + N+L+ E  +++++D GLA  +     +
Sbjct: 133 DLVSFAYQVARGMEFLASKKC----IHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188

Query: 597 SGSTNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGE 654
             +TN    G L      APE      Y+ QSDV+S GV++ E+ T G  PY    P   
Sbjct: 189 RKTTN----GRLPVKWM-APEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY----P--- 236

Query: 655 QSLVRWAIPRLHDIDAL----SRMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPP 708
                  IP + ++  L     RM  P       Y          ++  C    P  RP 
Sbjct: 237 ------GIP-VEELFKLLKEGYRMEKPQNCTQELYH---------LMRDCWHEVPSQRPT 280

Query: 709 MSEIVQDLLCMI 720
             ++V+DL  M+
Sbjct: 281 FKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 68/288 (23%), Positives = 121/288 (42%), Gaps = 57/288 (19%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V K   +P G ++AVK++  TV+ ++     ++L  ++  +     V   G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRI------RVALGAARALQYLQE 560
               G   +  +             D+   K +   + I      ++A+   +AL+YL  
Sbjct: 69  LFREGDVWICMEVMDTSL-------DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA----- 615
                ++H + K SN+L++    V++ D G+     SG    L + +     +G      
Sbjct: 122 KLS--VIHRDVKPSNVLINRNGQVKLCDFGI-----SG---YLVDSVAKTIDAGCKPYMA 171

Query: 616 -----PEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
                PE     Y  +SDV+SLG+ M+EL TGR PYD  +   +Q               
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ--------------- 216

Query: 671 LSRMVD---PSLDGAYLAKSLS-RFADIISRCVQWEPGFRPPMSEIVQ 714
           L ++V+   P L     A+  S  F D +++C++     RP   E++Q
Sbjct: 217 LKQVVEEPSPQLP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 105/395 (26%), Positives = 153/395 (38%), Gaps = 95/395 (24%)

Query: 347 NSPLQ-PSGQVEEVSKEPVVKSQDGHGVDSRRMVSSPRPQDEKLPLP--------PLPLP 397
             P+Q P G     +     KS+       RR     RP D  LPLP        PLPLP
Sbjct: 1   MKPIQPPPGVPLPSTARHTTKSR------PRR-----RP-DLTLPLPQRDPSLAVPLPLP 48

Query: 398 LVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSE---GNFIGEGLLG 454
                             SS S++  SSS S     S      S SE    N IG G  G
Sbjct: 49  P----------------PSSSSSSSSSSSAS----GSAPSAAKSLSELERVNRIGSGAGG 88

Query: 455 SVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR---HGNIVELIGYCNEH 510
           +VYK    P G+L A+K +         D    ++   I  LR   H N+V+     + +
Sbjct: 89  TVYKVIHRPTGRLYALKVIYGN----HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144

Query: 511 G--QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVH 568
           G  Q LL +  GG+     +      A           VA      + YL       IVH
Sbjct: 145 GEIQVLLEFMDGGSLEGTHIADEQFLAD----------VARQILSGIAYLHR---RHIVH 191

Query: 569 GNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA---PE-----FES 620
            + K SN+L++    V+++D G++ +L      +  +   ++ G+ A   PE        
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRIL-----AQTMDPCNSSVGTIAYMSPERINTDLNH 246

Query: 621 GSYS-CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
           G+Y     D++SLGV +LE   GR P+   R +G+ + +  AI           M  P  
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWASLMCAIC----------MSQPP- 294

Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                A +   F   IS C+Q EP  R    +++Q
Sbjct: 295 --EAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 17/219 (7%)

Query: 442 FSEGNFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH 497
           F+ G  +G+G  GSV +A+L       + +AVK L   +      EEFL  A+ +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 498 GNIVELIG---YCNEHGQ---HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVAL 549
            N+++LIG        G+    +++  +  +  LH  L       + F+  ++  +R  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS-TNELSEGLL 608
             A  ++YL        +H +  + N +L+E + V V+D GL+  ++SG    +     L
Sbjct: 121 DIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 609 TAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                         Y+  SDV++ GV M E++T G+ PY
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 70/282 (24%), Positives = 123/282 (43%), Gaps = 55/282 (19%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKL-----SNTVSQRQTDEEFLELASTISRLRHGNIV 501
           IG G  G+VY+   +P G+++A+K +      + VS  Q +   L      S+LR     
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALL------SQLRQSQPP 62

Query: 502 ELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            +  Y   +G +L      ++ +Y    ++  L+ +   A K  S  + IR  L    AL
Sbjct: 63  NITKY---YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS--VIIREVL---VAL 114

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG- 614
           +Y+ +V    ++H + K++NIL+     V++ D G+A LL   S+        T  G+  
Sbjct: 115 KYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS-----TFVGTPY 166

Query: 615 --APEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
             APE   E   Y  ++D++SLG+ + E+ TG  PY               +     +  
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-------------VDAFRAMML 213

Query: 671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
           + +   P L+    +K L  F   ++ C+  EP  R    E+
Sbjct: 214 IPKSKPPRLEDNGYSKLLREF---VAACLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 24/211 (11%)

Query: 448 IGEGLLGSVY--KAELPGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IG G  G V   + +LPG +   +A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPNIIHL 70

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +Y  N +L   L   +    +F+    + +  G A  ++YL ++  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM-- 125

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------APE 617
              VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G        APE
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKIPIRWTAPE 179

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+VM E+++ G +PY
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 70/278 (25%), Positives = 115/278 (41%), Gaps = 32/278 (11%)

Query: 448 IGEGLLGSVYKAEL--PGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G+G  G V + E    GGK++  AVK L +       D+ FL+ A+ +  L H N++ L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-FLKEAAIMHSLDHENLIRL 61

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G    H   ++V +     +L D L  D   H  F  +     A+  A  ++YL+    
Sbjct: 62  YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGH--FLISTLCDYAVQIANGMRYLE---S 115

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN-ELSEGLLTAHGSGAPE-FESG 621
              +H +  + NILL     V++ D GL   L     +  + E L       APE   + 
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 622 SYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRMVDPSL 679
           ++S  SDV+  GV + E+ T G +P+  +   G Q         L  ID    R+  P  
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPW--AGLSGSQI--------LKKIDKEGERLERPE- 224

Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
                        +++ +C    P  RP  + + + L 
Sbjct: 225 ------ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.9 bits (156), Expect = 5e-11
 Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 35/276 (12%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG--NIVELI 504
           IG G  G VYK      G ++AVK++  T ++ +     ++L   +    H    IV+  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL--DVVLKSHDCPYIVKCY 80

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY        +  +    C L  LL   +        +I  ++ +   +AL YL+E  + 
Sbjct: 81  GYFITDSDVFICMELMSTC-LDKLL---KRIQGPIPEDILGKMTVAIVKALHYLKE--KH 134

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG--LLTAHGSGAPEFESGS 622
            ++H + K SNILLD    V++ D G++  L        S G     A     P   +  
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPK 194

Query: 623 YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD---PSL 679
           Y  ++DV+SLG+ ++EL TG+ PY   +                + + L++++    PSL
Sbjct: 195 YDIRADVWSLGISLVELATGQFPYKNCKT---------------EFEVLTKILQEEPPSL 239

Query: 680 DGAYLAKSLSR-FADIISRCVQWEPGFRPPMSEIVQ 714
                 +  S  F   +  C+  +   RP   E++Q
Sbjct: 240 PP---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 70/247 (28%), Positives = 113/247 (45%), Gaps = 35/247 (14%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVK---KLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G+VYK   +P G+ + +    K+ N  +  + + EF++ A  ++ + H ++V L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEE---AHKKFSWNIRIRVALGAARALQYLQE 560
           +G C      L+       C L D +H  ++   +    +W ++I      A+ + YL+ 
Sbjct: 75  LGVCLSPTIQLVTQLMPHGCLL-DYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE- 126

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP---- 616
             E  +VH +  + N+L+     V+++D GLA LL      E  E    A G   P    
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL------EGDEKEYNADGGKMPIKWM 178

Query: 617 EFESGSY---SCQSDVYSLGVVMLELLT-GRKPYD----RSRPRGEQSLVRWAIPRLHDI 668
             E   Y   + QSDV+S GV + EL+T G KPYD    R  P   +   R   P +  I
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTI 238

Query: 669 DALSRMV 675
           D    MV
Sbjct: 239 DVYMVMV 245

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 78/275 (28%), Positives = 127/275 (46%), Gaps = 53/275 (19%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVK--KLSNTVS-QRQTDEEFLEL-----ASTISRLRHG 498
           +G G  G+VYKA  L   ++LAVK   L  TV  Q+Q   E LE+     +  I      
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE-LEILYKCDSPYIIGFYGA 67

Query: 499 NIVE-LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
             VE  I  C E       +  GG+           + ++K   ++  R+A+   + L Y
Sbjct: 68  FFVENRISICTE-------FMDGGSL----------DVYRKIPEHVLGRIAVAVVKGLTY 110

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L  +    I+H + K SN+L++ +  V++ D G++  L     N +++  +  +   APE
Sbjct: 111 LWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPE 163

Query: 618 FESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
             SG  Y   SDV+SLG+  +EL  GR PY + + + + SL+         +  L  +VD
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ-KNQGSLM--------PLQLLQCIVD 214

Query: 677 ---PSL-DGAYLAKSLSRFADIISRCVQWEPGFRP 707
              P L  G +  K    F   I++C++ +P  RP
Sbjct: 215 EDPPVLPVGQFSEK----FVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 33/222 (14%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISRLR 496
           F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ + 
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVD 67

Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEE---AHKKFSWNIRIRVALGAAR 553
           + ++  L+G C      L+       C L D +   ++   +    +W ++I      A+
Sbjct: 68  NPHVCRLLGICLTSTVQLITQLMPFGCLL-DYVREHKDNIGSQYLLNWCVQI------AK 120

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
            + YL+E     +VH +  + N+L+     V+++D GLA LL +       E    A G 
Sbjct: 121 GMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA------DEKEYHAEGG 171

Query: 614 GAP----EFES---GSYSCQSDVYSLGVVMLELLT-GRKPYD 647
             P      ES     Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 73/293 (24%), Positives = 122/293 (41%), Gaps = 52/293 (17%)

Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G V  +E+    G   + VK+L    S ++ +E FL+       L+H NI++ +
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNE-FLQQGDPYRILQHPNILQCL 61

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLH--SDEEAHKKFSWNIRI-RVALGAARALQYLQEV 561
           G C E   +LLV++Y   C L DL    S E+ H++ S  + + R+A   A  + ++ + 
Sbjct: 62  GQCVEAIPYLLVFEY---CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE---- 617
                +H +    N  L   L V+V D G+ P  +     E  +         APE    
Sbjct: 119 ---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 618 FESGSYSCQ----SDVYSLGVVMLELL-TGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
           F  G  + +    S+V++LGV + EL     +PY                  L D + L+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPY----------------SHLSDREVLN 219

Query: 673 --------RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
                   ++  P L+  Y      R+ +++  C  W    +   +E V  LL
Sbjct: 220 HVIKDQQVKLFKPQLELPY----SERWYEVLQFC--WLSPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 20/213 (9%)

Query: 446 NFIGEGLLGSVYKA-ELPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVEL 503
             IG+G  G+V K      GK+L  K++    +++++  +   E+ + +  L+H NIV  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV-NILRELKHPNIVRY 64

Query: 504 IGYCNEHGQHLL--VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ-- 559
                +     L  V +Y     L  L+   ++  K        R+      AL      
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K +NI LD    V++ D GLA +L   S+             G P + 
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-------FAKTYVGTPYYM 177

Query: 620 S------GSYSCQSDVYSLGVVMLELLTGRKPY 646
           S       SY  +SD++SLG ++ EL     P+
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 75/289 (25%), Positives = 125/289 (43%), Gaps = 52/289 (17%)

Query: 448 IGEGLLGSVYKA-ELPGGK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  G+VYK   +P G+     +A+K L    S +  ++E L+ A  ++ +    +  
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGVGSPYVCR 73

Query: 503 LIGYCNEHGQHLLVYDYGGNCTL-HDLLHSDEEAHKKF-SWNIRIRVALGAARALQYLQE 560
           L+G C      L+       C L +   + D    +   +W ++I      A+ + YL+E
Sbjct: 74  LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP---- 616
           V    +VH +  + N+L+     V+++D GLA LL      ++ E    A G   P    
Sbjct: 128 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLL------DIDETEYHADGGKVPIKWM 178

Query: 617 EFES---GSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
             ES     ++ QSDV+S GV + EL+T G KPYD    R         IP L  ++   
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDL--LEKGE 228

Query: 673 RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM 719
           R+  P +     Y+         I+ +C   +   RP   E+V +   M
Sbjct: 229 RLPQPPICTIDVYM---------IMVKCWMIDSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 76/291 (26%), Positives = 116/291 (39%), Gaps = 47/291 (16%)

Query: 448 IGEGLLGSVYKAELPGGKLLA---VKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G V   E   G   A   VK+L  + +  +    FL+       L H N+++ +
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL-FLQEVQPYRELNHPNVLQCL 61

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDL---LHSDEEAHKKFSW-NIRIRVALGAARALQYLQE 560
           G C E   +LLV ++   C L DL   L S+     + +  ++  R+A   A  L +L +
Sbjct: 62  GQCIESIPYLLVLEF---CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF-- 618
                 +H +    N  L   L V++ D GLA   +        +         APE   
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 619 ESGS------YSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL 671
             G        + +S+++SLGV M EL T   +PY                P L D   L
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY----------------PDLSDEQVL 219

Query: 672 SRMV---DPSLDGAYLAKSLS-RFADIISRCVQW-EPGFRPPMSEIVQDLL 717
            ++V   D  L    L    S R+ +++  C  W +P  RP   E V +LL
Sbjct: 220 KQVVREQDIKLPKPQLDLKYSDRWYEVMQFC--WLDPETRPTAEE-VHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 33/228 (14%)

Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRL- 495
           G  +GEG  G V +AE  G           +AVK L +      TD++  +L S +  + 
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----TDKDLADLISEMELMK 72

Query: 496 ---RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR-------- 544
              +H NI+ L+G C + G   ++ +Y     L + L +       ++++I         
Sbjct: 73  LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132

Query: 545 ----IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS-GS 599
               +  A   AR ++YL+       +H +  + N+L+ E  +++++D GLA  +     
Sbjct: 133 FKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189

Query: 600 TNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
             + S G L              Y+ QSDV+S G++M E+ T G  PY
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 45/297 (15%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GK-----LLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N+ S G  +G G  G V +A   G  K      +AVK L  T    + +    EL   +S
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSEL-KIMS 93

Query: 494 RL-RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
            L  H NIV L+G C   G  L++ +Y     L + L    +     +    +  +   A
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVA 151

Query: 553 RALQYLQ-EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG--LLT 609
           + + +L  + C    +H +  + N+LL    IV++ D GLA  + + S N + +G   L 
Sbjct: 152 KGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDS-NYVVKGNARLP 206

Query: 610 AHGSGAPE--FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLH 666
                APE  F    Y+ +SDV+S G+++ E+ + G  PY                    
Sbjct: 207 VKWM-APESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYP------------------- 245

Query: 667 DIDALSRMVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
            +   S+      +G  +A+   + +   DI+  C   +P  RP   +IVQ +   +
Sbjct: 246 GMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 448 IGEGLLGSVYKAEL----PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IGEG  G   KA L      GK   +K+++ +    +  EE  +  + +S ++H NIV+ 
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDE----EAHKKFSWNIRIRVALGAARALQYLQ 559
                E+G   +V DY     L+  +++         +   W ++I +AL         +
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL---------K 115

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF- 618
            V +  I+H + KS NI L +   +++ D G+A +L   ST EL+   +      +PE  
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSPEIC 173

Query: 619 ESGSYSCQSDVYSLGVVMLELLT 641
           E+  Y+ +SD+++LG V+ E+ T
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 16/214 (7%)

Query: 445 GNFIGEGLLGSVYKA----ELPGG-KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
            + + EG  G ++      E PG  + + VK + +  S+ Q     L+ +  +  L H N
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLSHQN 69

Query: 500 IVELIGYCNE-HGQHLLVYDYGGNCTLHDLL----HSDEEAHKKFSWNIRIRVALGAARA 554
           I+ ++  C E      ++Y Y     L   L      +    +  S    + +A+  A  
Sbjct: 70  ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL +     ++H +  + N ++DE+L V+++D  L+  LF    + L +         
Sbjct: 130 MSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186

Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           A E   +  YS  SDV+S GV++ EL+T G+ PY
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 5e-10
 Identities = 73/295 (24%), Positives = 119/295 (40%), Gaps = 57/295 (19%)

Query: 448 IGEGLLGSVY----KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY    K  + G      A+K ++   S R+   EFL  AS +      ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER-IEFLNEASVMKEFNCHHVV 72

Query: 502 ELIGYCNEHGQH-LLVYDYGGNCTLHDLLHS---DEE---------AHKKFSWNIRIRVA 548
            L+G  +  GQ  L+V +      L   L S   + E           K       I   
Sbjct: 73  RLLGVVST-GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI--- 128

Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGL 607
              A  + YL        VH +  + N ++ E L V++ D G+   ++ +    +  +GL
Sbjct: 129 ---ADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182

Query: 608 LTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRL 665
           L      APE  + G ++ +SDV+S GVV+ E+ T   +PY        Q L        
Sbjct: 183 LPVRWM-APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--------QGLSN------ 227

Query: 666 HDIDALSRMVDPSLDGAYLAKSL---SRFADIISRCVQWEPGFRPPMSEIVQDLL 717
              + + + V   +DG +L        +  +++  C Q+ P  RP   EIV  L 
Sbjct: 228 ---EEVLKFV---IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 33/228 (14%)

Query: 445 GNFIGEGLLGSVYKAELPG------GKL--LAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G       ++  +AVK L +  +++   +   E+       +
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C + G   ++ +Y     L + L +      ++ +N              
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGS 599
           +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +     +  +
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 600 TNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           TN    G L              Y+ QSDV+S GV++ E+ T G  PY
Sbjct: 200 TN----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.9 bits (145), Expect = 7e-10
 Identities = 65/254 (25%), Positives = 108/254 (42%), Gaps = 48/254 (18%)

Query: 477 SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAH 536
           S R   E F E AS +S+L H ++V   G C    + ++V +Y    +L   L  ++   
Sbjct: 38  SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL- 96

Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL----DEKL----IVRVSD 588
              SW  ++ VA   A AL +L+   +  + HGN  + N+LL    D K      +++SD
Sbjct: 97  INISW--KLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151

Query: 589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTG-RKP 645
            G++  +         E LL       PE      + S  +D +S G  + E+ +G  KP
Sbjct: 152 PGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205

Query: 646 ---YDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWE 702
               D  +             +L   +   R   P       A   +  A++I++C+ +E
Sbjct: 206 LSALDSQK-------------KLQFYE--DRHQLP-------APKWTELANLINQCMDYE 243

Query: 703 PGFRPPMSEIVQDL 716
           P FRP    I++DL
Sbjct: 244 PDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 80/299 (26%), Positives = 117/299 (39%), Gaps = 55/299 (18%)

Query: 439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR- 496
           T  F     IGEG  G VYKA     G+L+A+K +         ++E  E+    + LR 
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------EDEEEEIKEEYNILRK 58

Query: 497 ---HGNIVELIG------YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRV 547
              H NI    G            Q  LV +  G  ++ DL+    +  K+        +
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 548 ALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS--GSTNELSE 605
                R L YL E     ++H + K  NILL +   V++ D G++  L S  G  N    
Sbjct: 119 LRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN---- 171

Query: 606 GLLTAHGSG---APEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQ 655
              T  G+    APE  +       SY  +SDV+SLG+  +EL  G+ P     P R   
Sbjct: 172 ---TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF 228

Query: 656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            + R   P L   +  S+                 F D IS C+      RP M E+++
Sbjct: 229 KIPRNPPPTLKSPENWSKK----------------FNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 60.0 bits (145), Expect = 8e-10
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 26/219 (11%)

Query: 448 IGEGLLGSVYKAE----LPGGK--LLAVKKLSN-TVSQRQTDEEFLELASTISRLRHGNI 500
           +GEG  G V+ AE    LP     L+AVK L   + S RQ   +F   A  ++ L+H +I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ---DFQREAELLTVLQHQHI 69

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHS-----------DEEAHKKFSWNIRIRVAL 549
           V   G C E    L+V++Y  +  L+  L S           ++ A  + +    + +A 
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             A  + YL  +     VH +  + N L+ + L+V++ D G++  ++S     +    + 
Sbjct: 130 QIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 PE      ++ +SD++S GVV+ E+ T G++P+
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 25/219 (11%)

Query: 446 NFIGEGLLGSVYKAELP--GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVE 502
           + IGEG  G V +A +   G K+ A  K+    +      +F      + +L  H NI+ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKF----------SWNIRIRVALG 550
           L+G C   G   +  +Y     L D L      E    F          +    ++ A  
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE--GLL 608
            A  +QYL E      +H +  + N+L+ E L  +++D GL+     G    + +  G L
Sbjct: 128 VATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYVKKTMGRL 180

Query: 609 TAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                         Y+ +SDV+S GV++ E+++ G  PY
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 17/214 (7%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHGNIVELIG 505
           +G+G  G V   ++   GKL A KKL+   + +R+  E  +     ++++    IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 506 YCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           Y  +    L LV     GG+   H  +++ +E +  F      R     A+ +  L+ + 
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYH--IYNVDEENPGFP---EPRACFYTAQIISGLEHLH 114

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG- 621
           +  I++ + K  N+LLD    VR+SD GLA  L  G +   ++G     G  APE   G 
Sbjct: 115 QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGE 172

Query: 622 SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ 655
            Y    D ++LGV + E++  R P+   R RGE+
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPF---RARGEK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 32/226 (14%)

Query: 448 IGEGLLGSVYKAELPG---------------GKLLAVKKLSNTVSQRQTDEEFLELASTI 492
           +GEG  G V+  E  G                 L+AVK L   V++   ++ FL+    +
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND-FLKEIKIM 71

Query: 493 SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF---------SWNI 543
           SRL++ NI+ L+G C       ++ +Y  N  L+  L S  E    F         S   
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL-SQREIESTFTHANNIPSVSIAN 130

Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
            + +A+  A  ++YL  +     VH +  + N L+     ++++D G++  L+SG    +
Sbjct: 131 LLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 604 S-EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLEL--LTGRKPY 646
               +L            G ++  SDV++ GV + E+  L   +PY
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 16/203 (7%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+ A       +AVK +        + E FL  A+ +  L+H  +V+L    
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  ++    +L D L SDE + +     I     +  A  + ++++      +
Sbjct: 71  TKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQ---RNYI 124

Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+   L+ +++D GLA ++     NE +  EG        APE    GS++
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFT 181

Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G++++E++T GR PY
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)

Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +GEG  G V+ AE           L+AVK L +     + D  F   A  ++ L+H +IV
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--FHREAELLTNLQHEHIV 70

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLH---------SDEEAHKKFSWNIRIRVALGAA 552
           +  G C E    ++V++Y  +  L+  L          ++     + + +  + +A   A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + YL        VH +  + N L+ E L+V++ D G++  ++S     +    +    
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              PE      ++ +SDV+SLGVV+ E+ T G++P+
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 52/210 (24%), Positives = 100/210 (47%), Gaps = 24/210 (11%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IGEG  G +Y A+     +   +K++  T    +  E   +    +++++H NIV     
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAH-------KKFSWNIRIRVALGAARALQYLQ 559
             E+G+  +V +Y   C   DL+              +  SW ++I  +LG       L+
Sbjct: 68  FQENGRLFIVMEY---CDGGDLMKRINRQRGVLFSEDQILSWFVQI--SLG-------LK 115

Query: 560 EVCEPPIVHGNFKSSNILLDEK-LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF 618
            + +  I+H + KS NI L +  ++ ++ D G+A  L    + EL+   +      +PE 
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSPEI 173

Query: 619 -ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
            ++  Y+ ++D++SLG V+ EL T + P++
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 26/211 (12%)

Query: 448 IGEGLLGSVYKA--ELPGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G + +   +LP  +   +A+  L    S +Q    FL  A T+ +  H NIV L
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQFDHSNIVRL 71

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G        ++V +Y  N  L   L   E    +      + +  G A  ++YL E+  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM-- 126

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS------GAPE 617
              VH    +  +L++  L+ ++S  G   L       + SE + T           APE
Sbjct: 127 -GYVHKGLAAHKVLVNSDLVCKIS--GFRRL-----QEDKSEAIYTTMSGKSPVLWAAPE 178

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
             +   +S  SDV+S G+VM E+++ G +PY
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 41/245 (16%)

Query: 482 DEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSW 541
              F E AS +S+L H ++V+L G C     +++V +Y     L   LH  E+ +    W
Sbjct: 45  SLAFFETASLMSQLSHKHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHR-EKNNVSLHW 102

Query: 542 NIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-------KLIVRVSDCGLAPL 594
             ++ VA   A AL YL++     +VHGN    NIL+            +++SD G+   
Sbjct: 103 --KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157

Query: 595 LFSGSTNELSEGLLTAHGSGAPEF---ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
           + S          +      APE       S +  +D +S G  +LE+ +  +    +  
Sbjct: 158 VLSREERVERIPWI------APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211

Query: 652 RGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSE 711
             E+        RL           P  D A LA        +I++C  ++P  RP    
Sbjct: 212 SSEKERFYQDQHRL-----------PMPDCAELAN-------LINQCWTYDPTKRPSFRA 253

Query: 712 IVQDL 716
           I++DL
Sbjct: 254 ILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 34/211 (16%)

Query: 447 FIGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIV 501
            IGEG  G VYKA +   G+++A+KK+     +    +    E       +  L H NI+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREI----KLLKELNHPNII 61

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           +L+      G   LV+++       DL    ++  +       I+  L      Q LQ +
Sbjct: 62  KLLDVFRHKGDLYLVFEF----MDTDLYKLIKDRQRGLP-ESLIKSYL-----YQLLQGL 111

Query: 562 --CEPP-IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---- 614
             C    I+H + K  N+L++ + +++++D GLA    S           T +       
Sbjct: 112 AFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGS------PVRPYTHYVVTRWYR 165

Query: 615 APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
           APE       YS   D++S+G +  ELL+ R
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 25/219 (11%)

Query: 446 NFIGEGLLGSVYKAELP--GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVE 502
           + IGEG  G V KA +   G ++ A  K     + +    +F      + +L  H NI+ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKF----------SWNIRIRVALG 550
           L+G C   G   L  +Y  +  L D L      E    F          S    +  A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE--GLL 608
            AR + YL +      +H +  + NIL+ E  + +++D GL+     G    + +  G L
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRL 173

Query: 609 TAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                         Y+  SDV+S GV++ E+++ G  PY
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 18/220 (8%)

Query: 441 SFSEGNFIGEGLLGSVYKAELPGGKLLAVK-----KLSNTVSQRQTDEEFLELASTISRL 495
           S +    +G G  G VY+    G    AV+     K        Q + +FL  A  +S+ 
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 496 RHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGA 551
            H NIV LIG   E     ++ +   GG+     L  +     +  S  ++  +  A   
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGD-LKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEK---LIVRVSDCGLAPLLFSGSTNELSEGLL 608
           A+  +YL+   E   +H +  + N LL  K    + +++D G+A  ++  S        +
Sbjct: 126 AKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 609 TAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                  PE F  G ++ ++DV+S GV++ E+ + G  PY
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 38/278 (13%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI-GY 506
           +G+G  G VYKA+     L A  K+    S+ +  E+F+     +S  +H NIV L   Y
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL-EDFMVEIDILSECKHPNIVGLYEAY 71

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
             E  +  ++ ++     L  ++   E         IR  V      AL +L       +
Sbjct: 72  FYE-NKLWILIEFCDGGALDSIM--LELERGLTEPQIRY-VCRQMLEALNFLHS---HKV 124

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE------FES 620
           +H + K+ NILL     V+++D G++      ST +  +  +      APE      F+ 
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKN--KSTLQKRDTFIGTPYWMAPEVVACETFKD 182

Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD---P 677
             Y  ++D++SLG+ ++EL     P+                  L+ +  L +++    P
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHH----------------ELNPMRVLLKILKSEPP 226

Query: 678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           +LD    +K  S F D +  C+  +P  RP  +E+++ 
Sbjct: 227 TLDQP--SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 30/215 (13%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDE-EFLELAS-----TISR 494
           F + N IGEG  G VY+A +   G+++A+KK+      R  +E + + ++S      +  
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLN 62

Query: 495 LRHGNIVELIGYCNEHGQHL----LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALG 550
           LRH NIVEL       G+HL    LV +Y   C   DL    +     FS +    + L 
Sbjct: 63  LRHPNIVELKEVVV--GKHLDSIFLVMEY---CE-QDLASLLDNMPTPFSESQVKCLMLQ 116

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
             R LQYL E     I+H + K SN+LL +K  ++++D GLA   +      ++  ++T 
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPKVVTL 172

Query: 611 HGSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
               APE      +Y+   D++++G ++ ELL  +
Sbjct: 173 WYR-APELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 58/302 (19%)

Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G           +AVK L +      TD++  +L S +  ++
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA----TDKDLSDLVSEMEMMK 72

Query: 497 ----HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNI--------- 543
               H NI+ L+G C + G   ++ +Y     L + L +       +S++          
Sbjct: 73  MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132

Query: 544 ---RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL----- 595
               +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +     
Sbjct: 133 FKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189

Query: 596 FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGE 654
           +  +TN    G L              Y+ QSDV+S GV++ E+ T G  PY        
Sbjct: 190 YKKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP------- 238

Query: 655 QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                  IP    ++ L +++         A        I+  C    P  RP   ++V+
Sbjct: 239 ------GIP----VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Query: 715 DL 716
           DL
Sbjct: 289 DL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 52/246 (21%), Positives = 109/246 (44%), Gaps = 34/246 (13%)

Query: 477 SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAH 536
           S+++  +   E+   +S L+H NI+    +  +    L+  +Y    TL+D +   +   
Sbjct: 39  SEKERRDALNEI-VILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL 97

Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
             F   + +        A+ Y+ +     I+H + K+ NI L +  ++++ D G++ +L 
Sbjct: 98  --FEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKIL- 151

Query: 597 SGSTNELSEGLLTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ 655
            GS   ++E ++      +PE   G  Y+ +SD+++LG V+ ELLT ++ +D + P    
Sbjct: 152 -GSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---- 206

Query: 656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFA----DIISRCVQWEPGFRPPMSE 711
                             +V   + G Y    +S ++     ++   +Q +P  RP   E
Sbjct: 207 ----------------LNLVVKIVQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADE 249

Query: 712 IVQDLL 717
           ++   L
Sbjct: 250 VLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 34/193 (17%)

Query: 464 GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH--LLVYDYGG 521
           G+++AVKKL ++ ++   D  F      +  L+H NIV+  G C   G+    LV +Y  
Sbjct: 33  GEVVAVKKLQHSTAEHLRD--FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90

Query: 522 NCTLHDLL--HSDEEAHKK---FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNI 576
             +L D L  H +   H+K   ++  I         + ++YL        VH +  + NI
Sbjct: 91  YGSLRDYLQKHRERLDHRKLLLYASQI--------CKGMEYLGS---KRYVHRDLATRNI 139

Query: 577 LLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APEFESGS-YSCQSD 628
           L++ +  V++ D GL  +L         +        G       APE  + S +S  SD
Sbjct: 140 LVESENRVKIGDFGLTKVL------PQDKEYYKVREPGESPIFWYAPESLTESKFSVASD 193

Query: 629 VYSLGVVMLELLT 641
           V+S GVV+ EL T
Sbjct: 194 VWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 71/288 (24%), Positives = 115/288 (39%), Gaps = 40/288 (13%)

Query: 448 IGEGLLGSV----YKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +GEG  G V    Y     G G+++AVK L     Q Q    + +  + +  L H NIV+
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-QNTSGWKKEINILKTLYHENIVK 70

Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C+E G     L+ +Y    +L D L                +  L  A+ L + Q+
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---------------KHKLNLAQLLLFAQQ 115

Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN-ELSEGLLTAHG 612
           +CE          +H +  + N+LLD   +V++ D GLA  +  G     + E   +   
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175

Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL--VRWAIPRLHDID 669
             A E  +   +S  SDV+S GV + ELLT          + E+ +   +  +  +  I+
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235

Query: 670 ALSR-MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            L R M  P                ++  C + E  FRP    ++  L
Sbjct: 236 LLERGMRLPCPK-----NCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 57.5 bits (140), Expect = 4e-09
 Identities = 66/219 (30%), Positives = 95/219 (43%), Gaps = 44/219 (20%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVELIG 505
           +G+G  G V        GKL A+K L    + +R+  E  L   + +SR+ H  IV+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 506 YCNEHGQHL-LVYDY--GGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR---AL 555
           Y  +  + L LV +Y  GG   L   L       EE           R    AA    AL
Sbjct: 60  YAFQTEEKLYLVLEYAPGGE--LFSHLSKEGRFSEE-----------RARFYAAEIVLAL 106

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS-G 614
           +YL  +    I++ + K  NILLD    ++++D GLA         ELS      +   G
Sbjct: 107 EYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLA--------KELSSEGSRTNTFCG 155

Query: 615 -----APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
                APE      Y    D +SLGV++ E+LTG+ P+ 
Sbjct: 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY 194

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.8 bits (139), Expect = 5e-09
 Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 42/281 (14%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F++   IG+G  G V+K  +    K++A+K     +   + ++E  ++   I+ L   + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK----IIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 501 VELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
             +  Y   +G +L      ++ +Y G  +  DLL        + +  +R        + 
Sbjct: 62  PYVTKY---YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKG 113

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L YL    +   +H + K++N+LL E   V+++D G+A  L    T       +      
Sbjct: 114 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWM 168

Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
           APE  +  +Y  ++D++SLG+  +EL  G  P+    P      V + IP+ +       
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK----VLFLIPKNN------- 217

Query: 674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
              P+L+G Y +K L  F   +  C+  EP FRP   E+++
Sbjct: 218 --PPTLEGNY-SKPLKEF---VEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 66/303 (21%), Positives = 121/303 (39%), Gaps = 65/303 (21%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +GEG  G V K +    G+++A+KK   +   +   +  +     + +LRH N+V LI  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
                +  LV+++  +  L DL       DE   +K+ + I         R +++     
Sbjct: 69  FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI--------LRGIEFCH--- 117

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG- 621
              I+H + K  NIL+ +  +V++ D G A  L   +  E+    +      APE   G 
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDYVATRWYRAPELLVGD 175

Query: 622 -SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV----- 675
             Y    D++++G ++ E+LTG +P                 P   DID L  ++     
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG-EPL---------------FPGDSDIDQLYHIIKCLGN 219

Query: 676 -----------DPSLDGAYL-----AKSLSR--------FADIISRCVQWEPGFRPPMSE 711
                      +P   G  L      + L +          D+  +C++ +P  RP  S+
Sbjct: 220 LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279

Query: 712 IVQ 714
           ++ 
Sbjct: 280 LLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 17/136 (12%)

Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESG-SY 623
           +V+ + K +NILLDE   VR+SD GLA   FS      S G    HG  APE  + G +Y
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVG---THGYMAPEVLQKGVAY 173

Query: 624 SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAY 683
              +D +SLG ++ +LL G  P+ + + + +           H+ID ++  +   L  ++
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----------HEIDRMTLTMAVELPDSF 222

Query: 684 LAKSLSRFADIISRCV 699
             +  S    ++ R V
Sbjct: 223 SPELRSLLEGLLQRDV 238

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 19/216 (8%)

Query: 446 NFIGEGLLGSVYKAELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           + IGEG  G V KA +    L    A+K++    S+    +   EL        H NI+ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARALQYLQE 560
           L+G C   G   L  +Y  +  L D L      E    F+        L + + L +  +
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 561 VC-------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE--GLLTAH 611
           V        +   +H +  + NIL+ E  + +++D GL+     G    + +  G L   
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRLPVR 188

Query: 612 GSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                      Y+  SDV+S GV++ E+++ G  PY
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 19/207 (9%)

Query: 448 IGEGLLGSVYKA---ELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IGEG  G VY+         K+ +AVK   N  S     E+FL+ A  + +  H +IV+L
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR-EKFLQEAYIMRQFDHPHIVKL 72

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           IG   E+   +++        L +L    +           I  +   + AL YL+    
Sbjct: 73  IGVITENPVWIVME----LAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK-- 126

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE---FES 620
              VH +  + N+L+     V++ D GL+  L   S  + S+G L      APE   F  
Sbjct: 127 -RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM-APESINFR- 183

Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++  SDV+  GV M E+L  G KP+
Sbjct: 184 -RFTSASDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 58.3 bits (141), Expect = 9e-09
 Identities = 51/186 (27%), Positives = 76/186 (40%), Gaps = 40/186 (21%)

Query: 146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG-- 203
           L L+N  L G IP+   +   L + +LS N++ G +PPS  +++SL  L L  N  +G  
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 204 --TLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTAIPPSIA 261
             +L  L  L +++LN   N  SG +P  L      R     FN T              
Sbjct: 483 PESLGQLTSLRILNLN--GNSLSGRVPAALGGRLLHRAS---FNFT-------------D 524

Query: 262 PAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSA-AAILCALGCSLFMWRYC 320
            A     PG +A  P    ++  AK          I +A     A L  + C++  W+  
Sbjct: 525 NAGLCGIPGLRACGPH---LSVGAK----------IGIAFGVSVAFLFLVICAMCWWK-- 569

Query: 321 KTRRVN 326
             RR N
Sbjct: 570 --RRQN 573

Length = 623

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 67/280 (23%), Positives = 130/280 (46%), Gaps = 40/280 (14%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G+G  GSVYK    P G  +A+K++   + + + ++  +EL   + +     IV+  G 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMEL-DILHKAVSPYIVDFYGA 67

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
               G   +  +Y    +L D L++   A +    ++  R+     + L++L+E  E  I
Sbjct: 68  FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-------FE 619
           +H + K +N+L++    V++ D G++  L +     L++  +      APE        +
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA----SLAKTNIGCQSYMAPERIKSGGPNQ 180

Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD--IDALSRMVD- 676
           + +Y+ QSDV+SLG+ +LE+  GR PY                P  +      LS +VD 
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYP---------------PETYANIFAQLSAIVDG 225

Query: 677 --PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
             P+L   Y   +     D +++C+   P  RP  +++++
Sbjct: 226 DPPTLPSGYSDDA----QDFVAKCLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 52/220 (23%), Positives = 101/220 (45%), Gaps = 27/220 (12%)

Query: 448 IGEGLLGSVYKAE------LPGGKLLAVKKLSN-TVSQRQTDEEFLELASTISRLRHGNI 500
           +GEG  G V+ AE           L+AVK L + T++ R+   +F   A  ++ L+H +I
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQHEHI 69

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD------------EEAHKKFSWNIRIRVA 548
           V+  G C +    ++V++Y  +  L+  L +              +A  +   +  + +A
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
              A  + YL        VH +  + N L+   L+V++ D G++  ++S     +    +
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 609 TAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                  PE      ++ +SDV+S GV++ E+ T G++P+
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 30/213 (14%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV---EL 503
           IG G  G V  A +   GK +A+KK+ +        +  L     +   +H NI+   ++
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 504 IGYCNEHGQHL-LVYDYGGNCTLHDLLHSD---EEAHKKFSWNIRIRVALGAA-RALQYL 558
           +       + + +V D      LH ++HSD    E H        IR  L    R L+Y+
Sbjct: 73  LRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEH--------IRYFLYQLLRGLKYI 123

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---- 614
                  ++H + K SN+L++E   +R+ D G+A  L S  T    +  +T + +     
Sbjct: 124 HSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH--KYFMTEYVATRWYR 178

Query: 615 APE--FESGSYSCQSDVYSLGVVMLELLTGRKP 645
           APE       Y+   D++S+G +  E+L GR+ 
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 63/276 (22%), Positives = 114/276 (41%), Gaps = 32/276 (11%)

Query: 442 FSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           F++   IG+G  G VYK      K +   K+ +        E+  +  + +S+     I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD--EEAHKKFSWNIRIRVALGAARALQYLQ 559
              G   +  +  ++ +Y G  +  DLL     EE +          +A      L+ L 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETY----------IATILREILKGLD 115

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-F 618
            +     +H + K++N+LL E+  V+++D G+A  L    T       +      APE  
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVI 173

Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
           +  +Y  ++D++SLG+  +EL  G  P     P      V + IP         +   P+
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVLFLIP---------KNSPPT 220

Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           L+G Y       F + +  C+  +P FRP   E+++
Sbjct: 221 LEGQYSKP----FKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 56.1 bits (136), Expect = 2e-08
 Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 46/229 (20%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLS-------NTVSQRQTDEEFLELASTISRLRHGN 499
           I +G  G V+ A+    G + A+K +        N V Q  T+ + L  A +        
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY------ 54

Query: 500 IVELIGYCNEHGQHL-LVYDY--GGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAA 552
           +V+L  Y  +  ++L LV +Y  GG+     LL +    DE+  + +   I +       
Sbjct: 55  VVKLY-YSFQGKKNLYLVMEYLPGGDL--ASLLENVGSLDEDVARIYIAEIVL------- 104

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
            AL+YL       I+H + K  NIL+D    ++++D GL+ +        L++       
Sbjct: 105 -ALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD--EKED 158

Query: 613 SG--------APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR 652
                     APE      +S   D +SLG ++ E L G  P+    P 
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 65/256 (25%), Positives = 110/256 (42%), Gaps = 53/256 (20%)

Query: 477 SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAH 536
           S R     F E AS +S++ H ++  + G C    ++++V ++  +  L D+    E+  
Sbjct: 55  SHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGR 113

Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI-------VRVSDC 589
              +W  +I VA   A AL YL++     +VHGN  + NILL    +       +++SD 
Sbjct: 114 VPVAW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDP 168

Query: 590 GLAPLLFSGSTNELSEGLLTAHGSGAPEF--ESGSYSCQSDVYSLGVVMLEL-------L 640
           G++    + S  E  E +       APE      S S  +D +S G  +LE+       L
Sbjct: 169 GVS--FTALSREERVERIPWI----APECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL 222

Query: 641 TGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQ 700
             R P ++ R   ++                 R+ +PS             A +IS+C+ 
Sbjct: 223 KERTPSEKERFYEKKH----------------RLPEPSC---------KELATLISQCLT 257

Query: 701 WEPGFRPPMSEIVQDL 716
           +EP  RP    I++DL
Sbjct: 258 YEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 31/225 (13%)

Query: 441 SFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHG 498
           +F +   +G+G  G V   ++   GK+ A KKL    + +R+ +   L     + ++   
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60

Query: 499 NIVELIGYCNEHGQHL---LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            +V L  Y  E    L   L    GG+   H + H  E   ++              RA+
Sbjct: 61  FVVSL-AYAYETKDALCLVLTLMNGGDLKFH-IYHMGEAGFEE-------------GRAV 105

Query: 556 QYLQEVC-------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
            Y  E+C       +  IV+ + K  NILLD+   +R+SD GLA  +  G T    +G +
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRV 162

Query: 609 TAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR 652
              G  APE  ++  Y+   D ++LG ++ E++ G+ P+ + + +
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 28/224 (12%)

Query: 437 QYTNSFSEGN---FIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI 492
           +Y   + E      +G+G  G VY A +L     +A+K++    S+    +   E  +  
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV--QPLHEEIALH 59

Query: 493 SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIR 546
           S L+H NIV+ +G  +E+G   +  +     +L  LL S      D E    F +  +I 
Sbjct: 60  SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF-YTKQI- 117

Query: 547 VALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KLIVRVSDCGLAPLLFSGSTNELSE 605
                   L+YL +     IVH + K  N+L++    +V++SD G +  L     N  +E
Sbjct: 118 -----LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTE 167

Query: 606 GLLTAHGSGAPE-FESG--SYSCQSDVYSLGVVMLELLTGRKPY 646
                    APE  + G   Y   +D++SLG  ++E+ TG+ P+
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 27/220 (12%)

Query: 441 SFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTIS---RLR 496
           ++  G  +G+G  G VY   ++  G+ LA K++       +T +E   L   I     L+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 497 HGNIVELIGYCNEHGQHLLV--YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           H  IV+  G   +  +  L    +Y    ++ D L    +A+   + ++  +        
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEG 118

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG----LAPLLFSGSTNELSEGLLTA 610
           + YL       IVH + K +NIL D    V++ D G    L  +  SG+      G+ + 
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT------GIRSV 169

Query: 611 HGSG---APEFESGS-YSCQSDVYSLGVVMLELLTGRKPY 646
            G+    +PE  SG  Y  ++DV+SLG  ++E+LT + P+
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 30/201 (14%)

Query: 466 LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL 525
           L+AVK L    S     E+FL+    +SRL   NI  L+G C       ++ +Y  N  L
Sbjct: 48  LVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 526 HDLLHSDEEAHKKFSWNIR-------IRVALGAARALQYLQEVCEPPIVHGNFKSSNILL 578
           +  L          + N +       + +A   A  ++YL+ +     VH +  + N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163

Query: 579 DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP------EFES---GSYSCQSDV 629
            +   ++++D G++  L+S     + +G        AP       +ES   G ++ +SDV
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRV-QG-------RAPLPIRWMAWESVLLGKFTTKSDV 215

Query: 630 YSLGVVMLELLT--GRKPYDR 648
           ++ GV + E+LT    +PY+ 
Sbjct: 216 WAFGVTLWEILTLCREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 33/214 (15%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELAS---TISRLRHGNIVELI 504
           +G G  G V+       + L + K      ++ T +E L   +    +  L H NI+E  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPV--EQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIRVALGAARALQYL 558
               E    ++V +Y    TL + +        DE+    F   I           L  L
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI-----------LLAL 114

Query: 559 QEVCEPPIVHGNFKSSNILLDE-KLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG--- 614
             V    I+H + K+ NILLD+ K++V++ D G++ +L S S         T  G+    
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY------TVVGTPCYI 168

Query: 615 APEF-ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
           +PE  E   Y+ +SD+++LG V+ EL + ++ ++
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 65/281 (23%), Positives = 125/281 (44%), Gaps = 42/281 (14%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F++   IG+G  G V+K  +    +++A+K     +   + ++E  ++   I+ L   + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIK----IIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 501 VELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
             +  Y   +G +L      ++ +Y G  +  DLL +      +F     ++  L   + 
Sbjct: 62  PYVTKY---YGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEIL---KG 113

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L YL    +   +H + K++N+LL E+  V+++D G+A  L    T       +      
Sbjct: 114 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWM 168

Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
           APE  +  +Y  ++D++SLG+  +EL  G  P     P      V + IP+ +       
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----RVLFLIPKNN------- 217

Query: 674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
              P+L G + +K    F D    C+  +P FRP   E+++
Sbjct: 218 --PPTLTGEF-SKPFKEFIDA---CLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 29/221 (13%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI---SRL 495
            ++  G  +G+G  G VY   ++  G+ LAVK++       +T +E   L   I     L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 496 RHGNIVELIGYCNEHGQHLLVY-DYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALG 550
           +H  IV+  G C    + L ++ +Y    ++ D L +     E   +K++  I       
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------- 113

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE-GLLT 609
               ++YL       IVH + K +NIL D    V++ D G +  L    T   S  G+ +
Sbjct: 114 -LEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICSSGTGMKS 166

Query: 610 AHGSG---APEFESG-SYSCQSDVYSLGVVMLELLTGRKPY 646
             G+    +PE  SG  Y  ++DV+S+G  ++E+LT + P+
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 69/251 (27%), Positives = 114/251 (45%), Gaps = 24/251 (9%)

Query: 436 QQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
           ++Y +SF +   IGEG  G V  A E   GK +AVKK+     QR+   E L     I R
Sbjct: 21  REYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMR 74

Query: 495 -LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
              H N+V++        +  +V ++     L D++      H + +      V L   R
Sbjct: 75  DYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLR 129

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL--SEGLLTAH 611
           AL YL       ++H + KS +ILL     +++SD G    +    + E+   + L+   
Sbjct: 130 ALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV----SKEVPKRKSLVGTP 182

Query: 612 GSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-PRLHDID 669
              APE  S   Y  + D++SLG++++E++ G  PY    P      +R  + PR+ D  
Sbjct: 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSH 242

Query: 670 ALSRMVDPSLD 680
            +S ++   LD
Sbjct: 243 KVSSVLRGFLD 253

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 18/166 (10%)

Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
           ++A+     L YL  V    I+H + K SNIL++ +  +++ D G++  L     N +++
Sbjct: 107 KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELI----NSIAD 160

Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR 664
             +      +PE  + G Y+ +SDV+SLG+ ++EL  G+ P+  S    +       I  
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-- 218

Query: 665 LHDIDALSRMVD---PSLDGAYLAKSLSRFADIISRCVQWEPGFRP 707
              +D L ++V    P L  +   + L  F D    C+  +P  RP
Sbjct: 219 ---LDLLQQIVQEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 55.3 bits (134), Expect = 3e-08
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 46/223 (20%)

Query: 445 GNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR--------- 494
           G  +GEG    VYKA     G+++A+KK+           E  E    I+          
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIKL--------GERKEAKDGINFTALREIKLL 56

Query: 495 --LRHGNIVELIG-YCNEHGQHL-LVYDYGGNCTLHDLLHSDEEA--HKKFSWNIRIRVA 548
             L+H NI+ L+  +   H  ++ LV+++         + +D E     K   +I +  A
Sbjct: 57  QELKHPNIIGLLDVFG--HKSNINLVFEF---------METDLEKVIKDK---SIVLTPA 102

Query: 549 LGAARALQYLQ--EVC-EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
              +  L  L+  E      I+H + K +N+L+    +++++D GLA   F     +++ 
Sbjct: 103 DIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS-FGSPNRKMTH 161

Query: 606 GLLTAHGSGAPE--FESGSYSCQSDVYSLGVVMLELLTGRKPY 646
            ++T     APE  F +  Y    D++S+G +  ELL  R P+
Sbjct: 162 QVVTRWYR-APELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (133), Expect = 3e-08
 Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 53/281 (18%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI---SRLRHGNIVEL 503
           IG+G  G VYKA +    +++A+K     +   + ++E  ++   I   S+ R   I + 
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKV----IDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64

Query: 504 IGYCNEHGQHL-LVYDYGGNCTLHDLLHS--DEEAHKKFSWNIRIRVALGAARALQYLQE 560
            G     G  L ++ +Y G  +  DLL     +E +  F   I +R  L     L+YL E
Sbjct: 65  YG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF---I-LREVL---LGLEYLHE 116

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE 617
             E  I H + K++NILL E+  V+++D G+     SG          T  G+    APE
Sbjct: 117 --EGKI-HRDIKAANILLSEEGDVKLADFGV-----SGQLTSTMSKRNTFVGTPFWMAPE 168

Query: 618 -FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
             +   Y  ++D++SLG+  +EL  G  P                   LH +  L  +  
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLS----------------DLHPMRVLFLIPK 212

Query: 677 ---PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
              PSL+G   +K    F D +S C+  +P  RP   E+++
Sbjct: 213 NNPPSLEGNKFSKP---FKDFVSLCLNKDPKERPSAKELLK 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 37/218 (16%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKL--SNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           I +G  GSVY A+    G   A+K L  S+ +++ Q      E A  + +     + +L 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 505 GYCNEHGQHL-LVYDY--GGNC-TLHDLLHS-DEEAHKKFSWNIRIRVALGAARALQYLQ 559
            Y  +   +L LV +Y  GG+C +L   L    E+  K++            A  +  ++
Sbjct: 64  -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY-----------IAEVVLGVE 111

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-----PLLFSGSTNELSEGLLTAHGSG 614
           ++ +  I+H + K  N+L+D+   ++++D GL+        F G+ + L           
Sbjct: 112 DLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYL----------- 160

Query: 615 APEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
           APE   G      SD +SLG V+ E L G  P+    P
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 73/283 (25%), Positives = 119/283 (42%), Gaps = 48/283 (16%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL---RHGNIVEL 503
           IG G  G VYKA ++  G+L+A+K     V + +  ++F  +   IS L   RH NIV  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G      +  +V +Y G  +L D+         +       R  L   + L YL E  +
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETGK 122

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE-----GLLTAHGSGAPEF 618
              +H + K +NILL E   V+++D G++  L    T  +++     G  T +   APE 
Sbjct: 123 ---IHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIG--TPYWM-APEV 172

Query: 619 ----ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM 674
                 G Y  + D+++LG+  +EL   + P     P        + I +       S  
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR----ALFLISK-------SNF 221

Query: 675 VDPSLDGAYLAKSL--SRFADIISRCVQWEPGFRPPMSEIVQD 715
             P L      K      F D I +C+  +P  RP  ++++Q 
Sbjct: 222 PPPKLK----DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 25/222 (11%)

Query: 441 SFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHG 498
           +F     +G+G  G V   ++   GK+ A KKL    + +R+ +   L     + ++   
Sbjct: 1   TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60

Query: 499 NIVELIGYCNEHGQHL---LVYDYGGNCTLH--DLLHS--DEEAHKKFSWNIRIRVALGA 551
            +V L  Y  E    L   L    GG+   H  ++ +   DE+           R    A
Sbjct: 61  FVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ-----------RAIFYA 108

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           A     L+++    IV+ + K  NILLD++  +R+SD GLA  +  G T     G +   
Sbjct: 109 AELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTV 165

Query: 612 GSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR 652
           G  APE   +  Y+   D + LG ++ E++ G+ P+ + + R
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 53.9 bits (129), Expect = 9e-08
 Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 17/136 (12%)

Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF--ESGSY 623
           +V+ + K +NILLDE   VR+SD GLA   FS      S G    HG  APE   +  +Y
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVG---THGYMAPEVLQKGTAY 173

Query: 624 SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAY 683
              +D +SLG ++ +LL G  P+ + + + +           H+ID ++  V+  L  ++
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----------HEIDRMTLTVNVELPDSF 222

Query: 684 LAKSLSRFADIISRCV 699
             +  S    ++ R V
Sbjct: 223 SPELKSLLEGLLQRDV 238

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 62/249 (24%), Positives = 109/249 (43%), Gaps = 39/249 (15%)

Query: 477 SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAH 536
           S R     F E AS + ++ H +IV L G C    ++++V ++     L   +H   +  
Sbjct: 43  SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVL 102

Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI-------VRVSDC 589
               W  + +VA   A AL YL+   +  +VHGN  + NILL  + I       +++SD 
Sbjct: 103 TT-PW--KFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156

Query: 590 GLAPLLFSGSTNELSEGLLTAHGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
           G+   +   S  E  E +       APE   +S + S  +D +S G  + E+      Y+
Sbjct: 157 GIPITVL--SRQECVERIPWI----APECVEDSKNLSIAADKWSFGTTLWEIC-----YN 205

Query: 648 RSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP 707
              P  +++L      R +  +    +V PS             AD+++ C+ ++P  RP
Sbjct: 206 GEIPLKDKTLAE--KERFY--EGQCMLVTPSCK---------ELADLMTHCMNYDPNQRP 252

Query: 708 PMSEIVQDL 716
               I++D+
Sbjct: 253 FFRAIMRDI 261

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 66/286 (23%), Positives = 121/286 (42%), Gaps = 41/286 (14%)

Query: 448 IGEGLLGSVYKA---ELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    ++  G+    +AVK ++ + S R+  E FL  AS +      ++V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 72

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIR--IRVALGAARAL 555
            L+G  ++    L+V +   +  L   L S     E    +    ++  I++A   A  +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++     V++ D G+   ++ +    +  +GLL      
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SD++S GVV+ E+ +   +PY        Q L    + +         
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------QGLSNEQVLKF-------- 233

Query: 674 MVDPSLDGAYLAKSLS---RFADIISRCVQWEPGFRPPMSEIVQDL 716
                +DG YL +  +   R  D++  C Q+ P  RP   EIV  L
Sbjct: 234 ----VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 27/209 (12%)

Query: 448 IGEGLLGSVYKAEL-PGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVELIG 505
           +G G  G V   ++    +  A+K +    + +    E        +    H  IV+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 506 YC----NEHGQHLLVYDYGGNCTLHDLLHSD---EEAHKKFSWNIRIRVALGAARALQYL 558
           Y      ++   L+ Y  GG   L  +L      +E   +F       +A     A +YL
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGE--LWTILRDRGLFDEYTARFY------IA-CVVLAFEYL 109

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE- 617
                  I++ + K  N+LLD    V++ D G A  L SG       G  T     APE 
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCG--TPE-YVAPEI 163

Query: 618 FESGSYSCQSDVYSLGVVMLELLTGRKPY 646
             +  Y    D +SLG+++ ELLTGR P+
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 70/250 (28%), Positives = 114/250 (45%), Gaps = 28/250 (11%)

Query: 448 IGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHGNIVELIG 505
           IGEG  G V  A +   GKL+AVKK+     QR+   E L     I R  +H N+VE+  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 84

Query: 506 YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP 565
                 +  +V ++     L D++      H + +      V L   +AL  L       
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHA---QG 136

Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APEFESG- 621
           ++H + KS +ILL     V++SD G     F    ++      +  G+    APE  S  
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFG-----FCAQVSKEVPRRKSLVGTPYWMAPELISRL 191

Query: 622 SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-PRLHDIDALSRMVDPSLD 680
            Y  + D++SLG++++E++ G  PY    P     ++R  + P+L ++  +S    PSL 
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVS----PSLK 247

Query: 681 GAYLAKSLSR 690
           G +L + L R
Sbjct: 248 G-FLDRLLVR 256

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 62/289 (21%), Positives = 127/289 (43%), Gaps = 35/289 (12%)

Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFL-EL 488
           TI S+      ++    IG+G  G+V+ A ++  G+ +A+K+++    Q+Q  +E +   
Sbjct: 10  TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINE 66

Query: 489 ASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD--EEAHKKFSWNIRIR 546
              +  L++ NIV  +       +  +V +Y    +L D++     +EA          +
Sbjct: 67  ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA----------Q 116

Query: 547 VALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG 606
           +A      LQ L+ +    ++H + KS N+LL     V+++D G    + +   ++ S  
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI-TPEQSKRSTM 175

Query: 607 LLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAIPRL 665
           + T +          +Y  + D++SLG++ +E++ G  PY    P R    +     P L
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235

Query: 666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            + + LS +                F D ++RC++ +   R    E++Q
Sbjct: 236 QNPEKLSPI----------------FRDFLNRCLEMDVEKRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 33/233 (14%)

Query: 441 SFSEGNFIGEGLLGSVYKAELPGGK-----------------LLAVKKLSNTVSQRQTDE 483
           +F E   +GEG  G V+  E  G +                 L+AVK L    + +    
Sbjct: 8   TFKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARN 64

Query: 484 EFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL--HSDEEAHKK--- 538
           +FL+    +SRL+  NI+ L+  C       ++ +Y  N  L+  L  H  +EA +K   
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 539 --FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
              S++  I +A   A  ++YL  +     VH +  + N L+ +   ++++D G++  L+
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 597 SGSTNELS-EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT--GRKPY 646
           SG    +    +L            G ++  SDV++ GV + E+LT    +PY
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 39/217 (17%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKL-SNTVSQR------QTDEEFLELASTISRLRHGN 499
           +G+G  G V  AEL G  +L AVK L  + + Q        T++  L LA      +H  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHPF 57

Query: 500 IVELIGYCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           + +L   C +    L  V +Y  GG+   H  +        +F        A      LQ
Sbjct: 58  LTQLHS-CFQTKDRLFFVMEYVNGGDLMFH--IQRS----GRFDEPRARFYAAEIVLGLQ 110

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           +L E     I++ + K  N+LLD +  ++++D G+           +  G+ T+   G  
Sbjct: 111 FLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGM-------CKEGILGGVTTSTFCGTP 160

Query: 615 ---APEFESG-SYSCQSDVYSLGVVMLELLTGRKPYD 647
              APE  S   Y    D ++LGV++ E+L G+ P++
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 63/292 (21%), Positives = 127/292 (43%), Gaps = 41/292 (14%)

Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           +I S+      ++    IG+G  G+VY A ++  G+ +A+++++    Q+Q  +E +   
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELI--I 65

Query: 490 STISRLRHGNIVELIGYCNEH--GQHL-LVYDYGGNCTLHDLLHS---DEEAHKKFSWNI 543
           + I  +R      ++ Y + +  G  L +V +Y    +L D++     DE          
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------- 116

Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
             ++A      LQ L+ +    ++H + KS NILL     V+++D G    + +   ++ 
Sbjct: 117 --QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKR 173

Query: 604 SEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAI 662
           S  + T +          +Y  + D++SLG++ +E++ G  PY    P R    +     
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233

Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           P L + + LS +                F D ++RC+  +   R    E++Q
Sbjct: 234 PELQNPEKLSAI----------------FRDFLNRCLDMDVEKRGSAKELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 31/216 (14%)

Query: 441 SFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR----- 494
           +F +   IGEG  G VYKA     G+++A+KK+       + D E   + ST  R     
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLL 53

Query: 495 --LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
             L H NIV+L+   +   +  LV+++         LH D +     S    I + L  +
Sbjct: 54  KELNHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKS 104

Query: 553 RALQYLQEV--CEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
              Q LQ +  C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T
Sbjct: 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVT 163

Query: 610 AHGSGAPEFESGS--YSCQSDVYSLGVVMLELLTGR 643
                APE   G   YS   D++SLG +  E++T R
Sbjct: 164 LWYR-APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 35/225 (15%)

Query: 448 IGEGLLGSVYKAE------LP----------GGKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +GEG  G V+  E      LP          G  LL   K+    + +    +FL+    
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS-------------DEEAHK- 537
           +SRL+  NI+ L+G C +     ++ +Y  N  L+  L S                AH  
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 538 -KFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
              S++  + VAL  A  ++YL  +     VH +  + N L+ E L ++++D G++  L+
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 597 SGSTNELS-EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELL 640
           +G    +    +L            G ++  SDV++ GV + E+L
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 20/221 (9%)

Query: 441 SFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHG 498
           +F +   +G+G  G V   ++   GK+ A K+L    + +R+ +   L     + ++   
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60

Query: 499 NIVELIGYCNEHGQHL---LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            +V L  Y  E    L   L    GG+   H     +    ++       R    AA  L
Sbjct: 61  FVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE-------RALFYAAEIL 112

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
             L+++     V+ + K  NILLD+   +R+SD GLA  +  G   E   G +   G  A
Sbjct: 113 CGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRVGTVGYMA 169

Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ 655
           PE   +  Y+   D + LG ++ E++ G+ P+   R R E+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---RGRKEK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 52.2 bits (126), Expect = 3e-07
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 22/207 (10%)

Query: 446 NFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEF----LELASTISRLRHGNI 500
           N I EG  G VY+A +   G+++A+KKL       +  E F    L   + + +L+H NI
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKM----EKEKEGFPITSLREINILLKLQHPNI 66

Query: 501 VEL--IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           V +  +   +   +  +V +Y      HDL    E   + F  +    + L     + +L
Sbjct: 67  VTVKEVVVGSNLDKIYMVMEY----VEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE- 617
            +     I+H + K+SN+LL+ + I+++ D GLA   +       ++ ++T     APE 
Sbjct: 123 HDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVT-LWYRAPEL 177

Query: 618 -FESGSYSCQSDVYSLGVVMLELLTGR 643
              +  YS   D++S+G +  ELLT +
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 4e-07
 Identities = 39/129 (30%), Positives = 58/129 (44%), Gaps = 31/129 (24%)

Query: 117 VTVRNFS------LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDA-FHQFTGLIN 169
           +T  N S      LSG  ++G I  ++ RL  +  ++L+NN L+G IPD  F   + L  
Sbjct: 63  ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122

Query: 170 FDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPE 229
            +LS NN TG +P                    G++  LE L L      NN+ SG IP 
Sbjct: 123 LNLSNNNFTGSIP-------------------RGSIPNLETLDL-----SNNMLSGEIPN 158

Query: 230 KLLSIPNFR 238
            + S  + +
Sbjct: 159 DIGSFSSLK 167

Length = 968

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 25/216 (11%)

Query: 448 IGEGLLGSVYKAELPGG---KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G V   E+  G     + VK+L  + S  Q   +FLE A     L+H N+++ +
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDL---LHSDEEAHKKFSWNIRI--RVALGAARALQYLQ 559
           G C E   +LLV ++   C L DL   L S  +A +  + +     R+A   A  L +L 
Sbjct: 62  GQCTEVTPYLLVMEF---CPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLH 117

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
              +   +H +    N LL   L V++ D GL+   +        + L       APE  
Sbjct: 118 ---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174

Query: 620 SGSY--------SCQSDVYSLGVVMLELLT-GRKPY 646
              +        + +S+V+SLGV + EL   G +PY
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 58/233 (24%), Positives = 89/233 (38%), Gaps = 66/233 (28%)

Query: 447 FIGEGLLGSVYKA---ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-------LR 496
            IG G  G VYKA       GK  A+KK       +   E++  ++ +  R       L+
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKF------KGDKEQYTGISQSACREIALLRELK 60

Query: 497 HGNIVELIGYCNEHGQHL--LVYDYGGNCTLHDLL-----HSDEEAH-------KKFSWN 542
           H N+V L+    EH      L++DY      HDL      H   +         K   W 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 543 IRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCGLAPLLFSG 598
           I           + YL       ++H + K +NIL+     E+ +V++ D GLA L  + 
Sbjct: 117 I--------LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165

Query: 599 STNELSEGLLTAHGSG--------APEFESGS--YSCQSDVYSLGVVMLELLT 641
                      A            APE   G+  Y+   D++++G +  ELLT
Sbjct: 166 L-------KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 25/208 (12%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IGEG  G VYK      G+++A+KK+     +       +   S +  L+H NIV L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP-- 564
             +  +  L++++       DL        KK+  ++     + A     YL ++ +   
Sbjct: 68  LMQESRLYLIFEF----LSMDL--------KKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 565 -----PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+L+D K +++++D GLA   F       +  ++T     APE  
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYR-APEVL 173

Query: 620 SGS--YSCQSDVYSLGVVMLELLTGRKP 645
            GS  YS   D++S+G +  E+ T +KP
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT-KKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.1 bits (125), Expect = 5e-07
 Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 45/231 (19%)

Query: 445 GNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNT------VSQRQTDEE------FLELAST 491
           G  +GEG  G V KA     GK++A+KK+            RQ           L     
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 492 ISRLRHGNIVELIG-YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALG 550
           ++ ++H NI+ L+  Y           D+     + D++ SD    K     IR+  +  
Sbjct: 74  MNEIKHENIMGLVDVYVEG--------DF--INLVMDIMASD--LKKVVDRKIRLTESQV 121

Query: 551 AARALQYLQEVCE---PPIVHGNFKSSNILLDEKLIVRVSDCGLA-----PLLF------ 596
               LQ L  +        +H +   +NI ++ K I +++D GLA     P         
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 597 --SGSTNELSEGLLTAHGSGAPEFESGS--YSCQSDVYSLGVVMLELLTGR 643
                  E++  ++T     APE   G+  Y    D++S+G +  ELLTG+
Sbjct: 182 ETMQRREEMTSKVVTLWYR-APELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 52.0 bits (124), Expect = 6e-07
 Identities = 31/101 (30%), Positives = 58/101 (57%), Gaps = 7/101 (6%)

Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
           +V++   R L YL+E  +  I+H + K SNIL++ +  +++ D G++  L     + ++ 
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMAN 160

Query: 606 GLLTAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKP 645
             +      +PE   G+ YS QSD++S+G+ ++EL  GR P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 52.2 bits (125), Expect = 6e-07
 Identities = 40/157 (25%), Positives = 78/157 (49%), Gaps = 24/157 (15%)

Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYS 624
           ++H + KS+NILL    +V++ D G + +  +  ++++           APE +    YS
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223

Query: 625 CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI--DALSRMVDPSLDGA 682
            ++D++SLGV++ ELLT ++P+D     GE          + ++    L+   DP     
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD-----GEN---------MEEVMHKTLAGRYDP----- 264

Query: 683 YLAKSLS-RFADIISRCVQWEPGFRPPMSEIVQDLLC 718
            L  S+S    +I++  +  +P  RP  S+++   +C
Sbjct: 265 -LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC 300

Length = 496

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL---RHGNI 500
           G  +G G  G VY   +   G+ LAVK++      ++T +E   L   I  L   RH  I
Sbjct: 7   GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66

Query: 501 VELIGYCNEHGQHLL--VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           V+  G   +  +  L    +Y    ++ D L    +A+   + N+  R      + + YL
Sbjct: 67  VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYL 122

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG----LAPLLFSGSTNELSEGLLTAHGSG 614
                  IVH + K +NIL D    V++ D G    +  +  SG+      G+ +  G+ 
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT------GIKSVTGTP 173

Query: 615 ---APEFESGS-YSCQSDVYSLGVVMLELLTGRKPY 646
              +PE  SG  Y  ++DV+S+   ++E+LT + P+
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 31/217 (14%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS--NTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           +G G  G V+   +       A+K ++    +  +Q      E    +  + H  I+ L 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNE-KRVLKEVSHPFIIRL- 66

Query: 505 GYCNEHGQHLL--VYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
            +  EH Q  L  + +Y  GG       L S      +FS +  +  A     AL+YL  
Sbjct: 67  -FWTEHDQRFLYMLMEYVPGGE------LFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE 617
                IV+ + K  NILLD++  ++++D G A         +L +   T  G+    APE
Sbjct: 120 K---EIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCGTPEYLAPE 168

Query: 618 -FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRG 653
             +S  ++   D ++LG+++ E+L G  P+    P G
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 51.3 bits (122), Expect = 8e-07
 Identities = 64/292 (21%), Positives = 127/292 (43%), Gaps = 41/292 (14%)

Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           +I S+      ++    IG+G  G+VY A ++  G+ +A+K+++    Q+Q  +E +   
Sbjct: 10  SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELI--I 64

Query: 490 STISRLRHGNIVELIGYCNEH--GQHL-LVYDYGGNCTLHDLLHS---DEEAHKKFSWNI 543
           + I  +R      ++ Y + +  G  L +V +Y    +L D++     DE          
Sbjct: 65  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------- 115

Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
             ++A      LQ L  +    ++H + KS NILL     V+++D G    + +   ++ 
Sbjct: 116 --QIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKR 172

Query: 604 SEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAI 662
           S  + T +          +Y  + D++SLG++ +E++ G  PY    P R    +     
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232

Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           P L + + LS +                F D ++RC++ +   R    E++Q
Sbjct: 233 PELQNPERLSAV----------------FRDFLNRCLEMDVDRRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 50.8 bits (121), Expect = 8e-07
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR---HGNI 500
           G  +G+G  G VY   +   G+ LAVK++       +T +E   L   I  L+   H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66

Query: 501 VELIGYCNEHGQHLL--VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           V+  G   +  +  L    ++    ++ D L    +++   + N+  +        + YL
Sbjct: 67  VQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYL 122

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG----LAPLLFSGSTNELSEGLLTAHGSG 614
                  IVH + K +NIL D    V++ D G    L  +  SG+      G+ +  G+ 
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT------GMKSVTGTP 173

Query: 615 ---APEFESGS-YSCQSDVYSLGVVMLELLTGRKPY 646
              +PE  SG  Y  ++D++S+G  ++E+LT + P+
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 50.7 bits (121), Expect = 9e-07
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 28/214 (13%)

Query: 448 IGEGLLGSVYKAELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           +G G  G V K      K    +A+K L N   +   DE   E A  + +L +  IV +I
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMRE-AEIMHQLDNPYIVRMI 61

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSD-EEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C E    +LV +      L+  L    +E        +  +V++G    ++YL+    
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEG--- 113

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------AP 616
              VH +  + N+LL  +   ++SD GL+  L +       +    A  +G       AP
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA------DDSYYKARSAGKWPLKWYAP 167

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDR 648
           E      +S +SDV+S G+ M E  + G+KPY +
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 50.9 bits (122), Expect = 9e-07
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 61/289 (21%)

Query: 445 GNF--IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHGNI 500
            NF  IGEG  G V  A +   G+ +AVKK+     QR+   E L     I R  +H NI
Sbjct: 22  DNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHPNI 78

Query: 501 VELIGYCNEHGQHL------LVYDY--GGNCT---LHDLLHSDEEAHKKFSWNIRIRVAL 549
           VE+      +  +L      +V ++  GG  T    H  ++ ++ A           V L
Sbjct: 79  VEM------YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT----------VCL 122

Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE---LSEG 606
              +AL +L       ++H + KS +ILL     V++SD G     F    ++     + 
Sbjct: 123 AVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFG-----FCAQVSKEVPRRKS 174

Query: 607 LLTAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL 665
           L+      APE  S   Y  + D++SLG++++E++ G  PY    P         A+ R+
Sbjct: 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-------AMKRI 227

Query: 666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            D       + P L   +  K   R    + R +  +P  R   +E++ 
Sbjct: 228 RD------NLPPKLKNLH--KVSPRLRSFLDRMLVRDPAQRATAAELLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 46/199 (23%), Positives = 87/199 (43%), Gaps = 35/199 (17%)

Query: 542 NIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN 601
           NI  ++++   R L YL+E  +  I+H + K SNIL++ +  +++ D G++  L     +
Sbjct: 99  NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----D 152

Query: 602 ELSEGLLTAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKP------------YDR 648
            ++   +      +PE   G+ Y+ QSD++SLG+ ++E+  GR P            + R
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212

Query: 649 SRPRGEQSLVRWAIPRLHDID-----ALSRMVD-------PSLDGAYLAKSLSRFADIIS 696
               GE           H  D     A+  ++D       P L     +     F D + 
Sbjct: 213 PVSEGEAKESHRP-VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDE---FQDFVD 268

Query: 697 RCVQWEPGFRPPMSEIVQD 715
           +C++  P  R  + E+ + 
Sbjct: 269 KCLKKNPKERADLKELTKH 287

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 62/286 (21%), Positives = 115/286 (40%), Gaps = 41/286 (14%)

Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 72

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS---DEEAHKKFS---WNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S   + E +   +       I++A   A  +
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   ++ +    +  +GLL      
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q +    + R         
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGMSNEQVLRF-------- 233

Query: 674 MVDPSLDGAYLAKSLS---RFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K  +      +++  C Q+ P  RP   EI+  +
Sbjct: 234 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 22/203 (10%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IGEG  G V+K      G+++A+KK   +       +  L     + +L+H N+V LI  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAARALQYL-QEV 561
                +  LV++Y  +  L++L  +     E   KK  W           +A+ +  +  
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT--------LQAVNFCHKHN 120

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG 621
           C    +H + K  NIL+ ++  +++ D G A +L +G  ++ ++ + T     APE   G
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARIL-TGPGDDYTDYVAT-RWYRAPELLVG 174

Query: 622 --SYSCQSDVYSLGVVMLELLTG 642
              Y    DV+++G V  ELLTG
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 49.9 bits (120), Expect = 2e-06
 Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 35/233 (15%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNT--VSQRQTDEEFLELASTISRL- 495
           + F  G  IGEG   +V  A E    K  A+K L     + +++     +E    ++RL 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE-VLTRLN 59

Query: 496 RHGNIVELIGYCNEHGQHLL--VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
            H  I++L  Y     +  L  V +Y  N  L   +      +           A     
Sbjct: 60  GHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILL 113

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILLD+ + ++++D G A +L   S+ E ++G  T   S
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 614 -------------GAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYD 647
                        G  E+ S            SD+++LG ++ ++LTG+ P+ 
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 30/215 (13%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA----STISRLRHGNIVE 502
           IGEG  G VYKA +   G+L+A+KK    V      E F   A      + +L H NIV 
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKK----VRLDNEKEGFPITAIREIKILRQLNHRNIVN 70

Query: 503 L----------IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           L          + +  + G   LV++Y      HDL+   E     FS +    +     
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLVHFSED---HIKSFMK 123

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           + L+ L    +   +H + K SNILL+ K  ++++D GLA L  S  +   +  ++T   
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183

Query: 613 SGAPEFESGS--YSCQSDVYSLGVVMLELLTGRKP 645
              PE   G   Y    DV+S G ++ EL T +KP
Sbjct: 184 R-PPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 65/244 (26%), Positives = 100/244 (40%), Gaps = 29/244 (11%)

Query: 448 IGEGLLGSVYKAELPG----GKLLAVKKLSNT--VSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G V+     G    GKL A+K L     V + +T E        +  +R    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 502 ELIGYCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGA-ARALQY 557
             + Y  +    L L+ DY  GG    H  L+  E     F+ +  +RV +     AL +
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTH--LYQRE----HFTES-EVRVYIAEIVLALDH 120

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L ++    I++ + K  NILLD +  V ++D GL+    +           T     APE
Sbjct: 121 LHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE-YMAPE 176

Query: 618 F---ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-----PRLHDID 669
                SG +    D +SLGV+  ELLTG  P+     +  QS +   I     P    + 
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236

Query: 670 ALSR 673
           A +R
Sbjct: 237 AEAR 240

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 49.8 bits (120), Expect = 2e-06
 Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 59/228 (25%)

Query: 446 NFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-------LRH 497
             IG G  G V  A     G+ +A+KK+SN         + L  A  I R       LRH
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRH 58

Query: 498 GNIVELIG-------------YCNEHGQHLLVYDYGGNCT-LHDLLHS----DEEAHKKF 539
            NI+ L+              Y        +V +     T LH ++ S     ++  + F
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVY--------IVTELME--TDLHKVIKSPQPLTDDHIQYF 108

Query: 540 SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS-- 597
            + I         R L+YL       ++H + K SNIL++    +++ D GLA  +    
Sbjct: 109 LYQI--------LRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157

Query: 598 GSTNELSEGLLTAHGSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
                L+E ++T     APE    S  Y+   D++S+G +  ELLT +
Sbjct: 158 DEKGFLTEYVVTRWYR-APELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 49.5 bits (119), Expect = 2e-06
 Identities = 81/314 (25%), Positives = 126/314 (40%), Gaps = 88/314 (28%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFL---ELASTISRLRHGNIVEL 503
           +G+G  GSVY A     G+L+A+KK+        + EE +   E+ S      H NIV+L
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFY---SWEECMNLREVKSLRKLNEHPNIVKL 63

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIR-----VALGAARALQYL 558
                E+ +   V++Y     L+ L+   +   K FS    IR     +  G    L ++
Sbjct: 64  KEVFRENDELYFVFEYM-EGNLYQLMKDRK--GKPFS-ESVIRSIIYQILQG----LAHI 115

Query: 559 QEVCEPPIVHGNF----KSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
            +       HG F    K  N+L+    +V+++D GLA  + S           T + S 
Sbjct: 116 HK-------HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-------YTDYVST 161

Query: 615 ----APE--FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI 668
               APE    S SYS   D+++LG +M EL T R  +                P   +I
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF----------------PGSSEI 205

Query: 669 DALSRMVD----PS----LDGAYLAKSLS-RF-------------------ADIISRCVQ 700
           D L ++      P+     +G  LA  L  RF                    D+I   ++
Sbjct: 206 DQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLR 265

Query: 701 WEPGFRPPMSEIVQ 714
           W+P  RP  S+ +Q
Sbjct: 266 WDPKKRPTASQALQ 279

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 49.9 bits (120), Expect = 3e-06
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 42/219 (19%)

Query: 446 NFIGEGLLGSVYKA-ELPGGKLLAVKKL----SN-TVSQRQTDEE--FLELASTISRLR- 496
             +G+G  G V+KA +    +++A+KK+     N T +QR T  E  FL        L  
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR-TFREIMFL------QELGD 65

Query: 497 HGNIVELIG-YCNEHGQHL-LVYDYGGNCTLHDLLHSD--EEAHKKFSWNIRIRVALGAA 552
           H NIV+L+     E+ + + LV++Y     LH ++ ++  E+ HK++       +     
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILEDVHKRY-------IMYQLL 117

Query: 553 RALQYL--QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
           +AL+Y+    V     +H + K SNILL+    V+++D GLA  L           +LT 
Sbjct: 118 KALKYIHSGNV-----IHRDLKPSNILLNSDCRVKLADFGLARSLSELE-ENPENPVLTD 171

Query: 611 HGSG----APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
           + +     APE    S  Y+   D++S+G ++ E+L G+
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 29/236 (12%)

Query: 447 FIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIG 505
            +G G  G VYK   +  G+L A+K +  T  + +  ++ + +    S   H NI    G
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATYYG 70

Query: 506 YC---NEHG---QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
                N  G   Q  LV ++ G  ++ DL+ + +    K  W     +A      L+ L 
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILRGLS 125

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL---------FSGSTNELSEGLLTA 610
            + +  ++H + K  N+LL E   V++ D G++  L         F G+   ++  ++  
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 611 HGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWAIPRL 665
                 E    +Y  +SD++SLG+  +E+  G  P     P     L+ R   PRL
Sbjct: 186 D-----ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 50.1 bits (119), Expect = 4e-06
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 36/212 (16%)

Query: 68  CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGN 127
           C+ +N TE+RL  + L  + A      E +  + L NN +  S+P NL   ++    + N
Sbjct: 175 CLKNNKTELRLKILGLTTIPACIP---EQITTLILDNNELK-SLPENLQGNIKTLYANSN 230

Query: 128 QLTGSIPESLSRLTQLLDLSLNN-NHLNGGIPDAFHQFTGLINFDLSANNLTG---QLPP 183
           QLT SIP +L    Q ++LS+N    L   +P A      L + DL  N ++     LP 
Sbjct: 231 QLT-SIPATLPDTIQEMELSINRITELPERLPSA------LQSLDLFHNKISCLPENLPE 283

Query: 184 STRNL---------------SSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIP 228
             R L               S +  L++Q+N L+     L    L  L    N  +  +P
Sbjct: 284 ELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSLTALPETLP-PGLKTLEAGENALTS-LP 341

Query: 229 EKLLSIPNFRKDGNPFNTTVIALPPTAIPPSI 260
               S+P   +  +     +  LP T +PP+I
Sbjct: 342 A---SLPPELQVLDVSKNQITVLPET-LPPTI 369

Length = 754

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 23/208 (11%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G+G  G V   ++   GK+ A KKL     ++++ E+   L   I    +   +  + Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC---- 562
             E   HL        C +  L++  +  +  ++   R    L   R + Y  ++     
Sbjct: 61  AFESKTHL--------CLVMSLMNGGDLKYHIYNVGER---GLEMERVIHYSAQITCGIL 109

Query: 563 ---EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-F 618
                 IV+ + K  N+LLD++   R+SD GLA  L  G T     G    +G  APE  
Sbjct: 110 HLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG---TNGYMAPEIL 166

Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           +   YS   D +++G  + E++ GR P+
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 60/274 (21%), Positives = 122/274 (44%), Gaps = 32/274 (11%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI-GY 506
           +G+G  G VYKA+     +LA  K+ +T S+ + ++  +E+   ++   H NIV+L+  +
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEI-DILASCDHPNIVKLLDAF 71

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
             E+   +L+    G      +L  +    +     IR+ V      AL YL    E  I
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEP---QIRV-VCKQTLEALNYLH---ENKI 124

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF------ES 620
           +H + K+ NIL      ++++D G++    +  T +  +  +      APE       + 
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD 680
             Y  ++DV+SLG+ ++E+     P+    P             +  +  +++   P+L 
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNP-------------MRVLLKIAKSEPPTL- 228

Query: 681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            A  ++  S F D + +C++     R   ++++Q
Sbjct: 229 -AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 68/292 (23%), Positives = 131/292 (44%), Gaps = 41/292 (14%)

Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           TI S+      ++    IG+G  G+VY A ++  G+ +A+K+++  + Q+   E  +   
Sbjct: 10  TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEI 67

Query: 490 STISRLRHGNIVELIGYCNEH--GQHL-LVYDYGGNCTLHDLLHSD--EEAHKKFSWNIR 544
             +   +H NIV    Y + +  G  L +V +Y    +L D++     +E          
Sbjct: 68  LVMRENKHPNIVN---YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------- 115

Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
            ++A      LQ L+ +    ++H + KS NILL     V+++D G    + +   ++ S
Sbjct: 116 -QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRS 173

Query: 605 EGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAI 662
             + T +   APE  +  +Y  + D++SLG++ +E++ G  PY    P R    +     
Sbjct: 174 TMVGTPYWM-APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232

Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           P L + + LS                + F D ++RC++ +   R    E++Q
Sbjct: 233 PELQNPEKLS----------------AIFRDFLNRCLEMDVEKRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 5e-06
 Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 41/173 (23%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELAST--ISRLR-- 496
           + E   IGEG  G+VYKA +L  G+ +A+KK+          EE + L++   I+ L+  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR-----VPLSEEGIPLSTLREIALLKQL 55

Query: 497 ----HGNIVELIGYCNEHGQHL-------LVYDYGGNCTLHDLLHS------DEEAHKKF 539
               H NIV L+  C  HG          LV+++  +  L   L          E  K  
Sbjct: 56  ESFEHPNIVRLLDVC--HGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDL 112

Query: 540 SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA 592
              +         R + +L       IVH + K  NIL+     V+++D GLA
Sbjct: 113 MRQL--------LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 48.5 bits (116), Expect = 6e-06
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 50/220 (22%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-------LRHGN 499
           IGEG  G VYKA +   G+++A+KK+     + +T++E   + ST  R       L H N
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI-----RLETEDE--GVPSTAIREISLLKELNHPN 59

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV L+   +   +  LV+++         L  D    KK+  +      L       YL 
Sbjct: 60  IVRLLDVVHSENKLYLVFEF---------LDLD---LKKYMDSSP-LTGLDPPLIKSYLY 106

Query: 560 EVCEP-------PIVHGNFKSSNILLDEKLIVRVSDCGLA-----PLLFSGSTNELSEGL 607
           ++ +         ++H + K  N+L+D +  ++++D GLA     P+     T+E    +
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTYTHE----V 160

Query: 608 LTAHGSGAPEFESGS--YSCQSDVYSLGVVMLELLTGRKP 645
           +T     APE   GS  YS   D++S+G +  E++  R+P
Sbjct: 161 VTLWYR-APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 34/117 (29%), Positives = 55/117 (47%), Gaps = 16/117 (13%)

Query: 552 ARALQYLQEVC-------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
            RA+ Y  E+           IV+ + K  NILLD+   +R+SD GLA  +  G   E  
Sbjct: 102 ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ETI 158

Query: 605 EGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW 660
            G +   G  APE  ++  Y+   D + LG ++ E++ G+ P+     R  +  V+ 
Sbjct: 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF-----RQRKEKVKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 48.1 bits (114), Expect = 8e-06
 Identities = 30/101 (29%), Positives = 56/101 (55%), Gaps = 7/101 (6%)

Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
           +V++   + L YL+E  +  I+H + K SNIL++ +  +++ D G++  L     N    
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-- 162

Query: 606 GLLTAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKP 645
             +      +PE   G+ YS QSD++S+G+ ++E+  GR P
Sbjct: 163 --VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 53/230 (23%), Positives = 97/230 (42%), Gaps = 28/230 (12%)

Query: 432 IASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELAS 490
           +++L+     F     +G G  G VYK   +  G+L A+K +   V++ + +E  LE+  
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINM 65

Query: 491 TISRLRHGNIVELIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR 544
                 H NI    G            Q  LV ++ G  ++ DL+ + +    K  W   
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--- 122

Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--------- 595
             +A      L+ L  +    ++H + K  N+LL E   V++ D G++  L         
Sbjct: 123 --IAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 180

Query: 596 FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKP 645
           F G+   ++  ++        E    +Y  +SD++SLG+  +E+  G  P
Sbjct: 181 FIGTPYWMAPEVIACD-----ENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 10/206 (4%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           N F     +GEG  G V K      K ++A+KK  ++    +  E  L     +  L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIVEL       G+  LV++Y     L  L     E         ++R  +   + ++ +
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELL-----EEMPNGVPPEKVRSYI--YQLIKAI 113

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF 618
               +  IVH + K  N+L+    ++++ D G A  L  GS    +E + T     +PE 
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVAT-RWYRSPEL 172

Query: 619 ESGS-YSCQSDVYSLGVVMLELLTGR 643
             G+ Y    D++S+G ++ EL  G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 26/220 (11%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +GEG   +VYK      G+++A+K++ +  ++  T    +   S +  L+H NIV L   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV----- 561
            +   + +LV++Y       DL        KK+     +R AL       +  ++     
Sbjct: 67  IHTENKLMLVFEYMDK----DL--------KKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 562 -C-EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
            C E  ++H + K  N+L++++  ++++D GLA   F    N  S  ++T     AP+  
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARA-FGIPVNTFSNEVVTLWYR-APDVL 172

Query: 620 SGS--YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL 657
            GS  YS   D++S+G +M E++TGR P        +Q L
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLL 211

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 60/283 (21%), Positives = 125/283 (44%), Gaps = 48/283 (16%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLS--NTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG+G    VYKA  L  G+++A+KK+     +  +   +   E+   + +L H N+++ +
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEI-DLLKQLDHPNVIKYL 68

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFS----WNIRIRVALGAARALQYLQE 560
               E+ +  +V +      L  ++   ++  +       W   +++      AL+++  
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMHS 124

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS-GAPEF- 618
                I+H + K +N+ +    +V++ D GL    FS  T         AH   G P + 
Sbjct: 125 ---KRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTA-------AHSLVGTPYYM 173

Query: 619 ------ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI-DAL 671
                 E+G Y+ +SD++SLG ++ E+   + P+   +              L+ +   +
Sbjct: 174 SPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDK------------MNLYSLCKKI 220

Query: 672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +   P L   + ++ L    D++SRC+  +P  RP +S ++Q
Sbjct: 221 EKCDYPPLPADHYSEELR---DLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 31/212 (14%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRL--RHGNIVELI 504
           +G+G  G V+ AEL G  +  A+K L   V     D E   +   +  L   H  +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61

Query: 505 GYCN----EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
            YC     E+   ++ Y  GG     DL+   +  HK F      R    AA  +  LQ 
Sbjct: 62  -YCTFQTKENLFFVMEYLNGG-----DLMFHIQSCHK-FDLP---RATFYAAEIICGLQF 111

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP--LLFSGSTNELSEGLLTAHGSG---A 615
           +    IV+ + K  NILLD    ++++D G+    +L    T        T  G+    A
Sbjct: 112 LHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC-------TFCGTPDYIA 164

Query: 616 PEFESGS-YSCQSDVYSLGVVMLELLTGRKPY 646
           PE   G  Y+   D +S GV++ E+L G+ P+
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 25/168 (14%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEF----LELASTISRLRHGNIVE 502
           IG+G  G V+KA      +++A+KK    V      E F    L     +  L+H N+V 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKK----VLMENEKEGFPITALREIKILQLLKHENVVN 75

Query: 503 LIGYC--------NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           LI  C           G   LV+++   C  HDL       + KF+ +   +V       
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEF---CE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE 602
           L Y+       I+H + K++NIL+ +  I++++D GLA   FS S N 
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLAR-AFSLSKNS 175

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 60/243 (24%), Positives = 109/243 (44%), Gaps = 34/243 (13%)

Query: 444 EGNFIGEGLLGSVYKAELPGG---KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           EG  +G G  G VYKA+   G   +  A+K++  T        E     + +  L+H N+
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREI----ALLRELKHPNV 60

Query: 501 VELIGYCNEHGQH--LLVYDYGGNCTLHDL-LHSDEEAHKKFSWNIRIRVALGAARALQY 557
           + L      H      L++DY  +   H +  H   +A+KK      +++  G  ++L Y
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKK-----PVQLPRGMVKSLLY 115

Query: 558 -----LQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCGLAPLLFSGSTNELS--EG 606
                +  +    ++H + K +NIL+     E+  V+++D G A  LF+     L+  + 
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDP 174

Query: 607 LLTAHGSGAPEFESGS--YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR 664
           ++      APE   G+  Y+   D++++G +  ELLT  +P    R    Q  ++ + P 
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR----QEDIKTSNPY 229

Query: 665 LHD 667
            HD
Sbjct: 230 HHD 232

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 2e-05
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 51/223 (22%)

Query: 446 NFIGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNI 500
           ++IGEG  G V  A   P G  +A+KK+S     T  QR   E  +     + R +H NI
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKI-----LRRFKHENI 65

Query: 501 VEL------IGYCNEHG----QHLLVYDYGGNCTLHDLLH----SDEEAHKKFSWNIRIR 546
           + +        + + +     Q L+  D      L+ L+     S++   + F + I   
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMETD------LYKLIKTQHLSNDHI-QYFLYQI--- 115

Query: 547 VALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG 606
                 R L+Y+       ++H + K SN+LL+    +++ D GLA             G
Sbjct: 116 -----LRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEHDHTG 164

Query: 607 LLTAHGSG----APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
            LT + +     APE    S  Y+   D++S+G ++ E+L+ R
Sbjct: 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 74/278 (26%), Positives = 116/278 (41%), Gaps = 47/278 (16%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHGNIVE--- 502
           IGEG  G V  A E   G+ +AVK +     QR+   E L     I R  +H N+VE   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHQNVVEMYK 85

Query: 503 --LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             L+G   E    L+ +  GG   L D++       ++ +      V     +AL YL  
Sbjct: 86  SYLVG---EELWVLMEFLQGG--ALTDIVSQTRLNEEQIA-----TVCESVLQALCYLHS 135

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES 620
                ++H + KS +ILL     V++SD G    +        S  L+      APE  S
Sbjct: 136 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 190

Query: 621 GS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD--- 676
            + Y  + D++SLG++++E++ G  PY    P                + A+ R+ D   
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----------------VQAMKRLRDSPP 234

Query: 677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           P L  A+    + R  D + R +  EP  R    E++ 
Sbjct: 235 PKLKNAHKISPVLR--DFLERMLTREPQERATAQELLD 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 43/217 (19%)

Query: 446 NFIGEGLLGSVYKAELPGGKL-LAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNI 500
           + +G G  G V  A        +A+KKLS    + +  ++T  E   L      + H N+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLK----HMDHENV 76

Query: 501 VELI-----GYCNEHGQ------HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
           + L+         E  Q      HL+  D      L++++       +K S +  I+  +
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLMGAD------LNNIV-----KCQKLSDD-HIQFLV 124

Query: 550 -GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
               R L+Y+       I+H + K SNI ++E   +++ D GLA       T++   G +
Sbjct: 125 YQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYV 176

Query: 609 TAHGSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
                 APE       Y+   D++S+G +M ELLTG+
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 46.5 bits (111), Expect = 3e-05
 Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 49/236 (20%)

Query: 439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEF----LELASTIS 493
              +     +GEG  G VYKA ++  G+++A+KK+     +    + F    L     + 
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK----DGFPITALREIKILK 62

Query: 494 RLRHGNIVELI--------GYCNEHGQHLLVYDYGGNCTLHDL---LHSD----EEAHKK 538
           +L+H N+V LI            + G   +V  Y      HDL   L +      E+  K
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPY----MDHDLSGLLENPSVKLTESQIK 118

Query: 539 FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA------ 592
                 +++  G    + YL E     I+H + K++NIL+D + I++++D GLA      
Sbjct: 119 ---CYMLQLLEG----INYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Query: 593 -PLLFSGSTNELSE--GLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGR 643
            P    G      +   L+       PE   G   Y+   D++ +G V  E+ T R
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 46/228 (20%), Positives = 93/228 (40%), Gaps = 30/228 (13%)

Query: 494 RLRHGNIVELIGYCNEHGQHL----LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
           R+   NI+++ G+  +    L    L+ +Y     L ++L  D+E  K  S+  ++ +A+
Sbjct: 74  RIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL--DKE--KDLSFKTKLDMAI 129

Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
              + L  L +    P  + N  S + L+ E   +++   GL  +L S     ++  +  
Sbjct: 130 DCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF 187

Query: 610 AHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID 669
           ++      F    Y+ + D+YSLGVV+ E+ TG+ P++                      
Sbjct: 188 SYKMLNDIFSE--YTIKDDIYSLGVVLWEIFTGKIPFENL-----------------TTK 228

Query: 670 ALSRMVDPSLDGAYLAKSLSRF-ADIISRCVQWEPGFRPPMSEIVQDL 716
            +  ++    +   L          I+  C   +   RP + EI+ +L
Sbjct: 229 EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 26/209 (12%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIG 505
           +G+G  G V    E   GK  A+K L   V   +      L  +  +   RH  +  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 506 YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGA--ARALQYLQEVCE 563
               H +   V +Y     L    H   E  + FS + R R   GA    AL YL   C+
Sbjct: 63  SFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSED-RARF-YGAEIVSALGYLHS-CD 115

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----- 618
             +V+ + K  N++LD+   ++++D GL           +S+G       G PE+     
Sbjct: 116 --VVYRDLKLENLMLDKDGHIKITDFGLC-------KEGISDGATMKTFCGTPEYLAPEV 166

Query: 619 -ESGSYSCQSDVYSLGVVMLELLTGRKPY 646
            E   Y    D + LGVVM E++ GR P+
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 51/227 (22%)

Query: 439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKL----SNTVSQRQTDEEFLELASTIS 493
           TN + +   +G G  G V  A +   G+ +A+KK+    S  V  ++T  E L+L   + 
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-LKL---LK 64

Query: 494 RLRHGNIVEL----------IGYCNEHGQHLLVYDYGGNCTLHDLLHS---DEEAHKKFS 540
            LRH NI+ L          I +  E    LL  D      LH LL S   +++  + F 
Sbjct: 65  HLRHENIISLSDIFISPLEDIYFVTE----LLGTD------LHRLLTSRPLEKQFIQYFL 114

Query: 541 WNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST 600
           + I         R L+Y+       +VH + K SNIL++E   +++ D GLA +     T
Sbjct: 115 YQI--------LRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT 163

Query: 601 NELSEGLLTAHGSGAPE--FESGSYSCQSDVYSLGVVMLELLTGRKP 645
                G ++     APE       Y  + D++S G +  E+L G KP
Sbjct: 164 -----GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KP 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 46/220 (20%)

Query: 448 IGEGLLGSVYKAEL-PGGKLLAVKKLS--NTVSQRQTDEEFLE--LASTISRLRHGNIVE 502
           +G G  G V  AE    G+L A+K L   + +++ + +    E  +  T +  RH  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 503 LIGYCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR---ALQ 556
           L   C +   H+  V +Y  GG+  +H  +H+D      FS     R    AA     LQ
Sbjct: 67  LFA-CFQTEDHVCFVMEYAAGGDLMMH--IHTD-----VFS---EPRAVFYAACVVLGLQ 115

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL----LTAHG 612
           YL E     IV+ + K  N+LLD +  V+++D GL             EG+     T+  
Sbjct: 116 YLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLC-----------KEGMGFGDRTSTF 161

Query: 613 SGAPEF------ESGSYSCQSDVYSLGVVMLELLTGRKPY 646
            G PEF         SY+   D + LGV++ E+L G  P+
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 46/162 (28%), Positives = 70/162 (43%), Gaps = 9/162 (5%)

Query: 87  LADTLGDLESVINIDLSNNHIGGSIPS--NLPVTVRNFSLSGNQLTGSIPESLSRLTQLL 144
           L   L +L ++ N+DLS N I   +P    L   +    LS N +   +  SLS L  L 
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235

Query: 145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT 204
            L L+NN L   +P++    + L   DLS N ++     S  +L++L  L L  N LS  
Sbjct: 236 GLELSNNKLED-LPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNA 292

Query: 205 LNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNF--RKDGNPF 244
           L ++  L L+   + N L +    E  L+          N  
Sbjct: 293 LPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGE 334

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.8 bits (99), Expect = 4e-05
 Identities = 21/59 (35%), Positives = 30/59 (50%)

Query: 119 VRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL 177
           +++  LS N+LT     +   L  L  L L+ N+L    P+AF     L + DLS NNL
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 31/211 (14%)

Query: 448 IGEGLLGSVYKAELP-GGKLLAVKKLSNT----VSQRQTDEEFLELASTISRLRHGNIVE 502
           IG G  G V+    P  GK +A+KK+ N     VS ++    F EL   +   +H N++ 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRV---FREL-KMLCFFKHDNVLS 63

Query: 503 LIGYCN----EHGQHLLVYDYGGNCTLHDLLHSDE----EAHKKFSWNIRIRVALGAARA 554
            +        +  + + V        LH ++ S +    +  K F + I         R 
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQI--------LRG 115

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+YL       I+H + K  N+L++   ++++ D GLA +     +  +++ ++T +   
Sbjct: 116 LKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR- 171

Query: 615 APEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           APE   GS  Y+   D++S+G +  ELL  R
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 4/134 (2%)

Query: 514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKS 573
           LL+ +YG    L+  +    + H  F       V L   + +  L EV    ++H + KS
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQ---EYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197

Query: 574 SNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSL 632
           +NI L    I+++ D G +       + +++          APE +E   YS ++D++SL
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL 257

Query: 633 GVVMLELLTGRKPY 646
           GV++ ELLT  +P+
Sbjct: 258 GVILYELLTLHRPF 271

Length = 478

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 65/240 (27%), Positives = 101/240 (42%), Gaps = 27/240 (11%)

Query: 428 SVFTIASLQQYTNSFSEGNFIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFL 486
           S+  + SL   T+++     IG+G  G VYK      G L AVK L         DEE  
Sbjct: 10  SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIE 66

Query: 487 ELASTISRL-RHGNIVELIG--YCNEH---GQHLLVYDYGGNCTLHDLLHSDEEAHKKFS 540
              + +  L  H N+V+  G  Y  +    GQ  LV +     ++ +L+       ++  
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126

Query: 541 WNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST 600
             +   +  GA   LQ+L       I+H + K +NILL  +  V++ D G++  L S   
Sbjct: 127 EAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183

Query: 601 NELSEGLLTAHGSG---APEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
                   T+ G+    APE  +       SY  + DV+SLG+  +EL  G  P     P
Sbjct: 184 RRN-----TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 8e-05
 Identities = 65/242 (26%), Positives = 96/242 (39%), Gaps = 61/242 (25%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-------NTVSQRQTDEEFLELASTISRLRHGN 499
           +G+G +G V+   L G GKL A+K L        N V +  T++E L      + L H  
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL------ATLDHPF 62

Query: 500 IVELIGYCN-EHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR-- 553
           +  L  Y + +   +L LV DY  GG   L  LL    +  K  S  +       AA   
Sbjct: 63  LPTL--YASFQTETYLCLVMDYCPGGE--LFRLL--QRQPGKCLSEEV---ARFYAAEVL 113

Query: 554 -ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-------------------- 592
            AL+YL       IV+ + K  NILL E   + +SD  L+                    
Sbjct: 114 LALEYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 593 -------PLLFSGSTNELSEGLLTAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRK 644
                     FS   +  S   +      APE  SG  +    D ++LG+++ E+L G  
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230

Query: 645 PY 646
           P+
Sbjct: 231 PF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 44.8 bits (106), Expect = 9e-05
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 31/212 (14%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEE-------FLELASTISRLRHGN 499
           +G+G  G V  AEL G  +  A+K L   V     D E        L LA     L H  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61

Query: 500 IVELIGYC----NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
                 +C     EH   ++ Y  GG     DL+   + + + F      R    AA  +
Sbjct: 62  ------FCTFQTKEHLFFVMEYLNGG-----DLMFHIQSSGR-FD---EARARFYAAEII 106

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
             LQ + +  I++ + K  N+LLD+   ++++D G+     +G     +          A
Sbjct: 107 CGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIA 164

Query: 616 PEFESGS-YSCQSDVYSLGVVMLELLTGRKPY 646
           PE   G  Y+   D +S GV++ E+L G+ P+
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 34/213 (15%)

Query: 448 IGEGLLG-SVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +GEG  G ++    +   +  A+K++    S    ++   E A  +++++H NIV     
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKE-AVLLAKMKHPNIVAFKES 66

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF-------SWNIRIRVALGAARALQYLQ 559
               G   +V +Y   C   DL+   +    K         W +++ + +         Q
Sbjct: 67  FEADGHLYIVMEY---CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV---------Q 114

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF- 618
            + E  ++H + KS NI L +   V++ D G A LL        S G       G P + 
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-------TSPGAYACTYVGTPYYV 167

Query: 619 -----ESGSYSCQSDVYSLGVVMLELLTGRKPY 646
                E+  Y+ +SD++SLG ++ EL T + P+
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.2 bits (95), Expect = 1e-04
 Identities = 24/56 (42%), Positives = 26/56 (46%)

Query: 146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKL 201
           L L+NN L      AF     L   DLS NNLT   P +   L SL SL L  N L
Sbjct: 5   LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 47/223 (21%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-------NTVSQRQTDEEFLELASTISRLRHGN 499
           +G+G  G V+ A+    G+++A+K++        N V    T+ + L         +   
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT------KSEW 62

Query: 500 IVELIGYCNEHGQHL-LVYDY--GGNC-TLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
           +V+L+ Y  +  ++L L  +Y  GG+  TL + L    E H +F +   +  A+ A   L
Sbjct: 63  LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHEL 120

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH---G 612
            Y         +H + K  N L+D    ++++D GL+              +  A+   G
Sbjct: 121 GY---------IHRDLKPENFLIDASGHIKLTDFGLS-----------KGIVTYANSVVG 160

Query: 613 SG---APEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
           S    APE   G  Y    D +SLG ++ E L G  P+  S P
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 49/214 (22%), Positives = 99/214 (46%), Gaps = 23/214 (10%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G VYKA+      LA  K+  T S+ + ++  +E+   ++   H  IV+L+G  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI-EILATCNHPYIVKLLGAF 78

Query: 508 NEHGQHLLVYDY--GG--NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
              G+  ++ ++  GG  +  + +L     E        I++ +      ALQYL  +  
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ------IQV-ICRQMLEALQYLHSM-- 129

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE------ 617
             I+H + K+ N+LL     ++++D G++    +  T +  +  +      APE      
Sbjct: 130 -KIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 618 FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
            +   Y  ++D++SLG+ ++E+     P+    P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 31/177 (17%)

Query: 480 QTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSD-EEAH 536
           QT++   E AS      H  +V L        +   V +Y  GG+   H        E H
Sbjct: 43  QTEKHVFEQASN-----HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 97

Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
            +F ++  I +AL       YL E     I++ + K  N+LLD +  ++++D G+     
Sbjct: 98  ARF-YSAEISLAL------NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC---- 143

Query: 597 SGSTNELSEGLLTAHGSG-----APEFESGS-YSCQSDVYSLGVVMLELLTGRKPYD 647
                 L  G  T+   G     APE   G  Y    D ++LGV+M E++ GR P+D
Sbjct: 144 ---KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 19/212 (8%)

Query: 444 EGNFIGEGLLGSVYKAELPGG---KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           EG  +G G  G VYKA+   G   K  A+K++  T        E     + +  L+H N+
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREI----ALLRELKHPNV 60

Query: 501 VELIGYCNEHGQH--LLVYDYGGNCTLHDL-LHSDEEAHKKFSWNIRIRVALGAARALQY 557
           + L      H      L++DY  +   H +  H   +A+KK     R  V     + L  
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 558 LQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAH 611
           +  +    ++H + K +NIL+     E+  V+++D G A  LF+     L+  + ++   
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTF 179

Query: 612 GSGAPEFESGS--YSCQSDVYSLGVVMLELLT 641
              APE   G+  Y+   D++++G +  ELLT
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 31/223 (13%)

Query: 442 FSEGNFI---GEGLLGSVYKAELPGGKL--LAVKKL--SNTVSQRQTDEEFLELASTISR 494
           + + NFI   G G  G V  A         +A+K+   S  + Q+Q D  F E    ++ 
Sbjct: 29  YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE-RKILNY 87

Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + H   V L G   +     LV ++         L  +    K+F  ++    A      
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLI 143

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL------FSGSTNELSEGLL 608
            +YLQ +    IV+ + K  N+LLD+   ++++D G A ++        G+   ++  +L
Sbjct: 144 FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEIL 200

Query: 609 TAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
              G G            +D ++LG+ + E+L G  P+  + P
Sbjct: 201 LNVGHGK----------AADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 22/206 (10%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR---HGNIVEL 503
           IG G  G VYKA  +  G+L A+K     V + +  E+F  +   I  ++   H NIV  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIK-----VIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G      +  +  ++ G  +L D+ H      +        ++A  +   LQ L  +  
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE-------SQIAYVSRETLQGLYYLHS 124

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES--- 620
              +H + K +NILL +   V+++D G++  +   +T    +  +      APE  +   
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQI--TATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 621 -GSYSCQSDVYSLGVVMLELLTGRKP 645
            G Y+   D++++G+  +EL   + P
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 71/291 (24%), Positives = 121/291 (41%), Gaps = 53/291 (18%)

Query: 448 IGEGLLGSVYKAE--LPGGKLLAVKKLSNTVSQRQTDEEFLELAST--ISRLR------H 497
           IGEG  G V+KA     GG+ +A+K++     + QT EE + L++   ++ LR      H
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRV-----RVQTGEEGMPLSTIREVAVLRHLETFEH 63

Query: 498 GNIVELIGYC-----NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIR-VALGA 551
            N+V L   C     +   +  LV+++       DL    ++  +       I+ +    
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEH----VDQDLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
            R L +L       +VH + K  NIL+     ++++D GLA +    S       ++   
Sbjct: 120 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 173

Query: 612 GSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
              APE     SY+   D++S+G +  E+   RKP  R                  D+D 
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSS---------------DVDQ 217

Query: 671 LSRMVD----PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
           L +++D    P  +      +L R A   S+  Q    F   + E+ +DLL
Sbjct: 218 LGKILDVIGLPGEEDWPRDVALPRQA-FHSKSAQPIEKFVTDIDELGKDLL 267

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 28/209 (13%)

Query: 448 IGEGLLGSV----YKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +GEG  G V    Y  E    G+ +AVK L          +   E+   +  L H NIV+
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI-EILRNLYHENIVK 70

Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C E G +   L+ ++  + +L + L  ++    K +   +++ A+   + + YL  
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS 127

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS------- 613
                 VH +  + N+L++ +  V++ D GL   +      E  +   T           
Sbjct: 128 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI------ETDKEYYTVKDDLDSPVFW 178

Query: 614 GAPE-FESGSYSCQSDVYSLGVVMLELLT 641
            APE      +   SDV+S GV + ELLT
Sbjct: 179 YAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 15/90 (16%)

Query: 567 VHGNFKSSNILLDEKLIVRVSDCG----------LAPLLFSGSTNELSEGLLTAHGSGAP 616
           VH + K  N+LLD+   +R++D G          +   +  G+ + +S  +L A   G  
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG-- 181

Query: 617 EFESGSYSCQSDVYSLGVVMLELLTGRKPY 646
               G Y  + D +SLGV M E+L G  P+
Sbjct: 182 ---KGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 29/99 (29%), Positives = 46/99 (46%), Gaps = 15/99 (15%)

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL YL    E  +V+ + K  N++LD+   ++++D GL           + +G       
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLC-------KEGIKDGATMKTFC 157

Query: 614 GAPEF------ESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           G PE+      E   Y    D + LGVVM E++ GR P+
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 16/100 (16%)

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL +L E     I++ + K  N+LLD +  ++++D G+           +  G  T+   
Sbjct: 108 ALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMC-------KEGIRPGDTTSTFC 157

Query: 614 G-----APEFESGS-YSCQSDVYSLGVVMLELLTGRKPYD 647
           G     APE   G  Y    D ++LGV+M E++ GR P+D
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 22/206 (10%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI---SRLRHGNIVEL 503
           +G G  G VYKA  L  G+L AVK     + + +  ++F  +   I      +H NIV  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVK-----IIKLEPGDDFSLIQQEIFMVKECKHCNIVAY 71

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G      +  +  +Y G  +L D+ H      +       +++A      LQ L  +  
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSE-------LQIAYVCRETLQGLAYLHS 124

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----E 619
              +H + K +NILL +   V+++D G+A  +   +T    +  +      APE     +
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFIGTPYWMAPEVAAVEK 182

Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKP 645
           +G Y+   D++++G+  +EL   + P
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 10/93 (10%)

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           R L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +    
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRW 182

Query: 613 SGAPEFESG--SYSCQSDVYSLGVVMLELLTGR 643
             APE       Y+   D++S+G +M ELLTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 28/208 (13%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA----STISRLRHGNIVE 502
           IGEG  G VYKA +    + +A+KK    +   Q DE     A    S +  ++HGNIV 
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKK----IRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDL-LHSDEEAHKKFSWNIR-IRVAL-GAARALQYLQ 559
           L    +   +  LV++Y       DL L    ++   F+ N R I+  L    R + Y  
Sbjct: 66  LQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY-- 117

Query: 560 EVCEP-PIVHGNFKSSNILLDEKL-IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
             C    ++H + K  N+L+D +   ++++D GLA   F       +  ++T     APE
Sbjct: 118 --CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVVTLWYR-APE 173

Query: 618 FESGS--YSCQSDVYSLGVVMLELLTGR 643
              GS  YS   D++S+G +  E++  +
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 36/226 (15%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
             F   + +G G  G V    E   G + A+K +  +V   Q    F E    I  + + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 499 NIVELIGYCNEHGQHL-LVYDY--GGNCTLHDLL--HSD--EEAHKKFSWNIRIRVALGA 551
             +  + Y  +   +L LV +Y  GG+  L  LL  + D  +E   +F +   + +A+ +
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGD--LLSLLNRYEDQFDEDMAQF-YLAELVLAIHS 117

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA----------PLLFSGSTN 601
              + Y         VH + K  N+L+D    ++++D G A            L  G+ +
Sbjct: 118 VHQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168

Query: 602 ELSEGLLTA-HGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY 646
            ++  +LT  +G G      G+Y  + D +SLGV+  E++ GR P+
Sbjct: 169 YIAPEVLTTMNGDG-----KGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 33/108 (30%), Positives = 50/108 (46%), Gaps = 28/108 (25%)

Query: 557 YLQEVC-------EPPIVHGNFKSSNILLDEKLIVRVSD---C--GLAP----LLFSGST 600
           Y  E+C       E  I++ + K  N+LLD    ++++D   C  GL P      F G+ 
Sbjct: 101 YAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160

Query: 601 NELSEGLLTAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYD 647
           N +           APE   G  Y    D ++LGV+M E++ GR P+D
Sbjct: 161 NYI-----------APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 48/153 (31%), Positives = 72/153 (47%), Gaps = 26/153 (16%)

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG-LLTAHGSGAPE--FESGSY 623
           VH +  + N+L+ E  +V++ D GLA  +   S N +S+G         APE  F +  Y
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDS-NYISKGSTFLPLKWMAPESIFNN-LY 318

Query: 624 SCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA 682
           +  SDV+S G+++ E+ T G  PY    P  EQ     AI R +      RM  P     
Sbjct: 319 TTLSDVWSFGILLWEIFTLGGTPYP-ELPMNEQFYN--AIKRGY------RMAKP----- 364

Query: 683 YLAKSLSRFADIISRCVQWEPGF--RPPMSEIV 713
             A +     +I+ +C  WE  F  RP  S++V
Sbjct: 365 --AHASDEIYEIMQKC--WEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 60/244 (24%), Positives = 102/244 (41%), Gaps = 29/244 (11%)

Query: 448 IGEGLLGSVYKA-ELPG---GKLLAVK--KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G V+   ++ G   GKL A+K  K +  V + +T E        +  +R    +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 502 ELIGYCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGA-ARALQY 557
             + Y  +    L L+ DY  GG    H          ++F     +++  G    AL++
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTH------LSQRERFKEQ-EVQIYSGEIVLALEH 120

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L ++    I++ + K  NILLD    V ++D GL+   F     E +          AP+
Sbjct: 121 LHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FHEDEVERAYSFCGTIEYMAPD 176

Query: 618 FESGSYSCQS---DVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-----PRLHDID 669
              G         D +S+GV+M ELLTG  P+     +  Q+ +   I     P   ++ 
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 236

Query: 670 ALSR 673
           AL++
Sbjct: 237 ALAK 240

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 16/99 (16%)

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       +V+ + K  N++LD+   ++++D GL      G ++  +         
Sbjct: 107 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFC---- 156

Query: 614 GAPEF------ESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           G PE+      E   Y    D + LGVVM E++ GR P+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.9 bits (98), Expect = 8e-04
 Identities = 37/135 (27%), Positives = 58/135 (42%), Gaps = 33/135 (24%)

Query: 89  DTLGDLESVINIDLSNNHIGGSIPS---NLPVTVRNFSLSGNQLTGSIPESLSRLTQLLD 145
             L +L ++ ++DL NN+I   IP     L   ++   LS N++  S+P  L  L  L +
Sbjct: 110 SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKN 167

Query: 146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS--- 202
           L L+ N L+                          LP    NLS+L +L L  NK+S   
Sbjct: 168 LDLSFNDLS-------------------------DLPKLLSNLSNLNNLDLSGNKISDLP 202

Query: 203 GTLNVLEDLHLIDLN 217
             + +L  L  +DL+
Sbjct: 203 PEIELLSALEELDLS 217

Length = 394

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 72/284 (25%), Positives = 117/284 (41%), Gaps = 44/284 (15%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIG 505
           IG+G  G V+K      G   AVK L         DEE     + +  L  H N+V+  G
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYG 82

Query: 506 YCNE----HGQHL-LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
              +    +G  L LV +     ++ DL+    +  ++    I   +A     AL  LQ 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI---IAYILHEALMGLQH 139

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE 617
           +     +H + K +NILL  +  V++ D G++  L   ++  L     T+ G+    APE
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL---TSTRLRRN--TSVGTPFWMAPE 194

Query: 618 FES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAIPRLHDIDA 670
             +       +Y  + DV+SLG+  +EL  G  P     P R    + R   P LH  + 
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPEL 254

Query: 671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            S                + F D I +C+  +   RP +S+++Q
Sbjct: 255 WS----------------NEFNDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 44/197 (22%), Positives = 87/197 (44%), Gaps = 11/197 (5%)

Query: 448 IGEGLLGSVY----KAELPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  G+VY    K  +   +L  +K++    ++  +T +   E A  +S+L H  IV+
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE-AQLLSKLDHPAIVK 66

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
                 E     ++ +Y     L   L   +   K  S N      +     + Y+ +  
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-- 124

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS 622
              I+H + K+ NI L +  ++++ D G++ LL  GS +  +    T +       +   
Sbjct: 125 -RRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLM-GSCDLATTFTGTPYYMSPEALKHQG 181

Query: 623 YSCQSDVYSLGVVMLEL 639
           Y  +SD++SLG ++ E+
Sbjct: 182 YDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 23/168 (13%)

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           AR +++L        +H +  + NILL E  +V++ D GLA  ++               
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 612 GSGAPE--FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDI 668
              APE  F+   Y+ QSDV+S GV++ E+ + G  PY   +   E         RL D 
Sbjct: 241 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKD- 292

Query: 669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
              +RM  P      + +       I+  C Q +P  RP  S +V+ L
Sbjct: 293 --GTRMRAPENATPEIYR-------IMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 41/221 (18%)

Query: 447 FIGEGLLG---SVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVE 502
            +G+G  G   S   AE    + +A+KK++N  S++   +  L     +   R H NI  
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66

Query: 503 LI-------GYCNEHGQHLLVYDYGGNCTLHDLLHSD---EEAH-KKFSWNIRIRVALGA 551
           L        G  NE    L +Y+      LH ++ S     +AH + F + I        
Sbjct: 67  LYDMDIVFPGNFNE----LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQI-------- 114

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN-ELSEGLLTA 610
              L+Y+       ++H + K  N+L++    +++ D GLA      S N   + G +T 
Sbjct: 115 LCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR---GFSENPGENAGFMTE 168

Query: 611 HGSG----APE--FESGSYSCQSDVYSLGVVMLELLTGRKP 645
           + +     APE      SY+   DV+S+G ++ ELL GRKP
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 42/158 (26%), Positives = 62/158 (39%), Gaps = 30/158 (18%)

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE--FESGSYS 624
           +H +  + NILL E  +V++ D GLA  ++                  APE  F+   Y+
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYT 259

Query: 625 CQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            QSDV+S GV++ E+ + G  PY     D    R  +   R   P     +    M+D  
Sbjct: 260 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-- 317

Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                              C   EP  RP  SE+V+ L
Sbjct: 318 -------------------CWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 40.6 bits (96), Expect = 0.002
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 42/220 (19%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNT--VSQRQTDEEFLELASTISRLRHGNIVELI 504
           +G G  G V        GK  A+K LS    V  +Q +    E    +  +RH  +V L 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEK-RILQSIRHPFLVNLY 67

Query: 505 GYCNEHGQHL-LVYDY--GGNCTLHDLLHSD---EEAHKKFSWNIRIRVALGAAR---AL 555
           G   +   +L LV +Y  GG   L   L       E   +F           AA+   AL
Sbjct: 68  G-SFQDDSNLYLVMEYVPGGE--LFSHLRKSGRFPEPVARFY----------AAQVVLAL 114

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS---EGLLTAHG 612
           +YL    +  IV+ + K  N+LLD    ++++D G A  +  G T  L    E L     
Sbjct: 115 EYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLCGTPEYL----- 165

Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSR 650
             APE   S  Y    D ++LG+++ E+L G  P +D + 
Sbjct: 166 --APEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 27/211 (12%)

Query: 448 IGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN-IVELIG 505
           +G+G  G V  A L   G+L AVK L   V  +  D E       I  L   +  +  + 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 506 YCNEHGQHLL-VYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
            C +    L  V ++  GG+   H       +  ++F      R    AA     L  + 
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHI------QKSRRFD---EARARFYAAEITSALMFLH 113

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF---- 618
           +  I++ + K  N+LLD +   +++D G+           +  G  T+   G P++    
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMC-------KEGIFNGKTTSTFCGTPDYIAPE 166

Query: 619 --ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
             +   Y    D +++GV++ E+L G  P++
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 23/208 (11%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G+G  G V  AEL G G+  AVK L   V     D E   +   +  L   N      Y
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 507 CN----EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           C     EH   ++ +  GG+   H           K  +++  R    AA  +  LQ + 
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFH--------IQDKGRFDL-YRATFYAAEIVCGLQFLH 113

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APEFE 619
              I++ + K  N++LD    ++++D G+      G  N  S    T  G+    APE  
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS----TFCGTPDYIAPEIL 168

Query: 620 SG-SYSCQSDVYSLGVVMLELLTGRKPY 646
            G  Y+   D +S GV++ E+L G+ P+
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 27/211 (12%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRL--RHGNIVELI 504
           +G+G  G V  AEL G  ++ A+K L   V  +  D +       I  L  +H  +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 505 GYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
                  +   V +Y  GG     DL+   + + +KF      R    AA     L  + 
Sbjct: 63  CCFQTKDRLFFVMEYVNGG-----DLMFQIQRS-RKFDEP---RSRFYAAEVTLALMFLH 113

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF---- 618
              +++ + K  NILLD +   +++D G+           +  G+ T    G P++    
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMC-------KEGILNGVTTTTFCGTPDYIAPE 166

Query: 619 --ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
             +   Y    D ++LGV+M E++ G+ P++
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 40/166 (24%), Positives = 60/166 (36%), Gaps = 33/166 (19%)

Query: 547 VALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG 606
           V L    AL+ L         H   KS NILL    ++++   G   + F        + 
Sbjct: 22  VCLQCLGALREL---------HRQAKSGNILLTWDGLLKLD--GS--VAFKTPEQSRPDP 68

Query: 607 LLTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL 665
                   APE   G SY+ ++D+YSLG+ + E L    PY+      E+ L       L
Sbjct: 69  YF-----MAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE-----ERELS----AIL 114

Query: 666 HDIDALSRMVDPSLDGAYLAKSLSR---FADIISRCVQWEPGFRPP 708
             +  L+ M           + +S    F D +  C    P  R  
Sbjct: 115 EIL--LNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREA 158

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 29/149 (19%), Positives = 65/149 (43%), Gaps = 15/149 (10%)

Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSC 625
           ++H + K +N+ +    +V++ D GL    FS  T      + T +           Y+ 
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSPERIHENGYNF 185

Query: 626 QSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLA 685
           +SD++SLG ++ E+   + P+      G++  +     ++   D       P L   + +
Sbjct: 186 KSDIWSLGCLLYEMAALQSPF-----YGDKMNLFSLCQKIEQCDY------PPLPTEHYS 234

Query: 686 KSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           +   +  +++S C+  +P  RP +  + Q
Sbjct: 235 E---KLRELVSMCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 64/230 (27%), Positives = 95/230 (41%), Gaps = 37/230 (16%)

Query: 448 IGEGLLGSVYKAELPGG----KLLAVKKLSNT--VSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G V+      G    KL A+K L     V + +T E      + +  +R    +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 502 ELIGYCNEHGQHL-LVYDY--GGNCTLH----DLLHSDEEAHKKFSWNIRIRVALGAA-R 553
             + Y  +    L L+ DY  GG    H    D    DE           +R   G    
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE-----------VRFYSGEIIL 116

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL++L ++    IV+ + K  NILLD +  V ++D GL+    S    E  E   +  G+
Sbjct: 117 ALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS----EEKERTYSFCGT 169

Query: 614 ---GAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV 658
               APE     G +    D +SLG+++ ELLTG  P+     R  QS V
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 25/222 (11%)

Query: 428 SVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTV-SQRQTDEEFL 486
           S FT+    Q       G    +G++ + +   L  G  +AVKKLS    +Q      + 
Sbjct: 15  STFTVLKRYQQLKPIGSG---AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR 69

Query: 487 ELASTISRLRHGNIVELIGYCN-----EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSW 541
           EL   +  + H NI+ L+         E  Q + +     +  L  ++H + + H++ S+
Sbjct: 70  ELV-LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD-HERMSY 127

Query: 542 NIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN 601
            +         + L  ++ +    I+H + K SNI++     +++ D GLA    +  TN
Sbjct: 128 LLY--------QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTN 176

Query: 602 ELSEGLLTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTG 642
            +    +      APE   G  Y    D++S+G +M EL+ G
Sbjct: 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 25/220 (11%)

Query: 448 IGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEE-----FLELASTISRLRHGNIV 501
           +GEG   +V+K        L+A+K++      R   EE      +   S +  L+H NIV
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEI------RLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSW-NIRIRVALGAARALQYLQE 560
            L    +      LV++Y  +    DL    +      S  N++I       R L Y  +
Sbjct: 67  TLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHK 121

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES 620
                I+H + K  N+L++EK  ++++D GLA    S  T   S  ++T      P+   
Sbjct: 122 ---RKILHRDLKPQNLLINEKGELKLADFGLARAK-SVPTKTYSNEVVTLWYR-PPDVLL 176

Query: 621 GS--YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV 658
           GS  YS   D++ +G ++ E+ TGR  +  S  + E  L+
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 19/110 (17%)

Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL---------LF 596
           R     A  L  L+ + +  +++ + K  NILLD +  + + D GL  L          F
Sbjct: 94  RARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153

Query: 597 SGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY 646
            G+   L+  LL  HG          Y+   D ++LGV++ E+LTG  P+
Sbjct: 154 CGTPEYLAPELLLGHG----------YTKAVDWWTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 40.1 bits (93), Expect = 0.003
 Identities = 31/103 (30%), Positives = 46/103 (44%), Gaps = 24/103 (23%)

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG- 612
           AL YL       IV+ + K  N++LD+   ++++D GL             EG+  A   
Sbjct: 107 ALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLC-----------KEGITDAATM 152

Query: 613 ---SGAPEF------ESGSYSCQSDVYSLGVVMLELLTGRKPY 646
               G PE+      E   Y    D + LGVVM E++ GR P+
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 19/203 (9%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +    + +AVKKLS    + +  R+T  E L L   +  ++H N+  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRE-LRL---LKHMKHENV-- 76

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
            IG  +       + ++     + +L+ +D     K        V     + L+ L+ + 
Sbjct: 77  -IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG- 621
              I+H + K SN+ ++E   +R+ D GLA        ++   G +      APE     
Sbjct: 136 SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNW 190

Query: 622 -SYSCQSDVYSLGVVMLELLTGR 643
             Y+   D++S+G +M ELL G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	720
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
PRK10345	210	hypothetical protein; Provisional	99.75
PLN03150	623	hypothetical protein; Provisional	99.74
smart00090	237	RIO RIO-like kinase.	99.71
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.67
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.66
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.65
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.62
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.56
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.55
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.54
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.53
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.46
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.45
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.45
PLN03150	623	hypothetical protein; Provisional	99.45
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.3
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.26
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.25
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.21
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.21
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.18
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.18
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.17
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.17
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.14
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.11
KOG1243	690	consensus Protein kinase [General function predict	99.1
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.1
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.07
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.04
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.0
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.97
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.96
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.89
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.88
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.86
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.83
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.82
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.8
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.76
KOG3087	229	consensus Serine/threonine protein kinase [General	98.75
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.74
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.72
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.62
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.56
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.47
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.47
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.45
COG4248	637	Uncharacterized protein with protein kinase and he	98.43
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.42
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.41
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.4
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.31
PRK09902	216	hypothetical protein; Provisional	98.31
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.3
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.3
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.29
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.23
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.06
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.04

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-61  Score=588.67  Aligned_cols=537  Identities=26%  Similarity=0.412  Sum_probs=345.1

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccccccc
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN  149 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~  149 (720)
                      +|+.|+|++|++++.+|..+..+++|+.|+|++|+++|.+|..+.  .+|+.|+|++|++.|.+|..+ .+++|+.|+|+
T Consensus       405 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls  483 (968)
T PLN00113        405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLS  483 (968)
T ss_pred             CCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECc
Confidence            444444444444444444444455555555555555544444332  456666666666665555544 34667777778


Q ss_pred             ccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCcccC
Q 004994          150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSGPI  227 (720)
Q Consensus       150 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g~~  227 (720)
                      +|++++.+|..|.++++|+.|+|++|++++.+|..+.++++|+.|+|++|.++|.++ .+..+. |+.|+|++|+++|.+
T Consensus       484 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  563 (968)
T PLN00113        484 RNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEI  563 (968)
T ss_pred             CCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccC
Confidence            888888888888888888888888888888888888888889999999999888775 455554 888999999999999


Q ss_pred             CcccCCCccccccCccCCCcccCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CcccCcccccccccCcchHHHHHHHHHH
Q 004994          228 PEKLLSIPNFRKDGNPFNTTVIALPPTAIPPSIAPAPTFQAPGDQADAPS--AFEMTNSAKAKKFWTTKRVIWVALSAAA  305 (720)
Q Consensus       228 p~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~v~~i~~~  305 (720)
                      |..+..++.|+..+...|...+..|................+......+.  ..++..   ..+ . ....++|++++++
T Consensus       564 p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~---~~~-~-~~~~~~~~~~~~~  638 (968)
T PLN00113        564 PKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR---VRK-T-PSWWFYITCTLGA  638 (968)
T ss_pred             ChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc---ccc-c-ceeeeehhHHHHH
Confidence            98887777766655555555444543322111100000000000000000  000110   000 1 1111122222222


Q ss_pred             HHHHHHHHHHHHHHHHhhccccccCCCCCcccCCCCCCCCCCCCCCCCCCccccccCccccccCCCCccccccccCCCCC
Q 004994          306 ILCALGCSLFMWRYCKTRRVNRDAEKNTGTYKGHGEKPNYKNSPLQPSGQVEEVSKEPVVKSQDGHGVDSRRMVSSPRPQ  385 (720)
Q Consensus       306 ~~~~l~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (720)
                      +++++++++ ++.++++|++...  +......                +     .++..                     
T Consensus       639 ~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~----------------~-----~~~~~---------------------  673 (968)
T PLN00113        639 FLVLALVAF-GFVFIRGRNNLEL--KRVENED----------------G-----TWELQ---------------------  673 (968)
T ss_pred             HHHHHHHHH-HHHHHHhhhcccc--ccccccc----------------c-----ccccc---------------------
Confidence            222222222 2223332221110  0000000                0     00000                     


Q ss_pred             CCCCCCCCCCCCcccccccCCCCccccccCCCCCCCccCCcccccCHHHHHHHhcCCCCCCeeccCCCceEEEEEe-CCC
Q 004994          386 DEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGG  464 (720)
Q Consensus       386 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g  464 (720)
                                  ...                       ......++.+++   ...|...++||+|+||.||+|.. .+|
T Consensus       674 ------------~~~-----------------------~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~  715 (968)
T PLN00113        674 ------------FFD-----------------------SKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNG  715 (968)
T ss_pred             ------------ccc-----------------------cccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCC
Confidence                        000                       000011233333   34577788999999999999975 578


Q ss_pred             cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHH
Q 004994          465 KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR  544 (720)
Q Consensus       465 ~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~  544 (720)
                      ..||||++.....      ...+|++++++++|||||+++|+|.+.+..++||||+++|+|.++++       .++|..+
T Consensus       716 ~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~  782 (968)
T PLN00113        716 MQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERR  782 (968)
T ss_pred             cEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHH
Confidence            9999999864321      11245888999999999999999999999999999999999999984       3789999


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCC
Q 004994          545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSY  623 (720)
Q Consensus       545 ~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~  623 (720)
                      .+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+......      ....++.+|+|||+. .+.+
T Consensus       783 ~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~  855 (968)
T PLN00113        783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDI  855 (968)
T ss_pred             HHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCC
Confidence            9999999999999998878899999999999999999988876 6665443211      123567899999998 5579


Q ss_pred             CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch--hhHHHHHHHHHHHHHHhcc
Q 004994          624 SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA--YLAKSLSRFADIISRCVQW  701 (720)
Q Consensus       624 ~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~  701 (720)
                      +.++|||||||++|||+||+.||+.... ....+++|+.....+ .....++|+.+...  ...+...++.+++.+||+.
T Consensus       856 ~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~  933 (968)
T PLN00113        856 TEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT  933 (968)
T ss_pred             CcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcC
Confidence            9999999999999999999999964322 223455555433222 22345566655332  2345566788999999999


Q ss_pred             CCCCCCCHHHHHHHHHhh
Q 004994          702 EPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       702 dP~~RPt~~evl~~L~~~  719 (720)
                      ||++||||+||++.|+++
T Consensus       934 ~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        934 DPTARPCANDVLKTLESA  951 (968)
T ss_pred             CchhCcCHHHHHHHHHHh
Confidence            999999999999999986

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-56  Score=468.24  Aligned_cols=287  Identities=47%  Similarity=0.802  Sum_probs=252.5

Q ss_pred             cccccCHHHHHHHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEe
Q 004994          426 SVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIG  505 (720)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~  505 (720)
                      ....|+++++..+|++|...++||+|+||.||+|.+.+|..||||++.......  .++|..|++++.+++|||+|+|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG  138 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG  138 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence            456799999999999999999999999999999999999999999887543322  566999999999999999999999


Q ss_pred             EeccCC-eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCe
Q 004994          506 YCNEHG-QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIV  584 (720)
Q Consensus       506 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  584 (720)
                      ||.+.+ +.+||||||++|+|.++++.....  .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            999988 599999999999999999875433  78999999999999999999999999899999999999999999999


Q ss_pred             EEccccCCCCCCCCCCcccccCc-cccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 004994          585 RVSDCGLAPLLFSGSTNELSEGL-LTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       585 kl~DFGla~~~~~~~~~~~~~~~-~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      ||+|||+|+........  .... .||.+|+||||. .+..+.|+|||||||+|+|++||+.|.+...+.....++.|+.
T Consensus       217 KlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~  294 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK  294 (361)
T ss_pred             EccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence            99999999765431111  1112 789999999999 6899999999999999999999999998766666677899987


Q ss_pred             cccCchhhhhhhcCCCCC-chhhH-HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          663 PRLHDIDALSRMVDPSLD-GAYLA-KSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      +.+.+. .+.+++|+.+. +.+.. ++...+..++.+|++.+|.+||+|.||+++|+.+
T Consensus       295 ~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  295 PLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            777665 78899999987 55554 6788899999999999999999999999999764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-48  Score=385.73  Aligned_cols=250  Identities=27%  Similarity=0.432  Sum_probs=206.6

Q ss_pred             CCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC-eEEEEEeeC
Q 004994          443 SEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG-QHLLVYDYG  520 (720)
Q Consensus       443 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~  520 (720)
                      +..+.||+|..|+|||+.+ .+++.+|+|++... .+....++..+|++++++.+|||||.+||.|...+ +..++||||
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            3457899999999999966 57999999999543 34566789999999999999999999999999888 599999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      ++|||.+++..    .+.+++....+|+.+|.+||.|||+.  .+||||||||+|||++..|++||||||.++.+..+  
T Consensus       161 DgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  161 DGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             CCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999999853    25688999999999999999999974  38999999999999999999999999999987543  


Q ss_pred             cccccCccccccCCCCccCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCC
Q 004994          601 NELSEGLLTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL  679 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  679 (720)
                        ......||..|||||.+.+ .|+.++||||||+.++|+.+|+.||....+.. .+          -.+-+..+++...
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~----------~~~Ll~~Iv~~pp  299 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LD----------IFELLCAIVDEPP  299 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CC----------HHHHHHHHhcCCC
Confidence              4556889999999999955 79999999999999999999999997541100 00          0122333333111


Q ss_pred             CchhhH-HHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          680 DGAYLA-KSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       680 ~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      + ..+. ..+++|++|+..||++||.+|||++|+++|
T Consensus       300 P-~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  300 P-RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             C-CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1 1222 467899999999999999999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=400.66  Aligned_cols=252  Identities=33%  Similarity=0.512  Sum_probs=208.2

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC-eEEEEEeeCCCC
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG-QHLLVYDYGGNC  523 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~~g  523 (720)
                      .+.||+|+||+||+|.+.+...||||++..........++|.+|+.+|.+++|||||+++|+|.+.. ...+|||||++|
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            4559999999999999976656999999865433333679999999999999999999999999887 799999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCeEEcCCC-CeEEccccCCCCCCCCCCc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP-IVHGNFKSSNILLDEKL-IVRVSDCGLAPLLFSGSTN  601 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~-ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~~~~  601 (720)
                      +|.++++..  ....+++..+++++.+||+||.|||+.   + ||||||||+|||++.++ ++||+|||+++......  
T Consensus       126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            999999753  357899999999999999999999997   5 99999999999999998 99999999998764321  


Q ss_pred             ccccCccccccCCCCccCCC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          602 ELSEGLLTAHGSGAPEFESG---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       602 ~~~~~~~~~~~~~aPE~~~~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .......||+.|||||.+.+   .|+.|+|||||||+||||+||+.||....+..                ....++...
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~----------------~~~~v~~~~  262 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ----------------VASAVVVGG  262 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHHhcC
Confidence            22233678999999999974   49999999999999999999999998654311                111111111


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .....+..++..+..++.+||+.||+.||++.|++..|+.+
T Consensus       263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            12222233567888999999999999999999999999865

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-46  Score=371.97  Aligned_cols=253  Identities=21%  Similarity=0.332  Sum_probs=204.5

Q ss_pred             HhcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccc-----cHHHHHHHHHHHHccCCCceeEEEeEeccCC
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQ-----TDEEFLELASTISRLRHGNIVELIGYCNEHG  511 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  511 (720)
                      +.+.|...+.||+|+||.|-+| ..++|+.||||++.+......     ......+|+++|++|+|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4567778899999999999999 667899999999986543221     1223469999999999999999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC---CCeEEcc
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK---LIVRVSD  588 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~D  588 (720)
                      ..||||||++||+|.+.+...    +.+....-.-++.|+..|+.|||+.   ||+||||||+|||+..+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence            999999999999999998543    4455556677999999999999998   99999999999999765   7899999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccCC-C--C-CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFES-G--S-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~--~-~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                      ||+|+..+.   ..+....+||+.|.|||++. +  . +..++|+||+|||||-+++|.+||.+......          
T Consensus       323 FGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----------  389 (475)
T KOG0615|consen  323 FGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----------  389 (475)
T ss_pred             cchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----------
Confidence            999998753   34566789999999999983 2  2 34589999999999999999999976432210          


Q ss_pred             cCchhhhhhhcCCCC--CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          665 LHDIDALSRMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                           ...++...+.  ...++.+..++..+++.+||..||++|||+.|++++
T Consensus       390 -----l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  390 -----LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             -----HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                 0011111111  123456677889999999999999999999999975

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=383.06  Aligned_cols=249  Identities=27%  Similarity=0.420  Sum_probs=209.5

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCC
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCT  524 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  524 (720)
                      .+.||+|.||+||.|.++....||+|.++..   ....+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.|+
T Consensus       211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            4679999999999999988889999999754   3456789999999999999999999999999889999999999999


Q ss_pred             HHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccc
Q 004994          525 LHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS  604 (720)
Q Consensus       525 L~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  604 (720)
                      |.++|+..  ....+...+.+.++.|||+|++||++.   ++|||||.++|||++++..+||+|||+|+...+..+ ...
T Consensus       288 Ll~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~~  361 (468)
T KOG0197|consen  288 LLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TAS  361 (468)
T ss_pred             HHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce-eec
Confidence            99999862  356788889999999999999999998   899999999999999999999999999996544332 233


Q ss_pred             cCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch
Q 004994          605 EGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA  682 (720)
Q Consensus       605 ~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (720)
                      .+..-...|.|||.+ .+.|+.|||||||||+||||+| |+.||......                 .+.+.++....-.
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----------------ev~~~le~GyRlp  424 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----------------EVLELLERGYRLP  424 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----------------HHHHHHhccCcCC
Confidence            333335678899998 7889999999999999999999 99999754322                 1222233333333


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          683 YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       683 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .+..|++++.++|..||+.+|++|||++.+...|+++
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            4556778999999999999999999999999998875

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-44  Score=380.29  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=210.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ..|..+++||+|||++||+++. .+|+.||+|++.+... .....+....|+++.+.|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5789999999999999999965 8899999999976432 3455677889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      |+|.+++|.++++    .++.+++.+...++.||+.||.|||+.   +|||||||-.|++|+++.++||+|||+|..+..
T Consensus        98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999985    457899999999999999999999998   999999999999999999999999999998854


Q ss_pred             CCCcccccCccccccCCCCccCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .+  .......||+.|.|||++.+ ..+..+||||+|||||.|++|++||+...-.+....++..              +
T Consensus       171 ~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--------------~  234 (592)
T KOG0575|consen  171 DG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--------------E  234 (592)
T ss_pred             cc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--------------C
Confidence            32  23345889999999999954 5789999999999999999999999765433332222211              1


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..    .+...+.+..+||.++|+.||.+|||+++|+.+
T Consensus       235 Y~----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  235 YS----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             cc----cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            11    112334577899999999999999999999975

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-45  Score=354.14  Aligned_cols=266  Identities=21%  Similarity=0.347  Sum_probs=208.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      +.|+...++|+|+||+|||++. ++|+.||||++.....+....+-.++|+++|++++|+|+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            3577778999999999999965 569999999998766555666778999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |++.--|.++-    .....++.....+++.|+++|+.|+|+.   ++|||||||+|||++.++.+||||||+|+.+...
T Consensus        82 ~~dhTvL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDHTVLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecchHHHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            99985444432    3445678888999999999999999987   8999999999999999999999999999998632


Q ss_pred             CCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc--------h
Q 004994          599 STNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD--------I  668 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------~  668 (720)
                        .........|+||+|||.+-  .+|+..+||||+||++.||+||++-|.+..+.+....++.....+..        .
T Consensus       155 --gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  155 --GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             --cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence              33445578899999999983  47999999999999999999999999876554443333332222211        0


Q ss_pred             hhhhhhcCCCCC------chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLD------GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+..+.-|...      ..++ .....+.++++.||+.||++|++.+|++.+
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            111111111111      1122 233467899999999999999999999864

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=363.42  Aligned_cols=203  Identities=27%  Similarity=0.447  Sum_probs=181.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ..+|...+.||+|+|++||+|++ +++..||||.+.+....+...+-...|+++|++++|||||.++++++..+.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            35788888899999999999976 46899999999876555667778899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC------CCeEEccccC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK------LIVRVSDCGL  591 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~------~~~kl~DFGl  591 (720)
                      |||.+|+|.++++.    +..+++......+.|+|.||++||+.   +||||||||.||||+..      -.+||+|||+
T Consensus        89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999964    34788899999999999999999998   89999999999999764      4689999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP  651 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~  651 (720)
                      |+.+..   ..+.....|++.|||||+. .++|+.|+|+||.|+|+||+++|+.||+....
T Consensus       162 AR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  162 ARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             hhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            999864   3455668899999999999 88999999999999999999999999986544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-45  Score=351.71  Aligned_cols=259  Identities=22%  Similarity=0.323  Sum_probs=212.0

Q ss_pred             CCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEe-EeccCCe-EEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIG-YCNEHGQ-HLLVY  517 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~-~~lv~  517 (720)
                      +|.+.++||+|.||+|||+ .+.+|..||.|.+.-...+.+..+.+..|+.+|++|+|||||++++ -+.++.+ ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            4566788999999999999 5689999999999865556677788999999999999999999998 4444444 89999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE-PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~-~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      ||++.|+|..+++...+.++.++++..++++.|+++||..+|.... .-|+||||||.||+++.+|.|||+|||+++++.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            9999999999998888888899999999999999999999998432 239999999999999999999999999999985


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ..  ........||++||+||.+ ...|+.|+||||+||++|||..-++||.+..-      .+          -..++-
T Consensus       180 s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~----------L~~KI~  241 (375)
T KOG0591|consen  180 SK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LS----------LCKKIE  241 (375)
T ss_pred             ch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HH----------HHHHHH
Confidence            43  3455568899999999999 56799999999999999999999999975421      10          011111


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      .......-.+..+..+..++..|+..||+.||+.-.+++++.
T Consensus       242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            111111112445678899999999999999999666666554

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-43  Score=364.34  Aligned_cols=267  Identities=24%  Similarity=0.371  Sum_probs=208.6

Q ss_pred             hcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC--CeEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l  515 (720)
                      .+.|+..+.||+|+||.|||| +..+|+.||+|+++..........-..+||.+|++|+||||+++.+...+.  +.+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            345677789999999999999 668899999999987666667777789999999999999999999988765  78999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      |+|||+. +|.-++..   ..-.|+..++..++.|+++||.|+|..   +|+|||||.+|||||.+|++||+|||+|+++
T Consensus       196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            9999998 78777753   245789999999999999999999998   9999999999999999999999999999988


Q ss_pred             CCCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh----------hhccc
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV----------RWAIP  663 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~----------~~~~~  663 (720)
                      ........+ ...-|.||+|||.+-|  .|+.++|+||.||||.||++|++.|.+..+.+....+          .|...
T Consensus       269 ~~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  269 TPSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cCCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            665443333 3455889999999844  6999999999999999999999999876543322211          12222


Q ss_pred             ccCchhhhhhhcC--CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          664 RLHDIDALSRMVD--PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       664 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                      .++....+...-.  ..+.+ .....+....+|+..+|..||++|.|+.++++
T Consensus       348 kLP~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            2221111000000  00000 01122456789999999999999999999985

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.8e-43  Score=332.03  Aligned_cols=266  Identities=23%  Similarity=0.329  Sum_probs=210.3

Q ss_pred             cCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ..|...+++|+|.||.||+| +.++|+.||||+++.............+|++.|++++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            35777889999999999999 56789999999998765555566788999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      ||+. +|+.++++.   ...++..+...++.++.+|++|+|..   .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus        82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9997 899998653   45678888999999999999999997   8999999999999999999999999999998654


Q ss_pred             CCcccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh--hcccc---------c
Q 004994          599 STNELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR--WAIPR---------L  665 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~--~~~~~---------~  665 (720)
                      .....  ...-|.||+|||.+  +..|+..+|+||.|||+.||+-|.+-|.+..+.+....+-  ...|.         +
T Consensus       155 ~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  155 NRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             Ccccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            43322  23678999999988  4579999999999999999999987776554433222211  11111         1


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ++...+...-.+.... ....+.+...+|+.+++..||.+|+|+.|++++
T Consensus       233 pdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            2222222111222222 223344556899999999999999999999875

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-42  Score=355.18  Aligned_cols=265  Identities=24%  Similarity=0.354  Sum_probs=217.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .+.....+.||+|.||+|..+....+..||||.++... ......+|.+|+++|.+++|||||+++|+|..++.+++|+|
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            44566678999999999999999888999999998654 34556899999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      ||++|+|.+++...+..  ...-....+|+.|||.||+||.+.   ++|||||.++|+|+|.++++||+|||+++-+..+
T Consensus       616 YmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence            99999999999765322  234556778999999999999998   9999999999999999999999999999998888


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh--CCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT--GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      .+........-...|||+|.+ .++++.++|||+|||.+||+++  .+.||.....+.   .++-....+.+..      
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~------  761 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQG------  761 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCC------
Confidence            877776666677899999987 8999999999999999999976  888997543322   1111111111100      


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       ...--..+..++.++.+++.+||..|.++||+++++...|++.
T Consensus       762 -~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 -RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence             1111123455678899999999999999999999999998863

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-43  Score=348.20  Aligned_cols=242  Identities=24%  Similarity=0.319  Sum_probs=199.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..++||+|+||+||.++. ++++.||+|++++... .....+....|..+|.+++||.||+++-.|++.+.+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            5788899999999999999954 5699999999986543 3345677889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+.||.|...|..    ...|++....-++..|+.||.|||+.   +||||||||+|||||.+|+++|+|||+++....
T Consensus       105 d~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  105 DYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             eccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999853    45688888888999999999999998   999999999999999999999999999986533


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .  ...+...+||+.|||||++ ...|+..+|+||+||++|||++|.+||...+.......+                ..
T Consensus       178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I----------------~~  239 (357)
T KOG0598|consen  178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI----------------LK  239 (357)
T ss_pred             C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH----------------hc
Confidence            2  2234457899999999998 668999999999999999999999999765433221111                11


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCC
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRP  707 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  707 (720)
                      ..+. ..+.-...+.++++.+.|..||++|.
T Consensus       240 ~k~~-~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  240 GKLP-LPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CcCC-CCCccCCHHHHHHHHHHhccCHHHhc
Confidence            1100 01111235788999999999999995

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.9e-43  Score=383.79  Aligned_cols=256  Identities=27%  Similarity=0.439  Sum_probs=217.8

Q ss_pred             CCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          443 SEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       443 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ...+.||+|+||+||+|+..      +...||||.+++.. ..+..++|++|++++..++|||||+++|+|.+++..++|
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv  567 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV  567 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence            34577999999999999753      34689999998653 345678999999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccch----------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEE
Q 004994          517 YDYGGNCTLHDLLHSDEE----------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRV  586 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  586 (720)
                      +|||..|||.++|.....          ...+++..+.+.||.|||.|+.||-+.   .+|||||..+|+|+.++..|||
T Consensus       568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI  644 (774)
T KOG1026|consen  568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI  644 (774)
T ss_pred             EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence            999999999999964311          133488899999999999999999987   7999999999999999999999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                      +|||++|.....++........-...|||||.+ .++|+.+||||||||||||+++ |+.||.+...             
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------------  711 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------------  711 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------------
Confidence            999999999888777666555567789999988 7899999999999999999998 9999965332             


Q ss_pred             cCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                         .+.+..+.+..+ -..++.++.++.+||..||+..|++||+++||-..|+.+
T Consensus       712 ---~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  712 ---QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             ---HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence               233333334444 345677889999999999999999999999999999864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=361.66  Aligned_cols=267  Identities=22%  Similarity=0.356  Sum_probs=211.8

Q ss_pred             HhcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCC-eEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHG-QHL  514 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~  514 (720)
                      +.++|...+.||.|+||.||+|+ ..+|..||||++++..... ..-.=++|++.|+++. |||||++.+++.+.+ .+|
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            44677788999999999999994 5679999999998664332 2223368999999998 999999999999988 999


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +|||||+. +|.++++++   .+.|+...+..|+.||.+||+|+|..   |+.|||+||+|||+.....+||+|||+||.
T Consensus        87 fVfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence            99999985 999999754   67899999999999999999999987   999999999999999889999999999998


Q ss_pred             CCCCCCcccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc--cccC---c
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI--PRLH---D  667 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~---~  667 (720)
                      +....   -......|+||+|||++  ++.|+.+.|+||+|||++|+.+-++-|.+..+.+....+-.+.  +.-.   .
T Consensus       160 v~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  160 VRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            75432   23456789999999998  7889999999999999999999999998766544433322221  1111   1


Q ss_pred             hhhhhhhcCCCCC---ch----hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDALSRMVDPSLD---GA----YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~~~~~~~~~~~---~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...+...+.-.++   +.    ....++.++.+++.+|+.+||.+|||++|++++
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1122222222221   11    112256788999999999999999999999875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-42  Score=354.95  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=207.5

Q ss_pred             HHhcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccc-cccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  513 (720)
                      +--++|..++.||+|+|++||+| +.++++.||||++.+...- ....+....|-++|.+| .||.||+|+..|.+...+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34468999999999999999999 5567999999999765332 23345667888889999 899999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      |+|+||+++|+|.++++.    ...|+......++.+|..||+|||..   |||||||||+|||||+|+++||+|||.|+
T Consensus       150 YFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             EEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence            999999999999999964    35788888889999999999999998   99999999999999999999999999999


Q ss_pred             CCCCCCCc---------ccc--cCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 004994          594 LLFSGSTN---------ELS--EGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA  661 (720)
Q Consensus       594 ~~~~~~~~---------~~~--~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~  661 (720)
                      .+.+....         ...  ..+.||..|.+||++ .+..+..+|+|+||||+|+|+.|++||...++-.        
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl--------  294 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL--------  294 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH--------
Confidence            98653221         111  347899999999999 5678999999999999999999999997654321        


Q ss_pred             ccccCchhhhhhhc--CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          662 IPRLHDIDALSRMV--DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       662 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                              .+.+++  +..+...    .++.+.+|+.+.|..||.+|+|.+||-+|
T Consensus       295 --------iFqkI~~l~y~fp~~----fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  295 --------IFQKIQALDYEFPEG----FPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             --------HHHHHHHhcccCCCC----CCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                    122222  2222222    23567899999999999999999998775

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=358.55  Aligned_cols=266  Identities=27%  Similarity=0.420  Sum_probs=210.9

Q ss_pred             HHHHHHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe
Q 004994          433 ASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       433 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  512 (720)
                      ++.....+.+..++.||+|.||+||||.+.+  .||||++..........+.|..|+..+++-+|.||+-+.|||...+.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            4444445566678999999999999998754  59999998766556677899999999999999999999999998877


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                       .||+.+|++-+|+.++|-.+   ..|+..+.+.||.|+|+|+.|||..   +|||||||..||++++++.|||+|||++
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence             99999999999999998543   5688889999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcccccCccccccCCCCccC----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFE----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      ..-.............+..-|||||++    ..+|+..+||||||+|+|||+||..||.....+    .+.|.+.+    
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d----qIifmVGr----  607 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD----QIIFMVGR----  607 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh----heEEEecc----
Confidence            654222111122233456779999987    235999999999999999999999999843221    12222111    


Q ss_pred             hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                          ....+.+. ..-..++.++.+|+..||..++++||.+.+|+..|++++
T Consensus       608 ----G~l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  608 ----GYLMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             ----cccCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence                00001110 112345678999999999999999999999999998874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.6e-41  Score=360.34  Aligned_cols=262  Identities=24%  Similarity=0.391  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccC-
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEH-  510 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-  510 (720)
                      .++|...+.||+|+||.||+|..      .+++.||||++.... .....+.+.+|++++.++ +|||||+++++|... 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            35788889999999999999963      235689999997532 223446789999999999 899999999988764 


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchh-------------------------------------------------------
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEA-------------------------------------------------------  535 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------  535 (720)
                      +..++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            4688999999999999998642110                                                       


Q ss_pred             ---ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCcccccc
Q 004994          536 ---HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG  612 (720)
Q Consensus       536 ---~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~  612 (720)
                         ...+++....+++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               13478888999999999999999987   999999999999999999999999999987643322222222345678


Q ss_pred             CCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHH
Q 004994          613 SGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSR  690 (720)
Q Consensus       613 ~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  690 (720)
                      |+|||.+ ...++.++|||||||++|||++ |+.||........  ...             .+.+.. ....+...+.+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~-------------~~~~~~-~~~~~~~~~~~  305 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ-------------RLKDGT-RMRAPENATPE  305 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH-------------HHhcCC-CCCCCCCCCHH
Confidence            9999987 5678999999999999999997 9999975332110  000             000000 00011223457


Q ss_pred             HHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          691 FADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       691 l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      +.+++.+||+.||++|||+.|+++.|++++
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=345.76  Aligned_cols=254  Identities=28%  Similarity=0.409  Sum_probs=199.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC--eEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG--QHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv  516 (720)
                      .+|..++.||+|+||.||++.. ++|...|||.+.....  ...+.+.+|+.+|++++|||||+++|......  .+++.
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            3566789999999999999965 4599999999865421  11567899999999999999999999855444  68999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-CCCeEEccccCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KLIVRVSDCGLAPLL  595 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~  595 (720)
                      |||+++|+|.+++....  . .++.....+++.++++||.|||+.   +||||||||+|||++. ++.+||+|||+++..
T Consensus        95 mEy~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            99999999999996432  1 689999999999999999999986   9999999999999999 799999999999877


Q ss_pred             CC-CCCcccccCccccccCCCCccCC-CCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          596 FS-GSTNELSEGLLTAHGSGAPEFES-GSY-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       596 ~~-~~~~~~~~~~~~~~~~~aPE~~~-~~~-~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      .. ...........||+.|||||... +.. ..++|||||||++.||+||+.||.... .....+....           
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-~~~~~~~~ig-----------  236 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-EEAEALLLIG-----------  236 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-chHHHHHHHh-----------
Confidence            53 11122334578999999999996 433 349999999999999999999997520 0001011100           


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                        ... .....+...+.+..+++.+|+++||++||||+|++++.
T Consensus       237 --~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  237 --RED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             --ccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence              000 00122333456788999999999999999999999874

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=355.36  Aligned_cols=248  Identities=22%  Similarity=0.365  Sum_probs=207.9

Q ss_pred             cCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ..|.....||+|+.|.||.| +..+++.||||++....  ....+-...|+.+|+..+|+|||.+++.|...+++|+|||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            45667788999999999999 56678999999997543  3344567899999999999999999999988899999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      ||++|+|.|++..     ..+++.++..|+.++++||+|||..   +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus       351 ym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  351 YMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             ecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            9999999999853     3488899999999999999999998   9999999999999999999999999999887544


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh-hcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR-WAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  676 (720)
                      ..  ......||++|||||.. ...|++|+||||||++++||+-|++||-..++-....++. -..+.+           
T Consensus       423 ~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l-----------  489 (550)
T KOG0578|consen  423 QS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL-----------  489 (550)
T ss_pred             cC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc-----------
Confidence            33  34557899999999999 5579999999999999999999999997655433222111 111111           


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                           ..++..+.+|.+|+.+||+.|+++|+++.|+|+|
T Consensus       490 -----k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 -----KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             -----CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence                 2344556789999999999999999999999976

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-41  Score=338.25  Aligned_cols=263  Identities=21%  Similarity=0.320  Sum_probs=208.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .+.|+..++||.|..++||+|. .+.+..||||++.-+.... +...+++|+..|+.++||||++++..|..+..+|+||
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            3578888999999999999995 5678999999997654433 3678999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      .||.+||+.+++....  ...+++..+..|..++.+||.|||+.   |.||||||+.|||||.+|.|||+|||.+..+..
T Consensus       104 pfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            9999999999997532  34588888999999999999999998   999999999999999999999999999876655


Q ss_pred             CCCc-ccc-cCccccccCCCCccCC---CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          598 GSTN-ELS-EGLLTAHGSGAPEFES---GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       598 ~~~~-~~~-~~~~~~~~~~aPE~~~---~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      .... ... ....+++.|||||.+.   ..|+.|+||||||+...||.+|..||....+....  ..    .+.......
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~----tLqn~pp~~  252 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LL----TLQNDPPTL  252 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HH----HhcCCCCCc
Confidence            4322 222 4567899999999952   35999999999999999999999999765432211  00    000000000


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .  -..+...........|++++..||++||++|||+++++++
T Consensus       253 ~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  253 L--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             c--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            0  0011112223344589999999999999999999999864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-41  Score=378.91  Aligned_cols=259  Identities=25%  Similarity=0.416  Sum_probs=213.9

Q ss_pred             CCCCCCeeccCCCceEEEEEeCC--Cc----EEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPG--GK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~--g~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ..+..+.||+|+||.||+|...+  |.    .||||.+++. .+.+...+|.+|..+|++++|||||+++|+|.+.+..+
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            44456899999999999997643  43    4899999754 34567789999999999999999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccc---hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          515 LVYDYGGNCTLHDLLHSDE---EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      +++|||++|+|..++++..   .....++....+.++.|||+|+.||++.   ++|||||.++|+||+..+.|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999997642   1245688889999999999999999998   899999999999999999999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchh
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      |+.+...++........-...|||||.+ .+.|+.|+|||||||+|||++| |..||...+..+..              
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~--------------  914 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL--------------  914 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH--------------
Confidence            9987766655544443345689999998 6899999999999999999999 99999765432211              


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                        ..+.... .-..+..+++.+.++|..||+.+|++||++..+++.+..++
T Consensus       915 --~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  915 --LDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             --HHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence              1111111 11234567788999999999999999999999999887653

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8e-41  Score=326.69  Aligned_cols=267  Identities=24%  Similarity=0.294  Sum_probs=205.9

Q ss_pred             cCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--CCeEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--HGQHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv  516 (720)
                      +.|+..+.|++|+||.||+|+ ..+++.||+|+++.+.......---++|+.+|.+++|||||.+.++...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            346667889999999999994 5679999999998776556666677899999999999999999997754  4679999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      ||||+. +|..+++..   ..+|...+...++.|+.+|++|||..   .|+|||||++|+|+...|.+||+|||+|+.+.
T Consensus       156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999998 899888643   36788899999999999999999997   89999999999999999999999999999885


Q ss_pred             CCCCcccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh--------hcccccC
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR--------WAIPRLH  666 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~--------~~~~~~~  666 (720)
                      ..-.  -.....-|.||+|||.+  ...|+..+|+||+|||+.||+++++-|.+..+.+..+.+-        ..++.+.
T Consensus       229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            4422  22345668999999998  4469999999999999999999999887654433222110        0111111


Q ss_pred             chhhhh-----hhcCCCCCchhhHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 DIDALS-----RMVDPSLDGAYLAK-SLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 ~~~~~~-----~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ......     ......+...+... ..+.-.+|+...|..||.+|.|++|.+++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            111110     00001112222222 34667899999999999999999999865

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-41  Score=331.70  Aligned_cols=268  Identities=21%  Similarity=0.333  Sum_probs=211.1

Q ss_pred             hcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc-----CCe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-----HGQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~  512 (720)
                      ...|...+.||+|+||.|..+ ...+|+.||||++..........++-.+|+++++.++|+||+.+++.+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345555788999999999999 45689999999998777667778889999999999999999999998854     347


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .|+|+|+|+ .+|..+++.    ...++.....-++.|+.+||.|+|+.   +|+||||||+|+|++.+..+||+|||+|
T Consensus       101 vYiV~elMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eEEehhHHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence            899999995 489998864    34477888888999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhh
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      +............+...|.||+|||..  ...|+...||||.|||+.||++|++-|.+.+......++....+.. +.+.
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e~  251 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEED  251 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHHH
Confidence            988554333444567789999999987  5679999999999999999999999998766544333333322222 2222


Q ss_pred             hhhhcC----------CCCCch----hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          671 LSRMVD----------PSLDGA----YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       671 ~~~~~~----------~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +..+-.          |..+..    ......+...+|+.+||..||.+|+|++|+++|
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            222221          111110    011234577899999999999999999999875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6e-41  Score=346.79  Aligned_cols=248  Identities=24%  Similarity=0.369  Sum_probs=208.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|.+.+.||+|+||+||||+. .+.+.||+|.+.+.....++.+...+|++++++++|||||.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4677788999999999999954 578999999998776666677889999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+.+ +|+.++..    ...+++.....|+.++..||.|||+.   +|+|||+||.|||++..+.+|+||||+|+.+.. 
T Consensus        82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            9987 99999954    45688899999999999999999998   999999999999999999999999999998754 


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                       ...+...+.||+.|||||.. .+.|+..+|.||+|||+||+++|++||-...   ...+++..   ..         |+
T Consensus       153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~~I---~~---------d~  216 (808)
T KOG0597|consen  153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVKSI---LK---------DP  216 (808)
T ss_pred             -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHHHH---hc---------CC
Confidence             23345567899999999998 6689999999999999999999999995321   11111110   00         11


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .   ..+......+..++...|.+||.+|.|..+++.|
T Consensus       217 v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 V---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             C---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            1   1233556789999999999999999999998865

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-39  Score=338.50  Aligned_cols=247  Identities=19%  Similarity=0.275  Sum_probs=196.7

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEeccccccc-ccHHHHHHHHHHHHccCCCceeEEEeEecc----CCeEEEEEee
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQR-QTDEEFLELASTISRLRHGNIVELIGYCNE----HGQHLLVYDY  519 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~  519 (720)
                      ...|++|++|.||+|.. +|+.||||+++...... ...+.|.+|++++++++|||||+++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999987 68899999997543222 224678899999999999999999999866    3478899999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++|+|.+++..    ...++|....+++.+++.||.|||...  +++||||||+|||+++++.+||+|||+++.+....
T Consensus       104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999964    246889999999999999999999742  67899999999999999999999999998653321


Q ss_pred             CcccccCccccccCCCCccCC---CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          600 TNELSEGLLTAHGSGAPEFES---GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                           ....++..|+|||...   +.++.++|||||||++|||+||+.||.........   ..             +..
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~---~~-------------i~~  236 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---DL-------------IIN  236 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH---HH-------------HHh
Confidence                 1234678899999984   47899999999999999999999999754322111   10             000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .......+..++.++.+++.+||+.||++|||++|+++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        237 KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            0000011123456789999999999999999999999999864

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6e-40  Score=355.11  Aligned_cols=262  Identities=24%  Similarity=0.345  Sum_probs=203.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHG  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  511 (720)
                      .++|...+.||+|+||+||+|..      .++..||||+++.... ....+.+.+|+++++.+ +|||||+++++|.+.+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            34678889999999999999953      2466899999974432 23456788999999999 8999999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccch---------------------------------------------------------
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEE---------------------------------------------------------  534 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  534 (720)
                      ..++||||+++|+|.++++....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999999999999864211                                                         


Q ss_pred             --------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          535 --------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       535 --------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                                    ....++|....+++.++++||+|||+.   +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                          012478889999999999999999987   999999999999999999999999999987643322


Q ss_pred             cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          601 NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      ........++..|+|||.. ...++.++|||||||++|||++ |..||.......  ...+..              ...
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~--------------~~~  333 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMI--------------KEG  333 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHH--------------HhC
Confidence            2222223345679999998 5578999999999999999998 899986532211  111110              000


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .....+...+.++.+++.+||+.||++|||+.||++.|++.|
T Consensus       334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~  375 (375)
T cd05104         334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL  375 (375)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence            000011112357889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=359.03  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=208.9

Q ss_pred             CCCCeeccCCCceEEEEEeCC----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          443 SEGNFIGEGLLGSVYKAELPG----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       443 ~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .+.++||.|.||+||+|+++-    ...||||.++.... .+...+|+.|+.||.+++||||++|.|+.......+||+|
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            356899999999999997742    45799999986544 4556799999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      ||+||+|..+|+..+   ..|++.+...+..+||.|+.||-+.   ++|||||.++|||++.+...||+|||++|.+.++
T Consensus       711 yMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  711 YMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            999999999998654   4589999999999999999999988   9999999999999999999999999999988654


Q ss_pred             CCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          599 STN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       599 ~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ... ..+.+-.-...|.|||.+ ..+++.++|||||||||||+++ |+.||.+....+.   +             . .+
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV---I-------------k-aI  847 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---I-------------K-AI  847 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH---H-------------H-HH
Confidence            321 111111113568999998 6789999999999999999887 9999965432221   1             1 11


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      +....-.-+.+++..+.+||..||++|-.+||++.+|+..|.+||
T Consensus       848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence            111111234567889999999999999999999999999999986

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.5e-40  Score=354.00  Aligned_cols=261  Identities=24%  Similarity=0.378  Sum_probs=202.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~  512 (720)
                      ++|...+.||+|+||.||+|..      .++..||||++..... ....+.+.+|+++++.+ +|+|||+++++|.+.+.
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            4688889999999999999853      2345799999975432 23346788999999999 89999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccch----------------------------------------------------------
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEE----------------------------------------------------------  534 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  534 (720)
                      .++||||+++|+|.+++.....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            9999999999999998853211                                                          


Q ss_pred             --------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccC
Q 004994          535 --------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG  606 (720)
Q Consensus       535 --------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~  606 (720)
                              ....+++....+++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++.+...........
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    112478888999999999999999987   999999999999999999999999999986643322222222


Q ss_pred             ccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhh
Q 004994          607 LLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL  684 (720)
Q Consensus       607 ~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  684 (720)
                      ..++..|+|||.. .+.++.++|||||||++|||++ |+.||........  ..              ..+........+
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~--------------~~~~~~~~~~~~  337 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY--------------KMVKRGYQMSRP  337 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH--------------HHHHcccCccCC
Confidence            3345679999987 5679999999999999999997 9999965322110  00              000000000011


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       685 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ...+.++.+++.+||+.||++|||+.+|++.|++++
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            112367889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=350.20  Aligned_cols=254  Identities=26%  Similarity=0.417  Sum_probs=203.5

Q ss_pred             CCCCCCeeccCCCceEEEEEeCC--C--cE-EEEEEecc-cccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPG--G--KL-LAVKKLSN-TVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~l~~-~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      +....++||+|+||+||+|.+..  +  .. ||||..+. ....+....+|..|+++|++++|||||++||++.....++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            33445899999999999996643  3  23 89999885 3345667789999999999999999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +|||+|.||+|.++|....   ..++..++.+++.++|+||+|||+.   ++|||||.++|+|++.++.+||+|||+++.
T Consensus       238 ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence            9999999999999997532   3689999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCccccc-CccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          595 LFSGSTNELSE-GLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       595 ~~~~~~~~~~~-~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      -.   ...... ...-...|+|||.+ .+.|+.++|||||||++||+++ |..||.+........               
T Consensus       312 ~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~---------------  373 (474)
T KOG0194|consen  312 GS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA---------------  373 (474)
T ss_pred             Cc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH---------------
Confidence            42   111111 12234679999998 7789999999999999999999 899997644322111               


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       .++........+...+.++..++.+||..+|++||+|.++.+.|+.+
T Consensus       374 -kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~  420 (474)
T KOG0194|consen  374 -KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL  420 (474)
T ss_pred             -HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence             11011111111223456788999999999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=344.44  Aligned_cols=251  Identities=25%  Similarity=0.351  Sum_probs=202.6

Q ss_pred             HhcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccc---cccHHHHHHHHHHHHccC-CCceeEEEeEeccCCe
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQ---RQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQ  512 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~  512 (720)
                      ....|..++.||+|+||+||.|. ..+|..||+|.+.+....   ....+...+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            45688899999999999999995 457899999977654221   123456668999999999 9999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC-CCeEEccccC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-LIVRVSDCGL  591 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGl  591 (720)
                      .++||||+.+|+|.+++..    ...+.+.....++.|++.|++|+|+.   +|+||||||+|||+|.+ +++||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999964    45677788999999999999999998   99999999999999999 9999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccCCC-C-CC-CccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFESG-S-YS-CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~-~~-~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      +....  ..........|++.|+|||++.+ . |+ .++||||+||+||.|++|+.||++.........           
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-----------  234 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-----------  234 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-----------
Confidence            98773  22334556789999999999954 4 64 689999999999999999999986332111110           


Q ss_pred             hhhhhhcCCCCCchhhHHH-HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDGAYLAKS-LSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                           +.....  .++... ..++.+++.+||..||.+|+|+.|++++
T Consensus       235 -----i~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  235 -----IRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             -----HhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence                 010000  011111 4678899999999999999999999843

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.6e-39  Score=342.27  Aligned_cols=265  Identities=24%  Similarity=0.361  Sum_probs=200.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC-----------------CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG-----------------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE  502 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~  502 (720)
                      ++|...+.||+|+||.||+|...+                 +..||+|.+.... ......+|.+|++++++++||||++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            467788999999999999996432                 3479999987543 2334567999999999999999999


Q ss_pred             EEeEeccCCeEEEEEeeCCCCCHHHHhhccch---------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 004994          503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEE---------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIV  567 (720)
Q Consensus       503 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~iv  567 (720)
                      +++++.+.+..++||||+++|+|.+++.....               ....++|....+++.|+++||.|||+.   +|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            99999999999999999999999998854211               123578889999999999999999987   899


Q ss_pred             ecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh--CCC
Q 004994          568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT--GRK  644 (720)
Q Consensus       568 HrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt--G~~  644 (720)
                      ||||||+|||+++++.+||+|||+++.+.............++..|+|||+. .+.++.++|||||||++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999876443322222233446789999987 5679999999999999999987  567


Q ss_pred             CCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          645 PYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       645 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      ||.......   .............       .......+..++..+.+++.+||+.||++|||++||.+.|++
T Consensus       241 p~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDEQ---VIENAGEFFRDQG-------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHHH---HHHHHHHHhhhcc-------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            776432211   1111100000000       000000111234678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-40  Score=347.17  Aligned_cols=249  Identities=25%  Similarity=0.344  Sum_probs=205.4

Q ss_pred             cCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ..|..++.||+|+.|.|-.|+ ..+|+.+|||++.+.. ..........+|+.+|+-+.||||+++|+++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            457788999999999999995 4789999999997652 22333456779999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|.|++++..    +..+...+..+++.||..|+.|+|..   +|+||||||+|+|||..+++||+|||+|..-.+
T Consensus        92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            99999999999953    56788899999999999999999998   899999999999999999999999999977544


Q ss_pred             CCCcccccCccccccCCCCccCCC-CC-CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG-SY-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~-~~-~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      +.   .-+..+|.+.|.+||++.| .| +.++||||+|||||.|+||+.||++.+.+.-...++....            
T Consensus       165 gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f------------  229 (786)
T KOG0588|consen  165 GK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF------------  229 (786)
T ss_pred             Cc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc------------
Confidence            33   4455678999999999965 56 5689999999999999999999985432211111111100            


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                            ..+...+.+..+|+.+|+..||+.|.|++||++|-
T Consensus       230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                  01233456788999999999999999999999873

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-40  Score=314.58  Aligned_cols=237  Identities=23%  Similarity=0.321  Sum_probs=199.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccc-ccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||.|+||+|..++. .+|..+|+|++.+. +......+....|..+|+.+.||.++++++.|.+.+..||||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            4677789999999999999965 46899999999754 233344566788999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||.++|.|..+++.    .+.|+.+...-+|.+|+.||+|||+.   +|++|||||+|||+|.+|.+||+|||+|+.+..
T Consensus       124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            99999999999964    35788899999999999999999998   899999999999999999999999999998743


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .     +...+||+.|+|||.+ +..|+.++|+|||||++|||+.|.+||....+..                ...+++.
T Consensus       197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~----------------iY~KI~~  255 (355)
T KOG0616|consen  197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ----------------IYEKILE  255 (355)
T ss_pred             c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH----------------HHHHHHh
Confidence            2     3457899999999998 6679999999999999999999999997655422                2223333


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCC
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFR  706 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  706 (720)
                      ..+.  ++.....++.+|+.+.|++|-.+|
T Consensus       256 ~~v~--fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  256 GKVK--FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             Cccc--CCcccCHHHHHHHHHHHhhhhHhh
Confidence            2222  333445678899999999999999

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=342.37  Aligned_cols=238  Identities=26%  Similarity=0.420  Sum_probs=197.4

Q ss_pred             CCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          444 EGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       444 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      +.+-||.|+.|.||+|+++ ++.||||+++.-.         ..+|+-|++|+|+||+.+.|+|....-++||||||..|
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            4578999999999999985 4689999986321         24688899999999999999999999999999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL  603 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  603 (720)
                      -|.++|+.    ...+......++..+||.|+.|||..   .|||||||+-||||+.+-.|||+|||-++.....++   
T Consensus       198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---  267 (904)
T KOG4721|consen  198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---  267 (904)
T ss_pred             cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh---
Confidence            99999964    35677778889999999999999987   899999999999999999999999999987754322   


Q ss_pred             ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch
Q 004994          604 SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA  682 (720)
Q Consensus       604 ~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (720)
                      .-.+.||..|||||++ ..++++|+||||||||||||+||..||.+.+.    ..+.|...            ...+.-.
T Consensus       268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVG------------sNsL~Lp  331 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVG------------SNSLHLP  331 (904)
T ss_pred             hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEecc------------CCccccc
Confidence            2347789999999999 55799999999999999999999999975432    22223221            1111112


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          683 YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       683 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      .+..++..|.-|++.||+..|..||++.+++.||+
T Consensus       332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            34456778889999999999999999999999986

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=332.70  Aligned_cols=257  Identities=24%  Similarity=0.308  Sum_probs=203.1

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEeccccccc------------ccHHHHHHHHHHHHccCCCceeEE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQR------------QTDEEFLELASTISRLRHGNIVEL  503 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~------------~~~~~~~~e~~~l~~l~H~niv~l  503 (720)
                      +..++|+..+.||+|.||+|-+|. ..+++.||||++.+....+            ...+...+|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            345789999999999999999995 4579999999997542211            123578999999999999999999


Q ss_pred             EeEeccC--CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC
Q 004994          504 IGYCNEH--GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK  581 (720)
Q Consensus       504 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~  581 (720)
                      +++..+.  +.+|||+|||..|.+...-.    ....++..+..+++.++..||.|||.+   +||||||||+|+|++++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence            9999764  58999999999988764321    223388999999999999999999997   99999999999999999


Q ss_pred             CCeEEccccCCCCCCCCCC---cccccCccccccCCCCccCCC-C----CCCccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 004994          582 LIVRVSDCGLAPLLFSGST---NELSEGLLTAHGSGAPEFESG-S----YSCQSDVYSLGVVMLELLTGRKPYDRSRPRG  653 (720)
Q Consensus       582 ~~~kl~DFGla~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~-~----~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~  653 (720)
                      |+|||+|||.+.....+..   ........||+.|+|||...+ .    .+.+.||||+||+||.|+.|+.||-..... 
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-  325 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-  325 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-
Confidence            9999999999987643321   112234779999999999844 2    356899999999999999999999654321 


Q ss_pred             ccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          654 EQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                                     +...+++...+......+..+++.+|++++|.+||++|.+..+|..|.
T Consensus       326 ---------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  326 ---------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ---------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                           223334443333322334557889999999999999999999987664

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-39  Score=337.23  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=201.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|.....||+|+||.||.|+ ..+|..+|+|++++.. ......+..+.|-.+|...++|+||++|..|.+.+.+|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            4678889999999999999995 4679999999998653 3345556788899999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||++||++..+|..    ...++......++.+.+-|+..||+.   |+|||||||+|+|||..|++||+|||++.-+.
T Consensus       220 MEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999953    45677777788888888999999988   99999999999999999999999999985431


Q ss_pred             CC----------------------C-C-----c-----------------ccccCccccccCCCCccC-CCCCCCccchH
Q 004994          597 SG----------------------S-T-----N-----------------ELSEGLLTAHGSGAPEFE-SGSYSCQSDVY  630 (720)
Q Consensus       597 ~~----------------------~-~-----~-----------------~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~  630 (720)
                      ..                      + .     .                 .......||+-|+|||++ ...|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                      0 0     0                 001235789999999998 55699999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCccc-cchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-
Q 004994          631 SLGVVMLELLTGRKPYDRSRPRGE-QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-  708 (720)
Q Consensus       631 S~Gvvl~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-  708 (720)
                      |+|||||||+.|.+||...++... ..++.|... +...              .......+..|||.+|+. ||++|-- 
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-l~fP--------------~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-LKFP--------------EEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-ccCC--------------CcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            999999999999999988776553 344444321 1100              001122577899999999 9999964 


Q ss_pred             --HHHHHH
Q 004994          709 --MSEIVQ  714 (720)
Q Consensus       709 --~~evl~  714 (720)
                        ++||-+
T Consensus       437 ~G~~EIK~  444 (550)
T KOG0605|consen  437 KGAEEIKK  444 (550)
T ss_pred             ccHHHHhc
Confidence              666644

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-40  Score=330.38  Aligned_cols=261  Identities=23%  Similarity=0.342  Sum_probs=196.7

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC---C--eEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH---G--QHL  514 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~---~--~~~  514 (720)
                      .|...+++|.|+||.||+|.. .+++.||||++..+.      +.-.+|+++|++++|||||++.-+|...   +  ...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            456679999999999999965 567999999986432      2335789999999999999999888532   2  334


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC-CCeEEccccCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-LIVRVSDCGLAP  593 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~  593 (720)
                      +|||||+. +|.++++.....+..++...+.-+..|+.+||+|||..   +|+||||||.|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999997 89998875444456677777778999999999999996   99999999999999976 899999999999


Q ss_pred             CCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      .+..++.+   ....-+++|+|||.+.  ..|+.+.||||.|||+.||+-|++-|.+....+....+-.+. ..+..+.+
T Consensus       175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l-G~Pt~e~I  250 (364)
T KOG0658|consen  175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL-GTPTREDI  250 (364)
T ss_pred             eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh-CCCCHHHH
Confidence            98765543   2345678999999984  479999999999999999999999998754332211111111 11111122


Q ss_pred             hhhcC-------CCCCch-----hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRMVD-------PSLDGA-----YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~-------~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..|-.       |.+...     ......++..+|+.++|+.+|.+|.++.|++.+
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            21111       111111     223345778899999999999999999999864

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=337.20  Aligned_cols=248  Identities=26%  Similarity=0.406  Sum_probs=205.1

Q ss_pred             CCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      .|+..++||+|+||.|||| +..+++.||+|++..+.. ....++..+|+.++..++|+||.++||.+..+..++++|||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4666789999999999999 556899999999975432 45567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      |.+|++.+.+...    ..+.+....-|+.++..||.|||..   +.+|||||+.|||+..+|.||++|||++-.+....
T Consensus        93 ~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             hcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            9999999999643    2335556667888999999999997   89999999999999999999999999998775433


Q ss_pred             CcccccCccccccCCCCccCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .  ....+.||++|||||++.+ .|+.|+||||+|++++||.+|.+|+....+.....++             .+-..|.
T Consensus       166 ~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------------pk~~PP~  230 (467)
T KOG0201|consen  166 K--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------------PKSAPPR  230 (467)
T ss_pred             h--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------------cCCCCCc
Confidence            2  3366889999999999954 7999999999999999999999999876652211111             1112333


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +.+    .....|.+|+..||.+||+.||++.+++++
T Consensus       231 L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  231 LDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            333    344678999999999999999999999976

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.6e-39  Score=336.65  Aligned_cols=268  Identities=20%  Similarity=0.290  Sum_probs=202.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||+||+|+.. +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888899999999999999764 68899999997654444455678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |++++.+..+..    ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            999987765442    234588888999999999999999987   9999999999999999999999999999876432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch--------h
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI--------D  669 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~  669 (720)
                      ... ......++..|+|||.. ...++.++|||||||++|||++|+.||...........+......+...        .
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            211 12234578899999988 5578999999999999999999999997643322111111110000000        0


Q ss_pred             hhhhhcCCCC------CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSL------DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .......+..      ...+....+.++.+++.+||+.||++|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000000      011112245678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.1e-39  Score=340.48  Aligned_cols=267  Identities=21%  Similarity=0.348  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|+..+.||+|+||.||++.. .+|..||+|.+..... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            36788899999999999999965 4688999999875432 334567999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++..    ...+++.....++.+++.||.|||+.+  +|+||||||+|||++.++.+||+|||+++....
T Consensus        83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          83 EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            99999999999853    345788889999999999999999852  699999999999999999999999999976533


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc------------cc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI------------PR  664 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~------------~~  664 (720)
                      .    ......++..|+|||.. ...++.++|||||||++|||+||+.||................            +.
T Consensus       157 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             c----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence            2    12234678899999998 4568999999999999999999999996533211110000000            00


Q ss_pred             c------------------CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          665 L------------------HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       665 ~------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      .                  ...+....+...............++.+|+.+||+.||++|||++|++++-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            0                  000000000000000000112346789999999999999999999999763

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.5e-39  Score=334.32  Aligned_cols=252  Identities=24%  Similarity=0.306  Sum_probs=198.8

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      |...+.||+|+||+||+|.. .+|+.||+|.+.+.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            56678999999999999954 67999999998754322 23345678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++|+|.+++...  ....+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++.......
T Consensus        82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999998877532  234688999999999999999999987   99999999999999999999999999997653322


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                         ......++..|+|||+. ...++.++|||||||++|||++|+.||...........+.            ..+... 
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~------------~~~~~~-  220 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD------------RRVKED-  220 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH------------HHhhcc-
Confidence               12234678999999998 5579999999999999999999999997543221110000            000000 


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                       ...+....+.++.+|+.+||+.||++||+     ++|++++
T Consensus       221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence             01122233467889999999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-38  Score=331.19  Aligned_cols=259  Identities=25%  Similarity=0.427  Sum_probs=204.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC------CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ++|+..+.||+|+||.||+|....      ...||+|.+.... ......+|.+|++++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            357778999999999999996532      2579999987443 233456789999999999999999999999998999


Q ss_pred             EEEEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK  581 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~  581 (720)
                      +++|||+++++|.+++.....            ....+++.....++.+++.||+|||+.   +++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence            999999999999999864311            114578889999999999999999987   89999999999999999


Q ss_pred             CCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhh
Q 004994          582 LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVR  659 (720)
Q Consensus       582 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~  659 (720)
                      +.+||+|||+++...............++..|+|||.. .+.++.++|||||||++|||++ |..||.......   ...
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~  237 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIE  237 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            99999999999866443322223334456789999987 5679999999999999999998 999996543221   111


Q ss_pred             hcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .              +........+..++.++.+++.+||+.||.+||++.||+++|+++
T Consensus       238 ~--------------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         238 M--------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             H--------------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1              000000111234457889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.3e-38  Score=339.27  Aligned_cols=247  Identities=24%  Similarity=0.331  Sum_probs=190.6

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            455668899999999999965 478999999986432 233456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +.+|+|.+..        ...+.....++.++++||.|||+.   +|+||||||+|||+++++.+||+|||+++.+....
T Consensus       154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            9999986532        234566778999999999999987   99999999999999999999999999998763221


Q ss_pred             CcccccCccccccCCCCccCC-----CC-CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          600 TNELSEGLLTAHGSGAPEFES-----GS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~-----~~-~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      .  ......++..|+|||.+.     +. .+.++|||||||++|||++|+.||...............            
T Consensus       223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~------------  288 (353)
T PLN00034        223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI------------  288 (353)
T ss_pred             c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH------------
Confidence            1  122346788999999863     22 356899999999999999999999733221111111000            


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       . .............++.+++.+||+.||++|||++|++++
T Consensus       289 -~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        289 -C-MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -h-ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0 000000112234578899999999999999999999976

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.7e-38  Score=344.75  Aligned_cols=262  Identities=23%  Similarity=0.350  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHG  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~  511 (720)
                      .+.|...++||+|+||.||+|...      .+..||||++.... .....+.|.+|+++++++. |||||+++++|.+.+
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            457788899999999999999642      23479999997543 2334567999999999996 999999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccch---------------------------------------------------------
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEE---------------------------------------------------------  534 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  534 (720)
                      ..++||||+++|+|.++++....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999998864211                                                         


Q ss_pred             -----------------------------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc
Q 004994          535 -----------------------------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD  579 (720)
Q Consensus       535 -----------------------------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~  579 (720)
                                                         ....+++..+.+++.|+++||.|||+.   +|+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence                                               012478888999999999999999987   899999999999999


Q ss_pred             CCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccch
Q 004994          580 EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSL  657 (720)
Q Consensus       580 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~  657 (720)
                      +++.+||+|||+++.+.............++..|+|||.+ ...++.++|||||||++|||++ |..||........  +
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H
Confidence            9999999999999866432222122233456789999987 5678999999999999999997 9999865321110  0


Q ss_pred             hhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       658 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ...          +..    ......+...+.++.+++.+||+.||++|||+.+|.+.|++++
T Consensus       350 ~~~----------~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         350 YNK----------IKS----GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHH----------Hhc----CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            000          000    0000111233467889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-38  Score=327.49  Aligned_cols=256  Identities=23%  Similarity=0.319  Sum_probs=201.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|...+.||+|+||.||+|.+.    .+..||+|.++.... ....+.|.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            46778899999999999999653    367899999975432 2334678999999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++|+|.+++...   ...+++.....++.+++.||+|||+.   +++||||||+|||++.++.+|++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999998642   24688999999999999999999987   8999999999999999999999999987654


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      .... ........++..|+|||.. .+.++.++|||||||++||+++ |+.||.......   ....             
T Consensus       158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~-------------  220 (266)
T cd05064         158 KSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKA-------------  220 (266)
T ss_pred             cccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH-------------
Confidence            2211 1111122345679999987 5678999999999999999775 999996543211   1111             


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      +.+. .....+..++..+.+++.+||+.+|++||+++|+++.|++++
T Consensus       221 ~~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         221 VEDG-FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             HHCC-CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence            0000 000012234467889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-39  Score=304.12  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=205.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      -++|+.++.||+|.||.||.|+. +++..||+|++.+.. ......+++.+|+++-..|+||||+++|+||.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            35788999999999999999954 568899999987543 2344567899999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      +||...|++...|.+.  ....++......++.|+|.||.|+|..   +||||||||+|+|++.++..||+|||.+-.-.
T Consensus       101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999742  345677888888999999999999987   89999999999999999999999999986543


Q ss_pred             CCCCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      .    .......||.-|.+||+.. ...+.++|+|++||+.||++.|.+||......+..                .++.
T Consensus       176 ~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY----------------krI~  235 (281)
T KOG0580|consen  176 S----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY----------------KRIR  235 (281)
T ss_pred             C----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH----------------HHHH
Confidence            1    2234478899999999994 46899999999999999999999999764322211                1111


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      .-.+  .++.....+..|++.+|+.++|.+|.+..|++++-
T Consensus       236 k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  236 KVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             Hccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            1111  11233446788999999999999999999999863

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-38  Score=339.42  Aligned_cols=261  Identities=24%  Similarity=0.380  Sum_probs=200.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEecc-CC
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNE-HG  511 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~-~~  511 (720)
                      ++|...+.||+|+||.||+|..      .+++.||+|+++.... ....+.+..|++++.++ +|+||++++++|.. ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            4688889999999999999953      2357899999875432 23345678899999999 89999999998864 45


Q ss_pred             eEEEEEeeCCCCCHHHHhhccch---------------------------------------------------------
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEE---------------------------------------------------------  534 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  534 (720)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            78899999999999998853211                                                         


Q ss_pred             hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCC
Q 004994          535 AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG  614 (720)
Q Consensus       535 ~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~  614 (720)
                      ....++|..+..++.++++||+|||+.   +|+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            123689999999999999999999987   99999999999999999999999999998764332222222334567899


Q ss_pred             CCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHH
Q 004994          615 APEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFA  692 (720)
Q Consensus       615 aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  692 (720)
                      |||++ ...++.++|||||||++|||++ |+.||......+.  ...              .+........+.....++.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~~~  306 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR--------------RLKEGTRMRAPEYATPEIY  306 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH--------------HHhccCCCCCCccCCHHHH
Confidence            99987 6679999999999999999998 9999965322111  000              0000000001112345788


Q ss_pred             HHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          693 DIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       693 ~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      +++.+||+.+|++||++.|++++|++++
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-38  Score=324.68  Aligned_cols=257  Identities=26%  Similarity=0.389  Sum_probs=203.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|+..+.||+|+||+||+|.+.    +...||||.++... .......|.+|+.++++++||||+++++++.+.+..++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            46888899999999999999764    24589999987543 23345678999999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++++|.+++...   ...+++..+.+++.+++.||+|||+.   +|+||||||+||++++++.+||+|||+++.+
T Consensus        83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            99999999999998643   23688999999999999999999987   8999999999999999999999999999877


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      .............++..|+|||.. ...++.++||||||+++|||++ |..||........   ...             
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~-------------  220 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKA-------------  220 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHH-------------
Confidence            422211112222345679999988 4578999999999999999998 9999964322111   110             


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      +... .....+...+..+.+++.+||+.+|++||+++||+++|+++|
T Consensus       221 ~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         221 VEDG-YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             HHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            0000 000011123467889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-39  Score=335.77  Aligned_cols=246  Identities=20%  Similarity=0.252  Sum_probs=197.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|.. .+|+.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            3678889999999999999965 4689999999864321 2234467889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999853    34678888999999999999999987   999999999999999999999999999986633


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..     ....++..|+|||.+ ...++.++|||||||++|||+||+.||..........                .+..
T Consensus       154 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~----------------~i~~  212 (291)
T cd05612         154 RT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE----------------KILA  212 (291)
T ss_pred             Cc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------HHHh
Confidence            21     224578899999988 4468999999999999999999999997543211110                0110


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                      ...  ..+......+.+++.+||+.||.+||+     ++|++++
T Consensus       213 ~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         213 GKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            000  011122356789999999999999995     8888865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.7e-39  Score=339.08  Aligned_cols=243  Identities=21%  Similarity=0.289  Sum_probs=194.2

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      ++||+|+||.||+|.. .+|+.||||++++... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999965 5789999999975422 2233456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL  603 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  603 (720)
                      +|.+++..    ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~  151 (323)
T cd05571          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT  151 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence            99988853    34688999999999999999999987   9999999999999999999999999999754221  112


Q ss_pred             ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch
Q 004994          604 SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA  682 (720)
Q Consensus       604 ~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (720)
                      .....++..|+|||.+ ...++.++|||||||++|||+||+.||.........   ..             +.....  .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~-------------~~~~~~--~  213 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---EL-------------ILMEEI--R  213 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH---HH-------------HHcCCC--C
Confidence            2335688999999998 456899999999999999999999999653221110   00             000000  0


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          683 YLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       683 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      ++.....++.+++.+||+.||++||     ++.+++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            1122345788999999999999999     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-38  Score=322.69  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|+..+.||+|++|.||+|...+++.||+|.++...   ...+++.+|++++++++|+||+++++++...+..++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            35678889999999999999987778899999987532   235678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++....  ...+++..+..++.+++.||.|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus        82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            999999999986432  34688999999999999999999987   8999999999999999999999999999876422


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ... ...+......|+|||+. ...++.++||||||+++|||+| |+.||...........+                 +
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-----------------~  218 (261)
T cd05068         157 IYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-----------------D  218 (261)
T ss_pred             ccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-----------------H
Confidence            111 11122234579999988 4578999999999999999999 99999653321111000                 0


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...........+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         219 QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            0000001112346788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.4e-38  Score=324.40  Aligned_cols=258  Identities=24%  Similarity=0.377  Sum_probs=197.9

Q ss_pred             CCCCeeccCCCceEEEEEeCC-Cc--EEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC------CeE
Q 004994          443 SEGNFIGEGLLGSVYKAELPG-GK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH------GQH  513 (720)
Q Consensus       443 ~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~  513 (720)
                      ..++.||+|+||.||+|...+ +.  .||+|.++.........+.+.+|++++++++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999997654 33  699999876544455567889999999999999999999987432      256


Q ss_pred             EEEEeeCCCCCHHHHhhccc--hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          514 LLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      +++|||+.+|+|.+++....  .....+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence            89999999999998874321  1234588999999999999999999986   899999999999999999999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchh
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      ++.+.............++..|++||.. ...++.++|||||||++|||++ |+.||...........+.       ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-------QGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cCC
Confidence            9876443221111222345679999988 4568999999999999999999 899996533211111000       000


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .      ..    .....+..+.+++.+||+.||++|||++|+++.|++++
T Consensus       232 ~------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         232 R------LK----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             C------CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            0      00    01123356889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.7e-38  Score=333.73  Aligned_cols=255  Identities=24%  Similarity=0.367  Sum_probs=198.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCc----EEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      .+|+..+.||+|+||+||+|.+ .++.    .||+|.++... .....+++.+|+.+++.++||||++++|+|... ..+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            4688889999999999999965 3343    48999986432 234456789999999999999999999999765 577


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +|+||+++|+|.+++...   ...+++....+++.++++||+|||+.   +|+||||||+|||+++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            999999999999998643   34578889999999999999999987   999999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +..............+..|+|||.. ...++.++|||||||++|||+| |+.||.......   +...            
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~------------  223 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI------------  223 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH------------
Confidence            6543322222223345679999988 5678999999999999999998 999996532211   1100            


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                        +........+..+...+.+++.+||+.+|++||++.++++.|.++
T Consensus       224 --~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         224 --LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             --HhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              000000000111234678999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-38  Score=323.55  Aligned_cols=259  Identities=24%  Similarity=0.392  Sum_probs=200.8

Q ss_pred             CCCCCeeccCCCceEEEEEeC-C---CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe-----
Q 004994          442 FSEGNFIGEGLLGSVYKAELP-G---GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ-----  512 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----  512 (720)
                      |...+.||+|+||.||+|... +   +..||+|+++...........+..|++.++.++||||+++++++.+.+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            456789999999999999653 2   3689999997544434445688999999999999999999998866543     


Q ss_pred             -EEEEEeeCCCCCHHHHhhccc--hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          513 -HLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       513 -~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                       .+++|||+++|+|.+++....  .....+++.....++.|++.||.|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             799999999999999885432  1234688999999999999999999987   8999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCc
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      |+++.+..............+..|+|||.. ...++.++|||||||++|||++ |..||.......   ....       
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~-------  227 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDY-------  227 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------
Confidence            999876443322222222345679999988 4568999999999999999999 999986533211   1111       


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                            +.... ....+...+.++.+++.+||+.||++|||+.|+++.|++++
T Consensus       228 ------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         228 ------LRHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             ------HHcCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                  00000 00011223457889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3e-38  Score=329.87  Aligned_cols=266  Identities=20%  Similarity=0.279  Sum_probs=199.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||+||+|.. .+++.||+|+++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            4688889999999999999965 4689999999874422 2334567899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++ +|.+++...   ...+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          84 YLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CCCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            9985 888887532   23578888999999999999999987   9999999999999999999999999999765322


Q ss_pred             CCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc--------cccCch
Q 004994          599 STNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI--------PRLHDI  668 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~~  668 (720)
                      .  .......++..|+|||...  ..++.++||||+||++|||+||+.||...........+....        +.+...
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         157 T--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             C--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            1  1122345688999999873  458999999999999999999999997654322211111000        011111


Q ss_pred             hhhhhhcCCCCCch----hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDGA----YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ........+.....    .......++.+++.+||+.||.+|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            11111111111000    001123567899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.3e-38  Score=326.09  Aligned_cols=260  Identities=22%  Similarity=0.348  Sum_probs=201.6

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG  511 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  511 (720)
                      .+++|+..+.||+|+||.||+|...      .+..||||++..... .....+|.+|+.+++.++||||+++++++.+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            3567888999999999999998642      356899999864322 234567889999999999999999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchh------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeE
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEA------HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR  585 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  585 (720)
                      ..++||||+++++|.+++......      ...+++..+..++.++++||.|||+.   +++||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence            999999999999999998642211      23467888999999999999999987   899999999999999999999


Q ss_pred             EccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhccc
Q 004994          586 VSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       586 l~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      |+|||+++.+.............++..|+|||.. .+.++.++|||||||++|||++ |+.||.......   ..+..  
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~--  234 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFV--  234 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH--
Confidence            9999999866433222111222346789999998 5578999999999999999999 788986533211   11110  


Q ss_pred             ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                                 ...... ..+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       235 -----------~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 -----------MEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -----------HcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                       000000 0111234578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-38  Score=354.48  Aligned_cols=258  Identities=20%  Similarity=0.288  Sum_probs=204.3

Q ss_pred             HhcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC-----
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG-----  511 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----  511 (720)
                      ..++|...+.||+|+||+||+|. ..+|+.||||++............+.+|+.++..++|+||+++++.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            35688999999999999999995 467999999999755444455567889999999999999999988764322     


Q ss_pred             ---eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcc
Q 004994          512 ---QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSD  588 (720)
Q Consensus       512 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  588 (720)
                         ..++||||+++|+|.+++.........+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               36899999999999999875444456788999999999999999999987   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      ||+++.+.............|++.|+|||.+ ...++.++|||||||++|||++|+.||.......   ..         
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~---------  254 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VM---------  254 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HH---------
Confidence            9999876433222233345688999999998 4569999999999999999999999996532211   00         


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                          ......... ..+...++++.+++.+||+.||++||++.+++++
T Consensus       255 ----~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 ----HKTLAGRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----HHHhcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                001100000 0112234678899999999999999999999875

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-38  Score=339.08  Aligned_cols=246  Identities=21%  Similarity=0.274  Sum_probs=196.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|.. .+++.||+|++.+.. ......+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            4677889999999999999966 468999999987532 12234467889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+.+|+|.+++..    ...+++.....++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999998853    34578888889999999999999987   999999999999999999999999999986633


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..     ....+++.|+|||.+ ...++.++|||||||++|||+||+.||.........                ..+..
T Consensus       171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----------------~~i~~  229 (329)
T PTZ00263        171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY----------------EKILA  229 (329)
T ss_pred             Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH----------------HHHhc
Confidence            21     124678899999998 456899999999999999999999999653321110                01111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                      ....  .+......+.+++.+||+.||.+||+     +++++.|
T Consensus       230 ~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        230 GRLK--FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCcC--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1000  01112346789999999999999997     6887754

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.1e-38  Score=326.96  Aligned_cols=259  Identities=25%  Similarity=0.392  Sum_probs=201.4

Q ss_pred             CCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      +|...+.||+|+||.||+|...      ....+|+|.+..... ....+.+..|+++++.++||||+++++.|...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            3667789999999999999642      235789998875432 233467889999999999999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccc--------------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDE--------------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSS  574 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~  574 (720)
                      +++||+.+++|.+++....                    .....+++.....++.+++.||+|||+.   +++||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence            9999999999999886421                    1124578999999999999999999987   9999999999


Q ss_pred             CeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCc
Q 004994          575 NILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR  652 (720)
Q Consensus       575 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~  652 (720)
                      |||+++++.+||+|||+++...............++..|+|||.. ...++.++||||||+++|||+| |+.||....+.
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999999999865433222112223345679999987 5568999999999999999999 99999653321


Q ss_pred             cccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ..   ....              ........+...+.++.+++.+||+.+|++||+++|+++.|++++
T Consensus       237 ~~---~~~~--------------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         237 RL---FNLL--------------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HH---HHHH--------------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            11   1110              000000111223457889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-39  Score=306.14  Aligned_cols=256  Identities=25%  Similarity=0.342  Sum_probs=207.8

Q ss_pred             HHHHHhcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEeccccccc------ccHHHHHHHHHHHHcc-CCCceeEEEe
Q 004994          434 SLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQR------QTDEEFLELASTISRL-RHGNIVELIG  505 (720)
Q Consensus       434 ~~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~------~~~~~~~~e~~~l~~l-~H~niv~l~~  505 (720)
                      .-..+.+.|...+.||+|..++|-++ ..++|+.+|+|++.......      ...+.-+.|+.+|+++ .||||+.+.+
T Consensus        11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D   90 (411)
T KOG0599|consen   11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD   90 (411)
T ss_pred             hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence            34456788889999999999999998 45678999999986432211      1224557889999998 7999999999


Q ss_pred             EeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeE
Q 004994          506 YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR  585 (720)
Q Consensus       506 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  585 (720)
                      +|+.+...++|+|.|+.|.|+|++.    ..-.++++...+|+.++.+|++|||..   +||||||||+|||+|++.++|
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceE
Confidence            9999999999999999999999995    346788999999999999999999998   999999999999999999999


Q ss_pred             EccccCCCCCCCCCCcccccCccccccCCCCccC-------CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh
Q 004994          586 VSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-------SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV  658 (720)
Q Consensus       586 l~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-------~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  658 (720)
                      |+|||+|+.+.++..   .....||++|.|||.+       ...|+..+|.||+|||||.++.|.+||-......     
T Consensus       164 isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-----  235 (411)
T KOG0599|consen  164 ISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-----  235 (411)
T ss_pred             EeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-----
Confidence            999999999876643   3457899999999976       1348889999999999999999999995422110     


Q ss_pred             hhcccccCchhhhhhhcCCC--CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          659 RWAIPRLHDIDALSRMVDPS--LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       659 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                 .++.+....  +....+++......+|+.+||+.||.+|.|++|+++|
T Consensus       236 -----------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  236 -----------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             -----------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence                       111111111  1222345566778899999999999999999999875

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.7e-38  Score=322.27  Aligned_cols=254  Identities=25%  Similarity=0.407  Sum_probs=202.0

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|...+.||+|+||.||+|.. +.++.||+|.+...   ....+++.+|++++++++|+||+++++++...+..++||||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            466778999999999999965 46889999998643   23356789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++....  ...+++..+..++.|+++||+|||..   +++||||||+||++++++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          84 MTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             CCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            99999999985422  34588999999999999999999987   89999999999999999999999999998764322


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .. .......+..|+|||.. ...++.++|||||||++|||++ |..||..........             .+..    
T Consensus       159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-------------~~~~----  220 (263)
T cd05052         159 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------------LLEK----  220 (263)
T ss_pred             ee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------------HHHC----
Confidence            11 11122335679999987 5578999999999999999998 999986532211100             0000    


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ......+...+.++.+++.+||+.||++|||+.|+++.|++++
T Consensus       221 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            0011111223467889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.7e-38  Score=322.24  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=203.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|+..+.||+|+||.||+|...++..||+|.+...   ....+.+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            467788999999999999998888889999998643   22356889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.++++..  ....+++..+..++.++++||+|||+.   +++||||||+||++++++.+||+|||+++......
T Consensus        83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            9999999998643  234678889999999999999999987   89999999999999999999999999998764322


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .. ......++..|+|||+. .+.++.++|||||||++|||+| |+.||........   ....          ......
T Consensus       158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----------~~~~~~  223 (261)
T cd05072         158 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSAL----------QRGYRM  223 (261)
T ss_pred             ee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHH----------HcCCCC
Confidence            11 11223345679999987 5678999999999999999998 9999965332111   1110          000000


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..    ....+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus       224 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 PR----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CC----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            00    112335688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-37  Score=321.42  Aligned_cols=261  Identities=19%  Similarity=0.299  Sum_probs=205.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||.||+|.. .+++.||||.+.... ........+.+|++++++++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688889999999999999965 578999999886422 22334467889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++.........+++.....++.++++||.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998864333345578888999999999999999987   999999999999999999999999999887643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...  ......++..|+|||.. ...++.++|+||||+++|||++|+.||....... .....          .+.....
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~----------~~~~~~~  225 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQ----------KIEQCDY  225 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHH----------HHhcCCC
Confidence            221  12234567789999987 4568899999999999999999999986432110 00110          0000001


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      +..   .....+..+.+++.+||+.+|++||+++||++.+++|
T Consensus       226 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         226 PPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            111   1123446788999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=337.29  Aligned_cols=243  Identities=24%  Similarity=0.290  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccc-cccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTV-SQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      .++|...++||+|+||+|+++..+ +++.||||++++.. ..+.+.+....|-+++... +||.++.++..|...+++|.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            467888999999999999999764 68899999998763 4556677888888888777 59999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+.||++..+.+     ...|+.....-++..|+.||+|||+.   +|||||||-+|||||.+|++||+|||+++..
T Consensus       447 vmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999544332     35688888889999999999999997   9999999999999999999999999999864


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      -.  ....+..+.||+.|+|||++ ...|+..+|+|||||+||||+.|+.||.+.++++..                +.+
T Consensus       519 m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F----------------dsI  580 (694)
T KOG0694|consen  519 MG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF----------------DSI  580 (694)
T ss_pred             CC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----------------HHH
Confidence            21  22345668899999999999 457999999999999999999999999865432211                111


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPM  709 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  709 (720)
                      +..  +..|+.-.+.+..++++++|.++|++|.-+
T Consensus       581 ~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 VND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             hcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            111  112444455778899999999999999866

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1e-37  Score=319.99  Aligned_cols=250  Identities=23%  Similarity=0.413  Sum_probs=198.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|+..+.||+|+||.||++.++++..+|+|.+...   ....+.|..|++++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            346777899999999999998888889999998643   23346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++|+|.++++...   ..+++..+..++.+++.||.|||+.   +|+||||||+||++++++.+||+|||.++......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          81 MENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            99999999886432   3588999999999999999999987   89999999999999999999999999998653322


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .. ......++..|+|||.. ...++.++||||||+++|||++ |+.||.......   ........       .....+
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~~-------~~~~~~  223 (256)
T cd05114         155 YT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISRG-------FRLYRP  223 (256)
T ss_pred             ee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCC-------CCCCCC
Confidence            11 11122345679999998 4568999999999999999999 999996543211   11111000       000011


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      .       ..+.++.+++.+||+.+|++||+++|+++.|
T Consensus       224 ~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 K-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             C-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            1       1235688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-38  Score=337.76  Aligned_cols=266  Identities=20%  Similarity=0.335  Sum_probs=195.5

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-----CeEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-----GQHL  514 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~  514 (720)
                      +|+..+.||+|+||.||+|.. .+|+.||||++............+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            367778999999999999964 5789999999875433334456788999999999999999999987532     3579


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||++ ++|.+++..    ...+++.....++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999996 588888753    34588999999999999999999987   999999999999999999999999999986


Q ss_pred             CCCCCC-cccccCccccccCCCCccCC---CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhh
Q 004994          595 LFSGST-NELSEGLLTAHGSGAPEFES---GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       595 ~~~~~~-~~~~~~~~~~~~~~aPE~~~---~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      ...... ........++..|+|||.+.   ..++.++|||||||++|||+||+.||...........+...... .....
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~  231 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT-PSPET  231 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC-CCHHH
Confidence            532221 11223456889999999873   46899999999999999999999999754321111000000000 00000


Q ss_pred             hhhh-----------cCCCCCchh---hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          671 LSRM-----------VDPSLDGAY---LAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       671 ~~~~-----------~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...+           +........   .......+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000           000000000   01123567899999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.5e-38  Score=328.74  Aligned_cols=261  Identities=24%  Similarity=0.394  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHG  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  511 (720)
                      .++|+..+.||+|+||.||++...      ....+|+|.+..... .....++.+|+++++++ +|+||+++++++...+
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            456778899999999999999653      236899999875432 23345688999999999 8999999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccc------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDE------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD  579 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~  579 (720)
                      ..+++|||+++|+|.++++...            .....+++..+..++.|++.||.|||+.   +|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence            9999999999999999986421            2245688999999999999999999987   999999999999999


Q ss_pred             CCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccch
Q 004994          580 EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSL  657 (720)
Q Consensus       580 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~  657 (720)
                      +++.+||+|||+++.+.............++..|+|||.. ...++.++|||||||++|||++ |..||...........
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            9999999999999876543222112222345679999987 5578999999999999999997 9999864322111100


Q ss_pred             hhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       658 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                                       +........+......+.+++.+||..||++|||++|+++.|++++
T Consensus       247 -----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         247 -----------------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -----------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                             0000000111223457889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=338.38  Aligned_cols=253  Identities=20%  Similarity=0.286  Sum_probs=201.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||.||+|... +++.||||++.+.... ....+.+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36788899999999999999764 6899999999754321 234467889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999853    34578888999999999999999987   999999999999999999999999999976532


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  675 (720)
                           ......++..|+|||++ ...++.++|||||||++|||++|+.||.......... +..|.. .+.         
T Consensus       154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~---------  218 (333)
T cd05600         154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-TLQ---------  218 (333)
T ss_pred             -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-ccc---------
Confidence                 22345688999999998 4578999999999999999999999997643322111 111100 000         


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+... ......+.++.+++.+||..+|.+||+++|++++
T Consensus       219 ~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 RPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00000 0001234678899999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.2e-38  Score=333.67  Aligned_cols=266  Identities=20%  Similarity=0.324  Sum_probs=199.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|+..+.||+|+||.||++... ++..+|+|.+..... ....+.+.+|++++++++|+||++++++|.+.+..++||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            367889999999999999999664 688999998875432 234567899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.+++.||.|||+.+  +|+||||||+|||++.++.+||+|||++..+..
T Consensus        83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999853    345788888999999999999999742  699999999999999999999999999976532


Q ss_pred             CCCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh----hcc------cccC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR----WAI------PRLH  666 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~----~~~------~~~~  666 (720)
                      .    ......++..|+|||... ..++.++|||||||++|||++|+.||.............    ...      +...
T Consensus       157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (333)
T cd06650         157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR  232 (333)
T ss_pred             h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence            2    122345788999999984 468999999999999999999999997533211110000    000      0000


Q ss_pred             ch--------------hhh----hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 DI--------------DAL----SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 ~~--------------~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..              ...    ..+...............++.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence            00              000    00000000000000123568899999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=303.19  Aligned_cols=265  Identities=23%  Similarity=0.306  Sum_probs=207.7

Q ss_pred             HhcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-----C
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-----G  511 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~  511 (720)
                      ..++|.+.+.||+|||+-||.++ ..+++.||+|++.-.  ...+.+..++|++..++++||||+++++++..+     .
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            45688999999999999999995 678999999999633  245667889999999999999999999987433     3


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      +.|++++|...|+|.+.+.........+++.+.++|+.++.+||.+||+. .+++.||||||.|||+.+++.+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            58999999999999999987666666899999999999999999999997 45799999999999999999999999999


Q ss_pred             CCCCCCCCCc-----cc--ccCccccccCCCCccCC----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhh
Q 004994          592 APLLFSGSTN-----EL--SEGLLTAHGSGAPEFES----GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW  660 (720)
Q Consensus       592 a~~~~~~~~~-----~~--~~~~~~~~~~~aPE~~~----~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  660 (720)
                      ++...-.-..     ..  ......|..|+|||.+.    ...++++|||||||+||+|+.|..||+.....+. .+.-.
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-SlaLA  254 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SLALA  254 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eEEEe
Confidence            8765311000     00  11223477899999983    2478999999999999999999999975433221 11100


Q ss_pred             cc-cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          661 AI-PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       661 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      +. +++.         -|.     ....++.+.+++++|++.||.+||++.+++..+.+++
T Consensus       255 v~n~q~s---------~P~-----~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  255 VQNAQIS---------IPN-----SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             eeccccc---------cCC-----CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            00 0000         000     0113467899999999999999999999999998764

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-38  Score=327.56  Aligned_cols=249  Identities=34%  Similarity=0.524  Sum_probs=190.7

Q ss_pred             CCeeccCCCceEEEEEeC-----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          445 GNFIGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      .+.||.|.||.||+|.+.     .+..|+||.++.. ......++|.+|++.+++++||||++++|+|...+..++||||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccccc
Confidence            367999999999999765     3578999999653 2234468899999999999999999999999988889999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++|+|.+++...  ....+++..+.+|+.|+++||+|||+.   +++|+||+++||+++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999753  235689999999999999999999997   89999999999999999999999999998763322


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .............|+|||.. ...++.++||||||+++|||+| |+.||.......   +..             .+.+.
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~-------------~~~~~  221 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIE-------------KLKQG  221 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHH-------------HHHTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc-------------ccccc
Confidence            22233334456789999998 5568999999999999999999 789986542211   111             11000


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      .. ...+..++..+.+++.+||+.||++|||++++++.|
T Consensus       222 ~~-~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 QR-LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             EE-TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cc-ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            00 001112345688999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-37  Score=318.09  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=194.8

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCT  524 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  524 (720)
                      +.||+|+||.||+|.. .+++.||+|.+.... .......|.+|++++++++||||++++++|...+..++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            3699999999999965 578999999986443 23345678999999999999999999999999999999999999999


Q ss_pred             HHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccc
Q 004994          525 LHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS  604 (720)
Q Consensus       525 L~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  604 (720)
                      |.+++...   ...+++.....++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++............
T Consensus        80 L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          80 FLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            99998532   24578999999999999999999987   8999999999999999999999999998765322111111


Q ss_pred             cCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch
Q 004994          605 EGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA  682 (720)
Q Consensus       605 ~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (720)
                      ........|+|||.. .+.++.++|||||||++|||++ |..||..........                 .+.......
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-----------------~~~~~~~~~  216 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-----------------AIEQGVRLP  216 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-----------------HHHcCCCCC
Confidence            111223569999988 5678999999999999999998 999986432211110                 000011111


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          683 YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       683 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      .+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            122234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-37  Score=323.15  Aligned_cols=255  Identities=27%  Similarity=0.423  Sum_probs=197.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCc----EEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ++|...+.||+|+||+||+|.+ .+++    .|++|.+.... ......++..|+.++++++||||+++++++.. ...+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            3577789999999999999965 3454    47777775322 22334577888889999999999999999864 4578


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +++||+++|+|.+++...   ...+++.....++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++.
T Consensus        85 ~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            899999999999998632   34688999999999999999999987   899999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +.............++..|++||.. .+.++.++|||||||++||++| |+.||..........++.       ..   .
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~---~  228 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KG---E  228 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CC---C
Confidence            6543332233334566789999988 5679999999999999999998 999996543221111110       00   0


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ....+.       .+...+.+++.+||..||++|||+.|+++.|+.|
T Consensus       229 ~~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         229 RLAQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             cCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            000111       1224567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.2e-38  Score=327.32  Aligned_cols=267  Identities=19%  Similarity=0.298  Sum_probs=194.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe--CCCcEEEEEEecccccccccHHHHHHHHHHHHcc---CCCceeEEEeEec-----c
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL--PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL---RHGNIVELIGYCN-----E  509 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~-----~  509 (720)
                      ++|...+.||+|+||+||+|..  .+++.||+|+++...........+.+|+++++.+   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688889999999999999965  3478899999875443333445566777776665   6999999999885     3


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                      ....++||||++ ++|.+++....  ...+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999997 58988885422  34578899999999999999999987   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhcc-cccC
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAI-PRLH  666 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~-~~~~  666 (720)
                      |+++.....   .......++..|+|||.. ...++.++|||||||++|||++|+.||......+.. .+..... +.-.
T Consensus       155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~  231 (290)
T cd07862         155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  231 (290)
T ss_pred             cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence            999765322   223345678899999988 557899999999999999999999999764432211 1111100 0000


Q ss_pred             chhh----hhhhcCCCCC---chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 DIDA----LSRMVDPSLD---GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 ~~~~----~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +...    ......+...   ..........+.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0000    0000000000   00111234567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.6e-38  Score=333.75  Aligned_cols=243  Identities=22%  Similarity=0.278  Sum_probs=193.9

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      +.||+|+||.||++.. .+|+.||+|++.+... .......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999964 5789999999975432 2334467889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL  603 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  603 (720)
                      +|.+++..    ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  151 (328)
T cd05593          81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT  151 (328)
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence            99988753    34688999999999999999999987   99999999999999999999999999987542211  11


Q ss_pred             ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch
Q 004994          604 SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA  682 (720)
Q Consensus       604 ~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (720)
                      .....++..|+|||.+ ...++.++|||||||++|||++|+.||...........+..              .+..    
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------~~~~----  213 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------EDIK----  213 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--------------CCcc----
Confidence            2235688999999998 55789999999999999999999999965332111100000              0001    


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          683 YLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       683 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      .+.....++.+++.+||+.||++||     ++.|++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1112335678999999999999997     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.6e-38  Score=339.56  Aligned_cols=261  Identities=24%  Similarity=0.369  Sum_probs=201.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~  512 (720)
                      ++|...+.||+|+||.||+|.+.      .++.||+|+++.... ....+.+.+|++++.++. |||||+++++|...+.
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            45677899999999999999753      346899999975432 233457889999999997 9999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccch----------------------------------------------------------
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEE----------------------------------------------------------  534 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  534 (720)
                      .++||||+++|+|.++++....                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999864311                                                          


Q ss_pred             ------------------------------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE
Q 004994          535 ------------------------------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       535 ------------------------------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl  578 (720)
                                                          ....+++.....++.+++.||.|||+.   +|+||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence                                                112467888899999999999999986   89999999999999


Q ss_pred             cCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccc
Q 004994          579 DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQS  656 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  656 (720)
                      ++++.+||+|||+++...............++..|+|||.. ...++.++|||||||++|||++ |+.||........  
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--  350 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--  350 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--
Confidence            99999999999999865332211111223456789999988 5568999999999999999998 8999865322111  


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                                    ....+........+...+.++.+++.+||+.+|++||+++||++.|++++
T Consensus       351 --------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 --------------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             --------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                          00000000000111123467889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.7e-38  Score=333.06  Aligned_cols=243  Identities=20%  Similarity=0.286  Sum_probs=193.4

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      +.||+|+||.||++.. .+|+.||+|++..... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999965 5789999999975432 2234456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL  603 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  603 (720)
                      +|.+++..    ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  151 (323)
T cd05595          81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT  151 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence            99988753    34688999999999999999999987   99999999999999999999999999987542221  11


Q ss_pred             ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch
Q 004994          604 SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA  682 (720)
Q Consensus       604 ~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (720)
                      .....++..|+|||.. .+.++.++|||||||++|||++|+.||...........                +.....  .
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~----------------~~~~~~--~  213 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----------------ILMEEI--R  213 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----------------HhcCCC--C
Confidence            2235678899999998 55789999999999999999999999965432111100                000000  0


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          683 YLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       683 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      .+...+.++.+++.+||+.||++||     ++.+++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            1112345788999999999999998     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.7e-38  Score=324.87  Aligned_cols=258  Identities=24%  Similarity=0.392  Sum_probs=202.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ++|...+.||+|+||.||+|...      +++.||||.++.... ....+.|.+|++++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            45777789999999999999653      347899999875432 22457899999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccc----------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDE----------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI  583 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  583 (720)
                      ++||||+++++|.+++....          .....+++.....++.+++.||+|||..   +++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999986432          1234578899999999999999999987   8999999999999999999


Q ss_pred             eEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhc
Q 004994          584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWA  661 (720)
Q Consensus       584 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  661 (720)
                      +||+|||+++................+..|+|||+. .+.++.++|||||||++|||++ |+.||........   ....
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECI  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH
Confidence            999999999765333222222233446789999988 5678999999999999999999 9999865332211   1110


Q ss_pred             ccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                                   ..... ...+...+..+.+++.+||+.||++||+++||++.|++
T Consensus       238 -------------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 -------------TQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -------------HcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                         00000 00111234678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=332.23  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=214.0

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeCC-CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      -..+....++||-|.||.||.|.|+. ...||||.++.+   ....++|+.|..+|+.++|||+|+++|+|..+..+|||
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi  341 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII  341 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence            33455566899999999999997754 678999999754   46678999999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      +|||..|+|.++|++..  +..++-...+.+|.||+.|++||...   ++|||||.++|+|+.++..|||+|||+++++.
T Consensus       342 TEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            99999999999998654  45567777889999999999999987   89999999999999999999999999999986


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      .+.+. -..+..-...|.|||-+ -..++.|+|||+|||+|||+.| |-.||.+.+-.                 .+-.+
T Consensus       417 gDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----------------qVY~L  478 (1157)
T KOG4278|consen  417 GDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYGL  478 (1157)
T ss_pred             CCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----------------HHHHH
Confidence            54332 22222234568899988 5679999999999999999998 88999754321                 22233


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ++.......++.|++.+.+||..||++.|++||++.|+-+.+|.|+
T Consensus       479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            3444444556678889999999999999999999999999999884

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.9e-38  Score=349.78  Aligned_cols=252  Identities=18%  Similarity=0.269  Sum_probs=199.3

Q ss_pred             CCCCCeeccCCCceEEEEEe-CC-CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      |...+.||+|+||.||+|.. .+ +..||+|.+...  .......+.+|+++++.++|||||++++++...+..++||||
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            67778999999999999954 34 678888876432  233445678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++|+|.+++.........+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+....
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999998865433345688889999999999999999987   99999999999999999999999999998764332


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .........|+++|+|||+. ...++.++|||||||++|||+||+.||.......   +.             ..+....
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~-------------~~~~~~~  287 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IM-------------QQVLYGK  287 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-------------HHHHhCC
Confidence            22233345689999999998 5568999999999999999999999996532211   01             1111000


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .. ..+...+.++.+++.+||+.||++||++++++++
T Consensus       288 ~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        288 YD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CC-CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            00 0111233578899999999999999999999754

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.1e-38  Score=314.56  Aligned_cols=269  Identities=22%  Similarity=0.291  Sum_probs=200.1

Q ss_pred             CCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCc-eeEEEeEeccCC------e
Q 004994          441 SFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN-IVELIGYCNEHG------Q  512 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~------~  512 (720)
                      .|...+.||+|+||+||+|+ ..+|+.||+|+++.....+.......+|+.++++++|+| ||.+++++....      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            34455779999999999995 567999999999865544445566789999999999999 999999998766      7


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||++. +|..++.........++...+..++.|+.+||+|||+.   +|+||||||.|||++++|.+||+|||+|
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence            8999999886 89998865432213566678999999999999999997   9999999999999999999999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh--hcccccCch
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR--WAIPRLHDI  668 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~--~~~~~~~~~  668 (720)
                      +...-...  .......|.+|+|||.+-  ..|+...||||+|||++||++++.-|.+..+.+....+-  ...+.-..+
T Consensus       168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            86642221  123345788999999983  369999999999999999999998887654322111110  011111112


Q ss_pred             hhhhhhcCCCCC-------chhhHHH---HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLD-------GAYLAKS---LSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~-------~~~~~~~---~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .......+....       .......   .....+++.+||+.+|.+|.|++.+++|
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111111111100       0000111   1367899999999999999999999976

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-37  Score=325.06  Aligned_cols=258  Identities=24%  Similarity=0.397  Sum_probs=202.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ++|...+.||+|+||+||++..      .++..+|+|.+....  ....+.+.+|++++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            5678889999999999999964      234678999986432  33456789999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccc---------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCe
Q 004994          514 LLVYDYGGNCTLHDLLHSDE---------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIV  584 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  584 (720)
                      ++||||+++++|.+++....         .....+++..+..++.+++.||+|||+.   +++||||||+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            99999999999999986432         1123589999999999999999999987   89999999999999999999


Q ss_pred             EEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcc
Q 004994          585 RVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       585 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      ||+|||+++...............++..|+|||.. ...++.++|||||||++|||+| |+.||.......   ....  
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~--  234 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC--  234 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH--
Confidence            99999999866433222222223346789999988 4568999999999999999998 999986543211   1110  


Q ss_pred             cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                                 +...... ..+...+.++.+++.+||+.||.+|||++|+++.|+++
T Consensus       235 -----------i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         235 -----------ITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             -----------HHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence                       0000000 00111235689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-37  Score=323.75  Aligned_cols=258  Identities=26%  Similarity=0.392  Sum_probs=200.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-----CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-----PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      .+|+..+.||+|+||+||+|..     .++..||+|.+..... ......+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            3566778999999999999963     3567899999975322 334467889999999999999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccc-------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC
Q 004994          515 LVYDYGGNCTLHDLLHSDE-------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK  581 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~  581 (720)
                      +||||+++++|.+++....             .....+++.....++.+++.||+|||+.   +|+||||||+|||++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence            9999999999999985321             1123578889999999999999999987   89999999999999999


Q ss_pred             CCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhh
Q 004994          582 LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVR  659 (720)
Q Consensus       582 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~  659 (720)
                      +.+||+|||+++...............++..|+|||+. .+.++.++|||||||++|||++ |..||.......   +..
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            99999999999876433222222333446679999988 5678999999999999999998 999986432211   111


Q ss_pred             hcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      ..              ........+...+.++.+++.+||+.||++||++.+|+++|..
T Consensus       238 ~~--------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MV--------------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH--------------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            10              0000000112234678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=346.83  Aligned_cols=254  Identities=20%  Similarity=0.320  Sum_probs=201.1

Q ss_pred             CCCCCCeeccCCCceEEEEEeCCC-cEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEe-Eec----c--CC
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPGG-KLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIG-YCN----E--HG  511 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~-~~~----~--~~  511 (720)
                      ++++.++|.+|||+.||.|....+ ..||+|++.-.  ++...+...+|+++|++|. |+|||.+++ ...    .  ..
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            455678999999999999976554 99999998643  4566678899999999996 999999999 331    1  24


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      +++|+||||.+|+|-|++..+..  ..|++.++++|+.++++|+++||.. .++|||||||-+||||+.+++.||||||.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            78999999999999999975433  3499999999999999999999986 77899999999999999999999999999


Q ss_pred             CCCCCCCC-C-cc---ccc--CccccccCCCCccC---C-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhh
Q 004994          592 APLLFSGS-T-NE---LSE--GLLTAHGSGAPEFE---S-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW  660 (720)
Q Consensus       592 a~~~~~~~-~-~~---~~~--~~~~~~~~~aPE~~---~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  660 (720)
                      |.-..... . ..   ...  ...+|+.|++||++   . ...++|+|||++||+||-|+....||+....-.   +.  
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---Il--  267 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---IL--  267 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---EE--
Confidence            86432221 1 11   111  23478999999987   3 368999999999999999999999997642211   11  


Q ss_pred             cccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          661 AIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       661 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                                     +.....--.......|.+||..||+.||++||++-+|+.++.+|
T Consensus       268 ---------------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  268 ---------------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             ---------------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                           11111000123457899999999999999999999999999876

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-38  Score=330.98  Aligned_cols=241  Identities=20%  Similarity=0.265  Sum_probs=191.1

Q ss_pred             eccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          448 IGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       448 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      ||+|+||+||+|.. .+++.||+|++.+.. ........+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999965 468899999986432 2233456788999999999999999999999999999999999999999


Q ss_pred             HHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccccc
Q 004994          526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE  605 (720)
Q Consensus       526 ~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  605 (720)
                      .+++..    ...+++..+..++.++++||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  151 (312)
T cd05585          81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN  151 (312)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence            998853    34588899999999999999999987   89999999999999999999999999997643221  1223


Q ss_pred             CccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhh
Q 004994          606 GLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL  684 (720)
Q Consensus       606 ~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  684 (720)
                      ...++..|+|||.. ...++.++|||||||++|||+||+.||........                ...+.....  ..+
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~----------------~~~~~~~~~--~~~  213 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM----------------YRKILQEPL--RFP  213 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH----------------HHHHHcCCC--CCC
Confidence            45688999999998 45689999999999999999999999965321110                011111000  011


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCC---HHHHHHH
Q 004994          685 AKSLSRFADIISRCVQWEPGFRPP---MSEIVQD  715 (720)
Q Consensus       685 ~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~  715 (720)
                      .....++.+++.+||+.||++||+   +.|++++
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            223457889999999999999975   6777654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.1e-37  Score=324.07  Aligned_cols=258  Identities=23%  Similarity=0.384  Sum_probs=202.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      .+|...+.||+|+||.||+|...      ++..+++|.+....  ....+.+.+|++++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            35677789999999999999642      35679999986432  23346788999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccc------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDE------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK  581 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~  581 (720)
                      ++||||+++++|.+++....            .....+++..+..++.+++.||+|||+.   +|+||||||+||+++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            99999999999999986432            1124588999999999999999999987   89999999999999999


Q ss_pred             CCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhh
Q 004994          582 LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVR  659 (720)
Q Consensus       582 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~  659 (720)
                      +.+||+|||+++...............++..|+|||.. ...++.++|||||||++|||+| |+.||........   .+
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~  236 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IE  236 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH
Confidence            99999999999866443322222334456789999987 5568999999999999999999 9999865432111   11


Q ss_pred             hcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .             +...... ......+..+.+++.+||+.||++|||+++|++.|+++
T Consensus       237 ~-------------~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         237 C-------------ITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             H-------------HhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            0             0000000 01112345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-38  Score=335.60  Aligned_cols=246  Identities=18%  Similarity=0.263  Sum_probs=197.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-C-CcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-G-GKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ++|...+.||+|+||.||+|... + +..||+|++.+.. ......+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            46888899999999999999653 3 4689999986432 1233456788999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++|+|.+++..    ...+++.....++.+++.||.|||+.   +|+||||||+|||++.++++||+|||+++.+.
T Consensus       110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999853    34688889999999999999999987   99999999999999999999999999998653


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ..     .....+++.|+|||.+ ...++.++|||||||++|||+||+.||..........                .+.
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----------------~i~  241 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ----------------KIL  241 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH----------------HHh
Confidence            22     1235678899999998 4568999999999999999999999997543211110                011


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      ....  .++......+.+++.+|++.||++|+     +++|++++
T Consensus       242 ~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        242 EGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             cCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            1000  01111234678999999999999995     89998875

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.8e-37  Score=322.11  Aligned_cols=259  Identities=23%  Similarity=0.337  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  512 (720)
                      +++|...+.||+|++|.||+|...      .+..||+|.+.... .......|..|+.++++++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            456888899999999999999654      35789999886432 23334678999999999999999999999999889


Q ss_pred             EEEEEeeCCCCCHHHHhhccch---hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC---CeEE
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEE---AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL---IVRV  586 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl  586 (720)
                      .++||||+++++|.+++.....   ....++|..+.+++.+++.||+|||+.   +++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999864321   123589999999999999999999987   899999999999998754   5999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                      +|||+++.+..............+..|+|||+. .+.++.++|||||||++|||++ |+.||.........   .     
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~-----  232 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---E-----  232 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H-----
Confidence            999999876332221111122234579999997 5679999999999999999997 99999754322111   1     


Q ss_pred             cCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                               .+........+...+..+.+++.+|++.+|++||++.+|+++|++
T Consensus       233 ---------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         233 ---------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             ---------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                     000000011112234578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.1e-37  Score=325.60  Aligned_cols=259  Identities=25%  Similarity=0.379  Sum_probs=203.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~  512 (720)
                      ++|...+.||+|+||.||++..      .++..||||.++.... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            4688889999999999999953      2355899999875422 23446789999999999 79999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||+.+|+|.++++...  ...+++.++..++.+++.||+|||+.   +|+|+||||+|||++.++.+|++|||++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence            999999999999999986422  23489999999999999999999987   8999999999999999999999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhh
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      +...............++..|+|||.. .+.++.++|||||||++|||+| |+.||........  +..           
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~-----------  255 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYK-----------  255 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHH-----------
Confidence            866433221122223456789999987 5678999999999999999998 9999865332111  000           


Q ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       671 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                         .+........+...+.++.+++.+||+.+|++|||+.|+++.|++++
T Consensus       256 ---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         256 ---LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             ---HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence               11100000011122357889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.5e-37  Score=323.17  Aligned_cols=249  Identities=23%  Similarity=0.297  Sum_probs=195.5

Q ss_pred             eccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          448 IGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       448 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      ||+|+||+||++.. .+|+.||+|.+.+... .....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999965 5789999999865322 122335678899999999999999999999999999999999999999


Q ss_pred             HHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccccc
Q 004994          526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE  605 (720)
Q Consensus       526 ~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  605 (720)
                      .+.+.........+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988754333445789999999999999999999987   999999999999999999999999999976643322  223


Q ss_pred             CccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhh
Q 004994          606 GLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL  684 (720)
Q Consensus       606 ~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  684 (720)
                      ...++..|+|||.. .+.++.++|||||||++|||++|+.||..........            .....+.....  .++
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~------------~~~~~~~~~~~--~~~  221 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK------------ELKQRILNDSV--TYP  221 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH------------HHHHhhcccCC--CCc
Confidence            35678899999998 5678999999999999999999999996533211100            00111111110  112


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          685 AKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       685 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      ...+.++.+++.+||+.||++||     ++++++++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            23446788999999999999999     77888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.6e-37  Score=316.27  Aligned_cols=261  Identities=21%  Similarity=0.329  Sum_probs=206.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEeccc-ccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++.. .......+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888899999999999999665 7999999998642 222334568899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++.........+++..+..++.++++||.|||+.   +|+||||||+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998865433345688999999999999999999987   999999999999999999999999999876533


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...  ......++..|.|||.. ...++.++|||||||++|||++|+.||...... ......             ....
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~-------------~~~~  222 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK-------------KIEK  222 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh-------------hhhc
Confidence            211  11224567789999987 456899999999999999999999999643211 000000             0000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...........+..+.+++.+||..+|++|||+.+|++.|++|
T Consensus       223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            0000000113345788999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-37  Score=317.44  Aligned_cols=250  Identities=25%  Similarity=0.393  Sum_probs=198.3

Q ss_pred             CCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      +|+..+.||+|+||.||+|...++..+|+|.+.+..   .....|.+|++++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            467788999999999999988777889999986432   23457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      ++++|.+++...   ...+++.....++.++++||+|||+.   +++||||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            999999998643   23688999999999999999999987   899999999999999999999999999986643211


Q ss_pred             cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          601 NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      . .......+..|+|||.. ...++.++|||||||++|||+| |+.||........   ...          ........
T Consensus       156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~----------~~~~~~~~  221 (256)
T cd05059         156 T-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VES----------VSAGYRLY  221 (256)
T ss_pred             c-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHH----------HHcCCcCC
Confidence            1 11112234579999988 5678999999999999999999 8999965332111   100          00000001


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                          .+...+.++.+++.+||+.+|++|||+.|+++.|.
T Consensus       222 ----~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         222 ----RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             ----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence                11123467889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.1e-37  Score=317.65  Aligned_cols=250  Identities=23%  Similarity=0.369  Sum_probs=198.7

Q ss_pred             CCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      +|...+.||+|+||+||+|+..++..||+|.+....   ...++|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            566778999999999999988777789999986432   23467899999999999999999999999988999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      .+|+|.+++...   ...+++..+..++.+++.||+|||+.   +++|+||||+||++++++.+||+|||.++.......
T Consensus        82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            999999988642   23689999999999999999999987   999999999999999999999999999886643221


Q ss_pred             cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          601 NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      . ......++..|++||.. .+.++.++|||||||++|||+| |+.||........   ...             +....
T Consensus       156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~-------------~~~~~  218 (256)
T cd05113         156 T-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEK-------------VSQGL  218 (256)
T ss_pred             e-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH-------------HhcCC
Confidence            1 11223345679999998 4578999999999999999999 9999965332111   000             00000


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                       ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       219 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         219 -RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             00001112357889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.6e-37  Score=321.44  Aligned_cols=260  Identities=23%  Similarity=0.332  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCC-----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc-CCe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPG-----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-HGQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~  512 (720)
                      .++|...++||+|+||.||+|....     +..|++|++.... .....+.+.+|+.++++++|+||+++++++.+ ...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            4577888999999999999997654     6889999987442 23445778899999999999999999998765 567


Q ss_pred             EEEEEeeCCCCCHHHHhhccchh----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcc
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEA----HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSD  588 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  588 (720)
                      .++++||+++++|.+++......    ...+++..+..++.+++.||+|||+.   +++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998653221    15689999999999999999999987   899999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccC
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLH  666 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  666 (720)
                      ||+++.+.............++..|+|||.. ...++.++|||||||++||+++ |+.||....+..   +..+....  
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~--  235 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKDG--  235 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHcC--
Confidence            9999876544332222233456779999988 4568999999999999999999 999997543221   11111000  


Q ss_pred             chhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       667 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                              ...    .....+++++.+++.+||+.||++|||+.|+++.|+++
T Consensus       236 --------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         236 --------YRL----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             --------CCC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                    000    01112345788999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.3e-37  Score=319.32  Aligned_cols=261  Identities=18%  Similarity=0.300  Sum_probs=206.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||.||+|.. .+++.||||.+.... .......++.+|+++++.++|+||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3577788999999999999964 578999999886432 22334467889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++.........+++.....++.++++||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998864333345689999999999999999999987   999999999999999999999999999876643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...  ......++..|+|||.. ...++.++||||||+++|||++|+.||....... .....          .......
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~----------~~~~~~~  225 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK----------KIEQCDY  225 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhh----------hhhcCCC
Confidence            221  12234577889999988 5568899999999999999999999996432110 00000          0111111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      +...   ....+.++.+++.+||+.||++||||.+|++.+++|
T Consensus       226 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         226 PPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            1111   122446788999999999999999999999999887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.1e-37  Score=326.63  Aligned_cols=260  Identities=23%  Similarity=0.381  Sum_probs=200.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC--------CCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccC
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP--------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEH  510 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~  510 (720)
                      ++|...+.||+|+||.||++...        ++..+|+|.+..... .....++.+|+++++++ +|+||++++++|.+.
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            46788899999999999999642        235799999975432 23345788899999999 799999999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl  578 (720)
                      +..++||||+++|+|.+++.....            ....++|.++.+++.+++.||+|||+.   +++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            999999999999999999965321            123588999999999999999999987   99999999999999


Q ss_pred             cCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccc
Q 004994          579 DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQS  656 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  656 (720)
                      ++++.+||+|||+++................+..|+|||.. ...++.++|||||||++|||++ |+.||..........
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            99999999999999766432211111112234579999987 5568999999999999999998 888986432111000


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ..                 ........+...+.++.+++.+||+.+|++|||+.||++.|++++
T Consensus       254 ~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         254 LL-----------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             HH-----------------HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            00                 000000111223467889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-38  Score=314.62  Aligned_cols=249  Identities=22%  Similarity=0.355  Sum_probs=205.8

Q ss_pred             hcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ..+|+..+.||+|.||+|-+| ++..|+.||||.+++... +.++...+++|+++|..|+||||+.+|++|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            345667788999999999999 567899999999986543 344556789999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||..+|.|.|++..    ...++.....+++.||..|+.|+|..   ++||||||.+|||+|.++++||+|||++..+.
T Consensus       132 MEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999954    46788999999999999999999987   99999999999999999999999999998875


Q ss_pred             CCCCcccccCccccccCCCCccCCC-CC-CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFESG-SY-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~-~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ..   .+...++|.+-|.+||+..| +| ++.+|-||+||+||.|+.|..||++.+...   +++.    +.. +   .+
T Consensus       205 ~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvrQ----Is~-G---aY  270 (668)
T KOG0611|consen  205 DK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVRQ----ISR-G---AY  270 (668)
T ss_pred             cc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHHH----hhc-c---cc
Confidence            43   34455788999999999954 45 678999999999999999999998754321   1111    000 0   01


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      ..|        +.+....-|+..||..+|++|-|+++|..|.
T Consensus       271 rEP--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  271 REP--------ETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             cCC--------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            111        1234566889999999999999999998774

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-38  Score=328.52  Aligned_cols=252  Identities=23%  Similarity=0.329  Sum_probs=209.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe-EEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ-HLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lv~  517 (720)
                      ++|...+.+|+|+||.++.++++ +++.|++|.+..........+....|+.++++++|||||.+++.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46788899999999999999654 67899999998665555555678899999999999999999999998887 99999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      +|++||++.+.+....  ...|+......++.|+..|+.|||+.   .|+|||||+.||+++.+..|||+|||+|+.+..
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999997543  46788999999999999999999976   899999999999999999999999999999854


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..  .......||+.|+.||++ ..+|+.|+||||+||++|||++-+.+|...+..   .++..         .......
T Consensus       159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~k---------i~~~~~~  224 (426)
T KOG0589|consen  159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILK---------INRGLYS  224 (426)
T ss_pred             ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHH---------HhhccCC
Confidence            32  245568899999999999 457999999999999999999999999764321   11110         1111111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      |     .+.....++..++..|+..+|+.||++.+++.+
T Consensus       225 P-----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 P-----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             C-----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1     223345688999999999999999999999875

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=303.55  Aligned_cols=252  Identities=21%  Similarity=0.279  Sum_probs=205.4

Q ss_pred             HhcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +++.|+.-+.||+|.|+.||++ ...+|+.+|+|.+..........+++.+|+++-+.|+|||||++.+.+.+.+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4567777789999999999999 557899999999875444445678899999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---CCCeEEccccCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIVRVSDCGLAP  593 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla~  593 (720)
                      +|+|.|++|..-+..    +..+++...-..+.|+.++|.|.|..   +|||||+||+|+|+..   .--+||+|||+|.
T Consensus        89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            999999998765532    24566777788999999999999998   9999999999999953   3468999999999


Q ss_pred             CCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      .+.   ......+..||++|+|||+. ..+|+..+|||+.|||||-++.|.+||.+.+...-                ..
T Consensus       162 ~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl----------------ye  222 (355)
T KOG0033|consen  162 EVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL----------------YE  222 (355)
T ss_pred             EeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH----------------HH
Confidence            886   34456778999999999999 56899999999999999999999999976332111                11


Q ss_pred             hhc--CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMV--DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ++.  +....+.+.....++..+|+.+||..||++|.|+.|++.|
T Consensus       223 ~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  223 QIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             HHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            111  1112222334455778999999999999999999999865

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-37  Score=329.38  Aligned_cols=243  Identities=21%  Similarity=0.302  Sum_probs=191.6

Q ss_pred             CeeccCCCceEEEEEe----CCCcEEEEEEeccccc--ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          446 NFIGEGLLGSVYKAEL----PGGKLLAVKKLSNTVS--QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +.||+|+||.||++..    .+++.||||++++...  .......+..|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999964    3578999999975321  123345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++..    ...+.+.....++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999998853    34567788888999999999999987   99999999999999999999999999987542221


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                        .......++..|+|||+. ...++.++|||||||++|||++|+.||........                ...+....
T Consensus       155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~----------------~~~~~~~~  216 (323)
T cd05584         155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT----------------IDKILKGK  216 (323)
T ss_pred             --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH----------------HHHHHcCC
Confidence              122335688999999998 44688999999999999999999999975432111                11111111


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      .  ..+......+.+++.+||+.||++||     ++++++++
T Consensus       217 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 L--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             C--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            0  01112235678999999999999999     88888764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-37  Score=323.17  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=200.2

Q ss_pred             CCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          442 FSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      |...+.||+|+||+||+|...      +++.||+|++..... ....+.|.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            445678999999999999653      257899999975432 2334678899999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccc------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDE------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI  583 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  583 (720)
                      ++||+.+++|.+++....            .....+++..+.+++.|+++||+|||+.   +|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999985321            1123578888999999999999999987   8999999999999999999


Q ss_pred             eEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhc
Q 004994          584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWA  661 (720)
Q Consensus       584 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  661 (720)
                      +||+|||+++.+.............+++.|+|||.. .+.++.++|||||||++|||+| |..||.......   ..   
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~---  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VI---  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---
Confidence            999999999876443322222333456789999987 5678999999999999999998 888886532211   11   


Q ss_pred             ccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                                ..+.+... ...+...+..+.+++.+||+.+|++||++.||++.|+.
T Consensus       237 ----------~~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 ----------EMIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ----------HHHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                      11111111 01122345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.7e-38  Score=333.00  Aligned_cols=244  Identities=22%  Similarity=0.285  Sum_probs=193.0

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      +.||+|+||+||++.. .+|+.||+|.+.+... .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999954 5789999999975432 2233456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL  603 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  603 (720)
                      +|.+++..    ...+++.....++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            99988753    34688999999999999999999972  289999999999999999999999999987542211  11


Q ss_pred             ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch
Q 004994          604 SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA  682 (720)
Q Consensus       604 ~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (720)
                      .....++..|+|||.+ .+.++.++|||||||++|||+||+.||...........+...              ...    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--------------~~~----  214 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------------EIR----  214 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--------------CCC----
Confidence            2234688999999998 557899999999999999999999999654321111111000              000    


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          683 YLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       683 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      .+.....++.+++.+||+.||++|+     ++.+++++
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            1112235688999999999999996     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.2e-37  Score=314.93  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=194.2

Q ss_pred             eeccCCCceEEEEEe---CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          447 FIGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       447 ~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      .||+|+||.||+|.+   .+++.+|+|+++.........+++.+|+.+++.++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999954   357899999987554444456789999999999999999999999864 4678999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL  603 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  603 (720)
                      +|.+++..    ...+++.....++.|++.||+|||..   +|+||||||+||++++++.+||+|||+++.+........
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999853    24588899999999999999999987   899999999999999999999999999987643322111


Q ss_pred             -ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCC
Q 004994          604 -SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD  680 (720)
Q Consensus       604 -~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  680 (720)
                       .....++..|+|||.. .+.++.++|||||||++|||+| |+.||...........+                 .....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-----------------~~~~~  216 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-----------------ESGER  216 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----------------HCCCC
Confidence             1112234689999987 4568889999999999999998 99999754321111111                 00000


Q ss_pred             chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       681 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...+...+.++.+++.+||+.||++||++++|.+.|++.
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            011122346788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-37  Score=324.73  Aligned_cols=261  Identities=23%  Similarity=0.389  Sum_probs=202.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe--------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEecc
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL--------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNE  509 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~  509 (720)
                      ..+|...+.||+|+||.||+|..        .++..||+|.+..... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            34677789999999999999963        1245799999875422 23446788999999999 89999999999999


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNIL  577 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiL  577 (720)
                      .+..++||||+++|+|.+++.....            ....+++..+.+++.|+++||+|||+.   +|+||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence            9999999999999999999864321            123578889999999999999999987   9999999999999


Q ss_pred             EcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCcccc
Q 004994          578 LDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQ  655 (720)
Q Consensus       578 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  655 (720)
                      +++++.+||+|||+++.+.............++..|+|||.. ...++.++||||||+++|||++ |..||........ 
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-  248 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-  248 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-
Confidence            999999999999999876433222222223345679999987 5568999999999999999998 8888864321111 


Q ss_pred             chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                        ...              +........+..++..+.+++.+||+.+|++|||+.|+++.|++++
T Consensus       249 --~~~--------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         249 --FKL--------------LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             --HHH--------------HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence              100              0000000011233467889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.5e-37  Score=324.32  Aligned_cols=267  Identities=20%  Similarity=0.280  Sum_probs=195.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|...+.||+|+||+||+|... +++.||||++..... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            357888999999999999999664 789999999874422 223346778999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+. ++|.+++...   ...+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++....
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          83 EYVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             ECCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            9996 5777777532   34578888999999999999999987   999999999999999999999999999875432


Q ss_pred             CCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc-cchhhhcc--c------ccC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE-QSLVRWAI--P------RLH  666 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~-~~~~~~~~--~------~~~  666 (720)
                      ..  .......++..|+|||...  ..++.++|||||||++|||+||+.||........ ........  +      ...
T Consensus       156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         156 PS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             CC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            11  1122345688999999873  3588999999999999999999999975432111 00000000  0      000


Q ss_pred             c-----hhhhhhhcCCCCCchhh-HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 D-----IDALSRMVDPSLDGAYL-AKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 ~-----~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .     .+.........+..... ......+.+++.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            0     00000000000000000 0112467899999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4e-37  Score=322.88  Aligned_cols=257  Identities=23%  Similarity=0.341  Sum_probs=198.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCc--EEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGK--LLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|+..+.||+|+||.||+|... ++.  .+++|.++... .....+.|.+|+++++++ +||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            46888899999999999999764 343  47888886322 233456789999999999 79999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI  583 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  583 (720)
                      |+||+++++|.+++.....            ....+++.....++.|++.||+|||+.   +|+||||||+|||+++++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence            9999999999999864321            123588899999999999999999987   9999999999999999999


Q ss_pred             eEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhc
Q 004994          584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWA  661 (720)
Q Consensus       584 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  661 (720)
                      +||+|||++........   ......+..|+|||.. ...++.++|||||||++|||++ |+.||........   ..  
T Consensus       158 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~--  229 (297)
T cd05089         158 SKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YE--  229 (297)
T ss_pred             EEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH--
Confidence            99999999864321101   1111224569999988 5568999999999999999997 9999965432111   00  


Q ss_pred             ccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                                 . +........+...+..+.+++.+||+.+|.+|||++++++.|++++
T Consensus       230 -----------~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         230 -----------K-LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             -----------H-HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                       0 0000000011123457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-37  Score=318.65  Aligned_cols=255  Identities=24%  Similarity=0.376  Sum_probs=204.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ..+|+..+.||+|+||.||+|...+++.+|+|.+....  .....++.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            35678889999999999999988779999999987542  2345678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++....  ...+++..+..++.+++.||+|||+.   +|+||||||+||++++++.+||+|||.+......
T Consensus        83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            999999999997532  34688999999999999999999987   8999999999999999999999999999776432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...  .....++..|++||.. .+.++.++||||||+++|||++ |+.||.......   .....             ..
T Consensus       158 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~-------------~~  219 (261)
T cd05148         158 VYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQI-------------TA  219 (261)
T ss_pred             ccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH-------------Hh
Confidence            211  1123345679999987 4578999999999999999998 899996533211   11110             00


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       ......+...++.+.+++.+||+.||++|||++++++.|+.+
T Consensus       220 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 -GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence             000011123346788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.4e-37  Score=320.42  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  512 (720)
                      .++|+..+.||+|+||.||+|...      .+..||+|.+..... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            467888999999999999999543      245899999864432 2334568899999999999999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccch------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEE
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEE------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRV  586 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  586 (720)
                      .++||||+++|+|.+++.....      .....++.....++.+++.||.|||+.   +|+||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999964221      123456778889999999999999987   9999999999999999999999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                      +|||+++...............++..|+|||.. .+.++.++|||||||++|||++ |+.||.......   ...     
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~-----  232 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK-----  232 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-----
Confidence            999999866433221111122345679999988 5678999999999999999998 788986432211   110     


Q ss_pred             cCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                              .+.+.... ..+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus       233 --------~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 --------FVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             --------HHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                    01111000 01112346789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=323.69  Aligned_cols=265  Identities=23%  Similarity=0.343  Sum_probs=199.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC---------------CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG---------------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI  504 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~  504 (720)
                      ++|...+.||+|+||.||++....               ...||+|.++.... ......|.+|++++++++|+||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            578888999999999999986532               23589999875432 33456789999999999999999999


Q ss_pred             eEeccCCeEEEEEeeCCCCCHHHHhhccch--------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 004994          505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEE--------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNI  576 (720)
Q Consensus       505 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~Ni  576 (720)
                      +++...+..++||||+++++|.+++.....        ....+++..+.+++.++++||+|||+.   +++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            999999999999999999999999854321        112478899999999999999999987   999999999999


Q ss_pred             EEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh--CCCCCCCCCCcc
Q 004994          577 LLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT--GRKPYDRSRPRG  653 (720)
Q Consensus       577 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt--G~~Pf~~~~~~~  653 (720)
                      ++++++.+||+|||+++.+.............++..|+|||.. .+.++.++|||||||++|||++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            9999999999999999866433222222223346689999987 5678999999999999999998  667776433211


Q ss_pred             ccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          654 EQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                         .+................       ......+..+.+++.+||+.||++||++++|++.|++
T Consensus       241 ---~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 ---VIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ---HHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence               111000000000000000       0011123578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.5e-37  Score=318.93  Aligned_cols=267  Identities=23%  Similarity=0.320  Sum_probs=200.4

Q ss_pred             CCCCCeeccCCCceEEEEEe-----CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC--CeEE
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-----PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQHL  514 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~  514 (720)
                      |...+.||+|+||+||++..     .+++.||+|.+..... ....+.|.+|++++++++||||+++++++...  ...+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            37789999999999987642     3578999999875422 23456788999999999999999999988653  4688


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++++|.+++..     ..+++..+..++.+++.||.|||+.   +|+||||||+|||+++++.+||+|||+++.
T Consensus        85 lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence            99999999999998853     3589999999999999999999987   899999999999999999999999999987


Q ss_pred             CCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ....... .......++..|+|||.. .+.++.++||||||+++|||+||+.||....... ............ ...+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~  234 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMT-VVRLI  234 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccc-hhhhh
Confidence            6433221 111222345668999987 4578999999999999999999999986533211 111111110110 01111


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..++.......+...+.++.+++.+||+.+|++|||++++++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            11111111111223456889999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-36  Score=338.61  Aligned_cols=268  Identities=19%  Similarity=0.257  Sum_probs=190.8

Q ss_pred             HHHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCC------CceeEEEe
Q 004994          433 ASLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH------GNIVELIG  505 (720)
Q Consensus       433 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~~  505 (720)
                      +++....++|...+.||+|+||+||+|.. .+++.||||+++...   ....++..|++++++++|      .+++.+++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~  198 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR  198 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence            34444568899999999999999999965 568899999996421   223445566677666654      45899999


Q ss_pred             EeccC-CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC--
Q 004994          506 YCNEH-GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL--  582 (720)
Q Consensus       506 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~--  582 (720)
                      ++... ++.++|||++ +++|.+++..    ...+++.....|+.|++.||.|||+.  .+||||||||+|||++.++  
T Consensus       199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        199 YFQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTV  271 (467)
T ss_pred             EEEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcc
Confidence            88754 5788999987 5578887743    34688999999999999999999973  2899999999999998765  


Q ss_pred             --------------CeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCC
Q 004994          583 --------------IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYD  647 (720)
Q Consensus       583 --------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~  647 (720)
                                    .+||+|||.+.....     ......++..|+|||++ ...|+.++|||||||++|||+||+.||.
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                          499999998864321     12235688999999998 5579999999999999999999999997


Q ss_pred             CCCCccccchhhhcccccCch-------hhhhhhcC------CCCCch-----------hhHHHHHHHHHHHHHHhccCC
Q 004994          648 RSRPRGEQSLVRWAIPRLHDI-------DALSRMVD------PSLDGA-----------YLAKSLSRFADIISRCVQWEP  703 (720)
Q Consensus       648 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~------~~~~~~-----------~~~~~~~~l~~l~~~cl~~dP  703 (720)
                      .....+....+......+...       .....+++      +.....           ........+.+|+.+||+.||
T Consensus       347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  426 (467)
T PTZ00284        347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR  426 (467)
T ss_pred             CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence            654322222211111111000       00000000      000000           000113467899999999999


Q ss_pred             CCCCCHHHHHHH
Q 004994          704 GFRPPMSEIVQD  715 (720)
Q Consensus       704 ~~RPt~~evl~~  715 (720)
                      ++|||++|+++|
T Consensus       427 ~~R~ta~e~L~H  438 (467)
T PTZ00284        427 QKRLNARQMTTH  438 (467)
T ss_pred             hhCCCHHHHhcC
Confidence            999999999975

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-38  Score=336.72  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=200.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|.. .+|+.||||++.+... .......+.+|++++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            3678889999999999999965 4789999999975432 2244567889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++...    ..+++.....++.++++||+|||..   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999998642    5688889999999999999999996   999999999999999999999999999987643


Q ss_pred             CC---------------------------CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 004994          598 GS---------------------------TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRS  649 (720)
Q Consensus       598 ~~---------------------------~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~  649 (720)
                      ..                           .........++..|+|||.+ ...++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                           00122335678999999998 457899999999999999999999999764


Q ss_pred             CCcccc-chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHH
Q 004994          650 RPRGEQ-SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-MSEIVQD  715 (720)
Q Consensus       650 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~  715 (720)
                      ...... .+..|.. .         ...+..     ...+.++.+++.+|+. ||.+||+ ++|++++
T Consensus       234 ~~~~~~~~i~~~~~-~---------~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         234 TLQETYNKIINWKE-S---------LRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CHHHHHHHHhccCC-c---------ccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            422111 1111100 0         000000     0134678899999997 9999999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.6e-37  Score=315.71  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=201.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CC---cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GG---KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|+..+.||+|+||.||+|... ++   ..+|+|.+..... ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            46777899999999999999764 33   3799999865432 2335678899999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++++|.+++...   ...+++.++..++.+++.||+|||+.   +++||||||+||++++++.+||+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999998532   24688999999999999999999987   8999999999999999999999999999766


Q ss_pred             CCCCCcccc-cCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          596 FSGSTNELS-EGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       596 ~~~~~~~~~-~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ......... .....+..|+|||+. .+.++.++|||||||++|||+| |+.||.......   ....            
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~------------  222 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKA------------  222 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHH------------
Confidence            432211111 111224569999987 4578999999999999999998 999996433211   1110            


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                       +.. ..........+.++.+++.+|++.+|++||++++|++.|+++|
T Consensus       223 -i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         223 -IND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             -Hhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence             000 0000011123467889999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.3e-37  Score=322.44  Aligned_cols=266  Identities=24%  Similarity=0.348  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCC-----------------CcEEEEEEecccccccccHHHHHHHHHHHHccCCCcee
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPG-----------------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV  501 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv  501 (720)
                      .++|...+.||+|+||.||+|...+                 +..||+|.+..... ....+.+.+|++++++++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence            3578888999999999999986532                 24689999875432 24457889999999999999999


Q ss_pred             EEEeEeccCCeEEEEEeeCCCCCHHHHhhccch-------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 004994          502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEE-------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSS  574 (720)
Q Consensus       502 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~  574 (720)
                      ++++++...+..+++|||+++++|.+++.....       ....+++.....++.+++.||+|||+.   +|+||||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence            999999999999999999999999999864321       123689999999999999999999987   8999999999


Q ss_pred             CeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh--CCCCCCCCCC
Q 004994          575 NILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT--GRKPYDRSRP  651 (720)
Q Consensus       575 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt--G~~Pf~~~~~  651 (720)
                      ||++++++.++|+|||+++...............++..|+|||+. .+.++.++|||||||++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            999999999999999999866443322223334456789999987 4579999999999999999998  7778854322


Q ss_pred             ccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          652 RGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      ..   .............       .......+...+.++.+++.+||+.||++|||+.||++.|++
T Consensus       240 ~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 QQ---VIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HH---HHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            11   1111100000000       000000111233578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1e-37  Score=343.81  Aligned_cols=263  Identities=22%  Similarity=0.305  Sum_probs=192.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-------
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-------  510 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-------  510 (720)
                      .++|...+.||+|+||+||+|.. .+++.||||++....      ....+|+.+++.++|||||++++++...       
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            45788899999999999999965 568999999885321      2345799999999999999999876321       


Q ss_pred             -CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-CeEEcc
Q 004994          511 -GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSD  588 (720)
Q Consensus       511 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~D  588 (720)
                       ...++||||+++ ++.+++.........+++.....++.|+++||+|||+.   +||||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence             246799999985 67777654333446788999999999999999999987   899999999999999665 799999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH  666 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  666 (720)
                      ||+|+.+.....   .....+++.|+|||.+.  ..|+.++|||||||++|||+||++||...........+...... .
T Consensus       215 FGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-p  290 (440)
T PTZ00036        215 FGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT-P  290 (440)
T ss_pred             cccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-C
Confidence            999987643221   22345688999999873  36899999999999999999999999764332211111000000 0


Q ss_pred             chhhhhhh------------cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 DIDALSRM------------VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 ~~~~~~~~------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+.+..+            ....+...++...+.++.+|+.+||+.||.+|||+.|+++|
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            00000000            00001111122234678899999999999999999999865

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7e-37  Score=313.51  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=201.6

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|++|.||+|.. .+++.|++|.+..........+.+..|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            466778999999999999965 4689999999875433445567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.++++..  ....+++.....++.+++.||.|||+.   +++||||||+||+++.++.+||+|||+++.+....
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999999998643  235688899999999999999999987   99999999999999999999999999988664322


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .  ......++..|+|||+. .+.++.++|||||||++|||++|+.||.......   ....             +....
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~-------------~~~~~  217 (256)
T cd08529         156 N--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILK-------------IIRGV  217 (256)
T ss_pred             c--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-------------HHcCC
Confidence            1  12234567889999988 5568999999999999999999999996543111   1110             00000


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .. .........+.+++.+||+.+|++||++.+++++
T Consensus       218 ~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 FP-PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CC-CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            00 0111234578899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.4e-37  Score=335.89  Aligned_cols=253  Identities=21%  Similarity=0.266  Sum_probs=194.2

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .|...+.||+|+||+||+|.. .+++.||||++.+.. ......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            577789999999999999954 578999999997532 223345678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++..    ...+++.....++.+++.||.|||..   +|+||||||+|||++.++++||+|||+++.+...
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999999853    34578888889999999999999987   9999999999999999999999999998643110


Q ss_pred             CCc---------------------------------------------ccccCccccccCCCCccC-CCCCCCccchHhH
Q 004994          599 STN---------------------------------------------ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSL  632 (720)
Q Consensus       599 ~~~---------------------------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~  632 (720)
                      ...                                             .......||..|+|||.+ ...++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            000                                             001124688999999998 4568999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcccc-chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHH--HhccCCCCCCCH
Q 004994          633 GVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISR--CVQWEPGFRPPM  709 (720)
Q Consensus       633 Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPt~  709 (720)
                      ||++|||+||+.||......... .+..|..             .....  .......++.+++.+  |+..+|..||++
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------------~~~~~--~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQLKVINWEN-------------TLHIP--PQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHHHHHHcccc-------------ccCCC--CCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            99999999999999754332111 1111100             00000  001123567788988  555666679999


Q ss_pred             HHHHHH
Q 004994          710 SEIVQD  715 (720)
Q Consensus       710 ~evl~~  715 (720)
                      +|++++
T Consensus       300 ~~~l~h  305 (381)
T cd05626         300 DDIKAH  305 (381)
T ss_pred             HHHhcC
Confidence            999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-37  Score=329.94  Aligned_cols=261  Identities=23%  Similarity=0.384  Sum_probs=198.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccC-C
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEH-G  511 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~  511 (720)
                      ++|...+.||+|+||+||+|..      .+++.||||+++.... ......+.+|++++.++ +|+||++++++|... .
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            4688899999999999999953      3578999999975432 23345788999999999 689999999988654 4


Q ss_pred             eEEEEEeeCCCCCHHHHhhccch---------------------------------------------------------
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEE---------------------------------------------------------  534 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  534 (720)
                      ..++||||+++|+|.++++....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999999864210                                                         


Q ss_pred             ------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCcc
Q 004994          535 ------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL  608 (720)
Q Consensus       535 ------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  608 (720)
                            ....+++....+++.++++||+|||+.   +|+||||||+|||++.++++||+|||+++.+.............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  013468888999999999999999987   99999999999999999999999999998653322211122233


Q ss_pred             ccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHH
Q 004994          609 TAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAK  686 (720)
Q Consensus       609 ~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  686 (720)
                      ++..|+|||.. ...++.++|||||||++|||++ |..||........  +....    ...      .....    +..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~----~~~------~~~~~----~~~  306 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRL----KEG------TRMRA----PDY  306 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHH----hcc------CCCCC----CCC
Confidence            45679999987 5678999999999999999997 9999965322110  00000    000      00000    111


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          687 SLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       687 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ..+++.+++.+||+.||++|||+.||+++|+.++
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            2346889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.6e-37  Score=317.74  Aligned_cols=255  Identities=25%  Similarity=0.355  Sum_probs=198.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCc----EEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ++|...+.||+|+||+||+|.+ .+|+    .||+|.++... .....+++.+|+.+++.++|+||+++++++... ..+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            4677889999999999999964 4454    48999987543 233456788999999999999999999999754 578


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      ++|||+++|+|.++++..   ...+++.....++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++.
T Consensus        85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence            999999999999998642   34688999999999999999999987   899999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +.............++..|++||.. .+.++.++|||||||++|||+| |+.||........   ..+..          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~----------  225 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDLLE----------  225 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH----------
Confidence            6433222112222345679999987 5578999999999999999998 9999865332111   11000          


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ......    .+...+..+.+++.+||+.||++||++.|+++.|+++
T Consensus       226 ~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         226 KGERLP----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             CCCcCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            000000    0112335688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.1e-37  Score=327.72  Aligned_cols=246  Identities=24%  Similarity=0.316  Sum_probs=190.3

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHH---HHccCCCceeEEEeEeccCCeEEEE
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELAST---ISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~---l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      |...+.||+|+||.||+|.. .+|+.||||++++... .....+.+.+|.++   ++.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            45678999999999999965 5689999999975421 12233455666554   4567899999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|...++.     ..+++.....++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999987742     3589999999999999999999987   99999999999999999999999999987542


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ...  .......++..|+|||.. ...++.++|||||||++|||++|+.||.........                ..+.
T Consensus       153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~----------------~~i~  214 (324)
T cd05589         153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF----------------DSIV  214 (324)
T ss_pred             CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH----------------HHHH
Confidence            211  122335678899999998 456899999999999999999999999754321111                0010


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      ....  .++...+..+.+++.+||+.||++||     ++.+++++
T Consensus       215 ~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         215 NDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             hCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            0000  01112345678999999999999999     57777654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-37  Score=318.67  Aligned_cols=259  Identities=23%  Similarity=0.355  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  512 (720)
                      .++|...+.||+|+||.||+|...      .+..||+|.+.... .......+.+|+.+++.++|+||+++++++...+.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            356778899999999999999653      24689999986442 22334678899999999999999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccch------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEE
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEE------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRV  586 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  586 (720)
                      .++||||+++|+|.+++.....      ....++|..+..++.+++.||.|||+.   +++||||||+||+++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence            9999999999999999864321      123478899999999999999999987   8999999999999999999999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                      +|||+++.+.............++..|+|||.. .+.++.++|||||||++||++| |+.||........   .+..   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~---  234 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFV---  234 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHH---
Confidence            999999866443222222233456789999987 5678999999999999999998 9999965332111   1110   


Q ss_pred             cCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                                .... ....+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       235 ----------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 ----------IDGG-HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ----------hcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                      0000 000111234678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.9e-37  Score=321.45  Aligned_cols=265  Identities=23%  Similarity=0.359  Sum_probs=200.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-----------------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-----------------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE  502 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~  502 (720)
                      ++|+..+.||+|+||.||++...                 ++..||+|++.... .......|.+|++++++++|+||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence            46888899999999999998432                 23468999987542 2334568899999999999999999


Q ss_pred             EEeEeccCCeEEEEEeeCCCCCHHHHhhccch-------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 004994          503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEE-------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSN  575 (720)
Q Consensus       503 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~N  575 (720)
                      +++++...+..++||||+++++|.+++.....       ....+++.....++.+++.||+|||+.   +++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            99999999999999999999999999865321       123478889999999999999999987   89999999999


Q ss_pred             eEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh--CCCCCCCCCCc
Q 004994          576 ILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT--GRKPYDRSRPR  652 (720)
Q Consensus       576 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt--G~~Pf~~~~~~  652 (720)
                      ||+++++.+||+|||+++.+.............++..|++||.. .+.++.++|||||||++|||+|  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            99999999999999999866433222222223345678999976 6679999999999999999998  77888643221


Q ss_pred             cccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      ..   +...........  .....+     .+..++..+.+++.+||+.||++||++.||++.|++
T Consensus       241 ~~---~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 QV---IENTGEFFRDQG--RQVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HH---HHHHHHHHhhcc--ccccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11   110000000000  000000     011234678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-36  Score=313.46  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=200.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|...+.||+|+||.||+|...+...||+|.++...   ...+.|.+|++++++++|+||+++++++.+ +..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            4688889999999999999987776789999997532   234678999999999999999999998754 457999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++|+|.+++...  ....+++..+..++.++++||+|||+.   +++||||||+||++++++.+||+|||.++.+....
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            9999999999642  134578999999999999999999987   89999999999999999999999999997664332


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .. ......++..|++||+. .+.++.++|||||||++|||+| |+.||...........                +.. 
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~----------------~~~-  218 (262)
T cd05071         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----------------VER-  218 (262)
T ss_pred             cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH----------------Hhc-
Confidence            11 11223456679999987 5678999999999999999999 8889865432111100                000 


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..........+..+.+++.+|++.||++||+++++++.|++.
T Consensus       219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            000001123446788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-37  Score=333.98  Aligned_cols=260  Identities=18%  Similarity=0.208  Sum_probs=194.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .+.|+..+.||+|+||.||+|. ..+++.||+|....        ..+.+|++++++++|||||++++++......++|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            3579999999999999999995 46789999997532        34678999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+. ++|.+++..    ...+++.....++.|+++||.|||+.   +||||||||+|||++.++.+||+|||+|+....
T Consensus       163 e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        163 PRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            9986 588887743    34578899999999999999999987   999999999999999999999999999975432


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc----c----hhhhccc---cc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ----S----LVRWAIP---RL  665 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~----~----~~~~~~~---~~  665 (720)
                      .. ........+|+.|+|||++ ...++.++|||||||++|||+||+.||.........    .    ++.....   ..
T Consensus       235 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        235 IN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             cc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            21 1122345689999999998 557899999999999999999999887543211100    0    0000000   00


Q ss_pred             C--chhhhhhhc---------CCCCC--chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          666 H--DIDALSRMV---------DPSLD--GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       666 ~--~~~~~~~~~---------~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .  ....+....         .+...  .......+.++.+++.+||+.||++|||++|++++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0  000000000         00000  01112345678899999999999999999999864

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-37  Score=321.80  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=198.9

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .|+..++||+|+||+||++.. .+++.||+|++..... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            366778999999999999965 5789999999975322 22234567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++...  ....+++.....++.|++.||.|||+.   +|+||||||+||++++++.++|+|||+++.....
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999887532  234688999999999999999999987   8999999999999999999999999999865322


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .   ......++..|+|||.. ...++.++|||||||++|||++|+.||..........             .+...+..
T Consensus       156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~-------------~~~~~~~~  219 (285)
T cd05605         156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE-------------EVERRVKE  219 (285)
T ss_pred             C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH-------------HHHHHhhh
Confidence            2   11234578899999998 5578999999999999999999999997533211100             00000100


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                       ....++...+..+.+++.+||+.||++||     ++++++++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence             00112223456788999999999999999     88898764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=312.95  Aligned_cols=253  Identities=19%  Similarity=0.290  Sum_probs=199.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc---cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ---RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|...+.||+|++|.||+|.. .+++.||+|.+......   ......+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688899999999999999964 57899999998643221   1233568899999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++++|.+++..    ...+++....+++.+++.||+|||+.   +|+||||||+||++++++.+||+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999999998853    34578888899999999999999987   9999999999999999999999999999765


Q ss_pred             CCCCCccc-ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          596 FSGSTNEL-SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       596 ~~~~~~~~-~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ........ .....++..|+|||.. ...++.++||||||+++|||++|+.||.........                ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------------~~  218 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI----------------FK  218 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH----------------HH
Confidence            33211111 1224467789999998 456899999999999999999999999653221110                00


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..........+......+.+++.+||..+|.+|||+.|++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         219 IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            001111111122334567899999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.5e-37  Score=325.99  Aligned_cols=242  Identities=21%  Similarity=0.278  Sum_probs=187.1

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHc-cCCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISR-LRHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      ++||+|+||+||+|.. .+++.||||+++.... .....+.+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 4688999999975432 12333455566666664 4899999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++..    ...+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~  151 (316)
T cd05592          81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G  151 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence            999988853    34578888999999999999999987   99999999999999999999999999997543222  2


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      ......++..|+|||.+ ...++.++|||||||++|||++|+.||...........+..              ..+.   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------------~~~~---  214 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--------------DRPH---  214 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------CCCC---
Confidence            22345688999999998 45689999999999999999999999975432111100000              0011   


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPMS-EIVQ  714 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  714 (720)
                       .+.....++.+++.+||+.||++||++. ++++
T Consensus       215 -~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         215 -FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             -CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence             1112235678999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-37  Score=310.36  Aligned_cols=253  Identities=26%  Similarity=0.302  Sum_probs=201.7

Q ss_pred             CCCCCeeccCCCceEEEEEeCC-CcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          442 FSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      |+..+.||.|.-|+||.++..+ +..+|+|++.+... .+........|-+||+.++||.++.||+.++.....++||||
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey  158 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY  158 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence            3445789999999999998754 68999999976533 244456678889999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC--
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS--  597 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~--  597 (720)
                      |+||+|+.+.+.  +..+.|+.....-++..|.-||+|||..   |||+|||||+|||+.++|++.|+||.++.....  
T Consensus       159 CpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  159 CPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             CCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999998875  3457789998999999999999999998   999999999999999999999999998754311  


Q ss_pred             -------------------------------CCC---------------------cccccCccccccCCCCccCCC-CCC
Q 004994          598 -------------------------------GST---------------------NELSEGLLTAHGSGAPEFESG-SYS  624 (720)
Q Consensus       598 -------------------------------~~~---------------------~~~~~~~~~~~~~~aPE~~~~-~~~  624 (720)
                                                     ...                     ...+..+.||..|.|||++.| .-+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           000                     011223568899999999965 468


Q ss_pred             CccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCC
Q 004994          625 CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPG  704 (720)
Q Consensus       625 ~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  704 (720)
                      .++|+|+|||++|||+.|+.||.+.+..+                .+..++-..+........+..+.|||++.|.+||.
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKE----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchh----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            89999999999999999999998765433                22233322222211224556789999999999999


Q ss_pred             CCCC----HHHHHHH
Q 004994          705 FRPP----MSEIVQD  715 (720)
Q Consensus       705 ~RPt----~~evl~~  715 (720)
                      +|..    +.||-+|
T Consensus       378 kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRH  392 (459)
T ss_pred             hhhccccchHHhhcC
Confidence            9987    7777553

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-36  Score=312.78  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=199.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|...+.||+|+||.||+|...++..||+|.+....   ...+.|.+|++++++++|+|++++++++.+ +..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT---MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY   81 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC---CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence            4677889999999999999988888889999987542   234678999999999999999999998854 568899999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.++++..  ....+++..+..++.+++.||+|||+.   +++||||||+||++++++.+||+|||++..+....
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            9999999998643  234578999999999999999999987   89999999999999999999999999997664322


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .. ......++..|+|||.. ...++.++||||||+++|||++ |+.||........   ...             +. .
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~-------------~~-~  218 (260)
T cd05070         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQ-------------VE-R  218 (260)
T ss_pred             cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH-------------HH-c
Confidence            11 11122345679999987 5578999999999999999999 8999965332111   110             00 0


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      ......+...+..+.+++.+|+..+|++|||++++.+.|++
T Consensus       219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            00001112234578899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3e-37  Score=327.10  Aligned_cols=243  Identities=21%  Similarity=0.287  Sum_probs=190.3

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||+||+|.. .+++.||||++.+... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 4689999999975422 223445677888888776 699999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++..    ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~  151 (320)
T cd05590          81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K  151 (320)
T ss_pred             chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence            999988853    34588889999999999999999987   89999999999999999999999999987542211  1


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      ......++..|+|||.+ ...++.++|||||||++|||++|+.||........   ..             .+.....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~-------------~i~~~~~--  213 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FE-------------AILNDEV--  213 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HH-------------HHhcCCC--
Confidence            22335688999999998 45689999999999999999999999975432111   11             0110000  


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCH------HHHHHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPM------SEIVQD  715 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  715 (720)
                      ..+.....++.+++.+||+.||++||++      ++++++
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            0111223567899999999999999998      666543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-36  Score=313.58  Aligned_cols=255  Identities=25%  Similarity=0.352  Sum_probs=191.5

Q ss_pred             CeeccCCCceEEEEEeCC---CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAELPG---GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||.||+|...+   +..+|+|.++.... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            358999999999996543   45799999875432 23345788999999999999999999999998999999999999


Q ss_pred             CCHHHHhhccch-hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCc
Q 004994          523 CTLHDLLHSDEE-AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN  601 (720)
Q Consensus       523 gsL~~~l~~~~~-~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  601 (720)
                      |+|.+++..... .....++.....++.|+++||+|||+.   +++||||||+||+++.++++||+|||+++........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            999999864322 123456778889999999999999987   8999999999999999999999999999765333222


Q ss_pred             ccccCccccccCCCCccCCC--------CCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          602 ELSEGLLTAHGSGAPEFESG--------SYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       602 ~~~~~~~~~~~~~aPE~~~~--------~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      .......++..|+|||+..+        .++.++|||||||++|||++ |+.||..........   ....     ....
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~~~-----~~~~  228 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YTVR-----EQQL  228 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHhh-----cccC
Confidence            22233445678999998742        35789999999999999996 999996543221110   0000     0001


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      +..++.+..    .....+.+++.+|+ .+|++|||++||++.|+
T Consensus       229 ~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         229 KLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111122111    12345778999999 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.8e-37  Score=322.53  Aligned_cols=257  Identities=24%  Similarity=0.348  Sum_probs=197.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCc--EEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGK--LLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|+..+.||+|+||.||+|... ++.  .+|+|.+.... .....+.+.+|++++.++ +|+||+++++++.+.+..++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            46778899999999999999753 454  45777775432 234456788999999999 89999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI  583 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  583 (720)
                      ||||+++++|.++++....            ....+++..+..++.|+++||+|||+.   +++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            9999999999999864321            123578999999999999999999987   9999999999999999999


Q ss_pred             eEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhc
Q 004994          584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWA  661 (720)
Q Consensus       584 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  661 (720)
                      +||+|||+++......   .......+..|+|||+. ...++.++|||||||++|||+| |..||........   ... 
T Consensus       163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~-  235 (303)
T cd05088         163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEK-  235 (303)
T ss_pred             EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HHH-
Confidence            9999999986432111   11111234579999987 4568899999999999999998 9999964332111   100 


Q ss_pred             ccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                                  + ........+...+.++.+++.+||+.+|++||+++++++.|++++
T Consensus       236 ------------~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         236 ------------L-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             ------------H-hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                        0 000000011122356889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.1e-37  Score=319.07  Aligned_cols=259  Identities=25%  Similarity=0.380  Sum_probs=201.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  512 (720)
                      .++|+..+.||+|+||.||+|...      ++..||+|.+..... .....+|.+|++++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            457888899999999999999753      467899999875432 2344678999999999999999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccc------------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDE------------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSS  574 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~  574 (720)
                      .++||||+++|+|.+++....                  .....+++..+..++.+++.||.|||..   +++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence            999999999999999986421                  1123578889999999999999999987   9999999999


Q ss_pred             CeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCc
Q 004994          575 NILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR  652 (720)
Q Consensus       575 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~  652 (720)
                      ||++++++.+||+|||++..+..............+..|+|||.. .+.++.++|||||||++|||++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999998765332211111222335579999987 5678999999999999999998 88888543221


Q ss_pred             cccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      .   ..             ..+.+.... ..+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus       240 ~---~~-------------~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 E---VI-------------YYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H---HH-------------HHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1   11             111111100 0111234678899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.4e-37  Score=327.02  Aligned_cols=243  Identities=20%  Similarity=0.258  Sum_probs=191.2

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      ++||+|+||+||+|.. .+++.||||++.+... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999965 4688999999975422 223445677888888866 799999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+.+..    ...+++.....++.++++||.|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~  151 (321)
T cd05591          81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V  151 (321)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence            999988853    34688889999999999999999987   89999999999999999999999999987542221  1


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      ......++..|+|||.. ...++.++|||||||++|||+||+.||........   ..             .+.....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~-------------~i~~~~~--  213 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FE-------------SILHDDV--  213 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HH-------------HHHcCCC--
Confidence            22335678899999988 45789999999999999999999999975432111   10             0110000  


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCC-------CHHHHHHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRP-------PMSEIVQD  715 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~evl~~  715 (720)
                      ..+.....++.+++.+||+.||++||       ++++++++
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            01111235678999999999999999       88888764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.8e-37  Score=329.40  Aligned_cols=253  Identities=25%  Similarity=0.289  Sum_probs=196.2

Q ss_pred             CCCCCCeeccCCCceEEEEEe----CCCcEEEEEEeccccc--ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL----PGGKLLAVKKLSNTVS--QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  513 (720)
                      +|+..+.||+|+||+||+++.    .+++.||+|++.+...  .....+.+..|+++++++ +|+||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            467789999999999999864    3688999999864321  123345678899999999 599999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++||||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            999999999999998853    34588899999999999999999987   89999999999999999999999999998


Q ss_pred             CCCCCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ........ ......++..|+|||.+.+  .++.++|||||||++|||+||+.||...........+..         ..
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---------~~  223 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---------RI  223 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---------HH
Confidence            65332211 2223568899999999844  478899999999999999999999964332211110000         00


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      .. .++..    +...+..+.+++.+||+.||++||     ++++++++
T Consensus       224 ~~-~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         224 LK-CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             hc-CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            00 11111    112345678999999999999999     77788764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.9e-37  Score=324.73  Aligned_cols=242  Identities=24%  Similarity=0.303  Sum_probs=188.2

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHc-cCCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISR-LRHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||+||+|.. .+++.||||+++.... .....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999965 4588999999975432 12233456677777775 4999999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++..    ...+++.....++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  151 (316)
T cd05619          81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A  151 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence            999998853    34678889999999999999999987   99999999999999999999999999987532211  1


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      ......++..|+|||.+ ...++.++|||||||++|||++|+.||...........+.              ...+..  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~--------------~~~~~~--  215 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR--------------MDNPCY--  215 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------hCCCCC--
Confidence            12235678899999998 4568999999999999999999999997543211111010              001111  


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPMS-EIVQ  714 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  714 (720)
                        +.....++.+++.+||+.||++||++. ++.+
T Consensus       216 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 --PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             --CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence              111235678999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=335.72  Aligned_cols=253  Identities=23%  Similarity=0.324  Sum_probs=197.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++.... ........+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4688889999999999999965 468999999997432 12234456788999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999999853    34588899999999999999999987   899999999999999999999999999876532


Q ss_pred             CCCcc------------------------------------cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHH
Q 004994          598 GSTNE------------------------------------LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELL  640 (720)
Q Consensus       598 ~~~~~------------------------------------~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ell  640 (720)
                      .....                                    ......||+.|+|||++ ...++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            11000                                    01123588999999998 556899999999999999999


Q ss_pred             hCCCCCCCCCCcccc-chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC---HHHHHHH
Q 004994          641 TGRKPYDRSRPRGEQ-SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP---MSEIVQD  715 (720)
Q Consensus       641 tG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~  715 (720)
                      +|+.||......... .+..|.. .+.        . +.     ....++++.+++.+|+. +|.+|++   ++|++++
T Consensus       234 ~G~~Pf~~~~~~~~~~~i~~~~~-~~~--------~-~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQETYRKIINWKE-TLQ--------F-PD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCC-ccC--------C-CC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999999754322111 1111100 000        0 00     00123567899999996 9999998   9998864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=307.79  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=207.1

Q ss_pred             CCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      |.+..+||+|+||.|||| +.+.|+.+|||.+.-    ..+.++..+|+.+|++++.|+||++||.|..+..+++|||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            445578999999999999 456799999999863    245678999999999999999999999998888999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      ..|+..+.++.   .+++++...+..|.....+||+|||..   .=||||||+-|||++.+|.+||+|||+|..+.+.  
T Consensus       111 GAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--  182 (502)
T KOG0574|consen  111 GAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--  182 (502)
T ss_pred             CCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh--
Confidence            99999999964   457899999999999999999999998   6799999999999999999999999999877432  


Q ss_pred             cccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCC
Q 004994          601 NELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL  679 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  679 (720)
                      ........||+.|||||++. -.|+.++||||+|+...||..|++||.+..+......+       +        ..|..
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------P--------T~PPP  247 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------P--------TKPPP  247 (502)
T ss_pred             HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------c--------CCCCC
Confidence            22344578999999999984 46999999999999999999999999765442211100       0        01122


Q ss_pred             CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       680 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....++..+.+|.+++++||.+.|++|-|+-++++|
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            233467788899999999999999999999999876

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-37  Score=329.50  Aligned_cols=239  Identities=21%  Similarity=0.260  Sum_probs=190.0

Q ss_pred             CeeccCCCceEEEEEe----CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCC
Q 004994          446 NFIGEGLLGSVYKAEL----PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGG  521 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  521 (720)
                      +.||+|+||.||++..    .+|+.||+|++.+..........+..|++++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999854    368999999997543333344567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCc
Q 004994          522 NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN  601 (720)
Q Consensus       522 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  601 (720)
                      +|+|.+++..    ...+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            9999998853    34588999999999999999999987   99999999999999999999999999997653321  


Q ss_pred             ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCC
Q 004994          602 ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD  680 (720)
Q Consensus       602 ~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  680 (720)
                      .......++..|+|||.. ...++.++|||||||++|||+||+.||.........                ..+..... 
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~----------------~~i~~~~~-  215 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM----------------TMILKAKL-  215 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH----------------HHHHcCCC-
Confidence            122235678899999998 456889999999999999999999999753321110                00100000 


Q ss_pred             chhhHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 004994          681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSE  711 (720)
Q Consensus       681 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  711 (720)
                       ..+...+..+.+++.+||+.||++||++.+
T Consensus       216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             011122356789999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-37  Score=335.53  Aligned_cols=253  Identities=20%  Similarity=0.270  Sum_probs=194.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||++.. .+++.||||++.+... .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3688889999999999999954 5789999999864321 2233467888999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999999853    34578888889999999999999987   999999999999999999999999999964321


Q ss_pred             CCCc---------------------------------------------ccccCccccccCCCCccC-CCCCCCccchHh
Q 004994          598 GSTN---------------------------------------------ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYS  631 (720)
Q Consensus       598 ~~~~---------------------------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S  631 (720)
                      ....                                             .......|+.+|+|||.+ ...++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            1000                                             000124588899999998 456899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCcccc-chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCC---C
Q 004994          632 LGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFR---P  707 (720)
Q Consensus       632 ~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---P  707 (720)
                      |||++|||+||+.||......... .+..|.. .+            .+..  ......++.+++.+|+. +|.+|   +
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~------------~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~  297 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHETYRKIINWRE-TL------------YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRG  297 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHHHHHHHHccCC-cc------------CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence            999999999999999754322111 1111100 00            0000  00123567899999998 67665   5


Q ss_pred             CHHHHHHH
Q 004994          708 PMSEIVQD  715 (720)
Q Consensus       708 t~~evl~~  715 (720)
                      ++.|++++
T Consensus       298 ~~~~~l~h  305 (377)
T cd05629         298 GAHEIKSH  305 (377)
T ss_pred             CHHHHhcC
Confidence            99999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.3e-36  Score=312.56  Aligned_cols=253  Identities=25%  Similarity=0.376  Sum_probs=201.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|...++||+|+||.||+|..++++.||+|.+....   ...+.+.+|+.++++++|+||+++++++. .+..+++||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            45788889999999999999988889999999987542   33467899999999999999999999874 456899999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+.+++|.+++....  ...+++.++..++.+++.||+|||+.   +++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            999999999886432  34688999999999999999999986   8999999999999999999999999999765422


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .. .......++..|+|||+. .+.++.++|||||||++||+++ |+.||........   ...          +.+...
T Consensus       156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----------~~~~~~  221 (260)
T cd05067         156 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQN----------LERGYR  221 (260)
T ss_pred             Cc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHH----------HHcCCC
Confidence            11 111223345689999988 5678999999999999999999 9999975432111   110          000000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      ..    .+...+.++.+++.+|+..+|++|||++++++.|+.
T Consensus       222 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 MP----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            00    111233578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-37  Score=331.61  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=198.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|.. .+|+.||+|++++... .....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            3678889999999999999965 5789999999975432 2234567889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++...   ...+++.....++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            999999999998642   24688899999999999999999987   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccCC-------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES-------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      .... ......++..|+|||++.       ..++.++|||||||++|||++|+.||...........+.       ..  
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~-------~~--  224 (330)
T cd05601         155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------NF--  224 (330)
T ss_pred             CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH-------cC--
Confidence            2221 222345788999999873       347889999999999999999999997543211110000       00  


Q ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       671 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       .+...  ..  .....+.++.+++.+|++ +|++|||+++++++
T Consensus       225 -~~~~~--~~--~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         225 -QRFLK--FP--EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -CCccC--CC--CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence             00000  00  001233568899999998 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.5e-37  Score=325.84  Aligned_cols=248  Identities=20%  Similarity=0.243  Sum_probs=193.1

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCC-ceeEEEeEeccCCeEEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHG-NIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~  517 (720)
                      +|+..+.||+|+||.||+|.. .+++.||||++.+... .....+.+..|.+++..++|+ +|+.+++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            477789999999999999965 4678999999975432 233446778899999999764 6888999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            99999999988853    34578889999999999999999987   999999999999999999999999999875321


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..  .......++..|+|||++ ...++.++|||||||++|||+||+.||........   .             ..+..
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~-------------~~i~~  215 (324)
T cd05587         154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---F-------------QSIME  215 (324)
T ss_pred             CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H-------------HHHHc
Confidence            11  122235678999999998 45689999999999999999999999975432111   1             00111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPM-----SEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  715 (720)
                      ..  ..++.....++.+++.+||+.||++|++.     ++++++
T Consensus       216 ~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         216 HN--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            00  01111233567899999999999999986     566543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.4e-37  Score=326.37  Aligned_cols=250  Identities=18%  Similarity=0.276  Sum_probs=190.8

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||+||+|.. .+++.||+|++++... .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999965 5688999999975432 223345677888888776 899999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++..    ...+++.....++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~  151 (329)
T cd05618          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D  151 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence            999988743    34688899999999999999999987   99999999999999999999999999987542211  1


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc--cchhhhcccccCchhhhhhhcCCCC
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE--QSLVRWAIPRLHDIDALSRMVDPSL  679 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  679 (720)
                      ......++..|+|||++ ...++.++|||||||++|||+||+.||........  .....+.         ...+.....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~---------~~~i~~~~~  222 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVILEKQI  222 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH---------HHHHhcCCC
Confidence            22335678999999998 55689999999999999999999999963221110  0000000         001111110


Q ss_pred             CchhhHHHHHHHHHHHHHHhccCCCCCCC------HHHHHHH
Q 004994          680 DGAYLAKSLSRFADIISRCVQWEPGFRPP------MSEIVQD  715 (720)
Q Consensus       680 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~~  715 (720)
                        ..+......+.+++.+||+.||++||+      +.+++++
T Consensus       223 --~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         223 --RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence              112223456789999999999999998      4677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.9e-37  Score=334.97  Aligned_cols=253  Identities=20%  Similarity=0.225  Sum_probs=198.4

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ..++|...+.||+|+||+||+|.. .+++.||+|++.+.. ......+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            346788889999999999999965 468999999996432 222344567899999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++|+|.+++..     ..++......++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            9999999999998853     2467777888999999999999987   9999999999999999999999999999866


Q ss_pred             CCCCCcccccCccccccCCCCccCCC-----CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFESG-----SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      ..... .......+++.|+|||.+.+     .++.++|||||||++|||++|+.||.........               
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---------------  256 (370)
T cd05596         193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY---------------  256 (370)
T ss_pred             cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH---------------
Confidence            43211 12234568899999998732     3789999999999999999999999754321110               


Q ss_pred             hhhhcCCC--CCchhhHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 004994          671 LSRMVDPS--LDGAYLAKSLSRFADIISRCVQWEPGF--RPPMSEIVQD  715 (720)
Q Consensus       671 ~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  715 (720)
                       ..+....  +........+.++.+++.+||+.+|.+  |||++|++++
T Consensus       257 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         257 -SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence             1111100  000001123467889999999999988  9999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.1e-37  Score=331.24  Aligned_cols=254  Identities=21%  Similarity=0.279  Sum_probs=193.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||+||+|.. .+++.||||++.+... .......+.+|++++.+++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4688889999999999999955 5689999999975321 2233456788999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.|++.||.|||+.   +|+||||||+|||++.++++||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            99999999999853    34688899999999999999999987   999999999999999999999999999976532


Q ss_pred             CCCc---------------------------------ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCC
Q 004994          598 GSTN---------------------------------ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGR  643 (720)
Q Consensus       598 ~~~~---------------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~  643 (720)
                      ....                                 .......||..|+|||.+ ...++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            1100                                 001234688999999998 556899999999999999999999


Q ss_pred             CCCCCCCCccccc-hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhc--cCCCCCCCHHHHHHH
Q 004994          644 KPYDRSRPRGEQS-LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQ--WEPGFRPPMSEIVQD  715 (720)
Q Consensus       644 ~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~RPt~~evl~~  715 (720)
                      .||.......... +..|.. .+        .+.+..      ...+++.+++.+++.  .++..||+++|++++
T Consensus       234 ~Pf~~~~~~~~~~~i~~~~~-~~--------~~p~~~------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETPQETYKKVMNWKE-TL--------IFPPEV------PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCHHHHHHHHHcCcC-cc--------cCCCcC------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            9997543322111 111100 00        011110      122456778877554  233456899999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.1e-36  Score=310.46  Aligned_cols=247  Identities=21%  Similarity=0.332  Sum_probs=192.3

Q ss_pred             eccCCCceEEEEEeC---CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCC
Q 004994          448 IGEGLLGSVYKAELP---GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCT  524 (720)
Q Consensus       448 lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  524 (720)
                      ||+|+||.||+|.+.   ++..||+|++.... .....+.|.+|++++++++|+||+++++++.. +..++||||+++++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            899999999999653   45679999987542 23445679999999999999999999999864 57899999999999


Q ss_pred             HHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccc-
Q 004994          525 LHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL-  603 (720)
Q Consensus       525 L~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~-  603 (720)
                      |.+++...   ...+++..+.+++.++++||.|||+.   +++||||||+|||++.++.+||+|||+++.......... 
T Consensus        81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99988532   34688999999999999999999987   899999999999999999999999999986543322111 


Q ss_pred             ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          604 SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       604 ~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      .....++..|+|||.. ...++.++|||||||++||+++ |+.||.........   ..              +......
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~--------------~~~~~~~  217 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM---SF--------------IEQGKRL  217 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HH--------------HHCCCCC
Confidence            1111224679999987 4568999999999999999996 99999754321111   10              0000000


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..+..+++++.+++.+||+.+|++||++.+|.+.|+..
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11123346788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-36  Score=309.28  Aligned_cols=247  Identities=25%  Similarity=0.411  Sum_probs=195.4

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      ++||+|+||.||+|...+++.||+|.+..... ......+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36999999999999888899999999875432 23345788999999999999999999999999999999999999999


Q ss_pred             HHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccccc
Q 004994          526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE  605 (720)
Q Consensus       526 ~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  605 (720)
                      .+++...   ...+++..+..++.+++.||.|+|..   +++||||||+||++++++.+||+|||++......... ...
T Consensus        80 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~  152 (250)
T cd05085          80 LSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSG  152 (250)
T ss_pred             HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCC
Confidence            9988532   23578999999999999999999987   9999999999999999999999999998754322111 111


Q ss_pred             CccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchh
Q 004994          606 GLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAY  683 (720)
Q Consensus       606 ~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  683 (720)
                      ...++..|+|||+. .+.++.++|||||||++||+++ |..||...........+             ..    ......
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-------------~~----~~~~~~  215 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-------------EK----GYRMSC  215 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------------Hc----CCCCCC
Confidence            12335679999988 5678999999999999999998 99999653321111000             00    000011


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          684 LAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       684 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      +...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            1123467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.1e-37  Score=331.40  Aligned_cols=265  Identities=20%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC-----eEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG-----QHL  514 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~  514 (720)
                      +|+..+.||+|+||+||++.. .+|+.||||++..........+.+.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477789999999999999965 57999999998754333344567889999999999999999999998766     789


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+. ++|.+.+..    ...+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999987 478777743    34688999999999999999999987   999999999999999999999999999986


Q ss_pred             CCCCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh-
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL-  671 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-  671 (720)
                      ....... ......++..|+|||.+.+  .++.++|||||||++|||++|+.||....+......+...... ...+.+ 
T Consensus       153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~-~~~~~~~  230 (372)
T cd07853         153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT-PSLEAMR  230 (372)
T ss_pred             cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC-CCHHHHH
Confidence            5432211 2223456788999998843  4789999999999999999999999765432221111110000 000000 


Q ss_pred             ------hhhc-----C-CCCCc--hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 ------SRMV-----D-PSLDG--AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ------~~~~-----~-~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            ...+     . +....  .......+++.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                  0000     0 00000  0011224578899999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.7e-37  Score=324.34  Aligned_cols=242  Identities=20%  Similarity=0.262  Sum_probs=187.5

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||.||+|.. .+|+.||+|.+++.... ....+.+..|.+++... +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999965 46899999999754321 22344566777777654 899999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++..    ...+++.....++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  151 (316)
T cd05620          81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N  151 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence            999988853    34578888999999999999999987   99999999999999999999999999987532211  1


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      ......++..|+|||.+ ...++.++|||||||++|||++|+.||...........+..              ..+..  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--------------~~~~~--  215 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--------------DTPHY--  215 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------CCCCC--
Confidence            22335678999999998 45789999999999999999999999965332111000000              01111  


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPMS-EIVQ  714 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  714 (720)
                        +.....++.+++.+||+.||++||++. ++++
T Consensus       216 --~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         216 --PRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             --CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence              111235678999999999999999984 6653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-36  Score=316.38  Aligned_cols=248  Identities=21%  Similarity=0.253  Sum_probs=191.2

Q ss_pred             eccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          448 IGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       448 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      ||+|+||.||++.. .+|+.||+|++...... ......+..|++++++++||||+++++++.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999965 56999999999653222 22334556799999999999999999999999999999999999999


Q ss_pred             HHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccccc
Q 004994          526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE  605 (720)
Q Consensus       526 ~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  605 (720)
                      .+++...  ....+++.....++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++.......   ...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~  152 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT  152 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence            9887532  234578899999999999999999987   99999999999999999999999999987664321   112


Q ss_pred             CccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhh
Q 004994          606 GLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL  684 (720)
Q Consensus       606 ~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  684 (720)
                      ...++..|+|||+. .+.++.++|||||||++|||++|+.||.........            .............. ..
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~------------~~~~~~~~~~~~~~-~~  219 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK------------EELKRRTLEDEVKF-EH  219 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH------------HHHHHHhhcccccc-cc
Confidence            34578899999998 556899999999999999999999999643221110            00111111111110 01


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       685 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      ...+.++.+++.+||+.||++||+++|+++++
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            12345688999999999999999997766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-36  Score=314.27  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=199.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++....  ......+.+|+.++++++||||+++++++...+..++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            35788899999999999999965 578999999986432  223456788999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.++++.    ...+++..+..++.|+++||.|||+.   +|+||||||+||++++++.+||+|||+++.+..
T Consensus        86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          86 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999998853    24578889999999999999999987   999999999999999999999999999986632


Q ss_pred             CCCcccccCccccccCCCCccCC----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES----GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ...  ......++..|+|||...    ..++.++|||||||++|||++|+.||....+.....  .+.....        
T Consensus       159 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~~~~~--------  226 (267)
T cd06646         159 TIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSKSNF--------  226 (267)
T ss_pred             ccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eeecCCC--------
Confidence            211  112345678899999862    347889999999999999999999996443221110  0000000        


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                       ..+....  ....+..+.+++.+||+.+|++|||+++++++|
T Consensus       227 -~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         227 -QPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -CCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence             0011100  112345788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.1e-37  Score=349.13  Aligned_cols=262  Identities=24%  Similarity=0.277  Sum_probs=201.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||.||+|.. .+|+.||+|++...... ....+.|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            4688889999999999999965 46899999999754322 233567999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccc-------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          518 DYGGNCTLHDLLHSDE-------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~-------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                      ||+++|+|.+++....       ......++....+++.++++||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886321       1123466778899999999999999987   99999999999999999999999999


Q ss_pred             CCCCCCCCCC----------------cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 004994          591 LAPLLFSGST----------------NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRG  653 (720)
Q Consensus       591 la~~~~~~~~----------------~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~  653 (720)
                      +++.......                ........|++.|+|||.. ...++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621100                0011224589999999988 5578999999999999999999999996532211


Q ss_pred             ccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhh
Q 004994          654 EQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-PMSEIVQDLLCM  719 (720)
Q Consensus       654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~  719 (720)
                      ...   .           ..+.++... ......+..+.+++.+|++.||++|| +++++++.|+..
T Consensus       239 i~~---~-----------~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 ISY---R-----------DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             hhh---h-----------hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            100   0           000010000 00113345688999999999999995 677788877764

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.5e-37  Score=325.38  Aligned_cols=250  Identities=18%  Similarity=0.265  Sum_probs=192.1

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      ++||+|+||+||+|.. .+++.||||++++... .......+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999965 4689999999975432 223345678899999888 799999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~  151 (329)
T cd05588          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD  151 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence            999988743    34689999999999999999999987   9999999999999999999999999998753211  11


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcc--ccchhhhcccccCchhhhhhhcCCCC
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRG--EQSLVRWAIPRLHDIDALSRMVDPSL  679 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  679 (720)
                      ......++..|+|||.. ...++.++|||||||++|||+||+.||+......  ......+.         ...+.....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~---------~~~~~~~~~  222 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL---------FQVILEKQI  222 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH---------HHHHHcCCC
Confidence            22335678999999998 4568999999999999999999999996422111  00000000         001111110


Q ss_pred             CchhhHHHHHHHHHHHHHHhccCCCCCCC------HHHHHHH
Q 004994          680 DGAYLAKSLSRFADIISRCVQWEPGFRPP------MSEIVQD  715 (720)
Q Consensus       680 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~~  715 (720)
                        ..+...+.++.+++.+||+.||++||+      +++++++
T Consensus       223 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         223 --RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence              011223456789999999999999997      6777654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.2e-37  Score=325.27  Aligned_cols=247  Identities=19%  Similarity=0.250  Sum_probs=192.5

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      +|...+.||+|+||+||+|.. .+++.||||++.+... .....+.+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            467789999999999999965 4678999999975432 122334566777787777 5899999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+.+..    ...+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            99999999988853    34588899999999999999999987   999999999999999999999999999975422


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..  .......+++.|+|||.+ .+.++.++|||||||++|||+||+.||........   .             ..+..
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~-------------~~i~~  215 (323)
T cd05616         154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F-------------QSIME  215 (323)
T ss_pred             CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---H-------------HHHHh
Confidence            11  122335678999999998 55789999999999999999999999975432111   1             11111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPM-----SEIVQ  714 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~  714 (720)
                      ...  .++.....++.+++.+|++.||++|++.     .++.+
T Consensus       216 ~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         216 HNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             CCC--CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence            000  1112234577899999999999999984     56554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.5e-37  Score=332.45  Aligned_cols=254  Identities=19%  Similarity=0.230  Sum_probs=197.8

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ...++|+..+.||+|+||.||++.. .+++.||+|.+.+.. ......+.+.+|+++++.++||||+++++++.+.+..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            3457899999999999999999965 468899999986432 22234456889999999999999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++|+|.+++..     ..+++.....++.+++.||+|||+.   +|+||||||+|||+++++.+||+|||+|+.
T Consensus       120 lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence            99999999999998853     2477888899999999999999987   999999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccCCC-----CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFESG-----SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      +..... .......++.+|+|||.+.+     .++.++|||||||++|||+||+.||........               
T Consensus       192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---------------  255 (370)
T cd05621         192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---------------  255 (370)
T ss_pred             cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---------------
Confidence            643221 11234568999999998732     378899999999999999999999975432111               


Q ss_pred             hhhhhcCCC--CCchhhHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 004994          670 ALSRMVDPS--LDGAYLAKSLSRFADIISRCVQWEPGF--RPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  715 (720)
                       ..++.+..  +........+..+.+++.+|+..++.+  |++++|+++|
T Consensus       256 -~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         256 -YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence             11111110  000001123456789999999865543  8999999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-36  Score=315.22  Aligned_cols=268  Identities=23%  Similarity=0.300  Sum_probs=198.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-----CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--CCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-----PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--HGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~  512 (720)
                      ++|...+.||+|+||.||++..     .++..||+|++....  ....+.|.+|++++++++||||+++++++..  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            4677789999999999999964     257899999986432  3345678999999999999999999998754  346


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||+++++|.+++...   ...+++..+..++.+++.||+|||+.   +|+||||||+||++++++.+||+|||++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence            88999999999999998532   24588999999999999999999987   9999999999999999999999999999


Q ss_pred             CCCCCCCCcc-cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC---c
Q 004994          593 PLLFSGSTNE-LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH---D  667 (720)
Q Consensus       593 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---~  667 (720)
                      +.+....... ......+...|+|||.. .+.++.++|||||||++|||++|..|+......    ..+.......   .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~  231 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMI  231 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccc
Confidence            8764332211 11112233458999988 457899999999999999999998776432110    0000000000   0


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...+.+.+........+...+.++.+++.+||+.+|++|||+.||++.|+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0001111111111011122346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.7e-36  Score=310.21  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=198.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|...+.||+|++|.||+|...++..+|+|.+....   ...+.+.+|++++++++|+|++++++++.. +..++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence            4577788999999999999988777789999986432   334678899999999999999999998864 568899999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +.+++|.+++....  ...+++..+..++.++++||.|||+.   +++||||||+||++++++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            99999999986432  34578999999999999999999987   89999999999999999999999999997664322


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      . .......++..|+|||.. .+.++.++|||||||++|||+| |+.||........   ..+.          .....+
T Consensus       157 ~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~----------~~~~~~  222 (260)
T cd05069         157 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQV----------ERGYRM  222 (260)
T ss_pred             c-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----------HcCCCC
Confidence            1 111223345679999988 5678999999999999999999 9999975432111   1110          000000


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                          ..+...+..+.+++.+||+.||++||++++|++.|++
T Consensus       223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 ----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                0112234678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.6e-36  Score=313.45  Aligned_cols=256  Identities=25%  Similarity=0.411  Sum_probs=200.0

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-CC---cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-GG---KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +|...+.||+|+||.||+|... ++   ..||||.+.... .....++|..|+.++++++||||+++++++.+.+..++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            4667789999999999999754 33   369999987543 233457899999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++...   ...+++..+..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||+++.+.
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999998643   34688999999999999999999987   99999999999999999999999999997664


Q ss_pred             CCCCccc-ccCcc--ccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          597 SGSTNEL-SEGLL--TAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       597 ~~~~~~~-~~~~~--~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ....... .....  .+..|+|||+. .+.++.++|||||||++||+++ |+.||......   ....+...        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~--------  226 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQ--------  226 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc--------
Confidence            3221111 11111  13469999998 5678999999999999999987 99999653321   11111100        


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                        ...  .  ..+.+.+..+.+++.+||+.+|++||++++|++.|++++
T Consensus       227 --~~~--~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         227 --DYR--L--PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             --CCc--C--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence              000  0  011223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-36  Score=309.12  Aligned_cols=249  Identities=27%  Similarity=0.441  Sum_probs=200.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|...+.||+|+||.||+|... |+.||+|.+.....   ..+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            46778899999999999999764 78899999975432   457889999999999999999999999988999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++....  ...+++.....++.+++.||.|||+.   +++||||||+||+++.++.+||+|||.++......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            99999999986432  23689999999999999999999987   99999999999999999999999999998763221


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .     ....+..|+|||.. .+.++.++||||||+++||+++ |+.||.......   .....              ..
T Consensus       157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~--------------~~  214 (256)
T cd05039         157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV--------------EK  214 (256)
T ss_pred             c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH--------------hc
Confidence            1     12335679999987 5678999999999999999997 999996432211   11000              00


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ......+...++++.+++.+||..+|++|||++|+++.|+.+
T Consensus       215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         215 GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            000011122346788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.8e-36  Score=310.72  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=196.6

Q ss_pred             CeeccCCCceEEEEEeCC--C--cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCC
Q 004994          446 NFIGEGLLGSVYKAELPG--G--KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGG  521 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  521 (720)
                      +.||+|++|.||+|.+.+  +  ..||||.+...... ...+.+..|++++++++||||+++++++.+ ...++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999997533  3  36999999865433 456789999999999999999999999988 88999999999


Q ss_pred             CCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCc
Q 004994          522 NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN  601 (720)
Q Consensus       522 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  601 (720)
                      +++|.+++.....  ..++|.....++.|+++||+|||..   +++||||||+||+++.++.+||+|||+++.+......
T Consensus        79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            9999999865321  4689999999999999999999987   9999999999999999999999999999876442211


Q ss_pred             -ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          602 -ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       602 -~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                       .......++..|+|||+. ...++.++|||||||++|||+| |+.||........   .....          .   ..
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~----------~---~~  217 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKID----------K---EG  217 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----------h---cC
Confidence             112223456789999988 4578999999999999999999 9999964332111   11000          0   00


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      .....+...+..+.+++.+|++.+|++||++.|+++.|.+
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence            0000112234678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-36  Score=315.98  Aligned_cols=257  Identities=24%  Similarity=0.377  Sum_probs=199.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ++|...+.||+|+||.||++..      .++..+|+|.+....  ....+.|.+|+++++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            4566778999999999999953      235689999886432  34456899999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccch-----------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEE-----------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL  582 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  582 (720)
                      +++|||+++++|.+++.....           ....+++..+..++.|++.||+|||+.   +++||||||+|||+++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence            999999999999999864321           113578999999999999999999987   899999999999999999


Q ss_pred             CeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhh
Q 004994          583 IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRW  660 (720)
Q Consensus       583 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~  660 (720)
                      .+||+|||+++.+.............++..|+|||.. ...++.++|||||||++|||++ |+.||..........    
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----  235 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE----  235 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH----
Confidence            9999999999765432221222223345789999987 4568999999999999999998 999986433211110    


Q ss_pred             cccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          661 AIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       661 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                                  .+.... ....+...+..+.+++.+||+.||++||+++||++.|+.
T Consensus       236 ------------~~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 ------------CITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ------------HHHcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                        000000 000111234568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.1e-36  Score=320.09  Aligned_cols=259  Identities=23%  Similarity=0.381  Sum_probs=199.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC--------CCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccC
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP--------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEH  510 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~  510 (720)
                      ++|...+.||+|+||.||+|...        ....||+|.++.... ......+..|+++++++ +||||++++++|.+.
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            46777899999999999999531        245799999875432 23345788999999999 699999999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl  578 (720)
                      +..++||||+++|+|.+++.....            ....++|....+++.+++.||.|||+.   +++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence            999999999999999999865321            124588999999999999999999987   99999999999999


Q ss_pred             cCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccc
Q 004994          579 DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQS  656 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  656 (720)
                      +.++.+||+|||+++...............++..|+|||.. .+.++.++|||||||++|||++ |..||..........
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999999866432221111112234579999987 5568999999999999999999 899986432211111


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..                .... ....+..++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       248 ~~----------------~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         248 LL----------------REGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HH----------------HcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            00                0000 0001112345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-36  Score=319.11  Aligned_cols=265  Identities=20%  Similarity=0.341  Sum_probs=199.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||.||++.. .++..||+|.+..... .....++.+|++++++++||||++++++|.+.+..++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            3688889999999999999965 4688999999865422 2344678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++..    ...+++.....++.++++||.|||+.  .+++||||||+|||+++++.+||+|||++......
T Consensus        80 y~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          80 HMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             ccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            9999999999853    24578888999999999999999974  27999999999999999999999999998765322


Q ss_pred             CCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch---------
Q 004994          599 STNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI---------  668 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------  668 (720)
                          ......++..|+|||... ..++.++|||||||++|||+||+.||......................         
T Consensus       154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence                122346778999999884 468999999999999999999999996433211111110000000000         


Q ss_pred             -----------hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 -----------DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 -----------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                 +....................++.+++.+||+.+|++|||++||+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       00000000000000001134568899999999999999999999976

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-36  Score=312.32  Aligned_cols=251  Identities=24%  Similarity=0.356  Sum_probs=192.6

Q ss_pred             CeeccCCCceEEEEEeC-CCc--EEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEeeCC
Q 004994          446 NFIGEGLLGSVYKAELP-GGK--LLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGG  521 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~  521 (720)
                      ++||+|+||.||+|... ++.  .+|+|.++... .....+.+..|++++.++ +||||+++++++...+..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            36899999999999764 444  46888886432 234456788999999999 89999999999999999999999999


Q ss_pred             CCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          522 NCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       522 ~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                      +|+|.+++.....            ....+++..+..++.+++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence            9999999864321            123578999999999999999999986   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCc
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      |+++......   .......+..|+|||+. ...++.++|||||||++|||++ |+.||........   ...       
T Consensus       157 gl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~-------  223 (270)
T cd05047         157 GLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEK-------  223 (270)
T ss_pred             CCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH---HHH-------
Confidence            9986332110   01111234579999987 5568999999999999999997 9999964322110   100       


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                            + ........+.....++.+++.+|++.+|.+|||+.|+++.|++|+
T Consensus       224 ------~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         224 ------L-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ------H-hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                  0 000000011123356889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-36  Score=323.42  Aligned_cols=260  Identities=23%  Similarity=0.378  Sum_probs=200.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC--------CCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccC
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP--------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEH  510 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~  510 (720)
                      .+|...+.||+|+||.||+|...        .+..||+|.+.... .....+++.+|+++++++ +||||++++++|.+.
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            45788899999999999999532        12368999886432 223456789999999999 899999999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccc------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDE------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl  578 (720)
                      +..+++|||+++|+|.+++....            .....++|..+..++.|+++||.|||..   +++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence            99999999999999999986432            1224588999999999999999999987   99999999999999


Q ss_pred             cCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccc
Q 004994          579 DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQS  656 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  656 (720)
                      ++++.+||+|||+++...............++..|+|||.. ...++.++|||||||++|||++ |+.||..........
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  247 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  247 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            99999999999999866432221111222334579999988 5578999999999999999998 889986532211110


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .+                .. ......+...+.++.+++.+||+.+|++|||+.|+++.|++++
T Consensus       248 ~~----------------~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         248 LL----------------KE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HH----------------Hc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            00                00 0000011123457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.4e-36  Score=311.91  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=200.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-C---CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-G---GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      .+|...+.||+|+||.||+|... +   +..+|+|.++.... ....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46777899999999999999653 2   34799999875432 2345688999999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++++|.+++...   ...+++.+..+++.+++.||.|||+.   +++||||||+|||++.++.+||+|||+++.+
T Consensus        83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999998643   24578999999999999999999987   8999999999999999999999999999876


Q ss_pred             CCCCCccc-ccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          596 FSGSTNEL-SEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       596 ~~~~~~~~-~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ........ ......+..|++||... +.++.++|||||||++||+++ |+.||........   .....          
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~----------  223 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIE----------  223 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHh----------
Confidence            43221111 11112245799999984 578999999999999999886 9999965432211   11100          


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      +.....    .....+..+.+++.+|++.+|++||+|.++++.|++++
T Consensus       224 ~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         224 EGYRLP----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             CCCcCC----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence            000000    01123457789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-36  Score=307.86  Aligned_cols=249  Identities=25%  Similarity=0.408  Sum_probs=196.6

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      +.||+|+||.||++...+++.||+|.+...... ...+.+..|++++++++|+||+++++++.+....++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            469999999999998766999999998754332 3456899999999999999999999999999999999999999999


Q ss_pred             HHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccccc
Q 004994          526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE  605 (720)
Q Consensus       526 ~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  605 (720)
                      .+++...   ...+++.....++.+++.||+|||+.   +++||||||+||+++.++.+||+|||+++............
T Consensus        80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            9998542   23578888999999999999999987   89999999999999999999999999998654222111111


Q ss_pred             CccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchh
Q 004994          606 GLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAY  683 (720)
Q Consensus       606 ~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  683 (720)
                      ....+..|+|||.. .+.++.++|||||||++|||+| |..||...........+                 ........
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-----------------~~~~~~~~  216 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-----------------ESGYRMPA  216 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-----------------hcCCCCCC
Confidence            12234569999987 5678999999999999999999 88998654321111110                 00000011


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          684 LAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       684 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      +...+.++.+++.+|++.+|++|||++|+++.|+.
T Consensus       217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            12334678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.8e-37  Score=329.39  Aligned_cols=197  Identities=24%  Similarity=0.380  Sum_probs=170.5

Q ss_pred             CCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CC-----ceeEEEeEeccCCeE
Q 004994          441 SFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HG-----NIVELIGYCNEHGQH  513 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~~~  513 (720)
                      +|.+.++||+|+||.|.|| ++++++.||||+++..   .....+...|+++|..++ |.     |+|++++||...++.
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            7888999999999999999 6778999999999865   345567788999999997 53     899999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC--CCCeEEccccC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE--KLIVRVSDCGL  591 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~DFGl  591 (720)
                      +||+|.++. +|.++++...  ...++......++.||+.||.+||+.   +|||+||||+||||.+  ...+||+|||.
T Consensus       264 ciVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  264 CIVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence            999999886 9999997654  45688899999999999999999987   9999999999999964  34799999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP  651 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~  651 (720)
                      |.+....-.     ...-+++|+|||++ +.+|+.+.|+||||||++||+||.+-|.+..+
T Consensus       338 Sc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  338 SCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             ccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            987643222     35667899999998 67899999999999999999999888876554

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.4e-36  Score=309.84  Aligned_cols=248  Identities=27%  Similarity=0.416  Sum_probs=196.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEec-cCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN-EHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||.||++... |..||+|.++..    ...+.|.+|+.++++++|+|++++++++. +.+..++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            46777899999999999999764 778999998643    23457899999999999999999999764 5567899999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++....  ...+++.....++.+++.||+|||+.   +++||||||+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            999999999986432  23578999999999999999999987   9999999999999999999999999998765322


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .     .....+..|+|||+. ...++.++|||||||++|||++ |+.||.......   .....              .
T Consensus       156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~--------------~  213 (256)
T cd05082         156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV--------------E  213 (256)
T ss_pred             C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH--------------h
Confidence            1     112334679999988 4568999999999999999998 999986432111   11110              0


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...........+..+.+++.+|++.+|++|||++++++.|+++
T Consensus       214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         214 KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            0000011122346788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.5e-36  Score=313.89  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=194.4

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|...+.||+|+||.||+|.. .+++.||+|.+..... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            567788999999999999954 6789999999865422 23446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|..+.        .+++.....++.+++.||.|||+.   +|+|+||||+|||++.++.+||+|||++..+... 
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            9999986542        356777889999999999999987   9999999999999999999999999999765322 


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                         ......++..|+|||+. ...++.++|||||||++|||++|+.||............         ......+.++.
T Consensus       149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---------~~~~~~~~~~~  216 (279)
T cd06619         149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---------LQLLQCIVDED  216 (279)
T ss_pred             ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------HHHHHHHhccC
Confidence               12234678899999998 456899999999999999999999999653221111000         00011111111


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...........++.+++.+|++.+|++||+++|++++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            1100011233568899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.3e-37  Score=323.51  Aligned_cols=243  Identities=22%  Similarity=0.295  Sum_probs=191.3

Q ss_pred             CeeccCCCceEEEEEeC-CCcEEEEEEeccccc-ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVS-QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||+||+|... +++.||||++++... .......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999654 588999999975432 223345677888888877 799999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+.+..    ...+++.....++.+++.||.|||+.   +|+||||||+|||+++++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~  151 (318)
T cd05570          81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V  151 (318)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence            999988753    34688999999999999999999987   99999999999999999999999999987532211  1


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      ......++..|+|||.+ ...++.++|||||||++|||+||+.||.......   ...             .+.....  
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~-------------~i~~~~~--  213 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQ-------------SILEDEV--  213 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHH-------------HHHcCCC--
Confidence            12234578899999998 5578999999999999999999999996533211   000             0000000  


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPM-----SEIVQD  715 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  715 (720)
                      .++...+.++.+++.+||+.||++||++     .+++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            0111234568899999999999999999     888754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.2e-37  Score=351.30  Aligned_cols=259  Identities=19%  Similarity=0.286  Sum_probs=200.4

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--CCeE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--HGQH  513 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~  513 (720)
                      ...++|.+.+.||+|+||+||+|.. .++..||+|.+............|..|+.++++++|||||+++++|.+  .+.+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            3457899999999999999999965 467899999987554444456788999999999999999999998853  4578


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC----CCCeeecCCCCCCeEEcCC--------
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC----EPPIVHGNFKSSNILLDEK--------  581 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~----~~~ivHrDlkp~NiLl~~~--------  581 (720)
                      |+||||+++|+|.+++.........+++..++.|+.||+.||+|||...    .++||||||||+|||++.+        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999998654333457899999999999999999999853    1469999999999999642        


Q ss_pred             ---------CCeEEccccCCCCCCCCCCcccccCccccccCCCCccCC---CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 004994          582 ---------LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES---GSYSCQSDVYSLGVVMLELLTGRKPYDRS  649 (720)
Q Consensus       582 ---------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~  649 (720)
                               +.+||+|||+++.+....   ......+++.|+|||++.   ..++.++||||||||+|||+||+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     358999999998763321   223456889999999873   34889999999999999999999999643


Q ss_pred             CCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          650 RPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....  .+..          .+...  +.+..   ...+.++.+|+.+||+.+|.+||++.|++++
T Consensus       247 ~~~~--qli~----------~lk~~--p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        247 NNFS--QLIS----------ELKRG--PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CcHH--HHHH----------HHhcC--CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            2211  0010          00000  11100   1123568899999999999999999999853

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.7e-36  Score=326.95  Aligned_cols=265  Identities=20%  Similarity=0.260  Sum_probs=195.5

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC------
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH------  510 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------  510 (720)
                      ..++|...+.||+|+||.||++.. .+|+.||||++............+.+|+.+++.++||||+++++++...      
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457889999999999999999954 5689999999976544445567788999999999999999999998643      


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                      ...++||||+++ ++.+.++      ..+++.....++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence            357999999986 5655553      2467788889999999999999987   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcc-cccCc
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAI-PRLHD  667 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~-~~~~~  667 (720)
                      +++.....   .......++..|+|||.+ ...++.++|||||||++|||+||+.||...+...... ..+... +....
T Consensus       169 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         169 LARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            99764321   122335678899999998 4578999999999999999999999997543221100 000000 00000


Q ss_pred             h----hhhhhhc--CCCCCc----------------hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 I----DALSRMV--DPSLDG----------------AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~----~~~~~~~--~~~~~~----------------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .    .......  .+...+                ........++.+++.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0    0000000  000000                0011123568899999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.8e-37  Score=324.14  Aligned_cols=238  Identities=23%  Similarity=0.277  Sum_probs=184.3

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHH-HHHccCCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELAS-TISRLRHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||+||+|.. .+|+.||+|++.+... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999965 5799999999975321 1222334444444 56889999999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++..    ...+++.....++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~  151 (323)
T cd05575          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K  151 (323)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence            999988853    34678888899999999999999987   99999999999999999999999999987542211  1


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      ......++..|+|||.. ...++.++|||||||++|||++|+.||........                ...+...... 
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----------------~~~i~~~~~~-  214 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM----------------YDNILNKPLR-  214 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH----------------HHHHHcCCCC-
Confidence            22335678999999988 55689999999999999999999999965332110                0011110000 


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPMS  710 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  710 (720)
                       .....+..+.+++.+||+.||.+||++.
T Consensus       215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 -LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             0111235678999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-36  Score=309.05  Aligned_cols=251  Identities=29%  Similarity=0.464  Sum_probs=201.0

Q ss_pred             CeeccCCCceEEEEEeCC----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCC
Q 004994          446 NFIGEGLLGSVYKAELPG----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGG  521 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  521 (720)
                      +.||+|+||.||+|....    +..||+|.+....... ..+.+.+|++.++.++|+||+++++++.+.+..++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            469999999999996643    7899999997654322 46788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccchh-----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          522 NCTLHDLLHSDEEA-----HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       522 ~gsL~~~l~~~~~~-----~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      +++|.+++......     ...+++..+.+++.++++||+|||+.   +++||||||+||++++++.+||+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999998654211     36789999999999999999999987   89999999999999999999999999998775


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ............++..|+|||.. ...++.++|||||||++|||++ |+.||.......   ...             .+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~-------------~~  220 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLE-------------YL  220 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-------------HH
Confidence            43322223344567789999988 4578999999999999999999 699997542211   111             01


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      .+. .....+...+.++.+++.+||+.+|++|||+.|++++|+
T Consensus       221 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         221 RKG-YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HcC-CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            100 000112223567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-37  Score=320.42  Aligned_cols=254  Identities=21%  Similarity=0.343  Sum_probs=208.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ...|++.+.||+||.++||++...+.+.||+|++.....+......|..|++.|.+| .|.+||++|+|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            456888899999999999999888888999999876666667778899999999999 5999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||.+ .+|..+|....  .....| .+..+..|++.|+.++|+.   ||||.||||.|+|+-+ |.+||+|||+|..+..
T Consensus       440 E~Gd-~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  440 ECGD-IDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             eccc-ccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            9955 59999996432  222334 5677889999999999997   9999999999999964 5899999999999988


Q ss_pred             CCCcccccCccccccCCCCccCCC------------CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG------------SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~------------~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      ..+........||..||+||.+..            .++.++||||+|||||+|+.|+.||....               
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---------------  576 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---------------  576 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---------------
Confidence            888888888999999999997621            15679999999999999999999996421               


Q ss_pred             CchhhhhhhcCCCCCchhhHHH-HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          666 HDIDALSRMVDPSLDGAYLAKS-LSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+..+..+.+|...-.|+.-. ..++.++++.||.+||.+|||..|+|++
T Consensus       577 n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  577 NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            0123455566665433333211 1238899999999999999999999975

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-36  Score=315.73  Aligned_cols=264  Identities=25%  Similarity=0.311  Sum_probs=202.8

Q ss_pred             cCHHHHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEe
Q 004994          430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYC  507 (720)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~  507 (720)
                      +.++.+....++|+..+.||+|+||+||+|.. .+++.+|+|++...   .....++..|+.+++++ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            34556667788999999999999999999955 56889999988642   22345678899999999 799999999987


Q ss_pred             c-----cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC
Q 004994          508 N-----EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL  582 (720)
Q Consensus       508 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  582 (720)
                      .     ..+..++||||+++++|.+++.........+++.....++.++++||.|||+.   +++||||||+||++++++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~  161 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence            3     34578999999999999998764322345678888999999999999999987   899999999999999999


Q ss_pred             CeEEccccCCCCCCCCCCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc
Q 004994          583 IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS  656 (720)
Q Consensus       583 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~  656 (720)
                      .+||+|||+++.+....  .......++..|+|||.+.      ..++.++|||||||++|||++|+.||......... 
T Consensus       162 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-  238 (286)
T cd06638         162 GVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-  238 (286)
T ss_pred             CEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-
Confidence            99999999987653321  1122345788999999862      34788999999999999999999999654321110 


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                       ...     ..      ...+...  .+......+.+++.+||+.||++|||+.|++++.
T Consensus       239 -~~~-----~~------~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         239 -FKI-----PR------NPPPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -hhc-----cc------cCCCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence             000     00      0000000  0111234688999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.5e-36  Score=311.91  Aligned_cols=252  Identities=26%  Similarity=0.414  Sum_probs=195.8

Q ss_pred             CeeccCCCceEEEEEeCC-------CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          446 NFIGEGLLGSVYKAELPG-------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      +.||+|+||.||+|...+       +..||+|.+.+... .....++.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            368999999999996532       35799999865422 2345678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccch---hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-----CeEEcccc
Q 004994          519 YGGNCTLHDLLHSDEE---AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-----IVRVSDCG  590 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-----~~kl~DFG  590 (720)
                      |+++++|.+++.....   ....+++..+..++.+++.||+|||+.   +++|+||||+||+++.+.     .+|++|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            9999999999864321   224578899999999999999999987   899999999999999877     89999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCch
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      +++.+..............+..|+|||+. .+.++.++|||||||++|||+| |+.||........   ...        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~--------  225 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQH--------  225 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHH--------
Confidence            99766433222222223345789999988 5678999999999999999998 9999964332111   000        


Q ss_pred             hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                            +........+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus       226 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         226 ------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ------HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                  00000001112334678899999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.1e-36  Score=315.83  Aligned_cols=266  Identities=20%  Similarity=0.262  Sum_probs=191.5

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc---CCCceeEEEeEecc-----CC
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL---RHGNIVELIGYCNE-----HG  511 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~  511 (720)
                      +|+..+.||+|+||+||+|.. .+|+.||+|.++...........+.+|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            467788999999999999955 5789999999875433333334555666666655   79999999998854     34


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      ..++||||+.+ +|.+++....  ...+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            68999999985 8888875422  24588999999999999999999987   899999999999999999999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhcc-cccCch
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAI-PRLHDI  668 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~-~~~~~~  668 (720)
                      ++......   ......++..|+|||.. ...++.++|||||||++|||++|+.||......... .+..... +....+
T Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07863         155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  231 (288)
T ss_pred             cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence            98763221   12234567889999988 557899999999999999999999999654322111 0110000 000000


Q ss_pred             hh----hhhhcCCCCC---chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DA----LSRMVDPSLD---GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~----~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..    ......+...   .........++.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00    0000000000   00111234567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6e-37  Score=333.19  Aligned_cols=252  Identities=22%  Similarity=0.271  Sum_probs=192.8

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .|+..+.||+|+||+||+|.. .+++.||+|++.+.. ......+.+.+|++++++++|+|||++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            577889999999999999954 568999999987432 122344678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++..    ...+++.....++.|++.||+|||+.   +||||||||+|||++.++.+||+|||+++.+...
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999998853    24577888888999999999999987   8999999999999999999999999997543110


Q ss_pred             CC---------------------------------------------cccccCccccccCCCCccC-CCCCCCccchHhH
Q 004994          599 ST---------------------------------------------NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSL  632 (720)
Q Consensus       599 ~~---------------------------------------------~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~  632 (720)
                      ..                                             ........|+..|+|||.+ ...++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            00                                             0001124588999999998 5579999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcccc-chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC---
Q 004994          633 GVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP---  708 (720)
Q Consensus       633 Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---  708 (720)
                      ||++|||+||+.||....+.... .+..|..               ...........+++.+++.+++ .+|++|++   
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~  298 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQMKVINWQT---------------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG  298 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---------------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence            99999999999999754332111 1111100               0000000112356678888876 59999987   


Q ss_pred             HHHHHHH
Q 004994          709 MSEIVQD  715 (720)
Q Consensus       709 ~~evl~~  715 (720)
                      ++|+++|
T Consensus       299 ~~ei~~h  305 (382)
T cd05625         299 ADEIKAH  305 (382)
T ss_pred             HHHHhcC
Confidence            8888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.5e-36  Score=320.45  Aligned_cols=266  Identities=19%  Similarity=0.271  Sum_probs=197.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||.||+|.. .+++.||+|+++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            4678889999999999999965 4688999999875432 2334567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++ +|.+++...   ...+++.....++.++++||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          85 YLDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             CCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            9986 788777532   34578888899999999999999987   9999999999999999999999999999764322


Q ss_pred             CCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc--------ccCch
Q 004994          599 STNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP--------RLHDI  668 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~--------~~~~~  668 (720)
                      ..  ......++..|+|||...  ..++.++|||||||++|||+||+.||......+....+.....        .+...
T Consensus       158 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         158 TK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             cc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            11  112245678899999873  3589999999999999999999999976543222111111100        00000


Q ss_pred             hhhhhhcCCCCCc----hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDG----AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ......-.+....    ........++.+++.+||+.||.+|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            0000000000000    0011234567899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3e-36  Score=311.46  Aligned_cols=253  Identities=25%  Similarity=0.340  Sum_probs=188.6

Q ss_pred             eeccCCCceEEEEEeCC---CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          447 FIGEGLLGSVYKAELPG---GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       447 ~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      .||+|+||+||+|...+   ...+|+|.+.... .......|.+|++.++.++|+||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            58999999999996533   4578888876432 2334467889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccchh-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          524 TLHDLLHSDEEA-HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       524 sL~~~l~~~~~~-~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      +|.+++...... ....++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999998654321 23456778889999999999999987   89999999999999999999999999987543322211


Q ss_pred             cccCccccccCCCCccCC--------CCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccc-hhhhcccccCchhhhh
Q 004994          603 LSEGLLTAHGSGAPEFES--------GSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQS-LVRWAIPRLHDIDALS  672 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~~--------~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~  672 (720)
                      ......++..|+|||+..        ..++.++|||||||++|||++ |+.||....+..... .+....         .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~---------~  228 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD---------I  228 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC---------c
Confidence            222334456799999752        246889999999999999999 888986543221100 000000         0


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      ...++..    ....+..+.+++..|+ .||++|||++||++.|.
T Consensus       229 ~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         229 KLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0111111    1223456678889998 59999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-36  Score=313.09  Aligned_cols=271  Identities=18%  Similarity=0.287  Sum_probs=200.4

Q ss_pred             CCCCCCeeccCCCceEEEEEe-----CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC--CeE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-----PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQH  513 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~  513 (720)
                      .|...+.||+|+||.||++..     .++..||+|.++... .....+.+.+|+++++.++||||+++++++.+.  ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            467788999999999999964     357899999987543 233456789999999999999999999998765  568


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++||||+++++|.+++...   ...++|..+..++.+++.||+|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            9999999999999998532   23588999999999999999999987   99999999999999999999999999998


Q ss_pred             CCCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          594 LLFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       594 ~~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      .+...... .......++..|+|||.. .+.++.++|||||||++|||+|++.|+....... .................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF-LKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh-hhhcccccccccHHHHH
Confidence            76432211 112234456679999987 4578999999999999999999887653321100 00000000000000000


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ..+.+.. ....+...+..+.+++.+||+.+|++|||++++++.|++++
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         237 RVLEEGK-RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HHHHcCc-cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            0000000 00011223467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-36  Score=307.17  Aligned_cols=248  Identities=26%  Similarity=0.337  Sum_probs=193.2

Q ss_pred             CeeccCCCceEEEEEeC--C--CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCC
Q 004994          446 NFIGEGLLGSVYKAELP--G--GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGG  521 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  521 (720)
                      +.||+|+||.||+|...  +  +..||+|.+...... ...+++.+|++++++++|+||+++++++.. +..++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            46999999999999542  2  368999999755432 345678999999999999999999998864 46899999999


Q ss_pred             CCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCc
Q 004994          522 NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN  601 (720)
Q Consensus       522 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  601 (720)
                      +++|.+++...    ..+++..+..++.++++||+|||..   +++||||||+|||++.++.+||+|||+++.+......
T Consensus        79 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          79 LGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            99999998642    3688999999999999999999987   8999999999999999999999999999876433221


Q ss_pred             cc-ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          602 EL-SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       602 ~~-~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .. .....++..|+|||.. .+.++.++|||||||++|||++ |+.||.......   ...+....              
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~~--------------  214 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLESG--------------  214 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcC--------------
Confidence            11 1111224579999988 5578999999999999999998 999997543211   11111000              


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       215 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            00001122345788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.7e-37  Score=334.20  Aligned_cols=253  Identities=22%  Similarity=0.271  Sum_probs=194.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||+||+|+. .+++.||||++.+.. ......+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3688889999999999999964 568999999986432 12234466889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...++......++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+|..+..
T Consensus        81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            99999999999853    24577888888999999999999987   999999999999999999999999999853310


Q ss_pred             CCC-----------------------------------------cccccCccccccCCCCccC-CCCCCCccchHhHHHH
Q 004994          598 GST-----------------------------------------NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVV  635 (720)
Q Consensus       598 ~~~-----------------------------------------~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvv  635 (720)
                      ...                                         ........|++.|+|||.+ ...++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            000                                         0001134688999999998 4568999999999999


Q ss_pred             HHHHHhCCCCCCCCCCccccc-hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCC---CHHH
Q 004994          636 MLELLTGRKPYDRSRPRGEQS-LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP---PMSE  711 (720)
Q Consensus       636 l~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~e  711 (720)
                      +|||+||+.||.......... +..|..               ............++.+++.+|+ .+|.+|+   ++.|
T Consensus       234 lyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e  297 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQLKVINWET---------------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE  297 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHHHHhccCc---------------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence            999999999997644322111 111100               0000001112356678888876 5999999   8999


Q ss_pred             HHHH
Q 004994          712 IVQD  715 (720)
Q Consensus       712 vl~~  715 (720)
                      ++++
T Consensus       298 ll~h  301 (376)
T cd05598         298 IKAH  301 (376)
T ss_pred             HhCC
Confidence            9875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-36  Score=308.69  Aligned_cols=254  Identities=28%  Similarity=0.420  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|...+.||+|+||.||+|..++++.||||.+....   ...+++.+|++++++++|+||+++++++......++|||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            45788889999999999999988788899999987532   345678999999999999999999999998889999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++....  ...+++..+..++.+++.|+.|||+.   +++|+||||+||++++++.+||+|||+++.+...
T Consensus        82 ~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          82 YMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             ccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            999999999986532  34688999999999999999999987   8999999999999999999999999999766432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .. ........+..|+|||.. .+.++.++|||||||++||++| |+.||........   .....          ....
T Consensus       157 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~----------~~~~  222 (261)
T cd05034         157 EY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQVE----------RGYR  222 (261)
T ss_pred             hh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----------cCCC
Confidence            11 111122234579999988 4568999999999999999999 9999965332111   11000          0000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      ..    .+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus       223 ~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MP----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            00    011124578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-36  Score=312.85  Aligned_cols=270  Identities=22%  Similarity=0.306  Sum_probs=202.3

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--CCeE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--HGQH  513 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~  513 (720)
                      .|...+.||+|+||.||+|.+.     ++..||||++...... ...+.|.+|+++++.++|+||+++++++..  ....
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            4666789999999999999753     3689999999754332 346789999999999999999999999877  5578


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++||||+++++|.+++...   ...+++..+..++.+++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            9999999999999998643   23589999999999999999999987   89999999999999999999999999998


Q ss_pred             CCCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          594 LLFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       594 ~~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ........ ...........|++||.. ...++.++||||||+++|||+||+.|+......... ..... ........+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~-~~~~~~~~~  235 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIA-QGQMIVTRL  235 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccc-cccccHHHH
Confidence            76532211 111122334568999987 557899999999999999999999998643221100 00000 000001111


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .+.+........+..++.++.+++.+||+.+|++||||.||+++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111111111111223346789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.1e-36  Score=309.16  Aligned_cols=256  Identities=22%  Similarity=0.293  Sum_probs=201.9

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--CCeEEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--HGQHLLVY  517 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~  517 (720)
                      +|+..+.||.|+||.||++.. .+++.||+|++..........+.+..|++++++++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            467788999999999999954 578999999987544444555778899999999999999999998753  45689999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC--EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||+++++|.+++.........+++.....++.++++||.|||..+  ..+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998654333567899999999999999999999443  459999999999999999999999999999876


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      .....  ......++..|+|||.. ...++.++||||||+++|+|++|+.||.......   ..+..             
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~-------------  222 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKI-------------  222 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHH-------------
Confidence            43321  12234578889999998 4568899999999999999999999997543111   11100             


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ... .....+...+..+.+++.+|++.+|++||++++|+++
T Consensus       223 ~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         223 KEG-KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             hcC-CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            000 0011122334678899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=320.43  Aligned_cols=253  Identities=22%  Similarity=0.309  Sum_probs=209.7

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccc-cccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~  514 (720)
                      ....|...+.||+|.||.||++..+ +|+.+|+|.+.+.... ....+...+|+++|+++. |||||.++++|++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4456888899999999999999654 5999999999765432 234578899999999998 999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC----CCeEEcccc
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK----LIVRVSDCG  590 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~DFG  590 (720)
                      +|||++.+|.|.+.+...     .++......++.+++.++.|+|+.   +||||||||+|+|+...    +.+|++|||
T Consensus       113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999998643     288999999999999999999997   99999999999999643    479999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      +|.....   ........||++|+|||... ..|+..+||||+||++|.|+.|..||...........+..         
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~---------  252 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR---------  252 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc---------
Confidence            9998754   33455688999999999996 6899999999999999999999999976543222111100         


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                           .+......+.......+.+++.+|+..||.+|+|+.++++|
T Consensus       253 -----~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  253 -----GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -----CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                 01122233444556788999999999999999999999986

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.9e-36  Score=313.25  Aligned_cols=268  Identities=18%  Similarity=0.279  Sum_probs=198.3

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|++|.||+|.. .+++.||+|++..........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            467788999999999999965 4689999999875443344456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      ++ ++|.+++.... ....+++.....++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            98 58888875432 235688999999999999999999987   99999999999999999999999999987653221


Q ss_pred             CcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhc-c------cccCchh
Q 004994          600 TNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWA-I------PRLHDID  669 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~-~------~~~~~~~  669 (720)
                        .......++..|+|||...  ..++.++|||||||++|||+||+.||......... ...+.. .      +......
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence              1112234577899999873  34789999999999999999999999754321110 000000 0      0000001


Q ss_pred             hhhhhcCCCCCc---hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSLDG---AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ......+.....   ......+.++.+++.+||+.||++|||+.+|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            111111100000   0011234677899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.4e-36  Score=312.63  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=195.5

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccC-----
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEH-----  510 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-----  510 (720)
                      +++.|+..+.||+|+||.||+|.. .+++.||+|++...   ......+..|+.+++++ +|+||+++++++...     
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            456778888999999999999965 46889999998643   23345778899999998 799999999998642     


Q ss_pred             -CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          511 -GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       511 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                       ...++||||+++++|.+++...  ....+++.....++.|++.||+|||+.   +|+||||||+||++++++.+||+||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence             4689999999999999998642  234688999999999999999999987   8999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      |+++......  .......++..|+|||++.      ..++.++|||||||++|||++|+.||............     
T Consensus       156 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-----  228 (272)
T cd06637         156 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-----  228 (272)
T ss_pred             CCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-----
Confidence            9997653221  1223355788899999873      24788999999999999999999999643321111000     


Q ss_pred             ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                              .....+..   .....+.++.+++.+||+.+|.+|||+.|++++
T Consensus       229 --------~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 --------PRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             --------hcCCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                    00000000   011233568899999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-36  Score=303.80  Aligned_cols=264  Identities=27%  Similarity=0.415  Sum_probs=198.5

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHc--cCCCceeEEEeEeccCC----eEEEEEe
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR--LRHGNIVELIGYCNEHG----QHLLVYD  518 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~e  518 (720)
                      .++||+|.||+||||.+.+ +.||||++..     ...+.|..|-++.+.  ++|+||++++++-....    +++||++
T Consensus       215 ~eli~~Grfg~V~KaqL~~-~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLDN-RLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             HHHhhcCccceeehhhccC-ceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            4679999999999999854 8999999963     445678888777654  48999999999876544    8999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC------EPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      |.+.|+|.++|.     ...++|....+|+..+++||+|||+.+      .++|+|||||++|||+..|++..|+|||+|
T Consensus       289 fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  289 FHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            999999999995     356899999999999999999999754      678999999999999999999999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCCCCCC-------CccchHhHHHHHHHHHhCCCCCCC-CCCccccchhhh--cc
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFESGSYS-------CQSDVYSLGVVMLELLTGRKPYDR-SRPRGEQSLVRW--AI  662 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-------~~~Dv~S~Gvvl~elltG~~Pf~~-~~~~~~~~~~~~--~~  662 (720)
                      ..+..+....-.....||..|||||++.|..+       .+.||||+|.|||||+++-.-+.. ..+.-..-+...  ..
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            98876655545556889999999999865432       258999999999999986544321 111000000000  00


Q ss_pred             cccCchh--hhhhhcCCCCCch-hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          663 PRLHDID--ALSRMVDPSLDGA-YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       663 ~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      |.+.+-.  .+++-..|.++.. .....+..+++.+..||..||+.|.|+.=|-+++.+|
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            1111100  1112222333221 1123456789999999999999999999998888776

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=288.04  Aligned_cols=244  Identities=24%  Similarity=0.431  Sum_probs=190.2

Q ss_pred             CCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          445 GNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      ...||.|+.|.|+++++ .+|..+|||.+.+.. .....+.++..++++.+- +.|+||+.+|||..+...++.||.|.-
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence            45699999999999965 568999999998653 234445566666666555 489999999999988888999998865


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      + +..++.   ...+++++...-++...+..||.||.+.|  +|||||+||+|||+|+.|++|+||||++-.+.++..+ 
T Consensus       176 C-~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-  248 (391)
T KOG0983|consen  176 C-AEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-  248 (391)
T ss_pred             H-HHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence            3 344443   23456888888899999999999999986  8999999999999999999999999999887654433 


Q ss_pred             cccCccccccCCCCccCCC----CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC--
Q 004994          603 LSEGLLTAHGSGAPEFESG----SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD--  676 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~~~----~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  676 (720)
                        ....|-+.|||||.+..    .|+.++|||||||.++||.||+.||...+.+               .+.+..+++  
T Consensus       249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---------------Fe~ltkvln~e  311 (391)
T KOG0983|consen  249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---------------FEVLTKVLNEE  311 (391)
T ss_pred             --ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---------------HHHHHHHHhcC
Confidence              23456678999999843    4899999999999999999999999763321               122222222  


Q ss_pred             -CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 -PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 -~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       |.+++..  ..++.|++++..||.+|+.+||.+.++++|
T Consensus       312 PP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  312 PPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence             3333221  145789999999999999999999999875

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-36  Score=326.76  Aligned_cols=265  Identities=18%  Similarity=0.223  Sum_probs=196.0

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC------
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH------  510 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------  510 (720)
                      ..++|...+.||+|+||.||+|.. ..++.||||++............+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            356888999999999999999954 5688999999976544444556788999999999999999999987543      


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                      ...++||||+++ +|.+.+.      ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence            357999999976 6766663      2477888899999999999999987   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccc-cCc-
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR-LHD-  667 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~-  667 (720)
                      +++.....   .......++..|+|||.+ ...++.++|||||||++|||++|+.||...+.......+...... ..+ 
T Consensus       172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99865322   122335678899999998 557899999999999999999999999754432211110000000 000 


Q ss_pred             hhh-------------------hhhhcCCCC---CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDA-------------------LSRMVDPSL---DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~-------------------~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...                   .........   ..........++.+++.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000                   000000000   000011123467899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=322.20  Aligned_cols=245  Identities=27%  Similarity=0.397  Sum_probs=200.1

Q ss_pred             CCCCCeeccCCCceEEEEE-eCCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      |...+-||.|+||.||-|+ ..+...||||++.-... ......++..|++.|++++|||+|.+.|+|......||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            4556789999999999994 56789999999974322 223346789999999999999999999999988899999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      |-| |-.|++.   -.++++....+..|..|+..||+|||+.   +.||||||+-|||+++.|.|||+|||.|.++.+..
T Consensus       108 ClG-SAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn  180 (948)
T KOG0577|consen  108 CLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN  180 (948)
T ss_pred             Hhc-cHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence            975 7778774   3456788888999999999999999997   89999999999999999999999999998775433


Q ss_pred             CcccccCccccccCCCCccC----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          600 TNELSEGLLTAHGSGAPEFE----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                            .++||++|||||++    .|.|+-|+||||+|+...|+...++|+...+......             .+...-
T Consensus       181 ------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY-------------HIAQNe  241 (948)
T KOG0577|consen  181 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------------HIAQNE  241 (948)
T ss_pred             ------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH-------------HHHhcC
Confidence                  37899999999987    4789999999999999999999999986543221111             011111


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .|.+.   ..+++..|+.|+..||++-|.+|||.+++++|
T Consensus       242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            22222   34566789999999999999999999999876

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-36  Score=327.61  Aligned_cols=266  Identities=18%  Similarity=0.223  Sum_probs=196.2

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-----
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-----  510 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----  510 (720)
                      ...++|...+.||+|+||.||++.. ..++.||||++..........+.+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3457899999999999999999954 5689999999976544444556788999999999999999999988543     


Q ss_pred             -CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          511 -GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       511 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                       ...++||||+++ ++.+.+.      ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence             357999999976 5666553      2477888889999999999999987   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcccccCc
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAIPRLHD  667 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~  667 (720)
                      |+++.....   .......++..|+|||.. ...++.++|||||||++|||++|+.||.......... .+........+
T Consensus       164 g~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         164 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             cccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999865322   122335678899999998 4568999999999999999999999997543211100 00000000000


Q ss_pred             -h----hhhhhhcC----------------CCC--CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 -I----DALSRMVD----------------PSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 -~----~~~~~~~~----------------~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       .    .....+++                ...  ..........++.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence             0    00000000                000  000111224567899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.5e-36  Score=306.90  Aligned_cols=254  Identities=24%  Similarity=0.372  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|...+.||+|+||.||++...++..+|+|.+...   ....+.|.+|++++++++|+||+++++++.+ ...+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            3567888999999999999998777888999998643   2335678999999999999999999999887 77899999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++....  ...+++..+..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||.+......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            999999999986432  34578889999999999999999987   8999999999999999999999999999765432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ... ......++..|+|||+. .+.++.++|||||||++||++| |+.||.......   ...+..              
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~--------------  217 (260)
T cd05073         156 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALE--------------  217 (260)
T ss_pred             Ccc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh--------------
Confidence            211 11223345679999998 5568999999999999999999 999996532211   111100              


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...........+.++.+++.+|++.+|++||++.++++.|+.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         218 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            0000001112345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.7e-36  Score=313.89  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=198.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+....  ....+.+.+|+++++.++|+||+++++++...++.++|||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            5788889999999999999964 578999999986433  2335678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++..     ..+++.+...++.+++.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             ccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            9999999998842     3478889999999999999999987   8999999999999999999999999998765332


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      ..  ......++..|+|||.. ...++.++|||||||++|||++|+.||....+....  ..+..           ...+
T Consensus       170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~~-----------~~~~  234 (296)
T cd06654         170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIAT-----------NGTP  234 (296)
T ss_pred             cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHhc-----------CCCC
Confidence            11  12234577889999988 456889999999999999999999999754321111  00000           0000


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..  ..+......+.+++.+||..+|++|||++|++++
T Consensus       235 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         235 EL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            00  0112234568899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-36  Score=309.97  Aligned_cols=255  Identities=24%  Similarity=0.346  Sum_probs=198.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCc----EEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      .+|...+.||+|+||+||+|... +|.    .||+|.+..... .....++.+|+.++++++||||++++++|.. ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            45677899999999999999653 333    689998865432 3445678899999999999999999999987 7889


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++|+|.+++...   ...+++.....++.|+++||+|||+.   +++||||||+||++++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999998643   23588999999999999999999986   999999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +..............+..|++||.. .+.++.++|||||||++||++| |+.||.......   +.....          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----------  225 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLE----------  225 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHh----------
Confidence            6533222222222234679999987 5678999999999999999999 999997543211   111100          


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                          .......+..+...+.+++.+||..+|.+||++.++++.|+++
T Consensus       226 ----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         226 ----KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             ----CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                0000000111224678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.6e-36  Score=322.57  Aligned_cols=250  Identities=18%  Similarity=0.255  Sum_probs=191.1

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||+||+|.. .+++.||+|++++.... ....+.+.+|+.++.++ +||||+.+++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999965 56889999999754322 23345678899998888 699999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  151 (327)
T cd05617          81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D  151 (327)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence            999988743    34689999999999999999999987   99999999999999999999999999987532211  1


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      ......++..|+|||.. ...++.++|||||||++|||+||+.||.............+.         ...+.....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~---------~~~~~~~~~--  220 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL---------FQVILEKPI--  220 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH---------HHHHHhCCC--
Confidence            22335678999999998 557899999999999999999999999643221111100000         001111000  


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCH------HHHHHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPM------SEIVQD  715 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  715 (720)
                      ..+...+..+.+++.+||+.||++|+++      ++++++
T Consensus       221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         221 RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            0111233567899999999999999984      566543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.7e-36  Score=313.50  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=196.9

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      |+..+.||+|+||.||++.. .+++.||||.+...... ....+.+..|+.++++++|+||+.+++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            56678999999999999954 57899999998754322 22335677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999988532  234588899999999999999999986   99999999999999999999999999987653222


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .   .....++..|+|||.. .+.++.++|||||||++|||++|+.||............             ...... 
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~-------------~~~~~~-  219 (285)
T cd05630         157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-------------ERLVKE-  219 (285)
T ss_pred             c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH-------------Hhhhhh-
Confidence            1   1234678899999998 557899999999999999999999999753221110000             000000 


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                      ....+......++.+++.+||+.||++|||     ++|++++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            000111223456889999999999999999     8898874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-36  Score=321.34  Aligned_cols=238  Identities=22%  Similarity=0.261  Sum_probs=183.0

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHH-HHHHccCCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELA-STISRLRHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      ++||+|+||+||+|+. .+|+.||+|++.+... .......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999965 5689999999875322 122233444444 467889999999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+.+..    ...++......++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~  151 (321)
T cd05603          81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E  151 (321)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence            999888743    34577788888999999999999987   99999999999999999999999999987532211  1


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      ......++..|+|||.+ ...++.++|||||||++|||++|+.||...+....   .             ..+.....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~-------------~~i~~~~~--  213 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---Y-------------DNILHKPL--  213 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---H-------------HHHhcCCC--
Confidence            22335678899999998 45689999999999999999999999965431110   0             01111000  


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPMS  710 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  710 (720)
                      ..+.....++.+++.+||+.||.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            01112235678999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.7e-36  Score=322.14  Aligned_cols=243  Identities=21%  Similarity=0.247  Sum_probs=185.2

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHH-HHHHHccCCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLEL-ASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e-~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||+||+|.. .+++.||+|++.+.... ......+..| ..+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999965 46789999999753211 1222334444 4456889999999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++..    ...+.......++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~  151 (325)
T cd05602          81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--G  151 (325)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--C
Confidence            999998853    24567777888999999999999987   99999999999999999999999999997542211  1


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      ......+++.|+|||.+ ...++.++|||||||++|||++|+.||........   ..             .+.....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~-------------~i~~~~~--  213 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD-------------NILNKPL--  213 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HH-------------HHHhCCc--
Confidence            22345688999999988 55689999999999999999999999975332111   00             0000000  


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ......+..+.+++.+||+.||.+||++.+.+..
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            0011223567899999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.7e-36  Score=320.24  Aligned_cols=242  Identities=19%  Similarity=0.243  Sum_probs=189.5

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  517 (720)
                      +|...+.||+|+||+||+|.. .+|+.||+|++.+... .....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            366678999999999999965 5789999999975422 2233456778888888885 578888999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            99999999988853    34688999999999999999999987   999999999999999999999999999875422


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..  .......++..|+|||.+ .+.++.++|||||||++|||+||+.||.......   ..             ..+..
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~-------------~~i~~  215 (323)
T cd05615         154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LF-------------QSIME  215 (323)
T ss_pred             CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HH-------------HHHHh
Confidence            21  122334578999999998 4568999999999999999999999997543211   11             11111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPM  709 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  709 (720)
                      ...  .++...+.++.+++.+||+.+|++|++.
T Consensus       216 ~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         216 HNV--SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCC--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            000  0112233567899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.5e-36  Score=313.76  Aligned_cols=252  Identities=22%  Similarity=0.299  Sum_probs=196.4

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      |+..+.||+|+||+||+|.. .+++.||+|.+...... ......+.+|++++++++|+||+.+++++...+..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            55668899999999999955 57899999998654322 22335678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++...  ....+++.....++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999999888532  234689999999999999999999987   99999999999999999999999999997653221


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                         ......++..|+|||.. ...++.++|||||||++|||+||+.||...........+..            ++... 
T Consensus       157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~------------~~~~~-  220 (285)
T cd05632         157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR------------RVLET-  220 (285)
T ss_pred             ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH------------hhhcc-
Confidence               11234678899999998 55789999999999999999999999975432111111100            00000 


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                       ...+......++.+++.+|++.||++||+     +++++++
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 -EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             -ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence             00112223456789999999999999999     6677654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.8e-36  Score=327.34  Aligned_cols=258  Identities=19%  Similarity=0.222  Sum_probs=198.6

Q ss_pred             HHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCC
Q 004994          434 SLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG  511 (720)
Q Consensus       434 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  511 (720)
                      ++....++|+..+.||+|+||.||+|.. .+++.||+|++.+.. ......+.+.+|+++++.++||||+++++++.+.+
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            3444557899999999999999999965 468899999986422 22234456789999999999999999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      ..++||||+++|+|.+++..     ..++......++.+++.||+|||+.   +|+||||||+|||++.++++||+|||+
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            99999999999999998853     2467778888999999999999987   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccCCC-----CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFESG-----SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH  666 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  666 (720)
                      ++.+..... .......+++.|+|||.+.+     .++.++|||||||++|||++|+.||.........           
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-----------  256 (371)
T cd05622         189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-----------  256 (371)
T ss_pred             eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH-----------
Confidence            987643221 12234568999999998732     3789999999999999999999999754321111           


Q ss_pred             chhhhhhhcCC--CCCchhhHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHHH
Q 004994          667 DIDALSRMVDP--SLDGAYLAKSLSRFADIISRCVQWEPGF--RPPMSEIVQDL  716 (720)
Q Consensus       667 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~L  716 (720)
                           ..+...  .+........+..+.+++.+|+..++.+  |++++|++++.
T Consensus       257 -----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         257 -----SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             -----HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                 111100  0000001123456789999999844433  78999998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.6e-36  Score=306.93  Aligned_cols=253  Identities=21%  Similarity=0.347  Sum_probs=197.9

Q ss_pred             CCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccc----cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQ----RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +|...+.||+|+||+||+|...+|+.+|+|.+......    ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            46778999999999999998778999999998643211    12235688999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..    ...+++.....++.+++.||+|||..   +|+|+||||+||++++++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            999999999999853    23578888899999999999999987   89999999999999999999999999987653


Q ss_pred             CCC----CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          597 SGS----TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       597 ~~~----~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ...    .........++..|+|||+. ...++.++|||||||++|||++|+.||.........  ....        ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~~~--------~~  223 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--FYIG--------AH  223 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--HHhh--------hc
Confidence            211    11122234578899999998 446889999999999999999999999653321110  0000        00


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      . ...+...    .....++.+++.+||+.+|++||++.|++++
T Consensus       224 ~-~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         224 R-GLMPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             c-CCCCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0 0011111    1233567899999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.1e-36  Score=308.46  Aligned_cols=258  Identities=25%  Similarity=0.398  Sum_probs=196.6

Q ss_pred             CCCCCeeccCCCceEEEEEeC----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC------
Q 004994          442 FSEGNFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG------  511 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------  511 (720)
                      |...+.||+|+||.||+|...    +++.||||++..........+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999643    3688999999765444445677889999999999999999999885432      


Q ss_pred             eEEEEEeeCCCCCHHHHhhccc--hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                      ..++++||+.+|+|.+++....  .....+++....+++.+++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            3478999999999998875321  1123578889999999999999999987   8999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCc
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      |+++...............++..|++||.. .+.++.++|||||||++|||++ |+.||.......   ...+..    .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~----~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI----K  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH----c
Confidence            999876433221112222344678999987 5568899999999999999999 899986433211   111100    0


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...      ..    .....+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       231 ~~~------~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNR------LK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCc------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            000      00    0012235788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-36  Score=312.81  Aligned_cols=261  Identities=21%  Similarity=0.317  Sum_probs=200.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|+||+||++.. .+|+.||+|++.... .....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            4566778999999999999965 568999999986442 23345788999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++..    ...+++.....++.++++||.|||+.+  +++||||||+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999998853    245889999999999999999999743  7999999999999999999999999998755222


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .    .....++..|+|||.. .+.++.++|||||||++||++||+.||.............   ..+  .+....++..
T Consensus       158 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~---~~~--~~~~~~~~~~  228 (284)
T cd06620         158 I----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP---MGI--LDLLQQIVQE  228 (284)
T ss_pred             c----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh---hHH--HHHHHHHhhc
Confidence            1    1234578899999987 5678999999999999999999999997543221100000   000  0011111111


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      ........+.+..+.+++.+|++.||++|||++|++++.
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            111001112446788999999999999999999999763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.7e-36  Score=322.26  Aligned_cols=241  Identities=23%  Similarity=0.258  Sum_probs=185.4

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHH-HHHccCCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELAS-TISRLRHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||+||+|.. .+|+.||+|++.+... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999954 5799999999975422 1223344555544 56789999999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++..    ...+++.....++.|+++||.|||+.   +|+||||||+|||+++++.+||+|||+++......  .
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~  151 (325)
T cd05604          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--D  151 (325)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--C
Confidence            999988753    34688899999999999999999987   99999999999999999999999999987542211  1


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      ......++..|+|||.+ .+.++.++|||||||++|||++|+.||.........                ..+...... 
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~----------------~~~~~~~~~-  214 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY----------------DNILHKPLV-  214 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH----------------HHHHcCCcc-
Confidence            22335678899999998 557899999999999999999999999653321110                011110000 


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPMSEIV  713 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  713 (720)
                       ........+.+++.+|++.+|.+||++.+.+
T Consensus       215 -~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         215 -LRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence             0011234677999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.3e-36  Score=308.01  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=187.7

Q ss_pred             eeccCCCceEEEEEeCCC---cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          447 FIGEGLLGSVYKAELPGG---KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       447 ~lg~G~~g~Vy~~~~~~g---~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      .||+|+||+||+|...++   ..+++|.+..... ....+.|.+|+++++.++||||++++++|.+....++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            599999999999965433   3566777654322 234578999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL  603 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  603 (720)
                      +|.++++.........++.....++.++++||+|||+.   +++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999975433334566777889999999999999987   899999999999999999999999999864322211111


Q ss_pred             ccCccccccCCCCccCC--------CCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          604 SEGLLTAHGSGAPEFES--------GSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       604 ~~~~~~~~~~~aPE~~~--------~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      .....++..|+|||+..        ..++.++|||||||++|||++ |..||....+...   .....   .  +.....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~~~---~--~~~~~~  229 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV---LNHVI---K--DQQVKL  229 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH---h--hccccc
Confidence            22345677899999862        235789999999999999997 5778864332111   11000   0  001112


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      .++.....    ..+.+.+++..|| .+|++||+++||++.|.
T Consensus       230 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22222211    2356778999999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=323.61  Aligned_cols=243  Identities=26%  Similarity=0.363  Sum_probs=198.3

Q ss_pred             eeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          447 FIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       447 ~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      +||+|.||+||-|+ ..+...+|||.+....  ....+-+.+|+.+.++++|+|||+++|.|.+++..-+.||-++||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            79999999999995 4567789999997432  34456688999999999999999999999999999999999999999


Q ss_pred             HHHhhccchhcccc--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc-CCCCeEEccccCCCCCCCCCCcc
Q 004994          526 HDLLHSDEEAHKKF--SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       526 ~~~l~~~~~~~~~~--~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      .++++..   ..++  .+.+.-.+..||.+||.|||+.   .|||||||-+|||++ -.|.+||+|||-++.+..  -+.
T Consensus       660 SsLLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP  731 (1226)
T KOG4279|consen  660 SSLLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INP  731 (1226)
T ss_pred             HHHHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc--CCc
Confidence            9999753   3344  6677888999999999999998   899999999999995 688999999999988743  344


Q ss_pred             cccCccccccCCCCccC-CC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCc-cccchhhhcccccCchhhhhhhcCCC
Q 004994          603 LSEGLLTAHGSGAPEFE-SG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPR-GEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .++.+.||..|||||++ .|  .|+.++|||||||.+.||.||++||-..... .....+-                -..
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG----------------myK  795 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG----------------MYK  795 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc----------------cee
Confidence            56678899999999999 44  4899999999999999999999999643221 1111110                011


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .....+.+...+...++.+|...||.+||++++++++
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            1122455677788999999999999999999999864

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=307.82  Aligned_cols=248  Identities=21%  Similarity=0.357  Sum_probs=209.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .-|...+.||+|.|.+|-.|++ -+|..||||++.+...+......+..|++.|+.++|||||++|++....-.+|||.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3466678899999999999954 589999999998877666667788899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE-cCCCCeEEccccCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL-DEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl-~~~~~~kl~DFGla~~~~~  597 (720)
                      +.++|+|+|++-..+   ..+.+....+++.||..|+.|+|+.   .+|||||||+||.+ .+-|-|||.|||++..+.+
T Consensus        98 LGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             ecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999996443   4578888899999999999999999   69999999999876 6678999999999988766


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCC-CccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYS-CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~-~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      +...   ....|...|.|||++ +..|+ +++||||+|||||.|+.|+.||...+                |.+.+..++
T Consensus       172 G~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------DSETLTmIm  232 (864)
T KOG4717|consen  172 GKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------DSETLTMIM  232 (864)
T ss_pred             cchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------chhhhhhhh
Confidence            5433   345788899999998 44675 58999999999999999999997543                334555666


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                      |....  .+.....+.++||.+||+.||.+|-+.+||+.
T Consensus       233 DCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  233 DCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            65433  34556778899999999999999999999874

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.3e-36  Score=312.83  Aligned_cols=263  Identities=27%  Similarity=0.343  Sum_probs=203.6

Q ss_pred             cCHHHHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEe
Q 004994          430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYC  507 (720)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~  507 (720)
                      ++.+++..++++|...+.||+|+||.||+|.. .+++.+|+|++...   ......+.+|+.+++++ +|||++++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            45566667788999999999999999999965 57899999998643   22345677889999998 899999999998


Q ss_pred             ccC-----CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC
Q 004994          508 NEH-----GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL  582 (720)
Q Consensus       508 ~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  582 (720)
                      ...     +..++||||+++++|.++++........+++..+..++.+++.||.|||+.   +++||||||+||++++++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~  165 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence            643     368999999999999998864333345688999999999999999999987   999999999999999999


Q ss_pred             CeEEccccCCCCCCCCCCcccccCccccccCCCCccCCC------CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc
Q 004994          583 IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG------SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS  656 (720)
Q Consensus       583 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~  656 (720)
                      .+||+|||++........  ......++..|+|||....      .++.++|||||||++|||++|+.||........  
T Consensus       166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--  241 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--  241 (291)
T ss_pred             CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--
Confidence            999999999876543221  1223456788999998732      268899999999999999999999965332111  


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...+..           ...+...  ...+....+.+++.+||+.+|++||++.|++++
T Consensus       242 ~~~~~~-----------~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 LFKIPR-----------NPPPTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHHhc-----------CCCCCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            111100           0000000  112233568899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.1e-36  Score=318.31  Aligned_cols=266  Identities=21%  Similarity=0.268  Sum_probs=193.2

Q ss_pred             CCeeccC--CCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCC
Q 004994          445 GNFIGEG--LLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGG  521 (720)
Q Consensus       445 ~~~lg~G--~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  521 (720)
                      .++||+|  +|++||++.. .+|+.||+|++..........+.+.+|+++++.++||||++++++|..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4689999  6889999954 679999999997554334445667889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC-
Q 004994          522 NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST-  600 (720)
Q Consensus       522 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-  600 (720)
                      +|+|.+++....  ...+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.++++||+.+........ 
T Consensus        83 ~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          83 YGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            999999985321  23588999999999999999999987   899999999999999999999999987544321111 


Q ss_pred             ----cccccCccccccCCCCccCCC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCccc-cchhhhcccccCch----
Q 004994          601 ----NELSEGLLTAHGSGAPEFESG---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE-QSLVRWAIPRLHDI----  668 (720)
Q Consensus       601 ----~~~~~~~~~~~~~~aPE~~~~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~----  668 (720)
                          ........++..|+|||++.+   .++.++|||||||++|||++|+.||........ ........+...+.    
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                001112335667999999843   588999999999999999999999964321110 00000000000000    


Q ss_pred             -hhh-------------------hhhc---CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 -DAL-------------------SRMV---DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 -~~~-------------------~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       +..                   ....   ..............++.+++.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence             000                   0000   0000001122345678999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-35  Score=305.86  Aligned_cols=251  Identities=25%  Similarity=0.391  Sum_probs=189.3

Q ss_pred             CeeccCCCceEEEEEeC----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEec-cCCeEEEEEeeC
Q 004994          446 NFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN-EHGQHLLVYDYG  520 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~  520 (720)
                      +.||+|+||.||+|...    ++..||+|++... ......+.+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            46899999999999643    2457999998532 22334567889999999999999999999875 455688999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      .+|+|.+++...   ....++.....++.++++||+|||+.   +++||||||+|||+++++.+||+|||+++.+.....
T Consensus        80 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          80 KHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            999999998632   23457777889999999999999987   899999999999999999999999999976533211


Q ss_pred             cc--cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhC-CCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          601 NE--LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTG-RKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       601 ~~--~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..  ......++..|+|||.. ...++.++|||||||++|||++| ..||......   .......          ....
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~----------~~~~  220 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLL----------QGRR  220 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh----------cCCC
Confidence            11  11123345679999987 56789999999999999999995 5666532211   1111100          0000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      +.    .+...+..+.+++.+||+.+|++||++.|+++.|++++
T Consensus       221 ~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         221 LL----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            00    01122356889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-35  Score=304.68  Aligned_cols=249  Identities=24%  Similarity=0.381  Sum_probs=200.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|+||.||+|... +++.||+|.+....    ..+++.+|++++++++|+||+++++++.+....++++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            57888899999999999999765 48899999986432    16789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++..   ....+++.....++.++++||.|||+.   +++||||+|+||++++++.+||+|||++......
T Consensus        79 ~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          79 YCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             cCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999853   235689999999999999999999987   8999999999999999999999999999876432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      ..  ......++..|+|||+. ...++.++|||||||++|||+||+.||....+......+.             ....+
T Consensus       153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~~  217 (256)
T cd06612         153 MA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP-------------NKPPP  217 (256)
T ss_pred             cc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc-------------cCCCC
Confidence            21  12234467789999988 4568999999999999999999999997543221110000             00000


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..  ..+......+.+++.+||+.||++|||++||+++
T Consensus       218 ~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         218 TL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            00  0112234578899999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-35  Score=305.72  Aligned_cols=238  Identities=25%  Similarity=0.394  Sum_probs=185.1

Q ss_pred             CeeccCCCceEEEEEeCC-------------CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe
Q 004994          446 NFIGEGLLGSVYKAELPG-------------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  512 (720)
                      +.||+|+||.||+|.+.+             ...||+|.+....  ......|.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            358999999999996532             2358889876432  3345678899999999999999999999999889


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC-------eE
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI-------VR  585 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~-------~k  585 (720)
                      .++||||+++++|..+++..   ...+++..+.+++.|+++||+|||+.   +|+||||||+|||++.++.       +|
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            99999999999998887532   24588999999999999999999987   9999999999999987664       89


Q ss_pred             EccccCCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHH-hCCCCCCCCCCccccchhhhcc
Q 004994          586 VSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELL-TGRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       586 l~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~ell-tG~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      ++|||++......      ....++..|+|||...  ..++.++|||||||++|||+ +|+.||..........      
T Consensus       153 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------  220 (262)
T cd05077         153 LSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER------  220 (262)
T ss_pred             eCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH------
Confidence            9999998765321      1234667899999873  46899999999999999998 5888886432111000      


Q ss_pred             cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                                 ........  ......++.+++.+||+.||.+||++.+|+++|
T Consensus       221 -----------~~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         221 -----------FYEGQCML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -----------HHhcCccC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                       00000000  001134678999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-35  Score=305.55  Aligned_cols=252  Identities=20%  Similarity=0.298  Sum_probs=192.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc---cccHHHHHHHHHHHHccCCCceeEEEeEecc--CCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ---RQTDEEFLELASTISRLRHGNIVELIGYCNE--HGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~  513 (720)
                      .+|...+.||+|+||.||+|.. .+++.||+|++......   ....+.+.+|+.++++++||||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688899999999999999955 56899999998643221   2234568899999999999999999998865  4578


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      +++|||+++++|.+++..    ...+++.....++.++++||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            899999999999998853    23578888999999999999999987   89999999999999999999999999997


Q ss_pred             CCCCCCC-cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          594 LLFSGST-NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       594 ~~~~~~~-~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      .+..... ........++..|+|||.. ...++.++|||||||++|||++|+.||.........                
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~----------------  218 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI----------------  218 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH----------------
Confidence            6532111 1111224467889999998 446889999999999999999999999653221110                


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ............+......+.+++ +||..+|++||+++||+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         219 FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            000000000111222334566676 7888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-35  Score=304.87  Aligned_cols=249  Identities=26%  Similarity=0.467  Sum_probs=197.2

Q ss_pred             CCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      +|+..+.||+|+||.||+|...++..+|+|.+....   ....+|.+|++++++++||||+++++++......++||||+
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            566678999999999999987778899999986432   23457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      .+++|.+++...   ...+++.....++.+++.||+|||+.   +++||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            999999988532   23578899999999999999999987   899999999999999999999999999876533211


Q ss_pred             cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          601 NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      . .......+.+|+|||.. .+.++.++|||||||++|||++ |+.||.......   .....    ...   .+...+.
T Consensus       156 ~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~---~~~~~~~  224 (256)
T cd05112         156 T-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETI----NAG---FRLYKPR  224 (256)
T ss_pred             c-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH----hCC---CCCCCCC
Confidence            1 11223345689999988 4678999999999999999998 999996533211   11100    000   0001111


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      .       .+.++.+++.+||+.+|++|||++|++++|
T Consensus       225 ~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 L-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             C-------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            1       235788999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-35  Score=304.80  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=197.9

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc-CCeEEEEEe
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-HGQHLLVYD  518 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e  518 (720)
                      +|+..+.||+|++|.||++.. .+++.||+|++..........+.+..|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            467789999999999999964 468899999997544334455678899999999999999999998764 446899999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++...  ....+++.+...++.+++.|++|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999988642  234588999999999999999999987   8999999999999999999999999999766322


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .  .......++..|+|||.. .+.++.++||||||+++|||++|+.||...+....   .             ..+...
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~-------------~~~~~~  217 (257)
T cd08223         156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL---V-------------YRIIEG  217 (257)
T ss_pred             C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---H-------------HHHHhc
Confidence            1  122334567889999998 55688999999999999999999999964321110   0             000000


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .. ...+.....++.+++.+|++.+|++|||+.|++++
T Consensus       218 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         218 KL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00 01112344678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.9e-36  Score=313.55  Aligned_cols=255  Identities=26%  Similarity=0.402  Sum_probs=195.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCc----EEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ++|...+.||+|+||.||+|.. .+|.    .||+|.+..... .....++.+|+.+++.++||||++++++|... ..+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            4677788999999999999964 4454    578888864322 23345788999999999999999999998764 467


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +++||+++|+|.+++...   ...+++.....++.+++.||.|||+.   +|+||||||+||++++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence            999999999999998532   23578889999999999999999987   899999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +.............++..|+|||.. ...++.++|||||||++|||++ |+.||...........+..       ...  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~~--  229 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-------GER--  229 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-------CCC--
Confidence            6433222122233346689999988 4568999999999999999997 9999965322111111100       000  


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       .  +     ....++..+.+++.+||..+|++||+++++++.|+++
T Consensus       230 -~--~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         230 -L--P-----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             -C--C-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             0  0     0111234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-36  Score=322.87  Aligned_cols=264  Identities=20%  Similarity=0.290  Sum_probs=195.7

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-----
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-----  510 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----  510 (720)
                      ...++|...+.||+|+||+||+|.. .+++.||||++..........+.+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            4567899999999999999999954 5788999999975443334456678899999999999999999987532     


Q ss_pred             -CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          511 -GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       511 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                       ...++++|++ +++|.+++..     ..+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence             3578999987 6788887742     3588899999999999999999987   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcc----
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAI----  662 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~----  662 (720)
                      |+++.....     .....++..|+|||.+.+  .++.++|||||||++|||++|+.||.......... +.....    
T Consensus       163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999865322     223467889999998843  58999999999999999999999996543211100 000000    


Q ss_pred             ---cccCchhhhhhhcC--CCCCch----hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 ---PRLHDIDALSRMVD--PSLDGA----YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 ---~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         ..+.. ........  +.....    ......+.+.+++.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISS-EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcch-hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00000 00000000  000000    001123457899999999999999999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-36  Score=328.96  Aligned_cols=262  Identities=18%  Similarity=0.220  Sum_probs=193.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ...|...+.||+|+||.||+|... +++.||||....        ..+.+|++++++++|+|||++++++...+..++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            457888999999999999999664 588999996421        24568999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+. ++|.+++...   ...++|..+..++.|+++||.|||+.   +||||||||+|||++.++.+||+|||+++.+..
T Consensus       240 e~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        240 PKYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            9986 6888877532   34689999999999999999999987   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCc-c-------ccchhhhcccccCch
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR-G-------EQSLVRWAIPRLHDI  668 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~-~-------~~~~~~~~~~~~~~~  668 (720)
                      ...........|+..|+|||++ ...++.++|||||||++|||++|..|+...... .       ...+++.......+.
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            3222223345689999999998 456899999999999999999988765322110 0       011111111000000


Q ss_pred             ------hhhhhh-------cCCCCCchhh---HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 ------DALSRM-------VDPSLDGAYL---AKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ------~~~~~~-------~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            .....+       ..+.......   ......+.+|+.+||+.||.+|||+.|++++
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                  000000       0000000000   0122467899999999999999999999986

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.3e-36  Score=311.32  Aligned_cols=267  Identities=20%  Similarity=0.324  Sum_probs=200.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|++|.||+|... +|+.||+|++..........+.+.+|++++++++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36778899999999999999664 68999999987543333344678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |++++.|..+...    ...+++..+..++.++++||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999888877642    23588999999999999999999997   9999999999999999999999999999876433


Q ss_pred             CCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh-hhcccccCc------h-
Q 004994          599 STNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWAIPRLHD------I-  668 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~------~-  668 (720)
                      ..  ......++..|+|||...  ..++.++|||||||++|||+||+.||......+..... .........      . 
T Consensus       154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            21  112244677899999873  45789999999999999999999999754432211111 000000000      0 


Q ss_pred             hhhhhhcCCCCCc-----hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDG-----AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ........+....     ......+..+.+++.+||+.+|++||++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0000000010000     0011234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-35  Score=319.79  Aligned_cols=191  Identities=19%  Similarity=0.255  Sum_probs=160.6

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ...+|...+.||+|+||.||+|... +++.||+|.....        ....|+.++++++|+||+++++++.+.+..++|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            3457999999999999999999664 5788999975432        234688999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+. ++|.+++..   ....+++..+.+++.|+++||.|||+.   +||||||||+|||++.++.+||+|||+++...
T Consensus       136 ~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        136 LPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            99986 588887753   235689999999999999999999987   89999999999999999999999999997542


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCC
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPY  646 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf  646 (720)
                      ..   .......++..|+|||++ ...++.++|||||||++|||+++..|+
T Consensus       209 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        209 VA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            21   112235678899999998 557899999999999999999865554

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-35  Score=308.34  Aligned_cols=238  Identities=27%  Similarity=0.422  Sum_probs=183.9

Q ss_pred             eeccCCCceEEEEEeCC-------------------------CcEEEEEEecccccccccHHHHHHHHHHHHccCCCcee
Q 004994          447 FIGEGLLGSVYKAELPG-------------------------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV  501 (720)
Q Consensus       447 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv  501 (720)
                      .||+|+||.||+|.+..                         ...||+|++....  .....+|.+|+++++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence            59999999999996421                         1358899886432  23446788999999999999999


Q ss_pred             EEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC
Q 004994          502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK  581 (720)
Q Consensus       502 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~  581 (720)
                      +++++|.+....++||||+++|+|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++++
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            9999999999999999999999999888532   34678889999999999999999987   89999999999999865


Q ss_pred             C-------CeEEccccCCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHH-hCCCCCCCCCC
Q 004994          582 L-------IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELL-TGRKPYDRSRP  651 (720)
Q Consensus       582 ~-------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~ell-tG~~Pf~~~~~  651 (720)
                      +       .+|++|||++......      ....++..|+|||.+.  ..++.++|||||||++|||+ +|+.||.....
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            4       3799999998644221      1124567799999873  35899999999999999995 79999965432


Q ss_pred             ccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          652 RGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      ........             .  ......    .....+.+++.+||+.+|++|||+++|+++|.
T Consensus       228 ~~~~~~~~-------------~--~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         228 SEKERFYE-------------K--KHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHHHH-------------h--ccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            21110000             0  000000    11246789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.5e-35  Score=303.69  Aligned_cols=252  Identities=21%  Similarity=0.342  Sum_probs=201.3

Q ss_pred             CCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|+||.||.++ ..+++.+++|.+..........+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            47778999999999999995 45689999999865433345556788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++....  ...+++..+..++.++++||.|||+.   +++||||||+||++++++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999986432  34678999999999999999999987   89999999999999999999999999997663322


Q ss_pred             CcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .  ......++..|.|||... ..++.++||||||+++|||++|+.||........                ..++....
T Consensus       156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~----------------~~~~~~~~  217 (256)
T cd08221         156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL----------------VVKIVQGN  217 (256)
T ss_pred             c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHHcCC
Confidence            1  223345788999999884 4688999999999999999999999965332111                11111111


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      ... .....+.++.+++.+||+.+|++||+++|+++++
T Consensus       218 ~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         218 YTP-VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCC-CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            110 1122345688999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-35  Score=306.81  Aligned_cols=257  Identities=21%  Similarity=0.320  Sum_probs=198.6

Q ss_pred             CCCCCCeeccCCCceEEEEEeCC--CcEEEEEEecccc--------cccccHHHHHHHHHHHHc-cCCCceeEEEeEecc
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPG--GKLLAVKKLSNTV--------SQRQTDEEFLELASTISR-LRHGNIVELIGYCNE  509 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~--------~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~  509 (720)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+....        .......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36777899999999999997654  7899999985321        112233557778887765 799999999999999


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                      .+..++||||+++++|.+++.........+++..+.+++.+++.||.|||+.  .+++|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999998854333345688899999999999999999963  27999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      |++.......   ......++..|++||.. .+.++.++||||||+++|||++|+.||........   ..         
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~---------  223 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---AT---------  223 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HH---------
Confidence            9997654322   22334567889999998 55689999999999999999999999964322110   00         


Q ss_pred             hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                          .+.+...........+..+.+++.+||+.||++||++.|+..++++
T Consensus       224 ----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         224 ----KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             ----HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence                0000000000011223568899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-36  Score=325.79  Aligned_cols=262  Identities=18%  Similarity=0.236  Sum_probs=196.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC---CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP---GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ..+|...+.||+|+||.||++...   .+..||+|.+...       +.+.+|++++++++|||||++++++...+..++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            457888999999999999999643   3678999988643       234579999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+. ++|.+++.    ....+++..+..++.|++.||.|||+.   +||||||||+|||++.++.+||+|||+++.+
T Consensus       164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999987 58888773    235689999999999999999999987   9999999999999999999999999999876


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc-------ccCc
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP-------RLHD  667 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~-------~~~~  667 (720)
                      .............++..|+|||++ ...++.++|||||||++|||++|+.||.................       .+..
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            544333333346789999999998 45789999999999999999999999965433211111100000       0000


Q ss_pred             h------hhhhhhc---CCCCC-chh--hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 I------DALSRMV---DPSLD-GAY--LAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~------~~~~~~~---~~~~~-~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .      ..+....   .+... ...  ......++.+++.+||+.||++|||+.|++.+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0      0000000   00000 000  01123467899999999999999999999875

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.7e-36  Score=310.33  Aligned_cols=254  Identities=24%  Similarity=0.365  Sum_probs=191.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHH-HHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELAST-ISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||.||+|.. .+|+.||+|+++...... ...++..|+.+ ++.++||||+++++++...+..+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            3678889999999999999965 469999999997543322 23344555554 66779999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||++ |+|.+++.........+++.....++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+++....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9997 588887754333345789999999999999999999974  2799999999999999999999999999986532


Q ss_pred             CCCcccccCccccccCCCCccCC-----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES-----GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ..   ......++..|+|||.+.     ..++.++|+|||||++|||++|+.||........ . ...          ..
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~-~~~----------~~  221 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-Q-LKQ----------VV  221 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-H-HHH----------HH
Confidence            21   112234677899999873     3468899999999999999999999964221100 0 000          00


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .-..+...   ....+.++.+++.+||..+|++||++++++++
T Consensus       222 ~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         222 EEPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             hcCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00011111   11234678899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.5e-35  Score=313.97  Aligned_cols=197  Identities=22%  Similarity=0.336  Sum_probs=158.4

Q ss_pred             CCeeccCCCceEEEEEeC---CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--CCeEEEEEee
Q 004994          445 GNFIGEGLLGSVYKAELP---GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--HGQHLLVYDY  519 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~  519 (720)
                      ++.||+|+||+||+|...   +++.||+|.+....    ....+.+|++++++++||||+++++++..  ....++||||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999754   46789999986432    23457789999999999999999998854  4578899999


Q ss_pred             CCCCCHHHHhhccc-----hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE----cCCCCeEEcccc
Q 004994          520 GGNCTLHDLLHSDE-----EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCG  590 (720)
Q Consensus       520 ~~~gsL~~~l~~~~-----~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFG  590 (720)
                      +++ +|.+++....     .....+++.....++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            875 7877764321     1123578888999999999999999987   89999999999999    456799999999


Q ss_pred             CCCCCCCCCC-cccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 004994          591 LAPLLFSGST-NELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRS  649 (720)
Q Consensus       591 la~~~~~~~~-~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~  649 (720)
                      +++....... ........++..|+|||++.  ..++.++||||+||++|||++|+.||...
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9987643211 11223456788999999873  35899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.5e-36  Score=325.63  Aligned_cols=253  Identities=21%  Similarity=0.304  Sum_probs=194.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||+||+|.. .+++.||||++.... ........+.+|++++.+++|+||+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3677889999999999999965 468999999997432 22334467888999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            99999999999853    34578888999999999999999987   999999999999999999999999999875532


Q ss_pred             CCCc---------------------------------ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCC
Q 004994          598 GSTN---------------------------------ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGR  643 (720)
Q Consensus       598 ~~~~---------------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~  643 (720)
                      ....                                 .......|+..|+|||.+ ...++.++|||||||++|||+||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            1100                                 011134688999999998 556899999999999999999999


Q ss_pred             CCCCCCCCccccc-hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC---HHHHHHH
Q 004994          644 KPYDRSRPRGEQS-LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP---MSEIVQD  715 (720)
Q Consensus       644 ~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~  715 (720)
                      .||....+..... +..|.. .+        .+.+..      ....++.+++.+++ .||.+|++   ++|+++|
T Consensus       234 ~Pf~~~~~~~~~~~i~~~~~-~~--------~~p~~~------~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         234 PPFCSETPQETYRKVMNWKE-TL--------VFPPEV------PISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCCHHHHHHHHHcCCC-ce--------ecCCCC------CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            9997644322111 111100 00        001100      12346778888876 49999985   6777754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-36  Score=312.75  Aligned_cols=252  Identities=28%  Similarity=0.447  Sum_probs=198.1

Q ss_pred             CCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          442 FSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      |+..+.||+|+||+||++... +++.||+|++..............+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            345688999999999999664 5779999999865444444445567999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      ++++|.+++.    ....+++..+..++.++++||.|||+.   +|+||||||+||++++++.++|+|||.+....  ..
T Consensus        81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~  151 (260)
T PF00069_consen   81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS--EN  151 (260)
T ss_dssp             TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST--ST
T ss_pred             cccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence            9999999996    346789999999999999999999997   99999999999999999999999999987541  11


Q ss_pred             cccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          601 NELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      ........++..|.|||...  ..++.++||||+|+++|+|++|+.||..............             .....
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~-------------~~~~~  218 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK-------------ILKRP  218 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH-------------HHHTH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh-------------ccccc
Confidence            22334456788999999985  5689999999999999999999999975411111111110             00000


Q ss_pred             CCchh--hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAY--LAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .....  ......++.+++.+||+.||++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  219 LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000  00112678999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-35  Score=305.08  Aligned_cols=251  Identities=24%  Similarity=0.387  Sum_probs=197.1

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc-------ccHHHHHHHHHHHHccCCCceeEEEeEeccCCe
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR-------QTDEEFLELASTISRLRHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  512 (720)
                      +|...+.||+|++|.||+|.. .+++.||+|.+.......       ...+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            366778999999999999954 568899999986432211       123568899999999999999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||+++++|.+++..    ...+++.....++.+++.||+|||+.   +++||||||+||++++++.+||+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            9999999999999999853    34578888999999999999999987   8999999999999999999999999999


Q ss_pred             CCCCCCCCc----ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc
Q 004994          593 PLLFSGSTN----ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       593 ~~~~~~~~~----~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      +........    .......++..|+|||.. .+.++.++|||||||++|||++|+.||........   +.        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~--------  222 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---IF--------  222 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---HH--------
Confidence            876422111    111224467889999988 45688999999999999999999999975322110   00        


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        .......+..    +...+..+.+++.+||+.||.+||++.|++++
T Consensus       223 --~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         223 --KIGENASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             --HHhccCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence              0000111111    12234678899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-35  Score=305.73  Aligned_cols=254  Identities=23%  Similarity=0.328  Sum_probs=195.9

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ..++++.....||+|+||.||+|.. .++..||+|.+....  ....+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3455666667899999999999964 568899999986442  2345678999999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhcccc--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-CCCeEEccccCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKF--SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KLIVRVSDCGLA  592 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~--~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla  592 (720)
                      |+||+++++|.+++....   ..+  ++..+..++.|+++||+|||+.   +|+||||||+||+++. ++.+||+|||++
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999999999986421   233  6778888999999999999987   9999999999999986 679999999998


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCCC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFESG---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      .......  .......++..|+|||+..+   .++.++|||||||++|||++|+.||........   ..+......   
T Consensus       157 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~---  228 (268)
T cd06624         157 KRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK---  228 (268)
T ss_pred             eecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc---
Confidence            7653221  11223456788999998732   378899999999999999999999964321110   000000000   


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                           ..+.    .+....+++.+++.+||+.+|++|||+.|++++
T Consensus       229 -----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         229 -----IHPE----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -----cCCC----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                 0111    122234578899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=319.75  Aligned_cols=256  Identities=21%  Similarity=0.273  Sum_probs=194.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccc-ccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||++.. .+++.||+|++.+. .......+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4688889999999999999965 46899999999642 222334566889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..   ....+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999999853   234578888999999999999999987   899999999999999999999999999876543


Q ss_pred             CCCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ... .......+++.|+|||.+.      +.++.++|||||||++|||++|+.||...........+.      ......
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~------~~~~~~  227 (331)
T cd05597         155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------NHKEHF  227 (331)
T ss_pred             CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH------cCCCcc
Confidence            221 1122345789999999874      347889999999999999999999996533211100000      000000


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCC--CCCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPG--FRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~--~RPt~~evl~~  715 (720)
                       . +.+.     ....+..+.+++.+|+..++.  .||++++++++
T Consensus       228 -~-~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 -Q-FPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -c-CCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence             0 0000     111345678899998865443  37899999876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-35  Score=304.53  Aligned_cols=250  Identities=21%  Similarity=0.298  Sum_probs=197.4

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|+||.||++.. .+++.||+|.++.... ....+.+..|+.++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            466778999999999999965 4689999999864322 33456788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++...  ....++......++.+++.||.|||+.   +|+|+||||+||++++++.++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          80 CDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            9999999987532  234578888999999999999999987   99999999999999999999999999997653321


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                        .......++..|+|||.. ...++.++||||||+++|+|++|+.||........   ..             ......
T Consensus       155 --~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~-------------~~~~~~  216 (255)
T cd08219         155 --AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---IL-------------KVCQGS  216 (255)
T ss_pred             --cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HH-------------HHhcCC
Confidence              122234577889999998 44689999999999999999999999975332111   00             000000


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      . ...+...+..+.+++.+||+.||++|||+.|++..
T Consensus       217 ~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 Y-KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C-CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0 00111233567899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.8e-36  Score=313.34  Aligned_cols=266  Identities=20%  Similarity=0.279  Sum_probs=196.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            4688889999999999999965 4688999999864432 2334567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |++ ++|.+++...   ...+++.....++.++++||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          85 YLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             ccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            998 5888887532   34578888999999999999999987   9999999999999999999999999999764322


Q ss_pred             CCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc--------cccCch
Q 004994          599 STNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI--------PRLHDI  668 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~~  668 (720)
                      .  .......++..|+|||...  ..++.++|||||||++|||+||+.||...........+....        +.+...
T Consensus       158 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         158 T--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             C--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence            1  1112234578899999873  357889999999999999999999997543321111000000        000000


Q ss_pred             hhhhhhcCCCCCch----hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDGA----YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +.......+.....    .....+..+.+++.+||+.||.+|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00000000111000    011234568899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-35  Score=306.62  Aligned_cols=256  Identities=23%  Similarity=0.367  Sum_probs=196.2

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc--------cccHHHHHHHHHHHHccCCCceeEEEeEeccCC
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ--------RQTDEEFLELASTISRLRHGNIVELIGYCNEHG  511 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  511 (720)
                      +|...+.||+|+||.||+|.. .+|+.||+|.++.....        ....+.+.+|+++++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            366778999999999999954 57899999998632111        112346788999999999999999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      ..++||||+++++|.+++...    ..+++..+..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999998643    4678888999999999999999987   899999999999999999999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccCC-C--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFES-G--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      ++...............++..|+|||... .  .++.++||||||+++||+++|+.||........  ......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~------  226 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLGN------  226 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHhhc------
Confidence            97653322111222345678899999873 2  378999999999999999999999964322110  000000      


Q ss_pred             hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                          ....+..........+..+.+++.+||..+|++|||+++|+++
T Consensus       227 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         227 ----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                0000111111112234678899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.2e-36  Score=314.10  Aligned_cols=267  Identities=21%  Similarity=0.350  Sum_probs=200.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|+||.||+|... +++.||+|++.+........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            35777899999999999999764 58999999987544333445678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.++...    ...+++..+..++.++++||.|||+.   +++||||+|+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999988877643    23488999999999999999999987   8999999999999999999999999998765432


Q ss_pred             CCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch--------
Q 004994          599 STNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI--------  668 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------  668 (720)
                      .  .......++..|+|||+..  ..++.++|||||||++|||++|+.||...........+......+...        
T Consensus       154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            2  1122345678899999874  347889999999999999999999996543211110000000000000        


Q ss_pred             hhhhhhcCCCCCch-----hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDGA-----YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .....+..+.....     .....+..+.+++.+||+.+|++||++++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00000111111000     011234678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-35  Score=308.04  Aligned_cols=249  Identities=22%  Similarity=0.323  Sum_probs=195.0

Q ss_pred             CCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          442 FSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      |+..+.||+|+||.||+|... ++..+++|.+....  ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            455678999999999999654 57889999986432  334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      ++++|.+++...   ...+++..+..++.++++||.|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus        85 ~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-  157 (282)
T cd06643          85 AGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  157 (282)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-
Confidence            999999887532   34689999999999999999999987   99999999999999999999999999987653221 


Q ss_pred             cccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          601 NELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                       .......++..|+|||+..      ..++.++|||||||++|||++|+.||........  ......           .
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~-----------~  223 (282)
T cd06643         158 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK-----------S  223 (282)
T ss_pred             -cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHhh-----------c
Confidence             1223345788999999862      2477899999999999999999999965332111  000000           0


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+..  ..+...+.++.+++.+||+.||++||++++++++
T Consensus       224 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         224 EPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000  0112234578899999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.3e-36  Score=310.49  Aligned_cols=246  Identities=22%  Similarity=0.359  Sum_probs=195.4

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      |+..+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            44457799999999999954 5688999999864432 234467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      ++++|.+++..     ..+++.....++.++++|+.|||+.   +++|+||+|+||++++++.+||+|||++..+.... 
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence            99999998842     4578899999999999999999986   99999999999999999999999999997664321 


Q ss_pred             cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCC
Q 004994          601 NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL  679 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  679 (720)
                       .......++..|+|||+. ...++.++|||||||++|||+||+.||....+...   ...          ......+.+
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----------~~~~~~~~~  221 (277)
T cd06642         156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----------IPKNSPPTL  221 (277)
T ss_pred             -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----------hhcCCCCCC
Confidence             112224567889999998 45689999999999999999999999864322111   000          000001111


Q ss_pred             CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       680 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                          ....+..+.+++.+||+.+|++||++.|++++
T Consensus       222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                12234568899999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.4e-36  Score=307.35  Aligned_cols=252  Identities=22%  Similarity=0.316  Sum_probs=196.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||.||+|.. .+++.||+|.++...  ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            4566678899999999999965 568999999986432  2334567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++..    ...+++.+...++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||++..+...
T Consensus        87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          87 FCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             ccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999998853    34688999999999999999999987   8999999999999999999999999998765322


Q ss_pred             CCcccccCccccccCCCCccC----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFE----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                        ........++..|+|||..    .+.++.++|||||||++|||++|+.||....+........  ...         .
T Consensus       160 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~~~---------~  226 (267)
T cd06645         160 --IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--KSN---------F  226 (267)
T ss_pred             --ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--ccC---------C
Confidence              1112334678899999986    3458899999999999999999999986433211110000  000         0


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+....  ....+..+.+++.+||+.+|++||++++++++
T Consensus       227 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         227 QPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            0011100  00123467899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-35  Score=303.96  Aligned_cols=258  Identities=26%  Similarity=0.375  Sum_probs=202.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||.|+||+||+|.. .++..+|+|++....... ....+.+|+++++.++|+||+++++.+...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            4688899999999999999965 468899999987543322 55788999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++..... ...+++.....++.+++.||+|||+.   +++||||||+||++++++.+||+|||++..+...
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          80 YLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             ccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            9999999999864221 24688999999999999999999987   9999999999999999999999999998776543


Q ss_pred             CCcc--cccCccccccCCCCccCC-C-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          599 STNE--LSEGLLTAHGSGAPEFES-G-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       599 ~~~~--~~~~~~~~~~~~aPE~~~-~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ....  ......++..|++||... . .++.++|||||||++|||++|+.||........  ..+....           
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~-----------  222 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN-----------  222 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC-----------
Confidence            3221  223345778899999873 3 589999999999999999999999975432211  1111000           


Q ss_pred             cCCCCCch-hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGA-YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+..... .....+.++.+++.+||+.||++|||++|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00111100 012334678899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-36  Score=310.92  Aligned_cols=267  Identities=24%  Similarity=0.352  Sum_probs=200.3

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5778899999999999999654 688999999875544444557889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      ++++.+..+...    ...+++.....++.++++||+|||+.   +++||||+|+||++++++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          82 VERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            998777665532    24478899999999999999999987   89999999999999999999999999998764432


Q ss_pred             CcccccCccccccCCCCccC-CC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc--------hh
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD--------ID  669 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~  669 (720)
                      .. ......++.+|+|||+. .. .++.++||||||+++|||++|+.||......+...........+..        ..
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            21 12234567889999998 44 6789999999999999999999999754321111000000000000        00


Q ss_pred             hhh--hhcCCCCC----chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALS--RMVDPSLD----GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~--~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...  +..+....    ..++...+.++.+++.+||..+|++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            000  00011000    01122235778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-35  Score=306.02  Aligned_cols=258  Identities=25%  Similarity=0.371  Sum_probs=199.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ++|...+.||+|+||+||+|..+      +.+.|++|.+.... .....+.+.+|++++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            46778899999999999999753      34679999886432 122456789999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchh-----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcc
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEA-----HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSD  588 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  588 (720)
                      ++||||+++|+|.+++......     ...+++..+..++.++++||+|||+.   +|+||||||+||+++.++.+|++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999998643211     12689999999999999999999987   899999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccC
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLH  666 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  666 (720)
                      ||+++....... .......++..|+|||.. .+.++.++|||||||++|||++ |..||.......   .....     
T Consensus       161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~-----  231 (275)
T cd05046         161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL-----  231 (275)
T ss_pred             cccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH-----
Confidence            999875532221 112223456679999987 5568899999999999999999 888986432211   11110     


Q ss_pred             chhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       667 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                              .............+..+.+++.+||+.+|++|||+.|+++.|.+
T Consensus       232 --------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         232 --------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             --------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                    00000000111233578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-35  Score=310.57  Aligned_cols=250  Identities=22%  Similarity=0.342  Sum_probs=198.8

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ..+|...+.||+|+||.||+|.. .+++.||+|.+....  ....+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            36788899999999999999964 579999999986432  233467889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++..     ..+++..+..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        96 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          96 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             cccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            99999999998842     3478889999999999999999987   999999999999999999999999999876533


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...  ......++..|++||.. ...++.++|||||||++|+|++|+.||....+....... +.. .           .
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-~~~-~-----------~  232 (297)
T cd06656         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATN-G-----------T  232 (297)
T ss_pred             Ccc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-ccC-C-----------C
Confidence            221  12234567889999988 456889999999999999999999999654322111000 000 0           0


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +..  ..+...+..+.+++.+||+.+|++||++++++++
T Consensus       233 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         233 PEL--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000  0112233567899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-35  Score=303.46  Aligned_cols=251  Identities=22%  Similarity=0.334  Sum_probs=199.0

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|+||.||++.. .+|+.||+|++..........+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            467789999999999999954 5789999999865433334456889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +.+++|.+.+...  ....+++.+..+++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999988632  123578889999999999999999987   89999999999999999999999999997653321


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                        .......++..|+|||+. .+.++.++|||||||+++||+||+.||........   +             ..+....
T Consensus       156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~-------------~~~~~~~  217 (256)
T cd08218         156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL---V-------------LKIIRGS  217 (256)
T ss_pred             --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH---H-------------HHHhcCC
Confidence              112234467789999998 55688999999999999999999999964322110   0             1111100


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .. ..+.....++.+++.+||+.+|++||++.||+++
T Consensus       218 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 YP-PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CC-CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            00 0112234578899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=306.37  Aligned_cols=248  Identities=26%  Similarity=0.374  Sum_probs=198.5

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||.|++|.||+|.. .+++.||+|.+.... .......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            577788999999999999965 468999999986442 233446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++...     .+++.....++.+++.||.|||+.   +++||||+|+||++++++.++|+|||+++.+....
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999998532     688999999999999999999987   89999999999999999999999999998774332


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .  ......++..|+|||+. ...++.++|||||||++|||+||+.||....+......             ......+.
T Consensus       153 ~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-------------~~~~~~~~  217 (274)
T cd06609         153 S--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-------------IPKNNPPS  217 (274)
T ss_pred             c--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-------------hhhcCCCC
Confidence            1  12234567789999988 45689999999999999999999999965432111000             00001111


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....   ..+..+.+++.+||+.+|++|||+++++++
T Consensus       218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1111   034568899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=320.05  Aligned_cols=249  Identities=25%  Similarity=0.344  Sum_probs=203.1

Q ss_pred             CCCeeccCCCceEEEEEeC--CCc--EEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          444 EGNFIGEGLLGSVYKAELP--GGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       444 ~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ..++||+|.||+|++|.|.  +|+  .||||.++..... ....+|++|+.+|.+|+|+|+|+|||+..+ ....||||+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            3478999999999999764  354  5899999865433 266799999999999999999999999987 678899999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      ++.|+|.+.|+.  .....|-......++.|||.||+||...   ++|||||..+|+|+.....|||+|||+.+-+...+
T Consensus       192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            999999999986  2345677778889999999999999987   89999999999999999999999999999887665


Q ss_pred             Ccccc-cCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          600 TNELS-EGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       600 ~~~~~-~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..+.. ....-...|+|||.+ .+.|+.++|||+|||.+|||+| |+.||.+......                 .+.+|
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI-----------------L~~iD  329 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI-----------------LKNID  329 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH-----------------HHhcc
Confidence            44433 223335579999998 7889999999999999999998 9999976433221                 11222


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      ....-..+..|++.+.++++.||..+|++|||+.+|.+++
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            2222223556788999999999999999999999997544

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-35  Score=309.66  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=198.8

Q ss_pred             cCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .+|+..+.||.|++|.||+|. ..+|+.||+|.+....  ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            457888999999999999995 4678999999986432  2345678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++..     ..+++.++..++.+++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          97 YLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             ecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            9999999998842     3578999999999999999999987   9999999999999999999999999998765432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      ..  ......++..|+|||.. ...++.++|||||||++|||++|+.||.............  ..           ..+
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~--~~-----------~~~  233 (296)
T cd06655         169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TN-----------GTP  233 (296)
T ss_pred             cc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hc-----------CCc
Confidence            21  12234577889999988 4568999999999999999999999997543221110000  00           000


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+  ..+...+..+.+++.+||..||++|||+.+++++
T Consensus       234 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         234 EL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             cc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            00  0112234568899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.9e-36  Score=318.03  Aligned_cols=256  Identities=22%  Similarity=0.248  Sum_probs=195.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||++... +++.||+|++.+.. ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36788899999999999999764 57899999986422 22233456888999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++...   ...+++.....++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999999632   34578888999999999999999987   999999999999999999999999999976533


Q ss_pred             CCCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ... .......++..|+|||++.      +.++.++|||||||++|||++|+.||...........+.      ....  
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~------~~~~--  225 (332)
T cd05623         155 DGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------NHKE--  225 (332)
T ss_pred             CCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh------CCCc--
Confidence            221 1222346889999999873      357899999999999999999999997543211111000      0000  


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGF--RPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  715 (720)
                       +   .... ......+.++.+++.+|+..++.+  |++++|++++
T Consensus       226 -~---~~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 -R---FQFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -c---ccCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             0   0000 011123467789999988665544  6899999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8e-36  Score=310.81  Aligned_cols=266  Identities=20%  Similarity=0.273  Sum_probs=195.0

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|+||.||+|.. .+|+.||+|++............+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            366778999999999999965 4789999999975433333445678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++ +|.+++...   ...+++.....++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            985 787776532   34588999999999999999999987   89999999999999999999999999997653221


Q ss_pred             CcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chh-hhcc-cccCchhhhhhh
Q 004994          600 TNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLV-RWAI-PRLHDIDALSRM  674 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~-~~~~-~~~~~~~~~~~~  674 (720)
                      .  ......++..|+|||.+.+  .++.++|||||||++|||+||..|+.......+. ..+ +... +...........
T Consensus       154 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             C--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence            1  1122345778999998733  4789999999999999999999986433221110 000 0000 000000000000


Q ss_pred             cCC----CCCc-----hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDP----SLDG-----AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~----~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+.    ....     ......+.++.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000    0000     0111234678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4e-35  Score=310.67  Aligned_cols=197  Identities=22%  Similarity=0.342  Sum_probs=158.4

Q ss_pred             CCeeccCCCceEEEEEeC---CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEec--cCCeEEEEEee
Q 004994          445 GNFIGEGLLGSVYKAELP---GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN--EHGQHLLVYDY  519 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~lv~e~  519 (720)
                      +..||+|+||+||+|...   ++..||+|.+....    ....+.+|++++++++||||+++++++.  .....++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            468999999999999764   45789999986432    2346788999999999999999999884  35678999999


Q ss_pred             CCCCCHHHHhhccc-----hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE----cCCCCeEEcccc
Q 004994          520 GGNCTLHDLLHSDE-----EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCG  590 (720)
Q Consensus       520 ~~~gsL~~~l~~~~-----~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFG  590 (720)
                      +++ +|.+++....     .....+++.....++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            885 7777764221     1223578889999999999999999987   89999999999999    566799999999


Q ss_pred             CCCCCCCCCCc-ccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 004994          591 LAPLLFSGSTN-ELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRS  649 (720)
Q Consensus       591 la~~~~~~~~~-~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~  649 (720)
                      +++........ .......++..|+|||.+.  ..++.++|||||||++|||+||+.||...
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            99876432211 1123356788999999873  35899999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=301.84  Aligned_cols=253  Identities=26%  Similarity=0.364  Sum_probs=200.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||.||+|.. .+++.+|+|.+....  ....+.+.+|++++++++||||+++++++.+.+..+++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            5688889999999999999965 468899999987442  2245788999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++...   ...+++.....++.+++.||.|||+.   +++|+||||+||++++++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          81 YCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             CCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            99999999988532   24688899999999999999999987   8999999999999999999999999999765432


Q ss_pred             CCcccccCccccccCCCCccCC-C---CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFES-G---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~-~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      .  .......++..|+|||... .   .++.++|||||||++|||+||+.||.............           ....
T Consensus       155 ~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~-----------~~~~  221 (262)
T cd06613         155 I--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS-----------KSNF  221 (262)
T ss_pred             h--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------hccC
Confidence            1  1122345677899999873 3   68899999999999999999999997543221110000           0000


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+..  ......+.++.+++.+||+.+|.+|||+++|+.+
T Consensus       222 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         222 PPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             CCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00111  1123345678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.7e-35  Score=307.15  Aligned_cols=251  Identities=21%  Similarity=0.340  Sum_probs=196.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      +.|+..+.||+|+||.||+|.. .+++.||+|.+...  .....+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            5677889999999999999966 45899999998643  23445678899999999999999999999998899999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|..++...   ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            99999998877432   34588999999999999999999986   9999999999999999999999999998754221


Q ss_pred             CCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                        ........++..|+|||++.      ..++.++|||||||++|||++|+.||........  .....           
T Consensus       164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~-----------  228 (292)
T cd06644         164 --LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIA-----------  228 (292)
T ss_pred             --ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHh-----------
Confidence              11122345678899999873      2367899999999999999999999965322110  00000           


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....+..  ..+.....++.+++.+||+.+|++||+++|++++
T Consensus       229 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         229 KSEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             cCCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000000  0111233567899999999999999999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.3e-35  Score=304.22  Aligned_cols=248  Identities=22%  Similarity=0.337  Sum_probs=198.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ..|+..+.||+|+||.||+|.. .++..||+|.+..... ......+.+|++++++++|+||+++++++.+....++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            3466678899999999999965 4688999999864322 2345678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++..     ..+++.....++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..+...
T Consensus        83 ~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          83 YLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             cCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            9999999998853     3477888899999999999999987   9999999999999999999999999999766432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .  .......++..|.|||.. ...++.++|||||||++|||+||+.||....+......                 +..
T Consensus       155 ~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-----------------~~~  215 (277)
T cd06640         155 Q--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-----------------IPK  215 (277)
T ss_pred             c--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-----------------hhc
Confidence            2  112224567789999988 55689999999999999999999999965432211100                 000


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..........+..+.+++.+||+.+|++||++++++++
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            11111223455678899999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.1e-35  Score=306.59  Aligned_cols=267  Identities=19%  Similarity=0.306  Sum_probs=200.8

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|...+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|++++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            467788999999999999965 5789999999976543344557889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      + +++|.+++...   ...+++.++..++.++++||+|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 99999988643   25688999999999999999999987   89999999999999999999999999998764332


Q ss_pred             CcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccch-hhhc-------ccccCchh
Q 004994          600 TNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL-VRWA-------IPRLHDID  669 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~-~~~~-------~~~~~~~~  669 (720)
                      . .......++.+|+|||...  ..++.++||||+||++|||+||+.||........... ....       .+.+.+..
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence            1 1122345788899999873  3468999999999999999999888864332111100 0000       00000000


Q ss_pred             hhhhhcCCCCCc----hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSLDG----AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....+..+....    ....+...++.+++.+||+.+|++|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000110000000    0111234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.2e-36  Score=317.67  Aligned_cols=256  Identities=20%  Similarity=0.217  Sum_probs=195.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+++. .+++.||+|.+.+.. ........+.+|..++..++|+||+.+++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688889999999999999965 468899999986432 22334456888999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++...   ...+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999642   34578888899999999999999987   999999999999999999999999999976643


Q ss_pred             CCCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ... .......++..|+|||++.      +.++.++|||||||++|||++|+.||...........+..      .... 
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~------~~~~-  226 (331)
T cd05624         155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN------HEER-  226 (331)
T ss_pred             CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc------CCCc-
Confidence            221 1122345889999999874      4578899999999999999999999965432111100000      0000 


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGF--RPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  715 (720)
                           ..+. ......+.++.+++.+|+..++.+  |+++++++++
T Consensus       227 -----~~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 -----FQFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -----ccCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                 0000 001123467889999999876654  4688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.5e-35  Score=301.87  Aligned_cols=246  Identities=26%  Similarity=0.413  Sum_probs=194.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|+..+.||+|+||.||++.. +++.||+|.+...    ...+.+.+|+.++++++||||+++++++... ..++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence            4577889999999999999964 6778999998643    2346788999999999999999999998765 47999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++....  ...+++..+..++.++++||.|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus        80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          80 MSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             CCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            99999999986432  34578899999999999999999987   99999999999999999999999999987543211


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                           ........|+|||+. .+.++.++|||||||++|||++ |+.||.............             .    
T Consensus       155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------------~----  212 (254)
T cd05083         155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------------K----  212 (254)
T ss_pred             -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------------C----
Confidence                 112334679999988 5678999999999999999997 999996543211110000             0    


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      ..........+..+.+++.+||+.+|++||+++++++.|++
T Consensus       213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         213 GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            00000112234678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.3e-35  Score=301.65  Aligned_cols=237  Identities=28%  Similarity=0.469  Sum_probs=185.3

Q ss_pred             CeeccCCCceEEEEEeCC-C----------cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          446 NFIGEGLLGSVYKAELPG-G----------KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~-g----------~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      +.||+|+||.||+|...+ +          ..|++|.+....   .....|.+|+.++++++||||+++++++.. +..+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            468999999999997653 3          257888775432   116788999999999999999999999988 7789


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-------CeEEc
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-------IVRVS  587 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-------~~kl~  587 (720)
                      +||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++       .+||+
T Consensus        77 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          77 MVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            999999999999998643   22688899999999999999999986   999999999999999888       79999


Q ss_pred             cccCCCCCCCCCCcccccCccccccCCCCccCCC---CCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhccc
Q 004994          588 DCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG---SYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       588 DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      |||++.....      .....+...|+|||++.+   .++.++|||||||++|||++ |..||.............    
T Consensus       151 Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~----  220 (259)
T cd05037         151 DPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ----  220 (259)
T ss_pred             CCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence            9999986533      112345567999999843   58899999999999999999 577876543211110000    


Q ss_pred             ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                         ..   .....+         ....+.+++.+||..+|++|||+.|+++.|+
T Consensus       221 ---~~---~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 ---DQ---HRLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---cC---CCCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               00   000000         0156889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.4e-35  Score=303.74  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=197.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|...+.||+|+||.||+|...+    ...||||....... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            356778899999999999996533    34689998864432 3345688999999999999999999999876 45789


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++++|.+++...   ...+++..+..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999998542   23589999999999999999999987   8999999999999999999999999999866


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ...... ......+...|+|||.. ...++.++|||||||++||+++ |+.||.............             .
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-------------~  223 (270)
T cd05056         158 EDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-------------N  223 (270)
T ss_pred             ccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------------c
Confidence            433211 11122234579999987 4568999999999999999986 999996543221111000             0


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .....    .+...+.++.+++.+|+..+|++|||+.++++.|+++
T Consensus       224 ~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         224 GERLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             CCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            00000    1112345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.7e-35  Score=306.50  Aligned_cols=259  Identities=24%  Similarity=0.368  Sum_probs=199.3

Q ss_pred             CHHHHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEec
Q 004994          431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCN  508 (720)
Q Consensus       431 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~  508 (720)
                      +..++....+.|+..+.||+|+||.||+|.. .+++.||+|++...   .....++..|+.+++++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            4455555677889999999999999999965 56899999998543   23345678888999888 7999999999985


Q ss_pred             c------CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC
Q 004994          509 E------HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL  582 (720)
Q Consensus       509 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  582 (720)
                      .      .+..+++|||+++|+|.+++....  ...+++.....++.|+++||.|||+.   +|+||||||+||++++++
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            2      457899999999999999886422  23577888889999999999999987   899999999999999999


Q ss_pred             CeEEccccCCCCCCCCCCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc
Q 004994          583 IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS  656 (720)
Q Consensus       583 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~  656 (720)
                      .++|+|||++.......  .......++..|+|||.+.      ..++.++|||||||++|||++|+.||....+.....
T Consensus       159 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~  236 (282)
T cd06636         159 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF  236 (282)
T ss_pred             CEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence            99999999987653211  1122345778899999863      347889999999999999999999996533211111


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..             .+...+...   ....+.++.+++.+||+.||.+|||+.|++++
T Consensus       237 ~~-------------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         237 LI-------------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hH-------------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            00             000111111   11234578899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8e-35  Score=300.12  Aligned_cols=252  Identities=20%  Similarity=0.287  Sum_probs=193.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc---cccHHHHHHHHHHHHccCCCceeEEEeEeccC--CeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ---RQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~  513 (720)
                      ++|+..+.||+|+||.||+|.. .+|+.||||.+......   ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4688889999999999999965 56899999998633211   22345788899999999999999999988763  467


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      +++|||+++++|.+++..    ...+++....+++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            899999999999998853    23477888899999999999999987   89999999999999999999999999997


Q ss_pred             CCCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          594 LLFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       594 ~~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ........ .......++..|+|||.. ...++.++|||||||++|||++|+.||........  +              
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~--------------  218 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--I--------------  218 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--H--------------
Confidence            65321111 111224577889999988 44688999999999999999999999964321110  0              


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+..........+......+.+++.+|+. +|++||+++|++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         219 FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            00000000111223344567899999995 99999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-35  Score=305.07  Aligned_cols=239  Identities=26%  Similarity=0.438  Sum_probs=185.6

Q ss_pred             CeeccCCCceEEEEEeC-CC-------cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          446 NFIGEGLLGSVYKAELP-GG-------KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~-~g-------~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      +.||+|+||.||+|... .+       ..||+|.+...  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            36999999999999653 22       34888887533  2344567889999999999999999999999988999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC--------eEEccc
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI--------VRVSDC  589 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~--------~kl~DF  589 (720)
                      ||+++|+|.++++..   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.        +|++||
T Consensus        79 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          79 EYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             ecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999998643   23678899999999999999999987   9999999999999987765        699999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhC-CCCCCCCCCccccchhhhcccccC
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTG-RKPYDRSRPRGEQSLVRWAIPRLH  666 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~  666 (720)
                      |++......      ....++..|+|||...+  .++.++|||||||++|||++| ..||.............       
T Consensus       153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-------  219 (258)
T cd05078         153 GISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-------  219 (258)
T ss_pred             ccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-------
Confidence            998755322      12346778999999843  579999999999999999998 46664432211110000       


Q ss_pred             chhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       667 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                            .  ...+    +.....++.+++.+||+.||++|||++++++.|+
T Consensus       220 ------~--~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 ------D--RHQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------c--cccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  0  0001    1112246789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-35  Score=306.32  Aligned_cols=257  Identities=25%  Similarity=0.357  Sum_probs=198.0

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--CCeEEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--HGQHLLVY  517 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~  517 (720)
                      +|...+.||.|++|.||+|.. .+++.||+|.+..... ......+.+|++++++++||||++++++|.+  .+..++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            567778999999999999966 4689999999875422 2345678999999999999999999998854  34789999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++.........+++.....++.++++||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999998754333345678889999999999999999987   999999999999999999999999999876532


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCc--cccchhhhcccccCchhhhhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR--GEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ..    .....++..|+|||.. .+.++.++|||||||++|||++|+.||......  .......+..          ..
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~  223 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----------NM  223 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----------cC
Confidence            21    1224467789999988 557899999999999999999999999754220  1111111110          00


Q ss_pred             cCCCCCch--hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGA--YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+.+...  .....++.+.+++.+||+.+|++|||+.|++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         224 PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            00011000  001234678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.2e-35  Score=300.59  Aligned_cols=249  Identities=25%  Similarity=0.415  Sum_probs=196.6

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-CCcEEEEEEeccccc---ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVS---QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +|...+.||+|++|+||+|... +++.|++|.+.....   .....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999765 789999999864321   123446789999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..    ...+++.....++.++++||+|||+.   +++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            999999999999853    24578899999999999999999987   89999999999999999999999999987653


Q ss_pred             CCCCcccccCccccccCCCCccCC-CC-CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFES-GS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~-~~-~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ...   ......++..|++||... .. ++.++|+|||||++|||++|+.||........  ...+.  ....       
T Consensus       154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~--~~~~-------  219 (258)
T cd06632         154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIG--RSKE-------  219 (258)
T ss_pred             ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHH--hccc-------
Confidence            322   122345678899999873 34 88999999999999999999999965431110  00000  0000       


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       .+    ..+......+.+++.+||+.+|++||++++++++
T Consensus       220 -~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         220 -LP----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -CC----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence             00    0111233567899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-36  Score=319.31  Aligned_cols=242  Identities=21%  Similarity=0.247  Sum_probs=184.2

Q ss_pred             eccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHcc---CCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          448 IGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRL---RHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       448 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      ||+|+||+||+|.. .+++.||||++.+... .......+..|..++...   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999965 5689999999864321 122233455566666655   699999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++..    ...+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~  151 (330)
T cd05586          81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K  151 (330)
T ss_pred             ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence            999988853    34688899999999999999999987   99999999999999999999999999997543221  1


Q ss_pred             cccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCC
Q 004994          603 LSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD  680 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  680 (720)
                      ......++..|+|||.+.+  .++.++|||||||++|||+||+.||...........+...              ...+.
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--------------~~~~~  217 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--------------KVRFP  217 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--------------CCCCC
Confidence            2234568899999998733  4799999999999999999999999653321111000000              00010


Q ss_pred             chhhHHHHHHHHHHHHHHhccCCCCCC----CHHHHHHH
Q 004994          681 GAYLAKSLSRFADIISRCVQWEPGFRP----PMSEIVQD  715 (720)
Q Consensus       681 ~~~~~~~~~~l~~l~~~cl~~dP~~RP----t~~evl~~  715 (720)
                      .   .....++.+++.+||+.||.+||    +++|++++
T Consensus       218 ~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         218 K---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             C---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            0   01235678999999999999998    56776653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-35  Score=306.77  Aligned_cols=253  Identities=23%  Similarity=0.350  Sum_probs=197.8

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|+||.||++... +|+.||+|.+.... .......+.+|++++++++|+||+++++++...+..++||||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            5777899999999999999764 78999999986432 223346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++.... ....+++.....++.++++||.|||+.  .+|+||||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999998886421 234689999999999999999999964  289999999999999999999999999997653221


Q ss_pred             CcccccCccccccCCCCccCCC-------CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          600 TNELSEGLLTAHGSGAPEFESG-------SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                          .....++..|+|||...+       .++.++|||||||++|||++|+.||..........             .+.
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-------------~~~  220 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-------------QLS  220 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH-------------HHH
Confidence                122346778999998732       25789999999999999999999996532211111             111


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+.+... ...+.....++.+++.+||+.+|++||++++++++
T Consensus       221 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         221 AIVDGDP-PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             HHhhcCC-CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            1111100 01122345678899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=304.35  Aligned_cols=255  Identities=29%  Similarity=0.395  Sum_probs=198.8

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccC-----
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEH-----  510 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-----  510 (720)
                      .+++|+..+.||+|++|.||+|.. .+++.|++|++....   ...+.+.+|+++++++ +|+||+++++++.+.     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            457899999999999999999976 468899999986442   2346789999999999 799999999999653     


Q ss_pred             -CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          511 -GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       511 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                       +..++||||+++++|.+++.........+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence             358999999999999999865333345788999999999999999999987   8999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      |++.......  .......++..|+|||...      ..++.++|||||||++|||+||+.||.........  ...   
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~---  230 (275)
T cd06608         158 GVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--FKI---  230 (275)
T ss_pred             ccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--HHh---
Confidence            9987653321  1122345778899999863      23678999999999999999999999643221110  000   


Q ss_pred             ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                              .....+..  ........++.+++.+||..||++|||++|++++
T Consensus       231 --------~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         231 --------PRNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             --------hccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                    00000111  1112245678899999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-35  Score=308.28  Aligned_cols=267  Identities=19%  Similarity=0.264  Sum_probs=196.5

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|++|.||+|.. .+|+.||||++............+..|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            477789999999999999965 4689999999875443334446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +. ++|.+++....  ...+++.....++.++++||+|||..   +++||||+|+||++++++.+||+|||+++.+....
T Consensus        81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 58888875432  35688999999999999999999987   89999999999999999999999999987653321


Q ss_pred             CcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhcccc-------cCchh
Q 004994          600 TNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIPR-------LHDID  669 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~-------~~~~~  669 (720)
                      .  ......++..|+|||...  ..++.++|||||||++|||+||+.||......... ...++....       .....
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence            1  112233567899999873  33688999999999999999999999654321110 011100000       00000


Q ss_pred             hhhhhcCCCCCc---hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSLDG---AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .....+......   ........++.+++.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            000000000000   0011123567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.4e-35  Score=301.19  Aligned_cols=255  Identities=25%  Similarity=0.432  Sum_probs=198.9

Q ss_pred             CCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccc----cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQ----RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      +|+..+.||+|++|.||++. ..+++.||+|++......    ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            47778999999999999995 467899999998643211    1234678999999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-CeEEccccCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPL  594 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~  594 (720)
                      ||||+++++|.+++..    ...+++.....++.+++.||.|||+.   +++||||||+||+++.++ .+||+|||.+..
T Consensus        81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            9999999999999853    34678899999999999999999987   999999999999998776 599999999977


Q ss_pred             CCCCCCc--ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          595 LFSGSTN--ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       595 ~~~~~~~--~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      +......  .......++..|+|||.. ...++.++||||+|+++|||++|+.||.............            
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------  221 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF------------  221 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH------------
Confidence            6432111  112234567889999988 4568899999999999999999999996433211111110            


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       +..........+.....++.+++.+|++.+|++|||+.|++++
T Consensus       222 -~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         222 -KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             -HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence             0000001111222344678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=310.22  Aligned_cols=253  Identities=26%  Similarity=0.384  Sum_probs=205.4

Q ss_pred             CCCCCCeeccCCCceEEEEEeCC---Cc--EEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPG---GK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~---g~--~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ..+..++||+|-||.||+|.+.+   |+  .||||.-+.+.. ....+.|+.|.-+|++++|||||+++|+|.+. ..++
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            34456889999999999996532   33  588998876543 44578999999999999999999999999875 5899


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      |||.++-|.|.++++..   ...++......++.|+..||+|||+.   ++|||||..+|||+.....||++|||+++.+
T Consensus       468 vmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             EEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence            99999999999999643   45677788889999999999999998   9999999999999999999999999999998


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      .+..+..-+ ...-...|||||.+ ..+++.++|||-|||.|||++. |..||..-...+..       ..+...+.   
T Consensus       542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGeR---  610 (974)
T KOG4257|consen  542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGER---  610 (974)
T ss_pred             cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCCC---
Confidence            765543322 22335679999998 6789999999999999999987 99999764433211       12222111   


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                             -..+..|++.+..++.+||..||.+||++.|+...|.++
T Consensus       611 -------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  611 -------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             -------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence                   113445678899999999999999999999999988775

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.3e-35  Score=299.55  Aligned_cols=250  Identities=20%  Similarity=0.326  Sum_probs=198.0

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|...+.||+|+||.||++.. .+++.+|+|++..........+.+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            467788999999999999954 5788999999875433344567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC-CCeEEccccCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-LIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~~~~~~  598 (720)
                      +++++|.+++...  ....+++..+.+++.++++||.|||+.   +++|+||||+||+++++ +.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999998642  234578899999999999999999987   99999999999999865 46899999999876432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .   ......++..|+|||.. ...++.++||||||+++|+|++|+.||........   .....         ..... 
T Consensus       156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~---------~~~~~-  219 (256)
T cd08220         156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIM---------SGTFA-  219 (256)
T ss_pred             c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHHH---------hcCCC-
Confidence            2   12234567889999998 44678999999999999999999999965432111   11000         00000 


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .    .+...+..+.+++.+||+.+|++|||+.|++++
T Consensus       220 ~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         220 P----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             C----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            0    111234568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.9e-35  Score=307.92  Aligned_cols=266  Identities=20%  Similarity=0.270  Sum_probs=197.1

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc---cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ---RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +|...+.||+|++|.||+|.. .+|+.||||++......   ......+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            366778999999999999965 46899999999754332   22345677899999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+ +++|.+++....   ..+++..+..++.|+++||+|||+.   +|+|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 889999986432   3689999999999999999999987   89999999999999999999999999998764


Q ss_pred             CCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC-----chh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH-----DID  669 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----~~~  669 (720)
                      ....  ......++..|+|||.+.  ..++.++|||||||++|||++|..||....+...............     ...
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence            3221  112234467899999873  3578999999999999999999888765432211110000000000     000


Q ss_pred             hhhhhcCCCC-----CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSL-----DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..........     ...........+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000     000112234678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-35  Score=304.50  Aligned_cols=251  Identities=23%  Similarity=0.337  Sum_probs=197.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||.||+|.. .++..||+|.+...  .....+.|..|++++++++|+||+++++++.+.+..++|||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            4577788999999999999966 46899999998643  23345678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++...   ...+++.....++.+++.||.|||+.   +|+|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999988532   34688999999999999999999987   8999999999999999999999999998765322


Q ss_pred             CCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      .  .......++..|++||...      ..++.++|||||||++|||++|+.||........  ...+..          
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~----------  222 (280)
T cd06611         157 L--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKILK----------  222 (280)
T ss_pred             c--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHhc----------
Confidence            1  1122345778899999862      3467899999999999999999999965432111  111000          


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       ...+.+.  .+...+.++.+++.+||+.+|++||++++++++
T Consensus       223 -~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         223 -SEPPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -CCCCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             0000000  111233567899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-36  Score=318.27  Aligned_cols=246  Identities=22%  Similarity=0.341  Sum_probs=193.6

Q ss_pred             CCeeccCCCceEEEE-EeCCCcEEEEEEeccc--ccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC--eEEEEEee
Q 004994          445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNT--VSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG--QHLLVYDY  519 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e~  519 (720)
                      ..+||+|+|-+|||| +-.+|..||=-.++-.  .......+.|.+|+++|+.|+|||||++|.++.+..  ...+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            467999999999999 4456777764333311  122334478999999999999999999999997654  47899999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-CCCeEEccccCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~  598 (720)
                      +..|+|..+...    .+.++.....+++.||.+||.|||+. .|+|||||||-+||+++. .|.|||+|.|+|..+...
T Consensus       125 ~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  125 FTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999853    45677888999999999999999996 679999999999999975 589999999999887433


Q ss_pred             CCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          599 STNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                          .....+||+.|||||+....|++.+||||||+.|+||+|+..||..-....  .             ...+++...
T Consensus       200 ----~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--Q-------------IYKKV~SGi  260 (632)
T KOG0584|consen  200 ----HAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--Q-------------IYKKVTSGI  260 (632)
T ss_pred             ----ccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--H-------------HHHHHHcCC
Confidence                223478999999999999999999999999999999999999997532211  1             112222221


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+..+..-..+++++||.+|+.. .++|||+.|+|++
T Consensus       261 KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  261 KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            11111111125788999999999 9999999999874

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=320.78  Aligned_cols=251  Identities=25%  Similarity=0.359  Sum_probs=204.3

Q ss_pred             CCCeeccCCCceEEEEEe-CCC----cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          444 EGNFIGEGLLGSVYKAEL-PGG----KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       444 ~~~~lg~G~~g~Vy~~~~-~~g----~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ..++||+|+||+||||.+ ..|    -+||+|++.... ..+..+++++|+-+|.+++|||+++++|+|.... ..||++
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            458899999999999954 444    368999987543 3455678999999999999999999999998765 889999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      ||+.|.|.|+++..   +..+.-+..+.+..|||+||.|||..   ++|||||.++|||+..-.++||.|||+|+.+...
T Consensus       778 ~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999753   45677788999999999999999987   9999999999999999999999999999999776


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      +...........+.|+|-|.+ ...|+.++|||||||.+||++| |..||+....++..++                 +.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-----------------le  914 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-----------------LE  914 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-----------------Hh
Confidence            655444444445567777777 5689999999999999999999 9999976443222211                 11


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...+-..+.-+...+.-++.+||..|+..||+++++...+.+|
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            1111223445567788999999999999999999999988876

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.2e-35  Score=307.47  Aligned_cols=256  Identities=20%  Similarity=0.236  Sum_probs=195.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||.||++.. .+++.||+|.+.+... .....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            3677889999999999999965 4688999999875422 1233467889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++..    ...+++.....++.++++||+|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            99999999999853    34588889999999999999999987   899999999999999999999999999874211


Q ss_pred             CCC-------------cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 004994          598 GST-------------NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       598 ~~~-------------~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      ...             ........++..|+|||+. ...++.++|||||||++|||++|+.||..............   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~---  230 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---  230 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---
Confidence            100             0011123467789999988 55789999999999999999999999964322111000000   


Q ss_pred             ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                              .....+...    ...+.++.+++.+||+.||++||++.++.+.|+
T Consensus       231 --------~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         231 --------DDIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             --------cccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence                    000011110    123456789999999999999999655554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.9e-35  Score=303.21  Aligned_cols=253  Identities=24%  Similarity=0.389  Sum_probs=198.7

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|++|.||++... +++.||+|++..... ....+++.+|++++++++||||+++++++...+..++++||
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            5667788999999999999664 689999999875432 24456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE-VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      +++++|.+++...   ...++.....+++.++++||+|||+ .   +++|+||||+||++++++.+||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            9999999998643   2567888899999999999999998 5   9999999999999999999999999998765322


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      ..    ....++..|+|||+. ...++.++||||||+++|||++|+.||........ ...          +....+...
T Consensus       155 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~----------~~~~~~~~~  219 (265)
T cd06605         155 LA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIF----------ELLQYIVNE  219 (265)
T ss_pred             Hh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHH----------HHHHHHhcC
Confidence            11    115567789999998 45689999999999999999999999965321110 000          011111111


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ............++.+++.+||..||++|||+.|++++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            11111111145678899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.7e-35  Score=307.36  Aligned_cols=267  Identities=23%  Similarity=0.306  Sum_probs=197.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC--CeEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv  516 (720)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++...........+.+|++++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46778899999999999999664 689999999975433333445677899999999999999999998776  889999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+.+ +|.+++...   ...+++.....++.|+++||+|||+.   +++||||||+||+++.++.+||+|||+++...
T Consensus        85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999985 898888532   23689999999999999999999987   89999999999999999999999999998664


Q ss_pred             CCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh-hhcc-c---------
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWAI-P---------  663 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~-~---------  663 (720)
                      ...  .......++..|+|||...+  .++.++|+||||+++|||++|+.||...........+ .... +         
T Consensus       158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            321  11222446778999998743  4689999999999999999999999754322111100 0000 0         


Q ss_pred             ccCchh--hhhhhcCCCCCchhhHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 RLHDID--ALSRMVDPSLDGAYLAK-SLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 ~~~~~~--~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+....  .........+...++.. ..+.+.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000000  00000000001111111 24567899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-34  Score=296.88  Aligned_cols=250  Identities=31%  Similarity=0.486  Sum_probs=195.8

Q ss_pred             CCCCeeccCCCceEEEEEeCC-----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          443 SEGNFIGEGLLGSVYKAELPG-----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       443 ~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      +..+.||+|+||.||++...+     +..||+|.+..... ....+.+..|++++++++|+||+++++++.+.+..+++|
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            456889999999999996643     38899999965432 225678899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++....  ...+++..+..++.+++.||+|||+.   +++||||||+||++++++.++|+|||+++....
T Consensus        81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            9999999999986422  12289999999999999999999987   999999999999999999999999999987654


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ...... ....++..|+|||.. ...++.++||||+|+++|||++ |+.||.......   ..+...             
T Consensus       156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~-------------  218 (258)
T smart00219      156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYLK-------------  218 (258)
T ss_pred             cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh-------------
Confidence            322111 122356789999988 5578999999999999999998 888886432111   111000             


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      ... ........+.++.+++.+|+..||++|||+.|+++.|
T Consensus       219 ~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      219 KGY-RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             cCC-CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            000 0001112346788999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.4e-34  Score=305.09  Aligned_cols=247  Identities=26%  Similarity=0.357  Sum_probs=194.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      +.|...+.||+|+||.||+|.. .+|+.||+|++.... ......+++.+|++++++++||||++++++|.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4577789999999999999965 468999999986432 22233457889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+. |++.+++...   ...+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.+||+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 5777766422   24588999999999999999999987   899999999999999999999999999876532


Q ss_pred             CCCcccccCccccccCCCCccC----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      .      ....++..|+|||..    .+.++.++||||||+++|||+||+.||..............             
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-------------  228 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------  228 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-------------
Confidence            2      123567789999986    24588999999999999999999999965332111000000             


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...+..   .....+..+.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         229 NDSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000111   112244678999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-34  Score=298.00  Aligned_cols=254  Identities=27%  Similarity=0.391  Sum_probs=199.2

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|...+.||+|+||.||+|.. .+++.||+|.++.........+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            467788999999999999965 4789999999976544334667899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++..    ...+++..+..++.++++||+|||+.   +|+|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999853    23478888999999999999999987   89999999999999999999999999998764432


Q ss_pred             Cccc--ccCccccccCCCCccCCC-C---CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          600 TNEL--SEGLLTAHGSGAPEFESG-S---YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       600 ~~~~--~~~~~~~~~~~aPE~~~~-~---~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ....  .....++..|++||+..+ .   ++.++||||||+++||+++|+.||.........  .....          .
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~--~~~~~----------~  221 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI--MFHVG----------A  221 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH--HHHHh----------c
Confidence            2111  113456788999999843 3   788999999999999999999999653211110  00000          0


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...+.+..  .......+.+++.+||+.+|++|||++|++.+
T Consensus       222 ~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         222 GHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00111111  11224567899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.5e-35  Score=300.00  Aligned_cols=251  Identities=23%  Similarity=0.320  Sum_probs=202.4

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+...........++.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            467778999999999999954 5788999999876543344556788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++.........+++.....++.++++||+|||+.   +++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999865444456789999999999999999999987   8999999999999999999999999999876433 


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                         ......++..|++||.. ...++.++|+||||+++|||++|+.||.......   +...              +...
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~--------------~~~~  216 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYK--------------VQRG  216 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH--------------HhcC
Confidence               22234567789999998 4568889999999999999999999996543211   0000              0000


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...........++.+++.+|++.+|++||++.|++++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0001112344678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-35  Score=304.40  Aligned_cols=265  Identities=20%  Similarity=0.282  Sum_probs=193.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|++|.||+|... +++.||||.+..... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            56888899999999999999654 689999999875432 2233456789999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++ +|.+++...   ...+++.....++.++++||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          84 YLDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            9985 899887532   23678889999999999999999987   8999999999999999999999999998754221


Q ss_pred             CCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhcccccCchhhhhh--
Q 004994          599 STNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIPRLHDIDALSR--  673 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~--  673 (720)
                      ..  ......++..|+|||...  ..++.++|||||||++|||++|+.||......... ......... ...+....  
T Consensus       157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  233 (291)
T cd07844         157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT-PTEETWPGVS  233 (291)
T ss_pred             Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC-CChhhhhhhh
Confidence            11  111223567899999873  35789999999999999999999999654311110 000000000 00000000  


Q ss_pred             ----hcC---CCCCc----hhhHHH--HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 ----MVD---PSLDG----AYLAKS--LSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ----~~~---~~~~~----~~~~~~--~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                          ...   +....    ......  ...+.+++.+||+.+|++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                000   00000    000001  1567799999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=299.97  Aligned_cols=248  Identities=22%  Similarity=0.390  Sum_probs=196.3

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC---CCceeEEEeEeccCCeEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR---HGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv  516 (720)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+++.+|++++++++   |||++++++++.+....++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            466778999999999999965 5789999999865422 334567888999999987   99999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..     ..+++.....++.++++||.|||+.   +|+||||+|+||++++++.++|+|||++..+.
T Consensus        81 ~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          81 MEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            999999999998853     2688999999999999999999987   99999999999999999999999999998764


Q ss_pred             CCCCcccccCccccccCCCCccCC-C-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFES-G-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~-~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ....  ......++..|+|||... + .++.++|||||||++|||++|+.||..........   .    +.      ..
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~----~~------~~  217 (277)
T cd06917         153 QNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM---L----IP------KS  217 (277)
T ss_pred             CCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh---c----cc------cC
Confidence            4321  122345778899999873 3 46899999999999999999999997543211110   0    00      00


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+.+...   ..+.++.+++.+||+.||++||++.|++++
T Consensus       218 ~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         218 KPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            01111111   133568899999999999999999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-35  Score=307.95  Aligned_cols=255  Identities=25%  Similarity=0.285  Sum_probs=199.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36778899999999999999654 5899999999754322 234567899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+.+++|.+++...  ....+++.....++.++++||+|||..   +++||||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999999998632  235688899999999999999999987   899999999999999999999999999875532


Q ss_pred             CCCc---------------------------ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 004994          598 GSTN---------------------------ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRS  649 (720)
Q Consensus       598 ~~~~---------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~  649 (720)
                      ....                           .......++..|+|||.. ...++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1110                           011123567889999998 456889999999999999999999999654


Q ss_pred             CCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC----HHHHHHH
Q 004994          650 RPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP----MSEIVQD  715 (720)
Q Consensus       650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~~  715 (720)
                      .....                +..+.+...........+.++.+++.+||+.||++|||    ++|++++
T Consensus       236 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         236 NRDET----------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             chHHH----------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            32111                11111111100001113467899999999999999999    7777764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-34  Score=303.19  Aligned_cols=267  Identities=20%  Similarity=0.243  Sum_probs=193.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      +++|...+.||+|+||.||+|.. .+|+.||+|++..... ......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            46788899999999999999954 5689999999865432 233346778999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+. +++.+.+...   ...+.+.....++.++++||.|||+.   +|+||||||+||+++.++++||+|||+++....
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9996 5777666422   23467788889999999999999987   899999999999999999999999999976432


Q ss_pred             CCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh---hhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID---ALS  672 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~  672 (720)
                      ..  .......++..|+|||...+  .++.++|||||||++|||+||+.||.......+.-...|.........   .+.
T Consensus       156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         156 PS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            21  11223346788999998743  578899999999999999999999975432111000000000000000   000


Q ss_pred             ---hhcCC---C-CCchh---h--HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 ---RMVDP---S-LDGAY---L--AKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ---~~~~~---~-~~~~~---~--~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         .....   . .....   .  ......+.+++.+|+..||++|||++|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence               00000   0 00000   0  0113567899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-35  Score=304.04  Aligned_cols=266  Identities=19%  Similarity=0.263  Sum_probs=196.2

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      |+..+.||+|++|.||+|.. .+|..||+|++..........+.+..|++++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            55678999999999999965 57999999998755433444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      + ++|.+++....  ...+++..+..++.++++||+|||+.   +++||||+|+||++++++.+||+|||+++.+.....
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 68998885432  14689999999999999999999987   899999999999999999999999999976532211


Q ss_pred             cccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhccc-------ccCchhh
Q 004994          601 NELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIP-------RLHDIDA  670 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~-------~~~~~~~  670 (720)
                        ......++..|+|||+..  ..++.++|||||||++|||++|+.||......... .+.++...       .......
T Consensus       155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence              111224567899999873  34789999999999999999999999754321110 11111000       0000000


Q ss_pred             hhhhcCC---CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          671 LSRMVDP---SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       671 ~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....+..   ..........+..+.+++.+|++.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000   00000111223578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.9e-34  Score=296.74  Aligned_cols=252  Identities=27%  Similarity=0.387  Sum_probs=201.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|++|.||+|... +++.||||++...... .....+..|++.+.+++|+||+++++++...+..++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            36778899999999999999665 5999999998754322 445789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE-VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      |+++++|.+++...    ..+++..+..++.++++|++|||+ .   +++||||+|+||+++.++.++|+|||++.....
T Consensus        80 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          80 YMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999998532    568899999999999999999998 6   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ....  .....++..|+|||.. .+.++.++||||||+++|||+||+.||................          ....
T Consensus       153 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------~~~~  220 (264)
T cd06623         153 TLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----------DGPP  220 (264)
T ss_pred             CCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----------cCCC
Confidence            2211  1234567889999988 5568899999999999999999999997643211111111110          0001


Q ss_pred             CCCCchhhHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAK-SLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +..    ... .+..+.+++.+||+.+|++||++.|++++
T Consensus       221 ~~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSL----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCC----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111    111 34678899999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-34  Score=299.58  Aligned_cols=247  Identities=22%  Similarity=0.348  Sum_probs=196.3

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      -|...+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            466778999999999999965 5788999999864322 23446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++..     ..+++.....++.+++.|+.|||+.   +++|+||||+||+++.++.++|+|||++..+....
T Consensus        84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            999999998852     3578999999999999999999986   99999999999999999999999999987653321


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .  ......++.+|++||.. ...++.++|||||||++|||++|+.||........   ....          .....+.
T Consensus       156 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~----------~~~~~~~  220 (277)
T cd06641         156 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFLI----------PKNNPPT  220 (277)
T ss_pred             h--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HHHH----------hcCCCCC
Confidence            1  11224567789999988 45688999999999999999999999964322110   0000          0000011


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +    ....+.++.+++.+||+.+|++||++++++++
T Consensus       221 ~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 L----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             C----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1    12234567899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.1e-35  Score=307.67  Aligned_cols=247  Identities=24%  Similarity=0.334  Sum_probs=194.6

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      |.....||+|+||.||++.. .++..||||.+....  ....+.+.+|+..++.++|+||+++++.+...+..++||||+
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            33346799999999999965 468899999986432  334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      ++++|.+++..     ..+++.....++.+++.||.|||+.   +|+||||||+||++++++.+||+|||++....... 
T Consensus       102 ~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-  172 (292)
T cd06658         102 EGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-  172 (292)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence            99999998742     3478889999999999999999987   89999999999999999999999999987653221 


Q ss_pred             cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCC
Q 004994          601 NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL  679 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  679 (720)
                       .......++..|+|||.. ...++.++|||||||++|||++|+.||..........             .......+..
T Consensus       173 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------------~~~~~~~~~~  238 (292)
T cd06658         173 -PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-------------RIRDNLPPRV  238 (292)
T ss_pred             -ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHhcCCCcc
Confidence             112234577889999998 4568999999999999999999999996533211110             0111111111


Q ss_pred             CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       680 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..  .......+.+++.+|+..||++|||++|++++
T Consensus       239 ~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 KD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11  11223567899999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.6e-34  Score=300.54  Aligned_cols=260  Identities=20%  Similarity=0.311  Sum_probs=191.0

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccC--CeEEEEE
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEH--GQHLLVY  517 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~  517 (720)
                      |...+.||+|+||.||+|.. .+++.||+|+++...... ......+|+.++.++. |+||+++++++.+.  +..++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            45568899999999999964 578999999987543222 2234457888888885 99999999999877  8899999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||++ +++.+.+...   ...++|..+..++.++++||+|||+.   +++||||||+||+++. +.+||+|||+++.+..
T Consensus        80 e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          80 ELMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             ecCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            9997 4787777532   24689999999999999999999987   8999999999999999 9999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ...   .....++..|+|||..  .+.++.++|||||||++|||++|+.||...+..+..............  ......
T Consensus       152 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  226 (282)
T cd07831         152 KPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA--EVLKKF  226 (282)
T ss_pred             CCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH--HHHHhh
Confidence            221   1224467889999975  345788999999999999999999999764432211100000000000  000000


Q ss_pred             ------C---CCCCc----hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 ------D---PSLDG----AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ------~---~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            +   +...+    ......+.++.+++.+||+.+|++|||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence                  0   00000    0012335788999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.6e-34  Score=302.04  Aligned_cols=246  Identities=24%  Similarity=0.323  Sum_probs=197.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||.||++.. .+++.||+|++.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            3677889999999999999965 4689999999864322 2234567889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++..    ...+++..+..++.++++||.|||+.   +++||||+|+||+++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            99999999999854    24688889999999999999999987   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .     .....++..|+|||.. ...++.++||||||+++|||++|+.||........                ...+..
T Consensus       154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~  212 (290)
T cd05580         154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI----------------YEKILE  212 (290)
T ss_pred             C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHhc
Confidence            3     2234577889999987 45688899999999999999999999965431110                000111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      ...  ..+......+.+++.+||+.||.+|+     +++|++++
T Consensus       213 ~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         213 GKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             CCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            000  01112235778999999999999999     77887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.9e-35  Score=310.43  Aligned_cols=269  Identities=21%  Similarity=0.306  Sum_probs=198.0

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccC--CeE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEH--GQH  513 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~  513 (720)
                      +.++|+..+.||+|+||.||+|.. .+|+.||+|++.+..........+.+|+.+++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            456788889999999999999965 4688999999865433334445677899999999 999999999998653  468


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++||||++ ++|.+++..     ..++|..+..++.+++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999998 488888743     2678889999999999999999987   99999999999999999999999999998


Q ss_pred             CCCCCCCc---ccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          594 LLFSGSTN---ELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       594 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      .+......   .......++..|+|||...  ..++.++|||||||++|||+||+.||...........+..........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            76433221   1222345788899999873  457899999999999999999999996543322111111110000000


Q ss_pred             --hh-----hhhhcC----CCCC--chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 --DA-----LSRMVD----PSLD--GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 --~~-----~~~~~~----~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ..     ...+++    ....  .......+.++.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence              00     000000    0000  00011134678899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-34  Score=303.70  Aligned_cols=270  Identities=19%  Similarity=0.269  Sum_probs=195.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCe-----
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQ-----  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~-----  512 (720)
                      ++|+..+.||+|+||.||+|.. .+|+.||+|++............+.+|+++++.++ |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3678889999999999999965 56899999998755433344567888999999995 6999999999876555     


Q ss_pred             EEEEEeeCCCCCHHHHhhccchh-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-CCCeEEcccc
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEA-HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KLIVRVSDCG  590 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFG  590 (720)
                      .++||||+++ +|.+++...... ...+++.....++.|+++||.|||..   +|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 788887543222 34689999999999999999999987   9999999999999998 8899999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhc-cccc-
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWA-IPRL-  665 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~-~~~~-  665 (720)
                      +++.+......  .....++..|+|||+..  ..++.++|||||||++|||++|+.||......... .+.... .+.- 
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            98765322111  11224567899999873  35789999999999999999999999754322111 000000 0000 


Q ss_pred             --Cchhhhhhhc-CCCCC----chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          666 --HDIDALSRMV-DPSLD----GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       666 --~~~~~~~~~~-~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        .......... -+...    .........++.+++.+||+.||++||+++|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence              0000000000 00000    00011234678899999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.4e-34  Score=311.23  Aligned_cols=265  Identities=17%  Similarity=0.211  Sum_probs=196.0

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC------
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH------  510 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------  510 (720)
                      ..++|+..+.||+|+||.||+|.. .+|+.||+|++.+........+.+.+|++++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999954 5799999999875433344456778899999999999999999988543      


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                      ...++||||+.+ +|.+.+..      .+++.....++.|+++||+|||..   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            357999999975 78777642      277888889999999999999987   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcccccC--
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAIPRLH--  666 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~--  666 (720)
                      +++......   ......++..|+|||.. ...++.++|||||||++|+|++|+.||...+...... +.........  
T Consensus       164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            998653321   12234567889999988 5578999999999999999999999997543211100 0000000000  


Q ss_pred             ------------------chhhhhhhcCCC----CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 ------------------DIDALSRMVDPS----LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 ------------------~~~~~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                        ......+.....    .........+.++.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                              000000111000    0000012335678899999999999999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.3e-35  Score=304.78  Aligned_cols=256  Identities=25%  Similarity=0.360  Sum_probs=191.2

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEEEe
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      +|...+.||+|+||.||++.. .+++.||+|.+...... .....+.+|+.++.++. |+||+++++++...+..+++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            344557899999999999955 56899999998754322 34567889999999996 9999999999998889999999


Q ss_pred             eCCCCCHHHHhhcc-chhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          519 YGGNCTLHDLLHSD-EEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       519 ~~~~gsL~~~l~~~-~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      |+.. ++.++.... ......+++.....++.++++||+|||+.  .+++||||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9874 555543211 11235688999999999999999999974  2899999999999999999999999999976532


Q ss_pred             CCCcccccCccccccCCCCccCCC----CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG----SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ...   .....++..|+|||.+.+    .++.++|||||||++|||++|+.||....... ....+.    ..       
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~----~~-------  225 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-DQLTQV----VK-------  225 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-HHHhhh----cC-------
Confidence            211   122356778999998843    48899999999999999999999996432100 000000    00       


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      -..+.+........+.++.+++.+||+.||++|||++||+++
T Consensus       226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            001111111112345678999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-34  Score=297.48  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=196.8

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|...+.||+|+||.||+|.. .+|..||+|.+..........+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            366778999999999999965 4688999999865432234456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-CeEEccccCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPLLFSG  598 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~  598 (720)
                      +++++|.+++....  ...+++..+..++.++++||+|||+.   +++|+||||+||++++++ .+||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            99999999986422  23578999999999999999999987   899999999999999885 5699999999766432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .  .......++..|+|||.. ...++.++|||||||++|||++|+.||........   +..         .......+
T Consensus       156 ~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~---------~~~~~~~~  221 (257)
T cd08225         156 M--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---VLK---------ICQGYFAP  221 (257)
T ss_pred             c--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHH---------HhcccCCC
Confidence            2  112234577889999987 45689999999999999999999999964322110   000         00000110


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .     ....+.++.+++.+|+..+|++|||+.|++++
T Consensus       222 ~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         222 I-----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             C-----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            0     11123568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.9e-34  Score=302.26  Aligned_cols=248  Identities=24%  Similarity=0.352  Sum_probs=194.3

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .|...+.||+|+||.||+|.. .++..||+|++..... .....+.+..|++++++++|+|++++++++.+.+..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            366778999999999999965 5689999999864321 22334578899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+.+ ++.+.+..   ....++|..+..++.++++||.|||+.   +|+||||+|+||+++.++.+||+|||++......
T Consensus       106 ~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            9975 77777642   234588999999999999999999987   8999999999999999999999999998754322


Q ss_pred             CCcccccCccccccCCCCccC----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFE----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                            ....++..|+|||+.    .+.++.++|||||||++|||++|+.||.........                ..+
T Consensus       179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~----------------~~~  236 (317)
T cd06635         179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------------YHI  236 (317)
T ss_pred             ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH----------------HHH
Confidence                  123567789999986    346889999999999999999999998653211110                001


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      .............+..+.+++.+||+.+|.+||++.++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             HhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            1000000111223456889999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.4e-34  Score=292.66  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=201.9

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC--CeEEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQHLLVY  517 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~  517 (720)
                      +|...+.||+|++|.||+|... +++.|++|++..........+.+.+|++++++++|+||+++++.+.+.  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999665 789999999875543334567889999999999999999999999888  8999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++...    ..+++..+..++.++++||+|||+.   +++|+||+|+||++++++.+||+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999998532    3789999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...........++..|.+||... ..++.++||||||+++|+|++|+.||.......  . .            ..+...
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-~------------~~~~~~  218 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--A-A------------LYKIGS  218 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--H-H------------HHhccc
Confidence            33211123355678899999984 458999999999999999999999997543100  0 0            000110


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .......+...+..+.+++.+|++.+|++||++.|++++
T Consensus       219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            001111122234678899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.5e-34  Score=298.81  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=200.0

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++.|+..+.||+|++|.||+|... ++..||+|++.....   ..+.+.+|+++++.++|+||+++++++...+..++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            4566788889999999999999765 688999999974422   456788999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      +||+++++|.+++....   ..+++..+..++.++++||+|||..   +++|+||||+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          94 MEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999999996422   3789999999999999999999986   99999999999999999999999999986553


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ....  ......++..|++||.. ...++.++|||||||++|||++|+.||....+....  ......          ..
T Consensus       168 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~~~~----------~~  233 (286)
T cd06614         168 KEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLITTK----------GI  233 (286)
T ss_pred             cchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhc----------CC
Confidence            2211  11223467789999987 456899999999999999999999999653321110  000000          00


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       +...  .....+..+.+++.+||+.+|.+|||+.+++++
T Consensus       234 -~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         234 -PPLK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -CCCc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             0000  111234678899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.6e-34  Score=300.87  Aligned_cols=249  Identities=22%  Similarity=0.344  Sum_probs=198.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||.||++.. .+++.||+|.+...  .....+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            5788889999999999999954 57889999998533  22335678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++..     ..+++..+..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             cCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            9999999998853     3477888999999999999999987   9999999999999999999999999998765432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      ..  ......++..|++||.. .+.++.++|||||||++||+++|+.||.............  .             .+
T Consensus       169 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~--~-------------~~  231 (293)
T cd06647         169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--T-------------NG  231 (293)
T ss_pred             cc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh--c-------------CC
Confidence            21  12234577889999987 5568999999999999999999999997543322111000  0             00


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .............+.+++.+||..+|++||++.+++++
T Consensus       232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000112234568899999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=306.48  Aligned_cols=270  Identities=21%  Similarity=0.312  Sum_probs=195.0

Q ss_pred             CCCCCeeccCCCceEEEEEeC---CCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccC--CeEEE
Q 004994          442 FSEGNFIGEGLLGSVYKAELP---GGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQHLL  515 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l  515 (720)
                      |...+.||+|+||.||+|...   +++.||+|.+.... ......+.+.+|++++++++||||+++++++.+.  +..++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            667788999999999999653   58899999997643 2233346778899999999999999999999887  78999


Q ss_pred             EEeeCCCCCHHHHhhccchh-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC----CCCeEEcccc
Q 004994          516 VYDYGGNCTLHDLLHSDEEA-HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE----KLIVRVSDCG  590 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~----~~~~kl~DFG  590 (720)
                      ||||+++ ++.+++...... ...++......++.|++.||+|||+.   +|+||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999986 666666432222 23678889999999999999999987   8999999999999999    9999999999


Q ss_pred             CCCCCCCCCC-cccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc------hhhhc
Q 004994          591 LAPLLFSGST-NELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS------LVRWA  661 (720)
Q Consensus       591 la~~~~~~~~-~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~------~~~~~  661 (720)
                      +++.+..... ........++..|+|||...  ..++.++|||||||++|||++|+.||..........      .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9987643222 11222345678899999773  357899999999999999999999997544322000      00000


Q ss_pred             c--------------cccCchhhhhhh-cCCCCC-----chhhH--HHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          662 I--------------PRLHDIDALSRM-VDPSLD-----GAYLA--KSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       662 ~--------------~~~~~~~~~~~~-~~~~~~-----~~~~~--~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .              ....+.....+. ......     .....  ....++.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0              000000000000 000000     00001  223568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3e-34  Score=298.21  Aligned_cols=243  Identities=24%  Similarity=0.286  Sum_probs=185.5

Q ss_pred             eeccCCCceEEEEEe-CCCcEEEEEEecccccccc-cHHHHHHHHHH---HHccCCCceeEEEeEeccCCeEEEEEeeCC
Q 004994          447 FIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQ-TDEEFLELAST---ISRLRHGNIVELIGYCNEHGQHLLVYDYGG  521 (720)
Q Consensus       447 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~-~~~~~~~e~~~---l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  521 (720)
                      +||+|+||.||++.. .+++.||+|.+.+...... ....+.+|..+   +...+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999965 5689999999875432222 22333444433   334479999999999999999999999999


Q ss_pred             CCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCc
Q 004994          522 NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN  601 (720)
Q Consensus       522 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  601 (720)
                      +++|.+++..    ...+++.....++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||++.......  
T Consensus        81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            9999988853    34689999999999999999999987   89999999999999999999999999987553221  


Q ss_pred             ccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCC
Q 004994          602 ELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL  679 (720)
Q Consensus       602 ~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  679 (720)
                        .....++..|+|||...  ..++.++|||||||++|||++|+.||..............           ....... 
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-----------~~~~~~~-  217 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----------TLTVNVE-  217 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-----------hhcCCcC-
Confidence              12245788999999873  3578999999999999999999999965332111110000           0001111 


Q ss_pred             CchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          680 DGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       680 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                         .+...+.++.+++.+||..||++||     |++|++++
T Consensus       218 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 ---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence               1223346788999999999999999     69999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.3e-34  Score=303.81  Aligned_cols=268  Identities=24%  Similarity=0.302  Sum_probs=196.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC--CeEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l  515 (720)
                      .++|...+.||+|+||.||+|.. .+|+.||+|+++...........+.+|++++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            35788889999999999999965 5689999999875433333344567899999999999999999998654  56899


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+.+ +|.+++...   ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++...
T Consensus        86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            9999975 788887532   35689999999999999999999997   8999999999999999999999999999876


Q ss_pred             CCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc--------cc
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP--------RL  665 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~--------~~  665 (720)
                      .....  ......++..|+|||...  ..++.++|||||||++|||++|+.||...........+.....        .+
T Consensus       159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            43221  111223467899999873  3578999999999999999999999975443221111110000        00


Q ss_pred             Cchhhhhhhc-C-CCCCc--hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          666 HDIDALSRMV-D-PSLDG--AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       666 ~~~~~~~~~~-~-~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .......... . .....  .........+.+++.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000000 0 00000  0001124567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.3e-34  Score=301.44  Aligned_cols=268  Identities=19%  Similarity=0.261  Sum_probs=193.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|++|+||+|.. .+|+.||+|.+..........+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            4678889999999999999965 478999999986543333444678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-CCCeEEccccCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~  597 (720)
                      |+++ +|.+.+....  ...+++.....++.+++.||+|||+.   +++||||||+||+++. ++.+||+|||++.....
T Consensus        82 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLDL-DLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             cccc-cHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            9974 7777764322  23457778889999999999999987   8999999999999985 55799999999976532


Q ss_pred             CCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccch-hhhcc-c------ccCc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL-VRWAI-P------RLHD  667 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~-~~~~~-~------~~~~  667 (720)
                      ...  ......++..|+|||+..  ..++.++|||||||++|||+||+.||......+.... ..... +      ....
T Consensus       156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        156 PVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             Ccc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            211  112234577899999873  3578999999999999999999999975432211110 00000 0      0000


Q ss_pred             hhhhhhhcC---CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDALSRMVD---PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .........   +...........+++.+++.+|++.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000000000   000000111234568899999999999999999999864

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.8e-35  Score=304.63  Aligned_cols=244  Identities=24%  Similarity=0.325  Sum_probs=192.6

Q ss_pred             CCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          445 GNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      ...||+|+||.||++.. .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            45799999999999965 578999999986432  234567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL  603 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  603 (720)
                      +|.+++..     ..+++..+..++.+++.||+|||+.   +++||||||+||+++.++.+||+|||++........  .
T Consensus       104 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~  173 (297)
T cd06659         104 ALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  173 (297)
T ss_pred             CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence            99987742     4578899999999999999999987   899999999999999999999999999875532211  1


Q ss_pred             ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch
Q 004994          604 SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA  682 (720)
Q Consensus       604 ~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (720)
                      .....++..|+|||+. ...++.++|||||||++|||++|+.||.............   .          ...+...  
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~----------~~~~~~~--  238 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---D----------SPPPKLK--  238 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---c----------cCCCCcc--
Confidence            2234578899999988 4578999999999999999999999996433211110000   0          0000000  


Q ss_pred             hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          683 YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       683 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ........+.+++.+||+.+|++||+++|++++
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            011223567899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-34  Score=324.82  Aligned_cols=274  Identities=14%  Similarity=0.199  Sum_probs=186.8

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEeC--CCcEEEEEEe--------------ccc-ccccccHHHHHHHHHHHHccCCCc
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAELP--GGKLLAVKKL--------------SNT-VSQRQTDEEFLELASTISRLRHGN  499 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l--------------~~~-~~~~~~~~~~~~e~~~l~~l~H~n  499 (720)
                      .+.++|...+.||+|+||+||++...  ++..+++|.+              .+. .........+.+|++++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            45678999999999999999998543  2322333211              111 111223456889999999999999


Q ss_pred             eeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccch-hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE
Q 004994          500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEE-AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       500 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl  578 (720)
                      ||++++++.+.+..|+|+|++.. ++.+++..... ............++.|++.||.|||+.   +||||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            99999999999999999999864 66666643211 112233456678999999999999987   99999999999999


Q ss_pred             cCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCC-CCCCCCccccc
Q 004994          579 DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPRGEQS  656 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~P-f~~~~~~~~~~  656 (720)
                      +.++.+||+|||+++.+..... .......++..|+|||.+ ...++.++|||||||++|||++|..+ +..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999987643221 222345688999999998 45699999999999999999998754 43322111111


Q ss_pred             hhhhc------ccccCch-hhhhhhcCCC--------CCchh-hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          657 LVRWA------IPRLHDI-DALSRMVDPS--------LDGAY-LAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       657 ~~~~~------~~~~~~~-~~~~~~~~~~--------~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +.+..      ...+.+. ..+...++..        +.... .......+.+++.+||+.||.+|||+.|++++
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11100      0000000 0011111100        00000 00123457788999999999999999999875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=287.76  Aligned_cols=268  Identities=21%  Similarity=0.287  Sum_probs=219.1

Q ss_pred             CHHHHHHHhcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEE
Q 004994          431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI  504 (720)
Q Consensus       431 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~  504 (720)
                      ..+++.....+++...++.+|.||+||+|.+.      +.+.|-+|.++...+ ......+..|.-.+..+.|||+..+.
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCcccee
Confidence            35566667777888899999999999999543      345677888875543 33446678888888999999999999


Q ss_pred             eEecc-CCeEEEEEeeCCCCCHHHHhhcc----chhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc
Q 004994          505 GYCNE-HGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD  579 (720)
Q Consensus       505 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~  579 (720)
                      +++.+ ....+.+|.++.-|+|..++.-.    ....+.++-.+...++.|++.|++|||..   +|||.||.++|++||
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence            98865 56789999999999999999721    23356677888999999999999999987   999999999999999


Q ss_pred             CCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccch
Q 004994          580 EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSL  657 (720)
Q Consensus       580 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~  657 (720)
                      +..++||+|-.+++.+.+.+++.....-.....||+||.+ ...|+.++|||||||+||||+| |+.||.+.++.+..  
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~--  508 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME--  508 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH--
Confidence            9999999999999999998887766666667789999998 5679999999999999999999 99999765543322  


Q ss_pred             hhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       658 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                                     .++.....-..+-.+++++..++..||..+|++||+++++++-|.+.
T Consensus       509 ---------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  509 ---------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ---------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                           22222222234456778999999999999999999999999998764

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=300.25  Aligned_cols=266  Identities=23%  Similarity=0.300  Sum_probs=197.3

Q ss_pred             CCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC--CeEEEEEe
Q 004994          442 FSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQHLLVYD  518 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e  518 (720)
                      |...+.||+|+||.||+|... +++.||+|++............+.+|++++++++|+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456788999999999999664 589999999986543344556788999999999999999999999887  89999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++ +|.+++...   ...+++.....++.++++||+|||+.   +++|+||||+||++++++.+||+|||++......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9985 888887532   24688999999999999999999987   8999999999999999999999999999876443


Q ss_pred             CCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc--Cchhhhhh-
Q 004994          599 STNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL--HDIDALSR-  673 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~-  673 (720)
                      ... ......++..|+|||...  ..++.++||||||+++|||+||+.||...........+.......  ........ 
T Consensus       154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            211 112234567899999763  357899999999999999999999997644321111110000000  00000000 


Q ss_pred             ----------hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 ----------MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                .....+.......++.++.+++.+||+.+|++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                      000000011111125678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.2e-34  Score=301.74  Aligned_cols=269  Identities=20%  Similarity=0.304  Sum_probs=194.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC-------
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG-------  511 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-------  511 (720)
                      ++|+..+.||+|+||.||+|.. .+++.||||.+............+.+|++++++++||||++++++|...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            4688889999999999999965 46899999998654333344456678999999999999999999986543       


Q ss_pred             -eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          512 -QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       512 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                       ..++||||+.+ +|.+.+...   ...+++.....++.|+++||+|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence             45999999975 787777432   24688999999999999999999987   89999999999999999999999999


Q ss_pred             CCCCCCCCCCc--ccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc---
Q 004994          591 LAPLLFSGSTN--ELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP---  663 (720)
Q Consensus       591 la~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~---  663 (720)
                      ++.........  .......++..|+|||...+  .++.++||||||+++|||+||+.||...........+.....   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99766432211  11123345778999998743  378899999999999999999999975443221111111110   


Q ss_pred             -----ccCchhhhhhhcCCCCC-chhh-----HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 -----RLHDIDALSRMVDPSLD-GAYL-----AKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 -----~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                           .....+.......+... ....     ......+.+++.+||+.||++|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence                 00000000000000000 0000     0012456799999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.9e-34  Score=298.06  Aligned_cols=267  Identities=20%  Similarity=0.323  Sum_probs=197.1

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|++|.||+|.. .+|+.||||++..... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            477789999999999999976 4689999999975432 23345677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++ +|.+++.... ....+++.....++.++++||+|||+.   +++||||||+||++++++.+||+|||+++......
T Consensus        80 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          80 MDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             CCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            985 8888775432 134689999999999999999999987   89999999999999999999999999997653221


Q ss_pred             CcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhc-ccccCchhhhh---
Q 004994          600 TNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWA-IPRLHDIDALS---  672 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~-~~~~~~~~~~~---  672 (720)
                      .  ......++..|++||...+  .++.++|||||||++|||++|+.||.......... +.+.. .+.......+.   
T Consensus       155 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         155 N--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             c--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence            1  1122345778999998733  47889999999999999999999997544321111 11100 00000000000   


Q ss_pred             ---hhcCCCCC---chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 ---RMVDPSLD---GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ---~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         ........   .......+..+.+++.+|++.||++||+++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               00000000   01112234678899999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.9e-34  Score=298.27  Aligned_cols=248  Identities=24%  Similarity=0.353  Sum_probs=195.2

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      .|...+.||+|++|.||++.. .+++.||+|++...  .....+.+.+|+.+++.++||||+++++++...++.++|+||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            344457899999999999965 57889999998532  223345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++..     ..+++..+..++.+++.||+|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          98 LEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            999999998853     3578889999999999999999987   89999999999999999999999999887653221


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .  ......++..|+|||.. ...++.++|||||||++|||++|+.||....+.......             .....+.
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~-------------~~~~~~~  234 (285)
T cd06648         170 P--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-------------RDNLPPK  234 (285)
T ss_pred             c--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH-------------HhcCCCC
Confidence            1  12234577899999998 456899999999999999999999999653321111100             0000111


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..  .....+..+.+++.+||+.+|++|||+.+++++
T Consensus       235 ~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         235 LK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             Cc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            11  011234578899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.9e-34  Score=289.13  Aligned_cols=249  Identities=26%  Similarity=0.408  Sum_probs=199.4

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|...+.||+|++|.||++... +++.+++|++.....  .....+.+|++++++++|+||+++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            4677789999999999999764 789999999975432  3557889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++...   ...+++..+..++.++++||.|||..   +++||||+|+||++++++.++|+|||.+.......
T Consensus        79 ~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          79 CSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            9999999998543   25689999999999999999999986   89999999999999999999999999998764432


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      .   .....++..|++||+. ...++.++||||||+++|||++|+.||.............             ....+.
T Consensus       153 ~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~~~  216 (253)
T cd05122         153 A---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-------------TNGPPG  216 (253)
T ss_pred             c---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-------------hcCCCC
Confidence            1   2335577889999988 4568899999999999999999999997543211110000             000000


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..  .....+..+.+++.+||+.||++|||+.|++++
T Consensus       217 ~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         217 LR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00  011124578899999999999999999999874

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.8e-34  Score=300.98  Aligned_cols=270  Identities=24%  Similarity=0.311  Sum_probs=197.7

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC----
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG----  511 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----  511 (720)
                      ...++|+..+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578888999999999999999764 6899999999754433444567788999999999999999999987654    


Q ss_pred             ------eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeE
Q 004994          512 ------QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR  585 (720)
Q Consensus       512 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  585 (720)
                            ..++|+||+++ ++.+.+...   ...+++.....++.+++.||+|||+.   +|+||||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  78999999986 676666432   34689999999999999999999987   999999999999999999999


Q ss_pred             EccccCCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 004994          586 VSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       586 l~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      |+|||++........ ........+..|+|||...  ..++.++|||||||++|||++|+.||...........+.....
T Consensus       157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999987643321 1112233466899999873  3478899999999999999999999975432211111110000


Q ss_pred             c-----cCchhhhhhh--cCC------CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 R-----LHDIDALSRM--VDP------SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 ~-----~~~~~~~~~~--~~~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .     ..+.......  .++      ... ......+..+.+++.+||+.||++||++++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0     0000000000  000      000 0011234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.4e-34  Score=308.92  Aligned_cols=269  Identities=21%  Similarity=0.321  Sum_probs=198.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc----CCeE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE----HGQH  513 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~  513 (720)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++............+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            36788889999999999999954 569999999997654333455677889999999999999999998753    3468


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++||||+. ++|.+++..    ...+++.....++.++++||+|||+.   +|+||||||+||++++++.+||+|||+++
T Consensus        84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999996 588888753    24588999999999999999999987   89999999999999999999999999997


Q ss_pred             CCCCCCCc--ccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccc----c
Q 004994          594 LLFSGSTN--ELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR----L  665 (720)
Q Consensus       594 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~----~  665 (720)
                      ........  .......++..|+|||.+.  ..++.++|||||||++|||++|+.||...........+......    +
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            65332211  1122346778899999873  35899999999999999999999999654321111000000000    0


Q ss_pred             Cc---hhhhhhhcC---CCCC---chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          666 HD---IDALSRMVD---PSLD---GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       666 ~~---~~~~~~~~~---~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+   .+...+..+   ....   .......+.++.+++.+||+.+|++|||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00   000000000   0000   00112235678999999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=309.25  Aligned_cols=249  Identities=22%  Similarity=0.351  Sum_probs=198.7

Q ss_pred             CCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          442 FSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      |.+..-||.|+||+||+|..+ ++-..|.|++.-  ......++|+-|+++|..++||+||++++.|...+.++++.|||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            444567999999999999554 455567777742  22445678999999999999999999999888888999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      +||-...++..   ..+.+...++..++.+++.||.|||+.   +|||||||+-|||++-+|.++|+|||++-...  .+
T Consensus       112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t  183 (1187)
T KOG0579|consen  112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--ST  183 (1187)
T ss_pred             CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch--hH
Confidence            99999888753   456788999999999999999999997   99999999999999999999999999975431  22


Q ss_pred             cccccCccccccCCCCccC------CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          601 NELSEGLLTAHGSGAPEFE------SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~------~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ......++||++|||||+.      ..+|+.++||||||+.|.||..+.+|.....+..  .++....           -
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllKiaK-----------S  250 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAK-----------S  250 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHHHhh-----------c
Confidence            3344568999999999975      3469999999999999999999999976543211  1111100           0


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      -.|.+  ..+..+...|.|++.+||.++|..||++.++++|
T Consensus       251 ePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  251 EPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            01221  1344566789999999999999999999999975

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-34  Score=297.03  Aligned_cols=249  Identities=25%  Similarity=0.292  Sum_probs=198.1

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-CCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      +|...+.||+|+||.||+|... +++.||+|.+.+... .....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4677789999999999999664 689999999975432 22445788999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+.+++|.+++...    ..+++.....++.++++||.|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999988532    4688899999999999999999987   8999999999999999999999999998766433


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .   ......++..|+|||.. ...++.++|+||||+++|+|++|+.||.............              ....
T Consensus       154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------------~~~~  216 (258)
T cd05578         154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA--------------KQET  216 (258)
T ss_pred             c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH--------------Hhcc
Confidence            2   12234567789999988 4457999999999999999999999997544221111110              0000


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCH--HHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPM--SEIVQ  714 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~evl~  714 (720)
                       .....+...+..+.+++.+||+.||.+||++  +|+++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             0011122334678899999999999999999  77654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.5e-34  Score=291.90  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=202.5

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|...+.||+|+||.||++.. .+++.||+|++..........+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            466778999999999999965 4689999999975544445567789999999999999999999999988999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++.........+++.....++.++++||.|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999865432346789999999999999999999987   99999999999999999999999999997664332


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                        .......++..|+|||.. ...++.++||||+|+++++|++|+.||.......   .....         ..... +.
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~---------~~~~~-~~  222 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKI---------LKGQY-PP  222 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHHH---------hcCCC-CC
Confidence              122334567889999987 5568899999999999999999999996543111   00000         00000 01


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +    +.....++.+++.+||..+|++|||+.|++++
T Consensus       223 ~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         223 I----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1    11233568899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=308.34  Aligned_cols=266  Identities=19%  Similarity=0.316  Sum_probs=195.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-----Ce
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-----GQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  512 (720)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|+.++++++|+||+++++++...     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            46788999999999999999954 578999999986422 233456688899999999999999999987543     35


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++|+||+++ ++.+++..     ..+++.....++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        83 ~~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          83 VYIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence            7999999985 77776642     4588899999999999999999987   8999999999999999999999999999


Q ss_pred             CCCCCCCCc-ccccCccccccCCCCccC-C-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          593 PLLFSGSTN-ELSEGLLTAHGSGAPEFE-S-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       593 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      +........ .......++..|+|||.. . ..++.++|||||||++|||++|+.||...+............. ....+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~-~~~~~  232 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG-TPSQE  232 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC-CCCHH
Confidence            765432211 112234578889999976 3 4588999999999999999999999965432111000000000 00001


Q ss_pred             hhhhhcCCC-------------CCc-hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPS-------------LDG-AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~-------------~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....+.+..             ... ........++.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111111100             000 0011224568899999999999999999999976

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=337.13  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=203.0

Q ss_pred             HHhcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ..+-++..+.+||.|.||.||-| ..++|...|+|.++-........+...+|+.++..++|||+|++||+=.+.+..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            34567888899999999999999 56789999999987443335555678899999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      -||||.+|+|.+++...    .-.++.....+..|++.|++|||+.   +||||||||.||+||.+|.+|++|||.|..+
T Consensus      1312 FMEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence            99999999999999543    2344555666788999999999997   9999999999999999999999999999877


Q ss_pred             CCCCCc--ccccCccccccCCCCccCCCC----CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          596 FSGSTN--ELSEGLLTAHGSGAPEFESGS----YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       596 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~----~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      ......  ..-....||+.|||||.++|.    -..+.||||+|||+.||+||+.||...+..       |.+       
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aI------- 1450 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAI------- 1450 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHH-------
Confidence            543211  112356799999999999653    345899999999999999999999754321       111       


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       +-.+ ...-....+....++-.+++.+||+.||++|.++.|++++
T Consensus      1451 -My~V-~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1451 -MYHV-AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -HhHH-hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence             0000 0011112334466778899999999999999999998875

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.6e-34  Score=292.68  Aligned_cols=244  Identities=21%  Similarity=0.277  Sum_probs=193.4

Q ss_pred             eccCCCceEEEEEeC-CCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          448 IGEGLLGSVYKAELP-GGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       448 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      ||+|++|.||+|... +++.||+|++.+... .....+.+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999664 589999999975432 223456789999999999999999999999999999999999999999


Q ss_pred             HHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccccc
Q 004994          526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE  605 (720)
Q Consensus       526 ~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  605 (720)
                      .+++...    ..+++..+..++.++++||.|||+.   +++|+||||+||+++.++.+||+|||+++......   ...
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            9998542    3478889999999999999999986   99999999999999999999999999998764332   122


Q ss_pred             CccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhh
Q 004994          606 GLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL  684 (720)
Q Consensus       606 ~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  684 (720)
                      ...++..|++||.. ...++.++|+||||+++|||++|+.||....... .             +....+.+......++
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~-------------~~~~~~~~~~~~~~~~  216 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-M-------------EIYNDILKGNGKLEFP  216 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-H-------------HHHHHHhccCCCCCCC
Confidence            34567889999987 4568999999999999999999999997543211 0             0111111111111122


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          685 AKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       685 ~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                      .....++.+++.+||+.+|++||+     ++|++++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            223467899999999999999999     7888763

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.6e-34  Score=295.88  Aligned_cols=246  Identities=25%  Similarity=0.312  Sum_probs=190.6

Q ss_pred             eccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          448 IGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       448 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      ||+|+||+||+|.. .+|+.||+|.+.+... .....+.+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999954 5789999999865322 223345678899999999999999999999999999999999999999


Q ss_pred             HHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccccc
Q 004994          526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE  605 (720)
Q Consensus       526 ~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  605 (720)
                      .+++....  ...+++..+..++.+++.||.|||+.   +++||||+|+||++++++.+||+|||++.......   ...
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~  152 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK  152 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence            99886432  24688999999999999999999987   99999999999999999999999999987653311   122


Q ss_pred             CccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhh
Q 004994          606 GLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL  684 (720)
Q Consensus       606 ~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  684 (720)
                      ...++..|+|||.. .+.++.++|||||||++|||++|+.||.............             +.... .....+
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~~-~~~~~~  218 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK-------------RRTLE-MAVEYP  218 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-------------hcccc-ccccCC
Confidence            34567789999987 5568999999999999999999999996543211111000             00000 000111


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          685 AKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       685 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      ....+.+.+++.+||+.||++||     ++.+++++
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            22346788999999999999999     77777653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.8e-34  Score=302.71  Aligned_cols=264  Identities=22%  Similarity=0.276  Sum_probs=191.1

Q ss_pred             eeccC--CCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          447 FIGEG--LLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       447 ~lg~G--~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      .||+|  +||+||++.. .+|+.||+|.+..........+.+.+|+.+++.++||||++++++|...+..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  9999999965 57999999998754333344577889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC-cc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST-NE  602 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~  602 (720)
                      ++.+++....  ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+|++||+.+........ ..
T Consensus        85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9999886432  23578888999999999999999987   899999999999999999999999986543321110 00


Q ss_pred             ----cccCccccccCCCCccCCC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhh------cccccCch
Q 004994          603 ----LSEGLLTAHGSGAPEFESG---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRW------AIPRLHDI  668 (720)
Q Consensus       603 ----~~~~~~~~~~~~aPE~~~~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~------~~~~~~~~  668 (720)
                          ......++..|++||+..+   .++.++|||||||++|||++|+.||......... .....      ........
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                0011123456999999843   4789999999999999999999999754321100 00000      00000000


Q ss_pred             h-----------------hh-----hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 D-----------------AL-----SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~-----------------~~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .                 ..     ..+.+..+...........+.+++.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            0                 00     00011111112233456788999999999999999999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3e-35  Score=284.59  Aligned_cols=272  Identities=20%  Similarity=0.277  Sum_probs=200.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC-----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc-CCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG-----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-HGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~  513 (720)
                      ..|+....||+|.||.||+|...+     .+.+|+|+++.+...........+|+.++++++||||+.+..++.+ +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            467788999999999999994322     2379999998765555566778899999999999999999999877 6789


Q ss_pred             EEEEeeCCCCCHHHHhhccc-hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC----CCeEEcc
Q 004994          514 LLVYDYGGNCTLHDLLHSDE-EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK----LIVRVSD  588 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~D  588 (720)
                      ++++||.+. +|.++++... ...+.++......|+-|+..|+.|||+.   =|+||||||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 7888876432 2235788888999999999999999997   69999999999999877    8999999


Q ss_pred             ccCCCCCCCCC-CcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc------hhh
Q 004994          589 CGLAPLLFSGS-TNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS------LVR  659 (720)
Q Consensus       589 FGla~~~~~~~-~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~------~~~  659 (720)
                      ||+|+.+...- .-.......-|.+|+|||.+-  ..|+.+.||||.|||..||+|-++-|.....+-...      .+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999875432 122334566789999999983  469999999999999999999998886543221111      000


Q ss_pred             h-----cccccCchhhhhhhcCC--------------C-CCchhhHH--HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          660 W-----AIPRLHDIDALSRMVDP--------------S-LDGAYLAK--SLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       660 ~-----~~~~~~~~~~~~~~~~~--------------~-~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .     ..+.-.++..+..+-+.              . +...+...  -.+...+|+.++|..||.+|.|+++++++
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            0     00111122222222111              0 00000000  11336799999999999999999999876

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.3e-34  Score=307.55  Aligned_cols=266  Identities=20%  Similarity=0.304  Sum_probs=197.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-----Ce
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-----GQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  512 (720)
                      .++|...+.||+|+||+||+|.. .+++.||||.+............+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788889999999999999954 5789999999875443344456778899999999999999999988643     35


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||+. ++|.+++..    ...+++.....++.++++||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999997 588888753    34688899999999999999999987   8999999999999999999999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC----
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH----  666 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----  666 (720)
                      +......  .......++..|+|||...  ..++.++|||||||++|||++|+.||....................    
T Consensus       156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            8664321  1222345677899999873  4689999999999999999999999965432111110000000000    


Q ss_pred             ---chhhhhhhc-------CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 ---DIDALSRMV-------DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 ---~~~~~~~~~-------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         ......+.+       ++.... .....+.++.+++.+||+.+|++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence               000000000       000000 111245678899999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=290.07  Aligned_cols=252  Identities=20%  Similarity=0.277  Sum_probs=194.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc---ccccHHHHHHHHHHHHccCCCceeEEEeEeccC--CeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS---QRQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~  513 (720)
                      .+|...+.||+|+||.||+|.. .+++.||+|.+.....   .......+.+|++++++++|+||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688889999999999999964 5689999998753211   123446788999999999999999999998653  468


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++++||+++++|.+++..    ...+++....+++.+++.||.|||+.   +++||||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            899999999999998853    23477888999999999999999987   89999999999999999999999999998


Q ss_pred             CCCCCCC-cccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          594 LLFSGST-NELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       594 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ....... ........++..|+|||+.. ..++.++|||||||++|||++|+.||.......                ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~  218 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA----------------AI  218 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----------------HH
Confidence            6532111 11112345778899999984 458899999999999999999999996532111                01


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ............+....+++.+++.+|++ +|..||++.+++.+
T Consensus       219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            11111111111223344678899999999 57999999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-34  Score=288.16  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=193.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHc--cCCCceeEEEeEeccC-C---eE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR--LRHGNIVELIGYCNEH-G---QH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~-~---~~  513 (720)
                      ++....+.||+|.||+||+|++. |..||||++..     .+.+.+.+|.++.+.  |+|+||+.+++.-..+ +   ++
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            44556789999999999999885 67899999963     234567777777755  5999999999876432 2   78


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeEEcCCCCeEEcc
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV-----CEPPIVHGNFKSSNILLDEKLIVRVSD  588 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivHrDlkp~NiLl~~~~~~kl~D  588 (720)
                      +||++|.++|||+|+|..     ..++....++++..+|.||++||..     ..|.|.|||||+.|||+.+++..-|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            999999999999999953     5688889999999999999999974     367899999999999999999999999


Q ss_pred             ccCCCCCCCCCC--cccccCccccccCCCCccCCCCCC-------CccchHhHHHHHHHHHhC----------CCCCCCC
Q 004994          589 CGLAPLLFSGST--NELSEGLLTAHGSGAPEFESGSYS-------CQSDVYSLGVVMLELLTG----------RKPYDRS  649 (720)
Q Consensus       589 FGla~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~-------~~~Dv~S~Gvvl~elltG----------~~Pf~~~  649 (720)
                      +|+|-.......  ........||..|||||++.....       ..+||||||.|+||+..+          +.||.+-
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            999966543321  112345679999999999854322       258999999999999863          3555432


Q ss_pred             CCccccchhhhcccccCchhhhhhh-----cCCCCCc-hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          650 RPRGEQSLVRWAIPRLHDIDALSRM-----VDPSLDG-AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       650 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      -+.+.            ..+.+.++     +.|..+. ....+++..+.++|+.||..+|.-|-|+-.+-+.|.++
T Consensus       440 Vp~DP------------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  440 VPSDP------------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             CCCCC------------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            22111            01111111     1122221 12345677889999999999999999999998888765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.6e-34  Score=323.78  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=186.9

Q ss_pred             HHHhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC----
Q 004994          436 QQYTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH----  510 (720)
Q Consensus       436 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~----  510 (720)
                      .+..++|++.++||+||||.|||++-+ ||+.||||++.-.. .........+|++.+.+|+|||||+++..+.+.    
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            456778899999999999999999654 89999999998654 344556778999999999999999976532000    


Q ss_pred             --------------------------------------------------------------------------------
Q 004994          511 --------------------------------------------------------------------------------  510 (720)
Q Consensus       511 --------------------------------------------------------------------------------  510 (720)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHH
Q 004994          511 -----------------------------------GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL  555 (720)
Q Consensus       511 -----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L  555 (720)
                                                         -.+||-||||+...+.++++.....   -......+++.+|++||
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGL  710 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHH
Confidence                                               1246788888887777776533211   02445678999999999


Q ss_pred             HHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC----------------CCCCcccccCccccccCCCCccC
Q 004994          556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF----------------SGSTNELSEGLLTAHGSGAPEFE  619 (720)
Q Consensus       556 ~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~~~~~~~aPE~~  619 (720)
                      +|+|+.   +||||||||.||++|++..|||+|||+|+...                .+..........||.-|+|||.+
T Consensus       711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            999998   89999999999999999999999999998731                01111133456789999999998


Q ss_pred             C--C--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch--hhHHHHHHHHH
Q 004994          620 S--G--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA--YLAKSLSRFAD  693 (720)
Q Consensus       620 ~--~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~  693 (720)
                      .  .  .|+.|+|+||+|||++||+.   ||...-+.               ...+....++.++..  +.....+.-.+
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER---------------a~iL~~LR~g~iP~~~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER---------------ASILTNLRKGSIPEPADFFDPEHPEEAS  849 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc---cCCchHHH---------------HHHHHhcccCCCCCCcccccccchHHHH
Confidence            3  2  59999999999999999995   66532111               011111122222211  22222334459


Q ss_pred             HHHHHhccCCCCCCCHHHHHH
Q 004994          694 IISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       694 l~~~cl~~dP~~RPt~~evl~  714 (720)
                      ++.++++.||.+|||+.|+|.
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhh
Confidence            999999999999999999985

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-34  Score=306.28  Aligned_cols=262  Identities=19%  Similarity=0.302  Sum_probs=192.8

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC------
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH------  510 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------  510 (720)
                      ..++|...+.||+|+||.||+|.. .+|+.||||++............+.+|++++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            347888899999999999999965 5789999999875443334456788999999999999999999988654      


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                      ...++|+||+.. +|.++.      ...+++.....++.++++||+|||..   +|+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             ceEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence            356899999875 666554      23578888999999999999999987   89999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      +++.....     .....++..|+|||...  ..++.++|||||||++|||++|+.||...........+....+ ....
T Consensus       163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~  236 (342)
T cd07879         163 LARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG-VPGP  236 (342)
T ss_pred             CCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCCH
Confidence            99765321     12245677899999873  3588999999999999999999999975432111111100000 0000


Q ss_pred             hhhh--------hhcC--CCC-Cchh---hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALS--------RMVD--PSL-DGAY---LAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~--------~~~~--~~~-~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....        ....  +.. ....   .......+.+++.+||+.||++||+++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000        0000  000 0000   01123567899999999999999999999965

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.7e-33  Score=292.32  Aligned_cols=243  Identities=25%  Similarity=0.304  Sum_probs=186.3

Q ss_pred             eeccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHHH---HHHHccCCCceeEEEeEeccCCeEEEEEeeCC
Q 004994          447 FIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLELA---STISRLRHGNIVELIGYCNEHGQHLLVYDYGG  521 (720)
Q Consensus       447 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~---~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  521 (720)
                      +||+|+||.||+|.. .+++.||+|.+.+.... ......+..|.   +.++...||||+.+++++.+.+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999965 56899999998754322 12222333343   34555689999999999999999999999999


Q ss_pred             CCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCc
Q 004994          522 NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN  601 (720)
Q Consensus       522 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  601 (720)
                      +++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+|||+++.+....  
T Consensus        81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            9999988843    34689999999999999999999987   89999999999999999999999999987653221  


Q ss_pred             ccccCccccccCCCCccCC-C-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCC
Q 004994          602 ELSEGLLTAHGSGAPEFES-G-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL  679 (720)
Q Consensus       602 ~~~~~~~~~~~~~aPE~~~-~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  679 (720)
                        .....++..|+|||... + .++.++|||||||++|||++|+.||............           ......++.+
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-----------~~~~~~~~~~  218 (278)
T cd05606         152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------RMTLTMAVEL  218 (278)
T ss_pred             --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-----------HHhhccCCCC
Confidence              12345788999999984 3 5899999999999999999999999754322111100           0000011111


Q ss_pred             CchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          680 DGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       680 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      .    ...+.++.+++.+|+..+|++||     +++|++++
T Consensus       219 ~----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         219 P----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             C----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            1    12246788999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-34  Score=295.48  Aligned_cols=265  Identities=20%  Similarity=0.318  Sum_probs=198.6

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      |...+.||+|++|.||+|.. .+++.+|+|++............+.+|++++++++|+||+++++++...+..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            45668899999999999965 47899999998765444345577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      ++ ++.+.+...   ...+++..+..++.++++||.|||+.   +|+|+||||+||++++++.+||+|||.+....... 
T Consensus        81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            85 888877532   24688999999999999999999987   89999999999999999999999999997764432 


Q ss_pred             cccccCccccccCCCCccCC-C-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh-hhc-------ccccCchh-
Q 004994          601 NELSEGLLTAHGSGAPEFES-G-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWA-------IPRLHDID-  669 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~~-~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~-------~~~~~~~~-  669 (720)
                       .......++..|+|||... . .++.++||||||+++|+|+||+.||......+....+ +..       ...+.+.. 
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence             1122245677899999873 3 5889999999999999999999999654322111100 000       00000000 


Q ss_pred             hh-hhhcCCCC--CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 AL-SRMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~-~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .. ........  ........+.++.+++.+||+.||.+||++++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00 00000000  011122345789999999999999999999999874

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=292.30  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=192.6

Q ss_pred             CCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHcc---CCCceeEEEeEeccCCe-----
Q 004994          442 FSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL---RHGNIVELIGYCNEHGQ-----  512 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~-----  512 (720)
                      |+..+.||+|+||.||+|... +++.||+|+++...........+..|+++++++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            456788999999999999765 589999999975443333344566677766655   69999999999987766     


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .+++|||+.+ +|.+++....  ...+++..+..++.++++||.|||+.   +++|+||+|+||++++++.+||+|||++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999985 7888875422  23589999999999999999999987   8999999999999999999999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhh---------hc
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVR---------WA  661 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~---------~~  661 (720)
                      .......   ......++..|+|||.. ...++.++|||||||++|||++|+.||.......... +.+         |.
T Consensus       155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence            7763321   11223467789999988 4568999999999999999999999997543221110 000         00


Q ss_pred             ccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ................. ......+....+.+++.+||+.||++||+++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         232 RNVSLPRSSFPSYTPRS-FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCcccchhhcccccccc-hhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            00000000000000000 011112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=8.6e-34  Score=297.47  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=190.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC-CcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|...+ ++.||||.++.... .....++.+|++++.+. .|+||+++++++.+....++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            567788999999999999997754 89999999975432 22345566677766666 4999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++ .+.++...   ....+++..+.+++.++++||+|||+.  ++|+||||+|+||++++++.+||+|||++..+..
T Consensus        94 e~~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            99865 67766643   234788999999999999999999974  2899999999999999999999999999976643


Q ss_pred             CCCcccccCccccccCCCCccCCC-----CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG-----SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ...   .....++..|+|||...+     .++.++||||||+++|||++|+.||....... .              .+.
T Consensus       168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~--------------~~~  229 (296)
T cd06618         168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-E--------------VLT  229 (296)
T ss_pred             CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-H--------------HHH
Confidence            221   122346678999998843     37889999999999999999999996422110 0              011


Q ss_pred             hhcCCCCCc-hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDG-AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ......... ........++.+++.+||+.||++||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         230 KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111100000 0000134578899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=287.67  Aligned_cols=249  Identities=25%  Similarity=0.437  Sum_probs=199.6

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|+..+.||+|++|.||++.. .+++.||+|.+..........+.+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            467789999999999999965 4688999999976544334567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++...    ..+++..+..++.+++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999988532    5689999999999999999999987   99999999999999999999999999998764432


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      ..  .....++..|+|||.. ...++.++||||||+++|||++|+.||.........    +..         .....+.
T Consensus       154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~----~~~---------~~~~~~~  218 (254)
T cd06627         154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL----FRI---------VQDDHPP  218 (254)
T ss_pred             cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHH---------hccCCCC
Confidence            21  2234567889999987 445789999999999999999999999653311100    000         0000011


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                          .+...+..+.+++.+||..+|++|||+.+++.+
T Consensus       219 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         219 ----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             ----CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                111234678899999999999999999999863

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-35  Score=295.11  Aligned_cols=247  Identities=23%  Similarity=0.291  Sum_probs=201.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      +.|..-++||+|+||.||-++. .+|+.||.|.+.+... .+......+.|-.++.++..+.||.+--.|+..+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5688889999999999999954 5799999999865432 3344456678889999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ..|.||+|.-.+...  +...|+.+...-++.+|+.||++||..   +||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus       265 tlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999998777543  346799999999999999999999998   999999999999999999999999999988865


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      +..   ..+..||.||||||++ .+.|+...|+||+||++|||+.|+.||.....+...             +.+.+.+-
T Consensus       340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------eEvdrr~~  403 (591)
T KOG0986|consen  340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------EEVDRRTL  403 (591)
T ss_pred             CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------HHHHHHHh
Confidence            543   3345899999999999 557999999999999999999999999754433221             11111111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCC
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPP  708 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt  708 (720)
                       .....+++..+++..++....|++||++|..
T Consensus       404 -~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  404 -EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             -cchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence             1112344556678899999999999999964

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-34  Score=301.27  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ...|...+.||+|.|++|..|.+ .++..||||.+.+..........+.+|+++|..++|||||+++.+......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            45788889999999999999965 56999999999887766666667999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+.+|.+++++...    ..........++.|+..|++|+|+.   .|||||||++||||+.+.++||+|||++..+..
T Consensus       135 eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  135 EYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999643    3344467778899999999999998   899999999999999999999999999998853


Q ss_pred             CCCcccccCccccccCCCCccCCC-C-CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG-S-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~-~-~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                         ..+.....|++.|.|||+..| . .++++|+||+||++|-|+.|..||++..-+.-...+..           .++.
T Consensus       208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-----------gk~r  273 (596)
T KOG0586|consen  208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-----------GKYR  273 (596)
T ss_pred             ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-----------eeec
Confidence               334556788999999999855 3 46799999999999999999999986443221110000           0000


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                             .+-....+..+++++++..+|.+|++++++.++
T Consensus       274 -------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  274 -------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             -------ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                   011122456799999999999999999998865

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-33  Score=297.67  Aligned_cols=264  Identities=20%  Similarity=0.273  Sum_probs=189.3

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      +.+|.|+++.||++.. +++.||||++..........+.+.+|+++++.++|+||+++++++.+.+..+++|||+++|+|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3444455555555543 689999999976533344567899999999999999999999999999999999999999999


Q ss_pred             HHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCc----
Q 004994          526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN----  601 (720)
Q Consensus       526 ~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~----  601 (720)
                      .+++....  ...+++.....++.++++||+|||+.   +|+||||||+||+++.++.+||+|||.+..+......    
T Consensus        87 ~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          87 EDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            99986432  23577888889999999999999987   8999999999999999999999999998755322111    


Q ss_pred             -ccccCccccccCCCCccCCC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhcccccCchh-------
Q 004994          602 -ELSEGLLTAHGSGAPEFESG---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIPRLHDID-------  669 (720)
Q Consensus       602 -~~~~~~~~~~~~~aPE~~~~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~-------  669 (720)
                       .......++..|+|||.+.+   .++.++|||||||++|||++|+.||......... .......+...+..       
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence             11122345678999998743   4889999999999999999999999753321100 00000000000000       


Q ss_pred             hhhh----hcCCC----CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSR----MVDPS----LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~----~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....    ..++.    ...........++.+++.+||+.||++|||++|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0000    00000    0011222344678899999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-33  Score=302.94  Aligned_cols=272  Identities=19%  Similarity=0.259  Sum_probs=200.1

Q ss_pred             cCHHHHHHHhcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEec
Q 004994          430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN  508 (720)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~  508 (720)
                      ....++..++++|...+.||+|+||.||+|. ..+|+.||+|++..........+.+.+|++++++++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            4556777788999999999999999999995 467899999999754333334567889999999999999999999885


Q ss_pred             cC------CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC
Q 004994          509 EH------GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL  582 (720)
Q Consensus       509 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  582 (720)
                      ..      ...+++++++ +++|.+++..     ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence            32      3467888876 6789887742     3588999999999999999999987   899999999999999999


Q ss_pred             CeEEccccCCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhh
Q 004994          583 IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVR  659 (720)
Q Consensus       583 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~  659 (720)
                      .+||+|||+++.....     .....++..|+|||...  ..++.++|||||||++|||++|+.||.......... +.+
T Consensus       158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999998765321     12345678899999873  357889999999999999999999996543221111 111


Q ss_pred             hcc-------cccCchh--hhhhhcCCCCCc---hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          660 WAI-------PRLHDID--ALSRMVDPSLDG---AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       660 ~~~-------~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...       ..+.+..  ......+.....   ........++.+++.+|++.||.+||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000       0000000  000000000000   0001124568899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=257.35  Aligned_cols=266  Identities=19%  Similarity=0.271  Sum_probs=201.6

Q ss_pred             CCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|...++||+|.||+||||+ +++++.||+|+++....+........+|+.++++++|+|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45566889999999999995 56799999999987666666677889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      |.. +|..+..   .....++.......+.|+.+||.|.|+.   ++.|||+||.|.|++.+|+.|++|||+|+.++-.-
T Consensus        83 cdq-dlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            986 6776664   3356688888999999999999999987   89999999999999999999999999998764321


Q ss_pred             CcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhccccc--Cchhhhhhh
Q 004994          600 TNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRL--HDIDALSRM  674 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  674 (720)
                        .-.....-|.+|.+|+.+.|  -|+...|+||-|||+.|+.. |++-|.+.+-.+....+-|.....  ..+..+.+.
T Consensus       156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence              11122345789999998843  59999999999999999987 777776654333222222221111  112222222


Q ss_pred             cCCCCCchhh-----HH----HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYL-----AK----SLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~-----~~----~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .|...-..|+     ..    ....-++++.+.+.-+|.+|.++++.+++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            2322211111     11    12345789999999999999999999875

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.4e-33  Score=295.40  Aligned_cols=261  Identities=16%  Similarity=0.199  Sum_probs=180.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCC----CcEEEEEEeccccccccc---------HHHHHHHHHHHHccCCCceeEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPG----GKLLAVKKLSNTVSQRQT---------DEEFLELASTISRLRHGNIVELIG  505 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~---------~~~~~~e~~~l~~l~H~niv~l~~  505 (720)
                      .+.|...++||+|+||+||+|...+    +..+|+|...........         ......+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3578889999999999999997643    456666654321110000         112233345566779999999999


Q ss_pred             EeccCC----eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC
Q 004994          506 YCNEHG----QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK  581 (720)
Q Consensus       506 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~  581 (720)
                      ++....    ..++++|++.. ++.+.+..    ....++.....++.|+++||+|||+.   +|+||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            765433    44677777654 55555532    22356778889999999999999987   99999999999999999


Q ss_pred             CCeEEccccCCCCCCCCCCc-----ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc
Q 004994          582 LIVRVSDCGLAPLLFSGSTN-----ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ  655 (720)
Q Consensus       582 ~~~kl~DFGla~~~~~~~~~-----~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~  655 (720)
                      +.+||+|||+|+.+......     .......+|..|+|||.. ...++.++|||||||++|||++|+.||........ 
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-  241 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-  241 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-
Confidence            99999999999876432211     111224588999999988 45689999999999999999999999975422111 


Q ss_pred             chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                       .+...     ..+...++..+...   ...++.++.+++..|+..+|++||+++++++.++
T Consensus       242 -~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 -LIHAA-----KCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             -HHHHh-----HHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence             01000     00111111111110   1123467889999999999999999999998763

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=272.56  Aligned_cols=252  Identities=19%  Similarity=0.230  Sum_probs=196.4

Q ss_pred             HHhcCCCCC-CeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEecc----
Q 004994          437 QYTNSFSEG-NFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNE----  509 (720)
Q Consensus       437 ~~~~~~~~~-~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----  509 (720)
                      ..+++|++. ++||-|-.|+|-.+. ..+|+.+|+|++...       ...++|++..-.. .|||||.++++|..    
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            356777764 689999999999985 457999999999643       3456777776555 79999999999864    


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---CCCeEE
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIVRV  586 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl  586 (720)
                      ...+++|||.|+||.|+..+++.  +...|++.+...|+.+|+.|+.|||+.   +|.||||||+|+|...   +-.+||
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence            34678999999999999998753  356799999999999999999999998   9999999999999964   557899


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      +|||+|+.-...   .....-.-|++|.|||.++ ..|+..+|+||+||+||-|+.|.+||-......   +.       
T Consensus       206 tDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---is-------  272 (400)
T KOG0604|consen  206 TDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---IS-------  272 (400)
T ss_pred             cccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CC-------
Confidence            999999875432   1122234578999999994 469999999999999999999999996433211   00       


Q ss_pred             Cchhhhhhh--cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          666 HDIDALSRM--VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       666 ~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        .+.-.++  -...++...+..++++..++++.+|..+|++|.|++|++.+
T Consensus       273 --pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  273 --PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             --hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence              0111111  12233344556778889999999999999999999999864

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.8e-33  Score=287.91  Aligned_cols=250  Identities=21%  Similarity=0.285  Sum_probs=190.0

Q ss_pred             HHHHHHHhcCCCCCCee--ccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEe
Q 004994          432 IASLQQYTNSFSEGNFI--GEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYC  507 (720)
Q Consensus       432 ~~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~  507 (720)
                      ..+.....++|...+.+  |+|+||.||++.. .++..+|+|.+.......  .     |+.....+ +||||+++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~-----e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--I-----EPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--h-----hHHHHHHhhcCCCEEEEEEEE
Confidence            44555666777777766  9999999999964 578899999986432111  1     11122212 799999999999


Q ss_pred             ccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-CeEE
Q 004994          508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRV  586 (720)
Q Consensus       508 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl  586 (720)
                      ...+..++||||+++++|.+++...    ..+++.....++.|+++||.|||+.   +++||||||+||+++.++ .++|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEE
Confidence            9999999999999999999998532    3789999999999999999999987   899999999999999998 9999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      +|||+++......      ...++..|+|||.. ...++.++|||||||++|||++|+.||....... .....+     
T Consensus       152 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~-----  219 (267)
T PHA03390        152 CDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESL-----  219 (267)
T ss_pred             ecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHH-----
Confidence            9999987653221      23467889999998 5578999999999999999999999997432211 111111     


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHH
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-MSEIVQD  715 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~  715 (720)
                            ........  ......+..+.+++.+||+.+|.+||+ ++|++++
T Consensus       220 ------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        220 ------LKRQQKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ------HHhhcccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                  00011000  111234467889999999999999996 6999864

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.9e-33  Score=296.58  Aligned_cols=247  Identities=26%  Similarity=0.365  Sum_probs=191.6

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccc-ccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .|...+.||+|+||.||+|.. .+++.||+|.+... .......+++.+|+++++.++|+|++++++++...+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            355668899999999999965 46889999998642 1222334578899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+. |++.+.+...   ...+++..+..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            997 5787776432   34578889999999999999999987   8999999999999999999999999998765322


Q ss_pred             CCcccccCccccccCCCCccCC----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFES----GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                            ....++..|+|||...    +.++.++|||||||++|||++|+.||..........  .+.           +-
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~-----------~~  229 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA-----------QN  229 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHh-----------hc
Confidence                  1235677899999862    457889999999999999999999986432111100  000           00


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      ..+..   ........+.+++.+||+.+|++||++++++++-
T Consensus       230 ~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         230 ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             CCCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            00110   1112345678999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=320.31  Aligned_cols=260  Identities=24%  Similarity=0.420  Sum_probs=206.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC----C----CcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccC
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP----G----GKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEH  510 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~  510 (720)
                      ++....+.+|+|.||.|++|...    .    ...||||.++..... ...+.+..|+++|+.+ +|+||+.++|+|...
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            34445569999999999999642    1    457999999876554 6778999999999999 699999999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccc---hh-------c--cccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDE---EA-------H--KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl  578 (720)
                      +..++|+||+..|+|.++++...   ..       .  ..++....+.++.|||.|++||++.   ++|||||.++|||+
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence            99999999999999999997654   00       1  2388889999999999999999998   89999999999999


Q ss_pred             cCCCCeEEccccCCCCCCCCCCcccccCc-cccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCcccc
Q 004994          579 DEKLIVRVSDCGLAPLLFSGSTNELSEGL-LTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQ  655 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~-~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  655 (720)
                      .++..+||+|||+|+.............. .-...|||||.+ ...|+.|+|||||||+|||++| |..||.+....  .
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~  529 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--E  529 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--H
Confidence            99999999999999976554433222111 123469999998 4579999999999999999999 99999652100  0


Q ss_pred             chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                                   + +-+.+........+..+..++.++|+.||+.+|++||++.|+.+.++.+
T Consensus       530 -------------~-l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  530 -------------E-LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             -------------H-HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                         1 1112222222233445567899999999999999999999999999874

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=293.77  Aligned_cols=264  Identities=24%  Similarity=0.347  Sum_probs=194.2

Q ss_pred             CCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEEEee
Q 004994          442 FSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      |...+.||+|++|+||+|... +++.||||++...... .......+|+..+++++ |+||+++++++.+.+..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            456788999999999999764 5889999998754322 22334557889999999 99999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      + +|+|.+.+....  ...+++..+..++.+++++|.|||+.   +++|+||+|+||++++++.++|+|||+++......
T Consensus        80 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          80 M-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             C-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            9 789988886432  24689999999999999999999987   99999999999999999999999999997664321


Q ss_pred             CcccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhccccc----Cchhhhh
Q 004994          600 TNELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAIPRL----HDIDALS  672 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~----~~~~~~~  672 (720)
                      .   .....++..|+|||..  ...++.++|+||||++++||++|+.||.......... .........    .+.....
T Consensus       154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         154 P---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             C---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence            1   1234567789999987  3457899999999999999999999996543221110 000000000    0000000


Q ss_pred             hhcCCCCC-------chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLD-------GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..++....       ..........+.+++.+||+.||++|||++|++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000       00011113678899999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=305.71  Aligned_cols=199  Identities=28%  Similarity=0.405  Sum_probs=171.6

Q ss_pred             CCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC------CeEE
Q 004994          442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH------GQHL  514 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~  514 (720)
                      |...+.||+|+||.||+++ .++|+.||||.+++.. .....+...+|++++++++|+|||++++.=++.      ....
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            4445789999999999997 5789999999998654 345667889999999999999999999876543      3678


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc--CCC--CeEEcccc
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD--EKL--IVRVSDCG  590 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~--~~~--~~kl~DFG  590 (720)
                      +|||||.+|||...+...+ ....++....+.+..+++.||.|||+.   +||||||||.||++-  .+|  ..||+|||
T Consensus        94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            9999999999999997653 467799999999999999999999986   999999999999993  333  46999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDR  648 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~  648 (720)
                      .|+.+.+++   ......||..|.+||...  +.|+..+|.|||||++||.+||..||..
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            999986544   445588999999999884  7799999999999999999999999964

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=288.49  Aligned_cols=241  Identities=19%  Similarity=0.226  Sum_probs=181.2

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHH-HHHccCCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELAS-TISRLRHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||.||+|.. .+|+.||+|.+.+... .......+..|.. +....+|+|++++++++.+.+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5699999999999965 5689999999865321 1112223344444 34556899999999999999999999999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      ++|.+++..    ...+++.....++.|++.||.|||+.   +++||||+|+||++++++.+||+|||+++....     
T Consensus        82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            999999853    24578888999999999999999987   899999999999999999999999999875432     


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                       .....++..|++||.. ...++.++||||||+++|||+||+.||.............  .          ...  ....
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~----------~~~--~~~~  214 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL--S----------RRI--NWPE  214 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--h----------ccc--CCCC
Confidence             1224567789999988 4457999999999999999999999996543211100000  0          000  0000


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPMSEIV  713 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  713 (720)
                      ......+..+.+++.+||+.+|++||++.++.
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~  246 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQ  246 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHH
Confidence            01112346788999999999999999765333

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.7e-33  Score=293.53  Aligned_cols=245  Identities=26%  Similarity=0.347  Sum_probs=190.4

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      |...+.||+|+||+||+|.. .+|+.||+|++..... .....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55567899999999999965 5689999999864322 223345688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +. |++.+++..   ....+++..+..++.+++.||.|||+.   +++||||||+||++++++.+||+|||++.....  
T Consensus       103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            96 477777643   234688999999999999999999987   899999999999999999999999999864321  


Q ss_pred             CcccccCccccccCCCCccC----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          600 TNELSEGLLTAHGSGAPEFE----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                          .....++..|+|||++    .+.++.++|||||||++|||++|+.||..............             ..
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------~~  236 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------ND  236 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------------cC
Confidence                1234567889999987    24588899999999999999999999865432111100000             00


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+..   .....+..+.+++.+||+.+|.+||++.+++++
T Consensus       237 ~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 SPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000   011123467899999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.8e-34  Score=299.06  Aligned_cols=270  Identities=23%  Similarity=0.294  Sum_probs=194.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-------
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-------  510 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-------  510 (720)
                      .++|...+.||+|+||.||+|.. .+++.||||++............+.+|++++++++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            46788899999999999999965 4689999999865433333345677899999999999999999987443       


Q ss_pred             -CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          511 -GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       511 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                       ...++|+||+.. ++.+.+..   ....+++.....++.++++||.|||+.   +|+||||||+||++++++.+||+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence             356999999875 67666643   234689999999999999999999987   8999999999999999999999999


Q ss_pred             cCCCCCCCCCCccc---------ccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh
Q 004994          590 GLAPLLFSGSTNEL---------SEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV  658 (720)
Q Consensus       590 Gla~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  658 (720)
                      |+++..........         .....++..|+|||...  ..++.++|||||||++|||++|+.||...........+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99976543221111         11234567899999873  34789999999999999999999999754432211111


Q ss_pred             hhcccc-----cCchhhhhhhc----CCCCCch---hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          659 RWAIPR-----LHDIDALSRMV----DPSLDGA---YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       659 ~~~~~~-----~~~~~~~~~~~----~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ......     ......+....    .......   ........+.+++.+||+.||++|||+.|++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            100000     00000000000    0000000   011123568899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.9e-33  Score=298.99  Aligned_cols=267  Identities=21%  Similarity=0.308  Sum_probs=197.0

Q ss_pred             HHHHhcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc-CCe
Q 004994          435 LQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-HGQ  512 (720)
Q Consensus       435 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~  512 (720)
                      +..++++|+..+.||+|+||.||+|. ..+++.||+|++.+........+.+..|++++++++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            34467889999999999999999995 4579999999987544434455678899999999999999999998865 567


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++|+||++ ++|.+++..     ..+++.....++.++++||.|||+.   +|+||||||+||++++++.+||+|||++
T Consensus        85 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          85 IYFVTELLG-TDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             EEEEeehhc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            899999985 588887742     3467788888999999999999987   8999999999999999999999999998


Q ss_pred             CCCCCCCCcccccCccccccCCCCccC-C-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccch-hhhccc------
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFE-S-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL-VRWAIP------  663 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~-~~~~~~------  663 (720)
                      +......     ....++..|+|||.. . ..++.++|||||||++|||+||+.||........... .+....      
T Consensus       156 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         156 RIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             cccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            7543211     123456789999987 3 3689999999999999999999999965432111100 000000      


Q ss_pred             -ccCchhhhhhhcCCCCCch-----hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 -RLHDIDALSRMVDPSLDGA-----YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 -~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       ...+......+..-.....     ........+.+++.+||+.+|++|||+++++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0000000000000000000     001124678899999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-33  Score=289.01  Aligned_cols=244  Identities=21%  Similarity=0.288  Sum_probs=189.2

Q ss_pred             eccCCCceEEEEEeC-CCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          448 IGEGLLGSVYKAELP-GGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       448 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      ||+|+||.||++... +|+.||+|++..... .....+.+.+|++++++++|+||+++++.+......+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999765 599999999865422 224456788999999999999999999999999999999999999999


Q ss_pred             HHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC-----
Q 004994          526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST-----  600 (720)
Q Consensus       526 ~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-----  600 (720)
                      .+++...    ..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9998532    3688999999999999999999987   899999999999999999999999999876533211     


Q ss_pred             -cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          601 -NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       601 -~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                       ........++..|++||.. ...++.++||||||+++||+++|+.||.........   .             .+....
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---~-------------~~~~~~  217 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF---Q-------------NILNGK  217 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---H-------------HHhcCC
Confidence             0112234567789999987 456888999999999999999999999754322111   0             000000


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                      .........+..+.+++.+||+.+|++|||+.++.+
T Consensus       218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~  253 (265)
T cd05579         218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE  253 (265)
T ss_pred             cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence            000000012467889999999999999999944433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-33  Score=300.37  Aligned_cols=265  Identities=18%  Similarity=0.279  Sum_probs=195.8

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC----
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG----  511 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----  511 (720)
                      ...++|...+.||+|+||.||+|. ..+|..||||++..........+.+.+|++++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            356789999999999999999995 457999999998654333344567889999999999999999999886543    


Q ss_pred             --eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          512 --QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       512 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                        ..++||||+ +++|.+++..     ..+++..+..++.++++||+|||..   +|+||||||+||+++.++.+||+||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence              468999998 5688887742     3588999999999999999999987   8999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhccc---
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIP---  663 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~---  663 (720)
                      |++.......     ....++..|++||...  ..++.++|||||||++|++++|+.||......... .+......   
T Consensus       163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            9998653221     2235577899999874  35889999999999999999999999754321110 00000000   


Q ss_pred             ----ccCch--hhhhhhcCCCCCc---hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 ----RLHDI--DALSRMVDPSLDG---AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 ----~~~~~--~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                          .+...  ......+......   ........++.+++.+|++.||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                00000  0000000000000   0111234568899999999999999999999853

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.4e-33  Score=291.19  Aligned_cols=252  Identities=25%  Similarity=0.310  Sum_probs=193.4

Q ss_pred             CCCCCCeeccCCCceEEEEEe----CCCcEEEEEEeccccc--ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL----PGGKLLAVKKLSNTVS--QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  513 (720)
                      +|+..+.||+|+||.||+|..    .+|+.||+|++.....  .....+.+.+|+++++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            366778999999999999965    4689999999875322  123446788899999999 599999999999998999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++||||+++++|.+++..    ...+++.....++.++++||.|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            999999999999998853    34577888888999999999999987   99999999999999999999999999997


Q ss_pred             CCCCCCCcccccCccccccCCCCccCCC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhcccccCchh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFESG---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIPRLHDID  669 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~  669 (720)
                      ....... .......++..|+|||...+   .++.++||||||+++|||+||+.||......... .+...         
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---------  223 (290)
T cd05613         154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR---------  223 (290)
T ss_pred             ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH---------
Confidence            6533221 11223457788999999842   4678999999999999999999999643221110 00000         


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                       ... ..+.    ++......+.+++.+||+.||++||     ++++++.+
T Consensus       224 -~~~-~~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         224 -ILK-SEPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -hhc-cCCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence             000 0011    1122345678999999999999997     77777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.7e-33  Score=292.89  Aligned_cols=243  Identities=25%  Similarity=0.370  Sum_probs=191.9

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCT  524 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  524 (720)
                      ..||+|+||.||++.. .+++.||||++....  ......+.+|+.+++.++|+||+++++++...+..++||||+++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            5699999999999966 578999999985322  2345678899999999999999999999999999999999999999


Q ss_pred             HHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccc
Q 004994          525 LHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS  604 (720)
Q Consensus       525 L~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  604 (720)
                      |.+++..     ..+++.....++.+++.||+|||+.   +++||||||+||++++++.++|+|||++.......  ...
T Consensus       104 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~  173 (292)
T cd06657         104 LTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR  173 (292)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccc
Confidence            9987742     3478889999999999999999987   89999999999999999999999999987653321  112


Q ss_pred             cCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchh
Q 004994          605 EGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAY  683 (720)
Q Consensus       605 ~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  683 (720)
                      ....++.+|++||+. ...++.++|||||||++|||++|+.||...........             ......+.+..  
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-------------~~~~~~~~~~~--  238 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-------------IRDNLPPKLKN--  238 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhhCCcccCC--
Confidence            234567889999988 45689999999999999999999999964322111100             01111111110  


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          684 LAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       684 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....+..+.+++.+||+.+|.+||++.+++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            11223567899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-33  Score=299.59  Aligned_cols=267  Identities=20%  Similarity=0.293  Sum_probs=198.8

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC-----eEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG-----QHL  514 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~  514 (720)
                      +|...+.||+|++|.||+|... +++.||||++..........+.+.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4677899999999999999764 5899999999765433455578899999999999999999999987765     789


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++ +|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+|||++.++.++|+|||++..
T Consensus        81 lv~e~~~~-~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELMET-DLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchhh-hHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999984 88888753    23788999999999999999999987   899999999999999999999999999987


Q ss_pred             CCCCCCc-ccccCccccccCCCCccC-CC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC-----
Q 004994          595 LFSGSTN-ELSEGLLTAHGSGAPEFE-SG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH-----  666 (720)
Q Consensus       595 ~~~~~~~-~~~~~~~~~~~~~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----  666 (720)
                      ....... .......++..|+|||.+ .. .++.++||||||+++|+|++|+.||...........+........     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            6443210 112234567889999998 33 588999999999999999999999976543211110000000000     


Q ss_pred             --chhhhhhhcC---CCCC---chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 --DIDALSRMVD---PSLD---GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 --~~~~~~~~~~---~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ........+.   ....   .......+..+.+++.+||+.+|++|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              0000000000   0000   00011234678899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.2e-33  Score=287.29  Aligned_cols=252  Identities=19%  Similarity=0.295  Sum_probs=192.9

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccc---cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTV---SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +|...+.||+|+||.||++... .+..+++|.++...   .......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            3677789999999999999653 34556666654321   1223345677889999999999999999999998899999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++.........+++..+..++.++++||.|||+.   +++|+||||+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998865433456789999999999999999999987   9999999999999986 569999999987764


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ....  ......++..|+|||.. ...++.++|+||||+++|+|++|+.||.......   .             .....
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~-------------~~~~~  218 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---V-------------VLRIV  218 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---H-------------HHHHH
Confidence            3221  22234567789999987 4568889999999999999999999996432110   0             00111


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ... ....+...+.++.+++.+||+.+|++||++.|++++
T Consensus       219 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         219 EGP-TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             cCC-CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            100 001122344678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.6e-33  Score=297.70  Aligned_cols=266  Identities=19%  Similarity=0.267  Sum_probs=191.1

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-C--CcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEecc----CCe
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-G--GKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNE----HGQ  512 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~  512 (720)
                      +|...+.||+|+||.||++... .  +..||+|++..........+.+.+|+++++++ +||||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3666789999999999999653 4  78999999875443334456788899999999 59999999987532    245


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++++||++ ++|.+++..    ...+++.....++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            788888887 588888743    34688999999999999999999987   8999999999999999999999999999


Q ss_pred             CCCCCCCCc--ccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          593 PLLFSGSTN--ELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       593 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      +.+......  .......++..|+|||...  ..++.++|||||||++|+|++|+.||...........+..... ....
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~  231 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG-TPDE  231 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC-CCCH
Confidence            865432211  1122345788899999863  3589999999999999999999999975432111000000000 0000


Q ss_pred             hhhhhhcCC-----------CCC---chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDP-----------SLD---GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~-----------~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +...++..+           ...   ..........+.+++.+|++.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            001100000           000   00001123578899999999999999999999853

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-33  Score=290.46  Aligned_cols=265  Identities=22%  Similarity=0.318  Sum_probs=196.6

Q ss_pred             CCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          442 FSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      |+..+.||+|++|.||+|... +++.||+|.+..........+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455688999999999999664 5899999999865434445577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      + ++|.+++...   ...+++..+.+++.++++||+|||+.   +|+||||+|+||++++++.+||+|||+++.......
T Consensus        81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            8 4899998642   14688999999999999999999997   899999999999999999999999999987643221


Q ss_pred             cccccCccccccCCCCccC-CC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcc-------cccCchhh
Q 004994          601 NELSEGLLTAHGSGAPEFE-SG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAI-------PRLHDIDA  670 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~-------~~~~~~~~  670 (720)
                        .......+..|+|||.. .. .++.++|||||||++|||++|+.||.......... +.+...       ..+.+...
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence              11223346679999987 33 68899999999999999999999996543211100 000000       00000000


Q ss_pred             hhhhcCC---CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          671 LSRMVDP---SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       671 ~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .......   .............+.+++.+||+.||++||++++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0000000   00000011124578999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.2e-33  Score=291.46  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=198.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv  516 (720)
                      ++|...+.||+|+||.||+|.. .+|+.||+|++.+... .....+.+.+|.+++++++ |+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            3678889999999999999965 4799999999875322 2233467889999999998 99999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..    ...+++.....++.+++.||.|||+.   +++|+||||+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999999853    23689999999999999999999987   89999999999999999999999999987664


Q ss_pred             CCCCc------------------ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccch
Q 004994          597 SGSTN------------------ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL  657 (720)
Q Consensus       597 ~~~~~------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~  657 (720)
                      .....                  .......++..|++||.. ...++.++||||||++++|+++|+.||.......    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----  229 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----  229 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence            32210                  112234467789999987 4568899999999999999999999997543111    


Q ss_pred             hhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCH----HHHHHH
Q 004994          658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPM----SEIVQD  715 (720)
Q Consensus       658 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~evl~~  715 (720)
                                  ....+.+..  ...+...++.+.+++.+||+.+|++||++    ++++++
T Consensus       230 ------------~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         230 ------------TFQKILKLE--YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ------------HHHHHHhcC--CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                        001111000  00111224578899999999999999999    888764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6e-33  Score=296.45  Aligned_cols=268  Identities=21%  Similarity=0.273  Sum_probs=192.6

Q ss_pred             cCCC-CCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccc------------cHHHHHHHHHHHHccCCCceeEEEe
Q 004994          440 NSFS-EGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQ------------TDEEFLELASTISRLRHGNIVELIG  505 (720)
Q Consensus       440 ~~~~-~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~------------~~~~~~~e~~~l~~l~H~niv~l~~  505 (720)
                      ++|. ..+.||+|+||+||+|.. .+++.||||.++.......            ....+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 357799999999999964 5789999999864322110            1125778999999999999999999


Q ss_pred             EeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeE
Q 004994          506 YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR  585 (720)
Q Consensus       506 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  585 (720)
                      ++...+..++||||+. |+|.+++..    ...+++.....++.++++||+|||+.   +++||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            9999999999999997 589888843    34578889999999999999999987   999999999999999999999


Q ss_pred             EccccCCCCCCCCCC------------cccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 004994          586 VSDCGLAPLLFSGST------------NELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRP  651 (720)
Q Consensus       586 l~DFGla~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~  651 (720)
                      |+|||+++.......            ........++..|+|||.+.+  .++.++|||||||++|||+||+.||...+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999976541110            011112335678999998843  478999999999999999999999975543


Q ss_pred             ccccc-hhhhcc-cc---cCchhhhhhh--cCCCCCch---hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          652 RGEQS-LVRWAI-PR---LHDIDALSRM--VDPSLDGA---YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       652 ~~~~~-~~~~~~-~~---~~~~~~~~~~--~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..... +..... +.   +.....+...  ........   .......++.+++.+||+.+|++|||++|++.+
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            21110 000000 00   0000000000  00000000   011124568899999999999999999999864

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=277.04  Aligned_cols=247  Identities=26%  Similarity=0.365  Sum_probs=187.6

Q ss_pred             CeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          446 NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      ..||.|+||+|+|-.+ +.|+..|||+++.... ..+.++++.|.++..+- +.||||++||.+..++..|+.||.|+- 
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            5699999999999854 6799999999986544 34557788888876555 789999999999999999999999975 


Q ss_pred             CHHHHhhcc-chhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          524 TLHDLLHSD-EEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       524 sL~~~l~~~-~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+..+...- ......+++.....|+.....||.||...+  .|||||+||+|||+|..|.+||||||++..+..+-.  
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence            655443211 123456788888889999999999998764  799999999999999999999999999977643211  


Q ss_pred             cccCccccccCCCCccCC--C-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC---
Q 004994          603 LSEGLLTAHGSGAPEFES--G-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD---  676 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~~--~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  676 (720)
                       ...-.|-..|||||.+.  + .|+.++||||+|+.|||+.||+.||..-..  .             .+.+..++.   
T Consensus       224 -kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--v-------------feql~~Vv~gdp  287 (361)
T KOG1006|consen  224 -KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--V-------------FEQLCQVVIGDP  287 (361)
T ss_pred             -hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--H-------------HHHHHHHHcCCC
Confidence             12234667899999983  3 399999999999999999999999964211  0             011111111   


Q ss_pred             CCCC-chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          677 PSLD-GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       677 ~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                      |.+. ..........+.+++-.||.+|-+.||.+.++.+
T Consensus       288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1111 1111234567899999999999999999998865

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-33  Score=301.13  Aligned_cols=264  Identities=20%  Similarity=0.292  Sum_probs=195.8

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe----
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ----  512 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----  512 (720)
                      +.++|...+.||+|++|.||+|.. .+++.||||++..........+.+.+|+.++++++|+||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            467888899999999999999966 468899999987543333344667889999999999999999998765544    


Q ss_pred             --EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          513 --HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       513 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                        .++|+||++ ++|.+++..     ..+++.....++.++++||+|||+.   +|+||||||+||++++++.+||+|||
T Consensus        93 ~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLMG-ADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecCC-CCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              899999984 589888853     4588999999999999999999987   89999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh-hhcc-----
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWAI-----  662 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~-----  662 (720)
                      ++......     .....++..|+|||...  ..++.++|||||||++||++||+.||...........+ ....     
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence            99865322     12235677899999873  35789999999999999999999999754332111100 0000     


Q ss_pred             --cccCch--hhhhhhcCCCCCchh---hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 --PRLHDI--DALSRMVDPSLDGAY---LAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 --~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ..+...  ......+.......+   ....+.++.+++.+||+.||++|||+.||+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence              000000  000000000000000   01124678899999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=8.3e-33  Score=288.78  Aligned_cols=254  Identities=23%  Similarity=0.259  Sum_probs=193.5

Q ss_pred             CCCCCeeccCCCceEEEEEe----CCCcEEEEEEeccccc--ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEE
Q 004994          442 FSEGNFIGEGLLGSVYKAEL----PGGKLLAVKKLSNTVS--QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  514 (720)
                      |...+.||+|++|.||++..    .+++.||||.+++...  .....+.+..|++++.++ +||||+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            66678999999999999864    3578899999874321  123345788999999999 5999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++++|.+++..    ...+++.....++.|+++||.|||+.   +++||||||+||+++.++.++|+|||+++.
T Consensus        82 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          82 LILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999998853    24578888999999999999999987   899999999999999999999999999877


Q ss_pred             CCCCCCcccccCccccccCCCCccCCC-C--CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFESG-S--YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~--~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      +..... .......++..|++||...+ .  .+.++||||||+++|||+||+.||.........  .          +..
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~----------~~~  221 (288)
T cd05583         155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--S----------EIS  221 (288)
T ss_pred             cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--H----------HHH
Confidence            543221 11223456788999998743 2  688999999999999999999999643211100  0          000


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      ..+.....  ..+......+.+++.+||+.||++|||+.++.+.|+
T Consensus       222 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         222 RRILKSKP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             HHHHccCC--CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            00000000  011123356789999999999999999887766554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-33  Score=269.53  Aligned_cols=266  Identities=21%  Similarity=0.299  Sum_probs=202.9

Q ss_pred             CHHHHHHHhcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEec
Q 004994          431 TIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCN  508 (720)
Q Consensus       431 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~  508 (720)
                      .+++..+.|.     +.||+|+|+.|--+ .+.+|..||||++.+.  .........+|++++... .|+||+.++++|+
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            4677777775     78999999999988 6789999999999754  234556778999999988 6999999999999


Q ss_pred             cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC---CeE
Q 004994          509 EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL---IVR  585 (720)
Q Consensus       509 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~k  585 (720)
                      ++..+|||||-|.||.|...++.    ++.|++.+..++..+||.||.|||..   +|.|||+||+|||.....   -+|
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCcee
Confidence            99999999999999999988853    46788999999999999999999998   999999999999997554   479


Q ss_pred             EccccCCCCCCCCCC-cccc----cCccccccCCCCccC---CC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 004994          586 VSDCGLAPLLFSGST-NELS----EGLLTAHGSGAPEFE---SG---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE  654 (720)
Q Consensus       586 l~DFGla~~~~~~~~-~~~~----~~~~~~~~~~aPE~~---~~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~  654 (720)
                      ||||.++..+..... ...+    -.-.|+..|||||+.   .+   .|+.++|.||+|||+|-|+.|.+||.+.-..+-
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC  299 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC  299 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence            999998754321110 0111    123466789999975   22   489999999999999999999999975432211


Q ss_pred             cchhhhcccccC---chhhhhhhcC--CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          655 QSLVRWAIPRLH---DIDALSRMVD--PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       655 ~~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                          -|...+.=   ...-+..+-+  ..+++..+...+.+..+++...+..|+.+|-++.++++
T Consensus       300 ----GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  300 ----GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ----CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                11111110   0011122222  22334455667788999999999999999999999886

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-34  Score=273.05  Aligned_cols=268  Identities=21%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--------CC
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--------HG  511 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~~  511 (720)
                      .|....+||+|.||+||+|+. ++|+.||+|++-.+...........+|++++..++|+|++.+++.|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            345567899999999999965 568889999876544445666778899999999999999999998853        23


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      .+|+||++|+. +|.-++...   ...++..++.+++.++..||.|+|..   .|+|||+||+|+||+.++.+||+|||+
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            58999999997 788877532   35688889999999999999999997   899999999999999999999999999


Q ss_pred             CCCCCCCCCcc--cccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh--------
Q 004994          592 APLLFSGSTNE--LSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR--------  659 (720)
Q Consensus       592 a~~~~~~~~~~--~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~--------  659 (720)
                      |+.+.......  ......-|.+|++||.+-  .+|+.+.|||.-||||.||+||.+-+....+.....+++        
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            98764332211  112234488999999983  479999999999999999999998887655433322222        


Q ss_pred             hcccccCchhhhhhhc-CCCCCchhh--HHH------HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          660 WAIPRLHDIDALSRMV-DPSLDGAYL--AKS------LSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~------~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .++|.....+-...+- .|...+.+.  .+.      .++..+|+.+++..||.+|+++.+++.|
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            2223222222111111 111111110  000      1367799999999999999999999865

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=274.58  Aligned_cols=248  Identities=22%  Similarity=0.270  Sum_probs=197.6

Q ss_pred             cCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...++||+|.||+|..++ ..+|+.||+|++++++.- +.....-..|-++|+..+||.+..+.-.|...+++++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            567778999999999999994 567999999999887543 333344567889999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||..||.|.-.|..    .+.++.....-+-..|..||.|||+.   +||+||||.+|.|+|+||++||+|||+++.-  
T Consensus       248 eyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--  318 (516)
T KOG0690|consen  248 EYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE--  318 (516)
T ss_pred             EEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc--
Confidence            99999999877743    45677766667778899999999997   9999999999999999999999999999753  


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      -..........||+.|.|||++ ...|+.++|+|.+|||||||+.|+.||-..+...-..++                .-
T Consensus       319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI----------------l~  382 (516)
T KOG0690|consen  319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI----------------LM  382 (516)
T ss_pred             ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH----------------Hh
Confidence            2334455668899999999999 567999999999999999999999999654322111111                00


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQ  714 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~  714 (720)
                      ..  -.++....++...|+...|.+||.+|.     .+.||.+
T Consensus       383 ed--~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  383 ED--LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             hh--ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            00  113334446788999999999999994     4555544

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-32  Score=295.09  Aligned_cols=266  Identities=21%  Similarity=0.299  Sum_probs=190.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-------
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-------  510 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-------  510 (720)
                      ..+|...+.||+|+||.||+|.. .+|+.||+|.+....  ....+.+.+|++++++++||||+++++++...       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            35788889999999999999955 568999999986432  24456788999999999999999999876543       


Q ss_pred             -------CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-CC
Q 004994          511 -------GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KL  582 (720)
Q Consensus       511 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~  582 (720)
                             ...++||||++ ++|.+++..     ..+++.....++.|+++||.|||+.   +|+||||||+||+++. ++
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence                   35789999998 488887742     3578899999999999999999987   8999999999999974 56


Q ss_pred             CeEEccccCCCCCCCCCCcc-cccCccccccCCCCccC-C-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh
Q 004994          583 IVRVSDCGLAPLLFSGSTNE-LSEGLLTAHGSGAPEFE-S-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR  659 (720)
Q Consensus       583 ~~kl~DFGla~~~~~~~~~~-~~~~~~~~~~~~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  659 (720)
                      .+|++|||+++.+....... ......++..|+|||.. . ..++.++|||||||++|||++|+.||....+........
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            78999999997653221111 11123457789999976 3 357889999999999999999999997543322111111


Q ss_pred             hcccccCc--hhhhh-----hhc----CCCCC-chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          660 WAIPRLHD--IDALS-----RMV----DPSLD-GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       660 ~~~~~~~~--~~~~~-----~~~----~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...+....  .....     .+.    .+... .........++.+++.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00000000  00000     000    00000 00011233568899999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=283.77  Aligned_cols=258  Identities=24%  Similarity=0.343  Sum_probs=197.4

Q ss_pred             cCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEeccccc--c---cccHHHHHHHHHHHHccCCCceeEEEeEec-cCCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVS--Q---RQTDEEFLELASTISRLRHGNIVELIGYCN-EHGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~--~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~  512 (720)
                      ++|-...+||+|||+.|||| ++...+.||||+-.....  +   ....+...+|.++.+.|+||.||++|+|+. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            34555678999999999999 677889999998643221  1   122345688999999999999999999996 5678


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc---CCCCeEEccc
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD---EKLIVRVSDC  589 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DF  589 (720)
                      ++-|.|||+|-+|.=+|.    .++.++......|+++|+.||.||.+. .++|||-||||.|||+-   ..|.+||+||
T Consensus       543 FCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            899999999999988884    456788999999999999999999987 67899999999999994   4578999999


Q ss_pred             cCCCCCCCCCCc-----ccccCccccccCCCCccC--C---CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh
Q 004994          590 GLAPLLFSGSTN-----ELSEGLLTAHGSGAPEFE--S---GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR  659 (720)
Q Consensus       590 Gla~~~~~~~~~-----~~~~~~~~~~~~~aPE~~--~---~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  659 (720)
                      |+++++...++.     ..+....||+||.+||.+  .   ...+.|+||||.|||+|+.+.|+.||.....  .+++..
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq  695 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ  695 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh
Confidence            999999765544     234456789999999987  2   2478999999999999999999999975321  122222


Q ss_pred             hcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                      ...        +-....-.++  .-..+..+..++|.+||++.-++|....++..
T Consensus       696 eNT--------IlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  696 ENT--------ILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhc--------hhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            110        0000000000  00123467789999999999999988877653

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=287.63  Aligned_cols=246  Identities=21%  Similarity=0.277  Sum_probs=199.5

Q ss_pred             CCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          445 GNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      .++||.|.||+||-|. .++|+.||||++.+.........+.+.|+.+|++++||.||.+...|+..+..+.|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            4899999999999995 468999999999877666667789999999999999999999999999999999999998875


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---CCCeEEccccCCCCCCCCCC
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla~~~~~~~~  600 (720)
                      -|+-+|..   ....++.....-++.||..||.|||..   +|||+||||+|||+..   --++||||||+|+++++.  
T Consensus       649 MLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--  720 (888)
T KOG4236|consen  649 MLEMILSS---EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--  720 (888)
T ss_pred             HHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence            55555532   245677888888899999999999998   9999999999999954   348999999999998653  


Q ss_pred             cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCC
Q 004994          601 NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL  679 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  679 (720)
                       .+.....||+.|.|||.+ ...|+..-|+||.|||+|--+.|..||....+..  +.++-+          .-|..   
T Consensus       721 -sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNA----------aFMyP---  784 (888)
T KOG4236|consen  721 -SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNA----------AFMYP---  784 (888)
T ss_pred             -hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhcc----------ccccC---
Confidence             355668899999999999 5679999999999999999999999996543221  111110          01111   


Q ss_pred             CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       680 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       ..-+.+...+..|||...|+..=.+|-+....+.+
T Consensus       785 -p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  785 -PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             -CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence             12234556678899999999999999998876643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-33  Score=295.60  Aligned_cols=240  Identities=25%  Similarity=0.295  Sum_probs=189.2

Q ss_pred             HhcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      +++.|.....+|.|+|+.|-++. ..+++..+||++.+...      +-.+|+.++... +||||+++.+.+.+..+.|+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence            46677777889999999998884 56789999999976521      233455555444 79999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE-cCCCCeEEccccCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL-DEKLIVRVSDCGLAPL  594 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl-~~~~~~kl~DFGla~~  594 (720)
                      |||++.++-+.+.+...    +.+. ..+..|+.+++.|+.|||..   +||||||||+|||+ +..++++|+|||.++.
T Consensus       394 v~e~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             eehhccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            99999999888776432    2333 66778999999999999996   99999999999999 6999999999999988


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      +...     ...-.-|..|.|||+. ...|++++||||||++||||++|+.||......               .+...+
T Consensus       466 ~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------------~ei~~~  525 (612)
T KOG0603|consen  466 LERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------------IEIHTR  525 (612)
T ss_pred             Cchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------------HHHHHh
Confidence            7543     1112346789999999 457999999999999999999999999653221               112222


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +..+..    ....+.++.+|+..||+.||.+||+|.++..+
T Consensus       526 i~~~~~----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  526 IQMPKF----SECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             hcCCcc----ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            222222    13456788999999999999999999998764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=314.24  Aligned_cols=259  Identities=22%  Similarity=0.259  Sum_probs=203.1

Q ss_pred             HHHHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccc-ccccccHHHHHHHHHHHHccCCCceeEEEeEecc
Q 004994          432 IASLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHGNIVELIGYCNE  509 (720)
Q Consensus       432 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~  509 (720)
                      +.++.--.++|.+.++||+|+||.|..+++ .+++.||+|++.+- ...+.....|++|-++|..-+.+.||.+.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            344555568899999999999999999966 56899999999762 2335566789999999999999999999999999


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                      ..++|+|||||+||+|-.++....    .++......++..+.-||.-||+.   |+|||||||+|||||..|++||+||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            999999999999999999996432    466666667778888899999988   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-----C-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-----S-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-----~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      |.+-.+...+ ...+....||+-|.+||++     . |.|+..+|+||+||++|||+.|..||-...      ++.    
T Consensus       220 GsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lve----  288 (1317)
T KOG0612|consen  220 GSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVE----  288 (1317)
T ss_pred             hhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHH----
Confidence            9887665333 3345667899999999986     2 569999999999999999999999995422      111    


Q ss_pred             ccCchhhhhhhcCCCCCchhh--HHHHHHHHHHHHHHhccCCCCCCC---HHHHHHH
Q 004994          664 RLHDIDALSRMVDPSLDGAYL--AKSLSRFADIISRCVQWEPGFRPP---MSEIVQD  715 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~  715 (720)
                            .+.++++-.-.-.+|  .+++++..+||.+.+. +|+.|..   ++++-.|
T Consensus       289 ------TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  289 ------TYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             ------HHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence                  122222221111122  2356788899988775 5667776   7776544

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-32  Score=277.05  Aligned_cols=240  Identities=28%  Similarity=0.349  Sum_probs=190.0

Q ss_pred             eccCCCceEEEEEeC-CCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          448 IGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       448 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      ||+|+||.||++... +++.||+|.+.+.... ......+..|++++++++|+||+++++.+...+..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999664 5899999998754322 23456788999999999999999999999999999999999999999


Q ss_pred             HHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccccc
Q 004994          526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE  605 (720)
Q Consensus       526 ~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  605 (720)
                      .+++...    ..+++.....++.++++||.|||+.   +++|+||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~  151 (250)
T cd05123          81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN  151 (250)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence            9998532    3578999999999999999999986   99999999999999999999999999997664321  1223


Q ss_pred             CccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhh
Q 004994          606 GLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL  684 (720)
Q Consensus       606 ~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  684 (720)
                      ...++..|++||.. ....+.++|+||||+++||+++|+.||.......   ...             .+.....  ..+
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~-------------~~~~~~~--~~~  213 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYE-------------KILKDPL--RFP  213 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH-------------HHhcCCC--CCC
Confidence            34567789999988 4457889999999999999999999996533211   011             1110000  011


Q ss_pred             HHHHHHHHHHHHHHhccCCCCCCCH---HHHHH
Q 004994          685 AKSLSRFADIISRCVQWEPGFRPPM---SEIVQ  714 (720)
Q Consensus       685 ~~~~~~l~~l~~~cl~~dP~~RPt~---~evl~  714 (720)
                      ...+..+.+++.+||..||++||++   +++++
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            1224567899999999999999999   56554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-32  Score=297.70  Aligned_cols=259  Identities=25%  Similarity=0.371  Sum_probs=210.3

Q ss_pred             HHHHHHHhcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEec-
Q 004994          432 IASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCN-  508 (720)
Q Consensus       432 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~-  508 (720)
                      ++.+...+.-|++.++||.|.+|.||++. .++++..|+|++....   ..+++...|.++++.. .|||++.+||++. 
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            34444456678888999999999999994 5689999999987543   4456677888898887 7999999999884 


Q ss_pred             ----cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCe
Q 004994          509 ----EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIV  584 (720)
Q Consensus       509 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  584 (720)
                          .+++++||||||.+||..|+++...  ...+.|..+..|+..+.+||++||..   .++|||||-.|||++.++.|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence                4679999999999999999997654  56789999999999999999999987   89999999999999999999


Q ss_pred             EEccccCCCCCCCCCCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh
Q 004994          585 RVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV  658 (720)
Q Consensus       585 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  658 (720)
                      |+.|||++..+..  +........||+.|||||.+.      ..|+.++|+||+|++..||--|.+|+.+..+.-....+
T Consensus       163 KLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I  240 (953)
T KOG0587|consen  163 KLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  240 (953)
T ss_pred             EEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence            9999999988743  233345578999999999872      23788999999999999999999999765542211100


Q ss_pred             hhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       659 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                   .  ..|...-..+....++|.+++..||.+|-++||++.++++|
T Consensus       241 -------------p--RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  241 -------------P--RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             -------------C--CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                         0  11222223466778899999999999999999999999865

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=4.6e-32  Score=312.80  Aligned_cols=147  Identities=23%  Similarity=0.302  Sum_probs=129.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|... +++.||||+++... ......+.+..|+++++.++|+||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56788899999999999999664 68999999997432 22334467889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ||+.+++|.+++..    ...+++.....++.+++.||.|||..   +||||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999853    23578888999999999999999987   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=6.8e-32  Score=273.43  Aligned_cols=218  Identities=20%  Similarity=0.195  Sum_probs=171.1

Q ss_pred             CCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCHHHHh
Q 004994          451 GLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL  529 (720)
Q Consensus       451 G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l  529 (720)
                      |.+|.||++. ..+++.||+|++....       .+..|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            8999999995 4678999999996532       2334445555567999999999999999999999999999999988


Q ss_pred             hccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccc
Q 004994          530 HSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT  609 (720)
Q Consensus       530 ~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~  609 (720)
                      ..    ...+++.....++.++++||.|||+.   +|+||||||+||+++.++.++++|||.+..+....     ....+
T Consensus        77 ~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~  144 (237)
T cd05576          77 SK----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAV  144 (237)
T ss_pred             HH----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCc
Confidence            53    23588999999999999999999987   89999999999999999999999999886653321     12334


Q ss_pred             cccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHH
Q 004994          610 AHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSL  688 (720)
Q Consensus       610 ~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  688 (720)
                      +..|+|||.. .+.++.++||||+||++|||++|+.|+..... ......                 ...+    +....
T Consensus       145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~-~~~~~~-----------------~~~~----~~~~~  202 (237)
T cd05576         145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS-GINTHT-----------------TLNI----PEWVS  202 (237)
T ss_pred             CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch-hccccc-----------------ccCC----cccCC
Confidence            5679999988 45689999999999999999999988753211 000000                 0000    11123


Q ss_pred             HHHHHHHHHHhccCCCCCCCH
Q 004994          689 SRFADIISRCVQWEPGFRPPM  709 (720)
Q Consensus       689 ~~l~~l~~~cl~~dP~~RPt~  709 (720)
                      ..+.+++.+|++.||++||++
T Consensus       203 ~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         203 EEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHHHccCCHHHhcCC
Confidence            567899999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=273.62  Aligned_cols=264  Identities=18%  Similarity=0.305  Sum_probs=200.5

Q ss_pred             HhcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCC--C----ceeEEEeEeccC
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH--G----NIVELIGYCNEH  510 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H--~----niv~l~~~~~~~  510 (720)
                      .+++|.+.+.+|+|.||.|-++ +.+.+..||||+++.-   ....+..+-|+++++++.+  |    -+|.+.+||+-.
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            4788999999999999999999 4556899999999742   3455677889999999943  2    478888999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC----------
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE----------  580 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~----------  580 (720)
                      ++.++|+|.++- |+.+++...  ...+++...+..|+.|+.++++|||+.   +++|-||||+|||+.+          
T Consensus       164 ghiCivfellG~-S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  164 GHICIVFELLGL-STFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             CceEEEEeccCh-hHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence            999999999754 899999753  346788899999999999999999998   9999999999999932          


Q ss_pred             ----------CCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 004994          581 ----------KLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRS  649 (720)
Q Consensus       581 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~  649 (720)
                                +..+||+|||.|+.-..     ....+..|..|+|||++ +-..+..+||||+||||.|+.||..-|...
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence                      34689999999986532     23557789999999998 447999999999999999999999999765


Q ss_pred             CCccccchhhhcccccCchhh------------------------hhhhcCCCCC-c---hhhHHHHHHHHHHHHHHhcc
Q 004994          650 RPRGEQSLVRWAIPRLHDIDA------------------------LSRMVDPSLD-G---AYLAKSLSRFADIISRCVQW  701 (720)
Q Consensus       650 ~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~-~---~~~~~~~~~l~~l~~~cl~~  701 (720)
                      +..+.....+.....++....                        ...+.++-.+ .   .....+..++.||+.++|..
T Consensus       313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            543332222222111110000                        0000110000 0   11233456799999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 004994          702 EPGFRPPMSEIVQD  715 (720)
Q Consensus       702 dP~~RPt~~evl~~  715 (720)
                      ||.+|+|+.|++++
T Consensus       393 DP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  393 DPARRITLREALSH  406 (415)
T ss_pred             CccccccHHHHhcC
Confidence            99999999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=272.70  Aligned_cols=241  Identities=20%  Similarity=0.267  Sum_probs=191.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccH-HHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTD-EEFLELASTISRL-RHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~-~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .+|....+||+|+||+|-.|+.+ +.+.||||++++.+.-..++ +--+.|-++|... +-|.++++..+|..-+.+|.|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46778899999999999999654 57889999999876544333 3334555666655 568999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+.+|+|.-.++.    -..+.+....-+|..||-||-|||+.   +||+||||.+|||+|.+|++||+|||+++.--
T Consensus       429 MEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence            999999999887753    34566677888999999999999987   99999999999999999999999999997532


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      -  ....+....||+.|+|||++ -.+|+..+|+|||||+||||+.|++||++.++.+                ....+.
T Consensus       502 ~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----------------lF~aI~  563 (683)
T KOG0696|consen  502 F--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQAIM  563 (683)
T ss_pred             c--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHHH
Confidence            2  12344567899999999998 6789999999999999999999999998754322                111111


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCC
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRP  707 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  707 (720)
                      +..  -.|+...+.+..++.+..+.+.|.+|.
T Consensus       564 ehn--vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  564 EHN--VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             Hcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            111  124445556778999999999999995

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=245.88  Aligned_cols=202  Identities=24%  Similarity=0.341  Sum_probs=165.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++......||+|++|.|-+-++ .+|...|+|+++.... .+..++..+|+++..+. ..|.+|.+||.+...+..++.|
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            3444567799999999988855 5799999999986543 34456677777776554 7999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      |.|.- ||..+...--.....+++...-+||..+.+||.|||+.-  .|||||+||+|||++.+|++|+||||++-.+.+
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99986 777776554455677888889999999999999999973  799999999999999999999999999987754


Q ss_pred             CCCcccccCccccccCCCCccCCC-----CCCCccchHhHHHHHHHHHhCCCCCCC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG-----SYSCQSDVYSLGVVMLELLTGRKPYDR  648 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~Dv~S~Gvvl~elltG~~Pf~~  648 (720)
                      +-...   ...|-..|+|||.+.+     .|+.|+||||+|+.+.||.+++.||+.
T Consensus       202 SiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  202 SIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             hhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            32111   1345567999998732     489999999999999999999999974

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=6.4e-31  Score=295.80  Aligned_cols=264  Identities=22%  Similarity=0.261  Sum_probs=168.7

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CC----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeE------
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PG----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY------  506 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~------  506 (720)
                      ..++|...+.||+|+||.||+|.. .+    +..||||++....    ..+.+..+  .+++..+.+++.++..      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            456889999999999999999966 45    7899999986421    11222211  2222223333322211      


Q ss_pred             eccCCeEEEEEeeCCCCCHHHHhhccchh----------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 004994          507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEA----------------HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGN  570 (720)
Q Consensus       507 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrD  570 (720)
                      +.+.++.++||||+++++|.+++......                ...........++.|+++||+|||+.   +|||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD  280 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD  280 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence            24566899999999999999998643210                00112234567899999999999987   899999


Q ss_pred             CCCCCeEEcC-CCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CC----------------------CCCCc
Q 004994          571 FKSSNILLDE-KLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SG----------------------SYSCQ  626 (720)
Q Consensus       571 lkp~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~----------------------~~~~~  626 (720)
                      |||+|||++. ++.+||+|||+|+.+.... ........+++.|+|||.+ ..                      .++.+
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            9999999986 5799999999998764332 2233445678899999954 11                      23456


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch----h--hHHHHHHHHHHHHHHhc
Q 004994          627 SDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA----Y--LAKSLSRFADIISRCVQ  700 (720)
Q Consensus       627 ~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~l~~l~~~cl~  700 (720)
                      +|||||||++|||+++..|++....    .+.+.....-.+.......+.+.....    +  .........+|+.+||+
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLI----QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHH----HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            7999999999999998776543110    000000000000001111111111000    0  00011235589999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 004994          701 WEPGFRPPMSEIVQD  715 (720)
Q Consensus       701 ~dP~~RPt~~evl~~  715 (720)
                      .||++|||++|+++|
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999976

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.5e-30  Score=285.21  Aligned_cols=262  Identities=19%  Similarity=0.263  Sum_probs=180.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-----------------CCCcEEEEEEecccccc------------cccHHHHHHHH
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-----------------PGGKLLAVKKLSNTVSQ------------RQTDEEFLELA  489 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~------------~~~~~~~~~e~  489 (720)
                      .++|...++||+|+||+||+|..                 .+++.||||++......            ....+.+..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999953                 23568999998643110            11123344567


Q ss_pred             HHHHccCCCce-----eEEEeEecc--------CCeEEEEEeeCCCCCHHHHhhccch--------------------hc
Q 004994          490 STISRLRHGNI-----VELIGYCNE--------HGQHLLVYDYGGNCTLHDLLHSDEE--------------------AH  536 (720)
Q Consensus       490 ~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~  536 (720)
                      .++.+++|.++     +++++||..        .+..++||||+++++|.++++....                    ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777776654     677887753        3568999999999999999874211                    11


Q ss_pred             cccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCC
Q 004994          537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP  616 (720)
Q Consensus       537 ~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aP  616 (720)
                      ..++|..+..++.+++++|.|||+.   +|+||||||+|||++.++.+||+|||+++.+...... .......++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence            2356788899999999999999987   8999999999999999999999999999765432211 11112236789999


Q ss_pred             ccCCC-C--------------------C--CCccchHhHHHHHHHHHhCCC-CCCCCCCcc------ccchhhhcccccC
Q 004994          617 EFESG-S--------------------Y--SCQSDVYSLGVVMLELLTGRK-PYDRSRPRG------EQSLVRWAIPRLH  666 (720)
Q Consensus       617 E~~~~-~--------------------~--~~~~Dv~S~Gvvl~elltG~~-Pf~~~~~~~------~~~~~~~~~~~~~  666 (720)
                      |.+.. .                    |  ..+.||||+||++|||++|.. ||.......      ......|..    
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~----  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM----  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh----
Confidence            97621 1                    1  124799999999999999875 664321110      011111110    


Q ss_pred             chhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCC---CCCCCHHHHHHH
Q 004994          667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEP---GFRPPMSEIVQD  715 (720)
Q Consensus       667 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~evl~~  715 (720)
                             +..............+...+++.++|..+|   .+|+|++|+++|
T Consensus       456 -------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        456 -------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             -------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                   000111111122334677899999999876   689999999976

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=4.5e-30  Score=259.90  Aligned_cols=238  Identities=31%  Similarity=0.391  Sum_probs=187.8

Q ss_pred             CCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCHHHHhh
Q 004994          452 LLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLH  530 (720)
Q Consensus       452 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~  530 (720)
                      +||.||+|... +|+.+|+|++........ .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999775 589999999975432211 6789999999999999999999999999899999999999999999885


Q ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCcccc
Q 004994          531 SDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA  610 (720)
Q Consensus       531 ~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~  610 (720)
                      ..    ..+++.....++.++++++.|||..   +++|+||+|+||++++++.++|+|||.+.......   ......++
T Consensus        80 ~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~  149 (244)
T smart00220       80 KR----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGT  149 (244)
T ss_pred             hc----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCC
Confidence            42    2278899999999999999999987   99999999999999999999999999998764432   22234567


Q ss_pred             ccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch-hhHHHH
Q 004994          611 HGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA-YLAKSL  688 (720)
Q Consensus       611 ~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  688 (720)
                      ..|++||.. ...++.++||||||++++|+++|..||......  ....+..             ........ .....+
T Consensus       150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~-------------~~~~~~~~~~~~~~~  214 (244)
T smart00220      150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKI-------------GKPKPPFPPPEWKIS  214 (244)
T ss_pred             cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH-------------hccCCCCccccccCC
Confidence            789999988 467889999999999999999999999652111  1111110             00000000 000034


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          689 SRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       689 ~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .++.+++.+|+..+|++||++.+++++
T Consensus       215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      215 PEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHHHHHHHHHccCCchhccCHHHHhhC
Confidence            578899999999999999999999873

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.2e-30  Score=273.21  Aligned_cols=209  Identities=22%  Similarity=0.310  Sum_probs=172.5

Q ss_pred             CCCCCCeeccCCCceEEEEE-eCCCcEEEEEEeccc-ccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          441 SFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      -|...+.||-|+||+|.++. .++...||+|.+++. +..+........|-+||.+.+.+.||+||-.|.+.+.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            36677899999999999994 566789999999753 3344445566788899999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC---
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL---  595 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~---  595 (720)
                      |++||++..+|..    ..-|.+.....++..+..|+++.|..   |+|||||||+|||||.+|++||+|||++.-+   
T Consensus       710 YIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             ccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999853    34567777777788899999999998   9999999999999999999999999997543   


Q ss_pred             ------CCCCCc-------------------------------ccccCccccccCCCCccC-CCCCCCccchHhHHHHHH
Q 004994          596 ------FSGSTN-------------------------------ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVML  637 (720)
Q Consensus       596 ------~~~~~~-------------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~  637 (720)
                            ..++..                               .......||..|+|||++ ...|+..+|+||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                  111000                               011235689999999998 556999999999999999


Q ss_pred             HHHhCCCCCCCCCCccccc
Q 004994          638 ELLTGRKPYDRSRPRGEQS  656 (720)
Q Consensus       638 elltG~~Pf~~~~~~~~~~  656 (720)
                      ||+.|+.||-...+.+.+.
T Consensus       863 em~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQY  881 (1034)
T ss_pred             HHhhCCCCccCCCCCccee
Confidence            9999999998777666543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.4e-31  Score=269.36  Aligned_cols=243  Identities=20%  Similarity=0.265  Sum_probs=196.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCc-EEEEEEeccc-ccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNT-VSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~l~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++.....||-|+||.|-.+..+... .+|+|.+++. ..+....+....|-.+|...+.|.||++|--|.+....|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34555678999999999998765543 4899998754 233344455678889999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      |-|-||.+...+++    +..|+..+..-++..+.+|+.|||..   +||+|||||+|.++|.+|-+||.|||+|+.+..
T Consensus       500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999999964    45677778888899999999999997   999999999999999999999999999999866


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      +...   -.+.||+.|.|||++ ...-+.++|.||+|+++|||+||.+||...++....+++-.....+           
T Consensus       573 g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-----------  638 (732)
T KOG0614|consen  573 GRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-----------  638 (732)
T ss_pred             CCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-----------
Confidence            5433   347899999999998 5557889999999999999999999998877655444332111100           


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCC
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPP  708 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt  708 (720)
                           .++........+++++.+..+|.+|..
T Consensus       639 -----~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 -----EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -----hcccccchhHHHHHHHHHhcCcHhhhc
Confidence                 122233345679999999999999975

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-30  Score=278.40  Aligned_cols=247  Identities=26%  Similarity=0.368  Sum_probs=183.2

Q ss_pred             CCCCCeeccCCCce-EEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEee
Q 004994          442 FSEGNFIGEGLLGS-VYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       442 ~~~~~~lg~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      |...+++|.|+.|+ ||+|.. .|+.||||++-.+     ...-..+|+..++.- +|||||++|+.-.+.+..|+..|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            44457799998876 699987 5689999998643     223457899999887 699999999998899999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---C--CCeEEccccCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---K--LIVRVSDCGLAPL  594 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~--~~~kl~DFGla~~  594 (720)
                      |. ++|.+++..............-..+..|++.||++||+.   +||||||||.||||+.   +  ..++|+|||+++.
T Consensus       585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            87 499999975311111111133456888999999999997   9999999999999976   3  4799999999998


Q ss_pred             CCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhC-CCCCCCCCCccccchhhhcccccCchhhh
Q 004994          595 LFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTG-RKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       595 ~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      +..+... ....+..||-||+|||.+ ...-+..+||||+|||+|+.++| ..||...-..+. +++.       ....+
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl~-------~~~~L  732 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NILT-------GNYTL  732 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhhc-------Cccce
Confidence            8655332 224567789999999998 44556789999999999999995 999975432211 1111       11111


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+. +      ..++  +..+||.+|++.||..||++.+|+.|
T Consensus       733 ~~L~-~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  733 VHLE-P------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             eeec-c------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            1100 0      0111  67799999999999999999999864

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=1.2e-29  Score=235.92  Aligned_cols=256  Identities=18%  Similarity=0.309  Sum_probs=193.6

Q ss_pred             hcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccC--CeEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEH--GQHL  514 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~  514 (720)
                      .++|+..+.+|+|.|++||.| ...+.+.++||.+++-     ..+...+|+++|+.|+ ||||+++++...+.  ....
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            457778899999999999999 4567889999999743     3457889999999996 99999999998765  4677


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC-CCeEEccccCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-LIVRVSDCGLAP  593 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~  593 (720)
                      +|+||+.+-+...+.       ..++...+..++.++..||.|+|+.   ||.|||+||.|+++|.. ..++|+|+|+|.
T Consensus       112 LiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence            999999998877655       3466677788999999999999998   99999999999999864 578999999999


Q ss_pred             CCCCCCCcccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      +..++...   .....+.+|.-||.+  -..|+..-|+|||||++..|+..+.||-.... ....+++.+. .+ ..+.+
T Consensus       182 FYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIak-VL-Gt~el  255 (338)
T KOG0668|consen  182 FYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAK-VL-GTDEL  255 (338)
T ss_pred             hcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHH-Hh-ChHHH
Confidence            88665433   234567788999998  45799999999999999999999999965332 1222222211 00 00111


Q ss_pred             hh-------hcCCCCCc----------------hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SR-------MVDPSLDG----------------AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~-------~~~~~~~~----------------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..       .+||...+                ....-..++..+++.+.|..|..+|+|++|++.|
T Consensus       256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            10       01111110                0011123678899999999999999999998764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-29  Score=243.85  Aligned_cols=248  Identities=17%  Similarity=0.259  Sum_probs=185.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccH-HHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTD-EEFLELASTISRL-RHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~-~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ++|...++||+|+|.+|..+++ ++.+.||+|+++++....... .-...|-.+.... +||.+|-+..+|..+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            5788899999999999999976 568899999998765433322 2334444444444 799999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      .||+++|+|.-.++    ..+.++.....-+...|.-||.|||+.   |||+||||.+|||+|.+|++|++|||+.+.--
T Consensus       330 ieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999875553    235677777777888999999999998   99999999999999999999999999987532


Q ss_pred             CCCCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc-cchhhhcccccCchhhhhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE-QSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  674 (720)
                        .....+..+.||+.|.|||++. ..|...+|+|++||+|+||+.|+.||+...-... .+-..+         -+.-+
T Consensus       403 --~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy---------lfqvi  471 (593)
T KOG0695|consen  403 --GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY---------LFQVI  471 (593)
T ss_pred             --CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH---------HHHHH
Confidence              2234556688999999999995 4799999999999999999999999974221110 100000         00011


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCC
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP  707 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  707 (720)
                      +...+.  .+...+.....+++.-|.+||.+|.
T Consensus       472 lekqir--iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  472 LEKQIR--IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hhhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence            111110  1122223455788999999999984

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7e-31  Score=249.75  Aligned_cols=265  Identities=20%  Similarity=0.343  Sum_probs=192.0

Q ss_pred             CCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-----CeEEEE
Q 004994          443 SEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-----GQHLLV  516 (720)
Q Consensus       443 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv  516 (720)
                      +..+-||-|+||+||-+. -.+|+.||+|++..-...-...+.+.+|++++..++|.|++..++...-.     ++.|.+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            345789999999999994 46899999999976544455668899999999999999999988876433     256788


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      +|.|.. +|+.++.    ....++-....-...||.+||.|||+.   +|.||||||-|.|++.+..+||||||+|+.-.
T Consensus       136 TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  136 TELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence            888764 6776664    345566666777889999999999998   99999999999999999999999999998765


Q ss_pred             CCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc--cccCc-----
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI--PRLHD-----  667 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~-----  667 (720)
                      ..+...++. ..-|.+|+|||++.|  .|+.++||||.|||+.|++.++.-|....+.....++.-..  +..++     
T Consensus       208 ~d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  208 QRDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hhhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            443333322 334778999999844  69999999999999999999999887655544333221110  10000     


Q ss_pred             hhhhhhhcC-----CCCCchh----hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          668 IDALSRMVD-----PSLDGAY----LAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       668 ~~~~~~~~~-----~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      .+.-..++.     |.+.-.|    ++.--.+..++.+.++..||++|.+.++.+.++
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            000011111     1111101    111123456889999999999999999988764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=240.45  Aligned_cols=261  Identities=19%  Similarity=0.249  Sum_probs=190.9

Q ss_pred             CCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC------CeE
Q 004994          441 SFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH------GQH  513 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~  513 (720)
                      +|...+.+|.|.- .|.-+ +.-.++.||+|++..........+...+|...+..+.|+||++++.+|.-.      .+.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4555677888887 45444 344588999999876665566677888999999999999999999998532      368


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      |+|||||.. +|.+.++      ..++......|..|+..|+.|||+.   +|+||||||+||++..+..+||.|||+|+
T Consensus        97 y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   97 YLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence            999999985 8888775      2356677888999999999999998   99999999999999999999999999997


Q ss_pred             CCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc--c------c
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI--P------R  664 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~--~------~  664 (720)
                      .-..   .........+..|.|||.+ +-.|.+.+||||.||++.||++|+.-|.+.+..+....+....  +      +
T Consensus       167 ~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  167 TEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             ccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            5422   2234456778999999998 4459999999999999999999999987544322111110000  0      0


Q ss_pred             cCch-------------hhhhhhc-CCCCCch--hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          665 LHDI-------------DALSRMV-DPSLDGA--YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       665 ~~~~-------------~~~~~~~-~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +...             -...+.+ |..+...  ........+++++.+||..+|++|.+++++|+|
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            0000             0000111 1111100  011123467899999999999999999999975

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=8.6e-27  Score=230.05  Aligned_cols=211  Identities=36%  Similarity=0.542  Sum_probs=179.0

Q ss_pred             eccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCHH
Q 004994          448 IGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLH  526 (720)
Q Consensus       448 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~  526 (720)
                      ||+|.+|.||++... +++.+++|++....... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999765 48999999997543211 3467899999999999999999999999989999999999999999


Q ss_pred             HHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-CCCeEEccccCCCCCCCCCCccccc
Q 004994          527 DLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KLIVRVSDCGLAPLLFSGSTNELSE  605 (720)
Q Consensus       527 ~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~~~  605 (720)
                      +++....   ..+++..+..++.+++++++|||+.   +++|+||+|.||+++. ++.++|+|||.+........  ...
T Consensus        80 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~  151 (215)
T cd00180          80 DLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLK  151 (215)
T ss_pred             HHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhh
Confidence            9985321   4578899999999999999999987   9999999999999999 89999999999976643221  122


Q ss_pred             CccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchh
Q 004994          606 GLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAY  683 (720)
Q Consensus       606 ~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  683 (720)
                      ...+...|.+||....  .++.+.|+|++|++++++                                            
T Consensus       152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            2446678999998843  788999999999999999                                            


Q ss_pred             hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          684 LAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       684 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                           ..+.+++.+|++.+|++||++.++++++
T Consensus       188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                 2467999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=9.1e-29  Score=261.60  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=200.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|....++|.|+||.|||++ ...++..|+|+++.+..  ....-...|+-+++..+|||||.++|.+...+..++.|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            4578888999999999999994 56799999999975432  33345667888999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      |||.+|+|++..+.    ...+++.++..+.....+||.|||+.   +=+|||||-.|||+++.|.+|++|||.+-.+..
T Consensus        92 EycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence            99999999998753    45677888888889999999999987   779999999999999999999999999876632


Q ss_pred             CCCcccccCccccccCCCCccC----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                        +-.......||++|||||+.    .+.|..++|||+.|+...|+-.-+.|..+..+.....+.....           
T Consensus       165 --ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~-----------  231 (829)
T KOG0576|consen  165 --TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG-----------  231 (829)
T ss_pred             --hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC-----------
Confidence              22234457899999999986    4679999999999999999999888865433322111111100           


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .-.|.+.+  .....+.|.+|++.|+.++|.+|||++.++++
T Consensus       232 ~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  232 FQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             CCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            01122221  12344678899999999999999999987753

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=8.9e-28  Score=247.00  Aligned_cols=268  Identities=19%  Similarity=0.272  Sum_probs=196.6

Q ss_pred             HHHHhcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCC------CceeEEEeEe
Q 004994          435 LQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH------GNIVELIGYC  507 (720)
Q Consensus       435 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~~~~  507 (720)
                      .+.....|.+....|+|-|++|.+|. ...|+.||||+|.....   ..+.=+.|+++|++|..      -|+++++-.|
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            34456778888889999999999994 45688999999986532   22344688999999953      3899999999


Q ss_pred             ccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-CeEE
Q 004994          508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRV  586 (720)
Q Consensus       508 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl  586 (720)
                      ...++++||||-+.- +|.++|.... ....+.......++.|+.-||..|...   +|+|.||||+|||+++.. .+||
T Consensus       504 ~hknHLClVFE~Lsl-NLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  504 KHKNHLCLVFEPLSL-NLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             hhcceeEEEehhhhc-hHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence            999999999998764 8999997543 344567778889999999999999987   999999999999998765 5799


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      ||||.|-....   +.+++ ..-+.+|.|||++ +-.|+...|+||.||.||||.||+.-|.+...-....+.--....+
T Consensus       579 CDfGSA~~~~e---neitP-YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  579 CDFGSASFASE---NEITP-YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             ccCcccccccc---ccccH-HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            99999976533   22222 3345689999998 5589999999999999999999999887654322111100000000


Q ss_pred             C-----------------------------ch-------------hhhhhhcC-CCCCchhhHHHHHHHHHHHHHHhccC
Q 004994          666 H-----------------------------DI-------------DALSRMVD-PSLDGAYLAKSLSRFADIISRCVQWE  702 (720)
Q Consensus       666 ~-----------------------------~~-------------~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~d  702 (720)
                      +                             +.             +...+++. +.+++ .......+|.+|+.+|+..|
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~d-eq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPD-EQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCc-hhHHHHHHHHHHHHHHhccC
Confidence            0                             00             00000000 11111 12345678999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 004994          703 PGFRPPMSEIVQD  715 (720)
Q Consensus       703 P~~RPt~~evl~~  715 (720)
                      |++|.|..++|+|
T Consensus       734 P~KRit~nqAL~H  746 (752)
T KOG0670|consen  734 PEKRITVNQALKH  746 (752)
T ss_pred             hhhcCCHHHHhcC
Confidence            9999999999876

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-26  Score=238.06  Aligned_cols=131  Identities=19%  Similarity=0.358  Sum_probs=111.3

Q ss_pred             cCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC-----C---CceeEEEeEecc-
Q 004994          440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-----H---GNIVELIGYCNE-  509 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~~~~~~-  509 (720)
                      .+|.+.++||.|.|++||++ +..+.+.||+|+.+..   ....+..+.||++|++++     |   .+||+|+++|.. 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            67888899999999999999 5567899999999643   456677889999999884     3   379999999964 


Q ss_pred             ---CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE
Q 004994          510 ---HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       510 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl  578 (720)
                         +.+++||+|++.. +|..++...  ..+.++...+.+|+.||+.||.|||..|  +|||-||||+|||+
T Consensus       155 GpNG~HVCMVfEvLGd-nLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVLGD-NLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCCcEEEEEehhhhh-HHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence               4589999999876 777777643  3466888899999999999999999988  99999999999998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=248.10  Aligned_cols=197  Identities=20%  Similarity=0.309  Sum_probs=165.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEeccccccc------ccHHHHHHHHHHHHccC---CCceeEEEeEecc
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQR------QTDEEFLELASTISRLR---HGNIVELIGYCNE  509 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~------~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~  509 (720)
                      .+|+..+.+|+|+||.|+.|.++ +...|+||.+.++..-.      ...-..-.|+.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46888899999999999999654 57789999987653211      11122456899999997   9999999999999


Q ss_pred             CCeEEEEEee-CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcc
Q 004994          510 HGQHLLVYDY-GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSD  588 (720)
Q Consensus       510 ~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  588 (720)
                      ++.+||+||- -++.+|++++.    .+..+++....-|+.||+.|+++||+.   +|||||||-+||.+|.+|-+||+|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            9999999997 46778999984    456788999999999999999999987   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccCCCC-C-CCccchHhHHHHHHHHHhCCCCCC
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS-Y-SCQSDVYSLGVVMLELLTGRKPYD  647 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~-~~~~Dv~S~Gvvl~elltG~~Pf~  647 (720)
                      ||.|.....+.    ...+.||.+|.|||.+.|. | +...|||++|++||.++..+.||-
T Consensus       714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99987664332    3457899999999999664 5 556999999999999999998883

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.94  E-value=2.3e-26  Score=279.60  Aligned_cols=216  Identities=33%  Similarity=0.527  Sum_probs=139.1

Q ss_pred             cCCCCCHHHHHHHHHHHHhcCCC--CCCCccCCCCCCCCCCCceeEee-cCceeEEEecCCcccccCCcCcCCCCCccEE
Q 004994           24 CAGVTDPRDVMALNSLYISLNFP--PLEKWLSFGGDPCGDSWQGVFCV-FSNVTEIRLTGMNLGGVLADTLGDLESVINI  100 (720)
Q Consensus        24 ~~~~~~~~~~~al~~~~~~l~~~--~~~~w~~~~~~~c~~~w~gv~c~-~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L  100 (720)
                      ..+..+++|+.||++||+++.+|  .+.+|.. +.|+|  .|.||.|. .++++.|+|++|+++|.++..|..+++|+.|
T Consensus        22 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c--~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L   98 (968)
T PLN00113         22 NFSMLHAEELELLLSFKSSINDPLKYLSNWNS-SADVC--LWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTI   98 (968)
T ss_pred             HccCCCHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCC--cCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEE
Confidence            33445889999999999999876  4788964 56777  89999997 4689999999999998888888888888888


Q ss_pred             eccCCcccccCCCCcc---ccCcEEEecCCcCCCCC----------------------cchhhcccccccccccccccCC
Q 004994          101 DLSNNHIGGSIPSNLP---VTVRNFSLSGNQLTGSI----------------------PESLSRLTQLLDLSLNNNHLNG  155 (720)
Q Consensus       101 ~L~~N~l~g~ip~~~~---~~L~~L~Ls~N~l~g~~----------------------p~~l~~l~~L~~L~l~~N~l~g  155 (720)
                      +|++|+++|.+|..+.   .+|++|+|++|+++|.+                      |..++++++|++|+|++|.+.+
T Consensus        99 ~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~  178 (968)
T PLN00113         99 NLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG  178 (968)
T ss_pred             ECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc
Confidence            8888888888886543   45666666666555544                      4445555555555555555555


Q ss_pred             CCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCcccCCcccCC
Q 004994          156 GIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSGPIPEKLLS  233 (720)
Q Consensus       156 ~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g~~p~~~~~  233 (720)
                      .+|..|+++++|++|+|++|++++.+|..++++++|+.|+|++|++++.++ .+..+. |+.|++++|+++|.+|..+.+
T Consensus       179 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~  258 (968)
T PLN00113        179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN  258 (968)
T ss_pred             cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhC
Confidence            555555555555555555555555555555555555555555555554332 233332 555555555555555555555


Q ss_pred             CccccccCc
Q 004994          234 IPNFRKDGN  242 (720)
Q Consensus       234 l~~l~~~~n  242 (720)
                      +++|+..+.
T Consensus       259 l~~L~~L~L  267 (968)
T PLN00113        259 LKNLQYLFL  267 (968)
T ss_pred             CCCCCEEEC
Confidence            554444333

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.3e-26  Score=234.92  Aligned_cols=266  Identities=24%  Similarity=0.330  Sum_probs=192.6

Q ss_pred             HHHHhcCCCCCCeeccCCCceEEEEEe-C---CCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEecc
Q 004994          435 LQQYTNSFSEGNFIGEGLLGSVYKAEL-P---GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNE  509 (720)
Q Consensus       435 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~  509 (720)
                      +....+.|...++||+|.|++||++.. .   ..+.||+|.+...    ........|+++|..+ .+.||+++.+++..
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            334557788899999999999999943 2   4679999998643    3345688999999998 58999999999999


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC-CCeEEcc
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-LIVRVSD  588 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~D  588 (720)
                      +++..+|+||++.....+++.       .++......+...+.+||+++|..   |||||||||+|+|.+.. +.-.|.|
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             CCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence            999999999999999888874       355677888999999999999987   99999999999999854 5678999


Q ss_pred             ccCCCCCC-----------------C--C-----------------------CCcccccCccccccCCCCccC--CCCCC
Q 004994          589 CGLAPLLF-----------------S--G-----------------------STNELSEGLLTAHGSGAPEFE--SGSYS  624 (720)
Q Consensus       589 FGla~~~~-----------------~--~-----------------------~~~~~~~~~~~~~~~~aPE~~--~~~~~  624 (720)
                      ||+|....                 .  +                       ..........||+||.|||.+  .+..+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            99986210                 0  0                       000011234589999999998  45689


Q ss_pred             CccchHhHHHHHHHHHhCCCCCCCCCCccccchh----------------------hhcccccCch-------hhhh-hh
Q 004994          625 CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV----------------------RWAIPRLHDI-------DALS-RM  674 (720)
Q Consensus       625 ~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~----------------------~~~~~~~~~~-------~~~~-~~  674 (720)
                      .++||||.|||++-+++++.||-....+. ..+.                      -|....+...       +.+. +.
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~  335 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES  335 (418)
T ss_pred             CccceeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence            99999999999999999999995432211 1111                      0110000000       0000 00


Q ss_pred             cCCC----CCchhh-HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPS----LDGAYL-AKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~----~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +.+.    ...... +..+..+.+++.+|++.||.+|.|++|+|+|
T Consensus       336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0000    000011 1123467899999999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=2.1e-25  Score=223.30  Aligned_cols=199  Identities=33%  Similarity=0.482  Sum_probs=167.2

Q ss_pred             CCCCCeeccCCCceEEEEEeCC-CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          442 FSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      |...+.||+|++|.||++...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            4556889999999999997654 889999999754322 24578899999999999999999999999989999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      ++++|.+++....   ..+++.....++.++++++.|||..   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        80 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       80 EGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            9999999986422   1178899999999999999999987   999999999999999999999999999987644321


Q ss_pred             cccccCccccccCCCCccC-C-CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 004994          601 NELSEGLLTAHGSGAPEFE-S-GSYSCQSDVYSLGVVMLELLTGRKPYDR  648 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~  648 (720)
                      . ......++..|++||.. . ..++.++|||+||++++||++|+.||..
T Consensus       154 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 A-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             c-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            1 12234566789999986 3 3577899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.3e-26  Score=216.80  Aligned_cols=249  Identities=16%  Similarity=0.254  Sum_probs=179.3

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeE-eccCCeEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGY-CNEHGQHL  514 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~-~~~~~~~~  514 (720)
                      +.+.|.+.+.+|+|-||.+-.++++ ..+.+++|-+....   ...++|.+|...--.| .|.||+.-|++ |+..+.++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            4456888899999999999999765 57889999987543   4457899998876666 58999998874 56678889


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE-c-CCCCeEEccccCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL-D-EKLIVRVSDCGLA  592 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl-~-~~~~~kl~DFGla  592 (720)
                      +++||++-|+|.+-+..     ..+.+....+++.|++.|+.|+|+.   ++||||||.+|||+ + +...+||||||+.
T Consensus        99 F~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             EeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence            99999999999987743     3455667788999999999999997   99999999999999 3 3448999999998


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCC----C--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccc--cchhhhcccc
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFES----G--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE--QSLVRWAIPR  664 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~--~~~~~~~~~~  664 (720)
                      +..+..     -....-+..|.+||...    +  ...+.+|||.||+|+|..+||+.||......+.  .....|....
T Consensus       171 ~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk  245 (378)
T KOG1345|consen  171 RKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK  245 (378)
T ss_pred             cccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence            765321     11123355688888752    2  257789999999999999999999973221111  1122222111


Q ss_pred             cCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                      .           +.++..+ ....+.+.++.++-+..+|++|-...++-+
T Consensus       246 ~-----------~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  246 N-----------PALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             C-----------ccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            1           1111111 112345668888889999988844444433

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=1.3e-25  Score=265.81  Aligned_cols=196  Identities=19%  Similarity=0.234  Sum_probs=136.9

Q ss_pred             ccCC-CceeEEEeEec-------cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 004994          494 RLRH-GNIVELIGYCN-------EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP  565 (720)
Q Consensus       494 ~l~H-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~  565 (720)
                      .++| +||++++++|.       +.+..++++||++ ++|.+++...   ...+++..+..++.|+++||.|||+.   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3455 68888888872       2345677888874 5999999632   35589999999999999999999987   9


Q ss_pred             eeecCCCCCCeEEcC-------------------CCCeEEccccCCCCCCCCCCc--------------ccccCcccccc
Q 004994          566 IVHGNFKSSNILLDE-------------------KLIVRVSDCGLAPLLFSGSTN--------------ELSEGLLTAHG  612 (720)
Q Consensus       566 ivHrDlkp~NiLl~~-------------------~~~~kl~DFGla~~~~~~~~~--------------~~~~~~~~~~~  612 (720)
                      ||||||||+|||++.                   ++.+|++|||+++........              .......+|++
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   445666777776543110000              00011346788


Q ss_pred             CCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHH
Q 004994          613 SGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRF  691 (720)
Q Consensus       613 ~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  691 (720)
                      |+|||++ ...|+.++|||||||+||||++|..|+.....    .+...          .....++..     .......
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~----------~~~~~~~~~-----~~~~~~~  241 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSL----------RHRVLPPQI-----LLNWPKE  241 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHH----------HHhhcChhh-----hhcCHHH
Confidence            9999998 56799999999999999999999888743110    00000          000111110     0112345


Q ss_pred             HHHHHHHhccCCCCCCCHHHHHHH
Q 004994          692 ADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       692 ~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+++.+||+.+|.+||+|.|++++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            688999999999999999999875

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.2e-25  Score=211.20  Aligned_cols=248  Identities=22%  Similarity=0.345  Sum_probs=187.3

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCH
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL  525 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  525 (720)
                      -+|.+...|+.|+|++..+ .+++|++.-........++|.+|.-.++-+.||||+.++|.|.......++..||+.|+|
T Consensus       196 tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            3578889999999998654 566677764333344457899999999999999999999999999999999999999999


Q ss_pred             HHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccccc
Q 004994          526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE  605 (720)
Q Consensus       526 ~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  605 (720)
                      +.++++.  ..-..+..+..+.+.++|+|++|||+. .+-|.---|.+..+++|++.+++|+- +-+++..      ...
T Consensus       275 ynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf------qe~  344 (448)
T KOG0195|consen  275 YNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF------QEV  344 (448)
T ss_pred             HHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee------ecc
Confidence            9999864  344566778899999999999999997 33344447899999999999988862 2122111      111


Q ss_pred             CccccccCCCCccCCCC----CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          606 GLLTAHGSGAPEFESGS----YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       606 ~~~~~~~~~aPE~~~~~----~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                      +..-.+.|++||.++..    .-.++|+|||++++||+.|.+.||.+-.+.+....+.        .+.++..+.|    
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------leglrv~ipp----  412 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------LEGLRVHIPP----  412 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--------hccccccCCC----
Confidence            23345789999988442    2357999999999999999999997654433211111        1122222232    


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                          ..+..+.+++.-|+..||.+||.+..|+-.||+|+
T Consensus       413 ----gis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  413 ----GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                33467889999999999999999999999999985

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=5e-24  Score=205.23  Aligned_cols=165  Identities=24%  Similarity=0.303  Sum_probs=122.4

Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.+++...   ...++|..+..++.|+++||+|||+.   +      ||+|||++.++.+|+  ||+++......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            6888988632   34689999999999999999999987   3      999999999999999  99987653321   


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCC-
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD-  680 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  680 (720)
                          ..++..|+|||.+ .+.++.++|||||||++|||+||+.||........  .....         ...+...... 
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~---------~~~~~~~~~~~  128 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEIL---------LNGMPADDPRD  128 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHH---------HHHhccCCccc
Confidence                2467899999998 56799999999999999999999999964322110  00000         0000000000 


Q ss_pred             chhhHHHHH--HHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          681 GAYLAKSLS--RFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       681 ~~~~~~~~~--~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .........  ++.+++.+||..+|++||++.|+++++..+
T Consensus       129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            001122222  689999999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=4e-23  Score=217.49  Aligned_cols=166  Identities=20%  Similarity=0.206  Sum_probs=127.4

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC--CCcEEEEEEeccccc---ccccHHHHHHHHHHHHccCCCceeE-EEeEeccCC
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP--GGKLLAVKKLSNTVS---QRQTDEEFLELASTISRLRHGNIVE-LIGYCNEHG  511 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~  511 (720)
                      +...|...+.||+|+||+||+|...  +++.||||++.....   .....+.|.+|++++++++|+|++. ++++    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            3467889999999999999999653  578889998753311   1223567899999999999999985 4432    4


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeEEcCCCCeEEcccc
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNF-KSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDl-kp~NiLl~~~~~~kl~DFG  590 (720)
                      ..++||||+++++|... ..    ..      ...++.+++++|.|||+.   +|+|||| ||+|||++.++.+||+|||
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~----~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP----HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc----cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            57999999999999732 10    00      135778899999999987   9999999 9999999999999999999


Q ss_pred             CCCCCCCCCCccc------ccCccccccCCCCccCCC
Q 004994          591 LAPLLFSGSTNEL------SEGLLTAHGSGAPEFESG  621 (720)
Q Consensus       591 la~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~  621 (720)
                      +|+.+........      -....+++.|++||+...
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9987754332111      123556778999998743

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=1.1e-20  Score=199.97  Aligned_cols=262  Identities=27%  Similarity=0.379  Sum_probs=194.1

Q ss_pred             CCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccc-cHHHHHHHHHHHHccCCC-ceeEEEeEeccCCeEEEEEee
Q 004994          442 FSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQ-TDEEFLELASTISRLRHG-NIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~-~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~  519 (720)
                      |...+.||.|+||.||++...  ..+++|.+........ ....|.+|+.+++.+.|+ +++++++++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            455678999999999999765  7899999986554433 577899999999999988 799999999777778999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-CeEEccccCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPLLFSG  598 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~  598 (720)
                      +.++++.+++...... ..+.......++.+++.++.|+|..   +++|||+||+||+++... .++++|||.++.+...
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999776432111 2577888999999999999999998   899999999999999988 7999999999865433


Q ss_pred             CCcc----cccCccccccCCCCccCC----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCc-cccchhhhcccccCchh
Q 004994          599 STNE----LSEGLLTAHGSGAPEFES----GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR-GEQSLVRWAIPRLHDID  669 (720)
Q Consensus       599 ~~~~----~~~~~~~~~~~~aPE~~~----~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~  669 (720)
                      ....    ......++..|++||...    ..++...|+||+|++++++++|..||...... ...............  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence            2221    335577899999999984    36888999999999999999999997654321 000000000000000  


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                          .................+.+++.+|+..+|..|.++.+....
T Consensus       234 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 ----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                000000000001122467799999999999999998876653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.5e-22  Score=227.13  Aligned_cols=255  Identities=24%  Similarity=0.266  Sum_probs=185.8

Q ss_pred             CCCeeccCCCceEEEEE-eCCCcEEEEEEec----ccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          444 EGNFIGEGLLGSVYKAE-LPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       444 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~----~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ...++|.|++|.|+.+. ....+.++.|..+    ...........+..|+.+-..+.|+|++..+..+.+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            45789999999887773 3444555555443    222223333346778888899999999988888877766666699


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |++. +|..++...    ..+....+-.++.|+..|+.|+|..   +|.|||+|++|++++.+|.+||+|||.+....-.
T Consensus       402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            9999 999988532    3566777889999999999999998   9999999999999999999999999998765433


Q ss_pred             CCc--ccccCccccccCCCCccCC-CCCCC-ccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          599 STN--ELSEGLLTAHGSGAPEFES-GSYSC-QSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       599 ~~~--~~~~~~~~~~~~~aPE~~~-~~~~~-~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ...  ....+..|.-.|+|||... .+|++ ..||||.|||+..|++|+.||......+... ..     ........  
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~-----~~~~~~~~--  545 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT-----NNYSDQRN--  545 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh-----hccccccc--
Confidence            222  4566788899999999994 46766 5899999999999999999996533222110 00     00000000  


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       ...-........+.+.+.++.++|+.||.+|-|+++|++.
T Consensus       546 -~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  546 -IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             -cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence             0000011223445677899999999999999999999863

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=8.8e-21  Score=200.57  Aligned_cols=258  Identities=19%  Similarity=0.226  Sum_probs=187.6

Q ss_pred             CCCCCCeeccCCCceEEEEEeCC--CcEEEEEEecccccccccHHHHHHHHHHHHccCC----CceeEEEeEe-ccCCeE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPG--GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH----GNIVELIGYC-NEHGQH  513 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~  513 (720)
                      .|...+.||+|+||.||+|....  ...+|+|.-....... . ..+..|..++..+.+    +++..+++.. ...+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~-~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK-P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC-C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            78899999999999999996544  3578888876432211 1 156677888888763    6899999988 477788


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC-----CCeEEcc
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-----LIVRVSD  588 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-----~~~kl~D  588 (720)
                      ++||+.+.. +|.++.....  ...++..+..+|+.|+..+|.+||+.   |+|||||||+|+++...     ..+.|.|
T Consensus        97 ~iVM~l~G~-sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   97 FIVMSLLGP-SLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             EEEEeccCc-cHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            999988654 8999775433  46789999999999999999999998   99999999999999765     4699999


Q ss_pred             ccCCC--CCCCCCCc--c---c-ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh
Q 004994          589 CGLAP--LLFSGSTN--E---L-SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR  659 (720)
Q Consensus       589 FGla~--~~~~~~~~--~---~-~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  659 (720)
                      ||+|+  ........  .   . .....||..|.++... ..+.+.+.|+||++.++.|++.|..||.............
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            99998  33221111  1   1 2245588999998876 4578999999999999999999999996543221111000


Q ss_pred             hcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..        ........     .....+.++.++...+-..+..++|....+...+++.
T Consensus       251 ~~--------~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  251 KD--------PRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HH--------hhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            00        00000000     1112335677777777779999999999998887654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=2.7e-20  Score=182.91  Aligned_cols=255  Identities=17%  Similarity=0.217  Sum_probs=193.3

Q ss_pred             cCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  517 (720)
                      -.|.++++||+|+||+++.| .+-+++.||||.=..    +....++..|.+..+.|. .++|..+|-|..++-+-.||+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            47889999999999999999 567899999997432    234457778888888884 689999998888888889999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC-----CCeEEccccCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-----LIVRVSDCGLA  592 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-----~~~kl~DFGla  592 (720)
                      |++.. ||+|+..-   ..+.|+.++...||.|+..-++|+|+.   .+|.|||||+|+||...     ..+.|+|||+|
T Consensus       104 dLLGP-SLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  104 DLLGP-SLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhCc-CHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            99765 89998853   357799999999999999999999997   89999999999999643     36899999999


Q ss_pred             CCCCCCCCccc-----ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC
Q 004994          593 PLLFSGSTNEL-----SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH  666 (720)
Q Consensus       593 ~~~~~~~~~~~-----~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  666 (720)
                      +.+.+..+...     .....||..||+=-.. +.+.+.+-|+=|+|-+++.++.|..||.+.....-            
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn------------  244 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN------------  244 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch------------
Confidence            98876554332     3356788999976543 55789999999999999999999999976432110            


Q ss_pred             chhhhhhhcCCCC---CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          667 DIDALSRMVDPSL---DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       667 ~~~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                       .+...++-+..-   .....+..+.+|...+.-.-..+-++-|..+-+..-+.+
T Consensus       245 -K~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d  298 (449)
T KOG1165|consen  245 -KEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD  298 (449)
T ss_pred             -HHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence             011111111110   111223345677788888778888888988876655544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.1e-20  Score=177.88  Aligned_cols=255  Identities=18%  Similarity=0.227  Sum_probs=191.2

Q ss_pred             hcCCCCCCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCC-CceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH-GNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv  516 (720)
                      ...|...+.||.|+||.+|.| ...+|..||||+=+....    ..++..|.++.+.|+| ..|..+..|..+...-.+|
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            467888999999999999999 567899999998654432    2356778888888875 6888888899999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC---CCeEEccccCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK---LIVRVSDCGLAP  593 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGla~  593 (720)
                      ||.+.. +|+++..-.   .+.++..+.+-++.|+..-++|+|..   ++|||||||+|+|..-+   ..+.++|||+|+
T Consensus        90 MdLLGP-sLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   90 MDLLGP-SLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eeccCc-cHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence            999765 999988543   46788899999999999999999987   89999999999999643   368999999999


Q ss_pred             CCCCCCCccc-----ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc
Q 004994          594 LLFSGSTNEL-----SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       594 ~~~~~~~~~~-----~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      .+.+..+...     .....||..|.+--.. .-+.+.+.|+=|+|.+|..+-.|..||.+........           
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-----------  231 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-----------  231 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-----------
Confidence            8765443322     2345677777754433 3356788999999999999999999997654322111           


Q ss_pred             hhhhhhhcCCCC---CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          668 IDALSRMVDPSL---DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       668 ~~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                        ..+++.+...   ........+.+|.-.+.-|-..--++-|...-+-+..+
T Consensus       232 --KyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  232 --KYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             --HHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence              1111111111   11223334567888899999988888898877666544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.7e-20  Score=181.92  Aligned_cols=141  Identities=17%  Similarity=0.147  Sum_probs=106.6

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEeccccccccc-------HH-----------------HHHHHHHHHHccCCCce
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQT-------DE-----------------EFLELASTISRLRHGNI  500 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~-------~~-----------------~~~~e~~~l~~l~H~ni  500 (720)
                      ...||+|+||.||+|...+|+.||||+++........       ..                 ....|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3679999999999998778999999999754321111       01                 22348899999988776


Q ss_pred             eEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCeEEc
Q 004994          501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLD  579 (720)
Q Consensus       501 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~L-H~~~~~~ivHrDlkp~NiLl~  579 (720)
                      .....+...  ..++||||++++++......    ...+++....+++.+++.+|.|+ |..   +|+||||||+|||++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            433322222  23899999998776544321    24578888999999999999999 555   899999999999998


Q ss_pred             CCCCeEEccccCCCCC
Q 004994          580 EKLIVRVSDCGLAPLL  595 (720)
Q Consensus       580 ~~~~~kl~DFGla~~~  595 (720)
                       ++.++|+|||+|...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=2.3e-20  Score=199.74  Aligned_cols=215  Identities=25%  Similarity=0.422  Sum_probs=160.5

Q ss_pred             HHccCCCceeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 004994          492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNF  571 (720)
Q Consensus       492 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDl  571 (720)
                      |+.+.|.|+.+++|.+.++...+.|.+|+.-|+|.|.+..   ....++|.....++.++++||+|+|..  +--.|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence            3568999999999999999999999999999999999965   346789999999999999999999986  23399999


Q ss_pred             CCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccCCCC--------CCCccchHhHHHHHHHHHhCC
Q 004994          572 KSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS--------YSCQSDVYSLGVVMLELLTGR  643 (720)
Q Consensus       572 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~Dv~S~Gvvl~elltG~  643 (720)
                      +++|+++|..+.+||+|||+....................-|.|||.+.+.        .+.+.||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998776431111111122234457899987442        467899999999999999999


Q ss_pred             CCCCCCCCccc-cchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          644 KPYDRSRPRGE-QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       644 ~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .||+....... ..++..+..      .....+.|.+...  .+..+++..++.+||..+|++||++++|-..++.+
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             CccccccccCChHHHHHHHHh------cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            99986433221 112221110      0111122222211  14445788999999999999999999998887754

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.7e-19  Score=175.59  Aligned_cols=141  Identities=18%  Similarity=0.127  Sum_probs=109.5

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEeccccccccc------------------------HHHHHHHHHHHHccCCCce
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQT------------------------DEEFLELASTISRLRHGNI  500 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~------------------------~~~~~~e~~~l~~l~H~ni  500 (720)
                      .+.||+|++|.||+|...+|+.||||+++........                        ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999998778999999999764321100                        1224578899999999987


Q ss_pred             eEEEeEeccCCeEEEEEeeCCCCCHHHH-hhccchhccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEE
Q 004994          501 VELIGYCNEHGQHLLVYDYGGNCTLHDL-LHSDEEAHKKFSWNIRIRVALGAARALQYLQE-VCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       501 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDlkp~NiLl  578 (720)
                      .....+...  ..++||||++++++... +.     ...++.....+++.+++.++.++|+ .   +|+||||||+|||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            544443332  24899999998755433 32     1345677888999999999999998 6   99999999999999


Q ss_pred             cCCCCeEEccccCCCCCC
Q 004994          579 DEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~~  596 (720)
                      + ++.++|+|||+|..+.
T Consensus       152 ~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         152 H-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             E-CCCEEEEEcccceecC
Confidence            9 8899999999997663

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=2.9e-20  Score=182.01  Aligned_cols=172  Identities=13%  Similarity=0.154  Sum_probs=131.3

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEeccccccccc-H------HHHHHHHHHHHccCCCceeEEEeEeccC
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQT-D------EEFLELASTISRLRHGNIVELIGYCNEH  510 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~-~------~~~~~e~~~l~~l~H~niv~l~~~~~~~  510 (720)
                      ..++|...+++|.|+||.||.++. ++..+|||.+.+....... .      +.+.+|++.+.++.|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468899999999999999999765 5668999999755432211 1      2267899999999999999998886532


Q ss_pred             --------CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC
Q 004994          511 --------GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL  582 (720)
Q Consensus       511 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  582 (720)
                              +..++||||++|.+|.++..        ++.    ....+++.++..+|..   +++|||+||+||++++++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence                    35789999999999987642        111    2455888999999987   999999999999999998


Q ss_pred             CeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHH
Q 004994          583 IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELL  640 (720)
Q Consensus       583 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ell  640 (720)
                       ++|+|||............              .+. ...|+.++|+|||||.+..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence             9999999876542211100              011 334678999999999987654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=4.7e-19  Score=169.59  Aligned_cols=186  Identities=16%  Similarity=0.056  Sum_probs=134.0

Q ss_pred             CCCeeccCCCceEEEEEeCCCcEEEEEEeccccc--ccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEEEeeC
Q 004994          444 EGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVS--QRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       444 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      +...|++|+||+||.+.. ++..++.+.+.....  .......|.+|+++|+++. |++|++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999998865 677888887764321  1112235889999999995 5889999886    3479999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNF-KSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDl-kp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      .+.+|.+....           ....++.+++++|.++|..   +|||||| ||+|||++.++.++|+|||+|.......
T Consensus        81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99888754321           0134677889999999987   9999999 7999999999999999999998654322


Q ss_pred             Cc--ccc---------cCccccccCCCCccC--CCCCC-CccchHhHHHHHHHHHhCCCCCCC
Q 004994          600 TN--ELS---------EGLLTAHGSGAPEFE--SGSYS-CQSDVYSLGVVMLELLTGRKPYDR  648 (720)
Q Consensus       600 ~~--~~~---------~~~~~~~~~~aPE~~--~~~~~-~~~Dv~S~Gvvl~elltG~~Pf~~  648 (720)
                      ..  ...         .-...++.|++|+-.  ....+ ...++++-|.-+|.++||+.|+-.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            10  000         001123444555432  11233 567899999999999999988754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=2.6e-20  Score=198.80  Aligned_cols=227  Identities=20%  Similarity=0.238  Sum_probs=174.9

Q ss_pred             eeccCCCceEEEEE----eCCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEEEeeCC
Q 004994          447 FIGEGLLGSVYKAE----LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLVYDYGG  521 (720)
Q Consensus       447 ~lg~G~~g~Vy~~~----~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~  521 (720)
                      ++|+|.||.|+.++    .+.|..+|+|++++.............|..++...+ ||.+|++...+......+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999873    345888999998765332222224556677888886 9999999999999999999999999


Q ss_pred             CCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCc
Q 004994          522 NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN  601 (720)
Q Consensus       522 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~  601 (720)
                      +|.+...+...    ..+.......+...++-++.++|..   +|+|||+|++||+++.+|++|+.|||+++....... 
T Consensus        81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            99998877432    3445555555666778889999988   999999999999999999999999999987644322 


Q ss_pred             ccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCc
Q 004994          602 ELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG  681 (720)
Q Consensus       602 ~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (720)
                           ..|+..|||||+.. .....+|.||||++++||+||..||..                    +....+....  .
T Consensus       153 -----~cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~~~--~  204 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILKAE--L  204 (612)
T ss_pred             -----cccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhhhc--c
Confidence                 16789999999987 456789999999999999999999964                    1111111111  1


Q ss_pred             hhhHHHHHHHHHHHHHHhccCCCCCCCH
Q 004994          682 AYLAKSLSRFADIISRCVQWEPGFRPPM  709 (720)
Q Consensus       682 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~  709 (720)
                      ..+.+....+.+++..++..+|..|--.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2344556677899999999999999654

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=4.7e-21  Score=171.17  Aligned_cols=170  Identities=29%  Similarity=0.500  Sum_probs=153.9

Q ss_pred             cCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccccc
Q 004994           70 FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLS  147 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~  147 (720)
                      +.+++.|.|++|+|+ .+|+.+..|.+|+.|++++|+++ .+|..+.  ++|+.|+++-|++. .+|..|+.++.|+.||
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld  108 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD  108 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence            578899999999999 67889999999999999999999 9999987  78999999999999 9999999999999999


Q ss_pred             ccccccCC-CCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcCcc
Q 004994          148 LNNNHLNG-GIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSG  225 (720)
Q Consensus       148 l~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g  225 (720)
                      |..|+++. .+|..|..+..|+.|+|++|.+. .+|..+++|++|+.|.+..|.+-..+..++.+. |++|++.+|+++ 
T Consensus       109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~-  186 (264)
T KOG0617|consen  109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT-  186 (264)
T ss_pred             ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-
Confidence            99999964 68999999999999999999998 899999999999999999999998888888776 999999999999 


Q ss_pred             cCCcccCCCcc------ccccCccC
Q 004994          226 PIPEKLLSIPN------FRKDGNPF  244 (720)
Q Consensus       226 ~~p~~~~~l~~------l~~~~n~~  244 (720)
                      .+|.+++++.-      ++...|||
T Consensus       187 vlppel~~l~l~~~k~v~r~E~NPw  211 (264)
T KOG0617|consen  187 VLPPELANLDLVGNKQVMRMEENPW  211 (264)
T ss_pred             ecChhhhhhhhhhhHHHHhhhhCCC
Confidence            88888876542      33455555

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.77  E-value=1.6e-19  Score=201.62  Aligned_cols=250  Identities=19%  Similarity=0.174  Sum_probs=176.3

Q ss_pred             CCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccc--cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQ--RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++...+.||.+.|=+|.+|+.+.|. |+||++.+....  -..-++-.+|++ ...++|||++++.-+-.....-|||=+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4555688999999999999888886 999998643211  122233445555 556699999998777666666778888


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC--C
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--F  596 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~--~  596 (720)
                      |..+ +|+|.+.    .+.-+...+..-|+.|+..||.-+|..   +|+|+|||.+|||++.-..+.|+||..-+..  .
T Consensus       102 yvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence            8766 7888774    345566777888999999999999988   9999999999999999999999999865433  2


Q ss_pred             CCCCc---ccccCccccccCCCCccC-C-C----------CCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhh
Q 004994          597 SGSTN---ELSEGLLTAHGSGAPEFE-S-G----------SYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRW  660 (720)
Q Consensus       597 ~~~~~---~~~~~~~~~~~~~aPE~~-~-~----------~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~  660 (720)
                      .+...   .+.........|.|||.+ . +          ..+++-||||.|||++|+++ |++||.-.      .+..+
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY  247 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY  247 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH
Confidence            22211   122222233469999976 2 1          14567899999999999988 89998531      11111


Q ss_pred             cccccCchh-hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          661 AIPRLHDID-ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       661 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      ....-.+.+ .++++-|            ..+++++..|++.||++|.++++.|+.-+.
T Consensus       248 r~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  248 RSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             hccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            111111111 2222222            246799999999999999999999987554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=9.3e-19  Score=176.56  Aligned_cols=233  Identities=21%  Similarity=0.299  Sum_probs=146.0

Q ss_pred             CCCCeeccCCCceEEEEEe-CCCcEEEEEEeccc-ccccccHHHHHHHHHHHHccCC----------CceeEEEeEe---
Q 004994          443 SEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRH----------GNIVELIGYC---  507 (720)
Q Consensus       443 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~~~e~~~l~~l~H----------~niv~l~~~~---  507 (720)
                      ..++.||.|+++.||.++. ++|+.+|||+.... .......+++.+|.-....+.+          -.++.-++..   
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            3467899999999999965 56999999997533 2233445677777655544333          1222222211   


Q ss_pred             ------ccC---C-----eEEEEEeeCCCCCHHHHhhcc---chhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 004994          508 ------NEH---G-----QHLLVYDYGGNCTLHDLLHSD---EEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGN  570 (720)
Q Consensus       508 ------~~~---~-----~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrD  570 (720)
                            ...   .     ..+++|+-+ .++|.+++..-   ......+....++.+..|+.+.+++||+.   |+||+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence                  111   1     235677776 45888876431   11123345566788889999999999998   999999


Q ss_pred             CCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccCCC---------CCCCccchHhHHHHHHHHHh
Q 004994          571 FKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG---------SYSCQSDVYSLGVVMLELLT  641 (720)
Q Consensus       571 lkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~Dv~S~Gvvl~ellt  641 (720)
                      |||+|++++.+|.++|+||+.......  ..  .. ...+.+|.+||....         .++.+.|.|++|+++|.|+.
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~--~~--~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGT--RY--RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTE--EE--EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCc--ee--ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999999999999987654321  11  11 233467889997621         37889999999999999999


Q ss_pred             CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCC
Q 004994          642 GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFR  706 (720)
Q Consensus       642 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  706 (720)
                      |+.||+...+....   .|                 .+  ..+.+.++.+.+|+..+|+.+|.+|
T Consensus       246 ~~lPf~~~~~~~~~---~~-----------------~f--~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADP---EW-----------------DF--SRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTS---GG-----------------GG--TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccc---cc-----------------cc--hhcCCcCHHHHHHHHHHccCCcccC
Confidence            99999764322111   00                 01  1112566789999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=1.5e-17  Score=162.70  Aligned_cols=137  Identities=19%  Similarity=0.212  Sum_probs=104.0

Q ss_pred             CCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHcc-----CCCceeEEEeEeccCC---eE
Q 004994          442 FSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-----RHGNIVELIGYCNEHG---QH  513 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~~  513 (720)
                      +...+.||+|+||.||. .-.++.. +||++....  ....+.+.+|+++++.+     .||||++++|++.+..   ..
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            34568899999999996 3334444 699886432  23456789999999999     5799999999998763   43


Q ss_pred             E-EEEee--CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCeEEcC----CCCeE
Q 004994          514 L-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL-QYLQEVCEPPIVHGNFKSSNILLDE----KLIVR  585 (720)
Q Consensus       514 ~-lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L-~~LH~~~~~~ivHrDlkp~NiLl~~----~~~~k  585 (720)
                      + +|+||  +.+++|.+++...     .++..  ..++.++..++ +|||+.   +||||||||+|||++.    ++.++
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~  149 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV  149 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence            4 78999  5589999999532     24443  35567777777 999987   8999999999999974    34799


Q ss_pred             EccccCC
Q 004994          586 VSDCGLA  592 (720)
Q Consensus       586 l~DFGla  592 (720)
                      |+||+-+
T Consensus       150 LiDg~G~  156 (210)
T PRK10345        150 VCDNIGE  156 (210)
T ss_pred             EEECCCC
Confidence            9995433

>PLN03150 hypothetical protein; Provisional

Probab=99.74  E-value=6.4e-18  Score=192.84  Aligned_cols=152  Identities=33%  Similarity=0.546  Sum_probs=106.0

Q ss_pred             CCCCCHHHHHHHHHHHHhcCCCCCCCccCCCCCCCC---CCCceeEeecC------ceeEEEecCCcccccCCcCcCCCC
Q 004994           25 AGVTDPRDVMALNSLYISLNFPPLEKWLSFGGDPCG---DSWQGVFCVFS------NVTEIRLTGMNLGGVLADTLGDLE   95 (720)
Q Consensus        25 ~~~~~~~~~~al~~~~~~l~~~~~~~w~~~~~~~c~---~~w~gv~c~~~------~l~~l~L~~n~l~~~~~~~~~~l~   95 (720)
                      ...+.++|+.||+++|++++++...+|.   +|||.   +.|.|+.|...      .++.|+|++|+|.|.+|..++.|+
T Consensus       366 ~~~t~~~~~~aL~~~k~~~~~~~~~~W~---g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~  442 (623)
T PLN03150        366 ESKTLLEEVSALQTLKSSLGLPLRFGWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR  442 (623)
T ss_pred             ccccCchHHHHHHHHHHhcCCcccCCCC---CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence            4577889999999999999876545783   57885   36999999642      367777777777777777777777


Q ss_pred             CccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCC
Q 004994           96 SVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSAN  175 (720)
Q Consensus        96 ~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N  175 (720)
                      +|+.|+|++|+|.|                      .+|..++++++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|
T Consensus       443 ~L~~L~Ls~N~l~g----------------------~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N  500 (623)
T PLN03150        443 HLQSINLSGNSIRG----------------------NIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN  500 (623)
T ss_pred             CCCEEECCCCcccC----------------------cCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence            77777766666665                      55555666666666666666666666666666666666666666


Q ss_pred             cccccCCCCCCCC-CCCceeecccccc
Q 004994          176 NLTGQLPPSTRNL-SSLYSLHLQNNKL  201 (720)
Q Consensus       176 ~l~g~~p~~~~~l-~~L~~L~l~~N~l  201 (720)
                      +|+|.+|..++.+ .++..+++++|..
T Consensus       501 ~l~g~iP~~l~~~~~~~~~l~~~~N~~  527 (623)
T PLN03150        501 SLSGRVPAALGGRLLHRASFNFTDNAG  527 (623)
T ss_pred             cccccCChHHhhccccCceEEecCCcc
Confidence            6666666665543 3555667777654

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=4.8e-17  Score=163.20  Aligned_cols=144  Identities=19%  Similarity=0.139  Sum_probs=110.5

Q ss_pred             cCCCCCCeeccCCCceEEEEE--eCCCcEEEEEEecccccccc----------------------cHHHHHHHHHHHHcc
Q 004994          440 NSFSEGNFIGEGLLGSVYKAE--LPGGKLLAVKKLSNTVSQRQ----------------------TDEEFLELASTISRL  495 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~~~----------------------~~~~~~~e~~~l~~l  495 (720)
                      ..|...+.||+|++|.||+|.  ..+|+.||||+++.......                      ....+..|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357788999999999999997  56899999999874321100                      112356899999999


Q ss_pred             CCC--ceeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCC
Q 004994          496 RHG--NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP-IVHGNFK  572 (720)
Q Consensus       496 ~H~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~-ivHrDlk  572 (720)
                      .+.  .+.+++++    ...++||||+++.+|......    ...+.......++.++++++++||..   + |+|||||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dik  176 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLS  176 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCC
Confidence            753  34455553    235899999999888765421    12344556678999999999999987   8 9999999


Q ss_pred             CCCeEEcCCCCeEEccccCCCCC
Q 004994          573 SSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       573 p~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      |+||+++ ++.++|+|||.|...
T Consensus       177 p~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      177 EYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhhEEEE-CCCEEEEEChhhhcc
Confidence            9999999 889999999998754

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.71  E-value=2e-18  Score=180.88  Aligned_cols=186  Identities=24%  Similarity=0.296  Sum_probs=162.4

Q ss_pred             CceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcc
Q 004994           63 WQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRL  140 (720)
Q Consensus        63 w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l  140 (720)
                      -.|+|-.+.+++.|+|+.|+++..-..++.+|+.|+.||||+|.|...-++.+.  .+|++|+|++|+|+...+..|..|
T Consensus       261 ~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L  340 (873)
T KOG4194|consen  261 DDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVL  340 (873)
T ss_pred             cCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHH
Confidence            569999999999999999999988889999999999999999999977787775  899999999999998888889999


Q ss_pred             cccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCC---CCCCCCCCceeecccccccccc-ccccccc-cce
Q 004994          141 TQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPP---STRNLSSLYSLHLQNNKLSGTL-NVLEDLH-LID  215 (720)
Q Consensus       141 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~---~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~-l~~  215 (720)
                      .+|+.|+|++|+++...-.+|..+++|+.|||++|.|++.|-+   .|..|++|+.|+|.+|+|..++ .++..+. |++
T Consensus       341 ~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~  420 (873)
T KOG4194|consen  341 SQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEH  420 (873)
T ss_pred             HHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccce
Confidence            9999999999999976677899999999999999999988765   4778999999999999999888 4566666 999


Q ss_pred             EEccCCcCcccCCcccCCC--ccccccCccCCCcc
Q 004994          216 LNIENNLFSGPIPEKLLSI--PNFRKDGNPFNTTV  248 (720)
Q Consensus       216 l~l~~N~l~g~~p~~~~~l--~~l~~~~n~~~~~~  248 (720)
                      |||.+|.|...-|..|..+  +.|-+..-++-|+|
T Consensus       421 LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDC  455 (873)
T KOG4194|consen  421 LDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDC  455 (873)
T ss_pred             ecCCCCcceeecccccccchhhhhhhcccceEEec
Confidence            9999999998888888766  33334444455554

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=9.3e-17  Score=157.59  Aligned_cols=145  Identities=20%  Similarity=0.149  Sum_probs=111.1

Q ss_pred             HHHHHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEeccccccc--------------------ccHHHHHHHHHHHH
Q 004994          434 SLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQR--------------------QTDEEFLELASTIS  493 (720)
Q Consensus       434 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--------------------~~~~~~~~e~~~l~  493 (720)
                      ++......|...+.||+|+||.||++...+|+.||||++.......                    .....+..|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3444444477789999999999999988889999999876432100                    01123677888899


Q ss_pred             ccCCC--ceeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 004994          494 RLRHG--NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNF  571 (720)
Q Consensus       494 ~l~H~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDl  571 (720)
                      .+.|+  .++..++.    ...++||||+++++|.++...          ....+++.++++++.++|+.   +|+||||
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl  151 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL  151 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence            88887  44555542    345899999999998765421          22456888999999999986   9999999


Q ss_pred             CCCCeEEcCCCCeEEccccCCCCC
Q 004994          572 KSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       572 kp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||+||+++++++++|+|||++..+
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccC
Confidence            999999999999999999999655

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=3.8e-17  Score=186.93  Aligned_cols=196  Identities=23%  Similarity=0.280  Sum_probs=151.2

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC---CCceeEEEeEeccCCeE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR---HGNIVELIGYCNEHGQH  513 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~  513 (720)
                      .-...|.+.+.||+|+||+||+|...+|+.||+|+=++...-     +|.--.+++.+|+   -+-|..+...+.-.+.-
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            344667888899999999999998878999999987654321     1222234445555   12334444444455677


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc-------CCCCeEE
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD-------EKLIVRV  586 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~-------~~~~~kl  586 (720)
                      ++|+||.+.|+|.+++.    ..+.++|.....++.++++.+..||..   +|||+||||+|+||.       +...++|
T Consensus       770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence            89999999999999996    456789999999999999999999998   999999999999993       2346899


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccCCC-CCCCccchHhHHHHHHHHHhCCC
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRK  644 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Dv~S~Gvvl~elltG~~  644 (720)
                      +|||.+..+..-..........+|-++-.+|+..| ..+..+|.|.|+-+++-|+.|+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999987644333333344566777888999855 68999999999999999999974

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1.2e-16  Score=158.56  Aligned_cols=136  Identities=21%  Similarity=0.292  Sum_probs=112.2

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEeccccccc------ccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQR------QTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +.||+|++|.||+|.. +|..+++|+........      .....+..|++++..++|++|+....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999977 67789999865332111      1224678899999999999988777777677788999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +++++|.+++...       .+ .+..++.+++.+|.++|..   +++|||++|.|||++ ++.++|+|||.++.
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988432       12 6788999999999999987   999999999999999 78999999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.68  E-value=2.1e-16  Score=155.34  Aligned_cols=132  Identities=21%  Similarity=0.307  Sum_probs=105.3

Q ss_pred             eeccCCCceEEEEEeCCCcEEEEEEecccccc------cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          447 FIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQ------RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       447 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      .||+|+||.||+|.+ +|..|++|+.......      ......+.+|+++++.++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 5678999986532211      112356788999999999887655554555556678999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      ++++|.+++.....           .++.+++++|.++|..   +++|+|++|.||+++ ++.+++.|||+++.
T Consensus        80 ~g~~l~~~~~~~~~-----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND-----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH-----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988743210           6888999999999987   999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=1.9e-16  Score=178.87  Aligned_cols=139  Identities=21%  Similarity=0.287  Sum_probs=111.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEE-ecccccc-----cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKK-LSNTVSQ-----RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ..|...+.||+|+||+||+|.+.+.. +++|+ +.+....     ....+.+.+|+++++.++|++++..+.++.+....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34556789999999999999775544 44443 3221111     12235688999999999999999888887777778


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++||||+++++|.+++.            ....++.+++++|.|||+.   +++||||||+|||+ +++.++|+|||+++
T Consensus       412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            99999999999998874            2457889999999999987   99999999999999 57799999999997


Q ss_pred             CC
Q 004994          594 LL  595 (720)
Q Consensus       594 ~~  595 (720)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.67  E-value=8e-18  Score=177.26  Aligned_cols=165  Identities=29%  Similarity=0.439  Sum_probs=105.4

Q ss_pred             cCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc---ccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           70 FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP---VTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      +..|+.|||++|+|. ..|..+..-+++-+|+||+|+|. +||..+.   ..|-.||||+|+|. .+|+.+.+|..|+.|
T Consensus       102 l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL  178 (1255)
T KOG0444|consen  102 LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTL  178 (1255)
T ss_pred             cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhh
Confidence            345666666666665 35566666666666666666666 6666555   33445666666666 666666666666666


Q ss_pred             cccccccC-------------------------CCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccc
Q 004994          147 SLNNNHLN-------------------------GGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKL  201 (720)
Q Consensus       147 ~l~~N~l~-------------------------g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l  201 (720)
                      .|++|.|.                         ..+|..+..|.+|..+|||.|+|. .+|+.+.++.+|+.|+||+|+|
T Consensus       179 ~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i  257 (1255)
T KOG0444|consen  179 KLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKI  257 (1255)
T ss_pred             hcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCce
Confidence            66666442                         135555666666777777777776 6777777777777777777777


Q ss_pred             ccccccccc-cccceEEccCCcCcccCCcccCCCccccc
Q 004994          202 SGTLNVLED-LHLIDLNIENNLFSGPIPEKLLSIPNFRK  239 (720)
Q Consensus       202 ~~~~~~~~~-~~l~~l~l~~N~l~g~~p~~~~~l~~l~~  239 (720)
                      +..--..+. -.|+.||||.|+++ .+|+.+..|+.|+.
T Consensus       258 teL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k  295 (1255)
T KOG0444|consen  258 TELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK  295 (1255)
T ss_pred             eeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence            654322222 23777888888888 78887777766553

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.66  E-value=9.7e-16  Score=154.30  Aligned_cols=194  Identities=19%  Similarity=0.198  Sum_probs=130.2

Q ss_pred             CCCceeEEEeEecc---------------------------CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHH
Q 004994          496 RHGNIVELIGYCNE---------------------------HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA  548 (720)
Q Consensus       496 ~H~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~  548 (720)
                      +|||||++.++|.+                           ....|+||.-.+. +|.+++..     ...+.....-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence            69999999887622                           2246888887664 88888853     234455666788


Q ss_pred             HHHHHHHHHHHhcCCCCeeecCCCCCCeEE--cCCC--CeEEccccCCCCCCCCC----CcccccCccccccCCCCccCC
Q 004994          549 LGAARALQYLQEVCEPPIVHGNFKSSNILL--DEKL--IVRVSDCGLAPLLFSGS----TNELSEGLLTAHGSGAPEFES  620 (720)
Q Consensus       549 ~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl--~~~~--~~kl~DFGla~~~~~~~----~~~~~~~~~~~~~~~aPE~~~  620 (720)
                      .|+.+|+.|||..   +|.|||+|++|||+  |+|.  .+.|+|||++---....    +....-...|....||||+.+
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            8999999999987   99999999999999  4444  57899999863221100    000111233556679999874


Q ss_pred             CCC-------CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHH
Q 004994          621 GSY-------SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFAD  693 (720)
Q Consensus       621 ~~~-------~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  693 (720)
                      ...       -.|+|.|+.|-+.||+++...||-...   +..+         +.....+---|.    .++.++..+++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~L---------~~r~Yqe~qLPa----lp~~vpp~~rq  488 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EMLL---------DTRTYQESQLPA----LPSRVPPVARQ  488 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc---hhee---------chhhhhhhhCCC----CcccCChHHHH
Confidence            321       348999999999999999999995421   1100         000111111112    22345567889


Q ss_pred             HHHHHhccCCCCCCCHHHHHH
Q 004994          694 IISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       694 l~~~cl~~dP~~RPt~~evl~  714 (720)
                      ++...|+.||++|++..-...
T Consensus       489 lV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             HHHHHhcCCccccCCccHHHh
Confidence            999999999999998765433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=6.1e-17  Score=181.30  Aligned_cols=207  Identities=21%  Similarity=0.271  Sum_probs=138.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .+|..++.|..|+||.||.++++ +.+.+|+|.=++..        ..+-  ++.....|.+|                 
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l--------ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL--------ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccch--------hhhc--cccccCCccee-----------------
Confidence            57888899999999999999765 46788884322211        0110  33333344443                 


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                          |+-...+...    ..++.        +.+.+++|+|+.   +|||||+||+|.+|+.-|++|+.|||+++.....
T Consensus       136 ----gDc~tllk~~----g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 ----GDCATLLKNI----GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             ----chhhhhcccC----CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                3434444321    12221        126789999987   9999999999999999999999999998653211


Q ss_pred             ------------CCccc-ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 004994          599 ------------STNEL-SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       599 ------------~~~~~-~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                                  .++.+ .....+|+.|.|||++ ...|+..+|+|++|+|+||.+.|..||....+.+-...+      
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v------  270 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV------  270 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh------
Confidence                        11111 2345789999999998 456999999999999999999999999876543321111      


Q ss_pred             cCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCC
Q 004994          665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP  707 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  707 (720)
                      +.+...        ..+ .+...+.+..+++.+.|+.+|.+|-
T Consensus       271 isd~i~--------wpE-~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  271 ISDDIE--------WPE-EDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhcc--------ccc-cCcCCCHHHHHHHHHHHHhChHhhc
Confidence            000000        000 0223346788999999999999994

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.65  E-value=4.3e-17  Score=171.13  Aligned_cols=175  Identities=21%  Similarity=0.294  Sum_probs=129.3

Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      ..|+.|++|...+|.+|+.... .....+|...+.++.+++.|+.|   .   +.+|||+||.||++..+.++||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            5789999999999999997543 34566788899999999999999   3   899999999999999999999999999


Q ss_pred             CCCCCCCC----CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhccccc
Q 004994          592 APLLFSGS----TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       592 a~~~~~~~----~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      ........    ...-.....+|..||+||.+ +..|+.|+||||+|+||+|+++ =..+|..                 
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----------------  465 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-----------------  465 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------------
Confidence            87765443    11123346789999999999 4679999999999999999997 2223221                 


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIV  713 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  713 (720)
                        ...+..+.|..++..+..+.+. -..|+.++++..|.+||++.++-
T Consensus       466 --~~t~~d~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  466 --IATLTDIRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             --HHhhhhhhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHHHHh
Confidence              0112222222222222222222 34889999999999999655543

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.63  E-value=3.1e-17  Score=172.87  Aligned_cols=172  Identities=29%  Similarity=0.432  Sum_probs=120.7

Q ss_pred             CceeEeecCceeEEEecCCcccc-cCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcch-hh
Q 004994           63 WQGVFCVFSNVTEIRLTGMNLGG-VLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPES-LS  138 (720)
Q Consensus        63 w~gv~c~~~~l~~l~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~-l~  138 (720)
                      -.|-...+++|+.+.+..|+|.. -+|+.+..|..|+.||||.|+|. +.|.++-  +++-.|+||+|+|. +||.. |.
T Consensus        70 vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfi  147 (1255)
T KOG0444|consen   70 VHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFI  147 (1255)
T ss_pred             hhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHH
Confidence            45666677889999999999963 37888999999999999999999 8998886  78999999999999 67755 67


Q ss_pred             cccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccc--cccccccccccc-cce
Q 004994          139 RLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNK--LSGTLNVLEDLH-LID  215 (720)
Q Consensus       139 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~--l~~~~~~~~~~~-l~~  215 (720)
                      +|+.|-+||||+|+|. .+|+.+..|..|+.|+|++|.|.-.--..+-.+++|+.|++++.+  +...++.+..+. |.+
T Consensus       148 nLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~d  226 (1255)
T KOG0444|consen  148 NLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRD  226 (1255)
T ss_pred             hhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhh
Confidence            8999999999999998 788889999999999999997652111122233344444444432  222333333333 444


Q ss_pred             EEccCCcCcccCCcccCCCcccc
Q 004994          216 LNIENNLFSGPIPEKLLSIPNFR  238 (720)
Q Consensus       216 l~l~~N~l~g~~p~~~~~l~~l~  238 (720)
                      +|||.|++. .+|+.+..+.+|+
T Consensus       227 vDlS~N~Lp-~vPecly~l~~Lr  248 (1255)
T KOG0444|consen  227 VDLSENNLP-IVPECLYKLRNLR  248 (1255)
T ss_pred             ccccccCCC-cchHHHhhhhhhh
Confidence            444444444 4444444444433

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=3.7e-15  Score=139.01  Aligned_cols=134  Identities=18%  Similarity=0.193  Sum_probs=113.9

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCC--CceeEEEeEeccCCeEEEEEeeCCC
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH--GNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      .+.||+|.++.||++...+ ..+++|.......    ...+..|+..++.++|  .+++++++++...+..+++|||+.+
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            4679999999999998755 7899999865432    4578899999999977  5999999999888899999999998


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +.+..+           ++.....++.+++++++++|..+..+++|+|++|+||++++++.+++.|||.++.
T Consensus        78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            766543           4456677889999999999997666899999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.62  E-value=2.3e-17  Score=147.72  Aligned_cols=154  Identities=27%  Similarity=0.382  Sum_probs=138.1

Q ss_pred             CcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCC
Q 004994           90 TLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGL  167 (720)
Q Consensus        90 ~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L  167 (720)
                      .+.++.+++.|.||+|+++ .+|+.+.  .+|+.|++++|+++ .+|.+++.++.|+.|+++-|++. .+|..|+.++.|
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence            3557889999999999999 8999987  79999999999999 89999999999999999999998 899999999999


Q ss_pred             ceEeccCCcccc-cCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcCcccCCcccCCCccccccCccCC
Q 004994          168 INFDLSANNLTG-QLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       168 ~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      +.|||++|+++. .+|..|..+..|+.|+|+.|.|.-.++.++.+. |+.|.+..|.+- .+|.+++.++.|+......|
T Consensus       105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence            999999999975 589999999999999999999998888888876 999999999998 89999988887765544444


Q ss_pred             Cc
Q 004994          246 TT  247 (720)
Q Consensus       246 ~~  247 (720)
                      -.
T Consensus       184 rl  185 (264)
T KOG0617|consen  184 RL  185 (264)
T ss_pred             ee
Confidence            33

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=3e-15  Score=145.53  Aligned_cols=137  Identities=22%  Similarity=0.224  Sum_probs=97.3

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHH----------------------HHHHHHHHHccCCCc--e
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEE----------------------FLELASTISRLRHGN--I  500 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~----------------------~~~e~~~l~~l~H~n--i  500 (720)
                      .+.||+|+||+||+|...+|+.||||++............                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999998778999999998754221111111                      134556666664433  4


Q ss_pred             eEEEeEeccCCeEEEEEeeCCCCCHHHH-hhccchhccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEE
Q 004994          501 VELIGYCNEHGQHLLVYDYGGNCTLHDL-LHSDEEAHKKFSWNIRIRVALGAARALQYLQE-VCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       501 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDlkp~NiLl  578 (720)
                      .+.+++    ...++||||++++.+... +....     .. .....++.+++.++.++|. .   +|+||||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            445543    245899999998543211 11100     00 4466789999999999998 5   89999999999999


Q ss_pred             cCCCCeEEccccCCCCC
Q 004994          579 DEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~  595 (720)
                      + ++.++++|||.+...
T Consensus       149 ~-~~~~~liDfg~a~~~  164 (187)
T cd05119         149 D-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             E-CCcEEEEECcccccc
Confidence            9 899999999999655

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.56  E-value=2.8e-16  Score=164.97  Aligned_cols=137  Identities=26%  Similarity=0.251  Sum_probs=78.4

Q ss_pred             eeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc---ccCcEEEecCCcCCCCCcchhhccc
Q 004994           65 GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP---VTVRNFSLSGNQLTGSIPESLSRLT  141 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~L~~L~Ls~N~l~g~~p~~l~~l~  141 (720)
                      -+|-.+++|+.|+|..|.|.-.---.|..|++|+.|.|..|+++ .+-+...   .+++.|+|+.|+++..--.++.+|+
T Consensus       215 r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt  293 (873)
T KOG4194|consen  215 RSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT  293 (873)
T ss_pred             HHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecccchhhhhhcccccccc
Confidence            45555677777777777776333345666666666666666666 3333222   4556666666666544445555566


Q ss_pred             ccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccc
Q 004994          142 QLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS  202 (720)
Q Consensus       142 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  202 (720)
                      .|+.|+||+|.|....++.+.-+++|++|+|++|+|+..-+.+|..|.+|+.|+|++|.++
T Consensus       294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~  354 (873)
T KOG4194|consen  294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID  354 (873)
T ss_pred             hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence            6666666666665555555555566666666666665333344444555555555555444

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.56  E-value=9.3e-16  Score=154.49  Aligned_cols=195  Identities=25%  Similarity=0.305  Sum_probs=131.9

Q ss_pred             CCCCCCCC---ceeEeecC-----------ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccC
Q 004994           56 GDPCGDSW---QGVFCVFS-----------NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTV  119 (720)
Q Consensus        56 ~~~c~~~w---~gv~c~~~-----------~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L  119 (720)
                      .-||.|+=   .-|+|...           ..++|+|..|+|+.+.|.+|+.+++|+.||||+|+|+..-|..|.  .+|
T Consensus        38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l  117 (498)
T KOG4237|consen   38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL  117 (498)
T ss_pred             CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence            35676554   55778643           456889999999988889999999999999999999977777764  343


Q ss_pred             c-EEEecCCcCCCCCcchhhcccccccccccccccCCCCCc---------------------------------------
Q 004994          120 R-NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD---------------------------------------  159 (720)
Q Consensus       120 ~-~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~---------------------------------------  159 (720)
                      . -+++++|+|+...-..|++|..|+.|.+.-|++.-...+                                       
T Consensus       118 ~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~  197 (498)
T KOG4237|consen  118 LSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQ  197 (498)
T ss_pred             hHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhc
Confidence            3 344455777743334466655555544444433211111                                       


Q ss_pred             -----------------------------------------------------------------------hhcCCCCCc
Q 004994          160 -----------------------------------------------------------------------AFHQFTGLI  168 (720)
Q Consensus       160 -----------------------------------------------------------------------~~~~l~~L~  168 (720)
                                                                                             .|..|++|+
T Consensus       198 np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~  277 (498)
T KOG4237|consen  198 NPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLR  277 (498)
T ss_pred             CccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccce
Confidence                                                                                   245666677


Q ss_pred             eEeccCCcccccCCCCCCCCCCCceeecccccccccc-ccccccc-cceEEccCCcCcccCCcccC---CCccccccCcc
Q 004994          169 NFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL-NVLEDLH-LIDLNIENNLFSGPIPEKLL---SIPNFRKDGNP  243 (720)
Q Consensus       169 ~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~-l~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~  243 (720)
                      .|+|++|+|++.-+.+|..+..|+.|+|..|+|...- ..+..++ |+.|+|.+|+|+-.-|..|.   ++..|.+..||
T Consensus       278 ~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np  357 (498)
T KOG4237|consen  278 KLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNP  357 (498)
T ss_pred             EeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCc
Confidence            7777777777666667777777777777777765443 2344554 88899999999987787664   45667788999


Q ss_pred             CCCcccC
Q 004994          244 FNTTVIA  250 (720)
Q Consensus       244 ~~~~~~~  250 (720)
                      |||.|..
T Consensus       358 ~~CnC~l  364 (498)
T KOG4237|consen  358 FNCNCRL  364 (498)
T ss_pred             ccCccch
Confidence            9987643

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=5.7e-14  Score=141.25  Aligned_cols=138  Identities=14%  Similarity=0.144  Sum_probs=104.9

Q ss_pred             CCeec-cCCCceEEEEEeCCCcEEEEEEecccc------c-----ccccHHHHHHHHHHHHccCCCce--eEEEeEeccC
Q 004994          445 GNFIG-EGLLGSVYKAELPGGKLLAVKKLSNTV------S-----QRQTDEEFLELASTISRLRHGNI--VELIGYCNEH  510 (720)
Q Consensus       445 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~l~~~~------~-----~~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~  510 (720)
                      ...|| .|+.|+||++... +..++||++....      .     .......+.+|++++.+++|++|  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            46788 8999999999775 6688999885321      0     01233567889999999998875  6777765432


Q ss_pred             -C---eEEEEEeeCCC-CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeE
Q 004994          511 -G---QHLLVYDYGGN-CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR  585 (720)
Q Consensus       511 -~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  585 (720)
                       .   ..++||||+++ .+|.+++...     .++..    .+.+++++|.+||+.   ||+||||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence             2   23599999997 6898887431     23332    356789999999997   999999999999999999999


Q ss_pred             EccccCCCCC
Q 004994          586 VSDCGLAPLL  595 (720)
Q Consensus       586 l~DFGla~~~  595 (720)
                      |+|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999998653

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.55  E-value=4.2e-14  Score=162.30  Aligned_cols=207  Identities=23%  Similarity=0.336  Sum_probs=135.4

Q ss_pred             cCCCCCHHHHHHHHHHHHhcCCC-CCCC----ccCCCCCCCCCC--------------CceeEeec--------------
Q 004994           24 CAGVTDPRDVMALNSLYISLNFP-PLEK----WLSFGGDPCGDS--------------WQGVFCVF--------------   70 (720)
Q Consensus        24 ~~~~~~~~~~~al~~~~~~l~~~-~~~~----w~~~~~~~c~~~--------------w~gv~c~~--------------   70 (720)
                      ..+.+.+++...+.++.+.|.+| .+.+    |.. .+|.|.-.              -.-|.|..              
T Consensus        56 ~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~-~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~  134 (754)
T PRK15370         56 PPETASPEEIKSKFECLRMLAFPAYADNIQYSRGG-ADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQA  134 (754)
T ss_pred             CCCCCCHHHHHHHHHHHHHhcCCchhhccccccCC-CCcccccCCcchhhheeeecCCceEEecCCCccccccccccccc
Confidence            35788999999999999999998 4555    865 56788411              11255522              


Q ss_pred             -------------------------------------------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcc
Q 004994           71 -------------------------------------------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHI  107 (720)
Q Consensus        71 -------------------------------------------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  107 (720)
                                                                 .+.+.|+|++++|+. +|..+.  ++|+.|+|++|+|
T Consensus       135 ~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~L  211 (754)
T PRK15370        135 SSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNNEL  211 (754)
T ss_pred             ccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCC
Confidence                                                       335667777777763 454443  4677778888877


Q ss_pred             cccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCC
Q 004994          108 GGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRN  187 (720)
Q Consensus       108 ~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~  187 (720)
                      + .+|..+..+|+.|+|++|+|+ .+|..+.  .+|+.|+|++|++. .+|..+.  ++|+.|+|++|+|+ .+|..+. 
T Consensus       212 t-sLP~~l~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~-  282 (754)
T PRK15370        212 K-SLPENLQGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP-  282 (754)
T ss_pred             C-cCChhhccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC-
Confidence            7 677776677777888777777 5666553  36777777777776 5666554  46777888888877 5676553 


Q ss_pred             CCCCceeeccccccccccccccccccceEEccCCcCcccCCcc-cCCCccccccCccCCC
Q 004994          188 LSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEK-LLSIPNFRKDGNPFNT  246 (720)
Q Consensus       188 l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~g~~p~~-~~~l~~l~~~~n~~~~  246 (720)
                       ++|+.|+|++|+|++.+..+. ..|+.|++++|+|+. +|.. ..+|..|.+.+|.+.+
T Consensus       283 -~sL~~L~Ls~N~Lt~LP~~lp-~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~Lt~  339 (754)
T PRK15370        283 -EELRYLSVYDNSIRTLPAHLP-SGITHLNVQSNSLTA-LPETLPPGLKTLEAGENALTS  339 (754)
T ss_pred             -CCCcEEECCCCccccCcccch-hhHHHHHhcCCcccc-CCccccccceeccccCCcccc
Confidence             477778888887776543221 136666667776663 4432 2344555555555443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=1.1e-15  Score=172.02  Aligned_cols=255  Identities=24%  Similarity=0.292  Sum_probs=183.8

Q ss_pred             CCCCCCeeccCCCceEEEEEe--CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL--PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .|...+.||+|+|+.|-....  .....+|+|.+..........+....|..+-..+. |+|++.+++...+.+..++..
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            345556699999999987744  33556777777544322333344455666767776 999999999999999999999


Q ss_pred             eeCCCCCHHHHh-hccchhccccCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCCeEEcCCC-CeEEccccCCCC
Q 004994          518 DYGGNCTLHDLL-HSDEEAHKKFSWNIRIRVALGAARALQYLQ-EVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPL  594 (720)
Q Consensus       518 e~~~~gsL~~~l-~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH-~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~  594 (720)
                      +|..++++.+-+ +...   ...+......+..++..++.|+| ..   ++.|||+||+|.+++..+ ..|++|||+|..
T Consensus       101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            999999998877 3221   12334456678889999999999 55   899999999999999999 999999999987


Q ss_pred             CCC-CCCcccccCccc-cccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhh
Q 004994          595 LFS-GSTNELSEGLLT-AHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       595 ~~~-~~~~~~~~~~~~-~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      +.. .+.........| ++.|+|||...+  -.....|+||.|+++.-+++|..|++....... ....|....-.    
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~----  249 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNKGR----  249 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccccc----
Confidence            765 344444445566 899999999865  356789999999999999999999976543331 11112111000    


Q ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       671 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                              ..............++..+++..+|+.|.+.+++-.
T Consensus       250 --------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 --------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence                    000011122245568899999999999999887643

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.53  E-value=1.9e-16  Score=159.52  Aligned_cols=167  Identities=25%  Similarity=0.413  Sum_probs=136.3

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCc-c-ccCcEEEecCCcCCCCCcchhhcccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL-P-VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL  148 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~-~-~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l  148 (720)
                      ..+..++..+|+++ .+|+.++++.+|..|++.+|++. .+|+.. . +.|+.||...|-++ ++|++++.+.+|..|+|
T Consensus       137 ~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL  213 (565)
T KOG0472|consen  137 LDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYL  213 (565)
T ss_pred             hhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHh
Confidence            35677788888887 57788888888888888888888 455443 3 67899999999988 88989999999999999


Q ss_pred             cccccCCCCCchhcCCCCCceEeccCCcccccCCCCCC-CCCCCceeeccccccccccccccccc-cceEEccCCcCccc
Q 004994          149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTR-NLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGP  226 (720)
Q Consensus       149 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g~  226 (720)
                      ..|+|. .+| +|.+|..|.+|+++.|+|+ .+|.+.. ++++|..|||..|+++..+..+..+. |..||+|+|.++ .
T Consensus       214 ~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~  289 (565)
T KOG0472|consen  214 RRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-S  289 (565)
T ss_pred             hhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-c
Confidence            999997 777 7899999999999999998 7887765 89999999999999999888777776 889999999999 6


Q ss_pred             CCcccCCC--ccccccCccC
Q 004994          227 IPEKLLSI--PNFRKDGNPF  244 (720)
Q Consensus       227 ~p~~~~~l--~~l~~~~n~~  244 (720)
                      +|.+++++  ..|.+.|||.
T Consensus       290 Lp~sLgnlhL~~L~leGNPl  309 (565)
T KOG0472|consen  290 LPYSLGNLHLKFLALEGNPL  309 (565)
T ss_pred             CCcccccceeeehhhcCCch
Confidence            77778776  2233456654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.46  E-value=1e-13  Score=159.04  Aligned_cols=160  Identities=25%  Similarity=0.411  Sum_probs=126.5

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN  150 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~  150 (720)
                      .+++.|+|++|+|+. +|..+.  ++|+.|+|++|+|+ .+|..++.+|+.|+|++|++. .+|..+.  .+|+.|+|++
T Consensus       199 ~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~  271 (754)
T PRK15370        199 EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLPDTIQEMELSINRIT-ELPERLP--SALQSLDLFH  271 (754)
T ss_pred             cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhhccccEEECcCCccC-cCChhHh--CCCCEEECcC
Confidence            478999999999995 566554  58999999999999 789888889999999999999 7888775  5899999999


Q ss_pred             cccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCcCcccCCcc
Q 004994          151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEK  230 (720)
Q Consensus       151 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~g~~p~~  230 (720)
                      |+|+ .+|..+.  .+|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+..+..+. ..|+.|++++|.|++ +|..
T Consensus       272 N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~-~sL~~L~Ls~N~Lt~-LP~~  343 (754)
T PRK15370        272 NKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLP-PGLKTLEAGENALTS-LPAS  343 (754)
T ss_pred             CccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCcccc-ccceeccccCCcccc-CChh
Confidence            9998 5787664  58999999999998 5776553  478888999998887654322 357888888888884 6654


Q ss_pred             cC-CCccccccCccCC
Q 004994          231 LL-SIPNFRKDGNPFN  245 (720)
Q Consensus       231 ~~-~l~~l~~~~n~~~  245 (720)
                      +. +|..|.+.+|.+.
T Consensus       344 l~~sL~~L~Ls~N~L~  359 (754)
T PRK15370        344 LPPELQVLDVSKNQIT  359 (754)
T ss_pred             hcCcccEEECCCCCCC
Confidence            43 5566666666554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.45  E-value=1.4e-15  Score=159.76  Aligned_cols=170  Identities=26%  Similarity=0.393  Sum_probs=150.8

Q ss_pred             ecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      ++...+..||+.|++. .+|..+..+..|..|.|..|.|. .||..+.  ..|++|||+.|+++ .+|..++.|+ |+.|
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl  148 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL  148 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence            3455677899999998 68889999999999999999999 8888886  67899999999999 8899998876 9999


Q ss_pred             cccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCcCccc
Q 004994          147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGP  226 (720)
Q Consensus       147 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~g~  226 (720)
                      .+++|+++ .+|+.++.+..|..||.+.|++. .+|..++++.+|+.|.+..|++.-.++.+..+.|..||+|+|+++ .
T Consensus       149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~  225 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-Y  225 (722)
T ss_pred             EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-e
Confidence            99999998 89999998899999999999998 899999999999999999999999998888999999999999999 8


Q ss_pred             CCcccCCCcccc---ccCccCC
Q 004994          227 IPEKLLSIPNFR---KDGNPFN  245 (720)
Q Consensus       227 ~p~~~~~l~~l~---~~~n~~~  245 (720)
                      ||-.|.+|..|+   +.+||..
T Consensus       226 iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  226 LPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             cchhhhhhhhheeeeeccCCCC
Confidence            999888777665   5667664

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.45  E-value=1.2e-15  Score=153.80  Aligned_cols=155  Identities=23%  Similarity=0.390  Sum_probs=141.3

Q ss_pred             ceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccc
Q 004994           64 QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLT  141 (720)
Q Consensus        64 ~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~  141 (720)
                      ++.+-++.++..|++.+|++....|..+. ++.|+.||.-.|-+. .+|++++  .+|.-|||..|++. .+| +|..|.
T Consensus       153 p~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs  228 (565)
T KOG0472|consen  153 PEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCS  228 (565)
T ss_pred             chHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccH
Confidence            34444456788999999999976665555 999999999999998 9999998  78999999999999 888 899999


Q ss_pred             ccccccccccccCCCCCchhc-CCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccC
Q 004994          142 QLLDLSLNNNHLNGGIPDAFH-QFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIEN  220 (720)
Q Consensus       142 ~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~  220 (720)
                      .|.+|+++.|+|. .+|.+.+ +|.+|..|||.+|+++ .+|+.+.-+.+|..||||+|.+++.+..++++.|+.|-+.+
T Consensus       229 ~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leG  306 (565)
T KOG0472|consen  229 LLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEG  306 (565)
T ss_pred             HHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcC
Confidence            9999999999998 7888876 8999999999999999 99999999999999999999999999999999999999999


Q ss_pred             CcCc
Q 004994          221 NLFS  224 (720)
Q Consensus       221 N~l~  224 (720)
                      |.+.
T Consensus       307 NPlr  310 (565)
T KOG0472|consen  307 NPLR  310 (565)
T ss_pred             CchH
Confidence            9987

>PLN03150 hypothetical protein; Provisional

Probab=99.45  E-value=9.6e-14  Score=158.67  Aligned_cols=104  Identities=32%  Similarity=0.476  Sum_probs=66.3

Q ss_pred             cccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccC
Q 004994          143 LLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIEN  220 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~  220 (720)
                      ++.|+|++|.|+|.+|..++.|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.++ .+..+. |+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            5566666666666666666666666666666666666666666666666666666666666554 244443 66677777


Q ss_pred             CcCcccCCcccCCC----ccccccCccCCC
Q 004994          221 NLFSGPIPEKLLSI----PNFRKDGNPFNT  246 (720)
Q Consensus       221 N~l~g~~p~~~~~l----~~l~~~~n~~~~  246 (720)
                      |+|+|.+|..+..+    ..+.+.+|+..|
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc  529 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLC  529 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCcccc
Confidence            77777777665432    234556666544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=6.1e-13  Score=145.43  Aligned_cols=147  Identities=20%  Similarity=0.218  Sum_probs=99.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEeccccccccc--------------------------------------
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQT--------------------------------------  481 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~--------------------------------------  481 (720)
                      ..|. .+.||.|++|.||+|++.+|+.||||+.++.......                                      
T Consensus       118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            3444 3679999999999999999999999998764311100                                      


Q ss_pred             HHHHHHHHHHHHcc----CCCceeEEEeEec-cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHH-HH
Q 004994          482 DEEFLELASTISRL----RHGNIVELIGYCN-EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR-AL  555 (720)
Q Consensus       482 ~~~~~~e~~~l~~l----~H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~-~L  555 (720)
                      .-+|..|.+.+.++    +|.+-+.+-.++. .....++||||++|++|.++.....   ...   .+.+++..+++ .+
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l  270 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFL  270 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHH
Confidence            01244455544444    2333333333332 2345799999999999988764211   111   23456655555 34


Q ss_pred             HHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       556 ~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      ..+|..   |++|+|+||.||++++++.++++|||++..+.
T Consensus       271 ~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            556654   99999999999999999999999999997764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.42  E-value=2.6e-13  Score=154.87  Aligned_cols=147  Identities=27%  Similarity=0.415  Sum_probs=74.7

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccccccccccccc
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNN  151 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N  151 (720)
                      +|+.|+|++|+|+. +|.   .+++|+.|+|++|+|+ .+|. ++.+|+.|++++|+|+ .+|..   ..+|+.|+|++|
T Consensus       283 ~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~-~Lp~-lp~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N  352 (788)
T PRK15387        283 GLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLA-SLPA-LPSELCKLWAYNNQLT-SLPTL---PSGLQELSVSDN  352 (788)
T ss_pred             hcCEEECcCCcccc-ccc---cccccceeECCCCccc-cCCC-CcccccccccccCccc-ccccc---ccccceEecCCC
Confidence            45556666666653 332   2356777777777777 3443 2334444444444444 23321   123444444444


Q ss_pred             ccCC-------------------CCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc
Q 004994          152 HLNG-------------------GIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH  212 (720)
Q Consensus       152 ~l~g-------------------~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~  212 (720)
                      +|++                   .+|..   ..+|+.|+|++|+|+ .+|...   ++|+.|+|++|+|++.+...  ..
T Consensus       353 ~Ls~LP~lp~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~LssIP~l~--~~  423 (788)
T PRK15387        353 QLASLPTLPSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTSLPMLP--SG  423 (788)
T ss_pred             ccCCCCCCCcccceehhhccccccCccc---ccccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCCCCcch--hh
Confidence            4442                   23322   134556666666665 344332   45566666666666543321  12


Q ss_pred             cceEEccCCcCcccCCcccCCCcccc
Q 004994          213 LIDLNIENNLFSGPIPEKLLSIPNFR  238 (720)
Q Consensus       213 l~~l~l~~N~l~g~~p~~~~~l~~l~  238 (720)
                      |..|++++|+|+ .+|..+.+++.|.
T Consensus       424 L~~L~Ls~NqLt-~LP~sl~~L~~L~  448 (788)
T PRK15387        424 LLSLSVYRNQLT-RLPESLIHLSSET  448 (788)
T ss_pred             hhhhhhccCccc-ccChHHhhccCCC
Confidence            555666666666 5666555444433

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=2.4e-13  Score=134.27  Aligned_cols=206  Identities=19%  Similarity=0.330  Sum_probs=143.1

Q ss_pred             HHHHHccCCCceeEEEeEeccC-----CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 004994          489 ASTISRLRHGNIVELIGYCNEH-----GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE  563 (720)
Q Consensus       489 ~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~  563 (720)
                      +.-+-.+.|.|||++..|+.+.     .+..++.|||..|++..+|+........+......++..||..||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            3445556799999999998654     357899999999999999987766667777777788999999999999985 7


Q ss_pred             CCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC---CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHH
Q 004994          564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS---TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLEL  639 (720)
Q Consensus       564 ~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~---~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~el  639 (720)
                      |+|+|+++.-+-|++..++-+|+.----. ......   .......-.+.++|.+||+- ..+.+..+|||+||+..+||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            89999999999999999988887531111 110000   00111223356789999987 44677899999999999999


Q ss_pred             HhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          640 LTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       640 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      ..+..--.......+   ++         +.....+-..-.+        .=++++.+|++..|..||+|.+++.|.
T Consensus       276 ailEiq~tnseS~~~---~e---------e~ia~~i~~len~--------lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  276 AILEIQSTNSESKVE---VE---------ENIANVIIGLENG--------LQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HHheeccCCCcceee---hh---------hhhhhheeeccCc--------cccCcCcccccCCCCCCcchhhhhcCc
Confidence            988754322211110   00         1111111100000        013678999999999999999988664

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.40  E-value=9.2e-13  Score=150.40  Aligned_cols=153  Identities=25%  Similarity=0.361  Sum_probs=93.4

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccccccccccccc
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNN  151 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N  151 (720)
                      +|+.|+|.+|+|+. +|.   .+++|++|+|++|+|+ .+|. ++.+|+.|+|++|.|+ .+|..+   .+|+.|+|++|
T Consensus       223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~-lp~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N  292 (788)
T PRK15387        223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV-LPPGLLELSIFSNPLT-HLPALP---SGLCKLWIFGN  292 (788)
T ss_pred             CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccC-cccccceeeccCCchh-hhhhch---hhcCEEECcCC
Confidence            56777777777774 443   2466777777777777 5664 3456777777777776 455432   45667777777


Q ss_pred             ccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCcCcccCCccc
Q 004994          152 HLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKL  231 (720)
Q Consensus       152 ~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~g~~p~~~  231 (720)
                      +|+ .+|..   +++|+.|+|++|+|+ .+|...   .+|+.|++++|+|++.+...  ..|+.|+|++|+|+ .+|...
T Consensus       293 ~Lt-~LP~~---p~~L~~LdLS~N~L~-~Lp~lp---~~L~~L~Ls~N~L~~LP~lp--~~Lq~LdLS~N~Ls-~LP~lp  361 (788)
T PRK15387        293 QLT-SLPVL---PPGLQELSVSDNQLA-SLPALP---SELCKLWAYNNQLTSLPTLP--SGLQELSVSDNQLA-SLPTLP  361 (788)
T ss_pred             ccc-ccccc---ccccceeECCCCccc-cCCCCc---ccccccccccCccccccccc--cccceEecCCCccC-CCCCCC
Confidence            777 45542   357888888888887 455432   24555666666666543211  13667777777777 355544


Q ss_pred             CCCccccccCccCC
Q 004994          232 LSIPNFRKDGNPFN  245 (720)
Q Consensus       232 ~~l~~l~~~~n~~~  245 (720)
                      .++..|.+.+|...
T Consensus       362 ~~L~~L~Ls~N~L~  375 (788)
T PRK15387        362 SELYKLWAYNNRLT  375 (788)
T ss_pred             cccceehhhccccc
Confidence            55555555555443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.31  E-value=1.5e-12  Score=143.79  Aligned_cols=151  Identities=14%  Similarity=0.177  Sum_probs=96.6

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeCC-CcEEEEEEeccccccc--------------------------------ccHH-
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQR--------------------------------QTDE-  483 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~--------------------------------~~~~-  483 (720)
                      .-..|+. +.||+|++|.||+|++++ |+.||||+.++.....                                ...+ 
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3455666 789999999999999877 9999999998653110                                0011 


Q ss_pred             -----HHHHHHHHHHcc----CCCceeEEEeEecc-CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHH
Q 004994          484 -----EFLELASTISRL----RHGNIVELIGYCNE-HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR  553 (720)
Q Consensus       484 -----~~~~e~~~l~~l----~H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~  553 (720)
                           +|.+|+.-+.++    .+.+.+.+-.++.+ ....+|||||+.|+.+.++-....   ...+   +..++...++
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~---~g~d---~~~la~~~v~  270 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA---AGTD---MKLLAERGVE  270 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh---cCCC---HHHHHHHHHH
Confidence                 234444433333    24444444444433 446789999999999987532111   1111   1122222221


Q ss_pred             HHHHHHhcCCCCeeecCCCCCCeEEcCCC----CeEEccccCCCCCCC
Q 004994          554 ALQYLQEVCEPPIVHGNFKSSNILLDEKL----IVRVSDCGLAPLLFS  597 (720)
Q Consensus       554 ~L~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFGla~~~~~  597 (720)
                        .|+++....|++|+|+||.||+++.++    ++++.|||++..+..
T Consensus       271 --~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        271 --VFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             --HHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence              234444445999999999999999988    999999999877643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=2.3e-12  Score=138.53  Aligned_cols=251  Identities=21%  Similarity=0.236  Sum_probs=176.1

Q ss_pred             cCCCCCCeecc--CCCceEEEEEe---CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGE--GLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  513 (720)
                      ..|.....+|.  |.+|.||.+..   .++..+|+|+-+...........-.+|+...+++ .|+|.++.+..+.+.+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34555678999  99999999954   5688999998443333223333344566666666 499999989999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCeEEcCC-CCeEEcc
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR----ALQYLQEVCEPPIVHGNFKSSNILLDEK-LIVRVSD  588 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~----~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~D  588 (720)
                      ++-+|++. .+|.++-+...   ..++......+..+..+    ||..+|..   +++|-|+||.||+...+ ...+++|
T Consensus       194 fiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             eeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence            99999988 47776665321   22334444555555555    88888876   89999999999999999 8899999


Q ss_pred             ccCCCCCCCCCCcccc---cCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          589 CGLAPLLFSGSTNELS---EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       589 FGla~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      ||+...+.++......   ....+..-|++||...+-++...|+|++|.+.+|..++..+........      |.    
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~----  336 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WS----  336 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC------cc----
Confidence            9999887654422111   1124556799999999999999999999999999999987764431111      11    


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                          .++.+.   +...+.+....++...+..++..+|-.|++.+++..
T Consensus       337 ----~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  337 ----QLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ----cccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                111111   111222222345566899999999999999887653

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.26  E-value=1.8e-13  Score=144.06  Aligned_cols=151  Identities=26%  Similarity=0.463  Sum_probs=78.2

Q ss_pred             eecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc-ccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           68 CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP-VTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        68 c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~-~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      |.+-.|+.+.|..|.+- .+|..+++|..|++|||+.|+++ .+|..+. --|+.|.+++|+++ .+|+.++.+..|..|
T Consensus        95 ~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sNNkl~-~lp~~ig~~~tl~~l  171 (722)
T KOG0532|consen   95 CAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSNNKLT-SLPEEIGLLPTLAHL  171 (722)
T ss_pred             HHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEecCccc-cCCcccccchhHHHh
Confidence            33344555555555554 45555555555555555555555 4454443 34555555555555 555555555555555


Q ss_pred             cccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcCc
Q 004994          147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFS  224 (720)
Q Consensus       147 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~  224 (720)
                      |.+.|.+. .+|..++++.+|+.|.+..|++. .+|+.+..| .|..||+|+|+++..+-.+..+. |++|-|.+|.|.
T Consensus       172 d~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  172 DVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             hhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCC
Confidence            55555554 45555555555555555555554 455555433 35555555555555444443333 555555555554

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.25  E-value=2.6e-11  Score=115.67  Aligned_cols=129  Identities=18%  Similarity=0.116  Sum_probs=94.5

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCcee-EEEeEeccCCeEEEEEeeCCCCC
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV-ELIGYCNEHGQHLLVYDYGGNCT  524 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~gs  524 (720)
                      +.++.|.++.||+++.. +..|++|.......   ....+..|+++++.+.+.+++ +++.+..+  ..++||||+++.+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G~~   77 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEGSE   77 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCCCc
Confidence            56889999999999865 67899999764421   123456788888888655544 55555432  3579999999987


Q ss_pred             HHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          525 LHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC--EPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       525 L~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      +.+..         .   ....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            75420         0   11235678899999999873  23469999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PLN03210 Resistant to P

Probab=99.21  E-value=7.2e-11  Score=144.94  Aligned_cols=96  Identities=21%  Similarity=0.213  Sum_probs=43.5

Q ss_pred             cccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCc
Q 004994          143 LLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNL  222 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~  222 (720)
                      |+.|+|++|...+.+|..++++++|+.|+|++|..-+.+|..+ ++++|+.|+|++|..-..++.. ...|+.|+|++|.
T Consensus       780 L~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~-~~nL~~L~Ls~n~  857 (1153)
T PLN03210        780 LTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI-STNISDLNLSRTG  857 (1153)
T ss_pred             chheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc-ccccCEeECCCCC
Confidence            3333444443333444444444444444444432222344333 3444444444443221111111 0135667777777


Q ss_pred             CcccCCcccCCCccccccC
Q 004994          223 FSGPIPEKLLSIPNFRKDG  241 (720)
Q Consensus       223 l~g~~p~~~~~l~~l~~~~  241 (720)
                      ++ .+|..+..+++|+..+
T Consensus       858 i~-~iP~si~~l~~L~~L~  875 (1153)
T PLN03210        858 IE-EVPWWIEKFSNLSFLD  875 (1153)
T ss_pred             Cc-cChHHHhcCCCCCEEE
Confidence            76 5676666666655543

syringae 6; Provisional

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.21  E-value=7.9e-13  Score=146.67  Aligned_cols=167  Identities=29%  Similarity=0.414  Sum_probs=96.4

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc----------------------------ccCcEEE
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP----------------------------VTVRNFS  123 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~----------------------------~~L~~L~  123 (720)
                      +|+.|.+..|.++ .+|+.+..+++|++|||..|+|. .+|..+.                            ..|+.|+
T Consensus       288 ~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Ly  365 (1081)
T KOG0618|consen  288 SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELY  365 (1081)
T ss_pred             hHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHH
Confidence            4555566666665 45556666666666666666665 4442110                            2355566


Q ss_pred             ecCCcCCCCCcchhhcccccccccccccccCCCCCc-hhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccc
Q 004994          124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS  202 (720)
Q Consensus       124 Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  202 (720)
                      |.+|.|+...=+.|.+...|+.|+|++|+|. .+|+ .+.+|..|++|+||+|+|+ .+|..+.++..|++|...+|+|.
T Consensus       366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~  443 (1081)
T KOG0618|consen  366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL  443 (1081)
T ss_pred             HhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence            6666666655555666666666666666665 3443 3556666666666666666 66666666666666666666666


Q ss_pred             ccccccccc-ccceEEccCCcCcc-cCCcccC--CCccccccCcc
Q 004994          203 GTLNVLEDL-HLIDLNIENNLFSG-PIPEKLL--SIPNFRKDGNP  243 (720)
Q Consensus       203 ~~~~~~~~~-~l~~l~l~~N~l~g-~~p~~~~--~l~~l~~~~n~  243 (720)
                      ..| .+..+ .|+.+|+|.|+|+- .+|..+.  +|..|.+.||.
T Consensus       444 ~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  444 SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            555 33333 36666666666653 2333222  34444444554

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.18  E-value=6e-13  Score=147.58  Aligned_cols=170  Identities=25%  Similarity=0.408  Sum_probs=93.4

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc-------------------------ccCcEEEec
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP-------------------------VTVRNFSLS  125 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~-------------------------~~L~~L~Ls  125 (720)
                      .+++.++++.|++++ +|++++.+.+|+.|+..+|+|+ .+|..+.                         ..|+.|+|.
T Consensus       241 ~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~  318 (1081)
T KOG0618|consen  241 LNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQ  318 (1081)
T ss_pred             ccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeeh
Confidence            468888889899886 4588899999999999999986 6665443                         244455555


Q ss_pred             CCcCCCCCcchhhc--------------------------ccccccccccccccCCCCCchhcCCCCCceEeccCCcccc
Q 004994          126 GNQLTGSIPESLSR--------------------------LTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG  179 (720)
Q Consensus       126 ~N~l~g~~p~~l~~--------------------------l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g  179 (720)
                      .|+|. .+|+.+-.                          ++.|+.|+|.+|.|+...-+.+.+.+.|+.|+|++|+|. 
T Consensus       319 ~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-  396 (1081)
T KOG0618|consen  319 SNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-  396 (1081)
T ss_pred             hcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-
Confidence            55554 33332211                          112334444444444433334444555555555555554 


Q ss_pred             cCCC-CCCCCCCCceeeccccccccccccccccc-cceEEccCCcCcccCCcccCCCccccccCccCCC
Q 004994          180 QLPP-STRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNT  246 (720)
Q Consensus       180 ~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~  246 (720)
                      .+|. .+.++..|+.|+||+|+|+..+..+..+. |..|...+|++. ..| ++..++.|++.+.+.|.
T Consensus       397 ~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~  463 (1081)
T KOG0618|consen  397 SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNN  463 (1081)
T ss_pred             cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccch
Confidence            3433 23445555555555555554443333332 445555555555 445 45555555555555443

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.18  E-value=2.2e-12  Score=136.59  Aligned_cols=173  Identities=24%  Similarity=0.350  Sum_probs=122.5

Q ss_pred             cCceeEEEecCCcccccCCcCcCCCCC---ccEEeccCCccccc----CCCCc---cccCcEEEecCCcCCCC----Ccc
Q 004994           70 FSNVTEIRLTGMNLGGVLADTLGDLES---VINIDLSNNHIGGS----IPSNL---PVTVRNFSLSGNQLTGS----IPE  135 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~~~~l~~---L~~L~L~~N~l~g~----ip~~~---~~~L~~L~Ls~N~l~g~----~p~  135 (720)
                      +.+|+.|+|++|.+.+..+..+..+.+   |+.|+|++|++++.    +...+   +.+|+.|+|++|.+++.    ++.
T Consensus        80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~  159 (319)
T cd00116          80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK  159 (319)
T ss_pred             cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence            458999999999998766666666655   99999999998732    21222   25789999999999853    344


Q ss_pred             hhhcccccccccccccccCCC----CCchhcCCCCCceEeccCCccccc----CCCCCCCCCCCceeecccccccccc--
Q 004994          136 SLSRLTQLLDLSLNNNHLNGG----IPDAFHQFTGLINFDLSANNLTGQ----LPPSTRNLSSLYSLHLQNNKLSGTL--  205 (720)
Q Consensus       136 ~l~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~--  205 (720)
                      .+..+++|+.|+|++|.+++.    ++..+..+++|+.|+|++|.+++.    ++..+..+++|+.|++++|.+++..  
T Consensus       160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~  239 (319)
T cd00116         160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA  239 (319)
T ss_pred             HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence            566778899999999999842    444566677999999999998742    4455677889999999999988521  


Q ss_pred             cccc-----ccccceEEccCCcCc----ccCCcccCCCccccccCc
Q 004994          206 NVLE-----DLHLIDLNIENNLFS----GPIPEKLLSIPNFRKDGN  242 (720)
Q Consensus       206 ~~~~-----~~~l~~l~l~~N~l~----g~~p~~~~~l~~l~~~~n  242 (720)
                      ....     ...|+.|++++|.++    ..+...+..+++|+..+.
T Consensus       240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l  285 (319)
T cd00116         240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDL  285 (319)
T ss_pred             HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEEC
Confidence            1111     235899999999987    223334444444444333

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=1.8e-11  Score=131.72  Aligned_cols=257  Identities=19%  Similarity=0.162  Sum_probs=175.2

Q ss_pred             ccCHHH-HHHHhcCCCCCCeeccCCCceEEEEEe--CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEE
Q 004994          429 VFTIAS-LQQYTNSFSEGNFIGEGLLGSVYKAEL--PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELI  504 (720)
Q Consensus       429 ~~~~~~-~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~  504 (720)
                      .|...+ ......+|.....||.|.|+.||++..  .++..|++|.+.+.......+..-..|+-+...+ .|.+++.++
T Consensus       253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~  332 (524)
T KOG0601|consen  253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN  332 (524)
T ss_pred             eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence            344444 445667888899999999999999854  4688999999876654443333334555555555 588999988


Q ss_pred             eEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC-CC
Q 004994          505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-LI  583 (720)
Q Consensus       505 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~  583 (720)
                      ..+...++.|+--||++++++....    .....++...++++..+++.++.++|+.   .++|+|+||+||++..+ +.
T Consensus       333 ~~W~~~r~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  333 SSWSQLRQGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFF  405 (524)
T ss_pred             CCccccccccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhh
Confidence            8887777788999999999877655    2234456667788889999999999976   89999999999999886 88


Q ss_pred             eEEccccCCCCCCCCCCcccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 004994          584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA  661 (720)
Q Consensus       584 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~  661 (720)
                      .+++|||++..+.-...    ........|...|.+  ...+..+.|+||||.-+.|.++|.. +....       +.|.
T Consensus       406 ~~~~~~~~~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~-ls~~~-------~~~~  473 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP-LSESG-------VQSL  473 (524)
T ss_pred             hhccccccccccceecc----cccccccccccchhhccccccccccccccccccccccccCcc-cCccc-------ccce
Confidence            89999999864321110    001122233224444  3456789999999999999999864 32211       1111


Q ss_pred             ccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      .        +..-.-+...+.     ..++..+.+.+...++..||.+.++..+.+
T Consensus       474 ~--------i~~~~~p~~~~~-----~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  474 T--------IRSGDTPNLPGL-----KLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             e--------eecccccCCCch-----HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            0        000001111111     145667888999999999999988776543

>PLN03210 Resistant to P

Probab=99.17  E-value=1.1e-10  Score=143.21  Aligned_cols=87  Identities=25%  Similarity=0.355  Sum_probs=47.4

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL  148 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l  148 (720)
                      .+|+.|+|.+|+|. .++..+..+++|+.|+|++|..-+.+|. +.  ++|+.|+|++|..-..+|..++++++|+.|++
T Consensus       611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L  688 (1153)
T PLN03210        611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM  688 (1153)
T ss_pred             cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence            45666666666655 3455555666666666665543335553 22  45666666655444455656666666666666


Q ss_pred             cccccCCCCCc
Q 004994          149 NNNHLNGGIPD  159 (720)
Q Consensus       149 ~~N~l~g~~p~  159 (720)
                      ++|..-+.+|.
T Consensus       689 ~~c~~L~~Lp~  699 (1153)
T PLN03210        689 SRCENLEILPT  699 (1153)
T ss_pred             CCCCCcCccCC
Confidence            55433234444

syringae 6; Provisional

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.14  E-value=5.5e-10  Score=107.37  Aligned_cols=137  Identities=17%  Similarity=0.158  Sum_probs=96.1

Q ss_pred             CeeccCCCceEEEEEeCC-------CcEEEEEEecccccc--------------------cccHHHHH----HHHHHHHc
Q 004994          446 NFIGEGLLGSVYKAELPG-------GKLLAVKKLSNTVSQ--------------------RQTDEEFL----ELASTISR  494 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~~--------------------~~~~~~~~----~e~~~l~~  494 (720)
                      ..||.|.=+.||.|.-.+       +..+|||+.+-....                    ....+.+.    +|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999996443       479999987532110                    01122333    78889988


Q ss_pred             cCC--CceeEEEeEeccCCeEEEEEeeCCCCCHHH-HhhccchhccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecC
Q 004994          495 LRH--GNIVELIGYCNEHGQHLLVYDYGGNCTLHD-LLHSDEEAHKKFSWNIRIRVALGAARALQYL-QEVCEPPIVHGN  570 (720)
Q Consensus       495 l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~L-H~~~~~~ivHrD  570 (720)
                      +..  -++...+++    ...++||||+++..+.. .+..     ..++......+..++..+|..+ |..   +|||+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            853  567777765    45789999998754321 1211     1233344566778899999988 555   999999


Q ss_pred             CCCCCeEEcCCCCeEEccccCCCCC
Q 004994          571 FKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       571 lkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      |++.|||++ ++.+.|+|||.|-..
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999997 467999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.11  E-value=5e-11  Score=130.21  Aligned_cols=133  Identities=31%  Similarity=0.456  Sum_probs=68.5

Q ss_pred             CceeEeecCcee---EEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--c-cCcEEEecCCcCCCCCcch
Q 004994           63 WQGVFCVFSNVT---EIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--V-TVRNFSLSGNQLTGSIPES  136 (720)
Q Consensus        63 w~gv~c~~~~l~---~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~-~L~~L~Ls~N~l~g~~p~~  136 (720)
                      +.+..+...++.   .+++..|.+... ...+..++.++.|++.+|.++ .||....  . +|+.|++++|++. .+|..
T Consensus        82 ~l~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~  158 (394)
T COG4886          82 SLDGSENLLNLLPLPSLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSP  158 (394)
T ss_pred             cccccccccCCCCCceeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhh
Confidence            334444444433   355555555322 223334455555555555555 4444433  1 4555555555555 45455


Q ss_pred             hhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccc
Q 004994          137 LSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNK  200 (720)
Q Consensus       137 l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  200 (720)
                      +..+++|+.|++++|+++ .+|...+.++.|+.|++++|+++ .+|..+..+..|+.|.+++|.
T Consensus       159 ~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~  220 (394)
T COG4886         159 LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS  220 (394)
T ss_pred             hhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence            555555555555555555 44444445555555555555555 555544444445555555554

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.10  E-value=1.3e-09  Score=118.57  Aligned_cols=168  Identities=20%  Similarity=0.226  Sum_probs=120.8

Q ss_pred             EeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhcccc
Q 004994          460 ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF  539 (720)
Q Consensus       460 ~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~  539 (720)
                      +..++.+|.|...+....  .......+-++.++.++||||++++..+...+..|+|+|-+.-  |..++...       
T Consensus        33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l-------  101 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL-------  101 (690)
T ss_pred             eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh-------
Confidence            456788898888864322  2234456778899999999999999999999999999998754  55555321       


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC
Q 004994          540 SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE  619 (720)
Q Consensus       540 ~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~  619 (720)
                      ......-.+.||+.||.|||+.|  +++|++|.-+.|+++..|+.||++|-++.......  ...........|..|+-.
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~--~~~~~~~~~~s~~~P~~~  177 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN--APAKSLYLIESFDDPEEI  177 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC--cccccchhhhcccChhhc
Confidence            12334456789999999999765  89999999999999999999999998875432111  111112223344555433


Q ss_pred             CCCCCCccchHhHHHHHHHHHhCC
Q 004994          620 SGSYSCQSDVYSLGVVMLELLTGR  643 (720)
Q Consensus       620 ~~~~~~~~Dv~S~Gvvl~elltG~  643 (720)
                      .. -+-..|.|-||++++|++.|.
T Consensus       178 ~~-s~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  178 DP-SEWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             Cc-cccchhhhhHHHHHHHHhCcc
Confidence            11 113579999999999999993

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.10  E-value=7.1e-10  Score=110.73  Aligned_cols=143  Identities=22%  Similarity=0.311  Sum_probs=107.0

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCC--ceeEEEeEeccC---CeEEEEEeeC
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG--NIVELIGYCNEH---GQHLLVYDYG  520 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~~~---~~~~lv~e~~  520 (720)
                      +.|+.|.++.||++...+|+.+++|........ .....+..|.++++.+++.  .+.+++.+..+.   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998877789999997643221 2345678899999998763  467788877664   3678999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC--------------------------------------  562 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------  562 (720)
                      ++.++.+.+..     ..++...+..++.+++++|.+||+..                                      
T Consensus        83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            99887765421     23455566677777777777777421                                      


Q ss_pred             ---------------CCCeeecCCCCCCeEEcC--CCCeEEccccCCCC
Q 004994          563 ---------------EPPIVHGNFKSSNILLDE--KLIVRVSDCGLAPL  594 (720)
Q Consensus       563 ---------------~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~  594 (720)
                                     ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           245799999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.07  E-value=8.4e-12  Score=132.20  Aligned_cols=161  Identities=29%  Similarity=0.345  Sum_probs=84.0

Q ss_pred             CceeEeecCceeEEEecCCccccc----CCcCcCCCCCccEEeccCCcccccCCC-------Ccc--ccCcEEEecCCcC
Q 004994           63 WQGVFCVFSNVTEIRLTGMNLGGV----LADTLGDLESVINIDLSNNHIGGSIPS-------NLP--VTVRNFSLSGNQL  129 (720)
Q Consensus        63 w~gv~c~~~~l~~l~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~g~ip~-------~~~--~~L~~L~Ls~N~l  129 (720)
                      |...+-.+.+++.|+|+++.++..    ++..+...++|+.|++++|.+.+ ++.       .+.  .+|+.|+|++|.+
T Consensus        15 ~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~~~~~~~l~~~~~L~~L~l~~~~~   93 (319)
T cd00116          15 ATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGLQSLLQGLTKGCGLQELDLSDNAL   93 (319)
T ss_pred             hHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHHHHHHHHHHhcCceeEEEccCCCC
Confidence            444444444566666666666321    34445555566666666665542 121       111  3566666666666


Q ss_pred             CCCCcchhhcccc---cccccccccccCC----CCCchhcCC-CCCceEeccCCccccc----CCCCCCCCCCCceeecc
Q 004994          130 TGSIPESLSRLTQ---LLDLSLNNNHLNG----GIPDAFHQF-TGLINFDLSANNLTGQ----LPPSTRNLSSLYSLHLQ  197 (720)
Q Consensus       130 ~g~~p~~l~~l~~---L~~L~l~~N~l~g----~~p~~~~~l-~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~  197 (720)
                      .+..+..+..+.+   |+.|++++|++++    .+...+..+ ++|+.|+|++|.+++.    ++..+..+.+|+.|+|+
T Consensus        94 ~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~  173 (319)
T cd00116          94 GPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLA  173 (319)
T ss_pred             ChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECc
Confidence            6555555555544   6666666666652    222334444 5666666666666532    22334455566666666


Q ss_pred             cccccccc-----cccc-ccccceEEccCCcCc
Q 004994          198 NNKLSGTL-----NVLE-DLHLIDLNIENNLFS  224 (720)
Q Consensus       198 ~N~l~~~~-----~~~~-~~~l~~l~l~~N~l~  224 (720)
                      +|.+++..     ..+. ...|+.|++++|.++
T Consensus       174 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  206 (319)
T cd00116         174 NNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT  206 (319)
T ss_pred             CCCCchHHHHHHHHHHHhCCCCCEEeccCCccC
Confidence            66665321     1111 123666666666655

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.04  E-value=1.2e-10  Score=127.11  Aligned_cols=168  Identities=34%  Similarity=0.489  Sum_probs=137.3

Q ss_pred             CceeEEEecCCcccccCCcCcCCCC-CccEEeccCCcccccCCCCc--cccCcEEEecCCcCCCCCcchhhccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLE-SVINIDLSNNHIGGSIPSNL--PVTVRNFSLSGNQLTGSIPESLSRLTQLLDLS  147 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~g~ip~~~--~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~  147 (720)
                      +.++.|++.+|.++ .+++....+. +|+.|++++|++. .+|..+  .++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus       116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~  192 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD  192 (394)
T ss_pred             cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence            56899999999999 4677777785 9999999999999 775444  489999999999999 8887777889999999


Q ss_pred             ccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcCccc
Q 004994          148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGP  226 (720)
Q Consensus       148 l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g~  226 (720)
                      +++|+++ .+|.....+..|++|.+++|.+. .++..+.++.++..|.+.+|++...+..+..+. ++.|++++|.++ .
T Consensus       193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~  269 (394)
T COG4886         193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-S  269 (394)
T ss_pred             ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc-c
Confidence            9999998 78887777788999999999655 677788999999999999999887666666555 899999999998 5


Q ss_pred             CCcccCCCccccccCccCC
Q 004994          227 IPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       227 ~p~~~~~l~~l~~~~n~~~  245 (720)
                      ++. ++.+.+++..+...+
T Consensus       270 i~~-~~~~~~l~~L~~s~n  287 (394)
T COG4886         270 ISS-LGSLTNLRELDLSGN  287 (394)
T ss_pred             ccc-ccccCccCEEeccCc
Confidence            555 666666555544443

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.00  E-value=3.1e-10  Score=106.90  Aligned_cols=81  Identities=28%  Similarity=0.454  Sum_probs=21.4

Q ss_pred             cCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchh-cCCCCCceEeccCCcccccCC--CCCCCCCCCcee
Q 004994          118 TVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAF-HQFTGLINFDLSANNLTGQLP--PSTRNLSSLYSL  194 (720)
Q Consensus       118 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L~ls~N~l~g~~p--~~~~~l~~L~~L  194 (720)
                      +|+.|+|++|+++ .++ .+..+++|+.|++++|+|+ .+.+.+ ..+++|+.|+|++|+|.. +-  ..+..+++|+.|
T Consensus        43 ~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   43 KLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRVL  118 (175)
T ss_dssp             T--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--EE
T ss_pred             CCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCccee
Confidence            3444444444444 222 2444455555555555554 233222 234555555555555542 11  123345555555


Q ss_pred             eccccccc
Q 004994          195 HLQNNKLS  202 (720)
Q Consensus       195 ~l~~N~l~  202 (720)
                      +|.+|.++
T Consensus       119 ~L~~NPv~  126 (175)
T PF14580_consen  119 SLEGNPVC  126 (175)
T ss_dssp             E-TT-GGG
T ss_pred             eccCCccc
Confidence            55555554

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.97  E-value=5.9e-09  Score=96.60  Aligned_cols=133  Identities=23%  Similarity=0.323  Sum_probs=96.2

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEE-eccccccc-----ccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKK-LSNTVSQR-----QTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ..+++|+=+.+|.+.+.+.. +++|. +.+....+     -..+.-.+|++++.+++--.|..-+=|..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999999775443 55664 43332222     2234567788888888654444333344455667899999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +++-.|.+.+...           +..++..+-+-+.-||..   +|||+||.++||++..+. +.++|||++.+
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998888888532           245666777778889987   999999999999998775 99999999864

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.96  E-value=6e-11  Score=115.86  Aligned_cols=122  Identities=26%  Similarity=0.401  Sum_probs=71.4

Q ss_pred             ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeec
Q 004994          117 VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHL  196 (720)
Q Consensus       117 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  196 (720)
                      ..|++||||+|.++ .|.++..-++.++.|++|+|.|. .+- .+..|++|+.||||+|.|+ .+-.+-..|.+++.|.|
T Consensus       284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL  359 (490)
T ss_pred             hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence            35666777777776 66666666677777777777765 332 2666677777777777776 55555556666677777


Q ss_pred             ccccccccccccccc-ccceEEccCCcCcccCC--cccCCCcccc---ccCccC
Q 004994          197 QNNKLSGTLNVLEDL-HLIDLNIENNLFSGPIP--EKLLSIPNFR---KDGNPF  244 (720)
Q Consensus       197 ~~N~l~~~~~~~~~~-~l~~l~l~~N~l~g~~p--~~~~~l~~l~---~~~n~~  244 (720)
                      +.|.+...- .+..+ +|..||+++|++.. +-  ..+++++-|.   +.+||.
T Consensus       360 a~N~iE~LS-GL~KLYSLvnLDl~~N~Ie~-ldeV~~IG~LPCLE~l~L~~NPl  411 (490)
T KOG1259|consen  360 AQNKIETLS-GLRKLYSLVNLDLSSNQIEE-LDEVNHIGNLPCLETLRLTGNPL  411 (490)
T ss_pred             hhhhHhhhh-hhHhhhhheeccccccchhh-HHHhcccccccHHHHHhhcCCCc
Confidence            777653221 12222 36667777776652 21  2344554433   445554

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.95  E-value=9.2e-11  Score=114.60  Aligned_cols=136  Identities=26%  Similarity=0.373  Sum_probs=97.2

Q ss_pred             cccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchh
Q 004994           84 GGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAF  161 (720)
Q Consensus        84 ~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~  161 (720)
                      .|..-..+.....|+.||||+|.|+ .+-.+..  +.++.|+||+|.+. .+-. +..|++|+.||||+|.|+ .+-..-
T Consensus       273 ~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh  348 (490)
T KOG1259|consen  273 NGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWH  348 (490)
T ss_pred             CCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhH
Confidence            3444444555667888888888887 5655543  67888888888887 4443 788888888888888887 444444


Q ss_pred             cCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccc--cccccccc-cceEEccCCcCcc
Q 004994          162 HQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT--LNVLEDLH-LIDLNIENNLFSG  225 (720)
Q Consensus       162 ~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~-l~~l~l~~N~l~g  225 (720)
                      ..|.+++.|.|+.|.|. .+. .+..|-+|..||+++|++...  ...++.+. |+.+.|.+|.+.+
T Consensus       349 ~KLGNIKtL~La~N~iE-~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  349 LKLGNIKTLKLAQNKIE-TLS-GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             hhhcCEeeeehhhhhHh-hhh-hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence            56777888888888886 332 467778888888888888643  34566666 7888888888884

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.89  E-value=6.9e-10  Score=125.59  Aligned_cols=246  Identities=18%  Similarity=0.151  Sum_probs=152.9

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +...+-+.+|.++.++-+.- ..|...++|+....- ......+....+-.++-.-+||-++....-+......++|++|
T Consensus       806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~  885 (1205)
T KOG0606|consen  806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY  885 (1205)
T ss_pred             ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence            34445566777887776633 234445555543211 1111122222222222223456666554444556678999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC-
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG-  598 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~-  598 (720)
                      ..+++|...++...    ..+..........+.++++|||..   .++|||++|.|+|...+++.+++|||........ 
T Consensus       886 ~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  886 LNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             hccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccccc
Confidence            99999999887543    112112223344566889999986   6899999999999999999999999843322100 


Q ss_pred             --------------------C--------CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 004994          599 --------------------S--------TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRS  649 (720)
Q Consensus       599 --------------------~--------~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~  649 (720)
                                          .        .........++..|.+||.. +..-...+|+|++|++++|.++|..||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                0        00112235578899999988 445678899999999999999999999876


Q ss_pred             CCccc-cchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHH
Q 004994          650 RPRGE-QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMS  710 (720)
Q Consensus       650 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  710 (720)
                      .+... .++.....+..                ..+.+...++.+++.+.+..+|.+|-.|.
T Consensus      1039 tpq~~f~ni~~~~~~~p----------------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWP----------------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             chhhhhhccccCCCCCC----------------CCccccChhhhhhhhhhhccCchhccCcc
Confidence            54332 11111111100                01122335667889999999999997665

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.88  E-value=7.8e-10  Score=104.21  Aligned_cols=104  Identities=34%  Similarity=0.499  Sum_probs=40.5

Q ss_pred             ccCcEEEecCCcCCCCCcchhh-cccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCC-CCCCCCcee
Q 004994          117 VTVRNFSLSGNQLTGSIPESLS-RLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSL  194 (720)
Q Consensus       117 ~~L~~L~Ls~N~l~g~~p~~l~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l~~L~~L  194 (720)
                      .++++|+|++|+|+ .|. .++ .+.+|+.|+|++|.|+ .++ .+..++.|+.|++++|+|+ .+...+ ..+++|+.|
T Consensus        19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL   93 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred             cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence            45778888888887 553 566 5889999999999998 454 5888999999999999998 565544 468999999


Q ss_pred             eccccccccc--cccccccc-cceEEccCCcCcc
Q 004994          195 HLQNNKLSGT--LNVLEDLH-LIDLNIENNLFSG  225 (720)
Q Consensus       195 ~l~~N~l~~~--~~~~~~~~-l~~l~l~~N~l~g  225 (720)
                      +|++|+|...  +..+..++ |+.|+|.+|.++.
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            9999999754  34455554 8999999998873

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.86  E-value=3.2e-10  Score=115.02  Aligned_cols=146  Identities=27%  Similarity=0.382  Sum_probs=113.9

Q ss_pred             eccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEec-cCCcccc
Q 004994          101 DLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDL-SANNLTG  179 (720)
Q Consensus       101 ~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l-s~N~l~g  179 (720)
                      |-++-.|+ .||..+|.....|+|..|+|+...|.+|+.+++|+.|||++|+|+-.-|++|.+|.+|..|-+ ++|+|+.
T Consensus        52 dCr~~GL~-eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~  130 (498)
T KOG4237|consen   52 DCRGKGLT-EVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD  130 (498)
T ss_pred             EccCCCcc-cCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence            44444555 899999999999999999999777788999999999999999999888999999998887755 5599994


Q ss_pred             cCCCCCCCCCCCceeecccccccccc-ccccccc-cceEEccCCcCcccCCc-ccCCCcccc---ccCccCCCcc
Q 004994          180 QLPPSTRNLSSLYSLHLQNNKLSGTL-NVLEDLH-LIDLNIENNLFSGPIPE-KLLSIPNFR---KDGNPFNTTV  248 (720)
Q Consensus       180 ~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~-l~~l~l~~N~l~g~~p~-~~~~l~~l~---~~~n~~~~~~  248 (720)
                      .....|++|.+|+.|.+.-|++.-.. ..+..+. +..|.+-.|.+. .|+. .+..+..++   +.-|++-|.|
T Consensus       131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdC  204 (498)
T KOG4237|consen  131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDC  204 (498)
T ss_pred             hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccccc
Confidence            44467899999999999999998776 3455555 777888888887 5665 555554444   4455554444

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.83  E-value=7.4e-08  Score=98.04  Aligned_cols=144  Identities=15%  Similarity=0.062  Sum_probs=101.1

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEeccccccc---------ccHHHHHHHHHHHHccCCC--ceeEEEeEecc----
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQR---------QTDEEFLELASTISRLRHG--NIVELIGYCNE----  509 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---------~~~~~~~~e~~~l~~l~H~--niv~l~~~~~~----  509 (720)
                      ++.+-+-....|+++.+ +|+.|.||+........         .....+.+|.+.+.++...  .++..+++...    
T Consensus        27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            45666666667888766 57789999874322110         1112477888888777433  33344555432    


Q ss_pred             -CCeEEEEEeeCCCC-CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-------
Q 004994          510 -HGQHLLVYDYGGNC-TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-------  580 (720)
Q Consensus       510 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-------  580 (720)
                       ...-++|||++++. +|.+++....  ....+...+..++.++++.+.-||..   ||+|+|++++|||++.       
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence             23578999999986 7988874211  12344556778999999999999998   9999999999999985       


Q ss_pred             CCCeEEccccCCCC
Q 004994          581 KLIVRVSDCGLAPL  594 (720)
Q Consensus       581 ~~~~kl~DFGla~~  594 (720)
                      +..+.++||+.+..
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            46899999998753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.82  E-value=9.3e-08  Score=101.05  Aligned_cols=218  Identities=21%  Similarity=0.278  Sum_probs=147.7

Q ss_pred             CCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEec----cCCeEEEEEeeCCC-CCH
Q 004994          452 LLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN----EHGQHLLVYDYGGN-CTL  525 (720)
Q Consensus       452 ~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~----~~~~~~lv~e~~~~-gsL  525 (720)
                      -..+.||+.. .||..|++|++.....  ........-+++.+++.|.|||++.+++.    ....+++||+|.++ ++|
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            3457899954 5899999999953322  22223445678899999999999999875    34478999999876 567


Q ss_pred             HHHhhccc-----------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          526 HDLLHSDE-----------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       526 ~~~l~~~~-----------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      .++.-...           ......++...+.++.|+..||.++|+.   |+.-+-|.+.+||++.+.+++|+..|+...
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence            76643211           1123456678889999999999999998   888899999999999999999998888766


Q ss_pred             CCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      +.....              +|  +  +--.+-|.=.||.+++.|.||..--...+..  +            ...+.+ 
T Consensus       443 l~~d~~--------------~~--l--e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~--~------------~s~~~~-  489 (655)
T KOG3741|consen  443 LQEDPT--------------EP--L--ESQQQNDLRDLGLLLLALATGTENSNRTDST--Q------------SSHLTR-  489 (655)
T ss_pred             ecCCCC--------------cc--h--hHHhhhhHHHHHHHHHHHhhcccccccccch--H------------HHHHHH-
Confidence            543220              00  1  1123678889999999999996321110000  0            000111 


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                              .......++++++.-.....+.+ -+..+++.++
T Consensus       490 --------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  490 --------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             --------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                    01123346677777777777776 5667766554

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.80  E-value=1.4e-09  Score=111.94  Aligned_cols=159  Identities=22%  Similarity=0.220  Sum_probs=120.0

Q ss_pred             eeEeecCceeEEEecCCcccccC--CcCcCCCCCccEEeccCCcccccCCCCcc---ccCcEEEecCCcCCCC-Ccchhh
Q 004994           65 GVFCVFSNVTEIRLTGMNLGGVL--ADTLGDLESVINIDLSNNHIGGSIPSNLP---VTVRNFSLSGNQLTGS-IPESLS  138 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~L~~L~Ls~N~l~g~-~p~~l~  138 (720)
                      ++.-.+++++.|||+.|-|....  -.....|++|+.|+|+.|++.-...+...   ..|+.|.|+.+.|+-. +-.-+.
T Consensus       140 ~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~  219 (505)
T KOG3207|consen  140 EYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILL  219 (505)
T ss_pred             hhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHH
Confidence            46666789999999999887543  34567899999999999999733333332   6899999999999821 112245


Q ss_pred             cccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCC--CCCCCCCCCceeecccccccccc-ccc------c
Q 004994          139 RLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP--PSTRNLSSLYSLHLQNNKLSGTL-NVL------E  209 (720)
Q Consensus       139 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~-~~~------~  209 (720)
                      .+++|+.|+|..|..-+.--.....+..|+.|||++|++- .++  ...+.++.|..|+++.+.+...- +..      .
T Consensus       220 ~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~  298 (505)
T KOG3207|consen  220 TFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTH  298 (505)
T ss_pred             hCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhc
Confidence            6799999999999643344445567789999999999997 566  56788999999999999987542 221      2


Q ss_pred             c-cccceEEccCCcCc
Q 004994          210 D-LHLIDLNIENNLFS  224 (720)
Q Consensus       210 ~-~~l~~l~l~~N~l~  224 (720)
                      . .+|+.|+++.|++.
T Consensus       299 ~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  299 TFPKLEYLNISENNIR  314 (505)
T ss_pred             ccccceeeecccCccc
Confidence            2 24999999999996

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.76  E-value=4.1e-09  Score=81.57  Aligned_cols=59  Identities=42%  Similarity=0.585  Sum_probs=29.6

Q ss_pred             cCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCc
Q 004994          118 TVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANN  176 (720)
Q Consensus       118 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~  176 (720)
                      +|+.|+|++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34445555555553333445555555555555555554444445555555555555554

...

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.75  E-value=8.8e-08  Score=88.36  Aligned_cols=145  Identities=19%  Similarity=0.199  Sum_probs=99.0

Q ss_pred             CCCeeccCCCceEEEEEeCCCcEEEEEE-eccccc-----ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          444 EGNFIGEGLLGSVYKAELPGGKLLAVKK-LSNTVS-----QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       444 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ...++-+|+-+.|+++.+. |+.+.||. +.+...     .+-..+.-..|++.+.+++--.|..-.=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578899999999999874 55655654 433321     2223456678888888886545444333444445566999


Q ss_pred             eeCCC-CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC---CeEEccccCCC
Q 004994          518 DYGGN-CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL---IVRVSDCGLAP  593 (720)
Q Consensus       518 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~  593 (720)
                      ||.++ -++.+++.....  ...........+..+-+.+.-||..   +|||+||..+||++..++   .+.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 356776653211  1122223356788888999999987   899999999999996655   45899999975


Q ss_pred             C
Q 004994          594 L  594 (720)
Q Consensus       594 ~  594 (720)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            3

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.74  E-value=5.3e-09  Score=80.94  Aligned_cols=61  Identities=43%  Similarity=0.551  Sum_probs=54.5

Q ss_pred             cccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccc
Q 004994          141 TQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKL  201 (720)
Q Consensus       141 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l  201 (720)
                      ++|+.|+|++|+|+...+..|.++++|++|++++|+|+...|..|.++++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5789999999999966667899999999999999999977778899999999999999975

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=7e-08  Score=92.54  Aligned_cols=127  Identities=25%  Similarity=0.282  Sum_probs=81.0

Q ss_pred             eEEEEEeCCCcEEEEEEeccccc------------cc------------ccHHHHHHHHHHHHccCCC--ceeEEEeEec
Q 004994          455 SVYKAELPGGKLLAVKKLSNTVS------------QR------------QTDEEFLELASTISRLRHG--NIVELIGYCN  508 (720)
Q Consensus       455 ~Vy~~~~~~g~~vavK~l~~~~~------------~~------------~~~~~~~~e~~~l~~l~H~--niv~l~~~~~  508 (720)
                      .||.|...+|..+|||..+....            .+            .......+|.+.|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999888999999998753210            00            1124567899999999766  567777653 


Q ss_pred             cCCeEEEEEeeCC--CCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCeEEcCCCCeE
Q 004994          509 EHGQHLLVYDYGG--NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVR  585 (720)
Q Consensus       509 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~L-H~~~~~~ivHrDlkp~NiLl~~~~~~k  585 (720)
                         ..++||||++  +..+..+....      ++......+..++.+.+..+ |..   +|||+||.+.|||++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3479999998  54454433211      11223445666676755554 454   99999999999999988 999


Q ss_pred             EccccCCCCC
Q 004994          586 VSDCGLAPLL  595 (720)
Q Consensus       586 l~DFGla~~~  595 (720)
                      |+|||.|...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.62  E-value=1.3e-09  Score=94.95  Aligned_cols=108  Identities=24%  Similarity=0.351  Sum_probs=73.7

Q ss_pred             eeEEEecCCcccccCCc---CcCCCCCccEEeccCCcccccCCCCcc---ccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           73 VTEIRLTGMNLGGVLAD---TLGDLESVINIDLSNNHIGGSIPSNLP---VTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        73 l~~l~L~~n~l~~~~~~---~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      +..++|+++.|- .+++   .+.....|+..+|++|.|. ..|..|.   +.++.|+|++|.|+ .+|.++..++.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            455677777765 2333   3445566777788888887 6666654   36777777777777 677777777777777


Q ss_pred             cccccccCCCCCchhcCCCCCceEeccCCcccccCCCCC
Q 004994          147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST  185 (720)
Q Consensus       147 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~  185 (720)
                      +++.|.|. ..|..+..|.+|-.||..+|.+. .+|..+
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl  142 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDL  142 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHH
Confidence            77777776 56666666777777777777775 566543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.56  E-value=6e-09  Score=113.23  Aligned_cols=55  Identities=27%  Similarity=0.297  Sum_probs=28.8

Q ss_pred             CCCHHHHHHHHHHHHhcCCC----CCCCccCCCCCCCCCCCceeEeecCceeEEEecCCccc
Q 004994           27 VTDPRDVMALNSLYISLNFP----PLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLG   84 (720)
Q Consensus        27 ~~~~~~~~al~~~~~~l~~~----~~~~w~~~~~~~c~~~w~gv~c~~~~l~~l~L~~n~l~   84 (720)
                      .-++.|..++.+++.-++.-    .+..--..+.||-.  .- ..--+..|+.|.|.++.|+
T Consensus        64 ~s~~ads~vl~qLq~i~d~lqkt~~lkl~~~pa~~pt~--pi-~ifpF~sLr~LElrg~~L~  122 (1096)
T KOG1859|consen   64 VSDNADSRVLEQLQRILDFLQKTKVLKLLPSPARDPTE--PI-SIFPFRSLRVLELRGCDLS  122 (1096)
T ss_pred             cCCcccchHHHHHHHHHHHHhhheeeeecccCCCCCCC--Cc-eeccccceeeEEecCcchh
Confidence            45677888888877544321    12111112334331  11 1123567888888888775

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.47  E-value=3.5e-08  Score=108.15  Aligned_cols=124  Identities=28%  Similarity=0.367  Sum_probs=58.6

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCC--CccccCcEEEecCCcCCCCCcchhhccccccccccc
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS--NLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN  149 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~--~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~  149 (720)
                      .+..++|..|.+.- +-..+..+++|..|+|.+|+|. .+..  .-..+|+.|+|++|+|+...+  +..++.|+.|+++
T Consensus        73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~  148 (414)
T KOG0531|consen   73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLS  148 (414)
T ss_pred             hHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhhheec
Confidence            34444455555442 2233455555555555555555 2222  112455555555555553222  4444555555555


Q ss_pred             ccccCCCCCchhcCCCCCceEeccCCcccccCCCC-CCCCCCCceeeccccccc
Q 004994          150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS-TRNLSSLYSLHLQNNKLS  202 (720)
Q Consensus       150 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~  202 (720)
                      +|.|+. +. .+..+..|+.+++++|.++ .+... ...+.+|+.+++.+|.+.
T Consensus       149 ~N~i~~-~~-~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  149 GNLISD-IS-GLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIR  199 (414)
T ss_pred             cCcchh-cc-CCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchh
Confidence            555542 21 2333555555555555555 23221 344555555555555543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.47  E-value=6.8e-08  Score=105.86  Aligned_cols=150  Identities=19%  Similarity=0.234  Sum_probs=101.7

Q ss_pred             HHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc-------cccCccccccCCCCccCCC
Q 004994          549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE-------LSEGLLTAHGSGAPEFESG  621 (720)
Q Consensus       549 ~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~  621 (720)
                      .+++.|+.|+|..  .++||++|.|++|.++..+..||+.|+.+..........       ..........|.|||++.+
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455899999985  589999999999999999999999999875443211111       1111223456899999854


Q ss_pred             -CCCCccchHhHHHHHHHHH-hCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHh
Q 004994          622 -SYSCQSDVYSLGVVMLELL-TGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCV  699 (720)
Q Consensus       622 -~~~~~~Dv~S~Gvvl~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  699 (720)
                       ..+.++|+||+||++|.+. .|+.-+..........+              ....+..-...+....++++++=+.+.+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--------------~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--------------SRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh--------------hhcccccccccccccCcHHHHHHHHHHh
Confidence             4688999999999999999 45554443322111111              1111111111223456678899999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 004994          700 QWEPGFRPPMSEIVQ  714 (720)
Q Consensus       700 ~~dP~~RPt~~evl~  714 (720)
                      ..++..||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998877653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.45  E-value=1.4e-06  Score=85.99  Aligned_cols=137  Identities=23%  Similarity=0.164  Sum_probs=94.0

Q ss_pred             CCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccc--------------------cccHHHHHHHHHHHHccCCC--c
Q 004994          442 FSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQ--------------------RQTDEEFLELASTISRLRHG--N  499 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------------------~~~~~~~~~e~~~l~~l~H~--n  499 (720)
                      ...+..||.|.=+.||.|..+.|..+|||.-+.....                    ........+|.++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4457899999999999999989999999975422110                    01234567889999988654  6


Q ss_pred             eeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc
Q 004994          500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD  579 (720)
Q Consensus       500 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~  579 (720)
                      |.+.+++    +...+||||+++-.|...--         +....-.|+..|.+-+.-+-..   ||||+|+.+-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence            6666654    46789999999866654321         0111112222233323322233   899999999999999


Q ss_pred             CCCCeEEccccCCCC
Q 004994          580 EKLIVRVSDCGLAPL  594 (720)
Q Consensus       580 ~~~~~kl~DFGla~~  594 (720)
                      +||.+.++||--+..
T Consensus       237 ~dg~~~vIDwPQ~v~  251 (304)
T COG0478         237 EDGDIVVIDWPQAVP  251 (304)
T ss_pred             cCCCEEEEeCccccc
Confidence            999999999976643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.43  E-value=3.5e-06  Score=87.11  Aligned_cols=260  Identities=16%  Similarity=0.193  Sum_probs=149.9

Q ss_pred             CCeeccCCCceEEEE-EeCCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEe------ccCC-eEEE
Q 004994          445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYC------NEHG-QHLL  515 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~------~~~~-~~~l  515 (720)
                      ++-||+|+-+.+|-. ...+   .+.|+....-...  ..+   .++.|... .||-+-.=+.+=      .+.+ ..-+
T Consensus        16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~--~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAA--QAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CccccCCccceeeecchhhc---hhheeecCCCchH--HHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            466999999999975 3222   3456665332111  111   12223332 565433211111      1222 2456


Q ss_pred             EEeeCCCC-CHHHHhhc--cchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          516 VYDYGGNC-TLHDLLHS--DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       516 v~e~~~~g-sL~~~l~~--~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      +|..+++. -..+++.-  .........|...++++..+|.+-+-||..   |.+-+|+.++|+|+.+++.+.|.|-..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence            77766553 23333321  123345679999999999999999999987   8899999999999999999999884321


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCC-C-----CCCCccchHhHHHHHHHHHhC-CCCCCCCCCcc-cc--chhhhcc
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFES-G-----SYSCQSDVYSLGVVMLELLTG-RKPYDRSRPRG-EQ--SLVRWAI  662 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~-----~~~~~~Dv~S~Gvvl~elltG-~~Pf~~~~~~~-~~--~~~~~~~  662 (720)
                      ...   .......+-.+...|.+||... +     .-+...|.|.+||++++++.| +.||.+..... +.  .......
T Consensus       165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            111   2222333456778899999763 2     346789999999999999986 99997532111 00  0001111


Q ss_pred             cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccC--CCCCCCHHHHHHHHHh
Q 004994          663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWE--PGFRPPMSEIVQDLLC  718 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPt~~evl~~L~~  718 (720)
                      ..+.+......-..+.....-..-.++.+..+..+|....  +.-|||++..+..|-+
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            1111111100000000000111223456777888888754  5689999987766543

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.42  E-value=1e-08  Score=89.35  Aligned_cols=106  Identities=22%  Similarity=0.293  Sum_probs=83.0

Q ss_pred             CccEEeccCCcccccCCCCcc-----ccCcEEEecCCcCCCCCcchhhc-ccccccccccccccCCCCCchhcCCCCCce
Q 004994           96 SVINIDLSNNHIGGSIPSNLP-----VTVRNFSLSGNQLTGSIPESLSR-LTQLLDLSLNNNHLNGGIPDAFHQFTGLIN  169 (720)
Q Consensus        96 ~L~~L~L~~N~l~g~ip~~~~-----~~L~~L~Ls~N~l~g~~p~~l~~-l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  169 (720)
                      .+-.+||++.+|- .++....     ..|+.++|++|.|. .+|+.|.. .+.++.|+|++|.|+ .+|.++..++.|+.
T Consensus        28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~  104 (177)
T KOG4579|consen   28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS  104 (177)
T ss_pred             Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence            4566788887775 5554432     46778899999998 66666654 458899999999998 78888999999999


Q ss_pred             EeccCCcccccCCCCCCCCCCCceeecccccccccc
Q 004994          170 FDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL  205 (720)
Q Consensus       170 L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~  205 (720)
                      |+++.|.|. ..|..+..|.+|..|+..+|.+....
T Consensus       105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid  139 (177)
T KOG4579|consen  105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEID  139 (177)
T ss_pred             cccccCccc-cchHHHHHHHhHHHhcCCCCccccCc
Confidence            999999998 78888888888888888888775444

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.41  E-value=2e-06  Score=84.73  Aligned_cols=125  Identities=22%  Similarity=0.227  Sum_probs=88.5

Q ss_pred             CcEEEEEEecccccc-----cccHHHHHHHHHHHHccCC--CceeEEEeEeccC----CeEEEEEeeCCCC-CHHHHhhc
Q 004994          464 GKLLAVKKLSNTVSQ-----RQTDEEFLELASTISRLRH--GNIVELIGYCNEH----GQHLLVYDYGGNC-TLHDLLHS  531 (720)
Q Consensus       464 g~~vavK~l~~~~~~-----~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~  531 (720)
                      ++.+-+|........     ........+|.+.+..+..  =.+.+.+++....    ..-++|+|++++. +|.+++..
T Consensus        32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~  111 (206)
T PF06293_consen   32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ  111 (206)
T ss_pred             ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence            556666654322111     1233456777777777743  3345566665442    2458999999884 78888854


Q ss_pred             cchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC---CeEEccccCCCCC
Q 004994          532 DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL---IVRVSDCGLAPLL  595 (720)
Q Consensus       532 ~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~~  595 (720)
                      ..    ..+...+..++.++++.+.-||..   +|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       112 ~~----~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  112 WE----QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hc----ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            21    144556778999999999999998   999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.40  E-value=6.9e-08  Score=99.72  Aligned_cols=134  Identities=17%  Similarity=0.217  Sum_probs=100.2

Q ss_pred             ecCceeEEEecCCcccccCCcC-cCCCCCccEEeccCCcccccCCCCc---cccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           69 VFSNVTEIRLTGMNLGGVLADT-LGDLESVINIDLSNNHIGGSIPSNL---PVTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~g~ip~~~---~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      .+++|+.|+|+.|+|.-..... -..+++|+.|.|+...|+-.-=..+   .++|+.|+|..|..-+.--.....+..|+
T Consensus       170 qLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~  249 (505)
T KOG3207|consen  170 QLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQ  249 (505)
T ss_pred             hcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHh
Confidence            4789999999999997544332 2357899999999999972110111   16899999999963334444456678899


Q ss_pred             cccccccccCCCCC--chhcCCCCCceEeccCCcccc-cCCCC-----CCCCCCCceeecccccccc
Q 004994          145 DLSLNNNHLNGGIP--DAFHQFTGLINFDLSANNLTG-QLPPS-----TRNLSSLYSLHLQNNKLSG  203 (720)
Q Consensus       145 ~L~l~~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~g-~~p~~-----~~~l~~L~~L~l~~N~l~~  203 (720)
                      .|||++|++- ..+  ...+.|+.|+.|+++.+.+.. .+|+.     ...+++|++|+++.|+++.
T Consensus       250 ~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~  315 (505)
T KOG3207|consen  250 ELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD  315 (505)
T ss_pred             hccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcccc
Confidence            9999999986 344  467889999999999999974 24544     4567899999999999853

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.31  E-value=1.8e-08  Score=109.64  Aligned_cols=121  Identities=32%  Similarity=0.408  Sum_probs=66.8

Q ss_pred             ccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCc-hhcCCCCCceEecc
Q 004994           97 VINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLS  173 (720)
Q Consensus        97 L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~ls  173 (720)
                      |...+.+.|.|. .+-.++.  +.|+.|||++|+|+. .. .+..|+.|++|||+.|+|. .+|. ....+. |..|.|+
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence            444445555554 3333222  445555666666552 22 5666777777777777776 3332 223333 6677777


Q ss_pred             CCcccccCCCCCCCCCCCceeecccccccccc--ccccccc-cceEEccCCcCc
Q 004994          174 ANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL--NVLEDLH-LIDLNIENNLFS  224 (720)
Q Consensus       174 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~~-l~~l~l~~N~l~  224 (720)
                      +|.++ .+ ..+.+|.+|+.|||++|-|++.-  ..+..+. |+.|+|.+|.+.
T Consensus       241 nN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            77776 22 24566777777777777666543  2233332 666777777654

>PRK09902 hypothetical protein; Provisional

Probab=98.31  E-value=7.6e-06  Score=79.01  Aligned_cols=142  Identities=15%  Similarity=0.130  Sum_probs=102.5

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccc----cccccHHHHHHHHHHHHccCCC--ceeEEEeEec---c--CCeEE
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTV----SQRQTDEEFLELASTISRLRHG--NIVELIGYCN---E--HGQHL  514 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~---~--~~~~~  514 (720)
                      ---|+||-+-||+..+.+. .+-+|+-....    .-......|.+|+..+.++..-  .+.+.+ ++.   .  ..+-+
T Consensus        24 pN~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~  101 (216)
T PRK09902         24 PNYRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL  101 (216)
T ss_pred             CCcCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence            3357788888999877544 68889865211    1123557899999999888543  344444 332   1  22567


Q ss_pred             EEEeeCCC-CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC--eEEccccC
Q 004994          515 LVYDYGGN-CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI--VRVSDCGL  591 (720)
Q Consensus       515 lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~DFGl  591 (720)
                      ||+|-+++ -+|.+++...  .....+...+..+..++++++.-||..   ++.|+|+.+.||+++.++.  ++++||--
T Consensus       102 LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk  176 (216)
T PRK09902        102 LVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEK  176 (216)
T ss_pred             EEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence            99997664 5888887432  123456677889999999999999998   9999999999999986666  99999986


Q ss_pred             CCC
Q 004994          592 APL  594 (720)
Q Consensus       592 a~~  594 (720)
                      ++.
T Consensus       177 ~r~  179 (216)
T PRK09902        177 SRR  179 (216)
T ss_pred             cch
Confidence            653

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.30  E-value=9.6e-08  Score=104.76  Aligned_cols=171  Identities=25%  Similarity=0.321  Sum_probs=123.0

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      .+.+.+++.|+|.+|+|... ...+..+++|++|+|++|+|+..-+-.-...|+.|++++|.++ .+. .+..+.+|+.+
T Consensus        91 l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l  167 (414)
T KOG0531|consen   91 LSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLL  167 (414)
T ss_pred             cccccceeeeeccccchhhc-ccchhhhhcchheeccccccccccchhhccchhhheeccCcch-hcc-CCccchhhhcc
Confidence            45677899999999999864 3337889999999999999985554444466999999999998 444 46668999999


Q ss_pred             cccccccCCCCCch-hcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc--ccceEEccCCcC
Q 004994          147 SLNNNHLNGGIPDA-FHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL--HLIDLNIENNLF  223 (720)
Q Consensus       147 ~l~~N~l~g~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~--~l~~l~l~~N~l  223 (720)
                      ++++|++.. +... ...+.+|+.+++.+|.+.  ....+..+..+..+++..|.++-.-+.....  .|+.+++++|.+
T Consensus       168 ~l~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i  244 (414)
T KOG0531|consen  168 DLSYNRIVD-IENDELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRI  244 (414)
T ss_pred             cCCcchhhh-hhhhhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCcc
Confidence            999999984 3332 578889999999999996  3344556666777788889886443322222  378889999998


Q ss_pred             cccCC---cccCCCccccccCccC
Q 004994          224 SGPIP---EKLLSIPNFRKDGNPF  244 (720)
Q Consensus       224 ~g~~p---~~~~~l~~l~~~~n~~  244 (720)
                      . .++   ..+..++.|...+|..
T Consensus       245 ~-~~~~~~~~~~~l~~l~~~~n~~  267 (414)
T KOG0531|consen  245 S-RSPEGLENLKNLPVLDLSSNRI  267 (414)
T ss_pred             c-cccccccccccccccchhhccc
Confidence            8 332   2334444444444443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.30  E-value=4.2e-06  Score=92.41  Aligned_cols=150  Identities=18%  Similarity=0.211  Sum_probs=95.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccc------------------------c-------------
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQ------------------------T-------------  481 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~------------------------~-------------  481 (720)
                      ...|+. +-|+.++-|.||+|++++|+.||||+.++......                        .             
T Consensus       125 F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         125 FSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             HHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            344443 67999999999999999999999999876532110                        0             


Q ss_pred             -HHHHHHHHHHHHcc----CCCceeEEEeEec-cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHH
Q 004994          482 -DEEFLELASTISRL----RHGNIVELIGYCN-EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL  555 (720)
Q Consensus       482 -~~~~~~e~~~l~~l----~H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L  555 (720)
                       .-++.+|..-+.++    ++.-=+.+=.+|. -.....|+|||++|-.+.+......   ..++   +..++..++++ 
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~-  276 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRA-  276 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHH-
Confidence             01233333333333    2222222323333 3456899999999988887743211   2233   22333333332 


Q ss_pred             HHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       556 ~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                       |+.+....++.|.|.+|-||+++.++.+-+.|||+...+.+
T Consensus       277 -f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         277 -FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             22222223899999999999999999999999999877643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.29  E-value=1.1e-05  Score=80.42  Aligned_cols=140  Identities=15%  Similarity=0.174  Sum_probs=85.0

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCc--eeEEEeEeccCCeEEEEEeeCCCC
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN--IVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      ..||+|..+.||+.   .|..+++|......    ......+|.++++.+..-.  +.+.+++....+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            56899999999984   24567888876432    2344678888988886433  467788887777888999999986


Q ss_pred             C-HHHHhhccc---------------hhc----cccCHHHHH-HHHH----------HH-HHHHHHHHhc-CCCCeeecC
Q 004994          524 T-LHDLLHSDE---------------EAH----KKFSWNIRI-RVAL----------GA-ARALQYLQEV-CEPPIVHGN  570 (720)
Q Consensus       524 s-L~~~l~~~~---------------~~~----~~~~~~~~~-~i~~----------~i-a~~L~~LH~~-~~~~ivHrD  570 (720)
                      . +.+.+....               ..+    .......+. ++..          .+ .....+|... ..+.++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 221111000               000    000100000 0000          01 1122333222 134578999


Q ss_pred             CCCCCeEEcCCCCeEEccccCCC
Q 004994          571 FKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       571 lkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      +.|.||++++++ +.|+||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999988 9999999774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.23  E-value=1.6e-06  Score=61.48  Aligned_cols=38  Identities=45%  Similarity=0.772  Sum_probs=28.3

Q ss_pred             HHHHHHHHHHHHhcCC-C--CCCCccCCC-CCCCCCCCceeEee
Q 004994           30 PRDVMALNSLYISLNF-P--PLEKWLSFG-GDPCGDSWQGVFCV   69 (720)
Q Consensus        30 ~~~~~al~~~~~~l~~-~--~~~~w~~~~-~~~c~~~w~gv~c~   69 (720)
                      ++|++||++||+++.+ +  .+.+|...+ .+||  +|.||.|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C--~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC--SWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC--CSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe--eeccEEeC
Confidence            5799999999999984 4  589998753 7888  79999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.06  E-value=1.4e-06  Score=94.58  Aligned_cols=181  Identities=18%  Similarity=0.098  Sum_probs=129.4

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCc-eeEEEeEeccCCeEEEEEeeCCCC-
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN-IVELIGYCNEHGQHLLVYDYGGNC-  523 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~~~~g-  523 (720)
                      +-+++|+++++||.+-...+...++.+...       ....-++++|.+++||| .+..++-++.++..+++++|+..+ 
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR  320 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence            457899999999986544445556665432       34567789999999999 777777777778889999999887 


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCccc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL  603 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  603 (720)
                      +-.....   .....+...+...+.....++++++|+.   .=+|||    ||+..+ ...|..||+.+..+....   .
T Consensus       321 s~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~  386 (829)
T KOG0576|consen  321 SSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---K  386 (829)
T ss_pred             cccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---c
Confidence            2221111   1111222233344555567889999975   348998    777766 578999999998775432   2


Q ss_pred             ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCC
Q 004994          604 SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYD  647 (720)
Q Consensus       604 ~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~  647 (720)
                      .....++..++|||.. .+.+..+.|+|+.|+-..++--|-+|-.
T Consensus       387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            3446678889999977 5679999999999998888888877754

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.04  E-value=2.9e-05  Score=85.50  Aligned_cols=141  Identities=18%  Similarity=0.223  Sum_probs=92.2

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEeccccccccc-----------------------------------HHHHHHHHH
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQT-----------------------------------DEEFLELAS  490 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~-----------------------------------~~~~~~e~~  490 (720)
                      +-||.-+.|.||+|++++|+.||||+=++.......                                   .-+|..|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            679999999999999999999999987654321100                                   012333333


Q ss_pred             ----HHHccCCCc------eeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHh
Q 004994          491 ----TISRLRHGN------IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE  560 (720)
Q Consensus       491 ----~l~~l~H~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~  560 (720)
                          ..+.+.|-+      |.++|-.+  .....|+||||+|..+.|+-.-.   ...++..   .|+..+.+  .|++.
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~---~i~~~l~~--~~~~q  316 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAID---KRGISPH---DILNKLVE--AYLEQ  316 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHH---HcCCCHH---HHHHHHHH--HHHHH
Confidence                223334544      44444332  34689999999998887764321   2233333   34433333  34455


Q ss_pred             cCCCCeeecCCCCCCeEEcC----CCCeEEccccCCCCCC
Q 004994          561 VCEPPIVHGNFKSSNILLDE----KLIVRVSDCGLAPLLF  596 (720)
Q Consensus       561 ~~~~~ivHrDlkp~NiLl~~----~~~~kl~DFGla~~~~  596 (720)
                      ....|++|+|-.|-||++..    ++++.+-|||+...+.
T Consensus       317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            54558999999999999984    6789999999987663

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	720
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-38
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-38
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-34
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-34
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-26
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-26
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-26
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-09
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		5e-09
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		7e-07
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		5e-09
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-07
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-07
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-07
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-04
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-04
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-04
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-04
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  158 bits (400), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 100/290 (34%), Positives = 151/290 (52%), Gaps = 6/290 (2%)
Query: 430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           F++  LQ  +++FS  N +G G  G VYK  L  G L+AVK+L     Q   + +F    
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQ-GGELQFQTEV 86
Query: 490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
             IS   H N++ L G+C    + LLVY Y  N ++   L    E+     W  R R+AL
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
           G+AR L YL + C+P I+H + K++NILLDE+    V D GLA L+       +   +  
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXHVXXAVRG 205
Query: 610 AHGSGAPEF-ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS--LVRWAIPRLH 666
             G  APE+  +G  S ++DV+  GV++LEL+TG++ +D +R   +    L+ W    L 
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 265
Query: 667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           +   L  +VD  L G Y  + + +   +   C Q  P  RP MSE+V+ L
Sbjct: 266 E-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  157 bits (397), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 99/290 (34%), Positives = 151/290 (52%), Gaps = 6/290 (2%)
Query: 430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           F++  LQ  +++F   N +G G  G VYK  L  G L+AVK+L    +Q   + +F    
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQ-GGELQFQTEV 78
Query: 490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
             IS   H N++ L G+C    + LLVY Y  N ++   L    E+     W  R R+AL
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
           G+AR L YL + C+P I+H + K++NILLDE+    V D GLA L+       +   +  
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXHVXXAVRG 197
Query: 610 AHGSGAPEF-ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS--LVRWAIPRLH 666
             G  APE+  +G  S ++DV+  GV++LEL+TG++ +D +R   +    L+ W    L 
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           +   L  +VD  L G Y  + + +   +   C Q  P  RP MSE+V+ L
Sbjct: 258 E-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  145 bits (365), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 96/286 (33%), Positives = 144/286 (50%), Gaps = 7/286 (2%)
Query: 432 IASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  L++ TN+F     IG G+ G VYK  L  G  +A+K+   T    Q  EEF     T
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR--RTPESSQGIEEFETEIET 88
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGA 551
           +S  RH ++V LIG+C+E  + +L+Y Y  N  L   L+  +      SW  R+ + +GA
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           AR L YL       I+H + KS NILLDE  + +++D G++          L   +    
Sbjct: 149 ARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTL 205
Query: 612 GSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
           G   PE F  G  + +SDVYS GVV+ E+L  R    +S PR   +L  WA+   H+   
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQ 264
Query: 671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           L ++VDP+L      +SL +F D   +C+      RP M +++  L
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 96/286 (33%), Positives = 144/286 (50%), Gaps = 7/286 (2%)
Query: 432 IASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  L++ TN+F     IG G+ G VYK  L  G  +A+K+   T    Q  EEF     T
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR--RTPESSQGIEEFETEIET 88
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGA 551
           +S  RH ++V LIG+C+E  + +L+Y Y  N  L   L+  +      SW  R+ + +GA
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           AR L YL       I+H + KS NILLDE  + +++D G++          L   +    
Sbjct: 149 ARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTL 205
Query: 612 GSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
           G   PE F  G  + +SDVYS GVV+ E+L  R    +S PR   +L  WA+   H+   
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQ 264
Query: 671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           L ++VDP+L      +SL +F D   +C+      RP M +++  L
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/298 (29%), Positives = 148/298 (49%), Gaps = 16/298 (5%)
Query: 430 FTIASLQQYTNSFSE------GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTV--SQRQT 481
           F+   L+  TN+F E      GN +GEG  G VYK  +     +AVKKL+  V  +  + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 482 DEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSW 541
            ++F +    +++ +H N+VEL+G+ ++     LVY Y  N +L D L S  +     SW
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSW 132
Query: 542 NIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN 601
           ++R ++A GAA  + +L E      +H + KS+NILLDE    ++SD GLA      +  
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 602 ELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA 661
            +   ++      APE   G  + +SD+YS GVV+LE++TG    D  R    Q L+   
Sbjct: 190 VMXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIK 247
Query: 662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM 719
                +   +   +D  ++ A  + S+     + S+C+  +   RP + ++ Q L  M
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/298 (29%), Positives = 148/298 (49%), Gaps = 16/298 (5%)
Query: 430 FTIASLQQYTNSFSE------GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTV--SQRQT 481
           F+   L+  TN+F E      GN +GEG  G VYK  +     +AVKKL+  V  +  + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 482 DEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSW 541
            ++F +    +++ +H N+VEL+G+ ++     LVY Y  N +L D L S  +     SW
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSW 132
Query: 542 NIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN 601
           ++R ++A GAA  + +L E      +H + KS+NILLDE    ++SD GLA      +  
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 602 ELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA 661
            +   ++      APE   G  + +SD+YS GVV+LE++TG    D  R    Q L+   
Sbjct: 190 VMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIK 247
Query: 662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM 719
                +   +   +D  ++ A  + S+     + S+C+  +   RP + ++ Q L  M
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/298 (29%), Positives = 148/298 (49%), Gaps = 16/298 (5%)
Query: 430 FTIASLQQYTNSFSE------GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTV--SQRQT 481
           F+   L+  TN+F E      GN +GEG  G VYK  +     +AVKKL+  V  +  + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 482 DEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSW 541
            ++F +    +++ +H N+VEL+G+ ++     LVY Y  N +L D L S  +     SW
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSW 126
Query: 542 NIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN 601
           ++R ++A GAA  + +L E      +H + KS+NILLDE    ++SD GLA      +  
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 602 ELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA 661
            +   ++      APE   G  + +SD+YS GVV+LE++TG    D  R    Q L+   
Sbjct: 184 VMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIK 241
Query: 662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM 719
                +   +   +D  ++ A  + S+     + S+C+  +   RP + ++ Q L  M
Sbjct: 242 EEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 141/293 (48%), Gaps = 16/293 (5%)
Query: 430 FTIASLQQYTNSFSE------GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTV--SQRQT 481
           F+   L+  TN+F E      GN  GEG  G VYK  +     +AVKKL+  V  +  + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 482 DEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSW 541
            ++F +     ++ +H N+VEL+G+ ++     LVY Y  N +L D L S  +     SW
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL-SCLDGTPPLSW 123
Query: 542 NIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN 601
           + R ++A GAA  + +L E      +H + KS+NILLDE    ++SD GLA      +  
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 602 ELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA 661
                ++      APE   G  + +SD+YS GVV+LE++TG    D  R    Q L+   
Sbjct: 181 VXXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIK 238
Query: 662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                +   +   +D   + A  + S+     + S+C+  +   RP + ++ Q
Sbjct: 239 EEIEDEEKTIEDYIDKKXNDAD-STSVEAXYSVASQCLHEKKNKRPDIKKVQQ 290

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 131/279 (46%), Gaps = 32/279 (11%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG G  G+V++AE  G  + AVK L       +   EFL   + + RLRH NIV  +G  
Sbjct: 45  IGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     +V +Y    +L+ LLH    A ++     R+ +A   A+ + YL     PPIV
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSY---- 623
           H N KS N+L+D+K  V+V D GL+ L       + S  L +   +G PE+ +       
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL-------KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 624 --SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG 681
             + +SDVYS GV++ EL T ++P+    P    + V +   RL     + R ++P +  
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE----IPRNLNPQV-- 268
Query: 682 AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                     A II  C   EP  RP  + I+  L  +I
Sbjct: 269 ----------AAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 32/279 (11%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG G  G+V++AE  G  + AVK L       +   EFL   + + RLRH NIV  +G  
Sbjct: 45  IGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     +V +Y    +L+ LLH    A ++     R+ +A   A+ + YL     PPIV
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSY---- 623
           H + KS N+L+D+K  V+V D GL+ L       + S  L +   +G PE+ +       
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRL-------KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 624 --SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDG 681
             + +SDVYS GV++ EL T ++P+    P    + V +   RL     + R ++P +  
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE----IPRNLNPQV-- 268
Query: 682 AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                     A II  C   EP  RP  + I+  L  +I
Sbjct: 269 ----------AAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 17  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY  +  Q  +V  +    +L+  LH+ E    KF     I +A   AR + YL      
Sbjct: 75  GYSTK-PQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---K 127
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E   V++ D GLA +    S +   E L  +    APE     +S
Sbjct: 128 SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 187
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 188 NPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY  +  Q  +V  +    +L+  LH+ E    KF     I +A   AR + YL      
Sbjct: 87  GYSTK-PQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---K 139
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E   V++ D GLA      S +   E L  +    APE     +S
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY     Q  +V  +    +L+  LH+ E    KF     I +A   AR + YL      
Sbjct: 87  GYSTA-PQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---K 139
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E   V++ D GLA      S +   E L  +    APE     +S
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 15  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY  +  Q  +V  +    +L+  LH  E    KF     I +A   A+ + YL      
Sbjct: 73  GYSTK-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---K 125
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E L V++ D GLA +    S +   E L  +    APE     + 
Sbjct: 126 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 185
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 186 NPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY  +  Q  +V  +    +L+  LH  E    KF     I +A   A+ + YL      
Sbjct: 71  GYSTK-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---K 123
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E L V++ D GLA +    S +   E L  +    APE     + 
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 18  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY  +  Q  +V  +    +L+  LH  E    KF     I +A   A+ + YL      
Sbjct: 76  GYSTK-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---K 128
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E L V++ D GLA +    S +   E L  +    APE     + 
Sbjct: 129 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 188
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 18  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY  +  Q  +V  +    +L+  LH  E    KF     I +A   A+ + YL      
Sbjct: 76  GYSTK-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---K 128
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E L V++ D GLA +    S +   E L  +    APE     + 
Sbjct: 129 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 188
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 40  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY  +  Q  +V  +    +L+  LH  E    KF     I +A   A+ + YL      
Sbjct: 98  GYSTK-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---K 150
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E L V++ D GLA +    S +   E L  +    APE     + 
Sbjct: 151 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 210
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 211 NPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 41  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY  +  Q  +V  +    +L+  LH  E    KF     I +A   A+ + YL      
Sbjct: 99  GYSTK-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---K 151
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E L V++ D GLA +    S +   E L  +    APE     + 
Sbjct: 152 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 211
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY     Q  +V  +    +L+  LH  E    KF     I +A   A+ + YL      
Sbjct: 71  GYSTA-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---K 123
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E L V++ D GLA +    S +   E L  +    APE     + 
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 33  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY  +  Q  +V  +    +L+  LH  E    KF     I +A   A+ + YL      
Sbjct: 91  GYSTK-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---K 143
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E L V++ D GLA      S +   E L  +    APE     + 
Sbjct: 144 SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 203
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 204 NPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY  +  Q  +V  +    +L+  LH  E    KF     I +A   A+ + YL      
Sbjct: 71  GYSTK-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---K 123
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E L V++ D GLA      S +   E L  +    APE     + 
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH NI+  +
Sbjct: 41  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           GY  +  Q  +V  +    +L+  LH  E    KF     I +A   A+ + YL      
Sbjct: 99  GYSTK-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---K 151
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ES 620
            I+H + KS+NI L E L V++ D GLA      S +   E L  +    APE     + 
Sbjct: 152 SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 211
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
             YS QSDVY+ G+V+ EL+TG+ PY
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG G  G V+         +A+K +        ++E+F+E A  + +L H  +V+L G C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            E     LV+++  +  L D L +       F+    + + L     + YL+E C   ++
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQ 626
           H +  + N L+ E  +++VSD G+   +        S G        +PE F    YS +
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 182
Query: 627 SDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLA 685
           SDV+S GV+M E+ + G+ PY+    R    +V        DI    R+  P L   ++ 
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYEN---RSNSEVV-------EDISTGFRLYKPRLASTHVY 232
Query: 686 KSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           +       I++ C +  P  RP  S +++ L
Sbjct: 233 Q-------IMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG G  G V+         +A+K +        ++E+F+E A  + +L H  +V+L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            E     LV+++  +  L D L +       F+    + + L     + YL+E C   ++
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQ 626
           H +  + N L+ E  +++VSD G+   +        S G        +PE F    YS +
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 184
Query: 627 SDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLA 685
           SDV+S GV+M E+ + G+ PY+    R    +V        DI    R+  P L   ++ 
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYEN---RSNSEVV-------EDISTGFRLYKPRLASTHVY 234
Query: 686 KSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           +       I++ C +  P  RP  S +++ L
Sbjct: 235 Q-------IMNHCWKERPEDRPAFSRLLRQL 258

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG G  G V+         +A+K +        ++E+F+E A  + +L H  +V+L G C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            E     LV+++  +  L D L +       F+    + + L     + YL+E C   ++
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQ 626
           H +  + N L+ E  +++VSD G+   +        S G        +PE F    YS +
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 187
Query: 627 SDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLA 685
           SDV+S GV+M E+ + G+ PY+    R    +V        DI    R+  P L   ++ 
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYEN---RSNSEVV-------EDISTGFRLYKPRLASTHVY 237
Query: 686 KSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           +       I++ C +  P  RP  S +++ L
Sbjct: 238 Q-------IMNHCWRERPEDRPAFSRLLRQL 261

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG G  G+VYK +  G   +AVK L       +  + F    + + + RH NI+  +GY 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     +V  +    +L+  LH  E   + F     I +A   A+ + YL       I+
Sbjct: 102 TKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQL---IDIARQTAQGMDYLHA---KNII 154
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF----ESGSY 623
           H + KS+NI L E L V++ D GLA +    S ++  E    +    APE     ++  +
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 624 SCQSDVYSLGVVMLELLTGRKPYDRSRPRGE 654
           S QSDVYS G+V+ EL+TG  PY     R +
Sbjct: 215 SFQSDVYSYGIVLYELMTGELPYSHINNRDQ 245

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 117/270 (43%), Gaps = 27/270 (10%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG G  G V+         +A+K +        ++++F+E A  + +L H  +V+L G C
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEG---SMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            E     LV+++  +  L D L +       F+    + + L     + YL+E C   ++
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQS 627
           H +  + N L+ E  +++VSD G+   +        +        +    F    YS +S
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 628 DVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAK 686
           DV+S GV+M E+ + G+ PY+    R    +V        DI    R+  P L   ++ +
Sbjct: 206 DVWSFGVLMWEVFSEGKIPYEN---RSNSEVV-------EDISTGFRLYKPRLASTHVYQ 255
Query: 687 SLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                  I++ C +  P  RP  S +++ L
Sbjct: 256 -------IMNHCWKERPEDRPAFSRLLRQL 278

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 131/283 (46%), Gaps = 39/283 (13%)
Query: 448 IGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTD-----EEFLELASTISRLRHGNIV 501
           IG+G  G V+K  L   K ++A+K L    S+ +T+     +EF      +S L H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           +L G    H    +V ++       DL H   +      W++++R+ L  A  ++Y+Q  
Sbjct: 87  KLYGLM--HNPPRMVMEF---VPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 562 CEPPIVHGNFKSSNILL---DEKLIV--RVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
             PPIVH + +S NI L   DE   V  +V+D GL+      S + +S GLL      AP
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVS-GLLGNFQWMAP 195
Query: 617 EF---ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
           E    E  SY+ ++D YS  +++  +LTG  P+D      E S  +        I  ++ 
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYSYGK--------IKFINM 241
Query: 674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           + +  L          R  ++I  C   +P  RP  S IV++L
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 29/271 (10%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG G  G V+         +A+K +        ++E+F+E A  + +L H  +V+L G C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            E     LV ++  +  L D L +       F+    + + L     + YL+E C   ++
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQ 626
           H +  + N L+ E  +++VSD G+   +        S G        +PE F    YS +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 185
Query: 627 SDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLA 685
           SDV+S GV+M E+ + G+ PY+    R    +V        DI    R+  P L   ++ 
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYEN---RSNSEVV-------EDISTGFRLYKPRLASTHVY 235
Query: 686 KSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           +       I++ C +  P  RP  S +++ L
Sbjct: 236 Q-------IMNHCWRERPEDRPAFSRLLRQL 259

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 447 FIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQ--RQTDEEFLELASTISRLRHGNIVELI 504
            IG G  G VY+A   G ++ AVK   +   +   QT E   + A   + L+H NI+ L 
Sbjct: 14  IIGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           G C +     LV ++     L+ +L       K+   +I +  A+  AR + YL +    
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 565 PIVHGNFKSSNILLDEKL--------IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
           PI+H + KSSNIL+ +K+        I++++D GLA   +  +T   + G   A+   AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTKMSAAG---AYAWMAP 183
Query: 617 EFESGS-YSCQSDVYSLGVVMLELLTGRKPY 646
           E    S +S  SDV+S GV++ ELLTG  P+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 29/271 (10%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG G  G V+         +A+K +        ++E+F+E A  + +L H  +V+L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            E     LV+++  +  L D L +       F+    + + L     + YL+E     ++
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---SVI 125
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQ 626
           H +  + N L+ E  +++VSD G+   +        S G        +PE F    YS +
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 184
Query: 627 SDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLA 685
           SDV+S GV+M E+ + G+ PY+    R    +V        DI    R+  P L   ++ 
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYEN---RSNSEVV-------EDISTGFRLYKPRLASTHVY 234
Query: 686 KSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           +       I++ C +  P  RP  S +++ L
Sbjct: 235 Q-------IMNHCWKERPEDRPAFSRLLRQL 258

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 39/283 (13%)
Query: 448 IGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTD-----EEFLELASTISRLRHGNIV 501
           IG+G  G V+K  L   K ++A+K L    S+ +T+     +EF      +S L H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           +L G    H    +V ++       DL H   +      W++++R+ L  A  ++Y+Q  
Sbjct: 87  KLYGLM--HNPPRMVMEF---VPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 562 CEPPIVHGNFKSSNILL---DEKLIV--RVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
             PPIVH + +S NI L   DE   V  +V+D G +      S + +S GLL      AP
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS----QQSVHSVS-GLLGNFQWMAP 195
Query: 617 EF---ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
           E    E  SY+ ++D YS  +++  +LTG  P+D      E S  +        I  ++ 
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYSYGK--------IKFINM 241
Query: 674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           + +  L          R  ++I  C   +P  RP  S IV++L
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 40/274 (14%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V KA+    K +A+K++ +  S+R+    F+     +SR+ H NIV+L G C
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKA---FIVELRQLSRVNHPNIVKLYGAC 71
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDE-----EAHKKFSWNIRIRVALGAARALQYLQEVC 562
                  LV +Y    +L+++LH  E      A    SW       L  ++ + YL  + 
Sbjct: 72  L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQ 123
Query: 563 EPPIVHGNFKSSNILLDEK-LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FES 620
              ++H + K  N+LL     ++++ D G A  + +  TN        A     PE FE 
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMA-----PEVFEG 178
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD 680
            +YS + DV+S G+++ E++T RKP+D     G    + WA+        +  +  P   
Sbjct: 179 SNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAVHNGTRPPLIKNLPKP--- 233
Query: 681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                        +++RC   +P  RP M EIV+
Sbjct: 234 ----------IESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 131/283 (46%), Gaps = 39/283 (13%)
Query: 448 IGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTD-----EEFLELASTISRLRHGNIV 501
           IG+G  G V+K  L   K ++A+K L    S+ +T+     +EF      +S L H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           +L G  +   + ++ +   G     DL H   +      W++++R+ L  A  ++Y+Q  
Sbjct: 87  KLYGLMHNPPRMVMEFVPCG-----DLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN- 140
Query: 562 CEPPIVHGNFKSSNILL---DEKLIV--RVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
             PPIVH + +S NI L   DE   V  +V+D  L+      S + +S GLL      AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS----QQSVHSVS-GLLGNFQWMAP 195
Query: 617 EF---ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
           E    E  SY+ ++D YS  +++  +LTG  P+D      E S  +        I  ++ 
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------EYSYGK--------IKFINM 241
Query: 674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           + +  L          R  ++I  C   +P  RP  S IV++L
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 40/274 (14%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V KA+    K +A+K++ +  S+R+    F+     +SR+ H NIV+L G C
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKA---FIVELRQLSRVNHPNIVKLYGAC 70
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDE-----EAHKKFSWNIRIRVALGAARALQYLQEVC 562
                  LV +Y    +L+++LH  E      A    SW       L  ++ + YL  + 
Sbjct: 71  L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQ 122
Query: 563 EPPIVHGNFKSSNILLDEK-LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FES 620
              ++H + K  N+LL     ++++ D G A  + +  TN        A     PE FE 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMA-----PEVFEG 177
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD 680
            +YS + DV+S G+++ E++T RKP+D     G    + WA+        +  +  P   
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAVHNGTRPPLIKNLPKP--- 232
Query: 681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                        +++RC   +P  RP M EIV+
Sbjct: 233 ----------IESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ S  + + +A   + A++YL+   +   
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H N  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 441
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ S  + + +A   + A++YL+   +   
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY    P     L          ++   RM  P       
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL----------LEKDYRMERPE------ 233
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 234 -GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 268

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ S  + + +A   + A++YL+   +   
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY    P     L          ++   RM  P       
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL----------LEKDYRMERPE------ 233
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 234 -GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 268

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY- 506
           IG+G  G V   +  G K+ AVK + N      T + FL  AS +++LRH N+V+L+G  
Sbjct: 20  IGKGEFGDVMLGDYRGNKV-AVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP- 565
             E G   +V +Y    +L D L S            R R  LG    L++  +VCE   
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRS------------RGRSVLGGDCLLKFSLDVCEAME 122
Query: 566 ------IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                  VH +  + N+L+ E  + +VSD GL       +++    G L    +      
Sbjct: 123 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALR 178
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPYDR 648
             ++S +SDV+S G+++ E+ + GR PY R
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGRVPYPR 208

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ S  + + +A   + A++YL+   +   
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 130
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY    P     L          ++   RM  P       
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL----------LEKDYRMERPE------ 233
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 234 -GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 268

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 378
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H N  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 438 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 480
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 481 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 516

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY- 506
           IG+G  G V   +  G K+ AVK + N      T + FL  AS +++LRH N+V+L+G  
Sbjct: 14  IGKGEFGDVMLGDYRGNKV-AVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP- 565
             E G   +V +Y    +L D L S            R R  LG    L++  +VCE   
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRS------------RGRSVLGGDCLLKFSLDVCEAME 116
Query: 566 ------IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                  VH +  + N+L+ E  + +VSD GL       +++    G L    +      
Sbjct: 117 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALR 172
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPYDR 648
              +S +SDV+S G+++ E+ + GR PY R
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 38/284 (13%)
Query: 448 IGEGLLGSVYKAELP--GGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           IG G  G VYK  L    GK    +A+K L    +++Q   +FL  A  + +  H NI+ 
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHNIIR 110
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L G  +++   +++ +Y  N  L   L    E   +FS    + +  G A  ++YL  + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG--STNELSEGLLTAHGSGAPEFES 620
               VH +  + NIL++  L+ +VSD GL+ +L     +T   S G +    +       
Sbjct: 168 ---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
             ++  SDV+S G+VM E++T G +PY             W +     + A++       
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPY-------------WELSNHEVMKAIN------- 264
Query: 680 DGAYLAKSL---SRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           DG  L   +   S    ++ +C Q E   RP  ++IV  L  +I
Sbjct: 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY- 506
           IG+G  G V   +  G K+ AVK + N      T + FL  AS +++LRH N+V+L+G  
Sbjct: 201 IGKGEFGDVMLGDYRGNKV-AVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP-- 564
             E G   +V +Y    +L D L S            R R  LG    L++  +VCE   
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRS------------RGRSVLGGDCLLKFSLDVCEAME 303
Query: 565 -----PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                  VH +  + N+L+ E  + +VSD GL       +++    G L    +      
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALR 359
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPYDR 648
              +S +SDV+S G+++ E+ + GR PY R
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY- 506
           IG+G  G V   +  G K+ AVK + N      T + FL  AS +++LRH N+V+L+G  
Sbjct: 29  IGKGEFGDVMLGDYRGNKV-AVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP- 565
             E G   +V +Y    +L D L S            R R  LG    L++  +VCE   
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRS------------RGRSVLGGDCLLKFSLDVCEAME 131
Query: 566 ------IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                  VH +  + N+L+ E  + +VSD GL       +++    G L    +      
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALR 187
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPYDR 648
              +S +SDV+S G+++ E+ + GR PY R
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ S  + + +A   + A++YL+   +   
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 137
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 239
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 275

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ S  + + +A   + A++YL+   +   
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 234
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ S  + + +A   + A++YL+   +   
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 234
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ S  + + +A   + A++YL+   +   
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 234
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ S  + + +A   + A++YL+   +   
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 234
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 137
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 239
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 275

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 133
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 235
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 236 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 271

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 137
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 239
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 275

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 137
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 239
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 275

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 136
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 238
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 132
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 234
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 137
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 239
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 275

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 132
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 234
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 133
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 235
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 236 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 271

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 145
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 205 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 247
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 248 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 283

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 134
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 236
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 272

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 134
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 236
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 272

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 123/276 (44%), Gaps = 29/276 (10%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY+       L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       ++ ++     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 134
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      +S 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV++ GV++ E+ T G  PY                P + D+  +  +++        
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPY----------------PGI-DLSQVYELLEKDYRMERP 236
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                +  +++  C QW P  RP  +EI Q    M 
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 272

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++++ +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 83  SEEPIYIVI-EYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 136
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPY 216

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++++ +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 83  SEEPIYIVI-EYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 136
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI---EDNEXTARQGAKFPIKWTAPEAALYGRFT 193
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPY 216

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 332 SEEPIYI-VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 385
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPY 465

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 75
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 76  SEEPIYI-VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 129
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 186
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 187 IKSDVWSFGILLTELTTKGRVPY 209

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 55/289 (19%)
Query: 445 GNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           G  IG G  G V+   L     L+AVK    T+       +FL+ A  + +  H NIV L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP-DLKAKFLQEARILKQYSHPNIVRL 177
Query: 504 IGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           IG C +     +V +   GG     D L        +      +++   AA  ++YL+  
Sbjct: 178 IGVCTQKQPIYIVMELVQGG-----DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS-------- 613
           C    +H +  + N L+ EK ++++SD G+        + E ++G+  A G         
Sbjct: 233 C---CIHRDLAARNCLVTEKNVLKISDFGM--------SREEADGVXAASGGLRQVPVKW 281
Query: 614 GAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLV----RWAIPRLHD 667
            APE    G YS +SDV+S G+++ E  + G  PY     +  +  V    R   P L  
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341
Query: 668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            DA+ R+++                    +C  +EPG RP  S I Q+L
Sbjct: 342 -DAVFRLME--------------------QCWAYEPGQRPSFSTIYQEL 369

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 55/289 (19%)
Query: 445 GNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           G  IG G  G V+   L     L+AVK    T+       +FL+ A  + +  H NIV L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP-DLKAKFLQEARILKQYSHPNIVRL 177
Query: 504 IGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           IG C +     +V +   GG     D L        +      +++   AA  ++YL+  
Sbjct: 178 IGVCTQKQPIYIVMELVQGG-----DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS-------- 613
           C    +H +  + N L+ EK ++++SD G+        + E ++G+  A G         
Sbjct: 233 C---CIHRDLAARNCLVTEKNVLKISDFGM--------SREEADGVYAASGGLRQVPVKW 281
Query: 614 GAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLV----RWAIPRLHD 667
            APE    G YS +SDV+S G+++ E  + G  PY     +  +  V    R   P L  
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341
Query: 668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            DA+ R+++                    +C  +EPG RP  S I Q+L
Sbjct: 342 -DAVFRLME--------------------QCWAYEPGQRPSFSTIYQEL 369

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 71
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 72  SEEPIYI-VTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 125
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 182
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 183 IKSDVWSFGILLTELTTKGRVPY 205

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 73
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 74  SEEPIYI-VTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 127
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 184
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 185 IKSDVWSFGILLTELTTKGRVPY 207

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 249 SEEPIYI-VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPY 382

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 249 SEEPIYI-VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPY 382

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 83  SEEPIYI-VTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 136
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPY 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 115/270 (42%), Gaps = 21/270 (7%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V K   +P G+++AVK++  TV+ ++     ++L  ++  +     V   G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
               G   +  +   + +L        +  +    +I  ++A+   +AL++L       +
Sbjct: 119 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 175
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL--LTAHGSGAPEFESGSYS 624
           +H + K SN+L++    V++ D G++  L       +  G     A     PE     YS
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYS 235
Query: 625 CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
            +SD++SLG+ M+EL   R PYD            W  P       L ++V+        
Sbjct: 236 VKSDIWSLGITMIELAILRFPYD-----------SWGTP----FQQLKQVVEEPSPQLPA 280
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            K  + F D  S+C++     RP   E++Q
Sbjct: 281 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 116/270 (42%), Gaps = 21/270 (7%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V K   +P G+++AVK++  TV+ ++     ++L  ++  +     V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
               G   +  +   + +L        +  +    +I  ++A+   +AL++L       +
Sbjct: 75  LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL--LTAHGSGAPEFESGSYS 624
           +H + K SN+L++    V++ D G++  L      ++  G     A     PE     YS
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYS 191
Query: 625 CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
            +SD++SLG+ M+EL   R PYD            W  P       L ++V+        
Sbjct: 192 VKSDIWSLGITMIELAILRFPYD-----------SWGTP----FQQLKQVVEEPSPQLPA 236
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            K  + F D  S+C++     RP   E++Q
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 83  SEEPIYI-VCEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPY 216

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y     L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 83  SEEPIYI-VMEYMSKGCLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPY 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 132/283 (46%), Gaps = 57/283 (20%)
Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI---SRLRH 497
           FS+   IG G  G+VY A ++   +++A+KK+S   S +Q++E++ ++   +    +LRH
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 498 GNIVELIG-YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIR-VALGAARAL 555
            N ++  G Y  EH   L++    G+ +  DLL    E HKK    + I  V  GA + L
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSAS--DLL----EVHKKPLQEVEIAAVTHGALQGL 167
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGSTNELSEGLLTA 610
            YL       ++H + K+ NILL E  +V++ D G A ++     F G+   ++  ++ A
Sbjct: 168 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILA 224
Query: 611 HGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
                   + G Y  + DV+SLG+  +EL   + P                   L +++A
Sbjct: 225 -------MDEGQYDGKVDVWSLGITCIELAERKPP-------------------LFNMNA 258
Query: 671 LSRMV------DPSLDGAYLAKSLSRFADIISRCVQWEPGFRP 707
           +S +        P+L   + ++    F D    C+Q  P  RP
Sbjct: 259 MSALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRP 298

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 35/234 (14%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++ +Y     L + L +      ++S++I        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--- 595
                +      AR ++YL  + C    +H +  + N+L+ E  ++R++D GLA  +   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLARDINNI 210
Query: 596 --FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
             +  +TN    G L              Y+ QSDV+S GV+M E+ T G  PY
Sbjct: 211 DYYKKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 249 SEEPIYI-VGEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPY 382

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 126/277 (45%), Gaps = 31/277 (11%)
Query: 448 IGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G VY        L +AVK L     +    EEFL+ A+ +  ++H N+V+L+G 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
           C       +V +Y     L D L   E   ++ +  + + +A   + A++YL+   +   
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLR--ECNREEVTAVVLLYMATQISSAMEYLE---KKNF 151
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        APE     ++S 
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNTFSI 210
Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHD-IDALSRMVDPSLDGAY 683
           +SDV++ GV++ E+ T G  PY    P  + S       +++D ++   RM  P      
Sbjct: 211 KSDVWAFGVLLWEIATYGMSPY----PGIDLS-------QVYDLLEKGYRMEQPE----- 254
Query: 684 LAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                 +  +++  C +W P  RP  +E  Q    M 
Sbjct: 255 --GCPPKVYELMRACWKWSPADRPSFAETHQAFETMF 289

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 448 IGEGLLGSVYKAEL--PGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IG G  G V +  L  PG K   +A+K L    ++RQ   EFL  AS + +  H NI+ L
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASIMGQFEHPNIIRL 82
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G        +++ ++  N  L   L  ++    +F+    + +  G A  ++YL E+  
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLND---GQFTVIQLVGMLRGIASGMRYLAEMS- 138
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN--ELSE--GLLTAHGSGAPEFE 619
              VH +  + NIL++  L+ +VSD GL+  L   S++  E S   G +    +      
Sbjct: 139 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              ++  SD +S G+VM E+++ G +PY
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMSFGERPY 224

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + ++RH  +V+L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKIRHEKLVQLYAVV 82
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 83  SEEPIYI-VTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 136
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPY 216

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L  +   + +    + +   + +  A  Y++ +     V
Sbjct: 80  SEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMA--YVERMN---YV 133
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLI---EDNEWTARQGAKFPIKWTAPEAALYGRFT 190
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPY 213

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +A+K L        + E FLE A  + +L+H  +V+L    
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGT---MSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L   E    K   N+ + +A   A  + Y++ +     +
Sbjct: 74  SEEPIYI-VTEYMNKGSLLDFLKDGEGRALKLP-NL-VDMAAQVAAGMAYIERMN---YI 127
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +S+NIL+   LI +++D GLA L+     NE +  +G        APE    G ++
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLI---EDNEXTARQGAKFPIKWTAPEAALYGRFT 184
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL+T GR PY
Sbjct: 185 IKSDVWSFGILLTELVTKGRVPY 207

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 72
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E     +V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 73  SEE-PIXIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 126
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLI---EDNEXTARQGAKFPIKWTAPEAALYGRFT 183
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 184 IKSDVWSFGILLTELTTKGRVPY 206

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y     L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 83  SEEPIYI-VTEYMSKGCLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPY 216

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L  +   + +    + +   + +  A  Y++ +     V
Sbjct: 80  SEEPIYI-VTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMA--YVERMN---YV 133
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 190
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 191 IKSDVWSFGILLTELTTKGRVPY 213

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 132/288 (45%), Gaps = 45/288 (15%)
Query: 448 IGEGLLGSVYKA--ELPGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IG G  G V     +LPG +   +A+K L +  +++Q   +FL  AS + +  H N++ L
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHPNVIHL 99
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    +++ ++  N +L   L  ++    +F+    + +  G A  ++YL ++  
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADMN- 155
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------AP 616
              VH +  + NIL++  L+ +VSD GL+  L     ++ S+   T+   G       AP
Sbjct: 156 --YVHRDLAARNILVNSNLVCKVSDFGLSRFL----EDDTSDPTYTSALGGKIPIRWTAP 209
Query: 617 E-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR- 673
           E  +   ++  SDV+S G+VM E+++ G +PY             W +     I+A+ + 
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-------------WDMTNQDVINAIEQD 256
Query: 674 -MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
             + P +D        S    ++  C Q +   RP   +IV  L  MI
Sbjct: 257 YRLPPPMDCP------SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 298

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 448 IGEGLLGSVYKAEL--PGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IG G  G V +  L  PG K   +A+K L    ++RQ   EFL  AS + +  H NI+ L
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASIMGQFEHPNIIRL 80
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G        +++ ++  N  L   L  ++    +F+    + +  G A  ++YL E+  
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLND---GQFTVIQLVGMLRGIASGMRYLAEMS- 136
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE----GLLTAHGSGAPEFE 619
              VH +  + NIL++  L+ +VSD GL+  L   S++        G +    +      
Sbjct: 137 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              ++  SD +S G+VM E+++ G +PY
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMSFGERPY 222

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 132/283 (46%), Gaps = 57/283 (20%)
Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI---SRLRH 497
           FS+   IG G  G+VY A ++   +++A+KK+S   S +Q++E++ ++   +    +LRH
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 498 GNIVELIG-YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIR-VALGAARAL 555
            N ++  G Y  EH   L++    G+ +  DLL    E HKK    + I  V  GA + L
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSAS--DLL----EVHKKPLQEVEIAAVTHGALQGL 128
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGSTNELSEGLLTA 610
            YL       ++H + K+ NILL E  +V++ D G A ++     F G+   ++  ++ A
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILA 185
Query: 611 HGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
                   + G Y  + DV+SLG+  +EL   + P                   L +++A
Sbjct: 186 -------MDEGQYDGKVDVWSLGITCIELAERKPP-------------------LFNMNA 219
Query: 671 LSRMV------DPSLDGAYLAKSLSRFADIISRCVQWEPGFRP 707
           +S +        P+L   + ++    F D    C+Q  P  RP
Sbjct: 220 MSALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRP 259

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 35/234 (14%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++ +Y     L + L +      ++S++I        
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--- 595
                +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  +   
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 596 --FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
             +  +TN    G L              Y+ QSDV+S GV+M E+ T G  PY
Sbjct: 257 DYYKKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 83  SEEPIYI-VTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 136
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H +  ++NIL+ E L+ +V+D GLA L+     NE +  +G        APE    G ++
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPY 216

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 52/304 (17%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++ +Y     L + L +      ++S++I        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--- 595
                +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  +   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 596 --FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR 652
             +  +TN    G L              Y+ QSDV+S GV+M E+ T G  PY      
Sbjct: 211 DYYKNTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP----- 261
Query: 653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
                    IP    ++ L +++         A   +    ++  C    P  RP   ++
Sbjct: 262 --------GIP----VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309
Query: 713 VQDL 716
           V+DL
Sbjct: 310 VEDL 313

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 52/304 (17%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++ +Y     L + L +      ++S++I        
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--- 595
                +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  +   
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLARDINNI 197
Query: 596 --FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR 652
             +  +TN    G L              Y+ QSDV+S GV+M E+ T G  PY      
Sbjct: 198 DYYKKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP----- 248
Query: 653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
                    IP    ++ L +++         A   +    ++  C    P  RP   ++
Sbjct: 249 --------GIP----VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 296
Query: 713 VQDL 716
           V+DL
Sbjct: 297 VEDL 300

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 124/284 (43%), Gaps = 45/284 (15%)
Query: 448 IGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG G  GSV K    P G+++AVK++ +TV +++  +  ++L   +       IV+  G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 507 CNEHGQHLLVYDYGGNCTL-HDLLHSDEEAHKKFSWN---------IRIRVALGAARALQ 556
               G          +C +  +L+ +  +   K+ ++         I  ++ L   +AL 
Sbjct: 90  LFREG----------DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL--LTAHGSG 614
           +L+E  +  I+H + K SNILLD    +++ D G++  L          G     A    
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 197
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI-DALSR 673
            P      Y  +SDV+SLG+ + EL TGR PY                P+ + + D L++
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPY----------------PKWNSVFDQLTQ 241
Query: 674 MVD---PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           +V    P L  +   +    F + ++ C+  +   RP   E+++
Sbjct: 242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 52/304 (17%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++ +Y     L + L +      ++S++I        
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--- 595
                +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  +   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 596 --FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR 652
             +  +TN    G L              Y+ QSDV+S GV+M E+ T G  PY      
Sbjct: 211 DYYKKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP----- 261
Query: 653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
                    IP    ++ L +++         A   +    ++  C    P  RP   ++
Sbjct: 262 --------GIP----VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309
Query: 713 VQDL 716
           V+DL
Sbjct: 310 VEDL 313

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 52/304 (17%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++ +Y     L + L +      ++S++I        
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--- 595
                +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  +   
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 199
Query: 596 --FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR 652
             +  +TN    G L              Y+ QSDV+S GV+M E+ T G  PY      
Sbjct: 200 DYYKKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP----- 250
Query: 653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
                    IP    ++ L +++         A   +    ++  C    P  RP   ++
Sbjct: 251 --------GIP----VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 298
Query: 713 VQDL 716
           V+DL
Sbjct: 299 VEDL 302

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 35/234 (14%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++ +Y     L + L +      ++S++I        
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--- 595
                +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  +   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 596 --FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
             +  +TN    G L              Y+ QSDV+S GV+M E+ T G  PY
Sbjct: 211 DYYKKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 52/304 (17%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++ +Y     L + L +      ++S++I        
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--- 595
                +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  +   
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 202
Query: 596 --FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR 652
             +  +TN    G L              Y+ QSDV+S GV+M E+ T G  PY      
Sbjct: 203 DYYKKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP----- 253
Query: 653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
                    IP    ++ L +++         A   +    ++  C    P  RP   ++
Sbjct: 254 --------GIP----VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 301
Query: 713 VQDL 716
           V+DL
Sbjct: 302 VEDL 305

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 100/230 (43%), Gaps = 27/230 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++ +Y     L + L +      ++S++I        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS- 597
                +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  + + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 598 GSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
               + + G L              Y+ QSDV+S GV+M E+ T G  PY
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +      T+E+  +L S 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEEDLSDLVSE 90
Query: 492 ISRLR----HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--- 544
           +  ++    H NI+ L+G C + G   ++ +Y     L + L +      ++S++I    
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 545 ---------IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL 594
                    +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 595 L-----FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           +     +  +TN    G L              Y+ QSDV+S GV+M E+ T G  PY
Sbjct: 207 INNIDYYKKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  +V+L    
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVV 249
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
           +E   ++ V +Y    +L D L    E  K       + +A   A  + Y++ +     V
Sbjct: 250 SEEPIYI-VTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERM---NYV 303
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEFE-SGSYS 624
           H + +++NIL+ E L+ +V+D GL  L+     NE +  +G        APE    G ++
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 360
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ EL T GR PY
Sbjct: 361 IKSDVWSFGILLTELTTKGRVPY 383

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 132/312 (42%), Gaps = 65/312 (20%)
Query: 445 GNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +GEG  G V KA         G   +AVK L    S  +   + L   + + ++ H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSEFNVLKQVNHP 86
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLL-----------------------HSDEEA 535
           ++++L G C++ G  LL+ +Y    +L   L                       H DE A
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 536 HK-----KFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG 590
                   F+W I        ++ +QYL E+    +VH +  + NIL+ E   +++SD G
Sbjct: 147 LTMGDLISFAWQI--------SQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFG 195
Query: 591 LAPLLF-SGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDR 648
           L+  ++   S  + S+G +              Y+ QSDV+S GV++ E++T G  PY  
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 649 SRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP 708
             P    +L++             RM  P       ++ + R   ++ +C + EP  RP 
Sbjct: 256 IPPERLFNLLKTG----------HRMERPD----NCSEEMYR---LMLQCWKQEPDKRPV 298
Query: 709 MSEIVQDLLCMI 720
            ++I +DL  M+
Sbjct: 299 FADISKDLEKMM 310

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 131/288 (45%), Gaps = 45/288 (15%)
Query: 448 IGEGLLGSVYKA--ELPGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IG G  G V     +LPG +   +A+K L +  +++Q   +FL  AS + +  H N++ L
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHPNVIHL 73
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    +++ ++  N +L   L  ++    +F+    + +  G A  ++YL ++  
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADM-- 128
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------AP 616
              VH    + NIL++  L+ +VSD GL+  L     ++ S+   T+   G       AP
Sbjct: 129 -NYVHRALAARNILVNSNLVCKVSDFGLSRFL----EDDTSDPTYTSALGGKIPIRWTAP 183
Query: 617 E-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR- 673
           E  +   ++  SDV+S G+VM E+++ G +PY             W +     I+A+ + 
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-------------WDMTNQDVINAIEQD 230
Query: 674 -MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
             + P +D        S    ++  C Q +   RP   +IV  L  MI
Sbjct: 231 YRLPPPMDCP------SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 132/312 (42%), Gaps = 65/312 (20%)
Query: 445 GNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +GEG  G V KA         G   +AVK L    S  +   + L   + + ++ H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSEFNVLKQVNHP 86
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLL-----------------------HSDEEA 535
           ++++L G C++ G  LL+ +Y    +L   L                       H DE A
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 536 HK-----KFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG 590
                   F+W I        ++ +QYL E+    +VH +  + NIL+ E   +++SD G
Sbjct: 147 LTMGDLISFAWQI--------SQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFG 195
Query: 591 LAPLLF-SGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDR 648
           L+  ++   S  + S+G +              Y+ QSDV+S GV++ E++T G  PY  
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 649 SRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP 708
             P    +L++             RM  P       ++ + R   ++ +C + EP  RP 
Sbjct: 256 IPPERLFNLLKTG----------HRMERPD----NCSEEMYR---LMLQCWKQEPDKRPV 298
Query: 709 MSEIVQDLLCMI 720
            ++I +DL  M+
Sbjct: 299 FADISKDLEKMM 310

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 122/304 (40%), Gaps = 52/304 (17%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++  Y     L + L +      ++S++I        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--- 595
                +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  +   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 596 --FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR 652
             +  +TN    G L              Y+ QSDV+S GV+M E+ T G  PY      
Sbjct: 211 DYYKKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP----- 261
Query: 653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
                    IP    ++ L +++         A   +    ++  C    P  RP   ++
Sbjct: 262 --------GIP----VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309
Query: 713 VQDL 716
           V+DL
Sbjct: 310 VEDL 313

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 132/312 (42%), Gaps = 65/312 (20%)
Query: 445 GNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +GEG  G V KA         G   +AVK L    S  +   + L   + + ++ H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSEFNVLKQVNHP 86
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLL-----------------------HSDEEA 535
           ++++L G C++ G  LL+ +Y    +L   L                       H DE A
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 536 HK-----KFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG 590
                   F+W I        ++ +QYL E+    +VH +  + NIL+ E   +++SD G
Sbjct: 147 LTMGDLISFAWQI--------SQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFG 195
Query: 591 LAPLLF-SGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDR 648
           L+  ++   S  + S+G +              Y+ QSDV+S GV++ E++T G  PY  
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 649 SRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP 708
             P    +L++             RM  P       ++ + R   ++ +C + EP  RP 
Sbjct: 256 IPPERLFNLLKTG----------HRMERPD----NCSEEMYR---LMLQCWKQEPDKRPV 298
Query: 709 MSEIVQDLLCMI 720
            ++I +DL  M+
Sbjct: 299 FADISKDLEKMM 310

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 446 NFIGEGLLGSVYKAEL--PGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
             IG G  G V    L  PG +   +A+K L    ++RQ   +FL  AS + +  H NI+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASIMGQFDHPNII 113
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
            L G        ++V +Y  N +L   L + +    +F+    + +  G    ++YL ++
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS--GSTNELSEGLLTAHGSGAPEFE 619
                VH +  + N+L+D  L+ +VSD GL+ +L     +    + G +    +      
Sbjct: 171 G---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIA 227
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++S  SDV+S GVVM E+L  G +PY
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 122/304 (40%), Gaps = 52/304 (17%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++  Y     L + L +      ++S++I        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--- 595
                +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  +   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 596 --FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR 652
             +  +TN    G L              Y+ QSDV+S GV+M E+ T G  PY      
Sbjct: 211 DYYKKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP----- 261
Query: 653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
                    IP    ++ L +++         A   +    ++  C    P  RP   ++
Sbjct: 262 --------GIP----VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309
Query: 713 VQDL 716
           V+DL
Sbjct: 310 VEDL 313

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ ++YL     
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKYL---AS 150
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ ++YL     
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKYL---AS 169
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPY 256

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ ++YL     
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKYL---AS 170
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPY 257

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 446 NFIGEGLLGSVYKAEL--PGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
             IG G  G V    L  PG +   +A+K L    ++RQ   +FL  AS + +  H NI+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASIMGQFDHPNII 113
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
            L G        ++V +Y  N +L   L + +    +F+    + +  G    ++YL ++
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS--GSTNELSEGLLTAHGSGAPEFE 619
                VH +  + N+L+D  L+ +VSD GL+ +L     +    + G +    +      
Sbjct: 171 G---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++S  SDV+S GVVM E+L  G +PY
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ ++YL     
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKYL---AS 143
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPY 230

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 27/230 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +  + G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------- 544
               +H NI+ L+G C + G   ++ +Y     L + L +      + S++I        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 545 -----IRVALGAARALQYL-QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS- 597
                +      AR ++YL  + C    +H +  + N+L+ E  +++++D GLA  + + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 598 GSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
               + + G L              Y+ QSDV+S GV+M E+ T G  PY
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ ++YL     
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKYL---AS 151
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ ++YL     
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKYL---AS 151
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ ++YL     
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKYL---AS 148
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPY 235

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ ++YL     
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKYL---AS 150
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 74  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 127
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H N +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 184
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 185 IKSDVWSFGILLTEIVTHGRIPY 207

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ ++YL     
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKYL---AS 149
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ ++YL     
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKYL---AS 146
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPY 233

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 33/228 (14%)
Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G           +AVK L +  +++   +   E+       +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C + G   ++ +Y     L + L + E    ++S+N              
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGS 599
           +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +     +  +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 600 TNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           TN    G L              Y+ QSDV+S GV++ E+ T G  PY
Sbjct: 210 TN----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V   +  G   +A+K +        +++EF+E A  +  L H  +V+L G C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     ++ +Y  N  L + L    E   +F     + +      A++YL+       +
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 127
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQS 627
           H +  + N L++++ +V+VSD GL+  +                 S         +S +S
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 628 DVYSLGVVMLELLT-GRKPYDR 648
           D+++ GV+M E+ + G+ PY+R
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYER 209

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V   +  G   +A+K +        +++EF+E A  +  L H  +V+L G C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     ++ +Y  N  L + L    E   +F     + +      A++YL+       +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQS 627
           H +  + N L++++ +V+VSD GL+  +                 S         +S +S
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 628 DVYSLGVVMLELLT-GRKPYDR 648
           D+++ GV+M E+ + G+ PY+R
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYER 224

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +GE   G VYK  L G       + +A+K L +  ++    EEF   A   +RL+H N+V
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVV 75
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLL-----HS-----DEEAHKKFSWNIRIRVALGA 551
            L+G   +     +++ Y  +  LH+ L     HS     D++   K +      V L A
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 552 --ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             A  ++YL       +VH +  + N+L+ +KL V++SD GL   +++    +L    L 
Sbjct: 136 QIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                APE    G +S  SD++S GVV+ E+ + G +PY
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V   +  G   +A+K +        +++EF+E A  +  L H  +V+L G C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     ++ +Y  N  L + L    E   +F     + +      A++YL+       +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQS 627
           H +  + N L++++ +V+VSD GL+  +                 S         +S +S
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 628 DVYSLGVVMLELLT-GRKPYDR 648
           D+++ GV+M E+ + G+ PY+R
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYER 224

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V   +  G   +A+K +        +++EF+E A  +  L H  +V+L G C
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     ++ +Y  N  L + L    E   +F     + +      A++YL+       +
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 126
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQS 627
           H +  + N L++++ +V+VSD GL+  +                 S         +S +S
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 628 DVYSLGVVMLELLT-GRKPYDR 648
           D+++ GV+M E+ + G+ PY+R
Sbjct: 187 DIWAFGVLMWEIYSLGKMPYER 208

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 25/224 (11%)
Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G           +AVK L +  +++   +   E+       +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C + G   ++ +Y     L + L +      +FS+N              
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-PLLFSGSTNEL 603
           +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +       + 
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 604 SEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           + G L              Y+ QSDV+S GV++ E+ T G  PY
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +GE   G VYK  L G       + +A+K L +  ++    EEF   A   +RL+H N+V
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVV 92
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLL-----HS-------DEEAHKKFSWNIRIRVAL 549
            L+G   +     +++ Y  +  LH+ L     HS       D            + +  
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             A  ++YL       +VH +  + N+L+ +KL V++SD GL   +++    +L    L 
Sbjct: 153 QIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                APE    G +S  SD++S GVV+ E+ + G +PY
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ +++L     
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKFL---AS 151
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V   +  G   +A+K +        +++EF+E A  +  L H  +V+L G C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     ++ +Y  N  L + L    E   +F     + +      A++YL+       +
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 127
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQS 627
           H +  + N L++++ +V+VSD GL+  +                 S         +S +S
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 628 DVYSLGVVMLELLT-GRKPYDR 648
           D+++ GV+M E+ + G+ PY+R
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYER 209

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V   +  G   +A+K +        +++EF+E A  +  L H  +V+L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     ++ +Y  N  L + L    E   +F     + +      A++YL+       +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQS 627
           H +  + N L++++ +V+VSD GL+  +                 S         +S +S
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 628 DVYSLGVVMLELLT-GRKPYDR 648
           D+++ GV+M E+ + G+ PY+R
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYER 204

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 448 IGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IG G  G V   + +LPG + L  A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIHL 88
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +Y  N +L   L  ++    +F+    + +  G +  ++YL ++  
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKND---GQFTVIQLVGMLRGISAGMKYLSDMG- 144
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------APE 617
              VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G        APE
Sbjct: 145 --YVHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKIPIRWTAPE 197
Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+VM E+++ G +PY
Sbjct: 198 AIAFRKFTSASDVWSYGIVMWEVVSYGERPY 228

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ +++L     
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKFL---AS 149
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS---GSTNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ +++L     
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKFL---AS 151
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS---GSTNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V   +  G   +A+K +        +++EF+E A  +  L H  +V+L G C
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     ++ +Y  N  L + L    E   +F     + +      A++YL+       +
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 133
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQS 627
           H +  + N L++++ +V+VSD GL+  +                 S         +S +S
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 628 DVYSLGVVMLELLT-GRKPYDR 648
           D+++ GV+M E+ + G+ PY+R
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYER 215

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ +++L     
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKFL---AS 156
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPY 243

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ +++L     
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKFL---AS 210
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPY 297

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+         +AVK L       Q    FLE A+ +  L+H  +V L    
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 77
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
                  ++ +Y    +L D L SDE    K      I  +   A  + Y++       +
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGG--KVLLPKLIDFSAQIAEGMAYIER---KNYI 132
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++N+L+ E L+ +++D GLA ++     NE +  EG        APE    G ++
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T G+ PY
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIPY 212

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ +++L     
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKFL---AS 152
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  ++     S +  +   L          ++
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPY 239

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 87  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 140
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIPY 220

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 88  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 141
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIPY 221

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 80  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 133
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFT 190
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 191 IKSDVWSFGILLTEIVTHGRIPY 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 84  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 137
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPY 217

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 78  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 83  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 136
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 194 IKSDVWSFGILLTEIVTHGRIPY 216

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 84  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 137
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPY 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 86  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 139
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 197 IKSDVWSFGILLTEIVTHGRIPY 219

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 448 IGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +Y  N +L   L   +    +F+    + +  G A  ++YL ++  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP------- 616
              VH +  + NIL++  L+ +VSD GLA +L      +  E   T  G   P       
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLARVL-----EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+V+ E+++ G +PY
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 79  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 132
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFT 189
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 190 IKSDVWSFGILLTEIVTHGRIPY 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 78  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+ A       +AVK +        + E FL  A+ +  L+H  +V+L    
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 79
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  ++    +L D L SDE + +     I     +    A      + +   +
Sbjct: 80  TKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF-----IEQRNYI 133
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+   L+ +++D GLA ++     NE +  EG        APE    GS++
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 625 CQSDVYSLGVVMLELLT-GRKPYD-RSRPRGEQSLVR-WAIPR 664
            +SDV+S G++++E++T GR PY   S P   ++L R + +PR
Sbjct: 191 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 233

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 78  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V   +  G   +AVK +        +++EF + A T+ +L H  +V+  G C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEG---SMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE---- 563
           ++     +V +Y  N  L + L S    H K          L  ++ L+   +VCE    
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRS----HGK---------GLEPSQLLEMCYDVCEGMAF 119
Query: 564 ---PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FE 619
                 +H +  + N L+D  L V+VSD G+   +        S G        APE F 
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFH 178
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
              YS +SDV++ G++M E+ + G+ PYD
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 73  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 126
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+ + L  +++D GLA L+     NE +  EG        APE    G+++
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +SDV+S G+++ E++T GR PY
Sbjct: 184 IKSDVWSFGILLTEIVTHGRIPY 206

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 33/228 (14%)
Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G           +AVK L +  +++   +   E+       +
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C + G   ++ +Y     L + L +      ++S+N              
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGS 599
           +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +     +  +
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 600 TNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           TN    G L              Y+ QSDV+S GV++ E+ T G  PY
Sbjct: 203 TN----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 246

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 33/228 (14%)
Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G           +AVK L +  +++   +   E+       +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C + G   ++ +Y     L + L +      ++S+N              
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGS 599
           +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +     +  +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 600 TNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           TN    G L              Y+ QSDV+S GV++ E+ T G  PY
Sbjct: 251 TN----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 448 IGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +Y  N +L   L   +    +F+    + +  G A  ++YL ++  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP------- 616
              VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G   P       
Sbjct: 168 --FVHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+V+ E+++ G +PY
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIG 505
           +GEG  G V  A     G+ +A+K ++  V  +   +  +E   +  RL RH +I++L  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 506 YCNEHGQHLLVYDYGGNCTLHDLLHSD---EEAHKKFSWNIRIRVALGAARALQYLQEVC 562
                 + ++V +Y GN     ++  D   E+  ++F   I          A++Y     
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQI--------ISAVEYCHR-- 121
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS 622
              IVH + K  N+LLDE L V+++D GL+ ++  G+  + S G   +    APE  SG 
Sbjct: 122 -HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVISGK 177
Query: 623 YSC--QSDVYSLGVVMLELLTGRKPYD 647
                + DV+S GV++  +L  R P+D
Sbjct: 178 LYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 33/228 (14%)
Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G           +AVK L +  +++   +   E+       +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C + G   ++ +Y     L + L +      ++S+N              
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGS 599
           +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +     +  +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 600 TNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           TN    G L              Y+ QSDV+S GV++ E+ T G  PY
Sbjct: 210 TN----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 33/228 (14%)
Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G           +AVK L +  +++   +   E+       +
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C + G   ++ +Y     L + L +      ++S+N              
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGS 599
           +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +     +  +
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 600 TNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           TN    G L              Y+ QSDV+S GV++ E+ T G  PY
Sbjct: 202 TN----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 245

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  +V L    
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  +Y  N +L D L +   +  K + N  + +A   A  + +++E      +
Sbjct: 78  TQEPIYIIT-EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQ 626
           H + +++NIL+ + L  +++D GLA L+   +     EG        APE    G+++ +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI-EDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 627 SDVYSLGVVMLELLT-GRKPY 646
           SDV+S G+++ E++T GR PY
Sbjct: 191 SDVWSFGILLTEIVTHGRIPY 211

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 33/228 (14%)
Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G           +AVK L +  +++   +   E+       +
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C + G   ++ +Y     L + L +      ++S+N              
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGS 599
           +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +     +  +
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 600 TNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           TN    G L              Y+ QSDV+S GV++ E+ T G  PY
Sbjct: 199 TN----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 242

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 119/274 (43%), Gaps = 25/274 (9%)
Query: 446 NFIGEGLLGSVYKAE-LPGGKLLAVK---KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
             +G G+ G+V+K   +P G+ + +    K+    S RQ+ +   +    I  L H +IV
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 502 ELIGYCNEHGQHL-LVYDYGGNCTLHDLLHSDEEA---HKKFSWNIRIRVALGAARALQY 557
            L+G C   G  L LV  Y    +L D +     A       +W ++I      A+ + Y
Sbjct: 97  RLLGLCP--GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYY 148
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL-SEGLLTAHGSGAP 616
           L+E     +VH N  + N+LL     V+V+D G+A LL       L SE           
Sbjct: 149 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSR----PRGEQSLVRWAIPRLHDIDAL 671
               G Y+ QSDV+S GV + EL+T G +PY   R    P   +   R A P++  ID  
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY 265
Query: 672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGF 705
             MV   +    +  +    A+  +R  +  P +
Sbjct: 266 MVMVKCWMIDENIRPTFKELANEFTRMARDPPRY 299

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIG 505
           +GEG  G V  A     G+ +A+K ++  V  +   +  +E   +  RL RH +I++L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 506 YCNEHGQHLLVYDYGGNCTLHDLLHSD---EEAHKKFSWNIRIRVALGAARALQYLQEVC 562
                 + ++V +Y GN     ++  D   E+  ++F   I          A++Y     
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQI--------ISAVEYCHR-- 131
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS 622
              IVH + K  N+LLDE L V+++D GL+ ++  G+  + S G   +    APE  SG 
Sbjct: 132 -HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVISGK 187
Query: 623 YSC--QSDVYSLGVVMLELLTGRKPYD 647
                + DV+S GV++  +L  R P+D
Sbjct: 188 LYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIG 505
           +GEG  G V  A     G+ +A+K ++  V  +   +  +E   +  RL RH +I++L  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 506 YCNEHGQHLLVYDYGGNCTLHDLLHSD---EEAHKKFSWNIRIRVALGAARALQYLQEVC 562
                 + ++V +Y GN     ++  D   E+  ++F   I          A++Y     
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQI--------ISAVEYCHR-- 125
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS 622
              IVH + K  N+LLDE L V+++D GL+ ++  G+  + S G   +    APE  SG 
Sbjct: 126 -HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVISGK 181
Query: 623 YSC--QSDVYSLGVVMLELLTGRKPYD 647
                + DV+S GV++  +L  R P+D
Sbjct: 182 LYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 14/207 (6%)
Query: 448 IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG G  G VY   L    G K+    K  N ++      +FL     +    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 505 GYC-NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           G C    G  L+V  Y  +  L + + +  E H     ++ I   L  A+ +++L     
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDL-IGFGLQVAKGMKFL---AS 152
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPEFES 620
              VH +  + N +LDEK  V+V+D GLA  +      S +  +   L          ++
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
             ++ +SDV+S GV++ EL+T G  PY
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPY 239

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIG 505
           +GEG  G V  A     G+ +A+K ++  V  +   +  +E   +  RL RH +I++L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 506 YCNEHGQHLLVYDYGGNCTLHDLLHSD---EEAHKKFSWNIRIRVALGAARALQYLQEVC 562
                 + ++V +Y GN     ++  D   E+  ++F   I          A++Y     
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQI--------ISAVEYCHR-- 130
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS 622
              IVH + K  N+LLDE L V+++D GL+ ++  G+  + S G   +    APE  SG 
Sbjct: 131 -HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAPEVISGK 186
Query: 623 YSC--QSDVYSLGVVMLELLTGRKPYD 647
                + DV+S GV++  +L  R P+D
Sbjct: 187 LYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 446 NFIGEGLLGSVYKA-ELPGGKLLAVK---KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
             +G G  G+VYK   +P G+ + +    K+ N  +  + + EF++ A  ++ + H ++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEE---AHKKFSWNIRIRVALGAARALQYL 558
            L+G C      L+       C L + +H  ++   +    +W ++I      A+ + YL
Sbjct: 104 RLLGVCLSPTIQLVTQLMPHGCLL-EYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 156
Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE--GLLTAHGSGAP 616
           +E     +VH +  + N+L+     V+++D GLA LL  G   E +   G +        
Sbjct: 157 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALE 212
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
                 ++ QSDV+S GV + EL+T G KPYD
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+ A       +AVK +        + E FL  A+ +  L+H  +V+L    
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  ++    +L D L SDE + +     I     +    A      + +   +
Sbjct: 253 TKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF-----IEQRNYI 306
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++NIL+   L+ +++D GLA ++     NE +  EG        APE    GS++
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 625 CQSDVYSLGVVMLELLT-GRKPY-DRSRPRGEQSLVR-WAIPR 664
            +SDV+S G++++E++T GR PY   S P   ++L R + +PR
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 406

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 448 IGEGLLGSVYKAEL--PGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IG G  G V    L  PG +   +A+K L    + +Q   +FL  AS + +  H NI+ L
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASIMGQFDHPNIIHL 95
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    +++ +Y  N +L   L  ++    +F+    + +  G    ++YL ++  
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKND---GRFTVIQLVGMLRGIGSGMKYLSDMSA 152
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------APE 617
              VH +  + NIL++  L+ +VSD G++ +L      +  E   T  G        APE
Sbjct: 153 ---VHRDLAARNILVNSNLVCKVSDFGMSRVL-----EDDPEAAYTTRGGKIPIRWTAPE 204
Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+VM E+++ G +PY
Sbjct: 205 AIAYRKFTSASDVWSYGIVMWEVMSYGERPY 235

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 119/274 (43%), Gaps = 25/274 (9%)
Query: 446 NFIGEGLLGSVYK-AELPGGKLLAVK---KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
             +G G+ G+V+K   +P G+ + +    K+    S RQ+ +   +    I  L H +IV
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 502 ELIGYCNEHGQHL-LVYDYGGNCTLHDLLHSDEEA---HKKFSWNIRIRVALGAARALQY 557
            L+G C   G  L LV  Y    +L D +     A       +W ++I      A+ + Y
Sbjct: 79  RLLGLCP--GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYY 130
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL-SEGLLTAHGSGAP 616
           L+E     +VH N  + N+LL     V+V+D G+A LL       L SE           
Sbjct: 131 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSR----PRGEQSLVRWAIPRLHDIDAL 671
               G Y+ QSDV+S GV + EL+T G +PY   R    P   +   R A P++  ID  
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY 247
Query: 672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGF 705
             MV   +    +  +    A+  +R  +  P +
Sbjct: 248 MVMVKCWMIDENIRPTFKELANEFTRMARDPPRY 281

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 446 NFIGEGLLGSVYKA-ELPGGKLLAVK---KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
             +G G  G+VYK   +P G+ + +    K+ N  +  + + EF++ A  ++ + H ++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEE---AHKKFSWNIRIRVALGAARALQYL 558
            L+G C      L+       C L + +H  ++   +    +W ++I      A+ + YL
Sbjct: 81  RLLGVCLSPTIQLVTQLMPHGCLL-EYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 133
Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE--GLLTAHGSGAP 616
           +E     +VH +  + N+L+     V+++D GLA LL  G   E +   G +        
Sbjct: 134 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALE 189
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
                 ++ QSDV+S GV + EL+T G KPYD
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 448 IGEGLLGSVYKAELPGGKL----LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           IG+G  G VY  E           A+K LS  +++ Q  E FL     +  L H N++ L
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 504 IGYC--NEHGQHLLV-YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           IG     E   H+L+ Y   G     DLL       +  +    I   L  AR ++YL  
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHG-----DLLQFIRSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSGAPE 617
             E   VH +  + N +LDE   V+V+D GLA  +      S  +     L    +    
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 618 FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRP 651
            ++  ++ +SDV+S GV++ ELLT G  PY    P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 440 NSFSEGNFIGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRL 495
            + S    +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + + 
Sbjct: 33  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 91
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            H NI+ L G   +    ++V +Y  N +L   L   +    +F+    + +  G A  +
Sbjct: 92  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGM 148
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +YL ++     VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G   
Sbjct: 149 KYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKI 200
Query: 616 P-------EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           P             ++  SDV+S G+V+ E+++ G +PY
Sbjct: 201 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 239

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 448 IGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +Y  N +L   L   +    +F+    + +  G A  ++YL ++  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP------- 616
              VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G   P       
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+V+ E+++ G +PY
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 440 NSFSEGNFIGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRL 495
            + S    +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + + 
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 74
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            H NI+ L G   +    ++V +Y  N +L   L   +    +F+    + +  G A  +
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGM 131
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +YL ++     VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G   
Sbjct: 132 KYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKI 183
Query: 616 P-------EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           P             ++  SDV+S G+V+ E+++ G +PY
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 110/270 (40%), Gaps = 21/270 (7%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V K   +P G++ AVK++  TV+ ++      +L  +   +     V   G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
               G   +  +   + +L        +  +    +I  ++A+   +AL++L       +
Sbjct: 102 LFREGDVWICXELX-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 158
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL--LTAHGSGAPEFESGSYS 624
           +H + K SN+L++    V+  D G++  L      ++  G     A     PE     YS
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYS 218
Query: 625 CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
            +SD++SLG+  +EL   R PYD            W  P       L ++V+        
Sbjct: 219 VKSDIWSLGITXIELAILRFPYD-----------SWGTP----FQQLKQVVEEPSPQLPA 263
Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            K  + F D  S+C++     RP   E+ Q
Sbjct: 264 DKFSAEFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 440 NSFSEGNFIGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRL 495
            + S    +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + + 
Sbjct: 43  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 101
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            H NI+ L G   +    ++V +Y  N +L   L   +    +F+    + +  G A  +
Sbjct: 102 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGM 158
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +YL ++     VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G   
Sbjct: 159 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKI 210
Query: 616 P-------EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           P             ++  SDV+S G+V+ E+++ G +PY
Sbjct: 211 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 249

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 448 IGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +Y  N +L   L   +    +F+    + +  G A  ++YL ++  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP------- 616
              VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G   P       
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+V+ E+++ G +PY
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 448 IGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +Y  N +L   L   +    +F+    + +  G A  ++YL ++  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP------- 616
              VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G   P       
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+V+ E+++ G +PY
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 448 IGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +Y  N +L   L   +    +F+    + +  G A  ++YL ++  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP------- 616
              VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G   P       
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+V+ E+++ G +PY
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 448 IGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +Y  N +L   L   +    +F+    + +  G A  ++YL ++  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP------- 616
              VH +  + NIL++  L+ +VSD GL  +L      +  E   T  G   P       
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLGRVL-----EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+V+ E+++ G +PY
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 18/219 (8%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
           Q   N       +G G  G V+K      G ++AVK++  + ++ +     ++L   +  
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS 80
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRV----ALG 550
                IV+  G    +    +  +  G C         E+  K+    I  R+     + 
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELMGTCA--------EKLKKRMQGPIPERILGKMTVA 132
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG---L 607
             +AL YL+E  +  ++H + K SNILLDE+  +++ D G++  L      + S G    
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAY 190
Query: 608 LTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           +       P+     Y  ++DV+SLG+ ++EL TG+ PY
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 46/234 (19%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           IGEG  G V++A  PG        ++AVK L    S      +F   A+ ++   + NIV
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDNPNIV 113
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEE------AHKKFSWNIRIR--------- 546
           +L+G C       L+++Y     L++ L S         +H   S   R+          
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 547 -----VALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN 601
                +A   A  + YL E      VH +  + N L+ E ++V+++D GL       S N
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL-------SRN 223
Query: 602 ELSEGLLTAHGSGA-------PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
             S     A G+ A       PE      Y+ +SDV++ GVV+ E+ + G +PY
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 446 NFIGEGLLGSVYKAEL--PGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
             IG G  G V    L  PG +   +A+K L    + +Q   +FL  AS + +  H NI+
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASIMGQFDHPNII 72
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
            L G   +    +++ +Y  N +L   L  ++    +F+    + +  G    ++YL ++
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKND---GRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------A 615
                VH +  + NIL++  L+ +VSD G++ +L      +  E   T  G        A
Sbjct: 130 ---SYVHRDLAARNILVNSNLVCKVSDFGMSRVL-----EDDPEAAYTTRGGKIPIRWTA 181
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE      ++  SDV+S G+VM E+++ G +PY
Sbjct: 182 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 214

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 446 NFIGEGLLGSVYKAEL--PGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
             IG G  G V    L  PG +   +A+K L    + +Q   +FL  AS + +  H NI+
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASIMGQFDHPNII 78
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
            L G   +    +++ +Y  N +L   L  ++    +F+    + +  G    ++YL ++
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKND---GRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------A 615
                VH +  + NIL++  L+ +VSD G++ +L      +  E   T  G        A
Sbjct: 136 ---SYVHRDLAARNILVNSNLVCKVSDFGMSRVL-----EDDPEAAYTTRGGKIPIRWTA 187
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE      ++  SDV+S G+VM E+++ G +PY
Sbjct: 188 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 220

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 77
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L++      C L  +    +    ++  N  +++A G    
Sbjct: 78  VDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 133
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 134 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 74
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L++      C L  +    +    ++  N  +++A G    
Sbjct: 75  VDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 130
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 131 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 76
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L++      C L  +    +    ++  N  +++A G    
Sbjct: 77  VDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 132
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 133 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 73
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L++      C L  +    +    ++  N  +++A G    
Sbjct: 74  VDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 129
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 75
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L++      C L  +    +    ++  N  +++A G    
Sbjct: 76  VDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 131
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 132 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 33/228 (14%)
Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G           +AVK L +  +++   +   E+       +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C + G   ++ +Y     L + L +      ++ +N              
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGS 599
           +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +     +  +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 600 TNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           TN    G L              Y+ QSDV+S GV++ E+ T G  PY
Sbjct: 210 TN----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 83
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 84  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 139
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 140 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 76
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 77  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 132
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 133 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 80
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 81  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 136
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 137 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 33/228 (14%)
Query: 445 GNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           G  +GEG  G V  AE  G           +AVK L +  +++   +   E+       +
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C + G   ++ +Y     L + L +      ++ +N              
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-----FSGS 599
           +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +     +  +
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 600 TNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           TN    G L              Y+ QSDV+S GV++ E+ T G  PY
Sbjct: 195 TN----GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 67
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 68  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 123
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 76
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 77  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 132
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 133 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 73
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 74  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 129
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE-GLLTAHGS 613
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +E G +     
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 614 GAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
                    Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 75
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 76  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 131
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 132 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 73
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 74  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 129
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 98
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 99  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 154
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 155 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 76
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 77  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 132
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 133 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 448 IGEGLLGSVY--KAELPGGKLLAVK----KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           IG G  G V   + +LPG + +AV     K+  T  QR+   +FL  AS + +  H N+V
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRR---DFLCEASIMGQFDHPNVV 107
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
            L G        ++V ++  N  L   L   +    +F+    + +  G A  ++YL ++
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHD---GQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------A 615
                VH +  + NIL++  L+ +VSD GL+ ++      +  E + T  G        A
Sbjct: 165 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVI-----EDDPEAVYTTTGGKIPVRWTA 216
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE  +   ++  SDV+S G+VM E+++ G +PY
Sbjct: 217 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 249

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 79
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 80  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 135
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 136 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 193 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+         +AVK L       Q    FLE A+ +  L+H  +V L    
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 76
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +     ++ ++    +L D L SDE    K      I  +   A  + Y++       +
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGG--KVLLPKLIDFSAQIAEGMAYIER---KNYI 131
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPE-FESGSYS 624
           H + +++N+L+ E L+ +++D GLA ++     NE +  EG        APE    G ++
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 625 CQSDVYSLGVVMLELLT-GRKPY 646
            +S+V+S G+++ E++T G+ PY
Sbjct: 189 IKSNVWSFGILLYEIVTYGKIPY 211

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 70
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 71  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEG---- 126
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 127 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 448 IGEGLLG-SVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IGEG  G ++       G+   +K+++ +    +  EE     + ++ ++H NIV+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDE----EAHKKFSWNIRIRVALGAARALQYLQEVC 562
             E+G   +V DY     L   +++ +    +  +   W ++I +AL         + V 
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL---------KHVH 142
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF-ESG 621
           +  I+H + KS NI L +   V++ D G+A +L   ST EL+   +      +PE  E+ 
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICENK 200
Query: 622 SYSCQSDVYSLGVVMLELLTGRKPYD 647
            Y+ +SD+++LG V+ EL T +  ++
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           G  +G+G  G   K      G+++ +K+L       +T   FL+    +  L H N+++ 
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           IG   +  +   + +Y    TL  ++ S +    ++ W+ R+  A   A  + YL  +  
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG--------- 614
             I+H +  S N L+ E   V V+D GLA L+    T    EGL +              
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ--PEGLRSLKKPDRKKRYTVVG 184
Query: 615 -----APEFESG-SYSCQSDVYSLGVVMLELL 640
                APE  +G SY  + DV+S G+V+ E++
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 445 GNFIGEGLLGSVYKAELP---GGKL-LAVK--KLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +GEG  GSV +  L    G  L +AVK  KL N+ SQR+  EEFL  A+ +    H 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREI-EEFLSEAACMKDFSHP 96
Query: 499 NIVELIGYCNEHGQH-----LLVYDYGGNCTLHD-LLHSD-EEAHKKFSWNIRIRVALGA 551
           N++ L+G C E         +++  +     LH  LL+S  E   K       ++  +  
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           A  ++YL        +H +  + N +L + + V V+D GL+  ++SG  +   +G +   
Sbjct: 157 ALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG--DYYRQGRIAKM 211
Query: 612 GSGAPEFESGS---YSCQSDVYSLGVVMLELLT-GRKPY 646
                  ES +   Y+ +SDV++ GV M E+ T G  PY
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 77
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L++      C L  +    +    ++  N  +++A G    
Sbjct: 78  VDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 133
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D G A LL +      +EG        
Sbjct: 134 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 75
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L++      C L  +    +    ++  N  +++A G    
Sbjct: 76  VDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 131
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D G A LL +      +EG        
Sbjct: 132 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 448 IGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +   N +L   L   +    +F+    + +  G A  ++YL ++  
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMGA 168
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP------- 616
              VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G   P       
Sbjct: 169 ---VHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+V+ E+++ G +PY
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 75
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L++      C L  +    +    ++  N  +++A G    
Sbjct: 76  VDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 131
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D G A LL +      +EG        
Sbjct: 132 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +  G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 80
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L++      C L  +    +    ++  N  +++A G    
Sbjct: 81  VDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 136
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 137 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 440 NSFSEGNFIGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRL 495
            + S    +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + + 
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQF 74
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            H NI+ L G   +    ++V +   N +L   L   +    +F+    + +  G A  +
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGM 131
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +YL ++     VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G   
Sbjct: 132 KYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKI 183
Query: 616 P-------EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           P             ++  SDV+S G+V+ E+++ G +PY
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 448 IGEGLLGSVY--KAELPGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V   + +LP  K +  A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111
Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +   N +L   L   +    +F+    + +  G A  ++YL ++  
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP------- 616
              VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G   P       
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 617 EFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                 ++  SDV+S G+V+ E+++ G +PY
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 445 GNFIGEGLLGSVYKA-----ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           G  IGEG  G V++      E P   + A+K   N  S     E+FL+ A T+ +  H +
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSD-SVREKFLQEALTMRQFDHPH 72
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQY 557
           IV+LIG   E+     V+     CTL +L    +   +KFS ++   I  A   + AL Y
Sbjct: 73  IVKLIGVITENP----VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 126
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L+       VH +  + N+L+     V++ D GL+  +   +  + S+G L         
Sbjct: 127 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPES 183
Query: 618 FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                ++  SDV+  GV M E+L  G KP+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 80
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 81  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 136
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D G A LL +      +EG        
Sbjct: 137 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 75
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 76  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 131
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D G A LL +      +EG        
Sbjct: 132 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 73
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 74  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 129
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D G A LL +      +EG        
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +  G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 73
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 74  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 129
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE-GLLTAHGS 613
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +E G +     
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 614 GAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
                    Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 31/229 (13%)
Query: 437 QYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTD-EEFLELAST--- 491
           +Y + F E   +G+G  G V KA      +  A+KK+ +T  +  T   E + LAS    
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 492 -ISR-----LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRI 545
            + R     L   N V+ +    +     +  +Y  N TL+DL+HS+    ++  +    
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL---------- 595
           R  L A      L  +    I+H + K  NI +DE   V++ D GLA  +          
Sbjct: 123 RQILEA------LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 596 ---FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELL 640
                GS++ L+  + TA        + +G Y+ + D+YSLG++  E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+ +L    S +  ++E L+ A  ++ 
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPK-ANKEILDEAYVMAS 107
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 108 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 163
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE-GLLTAHGS 613
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +E G +     
Sbjct: 164 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 220
Query: 614 GAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
                    Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 221 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +  G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 80
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+       C L  +    +    ++  N  +++A G    
Sbjct: 81  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG---- 136
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 137 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 31/229 (13%)
Query: 437 QYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTD-EEFLELAST--- 491
           +Y + F E   +G+G  G V KA      +  A+KK+ +T  +  T   E + LAS    
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 492 ------ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRI 545
                  + L   N V+ +    +     +  +Y  N TL+DL+HS+    ++  +    
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL---------- 595
           R  L A      L  +    I+H + K  NI +DE   V++ D GLA  +          
Sbjct: 123 RQILEA------LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 596 ---FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELL 640
                GS++ L+  + TA        + +G Y+ + D+YSLG++  E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 448 IGEGLLGSVYKAE----LP--GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +GEG  G V+ AE    LP     L+AVK L       + D  F   A  ++ L+H +IV
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTMLQHQHIV 83
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS-----------DEEAHKKFSWNIRIRVALG 550
              G C E    L+V++Y  +  L+  L S           ++ A         + VA  
Sbjct: 84  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
            A  + YL  +     VH +  + N L+ + L+V++ D G++  ++S     +    +  
Sbjct: 144 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 200
Query: 611 HGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                PE      ++ +SDV+S GVV+ E+ T G++P+
Sbjct: 201 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 238

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 110/225 (48%), Gaps = 19/225 (8%)
Query: 430 FTIASLQQYTNSFSEGNFIGEGLLGSVY--KAELPGGKLLAVKKLSNTVSQRQTDEE-FL 486
           F   S   +++ +     +G+G  G V   K ++ G +  AVK +S    +++TD+E  L
Sbjct: 22  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDKESLL 80
Query: 487 ELASTISRLRHGNIVELIGYCNEHGQHLLVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRI 545
                + +L H NI++L  +  + G   LV + Y G     +++     + K+FS     
Sbjct: 81  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAA 135
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI---VRVSDCGLAPLLFSGSTNE 602
           R+       + Y+ +     IVH + K  N+LL+ K     +R+ D GL+      ++ +
Sbjct: 136 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKK 190
Query: 603 LSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
           + + + TA+   APE   G+Y  + DV+S GV++  LL+G  P++
Sbjct: 191 MKDKIGTAYYI-APEVLHGTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 448 IGEGLLGSVYKAE----LP--GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +GEG  G V+ AE    LP     L+AVK L       + D  F   A  ++ L+H +IV
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTMLQHQHIV 77
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS-----------DEEAHKKFSWNIRIRVALG 550
              G C E    L+V++Y  +  L+  L S           ++ A         + VA  
Sbjct: 78  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
            A  + YL  +     VH +  + N L+ + L+V++ D G++  ++S     +    +  
Sbjct: 138 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 194
Query: 611 HGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                PE      ++ +SDV+S GVV+ E+ T G++P+
Sbjct: 195 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 232

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 23/226 (10%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTV-----SQRQTDEEFLELASTISRLRHGNIVE 502
           +G G + +VY AE     +L +K     +      + +T + F       S+L H NIV 
Sbjct: 19  LGGGGMSTVYLAE---DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           +I    E   + LV +Y    TL + +    E+H   S +  I       + L  ++   
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFT---NQILDGIKHAH 128
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS 622
           +  IVH + K  NIL+D    +++ D G+A  L   S  + +  L T     +PE   G 
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ-YFSPEQAKGE 187
Query: 623 YSCQ-SDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD 667
            + + +D+YS+G+V+ E+L G  P++     GE + V  AI  + D
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFN-----GETA-VSIAIKHIQD 227

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +GEG  G V+ AE           L+AVK L +     + D  F   A  ++ L+H +IV
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--FHREAELLTNLQHEHIV 78
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLH---------SDEEAHKKFSWNIRIRVALGAA 552
           +  G C E    ++V++Y  +  L+  L          ++     + + +  + +A   A
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + YL        VH +  + N L+ E L+V++ D G++  ++S     +    +    
Sbjct: 139 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              PE      ++ +SDV+SLGVV+ E+ T G++P+
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 231

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 121/287 (42%), Gaps = 26/287 (9%)
Query: 440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           + +     IG G    V  A   P  + +A+K+++    Q   DE   E+ + +S+  H 
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQA-MSQCHHP 68
Query: 499 NIVEL-IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
           NIV     +  +    L++    G   L  + H   +   K        +A      L+ 
Sbjct: 69  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSG 614
           L+ + +   +H + K+ NILL E   V+++D G++  L +G   + N++ +  +      
Sbjct: 129 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 615 APEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
           APE   +   Y  ++D++S G+  +EL TG  PY +  P     L     P         
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP--------- 239
Query: 673 RMVDPSL-----DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
               PSL     D   L K    F  +IS C+Q +P  RP  +E+++
Sbjct: 240 ----PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 282

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 445 GNFIGEGLLGSVYKA-----ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           G  IGEG  G V++      E P   + A+K   N  S     E+FL+ A T+ +  H +
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSD-SVREKFLQEALTMRQFDHPH 72
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQY 557
           IV+LIG   E+     V+     CTL +L    +   +KFS ++   I  A   + AL Y
Sbjct: 73  IVKLIGVITENP----VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 126
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L+       VH +  + N+L+     V++ D GL+  +   +  + S+G L         
Sbjct: 127 LES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 618 FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                ++  SDV+  GV M E+L  G KP+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 110/225 (48%), Gaps = 19/225 (8%)
Query: 430 FTIASLQQYTNSFSEGNFIGEGLLGSVY--KAELPGGKLLAVKKLSNTVSQRQTDEE-FL 486
           F   S   +++ +     +G+G  G V   K ++ G +  AVK +S    +++TD+E  L
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDKESLL 74
Query: 487 ELASTISRLRHGNIVELIGYCNEHGQHLLVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRI 545
                + +L H NI++L  +  + G   LV + Y G     +++     + K+FS     
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAA 129
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI---VRVSDCGLAPLLFSGSTNE 602
           R+       + Y+ +     IVH + K  N+LL+ K     +R+ D GL+      ++ +
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKK 184
Query: 603 LSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
           + + + TA+   APE   G+Y  + DV+S GV++  LL+G  P++
Sbjct: 185 MKDKIGTAYYI-APEVLHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 448 IGEGLLGSVYKAE----LP--GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +GEG  G V+ AE    LP     L+AVK L       + D  F   A  ++ L+H +IV
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTMLQHQHIV 106
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS-----------DEEAHKKFSWNIRIRVALG 550
              G C E    L+V++Y  +  L+  L S           ++ A         + VA  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
            A  + YL  +     VH +  + N L+ + L+V++ D G++  ++S     +    +  
Sbjct: 167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 611 HGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                PE      ++ +SDV+S GVV+ E+ T G++P+
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 121/287 (42%), Gaps = 26/287 (9%)
Query: 440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           + +     IG G    V  A   P  + +A+K+++    Q   DE   E+ + +S+  H 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQA-MSQCHHP 73
Query: 499 NIVEL-IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
           NIV     +  +    L++    G   L  + H   +   K        +A      L+ 
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSG 614
           L+ + +   +H + K+ NILL E   V+++D G++  L +G   + N++ +  +      
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 615 APEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
           APE   +   Y  ++D++S G+  +EL TG  PY +  P     L     P         
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP--------- 244
Query: 673 RMVDPSL-----DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
               PSL     D   L K    F  +IS C+Q +P  RP  +E+++
Sbjct: 245 ----PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+ A       +AVK +        + E FL  A+ +  L+H  +V+L    
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 246
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            +   +++  ++    +L D L SDE + +     I     +    A      + +   +
Sbjct: 247 TKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF-----IEQRNYI 300
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQ 626
           H + +++NIL+   L+ +++D GLA +           G        APE    GS++ +
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARV-----------GAKFPIKWTAPEAINFGSFTIK 349
Query: 627 SDVYSLGVVMLELLT-GRKPY-DRSRPRGEQSLVR-WAIPR 664
           SDV+S G++++E++T GR PY   S P   ++L R + +PR
Sbjct: 350 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 390

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 110/225 (48%), Gaps = 19/225 (8%)
Query: 430 FTIASLQQYTNSFSEGNFIGEGLLGSVY--KAELPGGKLLAVKKLSNTVSQRQTDEE-FL 486
           F   S   +++ +     +G+G  G V   K ++ G +  AVK +S    +++TD+E  L
Sbjct: 39  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDKESLL 97
Query: 487 ELASTISRLRHGNIVELIGYCNEHGQHLLVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRI 545
                + +L H NI++L  +  + G   LV + Y G     +++     + K+FS     
Sbjct: 98  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAA 152
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK---LIVRVSDCGLAPLLFSGSTNE 602
           R+       + Y+ +     IVH + K  N+LL+ K     +R+ D GL+      ++ +
Sbjct: 153 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKK 207
Query: 603 LSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
           + + + TA+   APE   G+Y  + DV+S GV++  LL+G  P++
Sbjct: 208 MKDKIGTAYYI-APEVLHGTYDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 110/225 (48%), Gaps = 19/225 (8%)
Query: 430 FTIASLQQYTNSFSEGNFIGEGLLGSVY--KAELPGGKLLAVKKLSNTVSQRQTDEE-FL 486
           F   S   +++ +     +G+G  G V   K ++ G +  AVK +S    +++TD+E  L
Sbjct: 40  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDKESLL 98
Query: 487 ELASTISRLRHGNIVELIGYCNEHGQHLLVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRI 545
                + +L H NI++L  +  + G   LV + Y G     +++     + K+FS     
Sbjct: 99  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAA 153
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI---VRVSDCGLAPLLFSGSTNE 602
           R+       + Y+ +     IVH + K  N+LL+ K     +R+ D GL+      ++ +
Sbjct: 154 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKK 208
Query: 603 LSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
           + + + TA+   APE   G+Y  + DV+S GV++  LL+G  P++
Sbjct: 209 MKDKIGTAYYI-APEVLHGTYDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 33/230 (14%)
Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           T A  Q +  ++     IG+G    V  A  +  GK +AVK +  T     + ++     
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV 64
Query: 490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIR 544
             +  L H NIV+L           LV +Y     + D L       ++EA  KF   + 
Sbjct: 65  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
                    A+QY  +     IVH + K+ N+LLD  + ++++D G         +NE +
Sbjct: 125 ---------AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGF--------SNEFT 164
Query: 605 EG--LLTAHGS---GAPE-FESGSYSC-QSDVYSLGVVMLELLTGRKPYD 647
            G  L T  GS    APE F+   Y   + DV+SLGV++  L++G  P+D
Sbjct: 165 FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 17/221 (7%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP--GGKLL--AVKKLSNTVSQRQTDEEFLELASTISRL 495
             F+ G  +G+G  GSV +A+L    G  +  AVK L   +      EEFL  A+ +   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 496 RHGNIVELIGYCNEHGQH------LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRV 547
            H ++ +L+G              +++  +  +  LH  L +       F+  ++  +R 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 548 ALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS-TNELSEG 606
            +  A  ++YL        +H +  + N +L E + V V+D GL+  ++SG    +    
Sbjct: 143 MVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 607 LLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
            L              Y+  SDV++ GV M E++T G+ PY
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 33/230 (14%)
Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           T A  Q +  ++     IG+G    V  A  +  GK +AVK +  T     + ++     
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV 64
Query: 490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIR 544
             +  L H NIV+L           LV +Y     + D L       ++EA  KF   + 
Sbjct: 65  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
                    A+QY  +     IVH + K+ N+LLD  + ++++D G         +NE +
Sbjct: 125 ---------AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGF--------SNEFT 164
Query: 605 EG--LLTAHGS---GAPE-FESGSYSC-QSDVYSLGVVMLELLTGRKPYD 647
            G  L T  GS    APE F+   Y   + DV+SLGV++  L++G  P+D
Sbjct: 165 FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 437 QYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR- 494
           +Y + F E   +G+G  G V KA      +  A+KK+ +T  +  T    + L ++++  
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQ 62
Query: 495 ---------LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRI 545
                    L   N V+      +     +  +Y  N TL+DL+HS+    ++  +    
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL---------- 595
           R  L A      L  +    I+H N K  NI +DE   V++ D GLA  +          
Sbjct: 123 RQILEA------LSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 596 ---FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELL 640
                GS++ L+  + TA        + +G Y+ + D YSLG++  E +
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 25/225 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           N     + IGEG  G V KA +    L    A+K++    S+    +   EL        
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C   G   L  +Y  +  L D L          ++ I             
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
           +  A   AR + YL    +   +H N  + NIL+ E  + +++D GL+     G    + 
Sbjct: 142 LHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLS----RGQEVYVK 194
Query: 605 E--GLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           +  G L              Y+  SDV+S GV++ E+++ G  PY
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 23/225 (10%)
Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           T A  Q +  ++     IG+G    V  A  +  GK +AVK +  T     + ++     
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV 64
Query: 490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIR 544
             +  L H NIV+L           LV +Y     + D L       ++EA  KF   + 
Sbjct: 65  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
                    A+QY  +     IVH + K+ N+LLD  + ++++D G +     G  N+L 
Sbjct: 125 ---------AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKL- 169
Query: 605 EGLLTAHGSGAPE-FESGSYSC-QSDVYSLGVVMLELLTGRKPYD 647
           +    A    APE F+   Y   + DV+SLGV++  L++G  P+D
Sbjct: 170 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 33/213 (15%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG+G    V  A  +  GK +AVK +  T     + ++       +  L H NIV+L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 507 CNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
                   LV +Y     + D L       ++EA  KF              A+QY  + 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR---------QIVSAVQYCHQK 125
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG--LLTAHGS---GAP 616
               IVH + K+ N+LLD  + ++++D G         +NE + G  L T  GS    AP
Sbjct: 126 F---IVHRDLKAENLLLDADMNIKIADFGF--------SNEFTFGNKLDTFCGSPPYAAP 174
Query: 617 E-FESGSYSC-QSDVYSLGVVMLELLTGRKPYD 647
           E F+   Y   + DV+SLGV++  L++G  P+D
Sbjct: 175 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 437 QYTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL 495
           ++  +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            H NIV+L+   +   +  LV+++         LH D +     S    I + L  +   
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 117
Query: 556 QYLQ--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           Q LQ    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T   
Sbjct: 118 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-W 175
Query: 613 SGAPEFESGS--YSCQSDVYSLGVVMLELLTGR 643
             APE   G   YS   D++SLG +  E++T R
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 74
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L++        L  +    +    ++  N  +++A G    
Sbjct: 75  VDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKG---- 130
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 131 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 4/164 (2%)
Query: 73  VTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPV--TVRNFSLSGNQLT 130
           + E+ L      G +  TL +   ++++ LS N++ G+IPS+L     +R+  L  N L 
Sbjct: 393 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 452
Query: 131 GSIPEXXXXXXXXXXXXXXXXXXXGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSS 190
           G IP+                   G IP      T L    LS N LTG++P     L +
Sbjct: 453 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 512
Query: 191 LYSLHLQNNKLSGTLNV-LEDLH-LIDLNIENNLFSGPIPEKLL 232
           L  L L NN  SG +   L D   LI L++  NLF+G IP  + 
Sbjct: 513 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 556

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 101/261 (38%), Gaps = 44/261 (16%)
Query: 102 LSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPEXXXXXXXXXXXXXXXXXXXGGIPD 159
           L NN   G IP  L     + +  LS N L+G+IP                    G IP 
Sbjct: 398 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 457
Query: 160 AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL----NVLEDLHLID 215
                  L    L  N+LTG++P    N ++L  + L NN+L+G +      LE+L ++ 
Sbjct: 458 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 517
Query: 216 LNIENNLFSGPIPEKL---LSIPNFRKDGNPFNTTVXXXXXXXXXXXXXXXXTFQAPGDQ 272
           L   NN FSG IP +L    S+     + N FN T+                        
Sbjct: 518 L--SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI------------------------ 551
Query: 273 ADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAILCALGCSLFMWRYCKTRRVNRDAEKN 332
              P+A    +   A  F   KR +++        C    +L  ++  ++ ++NR + +N
Sbjct: 552 ---PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 608
Query: 333 -----TGTYKGHGEKPNYKNS 348
                +  Y GH   P + N+
Sbjct: 609 PCNITSRVYGGH-TSPTFDNN 628

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 4/164 (2%)
Query: 73  VTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPV--TVRNFSLSGNQLT 130
           + E+ L      G +  TL +   ++++ LS N++ G+IPS+L     +R+  L  N L 
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 131 GSIPEXXXXXXXXXXXXXXXXXXXGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSS 190
           G IP+                   G IP      T L    LS N LTG++P     L +
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
Query: 191 LYSLHLQNNKLSGTLNV-LEDLH-LIDLNIENNLFSGPIPEKLL 232
           L  L L NN  SG +   L D   LI L++  NLF+G IP  + 
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 559

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 101/261 (38%), Gaps = 44/261 (16%)
Query: 102 LSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPEXXXXXXXXXXXXXXXXXXXGGIPD 159
           L NN   G IP  L     + +  LS N L+G+IP                    G IP 
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 160 AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL----NVLEDLHLID 215
                  L    L  N+LTG++P    N ++L  + L NN+L+G +      LE+L ++ 
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 216 LNIENNLFSGPIPEKL---LSIPNFRKDGNPFNTTVXXXXXXXXXXXXXXXXTFQAPGDQ 272
           L   NN FSG IP +L    S+     + N FN T+                        
Sbjct: 521 L--SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI------------------------ 554
Query: 273 ADAPSAFEMTNSAKAKKFWTTKRVIWVALSAAAILCALGCSLFMWRYCKTRRVNRDAEKN 332
              P+A    +   A  F   KR +++        C    +L  ++  ++ ++NR + +N
Sbjct: 555 ---PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611
Query: 333 -----TGTYKGHGEKPNYKNS 348
                +  Y GH   P + N+
Sbjct: 612 PCNITSRVYGGH-TSPTFDNN 631

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 437 QYTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL 495
           ++  +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            H NIV+L+   +   +  LV+++         LH D +     S    I + L  +   
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 117
Query: 556 QYLQ--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           Q LQ    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T   
Sbjct: 118 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-W 175
Query: 613 SGAPEFESGS--YSCQSDVYSLGVVMLELLTGR 643
             APE   G   YS   D++SLG +  E++T R
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 445 GNFIGEGLLGSVYKAEL--PGGKLLAVK-KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           G  IGEG  G V++     P    LAV  K     +     E+FL+ A T+ +  H +IV
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ 559
           +LIG   E+   +++      CTL +L    +   +K+S ++   I  A   + AL YL+
Sbjct: 103 KLIGVITENPVWIIM----ELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE 156
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                  VH +  + N+L+     V++ D GL+  +   +  + S+G L           
Sbjct: 157 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 213
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
              ++  SDV+  GV M E+L  G KP+ 
Sbjct: 214 FRRFTSASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 445 GNFIGEGLLGSVYKA-----ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           G  IGEG  G V++      E P   + A+K   N  S     E+FL+ A T+ +  H +
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSD-SVREKFLQEALTMRQFDHPH 452
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQY 557
           IV+LIG   E+     V+     CTL +L    +   +KFS ++   I  A   + AL Y
Sbjct: 453 IVKLIGVITENP----VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 506
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L+       VH +  + N+L+     V++ D GL+  +   +  + S+G L         
Sbjct: 507 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563
Query: 618 FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                ++  SDV+  GV M E+L  G KP+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 445 GNFIGEGLLGSVYKA-----ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           G  IGEG  G V++      E P   + A+K   N  S     E+FL+ A T+ +  H +
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSD-SVREKFLQEALTMRQFDHPH 72
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQY 557
           IV+LIG   E+     V+     CTL +L    +   +K+S ++   I  A   + AL Y
Sbjct: 73  IVKLIGVITENP----VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 126
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L+       VH +  + N+L+     V++ D GL+  +   +  + S+G L         
Sbjct: 127 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 183
Query: 618 FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                ++  SDV+  GV M E+L  G KP+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 445 GNFIGEGLLGSVYKAEL--PGGKLLAVK-KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           G  IGEG  G V++     P    LAV  K     +     E+FL+ A T+ +  H +IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ 559
           +LIG   E+     V+     CTL +L    +   +K+S ++   I  A   + AL YL+
Sbjct: 75  KLIGVITENP----VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE 128
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                  VH +  + N+L+     V++ D GL+  +   +  + S+G L           
Sbjct: 129 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              ++  SDV+  GV M E+L  G KP+
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK   +P G+ +    A+K+L    S +  ++E L+ A  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMAS 73
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C      L+         L  +    +    ++  N  +++A G    
Sbjct: 74  VDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKG---- 129
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +      +EG        
Sbjct: 130 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           A E      Y+ QSDV+S GV + EL+T G KPYD
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 445 GNFIGEGLLGSVYKAEL--PGGKLLAVK-KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           G  IGEG  G V++     P    LAV  K     +     E+FL+ A T+ +  H +IV
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ 559
           +LIG   E+   +++      CTL +L    +   +K+S ++   I  A   + AL YL+
Sbjct: 77  KLIGVITENPVWIIM----ELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE 130
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                  VH +  + N+L+     V++ D GL+  +   +  + S+G L           
Sbjct: 131 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 187
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              ++  SDV+  GV M E+L  G KP+
Sbjct: 188 FRRFTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 445 GNFIGEGLLGSVYKAEL--PGGKLLAVK-KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           G  IGEG  G V++     P    LAV  K     +     E+FL+ A T+ +  H +IV
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ 559
           +LIG   E+   +++      CTL +L    +   +K+S ++   I  A   + AL YL+
Sbjct: 80  KLIGVITENPVWIIM----ELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE 133
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                  VH +  + N+L+     V++ D GL+  +   +  + S+G L           
Sbjct: 134 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              ++  SDV+  GV M E+L  G KP+
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPF 218

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 33/230 (14%)
Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           T A  Q +  ++     IG+G    V  A  +  GK +AV+ +  T     + ++     
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREV 64
Query: 490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIR 544
             +  L H NIV+L           LV +Y     + D L       ++EA  KF   + 
Sbjct: 65  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
                    A+QY  +     IVH + K+ N+LLD  + ++++D G         +NE +
Sbjct: 125 ---------AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGF--------SNEFT 164
Query: 605 EG--LLTAHGS---GAPE-FESGSYSC-QSDVYSLGVVMLELLTGRKPYD 647
            G  L T  GS    APE F+   Y   + DV+SLGV++  L++G  P+D
Sbjct: 165 FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 445 GNFIGEGLLGSVYKA-----ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           G  IGEG  G V++      E P   + A+K   N  S     E+FL+ A T+ +  H +
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSD-SVREKFLQEALTMRQFDHPH 452
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQY 557
           IV+LIG   E+     V+     CTL +L    +   +KFS ++   I  A   + AL Y
Sbjct: 453 IVKLIGVITENP----VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 506
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L+       VH +  + N+L+     V++ D GL+  +   +  + S+G L         
Sbjct: 507 LES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563
Query: 618 FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                ++  SDV+  GV M E+L  G KP+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 445 GNFIGEGLLGSVYKAEL--PGGKLLAVK-KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           G  IGEG  G V++     P    LAV  K     +     E+FL+ A T+ +  H +IV
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ 559
           +LIG   E+   +++      CTL +L    +   +K+S ++   I  A   + AL YL+
Sbjct: 72  KLIGVITENPVWIIM----ELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE 125
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                  VH +  + N+L+     V++ D GL+  +   +  + S+G L           
Sbjct: 126 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              ++  SDV+  GV M E+L  G KP+
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 121/261 (46%), Gaps = 29/261 (11%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
           + Y ++F +   IGEG  G V  A +   GKL+AVKK+     QR+   E L     I R
Sbjct: 28  RSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMR 81
Query: 495 -LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
             +H N+VE+        +  +V ++     L D++      H + +      V L   +
Sbjct: 82  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQ 136
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL--SEGLLTAH 611
           AL  L       ++H + KS +ILL     V++SD G      +  + E+   + L+   
Sbjct: 137 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC----AQVSKEVPRRKXLVGTP 189
Query: 612 GSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-PRLHDID 669
              APE  S   Y  + D++SLG++++E++ G  PY    P     ++R  + PRL ++ 
Sbjct: 190 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH 249
Query: 670 ALSRMVDPSLDGAYLAKSLSR 690
            +S    PSL G +L + L R
Sbjct: 250 KVS----PSLKG-FLDRLLVR 265

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 445 GNFIGEGLLGSVYKAEL--PGGKLLAVK-KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           G  IGEG  G V++     P    LAV  K     +     E+FL+ A T+ +  H +IV
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ 559
           +LIG   E+   +++      CTL +L    +   +K+S ++   I  A   + AL YL+
Sbjct: 78  KLIGVITENPVWIIM----ELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE 131
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                  VH +  + N+L+     V++ D GL+  +   +  + S+G L           
Sbjct: 132 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 188
Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              ++  SDV+  GV M E+L  G KP+
Sbjct: 189 FRRFTSASDVWMFGVCMWEILMHGVKPF 216

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 121/261 (46%), Gaps = 29/261 (11%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
           + Y ++F +   IGEG  G V  A +   GKL+AVKK+     QR+   E L     I R
Sbjct: 30  RSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMR 83
Query: 495 -LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
             +H N+VE+        +  +V ++     L D++      H + +      V L   +
Sbjct: 84  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQ 138
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL--SEGLLTAH 611
           AL  L       ++H + KS +ILL     V++SD G      +  + E+   + L+   
Sbjct: 139 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC----AQVSKEVPRRKXLVGTP 191
Query: 612 GSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-PRLHDID 669
              APE  S   Y  + D++SLG++++E++ G  PY    P     ++R  + PRL ++ 
Sbjct: 192 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH 251
Query: 670 ALSRMVDPSLDGAYLAKSLSR 690
            +S    PSL G +L + L R
Sbjct: 252 KVS----PSLKG-FLDRLLVR 267

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 121/261 (46%), Gaps = 29/261 (11%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
           + Y ++F +   IGEG  G V  A +   GKL+AVKK+     QR+   E L     I R
Sbjct: 19  RSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMR 72
Query: 495 -LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
             +H N+VE+        +  +V ++     L D++      H + +      V L   +
Sbjct: 73  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQ 127
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL--SEGLLTAH 611
           AL  L       ++H + KS +ILL     V++SD G      +  + E+   + L+   
Sbjct: 128 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC----AQVSKEVPRRKXLVGTP 180
Query: 612 GSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-PRLHDID 669
              APE  S   Y  + D++SLG++++E++ G  PY    P     ++R  + PRL ++ 
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH 240
Query: 670 ALSRMVDPSLDGAYLAKSLSR 690
            +S    PSL G +L + L R
Sbjct: 241 KVS----PSLKG-FLDRLLVR 256

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 27/260 (10%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
           + Y ++F +   IGEG  G V  A +   GKL+AVKK+     QR+  E        +  
Sbjct: 23  RSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR--ELLFNEVVIMRD 77
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
            +H N+VE+        +  +V ++     L D++      H + +      V L   +A
Sbjct: 78  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQA 132
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL--SEGLLTAHG 612
           L  L       ++H + KS +ILL     V++SD G      +  + E+   + L+    
Sbjct: 133 LSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC----AQVSKEVPRRKXLVGTPY 185
Query: 613 SGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-PRLHDIDA 670
             APE  S   Y  + D++SLG++++E++ G  PY    P     ++R  + PRL ++  
Sbjct: 186 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK 245
Query: 671 LSRMVDPSLDGAYLAKSLSR 690
           +S    PSL G +L + L R
Sbjct: 246 VS----PSLKG-FLDRLLVR 260

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 23/225 (10%)
Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           T A  Q +  ++     IG+G    V  A  +  GK +AV+ +  T     + ++     
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREV 64
Query: 490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIR 544
             +  L H NIV+L           LV +Y     + D L       ++EA  KF   + 
Sbjct: 65  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
                    A+QY  +     IVH + K+ N+LLD  + ++++D G +     G  N+L 
Sbjct: 125 ---------AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLD 170
Query: 605 EGLLTAHGSGAPE-FESGSYSC-QSDVYSLGVVMLELLTGRKPYD 647
           E    +    APE F+   Y   + DV+SLGV++  L++G  P+D
Sbjct: 171 E-FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 451 GLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH 510
           G  G V+KA+L   + +AVK     +  +Q+ +   E+ S +  ++H NI++ IG   + 
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFP--IQDKQSWQNEYEVYS-LPGMKHENILQFIG-AEKR 89
Query: 511 GQHL-----LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC--- 562
           G  +     L+  +    +L D L ++       SWN    +A   AR L YL E     
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 563 ----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF 618
               +P I H + KS N+LL   L   ++D GLA    +G +   + G +      APE 
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204
Query: 619 ESGSYSCQS------DVYSLGVVMLEL 639
             G+ + Q       D+Y++G+V+ EL
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 76
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 123
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS----TNELSEGLLT 609
           +C+          +H N  + NIL++ +  V++ D GL  +L          E  E  + 
Sbjct: 124 ICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 183
Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
            +   APE      +S  SDV+S GVV+ EL T
Sbjct: 184 WY---APESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 121/261 (46%), Gaps = 29/261 (11%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
           + Y ++F +   IGEG  G V  A +   GKL+AVKK+     QR+   E L     I R
Sbjct: 73  RSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMR 126
Query: 495 -LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
             +H N+VE+        +  +V ++     L D++      H + +      V L   +
Sbjct: 127 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQ 181
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL--SEGLLTAH 611
           AL  L       ++H + KS +ILL     V++SD G      +  + E+   + L+   
Sbjct: 182 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC----AQVSKEVPRRKXLVGTP 234
Query: 612 GSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-PRLHDID 669
              APE  S   Y  + D++SLG++++E++ G  PY    P     ++R  + PRL ++ 
Sbjct: 235 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH 294
Query: 670 ALSRMVDPSLDGAYLAKSLSR 690
            +S    PSL G +L + L R
Sbjct: 295 KVS----PSLKG-FLDRLLVR 310

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 121/261 (46%), Gaps = 29/261 (11%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
           + Y ++F +   IGEG  G V  A +   GKL+AVKK+     QR+   E L     I R
Sbjct: 150 RSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMR 203
Query: 495 -LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
             +H N+VE+        +  +V ++     L D++      H + +      V L   +
Sbjct: 204 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQ 258
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL--SEGLLTAH 611
           AL  L       ++H + KS +ILL     V++SD G      +  + E+   + L+   
Sbjct: 259 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC----AQVSKEVPRRKXLVGTP 311
Query: 612 GSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-PRLHDID 669
              APE  S   Y  + D++SLG++++E++ G  PY    P     ++R  + PRL ++ 
Sbjct: 312 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH 371
Query: 670 ALSRMVDPSLDGAYLAKSLSR 690
            +S    PSL G +L + L R
Sbjct: 372 KVS----PSLKG-FLDRLLVR 387

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 115/294 (39%), Gaps = 46/294 (15%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 499 NIVELIGYCNEHGQHLLV---YDYGGNCTLHDLLHSDE-----EAHKKF-SWNIRIRVAL 549
           N+V L+G C + G  L+V   +   GN + +     +E     + +K F +    I  + 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             A+ +++L        +H +  + NILL EK +V++ D GLA  ++             
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLVRWAI 662
                APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   R   
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRA 268
Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 269 PDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 301

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 25/194 (12%)
Query: 467 LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLH 526
           +A+K L     +  T EE +  A  + +L +  IV LIG C      +LV +  G   LH
Sbjct: 366 VAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLH 423
Query: 527 D-LLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR 585
             L+   EE        +  +V++G    ++YL+E      VH N  + N+LL  +   +
Sbjct: 424 KFLVGKREEIPVSNVAELLHQVSMG----MKYLEE---KNFVHRNLAARNVLLVNRHYAK 476
Query: 586 VSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVML 637
           +SD GL+  L +       +   TA  +G       APE      +S +SDV+S GV M 
Sbjct: 477 ISDFGLSKALGA------DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
Query: 638 ELLT-GRKPYDRSR 650
           E L+ G+KPY + +
Sbjct: 531 EALSYGQKPYKKMK 544

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 89/225 (39%), Gaps = 25/225 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           N     + IGEG  G V KA +    L    A+K++    S+    +   EL        
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C   G   L  +Y  +  L D L          ++ I             
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
           +  A   AR + YL    +   +H +  + NIL+ E  + +++D GL+     G    + 
Sbjct: 135 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVK 187
Query: 605 E--GLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           +  G L              Y+  SDV+S GV++ E+++ G  PY
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 101/220 (45%), Gaps = 27/220 (12%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSN-TVSQRQTDEEFLELASTISRLRHGNI 500
           +GEG  G V+ AE           L+AVK L + T++ R+   +F   A  ++ L+H +I
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQHEHI 79
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD------------EEAHKKFSWNIRIRVA 548
           V+  G C +    ++V++Y  +  L+  L +              +A  +   +  + +A
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
              A  + YL        VH +  + N L+   L+V++ D G++  ++S     +    +
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 609 TAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
                  PE      ++ +SDV+S GV++ E+ T G++P+
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 89/225 (39%), Gaps = 25/225 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           N     + IGEG  G V KA +    L    A+K++    S+    +   EL        
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------------ 544
           H NI+ L+G C   G   L  +Y  +  L D L          ++ I             
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
           +  A   AR + YL    +   +H +  + NIL+ E  + +++D GL+     G    + 
Sbjct: 145 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVK 197
Query: 605 E--GLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           +  G L              Y+  SDV+S GV++ E+++ G  PY
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 67  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T     A
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-WYRA 175
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 449 GEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN 508
             G  G V+KA+L     +AVK     +  +Q+ +   E+ ST   ++H N+++ I    
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFP--LQDKQSWQSEREIFSTPG-MKHENLLQFIA-AE 78
Query: 509 EHGQHL-----LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC- 562
           + G +L     L+  +    +L D L  +       +WN    VA   +R L YL E   
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYLKGN-----IITWNELCHVAETMSRGLSYLHEDVP 133
Query: 563 -------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
                  +P I H +FKS N+LL   L   ++D GLA     G     + G +      A
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMA 193
Query: 616 PEFESGSYSCQS------DVYSLGVVMLELLTGRKPYD 647
           PE   G+ + Q       D+Y++G+V+ EL++  K  D
Sbjct: 194 PEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T     A
Sbjct: 114 QGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-WYRA 171
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T     A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-WYRA 171
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 74
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 121
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 122 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 181
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 182 WYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 79
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 126
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 127 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 186
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 187 WYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T     A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-WYRA 171
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T     A
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-WYRA 170
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 434 SLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTI 492
           S+++Y N       +GEG  G V K      G+++A+KK   +   +   +  +     +
Sbjct: 23  SMEKYENL----GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLL 78
Query: 493 SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVA 548
            +LRH N+V L+  C +  +  LV+++  +  L DL       D +  +K+ + I   + 
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
              +             I+H + K  NIL+ +  +V++ D G A  L   +  E+ +  +
Sbjct: 139 FCHSHN-----------IIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYDDEV 185
Query: 609 TAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTG 642
                 APE   G   Y    DV+++G ++ E+  G
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T     A
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-WYRA 170
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 75
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 122
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 81
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 128
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 129 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 188
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 189 WYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 442 FSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F +   +G G  G V+  ++   GKL A KKL+    +++   +   +   I    H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 501 VELIGYCNEHGQHL---LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
           +  + Y  E    L   +    GG+   H  +++ +E +  F      R     A+ +  
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYH--IYNVDEDNPGFQ---EPRAIFYTAQIVSG 301
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L+ + +  I++ + K  N+LLD+   VR+SD GLA  L +G T   ++G     G  APE
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 618 FESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ 655
              G  Y    D ++LGV + E++  R P+   R RGE+
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEK 395

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 442 FSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F +   +G G  G V+  ++   GKL A KKL+    +++   +   +   I    H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 501 VELIGYCNEHGQHL---LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
           +  + Y  E    L   +    GG+   H  +++ +E +  F      R     A+ +  
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYH--IYNVDEDNPGFQ---EPRAIFYTAQIVSG 301
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L+ + +  I++ + K  N+LLD+   VR+SD GLA  L +G T   ++G     G  APE
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 618 FESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ 655
              G  Y    D ++LGV + E++  R P+   R RGE+
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEK 395

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T     A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-WYRA 171
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 80
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 127
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 128 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 187
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 188 WYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 64  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T     A
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-WYRA 172
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 442 FSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F +   +G G  G V+  ++   GKL A KKL+    +++   +   +   I    H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 501 VELIGYCNEHGQHL---LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
           +  + Y  E    L   +    GG+   H  +++ +E +  F      R     A+ +  
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYH--IYNVDEDNPGFQ---EPRAIFYTAQIVSG 301
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L+ + +  I++ + K  N+LLD+   VR+SD GLA  L +G T   ++G     G  APE
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 618 FESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ 655
              G  Y    D ++LGV + E++  R P+   R RGE+
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEK 395

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 448 IGEGLLGSVYKA---ELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    ++  G+    +AVK ++ + S R+  E FL  AS +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 83
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIRVALGAARAL 555
            L+G  ++    L+V +   +  L   L S      +       +    I++A   A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH N  + N ++     V++ D G+   ++ +    +  +GLL      
Sbjct: 144 AYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SD++S GVV+ E+ +   +PY        Q L    + +         
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------QGLSNEQVLKF-------- 244
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIV 713
                +DG YL +      R  D++  C Q+ P  RP   EIV
Sbjct: 245 ----VMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 73
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 120
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 121 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 180
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 106
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 153
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 213
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 448 IGEGLLGSVYKA---ELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    ++  G+    +AVK ++ + S R+  E FL  AS +      ++V
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 84
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIRVALGAARAL 555
            L+G  ++    L+V +   +  L   L S      +       +    I++A   A  +
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH N  + N ++     V++ D G+   ++ +    +  +GLL      
Sbjct: 145 AYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SD++S GVV+ E+ +   +PY        Q L    + +         
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------QGLSNEQVLKF-------- 245
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIV 713
                +DG YL +      R  D++  C Q+ P  RP   EIV
Sbjct: 246 ----VMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 78
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 125
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 75
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 122
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 442 FSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F +   +G G  G V+  ++   GKL A KKL+    +++   +   +   I    H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 501 VELIGYCNEHGQHL---LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
           +  + Y  E    L   +    GG+   H  +++ +E +  F      R     A+ +  
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYH--IYNVDEDNPGFQ---EPRAIFYTAQIVSG 301
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L+ + +  I++ + K  N+LLD+   VR+SD GLA  L +G T   ++G     G  APE
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 618 FESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ 655
              G  Y    D ++LGV + E++  R P+   R RGE+
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEK 395

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           T A  Q +  ++     IG+G    V  A  +  GK +AVK +  T     + ++     
Sbjct: 5   TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV 64
Query: 490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIR 544
                L H NIV+L           LV +Y     + D L       ++EA  KF   + 
Sbjct: 65  RIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS 124
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
                    A+QY  +     IVH + K+ N+LLD    ++++D G +     G  N+L 
Sbjct: 125 ---------AVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFG--NKL- 169
Query: 605 EGLLTAHGSGAPE-FESGSYSC-QSDVYSLGVVMLELLTGRKPYD 647
           +    A    APE F+   Y   + DV+SLGV++  L++G  P+D
Sbjct: 170 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 82
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 129
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 130 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 189
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 190 WYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 33/213 (15%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG+G    V  A  +  G+ +AVK +  T     + ++       +  L H NIV+L   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 507 CNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
                   LV +Y     + D L       ++EA  KF   +          A+QY  + 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS---------AVQYCHQ- 132
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG--LLTAHGS---GAP 616
               IVH + K+ N+LLD  + ++++D G         +NE + G  L T  GS    AP
Sbjct: 133 --KYIVHRDLKAENLLLDGDMNIKIADFGF--------SNEFTVGNKLDTFCGSPPYAAP 182
Query: 617 E-FESGSYSC-QSDVYSLGVVMLELLTGRKPYD 647
           E F+   Y   + DV+SLGV++  L++G  P+D
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 108/242 (44%), Gaps = 19/242 (7%)
Query: 445 GNFI--GEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHGNI 500
            NFI  GEG  G V  A E   GK +AVKK+     QR+   E L     I R   H N+
Sbjct: 48  ANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYHHDNV 104
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           V++        +  +V ++     L D++      H + +      V L   RAL YL  
Sbjct: 105 VDMYSSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHN 159
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES 620
                ++H + KS +ILL     +++SD G    +         + L+      APE  S
Sbjct: 160 ---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KXLVGTPYWMAPEVIS 214
Query: 621 G-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-PRLHDIDALSRMVDPS 678
              Y  + D++SLG++++E++ G  PY    P      +R ++ PR+ D+  +S ++   
Sbjct: 215 RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGF 274
Query: 679 LD 680
           LD
Sbjct: 275 LD 276

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           +  +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L 
Sbjct: 2   HMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           H NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 557 YLQ--EVCEPP-IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
            LQ    C    ++H + K  N+L++ +  ++++D GLA   F          ++T    
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WY 170
Query: 614 GAPEFESGS--YSCQSDVYSLGVVMLELLTGR 643
            APE   G   YS   D++SLG +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 66  NIVKLLDVIHTENKLYLVFEF---------LHQDLKTFMDASALTGIPLPLIKSYLFQLL 116
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 174
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 75
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 122
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS----TNELSEGLLT 609
           +C+          +H +  + NIL++ +  V++ D GL  +L          E  E  + 
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
            +   APE      +S  SDV+S GVV+ EL T
Sbjct: 183 WY---APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 93
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 140
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 141 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 78
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L +  E              +   + LQY  +
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER-------------IDHIKLLQYTSQ 125
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 93
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ +Y    +L D L   +E              +   + LQY  +
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQ 140
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 141 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 116/287 (40%), Gaps = 33/287 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GK-----LLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N+   G  +G G  G V +A   G GK      +AVK L +T    + +    EL     
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLH-----SDEEAHKKFSWNIRIRVA 548
             +H NIV L+G C   G  L++ +Y   C   DLL+     ++ +  K+    + +R  
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEY---CCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 549 LG-AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL 607
           L  +++  Q +  +     +H +  + N+LL    + ++ D GLA  + + S   +    
Sbjct: 155 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 608 LTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRL 665
                  APE      Y+ QSDV+S G+++ E+ + G  PY                P +
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY----------------PGI 258
Query: 666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
                  ++V      A  A +      I+  C   EP  RP   +I
Sbjct: 259 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 33/213 (15%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG+G    V  A  +  G+ +A+K +  T     + ++       +  L H NIV+L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 507 CNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
                   L+ +Y     + D L       ++EA  KF   +          A+QY  + 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS---------AVQYCHQ- 129
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG--LLTAHGS---GAP 616
               IVH + K+ N+LLD  + ++++D G         +NE + G  L T  GS    AP
Sbjct: 130 --KRIVHRDLKAENLLLDADMNIKIADFGF--------SNEFTVGGKLDTFCGSPPYAAP 179
Query: 617 E-FESGSYSC-QSDVYSLGVVMLELLTGRKPYD 647
           E F+   Y   + DV+SLGV++  L++G  P+D
Sbjct: 180 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 171
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 66  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 174
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 65  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 173
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 32/286 (11%)
Query: 432 IASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELAS 490
           + S Q     F  G  +G+G  G+VY A     K +LA+K L     ++   E  L    
Sbjct: 3   LGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 491 TI-SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
            I S LRH NI+ L GY ++  +  L+ +Y    T++  L    +   KF          
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYIT 118
Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             A AL Y        ++H + K  N+LL     ++++D G +    S   ++L   L  
Sbjct: 119 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTL-- 173
Query: 610 AHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI 668
                 PE   G  +  + D++SLGV+  E L G+ P+       E +  +    R+  +
Sbjct: 174 --DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRV 224
Query: 669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           +      D   +GA          D+ISR ++  P  RP + E+++
Sbjct: 225 EFT--FPDFVTEGA---------RDLISRLLKHNPSQRPMLREVLE 259

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 65  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 173
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 66  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 174
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 170
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 170
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 171
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 65  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 116 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 173
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 440 NSFSEGNFIGEGLLGSVY---KAELPGGKLLAVKKLSNT-VSQRQTDEEFLELASTISRL 495
           N FS    IG G  G VY   KA+   GK+ A+K L    +  +Q +   L     +S +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 496 RHGNIVELIGYCNEHGQH-------LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
             G+   ++  C  +  H       +L    GG+      LH     H  FS      + 
Sbjct: 247 STGDCPFIV--CMSYAFHTPDKLSFILDLMNGGD------LHYHLSQHGVFS---EADMR 295
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
             AA  +  L+ +    +V+ + K +NILLDE   VR+SD GLA   FS      S G  
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVG-- 352
Query: 609 TAHGSGAPE-FESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI 662
             HG  APE  + G +Y   +D +SLG ++ +LL G  P+ + + + +  + R  +
Sbjct: 353 -THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 440 NSFSEGNFIGEGLLGSVY---KAELPGGKLLAVKKLSNT-VSQRQTDEEFLELASTISRL 495
           N FS    IG G  G VY   KA+   GK+ A+K L    +  +Q +   L     +S +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 496 RHGNIVELIGYCNEHGQH-------LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
             G+   ++  C  +  H       +L    GG+      LH     H  FS      + 
Sbjct: 247 STGDCPFIV--CMSYAFHTPDKLSFILDLMNGGD------LHYHLSQHGVFS---EADMR 295
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
             AA  +  L+ +    +V+ + K +NILLDE   VR+SD GLA   FS      S G  
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVG-- 352
Query: 609 TAHGSGAPE-FESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI 662
             HG  APE  + G +Y   +D +SLG ++ +LL G  P+ + + + +  + R  +
Sbjct: 353 -THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 115/294 (39%), Gaps = 46/294 (15%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 499 NIVELIGYCNEHGQHLLV---YDYGGNCTLHDLLHSDE-----EAHKKF-SWNIRIRVAL 549
           N+V L+G C + G  L+V   +   GN + +     +E     + +K F +    I  + 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
             A+ +++L        +H +  + NILL EK +V++ D GLA  ++             
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLVRWAI 662
                APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   R   
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 268
Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 269 PDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 301

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 67  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 175
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 171
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 25/194 (12%)
Query: 467 LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLH 526
           +A+K L     +  T EE +  A  + +L +  IV LIG C      +LV +  G   LH
Sbjct: 40  VAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLH 97
Query: 527 D-LLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR 585
             L+   EE        +  +V++G    ++YL+   E   VH +  + N+LL  +   +
Sbjct: 98  KFLVGKREEIPVSNVAELLHQVSMG----MKYLE---EKNFVHRDLAARNVLLVNRHYAK 150
Query: 586 VSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVML 637
           +SD GL+  L +       +   TA  +G       APE      +S +SDV+S GV M 
Sbjct: 151 ISDFGLSKALGA------DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 204
Query: 638 ELLT-GRKPYDRSR 650
           E L+ G+KPY + +
Sbjct: 205 EALSYGQKPYKKMK 218

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 64  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 172
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 64  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 172
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 435 LQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
            Q     + +   +GEG  G VYKA+   G+++A+K++             +   S +  
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL-GAAR 553
           L H NIV LI   +      LV+++     L  +L  ++   +     I +   L G A 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
             Q+        I+H + K  N+L++    ++++D GLA   F       +  ++T    
Sbjct: 135 CHQHR-------ILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTHEVVTL-WY 185
Query: 614 GAPEFESGS--YSCQSDVYSLGVVMLELLTGR 643
            AP+   GS  YS   D++S+G +  E++TG+
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 440 NSFSEGNFIGEGLLGSVY---KAELPGGKLLAVKKLSNT-VSQRQTDEEFLELASTISRL 495
           N FS    IG G  G VY   KA+   GK+ A+K L    +  +Q +   L     +S +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 496 RHGNIVELIGYCNEHGQH-------LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
             G+   ++  C  +  H       +L    GG+      LH     H  FS      + 
Sbjct: 247 STGDCPFIV--CMSYAFHTPDKLSFILDLMNGGD------LHYHLSQHGVFS---EADMR 295
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
             AA  +  L+ +    +V+ + K +NILLDE   VR+SD GLA   FS      S G  
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVG-- 352
Query: 609 TAHGSGAPE-FESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI 662
             HG  APE  + G +Y   +D +SLG ++ +LL G  P+ + + + +  + R  +
Sbjct: 353 -THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 171
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 113/296 (38%), Gaps = 48/296 (16%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 499 NIVELIGYCNEHGQHLLV-YDYGGNCTLHDLLHSD---------EEAHKKF-SWNIRIRV 547
           N+V L+G C + G  L+V  ++     L   L S          E+ +K F +    I  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 548 ALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL 607
           +   A+ +++L        +H +  + NILL EK +V++ D GLA  +            
Sbjct: 154 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 608 LTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLVRW 660
                  APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   R 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270
Query: 661 AIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
             P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 271 RAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 305

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 116/287 (40%), Gaps = 33/287 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GK-----LLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N+   G  +G G  G V +A   G GK      +AVK L +T    + +    EL     
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLH-----SDEEAHKKFSWNIRIRVA 548
             +H NIV L+G C   G  L++ +Y   C   DLL+     ++ +  K+    + +R  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEY---CCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 549 LG-AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL 607
           L  +++  Q +  +     +H +  + N+LL    + ++ D GLA  + + S   +    
Sbjct: 163 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 608 LTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRL 665
                  APE      Y+ QSDV+S G+++ E+ + G  PY                P +
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY----------------PGI 266
Query: 666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
                  ++V      A  A +      I+  C   EP  RP   +I
Sbjct: 267 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 440 NSFSEGNFIGEGLLGSVY---KAELPGGKLLAVKKLSNT-VSQRQTDEEFLELASTISRL 495
           N FS    IG G  G VY   KA+   GK+ A+K L    +  +Q +   L     +S +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 245
Query: 496 RHGNIVELIGYCNEHGQH-------LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
             G+   ++  C  +  H       +L    GG+      LH     H  FS      + 
Sbjct: 246 STGDCPFIV--CMSYAFHTPDKLSFILDLMNGGD------LHYHLSQHGVFS---EADMR 294
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
             AA  +  L+ +    +V+ + K +NILLDE   VR+SD GLA   FS      S G  
Sbjct: 295 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVG-- 351
Query: 609 TAHGSGAPE-FESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI 662
             HG  APE  + G +Y   +D +SLG ++ +LL G  P+ + + + +  + R  +
Sbjct: 352 -THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 406

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IGEG  G V+K      G+++A+KK   +       +  L     + +L+H N+V L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALGAARALQYLQEVC 562
                +  LV++Y  +  LH+L        E   K  +W           + LQ +    
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW-----------QTLQAVNFCH 119
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG- 621
           +   +H + K  NIL+ +  ++++ D G A LL +G ++   + + T     +PE   G 
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATR-WYRSPELLVGD 177
Query: 622 -SYSCQSDVYSLGVVMLELLTG 642
             Y    DV+++G V  ELL+G
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSG 199

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 114/298 (38%), Gaps = 50/298 (16%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 499 NIVELIGYCNEHGQHLLV-YDYGGNCTLHDLLHSD-----------EEAHKKF-SWNIRI 545
           N+V L+G C + G  L+V  ++     L   L S            E+ +K F +    I
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
             +   A+ +++L        +H +  + NILL EK +V++ D GLA  ++         
Sbjct: 189 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLV 658
                    APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 305
Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           R   P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 306 RMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 342

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 125
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S    EL   L        PE  
Sbjct: 126 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTL----DYLPPEMI 178
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 229
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 230 TEGA---------RDLISRLLKHNPSQRPMLREVLE 256

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 107/225 (47%), Gaps = 19/225 (8%)
Query: 430 FTIASLQQYTNSFSEGNFIGEGLLGSVY--KAELPGGKLLAVKKLSNTVSQRQTDEE-FL 486
           F   S   +++ +     +G+G  G V   K ++ G +  AVK +S    +++TD+E  L
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDKESLL 74
Query: 487 ELASTISRLRHGNIVELIGYCNEHGQHLLVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRI 545
                + +L H NI +L  +  + G   LV + Y G     +++     + K+FS     
Sbjct: 75  REVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEII-----SRKRFSEVDAA 129
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK---LIVRVSDCGLAPLLFSGSTNE 602
           R+       + Y  +     IVH + K  N+LL+ K     +R+ D GL+      ++ +
Sbjct: 130 RIIRQVLSGITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKK 184
Query: 603 LSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
             + + TA+   APE   G+Y  + DV+S GV++  LL+G  P++
Sbjct: 185 XKDKIGTAYYI-APEVLHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 114/298 (38%), Gaps = 50/298 (16%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 499 NIVELIGYCNEHGQHLLV-YDYGGNCTLHDLLHSD-----------EEAHKKF-SWNIRI 545
           N+V L+G C + G  L+V  ++     L   L S            E+ +K F +    I
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
             +   A+ +++L        +H +  + NILL EK +V++ D GLA  ++         
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLV 658
                    APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           R   P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 269 RMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 305

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 114/298 (38%), Gaps = 50/298 (16%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 499 NIVELIGYCNEHGQHLLV-YDYGGNCTLHDLLHSD-----------EEAHKKF-SWNIRI 545
           N+V L+G C + G  L+V  ++     L   L S            E+ +K F +    I
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
             +   A+ +++L        +H +  + NILL EK +V++ D GLA  ++         
Sbjct: 154 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLV 658
                    APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 270
Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           R   P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 271 RMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 307

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 114/298 (38%), Gaps = 50/298 (16%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 499 NIVELIGYCNEHGQHLLVY-DYGGNCTLHDLLHSD-----------EEAHKKF-SWNIRI 545
           N+V L+G C + G  L+V  ++     L   L S            E+ +K F +    I
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
             +   A+ +++L        +H +  + NILL EK +V++ D GLA  ++         
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLV 658
                    APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           R   P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 260 RMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 296

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 96/234 (41%), Gaps = 40/234 (17%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V  A   G         +AVK L       + +    EL        H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFS------------------ 540
           NIV L+G C   G   L+++Y   C   DLL+      +KFS                  
Sbjct: 110 NIVNLLGACTLSGPIYLIFEY---CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 541 ----WNIRIRVALGAARALQYLQ-EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL 595
               +   +  A   A+ +++L+ + C    VH +  + N+L+    +V++ D GLA  +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 596 FSGSTNELSEGLLTAHGSGAPE--FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
            S S   +           APE  FE G Y+ +SDV+S G+++ E+ + G  PY
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY 275

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 435 LQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
            Q     + +   +GEG  G VYKA+   G+++A+K++             +   S +  
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL-GAAR 553
           L H NIV LI   +      LV+++     L  +L  ++   +     I +   L G A 
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
             Q+        I+H + K  N+L++    ++++D GLA   F       +  ++T    
Sbjct: 135 CHQHR-------ILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTHEVVTL-WY 185
Query: 614 GAPEFESGS--YSCQSDVYSLGVVMLELLTGR 643
            AP+   GS  YS   D++S+G +  E++TG+
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 446 NFIGEGLLGSVYKA-ELPGGK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
             +G G  G+VYK   +P G+     +A+K L    S +  ++E L+ A  ++ +    +
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGVGSPYV 81
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             L+G C      L+       C L    H  E   +  S ++ +   +  A+ + YL++
Sbjct: 82  SRLLGICLTSTVQLVTQLMPYGCLLD---HVRENRGRLGSQDL-LNWCMQIAKGMSYLED 137
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP---- 616
           V    +VH +  + N+L+     V+++D GLA LL      ++ E    A G   P    
Sbjct: 138 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLL------DIDETEYHADGGKVPIKWM 188
Query: 617 EFES---GSYSCQSDVYSLGVVMLELLT-GRKPYD 647
             ES     ++ QSDV+S GV + EL+T G KPYD
Sbjct: 189 ALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 114/298 (38%), Gaps = 50/298 (16%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 499 NIVELIGYCNEHGQHLLV-YDYGGNCTLHDLLHSD-----------EEAHKKF-SWNIRI 545
           N+V L+G C + G  L+V  ++     L   L S            E+ +K F +    I
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
             +   A+ +++L        +H +  + NILL EK +V++ D GLA  ++         
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLV 658
                    APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           R   P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 269 RMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 305

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 114/298 (38%), Gaps = 50/298 (16%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 499 NIVELIGYCNEHGQHLLVY-DYGGNCTLHDLLHSD-----------EEAHKKF-SWNIRI 545
           N+V L+G C + G  L+V  ++     L   L S            E+ +K F +    I
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
             +   A+ +++L        +H +  + NILL EK +V++ D GLA  ++         
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLV 658
                    APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           R   P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 260 RMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 296

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         +H D +     S    I + L  +   Q L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEH---------VHQDLKTFMDASALTGIPLPLIKSYLFQLL 112
Query: 559 Q--EVCEPP-IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T     A
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-WYRA 170
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 89/183 (48%), Gaps = 15/183 (8%)
Query: 468 AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD-YGGNCTLH 526
           A+K +  T     ++ + LE  + +  L H NI++L  +  +   + LV + Y G     
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 527 DLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK---LI 583
           +++H       +  +N  +  A+   + L  +  + +  IVH + K  N+LL+ K    +
Sbjct: 126 EIIH-------RMKFN-EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDAL 177
Query: 584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGR 643
           +++ D GL+ +    +  ++ E L TA+   APE     Y  + DV+S+GV++  LL G 
Sbjct: 178 IKIVDFGLSAVF--ENQKKMKERLGTAYYI-APEVLRKKYDEKCDVWSIGVILFILLAGY 234
Query: 644 KPY 646
            P+
Sbjct: 235 PPF 237

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 14/235 (5%)
Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTIS-RLRHGN 499
           F  GN +G+G    VY+AE +  G  +A+K +      +    + ++    I  +L+H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+EL  Y  +     LV +   N  ++  L   +   K FS N            + YL 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 I+H +   SN+LL   + ++++D GLA  L     +E    L       +PE  
Sbjct: 130 S---HGILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPHEKHYTLCGTPNYISPEIA 184
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPR---GEQSLVRWAIPRLHDIDA 670
           + S +  +SDV+SLG +   LL GR P+D    +    +  L  + +P    I+A
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEA 239

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 74
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRY 187
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 74
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRY 187
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKDFMDASALTGIPLPLIKSYLFQLL 113
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 114 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 171
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 87
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 143
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 144 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRY 200
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHG 498
           S+++   IG G  G VY+A+L   G+L+A+KK+         D+ F      I R L H 
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHC 101
Query: 499 NIVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           NIV L  +    G+        LV DY    T++ +      A +       I V L   
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMY 157
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           +  + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + + 
Sbjct: 158 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSR 214
Query: 612 GSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
              APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 215 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 15/221 (6%)
Query: 439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDE-EFLELASTISRLR 496
           ++ +  G  +G G +  V+ A +L   + +AVK L   +++  +    F   A   + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 497 HGNIVEL--IGYCNEHGQHL--LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           H  IV +   G        L  +V +Y    TL D++H++     K +    I V   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA----IEVIADAC 126
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAH 611
           +AL +  +     I+H + K +NIL+     V+V D G+A  +  SG++   +  ++   
Sbjct: 127 QALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 612 GSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
              +PE   G S   +SDVYSLG V+ E+LTG  P+    P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 74
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRY 187
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 74
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRY 187
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 448 IGEGLLGSVYKA---ELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    ++  G+    +AVK ++ + S R+  E FL  AS +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 83
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIRVALGAARAL 555
            L+G  ++    L+V +   +  L   L S      +       +    I++A   A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++     V++ D G+   ++ +    +  +GLL      
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SD++S GVV+ E+ +   +PY        Q L    + +         
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------QGLSNEQVLKF-------- 244
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIV 713
                +DG YL +      R  D++  C Q+ P  RP   EIV
Sbjct: 245 ----VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 93
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 149
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 150 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRY 206
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHG 498
           S+++   IG G  G VY+A+L   G+L+A+KK+         D+ F      I R L H 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHC 107
Query: 499 NIVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           NIV L  +    G+        LV DY    T++ +      A +       I V L   
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMY 163
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           +  + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + + 
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSR 220
Query: 612 GSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
              APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 79
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 135
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 136 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRY 192
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHG 498
           S+++   IG G  G VY+A+L   G+L+A+KK+         D+ F      I R L H 
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHC 109
Query: 499 NIVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           NIV L  +    G+        LV DY    T++ +      A +       I V L   
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMY 165
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           +  + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + + 
Sbjct: 166 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSR 222
Query: 612 GSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
              APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 223 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 441 SFSEGNFIGEGLLGSVYKAELPGG-KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           +  EG+F G+  L + YK +     K ++ + L  +    + + E     S +  LRH +
Sbjct: 16  TLGEGSF-GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI----SYLKLLRHPH 70
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD---EEAHKKFSWNIRIRVALGAARALQ 556
           I++L          ++V +Y G      ++      E+  ++F   I          A++
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQI--------ICAIE 122
Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
           Y        IVH + K  N+LLD+ L V+++D GL+ ++  G+  + S G   +    AP
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCG---SPNYAAP 176
Query: 617 EFESGSYSC--QSDVYSLGVVMLELLTGRKPYD 647
           E  +G      + DV+S G+V+  +L GR P+D
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 82
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 138
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 139 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRY 195
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 75
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 131
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 132 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRY 188
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHG 498
           S+++   IG G  G VY+A+L   G+L+A+KK+         D+ F      I R L H 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHC 107
Query: 499 NIVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           NIV L  +    G+        LV DY    T++ +      A +       I V L   
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMY 163
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           +  + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + + 
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSR 220
Query: 612 GSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
              APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 86
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 142
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 143 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRY 199
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 86
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 142
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 143 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRY 199
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+     +R  + E       + +L H N
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNREL----QIMRKLDHCN 78
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 134
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 135 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRY 191
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG+G    V  A  +  G+ +A+K +  T     + ++       +  L H NIV+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 507 CNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
                   L+ +Y     + D L       ++EA  KF   +          A+QY  + 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS---------AVQYCHQ- 132
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FES 620
               IVH + K+ N+LLD  + ++++D G +     G      +    A    APE F+ 
Sbjct: 133 --KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQG 187
Query: 621 GSYSC-QSDVYSLGVVMLELLTGRKPYD 647
             Y   + DV+SLGV++  L++G  P+D
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHG 498
           S+++   IG G  G VY+A+L   G+L+A+KK+         D+ F      I R L H 
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHC 152
Query: 499 NIVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           NIV L  +    G+        LV DY    T++ +      A +       I V L   
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMY 208
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           +  + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + + 
Sbjct: 209 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSR 265
Query: 612 GSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
              APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 266 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 117/276 (42%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 151
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S   ++L   L        PE  
Sbjct: 152 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTL----DYLPPEMI 204
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 205 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 255
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 256 TEGA---------RDLISRLLKHNPSQRPMLREVLE 282

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHG 498
           S+++   IG G  G VY+A+L   G+L+A+KK+         D+ F      I R L H 
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHC 111
Query: 499 NIVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           NIV L  +    G+        LV DY    T++ +      A +       I V L   
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMY 167
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           +  + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + + 
Sbjct: 168 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSR 224
Query: 612 GSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
              APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 225 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 126
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S     LS  L        PE  
Sbjct: 127 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTL----DYLPPEMI 179
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 230
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 231 TEGA---------RDLISRLLKHNPSQRPMLREVLE 257

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+ K+             +   S +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T     A
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-WYRA 171
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+ K+             +   S +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         LH D +     S    I + L  +   Q L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F       +  ++T     A
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTL-WYRA 170
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 112/250 (44%), Gaps = 35/250 (14%)
Query: 435 LQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLS---NTVSQRQTDEEFLELAS 490
           ++     + + +F+GEG   +VYKA +    +++A+KK+     + ++   +   L    
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 491 TISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALG 550
            +  L H NI+ L+          LV+D+         + +D E   K +  +     + 
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDF---------METDLEVIIKDNSLVLTPSHIK 115
Query: 551 A--ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
           A     LQ L+ + +  I+H + K +N+LLDE  +++++D GLA     GS N      +
Sbjct: 116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYXHQV 173
Query: 609 TAHGSGAPEFESGS--YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH 666
                 APE   G+  Y    D++++G ++ ELL  R P+               +P   
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPF---------------LPGDS 217
Query: 667 DIDALSRMVD 676
           D+D L+R+ +
Sbjct: 218 DLDQLTRIFE 227

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 15/221 (6%)
Query: 439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDE-EFLELASTISRLR 496
           ++ +  G  +G G +  V+ A +L   + +AVK L   +++  +    F   A   + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 497 HGNIVEL--IGYCNEHGQHL--LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           H  IV +   G        L  +V +Y    TL D++H++     K +    I V   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA----IEVIADAC 126
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAH 611
           +AL +  +     I+H + K +NI++     V+V D G+A  +  SG++   +  ++   
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 612 GSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
              +PE   G S   +SDVYSLG V+ E+LTG  P+    P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 448 IGEGLLGSVYKA---ELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    ++  G+    +AVK ++ + S R+  E FL  AS +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 83
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIRVALGAARAL 555
            L+G  ++    L+V +   +  L   L S      +       +    I++A   A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++     V++ D G+   ++ +    +  +GLL      
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SD++S GVV+ E+ +   +PY        Q L    + +         
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------QGLSNEQVLKF-------- 244
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIV 713
                +DG YL +      R  D++  C Q+ P  RP   EIV
Sbjct: 245 ----VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 113/297 (38%), Gaps = 49/297 (16%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 499 NIVELIGYCNEHGQHLLV-YDYGGNCTLHDLLHSD----------EEAHKKF-SWNIRIR 546
           N+V L+G C + G  L+V  ++     L   L S           E+ +K F +    I 
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 547 VALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG 606
            +   A+ +++L        +H +  + NILL EK +V++ D GLA  +           
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 607 LLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLVR 659
                   APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   R
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 269
Query: 660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
              P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 270 MRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 305

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 15/221 (6%)
Query: 439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDE-EFLELASTISRLR 496
           ++ +  G  +G G +  V+ A +L   + +AVK L   +++  +    F   A   + L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 497 HGNIVEL--IGYCNEHGQHL--LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           H  IV +   G        L  +V +Y    TL D++H++     K +    I V   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA----IEVIADAC 126
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAH 611
           +AL +  +     I+H + K +NI++     V+V D G+A  +  SG++   +  ++   
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 612 GSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
              +PE   G S   +SDVYSLG V+ E+LTG  P+    P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 448 IGEGLLGSVYKA---ELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    ++  G+    +AVK ++ + S R+  E FL  AS +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 83
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIRVALGAARAL 555
            L+G  ++    L+V +   +  L   L S      +       +    I++A   A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-PLLFSGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++     V++ D G+   +  +    +  +GLL      
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SD++S GVV+ E+ +   +PY        Q L    + +         
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------QGLSNEQVLKF-------- 244
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIV 713
                +DG YL +      R  D++  C Q+ P  RP   EIV
Sbjct: 245 ----VMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 126
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S    +L   L        PE  
Sbjct: 127 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL----DYLPPEMI 179
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 230
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 231 TEGA---------RDLISRLLKHNPSQRPMLREVLE 257

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+    + +  + + +       +L H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMR------KLDHCN 74
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRY 187
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 125
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S    +L   L        PE  
Sbjct: 126 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL----DYLPPEMI 178
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 229
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 230 TEGA---------RDLISRLLKHNPSQRPMLREVLE 256

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 448 IGEGLLGSVYKA---ELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    ++  G+    +AVK ++ + S R+  E FL  AS +      ++V
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 82
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIRVALGAARAL 555
            L+G  ++    L+V +   +  L   L S      +       +    I++A   A  +
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++     V++ D G+   ++ +    +  +GLL      
Sbjct: 143 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SD++S GVV+ E+ +   +PY        Q L    + +         
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------QGLSNEQVLKF-------- 243
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIV 713
                +DG YL +      R  D++  C Q+ P  RP   EIV
Sbjct: 244 ----VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 111/291 (38%), Gaps = 37/291 (12%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GK-----LLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N+   G  +G G  G V +A   G GK      +AVK L +T    + +    EL     
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA---LG 550
             +H NIV L+G C   G  L++ +Y   C   DLL+      +    +    +A   L 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEY---CCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 551 AARALQYLQEVCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
               L +  +V +          +H +  + N+LL    + ++ D GLA  + + S   +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 604 SEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWA 661
                      APE      Y+ QSDV+S G+++ E+ + G  PY               
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY--------------- 267
Query: 662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
            P +       ++V      A  A +      I+  C   EP  RP   +I
Sbjct: 268 -PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/291 (21%), Positives = 127/291 (43%), Gaps = 41/291 (14%)
Query: 432 IASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELAS 490
           I S+      ++    IG+G  G+VY A ++  G+ +A+++++    Q+Q  +E +   +
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELI--IN 67
Query: 491 TISRLRHGNIVELIGYCNEH--GQHL-LVYDYGGNCTLHDLLHS---DEEAHKKFSWNIR 544
            I  +R      ++ Y + +  G  L +V +Y    +L D++     DE           
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG---------- 117
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
            ++A      LQ L+ +    ++H N KS NILL     V+++D G    + +   ++ S
Sbjct: 118 -QIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRS 175
Query: 605 EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAIP 663
             + T +          +Y  + D++SLG++ +E++ G  PY    P R    +     P
Sbjct: 176 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 235
Query: 664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            L + + LS +                F D ++RC++ +   R    E++Q
Sbjct: 236 ELQNPEKLSAI----------------FRDFLNRCLEMDVEKRGSAKELIQ 270

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+    + +  + + +       +L H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMR------KLDHCN 74
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRY 187
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 125/275 (45%), Gaps = 30/275 (10%)
Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F++   IG+G  G V+K  +    K++A+K +    ++ + ++   E+ + +S+     +
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYV 87
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
            +  G   +  +  ++ +Y G  +  DLL        + +  +R        + L YL  
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHS 142
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FE 619
             +   +H + K++N+LL E   V+++D G+A  L    T       +      APE  +
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIK 197
Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
             +Y  ++D++SLG+  +EL  G  P+    P      V + IP+ +          P+L
Sbjct: 198 QSAYDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNN---------PPTL 244
Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           +G Y +K L  F   +  C+  EP FRP   E+++
Sbjct: 245 EGNY-SKPLKEF---VEACLNKEPSFRPTAKELLK 275

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 130
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S    +L   L        PE  
Sbjct: 131 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL----DYLPPEMI 183
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 234
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 235 TEGA---------RDLISRLLKHNPSQRPMLREVLE 261

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 111/291 (38%), Gaps = 37/291 (12%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GK-----LLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N+   G  +G G  G V +A   G GK      +AVK L +T    + +    EL     
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
             +H NIV L+G C   G  L++ +Y   C   DLL+      +    +    +A   A 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEY---CCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 554 A---LQYLQEVCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
               L +  +V +          +H +  + N+LL    + ++ D GLA  + + S   +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 604 SEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWA 661
                      APE      Y+ QSDV+S G+++ E+ + G  PY               
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY--------------- 267
Query: 662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
            P +       ++V      A  A +      I+  C   EP  RP   +I
Sbjct: 268 -PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 448 IGEGLLGSVYKA---ELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    ++  G+    +AVK ++ + S R+  E FL  AS +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 83
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIRVALGAARAL 555
            L+G  ++    L+V +   +  L   L S      +       +    I++A   A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-PLLFSGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++     V++ D G+   +  +    +  +GLL      
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SD++S GVV+ E+ +   +PY        Q L    + +         
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------QGLSNEQVLKF-------- 244
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIV 713
                +DG YL +      R  D++  C Q+ P  RP   EIV
Sbjct: 245 ----VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+    + +  + + +       +L H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMR------KLDHCN 74
Query: 500 IVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY    T++ +      A +       I V L   +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + L  +    I H + K  N+LLD +  ++++ D G A  L  G  N      + +  
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SXICSRY 187
Query: 613 SGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE  F +  Y+   DV+S G V+ ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 38/288 (13%)
Query: 433 ASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELAST 491
           A  Q     F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 492 I-SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALG 550
           I S LRH NI+ L GY ++  +  L+ +Y    T++  L    +   KF           
Sbjct: 61  IQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITE 116
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
            A AL Y        ++H + K  N+LL     ++++D G +    S     L   L   
Sbjct: 117 LANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL--- 170
Query: 611 HGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ---SLVRWAIPRLH 666
                PE   G  +  + D++SLGV+  E L G+ P++ +  +      S V +  P   
Sbjct: 171 -DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFP--- 226
Query: 667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                    D   +GA          D+ISR ++  P  RP + E+++
Sbjct: 227 ---------DFVTEGA---------RDLISRLLKHNPSQRPMLREVLE 256

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +GEG  GSVYKA     G+++A+K+    V      +E ++  S + +    ++V+  G 
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQ----VPVESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
             ++    +V +Y G  ++ D++      +K  + +    +     + L+YL  + +   
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMRK--- 146
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE--GLLTAHGSGAPE-FESGSY 623
           +H + K+ NILL+ +   +++D G+A  L    T+ +++   ++      APE  +   Y
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQL----TDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 624 SCQSDVYSLGVVMLELLTGRKPYDRSRP 651
           +C +D++SLG+  +E+  G+ PY    P
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHP 230

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 87/213 (40%), Gaps = 32/213 (15%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNT---VSQRQTDEEFLELASTISRLRHGNIVELI 504
           IG+G  G V   +    K +   K  N    V + +    F EL   +  L H  +V L 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL-QIMQGLEHPFLVNLW 81
Query: 505 GYCNEHGQHLLVYDY--GGNCTLH--DLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
               +     +V D   GG+   H    +H  EE  K F   +          AL YLQ 
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL--------VMALDYLQN 133
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE 617
                I+H + K  NILLDE   V ++D  +A +L   +       + T  G+    APE
Sbjct: 134 ---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ------ITTMAGTKPYMAPE 184
Query: 618 FES----GSYSCQSDVYSLGVVMLELLTGRKPY 646
             S      YS   D +SLGV   ELL GR+PY
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 125/275 (45%), Gaps = 30/275 (10%)
Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F++   IG+G  G V+K  +    K++A+K +    ++ + ++   E+ + +S+     +
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYV 82
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
            +  G   +  +  ++ +Y G  +  DLL        + +  +R        + L YL  
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHS 137
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FE 619
             +   +H + K++N+LL E   V+++D G+A  L    T       +      APE  +
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIK 192
Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
             +Y  ++D++SLG+  +EL  G  P+    P      V + IP+ +          P+L
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNN---------PPTL 239
Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           +G Y +K L  F   +  C+  EP FRP   E+++
Sbjct: 240 EGNY-SKPLKEF---VEACLNKEPSFRPTAKELLK 270

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 448 IGEGLLGSVYKA---ELPGGKL---LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    ++  G+    +AVK ++ + S R+  E FL  AS +      ++V
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHHVV 80
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIRVALGAARAL 555
            L+G  ++    L+V +   +  L   L S      +       +    I++A   A  +
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-PLLFSGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++     V++ D G+   +  +    +  +GLL      
Sbjct: 141 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SD++S GVV+ E+ +   +PY        Q L    + +         
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------QGLSNEQVLKF-------- 241
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIV 713
                +DG YL +      R  D++  C Q+ P  RP   EIV
Sbjct: 242 ----VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 125
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S    +L   L        PE  
Sbjct: 126 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL----DYLPPEMI 178
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 229
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 230 TEGA---------RDLISRLLKHNPSQRPMLREVLE 256

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 70/139 (50%), Gaps = 9/139 (6%)
Query: 515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSS 574
           +V +Y    TL D++H++     K +    I V   A +AL +  +     I+H + K +
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRA----IEVIADACQALNFSHQNG---IIHRDVKPA 145
Query: 575 NILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSGAPEFESG-SYSCQSDVYSL 632
           NI++     V+V D G+A  +  SG++   +  ++      +PE   G S   +SDVYSL
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 633 GVVMLELLTGRKPYDRSRP 651
           G V+ E+LTG  P+    P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 126
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S   + L   L        PE  
Sbjct: 127 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTL----DYLPPEMI 179
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 230
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 231 TEGA---------RDLISRLLKHNPSQRPMLREVLE 257

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 113/298 (37%), Gaps = 50/298 (16%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 499 NIVELIGYCNEHGQHLLVY-DYGGNCTLHDLLHSD-----------EEAHKKF-SWNIRI 545
           N+V L+G C + G  L+V  ++     L   L S            E+ +K F +    I
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
             +   A+ +++L        +H +  + NILL EK +V++ D GLA  +          
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLV 658
                    APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           R   P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 260 RMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 296

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 70/139 (50%), Gaps = 9/139 (6%)
Query: 515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSS 574
           +V +Y    TL D++H++     K +    I V   A +AL +  +     I+H + K +
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRA----IEVIADACQALNFSHQNG---IIHRDVKPA 145
Query: 575 NILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSGAPEFESG-SYSCQSDVYSL 632
           NI++     V+V D G+A  +  SG++   +  ++      +PE   G S   +SDVYSL
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 633 GVVMLELLTGRKPYDRSRP 651
           G V+ E+LTG  P+    P
Sbjct: 206 GCVLYEVLTGEPPFTGDSP 224

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 113/298 (37%), Gaps = 50/298 (16%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 499 NIVELIGYCNEHGQHLLV-YDYGGNCTLHDLLHSD-----------EEAHKKF-SWNIRI 545
           N+V L+G C + G  L+V  ++     L   L S            E+ +K F +    I
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
             +   A+ +++L        +H +  + NILL EK +V++ D GLA  +          
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLV 658
                    APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 259
Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           R   P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 260 RMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 296

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 118/287 (41%), Gaps = 32/287 (11%)
Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELA 489
            + S Q     F  G  +G+G  G+VY A     K +LA+K L     ++   E  L   
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 490 STI-SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
             I S LRH NI+ L GY ++  +  L+ +Y    T++  L    +   KF         
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYI 117
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
              A AL Y        ++H + K  N+LL     ++++D G +    S     L   L 
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL- 173
Query: 609 TAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD 667
                  PE   G  +  + D++SLGV+  E L G+ P+       E +  +    R+  
Sbjct: 174 ---DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISR 223
Query: 668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           ++      D   +GA          D+ISR ++  P  RP + E+++
Sbjct: 224 VEFT--FPDFVTEGA---------RDLISRLLKHNPSQRPMLREVLE 259

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 70/139 (50%), Gaps = 9/139 (6%)
Query: 515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSS 574
           +V +Y    TL D++H++     K +    I V   A +AL +  +     I+H + K +
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTPKRA----IEVIADACQALNFSHQNG---IIHRDVKPA 162
Query: 575 NILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSGAPEFESG-SYSCQSDVYSL 632
           NI++     V+V D G+A  +  SG++   +  ++      +PE   G S   +SDVYSL
Sbjct: 163 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 222
Query: 633 GVVMLELLTGRKPYDRSRP 651
           G V+ E+LTG  P+    P
Sbjct: 223 GCVLYEVLTGEPPFTGDSP 241

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 113/298 (37%), Gaps = 50/298 (16%)
Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 499 NIVELIGYCNEHGQHLLV-YDYGGNCTLHDLLHSD-----------EEAHKKF-SWNIRI 545
           N+V L+G C + G  L+V  ++     L   L S            E+ +K F +    I
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
             +   A+ +++L        +H +  + NILL EK +V++ D GLA  +          
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLV 658
                    APE      Y+ QSDV+S GV++ E+ + G  PY     D    R  +   
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           R   P     +    M+D                     C   EP  RP  SE+V+ L
Sbjct: 269 RMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 305

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           + F   + +G G  G V K +     L+  +KL +   +     + +     +       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV   G     G+  +  ++    +L  +L   +EA K+    I  +V++   R L YL+
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEA-KRIPEEILGKVSIAVLRGLAYLR 131
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           E  +  I+H + K SNIL++ +  +++ D G++  L     N      +      APE  
Sbjct: 132 EKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMAPERL 185
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKP 645
            G+ YS QSD++S+G+ ++EL  GR P
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/292 (21%), Positives = 128/292 (43%), Gaps = 41/292 (14%)
Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           +I S+      ++    IG+G  G+VY A ++  G+ +A+++++    Q+Q  +E +   
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELI--I 65
Query: 490 STISRLRHGNIVELIGYCNEH--GQHL-LVYDYGGNCTLHDLLHS---DEEAHKKFSWNI 543
           + I  +R      ++ Y + +  G  L +V +Y    +L D++     DE          
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------- 116
Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
             ++A      LQ L+ +    ++H + KS NILL     V+++D G    + +   ++ 
Sbjct: 117 --QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKR 173
Query: 604 SEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAI 662
           SE + T +          +Y  + D++SLG++ +E++ G  PY    P R    +     
Sbjct: 174 SEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233
Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           P L + + LS +                F D ++RC+  +   R    E++Q
Sbjct: 234 PELQNPEKLSAI----------------FRDFLNRCLDMDVEKRGSAKELLQ 269

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 125/275 (45%), Gaps = 30/275 (10%)
Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F++   IG+G  G V+K  +    K++A+K +    ++ + ++   E+ + +S+     +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYV 67
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
            +  G   +  +  ++ +Y G  +  DLL        + +  +R        + L YL  
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHS 122
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FE 619
             +   +H + K++N+LL E   V+++D G+A  L    T       +      APE  +
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIK 177
Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
             +Y  ++D++SLG+  +EL  G  P+    P      V + IP+ +          P+L
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNN---------PPTL 224
Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           +G Y +K L  F   +  C+  EP FRP   E+++
Sbjct: 225 EGNY-SKPLKEF---VEACLNKEPSFRPTAKELLK 255

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G+++AVKKL ++  +   D  F      +  L+H NIV+
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVK 78
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C   G+    L+ ++    +L + L   +E              +   + LQY  +
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER-------------IDHIKLLQYTSQ 125
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHG 612
           +C+          +H +  + NIL++ +  V++ D GL  +L       ++ E   +   
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE      +S  SDV+S GVV+ EL T
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 125/275 (45%), Gaps = 30/275 (10%)
Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F++   IG+G  G V+K  +    K++A+K +    ++ + ++   E+ + +S+     +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYV 67
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
            +  G   +  +  ++ +Y G  +  DLL        + +  +R        + L YL  
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHS 122
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FE 619
             +   +H + K++N+LL E   V+++D G+A  L    T       +      APE  +
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIK 177
Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
             +Y  ++D++SLG+  +EL  G  P+    P      V + IP+ +          P+L
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNN---------PPTL 224
Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           +G Y +K L  F   +  C+  EP FRP   E+++
Sbjct: 225 EGNY-SKPLKEF---VEACLNKEPSFRPTAKELLK 255

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 130
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-F 618
                 ++H + K  N+LL     ++++D G +    S     L   L        PE  
Sbjct: 131 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL----DYLPPEXI 183
Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
           E   +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 184 EGRXHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 234
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 235 TEGA---------RDLISRLLKHNPSQRPXLREVLE 261

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 71/187 (37%), Gaps = 31/187 (16%)
Query: 27  VTDPRDVMALNSLYISLNFPP-LEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGG 85
           + +P+D  AL  +   L  P  L  WL    D C  +W GV C                 
Sbjct: 2   LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLC----------------- 43
Query: 86  VLADTLGDLESVINIDLSNNHIGGSIP-----SNLPVTVRNFSLSG--NQLTGSIPEXXX 138
              DT      V N+DLS  ++    P     +NLP    NF   G  N L G IP    
Sbjct: 44  ---DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL--NFLYIGGINNLVGPIPPAIA 98
Query: 139 XXXXXXXXXXXXXXXXGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQN 198
                           G IPD   Q   L+  D S N L+G LPPS  +L +L  +    
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 199 NKLSGTL 205
           N++SG +
Sbjct: 159 NRISGAI 165

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 125
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S     L   L        PE  
Sbjct: 126 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL----DYLPPEMI 178
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 229
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 230 TEGA---------RDLISRLLKHNPSQRPMLREVLE 256

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 113/290 (38%), Gaps = 33/290 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GK-----LLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N+   G  +G G  G V +A   G GK      +AVK L +T    + +    EL     
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWN--------IRI 545
             +H NIV L+G C   G  L++ +Y     L + L        ++S+N        +  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 546 RVALG-AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
           R  L  +++  Q +  +     +H +  + N+LL    + ++ D GLA  + + S   + 
Sbjct: 166 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 605 EGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAI 662
                     APE      Y+ QSDV+S G+++ E+ + G  PY                
Sbjct: 226 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY---------------- 269
Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
           P +       ++V      A  A +      I+  C   EP  RP   +I
Sbjct: 270 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 32/285 (11%)
Query: 433 ASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELAST 491
           A  Q     F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 492 I-SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALG 550
           I S LRH NI+ L GY ++  +  L+ +Y    T++  L    +   KF           
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITE 116
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
            A AL Y        ++H + K  N+LL     ++++D G +    S     L   L   
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL--- 170
Query: 611 HGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID 669
                PE   G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++
Sbjct: 171 -DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVE 222
Query: 670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                 D   +GA          D+ISR ++  P  RP + E+++
Sbjct: 223 FT--FPDFVTEGA---------RDLISRLLKHNPSQRPMLREVLE 256

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 151
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S     L   L        PE  
Sbjct: 152 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL----DYLPPEMI 204
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 205 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 255
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 256 TEGA---------RDLISRLLKHNPSQRPMLREVLE 282

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 130
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S     L   L        PE  
Sbjct: 131 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL----DYLPPEMI 183
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 234
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 235 TEGA---------RDLISRLLKHNPSQRPMLREVLE 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 128
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S     L   L        PE  
Sbjct: 129 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL----DYLPPEMI 181
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 232
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 233 TEGA---------RDLISRLLKHNPSQRPMLREVLE 259

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 32/276 (11%)
Query: 447 FIGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
            +GEG  G VY+       G K+    K           E+F+  A  +  L H +IV+L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 504 IGYCNEHGQHLLV--YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           IG   E    +++  Y YG      +L H  E           +  +L   +A+ YL+ +
Sbjct: 91  IGIIEEEPTWIIMELYPYG------ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 144
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG 621
                VH +    NIL+     V++ D GL+  +      + S   L             
Sbjct: 145 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 201
Query: 622 SYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD 680
            ++  SDV+   V M E+L+ G++P+     +         I  L   D L +   P L 
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVLEKGDRLPK---PDLC 251
Query: 681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
              L         +++RC  ++P  RP  +E+V  L
Sbjct: 252 PPVLYT-------LMTRCWDYDPSDRPRFTELVCSL 280

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 32/276 (11%)
Query: 447 FIGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
            +GEG  G VY+       G K+    K           E+F+  A  +  L H +IV+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 504 IGYCNEHGQHLLV--YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           IG   E    +++  Y YG      +L H  E           +  +L   +A+ YL+ +
Sbjct: 79  IGIIEEEPTWIIMELYPYG------ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG 621
                VH +    NIL+     V++ D GL+  +      + S   L             
Sbjct: 133 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 622 SYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD 680
            ++  SDV+   V M E+L+ G++P+     +         I  L   D L +   P L 
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVLEKGDRLPK---PDLC 239
Query: 681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
              L         +++RC  ++P  RP  +E+V  L
Sbjct: 240 PPVLYT-------LMTRCWDYDPSDRPRFTELVCSL 268

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH
Sbjct: 7   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 66
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            NI+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y
Sbjct: 67  PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 122
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
                   ++H + K  N+LL     ++++D G +    S     L   L        PE
Sbjct: 123 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL----DYLPPE 175
Query: 618 FESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
              G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D
Sbjct: 176 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPD 226
Query: 677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
              +GA          D+ISR ++  P  RP + E+++
Sbjct: 227 FVTEGA---------RDLISRLLKHNPSQRPMLREVLE 255

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 447 FIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHGNIVELI 504
           F+G+G     ++ ++    ++ A K +  ++  +    E + +  +I R L H ++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV--- 561
           G+  ++    +V +    C    LL    E HK+       R AL    A  YL+++   
Sbjct: 84  GFFEDNDFVFVVLEL---CRRRSLL----ELHKR-------RKALTEPEARYYLRQIVLG 129
Query: 562 CE----PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHGSGAP 616
           C+      ++H + K  N+ L+E L V++ D GLA  + + G   E  + L       AP
Sbjct: 130 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKTLCGTPNYIAP 186
Query: 617 EFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRM 674
           E  S   +S + DV+S+G +M  LL G+ P+       E S ++    R+   + ++ + 
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSCLKETYLRIKKNEYSIPKH 239
Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           ++P              A +I + +Q +P  RP ++E++ D
Sbjct: 240 INPVA------------ASLIQKMLQTDPTARPTINELLND 268

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 447 FIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHGNIVELI 504
           F+G+G     ++ ++    ++ A K +  ++  +    E + +  +I R L H ++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV--- 561
           G+  ++    +V +    C    LL    E HK+       R AL    A  YL+++   
Sbjct: 84  GFFEDNDFVFVVLEL---CRRRSLL----ELHKR-------RKALTEPEARYYLRQIVLG 129
Query: 562 CE----PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHGSGAP 616
           C+      ++H + K  N+ L+E L V++ D GLA  + + G   E  + L       AP
Sbjct: 130 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKTLCGTPNYIAP 186
Query: 617 EFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRM 674
           E  S   +S + DV+S+G +M  LL G+ P+       E S ++    R+   + ++ + 
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSCLKETYLRIKKNEYSIPKH 239
Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           ++P              A +I + +Q +P  RP ++E++ D
Sbjct: 240 INPVA------------ASLIQKMLQTDPTARPTINELLND 268

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            NI+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 123
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
                   ++H + K  N+LL     ++++D G +    S     L   L        PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTL----DYLPPE 176
Query: 618 FESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
              G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPD 227
Query: 677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
              +GA          D+ISR ++  P  RP + E+++
Sbjct: 228 FVTEGA---------RDLISRLLKHNPSQRPMLREVLE 256

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 447 FIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHGNIVELI 504
           F+G+G     ++ ++    ++ A K +  ++  +    E + +  +I R L H ++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV--- 561
           G+  ++    +V +    C    LL    E HK+       R AL    A  YL+++   
Sbjct: 88  GFFEDNDFVFVVLEL---CRRRSLL----ELHKR-------RKALTEPEARYYLRQIVLG 133
Query: 562 CE----PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHGSGAP 616
           C+      ++H + K  N+ L+E L V++ D GLA  + + G   E  + L       AP
Sbjct: 134 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKTLCGTPNYIAP 190
Query: 617 EFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRM 674
           E  S   +S + DV+S+G +M  LL G+ P+       E S ++    R+   + ++ + 
Sbjct: 191 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSCLKETYLRIKKNEYSIPKH 243
Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           ++P              A +I + +Q +P  RP ++E++ D
Sbjct: 244 INPVA------------ASLIQKMLQTDPTARPTINELLND 272

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 32/276 (11%)
Query: 447 FIGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
            +GEG  G VY+       G K+    K           E+F+  A  +  L H +IV+L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 504 IGYCNEHGQHLLV--YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           IG   E    +++  Y YG      +L H  E           +  +L   +A+ YL+ +
Sbjct: 75  IGIIEEEPTWIIMELYPYG------ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 128
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG 621
                VH +    NIL+     V++ D GL+  +      + S   L             
Sbjct: 129 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 185
Query: 622 SYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD 680
            ++  SDV+   V M E+L+ G++P+     +         I  L   D L +   P L 
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVLEKGDRLPK---PDLC 235
Query: 681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
              L         +++RC  ++P  RP  +E+V  L
Sbjct: 236 PPVLYT-------LMTRCWDYDPSDRPRFTELVCSL 264

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            NI+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 126
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
                   ++H + K  N+LL     ++++D G +    S     L   L        PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL----DYLPPE 179
Query: 618 FESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
              G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPD 230
Query: 677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
              +GA          D+ISR ++  P  RP + E+++
Sbjct: 231 FVTEGA---------RDLISRLLKHNPSQRPMLREVLE 259

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 87  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 142
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S     L   L        PE  
Sbjct: 143 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL----DYLPPEMI 195
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 196 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 246
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 247 TEGA---------RDLISRLLKHNPSQRPMLREVLE 273

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 116/282 (41%), Gaps = 32/282 (11%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-S 493
           Q     F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
            LRH NI+ L GY ++  +  L+ +Y    T++  L    +   KF            A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 123
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL Y        ++H + K  N+LL     ++++D G +    S     L   L      
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL----DY 176
Query: 614 GAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
             PE   G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++   
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT- 228
Query: 673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
              D   +GA          D+ISR ++  P  RP + E+++
Sbjct: 229 -FPDFVTEGA---------RDLISRLLKHNPSQRPMLREVLE 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 127
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S     L   L        PE  
Sbjct: 128 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL----DYLPPEMI 180
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 231
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 232 TEGA---------RDLISRLLKHNPSQRPMLREVLE 258

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/292 (21%), Positives = 128/292 (43%), Gaps = 41/292 (14%)
Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           +I S+      ++    IG+G  G+VY A ++  G+ +A+++++    Q+Q  +E +   
Sbjct: 12  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELI--I 66
Query: 490 STISRLRHGNIVELIGYCNEH--GQHL-LVYDYGGNCTLHDLLHS---DEEAHKKFSWNI 543
           + I  +R      ++ Y + +  G  L +V +Y    +L D++     DE          
Sbjct: 67  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------- 117
Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
             ++A      LQ L+ +    ++H + KS NILL     V+++D G    + +   ++ 
Sbjct: 118 --QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKR 174
Query: 604 SEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAI 662
           S  + T +          +Y  + D++SLG++ +E++ G  PY    P R    +     
Sbjct: 175 SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 234
Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           P L + + LS +                F D ++RC++ +   R    E++Q
Sbjct: 235 PELQNPEKLSAI----------------FRDFLNRCLEMDVEKRGSAKELIQ 270

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 29/229 (12%)
Query: 430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           F + +  ++++++     +G+G    V +       L    K+ NT      D + LE  
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 490 STISR-LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
           + I R L+H NIV L     E   H LV+D      L +              +I  R  
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE--------------DIVAREF 124
Query: 549 LGAARALQYLQEVCEP-------PIVHGNFKSSNILLDEK---LIVRVSDCGLAPLLFSG 598
              A A   +Q++ E         IVH N K  N+LL  K     V+++D GLA      
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEV 181
Query: 599 STNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           + +E   G     G  +PE  +   YS   D+++ GV++  LL G  P+
Sbjct: 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y     ++  L    +   KF            A AL Y  
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKEL----QKLSKFDEQRTATYITELANALSYCH 130
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S     L   L        PE  
Sbjct: 131 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL----DYLPPEMI 183
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 234
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 235 TEGA---------RDLISRLLKHNPSQRPMLREVLE 261

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y     ++  L    +   KF            A AL Y  
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKEL----QKLSKFDEQRTATYITELANALSYCH 130
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     ++++D G +    S     L   L        PE  
Sbjct: 131 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTL----DYLPPEMI 183
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 234
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 235 TEGA---------RDLISRLLKHNPSQRPMLREVLE 261

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 116/282 (41%), Gaps = 32/282 (11%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-S 493
           Q     F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
            LRH NI+ L GY ++  +  L+ +Y    T++  L    +   KF            A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN 119
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL Y        ++H + K  N+LL     ++++D G +    S     L   L      
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL----DY 172
Query: 614 GAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
             PE   G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++   
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT- 224
Query: 673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
              D   +GA          D+ISR ++  P  RP + E+++
Sbjct: 225 -FPDFVTEGA---------RDLISRLLKHNPSQRPMLREVLE 256

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 118/275 (42%), Gaps = 27/275 (9%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           + F + + +G G  G V+K       L+  +KL +   +     + +     +       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV   G     G+  +  ++    +L  +L    +   +    I  +V++   + L YL+
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           E  +  I+H + K SNIL++ +  +++ D G++  L     NE     +      +PE  
Sbjct: 125 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEF----VGTRSYMSPERL 178
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G+ YS QSD++S+G+ ++E+  GR P    RP         AI  L  +D +     P 
Sbjct: 179 QGTHYSVQSDIWSMGLSLVEMAVGRYP----RP-------PMAIFEL--LDYIVNEPPPK 225
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIV 713
           L  A  +     F D +++C+   P  R  + +++
Sbjct: 226 LPSAVFS---LEFQDFVNKCLIKNPAERADLKQLM 257

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 448 IGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G+G  G V K  +    +  AVK ++   ++ +     L     + +L H NI++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 507 CNEHGQHLLVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP 565
             +     +V + Y G     +++       K+FS +   R+       + Y+ +     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST-----NELSEGLLTAHGSGAPEFES 620
           IVH + K  NILL+ K      DC +  + F  ST      ++ + + TA+   APE   
Sbjct: 142 IVHRDLKPENILLESK----EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI-APEVLR 196
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
           G+Y  + DV+S GV++  LL+G  P+
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 40/224 (17%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEE--FLELASTISRLRHGNIVELI 504
           +G+G  G V+K+ +   G+++AVKK+ +   Q  TD +  F E+        H NIV L+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 505 GYCNEHGQH--LLVYDYGGNCTLHDLLHSD--EEAHKKFSWNIRIRVALGAARALQYLQE 560
                       LV+DY     LH ++ ++  E  HK++       V     + ++YL  
Sbjct: 76  NVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQY-------VVYQLIKVIKYLHS 127
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-------------PLLFSGSTNELSEG- 606
                ++H + K SNILL+ +  V+V+D GL+             PL  + +T    +  
Sbjct: 128 ---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 607 -LLTAHGSG----APEFESGS--YSCQSDVYSLGVVMLELLTGR 643
            +LT + +     APE   GS  Y+   D++SLG ++ E+L G+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G+G  G V K  +    +  AVK ++   ++ +     L     + +L H NI++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 507 CNEHGQHLLVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP 565
             +     +V + Y G     +++       K+FS +   R+       + Y+ +     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST-----NELSEGLLTAHGSGAPEFES 620
           IVH + K  NILL+ K      DC +  + F  ST      ++ + + TA+   APE   
Sbjct: 142 IVHRDLKPENILLESK----EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI-APEVLR 196
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
           G+Y  + DV+S GV++  LL+G  P+
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 447 FIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHGNIVELI 504
           F+G+G     ++ ++    ++ A K +  ++  +    E + +  +I R L H ++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV--- 561
           G+  ++    +V +    C    LL    E HK+       R AL    A  YL+++   
Sbjct: 106 GFFEDNDFVFVVLEL---CRRRSLL----ELHKR-------RKALTEPEARYYLRQIVLG 151
Query: 562 CE----PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHGSGAP 616
           C+      ++H + K  N+ L+E L V++ D GLA  + + G   E  + L       AP
Sbjct: 152 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKVLCGTPNYIAP 208
Query: 617 EFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRM 674
           E  S   +S + DV+S+G +M  LL G+ P+       E S ++    R+   + ++ + 
Sbjct: 209 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSCLKETYLRIKKNEYSIPKH 261
Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           ++P              A +I + +Q +P  RP ++E++ D
Sbjct: 262 INPVA------------ASLIQKMLQTDPTARPTINELLND 290

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            NI+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 126
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
                   ++H + K  N+LL     ++++D G +    S     L   L        PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL----DYLPPE 179
Query: 618 FESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
              G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPD 230
Query: 677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
              +GA          D+ISR ++  P  RP + E+++
Sbjct: 231 FVTEGA---------RDLISRLLKHNPSQRPMLREVLE 259

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 447 FIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHGNIVELI 504
           F+G+G     ++ ++    ++ A K +  ++  +    E + +  +I R L H ++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV--- 561
           G+  ++    +V +    C    LL    E HK+       R AL    A  YL+++   
Sbjct: 108 GFFEDNDFVFVVLEL---CRRRSLL----ELHKR-------RKALTEPEARYYLRQIVLG 153
Query: 562 CE----PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHGSGAP 616
           C+      ++H + K  N+ L+E L V++ D GLA  + + G   E  + L       AP
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKVLCGTPNYIAP 210
Query: 617 EFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRM 674
           E  S   +S + DV+S+G +M  LL G+ P+       E S ++    R+   + ++ + 
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSCLKETYLRIKKNEYSIPKH 263
Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           ++P              A +I + +Q +P  RP ++E++ D
Sbjct: 264 INPVA------------ASLIQKMLQTDPTARPTINELLND 292

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH
Sbjct: 5   EDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 64
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            NI+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y
Sbjct: 65  PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 120
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
                   ++H + K  N+LL     ++++D G +    S     L   L        PE
Sbjct: 121 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL----DYLPPE 173
Query: 618 FESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
              G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D
Sbjct: 174 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPD 224
Query: 677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
              +GA          D+ISR ++  P  RP + E+++
Sbjct: 225 FVTEGA---------RDLISRLLKHNPSQRPMLREVLE 253

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G+G  G V K  +    +  AVK ++   ++ +     L     + +L H NI++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 507 CNEHGQHLLVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP 565
             +     +V + Y G     +++       K+FS +   R+       + Y+ +     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHK---HN 141
Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST-----NELSEGLLTAHGSGAPEFES 620
           IVH + K  NILL+ K      DC +  + F  ST      ++ + + TA+   APE   
Sbjct: 142 IVHRDLKPENILLESK----EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI-APEVLR 196
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPY 646
           G+Y  + DV+S GV++  LL+G  P+
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF---SWNIRIRVALGAARAL 555
           NIV+L+   +   +  LV++           H D++  KKF   S    I + L  +   
Sbjct: 66  NIVKLLDVIHTENKLYLVFE-----------HVDQDL-KKFMDASALTGIPLPLIKSYLF 113
Query: 556 QYLQ--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           Q LQ    C    ++H + K  N+L++ +  ++++D GLA   F          ++T   
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-W 171
Query: 613 SGAPEFESGS--YSCQSDVYSLGVVMLELLTGR 643
             APE   G   YS   D++SLG +  E++T R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 32/229 (13%)
Query: 432 IASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +A+  ++T+ +     +G+G    V +            K+ NT      D + LE  + 
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREAR 82
Query: 492 ISRL-RHGNIVELIGYCNEHGQHLLVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
           I RL +H NIV L    +E G H LV+D   G     D++  +  +    S  I      
Sbjct: 83  ICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH----- 137
Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKL---IVRVSDCGLAPLL---------FS 597
              + L+ +  + +  IVH + K  N+LL  K     V+++D GLA  +         F+
Sbjct: 138 ---QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA 194
Query: 598 GSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           G+   LS  +L     G P           D+++ GV++  LL G  P+
Sbjct: 195 GTPGYLSPEVLRKDPYGKP----------VDIWACGVILYILLVGYPPF 233

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/277 (22%), Positives = 117/277 (42%), Gaps = 34/277 (12%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           F++   IG+G  G V+K      + +   K+ +        E+  +  + +S+     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS---DEEAHKKFSWNIRIRVALGAARALQYL 558
           +  G   +  +  ++ +Y G  +  DLL +   DE            ++A      L+ L
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDE-----------FQIATMLKEILKGL 133
Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE- 617
             +     +H + K++N+LL E+  V+++D G+A  L    T       +      APE 
Sbjct: 134 DYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEV 191
Query: 618 FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP 677
            +  +Y  ++D++SLG+  +EL  G  P     P      V + IP+ +          P
Sbjct: 192 IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLFLIPKNN---------PP 238
Query: 678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           +L G +  KS   F D    C+  +P FRP   E+++
Sbjct: 239 TLVGDF-TKSFKEFID---ACLNKDPSFRPTAKELLK 271

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/292 (21%), Positives = 128/292 (43%), Gaps = 41/292 (14%)
Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           +I S+      ++    IG+G  G+VY A ++  G+ +A+++++    Q+Q  +E +   
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELI--I 65
Query: 490 STISRLRHGNIVELIGYCNEH--GQHL-LVYDYGGNCTLHDLLHS---DEEAHKKFSWNI 543
           + I  +R      ++ Y + +  G  L +V +Y    +L D++     DE          
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------- 116
Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
             ++A      LQ L+ +    ++H + KS NILL     V+++D G    + +   ++ 
Sbjct: 117 --QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKR 173
Query: 604 SEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAI 662
           S  + T +          +Y  + D++SLG++ +E++ G  PY    P R    +     
Sbjct: 174 SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233
Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           P L + + LS +                F D ++RC++ +   R    E++Q
Sbjct: 234 PELQNPEKLSAI----------------FRDFLNRCLEMDVEKRGSAKELLQ 269

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/275 (21%), Positives = 117/275 (42%), Gaps = 17/275 (6%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           + F + + +G G  G V+K       L+  +KL +   +     + +     +       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV   G     G+  +  ++    +L  +L    +   +    I  +V++   + L YL+
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           E  +  I+H + K SNIL++ +  +++ D G++  L     N      +      +PE  
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERL 175
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G+ YS QSD++S+G+ ++E+  GR P      + E S    AI  L  +D +     P 
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK-EDSRPPMAIFEL--LDYIVNEPPPK 232
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIV 713
           L     +     F D +++C+   P  R  + +++
Sbjct: 233 LPSGVFS---LEFQDFVNKCLIKNPAERADLKQLM 264

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 15/220 (6%)
Query: 432 IASLQQYT-NSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELA 489
           + S +Q+T   F  G  +G+G  G+VY A     K +LA+K L  T  ++   E  L   
Sbjct: 3   LGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 490 STI-SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
             I S LRH NI+ L GY ++  +  L+ +Y    T++  L       +K S     R A
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-------QKLSRFDEQRTA 115
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
                    L       ++H + K  N+LL     ++++D G +    S   + L   L 
Sbjct: 116 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTL- 174
Query: 609 TAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYD 647
                  PE   G  +  + D++SLGV+  E L G  P++
Sbjct: 175 ---DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         L  D +     S    I + L  +   Q L
Sbjct: 66  NIVKLLDVIHTENKLYLVFEF---------LSMDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 117 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 174
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY- 506
           +G+G  G V++  L  G+ +AVK  S+   Q    E   E+ +T+  LRH NI+  I   
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRET--EIYNTVL-LRHDNILGFIASD 71
Query: 507 ---CNEHGQHLLVYDYGGNCTLHDLLHSDE-EAHKKFSWNIRIRVALGAARALQYLQ-EV 561
               N   Q  L+  Y  + +L+D L     E H      + +R+A+ AA  L +L  E+
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPH------LALRLAVSAACGLAHLHVEI 125
Query: 562 C----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG--- 614
                +P I H +FKS N+L+   L   ++D GLA ++ S  ++ L  G     G+    
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKRYM 184
Query: 615 APE----------FESGSYSCQSDVYSLGVVMLEL 639
           APE          FES  +   +D+++ G+V+ E+
Sbjct: 185 APEVLDEQIRTDCFESYKW---TDIWAFGLVLWEI 216

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 29/222 (13%)
Query: 437 QYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-L 495
           ++++++     +G+G    V +       L    K+ NT      D + LE  + I R L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
           +H NIV L     E   H LV+D      L +              +I  R     A A 
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFE--------------DIVAREFYSEADAS 108
Query: 556 QYLQEVCEPP-------IVHGNFKSSNILLDEK---LIVRVSDCGLAPLLFSGSTNELSE 605
             +Q++ E         IVH N K  N+LL  K     V+++D GLA      + +E   
Sbjct: 109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWH 165
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           G     G  +PE  +   YS   D+++ GV++  LL G  P+
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL 495
           +Q   +++    IG G  G V++A+L     +A+KK+         D+ F      I R+
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-------DKRFKNRELQIMRI 88
Query: 496 -RHGNIVELIGYCNEHGQHL------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
            +H N+V+L  +   +G         LV +Y          H  +         I++ + 
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM- 147
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPLLFSGSTNELSEGL 607
               R+L Y+  +    I H + K  N+LLD    ++++ D G A +L +G  N      
Sbjct: 148 YQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV---SX 201
Query: 608 LTAHGSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
           + +    APE  F + +Y+   D++S G VM EL+ G+
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 120/298 (40%), Gaps = 41/298 (13%)
Query: 433 ASLQQYTNSFSEGNFIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELAST 491
           A+ +++   +   + IG G+   V +      G   AVK +  T ++R + E+  E+   
Sbjct: 87  AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVT-AERLSPEQLEEVREA 145
Query: 492 ISR----LR----HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNI 543
             R    LR    H +I+ LI          LV+D      L D L       +K + +I
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
            +R  L A   L          IVH + K  NILLD+ + +R+SD G +  L  G   E 
Sbjct: 206 -MRSLLEAVSFLHANN------IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EK 255
Query: 604 SEGLLTAHGSGAPEFESGS-------YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS 656
              L    G  APE    S       Y  + D+++ GV++  LL G  P+   R    Q 
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----QI 311
Query: 657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           L+   I     ++   +   P  D        S   D+ISR +Q +P  R    + +Q
Sbjct: 312 LMLRMI-----MEGQYQFSSPEWDDRS-----STVKDLISRLLQVDPEARLTAEQALQ 359

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 29/222 (13%)
Query: 437 QYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-L 495
           ++++++     +G+G    V +       L    K+ NT      D + LE  + I R L
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
           +H NIV L     E   H LV+D      L +              +I  R     A A 
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFE--------------DIVAREFYSEADAS 107
Query: 556 QYLQEVCEPP-------IVHGNFKSSNILLDEK---LIVRVSDCGLAPLLFSGSTNELSE 605
             +Q++ E         IVH N K  N+LL  K     V+++D GLA      + +E   
Sbjct: 108 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWH 164
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           G     G  +PE  +   YS   D+++ GV++  LL G  P+
Sbjct: 165 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 29/222 (13%)
Query: 437 QYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-L 495
           ++++++     +G+G    V +       L    K+ NT      D + LE  + I R L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
           +H NIV L     E   H LV+D      L +              +I  R     A A 
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFE--------------DIVAREFYSEADAS 108
Query: 556 QYLQEVCEPP-------IVHGNFKSSNILLDEK---LIVRVSDCGLAPLLFSGSTNELSE 605
             +Q++ E         IVH N K  N+LL  K     V+++D GLA      + +E   
Sbjct: 109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWH 165
Query: 606 GLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           G     G  +PE  +   YS   D+++ GV++  LL G  P+
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
           + F  G  +G+G  G+VY A     K ++A+K L  +  +++  E  L     I S LRH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            NI+ +  Y ++  +  L+ ++     L+  L    + H +F            A AL Y
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHY 130
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL---APLL----FSGSTNELSEGLLTA 610
             E     ++H + K  N+L+  K  ++++D G    AP L      G+ + L   ++  
Sbjct: 131 CHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMI-- 185
Query: 611 HGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
                   E  ++  + D++  GV+  E L G  P+D
Sbjct: 186 --------EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 91
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF------SWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S   A          S +  I++A   A  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   ++ +    +  +GLL      
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 252
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K         +++  C Q+ P  RP   EI+  +
Sbjct: 253 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 447 FIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHGNIVELI 504
           F+G+G     ++ ++    ++ A K +  ++  +    E + +  +I R L H ++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV--- 561
           G+  ++    +V +    C    LL    E HK+       R AL    A  YL+++   
Sbjct: 82  GFFEDNDFVFVVLEL---CRRRSLL----ELHKR-------RKALTEPEARYYLRQIVLG 127
Query: 562 CE----PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHGSGAP 616
           C+      ++H + K  N+ L+E L V++ D GLA  + + G   E  + L       AP
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKVLCGTPNYIAP 184
Query: 617 EFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRM 674
           E  S   +S + DV+S+G +M  LL G+ P+       E S ++    R+   + ++ + 
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSCLKETYLRIKKNEYSIPKH 237
Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           ++P              A +I + +Q +P  RP ++E++ D
Sbjct: 238 INPVA------------ASLIQKMLQTDPTARPTINELLND 266

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         L  D +     S    I + L  +   Q L
Sbjct: 64  NIVKLLDVIHTENKLYLVFEF---------LSMDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 172
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 81
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF------SWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S   A          S +  I++A   A  +
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   ++ +    +  +GLL      
Sbjct: 142 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 198
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 199 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 242
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K         +++  C Q+ P  RP   EI+  +
Sbjct: 243 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 284

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         L  D +     S    I + L  +   Q L
Sbjct: 66  NIVKLLDVIHTENKLYLVFEF---------LSMDLKDFMDASALTGIPLPLIKSYLFQLL 116
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 174
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 445 GNFIGEGLLGSVY--KAELPGGKLLAVKKLSNTVSQRQTDE--EFLELASTISRLRHGNI 500
           G+ +G G  G V   K EL G K+ AVK L N    R  D   +       +   RH +I
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKV-AVKIL-NRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           ++L    +      +V +Y     L D +  +    +K S  +  ++  G     +++  
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES 620
                +VH + K  N+LLD  +  +++D GL+ ++  G     S G   +    APE  S
Sbjct: 137 -----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCG---SPNYAAPEVIS 188
Query: 621 GSYSC--QSDVYSLGVVMLELLTGRKPYD 647
           G      + D++S GV++  LL G  P+D
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 437 QYTNSFSEGNFIGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +Y +   +GNF      GSV            G L+AVK+L ++   +Q D  F      
Sbjct: 10  KYISQLGKGNF------GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD--FQREIQI 61
Query: 492 ISRLRHGNIVELIG--YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
           +  L    IV+  G  Y     +  LV +Y  +  L D L              R R  L
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQ-------------RHRARL 108
Query: 550 GAARALQYLQEVCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTN 601
            A+R L Y  ++C+          VH +  + NIL++ +  V+++D GLA LL       
Sbjct: 109 DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXX 168
Query: 602 ELSEGLLTAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLT 641
            + E   +     APE  S + +S QSDV+S GVV+ EL T
Sbjct: 169 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++     + SRL H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 498 GNIVELIGYCNEHGQHLLV-YDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAA 552
              V+L  +C +  + L     Y  N  L   +      DE   + ++  I         
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------V 147
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
            AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +    
Sbjct: 148 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 613 SGAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
             +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 113/297 (38%), Gaps = 40/297 (13%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GK-----LLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N+   G  +G G  G V +A   G GK      +AVK L +T    + +    EL     
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEA---------------HKK 538
             +H NIV L+G C   G  L++ +Y     L + L    EA                K+
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 539 FSWNIRIRVALG-AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS 597
               + +R  L  +++  Q +  +     +H +  + N+LL    + ++ D GLA  + +
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 210
Query: 598 GSTNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQ 655
            S   +           APE      Y+ QSDV+S G+++ E+ + G  PY         
Sbjct: 211 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY--------- 261
Query: 656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
                  P +       ++V      A  A +      I+  C   EP  RP   +I
Sbjct: 262 -------PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 311

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            +F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           NIV+L+   +   +  LV+++         L  D +     S    I + L  +   Q L
Sbjct: 65  NIVKLLDVIHTENKLYLVFEF---------LSMDLKDFMDASALTGIPLPLIKSYLFQLL 115
Query: 559 Q--EVCEP-PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           Q    C    ++H + K  N+L++ +  ++++D GLA   F          ++T     A
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYXHEVVTL-WYRA 173
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLTGR 643
           PE   G   YS   D++SLG +  E++T R
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G L+AVK+L ++   +Q D  F      +  L    IV+
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD--FQREIQILKALHSDFIVK 75
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G     G+    LV +Y  +  L D L              R R  L A+R L Y  +
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-------------RHRARLDASRLLLYSSQ 122
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           +C+          VH +  + NIL++ +  V+++D GLA LL       L +        
Sbjct: 123 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL------PLDKDYYVVREP 176
Query: 614 G-------APEFESGS-YSCQSDVYSLGVVMLELLT 641
           G       APE  S + +S QSDV+S GVV+ EL T
Sbjct: 177 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 432 IASLQQYT-NSFSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELA 489
           + S +Q+T   F  G  +G+G  G+VY A     K +LA+K L  T  ++   E  L   
Sbjct: 3   LGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 490 STI-SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
             I S LRH NI+ L GY ++  +  L+ +Y    T++  L       +K S     R A
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-------QKLSRFDEQRTA 115
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
                    L       ++H + K  N+LL     ++++D G +    S     L   L 
Sbjct: 116 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTL- 174
Query: 609 TAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYD 647
                  PE   G  +  + D++SLGV+  E L G  P++
Sbjct: 175 ---DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/292 (21%), Positives = 127/292 (43%), Gaps = 41/292 (14%)
Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           +I S+      ++    IG+G  G+VY A ++  G+ +A+++++    Q+Q  +E +   
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELI--I 65
Query: 490 STISRLRHGNIVELIGYCNEH--GQHL-LVYDYGGNCTLHDLLHS---DEEAHKKFSWNI 543
           + I  +R      ++ Y + +  G  L +V +Y    +L D++     DE          
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------- 116
Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
             ++A      LQ L+ +    ++H + KS NILL     V+++D G    + +   ++ 
Sbjct: 117 --QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKR 173
Query: 604 SEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAI 662
           S  + T +          +Y  + D++SLG++ +E++ G  PY    P R    +     
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233
Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           P L + + LS +                F D ++RC+  +   R    E++Q
Sbjct: 234 PELQNPEKLSAI----------------FRDFLNRCLDMDVEKRGSAKELLQ 269

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS 531
           L N  +     +E L  A+ + +L +  IV +IG C E    +LV +      L+  L  
Sbjct: 46  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 104
Query: 532 DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL 591
           +     K    +  +V++G    ++YL+   E   VH +  + N+LL  +   ++SD GL
Sbjct: 105 NRHVKDKNIIELVHQVSMG----MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 592 APLLFSGSTNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLT-GRK 644
           +  L +      ++     HG       APE      +S +SDV+S GV+M E  + G+K
Sbjct: 158 SKALRADENXYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 213
Query: 645 PY 646
           PY
Sbjct: 214 PY 215

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 127
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     +++++ G +    S     L   L        PE  
Sbjct: 128 ---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL----DYLPPEMI 180
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 231
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 232 TEGA---------RDLISRLLKHNPSQRPMLREVLE 258

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGN 499
           F  G  +G+G  G+VY A     K +LA+K L     ++   E  L     I S LRH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 128
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                 ++H + K  N+LL     +++++ G +    S     L   L        PE  
Sbjct: 129 ---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL----DYLPPEMI 181
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
            G  +  + D++SLGV+  E L G+ P+       E +  +    R+  ++      D  
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFT--FPDFV 232
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +GA          D+ISR ++  P  RP + E+++
Sbjct: 233 TEGA---------RDLISRLLKHNPSQRPMLREVLE 259

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 141
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++     + SRL H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 121
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 85/195 (43%), Gaps = 38/195 (19%)
Query: 464 GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH--LLVYDYGG 521
           G L+AVK+L ++   +Q D  F      +  L    IV+  G     G+    LV +Y  
Sbjct: 40  GALVAVKQLQHSGPDQQRD--FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 97
Query: 522 NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE-------PPIVHGNFKSS 574
           +  L D L              R R  L A+R L Y  ++C+          VH +  + 
Sbjct: 98  SGCLRDFLQ-------------RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 144
Query: 575 NILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APEFESGS-YSCQ 626
           NIL++ +  V+++D GLA LL       L +        G       APE  S + +S Q
Sbjct: 145 NILVESEAHVKIADFGLAKLL------PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ 198
Query: 627 SDVYSLGVVMLELLT 641
           SDV+S GVV+ EL T
Sbjct: 199 SDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 448 IGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G L+AVK+L ++   +Q D  F      +  L    IV+
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD--FQREIQILKALHSDFIVK 88
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G     G+    LV +Y  +  L D L              R R  L A+R L Y  +
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-------------RHRARLDASRLLLYSSQ 135
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           +C+          VH +  + NIL++ +  V+++D GLA LL       L +        
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL------PLDKDYYVVREP 189
Query: 614 G-------APEFESGS-YSCQSDVYSLGVVMLELLT 641
           G       APE  S + +S QSDV+S GVV+ EL T
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS 531
           L N  +     +E L  A+ + +L +  IV +IG C E    +LV +      L+  L  
Sbjct: 404 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 462
Query: 532 DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL 591
           +     K    +  +V++G    ++YL+E      VH +  + N+LL  +   ++SD GL
Sbjct: 463 NRHVKDKNIIELVHQVSMG----MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 515
Query: 592 APLLFSGSTNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLT-GRK 644
           +  L +      ++     HG       APE      +S +SDV+S GV+M E  + G+K
Sbjct: 516 SKALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 571
Query: 645 PY 646
           PY
Sbjct: 572 PY 573

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS 531
           L N  +     +E L  A+ + +L +  IV +IG C E    +LV +      L+  L  
Sbjct: 46  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 104
Query: 532 DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL 591
           +     K    +  +V++G    ++YL+   E   VH +  + N+LL  +   ++SD GL
Sbjct: 105 NRHVKDKNIIELVHQVSMG----MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 592 APLLFSGSTNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLT-GRK 644
           +  L +      ++     HG       APE      +S +SDV+S GV+M E  + G+K
Sbjct: 158 SKALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 213
Query: 645 PY 646
           PY
Sbjct: 214 PY 215

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS 531
           L N  +     +E L  A+ + +L +  IV +IG C E    +LV +      L+  L  
Sbjct: 60  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 118
Query: 532 DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL 591
           +     K    +  +V++G    ++YL+   E   VH +  + N+LL  +   ++SD GL
Sbjct: 119 NRHVKDKNIIELVHQVSMG----MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 592 APLLFSGSTNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLT-GRK 644
           +  L +      ++     HG       APE      +S +SDV+S GV+M E  + G+K
Sbjct: 172 SKALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 227
Query: 645 PY 646
           PY
Sbjct: 228 PY 229

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS 531
           L N  +     +E L  A+ + +L +  IV +IG C E    +LV +      L+  L  
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 120
Query: 532 DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL 591
           +     K    +  +V++G    ++YL+   E   VH +  + N+LL  +   ++SD GL
Sbjct: 121 NRHVKDKNIIELVHQVSMG----MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 592 APLLFSGSTNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLT-GRK 644
           +  L +      ++     HG       APE      +S +SDV+S GV+M E  + G+K
Sbjct: 174 SKALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229
Query: 645 PY 646
           PY
Sbjct: 230 PY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS 531
           L N  +     +E L  A+ + +L +  IV +IG C E    +LV +      L+  L  
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 120
Query: 532 DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL 591
           +     K    +  +V++G    ++YL+   E   VH +  + N+LL  +   ++SD GL
Sbjct: 121 NRHVKDKNIIELVHQVSMG----MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 592 APLLFSGSTNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLT-GRK 644
           +  L +      ++     HG       APE      +S +SDV+S GV+M E  + G+K
Sbjct: 174 SKALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229
Query: 645 PY 646
           PY
Sbjct: 230 PY 231

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 113/286 (39%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 82
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF------SWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S     +        S +  I++A   A  +
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   ++ +    +  +GLL      
Sbjct: 143 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 199
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 200 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 243
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K         +++  C Q+ P  RP   EI+  +
Sbjct: 244 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 285

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS 531
           L N  +     +E L  A+ + +L +  IV +IG C E    +LV +      L+  L  
Sbjct: 42  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 100
Query: 532 DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL 591
           +     K    +  +V++G    ++YL+   E   VH +  + N+LL  +   ++SD GL
Sbjct: 101 NRHVKDKNIIELVHQVSMG----MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 592 APLLFSGSTNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLT-GRK 644
           +  L +      ++     HG       APE      +S +SDV+S GV+M E  + G+K
Sbjct: 154 SKALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209
Query: 645 PY 646
           PY
Sbjct: 210 PY 211

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS 531
           L N  +     +E L  A+ + +L +  IV +IG C E    +LV +      L+  L  
Sbjct: 52  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 110
Query: 532 DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL 591
           +     K    +  +V++G    ++YL+   E   VH +  + N+LL  +   ++SD GL
Sbjct: 111 NRHVKDKNIIELVHQVSMG----MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 592 APLLFSGSTNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLT-GRK 644
           +  L +      ++     HG       APE      +S +SDV+S GV+M E  + G+K
Sbjct: 164 SKALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
Query: 645 PY 646
           PY
Sbjct: 220 PY 221

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++     + SRL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 144
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 145 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS 531
           L N  +     +E L  A+ + +L +  IV +IG C E    +LV +      L+  L  
Sbjct: 40  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 98
Query: 532 DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL 591
           +     K    +  +V++G    ++YL+   E   VH +  + N+LL  +   ++SD GL
Sbjct: 99  NRHVKDKNIIELVHQVSMG----MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 592 APLLFSGSTNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLT-GRK 644
           +  L +      ++     HG       APE      +S +SDV+S GV+M E  + G+K
Sbjct: 152 SKALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 207
Query: 645 PY 646
           PY
Sbjct: 208 PY 209

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS 531
           L N  +     +E L  A+ + +L +  IV +IG C E    +LV +      L+  L  
Sbjct: 405 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 463
Query: 532 DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL 591
           +     K    +  +V++G    ++YL+E      VH +  + N+LL  +   ++SD GL
Sbjct: 464 NRHVKDKNIIELVHQVSMG----MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 592 APLLFSGSTNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLT-GRK 644
           +  L +      ++     HG       APE      +S +SDV+S GV+M E  + G+K
Sbjct: 517 SKALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 572
Query: 645 PY 646
           PY
Sbjct: 573 PY 574

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 113/286 (39%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 84
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S      +       S +  I++A   A  +
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   ++ +    +  +GLL      
Sbjct: 145 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 245
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K         +++  C Q+ P  RP   EI+  +
Sbjct: 246 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 113/286 (39%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 78
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF------SWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S     +        S +  I++A   A  +
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   ++ +    +  +GLL      
Sbjct: 139 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 239
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K         +++  C Q+ P  RP   EI+  +
Sbjct: 240 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-R 496
           T+ +     +G+G    V +  ++P G+  A K + NT      D + LE  + I RL +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAK-IINTKKLSARDHQKLEREARICRLLK 61
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           H NIV L    +E G H LV+D      L +              +I  R     A A  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFE--------------DIVAREYYSEADASH 107
Query: 557 YLQEVCEPP-------IVHGNFKSSNILLDEK---LIVRVSDCGLAPLL---------FS 597
            +Q++ E         IVH + K  N+LL  K     V+++D GLA  +         F+
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA 167
Query: 598 GSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY-DRSRPRGEQS 656
           G+   LS  +L     G P           D+++ GV++  LL G  P+ D  + R  Q 
Sbjct: 168 GTPGYLSPEVLRKDPYGKP----------VDMWACGVILYILLVGYPPFWDEDQHRLYQQ 217
Query: 657 L 657
           +
Sbjct: 218 I 218

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++     + SRL H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 120
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-R 496
           T+ +     +G+G    V +  ++P G+  A K + NT      D + LE  + I RL +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAK-IINTKKLSARDHQKLEREARICRLLK 61
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           H NIV L    +E G H LV+D      L +              +I  R     A A  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFE--------------DIVAREYYSEADASH 107
Query: 557 YLQEVCEPP-------IVHGNFKSSNILLDEK---LIVRVSDCGLAPLL---------FS 597
            +Q++ E         IVH + K  N+LL  K     V+++D GLA  +         F+
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA 167
Query: 598 GSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY-DRSRPRGEQS 656
           G+   LS  +L     G P           D+++ GV++  LL G  P+ D  + R  Q 
Sbjct: 168 GTPGYLSPEVLRKDPYGKP----------VDMWACGVILYILLVGYPPFWDEDQHRLYQQ 217
Query: 657 L 657
           +
Sbjct: 218 I 218

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 113/286 (39%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 85
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF------SWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S     +        S +  I++A   A  +
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   ++ +    +  +GLL      
Sbjct: 146 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 202
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 246
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K         +++  C Q+ P  RP   EI+  +
Sbjct: 247 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++     + SRL H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 118
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 119 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 448 IGEGLLGSV----YKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +GEG  G V    Y     G G+++AVK L       Q    + +    +  L H +I++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGP-QHRSGWKQEIDILRTLYHEHIIK 80
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C + G+    LV +Y    +L D L                R ++G A+ L + Q+
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL---------------PRHSIGLAQLLLFAQQ 125
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG-STNELSEGLLTAHG 612
           +CE          +H N  + N+LLD   +V++ D GLA  +  G     + E   +   
Sbjct: 126 ICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 185
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE  +   +   SDV+S GV + ELLT
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 114/286 (39%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 113
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF------SWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S     +        S +  I++A   A  +
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   ++ +    +  +GLL      
Sbjct: 174 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 230
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 231 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 274
Query: 674 MVDPSLDGAYLAKSLS---RFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K  +      +++  C Q+ P  RP   EI+  +
Sbjct: 275 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 316

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 84
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS---DEEAHKKF---SWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S   + E +      S +  I++A   A  +
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   ++ +    +  +GLL      
Sbjct: 145 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 245
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K         +++  C Q+ P  RP   EI+  +
Sbjct: 246 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 448 IGEGLLGSV----YKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +GEG  G V    Y     G G+++AVK L      +       E+   +  L H +I++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEI-DILRTLYHEHIIK 80
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C + G+    LV +Y    +L D L                R ++G A+ L + Q+
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYL---------------PRHSIGLAQLLLFAQQ 125
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG-STNELSEGLLTAHG 612
           +CE          +H N  + N+LLD   +V++ D GLA  +  G     + E   +   
Sbjct: 126 ICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 185
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE  +   +   SDV+S GV + ELLT
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 11/109 (10%)
Query: 552 ARALQYLQEVC-------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
           ARA+ Y  E+C          IV+ + K  NILLD+   +R+SD GLA  +  G T    
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---I 342
Query: 605 EGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR 652
           +G +   G  APE  ++  Y+   D ++LG ++ E++ G+ P+ + + +
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 114/286 (39%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 91
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS------DEEAHKKFSWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S      +       S +  I++A   A  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   ++ +    +  +GLL      
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 252
Query: 674 MVDPSLDGAYLAKSLS---RFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K  +      +++  C Q+ P  RP   EI+  +
Sbjct: 253 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/274 (21%), Positives = 121/274 (44%), Gaps = 32/274 (11%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI-GY 506
           +G+G  G VYKA+     +LA  K+ +T S+ + ++  +E+   ++   H NIV+L+  +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI-DILASCDHPNIVKLLDAF 103
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
             E+   +L+    G      +L    E  +  + +    V      AL YL    +  I
Sbjct: 104 YYENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLH---DNKI 156
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF------ES 620
           +H + K+ NIL      ++++D G++    +  T +  +  +      APE       + 
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD 680
             Y  ++DV+SLG+ ++E+     P+    P             +  +  +++   P+L 
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNP-------------MRVLLKIAKSEPPTL- 260
Query: 681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            A  ++  S F D + +C++     R   S+++Q
Sbjct: 261 -AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++     + SRL H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 119
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 120 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+L H NIV
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKLNHQNIV 97
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 247

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 143
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 144 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 144
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 145 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++     + SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 143
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 144 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 141
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 112/286 (39%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 76
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF------SWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S     +        S +  I++A   A  +
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-PLLFSGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   +  +    +  +GLL      
Sbjct: 137 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 194 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 237
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K         +++  C Q+ P  RP   EI+  +
Sbjct: 238 ----VMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 279

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 11/109 (10%)
Query: 552 ARALQYLQEVC-------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
           ARA+ Y  E+C          IV+ + K  NILLD+   +R+SD GLA  +  G T    
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---I 342
Query: 605 EGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR 652
           +G +   G  APE  ++  Y+   D ++LG ++ E++ G+ P+ + + +
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++     + SRL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 141
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 146
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 147 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+L H NIV
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKLNHQNIV 111
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 143
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 144 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 143
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 144 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 112/286 (39%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 85
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF------SWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S     +        S +  I++A   A  +
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-PLLFSGSTNELSEGLLTAHGSG 614
            YL        VH +  + N ++ E   V++ D G+   +  +    +  +GLL      
Sbjct: 146 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 202
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 246
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K         +++  C Q+ P  RP   EI+  +
Sbjct: 247 ----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 105/252 (41%), Gaps = 44/252 (17%)
Query: 477 SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAH 536
           + R   E F E AS +S+L H ++V   G C    +++LV ++    +L   L  ++   
Sbjct: 51  AHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNC- 109
Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL----DEKL----IVRVSD 588
               W  ++ VA   A A+ +L+   E  ++HGN  + NILL    D K      +++SD
Sbjct: 110 INILW--KLEVAKQLAWAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164
Query: 589 CGLAPLLFSGSTNELSEGLLTAHGSGAPE---FESGSYSCQSDVYSLGVVMLELLT-GRK 644
            G+       S   L + +L       P        + +  +D +S G  + E+ + G K
Sbjct: 165 PGI-------SITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
Query: 645 PYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPG 704
           P                   L  +D+  ++          A   +  A++I+ C+ +EP 
Sbjct: 218 P-------------------LSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPD 258
Query: 705 FRPPMSEIVQDL 716
            RP    I++DL
Sbjct: 259 HRPSFRAIIRDL 270

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 105/252 (41%), Gaps = 44/252 (17%)
Query: 477 SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAH 536
           + R   E F E AS +S+L H ++V   G C    +++LV ++    +L   L  ++   
Sbjct: 51  AHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC- 109
Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL----DEKL----IVRVSD 588
               W  ++ VA   A A+ +L+   E  ++HGN  + NILL    D K      +++SD
Sbjct: 110 INILW--KLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164
Query: 589 CGLAPLLFSGSTNELSEGLLTAHGSGAPE---FESGSYSCQSDVYSLGVVMLELLT-GRK 644
            G+       S   L + +L       P        + +  +D +S G  + E+ + G K
Sbjct: 165 PGI-------SITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
Query: 645 PYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPG 704
           P                   L  +D+  ++          A   +  A++I+ C+ +EP 
Sbjct: 218 P-------------------LSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPD 258
Query: 705 FRPPMSEIVQDL 716
            RP    I++DL
Sbjct: 259 HRPSFRAIIRDL 270

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 432 IASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELAS 490
           +++L+     F     +G G  G VYK   +  G+L A+K +  T  + +  ++ + +  
Sbjct: 16  LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK 75
Query: 491 TISRLRHGNIVELIGYCNEHG------QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR 544
             S   H NI    G   +        Q  LV ++ G  ++ DL+ + +    K  W   
Sbjct: 76  KYSH--HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--- 130
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--------- 595
             +A      L+ L  + +  ++H + K  N+LL E   V++ D G++  L         
Sbjct: 131 --IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 596 FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKP 645
           F G+   ++  ++        E    +Y  +SD++SLG+  +E+  G  P
Sbjct: 189 FIGTPYWMAPEVI-----ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 140
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 141 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/300 (22%), Positives = 107/300 (35%), Gaps = 47/300 (15%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N  S G  +G G  G V +A   G         +AVK L  +    + +    EL     
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF-------------- 539
              H NIV L+G C   G  L++ +Y   C   DLL+        F              
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEY---CCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 540 ---SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
                   +  +   A+ + +L        +H +  + NILL    I ++ D GLA  + 
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 597 SGSTNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGE 654
           + S   +           APE   +  Y+ +SDV+S G+ + EL + G  PY        
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-------- 248
Query: 655 QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                   P +       +M+           + +   DI+  C   +P  RP   +IVQ
Sbjct: 249 --------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 8/208 (3%)
Query: 439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH 497
           ++ F +   +G G   +VYK      G  +A+K++    S+  T    +   S +  L+H
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIREISLMKELKH 62
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            NIV L    +   +  LV+++  N  L   + S    +      + + V     + LQ 
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL-VKYFQWQLLQG 120
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L    E  I+H + K  N+L++++  +++ D GLA   F    N  S  ++T     AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA-FGIPVNTFSSEVVTL-WYRAPD 178
Query: 618 FESGS--YSCQSDVYSLGVVMLELLTGR 643
              GS  YS   D++S G ++ E++TG+
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 46/229 (20%)
Query: 439 TNSFSEGNFIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-R 496
           T+ +     IG+G    V +  +L  G   A K + NT      D + LE  + I RL +
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAK-IINTKKLSARDHQKLEREARICRLLK 61
Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           H NIV L    +E G H LV+D      L +              +I  R     A A  
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFE--------------DIVAREYYSEADASH 107
Query: 557 YLQEVCEPP-------IVHGNFKSSNILLDEKL---IVRVSDCGLAPLL---------FS 597
            +Q++ E         +VH + K  N+LL  K     V+++D GLA  +         F+
Sbjct: 108 CIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA 167
Query: 598 GSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           G+   LS  +L     G P           D+++ GV++  LL G  P+
Sbjct: 168 GTPGYLSPEVLRKEAYGKP----------VDIWACGVILYILLVGYPPF 206

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 100/244 (40%), Gaps = 49/244 (20%)
Query: 437 QYTNSFSEGNFIGEGLLGSVYKAE--LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
           ++T  +     +G+G    V +    L G +  A+  + NT      D + LE  + I R
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM--IINTKKLSARDHQKLEREARICR 65
Query: 495 L-RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           L +H NIV L    +E G H L++D      L +              +I  R     A 
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE--------------DIVAREYYSEAD 111
Query: 554 ALQYLQEVCEPP-------IVHGNFKSSNILLDEKL---IVRVSDCGLAPLL-------- 595
           A   +Q++ E         +VH N K  N+LL  KL    V+++D GLA  +        
Sbjct: 112 ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 596 -FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY-DRSRPRG 653
            F+G+   LS  +L     G P           D+++ GV++  LL G  P+ D  + R 
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKP----------VDLWACGVILYILLVGYPPFWDEDQHRL 221
Query: 654 EQSL 657
            Q +
Sbjct: 222 YQQI 225

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/300 (22%), Positives = 107/300 (35%), Gaps = 47/300 (15%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N  S G  +G G  G V +A   G         +AVK L  +    + +    EL     
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF-------------- 539
              H NIV L+G C   G  L++ +Y   C   DLL+        F              
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEY---CCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 155
Query: 540 ---SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
                   +  +   A+ + +L        +H +  + NILL    I ++ D GLA  + 
Sbjct: 156 LALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 212
Query: 597 SGSTNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGE 654
           + S   +           APE   +  Y+ +SDV+S G+ + EL + G  PY        
Sbjct: 213 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-------- 264
Query: 655 QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                   P +       +M+           + +   DI+  C   +P  RP   +IVQ
Sbjct: 265 --------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/300 (22%), Positives = 107/300 (35%), Gaps = 47/300 (15%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N  S G  +G G  G V +A   G         +AVK L  +    + +    EL     
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF-------------- 539
              H NIV L+G C   G  L++ +Y   C   DLL+        F              
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEY---CCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 162
Query: 540 ---SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
                   +  +   A+ + +L        +H +  + NILL    I ++ D GLA  + 
Sbjct: 163 LALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIK 219
Query: 597 SGSTNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGE 654
           + S   +           APE   +  Y+ +SDV+S G+ + EL + G  PY        
Sbjct: 220 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-------- 271
Query: 655 QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                   P +       +M+           + +   DI+  C   +P  RP   +IVQ
Sbjct: 272 --------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           + F + + +G G  G V+K       L+  +KL +   +     + +     +       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV   G     G+  +  ++    +L  +L    +   +    I  +V++   + L YL+
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           E  +  I+H + K SNIL++ +  +++ D G++  L     N      +      +PE  
Sbjct: 184 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERL 237
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKP 645
            G+ YS QSD++S+G+ ++E+  GR P
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 115/276 (41%), Gaps = 32/276 (11%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           F++ + IG+G  G VYK      K +   K+ +        E+  +  + +S+     I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD--EEAHKKFSWNIRIRVALGAARALQYLQ 559
              G   +  +  ++ +Y G  +  DLL     EE +          +A      L+ L 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETY----------IATILREILKGLD 130
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-F 618
            +     +H + K++N+LL E+  V+++D G+A  L    T       +      APE  
Sbjct: 131 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVI 188
Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
           +  +Y  ++D++SLG+  +EL  G  P     P      V + IP         +   P+
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----VLFLIP---------KNSPPT 235
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           L+G +       F + +  C+  +P FRP   E+++
Sbjct: 236 LEGQHSKP----FKEFVEACLNKDPRFRPTAKELLK 267

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 125
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 126 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 21/214 (9%)
Query: 441 SFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRL--RH 497
            F     +G+G  G V+ AE     +  A+K L   V     D E   +   +  L   H
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 78
Query: 498 GNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
             +  +            V +Y  GG     DL++  +  HK F  +   R    AA  +
Sbjct: 79  PFLTHMFCTFQTKENLFFVMEYLNGG-----DLMYHIQSCHK-FDLS---RATFYAAEII 129
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP--LLFSGSTNELSEGLLTAHGS 613
             LQ +    IV+ + K  NILLD+   ++++D G+    +L    TNE           
Sbjct: 130 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC----GTPDY 185
Query: 614 GAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPY 646
            APE   G  Y+   D +S GV++ E+L G+ P+
Sbjct: 186 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 140
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 141 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/300 (22%), Positives = 107/300 (35%), Gaps = 47/300 (15%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N  S G  +G G  G V +A   G         +AVK L  +    + +    EL     
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF-------------- 539
              H NIV L+G C   G  L++ +Y   C   DLL+        F              
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEY---CCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 162
Query: 540 ---SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
                   +  +   A+ + +L        +H +  + NILL    I ++ D GLA  + 
Sbjct: 163 LALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 219
Query: 597 SGSTNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGE 654
           + S   +           APE   +  Y+ +SDV+S G+ + EL + G  PY        
Sbjct: 220 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-------- 271
Query: 655 QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                   P +       +M+           + +   DI+  C   +P  RP   +IVQ
Sbjct: 272 --------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 97
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMP 214
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 88
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 149 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 238

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           + F + + +G G  G V+K       L+  +KL +   +     + +     +       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV   G     G+  +  ++    +L  +L    +   +    I  +V++   + L YL+
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           E  +  I+H + K SNIL++ +  +++ D G++  L     N      +      +PE  
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERL 175
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKP 645
            G+ YS QSD++S+G+ ++E+  GR P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           + F + + +G G  G V+K       L+  +KL +   +     + +     +       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV   G     G+  +  ++    +L  +L    +   +    I  +V++   + L YL+
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           E  +  I+H + K SNIL++ +  +++ D G++  L     N      +      +PE  
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERL 175
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKP 645
            G+ YS QSD++S+G+ ++E+  GR P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           + F + + +G G  G V+K       L+  +KL +   +     + +     +       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV   G     G+  +  ++    +L  +L    +   +    I  +V++   + L YL+
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           E  +  I+H + K SNIL++ +  +++ D G++  L     N      +      +PE  
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERL 175
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKP 645
            G+ YS QSD++S+G+ ++E+  GR P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/300 (22%), Positives = 107/300 (35%), Gaps = 47/300 (15%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N  S G  +G G  G V +A   G         +AVK L  +    + +    EL     
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF-------------- 539
              H NIV L+G C   G  L++ +Y   C   DLL+        F              
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEY---CCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 157
Query: 540 ---SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
                   +  +   A+ + +L        +H +  + NILL    I ++ D GLA  + 
Sbjct: 158 LALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 214
Query: 597 SGSTNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGE 654
           + S   +           APE   +  Y+ +SDV+S G+ + EL + G  PY        
Sbjct: 215 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-------- 266
Query: 655 QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                   P +       +M+           + +   DI+  C   +P  RP   +IVQ
Sbjct: 267 --------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/281 (21%), Positives = 121/281 (43%), Gaps = 34/281 (12%)
Query: 440 NSFSEGNFIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRH 497
             +  G F+G+G     Y+  ++   ++ A K +  ++  +   +E +     I + L +
Sbjct: 26  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 85
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            ++V   G+  +      VY     C    LL    E HK+              + +Q 
Sbjct: 86  PHVVGFHGFFEDDD---FVYVVLEICRRRSLL----ELHKRRKAVTEPEARYFMRQTIQG 138
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHGSGAP 616
           +Q +    ++H + K  N+ L++ + V++ D GLA  + F G   E  + L       AP
Sbjct: 139 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG---ERKKDLCGTPNYIAP 195
Query: 617 E-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRM 674
           E      +S + D++SLG ++  LL G+ P+       E S ++    R+   + ++ R 
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPF-------ETSCLKETYIRIKKNEYSVPRH 248
Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           ++P      +A +L      I R +  +P  RP ++E++ D
Sbjct: 249 INP------VASAL------IRRMLHADPTLRPSVAELLTD 277

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IGEG  G VYKA+   G+  A+KK+             +   S +  L+H NIV+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC---EP 564
           +   + +LV+++  +  L  LL   E           +      +  LQ L  +    + 
Sbjct: 70  HTKKRLVLVFEH-LDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNGIAYCHDR 119
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS-- 622
            ++H + K  N+L++ +  ++++D GLA   F     + +  ++T     AP+   GS  
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTL-WYRAPDVLMGSKK 177
Query: 623 YSCQSDVYSLGVVMLELLTG 642
           YS   D++S+G +  E++ G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 111
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 96
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 105/216 (48%), Gaps = 15/216 (6%)
Query: 465 KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCT 524
           K +A+KK+   ++  Q+ +  L     I RL H NIV++       G  L   D  G+ T
Sbjct: 37  KRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT--DDVGSLT 92
Query: 525 LHDLLHSDEEAHKKFSWNIRIRVAL--GAARALQY-----LQEVCEPPIVHGNFKSSNIL 577
             + ++  +E  +    N+  +  L    AR   Y     L+ +    ++H + K +N+ 
Sbjct: 93  ELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF 152
Query: 578 LD-EKLIVRVSDCGLAPLLFSGSTNE--LSEGLLTA-HGSGAPEFESGSYSCQSDVYSLG 633
           ++ E L++++ D GLA ++    +++  LSEGL+T  + S        +Y+   D+++ G
Sbjct: 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212
Query: 634 VVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID 669
            +  E+LTG+  +  +    +  L+  +IP +H+ D
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
           +V++   + L YL+E  +  I+H + K SNIL++ +  +++ D G++  L     N    
Sbjct: 127 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-- 182
Query: 606 GLLTAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR 664
             +      +PE   G+ YS QSD++S+G+ ++E+  GR P       G  S+  + +  
Sbjct: 183 --VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG----SGSGSMAIFEL-- 234
Query: 665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIV 713
              +D +     P L     +     F D +++C+   P  R  + +++
Sbjct: 235 ---LDYIVNEPPPKLPSGVFS---LEFQDFVNKCLIKNPAERADLKQLM 277

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           + F + + +G G  G V+K       L+  +KL +   +     + +     +       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV   G     G+  +  ++    +L  +L    +   +    I  +V++   + L YL+
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           E  +  I+H + K SNIL++ +  +++ D G++  L     N      +      +PE  
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERL 175
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKP 645
            G+ YS QSD++S+G+ ++E+  GR P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IGEG  G VYKA+   G+  A+KK+             +   S +  L+H NIV+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC---EP 564
           +   + +LV+++  +  L  LL   E           +      +  LQ L  +    + 
Sbjct: 70  HTKKRLVLVFEH-LDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNGIAYCHDR 119
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS-- 622
            ++H + K  N+L++ +  ++++D GLA   F     + +  ++T     AP+   GS  
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVVTL-WYRAPDVLMGSKK 177
Query: 623 YSCQSDVYSLGVVMLELLTG 642
           YS   D++S+G +  E++ G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 96
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IGEG  G VYKA+   G+  A+KK+             +   S +  L+H NIV+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC---EP 564
           +   + +LV+++  +  L  LL   E           +      +  LQ L  +    + 
Sbjct: 70  HTKKRLVLVFEH-LDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNGIAYCHDR 119
Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS-- 622
            ++H + K  N+L++ +  ++++D GLA   F     + +  ++T     AP+   GS  
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVVTL-WYRAPDVLMGSKK 177
Query: 623 YSCQSDVYSLGVVMLELLTG 642
           YS   D++S+G +  E++ G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG 197

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 97
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 158 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 247

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/281 (20%), Positives = 118/281 (41%), Gaps = 34/281 (12%)
Query: 440 NSFSEGNFIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRH 497
             +  G F+G+G     Y+  ++   ++ A K +  ++  +   +E +     I + L +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            ++V   G+  +      VY     C    LL    E HK+              + +Q 
Sbjct: 102 PHVVGFHGFFEDDD---FVYVVLEICRRRSLL----ELHKRRKAVTEPEARYFMRQTIQG 154
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHGSGAP 616
           +Q +    ++H + K  N+ L++ + V++ D GLA  + F G   E  + L       AP
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG---ERKKDLCGTPNYIAP 211
Query: 617 E-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRM 674
           E      +S + D++SLG ++  LL G+ P+       E S ++    R+   + ++ R 
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPF-------ETSCLKETYIRIKKNEYSVPRH 264
Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           ++P                +I R +  +P  RP ++E++ D
Sbjct: 265 INPVASA------------LIRRMLHADPTLRPSVAELLTD 293

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/286 (22%), Positives = 112/286 (39%), Gaps = 41/286 (14%)
Query: 448 IGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  G VY+    G         +A+K ++   S R+  E FL  AS +      ++V
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 78
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF------SWNIRIRVALGAARAL 555
            L+G  ++    L++ +      L   L S     +        S +  I++A   A  +
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
            YL        VH +  + N  + E   V++ D G+   ++ +    +  +GLL      
Sbjct: 139 AYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G ++  SDV+S GVV+ E+ T   +PY        Q L    + R         
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------QGLSNEQVLRF-------- 239
Query: 674 MVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                ++G  L K         +++  C Q+ P  RP   EI+  +
Sbjct: 240 ----VMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 448 IGEGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGNIVELIG 505
           +G+G  G+VY A     K ++A+K L  +  +++  E  L     I S LRH NI+ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 506 YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP 565
           Y ++  +  L+ ++     L+  L    + H +F            A AL Y  E     
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHER---K 134
Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGL---APLL----FSGSTNELSEGLLTAHGSGAPEF 618
           ++H + K  N+L+  K  ++++D G    AP L      G+ + L   ++          
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMI---------- 184
Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
           E  ++  + D++  GV+  E L G  P+D
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/281 (20%), Positives = 118/281 (41%), Gaps = 34/281 (12%)
Query: 440 NSFSEGNFIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRH 497
             +  G F+G+G     Y+  ++   ++ A K +  ++  +   +E +     I + L +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            ++V   G+  +      VY     C    LL    E HK+              + +Q 
Sbjct: 102 PHVVGFHGFFEDDD---FVYVVLEICRRRSLL----ELHKRRKAVTEPEARYFMRQTIQG 154
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHGSGAP 616
           +Q +    ++H + K  N+ L++ + V++ D GLA  + F G   E  + L       AP
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG---ERKKTLCGTPNYIAP 211
Query: 617 E-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRM 674
           E      +S + D++SLG ++  LL G+ P+       E S ++    R+   + ++ R 
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPF-------ETSCLKETYIRIKKNEYSVPRH 264
Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           ++P                +I R +  +P  RP ++E++ D
Sbjct: 265 INPVASA------------LIRRMLHADPTLRPSVAELLTD 293

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/281 (20%), Positives = 118/281 (41%), Gaps = 34/281 (12%)
Query: 440 NSFSEGNFIGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRH 497
             +  G F+G+G     Y+  ++   ++ A K +  ++  +   +E +     I + L +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            ++V   G+  +      VY     C    LL    E HK+              + +Q 
Sbjct: 102 PHVVGFHGFFEDDD---FVYVVLEICRRRSLL----ELHKRRKAVTEPEARYFMRQTIQG 154
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL-FSGSTNELSEGLLTAHGSGAP 616
           +Q +    ++H + K  N+ L++ + V++ D GLA  + F G   E  + L       AP
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG---ERKKXLCGTPNYIAP 211
Query: 617 E-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRM 674
           E      +S + D++SLG ++  LL G+ P+       E S ++    R+   + ++ R 
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPF-------ETSCLKETYIRIKKNEYSVPRH 264
Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           ++P                +I R +  +P  RP ++E++ D
Sbjct: 265 INPVASA------------LIRRMLHADPTLRPSVAELLTD 293

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 113
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 174 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 230
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 231 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 263

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 103
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 164 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 220
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 221 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 253

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGS-VYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   + V   EL   +  A+K L      ++    ++      +SRL H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 141
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 614 GAPEFESGSYSCQ-SDVYSLGVVMLELLTGRKPY 646
            +PE  +   +C+ SD+++LG ++ +L+ G  P+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           + F + + +G G  G V+K       L+  +KL +   +     + +     +       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV   G     G+  +  ++    +L  +L    +   +    I  +V++   + L YL+
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           E  +  I+H + K SNIL++ +  +++ D G++  L     N      +      +PE  
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERL 202
Query: 620 SGS-YSCQSDVYSLGVVMLELLTGRKP 645
            G+ YS QSD++S+G+ ++E+  GR P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSE-QDELDFLMEALIISKFNHQNIV 111
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 45/208 (21%)
Query: 471 KLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL 529
           K+ NT      D + LE  + I RL +H NIV L    +E G H L++D      L +  
Sbjct: 53  KIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE-- 110
Query: 530 HSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP-------IVHGNFKSSNILLDEKL 582
                       +I  R     A A   +Q++ E         +VH + K  N+LL  KL
Sbjct: 111 ------------DIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKL 158
Query: 583 ---IVRVSDCGLAPLL---------FSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVY 630
               V+++D GLA  +         F+G+   LS  +L     G P           D++
Sbjct: 159 KGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKP----------VDLW 208
Query: 631 SLGVVMLELLTGRKPY-DRSRPRGEQSL 657
           + GV++  LL G  P+ D  + R  Q +
Sbjct: 209 ACGVILYILLVGYPPFWDEDQHRLYQQI 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/276 (21%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI-GY 506
           +G+G  G VYKA+     +LA  K+ +T S+ + ++  +E+   ++   H NIV+L+  +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI-DILASCDHPNIVKLLDAF 103
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
             E+   +L+    G      +L    E  +  + +    V      AL YL    +  I
Sbjct: 104 YYENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLH---DNKI 156
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS--EGLLTAHGSGAPEF------ 618
           +H + K+ NIL      ++++D G++    + +T  +   +  +      APE       
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
           +   Y  ++DV+SLG+ ++E+     P+    P             +  +  +++   P+
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-------------MRVLLKIAKSEPPT 259
Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           L  A  ++  S F D + +C++     R   S+++Q
Sbjct: 260 L--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/277 (20%), Positives = 121/277 (43%), Gaps = 38/277 (13%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI-GY 506
           +G+G  G VYKA+     +LA  K+ +T S+ + ++  +E+   ++   H NIV+L+  +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI-DILASCDHPNIVKLLDAF 103
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
             E+   +L+    G      +L    E  +  + +    V      AL YL    +  I
Sbjct: 104 YYENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLH---DNKI 156
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPL---------LFSGSTNELSEGLLTAHGSGAPE 617
           +H + K+ NIL      ++++D G++            F G+   ++  ++    S    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETS---- 212
Query: 618 FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP 677
            +   Y  ++DV+SLG+ ++E+     P+    P             +  +  +++   P
Sbjct: 213 -KDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-------------MRVLLKIAKSEPP 258
Query: 678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           +L  A  ++  S F D + +C++     R   S+++Q
Sbjct: 259 TL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 293

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 123
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +E      +H +  + N LL       + ++ D G+A  ++  S        +       
Sbjct: 184 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 240
Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
           PE F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 241 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 273

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEI--------VS 143
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 144 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 614 GAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPY 646
            +PE     S S  SD+++LG ++ +L+ G  P+
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 137
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
           +E      +H +  + N LL       + ++ D G+A  ++ +G   +    +L      
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 448 IGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G G  G VY+ ++      P    +AVK L    S+ Q + +FL  A  IS+  H NIV
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 114
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK---FSWNIRIRVALGAARALQYL 558
             IG   +     ++ +      L   L        +    +    + VA   A   QYL
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 559 QEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLF-SGSTNELSEGLLTAHGSG 614
           +E      +H +  + N LL       + ++ D G+A  ++ +G   +    +L      
Sbjct: 175 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 231
Query: 615 APEFESGSYSCQSDVYSLGVVMLELLT-GRKPY 646
              F  G ++ ++D +S GV++ E+ + G  PY
Sbjct: 232 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 264

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 120 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 120 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 21/220 (9%)
Query: 435 LQQYTNSFSEGNFIGEGLLGSVY--KAELPGGK--LLAVKKLSNTVSQRQTDEEFLELAS 490
            Q  ++ +     +G G  G V   K +L G +  +  +KK  ++V+        L+  +
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKK--SSVTTTSNSGALLDEVA 73
Query: 491 TISRLRHGNIVELIGYCNEHGQHLLVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
            + +L H NI++L  +  +   + LV + Y G     +++       +KFS    +  A+
Sbjct: 74  VLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-----LRQKFS---EVDAAV 125
Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEK---LIVRVSDCGLAPLLFSGSTNELSEG 606
              + L     + +  IVH + K  N+LL+ K    ++++ D GL+     G   ++ E 
Sbjct: 126 IMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKER 183
Query: 607 LLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           L TA+   APE     Y  + DV+S GV++  LL G  P+
Sbjct: 184 LGTAYYI-APEVLRKKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 448 IGEGLLGSVYKAEL--PGGKLL--AVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  G V + E   P GK +  AVK L  + +SQ +  ++F+   + +  L H N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L G        ++         L  LL    +    F      R A+  A  + YL+   
Sbjct: 80  LYGVVLTPPMKMVTE----LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 133
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE-LSEGLLTAHGSGAPE-FES 620
               +H +  + N+LL  + +V++ D GL   L     +  + E         APE  ++
Sbjct: 134 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
            ++S  SD +  GV + E+ T G++P+
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 117
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 118 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 120 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 120 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 120 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 448 IGEGLLGSVYKAEL--PGGKLL--AVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  G V + E   P GK +  AVK L  + +SQ +  ++F+   + +  L H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L G        ++         L  LL    +    F      R A+  A  + YL+   
Sbjct: 76  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE-LSEGLLTAHGSGAPE-FES 620
               +H +  + N+LL  + +V++ D GL   L     +  + E         APE  ++
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
            ++S  SD +  GV + E+ T G++P+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 448 IGEGLLGSVYKAEL--PGGKLL--AVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  G V + E   P GK +  AVK L  + +SQ +  ++F+   + +  L H N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L G        ++         L  LL    +    F      R A+  A  + YL+   
Sbjct: 86  LYGVVLTPPMKMVTE----LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE-LSEGLLTAHGSGAPE-FES 620
               +H +  + N+LL  + +V++ D GL   L     +  + E         APE  ++
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
            ++S  SD +  GV + E+ T G++P+
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 23/206 (11%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQR-----QTDEEFLELASTISRLRHGNIV 501
           +G G  G V+       G+  A+K L   +  R      T++E L L    S + H  I+
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML----SIVTHPFII 69
Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
            + G   +  Q  ++ DY     L  LL   +    +F   +    A     AL+YL   
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS- 124
Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG 621
               I++ + K  NILLD+   ++++D G     F+    +++  L       APE  S 
Sbjct: 125 --KDIIYRDLKPENILLDKNGHIKITDFG-----FAKYVPDVTYXLCGTPDYIAPEVVST 177
Query: 622 S-YSCQSDVYSLGVVMLELLTGRKPY 646
             Y+   D +S G+++ E+L G  P+
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 21/207 (10%)
Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRL--RHGNIVELI 504
           +G+G  G V+ AE     +  A+K L   V     D E   +   +  L   H  +  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 505 GYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
                      V +Y  GG     DL++  +  HK F  +   R    AA  +  LQ + 
Sbjct: 85  CTFQTKENLFFVMEYLNGG-----DLMYHIQSCHK-FDLS---RATFYAAEIILGLQFLH 135
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAP--LLFSGSTNELSEGLLTAHGSGAPEFES 620
              IV+ + K  NILLD+   ++++D G+    +L    TN             APE   
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC----GTPDYIAPEILL 191
Query: 621 G-SYSCQSDVYSLGVVMLELLTGRKPY 646
           G  Y+   D +S GV++ E+L G+ P+
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG+G  G V++ +  G ++ AVK  S+   +    E   E+  T+  LRH NI+  I   
Sbjct: 50  IGKGRFGEVWRGKWRGEEV-AVKIFSSREERSWFREA--EIYQTVM-LRHENILGFIAAD 105
Query: 508 NEHG----QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ-E 560
           N+      Q  LV DY  + +L D L+       +++  +   I++AL  A  L +L  E
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 561 VC----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           +     +P I H + KS NIL+ +     ++D GLA +    +T+ +   +   H  G  
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTID--IAPNHRVGTK 215
Query: 615 ---APEFESGSYSCQ-------SDVYSLGVVMLEL 639
              APE    S + +       +D+Y++G+V  E+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 94/232 (40%), Gaps = 32/232 (13%)
Query: 434 SLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELAST- 491
           S   +  ++     +G G+   V +    P  K  AVK +  T     + EE  EL    
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 492 ---ISRLR----HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR 544
              +  LR    H NI++L      +    LV+D      L D L       +K +  I 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI- 129
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
           +R  L    AL  L       IVH + K  NILLD+ + ++++D G +  L  G      
Sbjct: 130 MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------ 177
Query: 605 EGLLTAHGSG---APEFESGS-------YSCQSDVYSLGVVMLELLTGRKPY 646
           E L +  G+    APE    S       Y  + D++S GV+M  LL G  P+
Sbjct: 178 EKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 120 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG+G  G V++ +  G ++ AVK  S+   +    E   E+  T+  LRH NI+  I   
Sbjct: 12  IGKGRFGEVWRGKWRGEEV-AVKIFSSREERSWFREA--EIYQTVM-LRHENILGFIAAD 67
Query: 508 NEHG----QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ-E 560
           N+      Q  LV DY  + +L D L+       +++  +   I++AL  A  L +L  E
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHME 120
Query: 561 VC----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           +     +P I H + KS NIL+ +     ++D GLA +    +T+ +   +   H  G  
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTID--IAPNHRVGTK 177
Query: 615 ---APEFESGSYSCQ-------SDVYSLGVVMLEL 639
              APE    S + +       +D+Y++G+V  E+
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 448 IGEGLLGSV----YKAELPG-GKLLAVKKLSNTV--SQRQTDEEFLELASTISRLRHGNI 500
           +GEG  G V    Y     G G+++AVK L        R   +  +E+  T   L H +I
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRT---LYHEHI 72
Query: 501 VELIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           V+  G C + G+    LV +Y    +L D L                R  +G A+ L + 
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---------------PRHCVGLAQLLLFA 117
Query: 559 QEVCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG-STNELSEGLLTA 610
           Q++CE          +H    + N+LLD   +V++ D GLA  +  G     + E   + 
Sbjct: 118 QQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 177
Query: 611 HGSGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
               APE  +   +   SDV+S GV + ELLT
Sbjct: 178 VFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 448 IGEGLLGSV----YKAELPG-GKLLAVKKLSNTV--SQRQTDEEFLELASTISRLRHGNI 500
           +GEG  G V    Y     G G+++AVK L        R   +  +E+  T   L H +I
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRT---LYHEHI 73
Query: 501 VELIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           V+  G C + G+    LV +Y    +L D L                R  +G A+ L + 
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---------------PRHCVGLAQLLLFA 118
Query: 559 QEVCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG-STNELSEGLLTA 610
           Q++CE          +H    + N+LLD   +V++ D GLA  +  G     + E   + 
Sbjct: 119 QQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 178
Query: 611 HGSGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
               APE  +   +   SDV+S GV + ELLT
Sbjct: 179 VFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 448 IGEGLLGSV----YKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +GEG  G V    Y     G G+++AVK L      +       E+   +  L H +I++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI-DILRTLYHEHIIK 97
Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C + G     LV +Y    +L D L                R ++G A+ L + Q+
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYL---------------PRHSIGLAQLLLFAQQ 142
Query: 561 VCE-------PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG-STNELSEGLLTAHG 612
           +CE          +H +  + N+LLD   +V++ D GLA  +  G     + E   +   
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVF 202
Query: 613 SGAPE-FESGSYSCQSDVYSLGVVMLELLT 641
             APE  +   +   SDV+S GV + ELLT
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 17/207 (8%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +GEG  G V  A     +     K+ +        E   +     + L H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            E     L  +Y     L D +  D    E   ++F   +   V         YL  +  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV--------YLHGIG- 125
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF--ESG 621
             I H + K  N+LLDE+  +++SD GLA +    +   L   +       APE      
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 622 SYSCQSDVYSLGVVMLELLTGRKPYDR 648
            ++   DV+S G+V+  +L G  P+D+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 120 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG+G  G V++ +  G ++ AVK  S+   +    E   E+  T+  LRH NI+  I   
Sbjct: 14  IGKGRFGEVWRGKWRGEEV-AVKIFSSREERSWFREA--EIYQTVM-LRHENILGFIAAD 69
Query: 508 NEHG----QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ-E 560
           N+      Q  LV DY  + +L D L+       +++  +   I++AL  A  L +L  E
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHME 122
Query: 561 VC----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           +     +P I H + KS NIL+ +     ++D GLA +    +T+ +   +   H  G  
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTID--IAPNHRVGTK 179
Query: 615 ---APEFESGSYSCQ-------SDVYSLGVVMLEL 639
              APE    S + +       +D+Y++G+V  E+
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG+G  G V++ +  G ++ AVK  S+   +    E   E+  T+  LRH NI+  I   
Sbjct: 17  IGKGRFGEVWRGKWRGEEV-AVKIFSSREERSWFREA--EIYQTVM-LRHENILGFIAAD 72
Query: 508 NEHG----QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ-E 560
           N+      Q  LV DY  + +L D L+       +++  +   I++AL  A  L +L  E
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHME 125
Query: 561 VC----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           +     +P I H + KS NIL+ +     ++D GLA +    +T+ +   +   H  G  
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTID--IAPNHRVGTK 182
Query: 615 ---APEFESGSYSCQ-------SDVYSLGVVMLEL 639
              APE    S + +       +D+Y++G+V  E+
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD----EEAHKKFSWNIRIRVALG 550
           L H N+V+  G+  E     L  +Y     L D +  D    E   ++F   +   V   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
                 YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   +   
Sbjct: 119 ------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 611 HGSGAPEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
               APE       ++   DV+S G+V+  +L G  P+D+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG+G  G V++ +  G ++ AVK  S+   +    E   E+  T+  LRH NI+  I   
Sbjct: 37  IGKGRFGEVWRGKWRGEEV-AVKIFSSREERSWFREA--EIYQTVM-LRHENILGFIAAD 92
Query: 508 NEHG----QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ-E 560
           N+      Q  LV DY  + +L D L+       +++  +   I++AL  A  L +L  E
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHME 145
Query: 561 VC----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           +     +P I H + KS NIL+ +     ++D GLA +    +T+ +   +   H  G  
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTID--IAPNHRVGTK 202
Query: 615 ---APEFESGSYSCQ-------SDVYSLGVVMLEL 639
              APE    S + +       +D+Y++G+V  E+
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 81
Query: 503 LIGYCN-----EHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARAL 555
           L+         E    + +  +     L++++   +  + H +F       +     R L
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGL 134
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      A
Sbjct: 135 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMAGFVATRWYRA 186
Query: 616 PEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           PE       Y+   D++S+G +M ELLTGR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 448 IGEGLLGSVYKAEL--PGGKLL--AVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  G V + E   P GK +  AVK L  + +SQ +  ++F+   + +  L H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L G        ++         L  LL    +    F      R A+  A  + YL+   
Sbjct: 76  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE-LSEGLLTAHGSGAPE-FES 620
               +H +  + N+LL  + +V++ D GL   L     +  + E         APE  ++
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
            ++S  SD +  GV + E+ T G++P+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 448 IGEGLLGSVYKAEL--PGGKLL--AVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  G V + E   P GK +  AVK L  + +SQ +  ++F+   + +  L H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L G        ++         L  LL    +    F      R A+  A  + YL+   
Sbjct: 76  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE-LSEGLLTAHGSGAPE-FES 620
               +H +  + N+LL  + +V++ D GL   L     +  + E         APE  ++
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
            ++S  SD +  GV + E+ T G++P+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG+G  G V++ +  G ++ AVK  S+   +    E   E+  T+  LRH NI+  I   
Sbjct: 11  IGKGRFGEVWRGKWRGEEV-AVKIFSSREERSWFREA--EIYQTVM-LRHENILGFIAAD 66
Query: 508 NEHG----QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR--IRVALGAARALQYLQ-E 560
           N+      Q  LV DY  + +L D L+       +++  +   I++AL  A  L +L  E
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHME 119
Query: 561 VC----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           +     +P I H + KS NIL+ +     ++D GLA +    +T+ +   +   H  G  
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTID--IAPNHRVGTK 176
Query: 615 ---APEFESGSYSCQ-------SDVYSLGVVMLEL 639
              APE    S + +       +D+Y++G+V  E+
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 448 IGEGLLGSVYKAEL--PGGKLL--AVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  G V + E   P GK +  AVK L  + +SQ +  ++F+   + +  L H N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L G        ++         L  LL    +    F      R A+  A  + YL+   
Sbjct: 86  LYGVVLTPPMKMVTE----LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE-LSEGLLTAHGSGAPE-FES 620
               +H +  + N+LL  + +V++ D GL   L     +  + E         APE  ++
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
            ++S  SD +  GV + E+ T G++P+
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 32/228 (14%)
Query: 438 YTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELAST----I 492
           +  ++     +G G+   V +    P  K  AVK +  T     + EE  EL       +
Sbjct: 2   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 61
Query: 493 SRLR----HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
             LR    H NI++L      +    LV+D      L D L       +K +  I +R  
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MRAL 120
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
           L    AL  L       IVH + K  NILLD+ + ++++D G +  L  G      E L 
Sbjct: 121 LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------EKLR 168
Query: 609 TAHGSG---APEFESGS-------YSCQSDVYSLGVVMLELLTGRKPY 646
              G+    APE    S       Y  + D++S GV+M  LL G  P+
Sbjct: 169 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMAGFVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 448 IGEGLLGSVYKAEL--PGGKLL--AVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  G V + E   P GK +  AVK L  + +SQ +  ++F+   + +  L H N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L G        ++         L  LL    +    F      R A+  A  + YL+   
Sbjct: 80  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 133
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE-LSEGLLTAHGSGAPE-FES 620
               +H +  + N+LL  + +V++ D GL   L     +  + E         APE  ++
Sbjct: 134 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPY 646
            ++S  SD +  GV + E+ T G++P+
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMAGFVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 448 IGEGLLGSVY--KAELPGGK--LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V   K +L G +  +  +KK S T +        L+  + + +L H NI++L
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSG--ALLDEVAVLKQLDHPNIMKL 69
Query: 504 IGYCNEHGQHLLVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
             +  +   + LV + Y G     +++       +KFS    +  A+   + L     + 
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEII-----LRQKFS---EVDAAVIMKQVLSGTTYLH 121
Query: 563 EPPIVHGNFKSSNILLDEK---LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
           +  IVH + K  N+LL+ K    ++++ D GL+     G   ++ E L TA+   APE  
Sbjct: 122 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKERLGTAYYI-APEVL 178
Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPY 646
              Y  + DV+S GV++  LL G  P+
Sbjct: 179 RKKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 93/232 (40%), Gaps = 32/232 (13%)
Query: 434 SLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELAST- 491
           S   +  ++     +G G+   V +    P  K  AVK +  T     + EE  EL    
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 492 ---ISRLR----HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR 544
              +  LR    H NI++L      +    LV+D      L D L       +K +  I 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI- 129
Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
           +R  L    AL  L       IVH + K  NILLD+ + ++++D G +  L  G      
Sbjct: 130 MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------ 177
Query: 605 EGLLTAHGSG---APEFESGS-------YSCQSDVYSLGVVMLELLTGRKPY 646
           E L    G+    APE    S       Y  + D++S GV+M  LL G  P+
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 85
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 86  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 198
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRH 497
             F  G  +GEG   +V  A EL   +  A+K L      ++    ++      +SRL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAAR 553
              V+L     +  +      Y  N  L   +      DE   + ++  I          
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI--------VS 143
Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL+YL       I+H + K  NILL+E + ++++D G A +L   S    +   +     
Sbjct: 144 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 614 GAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPY 646
            +PE     S    SD+++LG ++ +L+ G  P+
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 83
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 84  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 196
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 83
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 84  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 196
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 103
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 104 IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 216
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 87
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 88  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKY 143
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 200
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 83
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 84  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 196
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 81
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 82  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 194
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 81
Query: 503 LIGYCN-----EHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARAL 555
           L+         E    + +  +     L++++   +  + H +F       +     R L
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGL 134
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      A
Sbjct: 135 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRA 186
Query: 616 PEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           PE       Y+   D++S+G +M ELLTGR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 91
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 92  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 147
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 148 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 204
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 205 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 83
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 84  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 196
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREI-KILLRFRHENI 87
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 88  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 200
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
           APE    +  Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 87
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 88  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 200
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 88
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 89  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 201
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 89
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 90  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 145
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 146 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 202
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 80
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 81  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 136
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 137 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 193
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 87
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 88  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 200
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 83
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 84  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 196
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 81
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 82  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 194
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           IG G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 90
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 142
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 143 LKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA-----RHTDDEMTGYVATRWYR 194
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/210 (20%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G VYKA+      LA  K+  T S+ + ++  +E+   ++   H  IV+L+G  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI-EILATCDHPYIVKLLGAY 77
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
              G+  ++ ++     +  ++   +    +    +  R  L    AL +L       I+
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALNFLH---SKRII 131
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE------FESG 621
           H + K+ N+L+  +  +R++D G++    +  T +  +  +      APE       +  
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 622 SYSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
            Y  ++D++SLG+ ++E+     P+    P
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPPHHELNP 219

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 33/210 (15%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  + ++  G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 114
Query: 503 LIGYCN-----EHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARAL 555
           L+         E    + +  +     L++++   +  + H +F       +     R L
Sbjct: 115 LLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGL 167
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      A
Sbjct: 168 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRA 219
Query: 616 PEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           PE       Y+   D++S+G +M ELLTGR
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 95
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 96  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 147
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 148 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 199
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 81
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L+           + ++     +  L+ +D     K +      V     + L+ L+ + 
Sbjct: 82  LLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH 138
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG- 621
              I+H + K SN+ ++E   +++ D GLA       T++   G +      APE     
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIMLNW 193
Query: 622 -SYSCQSDVYSLGVVMLELLTGR 643
             Y+   D++S+G +M ELLTGR
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 442 FSEGNFI---GEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           F + NF+    E   G ++K    G  ++ VK L       +   +F E    +    H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQGNDIV-VKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 499 NIVELIGYCNE--HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           N++ ++G C         L+  +    +L+++LH  E  +     +  ++ AL  AR + 
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMA 125
Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
           +L  + EP I      S ++++DE +  R+S   +A + FS      S G + A    AP
Sbjct: 126 FLHTL-EPLIPRHALNSRSVMIDEDMTARIS---MADVKFSFQ----SPGRMYAPAWVAP 177
Query: 617 EF----ESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           E        +    +D++S  V++ EL+T   P+
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 103
Query: 501 VELIGYCN----EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           + +         E  + + +  +     L+ LL +   ++    + +         R L+
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL-----YQILRGLK 158
Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           Y+       ++H + K SN+LL+    +++ D GLA +      +    G LT + +   
Sbjct: 159 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARV---ADPDHDHTGFLTEYVATRW 212
Query: 615 --APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
             APE    S  Y+   D++S+G ++ E+L+ R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 445 GNFIGEGLLGSVYKAE--LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-------L 495
           G+ +G G  G V   E  L G K+ AVK L+     RQ     L++   I R        
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKV-AVKILN-----RQKIRS-LDVVGKIKREIQNLKLF 68
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
           RH +I++L    +      +V +Y     L D +      H +       R+      A+
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAV 124
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS-- 613
            Y        +VH + K  N+LLD  +  +++D GL+ ++  G      E L T+ GS  
Sbjct: 125 DYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRTSCGSPN 175
Query: 614 -GAPEFESGSYSC--QSDVYSLGVVMLELLTGRKPYD 647
             APE  SG      + D++S GV++  LL G  P+D
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 448 IGEGLLGSVYKAELPGG---KLLAVKKLSNTVSQRQTD---------EEFLELASTISRL 495
           +G G  G V   +   G   K + V K S     R +D         EE     S +  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            H NI++L     +     LV ++     L + + +  +  +  + NI  ++  G     
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC--- 160
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEK---LIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
            YL +     IVH + K  NILL+ K   L +++ D GL+   F     +L + L TA+ 
Sbjct: 161 -YLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS--FFSKDYKLRDRLGTAYY 214
Query: 613 SGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY 646
             APE     Y+ + DV+S GV+M  LL G  P+
Sbjct: 215 I-APEVLKKKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 81
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 133
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 134 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 185
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/210 (20%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G+G  G VYKA+      LA  K+  T S+ + ++  +E+   ++   H  IV+L+G  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI-EILATCDHPYIVKLLGAY 85
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
              G+  ++ ++     +  ++   +    +    +  R  L    AL +L       I+
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALNFLH---SKRII 139
Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE------FESG 621
           H + K+ N+L+  +  +R++D G++    +  T +  +  +      APE       +  
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 622 SYSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
            Y  ++D++SLG+ ++E+     P+    P
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHELNP 227

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 105
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 157
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 158 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMXGXVATRWYR 209
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKXQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 105
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 157
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 158 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 209
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 82
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 83  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 134
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 135 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 186
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 82
Query: 503 LIGYCN-----EHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARAL 555
           L+         E    + +  +     L++++   +  + H +F       +     R L
Sbjct: 83  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGL 135
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      A
Sbjct: 136 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRA 187
Query: 616 PEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           PE       Y+   D++S+G +M ELLTGR
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 83
Query: 503 LIGYCN-----EHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARAL 555
           L+         E    + +  +     L++++   +  + H +F       +     R L
Sbjct: 84  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGL 136
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      A
Sbjct: 137 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRA 188
Query: 616 PEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           PE       Y+   D++S+G +M ELLTGR
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 16/222 (7%)
Query: 433 ASLQQYTNSFSEGN---FIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLEL 488
           + L +Y   + E      +G+G  G VY   +L     +A+K++    S+    +   E 
Sbjct: 12  SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS--QPLHEE 69
Query: 489 ASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
            +    L+H NIV+ +G  +E+G   +  +     +L  LL S     K     I     
Sbjct: 70  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI----G 125
Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPLLFSGSTNELSEGL 607
               + L+ L+ + +  IVH + K  N+L++    ++++SD G +  L     N  +E  
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETF 183
Query: 608 LTAHGSGAPEF-ESG--SYSCQSDVYSLGVVMLELLTGRKPY 646
                  APE  + G   Y   +D++SLG  ++E+ TG+ P+
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 90
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 142
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 143 LKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA-----RHTDDEMTGYVATRWYR 194
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 38/292 (13%)
Query: 446 NFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
             +GEG    V  A  L  GK  AVK +       ++   F E+ +      + NI+ELI
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS-RVFREVETLYQCQGNKNILELI 77
Query: 505 GYCNEHGQHLLVYD--YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
            +  +  +  LV++   GG+   H       +  K F+     RV    A AL +L    
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHI------QKQKHFNEREASRVVRDVAAALDFLHT-- 129
Query: 563 EPPIVHGNFKSSNILLD--EKLI-VRVSDCGLAP--LLFSGSTNELSEGLLTAHGSG--- 614
              I H + K  NIL +  EK+  V++ D  L     L +  T   +  L T  GS    
Sbjct: 130 -KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYM 188
Query: 615 APEF------ESGSYSCQSDVYSLGVVMLELLTGRKPY------DRSRPRGEQSLVRWAI 662
           APE       ++  Y  + D++SLGVV+  +L+G  P+      D    RGE  + R   
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGE--VCRVCQ 246
Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
            +L +     +   P  D A+++   S   D+IS+ +  +   R   ++++Q
Sbjct: 247 NKLFESIQEGKYEFPDKDWAHIS---SEAKDLISKLLVRDAKQRLSAAQVLQ 295

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 113/274 (41%), Gaps = 41/274 (14%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-LRHGNIVELIG 505
           IGEG  G V  A E   G+ +AVK +     QR+   E L     I R  +H N+VE+  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHFNVVEMYK 109
Query: 506 --YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
                E    L+ +  GG  T       D  +  + +      V     +AL YL     
Sbjct: 110 SYLVGEELWVLMEFLQGGALT-------DIVSQVRLNEEQIATVCEAVLQALAYLHA--- 159
Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS- 622
             ++H + KS +ILL     V++SD G    +         + L+      APE  S S 
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KXLVGTPYWMAPEVISRSL 217
Query: 623 YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD---PSL 679
           Y+ + D++SLG++++E++ G  PY    P                + A+ R+ D   P L
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSP----------------VQAMKRLRDSPPPKL 261
Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIV 713
             ++    + R  D + R +  +P  R    E++
Sbjct: 262 KNSHKVSPVLR--DFLERMLVRDPQERATAQELL 293

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 104
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 105 LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 156
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 157 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 208
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKXQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGXVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 87
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 139
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 140 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 191
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G+G  G VY   +L     +A+K++    S+    +   E  +    L+H NIV+ +G 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS--QPLHEEIALHKHLKHKNIVQYLGS 73
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
            +E+G   +  +     +L  LL S     K     I         + L+ L+ + +  I
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI----GFYTKQILEGLKYLHDNQI 129
Query: 567 VHGNFKSSNILLDEKL-IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF-ESG--S 622
           VH + K  N+L++    ++++SD G +  L     N  +E         APE  + G   
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEIIDKGPRG 187
Query: 623 YSCQSDVYSLGVVMLELLTGRKPY 646
           Y   +D++SLG  ++E+ TG+ P+
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPPF 211

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 90
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 142
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 143 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 194
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 92
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 144
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 196
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 96
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 97  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 148
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 149 LKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLA-----RHTDDEMTGYVATRWYR 200
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 91
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 143
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 144 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 195
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 108
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 109 LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 160
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 161 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMXGYVATRWYR 212
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 90
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 142
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 143 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 194
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A++K+S    Q        E+   + R RH NI
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREI-KILLRFRHENI 87
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 88  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 200
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 84
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 85  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 136
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 137 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 188
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGYCN-----EHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARAL 555
           L+         E    + +  +     L++++   +  + H +F       +     R L
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGL 138
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRA 190
Query: 616 PEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           PE       Y+   D++S+G +M ELLTGR
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 87
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 139
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 140 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 191
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 96
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 97  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 148
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 149 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 200
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 97
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 149
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 150 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 201
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 97
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 149
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 150 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 201
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 91
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 143
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 144 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 195
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 105
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 157
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 158 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 209
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYREL----RLLKHMKHENVIG 97
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 149
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 150 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 201
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 104
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 105 LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 156
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 157 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 208
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 87
Query: 503 LIGYCN-----EHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARAL 555
           L+         E    + +  +     L++++   +  + H +F       +     R L
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGL 140
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
           +Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      A
Sbjct: 141 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRA 192
Query: 616 PEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           PE       Y+   D++S+G +M ELLTGR
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 108
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 109 LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 160
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 161 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 212
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 92
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 144
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA      + +E++ G +      
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEMT-GYVATRWYR 196
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY- 506
           IG+G  G V+  +  G K+ AVK    T       E   E+  T+  +RH NI+  I   
Sbjct: 45  IGKGRYGEVWMGKWRGEKV-AVKVFFTTEEASWFRET--EIYQTV-LMRHENILGFIAAD 100
Query: 507 ---CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC- 562
                   Q  L+ DY  N +L+D L S     K       +++A  +   L +L     
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-----LKLAYSSVSGLCHLHTEIF 155
Query: 563 ----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA--- 615
               +P I H + KS NIL+ +     ++D GLA + F   TNE+     T  G+     
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 616 PEFESGSYS-------CQSDVYSLGVVMLEL 639
           PE    S +         +D+YS G+++ E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   ++  RH NI
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLA-FRHENI 85
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 86  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 198
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 92
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 144
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA      + +E++ G +      
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEMT-GYVATRWYR 196
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 91
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 143
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 144 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYR 195
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 92
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 144
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA      + +E++ G +      
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEMT-GYVATRWYR 196
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIG-- 505
           +G+G  G V++    G  + AVK  S+   +    E   EL +T+  LRH NI+  I   
Sbjct: 16  VGKGRYGEVWRGSWQGENV-AVKIFSSRDEKSWFRET--ELYNTVM-LRHENILGFIASD 71
Query: 506 YCNEHG--QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ-EVC 562
             + H   Q  L+  Y    +L+D L               +R+ L  A  L +L  E+ 
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIASGLAHLHIEIF 126
Query: 563 ----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---A 615
               +P I H + KS NIL+ +     ++D GLA ++ S STN+L  G     G+    A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 616 PEF--ESGSYSC-----QSDVYSLGVVMLEL 639
           PE   E+    C     + D+++ G+V+ E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++ S +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKSQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GL        T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLC-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 87
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 139
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 140 LKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLA-----RHTDDEMTGYVATRWYR 191
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 42/234 (17%)
Query: 432 IASLQQYTNSF---SEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLEL 488
           + + Q   NSF   S+   +G G  G V+K E     L    K+  T   +  +E   E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 489 ASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVA 548
            S +++L H N+++L          +LV +Y     L D +  +       S+N      
Sbjct: 138 -SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-------SYN------ 183
Query: 549 LGAARALQYLQEVCE-------PPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSG 598
           L     + +++++CE         I+H + K  NIL    D K I ++ D GLA      
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQI-KIIDFGLA------ 236
Query: 599 STNELSEGLLTAHGSGAPEF---ESGSY---SCQSDVYSLGVVMLELLTGRKPY 646
              +  E L    G+  PEF   E  +Y   S  +D++S+GV+   LL+G  P+
Sbjct: 237 RRYKPREKLKVNFGT--PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 91
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 143
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D GLA       T++   G +      
Sbjct: 144 LKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLA-----RHTDDEMTGYVATRWYR 195
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIG-- 505
           +G+G  G V++    G  + AVK  S+   +    E   EL +T+  LRH NI+  I   
Sbjct: 16  VGKGRYGEVWRGSWQGENV-AVKIFSSRDEKSWFRET--ELYNTVM-LRHENILGFIASD 71
Query: 506 YCNEHG--QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ-EVC 562
             + H   Q  L+  Y    +L+D L               +R+ L  A  L +L  E+ 
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIASGLAHLHIEIF 126
Query: 563 ----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---A 615
               +P I H + KS NIL+ +     ++D GLA ++ S STN+L  G     G+    A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 616 PEF--ESGSYSC-----QSDVYSLGVVMLEL 639
           PE   E+    C     + D+++ G+V+ E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 79/204 (38%), Gaps = 13/204 (6%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           +G G  G V+  E     L  V K  N    +   E+       +  L H NI+++    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
            ++    +V +      L + + S +   K  S      +      AL Y        +V
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVV 146
Query: 568 HGNFKSSNILLDE---KLIVRVSDCGLAPLLFSG--STNELSEGLLTAHGSGAPEFESGS 622
           H + K  NIL  +      +++ D GLA L  S   STN     L  A     PE     
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA-----PEVFKRD 201
Query: 623 YSCQSDVYSLGVVMLELLTGRKPY 646
            + + D++S GVVM  LLTG  P+
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 448 IGEGLLGSVYKAELPGGKLLAV-------KKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           IG G   +VYK  L     + V       +KL+ +  QR     F E A  +  L+H NI
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQR-----FKEEAEXLKGLQHPNI 87
Query: 501 VELIGYCNE--HGQH--LLVYDYGGNCTLHDLLHSDEEAHKKF--SWNIRIRVALGAARA 554
           V           G+   +LV +   + TL   L   +    K   SW  +I       + 
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKG 141
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           LQ+L     PPI+H + K  NI +      V++ D GLA L  +      ++ ++     
Sbjct: 142 LQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEF 196
Query: 614 GAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY 646
            APE     Y    DVY+ G   LE  T   PY
Sbjct: 197 XAPEXYEEKYDESVDVYAFGXCXLEXATSEYPY 229

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIG-- 505
           +G+G  G V++    G  + AVK  S+   +    E   EL +T+  LRH NI+  I   
Sbjct: 45  VGKGRYGEVWRGSWQGENV-AVKIFSSRDEKSWFRET--ELYNTV-MLRHENILGFIASD 100
Query: 506 YCNEHG--QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ-EVC 562
             + H   Q  L+  Y    +L+D L               +R+ L  A  L +L  E+ 
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIASGLAHLHIEIF 155
Query: 563 ----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---A 615
               +P I H + KS NIL+ +     ++D GLA ++ S STN+L  G     G+    A
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 616 PEF--ESGSYSC-----QSDVYSLGVVMLEL 639
           PE   E+    C     + D+++ G+V+ E+
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 492 ISRLRHGNIVELIG--YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
           + RLRH N+++L+   Y  E  +  +V +Y   C + ++L S  E  K+F          
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC-VCGMQEMLDSVPE--KRFPVCQAHGYFC 116
Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
                L+YL       IVH + K  N+LL     +++S  G+A  L   + ++      T
Sbjct: 117 QLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR---T 170
Query: 610 AHGSGA---PEFESG--SYS-CQSDVYSLGVVMLELLTGRKPYD 647
           + GS A   PE  +G  ++S  + D++S GV +  + TG  P++
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG+G  G V+KA     G+ +A+KK+     +       L     +  L+H N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 507 CNEH--------GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           C           G   LV+D+   C  HDL         KF+ +   RV       L Y+
Sbjct: 86  CRTKASPYNRCKGSIYLVFDF---CE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA---PLLFSGSTNELSEGLLTAHGSGA 615
                  I+H + K++N+L+    +++++D GLA    L  +   N     ++T      
Sbjct: 142 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL-WYRP 197
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLT 641
           PE   G   Y    D++  G +M E+ T
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 87
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 88  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--FSGSTNELSEGLLTAHGSGAPE- 617
           +    ++H + K SN+LL+    +++ D GLA +       T  L E + T     APE 
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT-RWYRAPEI 202
Query: 618 -FESGSYSCQSDVYSLGVVMLELLTGR 643
              S  Y+   D++S+G ++ E+L+ R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   + R RH NI
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENI 88
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 89  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--FSGSTNELSEGLLTAHGSGAPE- 617
           +    ++H + K SN+LL+    +++ D GLA +       T  L E + T     APE 
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT-RWYRAPEI 203
Query: 618 -FESGSYSCQSDVYSLGVVMLELLTGR 643
              S  Y+   D++S+G ++ E+L+ R
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG+G  G V+KA     G+ +A+KK+     +       L     +  L+H N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 507 CNEH--------GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           C           G   LV+D+   C  HDL         KF+ +   RV       L Y+
Sbjct: 86  CRTKASPYNRCKGSIYLVFDF---CE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA---PLLFSGSTNELSEGLLTAHGSGA 615
                  I+H + K++N+L+    +++++D GLA    L  +   N     ++T      
Sbjct: 142 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL-WYRP 197
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLT 641
           PE   G   Y    D++  G +M E+ T
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 116/294 (39%), Gaps = 58/294 (19%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GKLLA---VKKLSNTVSQRQTDEEFLELASTISR- 494
           + +  G  +G G    V K    G GK  A   +KK   + S+R    E +E    I R 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           +RH NI+ L          +L+ +      L D L   E              +L    A
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--------------SLTEDEA 110
Query: 555 LQYLQEVCE-------PPIVHGNFKSSNILLDEKLI----VRVSDCGLAPLLFSGSTNEL 603
            Q+L+++ +         I H + K  NI+L +K +    +++ D G+A  + +G  NE 
Sbjct: 111 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEF 168
Query: 604 SEGLLTAHGSGAPEF---ESGSYS---CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL 657
                     G PEF   E  +Y     ++D++S+GV+   LL+G  P+          L
Sbjct: 169 KNIF------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF----------L 212
Query: 658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSE 711
                  L +I A    V+   D  Y + +     D I R +  +P  R  +++
Sbjct: 213 GETKQETLTNISA----VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ 262

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIG 505
           +GEG    V   E L  G   A+K++   +   Q D E  +  + + RL  H NI+ L+ 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 506 YC-NEHG---QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           YC  E G   +  L+  +    TL + +   ++     + +  + + LG  R L+ +   
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152
Query: 562 CEPPIVHGNFKSSNILLDEK---LIVRVSDCGLAPLLFSGSTNELSEGLLTAH----GSG 614
                 H + K +NILL ++   +++ +     A +   GS   L+     A        
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 615 APEFESGSYSC----QSDVYSLGVVMLELLTGRKPYDRSRPRGE 654
           APE  S    C    ++DV+SLG V+  ++ G  PYD    +G+
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           ++  ++IGEG  G V  A     K+ +A+KK+S    Q        E+   ++  RH NI
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLA-FRHENI 85
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + +    N+  +   +        + DL+ +D     K        +     + L+ L+ 
Sbjct: 86  IGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----AP 616
           +    ++H + K SN+LL+    +++ D GLA +      +    G LT + +     AP
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAP 198
Query: 617 E--FESGSYSCQSDVYSLGVVMLELLTGR 643
           E    S  Y+   D++S+G ++ E+L+ R
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 44/229 (19%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GKLLA---VKKLSNTVSQRQTDEEFLELASTISR- 494
           + +  G  +G G    V K    G GK  A   +KK   + S+R    E +E    I R 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           +RH NI+ L          +L+ +      L D L   E              +L    A
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--------------SLTEDEA 117
Query: 555 LQYLQEVCE-------PPIVHGNFKSSNILLDEKLI----VRVSDCGLAPLLFSGSTNEL 603
            Q+L+++ +         I H + K  NI+L +K +    +++ D G+A  + +G  NE 
Sbjct: 118 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEF 175
Query: 604 SEGLLTAHGSGAPEF---ESGSYS---CQSDVYSLGVVMLELLTGRKPY 646
                     G PEF   E  +Y     ++D++S+GV+   LL+G  P+
Sbjct: 176 KNIF------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG+G  G V+KA     G+ +A+KK+     +       L     +  L+H N+V LI  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 507 CNEH--------GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           C           G   LV+D+   C  HDL         KF+ +   RV       L Y+
Sbjct: 85  CRTKASPYNRCKGSIYLVFDF---CE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA---PLLFSGSTNELSEGLLTAHGSGA 615
                  I+H + K++N+L+    +++++D GLA    L  +   N     ++T      
Sbjct: 141 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL-WYRP 196
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLT 641
           PE   G   Y    D++  G +M E+ T
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 34/217 (15%)
Query: 445 GNFIGEGLLGSVYKAE--LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-------L 495
           G+ +G G  G V   E  L G K+ AVK L+     RQ     L++   I R        
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKV-AVKILN-----RQKIRS-LDVVGKIKREIQNLKLF 68
Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
           RH +I++L    +      +V +Y     L D +      H +       R+      A+
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAV 124
Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS-- 613
            Y        +VH + K  N+LLD  +  +++D GL+ ++  G      E L  + GS  
Sbjct: 125 DYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRDSCGSPN 175
Query: 614 -GAPEFESGSYSC--QSDVYSLGVVMLELLTGRKPYD 647
             APE  SG      + D++S GV++  LL G  P+D
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 448 IGEGLLGSV---YKAELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNI 500
           +G G  GSV   Y A L   + +AVKKLS    + +  R+T  E       +  L+H N+
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYREL----RLLKHLKHENV 81
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
              IG  +       + D+     +  L+ +D     K        V     + L+ L+ 
Sbjct: 82  ---IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKY 138
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES 620
           +    I+H + K SN+ ++E   +R+ D GLA        +E   G +      APE   
Sbjct: 139 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLA-----RQADEEMTGYVATRWYRAPEIML 193
Query: 621 G--SYSCQSDVYSLGVVMLELLTGR 643
               Y+   D++S+G +M ELL G+
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 39/213 (18%)
Query: 448 IGEGLLGSV---YKAELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNI 500
           +G G  GSV   Y A L   + +AVKKLS    + +  R+T  E       +  L+H N+
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYREL----RLLKHLKHENV 89
Query: 501 VELIGY------CNEHGQHLLVYDYGGNCTLHDLLHSD--EEAHKKFSWNIRIRVALGAA 552
           + L+          +  +  LV    G   L++++ S    + H +F       +     
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKSQALSDEHVQF-------LVYQLL 141
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           R L+Y+       I+H + K SN+ ++E   +R+ D GLA        +E   G +    
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLA-----RQADEEMTGYVATRW 193
Query: 613 SGAPEFESG--SYSCQSDVYSLGVVMLELLTGR 643
             APE       Y+   D++S+G +M ELL G+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 448 IGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRHGNIVELIG 505
           +G G  G V++  E   G   A K +   ++  ++D+E +     T+S LRH  +V L  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 506 YCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC- 562
              +  + +++Y++  GG     +L     + H K S +           A++Y+++VC 
Sbjct: 222 AFEDDNEMVMIYEFMSGG-----ELFEKVADEHNKMSED----------EAVEYMRQVCK 266
Query: 563 ------EPPIVHGNFKSSNILLDEKLI--VRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
                 E   VH + K  NI+   K    +++ D GL   L    + +++ G        
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF---A 323
Query: 615 APEFESGS-YSCQSDVYSLGVVMLELLTGRKPY 646
           APE   G      +D++S+GV+   LL+G  P+
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 31/177 (17%)
Query: 480 QTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSD-EEAH 536
           QT++   E AS      H  +V L        +   V +Y  GG+   H        E H
Sbjct: 57  QTEKHVFEQASN-----HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 111
Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
            +F        +   + AL YL E     I++ + K  N+LLD +  ++++D G+     
Sbjct: 112 ARF-------YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC---- 157
Query: 597 SGSTNELSEGLLTAHGSG-----APEFESGS-YSCQSDVYSLGVVMLELLTGRKPYD 647
                 L  G  T+   G     APE   G  Y    D ++LGV+M E++ GR P+D
Sbjct: 158 ---KEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 442 FSEGNFIGEGLLGSVYKAELPGGKL-LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           +++  +IGEG  G V  A     K  +A+KK+S    Q        E+   + R RH N+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREI-QILLRFRHENV 103
Query: 501 VELIGYCN----EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           + +         E  + + +        L+ LL S + ++    + +         R L+
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFL-----YQILRGLK 158
Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL--FSGSTNELSEGLLTAHGSG 614
           Y+       ++H + K SN+L++    +++ D GLA +       T  L+E + T     
Sbjct: 159 YIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT-RWYR 214
Query: 615 APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
           APE    S  Y+   D++S+G ++ E+L+ R
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 27/219 (12%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL--R 496
           ++F     +G+G  G V  A +   G L AVK L   V  +  D E       I  L   
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 497 HGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           H  + +L        +   V ++  GG+   H       +  ++F      R    AA  
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI------QKSRRFD---EARARFYAAEI 133
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           +  L  + +  I++ + K  N+LLD +   +++D G+      G  N    G+ TA   G
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICN----GVTTATFCG 186
Query: 615 APEF------ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
            P++      +   Y    D +++GV++ E+L G  P++
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++ D  LA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 115/294 (39%), Gaps = 58/294 (19%)
Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GKLLA---VKKLSNTVSQRQTDEEFLELASTISR- 494
           + +  G  +G G    V K    G GK  A   +KK     S+R    E +E    I R 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           +RH NI+ L          +L+ +      L D L   E              +L    A
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--------------SLTEDEA 131
Query: 555 LQYLQEVCE-------PPIVHGNFKSSNILLDEKLI----VRVSDCGLAPLLFSGSTNEL 603
            Q+L+++ +         I H + K  NI+L +K +    +++ D G+A  + +G  NE 
Sbjct: 132 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEF 189
Query: 604 SEGLLTAHGSGAPEF---ESGSYS---CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL 657
                     G PEF   E  +Y     ++D++S+GV+   LL+G  P+          L
Sbjct: 190 KNIF------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF----------L 233
Query: 658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSE 711
                  L +I A    V+   D  Y + +     D I R +  +P  R  +++
Sbjct: 234 GETKQETLTNISA----VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQ 283

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 448 IGEGLLGSVYK-AELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRHGNIVELIG 505
           +G G  G V++  E   G   A K +   ++  ++D+E +     T+S LRH  +V L  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLRHPTLVNLHD 115
Query: 506 YCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC- 562
              +  + +++Y++  GG     +L     + H K S +           A++Y+++VC 
Sbjct: 116 AFEDDNEMVMIYEFMSGG-----ELFEKVADEHNKMSED----------EAVEYMRQVCK 160
Query: 563 ------EPPIVHGNFKSSNILLDEKLI--VRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
                 E   VH + K  NI+   K    +++ D GL   L    + +++ G        
Sbjct: 161 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF---A 217
Query: 615 APEFESGS-YSCQSDVYSLGVVMLELLTGRKPY 646
           APE   G      +D++S+GV+   LL+G  P+
Sbjct: 218 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 83/193 (43%), Gaps = 18/193 (9%)
Query: 464 GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL------IGYCNEHGQHLLVY 517
           G+ +A+K+    +S +  +   LE+   + +L H N+V        +     +   LL  
Sbjct: 40  GEQVAIKQCRQELSPKNRERWCLEI-QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 98
Query: 518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNIL 577
           +Y     L   L+  E         IR  ++   + AL+YL E     I+H + K  NI+
Sbjct: 99  EYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHE---NRIIHRDLKPENIV 154
Query: 578 LD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF-ESGSYSCQSDVYSLG 633
           L    ++LI ++ D G A  L  G   EL    +      APE  E   Y+   D +S G
Sbjct: 155 LQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 211
Query: 634 VVMLELLTGRKPY 646
            +  E +TG +P+
Sbjct: 212 TLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 83/193 (43%), Gaps = 18/193 (9%)
Query: 464 GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL------IGYCNEHGQHLLVY 517
           G+ +A+K+    +S +  +   LE+   + +L H N+V        +     +   LL  
Sbjct: 39  GEQVAIKQCRQELSPKNRERWCLEI-QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97
Query: 518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNIL 577
           +Y     L   L+  E         IR  ++   + AL+YL E     I+H + K  NI+
Sbjct: 98  EYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHE---NRIIHRDLKPENIV 153
Query: 578 LD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF-ESGSYSCQSDVYSLG 633
           L    ++LI ++ D G A  L  G   EL    +      APE  E   Y+   D +S G
Sbjct: 154 LQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 210
Query: 634 VVMLELLTGRKPY 646
            +  E +TG +P+
Sbjct: 211 TLAFECITGFRPF 223

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +GEG  G VYKA +    + +A+K++     +       +   S +  L+H NI+EL   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP-P 565
            + + +  L+++Y  N         D + +   + ++ +RV       L      C    
Sbjct: 102 IHHNHRLHLIFEYAEN---------DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 566 IVHGNFKSSNILL-----DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES 620
            +H + K  N+LL      E  ++++ D GLA   F     + +  ++T      PE   
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA-RAFGIPIRQFTHEIITL-WYRPPEILL 210
Query: 621 GS--YSCQSDVYSLGVVMLELL 640
           GS  YS   D++S+  +  E+L
Sbjct: 211 GSRHYSTSVDIWSIACIWAEML 232

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 64/299 (21%), Positives = 117/299 (39%), Gaps = 42/299 (14%)
Query: 435 LQQYTNSFSE---GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELAST 491
           LQ++   F +   G  IG+G  G VY     G   +A++ +          + F      
Sbjct: 25  LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMA 82
Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGA 551
             + RH N+V  +G C       ++       TL+ ++    +A      N   ++A   
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEI 139
Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
            + + YL       I+H + KS N+  D   +V ++D GL  +          + L   +
Sbjct: 140 VKGMGYLHA---KGILHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 612 G---SGAPEF----------ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV 658
           G     APE           +   +S  SDV++LG +  EL     P+ +++P      +
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-KTQP---AEAI 251
Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
            W          +   + P+L    + K +S   DI+  C  +E   RP  ++++ D+L
Sbjct: 252 IW---------QMGTGMKPNLSQIGMGKEIS---DILLFCWAFEQEERPTFTKLM-DML 297

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 75/178 (42%), Gaps = 33/178 (18%)
Query: 480 QTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSD--EEA 535
           QT++   E AS      H  +V L        +   V +Y  GG+   H        EE 
Sbjct: 68  QTEKHVFEQASN-----HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 122
Query: 536 HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL 595
            + +S  I +        AL YL E     I++ + K  N+LLD +  ++++D G+    
Sbjct: 123 ARFYSAEISL--------ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC--- 168
Query: 596 FSGSTNELSEGLLTAHGSG-----APEFESGS-YSCQSDVYSLGVVMLELLTGRKPYD 647
                  L  G  T+   G     APE   G  Y    D ++LGV+M E++ GR P+D
Sbjct: 169 ----KEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 31/177 (17%)
Query: 480 QTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSD-EEAH 536
           QT++   E AS      H  +V L        +   V +Y  GG+   H        E H
Sbjct: 53  QTEKHVFEQASN-----HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 107
Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
            +F        +   + AL YL E     I++ + K  N+LLD +  ++++D G+     
Sbjct: 108 ARF-------YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC---- 153
Query: 597 SGSTNELSEGLLTAHGSG-----APEFESGS-YSCQSDVYSLGVVMLELLTGRKPYD 647
                 L  G  T+   G     APE   G  Y    D ++LGV+M E++ GR P+D
Sbjct: 154 ---KEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 448 IGEGLLGSV---YKAELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNI 500
           +G G  GSV   Y A L   + +AVKKLS    + +  R+T  E       +  L+H N+
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYREL----RLLKHLKHENV 89
Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
              IG  +       + D+     +  L+ +D     K        V     + L+ L+ 
Sbjct: 90  ---IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKY 146
Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES 620
           +    I+H + K SN+ ++E   +R+ D GLA        +E   G +      APE   
Sbjct: 147 IHSAGIIHRDLKPSNVAVNEDSELRILDFGLA-----RQADEEMTGYVATRWYRAPEIML 201
Query: 621 G--SYSCQSDVYSLGVVMLELLTGR 643
               Y+   D++S+G +M ELL G+
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 28/157 (17%)
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + NILL EK +V++ D GLA  ++                  APE      Y+ 
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 272
Query: 626 QSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
           QSDV+S GV++ E+ + G  PY     D    R  +   R   P     +    M+D   
Sbjct: 273 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD--- 329
Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                             C   EP  RP  SE+V+ L
Sbjct: 330 ------------------CWHGEPSQRPTFSELVEHL 348

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 31/177 (17%)
Query: 480 QTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSD-EEAH 536
           QT++   E AS      H  +V L        +   V +Y  GG+   H        E H
Sbjct: 100 QTEKHVFEQASN-----HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 154
Query: 537 KKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
            +F ++  I +AL       YL E     I++ + K  N+LLD +  ++++D G+     
Sbjct: 155 ARF-YSAEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC---- 200
Query: 597 SGSTNELSEGLLTAHGSG-----APEFESGS-YSCQSDVYSLGVVMLELLTGRKPYD 647
                 L  G  T+   G     APE   G  Y    D ++LGV+M E++ GR P+D
Sbjct: 201 ---KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 28/157 (17%)
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + NILL EK +V++ D GLA  ++                  APE      Y+ 
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 626 QSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
           QSDV+S GV++ E+ + G  PY     D    R  +   R   P     +    M+D   
Sbjct: 275 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD--- 331
Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                             C   EP  RP  SE+V+ L
Sbjct: 332 ------------------CWHGEPSQRPTFSELVEHL 350

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 28/157 (17%)
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + NILL EK +V++ D GLA  ++                  APE      Y+ 
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 626 QSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
           QSDV+S GV++ E+ + G  PY     D    R  +   R   P     +    M+D   
Sbjct: 280 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD--- 336
Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                             C   EP  RP  SE+V+ L
Sbjct: 337 ------------------CWHGEPSQRPTFSELVEHL 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 28/157 (17%)
Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSC 625
           +H +  + NILL EK +V++ D GLA  ++                  APE      Y+ 
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 281
Query: 626 QSDVYSLGVVMLELLT-GRKPY-----DRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
           QSDV+S GV++ E+ + G  PY     D    R  +   R   P     +    M+D   
Sbjct: 282 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD--- 338
Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                             C   EP  RP  SE+V+ L
Sbjct: 339 ------------------CWHGEPSQRPTFSELVEHL 357

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 44/233 (18%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLA---VKKLSNTVSQRQTDEEFLELAST 491
           Q+  + +  G  +G G    V K  E   G   A   +KK  +  S+R    E +E   +
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 492 ISR-LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALG 550
           I R + H N++ L          +L+ +      L D L   E              +L 
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--------------SLS 113
Query: 551 AARALQYLQEVCE-------PPIVHGNFKSSNILLDEKLI----VRVSDCGLAPLLFSGS 599
              A  +++++ +         I H + K  NI+L +K I    +++ D GLA       
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA------- 166
Query: 600 TNELSEGLLTAHGSGAPEF---ESGSYS---CQSDVYSLGVVMLELLTGRKPY 646
            +E+ +G+   +  G PEF   E  +Y     ++D++S+GV+   LL+G  P+
Sbjct: 167 -HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 6/204 (2%)
Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE---- 502
           IG G  G   K      GK+L  K+L          +  +   + +  L+H NIV     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           +I   N     ++ Y  GG+        + E  +    + +R+   L  A    + +   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS 622
              ++H + K +N+ LD K  V++ D GLA +L +   +   E + T +     +    S
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDEDFAKEFVGTPYYMSPEQMNRMS 192
Query: 623 YSCQSDVYSLGVVMLELLTGRKPY 646
           Y+ +SD++SLG ++ EL     P+
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  GSV  A +   G  +AVKKLS    + +  ++T  E       +  ++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL----RLLKHMKHENVIG 85
Query: 503 LIGY------CNEHGQHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARA 554
           L+          E     LV    G   L++++   +  + H +F       +     R 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQF-------LIYQILRG 137
Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+Y+       I+H + K SN+ ++E   +++   GLA       T++   G +      
Sbjct: 138 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLA-----RHTDDEMTGYVATRWYR 189
Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGR 643
           APE       Y+   D++S+G +M ELLTGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG+G  G V+KA     G+ +A+KK+     +       L     +  L+H N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 507 CNEHGQHL--------LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           C               LV+D+   C  HDL         KF+ +   RV       L Y+
Sbjct: 86  CRTKASPYNRCKASIYLVFDF---CE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA---PLLFSGSTNELSEGLLTAHGSGA 615
                  I+H + K++N+L+    +++++D GLA    L  +   N     ++T      
Sbjct: 142 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL-WYRP 197
Query: 616 PEFESGS--YSCQSDVYSLGVVMLELLT 641
           PE   G   Y    D++  G +M E+ T
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 44/233 (18%)
Query: 436 QQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLA---VKKLSNTVSQRQTDEEFLELAST 491
           Q+  + +  G  +G G    V K  E   G   A   +KK  +  S+R    E +E   +
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 492 ISR-LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALG 550
           I R + H N++ L          +L+ +      L D L   E              +L 
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--------------SLS 113
Query: 551 AARALQYLQEVCE-------PPIVHGNFKSSNILLDEKLI----VRVSDCGLAPLLFSGS 599
              A  +++++ +         I H + K  NI+L +K I    +++ D GLA       
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA------- 166
Query: 600 TNELSEGLLTAHGSGAPEF---ESGSYS---CQSDVYSLGVVMLELLTGRKPY 646
            +E+ +G+   +  G PEF   E  +Y     ++D++S+GV+   LL+G  P+
Sbjct: 167 -HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 6/204 (2%)
Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE---- 502
           IG G  G   K      GK+L  K+L          +  +   + +  L+H NIV     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           +I   N     ++ Y  GG+        + E  +    + +R+   L  A    + +   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS 622
              ++H + K +N+ LD K  V++ D GLA +L +  T+     + T +     +    S
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFVGTPYYMSPEQMNRMS 192
Query: 623 YSCQSDVYSLGVVMLELLTGRKPY 646
           Y+ +SD++SLG ++ EL     P+
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 37/234 (15%)
Query: 439 TNSFSEGNFIGEGLLGSVYKAELPGG-KLLAVKKLSNTVSQRQTDEEFLELASTISRLRH 497
           ++ F   + +G G    VY+ +  G  K  A+K L  TV ++    E       + RL H
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEI----GVLLRLSH 107
Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIRIRVALGAA 552
            NI++L        +  LV +      L D +     +S+ +A            A    
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA------------ADAVK 155
Query: 553 RALQYLQEVCEPPIVHGNFKSSNILL-----DEKLIVRVSDCGLAPLLFSGSTNELSEGL 607
           + L+ +  + E  IVH + K  N+L      D  L  +++D GL+ ++       L + +
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL--KIADFGLSKIV---EHQVLMKTV 210
Query: 608 LTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKP-YDRSRPRGEQSLVR 659
               G  APE   G +Y  + D++S+G++   LL G +P YD    RG+Q + R
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE---RGDQFMFR 261

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 6/204 (2%)
Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE---- 502
           IG G  G   K      GK+L  K+L          +  +   + +  L+H NIV     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           +I   N     ++ Y  GG+        + E  +    + +R+   L  A    + +   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS 622
              ++H + K +N+ LD K  V++ D GLA +L +  T+     + T +     +    S
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFVGTPYYMSPEQMNRMS 192
Query: 623 YSCQSDVYSLGVVMLELLTGRKPY 646
           Y+ +SD++SLG ++ EL     P+
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 448 IGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV---EL 503
           IG G  G V  A     G+ +A+KK+ N        +  L     +   +H NI+   ++
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 504 IGYCNEHGQHLLVYDYGG--NCTLHDLLHSDE----EAHKKFSWNIRIRVALGAARALQY 557
           +     +G+   VY         LH ++HS +    E  + F + +         R L+Y
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQL--------LRGLKY 174
Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE---LSEGLLTAHGSG 614
           +       ++H + K SN+L++E   +++ D G+A  L +        ++E + T     
Sbjct: 175 MHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT-RWYR 230
Query: 615 APE--FESGSYSCQSDVYSLGVVMLELLTGRK 644
           APE       Y+   D++S+G +  E+L  R+
Sbjct: 231 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 38/221 (17%)
Query: 447 FIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIG- 505
            IG G  G+VYK  L   + +AVK  S    Q   +E+ +     +  + H NI   I  
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNI---YRVPLMEHDNIARFIVG 75
Query: 506 ----YCNEHGQHLLVYDYGGNCTLHDLL--HSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
                 +   ++LLV +Y  N +L   L  H+ +       W    R+A    R L YL 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-------WVSSCRLAHSVTRGLAYLH 128
Query: 560 ------EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA------PLLFSGSTNELSEGL 607
                 +  +P I H +  S N+L+       +SD GL+       L+  G  +  +   
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 608 LTAHGSGAPEFESGSYSC--------QSDVYSLGVVMLELL 640
           +      APE   G+ +         Q D+Y+LG++  E+ 
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	720
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-95
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-90
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-58
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-49
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-45
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-44
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-44
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-44
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-43
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-42
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-42
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-42
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-34
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-40
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-40
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-39
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-25
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-24
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-29
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-10
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-25
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-25
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-24
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-24
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-24
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-23
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-23
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-09
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-23
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-23
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-23
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-23
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-23
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-23
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-22
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-22
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-22
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-22
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-11
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-07
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-20
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-20
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-20
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-12
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-19
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-19
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-19
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-07
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-18
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-15
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-13
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-18
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-12
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-18
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-15
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-08
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-15
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-13
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-17
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-17
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-17
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-11
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-16
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-12
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-16
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-16
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-10
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-16
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-16
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-09
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-12
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-09
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-10
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-15
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-15
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-15
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-15
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-15
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-05
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-15
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-06
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-14
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-11
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-14
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-13
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-09
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-13
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-06
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-12
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-05
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-10
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-08
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-11
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-07
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-04
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-11
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-11
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-11
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-11
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-08
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-10
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-10
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-05
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-10
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-10
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-10
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-10
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-09
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-09
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-09
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-09
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-09
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-09
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-09
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-08
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-08
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-08
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-08
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-08
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-08
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-08
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-08
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-05
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-08
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-08
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-08
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-08
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-08
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-08
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-07
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-07
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-07
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-07
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-07
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-07
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-04
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-07
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-06
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-06
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-06
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-06
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-06
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	3e-06
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-05
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-05
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-05
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-04
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-04
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-04
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	6e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  302 bits (777), Expect = 2e-97
 Identities = 97/305 (31%), Positives = 150/305 (49%), Gaps = 7/305 (2%)

Query: 413 TRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKL 472
              +  S+ ++        +  L++ TN+F     IG G+ G VYK  L  G  +A+K+ 
Sbjct: 12  INDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR 71

Query: 473 SNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD 532
           +      Q  EEF     T+S  RH ++V LIG+C+E  + +L+Y Y  N  L   L+  
Sbjct: 72  TP--ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129

Query: 533 EEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA 592
           +      SW  R+ + +GAAR L YL       I+H + KS NILLDE  + +++D G++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS 186

Query: 593 PLLFSGSTNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP 651
                     LS  +    G   PE F  G  + +SDVYS GVV+ E+L  R    +S P
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

Query: 652 RGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSE 711
           R   +L  WA+   H+   L ++VDP+L      +SL +F D   +C+      RP M +
Sbjct: 247 REMVNLAEWAVE-SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305

Query: 712 IVQDL 716
           ++  L
Sbjct: 306 VLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  297 bits (762), Expect = 3e-95
 Identities = 102/299 (34%), Positives = 156/299 (52%), Gaps = 6/299 (2%)

Query: 421 NVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQ 480
            V    +  F++  LQ  +++FS  N +G G  G VYK  L  G L+AVK+L    +Q  
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-G 69

Query: 481 TDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFS 540
            + +F      IS   H N++ L G+C    + LLVY Y  N ++   L    E+     
Sbjct: 70  GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129

Query: 541 WNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST 600
           W  R R+ALG+AR L YL + C+P I+H + K++NILLDE+    V D GLA L+    T
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189

Query: 601 NELSEGLLTAHGSGAPEF-ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS--L 657
           + ++  +    G  APE+  +G  S ++DV+  GV++LEL+TG++ +D +R   +    L
Sbjct: 190 H-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248

Query: 658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           + W    L     L  +VD  L G Y  + + +   +   C Q  P  RP MSE+V+ L
Sbjct: 249 LDWVKG-LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  282 bits (725), Expect = 6e-90
 Identities = 88/306 (28%), Positives = 148/306 (48%), Gaps = 16/306 (5%)

Query: 419 STNVISSSVSVFTIASLQQYTNSFSE------GNFIGEGLLGSVYKAELPGGKLLAVKKL 472
           S  V  +    F+   L+  TN+F E      GN +GEG  G VYK  +     +AVKKL
Sbjct: 4   SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL 62

Query: 473 SNTVSQ--RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLH 530
           +  V     +  ++F +    +++ +H N+VEL+G+ ++     LVY Y  N +L D L 
Sbjct: 63  AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122

Query: 531 SDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG 590
              +     SW++R ++A GAA  + +L E      +H + KS+NILLDE    ++SD G
Sbjct: 123 -CLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFG 178

Query: 591 LAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSR 650
           LA      +   ++  ++      APE   G  + +SD+YS GVV+LE++TG    D  R
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

Query: 651 PRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMS 710
               Q L+        +   +   +D  ++    + S+     + S+C+  +   RP + 
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIK 295

Query: 711 EIVQDL 716
           ++ Q L
Sbjct: 296 KVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  199 bits (508), Expect = 3e-58
 Identities = 68/320 (21%), Positives = 112/320 (35%), Gaps = 41/320 (12%)

Query: 424 SSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDE 483
            SS       +L   +           G  G V+KA+    + +AVK       Q   +E
Sbjct: 8   HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNE 66

Query: 484 EFLELASTISRLRHGNIVELIGYC----NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKF 539
              E+ S    ++H NI++ IG      +      L+  +    +L D L          
Sbjct: 67  --YEVYSL-PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVV 118

Query: 540 SWNIRIRVALGAARALQYL-------QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA 592
           SWN    +A   AR L YL       ++  +P I H + KS N+LL   L   ++D GLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

Query: 593 PLLFSGSTNELSEGLLTAHGSG-----APEF------ESGSYSCQSDVYSLGVVMLELLT 641
            L F    +       T    G     APE              + D+Y++G+V+ EL +
Sbjct: 179 -LKFEAGKSAGD----THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

Query: 642 GRKPYDRSRPRGEQSL--VRWAIPRLHDIDAL--SRMVDPSLDGAYLAKS-LSRFADIIS 696
                D                 P L D+  +   +   P L   +   + ++   + I 
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293

Query: 697 RCVQWEPGFRPPMSEIVQDL 716
            C   +   R     + + +
Sbjct: 294 ECWDHDAEARLSAGCVGERI 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  174 bits (442), Expect = 4e-49
 Identities = 88/325 (27%), Positives = 135/325 (41%), Gaps = 50/325 (15%)

Query: 414 RRSSPSTNVISSSVSVFTIASLQQYTN---SFSE---GNFIGEGLLGSVYKAELPGGKLL 467
               P ++    +             +    + +      IG G  G+V++AE   G  +
Sbjct: 5   HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDV 63

Query: 468 AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHD 527
           AVK L       +   EFL   + + RLRH NIV  +G   +     +V +Y    +L+ 
Sbjct: 64  AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123

Query: 528 LLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVS 587
           LLH    A ++     R+ +A   A+ + YL     PPIVH N KS N+L+D+K  V+V 
Sbjct: 124 LLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVC 181

Query: 588 DCGLAPLLFSGSTNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLT 641
           D GL       S  + S  L +   +G     APE       + +SDVYS GV++ EL T
Sbjct: 182 DFGL-------SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

Query: 642 GRKPYDRSRPR------GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADII 695
            ++P+    P       G +   R  IPR  +++                    + A II
Sbjct: 235 LQQPWGNLNPAQVVAAVGFKCK-RLEIPR--NLN-------------------PQVAAII 272

Query: 696 SRCVQWEPGFRPPMSEIVQDLLCMI 720
             C   EP  RP  + I+  L  +I
Sbjct: 273 EGCWTNEPWKRPSFATIMDLLRPLI 297

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  161 bits (410), Expect = 9e-45
 Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 42/285 (14%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
                   +G G  G V KA+    K +A+K++ +        + F+     +SR+ H N
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPN 62

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV+L G C       LV +Y    +L+++LH   E    ++    +   L  ++ + YL 
Sbjct: 63  IVKLYGACLNP--VCLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 560 EVCEPPIVHGNFKSSNILLDEK-LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---A 615
            +    ++H + K  N+LL     ++++ D G A  + +  TN          GS    A
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--------GSAAWMA 171

Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP---RLHDIDAL 671
           PE FE  +YS + DV+S G+++ E++T RKP+D       +  + WA+    R      L
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHNGTRPP----L 225

Query: 672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            + +   +              +++RC   +P  RP M EIV+ +
Sbjct: 226 IKNLPKPI------------ESLMTRCWSKDPSQRPSMEEIVKIM 258

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  159 bits (405), Expect = 2e-44
 Identities = 74/291 (25%), Positives = 122/291 (41%), Gaps = 43/291 (14%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTD--EEFLELASTISRLRH 497
              +    IG G  G VY+A    G  +AVK   +   +  +   E   + A   + L+H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            NI+ L G C +     LV ++     L+ +L       K+   +I +  A+  AR + Y
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNY 120

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKL--------IVRVSDCGLAPLLFSGSTNELSEGLLT 609
           L +    PI+H + KSSNIL+ +K+        I++++D GL       +        ++
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL-------AREWHRTTKMS 173

Query: 610 AHGSG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL 665
           A G+    APE   +  +S  SDV+S GV++ ELLTG  P+           V + +   
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----LAVAYGVAMN 229

Query: 666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                   +  PS            FA ++  C   +P  RP  + I+  L
Sbjct: 230 K-----LALPIPS-------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  161 bits (409), Expect = 2e-44
 Identities = 55/285 (19%), Positives = 99/285 (34%), Gaps = 38/285 (13%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           G  IG+G  G VY     G   +A++ +          + F        + RH N+V  +
Sbjct: 38  GELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           G C       ++       TL+ ++   +        N   ++A    + + YL      
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH---AK 149

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS---GAPE---- 617
            I+H + KS N+  D    V ++D GL  +          + L   +G     APE    
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 618 ------FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL 671
                  +   +S  SDV++LG +  EL     P+       E   + W +         
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--EA--IIWQMGTGM----- 259

Query: 672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            +     +            +DI+  C  +E   RP  ++++  L
Sbjct: 260 -KPNLSQIG------MGKEISDILLFCWAFEQEERPTFTKLMDML 297

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  160 bits (406), Expect = 2e-44
 Identities = 72/296 (24%), Positives = 115/296 (38%), Gaps = 49/296 (16%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKL-----SNTVSQRQTDEEFLELASTIS 493
           N       IG+G  G V+K  L     ++A+K L            +  +EF      +S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
            L H NIV+L G  +      +V ++     L+  L           W++++R+ L  A 
Sbjct: 79  NLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIAL 133

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEK-----LIVRVSDCGLAPLLFSGSTNELSEGLL 608
            ++Y+Q    PPIVH + +S NI L        +  +V+D GL+       +  L     
Sbjct: 134 GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL----- 187

Query: 609 TAHGSG-----APE---FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW 660
                G     APE    E  SY+ ++D YS  +++  +LTG  P+D       +     
Sbjct: 188 -----GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY--GKIKFIN 240

Query: 661 AIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            I          R   P            R  ++I  C   +P  RP  S IV++L
Sbjct: 241 MIREEG-----LRPTIPE-------DCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  159 bits (405), Expect = 3e-44
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 31/284 (10%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
              + G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+  +GY     Q  +V  +    +L+  LH+ E    KF     I +A   AR + YL 
Sbjct: 82  ILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH 137

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---AP 616
                 I+H + KS+NI L E   V++ D GLA      S    S       GS    AP
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK---SRWSGSHQFEQLSGSILWMAP 191

Query: 617 E----FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
           E     +S  YS QSDVY+ G+V+ EL+TG+ PY     R +   +   + R        
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGS------ 242

Query: 673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
              D S   +   K +     +++ C++ +   RP    I+ ++
Sbjct: 243 LSPDLSKVRSNCPKRM---KRLMAECLKKKRDERPSFPRILAEI 283

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  157 bits (399), Expect = 1e-43
 Identities = 53/294 (18%), Positives = 98/294 (33%), Gaps = 55/294 (18%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
              +    + E   G ++K     G  + VK L       +   +F E    +    H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 500 IVELIGYCNE--HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
           ++ ++G C         L+  +    +L+++LH     +     +  ++ AL  AR + +
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAF 126

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG--- 614
           L    EP I      S ++++DE +  R+S   +     S                    
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR------------MYAPA 173

Query: 615 --APEF----ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR------GEQSLVRWAI 662
             APE        +    +D++S  V++ EL+T   P+              + L R  I
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL-RPTI 232

Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           P    I                       + ++  C+  +P  RP    IV  L
Sbjct: 233 PP--GIS-------------------PHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  155 bits (394), Expect = 2e-42
 Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 37/286 (12%)

Query: 445 GNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           G  +G+G  G   K      G+++ +K+L     + Q    FL+    +  L H N+++ 
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ--RTFLKEVKVMRCLEHPNVLKF 72

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           IG   +  +   + +Y    TL  ++ S +    ++ W+ R+  A   A  + YL  +  
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM-- 127

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLA---------PLLFSGSTNELSEGLLTAHGSG 614
             I+H +  S N L+ E   V V+D GLA         P           +   T  G+ 
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 615 ---APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
              APE     SY  + DV+S G+V+ E++          PR     +        ++  
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------NVRG 238

Query: 671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                 P             F  I  RC   +P  RP   ++   L
Sbjct: 239 FLDRYCPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  155 bits (393), Expect = 3e-42
 Identities = 65/315 (20%), Positives = 103/315 (32%), Gaps = 42/315 (13%)

Query: 439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
            ++      IG G  G+VYK  L   + +AVK  S     RQ       +      + H 
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA--NRQNFINEKNIYRV-PLMEHD 67

Query: 499 NIVELIGYCNE-----HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           NI   I            ++LLV +Y  N +L   L           W    R+A    R
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTR 122

Query: 554 ALQYL------QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL 607
            L YL       +  +P I H +  S N+L+       +SD GL+  L         E  
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 608 LTAHGS-G-----APEF--------ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRG 653
             A    G     APE         +  S   Q D+Y+LG++  E+              
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242

Query: 654 E-QSLVRWAIPRLHDIDALSRMVD-----PSLDGAYLAKS--LSRFADIISRCVQWEPGF 705
           E Q   +  +      + +  +V      P    A+   S  +    + I  C   +   
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302

Query: 706 RPPMSEIVQDLLCMI 720
           R       + +  ++
Sbjct: 303 RLTAQXAEERMAELM 317

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  154 bits (391), Expect = 5e-42
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 15/223 (6%)

Query: 27  VTDPRDVMALNSLYISLNFPP-LEKWLSFGGDPCGDSWQGVFC----VFSNVTEIRLTGM 81
           + +P+D  AL  +   L  P  L  WL    D C  +W GV C        V  + L+G+
Sbjct: 2   LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60

Query: 82  NLGGVLA--DTLGDLESVINIDLSN-NHIGGSIPS---NLPVTVRNFSLSGNQLTGSIPE 135
           NL        +L +L  +  + +   N++ G IP     L   +    ++   ++G+IP+
Sbjct: 61  NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT-QLHYLYITHTNVSGAIPD 119

Query: 136 SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLY-SL 194
            LS++  L+ L  + N L+G +P +      L+      N ++G +P S  + S L+ S+
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179

Query: 195 HLQNNKLSGTL-NVLEDLHLIDLNIENNLFSGPIPEKLLSIPN 236
            +  N+L+G +     +L+L  +++  N+  G       S  N
Sbjct: 180 TISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  133 bits (336), Expect = 2e-34
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 7/171 (4%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS---NLPVTVRNFSLSGN 127
           + +  + +T  N+ G + D L  +++++ +D S N + G++P    +LP  +   +  GN
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP-NLVGITFDGN 159

Query: 128 QLTGSIPESLSRLTQLL-DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTR 186
           +++G+IP+S    ++L   ++++ N L G IP  F     L   DLS N L G       
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFG 218

Query: 187 NLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGPIPEKLLSIPN 236
           +  +   +HL  N L+  L  +     L  L++ NN   G +P+ L  +  
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  116 bits (293), Expect = 8e-29
 Identities = 39/165 (23%), Positives = 57/165 (34%), Gaps = 10/165 (6%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLES-VINIDLSNNHIGGSIPS---NLPVTVRNFSLSG 126
            N+  I   G  + G + D+ G       ++ +S N + G IP    NL   +    LS 
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL--NLAFVDLSR 206

Query: 127 NQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTR 186
           N L G              + L  N L   +         L   DL  N + G LP    
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLT 265

Query: 187 NLSSLYSLHLQNNKLSG---TLNVLEDLHLIDLNIENNLFSGPIP 228
            L  L+SL++  N L G       L+   +        L   P+P
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  153 bits (388), Expect = 8e-42
 Identities = 62/306 (20%), Positives = 113/306 (36%), Gaps = 55/306 (17%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFL---ELASTISRLRHGNIV 501
              +G+G  G V++     G+ +AVK  S+     + ++ +    EL +T   LRH NI+
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSS-----RDEKSWFRETELYNT-VMLRHENIL 65

Query: 502 ELIGYC----NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
             I       +   Q  L+  Y    +L+D L               +R+ L  A  L +
Sbjct: 66  GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAH 120

Query: 558 L-----QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           L         +P I H + KS NIL+ +     ++D GLA ++ S STN+L  G     G
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVG 179

Query: 613 S----------GAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI 662
           +             + +      + D+++ G+V+ E+                    +  
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED--------YKP 231

Query: 663 P---RLHDIDALSRMVD--------PSLDGAYLAKS-LSRFADIISRCVQWEPGFRPPMS 710
           P    + +  +   M          P++   + +   L+  A ++  C    P  R    
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291

Query: 711 EIVQDL 716
            I + L
Sbjct: 292 RIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  151 bits (382), Expect = 1e-40
 Identities = 62/298 (20%), Positives = 106/298 (35%), Gaps = 39/298 (13%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRHGNIVEL 503
              IG+G  G V+  +   G+ +AVK         +    F E        +RH NI+  
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENILGF 96

Query: 504 IGYCNE----HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL- 558
           I    +      Q  L+ DY  N +L+D L               +++A  +   L +L 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLH 151

Query: 559 ----QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
                   +P I H + KS NIL+ +     ++D GLA + F   TNE+     T  G+ 
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VKFISDTNEVDIPPNTRVGTK 210

Query: 615 ---APE-------FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR 664
               PE                +D+YS G+++ E+               Q      +P 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY--QLPYHDLVPS 268

Query: 665 LHDIDALSRMVD-----PSLDGAYLAKS-LSRFADIISRCVQWEPGFRPPMSEIVQDL 716
               + +  +V      PS    + +   L +   +++ C    P  R     + + L
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  146 bits (371), Expect = 5e-39
 Identities = 67/300 (22%), Positives = 115/300 (38%), Gaps = 43/300 (14%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELA-STISRLRHGNIVEL 503
              IG+G  G V++ +   G+ +AVK  S     R+    F E        LRH NI+  
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGF 101

Query: 504 IGYC----NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL- 558
           I           Q  LV DY  + +L D L+         +    I++AL  A  L +L 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLH 156

Query: 559 ----QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
                   +P I H + KS NIL+ +     ++D GLA +    +T+ +   +   H  G
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTID--IAPNHRVG 213

Query: 615 -----APE-------FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI 662
                APE        +      ++D+Y++G+V  E+               Q      +
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED--YQLPYYDLV 271

Query: 663 PRLHDIDALSRMVD-----PSLDGAYLA-KSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           P    ++ + ++V      P++   + + ++L   A I+  C       R     I + L
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  136 bits (344), Expect = 2e-33
 Identities = 56/175 (32%), Positives = 86/175 (49%), Gaps = 12/175 (6%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGD--LESVINIDLSNNHIGGSIPS---NLPVTVRNFSLS 125
           +++  + L+  N  G +   L      ++  + L NN   G IP    N    + +  LS
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS-ELVSLHLS 426

Query: 126 GNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST 185
            N L+G+IP SL  L++L DL L  N L G IP        L    L  N+LTG++P   
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486

Query: 186 RNLSSLYSLHLQNNKLSGT----LNVLEDLHLIDLNIENNLFSGPIPEKLLSIPN 236
            N ++L  + L NN+L+G     +  LE+L ++ L+  NN FSG IP +L    +
Sbjct: 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS--NNSFSGNIPAELGDCRS 539

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  129 bits (327), Expect = 3e-31
 Identities = 40/174 (22%), Positives = 69/174 (39%), Gaps = 11/174 (6%)

Query: 70  FSNVTEIRLTGMNLGGVLADTL---GDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLS 125
            +++  + L+  ++ G              + ++ +S N I G +  S     +    +S
Sbjct: 150 LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV-NLEFLDVS 208

Query: 126 GNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST 185
            N  +  IP  L   + L  L ++ N L+G    A    T L   ++S+N   G +PP  
Sbjct: 209 SNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL- 266

Query: 186 RNLSSLYSLHLQNNKLSGTL--NVLEDL-HLIDLNIENNLFSGPIPEKLLSIPN 236
             L SL  L L  NK +G +   +      L  L++  N F G +P    S   
Sbjct: 267 -PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  128 bits (323), Expect = 9e-31
 Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 13/177 (7%)

Query: 70  FSNVTEIRLTGMNLGGVL-ADTLGDLESVINIDLSNNHIGGSIPSNLP---VTVRNFSLS 125
            + +  + ++     G +    L  L+    + L+ N   G IP  L     T+    LS
Sbjct: 246 CTELKLLNISSNQFVGPIPPLPLKSLQY---LSLAENKFTGEIPDFLSGACDTLTGLDLS 302

Query: 126 GNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIP-DAFHQFTGLINFDLSANNLTGQLPPS 184
           GN   G++P      + L  L+L++N+ +G +P D   +  GL   DLS N  +G+LP S
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362

Query: 185 TRNLS-SLYSLHLQNNKLSGT----LNVLEDLHLIDLNIENNLFSGPIPEKLLSIPN 236
             NLS SL +L L +N  SG     L       L +L ++NN F+G IP  L +   
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSE 419

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  126 bits (320), Expect = 2e-30
 Identities = 50/196 (25%), Positives = 76/196 (38%), Gaps = 7/196 (3%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSL 124
               S +  + L+   L G +  +LG L  + ++ L  N + G IP  L    T+    L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS 184
             N LTG IP  LS  T L  +SL+NN L G IP    +   L    LS N+ +G +P  
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533

Query: 185 TRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPF 244
             +  SL  L L  N  +GT+     +      I  N  +G     + +    ++     
Sbjct: 534 LGDCRSLIWLDLNTNLFNGTIP--AAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAG 591

Query: 245 NTTVIALPPTAIPPSI 260
           N              +
Sbjct: 592 NLLEFQ---GIRSEQL 604

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  125 bits (315), Expect = 8e-30
 Identities = 44/175 (25%), Positives = 69/175 (39%), Gaps = 2/175 (1%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSL 124
               S + +++L    L G +   L  ++++  + L  N + G IPS L     +   SL
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS 184
           S N+LTG IP+ + RL  L  L L+NN  +G IP        LI  DL+ N   G +P +
Sbjct: 498 SNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557

Query: 185 TRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRK 239
               S   + +    K    +                 F G   E+L  +     
Sbjct: 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  113 bits (284), Expect = 5e-26
 Identities = 41/196 (20%), Positives = 85/196 (43%), Gaps = 26/196 (13%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS---NLPVTVRNFS 123
                N+  ++L+  +  G +   LGD  S+I +DL+ N   G+IP+        +    
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 569

Query: 124 LSG---------------------NQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFH 162
           ++G                      +  G   E L+RL+     ++ +    G     F 
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD 629

Query: 163 QFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL-NVLEDLHLID-LNIEN 220
               ++  D+S N L+G +P    ++  L+ L+L +N +SG++ + + DL  ++ L++ +
Sbjct: 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSS 689

Query: 221 NLFSGPIPEKLLSIPN 236
           N   G IP+ + ++  
Sbjct: 690 NKLDGRIPQAMSALTM 705

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  112 bits (283), Expect = 7e-26
 Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 8/174 (4%)

Query: 78  LTGMNLGGVLADTLGDLESVINIDLSNN--HIGGSIPSNLP--VTVRNFSLSGNQLTGSI 133
           +    + G     + +         + N     G     L    T    +++     G  
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624

Query: 134 PESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYS 193
             +      ++ L ++ N L+G IP        L   +L  N+++G +P    +L  L  
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684

Query: 194 LHLQNNKLSGTL-NVLEDLH-LIDLNIENNLFSGPIPEK--LLSIPNFRKDGNP 243
           L L +NKL G +   +  L  L ++++ NN  SGPIPE     + P  +   NP
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 738

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  109 bits (276), Expect = 4e-25
 Identities = 37/139 (26%), Positives = 63/139 (45%), Gaps = 4/139 (2%)

Query: 68  CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRNFSL 124
                        +   G+ ++ L  L +    ++++   GG       N   ++    +
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG-SMMFLDM 639

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS 184
           S N L+G IP+ +  +  L  L+L +N ++G IPD      GL   DLS+N L G++P +
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699

Query: 185 TRNLSSLYSLHLQNNKLSG 203
              L+ L  + L NN LSG
Sbjct: 700 MSALTMLTEIDLSNNNLSG 718

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  107 bits (269), Expect = 3e-24
 Identities = 40/123 (32%), Positives = 59/123 (47%), Gaps = 6/123 (4%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL--PVTVRNFSL 124
               S      +T    GG  + T  +  S++ +D+S N + G IP  +     +   +L
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 663

Query: 125 SGNQLTGSIPESLSRLTQL--LDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP 182
             N ++GSIP+ +  L  L  LDLS  +N L+G IP A    T L   DLS NNL+G +P
Sbjct: 664 GHNDISGSIPDEVGDLRGLNILDLS--SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

Query: 183 PST 185
              
Sbjct: 722 EMG 724

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 94.2 bits (235), Expect = 4e-20
 Identities = 42/190 (22%), Positives = 64/190 (33%), Gaps = 51/190 (26%)

Query: 55  GGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN 114
             +PC  ++ GV C    VT I L+   L                               
Sbjct: 36  NKNPC--TFDGVTCRDDKVTSIDLSSKPLNVGF--------------------------- 66

Query: 115 LPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSA 174
                            ++  SL  LT L  L L+N+H+NG +   F     L + DLS 
Sbjct: 67  ----------------SAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSR 109

Query: 175 NNLTGQLPPST--RNLSSLYSLHLQNNKLSGTLNVLEDL---HLIDLNIENNLFSGPIPE 229
           N+L+G +   T   + S L  L++ +N L     V   L    L  L++  N  SG    
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVV 169

Query: 230 KLLSIPNFRK 239
             +      +
Sbjct: 170 GWVLSDGCGE 179

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  119 bits (301), Expect = 2e-29
 Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 63/294 (21%)

Query: 448 IGEGLLGSVYKAELPGGKLL-AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG G  G V+   L     L AVK    T+       +FL+ A  + +  H NIV LIG 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK-AKFLQEARILKQYSHPNIVRLIGV 180

Query: 507 CNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           C +     +V +   GG+      L ++     +      +++   AA  ++YL+     
Sbjct: 181 CTQKQPIYIVMELVQGGD--FLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK--- 232

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG--------AP 616
             +H +  + N L+ EK ++++SD G++         E ++G+  A G          AP
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMS--------REEADGVYAASGGLRQVPVKWTAP 284

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS-- 672
           E    G YS +SDV+S G+++ E  + G  PY                P L +       
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPY----------------PNLSNQQTREFV 328

Query: 673 ----RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
               R+  P L  D  +          ++ +C  +EPG RP  S I Q+L  + 
Sbjct: 329 EKGGRLPCPELCPDAVF---------RLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  116 bits (293), Expect = 4e-29
 Identities = 59/281 (20%), Positives = 99/281 (35%), Gaps = 38/281 (13%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
              IG G   +VYK  +      +A  +L +    +   + F E A  +  L+H NIV  
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 504 IGYC---NEHGQHLLVY-DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
                   +  + +++  +   + TL   L    +  K     +         + LQ+L 
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 560 EVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---A 615
               PPI+H + K  NI +      V++ D GLA L  +              G+    A
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-------AVIGTPEFMA 198

Query: 616 PEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
           PE     Y    DVY+ G+ MLE+ T   PY                    +   + R V
Sbjct: 199 PEMYEEKYDESVDVYAFGMCMLEMATSEYPY----------------SECQNAAQIYRRV 242

Query: 676 DPSLDGAYLAKSLSR-FADIISRCVQWEPGFRPPMSEIVQD 715
              +  A   K       +II  C++     R  + +++  
Sbjct: 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  113 bits (286), Expect = 4e-28
 Identities = 68/283 (24%), Positives = 114/283 (40%), Gaps = 47/283 (16%)

Query: 448 IGEGLLGSVYKAELPGGKLL---AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           +G G  G+V K      K++   AVK L N  +     +E L  A+ + +L +  IV +I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           G C      +LV +      L+  L      ++       I +    +  ++YL+E    
Sbjct: 85  GICEAE-SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN-- 137

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE 617
             VH +  + N+LL  +   ++SD GL+  L +       E    A   G       APE
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD------ENYYKAQTHGKWPVKWYAPE 190

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
                 +S +SDV+S GV+M E  + G+KPY       + S V         ++   RM 
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPY----RGMKGSEV------TAMLEKGERMG 240

Query: 676 DPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            P+      Y         D+++ C  ++   RP  + +   L
Sbjct: 241 CPAGCPREMY---------DLMNLCWTYDVENRPGFAAVELRL 274

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  118 bits (299), Expect = 6e-28
 Identities = 41/190 (21%), Positives = 76/190 (40%), Gaps = 11/190 (5%)

Query: 69  VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRNFSLS 125
           + +N+T + LT   L  + A        + ++D+  N I    P     LP  ++  +L 
Sbjct: 23  LPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLP-MLKVLNLQ 81

Query: 126 GNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST 185
            N+L+    ++ +  T L +L L +N +     + F +   LI  DLS N L+     + 
Sbjct: 82  HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141

Query: 186 RNLSSLYSLHLQNNKLSG----TLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRK-- 239
             L +L  L L NNK+       L++  +  L  L + +N      P    +I       
Sbjct: 142 VQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLF 201

Query: 240 -DGNPFNTTV 248
            +      ++
Sbjct: 202 LNNVQLGPSL 211

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  110 bits (277), Expect = 3e-25
 Identities = 31/139 (22%), Positives = 59/139 (42%), Gaps = 3/139 (2%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD 159
            D S+  +   +P +LP  +   +L+ NQL      + +R +QL  L +  N ++   P+
Sbjct: 9   ADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE 67

Query: 160 AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG-TLNVLEDL-HLIDLN 217
              +   L   +L  N L+     +    ++L  LHL +N +     N      +LI L+
Sbjct: 68  LCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127

Query: 218 IENNLFSGPIPEKLLSIPN 236
           + +N  S       + + N
Sbjct: 128 LSHNGLSSTKLGTQVQLEN 146

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  108 bits (271), Expect = 2e-24
 Identities = 39/184 (21%), Positives = 74/184 (40%), Gaps = 13/184 (7%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRN 121
             F   +N+TE+ L   ++  +  +     +++I +DLS+N +  +       L   ++ 
Sbjct: 91  KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE-NLQE 149

Query: 122 FSLSGNQLTGSIPESLS--RLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG 179
             LS N++     E L     + L  L L++N +    P  FH    L    L+   L  
Sbjct: 150 LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP 209

Query: 180 QLPPSTR---NLSSLYSLHLQNNKLSG----TLNVLEDLHLIDLNIENNLFSGPIPEKLL 232
            L          +S+ +L L N++LS     T   L+  +L  L++  N  +    +   
Sbjct: 210 SLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA 269

Query: 233 SIPN 236
            +P 
Sbjct: 270 WLPQ 273

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  107 bits (270), Expect = 2e-24
 Identities = 32/175 (18%), Positives = 63/175 (36%), Gaps = 11/175 (6%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRN 121
            +      +  + L    L  +   T     ++  + L +N I              +  
Sbjct: 67  ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK-NLIT 125

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQF--TGLINFDLSANNLTG 179
             LS N L+ +   +  +L  L +L L+NN +     +    F  + L   +LS+N +  
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185

Query: 180 QLPPSTRNLSSLYSLHLQNNKLSGTL-----NVLEDLHLIDLNIENNLFSGPIPE 229
             P     +  L+ L L N +L  +L       L +  + +L++ N+  S     
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  106 bits (267), Expect = 5e-24
 Identities = 30/173 (17%), Positives = 56/173 (32%), Gaps = 6/173 (3%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL--PVTVRNFSL 124
           F  +S +T + +    +  +  +    L  +  ++L +N +             +    L
Sbjct: 45  FTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPP- 183
             N +         +   L+ L L++N L+        Q   L    LS N +       
Sbjct: 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164

Query: 184 -STRNLSSLYSLHLQNNKLSGTL-NVLEDL-HLIDLNIENNLFSGPIPEKLLS 233
                 SSL  L L +N++          +  L  L + N      + EKL  
Sbjct: 165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  101 bits (254), Expect = 2e-22
 Identities = 44/204 (21%), Positives = 73/204 (35%), Gaps = 11/204 (5%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL----PVTVR 120
             F    N+  + L+   L      T   LE++  + LSNN I       L      +++
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174

Query: 121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQF---TGLINFDLSANNL 177
              LS NQ+    P     + +L  L LNN  L   + +        T + N  LS + L
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234

Query: 178 TGQLPPSTRNL--SSLYSLHLQNNKLSGTL-NVLEDL-HLIDLNIENNLFSGPIPEKLLS 233
           +     +   L  ++L  L L  N L+    +    L  L    +E N         L  
Sbjct: 235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG 294

Query: 234 IPNFRKDGNPFNTTVIALPPTAIP 257
           + N R      + T  ++   ++P
Sbjct: 295 LFNVRYLNLKRSFTKQSISLASLP 318

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  100 bits (250), Expect = 5e-22
 Identities = 48/229 (20%), Positives = 82/229 (35%), Gaps = 34/229 (14%)

Query: 36  LNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLE 95
           L  L + LN          G +  G  W+G      N+ EI L+      +  ++   + 
Sbjct: 407 LEVLDLGLN--------EIGQELTGQEWRG----LENIFEIYLSYNKYLQLTRNSFALVP 454

Query: 96  SVINIDLSNNHIGG--SIPS---NLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN 150
           S+  + L    +    S PS    L   +    LS N +     + L  L +L  L L +
Sbjct: 455 SLQRLMLRRVALKNVDSSPSPFQPLR-NLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513

Query: 151 NHLN--------GGIPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKL 201
           N+L         GG        + L   +L +N     +P    ++L  L  + L  N L
Sbjct: 514 NNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE-IPVEVFKDLFELKIIDLGLNNL 572

Query: 202 SGTL-NVLEDL-HLIDLNIENNLFSGPIPEKLL----SIPNFRKDGNPF 244
           +    +V  +   L  LN++ NL +    +       ++       NPF
Sbjct: 573 NTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  100 bits (250), Expect = 5e-22
 Identities = 40/188 (21%), Positives = 75/188 (39%), Gaps = 18/188 (9%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPV-----TVRN 121
               S++ ++ L+   +          +  +  + L+N  +G S+   L +     ++RN
Sbjct: 167 IFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRN 226

Query: 122 FSLSGNQLTGSIPESLS--RLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG 179
            SLS +QL+ +   +    + T L  L L+ N+LN    D+F     L  F L  NN+  
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286

Query: 180 QLPPSTRNLSSLYSLHLQNNKLSGTL--NVLEDLH---------LIDLNIENNLFSGPIP 228
               S   L ++  L+L+ +    ++    L  +          L  LN+E+N   G   
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346

Query: 229 EKLLSIPN 236
                + N
Sbjct: 347 NMFTGLIN 354

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 96.2 bits (240), Expect = 8e-21
 Identities = 39/221 (17%), Positives = 72/221 (32%), Gaps = 31/221 (14%)

Query: 36  LNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLE 95
           L  L+++            G          +    +++  + L+   L      T   L+
Sbjct: 197 LFGLFLNNVQ--------LGPSLT--EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246

Query: 96  --SVINIDLSNNHIGGSIP---SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN 150
             ++  +DLS N++        + LP  +  F L  N +      SL  L  +  L+L  
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLP-QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305

Query: 151 N---------HLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKL 201
           +          L      +F     L + ++  N++ G        L +L  L L N+  
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365

Query: 202 S------GTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPN 236
           S       T   L    L  LN+  N  S    +    + +
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.8 bits (239), Expect = 1e-20
 Identities = 42/180 (23%), Positives = 65/180 (36%), Gaps = 15/180 (8%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGV--LADTLGDLESVINIDLSNNHIGGSIPSNLP--VTV 119
           +  F +  ++  + L  + L  V         L ++  +DLSNN+I       L     +
Sbjct: 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL 506

Query: 120 RNFSLSGNQLT--------GSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFD 171
               L  N L         G     L  L+ L  L+L +N  +    + F     L   D
Sbjct: 507 EILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566

Query: 172 LSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT-LNVLEDL--HLIDLNIENNLFSGPIP 228
           L  NNL         N  SL SL+LQ N ++     V      +L +L++  N F     
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 90.4 bits (225), Expect = 6e-19
 Identities = 38/217 (17%), Positives = 73/217 (33%), Gaps = 28/217 (12%)

Query: 65  GVFCVFSNVTEIRLTG--MNLGGVLADTLGDLE--SVINIDLSNNHIGGSIP---SNLPV 117
            +F    N+  + L+    +L  +  +T   L    +  ++L+ N I        S L  
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG- 405

Query: 118 TVRNFSLSGNQLTGSIP-ESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANN 176
            +    L  N++   +  +    L  + ++ L+ N       ++F     L    L    
Sbjct: 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465

Query: 177 LTG--QLPPSTRNLSSLYSLHLQNNKLSG----TLNVLEDLHLIDL------NIENNLFS 224
           L      P   + L +L  L L NN ++      L  LE L ++DL       +  +   
Sbjct: 466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP 525

Query: 225 GPIPEKLLSIPNFRK---DGNPFNTTVIALPPTAIPP 258
           G     L  + +      + N F+     +P      
Sbjct: 526 GGPIYFLKGLSHLHILNLESNGFDE----IPVEVFKD 558

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 75.8 bits (187), Expect = 2e-14
 Identities = 25/180 (13%), Positives = 44/180 (24%), Gaps = 16/180 (8%)

Query: 64  QGVFCVFSNVTEIRLTGMNL--------GGVLADTLGDLESVINIDLSNNHIGGSIPSNL 115
             +      +  + L   NL         G     L  L  +  ++L +N          
Sbjct: 497 DDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF 556

Query: 116 P--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAF-HQFTGLINFDL 172
                ++   L  N L        +    L  L+L  N +       F   F  L   D+
Sbjct: 557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDM 616

Query: 173 SANNLTGQLPPSTR-----NLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPI 227
             N                N +      L ++ L  T        +   +  +   S   
Sbjct: 617 RFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDSAHH 676

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 63.5 bits (155), Expect = 2e-10
 Identities = 23/161 (14%), Positives = 49/161 (30%), Gaps = 12/161 (7%)

Query: 36  LNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLE 95
           L  L +  N   L                      S++  + L       +  +   DL 
Sbjct: 506 LEILDLQHN--NLA---RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560

Query: 96  SVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSR-LTQLLDLSLNNNH 152
            +  IDL  N++     S     V++++ +L  N +T    +        L +L +  N 
Sbjct: 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620

Query: 153 LNGGIP--DAFHQFTGLINFDLS--ANNLTGQLPPSTRNLS 189
            +        F  +    + ++   +++     PP      
Sbjct: 621 FDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFP 661

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  114 bits (287), Expect = 5e-27
 Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 33/281 (11%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLL-AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
            + +G G  G VY+       L  AVK L     +    EEFL+ A+ +  ++H N+V+L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQL 281

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           +G C       ++ ++     L D L       ++ S  + + +A   + A++YL++   
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN- 338

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGS 622
              +H N  + N L+ E  +V+V+D GL+ L+ +G T     G        APE      
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 395

Query: 623 YSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL-- 679
           +S +SDV++ GV++ E+ T G  PY    P  + S V   + + +      RM  P    
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPY----PGIDLSQVYELLEKDY------RMERPEGCP 445

Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           +  Y         +++  C QW P  RP  +EI Q    M 
Sbjct: 446 EKVY---------ELMRACWQWNPSDRPSFAEIHQAFETMF 477

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  109 bits (276), Expect = 5e-27
 Identities = 69/283 (24%), Positives = 115/283 (40%), Gaps = 47/283 (16%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
              IG G  G V+         +A+K +          E+F+E A  + +L H  +V+L 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLY 69

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           G C E     LV ++  +  L D L +       F+    + + L     + YL+E C  
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEAC-- 124

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE 617
            ++H +  + N L+ E  +++VSD G+           + +   T+           +PE
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMT--------RFVLDDQYTSSTGTKFPVKWASPE 175

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
            F    YS +SDV+S GV+M E+ + G+ PY         S V      + DI    R+ 
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEV------VEDISTGFRLY 225

Query: 676 DPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            P L     Y          I++ C +  P  RP  S +++ L
Sbjct: 226 KPRLASTHVY---------QIMNHCWRERPEDRPAFSRLLRQL 259

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  112 bits (283), Expect = 1e-26
 Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 47/283 (16%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
              +G G  G V+ A       +AVK +          E FL  A+ +  L+H  +V+L 
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQHDKLVKLH 249

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
               +     ++ ++    +L D L SDE    K      I  +   A  + ++++    
Sbjct: 250 AVVTKEP-IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN-- 304

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE 617
             +H + +++NIL+   L+ +++D GLA +        + +   TA           APE
Sbjct: 305 -YIHRDLRAANILVSASLVCKIADFGLARV--------IEDNEYTAREGAKFPIKWTAPE 355

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
               GS++ +SDV+S G++++E++T GR PY    P      V  A+ R +      RM 
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPY----PGMSNPEVIRALERGY------RMP 405

Query: 676 DPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            P    +  Y         +I+ RC +  P  RP    I   L
Sbjct: 406 RPENCPEELY---------NIMMRCWKNRPEERPTFEYIQSVL 439

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  108 bits (273), Expect = 2e-26
 Identities = 59/287 (20%), Positives = 112/287 (39%), Gaps = 47/287 (16%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
              +G G  G V   +  G   +A+K +          +EF+E A  +  L H  +V+L 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 85

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           G C +     ++ +Y  N  L + L        +F     + +      A++YL+     
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ-- 140

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE 617
             +H +  + N L++++ +V+VSD GL+          + +   T+            PE
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLS--------RYVLDDEYTSSVGSKFPVRWSPPE 191

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
                 +S +SD+++ GV+M E+ + G+ PY     R   S           I    R+ 
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY----ERFTNSET------AEHIAQGLRLY 241

Query: 676 DPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
            P L  +  Y          I+  C   +   RP    ++ ++L ++
Sbjct: 242 RPHLASEKVY---------TIMYSCWHEKADERPTFKILLSNILDVM 279

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  108 bits (273), Expect = 2e-26
 Identities = 72/284 (25%), Positives = 123/284 (43%), Gaps = 47/284 (16%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLL-AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
            + +G G  G VY+       L  AVK L     +    EEFL+ A+ +  ++H N+V+L
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQL 74

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           +G C       ++ ++     L D L       ++ S  + + +A   + A++YL++   
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN- 131

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------AP 616
              +H +  + N L+ E  +V+V+D GL+ L        ++    TAH          AP
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFPIKWTAP 181

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM 674
           E      +S +SDV++ GV++ E+ T G  PY    P  + S V         ++   RM
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----PGIDLSQV------YELLEKDYRM 231

Query: 675 VDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
             P    +  Y         +++  C QW P  RP  +EI Q  
Sbjct: 232 ERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQAF 266

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (274), Expect = 3e-26
 Identities = 66/296 (22%), Positives = 112/296 (37%), Gaps = 58/296 (19%)

Query: 445 GNFIGEGLLGSVYKAEL--PGGKLL---AVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
              +G G  G+VYK      G K+    A+K+L    S +   +E L+ A  ++ + + +
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 78

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           +  L+G C       L+        L D +   ++          +   +  A+ + YL+
Sbjct: 79  VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLE 134

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----- 614
           +     +VH +  + N+L+     V+++D GLA LL +             H  G     
Sbjct: 135 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPI 183

Query: 615 ---APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDID 669
              A E      Y+ QSDV+S GV + EL+T G KPY               IP      
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-------------DGIPASEISS 230

Query: 670 ALS---RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
            L    R+  P +     Y          I+ +C   +   RP   E++ +   M 
Sbjct: 231 ILEKGERLPQPPICTIDVY---------MIMRKCWMIDADSRPKFRELIIEFSKMA 277

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  107 bits (270), Expect = 4e-26
 Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 47/285 (16%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVELIG 505
           IG G  G   K      GK+L  K+L   ++++ +      E  + +  L+H NIV    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSE-VNLLRELKHPNIVRYYD 72

Query: 506 -YCNEHGQHL-LVYDYGGNCTLHDLLHSDEEAHKKFS----WNIRIRVALGAARALQYL- 558
              +     L +V +Y     L  ++    +  +         +  ++ L    AL+   
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL----ALKECH 128

Query: 559 -QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS---G 614
            +      ++H + K +N+ LD K  V++ D GLA +L        ++   T  G+    
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAK---TFVGTPYYM 183

Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
           +PE     SY+ +SD++SLG ++ EL     P+                        L+ 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----------------SQKELAG 226

Query: 674 MVDPSLDGAY--LAKSLSR-FADIISRCVQWEPGFRPPMSEIVQD 715
            +    +G +  +    S    +II+R +  +   RP + EI+++
Sbjct: 227 KI---REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  107 bits (270), Expect = 5e-26
 Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 37/279 (13%)

Query: 448 IGEGLLGSVYKAE---LPGGKLLAVKKLSNTVSQRQTDEEFLEL----ASTISRLRHGNI 500
           +G G + +VY AE   L     +A+K +       +  EE L+         S+L H NI
Sbjct: 19  LGGGGMSTVYLAEDTIL--NIKVAIKAIF---IPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           V +I    E   + LV +Y    TL + + S    H   S +  I         +++  +
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD 129

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES 620
           +    IVH + K  NIL+D    +++ D G+A  L   S  + +  L T     +PE   
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF-SPEQAK 185

Query: 621 GSY-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH-DIDALSRMVDPS 678
           G      +D+YS+G+V+ E+L G  P++     GE + V  AI  +   +  ++  V   
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFN-----GE-TAVSIAIKHIQDSVPNVTTDVRKD 239

Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPP-MSEIVQDL 716
           +  +         +++I R  + +   R   + E+  DL
Sbjct: 240 IPQS--------LSNVILRATEKDKANRYKTIQEMKDDL 270

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  107 bits (270), Expect = 8e-26
 Identities = 69/291 (23%), Positives = 109/291 (37%), Gaps = 45/291 (15%)

Query: 448 IGEGLLGSVYKAELPG-----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  GSV            G L+AVK+L ++   +Q D  F      +  L    IV+
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD--FQREIQILKALHSDFIVK 88

Query: 503 LIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G     G+    LV +Y  +  L D L        +   +  +  +    + ++YL  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGS 145

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------ 614
                 VH +  + NIL++ +  V+++D GLA LL       L +        G      
Sbjct: 146 RR---CVHRDLAARNILVESEAHVKIADFGLAKLL------PLDKDYYVVREPGQSPIFW 196

Query: 615 -APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHD-IDA 670
            APE      +S QSDV+S GVV+ EL T   K    S            +P L   ++ 
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256

Query: 671 LS---RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           L    R+  P       +         +++  C    P  RP  S +   L
Sbjct: 257 LEEGQRLPAPPACPAEVH---------ELMKLCWAPSPQDRPSFSALGPQL 298

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  106 bits (267), Expect = 9e-26
 Identities = 62/283 (21%), Positives = 108/283 (38%), Gaps = 47/283 (16%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
              +G G  G V   +  G   +AVK +          +EF + A T+ +L H  +V+  
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFY 69

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           G C++     +V +Y  N  L + L S     K    +  + +       + +L+     
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQ-- 124

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE 617
             +H +  + N L+D  L V+VSD G+           + +    +           APE
Sbjct: 125 -FIHRDLAARNCLVDRDLCVKVSDFGMT--------RYVLDDQYVSSVGTKFPVKWSAPE 175

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
            F    YS +SDV++ G++M E+ + G+ PY         S V      +  +    R+ 
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPY----DLYTNSEV------VLKVSQGHRLY 225

Query: 676 DPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            P L  D  Y          I+  C    P  RP   +++  +
Sbjct: 226 RPHLASDTIY---------QIMYSCWHELPEKRPTFQQLLSSI 259

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  110 bits (276), Expect = 1e-25
 Identities = 68/282 (24%), Positives = 116/282 (41%), Gaps = 45/282 (15%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
              +G+G  G V+     G   +A+K L          E FL+ A  + +LRH  +V+L 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY 245

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
              +E     +V +Y    +L D L  +    K       + +A   A  + Y++ +   
Sbjct: 246 AVVSEE-PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN-- 300

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSY 623
             VH + +++NIL+ E L+ +V+D GLA L+                 + APE    G +
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APEAALYGRF 358

Query: 624 SCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS------RMVD 676
           + +SDV+S G+++ EL T GR PY                P + + + L       RM  
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPY----------------PGMVNREVLDQVERGYRMPC 402

Query: 677 PSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           P    +  +         D++ +C + EP  RP    +   L
Sbjct: 403 PPECPESLH---------DLMCQCWRKEPEERPTFEYLQAFL 435

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  106 bits (267), Expect = 1e-25
 Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 59/289 (20%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
              +G G  G V+     G   +AVK L          + FL  A+ + +L+H  +V L 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY 74

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
               +     ++ +Y  N +L D L +      K + N  + +A   A  + +++E    
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN-- 129

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE 617
             +H + +++NIL+ + L  +++D GLA          + +   TA           APE
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLA--------RLIEDNEYTAREGAKFPIKWTAPE 180

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS--- 672
               G+++ +SDV+S G+++ E++T GR PY                P + + + +    
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPY----------------PGMTNPEVIQNLE 224

Query: 673 ---RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
              RMV P    +  Y          ++  C +  P  RP    +   L
Sbjct: 225 RGYRMVRPDNCPEELY---------QLMRLCWKERPEDRPTFDYLRSVL 264

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  108 bits (272), Expect = 1e-25
 Identities = 76/384 (19%), Positives = 144/384 (37%), Gaps = 59/384 (15%)

Query: 362 EPVVKSQDGHGVDSRRMVSSPRPQDEKLPLPPLP-LPLVEKVTVKPLAPAEVTRRSSPST 420
           +P+      HG     + +          L  +  +  +     K      +  + + + 
Sbjct: 5   DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTV 64

Query: 421 NVISSSVSVFTIASLQQYTNSFSE-----GNFIGEGLLGSVYKAEL--PGGKLL--AVKK 471
           ++  S+++   + ++Q      S         IG G  G VY   L    GK +  AVK 
Sbjct: 65  HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124

Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC-NEHGQHLLVYDYGGNCTLHDLLH 530
           L+      +   +FL     +    H N++ L+G C    G  L+V  Y  +  L + + 
Sbjct: 125 LNRITDIGEV-SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 183

Query: 531 SDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG 590
           ++       +    I   L  A+ +++L        VH +  + N +LDEK  V+V+D G
Sbjct: 184 NET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG 237

Query: 591 LAPLLFSGSTNEL---SEGLL----TAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT- 641
           LA  ++    + +   +   L          A E  ++  ++ +SDV+S GV++ EL+T 
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWM-----ALESLQTQKFTTKSDVWSFGVLLWELMTR 292

Query: 642 GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS---RMVDPS--LDGAYLAKSLSRFADIIS 696
           G  PY               +        L    R++ P    D  Y         +++ 
Sbjct: 293 GAPPY-------------PDVNTFDITVYLLQGRRLLQPEYCPDPLY---------EVML 330

Query: 697 RCVQWEPGFRPPMSEIVQDLLCMI 720
           +C   +   RP  SE+V  +  + 
Sbjct: 331 KCWHPKAEMRPSFSELVSRISAIF 354

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  106 bits (267), Expect = 1e-25
 Identities = 74/326 (22%), Positives = 129/326 (39%), Gaps = 62/326 (19%)

Query: 421 NVISSSVSVFTIASLQQYTNSFSE-----GNFIGEGLLGSVYKAEL--PGGKLL--AVKK 471
           ++  S+++   + ++Q      S         IG G  G VY   L    GK +  AVK 
Sbjct: 1   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60

Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC-NEHGQHLLVYDY--GGNCTLHDL 528
           L+      +   +FL     +    H N++ L+G C    G  L+V  Y   G+  L + 
Sbjct: 61  LNRITDIGEV-SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD--LRNF 117

Query: 529 LHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSD 588
           + ++       +    I   L  A+ ++YL        VH +  + N +LDEK  V+V+D
Sbjct: 118 IRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVAD 171

Query: 589 CGLAPLLFSG---STNELSEGLL----TAHGSGAPE-FESGSYSCQSDVYSLGVVMLELL 640
            GLA  ++     S +  +   L          A E  ++  ++ +SDV+S GV++ EL+
Sbjct: 172 FGLARDMYDKEYYSVHNKTGAKLPVKWM-----ALESLQTQKFTTKSDVWSFGVLLWELM 226

Query: 641 T-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS---RMVDPS--LDGAYLAKSLSRFADI 694
           T G  PY               +        L    R++ P    D  Y         ++
Sbjct: 227 TRGAPPY-------------PDVNTFDITVYLLQGRRLLQPEYCPDPLY---------EV 264

Query: 695 ISRCVQWEPGFRPPMSEIVQDLLCMI 720
           + +C   +   RP  SE+V  +  + 
Sbjct: 265 MLKCWHPKAEMRPSFSELVSRISAIF 290

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  108 bits (270), Expect = 1e-25
 Identities = 39/333 (11%), Positives = 83/333 (24%), Gaps = 50/333 (15%)

Query: 416 SSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSN 474
            + +  V   +      + L Q          +  G    V+   ++   +  A+K  + 
Sbjct: 38  EAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTM 97

Query: 475 TVSQRQTDEE-FLELASTISRLRHGNIVELIGYCN------------------------- 508
                +++ E   E     +RL   +  E                               
Sbjct: 98  GAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDD 157

Query: 509 -EHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP 565
                +LL+          L   L                 +     R    LQ      
Sbjct: 158 YAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214

Query: 566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF---ESGS 622
           +VHG+F   N+ +     + + D                            EF    + +
Sbjct: 215 LVHGHFTPDNLFIMPDGRLMLGDVSAL-----WKVGTRGPASSVPVTYAPREFLNASTAT 269

Query: 623 YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA 682
           ++   + + LG+ +  +     P+    P  + S  R ++              P  D  
Sbjct: 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFV 329

Query: 683 YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
                      +I R + ++   R    E ++ 
Sbjct: 330 ---------KTLIGRFLNFDRRRRLLPLEAMET 353

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (265), Expect = 2e-25
 Identities = 68/286 (23%), Positives = 111/286 (38%), Gaps = 53/286 (18%)

Query: 448 IGEGLLGSVYKAEL--PGGKLL-AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           +G G  GSV +        ++  A+K L     +  T EE +  A  + +L +  IV LI
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYIVRLI 76

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           G C      +LV +  G   LH  L       ++   +    +    +  ++YL+E    
Sbjct: 77  GVCQAE-ALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN-- 130

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE 617
             VH +  + N+LL  +   ++SD GL+  L         +   TA  +G       APE
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKAL------GADDSYYTARSAGKWPLKWYAPE 183

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPR---LHDIDALS 672
                 +S +SDV+S GV M E L+ G+KPY               +     +  I+   
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPY-------------KKMKGPEVMAFIEQGK 230

Query: 673 RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           RM  P       Y          ++S C  ++   RP    + Q +
Sbjct: 231 RMECPPECPPELY---------ALMSDCWIYKWEDRPDFLTVEQRM 267

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  110 bits (276), Expect = 3e-25
 Identities = 47/219 (21%), Positives = 85/219 (38%), Gaps = 22/219 (10%)

Query: 36  LNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLE 95
           L  L +S N       LSF G  C  S  G     +++  + L+   +  + ++ LG LE
Sbjct: 349 LEFLDLSRNG------LSFKG-CCSQSDFG----TTSLKYLDLSFNGVITMSSNFLG-LE 396

Query: 96  SVINIDLSNNHIGGSIPSNLPVTVRN---FSLSGNQLTGSIPESLSRLTQLLDLSLNNNH 152
            + ++D  ++++      ++ +++RN     +S      +     + L+ L  L +  N 
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456

Query: 153 LNGGI-PDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL-NVLED 210
                 PD F +   L   DLS   L    P +  +LSSL  L++ +N          + 
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516

Query: 211 L-HLIDLNIENNLFSGPIPEKLLSIPNFRK----DGNPF 244
           L  L  L+   N       ++L   P+         N F
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  109 bits (275), Expect = 3e-25
 Identities = 33/176 (18%), Positives = 62/176 (35%), Gaps = 8/176 (4%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN-- 121
             VF    N+  + ++  +           L S+  + ++ N    +   ++   +RN  
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473

Query: 122 -FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
              LS  QL    P + + L+ L  L++++N+        +     L   D S N++   
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 533

Query: 181 LPPSTRNL-SSLYSLHLQNNKLSGTLNVLEDLHLID----LNIENNLFSGPIPEKL 231
                ++  SSL  L+L  N  + T      L  I     L +E        P   
Sbjct: 534 KKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  109 bits (274), Expect = 5e-25
 Identities = 36/193 (18%), Positives = 67/193 (34%), Gaps = 15/193 (7%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRNFSLSG 126
             +   + L+   L  + + +      +  +DLS   I         +L   +    L+G
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS-HLSTLILTG 85

Query: 127 NQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG-QLPPST 185
           N +      + S L+ L  L     +L             L   +++ N +   +LP   
Sbjct: 86  NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145

Query: 186 RNLSSLYSLHLQNNKLSG----TLNVLEDLHL--IDLNIENNLFSGPIPEKLLSIPNFRK 239
            NL++L  L L +NK+       L VL  + L  + L++  N  +   P          K
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLHK 204

Query: 240 ---DGNPFNTTVI 249
                N  +  V+
Sbjct: 205 LTLRNNFDSLNVM 217

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  107 bits (268), Expect = 3e-24
 Identities = 31/142 (21%), Positives = 52/142 (36%), Gaps = 6/142 (4%)

Query: 101 DLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDA 160
                +    IP NLP + +N  LS N L      S     +L  L L+   +      A
Sbjct: 13  QCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71

Query: 161 FHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG----TLNVLEDLHLIDL 216
           +   + L    L+ N +      +   LSSL  L      L+      +  L+ L  +++
Sbjct: 72  YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131

Query: 217 NIENNLFSGPIPEKLLSIPNFR 238
              N + S  +PE   ++ N  
Sbjct: 132 A-HNLIQSFKLPEYFSNLTNLE 152

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 96.6 bits (241), Expect = 6e-21
 Identities = 35/180 (19%), Positives = 63/180 (35%), Gaps = 7/180 (3%)

Query: 60  GDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTV 119
            D    +F   +NV+   L  + +  V            +++L N   G   P+    ++
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ-FPTLKLKSL 327

Query: 120 RNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG 179
           +  + + N+   +  E      + LDLS N     G    +    T L   DLS N +  
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387

Query: 180 QLPPSTRNLSSLYSLHLQNNKLSGT--LNVLEDLH-LIDLNIENNLFSGPIPEKLLSIPN 236
            +  +   L  L  L  Q++ L      +V   L  LI L+I +             + +
Sbjct: 388 -MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 96.3 bits (240), Expect = 8e-21
 Identities = 34/178 (19%), Positives = 62/178 (34%), Gaps = 11/178 (6%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIG--GSIPSNL--PVTVRNF 122
                ++  +  T    G     +  DL S+  +DLS N +   G    +     +++  
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 123 SLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIP-DAFHQFTGLINFDLSANNLTGQL 181
            LS N +   +  +   L QL  L   +++L        F     LI  D+S  +     
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 182 PPSTRNLSSLYSLHLQNNKLSGTL--NVLEDL-HLIDLNIENNLFSGPIPEKLLSIPN 236
                 LSSL  L +  N        ++  +L +L  L++         P    S+ +
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 88.2 bits (219), Expect = 3e-18
 Identities = 31/196 (15%), Positives = 64/196 (32%), Gaps = 17/196 (8%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLES----VINIDLSNNHIGGSIPSNL-PVTVRN 121
           F   +N+  + L+   +  +    L  L       +++DLS N +    P     + +  
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHK 204

Query: 122 FSLSGNQLTGSIPES----LSRLTQLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLSANN 176
            +L  N  + ++ ++    L+ L ++  L L      G +         GL N  +    
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGL-EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 177 LT------GQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEK 230
           L         +      L+++ S  L +  +    +   +     L + N  F      K
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLK 323

Query: 231 LLSIPNFRKDGNPFNT 246
           L S+       N    
Sbjct: 324 LKSLKRLTFTSNKGGN 339

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 79.3 bits (196), Expect = 2e-15
 Identities = 25/163 (15%), Positives = 54/163 (33%), Gaps = 31/163 (19%)

Query: 64  QGVFCVFSNVTEIRLTGMNL-GGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVR 120
            G+F   S++  +++ G +     L D   +L ++  +DLS   +    P+      +++
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497

Query: 121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAF-HQFTGLINFDLSANNLTG 179
             ++S N            L  L  L  + NH+         H  + L   +L+ N+   
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

Query: 180 --------------------------QLPPSTRNLSSLYSLHL 196
                                       P   + +  + SL++
Sbjct: 558 TCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNI 599

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 66.6 bits (163), Expect = 2e-11
 Identities = 20/166 (12%), Positives = 47/166 (28%), Gaps = 14/166 (8%)

Query: 84  GGVLADTLGDLESVINIDLSNNHIGGS-----IPSNLPVTVRNFSLSGNQLT------GS 132
             V+   +  L  +    L                +    + N ++   +L         
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273

Query: 133 IPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLY 192
           I +  + LT +   SL +  +      ++    G  + +L             ++L  L 
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLT 331

Query: 193 SLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFR 238
               +       ++ L  L  +DL+     F G   +      + +
Sbjct: 332 FTSNKGGNAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  109 bits (274), Expect = 6e-25
 Identities = 32/228 (14%), Positives = 65/228 (28%), Gaps = 33/228 (14%)

Query: 40  YISLNFPPLEKWLSFGGDPCG-DSWQGVFC-VFSNVTEIRLTGMNLGGVLADTLGDLESV 97
                  P   W +F  +     +  GV       VT + L G    G + D +G L  +
Sbjct: 49  QQGFGTQPGANW-NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107

Query: 98  INIDLSNNHIGGSIPSNLPVTVRN------FSLSGNQLTGSIPESLSRL--TQLLDLSLN 149
             + L ++    +     P  +                  +  +   R   + L+   +N
Sbjct: 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCIN 167

Query: 150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT----- 204
           ++     I  +             +NN+T  +  +   L+ L   ++ N+          
Sbjct: 168 SDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA 226

Query: 205 --LNVLEDL--------------HLIDLNIENNLFSGPIPEKLLSIPN 236
                 E                 L D+ + N      +P  L ++P 
Sbjct: 227 WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE 274

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  100 bits (250), Expect = 4e-22
 Identities = 33/181 (18%), Positives = 71/181 (39%), Gaps = 27/181 (14%)

Query: 82  NLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFS------LSGNQLTG---- 131
            +  + A+  G  E V N+  ++N +   IP+      ++ S       S N++      
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLK-YIPNIF--DAKSVSVMSAIDFSYNEIGSVDGK 420

Query: 132 ---SIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG-------QL 181
               +  +  +   +  ++L+NN ++    + F   + L + +L  N LT          
Sbjct: 421 NFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDE 480

Query: 182 PPSTRNLSSLYSLHLQNNKLSG---TLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFR 238
             + +N   L S+ L+ NKL+            +L+ +++  N FS   P + L+    +
Sbjct: 481 NENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK 539

Query: 239 K 239
            
Sbjct: 540 G 540

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 99.0 bits (247), Expect = 1e-21
 Identities = 24/154 (15%), Positives = 53/154 (34%), Gaps = 18/154 (11%)

Query: 91  LGDLESVINIDLSNNHI-GGSIPS---NLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDL 146
               E +  I +  N++    + +    +   +       NQL G +P       +L  L
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMK-KLGMLECLYNQLEGKLPA-FGSEIKLASL 358

Query: 147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST--RNLSSLYSLHLQNNKLSG- 203
           +L  N +     +       + N   + N L   +P     +++S + ++    N++   
Sbjct: 359 NLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSV 417

Query: 204 TLNVLEDL--------HLIDLNIENNLFSGPIPE 229
                + L        ++  +N+ NN  S    E
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 96.3 bits (240), Expect = 9e-21
 Identities = 24/171 (14%), Positives = 46/171 (26%), Gaps = 17/171 (9%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLT 130
              T+I     N+   ++  +  L  +    + N+               N +    Q  
Sbjct: 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA---WENENSEYAQQY 238

Query: 131 GSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT--------GQLP 182
            +       L  L D+ + N      +P        +   +++ N            Q  
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298

Query: 183 PSTRNLSSLYSLHLQNNKLSGTLNVLEDL----HLIDLNIENNLFSGPIPE 229
                   +  +++  N L  T  V   L     L  L    N   G +P 
Sbjct: 299 ADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPA 348

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 95.1 bits (237), Expect = 2e-20
 Identities = 29/188 (15%), Positives = 58/188 (30%), Gaps = 22/188 (11%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTV------- 119
                NV+ I L+   +     +       + +I+L  N +   IP N            
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFKNT 487

Query: 120 ---RNFSLSGNQLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLI------N 169
               +  L  N+LT    +   + L  L+ + L+ N  +   P      + L        
Sbjct: 488 YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546

Query: 170 FDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG-TLNVLEDLHLIDLNIENNLFSGPIP 228
            D   N    + P       SL  L + +N +      +  ++ ++D+   +N       
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIK--DNPNISIDL 604

Query: 229 EKLLSIPN 236
             +     
Sbjct: 605 SYVCPYIE 612

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 79.7 bits (197), Expect = 1e-15
 Identities = 25/145 (17%), Positives = 41/145 (28%), Gaps = 13/145 (8%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLAD-TLGDLESVINIDLSNNHIGGSIPS---NLP-----V 117
           F     +T I L    L  +  D     L  ++ IDLS N      P+   N        
Sbjct: 484 FKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542

Query: 118 TVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL 177
                   GN+     PE ++    L  L + +N +   + +       +   D+  N  
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPN 599

Query: 178 TGQLPPSTRNLSSLYSLHLQNNKLS 202
                             L  +K  
Sbjct: 600 ISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 68.5 bits (168), Expect = 3e-12
 Identities = 25/148 (16%), Positives = 42/148 (28%), Gaps = 14/148 (9%)

Query: 121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
           NF+   +        SL+   ++  LSL     +G +PDA  Q T L    L ++     
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 181 ----LPPSTRNLSSLYSLHLQNNKLSGT----LNVLEDLHLIDLNIENNLFSGPIPEKLL 232
                P       S             T        +   LI   I ++     I +   
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

Query: 233 SIPNFRKDGNPFNTTVIALPPTAIPPSI 260
                 + G   N        T +  ++
Sbjct: 181 ITLKDTQIGQLSNNI------TFVSKAV 202

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  104 bits (261), Expect = 1e-24
 Identities = 70/299 (23%), Positives = 109/299 (36%), Gaps = 61/299 (20%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLL----AVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           G  +GEG  GSV +  L          AVK +    S ++  EEFL  A+ +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 501 VELIGYCNEHGQHLLVYDY-------GGNCTLHDLL--HSDEEAHKKFSWNIRIRVALGA 551
           + L+G C E     +            G+  LH  L     E   K       ++  +  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGD--LHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           A  ++YL        +H +  + N +L + + V V+D GL+  ++SG             
Sbjct: 157 ALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY-------YRQG 206

Query: 612 GSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAI 662
                     A E      Y+ +SDV++ GV M E+ T G  PY               +
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY-------------PGV 253

Query: 663 PRLHDIDALS---RMVDPS--LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                 D L    R+  P   LD  Y         +I+  C + +P  RP  S +   L
Sbjct: 254 QNHEMYDYLLHGHRLKQPEDCLDELY---------EIMYSCWRTDPLDRPTFSVLRLQL 303

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  108 bits (270), Expect = 1e-24
 Identities = 68/282 (24%), Positives = 116/282 (41%), Gaps = 45/282 (15%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
              +G+G  G V+     G   +A+K L          E FL+ A  + +LRH  +V+L 
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY 328

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
              +E     +V +Y    +L D L  +    K       + +A   A  + Y++ +   
Sbjct: 329 AVVSEEPI-YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN-- 383

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSY 623
             VH + +++NIL+ E L+ +V+D GLA L+                 + APE    G +
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APEAALYGRF 441

Query: 624 SCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS------RMVD 676
           + +SDV+S G+++ EL T GR PY                P + + + L       RM  
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPY----------------PGMVNREVLDQVERGYRMPC 485

Query: 677 PSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           P    +  +         D++ +C + EP  RP    +   L
Sbjct: 486 PPECPESLH---------DLMCQCWRKEPEERPTFEYLQAFL 518

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  103 bits (260), Expect = 2e-24
 Identities = 72/286 (25%), Positives = 118/286 (41%), Gaps = 45/286 (15%)

Query: 445 GNFIGEGLLGSVYKAEL--PGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
              IG G  G V    L  PG + +  A+K L    ++RQ   +FL  AS + +  H NI
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASIMGQFDHPNI 112

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           + L G        ++V +Y  N +L   L + +    +F+    + +  G    ++YL +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSD 169

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------ 614
           +     VH +  + N+L+D  L+ +VSD GL+ +L         +   T  G        
Sbjct: 170 LG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-----PDAAYTTTGGKIPIRWT 221

Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
           APE     ++S  SDV+S GVVM E+L  G +PY           V      +  ++   
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY----WNMTNRDV------ISSVEEGY 271

Query: 673 RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           R+  P       +          ++  C   +   RP  S+IV  L
Sbjct: 272 RLPAPMGCPHALH---------QLMLDCWHKDRAQRPRFSQIVSVL 308

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  103 bits (259), Expect = 2e-24
 Identities = 52/317 (16%), Positives = 115/317 (36%), Gaps = 42/317 (13%)

Query: 409 PAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLL 467
              +     P      +        +L  +         IG G    VY+A  L  G  +
Sbjct: 5   SQGMQGPPVPQFQPQKALRPDMGYNTLANFR----IEKKIGRGQFSEVYRAACLLDGVPV 60

Query: 468 AVKK--LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTL 525
           A+KK  + + +  +   +   E    + +L H N+++      E  +  +V +      L
Sbjct: 61  ALKKVQIFDLMDAKARADCIKE-IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119

Query: 526 HDLLHSDEEAHKKFS----WNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK 581
             ++   ++  +       W   +++      AL+++       ++H + K +N+ +   
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCS----ALEHMHS---RRVMHRDIKPANVFITAT 172

Query: 582 LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS---GAPE-FESGSYSCQSDVYSLGVVML 637
            +V++ D GL       S    +    +  G+    +PE      Y+ +SD++SLG ++ 
Sbjct: 173 GVVKLGDLGLGRFF--SSKTTAAH---SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227

Query: 638 ELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISR 697
           E+   + P+         SL +  I +            P     Y   S      +++ 
Sbjct: 228 EMAALQSPF-YGDKMNLYSLCK-KIEQCD--------YPPLPSDHY---S-EELRQLVNM 273

Query: 698 CVQWEPGFRPPMSEIVQ 714
           C+  +P  RP ++ +  
Sbjct: 274 CINPDPEKRPDVTYVYD 290

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  105 bits (265), Expect = 2e-24
 Identities = 74/287 (25%), Positives = 119/287 (41%), Gaps = 51/287 (17%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
              IG+G  G V   +  G K+ AVK + N      T + FL  AS +++LRH N+V+L+
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLL 252

Query: 505 GYCNEHGQHLLV---YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           G   E    L +   Y   G+  L D L S          +  ++ +L    A++YL+  
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGS--LVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL----TAHGSGAPE 617
                VH +  + N+L+ E  + +VSD GL     S        G L    T     APE
Sbjct: 309 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWT-----APE 356

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
                 +S +SDV+S G+++ E+ + GR PY    PR     V   + + +      +M 
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPY----PRIPLKDVVPRVEKGY------KMD 406

Query: 676 DPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
            P       Y         D++  C   +   RP   ++ + L  + 
Sbjct: 407 APDGCPPAVY---------DVMKNCWHLDAATRPTFLQLREQLEHIR 444

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  102 bits (257), Expect = 2e-24
 Identities = 59/289 (20%), Positives = 110/289 (38%), Gaps = 55/289 (19%)

Query: 448 IGEGLLGSVYKAEL--PGGKLL--AVKKL-SNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  G V + E   P GK +  AVK L  + +SQ +  ++F+   + +  L H N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L G         +V +     +L D L   +     F      R A+  A  + YL+   
Sbjct: 86  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKR 141

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------A 615
               +H +  + N+LL  + +V++ D GL   L        ++                A
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRAL------PQNDDHYVMQEHRKVPFAWCA 192

Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS- 672
           PE  ++ ++S  SD +  GV + E+ T G++P+               +     +  +  
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW-------------IGLNGSQILHKIDK 239

Query: 673 ---RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
              R+  P       Y         +++ +C   +P  RP    +   L
Sbjct: 240 EGERLPRPEDCPQDIY---------NVMVQCWAHKPEDRPTFVALRDFL 279

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  103 bits (260), Expect = 2e-24
 Identities = 75/294 (25%), Positives = 123/294 (41%), Gaps = 58/294 (19%)

Query: 448 IGEGLLGSVYKAEL--PGGKLL---AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           IG G  G VYK  L    GK     A+K L    +++Q   +FL  A  + +  H NI+ 
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHNIIR 110

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L G  +++   +++ +Y  N  L   L   +    +FS    + +  G A  ++YL  + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN 167

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------AP 616
               VH +  + NIL++  L+ +VSD GL+ +L      +  E   T  G        AP
Sbjct: 168 ---YVHRDLAARNILVNSNLVCKVSDFGLSRVL-----EDDPEATYTTSGGKIPIRWTAP 219

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS-- 672
           E      ++  SDV+S G+VM E++T G +PY                  L + + +   
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERPY----------------WELSNHEVMKAI 263

Query: 673 ----RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
               R+  P       Y          ++ +C Q E   RP  ++IV  L  +I
Sbjct: 264 NDGFRLPTPMDCPSAIY---------QLMMQCWQQERARRPKFADIVSILDKLI 308

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  102 bits (256), Expect = 3e-24
 Identities = 69/289 (23%), Positives = 116/289 (40%), Gaps = 63/289 (21%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
              IG+G  G V   +  G K+ AVK + N      T + FL  AS +++LRH N+V+L+
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLL 80

Query: 505 GYCNEHGQHLLV---YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           G   E    L +   Y   G+  L D L S          +  ++ +L    A++YL+  
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGS--LVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------- 614
                VH +  + N+L+ E  + +VSD GL             +   +   +G       
Sbjct: 137 N---FVHRDLAARNVLVSEDNVAKVSDFGLT------------KEASSTQDTGKLPVKWT 181

Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
           APE      +S +SDV+S G+++ E+ + GR PY               IP    +  + 
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-------------PRIPLKDVVPRVE 228

Query: 673 ---RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
              +M  P       Y         +++  C   +   RP   ++ + L
Sbjct: 229 KGYKMDAPDGCPPAVY---------EVMKNCWHLDAAMRPSFLQLREQL 268

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  103 bits (258), Expect = 3e-24
 Identities = 65/295 (22%), Positives = 107/295 (36%), Gaps = 56/295 (18%)

Query: 445 GNFIGEGLLGSVYKAEL--PGGKLL---AVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
              +G G+ G+V+K      G  +     +K + +   ++   +   +    I  L H +
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-QAVTDHMLAIGSLDHAH 76

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV L+G C       LV  Y    +L D +             + +   +  A+ + YL+
Sbjct: 77  IVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLE 132

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----- 614
           E     +VH N  + N+LL     V+V+D G+A LL       L                
Sbjct: 133 EHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-------AKTPIK 182

Query: 615 --APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
             A E    G Y+ QSDV+S GV + EL+T G +PY               +      D 
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY-------------AGLRLAEVPDL 229

Query: 671 LS---RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
           L    R+  P +     Y          ++ +C   +   RP   E+  +   M 
Sbjct: 230 LEKGERLAQPQICTIDVY---------MVMVKCWMIDENIRPTFKELANEFTRMA 275

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  102 bits (256), Expect = 3e-24
 Identities = 73/297 (24%), Positives = 113/297 (38%), Gaps = 63/297 (21%)

Query: 444 EGNFIGEGLLGSVYKAELPGGK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
               IG+G  G VY  E           A+K LS     +Q  E FL     +  L H N
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV-EAFLREGLLMRGLNHPN 83

Query: 500 IVELIGYC-NEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           ++ LIG      G   ++  Y   G+  L   + S +   +  +    I   L  AR ++
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGD--LLQFIRSPQ---RNPTVKDLISFGLQVARGME 138

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLL----T 609
           YL E      VH +  + N +LDE   V+V+D GLA  +      S  +     L    T
Sbjct: 139 YLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195

Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHD 667
                A E  ++  ++ +SDV+S GV++ ELLT G  PY                  +  
Sbjct: 196 -----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY----------------RHIDP 234

Query: 668 IDALS------RMVDPS--LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            D         R+  P    D  Y          ++ +C + +P  RP    +V ++
Sbjct: 235 FDLTHFLAQGRRLPQPEYCPDSLY---------QVMQQCWEADPAVRPTFRVLVGEV 282

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  106 bits (267), Expect = 4e-24
 Identities = 31/190 (16%), Positives = 60/190 (31%), Gaps = 12/190 (6%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRNFSLSG 126
            ++   +  +   L  +   T   L ++  +DL+   I         +    +    L+ 
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQH-RLDTLVLTA 90

Query: 127 NQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTR 186
           N L      +LS    L  L      ++       H    L +  L +N+++    P   
Sbjct: 91  NPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF 150

Query: 187 NLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRK--- 239
               L  L  QNN +       ++ L+    + LN+  N  +G I         F+    
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNF 209

Query: 240 DGNPFNTTVI 249
            G      + 
Sbjct: 210 GGTQNLLVIF 219

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  104 bits (262), Expect = 1e-23
 Identities = 37/193 (19%), Positives = 71/193 (36%), Gaps = 14/193 (7%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVR 120
                 S++  + L+      +  +   +   +  +DL+   +          NL   ++
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH-LLK 428

Query: 121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN---FDLSANNL 177
             +LS + L  S  +    L  L  L+L  NH   G     +    L       LS  +L
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488

Query: 178 TGQLPPST-RNLSSLYSLHLQNNKLSG-TLNVLEDLHLIDLNIENNLFSGPIPEKLLSIP 235
           +  +      +L  +  + L +N+L+  ++  L  L  I LN+ +N  S  +P  L  + 
Sbjct: 489 SS-IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILS 547

Query: 236 NFRK---DGNPFN 245
             R      NP +
Sbjct: 548 QQRTINLRQNPLD 560

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 99.7 bits (249), Expect = 6e-22
 Identities = 30/142 (21%), Positives = 43/142 (30%), Gaps = 3/142 (2%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD 159
            +  N  +   IP  LP +      S N L      + SRL  L  L L    +     D
Sbjct: 17  YNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75

Query: 160 AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG-TLNVLEDL-HLIDLN 217
            F     L    L+AN L      +     +L  L      +S      L +   L  L 
Sbjct: 76  TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135

Query: 218 IENNLFSGPIPEKLLSIPNFRK 239
           + +N  S     K       + 
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKV 157

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 91.6 bits (228), Expect = 2e-19
 Identities = 31/182 (17%), Positives = 57/182 (31%), Gaps = 16/182 (8%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLE--SVINIDLSNNHIGGSIP---SNLPVTVRN 121
                ++       M+   +       L   SV +I+L  ++               ++ 
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS-GLQE 282

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
             L+   L+  +P  L  L+ L  L L+ N        +   F  L +  +  N    +L
Sbjct: 283 LDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341

Query: 182 PPST-RNLSSLYSLHLQNNKLS------GTLNVLEDLHLIDLNIENNLFSGPIPEKLLSI 234
                 NL +L  L L ++ +         L  L  L  ++L+   N       E     
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS--YNEPLSLKTEAFKEC 399

Query: 235 PN 236
           P 
Sbjct: 400 PQ 401

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 90.8 bits (226), Expect = 4e-19
 Identities = 29/159 (18%), Positives = 59/159 (37%), Gaps = 6/159 (3%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPV-----T 118
           Q  F     +  + L+   L          L ++ +++L  NH                 
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477

Query: 119 VRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT 178
           +    LS   L+     + + L  +  + L++N L     +A     G+   +L++N+++
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHIS 536

Query: 179 GQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLN 217
             LP     LS   +++L+ N L  T + +  L     N
Sbjct: 537 IILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKEN 575

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 90.5 bits (225), Expect = 4e-19
 Identities = 23/187 (12%), Positives = 58/187 (31%), Gaps = 13/187 (6%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVR 120
           +        +  +      +  +    L + +++ ++ L +NHI              ++
Sbjct: 98  ETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE-KLK 156

Query: 121 NFSLSGNQLTGSIPESLSRLTQL--LDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT 178
                 N +     E +S L Q   L L+LN N +  GI           + +       
Sbjct: 157 VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNL 215

Query: 179 GQLPPSTRN--LSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENNLFSGPIPEKLL 232
             +    +N  + SL+    ++             L ++ +  +N++ + F         
Sbjct: 216 LVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFH 275

Query: 233 SIPNFRK 239
                ++
Sbjct: 276 CFSGLQE 282

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 89.3 bits (222), Expect = 1e-18
 Identities = 30/193 (15%), Positives = 57/193 (29%), Gaps = 12/193 (6%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRN 121
             F    N+T + LT   +  +  DT      +  + L+ N +        S     +++
Sbjct: 51  TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPK-ALKH 109

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
                  ++      L     L  L L +NH++            L   D   N +    
Sbjct: 110 LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169

Query: 182 PPSTRNLSSL--YSLHLQNNKLSG------TLNVLEDLHLIDLNIENNLFSGPIPEKLLS 233
                +L      SL+L  N ++G         V + L+         +F G     + S
Sbjct: 170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

Query: 234 IPNFRKDGNPFNT 246
           +     +      
Sbjct: 230 LWLGTFEDMDDED 242

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 86.6 bits (215), Expect = 9e-18
 Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 11/170 (6%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADT-LGDLESVINIDLSNNHIGGSIP---SNLPVTVR 120
             F     +  + L    L    A +   +L  +  ++LS++ +  S       LP  ++
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP-ALQ 452

Query: 121 NFSLSGNQLTGSI---PESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL 177
           + +L GN           SL  L +L  L L+   L+     AF     + + DLS N L
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512

Query: 178 TGQLPPSTRNLSSLYSLHLQNNKLSGT-LNVLEDL-HLIDLNIENNLFSG 225
           T     +  +L  +Y L+L +N +S    ++L  L     +N+  N    
Sbjct: 513 TSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.0 bits (203), Expect = 2e-16
 Identities = 39/182 (21%), Positives = 69/182 (37%), Gaps = 13/182 (7%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRN 121
             F  FS + E+ LT  +L  +    L  L ++  + LS N          SN P ++ +
Sbjct: 272 NTFHCFSGLQELDLTATHLSELP-SGLVGLSTLKKLVLSANKFENLCQISASNFP-SLTH 329

Query: 122 FSLSGNQLTGSI-PESLSRLTQLLDLSLNNNHLN--GGIPDAFHQFTGLINFDLSANNLT 178
            S+ GN     +    L  L  L +L L+++ +             + L + +LS N   
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389

Query: 179 GQLPPST-RNLSSLYSLHLQNNKLSG--TLNVLEDLH-LIDLNIENNLFSGPIPEKLLSI 234
             L     +    L  L L   +L      +  ++LH L  LN+ ++L      +    +
Sbjct: 390 S-LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL 448

Query: 235 PN 236
           P 
Sbjct: 449 PA 450

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 81.6 bits (202), Expect = 3e-16
 Identities = 24/181 (13%), Positives = 53/181 (29%), Gaps = 11/181 (6%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRN 121
             F     +  + LT   L  +    L   +++ ++      I         N   T+ +
Sbjct: 75  DTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQK-TLES 133

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGL--INFDLSANNLTG 179
             L  N ++           +L  L   NN ++    +          ++ +L+ N++ G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 180 QLPPSTRNLSSLYSLHLQNNKLSGT----LNVLEDLHLIDLNIENNLFSGPIPEKLLSIP 235
            + P   + +   SL+    +        L       L     E+       P     + 
Sbjct: 194 -IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252

Query: 236 N 236
            
Sbjct: 253 E 253

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  103 bits (258), Expect = 4e-24
 Identities = 66/297 (22%), Positives = 114/297 (38%), Gaps = 58/297 (19%)

Query: 440 NSFSEGNFIGEGLLGSVYKAEL--PGGKL---LAVKKLSNTVSQRQTDEEFLELASTISR 494
             F +   +G G  G+VYK      G K+   +A+K+L    S +   +E L+ A  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMAS 73

Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           + + ++  L+G C       L+        L D +   ++          +   +  A+ 
Sbjct: 74  VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKG 129

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           + YL++     +VH +  + N+L+     V+++D GLA LL +             H  G
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--------EYHAEG 178

Query: 615 --------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPR 664
                   A E      Y+ QSDV+S GV + EL+T G KPY               IP 
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-------------DGIPA 225

Query: 665 LHDIDALS---RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                 L    R+  P +     Y          I+ +C   +   RP   E++ + 
Sbjct: 226 SEISSILEKGERLPQPPICTIDVY---------MIMVKCWMIDADSRPKFRELIIEF 273

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  103 bits (259), Expect = 4e-24
 Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 45/287 (15%)

Query: 448 IGEGLLGSVYKAEL--PGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +G G  G V    L  P  K +  A+K L    +++Q   +FL  AS + +  H NI+ L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASIMGQFDHPNIIRL 111

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
            G   +    ++V +Y  N +L   L   +    +F+    + +  G A  ++YL ++  
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG- 167

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------APE 617
              VH +  + NIL++  L+ +VSD GL  +L         E   T  G        +PE
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD-----PEAAYTTRGGKIPIRWTSPE 220

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
                 ++  SDV+S G+V+ E+++ G +PY           V      +  +D   R+ 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY----WEMSNQDV------IKAVDEGYRLP 270

Query: 676 DPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
            P       Y          ++  C Q +   RP   +IV  L  +I
Sbjct: 271 PPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  106 bits (266), Expect = 5e-24
 Identities = 66/281 (23%), Positives = 113/281 (40%), Gaps = 38/281 (13%)

Query: 445 GNFIGEGLLGSVYKAEL--PGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           G  IGEG  G V++     P    +  A+K   N  S     E+FL+ A T+ +  H +I
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHI 453

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           V+LIG   E+    ++ +      L   L   +           I  A   + AL YL+ 
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLES 509

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FE 619
                 VH +  + N+L+     V++ D GL+  +   +  + S+G L      APE   
Sbjct: 510 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESIN 565

Query: 620 SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
              ++  SDV+  GV M E+L  G KP+                  + + D +   ++  
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPF----------------QGVKNNDVI-GRIE-- 606

Query: 679 LDGAYLAKSL---SRFADIISRCVQWEPGFRPPMSEIVQDL 716
            +G  L            ++++C  ++P  RP  +E+   L
Sbjct: 607 -NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  101 bits (254), Expect = 6e-24
 Identities = 68/287 (23%), Positives = 111/287 (38%), Gaps = 50/287 (17%)

Query: 445 GNFIGEGLLGSVYKAEL--PGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           G  IGEG  G V++     P    L  A+K   N  S     E+FL+ A T+ +  H +I
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHI 78

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           V+LIG   E+    ++ +      L   L   +           I  A   + AL YL+ 
Sbjct: 79  VKLIGVITEN-PVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES 134

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL----TAHGSGAP 616
                 VH +  + N+L+     V++ D GL+  +   +  + S+G L          AP
Sbjct: 135 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-----AP 186

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS-- 672
           E      ++  SDV+  GV M E+L  G KP+               +     I  +   
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKPF-------------QGVKNNDVIGRIENG 233

Query: 673 -RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            R+  P       Y          ++++C  ++P  RP  +E+   L
Sbjct: 234 ERLPMPPNCPPTLY---------SLMTKCWAYDPSRRPRFTELKAQL 271

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  105 bits (264), Expect = 7e-24
 Identities = 71/286 (24%), Positives = 111/286 (38%), Gaps = 53/286 (18%)

Query: 448 IGEGLLGSVYKAELPGGK---LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           +G G  GSV +      K    +A+K L     +  T EE +  A  + +L +  IV LI
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYIVRLI 402

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEP 564
           G C      +LV +  G   LH  L    E   +   +    +    +  ++YL+E    
Sbjct: 403 GVCQAE-ALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN-- 456

Query: 565 PIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE 617
             VH N  + N+LL  +   ++SD GL+  L         +   TA  +G       APE
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKAL------GADDSYYTARSAGKWPLKWYAPE 509

Query: 618 -FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPR---LHDIDALS 672
                 +S +SDV+S GV M E L+ G+KPY               +     +  I+   
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPY-------------KKMKGPEVMAFIEQGK 556

Query: 673 RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           RM  P       Y          ++S C  ++   RP    + Q +
Sbjct: 557 RMECPPECPPELY---------ALMSDCWIYKWEDRPDFLTVEQRM 593

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  101 bits (254), Expect = 7e-24
 Identities = 57/303 (18%), Positives = 109/303 (35%), Gaps = 44/303 (14%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-----GKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
                   +GEG  G V            G+ +AVK L           +  +    +  
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRN 79

Query: 495 LRHGNIVELIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           L H NIV+  G C E G +   L+ ++  + +L + L  ++    K +   +++ A+   
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQIC 136

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           + + YL        VH +  + N+L++ +  V++ D GL   +      E  +   T   
Sbjct: 137 KGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI------ETDKEYYTVKD 187

Query: 613 SG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLV-RWAI 662
                    APE      +   SDV+S GV + ELLT             +        +
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247

Query: 663 PRLHDIDALS---RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
                ++ L    R+  P    D  Y          ++ +C +++P  R     +++   
Sbjct: 248 TVTRLVNTLKEGKRLPCPPNCPDEVY---------QLMRKCWEFQPSNRTSFQNLIEGFE 298

Query: 718 CMI 720
            ++
Sbjct: 299 ALL 301

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  101 bits (254), Expect = 1e-23
 Identities = 63/303 (20%), Positives = 113/303 (37%), Gaps = 68/303 (22%)

Query: 445 GNFIGEGLLGSVYKAELPGGK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           G  +G+G  GSV +A+L         +AVK L   +      EEFL  A+ +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 501 VELIGYC------NEHGQHLLVYDY--GGNCTLHDLL--HSDEEAHKKFSWNIRIRVALG 550
            +L+G              +++  +   G+  LH  L      E          +R  + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGD--LHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
            A  ++YL        +H +  + N +L E + V V+D GL+  ++SG            
Sbjct: 146 IACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY-------YRQ 195

Query: 611 HGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWA 661
             +        A E      Y+  SDV++ GV M E++T G+ PY               
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY--------------- 240

Query: 662 IPRLHDIDALS------RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIV 713
              + + +  +      R+  P    +  Y         D++ +C   +P  RP  + + 
Sbjct: 241 -AGIENAEIYNYLIGGNRLKQPPECMEEVY---------DLMYQCWSADPKQRPSFTCLR 290

Query: 714 QDL 716
            +L
Sbjct: 291 MEL 293

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  100 bits (252), Expect = 1e-23
 Identities = 54/307 (17%), Positives = 105/307 (34%), Gaps = 58/307 (18%)

Query: 438 YTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           Y   F     +G G  G V++A+        A+K++     +   ++   E    +++L 
Sbjct: 3   YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE-VKALAKLE 61

Query: 497 HGNIVELIGY---------CNEHGQHLLVY---DYGGNCTLHDLLH---SDEEAHKKFSW 541
           H  IV                     + +Y          L D ++   + EE  +    
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 542 NIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN 601
           +I +++A     A+++L       ++H + K SNI      +V+V D GL   +      
Sbjct: 122 HIFLQIAE----AVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 602 ELSEGLLTAHGSG----------APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSR 650
           +     + A+             +PE     SYS + D++SLG+++ ELL    P+    
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231

Query: 651 PRGE--QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP 708
            R      +     P L                    +       ++   +   P  RP 
Sbjct: 232 ERVRTLTDVRNLKFPPLFT------------------QKYPCEYVMVQDMLSPSPMERPE 273

Query: 709 MSEIVQD 715
              I+++
Sbjct: 274 AINIIEN 280

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  101 bits (253), Expect = 2e-23
 Identities = 53/308 (17%), Positives = 99/308 (32%), Gaps = 39/308 (12%)

Query: 408 APAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKL 466
               +   +  +  V+ +          ++  +  +    +G G  G V++  +   G  
Sbjct: 26  KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85

Query: 467 LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY-DYGGNCTL 525
            AVKK+     +    EE        + L    IV L G     G  + ++ +     +L
Sbjct: 86  CAVKKVR---LEVFRVEEL----VACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGSL 137

Query: 526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-LIV 584
             L+    +       +  +     A   L+YL       I+HG+ K+ N+LL       
Sbjct: 138 GQLI----KQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRA 190

Query: 585 RVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APEFESGS-YSCQSDVYSLGVVMLELL 640
            + D G A  L      +         G+    APE   G     + D++S   +ML +L
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250

Query: 641 TGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLS-RFADIISRCV 699
            G  P+                 +        ++         +  S +   A  I   +
Sbjct: 251 NGCHPW----------------TQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGL 294

Query: 700 QWEPGFRP 707
           + EP  R 
Sbjct: 295 RKEPVHRA 302

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (253), Expect = 2e-23
 Identities = 61/293 (20%), Positives = 107/293 (36%), Gaps = 48/293 (16%)

Query: 448 IGEGLLGSVYKAELPG-----GKLLAVKKL-SNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  GSV            G+++AVKKL  +T        +F      +  L+H NIV
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 105

Query: 502 ELIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           +  G C   G+    L+ +Y    +L D L   +E   +      ++      + ++YL 
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG 162

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----- 614
                  +H +  + NIL++ +  V++ D GL  +L         +        G     
Sbjct: 163 TKR---YIHRDLATRNILVENENRVKIGDFGLTKVL------PQDKEYYKVKEPGESPIF 213

Query: 615 --APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL 671
             APE      +S  SDV+S GVV+ EL T  +          + +      ++     +
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273

Query: 672 S------RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                  R+  P    D  Y          I++ C       RP   ++   +
Sbjct: 274 ELLKNNGRLPRPDGCPDEIY---------MIMTECWNNNVNQRPSFRDLALRV 317

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  104 bits (261), Expect = 2e-23
 Identities = 32/146 (21%), Positives = 58/146 (39%), Gaps = 8/146 (5%)

Query: 98  INIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGI 157
           I     +  +   +P ++P + +N  LS N L      S S  ++L  L L+   +    
Sbjct: 14  ITYQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72

Query: 158 PDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLH 212
             A+H    L N  L+ N +     P +   L+SL +L     KL+      +  L  L 
Sbjct: 73  DKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131

Query: 213 LIDLNIENNLFSGPIPEKLLSIPNFR 238
            +++   N + S  +P    ++ N  
Sbjct: 132 KLNVA-HNFIHSCKLPAYFSNLTNLV 156

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  100 bits (251), Expect = 3e-22
 Identities = 38/194 (19%), Positives = 71/194 (36%), Gaps = 15/194 (7%)

Query: 69  VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRNFSLS 125
           + S+   I L+   L  + + +  +   +  +DLS   I          L   + N  L+
Sbjct: 30  IPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLH-HLSNLILT 88

Query: 126 GNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG-QLPPS 184
           GN +    P S S LT L +L      L         Q   L   +++ N +   +LP  
Sbjct: 89  GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148

Query: 185 TRNLSSLYSLHLQNNKLSG----TLNVLEDLH--LIDLNIENNLFSGPIPEKLLSIPNFR 238
             NL++L  + L  N +       L  L +     + L++  N     I ++        
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLH 207

Query: 239 K---DGNPFNTTVI 249
           +    GN  ++ ++
Sbjct: 208 ELTLRGNFNSSNIM 221

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 95.5 bits (238), Expect = 1e-20
 Identities = 26/142 (18%), Positives = 49/142 (34%), Gaps = 3/142 (2%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL---PVTVR 120
              F     +  + ++  N           L S+  + ++ N    +  SN+      + 
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT 476

Query: 121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
              LS  QL          L +L  L++++N+L       ++Q   L   D S N +   
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536

Query: 181 LPPSTRNLSSLYSLHLQNNKLS 202
                    SL   +L NN ++
Sbjct: 537 KGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 94.3 bits (235), Expect = 3e-20
 Identities = 36/178 (20%), Positives = 66/178 (37%), Gaps = 10/178 (5%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRN 121
             F  FS +  + L+   +  +       L  + N+ L+ N I    P   S L  ++ N
Sbjct: 50  YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLT-SLEN 108

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNG-GIPDAFHQFTGLINFDLSANNLTGQ 180
                 +L       + +L  L  L++ +N ++   +P  F   T L++ DLS N +   
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168

Query: 181 LPPSTRNLS----SLYSLHLQNNKLSG-TLNVLEDLHLIDLNIENNLFSGPIPEKLLS 233
                + L        SL +  N +        + + L +L +  N  S  I +  L 
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 90.5 bits (225), Expect = 5e-19
 Identities = 33/168 (19%), Positives = 58/168 (34%), Gaps = 10/168 (5%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLA-DTLGDLESVINIDLSNNHIGGSIPS---NLPVTVR 120
             F     +  +      L  V        LE ++ +D+S  +           L  ++ 
Sbjct: 393 ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT-SLN 451

Query: 121 NFSLSGNQLTGSIPES-LSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG 179
              ++GN    +   +  +  T L  L L+   L       F     L   ++S NNL  
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511

Query: 180 QLPPST-RNLSSLYSLHLQNNKLSGTLNVLEDL--HLIDLNIENNLFS 224
            L  S    L SL +L    N++  +  +L+     L   N+ NN  +
Sbjct: 512 -LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 87.0 bits (216), Expect = 5e-18
 Identities = 31/178 (17%), Positives = 63/178 (35%), Gaps = 9/178 (5%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLE--SVINIDLSNNHIGGSIPSNLP--VTVRNF 122
                +++ + L+   L      +  DL   S+ ++DLS N     + +N      +++ 
Sbjct: 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHL 404

Query: 123 SLSGNQLTGSIPES-LSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
               + L      S    L +LL L ++  +        F   T L    ++ N+     
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464

Query: 182 PPST-RNLSSLYSLHLQNNKLSG-TLNVLEDL-HLIDLNIENNLFSGPIPEKLLSIPN 236
             +   N ++L  L L   +L   +  V + L  L  LN+ +N            + +
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.9 bits (208), Expect = 6e-17
 Identities = 31/191 (16%), Positives = 66/191 (34%), Gaps = 21/191 (10%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVR 120
           G F   +++  +      L  + +  +G L ++  +++++N I         SNL   + 
Sbjct: 98  GSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT-NLV 156

Query: 121 NFSLSGNQLTGSIPESLSRLTQL----LDLSLNNNHLNGGIPDAFHQFTGLINFDLSANN 176
           +  LS N +       L  L +     L L ++ N ++     AF     L    L  N 
Sbjct: 157 HVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNF 215

Query: 177 LTGQLPPST-RNLSSLYSLHLQNNKLSG----------TLNVLEDLHLIDLNIENNLFSG 225
            +  +  +  +NL+ L+   L   +              +  L D+ + +  +       
Sbjct: 216 NSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFS 275

Query: 226 PIPEKLLSIPN 236
               K   + N
Sbjct: 276 DDIVKFHCLAN 286

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 77.8 bits (192), Expect = 5e-15
 Identities = 36/189 (19%), Positives = 57/189 (30%), Gaps = 25/189 (13%)

Query: 72  NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLT- 130
            + E RLT  N           L +V  + L+   I            ++ S+   QL  
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQ 321

Query: 131 ------------------GSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQF--TGLINF 170
                             GSI      L  L  L L+ N L+     ++       L + 
Sbjct: 322 FPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381

Query: 171 DLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT--LNVLEDLH-LIDLNIENNLFSGPI 227
           DLS N     +  +   L  L  L  Q++ L      +    L  L+ L+I         
Sbjct: 382 DLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440

Query: 228 PEKLLSIPN 236
               L + +
Sbjct: 441 DGIFLGLTS 449

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 72.0 bits (177), Expect = 3e-13
 Identities = 29/209 (13%), Positives = 61/209 (29%), Gaps = 42/209 (20%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGV-LADTLGDLESVINIDLSNNHIGGSIP------SNLPV 117
                   + ++ +    +    L     +L +++++DLS N+I              P 
Sbjct: 122 FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181

Query: 118 TVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQ-------------- 163
              +  +S N +   I +   +  +L +L+L  N  +  I     Q              
Sbjct: 182 VNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGE 240

Query: 164 --------------FTGLIN-----FDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT 204
                           GL +     F L+  N           L+++ ++ L    +   
Sbjct: 241 FKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL 300

Query: 205 LNVLEDLHLIDLNIENNLFSGPIPEKLLS 233
            +V +      L+I         P   L 
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQ-FPTLDLP 328

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 19/119 (15%), Positives = 39/119 (32%), Gaps = 22/119 (18%)

Query: 60  GDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTV 119
            ++   VF   +N+T + L+   L  +       L  +  +++S+               
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH--------------- 506

Query: 120 RNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT 178
                  N L        ++L  L  L  + N +        H    L  F+L+ N++ 
Sbjct: 507 -------NNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  101 bits (254), Expect = 2e-23
 Identities = 65/306 (21%), Positives = 132/306 (43%), Gaps = 46/306 (15%)

Query: 419 STNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLS-NTV 476
            ++ +          S+++Y         IGEG  G     +    G+   +K+++ + +
Sbjct: 7   HSSGVDLGTENLYFQSMEKYV----RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM 62

Query: 477 SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAH 536
           S ++ +E   E  + ++ ++H NIV+      E+G   +V DY     L   ++   +  
Sbjct: 63  SSKEREESRRE-VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN--AQKG 119

Query: 537 KKFS----WNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA 592
             F      +  +++ L    AL+++    +  I+H + KS NI L +   V++ D G+A
Sbjct: 120 VLFQEDQILDWFVQICL----ALKHV---HDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172

Query: 593 PLLFSGSTNELSEGLLTAHGS---GAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDR 648
            +L   ST EL+       G+    +PE  E+  Y+ +SD+++LG V+ EL T +  ++ 
Sbjct: 173 RVL--NSTVELAR---ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227

Query: 649 SRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP 708
                 ++LV   I        +S      L              ++S+  +  P  RP 
Sbjct: 228 GSM---KNLVL-KIIS-GSFPPVSLHYSYDL------------RSLVSQLFKRNPRDRPS 270

Query: 709 MSEIVQ 714
           ++ I++
Sbjct: 271 VNSILE 276

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 61/293 (20%), Positives = 107/293 (36%), Gaps = 48/293 (16%)

Query: 448 IGEGLLGSVYKAELPG-----GKLLAVKKL-SNTVSQRQTDEEFLELASTISRLRHGNIV 501
           +G+G  GSV            G+++AVKKL  +T        +F      +  L+H NIV
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 74

Query: 502 ELIGYCNEHGQH--LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           +  G C   G+    L+ +Y    +L D L   +E   +      ++      + ++YL 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG 131

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----- 614
                  +H +  + NIL++ +  V++ D GL  +L         +        G     
Sbjct: 132 TKR---YIHRDLATRNILVENENRVKIGDFGLTKVL------PQDKEFFKVKEPGESPIF 182

Query: 615 --APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL 671
             APE      +S  SDV+S GVV+ EL T  +          + +      ++     +
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242

Query: 672 S------RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                  R+  P    D  Y          I++ C       RP   ++   +
Sbjct: 243 ELLKNNGRLPRPDGCPDEIY---------MIMTECWNNNVNQRPSFRDLALRV 286

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  101 bits (253), Expect = 3e-23
 Identities = 60/354 (16%), Positives = 126/354 (35%), Gaps = 58/354 (16%)

Query: 380 SSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYT 439
           S   P+   +          + +    L   +  + SS +   IS    +++I       
Sbjct: 8   SGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI------- 60

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
                   IG G    V++      ++ A+K ++   +  QT + +    + +++L+  +
Sbjct: 61  -----LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 500 --IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
             I+ L  Y        +V + G    L+  L       K      R         A+  
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKK----KKSIDPWERKSYWKNMLEAVHT 170

Query: 558 LQEVCEPPIVHGNFKSSNILLDE---KLIVRVSDCGLAPLLFSGSTNELS---------- 604
           + +     IVH + K +N L+ +   KLI    D G+A  +   +T+ +           
Sbjct: 171 IHQHG---IVHSDLKPANFLIVDGMLKLI----DFGIANQMQPDTTSVVKDSQVGAVNYM 223

Query: 605 --EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI 662
             E +     S          S +SDV+SLG ++  +  G+ P+ +              
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------------ 271

Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
              + I  L  ++DP+ +  +      +   D++  C++ +P  R  + E++  
Sbjct: 272 ---NQISKLHAIIDPNHEIEF-PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  100 bits (252), Expect = 3e-23
 Identities = 68/350 (19%), Positives = 121/350 (34%), Gaps = 67/350 (19%)

Query: 405 KPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSE--------GNFIGEGLLGSV 456
             L   E       ++ +++     +  A      +   E           +G G  G V
Sbjct: 28  SELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 87

Query: 457 YKAELPGGK------LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH 510
           Y+ ++ G         +AVK L    S++    +FL  A  IS+  H NIV  IG   + 
Sbjct: 88  YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEALIISKFNHQNIVRCIGVSLQS 146

Query: 511 GQHLLVYDY--GGNCTLHDLLHS---DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP 565
               ++ +   GG+  L   L             +    + VA   A   QYL+E     
Sbjct: 147 LPRFILLELMAGGD--LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 201

Query: 566 IVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------A 615
            +H +  + N LL       + ++ D G+A  ++               G          
Sbjct: 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-------YRKGGCAMLPVKWMP 254

Query: 616 PE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
           PE F  G ++ ++D +S GV++ E+ + G  PY                P   + + L  
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----------------PSKSNQEVL-E 297

Query: 674 MVDPSLDGAYLAKSL---SRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
            V     G  +            I+++C Q +P  RP  + I++ +    
Sbjct: 298 FVT---SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  100 bits (250), Expect = 4e-23
 Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 59/302 (19%)

Query: 445 GNFIGEGLLGSVYKAELPGGK------LLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
              +G G  G VY+ ++ G         +AVK L    S++    +FL  A  IS+  H 
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEALIISKFNHQ 93

Query: 499 NIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHS---DEEAHKKFSWNIRIRVALGAAR 553
           NIV  IG   +     ++ +   GG+  L   L             +    + VA   A 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGD--LKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
             QYL+E      +H +  + N LL       + ++ D G+A  ++  S           
Sbjct: 152 GCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-------RK 201

Query: 611 HGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWA 661
            G          PE F  G ++ ++D +S GV++ E+ + G  PY               
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--------------- 246

Query: 662 IPRLHDIDALSRMVDPSLDGAYLAKSL---SRFADIISRCVQWEPGFRPPMSEIVQDLLC 718
            P   + + L   V     G  +            I+++C Q +P  RP  + I++ +  
Sbjct: 247 -PSKSNQEVL-EFVT---SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301

Query: 719 MI 720
             
Sbjct: 302 CT 303

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 98.8 bits (247), Expect = 4e-23
 Identities = 62/284 (21%), Positives = 111/284 (39%), Gaps = 44/284 (15%)

Query: 445 GNFIGEGLLGSVYKAEL--PGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
              +GEG  G VY+       G+ +  AVK      +     E+F+  A  +  L H +I
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPHI 75

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           V+LIG   E     ++ +      L   L  ++           +  +L   +A+ YL+ 
Sbjct: 76  VKLIGIIEEE-PTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLES 131

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL----TAHGSGAP 616
           +     VH +    NIL+     V++ D GL+  +      + S   L          +P
Sbjct: 132 IN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-----SP 183

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM 674
           E      ++  SDV+   V M E+L+ G++P+       +   V      +  ++   R+
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL--ENKD--V------IGVLEKGDRL 233

Query: 675 VDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
             P L     Y          +++RC  ++P  RP  +E+V  L
Sbjct: 234 PKPDLCPPVLY---------TLMTRCWDYDPSDRPRFTELVCSL 268

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 62/307 (20%), Positives = 113/307 (36%), Gaps = 69/307 (22%)

Query: 445 GNFIGEGLLGSVYKAELPGGK------LLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
              +G+G  G VY+    G         +A+K ++   S R+   EFL  AS +      
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASVMKEFNCH 88

Query: 499 NIVELIGYCNEHGQHLLVYDY--GGNCTLHDLL------HSDEEAHKKFSWNIRIRVALG 550
           ++V L+G  ++    L++ +    G+  L   L       ++       S +  I++A  
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGD--LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
            A  + YL        VH +  + N ++ E   V++ D G+   ++              
Sbjct: 147 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-------YRK 196

Query: 611 HGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWA 661
            G G       +PE  + G ++  SDV+S GVV+ E+ T   +PY               
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--------------- 241

Query: 662 IPRLHDIDALS------RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIV 713
              L +   L        +  P    D  +         +++  C Q+ P  RP   EI+
Sbjct: 242 -QGLSNEQVLRFVMEGGLLDKPDNCPDMLF---------ELMRMCWQYNPKMRPSFLEII 291

Query: 714 QDLLCMI 720
             +   +
Sbjct: 292 SSIKEEM 298

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 61/291 (20%), Positives = 100/291 (34%), Gaps = 46/291 (15%)

Query: 448 IGEGLLGSVYKAELPG-----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +GEG  G V            G+++AVK L      +     + +    +  L H +I++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR-SGWKQEIDILRTLYHEHIIK 97

Query: 503 LIGYCNEHGQ--HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
             G C + G     LV +Y    +L D L        +      +  A      + YL  
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHA 152

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG------ 614
                 +H +  + N+LLD   +V++ D GLA  +                  G      
Sbjct: 153 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV------PEGHEYYRVREDGDSPVFW 203

Query: 615 -APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLV-RWAIPRLHDIDA 670
            APE  +   +   SDV+S GV + ELLT             E   + +  +  L   + 
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263

Query: 671 LS---RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           L    R+  P       Y          ++  C + E  FRP    ++  L
Sbjct: 264 LERGERLPRPDKCPAEVY---------HLMKNCWETEASFRPTFENLIPIL 305

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 99.0 bits (247), Expect = 7e-23
 Identities = 60/294 (20%), Positives = 108/294 (36%), Gaps = 36/294 (12%)

Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           +     +GEG    V   E L  G   A+K++     ++Q  EE    A       H NI
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPNI 88

Query: 501 VELIGYCNEHGQH----LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           + L+ YC           L+  +    TL + +   ++     + +  + + LG  R L+
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA----PLLFSGSTNELSEGLLTAHG 612
            +         H + K +NILL ++    + D G        +         +       
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 613 S---GAPE-FESGSYSC---QSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL 665
           +    APE F   S+     ++DV+SLG V+  ++ G  PYD    +G+   V  A+   
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALAVQNQ 263

Query: 666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM 719
             I    R    S          S    +++  +  +P  RP +  ++  L  +
Sbjct: 264 LSIPQSPRH---S----------SALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 98.4 bits (246), Expect = 8e-23
 Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 65/304 (21%)

Query: 445 GNFIGEGLLGSVYKAELPGGK------LLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
              +GE   G VYK  L G         +A+K L +        EEF   A   +RL+H 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEAMLRARLQHP 72

Query: 499 NIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHS------------DEEAHKKFSWNIR 544
           N+V L+G   +     +++ Y   G+  LH+ L              D            
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGD--LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130

Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
           + +    A  ++YL       +VH +  + N+L+ +KL V++SD GL   +++       
Sbjct: 131 VHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY---- 183

Query: 605 EGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQ 655
                  G+        APE    G +S  SD++S GVV+ E+ + G +PY         
Sbjct: 184 ---YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY--------- 231

Query: 656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSL---SRFADIISRCVQWEPGFRPPMSEI 712
                      + D +  M+    +   L       +    ++  C    P  RP   +I
Sbjct: 232 -------CGYSNQDVV-EMIR---NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280

Query: 713 VQDL 716
              L
Sbjct: 281 HSRL 284

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 58/323 (17%), Positives = 117/323 (36%), Gaps = 56/323 (17%)

Query: 415 RSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSN 474
               S   + +    F   S++     +S    IG G    V++      ++ A+K    
Sbjct: 5   HHHSSGVDLGTENLYFQSMSVKGRI--YSILKQIGSGGSSKVFQVLNEKKQIYAIKY--- 59

Query: 475 TVSQRQTDEEFLE-LASTIS---RLRHGN--IVELIGYCNEHGQHLLVYDYGGNCTLHDL 528
            V+  + D + L+   + I+   +L+  +  I+ L  Y        +V + G    L+  
Sbjct: 60  -VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI-DLNSW 117

Query: 529 LHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIVR 585
           L       K      R         A+  + +     IVH + K +N L+ +   KLI  
Sbjct: 118 LKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-- 168

Query: 586 VSDCGLAPLLFSGSTNELS------------EGLLTAHGSGAPEFESGSYSCQSDVYSLG 633
             D G+A  +   +T+ +             E +     S          S +SDV+SLG
Sbjct: 169 --DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226

Query: 634 VVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFA- 692
            ++  +  G+ P+ +                 + I  L  ++DP+ +  +      +   
Sbjct: 227 CILYYMTYGKTPFQQII---------------NQISKLHAIIDPNHEIEF-PDIPEKDLQ 270

Query: 693 DIISRCVQWEPGFRPPMSEIVQD 715
           D++  C++ +P  R  + E++  
Sbjct: 271 DVLKCCLKRDPKQRISIPELLAH 293

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 66/305 (21%), Positives = 121/305 (39%), Gaps = 68/305 (22%)

Query: 445 GNFIGEGLLGSVYKAELPGGK------LLAVKKL-SNTVSQRQTDEEFLELASTISRLRH 497
              +GEG  G V+ AE           L+AVK L   T++ R+   +F   A  ++ L+H
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQH 76

Query: 498 GNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLL------------HSDEEAHKKFSWNI 543
            +IV+  G C +    ++V++Y   G+  L+  L                +A  +   + 
Sbjct: 77  EHIVKFYGVCGDGDPLIMVFEYMKHGD--LNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
            + +A   A  + YL        VH +  + N L+   L+V++ D G++  ++S      
Sbjct: 135 MLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-- 189

Query: 604 SEGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGE 654
                   G          PE      ++ +SDV+S GV++ E+ T G++P+        
Sbjct: 190 -----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-------- 236

Query: 655 QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSL---SRFADIISRCVQWEPGFRPPMSE 711
                    +L + + +   +     G  L +         D++  C Q EP  R  + E
Sbjct: 237 --------FQLSNTEVI-ECIT---QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKE 284

Query: 712 IVQDL 716
           I + L
Sbjct: 285 IYKIL 289

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 57/303 (18%), Positives = 108/303 (35%), Gaps = 68/303 (22%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLL--------AVKKLSNTVSQRQTDEEFLELASTISRLR 496
              +G+G    ++K                  +K L      R   E F E AS +S+L 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLS 70

Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           H ++V   G C    +++LV ++    +L   L  ++      +   ++ VA   A A+ 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMH 127

Query: 557 YLQEVCEPPIVHGNFKSSNILLD--------EKLIVRVSDCGLAPLLFSGS--------T 600
           +L+E     ++HGN  + NILL             +++SD G++  +             
Sbjct: 128 FLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184

Query: 601 NELSEGLLTAHGSGAPE--FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSL 657
                          PE      + +  +D +S G  + E+ + G KP        +   
Sbjct: 185 --------------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL----SALDSQR 226

Query: 658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
                  L   +   ++  P               ++I+ C+ +EP  RP    I++DL 
Sbjct: 227 K------LQFYEDRHQLPAPKAAELA---------NLINNCMDYEPDHRPSFRAIIRDLN 271

Query: 718 CMI 720
            + 
Sbjct: 272 SLF 274

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 55/296 (18%), Positives = 110/296 (37%), Gaps = 54/296 (18%)

Query: 442 FSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLE-LASTIS---RLRH 497
           +S    IG G    V++      ++ A+K     V+  + D + L+   + I+   +L+ 
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKY----VNLEEADNQTLDSYRNEIAYLNKLQQ 66

Query: 498 GN--IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            +  I+ L  Y        +V + G    L+  L       K      R         A+
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKK----KKSIDPWERKSYWKNMLEAV 121

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDE---KLIVRVSDCGLAPLLFSGSTNELS-------- 604
             + +     IVH + K +N L+ +   KLI    D G+A  +   +T+ +         
Sbjct: 122 HTIHQHG---IVHSDLKPANFLIVDGMLKLI----DFGIANQMQPDTTSVVKDSQVGTVN 174

Query: 605 ----EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW 660
               E +     S          S +SDV+SLG ++  +  G+ P+ +            
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------- 224

Query: 661 AIPRLHDIDALSRMVDPSLDGAYLAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
                + I  L  ++DP+ +  +      +   D++  C++ +P  R  + E++  
Sbjct: 225 -----NQISKLHAIIDPNHEIEF-PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 65/323 (20%), Positives = 108/323 (33%), Gaps = 51/323 (15%)

Query: 403 TVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-EL 461
           ++  L P  V+ R   S  + S         S   +  SF   + +G G  G V+K    
Sbjct: 22  SMHQLQPRRVSFRGEASETLQSPGYDPSRPESF--FQQSFQRLSRLGHGSYGEVFKVRSK 79

Query: 462 PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDY- 519
             G+L AVK+  +     +     L    +  ++ +H   V L     E G   L  +  
Sbjct: 80  EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139

Query: 520 GGNCTLHDLLHSDEEAHKKFS----WNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSN 575
           G +  L       E           W       L     L +L       +VH + K +N
Sbjct: 140 GPS--LQQHC---EAWGASLPEAQVWGYLRDTLLA----LAHLHS---QGLVHLDVKPAN 187

Query: 576 ILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APEFESGSYSCQSDVYSL 632
           I L  +   ++ D GL   L +    E         G     APE   GSY   +DV+SL
Sbjct: 188 IFLGPRGRCKLGDFGLLVELGTAGAGE------VQEGDPRYMAPELLQGSYGTAADVFSL 241

Query: 633 GVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSR-F 691
           G+ +LE+    +                     H  +   ++    L   + A  LS   
Sbjct: 242 GLTILEVACNMELP-------------------HGGEGWQQLRQGYLPPEFTAG-LSSEL 281

Query: 692 ADIISRCVQWEPGFRPPMSEIVQ 714
             ++   ++ +P  R     ++ 
Sbjct: 282 RSVLVMMLEPDPKLRATAEALLA 304

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 97.0 bits (241), Expect = 8e-22
 Identities = 41/358 (11%), Positives = 102/358 (28%), Gaps = 63/358 (17%)

Query: 396 LPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIAS-LQQYTNSFSEGNFIGEGLLG 454
              + +  V+  +    +   S  +  + ++   F + S L +   +   G  +G+    
Sbjct: 28  FNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPY 87

Query: 455 SVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL------------------ 495
           +  +A +   G+   V     T        + ++      RL                  
Sbjct: 88  AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147

Query: 496 --------RHGNIVELIGYCNEHGQHLLVYDY----GGNCTLHDLLHSDEEAHKKFSWNI 543
                   +   ++ +     +       + Y        T  ++L S    HK    + 
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207

Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-----PLLFSG 598
           R+++ L   R L  L       +VH   +  +I+LD++  V ++           ++ S 
Sbjct: 208 RLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSV 264

Query: 599 STNELS-EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL 657
           S      E                  +   D ++LG+V+  +     P  +    G    
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW 324

Query: 658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           +            + + V                  ++   +++    R    + ++ 
Sbjct: 325 I------FRSCKNIPQPV----------------RALLEGFLRYPKEDRLLPLQAMET 360

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 95.5 bits (238), Expect = 8e-22
 Identities = 52/300 (17%), Positives = 108/300 (36%), Gaps = 52/300 (17%)

Query: 438 YTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL- 495
           YT  F E   IG G  GSV+K  +   G + A+K+    ++    ++  L      + L 
Sbjct: 9   YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68

Query: 496 RHGNIVELIGYCNEHGQHLLVY-DYGGNCTLHDLLHSDEEAHKKFS----WNIRIRVALG 550
           +H ++V           H+L+  +Y    +L D +  +      F      ++ ++V  G
Sbjct: 69  QHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE---GL 607
               L+Y+       +VH + K SNI +    I   +        ++ +         G 
Sbjct: 128 ----LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 608 LTAHGSG----------APEF--ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ 655
           +T   S           A E   E+ ++  ++D+++L + ++                  
Sbjct: 181 VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--H 238

Query: 656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSR-FADIISRCVQWEPGFRPPMSEIVQ 714
            + +  +PR+                      LS+ F +++   +  +P  RP    +V+
Sbjct: 239 EIRQGRLPRIPQ-------------------VLSQEFTELLKVMIHPDPERRPSAMALVK 279

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 96.2 bits (240), Expect = 8e-22
 Identities = 70/304 (23%), Positives = 119/304 (39%), Gaps = 67/304 (22%)

Query: 445 GNFIGEGLLGSVYKAELPGGK------LLAVKKL-SNTVSQRQTDEEFLELASTISRLRH 497
              +GEG  G V+ AE           L+AVK L   + S RQ   +F   A  ++ L+H
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ---DFQREAELLTMLQH 102

Query: 498 GNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLL-----------HSDEEAHKKFSWNIR 544
            +IV   G C E    L+V++Y   G+  L+  L             ++ A         
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGD--LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELS 604
           + VA   A  + YL  +     VH +  + N L+ + L+V++ D G++  ++S       
Sbjct: 161 LAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---- 213

Query: 605 EGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQ 655
                  G          PE      ++ +SDV+S GVV+ E+ T G++P+         
Sbjct: 214 ---YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW--------- 261

Query: 656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSL---SRFADIISRCVQWEPGFRPPMSEI 712
                   +L + +A+   +     G  L +          I+  C Q EP  R  + ++
Sbjct: 262 -------YQLSNTEAI-DCIT---QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310

Query: 713 VQDL 716
              L
Sbjct: 311 HARL 314

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 97.9 bits (244), Expect = 9e-22
 Identities = 55/319 (17%), Positives = 103/319 (32%), Gaps = 56/319 (17%)

Query: 414 RRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLS 473
              S   +      SV  +  +      F   + +G G  G++    +   + +AVK++ 
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKIS-----FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI- 56

Query: 474 NTVSQRQTDEEFLELAST-ISRLR----HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDL 528
                     E    A   +  LR    H N++       +     +  +     TL + 
Sbjct: 57  --------LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEY 107

Query: 529 LHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-----LI 583
           +   E+          I +       L +L  +    IVH + K  NIL+        + 
Sbjct: 108 V---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIK 161

Query: 584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE----FESGSYSCQSDVYSLGVVM 636
             +SD GL   L  G  +          G+    APE        + +   D++S G V 
Sbjct: 162 AMISDFGLCKKLAVGRHS--FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219

Query: 637 LELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFA-DII 695
             +++         P G+               A   +   SLD  +  K     A ++I
Sbjct: 220 YYVISEGSH-----PFGKS----------LQRQANILLGACSLDCLHPEKHEDVIARELI 264

Query: 696 SRCVQWEPGFRPPMSEIVQ 714
            + +  +P  RP    +++
Sbjct: 265 EKMIAMDPQKRPSAKHVLK 283

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 64/290 (22%), Positives = 105/290 (36%), Gaps = 54/290 (18%)

Query: 448 IGEGLLGSVYKAE---LPGGKLLAVKKLSNTVSQRQTDEEFLEL----ASTISRLRHGNI 500
           +G G +  V+ A        + +AVK L    +    D  F       A   + L H  I
Sbjct: 20  LGFGGMSEVHLARDLRD--HRDVAVKVLR---ADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 501 VELIGYCNEHGQ----HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           V +               +V +Y    TL D++H+        +    I V   A +AL 
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALN 130

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL--TAHGSG 614
           +  +     I+H + K +NI++     V+V D G+A  +     +      +  TA    
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL- 186

Query: 615 APEFESGSY-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL------VRWAIPRLHD 667
           +PE   G     +SDVYSLG V+ E+LTG  P+      G+  +      VR        
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-----GDSPVSVAYQHVREDPIPPSA 241

Query: 668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-MSEIVQDL 716
                  +   LD             ++ + +   P  R    +E+  DL
Sbjct: 242 RHE---GLSADLD------------AVVLKALAKNPENRYQTAAEMRADL 276

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 99.6 bits (248), Expect = 1e-21
 Identities = 38/212 (17%), Positives = 69/212 (32%), Gaps = 31/212 (14%)

Query: 36  LNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLE 95
           + S+  S N          G +    S         N + + L+   +     +      
Sbjct: 646 MGSVDFSYN--------KIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697

Query: 96  SVINIDLSNNHIGGSIPSNLPVTV----------RNFSLSGNQLTGSIPESL--SRLTQL 143
            +  I LSNN +  SIP N                   L  N+LT S+ +    + L  L
Sbjct: 698 PISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYL 755

Query: 144 LDLSLNNNHLNGGIPDAFHQFTGLI------NFDLSANNLTGQLPPSTRNLSSLYSLHLQ 197
            ++ ++ N  +   P      + L         D   N +  Q P       SL  L + 
Sbjct: 756 SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814

Query: 198 NNKLSG-TLNVLEDLHLIDLNIENNLFSGPIP 228
           +N +      +   L+++D+  +N   S  + 
Sbjct: 815 SNDIRKVDEKLTPQLYILDIA-DNPNISIDVT 845

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 96.9 bits (241), Expect = 8e-21
 Identities = 33/197 (16%), Positives = 65/197 (32%), Gaps = 27/197 (13%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADT-LGDLESVINIDLSNNHIGGSIPSNLPVTVRNF- 122
                   V  +  +   L  +        +  + ++D S N IG S   N+  ++ ++ 
Sbjct: 613 DFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDYK 671

Query: 123 -------SLSGNQLTGSIPESLSRLTQLLDLSLNNNHL-------NGGIPDAFHQFTGLI 168
                  +LS N++     E  +  + +  + L+NN +              +     L 
Sbjct: 672 GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT 731

Query: 169 NFDLSANNLTGQLPPSTR--NLSSLYSLHLQNNKLS------GTLNVLEDLHLID-LNIE 219
             DL  N LT  L    R   L  L ++ +  N  S         + L+   +    + E
Sbjct: 732 TIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAE 790

Query: 220 NNLFSGPIPEKLLSIPN 236
            N      P  + + P+
Sbjct: 791 GNRILRQWPTGITTCPS 807

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 95.3 bits (237), Expect = 2e-20
 Identities = 30/250 (12%), Positives = 73/250 (29%), Gaps = 50/250 (20%)

Query: 36  LNSLYISLN----FPPLEKWL--SFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLAD 89
           L  +Y + +          W   +       ++ +  +    ++T++ L        L D
Sbjct: 450 LQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD 509

Query: 90  TLGDLESVINIDLSNNHIGGSIP-----SNLPVTVRNFS------LSGNQLTG------- 131
            L DL  + +++++ N    +       + L              +  N L         
Sbjct: 510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASL 569

Query: 132 ----------------SIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSAN 175
                              E+     +L DL L+ N +     D       +     S N
Sbjct: 570 QKMVKLGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHN 629

Query: 176 NLTGQLPP--STRNLSSLYSLHLQNNKLSG-------TLNVLEDLHLIDLNIENNLFSGP 226
            L   +P   + +++  + S+    NK+         +++  + ++   + +  N     
Sbjct: 630 KLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKF 688

Query: 227 IPEKLLSIPN 236
             E   +   
Sbjct: 689 PTELFATGSP 698

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 90.3 bits (224), Expect = 8e-19
 Identities = 36/280 (12%), Positives = 76/280 (27%), Gaps = 54/280 (19%)

Query: 31  RDVMALNSLYISLNFP------------PLEKWLSFGGDPCGDSWQGVFCVF----SNVT 74
           +D  AL +++ +L+                    +F  +     W     V       VT
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELD--MWGDQPGVDLDNNGRVT 326

Query: 75  EIRLTGMNLGGVLADTLGDLESVINIDLSNNHI---------GGSIPSNLPVTVRNFSLS 125
            + L G    G + D +G L  +  +    +               P           + 
Sbjct: 327 GLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMH 386

Query: 126 GNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST 185
             ++     + L+    LL  ++N N     I                 N +T  +  + 
Sbjct: 387 YKKMFLDYDQRLNLSD-LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAI 444

Query: 186 RNLSSLYSLHLQNNKLSG-------------TLNVLEDL--------HLIDLNIENNLFS 224
           + L+ L  ++  N+  +                   E+          L D+ + N    
Sbjct: 445 QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM 504

Query: 225 GPIPEKLLSIPNFRK---DGNPFNT-TVIALPPTAIPPSI 260
             +P+ L  +P  +      N   +   +    T +    
Sbjct: 505 TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 88.0 bits (218), Expect = 5e-18
 Identities = 30/192 (15%), Positives = 68/192 (35%), Gaps = 21/192 (10%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVT----VRNF 122
           F     +T+++L    +  +  D     + V  +  S+N +   IP+         + + 
Sbjct: 591 FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSV 649

Query: 123 SLSGNQLTGSIPE-----SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL 177
             S N++              +      ++L+ N +     + F   + +    LS N +
Sbjct: 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM 709

Query: 178 T-------GQLPPSTRNLSSLYSLHLQNNKLSG---TLNVLEDLHLIDLNIENNLFSGPI 227
           T            + +N   L ++ L+ NKL+            +L ++++  N FS   
Sbjct: 710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-F 768

Query: 228 PEKLLSIPNFRK 239
           P + L+    + 
Sbjct: 769 PTQPLNSSQLKA 780

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 71.1 bits (174), Expect = 8e-13
 Identities = 25/151 (16%), Positives = 45/151 (29%), Gaps = 21/151 (13%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLAD-TLGDLESVINIDLSNNHIGGSIPSNLPVTV---- 119
           G +     +T I L    L  +  D     L  + N+D+S N       S+ P       
Sbjct: 722 GNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCF-----SSFPTQPLNSS 776

Query: 120 --------RNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFD 171
                         GN++    P  ++    L+ L + +N +   + +       L   D
Sbjct: 777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILD 833

Query: 172 LSANNLTGQLPPSTRNLSSLYSLHLQNNKLS 202
           ++ N        S           L  +K  
Sbjct: 834 IADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 66.8 bits (163), Expect = 2e-11
 Identities = 30/188 (15%), Positives = 51/188 (27%), Gaps = 15/188 (7%)

Query: 82  NLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTV-RNFSLSGNQLTGSIPESLSRL 140
                + D          +D  N        +N   ++  NF+   +         L   
Sbjct: 263 ETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN 322

Query: 141 TQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNK 200
            ++  LSL      G +PDA  Q T L       ++ T           +      + ++
Sbjct: 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHR 382

Query: 201 LSGTLN--------VLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALP 252
           +              L    L+   I  N    PI +         + GN  N       
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI----- 437

Query: 253 PTAIPPSI 260
            T I  +I
Sbjct: 438 -TFISKAI 444

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 54/305 (17%), Positives = 104/305 (34%), Gaps = 70/305 (22%)

Query: 438 YTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           +   F E   IG G  G V+KA+    GK   +K++      +  +E+       +++L 
Sbjct: 9   FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVKALAKLD 62

Query: 497 HGNIVELIGY---------------CNEHGQHL-LVYDYGGNCTLHDLLHSDEEAH--KK 538
           H NIV   G                     + L +  ++    TL   +         K 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 539 FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG 598
            +  +  ++       + Y+       +++ + K SNI L +   V++ D GL       
Sbjct: 123 LALELFEQITK----GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLV------ 169

Query: 599 STNELSEGLLTAHGSG-----APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR 652
               L          G     +PE   S  Y  + D+Y+LG+++ ELL            
Sbjct: 170 --TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA------ 221

Query: 653 GEQSLVRWAIPRLHDIDAL-SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSE 711
                         +     + + D  +   +      +   ++ + +  +P  RP  SE
Sbjct: 222 -------------FETSKFFTDLRDGIISDIF---D-KKEKTLLQKLLSKKPEDRPNTSE 264

Query: 712 IVQDL 716
           I++ L
Sbjct: 265 ILRTL 269

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 95.0 bits (236), Expect = 3e-21
 Identities = 45/318 (14%), Positives = 95/318 (29%), Gaps = 27/318 (8%)

Query: 382 PRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTN- 440
                   P   +  P  +K+  K L+       S P+T      +      +  Q  + 
Sbjct: 6   SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSK 65

Query: 441 SFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
                + +GEG    VY+A           +   +K      +         +L   +  
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKP 123

Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKK-FSWNIRIRVALGAAR 553
                 ++           +LV +     TL + ++  +   +K     + I  A+    
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILL-----------DEKLIVRVSDCGLAPLLFSGSTNE 602
            ++ + +     I+HG+ K  N +L           D    + + D G +  +       
Sbjct: 184 MIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 603 LSEGLLTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA 661
           +        G    E  S   ++ Q D + +   +  +L G     ++   G +      
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN--EGGECKPEGL 298

Query: 662 IPRLHDIDALSRMVDPSL 679
             RL  +D  +      L
Sbjct: 299 FRRLPHLDMWNEFFHVML 316

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 96.3 bits (240), Expect = 6e-21
 Identities = 32/144 (22%), Positives = 52/144 (36%), Gaps = 8/144 (5%)

Query: 101 DLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDA 160
                +    IP NLP + +N  LS N L      S     +L  L L+   +      A
Sbjct: 13  QCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71

Query: 161 FHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLID 215
           +   + L    L+ N +   L       LSSL  L      L+      +  L+ L  ++
Sbjct: 72  YQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 216 LNIENNLFSGPIPEKLLSIPNFRK 239
           +   N + S  +PE   ++ N   
Sbjct: 131 VA-HNLIQSFKLPEYFSNLTNLEH 153

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 86.3 bits (214), Expect = 8e-18
 Identities = 37/194 (19%), Positives = 70/194 (36%), Gaps = 17/194 (8%)

Query: 69  VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVRNFSL 124
           +  +   + L+   L  + + +      +  +DLS   I  +I      +L   +    L
Sbjct: 26  LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLS-HLSTLIL 83

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT-GQLPP 183
           +GN +      + S L+ L  L     +L             L   +++ N +   +LP 
Sbjct: 84  TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143

Query: 184 STRNLSSLYSLHLQNNKLS----GTLNVLEDLHLID--LNIENNLFSGPIPEKLLSIPNF 237
              NL++L  L L +NK+       L VL  + L++  L++  N  +  I          
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRL 202

Query: 238 RK---DGNPFNTTV 248
            K     N  +  V
Sbjct: 203 HKLTLRNNFDSLNV 216

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 75.9 bits (187), Expect = 2e-14
 Identities = 31/151 (20%), Positives = 60/151 (39%), Gaps = 8/151 (5%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLA-DTLGDLESVINIDLSNNHI---GGSIPSNLPVTVRNF 122
           F     +  +     NL  +        L ++I +D+S+ H       I + L  ++   
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS-SLEVL 450

Query: 123 SLSGNQLTGSI-PESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
            ++GN    +  P+  + L  L  L L+   L    P AF+  + L   ++++N L   +
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SV 509

Query: 182 PPST-RNLSSLYSLHLQNNKLSGTLNVLEDL 211
           P      L+SL  + L  N    +   ++ L
Sbjct: 510 PDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 540

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 36/184 (19%), Positives = 70/184 (38%), Gaps = 22/184 (11%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIG----GSIPSNLPVTVR 120
           G F   S++ ++     NL  +    +G L+++  +++++N I         SNL   + 
Sbjct: 94  GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT-NLE 152

Query: 121 NFSLSGNQLTGSIPESLSRLTQL----LDLSLNNNHLNGGIPDAFHQFTGLINFDLSANN 176
           +  LS N++       L  L Q+    L L L+ N +N   P AF +   L    L  N 
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNF 211

Query: 177 LTGQLPPST-RNLSSLYSLHLQNNKL----------SGTLNVLEDLHLIDLNIE-NNLFS 224
            +  +  +  + L+ L    L   +              L  L +L + +  +   + + 
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271

Query: 225 GPIP 228
             I 
Sbjct: 272 DDII 275

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 37/180 (20%), Positives = 67/180 (37%), Gaps = 9/180 (5%)

Query: 61  DSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVR 120
           D    +F   +NV+   L  + +  V   +        +++L N   G   P+    +++
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFG-QFPTLKLKSLK 328

Query: 121 NFSLSGNQLTGSIPES-LSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG 179
             + + N+   +  E  L  L + LDLS N     G    +    T L   DLS N +  
Sbjct: 329 RLTFTSNKGGNAFSEVDLPSL-EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 386

Query: 180 QLPPSTRNLSSLYSLHLQNNKLSGT--LNVLEDL-HLIDLNIENNLFSGPIPEKLLSIPN 236
            +  +   L  L  L  Q++ L      +V   L +LI L+I +             + +
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 71.3 bits (175), Expect = 5e-13
 Identities = 23/117 (19%), Positives = 43/117 (36%), Gaps = 3/117 (2%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN-- 121
             VF    N+  + ++  +           L S+  + ++ N    +   ++   +RN  
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473

Query: 122 -FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL 177
              LS  QL    P + + L+ L  L++ +N L       F + T L    L  N  
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.4 bits (126), Expect = 4e-07
 Identities = 28/179 (15%), Positives = 53/179 (29%), Gaps = 20/179 (11%)

Query: 65  GVFCVFSNVTEIRLT---GMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN 121
               V   +  + L+    +N    +         +  + L NN    ++       +  
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAG 226

Query: 122 FSL---------SGNQLTGSIPESLSRLTQLLDLSLNNNHLNG---GIPDAFHQFTGLIN 169
             +         +   L      +L  L  L        +L+     I D F+  T + +
Sbjct: 227 LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS 286

Query: 170 FDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG-TLNVLEDLHLIDL--NIENNLFSG 225
           F L +  +  ++   + N      L L N K        L+ L  +    N   N FS 
Sbjct: 287 FSLVSVTIE-RVKDFSYN-FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 65/334 (19%), Positives = 123/334 (36%), Gaps = 56/334 (16%)

Query: 395 PLPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLG 454
           P P        P   A     ++P    I   +      S ++Y      G F+G+G   
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLV--DPRSRRRYV----RGRFLGKGGFA 55

Query: 455 SVYKA-ELPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ 512
             ++  +    ++ A K +  + + +    E+     S    L H ++V   G+  ++  
Sbjct: 56  KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115

Query: 513 HLLVYDYGGNCTLHDLLH-----SDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV 567
             +V +     +L +L       ++ EA                    QYL       ++
Sbjct: 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYL---------RQIVLGCQYLHRNR---VI 163

Query: 568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS---GAPE-FESGSY 623
           H + K  N+ L+E L V++ D GLA  +         E      G+    APE      +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKVLCGTPNYIAPEVLSKKGH 218

Query: 624 SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAY 683
           S + DV+S+G +M  LL G+ P++ S                  +      +       Y
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETS-----------------CLKETYLRI---KKNEY 258

Query: 684 -LAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
            + K ++  A  +I + +Q +P  RP ++E++ D
Sbjct: 259 SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 70/313 (22%), Positives = 112/313 (35%), Gaps = 72/313 (23%)

Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RH 497
           G  +G G  G V +A+  G       + +AVK L    +  +     +     +  +  H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHH 90

Query: 498 GNIVELIGYCNEHGQHLLV---YDYGGNCTLHDLLHSDEEAHKKFSWNIR---------- 544
            N+V L+G C + G  L+V   +   GN  L   L S       +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 545 --IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE 602
             I  +   A+ +++L        +H +  + NILL EK +V++ D GLA  ++      
Sbjct: 149 HLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205

Query: 603 LSEGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRG 653
                    G         APE      Y+ QSDV+S GV++ E+ + G  PY       
Sbjct: 206 -------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------- 251

Query: 654 EQSLVRWAIPRLHD-IDALS---RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRP 707
                   +    +    L    RM  P       Y           +  C   EP  RP
Sbjct: 252 ------PGVKIDEEFCRRLKEGTRMRAPDYTTPEMY---------QTMLDCWHGEPSQRP 296

Query: 708 PMSEIVQDLLCMI 720
             SE+V+ L  ++
Sbjct: 297 TFSELVEHLGNLL 309

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 62/297 (20%), Positives = 106/297 (35%), Gaps = 75/297 (25%)

Query: 448 IGEGLLGSVYKAE---LPGGKLLAVKKLSNTVSQRQTDEEFLEL----ASTISRLRHGNI 500
           +G G +G VY+AE       +++A+K +S       +D  F       A T  RL+  ++
Sbjct: 42  VGRGGMGDVYEAEDTVR--ERIVALKLMS---ETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           V +  +    GQ  +         L  +L                   L   RA+  +++
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--------------PLAPPRAVAIVRQ 142

Query: 561 VC-------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           +             H + K  NIL+       + D G+A        +  ++  LT  G+
Sbjct: 143 IGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA--------SATTDEKLTQLGN 194

Query: 614 --G-----APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA---- 661
             G     APE F     + ++D+Y+L  V+ E LTG  PY      G+Q  V  A    
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ-----GDQLSVMGAHINQ 249

Query: 662 -IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-MSEIVQDL 716
            IPR   +      +  + D             +I+R +   P  R     ++    
Sbjct: 250 AIPRPSTVR---PGIPVAFD------------AVIARGMAKNPEDRYVTCGDLSAAA 291

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 70/308 (22%), Positives = 116/308 (37%), Gaps = 70/308 (22%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLL---AVKKLSNTVSQRQTDEEFLELASTISRL-RHGNI 500
            + IGEG  G V KA +    L    A+K++    S+     +F      + +L  H NI
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNI 88

Query: 501 VELIGYCNEHGQHLLVYDY--GGNCTLHDLL--HSDEEAHKKFSWNIR----------IR 546
           + L+G C   G   L  +Y   GN  L D L      E    F+              + 
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGN--LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 547 VALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG 606
            A   AR + YL +      +H +  + NIL+ E  + +++D GL+            + 
Sbjct: 147 FAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLS----------RGQE 193

Query: 607 LLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSL 657
           +      G       A E      Y+  SDV+S GV++ E+++ G  PY           
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY----------- 242

Query: 658 VRWAIPRLHDIDALS---RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
               +      + L    R+  P    D  Y         D++ +C + +P  RP  ++I
Sbjct: 243 --CGMTCAELYEKLPQGYRLEKPLNCDDEVY---------DLMRQCWREKPYERPSFAQI 291

Query: 713 VQDLLCMI 720
           +  L  M+
Sbjct: 292 LVSLNRML 299

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 66/317 (20%), Positives = 116/317 (36%), Gaps = 83/317 (26%)

Query: 445 GNFIGEGLLGSVYKAELPGGK------LLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
              IGEG  G V++A  PG        ++AVK L    S      +F   A+ ++   + 
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNP 110

Query: 499 NIVELIGYCNEHGQHLLVYDY--GGNCTLHDLL--HSDEEAHKKFSWNIR---------- 544
           NIV+L+G C       L+++Y   G+  L++ L   S          ++           
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGD--LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168

Query: 545 --------IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
                   + +A   A  + YL E      VH +  + N L+ E ++V+++D GL+  ++
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY 225

Query: 597 SGSTNELSEGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           S            A G+         PE      Y+ +SDV++ GVV+ E+ + G +PY 
Sbjct: 226 SADY-------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY- 277

Query: 648 RSRPRGEQSLVRWAIPRLHDIDALS------RMVDPSL--DGAYLAKSLSRFADIISRCV 699
                            +   + +        +  P       Y         +++  C 
Sbjct: 278 ---------------YGMAHEEVIYYVRDGNILACPENCPLELY---------NLMRLCW 313

Query: 700 QWEPGFRPPMSEIVQDL 716
              P  RP    I + L
Sbjct: 314 SKLPADRPSFCSIHRIL 330

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 93.2 bits (231), Expect = 2e-20
 Identities = 37/318 (11%), Positives = 81/318 (25%), Gaps = 77/318 (24%)

Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR------ 494
              G  +G+    +  +A     G+   V     T        + ++      R      
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 495 -----------------LRHGNIVELIGYCNEHGQH-------LLVYDYGGNCTLHDLLH 530
                            ++     ++I    +           L         T  ++L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 531 SDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG 590
           S    HK    + R+++ L   R L  L       +VH   +  +I+LD++  V ++   
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 591 LAPLLFSGSTNELSEGLLTAHGS--GAPEF-----------ESGSYSCQSDVYSLGVVML 637
                            ++  G     PE                 +   D ++LG+ + 
Sbjct: 257 HL--------VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308

Query: 638 ELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISR 697
            +     P       G      W      +I    R                    ++  
Sbjct: 309 WIWCADLPNTDDAALG---GSEWIFRSCKNIPQPVR-------------------ALLEG 346

Query: 698 CVQWEPGFRPPMSEIVQD 715
            +++    R    + ++ 
Sbjct: 347 FLRYPKEDRLLPLQAMET 364

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 91.7 bits (228), Expect = 5e-20
 Identities = 74/347 (21%), Positives = 131/347 (37%), Gaps = 81/347 (23%)

Query: 413 TRRSSPSTNVISSSVSVFTIASLQQYT---NSFSEGNFIGEGLLGSVYKAELPGGKLL-- 467
           TR SS +   + + VS + +    ++    +  + G  +GEG  G V  AE  G      
Sbjct: 51  TRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKP 110

Query: 468 ------AVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDY- 519
                 AVK L +  +++    + +     +  + +H NI+ L+G C + G   ++ +Y 
Sbjct: 111 KEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 169

Query: 520 -GGNCTLHDLL--HSDEEAHKKFSWNIR----------IRVALGAARALQYLQEVCEPPI 566
             GN  L + L           +  N            +      AR ++YL        
Sbjct: 170 SKGN--LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---C 224

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-------APE-F 618
           +H +  + N+L+ E  +++++D GLA  + +    +          +G       APE  
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-------KTTNGRLPVKWMAPEAL 277

Query: 619 ESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS----- 672
               Y+ QSDV+S GV+M E+ T G  PY                P +   +        
Sbjct: 278 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY----------------PGIPVEELFKLLKEG 321

Query: 673 -RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            RM  P+   +  Y          ++  C    P  RP   ++V+DL
Sbjct: 322 HRMDKPANCTNELY---------MMMRDCWHAVPSQRPTFKQLVEDL 359

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 90.1 bits (224), Expect = 6e-20
 Identities = 58/281 (20%), Positives = 106/281 (37%), Gaps = 52/281 (18%)

Query: 444 EGNFIGEGLLGSVYKA-ELPGGKLLAVK--KLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           +   +G+G  G VY   +L     +A+K     ++   +   EE     +    L+H NI
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEI----ALHKHLKHKNI 81

Query: 501 VELIGYCNEHGQHLLVY-DYGGNCTLHDLLHSDEEAHKKFSWN---IRI--RVALGAARA 554
           V+ +G        + ++ +     +L  LL            N   I    +  L     
Sbjct: 82  VQYLG-SFSENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQIL---EG 134

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           L+YL +     IVH + K  N+L++    ++++SD G      S     ++    T  G+
Sbjct: 135 LKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGT-----SKRLAGINPCTETFTGT 186

Query: 614 G---APE---FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD 667
               APE        Y   +D++SLG  ++E+ TG+ P+      GE     + +     
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE---LGEPQAAMFKVGMFKV 243

Query: 668 IDALSRMVDPSLDGAYLAKSLSR-FADIISRCVQWEPGFRP 707
                    P +      +S+S      I +C + +P  R 
Sbjct: 244 H--------PEIP-----ESMSAEAKAFILKCFEPDPDKRA 271

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 90.4 bits (225), Expect = 8e-20
 Identities = 65/310 (20%), Positives = 116/310 (37%), Gaps = 74/310 (23%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLL--------AVKKLSNTVSQRQTDEEFLELASTISRL- 495
           G  +GEG  G V  AE  G            AVK L +  +++    + +     +  + 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIG 98

Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL------------HSDEEAHKKFSWNI 543
           +H NI+ L+G C + G   ++ +Y     L + L              +    ++ ++  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
            +      AR ++YL        +H +  + N+L+ E  +++++D GLA  + +      
Sbjct: 159 LVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINN------ 209

Query: 604 SEGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGE 654
                    +G       APE      Y+ QSDV+S GV+M E+ T G  PY        
Sbjct: 210 -IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-------- 260

Query: 655 QSLVRWAIPRLHDIDALS------RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFR 706
                   P +   +         RM  P+   +  Y          ++  C    P  R
Sbjct: 261 --------PGIPVEELFKLLKEGHRMDKPANCTNELY---------MMMRDCWHAVPSQR 303

Query: 707 PPMSEIVQDL 716
           P   ++V+DL
Sbjct: 304 PTFKQLVEDL 313

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 63/316 (19%), Positives = 106/316 (33%), Gaps = 73/316 (23%)

Query: 438 YTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR 496
           Y + F E   +G+G  G V KA      +  A+KK+ +T  +       L     ++ L 
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLN 60

Query: 497 HGNIVELIG------------YCNEHGQHL-LVYDY--GGNCTLHDLL-----HSDEEAH 536
           H  +V                   +    L +  +Y   G  TL+DL+     +   +  
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENG--TLYDLIHSENLNQQRDE- 117

Query: 537 KKFSWNIRIRVALGAARALQYL--QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL 594
               W +  R  L    AL Y+  Q      I+H + K  NI +DE   V++ D GLA  
Sbjct: 118 ---YWRL-FRQIL---EALSYIHSQG-----IIHRDLKPMNIFIDESRNVKIGDFGLAKN 165

Query: 595 LFSGSTNELSEGLLTAHGSG------------APE--FESGSYSCQSDVYSLGVVMLELL 640
           +         +       S             A E    +G Y+ + D+YSLG++  E++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

Query: 641 TGRKP-YDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCV 699
                  +R                L  +    R V       +    +     II   +
Sbjct: 226 YPFSTGMERVNI-------------LKKL----RSVSIEFPPDFDDNKMKVEKKIIRLLI 268

Query: 700 QWEPGFRPPMSEIVQD 715
             +P  RP    ++  
Sbjct: 269 DHDPNKRPGARTLLNS 284

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 58/285 (20%), Positives = 112/285 (39%), Gaps = 52/285 (18%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFL--ELASTISRLRHGNIV 501
           G F+G+G     ++  +    ++ A K +  ++  +    E +  E+ S    L H ++V
Sbjct: 20  GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI-SIHRSLAHQHVV 78

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLH-----SDEEAHKKFSWNIRIRVALGAARALQ 556
              G+  ++    +V +     +L +L       ++ EA                    Q
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---------QIVLGCQ 129

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS--- 613
           YL       ++H + K  N+ L+E L V++ D GLA  +         E      G+   
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKVLCGTPNY 181

Query: 614 GAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
            APE      +S + DV+S+G +M  LL G+ P++ S                  +    
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----------------CLKETY 224

Query: 673 RMVDPSLDGAY-LAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
             +       Y + K ++  A  +I + +Q +P  RP ++E++ D
Sbjct: 225 LRI---KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 66/274 (24%), Positives = 112/274 (40%), Gaps = 39/274 (14%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG G  GSV K    P G+++AVK++ +TV +++  +  ++L   +       IV+  G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
               G   +  +           +            I  ++ L   +AL +L+E     I
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKI 147

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-----APE---- 617
           +H + K SNILLD    +++ D G      SG   +L + +     +G     APE    
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFG-----ISG---QLVDSIAKTRDAGCRPYMAPERIDP 199

Query: 618 -FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
                 Y  +SDV+SLG+ + EL TGR PY +                    D L+++V 
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS---------------VFDQLTQVVK 244

Query: 677 ---PSLDGAYLAKSLSRFADIISRCVQWEPGFRP 707
              P L  +   +    F + ++ C+  +   RP
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 43/143 (30%), Positives = 63/143 (44%), Gaps = 9/143 (6%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN 169
            IP+NLP T+    L  N +    P + S   +L  + L+NN ++   PDAF     L +
Sbjct: 25  EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS 84

Query: 170 FDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENNLFS 224
             L  N +T +LP S    L SL  L L  NK++         L +L+L+ L  +N L +
Sbjct: 85  LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLY-DNKLQT 142

Query: 225 GP--IPEKLLSIPNFRKDGNPFN 245
                   L +I       NPF 
Sbjct: 143 IAKGTFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 32/137 (23%), Positives = 50/137 (36%), Gaps = 26/137 (18%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSL 124
           G F  +  +  I L+   +  +  D    L S+ ++ L                      
Sbjct: 50  GAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG-------------------- 89

Query: 125 SGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPP 183
             N++T  +P+SL   L  L  L LN N +N    DAF     L    L  N L   +  
Sbjct: 90  --NKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145

Query: 184 ST-RNLSSLYSLHLQNN 199
            T   L ++ ++HL  N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 89.7 bits (223), Expect = 3e-19
 Identities = 69/312 (22%), Positives = 117/312 (37%), Gaps = 78/312 (25%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLL--------AVKKLSNTVSQRQTDEEFLELASTISRL- 495
           G  +GEG  G V  AE  G            AVK L +  +++    + +     +  + 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIG 132

Query: 496 RHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLL------------HSDEEAHKKFSW 541
           +H NI+ L+G C + G   ++ +Y   GN  L + L            +      ++ S 
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGN--LREYLQARRPPGLEYSYNPSHNPEEQLSS 190

Query: 542 NIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN 601
              +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +      
Sbjct: 191 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247

Query: 602 ELSEGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR 652
                      +G       APE      Y+ QSDV+S GV++ E+ T G  PY      
Sbjct: 248 -------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------ 294

Query: 653 GEQSLVRWAIPRLHDIDALS------RMVDPSL--DGAYLAKSLSRFADIISRCVQWEPG 704
                     P +   +         RM  PS   +  Y          ++  C    P 
Sbjct: 295 ----------PGVPVEELFKLLKEGHRMDKPSNCTNELY---------MMMRDCWHAVPS 335

Query: 705 FRPPMSEIVQDL 716
            RP   ++V+DL
Sbjct: 336 QRPTFKQLVEDL 347

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 38/175 (21%), Positives = 73/175 (41%), Gaps = 18/175 (10%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFS 123
            G F    N+  + L    +  +       L  +  + LS N +   +P  +P T++   
Sbjct: 69  DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKTLQELR 127

Query: 124 LSGNQLTGSIPE-SLSRLTQLLDLSLNNNHL-NGGIPD-AFHQFTGLINFDLSANNLTGQ 180
           +  N++T  + +   + L Q++ + L  N L + GI + AF     L    ++  N+T  
Sbjct: 128 VHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 185

Query: 181 LPPSTRNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLN------IENNLFSG 225
           +P       SL  LHL  NK++     +L  L +L  + L+      ++N   + 
Sbjct: 186 IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 85.4 bits (212), Expect = 4e-18
 Identities = 33/138 (23%), Positives = 52/138 (37%), Gaps = 9/138 (6%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD 159
           +  S+  +   +P +LP       L  N++T         L  L  L L NN ++   P 
Sbjct: 36  VQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 94

Query: 160 AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS----GTLNVLEDLHLID 215
           AF     L    LS N L  +LP       +L  L +  N+++       N L  + +++
Sbjct: 95  AFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVE 151

Query: 216 LNIENNLFSGPIPEKLLS 233
           L   N L S  I      
Sbjct: 152 LG-TNPLKSSGIENGAFQ 168

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 30/143 (20%), Positives = 61/143 (42%), Gaps = 13/143 (9%)

Query: 69  VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN---FSLS 125
           +  ++TE+ L G  +  V A +L  L ++  + LS N I  ++ +       +     L+
Sbjct: 190 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLN 248

Query: 126 GNQLTGSIPESLSRLTQLLDLSLNNNHLNG------GIPDAFHQFTGLINFDLSANNLT- 178
            N+L   +P  L+    +  + L+NN+++         P    +        L +N +  
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307

Query: 179 GQLPPST-RNLSSLYSLHLQNNK 200
            ++ PST R +    ++ L N K
Sbjct: 308 WEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 32/174 (18%), Positives = 56/174 (32%), Gaps = 26/174 (14%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVR 120
           G F     ++ IR+   N+  +       L     + L  N I   +       L   + 
Sbjct: 165 GAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKIT-KVDAASLKGLNN-LA 219

Query: 121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
              LS N ++     SL+    L +L LNNN L   +P        +    L  NN++  
Sbjct: 220 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-A 277

Query: 181 LPPST-------RNLSSLYSLHLQNNKL------SGTLNVLEDLHLIDLNIENN 221
           +  +           +S   + L +N +        T   +     + L   N 
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLG--NY 329

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 61/274 (22%), Positives = 111/274 (40%), Gaps = 43/274 (15%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V K   +P G+++AVK++  TV+ ++     ++L  ++  +     V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
               G   +  +      L        +  +    +I  ++A+   +AL++L    +  +
Sbjct: 75  LFREGDVWICMELMDTS-LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSV 131

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-----APE---- 617
           +H + K SN+L++    V++ D G      SG    L + +     +G     APE    
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFG-----ISG---YLVDDVAKDIDAGCKPYMAPERINP 183

Query: 618 -FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
                 YS +SD++SLG+ M+EL   R PYD                       L ++V+
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYD---------------SWGTPFQQLKQVVE 228

Query: 677 ---PSLDGAYLAKSLSRFADIISRCVQWEPGFRP 707
              P L     +     F D  S+C++     RP
Sbjct: 229 EPSPQLPADKFSAE---FVDFTSQCLKKNSKERP 259

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 73/317 (23%), Positives = 121/317 (38%), Gaps = 83/317 (26%)

Query: 445 GNFIGEGLLGSVYKAELPGGK------LLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +GEG  G V KA     K       +AVK L    S  +   + L   + + ++ H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSEFNVLKQVNHP 86

Query: 499 NIVELIGYCNEHGQHLLVYDY--GGNCTLHDLL--HSDEEAHKKFSWNIR---------- 544
           ++++L G C++ G  LL+ +Y   G+  L   L            S   R          
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGS--LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144

Query: 545 --------IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
                   I  A   ++ +QYL E+    +VH +  + NIL+ E   +++SD GL+  ++
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVY 201

Query: 597 SGSTNELSEGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
              +             G       A E      Y+ QSDV+S GV++ E++T G  PY 
Sbjct: 202 EEDSYV-------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY- 253

Query: 648 RSRPRGEQSLVRWAIPRLHDIDALS------RMVDPSL--DGAYLAKSLSRFADIISRCV 699
                          P +      +      RM  P    +  Y          ++ +C 
Sbjct: 254 ---------------PGIPPERLFNLLKTGHRMERPDNCSEEMY---------RLMLQCW 289

Query: 700 QWEPGFRPPMSEIVQDL 716
           + EP  RP  ++I +DL
Sbjct: 290 KQEPDKRPVFADISKDL 306

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 67/306 (21%), Positives = 111/306 (36%), Gaps = 61/306 (19%)

Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RH 497
           G  +G G  G V +A   G         +AVK L +T    +  E  +     +S L +H
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK-EALMSELKIMSHLGQH 109

Query: 498 GNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLL----------HSDEEAHKKFSWNIRI 545
            NIV L+G C   G  L++ +Y   G+  L + L           +   A+   S    +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGD--LLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
             +   A+ + +L        +H +  + N+LL    + ++ D GLA  + + S      
Sbjct: 168 HFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY---- 220

Query: 606 GLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQS 656
                 G+        APE      Y+ QSDV+S G+++ E+ + G  PY        + 
Sbjct: 221 ---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-PGILVNSKF 276

Query: 657 LVRWAIPRLHDIDALSRMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                      +    +M  P+      Y          I+  C   EP  RP   +I  
Sbjct: 277 --------YKLVKDGYQMAQPAFAPKNIY---------SIMQACWALEPTHRPTFQQICS 319

Query: 715 DLLCMI 720
            L    
Sbjct: 320 FLQEQA 325

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 59/289 (20%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVK-----KLSNTVSQRQTDEEFLELASTISRLRHG 498
           GN +G+G    VY+A  +  G  +A+K      +      ++   E         +L+H 
Sbjct: 16  GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV----KIHCQLKHP 71

Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLH------SDEEAHKKFSWNIRIRVALGAA 552
           +I+EL  Y  +     LV +   N  ++  L       S+ EA                 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH---------QII 122

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             + YL       I+H +   SN+LL   + ++++D GLA  L         E   T  G
Sbjct: 123 TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-----EKHYTLCG 174

Query: 613 S---GAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI 668
           +    +PE     ++  +SDV+SLG +   LL GR P+D                    +
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD-----------------TV 217

Query: 669 DALSRMVDPSLDGAY-LAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
                 V   +   Y +   LS  A D+I + ++  P  R  +S ++  
Sbjct: 218 KNTLNKV---VLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 37/190 (19%), Positives = 81/190 (42%), Gaps = 16/190 (8%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLS 125
               + +  + +T   +  V    + +L  + ++ L+ N I    P ++L  ++  F+  
Sbjct: 151 LSNMTGLNYLTVTESKVKDV--TPIANLTDLYSLSLNYNQIEDISPLASLT-SLHYFTAY 207

Query: 126 GNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST 185
            NQ+T   P  ++ +T+L  L + NN +           + L   ++  N ++     + 
Sbjct: 208 VNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAV 261

Query: 186 RNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSGPIPEKLLSIPNFRK---DG 241
           ++L+ L  L++ +N++S  ++VL +L  L  L + NN       E +  + N        
Sbjct: 262 KDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQ 320

Query: 242 NPFNTTVIAL 251
           N   T +  L
Sbjct: 321 NHI-TDIRPL 329

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 79.9 bits (198), Expect = 3e-16
 Identities = 25/133 (18%), Positives = 58/133 (43%), Gaps = 8/133 (6%)

Query: 91  LGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
           + ++  + ++ + NN I    P +NL   +    +  NQ++     ++  LT+L  L++ 
Sbjct: 217 VANMTRLNSLKIGNNKITDLSPLANLS-QLTWLEIGTNQISD--INAVKDLTKLKMLNVG 273

Query: 150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLE 209
           +N ++       +  + L +  L+ N L  +       L++L +L L  N ++  +  L 
Sbjct: 274 SNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLA 330

Query: 210 DL-HLIDLNIENN 221
            L  +   +  N 
Sbjct: 331 SLSKMDSADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 79.1 bits (196), Expect = 5e-16
 Identities = 29/141 (20%), Positives = 55/141 (39%), Gaps = 8/141 (5%)

Query: 90  TLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
              DL   I   L    +   +      ++    ++G ++  SI   +  LT L  L+LN
Sbjct: 17  PDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLN 74

Query: 150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLE 209
            N +             L N  +  N +T     + +NL++L  L+L  + +S  ++ L 
Sbjct: 75  GNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD-ISPLA 129

Query: 210 DLH-LIDLNIENNLFSGPIPE 229
           +L  +  LN+  N     +  
Sbjct: 130 NLTKMYSLNLGANHNLSDLSP 150

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 78.7 bits (195), Expect = 7e-16
 Identities = 29/142 (20%), Positives = 59/142 (41%), Gaps = 9/142 (6%)

Query: 89  DTLGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLS 147
             L +L ++  + L+ ++I    P +NL   + + +L  N    S    LS +T L  L+
Sbjct: 104 SALQNLTNLRELYLNEDNISDISPLANLT-KMYSLNLGANHNL-SDLSPLSNMTGLNYLT 161

Query: 148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV 207
           +  + +           T L +  L+ N +         +L+SL+      N+++  +  
Sbjct: 162 VTESKVKD--VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD-ITP 216

Query: 208 LEDL-HLIDLNIENNLFSGPIP 228
           + ++  L  L I NN  +   P
Sbjct: 217 VANMTRLNSLKIGNNKITDLSP 238

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 29/114 (25%), Positives = 50/114 (43%), Gaps = 8/114 (7%)

Query: 91  LGDLESVINIDLSNNHIGGSIP--SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL 148
           L +L  +  +++  N I   I    +L   ++  ++  NQ++      L+ L+QL  L L
Sbjct: 239 LANLSQLTWLEIGTNQIS-DINAVKDLT-KLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294

Query: 149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS 202
           NNN L     +     T L    LS N++T  + P   +LS + S    N  + 
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLA-SLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 68.0 bits (167), Expect = 3e-12
 Identities = 24/132 (18%), Positives = 48/132 (36%), Gaps = 10/132 (7%)

Query: 99  NIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGI 157
            +      I    P ++L        L    +T  +      L  +  L +    +    
Sbjct: 4   TLATLPAPINQIFPDADLA-EGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-- 58

Query: 158 PDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDL 216
                  T L   +L+ N +T        NL  L +L++  NK++  ++ L++L +L +L
Sbjct: 59  IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT-DISALQNLTNLREL 115

Query: 217 NIENNLFSGPIP 228
            +  +  S   P
Sbjct: 116 YLNEDNISDISP 127

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 73/308 (23%), Positives = 112/308 (36%), Gaps = 61/308 (19%)

Query: 445 GNFIGEGLLGSVYKAELPGGK------LLAVKKLSNTVSQRQTDEEFLELASTISRL-RH 497
           G  +G G  G V +A   G         +AVK L  +    +  E  +     +S L  H
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-EALMSELKVLSYLGNH 86

Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLL--HSDEEAHKKFSWNIR----------- 544
            NIV L+G C   G  L++ +Y     L + L    D     K S  I            
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 545 -IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
            +  +   A+ + +L        +H +  + NILL    I ++ D GLA  + +      
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN------ 197

Query: 604 SEGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGE 654
            +      G+        APE   +  Y+ +SDV+S G+ + EL + G  PY    P   
Sbjct: 198 -DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVDS 255

Query: 655 QSLVRWAIPRLHDIDALSRMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
           +            I    RM+ P       Y         DI+  C   +P  RP   +I
Sbjct: 256 KF--------YKMIKEGFRMLSPEHAPAEMY---------DIMKTCWDADPLKRPTFKQI 298

Query: 713 VQDLLCMI 720
           VQ +   I
Sbjct: 299 VQLIEKQI 306

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 85.1 bits (211), Expect = 4e-18
 Identities = 59/274 (21%), Positives = 105/274 (38%), Gaps = 44/274 (16%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V+K      G ++AVK++  + ++ +     ++L   +       IV+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
              +    +  +  G C                   I  ++ +   +AL YL+E  +  +
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKE--KHGV 146

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-----APE---- 617
           +H + K SNILLDE+  +++ D G      SG    L +       +G     APE    
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFG-----ISG---RLVDDKAKDRSAGCAAYMAPERIDP 198

Query: 618 --FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ--SLVRWAIPRLHDIDALSR 673
                  Y  ++DV+SLG+ ++EL TG+ PY   +   E    +++   P L      S 
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258

Query: 674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP 707
                            F   +  C+  +   RP
Sbjct: 259 ----------------DFQSFVKDCLTKDHRKRP 276

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 85.3 bits (211), Expect = 6e-18
 Identities = 56/312 (17%), Positives = 97/312 (31%), Gaps = 62/312 (19%)

Query: 448 IGEGL--LGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLEL---ASTISRLRHGNIV 501
           IG+G   L +V  A   P G+ + V++++       ++E    L           H NIV
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLE---ACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 502 ELIGYCNEHGQHL-LVYDYGGNCTLHDLLHSD-----EEAHKKFSWNIRIRVALGAARAL 555
                       L +V  +    +  DL+ +       E        I   +  G  +AL
Sbjct: 90  PYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA------IAY-ILQGVLKAL 141

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG- 614
            Y+  +     VH + K+S+IL+     V +S       + S    +        +    
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 615 ----APEF---ESGSYSCQSDVYSLGVVMLELLTGRKPY--------------------- 646
               +PE        Y  +SD+YS+G+   EL  G  P+                     
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258

Query: 647 ------DRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSR-FADIISRCV 699
                            V  +        +  R  +         ++ S  F   + +C+
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318

Query: 700 QWEPGFRPPMSE 711
           Q  P  RP  S 
Sbjct: 319 QRNPDARPSAST 330

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 86.0 bits (213), Expect = 7e-18
 Identities = 32/138 (23%), Positives = 49/138 (35%), Gaps = 14/138 (10%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD 159
           +  +   +   +P  +P   R  +L  N +     ++   L  L  L L  N +      
Sbjct: 59  VVCTRRGLS-EVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG 117

Query: 160 AFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS-------GTLNVLEDL 211
           AF+    L   +L  N LT  +P      LS L  L L+NN +          +  L  L
Sbjct: 118 AFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRL 176

Query: 212 HLIDLN----IENNLFSG 225
            L +L     I    F G
Sbjct: 177 DLGELKKLEYISEGAFEG 194

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 43/192 (22%), Positives = 70/192 (36%), Gaps = 28/192 (14%)

Query: 59  CGDSWQGVFC-----------VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHI 107
           C + +  V C           + SN   + L   N+  + ADT   L  +  + L  N I
Sbjct: 52  CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 108 GGSIP----SNLPVTVRNFSLSGNQLTGSIP-ESLSRLTQLLDLSLNNNHLNGGIPDAFH 162
              I     + L  ++    L  N LT  IP  +   L++L +L L NN +      AF+
Sbjct: 112 -RQIEVGAFNGLA-SLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168

Query: 163 QFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS--GTLNVLEDLHLIDLN-- 217
           +   L+  DL        +       L +L  L+L    +     L  L  L  ++++  
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGN 228

Query: 218 ----IENNLFSG 225
               I    F G
Sbjct: 229 HFPEIRPGSFHG 240

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 74.0 bits (182), Expect = 5e-14
 Identities = 33/163 (20%), Positives = 66/163 (40%), Gaps = 15/163 (9%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSN-NHIGGSIP----SNLPVTV 119
           G F   S + E+ L    +  + +     + S++ +DL     +   I       L   +
Sbjct: 141 GAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLF-NL 198

Query: 120 RNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG 179
           +  +L    +   +P +L+ L  L +L ++ NH     P +FH  + L    +  + ++ 
Sbjct: 199 KYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS- 255

Query: 180 QLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLN 217
            +  +    L+SL  L+L +N LS         L  L  + L+
Sbjct: 256 LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLH 298

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 71.3 bits (175), Expect = 4e-13
 Identities = 32/139 (23%), Positives = 57/139 (41%), Gaps = 7/139 (5%)

Query: 65  GVFCVFSNVTEIRLTGMN-LGGVLADTLGDLESVINIDLSNNHIGGSIP--SNLPVTVRN 121
             F    ++  + L  +  L  +       L ++  ++L   +I   +P  + L   +  
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLV-GLEE 222

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
             +SGN      P S   L+ L  L + N+ ++    +AF     L+  +L+ NNL+  L
Sbjct: 223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SL 281

Query: 182 PPST-RNLSSLYSLHLQNN 199
           P      L  L  LHL +N
Sbjct: 282 PHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 23/116 (19%), Positives = 45/116 (38%), Gaps = 6/116 (5%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN--- 121
           G F    N+  + L   N+  +    L  L  +  +++S NH    I       + +   
Sbjct: 190 GAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKK 246

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL 177
             +  +Q++     +   L  L++L+L +N+L+    D F     L+   L  N  
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 86.3 bits (214), Expect = 9e-18
 Identities = 37/145 (25%), Positives = 57/145 (39%), Gaps = 9/145 (6%)

Query: 101 DLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDA 160
           D  +     SIPS L   +++  LS N++T      L     L  L L ++ +N    DA
Sbjct: 11  DGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69

Query: 161 FHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS-----GTLNVLEDLHLI 214
           F+    L + DLS N+L+  L  S    LSSL  L+L  N             L +L  +
Sbjct: 70  FYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128

Query: 215 DLNIENNLFSGPIPEKLLSIPNFRK 239
            +      FS         + +  +
Sbjct: 129 RIG-NVETFSEIRRIDFAGLTSLNE 152

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 79.8 bits (197), Expect = 1e-15
 Identities = 38/208 (18%), Positives = 70/208 (33%), Gaps = 28/208 (13%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHI-----GGSIPSNLPVTV 119
            V+ +   V  I +    +  V       L+S+  +DLS N +       S       ++
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363

Query: 120 RNFSLSGNQLT--GSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL 177
           +   LS N L       E L  L  L  L ++ N  +  +PD+      +   +LS+  +
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422

Query: 178 T---GQLPPSTR--------------NLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIEN 220
                 +P +                 L  L  L++  NKL    +      L+ + I  
Sbjct: 423 RVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISR 482

Query: 221 NLFSGPIPEKLLSIPNFRK---DGNPFN 245
           N            + + +K     NP++
Sbjct: 483 NQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 78.2 bits (193), Expect = 3e-15
 Identities = 29/181 (16%), Positives = 66/181 (36%), Gaps = 14/181 (7%)

Query: 69  VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVRNFSL 124
           + + +  + L+   +  +    L    ++  + L ++ I  +I      +L  ++ +  L
Sbjct: 24  LTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLG-SLEHLDL 81

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNG-GIPDAFHQFTGLINFDLSANNLTGQLPP 183
           S N L+         L+ L  L+L  N     G+   F   T L    +       ++  
Sbjct: 82  SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141

Query: 184 ST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFR 238
                L+SL  L ++   L      +L  + D+H + L+   +  +  +      + + R
Sbjct: 142 IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH--LSESAFLLEIFADILSSVR 199

Query: 239 K 239
            
Sbjct: 200 Y 200

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 30/198 (15%), Positives = 65/198 (32%), Gaps = 18/198 (9%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHI----GGSIPSNLPVTVR 120
             F    ++  + L+  +L  + +   G L S+  ++L  N        S+  NL   ++
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT-NLQ 126

Query: 121 NFSLSGNQLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG 179
              +   +    I     + LT L +L +    L      +      + +  L  +    
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186

Query: 180 QLPPSTRNLSSLYSLHLQNNKLSG----------TLNVLEDLHLIDLNIENNLFSG--PI 227
            L      LSS+  L L++  L+             + ++ L      + +  F+    +
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246

Query: 228 PEKLLSIPNFRKDGNPFN 245
              +L +     D    N
Sbjct: 247 LRYILELSEVEFDDCTLN 264

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 37/183 (20%), Positives = 74/183 (40%), Gaps = 17/183 (9%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNF-- 122
           G     +N+  + L    +  +  D    L S+ ++DLS+NH+  S+ S+    + +   
Sbjct: 44  GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL-SSLSSSWFGPLSSLKY 102

Query: 123 -SLSGNQLTGSIPES--LSRLTQLLDLSLNNNHLNGGIP-DAFHQFTGLINFDLSANNLT 178
            +L GN    ++  +     LT L  L + N      I    F   T L   ++ A +L 
Sbjct: 103 LNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161

Query: 179 GQLPPST-RNLSSLYSLHLQNNKLS-------GTLNVLEDLHLIDLNIENNLFSGPIPEK 230
                 + +++  ++ L L  ++ +         L+ +  L L D N+    FS    ++
Sbjct: 162 -NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDE 220

Query: 231 LLS 233
           + S
Sbjct: 221 VSS 223

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.8 bits (166), Expect = 6e-12
 Identities = 27/152 (17%), Positives = 55/152 (36%), Gaps = 12/152 (7%)

Query: 94  LESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHL 153
           L  + + + S + +   +     VT+R   +    L   +    S L ++  +++ N+ +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322

Query: 154 NGGIPDAFHQFTGLINFDLSANNLTGQLPPST---RNLSSLYSLHLQNNKL------SGT 204
                        L   DLS N +  +   ++       SL +L L  N L         
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382

Query: 205 LNVLEDLHLIDLNIENNLFSGPIPEKLLSIPN 236
           L  L++L  +D++  N     P+P+       
Sbjct: 383 LLTLKNLTSLDIS-RNTF--HPMPDSCQWPEK 411

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 27/183 (14%), Positives = 57/183 (31%), Gaps = 12/183 (6%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTL-GDLESVINIDLSNNHIGGSIP----SNLPVT 118
              F   S++  + L G     +   +L  +L ++  + + N      I     + L  +
Sbjct: 91  SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT-S 149

Query: 119 VRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT 178
           +    +    L     +SL  +  +  L+L+ +     +       + +   +L   NL 
Sbjct: 150 LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA 209

Query: 179 GQLPPST----RNLSSLYSLHLQNNKLS-GTLNVLEDLHLIDLNIENNLFSGPIPEKLLS 233
                S        S +  L  + + L+  + N L  L    L +    F       L  
Sbjct: 210 R-FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268

Query: 234 IPN 236
              
Sbjct: 269 FNP 271

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 21/199 (10%), Positives = 60/199 (30%), Gaps = 25/199 (12%)

Query: 65  GVFCVFSNVTEIRLTGMN-LGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN-- 121
            +F   +N+  +R+  +     +       L S+  +++    +  +  S    ++R+  
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIH 175

Query: 122 -FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT-- 178
             +L  ++    +      L+ +  L L + +L                    A   +  
Sbjct: 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVL 235

Query: 179 -----GQLPPSTRNLSSLYSLHLQNNKLSGTLNV-------------LEDLHLIDLNIEN 220
                 +L    R +  L  +   +  L+G  +              +E + +  L+I  
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295

Query: 221 NLFSGPIPEKLLSIPNFRK 239
                 +      +   ++
Sbjct: 296 FYLFYDLSTVYSLLEKVKR 314

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 29/184 (15%), Positives = 55/184 (29%), Gaps = 26/184 (14%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSL 124
                  ++  + L       +L      L SV  ++L + ++     S LPV   +  +
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPM 225

Query: 125 SGNQLTGSIPESLS--------------RLTQLLDLSLNN-NHLNGGIPDAFHQFTG--- 166
                 GS+    S                 +  D +LN     N    D   +      
Sbjct: 226 KKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET 285

Query: 167 --LINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIEN 220
             +    +    L   L      L  +  + ++N+K+          L+ L  +DL+   
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLS--E 343

Query: 221 NLFS 224
           NL  
Sbjct: 344 NLMV 347

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 28/138 (20%), Positives = 55/138 (39%), Gaps = 9/138 (6%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD 159
           +  S+  +  ++P  +        L  N ++    +    L  L  L L NN ++     
Sbjct: 38  VQCSDLGLK-AVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK 96

Query: 160 AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS----GTLNVLEDLHLID 215
           AF     L    +S N+L  ++PP+    SSL  L + +N++     G  + L +++ I+
Sbjct: 97  AFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIE 153

Query: 216 LNIENNLFSGPIPEKLLS 233
           +   N L +         
Sbjct: 154 MG-GNPLENSGFEPGAFD 170

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 37/173 (21%), Positives = 63/173 (36%), Gaps = 17/173 (9%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSL 124
             F    ++  + L    +  +       L  +  + +S NH+   IP NLP ++    +
Sbjct: 72  DDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL-VEIPPNLPSSLVELRI 130

Query: 125 SGNQLTGSIPE-SLSRLTQLLDLSLNNNHL-NGGIPDAFHQFTGLINFDLSANNLTGQLP 182
             N++   +P+   S L  +  + +  N L N G          L    +S   LT  +P
Sbjct: 131 HDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIP 188

Query: 183 PSTRNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLN------IENNLFSG 225
                  +L  LHL +NK+       L     L+ + L       IEN   S 
Sbjct: 189 KDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 32/186 (17%), Positives = 67/186 (36%), Gaps = 35/186 (18%)

Query: 69  VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGG------------------- 109
           + S++ E+R+    +  V       L ++  I++  N +                     
Sbjct: 121 LPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRIS 180

Query: 110 -----SIPSNLPVTVRNFSLSGNQLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIPDAFHQ 163
                 IP +LP T+    L  N++  +I    L R ++L  L L +N +      +   
Sbjct: 181 EAKLTGIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239

Query: 164 FTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS--------GTLNVLEDLHLID 215
              L    L  N L+ ++P    +L  L  ++L  N ++             ++  +   
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNG 298

Query: 216 LNIENN 221
           +++ NN
Sbjct: 299 ISLFNN 304

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 36/168 (21%), Positives = 58/168 (34%), Gaps = 28/168 (16%)

Query: 72  NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVRNFSLSGN 127
            +  +R++   L G+  D    L     + L +N I  +I           +    L  N
Sbjct: 173 KLNYLRISEAKLTGIPKDLPETLNE---LHLDHNKIQ-AIELEDLLRYS-KLYRLGLGHN 227

Query: 128 QLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST- 185
           Q+   I   SLS L  L +L L+NN L+  +P        L    L  NN+T ++  +  
Sbjct: 228 QIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDF 284

Query: 186 ------RNLSSLYSLHLQNNKLS------GTLNVLEDLHLIDLNIENN 221
                    +    + L NN +        T   + D   I     N 
Sbjct: 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG--NY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 22/145 (15%), Positives = 48/145 (33%), Gaps = 31/145 (21%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFS 123
                 +S +  + L    +  +   +L  L ++  + L N                   
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDN------------------- 250

Query: 124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINF------DLSANNL 177
              N+L+  +P  L  L  L  + L+ N++     + F      +         L  N +
Sbjct: 251 ---NKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV 306

Query: 178 T-GQLPPST-RNLSSLYSLHLQNNK 200
              ++ P+T R ++   ++   N K
Sbjct: 307 PYWEVQPATFRCVTDRLAIQFGNYK 331

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 85.2 bits (211), Expect = 1e-17
 Identities = 34/138 (24%), Positives = 50/138 (36%), Gaps = 14/138 (10%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD 159
           +     ++   +P  +    R  +L  NQ+      S   L  L  L L+ NH+      
Sbjct: 48  VICVRKNLR-EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG 106

Query: 160 AFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS-------GTLNVLEDL 211
           AF+    L   +L  N LT  +P      LS L  L L+NN +          +  L  L
Sbjct: 107 AFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRL 165

Query: 212 HLIDLN----IENNLFSG 225
            L +L     I    F G
Sbjct: 166 DLGELKRLSYISEGAFEG 183

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 77.1 bits (190), Expect = 5e-15
 Identities = 42/184 (22%), Positives = 72/184 (39%), Gaps = 22/184 (11%)

Query: 59  CGDSWQGVFC-----------VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHI 107
           C + +  V C           + +N   + L    +  +  ++   L  +  + LS NHI
Sbjct: 41  CSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 108 GGSIP----SNLPVTVRNFSLSGNQLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIPDAFH 162
             +I     + L   +    L  N+LT +IP  +   L++L +L L NN +      AF+
Sbjct: 101 -RTIEIGAFNGLA-NLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFN 157

Query: 163 QFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIEN 220
           +   L   DL        +       LS+L  L+L    L   +  L  L  L +L++  
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSG 216

Query: 221 NLFS 224
           N  S
Sbjct: 217 NHLS 220

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 41/186 (22%), Positives = 68/186 (36%), Gaps = 37/186 (19%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN--- 121
           G F   +N+  + L    L  +       L  +  + L NN I  SIPS     + +   
Sbjct: 106 GAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRR 164

Query: 122 ----------------F---------SLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGG 156
                           F         +L+   L   IP +L+ L +L +L L+ NHL+  
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAI 222

Query: 157 IPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDL 211
            P +F     L    +  + +   +  +   NL SL  ++L +N L+         L  L
Sbjct: 223 RPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281

Query: 212 HLIDLN 217
             I L+
Sbjct: 282 ERIHLH 287

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 33/139 (23%), Positives = 57/139 (41%), Gaps = 7/139 (5%)

Query: 65  GVFCVFSNVTEIRLTGMN-LGGVLADTLGDLESVINIDLSNNHIGGSIP--SNLPVTVRN 121
             F    ++  + L  +  L  +       L ++  ++L+  ++   IP  + L   +  
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLI-KLDE 211

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
             LSGN L+   P S   L  L  L +  + +     +AF     L+  +L+ NNLT  L
Sbjct: 212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LL 270

Query: 182 PPST-RNLSSLYSLHLQNN 199
           P      L  L  +HL +N
Sbjct: 271 PHDLFTPLHHLERIHLHHN 289

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 86.1 bits (213), Expect = 1e-17
 Identities = 52/281 (18%), Positives = 93/281 (33%), Gaps = 57/281 (20%)

Query: 448 IGEGLLGSVYKAE--LPGGKLLAVKKLSNTVSQRQTDEEFLEL----ASTISRLRHGNIV 501
           I  G LG +Y A      G+ + +K L ++      D E   +       ++ + H +IV
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHS-----GDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 502 ELIGYCNEHGQHL-----LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           ++  +     +H      +V +Y G  +L           +K      I   L    AL 
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALS 196

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
           YL  +    +V+ + K  NI+L E+  +++ D G    +   S   L     T     AP
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI--NSFGYL---YGTPGFQ-AP 246

Query: 617 EFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
           E      +  +D+Y++G  +  L       +     G               D       
Sbjct: 247 EIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE------------DDPVLKTY 294

Query: 677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-MSEIVQDL 716
            S               ++ R +  +P  R     E+   L
Sbjct: 295 DSYG------------RLLRRAIDPDPRQRFTTAEEMSAQL 323

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 85.2 bits (211), Expect = 1e-17
 Identities = 35/194 (18%), Positives = 69/194 (35%), Gaps = 31/194 (15%)

Query: 59  CGDSWQGVFC-----------VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHI 107
           C    + V C           + +    + L    +  +  D       +  ++L+ N +
Sbjct: 9   CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68

Query: 108 GGSIP----SNLPVTVRNFSLSGNQLTGSIP-ESLSRLTQLLDLSLNNNHLNGGIPDAFH 162
             ++     +NL   +R   L  N+L   IP    + L+ L  L ++ N +   +   F 
Sbjct: 69  -SAVEPGAFNNLF-NLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQ 125

Query: 163 QFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDL- 216
               L + ++  N+L   +       L+SL  L L+   L+      L+ L  L ++ L 
Sbjct: 126 DLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLR 184

Query: 217 -----NIENNLFSG 225
                 I +  F  
Sbjct: 185 HLNINAIRDYSFKR 198

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 84.4 bits (209), Expect = 3e-17
 Identities = 40/177 (22%), Positives = 79/177 (44%), Gaps = 18/177 (10%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTV 119
            GVF   SN+T++ ++   +  +L     DL ++ ++++ +N +   I     S L  ++
Sbjct: 97  LGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN-SL 154

Query: 120 RNFSLSGNQLTGSIP-ESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT 178
              +L    LT SIP E+LS L  L+ L L + ++N     +F +   L   ++S     
Sbjct: 155 EQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213

Query: 179 GQLPPSTRNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLN------IENNLFSG 225
             + P+     +L SL + +  L+      +  L  L  ++L+      IE ++   
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHE 270

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 25/142 (17%), Positives = 56/142 (39%), Gaps = 6/142 (4%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN--- 121
             F     +  + ++       +        ++ ++ +++ ++  ++P      +     
Sbjct: 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRF 252

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
            +LS N ++      L  L +L ++ L    L    P AF     L   ++S N LT  L
Sbjct: 253 LNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TL 311

Query: 182 PPST-RNLSSLYSLHLQNNKLS 202
             S   ++ +L +L L +N L+
Sbjct: 312 EESVFHSVGNLETLILDSNPLA 333

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 65/315 (20%), Positives = 115/315 (36%), Gaps = 70/315 (22%)

Query: 445 GNFIGEGLLGSVYKAELPGGK------LLAVKKLSNTVSQRQTDEEFLELASTISRL-RH 497
           G  +G G  G V  A   G         +AVK L       +  E  +     +++L  H
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-EALMSELKMMTQLGSH 108

Query: 498 GNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLL--HSDEEAHKKFSWNIR--------- 544
            NIV L+G C   G   L+++Y   G+  L + L    ++ +  +  +  +         
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGD--LLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 545 --------IRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF 596
                   +  A   A+ +++L+       VH +  + N+L+    +V++ D GLA  + 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIM 223

Query: 597 SGSTNELSEGLLTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYD 647
           S       +      G+        APE    G Y+ +SDV+S G+++ E+ + G  PY 
Sbjct: 224 S-------DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY- 275

Query: 648 RSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL--DGAYLAKSLSRFADIISRCVQWEPGF 705
              P                I    +M  P    +  Y          I+  C  ++   
Sbjct: 276 PGIPVDANF--------YKLIQNGFKMDQPFYATEEIY---------IIMQSCWAFDSRK 318

Query: 706 RPPMSEIVQDLLCMI 720
           RP    +   L C +
Sbjct: 319 RPSFPNLTSFLGCQL 333

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.8 bits (200), Expect = 1e-17
 Identities = 33/158 (20%), Positives = 66/158 (41%), Gaps = 7/158 (4%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQ 128
            +++T I L  +N+  +    +    ++ ++ ++N H     P S L   +    + G  
Sbjct: 43  MNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNPISGLS-NLERLRIMGKD 99

Query: 129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNL 188
           +T     +LS LT L  L ++++  +  I    +    + + DLS N     + P  + L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTL 158

Query: 189 SSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSG 225
             L SL++Q + +      +ED   L  L   +    G
Sbjct: 159 PELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 25/138 (18%), Positives = 50/138 (36%), Gaps = 13/138 (9%)

Query: 90  TLGDLESVINIDLSNNHIGGSIP-----SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLL 144
           T   + S+  I L+N ++   +       N+    ++ +++    T      +S L+ L 
Sbjct: 39  TEAQMNSLTYITLANINVT-DLTGIEYAHNI----KDLTINNIHATNY--NPISGLSNLE 91

Query: 145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT 204
            L +    +           T L   D+S +     +      L  + S+ L  N     
Sbjct: 92  RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151

Query: 205 LNVLEDL-HLIDLNIENN 221
           +  L+ L  L  LNI+ +
Sbjct: 152 IMPLKTLPELKSLNIQFD 169

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 52.3 bits (126), Expect = 6e-08
 Identities = 21/145 (14%), Positives = 52/145 (35%), Gaps = 31/145 (21%)

Query: 94  LESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHL 153
            ++ +N  L  +       + +  ++   +L+   +T  +   +     + DL++NN H 
Sbjct: 22  FKAYLNGLLGQSSTANITEAQMN-SLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA 78

Query: 154 NGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT-LNVLEDLH 212
                            + +   ++         LS+L  L +    ++   +  L  L 
Sbjct: 79  T----------------NYN--PIS--------GLSNLERLRIMGKDVTSDKIPNLSGLT 112

Query: 213 -LIDLNIENNLFSGPIPEKLLSIPN 236
            L  L+I ++     I  K+ ++P 
Sbjct: 113 SLTLLDISHSAHDDSILTKINTLPK 137

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 36/128 (28%), Positives = 53/128 (41%), Gaps = 13/128 (10%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLI 168
           ++P +LP       LS N L+    E + +RLT L  L L++NHLN    +AF     L 
Sbjct: 32  NVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLR 91

Query: 169 NFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLN------ 217
             DLS+N+L   L      +L +L  L L NN +          +  L  + L+      
Sbjct: 92  YLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR 150

Query: 218 IENNLFSG 225
               L   
Sbjct: 151 FPVELIKD 158

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 44/167 (26%), Positives = 66/167 (39%), Gaps = 18/167 (10%)

Query: 69  VFSNVTEIRLTGMNLGGVLADT-LGDLESVINIDLSNNHIGGSIP----SNLPVTVRNFS 123
           + S    + L+  NL  + A+     L ++ ++ LS+NH+   I       +P  +R   
Sbjct: 37  LPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP-NLRYLD 94

Query: 124 LSGNQLTGSIP-ESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP 182
           LS N L  ++     S L  L  L L NNH+     +AF     L    LS N ++ + P
Sbjct: 95  LSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFP 152

Query: 183 PST----RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENN 221
                    L  L  L L +NKL       L  L       L + NN
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 27/146 (18%), Positives = 58/146 (39%), Gaps = 13/146 (8%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS----NLPVTV 119
           +      +N+  + L+  +L  + ++    + ++  +DLS+NH+  ++      +L   +
Sbjct: 57  EWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQ-AL 114

Query: 120 RNFSLSGNQLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN---FDLSAN 175
               L  N +   +   +   + QL  L L+ N ++    +       L      DLS+N
Sbjct: 115 EVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSN 173

Query: 176 NLTGQLPPSTRNLSSLY--SLHLQNN 199
            L        + L +     L+L NN
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLYLHNN 199

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 83.0 bits (205), Expect = 4e-17
 Identities = 60/298 (20%), Positives = 116/298 (38%), Gaps = 51/298 (17%)

Query: 448 IGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V+K    P G ++A K +   +     ++   EL   +       IV   G 
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL-QVLHECNSPYIVGFYGA 99

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
               G+  +  ++    +L  +L        +    I  +V++   + L YL+E  +  I
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE--KHKI 153

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE-FESGS 622
           +H + K SNIL++ +  +++ D G++  L     N       +  G+    +PE  +   
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-------SFVGTRSYMSPERLQGTH 206

Query: 623 YSCQSDVYSLGVVMLELLTGRKPY--------------------------DRSRPRGEQS 656
           YS QSD++S+G+ ++E+  GR P                            R+  R    
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 657 LVRWAIPRLHDIDALSRMVD---PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSE 711
               + P +   + L  +V+   P L     +     F D +++C+   P  R  + +
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE---FQDFVNKCLIKNPAERADLKQ 321

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 32/157 (20%), Positives = 62/157 (39%), Gaps = 13/157 (8%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS--NLPVTVRNFSLSGNQ 128
             V E+  +  ++  V      +L     + L +N++        N P  +    LS N+
Sbjct: 205 IAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLT-DTAWLLNYP-GLVEVDLSYNE 259

Query: 129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNL 188
           L   +     ++ +L  L ++NN L   +         L   DLS N+L   +  +    
Sbjct: 260 LEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 317

Query: 189 SSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENN 221
             L +L+L +N +      T + L++L L   + + N
Sbjct: 318 DRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 34/170 (20%), Positives = 65/170 (38%), Gaps = 8/170 (4%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN---FSLSG 126
            +N   +      +  + A  L     V  ++L++  I   I +             +  
Sbjct: 44  LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGF 102

Query: 127 NQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST- 185
           N +    P     +  L  L L  N L+      FH    L    +S NNL  ++   T 
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 161

Query: 186 RNLSSLYSLHLQNNKLSG-TLNVLEDLHLIDLNIENNLFSGPIPEKLLSI 234
           +  +SL +L L +N+L+   L+++  L   +++  N L +  IP  +  +
Sbjct: 162 QATTSLQNLQLSSNRLTHVDLSLIPSLFHANVS-YNLLSTLAIPIAVEEL 210

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 38/173 (21%), Positives = 71/173 (41%), Gaps = 13/173 (7%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN--- 121
            +   F  V  + L  + +  +         ++  + +  N I   +P ++   V     
Sbjct: 63  ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTV 121

Query: 122 FSLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
             L  N L+ S+P  +     +L  LS++NN+L     D F   T L N  LS+N LT  
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-H 179

Query: 181 LPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLS 233
           +  S   + SL+  ++  N LS TL +   +  +D +  N++    +   +  
Sbjct: 180 VDLS--LIPSLFHANVSYNLLS-TLAIPIAVEELDAS-HNSINV--VRGPVNV 226

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 25/177 (14%), Positives = 61/177 (34%), Gaps = 21/177 (11%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN--- 121
             F     + ++ +    +  +      ++  +  + L  N +  S+P  +         
Sbjct: 87  YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTT 145

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
            S+S N L     ++    T L +L L++N L   +         L + ++S N L+   
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS--- 199

Query: 182 PPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFR 238
             +     ++  L   +N ++  +    ++ L  L +++N         L       
Sbjct: 200 --TLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHN--------NLTDTAWLL 245

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 25/146 (17%), Positives = 49/146 (33%), Gaps = 21/146 (14%)

Query: 99  NIDLSNNHIGGSIPSNLPVTVRNFS--------LSGNQLTGSIPESLSRLTQLLDLSLNN 150
           +    + HI      ++     + +           + +       L    Q+  L+LN+
Sbjct: 20  DCVFYDVHID-MQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 78

Query: 151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTL 205
             +      AF     +    +  N +   LPP   +N+  L  L L+ N LS    G  
Sbjct: 79  LQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIF 137

Query: 206 NVLEDLHLIDLN------IENNLFSG 225
           +    L  + ++      IE++ F  
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQA 163

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 14/129 (10%), Positives = 38/129 (29%), Gaps = 14/129 (10%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLS--RLTQLLDLSLNNNHLNGGIPDAFHQFTGL 167
            I SNL      + +  +  T  +        L     ++  N+ +          F  +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 168 INFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLN----- 217
              +L+   +  ++         ++  L++  N +          +  L ++ L      
Sbjct: 72  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 218 -IENNLFSG 225
            +   +F  
Sbjct: 131 SLPRGIFHN 139

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 21/141 (14%), Positives = 52/141 (36%), Gaps = 11/141 (7%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP---SNLPVTVRN 121
                +  + E+ L+   L  ++      ++ +  + +SNN +  ++      +P T++ 
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIP-TLKV 299

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
             LS N L   +  +  +  +L +L L++N +   +         L N  LS N+     
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW--DC 353

Query: 182 PPSTRNLSSLYSLHLQNNKLS 202
                   ++    + +    
Sbjct: 354 NSLRALFRNVARPAVDDADQH 374

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 83.6 bits (207), Expect = 4e-17
 Identities = 37/194 (19%), Positives = 71/194 (36%), Gaps = 28/194 (14%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVRNFSLSG 126
           ++V  + L+  ++  +   +   L+ +  + +     G  I       L  ++    L  
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS-SLIILKLDY 88

Query: 127 NQLTGSIPES-LSRLTQLLDLSLNNNHLNGGI--PDAFHQFTGLINFDLSANNLTGQLPP 183
           NQ    +     + L  L  L+L   +L+G +   + F   T L    L  NN+  ++ P
Sbjct: 89  NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQP 146

Query: 184 ST--RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNF 237
           ++   N+   + L L  NK+       L   +  H   L + +          L  +  +
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI--------TLQDMNEY 198

Query: 238 R----KDGNPFNTT 247
                K GNPF  T
Sbjct: 199 WLGWEKCGNPFKNT 212

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 74.8 bits (184), Expect = 3e-14
 Identities = 32/118 (27%), Positives = 43/118 (36%), Gaps = 8/118 (6%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIP-DAFHQFTGLI 168
            +P  LP  V    LS N +      S SRL  L  L +        I  + F   + LI
Sbjct: 24  QVPE-LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82

Query: 169 NFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLSGTL---NVLEDL-HLIDLNIENN 221
              L  N    QL       L++L  L L    L G +   N  + L  L  L + +N
Sbjct: 83  ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 74.0 bits (182), Expect = 5e-14
 Identities = 47/200 (23%), Positives = 73/200 (36%), Gaps = 16/200 (8%)

Query: 30  PRDVMALNSLYISLN-FPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLA 88
           P    ++ +L +S N F        F     G   Q +    S          N      
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDA-IAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266

Query: 89  DTLGDLE--SVINIDLSNNHIGGSIPSNLP---VTVRNFSLSGNQLTGSIPE-SLSRLTQ 142
            T   LE   V   DLS + I  ++  ++      +   +L+ N++   I + +   LT 
Sbjct: 267 FTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTH 324

Query: 143 LLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKL 201
           LL L+L+ N L       F     L   DLS N++   L   +   L +L  L L  N+L
Sbjct: 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQL 383

Query: 202 S----GTLNVLEDLHLIDLN 217
                G  + L  L  I L+
Sbjct: 384 KSVPDGIFDRLTSLQKIWLH 403

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 32/134 (23%), Positives = 47/134 (35%), Gaps = 8/134 (5%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL---PVTVRNFSLSGN 127
           S V    L+   +  +L         +  + L+ N I   I  N       +   +LS N
Sbjct: 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN 333

Query: 128 QLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST- 185
            L  SI       L +L  L L+ NH+      +F     L    L  N L   +P    
Sbjct: 334 FLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS-VPDGIF 391

Query: 186 RNLSSLYSLHLQNN 199
             L+SL  + L  N
Sbjct: 392 DRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 28/205 (13%), Positives = 59/205 (28%), Gaps = 22/205 (10%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHI-GGSIPSNL---PVTVR 120
             F   S++  ++L       +       L ++  + L+  ++ G  +  N      ++ 
Sbjct: 73  NTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE 132

Query: 121 NFSLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPDAFHQFTGL----------IN 169
              L  N +    P S    + +   L L  N +     +    F G             
Sbjct: 133 MLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL 192

Query: 170 FDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG-------TLNVLEDLHLIDLNIENNL 222
            D++   L  +   +    +S+ +L L  N                  +  + L+   N+
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252

Query: 223 FSGPIPEKLLSIPNFRKDGNPFNTT 247
            S           NF   G   +  
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGV 277

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 8/92 (8%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVR 120
             F   +++ ++ L+   LG + +    +L+ +  +DLS NHI  ++       LP  ++
Sbjct: 317 NAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLP-NLK 374

Query: 121 NFSLSGNQLTGSIPES-LSRLTQLLDLSLNNN 151
             +L  NQL  S+P+    RLT L  + L+ N
Sbjct: 375 ELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 34/139 (24%), Positives = 58/139 (41%), Gaps = 15/139 (10%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLN--GGI 157
           I  ++  +  S+P+ +P +     L  N+L         +LTQL  LSL++N L+  G  
Sbjct: 12  IRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70

Query: 158 PDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS-----GTLNVLEDLH 212
             +    T L   DLS N +   +  +   L  L  L  Q++ L           L +L 
Sbjct: 71  SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 129

Query: 213 LIDLN------IENNLFSG 225
            +D++        N +F+G
Sbjct: 130 YLDISHTHTRVAFNGIFNG 148

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 33/176 (18%), Positives = 60/176 (34%), Gaps = 23/176 (13%)

Query: 69  VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIG-GSIPS----NLPVTVRNFS 123
           + S+ T + L    L  +       L  +  + LS+N +      S        +++   
Sbjct: 26  IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT-SLKYLD 84

Query: 124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD--AFHQFTGLINFDLSANNLTGQL 181
           LS N +  ++  +   L QL  L   +++L   + +   F     LI  D+S  +     
Sbjct: 85  LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VA 141

Query: 182 PPST-RNLSSLYSLHLQNNKL-----SGTLNVLEDLHLIDL------NIENNLFSG 225
                  LSSL  L +  N             L +L  +DL       +    F+ 
Sbjct: 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 26/145 (17%), Positives = 53/145 (36%), Gaps = 8/145 (5%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN-- 121
             VF    N+  + ++  +           L S+  + ++ N    +   ++   +RN  
Sbjct: 119 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178

Query: 122 -FSLSGNQLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG 179
              LS  QL   +   + + L+ L  L++++N+        +     L   D S N++  
Sbjct: 179 FLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM- 236

Query: 180 QLPPST--RNLSSLYSLHLQNNKLS 202
                      SSL  L+L  N  +
Sbjct: 237 TSKKQELQHFPSSLAFLNLTQNDFA 261

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 69/278 (24%), Positives = 112/278 (40%), Gaps = 38/278 (13%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG G    V  A   P  + +A+K+++    Q   DE   E    +S+  H NIV     
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE-IQAMSQCHHPNIVSYYT- 80

Query: 507 CNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIR-------IRVALGAARALQ 556
                  L LV     GG+    D++       +  S  +        +R  L     L+
Sbjct: 81  SFVVKDELWLVMKLLSGGSVL--DIIKHIVAKGEHKSGVLDESTIATILREVL---EGLE 135

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           YL +      +H + K+ NILL E   V+++D G++  L +G     ++   T  G+   
Sbjct: 136 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 615 -APE--FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAIPRLHDIDA 670
            APE   +   Y  ++D++S G+  +EL TG  PY +  P +     ++   P L     
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252

Query: 671 LSRMVDPSLDGAYLAKSLSR-FADIISRCVQWEPGFRP 707
              M           K   + F  +IS C+Q +P  RP
Sbjct: 253 DKEM----------LKKYGKSFRKMISLCLQKDPEKRP 280

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 46/197 (23%), Positives = 72/197 (36%), Gaps = 22/197 (11%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTV 119
              F    N+T + L    L  + A     L  +  +DLS+N    S+       L   +
Sbjct: 49  AASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG-RL 107

Query: 120 RNFSLSGNQLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLSANNL 177
               L    L   +       L  L  L L +N L   +PD  F     L +  L  N +
Sbjct: 108 HTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRI 165

Query: 178 TGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENNLFSGPIPEKLL 232
           +  +P    R L SL  L L  N+++         L  L  + L   NNL +  +P + L
Sbjct: 166 S-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF-ANNLSA--LPTEAL 221

Query: 233 ----SIPNFRKDGNPFN 245
               ++   R + NP+ 
Sbjct: 222 APLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 33/129 (25%), Positives = 51/129 (39%), Gaps = 8/129 (6%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN 169
           ++P  +P   +   L GN+++     S      L  L L++N L      AF     L  
Sbjct: 25  AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQ 84

Query: 170 FDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENNLFS 224
            DLS N     + P+T   L  L++LHL    L     G    L  L  + L  +N L +
Sbjct: 85  LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ-DNALQA 143

Query: 225 GPIPEKLLS 233
             +P+    
Sbjct: 144 --LPDDTFR 150

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 38/173 (21%), Positives = 61/173 (35%), Gaps = 19/173 (10%)

Query: 69  VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVRNFSL 124
           + +    I L G  +  V A +     ++  + L +N +   I     + L   +    L
Sbjct: 30  IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLA-LLEQLDL 87

Query: 125 SGNQLTGSIP-ESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPP 183
           S N    S+   +   L +L  L L+   L    P  F     L    L  N L   LP 
Sbjct: 88  SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPD 146

Query: 184 ST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLN------IENNLFSG 225
            T R+L +L  L L  N++S         L  L  + L+      +  + F  
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 29/163 (17%), Positives = 60/163 (36%), Gaps = 9/163 (5%)

Query: 90  TLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
            L    S+  +  +NN+I   +  +     +N  L+ N++T          +++  L L 
Sbjct: 94  ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152

Query: 150 NNHLNG-GIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVL 208
            N ++     +       L + +L  N +   +       + L +L L +NKL+      
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEF 210

Query: 209 EDL-HLIDLNIENNLFSGPIPEKLLSIPNFRK---DGNPFNTT 247
           +    +  +++ NN     I + L    N       GN F+  
Sbjct: 211 QSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 32/171 (18%), Positives = 56/171 (32%), Gaps = 7/171 (4%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGV-LADTLGDLESVINIDLSNNHIGGSIPSNLPVT-VRNF 122
                 S V  + L    +  V  A+     +++ +++L  N I   +   +    ++  
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQVVFAKLKTL 196

Query: 123 SLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT-GQL 181
            LS N+L   +         +  +SL NN L   I  A      L +FDL  N    G L
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254

Query: 182 PPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLL 232
                    + ++  Q  K     N  E+  +  L          +P    
Sbjct: 255 RDFFSKNQRVQTVAKQTVKKLTGQN-EEECTVPTLGHYGAYCCEDLPAPFA 304

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 75.0 bits (185), Expect = 9e-15
 Identities = 34/159 (21%), Positives = 64/159 (40%), Gaps = 20/159 (12%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFS 123
            +     NV E+ L+G  L  + A  L     +  ++LS+N +  ++   +L  T+R   
Sbjct: 28  SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLS-TLRTLD 86

Query: 124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPP 183
           L+ N +       L     +  L   NN+++  +     +  G  N  L+ N +T  L  
Sbjct: 87  LNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKIT-MLRD 137

Query: 184 ST-RNLSSLYSLHLQNNKLS--------GTLNVLEDLHL 213
                 S +  L L+ N++          + + LE L+L
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 27/134 (20%), Positives = 55/134 (41%), Gaps = 15/134 (11%)

Query: 87  LADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN---FSLSGNQLTGSIPESLSRLTQL 143
           + +   +        ++++ +     ++L  +  N     LSGN L+      L+  T+L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSL-KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 144 LDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS- 202
             L+L++N L     D     + L   DL+ N +  +L        S+ +LH  NN +S 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNISR 113

Query: 203 ---GTLNVLEDLHL 213
                    ++++L
Sbjct: 114 VSCSRGQGKKNIYL 127

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 25/112 (22%), Positives = 44/112 (39%), Gaps = 5/112 (4%)

Query: 111 IPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINF 170
           I  N     +   ++ + L  ++         + +L L+ N L+         FT L   
Sbjct: 5   IKQNGN-RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 171 DLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNL 222
           +LS+N L         +LS+L +L L NN +   L V   +  +     NN+
Sbjct: 64  NLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAA-NNNI 111

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 34/174 (19%), Positives = 63/174 (36%), Gaps = 21/174 (12%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVRNFSLSG 126
           +     ++T  +L   LA       +V  +DLS N +   I     +     +   +LS 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL-SQISAADLAPFT-KLELLNLSS 67

Query: 127 NQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTR 186
           N L     + L  L+ L  L LNNN++             +     + NN++ ++  S  
Sbjct: 68  NVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR- 118

Query: 187 NLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPN 236
                 +++L NNK++            +  +DL   N + +    E   S   
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK-LNEIDTVNFAELAASSDT 170

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 21/95 (22%), Positives = 36/95 (37%), Gaps = 4/95 (4%)

Query: 132 SIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSS 190
           +I E      +     + ++ L   +         +   DLS N L+ Q+  +     + 
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTK 59

Query: 191 LYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFS 224
           L  L+L +N L      LE L  L  L++ NN   
Sbjct: 60  LELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 51.1 bits (123), Expect = 5e-07
 Identities = 20/135 (14%), Positives = 36/135 (26%), Gaps = 12/135 (8%)

Query: 94  LESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNN 151
              +  +DLS+N +   +         V   SL  N+L   I ++L     L    L  N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247

Query: 152 HLNGG-IPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLED 210
             + G + D F +   +                     +     H            L  
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE--ECTVPTLGHYGAY----CCEDLPA 301

Query: 211 LHLIDL-NIENNLFS 224
                L  + ++   
Sbjct: 302 PFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 19/114 (16%), Positives = 35/114 (30%), Gaps = 8/114 (7%)

Query: 87  LADTLGDLESVINIDLSNNHIGGSIPSNL--PVTVRNFSLSGNQLT-GSIPESLSRLTQL 143
           +         V  I L NN +   I   L     + +F L GN    G++ +  S+  ++
Sbjct: 206 MGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 144 LDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP-PSTRNLSSLYSLHL 196
             ++         +     +   +             LP P    L +L   H 
Sbjct: 265 QTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHH 315

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 81.8 bits (202), Expect = 2e-16
 Identities = 29/163 (17%), Positives = 60/163 (36%), Gaps = 9/163 (5%)

Query: 90  TLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
            L    S+  +  +NN+I   +  +     +N  L+ N++T          +++  L L 
Sbjct: 94  ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152

Query: 150 NNHLNG-GIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVL 208
            N ++     +       L + +L  N +   +       + L +L L +NKL+      
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEF 210

Query: 209 EDL-HLIDLNIENNLFSGPIPEKLLSIPNFRK---DGNPFNTT 247
           +    +  +++ NN     I + L    N       GN F+  
Sbjct: 211 QSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 76.8 bits (189), Expect = 8e-15
 Identities = 34/159 (21%), Positives = 65/159 (40%), Gaps = 20/159 (12%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFS 123
            +     NV E+ L+G  L  + A  L     +  ++LS+N +  ++   +L  T+R   
Sbjct: 28  SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLS-TLRTLD 86

Query: 124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPP 183
           L+ N +       L     +  L   NN+++  +  +  +  G  N  L+ N +T  L  
Sbjct: 87  LNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKIT-MLRD 137

Query: 184 ST-RNLSSLYSLHLQNNKLS--------GTLNVLEDLHL 213
                 S +  L L+ N++          + + LE L+L
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 73.7 bits (181), Expect = 6e-14
 Identities = 27/134 (20%), Positives = 55/134 (41%), Gaps = 15/134 (11%)

Query: 87  LADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN---FSLSGNQLTGSIPESLSRLTQL 143
           + +   +        ++++ +     ++L  +  N     LSGN L+      L+  T+L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSL-KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 144 LDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS- 202
             L+L++N L     D     + L   DL+ N +  +L        S+ +LH  NN +S 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNISR 113

Query: 203 ---GTLNVLEDLHL 213
                    ++++L
Sbjct: 114 VSCSRGQGKKNIYL 127

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 73.7 bits (181), Expect = 7e-14
 Identities = 23/100 (23%), Positives = 41/100 (41%), Gaps = 4/100 (4%)

Query: 123 SLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP 182
            ++ + L  ++         + +L L+ N L+         FT L   +LS+N L     
Sbjct: 16  KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--T 73

Query: 183 PSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNL 222
               +LS+L +L L NN +   L V   +  +     NN+
Sbjct: 74  LDLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAA-NNNI 111

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 73.0 bits (179), Expect = 1e-13
 Identities = 33/182 (18%), Positives = 60/182 (32%), Gaps = 13/182 (7%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGV-LADTLGDLESVINIDLSNNHIGGSIPSNLPVT-VRNF 122
                 S V  + L    +  V  A+     +++ +++L  N I   +   +    ++  
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTL 196

Query: 123 SLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL-TGQL 181
            LS N+L   +         +  +SL NN L   I  A      L +FDL  N    G L
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTL 254

Query: 182 PPSTRNLSSLYSLHLQNNK-----LSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPN 236
                    + ++  Q  K           V    H      E+     P  ++L+++  
Sbjct: 255 RDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED--LPAPFADRLIALKR 312

Query: 237 FR 238
             
Sbjct: 313 KE 314

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 64.1 bits (156), Expect = 7e-11
 Identities = 21/95 (22%), Positives = 36/95 (37%), Gaps = 4/95 (4%)

Query: 132 SIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSS 190
           +I E      +     + ++ L   +         +   DLS N L+ Q+  +     + 
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTK 59

Query: 191 LYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFS 224
           L  L+L +N L      LE L  L  L++ NN   
Sbjct: 60  LELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 11/161 (6%), Positives = 37/161 (22%), Gaps = 11/161 (6%)

Query: 87  LADTLGDLESVINIDLSNNHI-GGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLD 145
           +   L   +++ + DL  N    G++        R  +++   +     ++    T    
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288

Query: 146 LSLNNNHLNGGIPDAFHQFTGLINFDLS----ANNLTGQLPPSTRNLSSLYSLHLQNNKL 201
                            +   L   + +      + T +L     N +    +     + 
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348

Query: 202 S----GTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFR 238
                      +    ++           +     +     
Sbjct: 349 RTVIDQVTLRKQAKITLEQK--KKALDEQVSNGRRAHAELD 387

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 13/166 (7%), Positives = 35/166 (21%), Gaps = 12/166 (7%)

Query: 70  FSNVTEIRLTGMN-LGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQ 128
           FS    ++      +  +      +                 +P+     +       + 
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHA 316

Query: 129 LT-------GSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
           L          +        +  ++          I     +    I  +     L  Q+
Sbjct: 317 LLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQV 376

Query: 182 PPSTRNLSSLYSL---HLQNNKLSGTLNVLEDLHLIDLNIENNLFS 224
               R  + L       +   +L         L L+   ++     
Sbjct: 377 SNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEM 422

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 82.3 bits (203), Expect = 2e-16
 Identities = 35/167 (20%), Positives = 67/167 (40%), Gaps = 8/167 (4%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL---PVTVRNFSLSG 126
            +N   +      +  + A  L     V  ++L++  I   I +       T++   +  
Sbjct: 50  LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGF 108

Query: 127 NQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST- 185
           N +    P     +  L  L L  N L+      FH    L    +S NNL  ++   T 
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 167

Query: 186 RNLSSLYSLHLQNNKLSG-TLNVLEDLHLIDLNIENNLFSGPIPEKL 231
           +  +SL +L L +N+L+   L+++  L   +++  N L +  IP  +
Sbjct: 168 QATTSLQNLQLSSNRLTHVDLSLIPSLFHANVS-YNLLSTLAIPIAV 213

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 81.9 bits (202), Expect = 3e-16
 Identities = 32/157 (20%), Positives = 62/157 (39%), Gaps = 13/157 (8%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS--NLPVTVRNFSLSGNQ 128
             V E+  +  ++  V      +L     + L +N++        N P  +    LS N+
Sbjct: 211 IAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLT-DTAWLLNYP-GLVEVDLSYNE 265

Query: 129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNL 188
           L   +     ++ +L  L ++NN L   +         L   DLS N+L   +  +    
Sbjct: 266 LEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 323

Query: 189 SSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENN 221
             L +L+L +N +      T + L++L L   + + N
Sbjct: 324 DRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCN 360

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 79.6 bits (196), Expect = 1e-15
 Identities = 38/162 (23%), Positives = 69/162 (42%), Gaps = 11/162 (6%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN--- 121
            +   F  V  + L  + +  +         ++  + +  N I   +P ++   V     
Sbjct: 69  ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTV 127

Query: 122 FSLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
             L  N L+ S+P  +     +L  LS++NN+L     D F   T L N  LS+N LT  
Sbjct: 128 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-H 185

Query: 181 LPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNL 222
           +  S   + SL+  ++  N LS TL +   +  +D +  N++
Sbjct: 186 VDLS--LIPSLFHANVSYNLLS-TLAIPIAVEELDAS-HNSI 223

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 73.0 bits (179), Expect = 1e-13
 Identities = 36/174 (20%), Positives = 61/174 (35%), Gaps = 16/174 (9%)

Query: 68  CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN---FSL 124
           CVF +V     T     G    TL + +    +   N+ +   +P+ L  + R     +L
Sbjct: 27  CVFYDVHIDMQTQDVYFGFEDITLNNQKI---VTFKNSTM-RKLPAALLDSFRQVELLNL 82

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS 184
           +  Q+      + +    +  L +  N +    P  F     L    L  N+L+  LP  
Sbjct: 83  NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRG 141

Query: 185 T-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENNLFSGPIPEKLLS 233
              N   L +L + NN L      T      L  + L+  N L    +   L+ 
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS-SNRLTH--VDLSLIP 192

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 71.5 bits (175), Expect = 4e-13
 Identities = 25/163 (15%), Positives = 57/163 (34%), Gaps = 16/163 (9%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN--- 121
             F     + ++ +    +  +      ++  +  + L  N +  S+P  +         
Sbjct: 93  YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTT 151

Query: 122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
            S+S N L     ++    T L +L L++N L   +         L + ++S N L+   
Sbjct: 152 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS--- 205

Query: 182 PPSTRNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIEN 220
             +     ++  L   +N ++         L  L L   N+ +
Sbjct: 206 --TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD 246

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 14/129 (10%), Positives = 38/129 (29%), Gaps = 14/129 (10%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLS--RLTQLLDLSLNNNHLNGGIPDAFHQFTGL 167
            I SNL      + +  +  T  +        L     ++  N+ +          F  +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 168 INFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLN----- 217
              +L+   +  ++         ++  L++  N +          +  L ++ L      
Sbjct: 78  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136

Query: 218 -IENNLFSG 225
            +   +F  
Sbjct: 137 SLPRGIFHN 145

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 57.6 bits (139), Expect = 9e-09
 Identities = 23/142 (16%), Positives = 50/142 (35%), Gaps = 16/142 (11%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFS- 123
                +  + E+ L+   L  ++      ++ +  + +SNN +       L +  +    
Sbjct: 248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-----VALNLYGQPIPT 302

Query: 124 -----LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT 178
                LS N L   +  +  +  +L +L L++N +   +         L N  LS N+  
Sbjct: 303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358

Query: 179 G-QLPPSTRNLSSLYSLHLQNN 199
              L    RN++         +
Sbjct: 359 CNSLRALFRNVARPAVDDADQH 380

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 33/146 (22%), Positives = 63/146 (43%), Gaps = 14/146 (9%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLI 168
            IP ++P       L+ N+ T      +  +L QL  ++ +NN +      AF   +G+ 
Sbjct: 25  KIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN 84

Query: 169 NFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENNLF 223
              L++N L   +     + L SL +L L++N+++     +   L  + L+ L  +N + 
Sbjct: 85  EILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLY-DNQIT 142

Query: 224 SGPIPE----KLLSIPNFRKDGNPFN 245
           +  +       L S+       NPFN
Sbjct: 143 T--VAPGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 30/139 (21%), Positives = 51/139 (36%), Gaps = 17/139 (12%)

Query: 71  SNVTEIRLTGMNLGGVLAD-TLGDLESVINIDLSNNHIGGSIPSNLPVTV-------RNF 122
               E+RL       + A      L  +  I+ SNN I     +++              
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-----TDIEEGAFEGASGVNEI 86

Query: 123 SLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQL 181
            L+ N+L  ++   +   L  L  L L +N +     D+F   + +    L  N +T  +
Sbjct: 87  LLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TV 144

Query: 182 PPST-RNLSSLYSLHLQNN 199
            P     L SL +L+L  N
Sbjct: 145 APGAFDTLHSLSTLNLLAN 163

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 80.2 bits (198), Expect = 3e-16
 Identities = 47/301 (15%), Positives = 101/301 (33%), Gaps = 49/301 (16%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI--------------- 492
           + +G    +   E    K  A+KK   ++ +++ D                         
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 493 SRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           + +++   +   G    + +  ++Y+Y  N ++           K ++  I I+V     
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 553 R----ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
           +    +  Y+    E  I H + K SNIL+D+   V++SD G +          + +  +
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGES--------EYMVDKKI 207

Query: 609 -TAHGS---GAPEFESGS---YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL---- 657
             + G+     PEF S        + D++SLG+ +  +     P+       + SL    
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVELF 262

Query: 658 --VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQ 714
             +R                  +         LS    D +   ++  P  R    + ++
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322

Query: 715 D 715
            
Sbjct: 323 H 323

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 55/288 (19%), Positives = 104/288 (36%), Gaps = 38/288 (13%)

Query: 413 TRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKK 471
            R +      + ++  +F  +     +  +     +G G  G V    +       A+K 
Sbjct: 10  GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69

Query: 472 LS-NTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDL 528
           +   +VS     +   E+A  +  L H NI++L  +  +   + LV +   GG   L D 
Sbjct: 70  IRKTSVSTSSNSKLLEEVA-VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE--LFDE 126

Query: 529 LHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVR 585
           +        KF+      +       + YL +     IVH + K  N+LL   ++  +++
Sbjct: 127 I----IHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIK 179

Query: 586 VSDCGLAPLLFSGSTNELSEGLLTAHGSG---APEFESGSYSCQSDVYSLGVVMLELLTG 642
           + D GL+ +  +         +    G+    APE     Y  + DV+S+GV++  LL G
Sbjct: 180 IVDFGLSAVFENQKK------MKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAG 233

Query: 643 RKPYDRSRPRGEQSLVRWAIPRLHD----------IDALSRM--VDPS 678
             P+     +     V                    D + +M   D  
Sbjct: 234 YPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQ 281

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 81.3 bits (200), Expect = 4e-16
 Identities = 64/299 (21%), Positives = 109/299 (36%), Gaps = 53/299 (17%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELI-- 504
           +G G  G V +      G+ +A+K+    +S +  +   LE+   + +L H N+V     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEI-QIMKKLNHPNVVSAREV 80

Query: 505 ----GYCNEHGQHLLVYDY--GGNCTLHDLLHS-------DEEAHKKFSWNIRIRVALGA 551
                    +   LL  +Y  GG+  L   L+         E   +    +I        
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGD--LRKYLNQFENCCGLKEGPIRTLLSDI-------- 130

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEG-- 606
           + AL+YL E     I+H + K  NI+L    ++LI ++ D G A         EL +G  
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYA--------KELDQGEL 179

Query: 607 LLTAHGS---GAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPY-DRSRPRGEQSLVR-- 659
                G+    APE  E   Y+   D +S G +  E +TG +P+    +P      VR  
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239

Query: 660 --WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
               I    D+    +         +L+  L+      +   + W    R    +    
Sbjct: 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 79.8 bits (197), Expect = 5e-16
 Identities = 63/317 (19%), Positives = 114/317 (35%), Gaps = 70/317 (22%)

Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELAST-ISR 494
           Q   N       +G G  G+V       G+ +AVK++           +F ++A   I  
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---------LIDFCDIALMEIKL 61

Query: 495 LR----HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALG 550
           L     H N++             +  +      L DL+    E+      N++++    
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLV----ESKNVSDENLKLQKEYN 116

Query: 551 AAR-------ALQYLQEVCEPPIVHGNFKSSNILLDEK-------------LIVRVSDCG 590
                      + +L  +    I+H + K  NIL+                L + +SD G
Sbjct: 117 PISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173

Query: 591 LAPLLFSGSTNELSEGLLTAHGSG---APEFESGS--------YSCQSDVYSLGVVMLEL 639
           L   L SG ++  +  L    G+    APE    S         +   D++S+G V   +
Sbjct: 174 LCKKLDSGQSSFRTN-LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

Query: 640 LT-GRKPYDRSRPRGEQSLVRWAIPR-LHDIDALSRMVDPSLDGAYLAKSLSRFADIISR 697
           L+ G+ P+     R         I R +  +D +  + D SL     A       D+IS+
Sbjct: 233 LSKGKHPFGDKYSRESN------IIRGIFSLDEMKCLHDRSL--IAEAT------DLISQ 278

Query: 698 CVQWEPGFRPPMSEIVQ 714
            +  +P  RP   ++++
Sbjct: 279 MIDHDPLKRPTAMKVLR 295

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 80.0 bits (198), Expect = 7e-16
 Identities = 27/145 (18%), Positives = 56/145 (38%), Gaps = 8/145 (5%)

Query: 90  TLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
           T   L   +   L   ++  ++       V         +     + +  L  L  ++ +
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFS 76

Query: 150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLE 209
           NN L    P      T L++  ++ N +         NL++L  L L NN+++  ++ L+
Sbjct: 77  NNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD-IDPLK 131

Query: 210 DL-HLIDLNIENNLFSGPIPEKLLS 233
           +L +L  L + +N  S       L+
Sbjct: 132 NLTNLNRLELSSNTISDISALSGLT 156

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 40/142 (28%), Positives = 63/142 (44%), Gaps = 10/142 (7%)

Query: 89  DTLGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLS 147
             L  L ++ ++  +NN I    P   L   +   SL+GNQL      +L+ LT L DL 
Sbjct: 193 SVLAKLTNLESLIATNNQISDITPLGILT-NLDELSLNGNQLKD--IGTLASLTNLTDLD 249

Query: 148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV 207
           L NN ++   P      T L    L AN ++         L++L +L L  N+L   ++ 
Sbjct: 250 LANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED-ISP 304

Query: 208 LEDL-HLIDLNIENNLFSGPIP 228
           + +L +L  L +  N  S   P
Sbjct: 305 ISNLKNLTYLTLYFNNISDISP 326

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 35/139 (25%), Positives = 57/139 (41%), Gaps = 9/139 (6%)

Query: 91  LGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN 150
           L +L ++  + L NN I    P      +    LS N ++     +LS LT L  LS  N
Sbjct: 108 LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGN 165

Query: 151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLED 210
              +          T L   D+S+N ++         L++L SL   NN++S  +  L  
Sbjct: 166 QVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGI 219

Query: 211 L-HLIDLNIENNLFSGPIP 228
           L +L +L++  N       
Sbjct: 220 LTNLDELSLNGNQLKDIGT 238

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 76.9 bits (190), Expect = 6e-15
 Identities = 30/165 (18%), Positives = 65/165 (39%), Gaps = 11/165 (6%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQL 129
            + +TE++L    +  +    L  L ++ N++L+ N +    P +    +   +L  N +
Sbjct: 264 LTKLTELKLGANQISNI--SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 321

Query: 130 TGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLS 189
           +   P  +S LT+L  L   NN ++     +    T +       N ++        NL+
Sbjct: 322 SDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLT 375

Query: 190 SLYSLHLQNNKLSG-TLNVLEDLHLIDLNIENNLFSGPIPEKLLS 233
            +  L L +   +   +N   ++ +   N   N+    I    +S
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVSI--PNTVKNVTGALIAPATIS 418

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 74.2 bits (183), Expect = 5e-14
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 13/161 (8%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQ 128
            +N+T + L    +  +  D L +L ++  ++LS+N I      S L  +++  S   NQ
Sbjct: 111 LTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDISALSGLT-SLQQLSFG-NQ 166

Query: 129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNL 188
           +T   P  L+ LT L  L +++N ++        + T L +   + N ++   P     L
Sbjct: 167 VTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLG--IL 220

Query: 189 SSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSGPIP 228
           ++L  L L  N+L   +  L  L +L DL++ NN  S   P
Sbjct: 221 TNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP 260

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 73.8 bits (182), Expect = 6e-14
 Identities = 32/182 (17%), Positives = 67/182 (36%), Gaps = 10/182 (5%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQL 129
           + +T + L    L  +    + +L+++  + L  N+I    P S+L   ++      N++
Sbjct: 287 TALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISPVSSLT-KLQRLFFYNNKV 343

Query: 130 TGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLS 189
           +     SL+ LT +  LS  +N ++   P      T +    L+    T        N+S
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399

Query: 190 SLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNL--FSGPIPEKLLSIPNFRKDGNPFNTT 247
              ++      L     + +     + +I  NL  ++  +           K    F+ T
Sbjct: 400 IPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGT 459

Query: 248 VI 249
           V 
Sbjct: 460 VT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 69.2 bits (170), Expect = 2e-12
 Identities = 25/131 (19%), Positives = 46/131 (35%), Gaps = 8/131 (6%)

Query: 99  NIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIP 158
                +  I                L    +T ++    + L Q+  L  +   +     
Sbjct: 6   ATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SI 61

Query: 159 DAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLN 217
           D       L   + S N LT  + P   NL+ L  + + NN+++  +  L +L +L  L 
Sbjct: 62  DGVEYLNNLTQINFSNNQLTD-ITPLK-NLTKLVDILMNNNQIAD-ITPLANLTNLTGLT 118

Query: 218 IENNLFSGPIP 228
           + NN  +   P
Sbjct: 119 LFNNQITDIDP 129

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 58.1 bits (141), Expect = 6e-09
 Identities = 15/112 (13%), Positives = 43/112 (38%), Gaps = 7/112 (6%)

Query: 118 TVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL 177
            + + +++ +     I  + + L + +   L   ++   +         +         +
Sbjct: 2   PLGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58

Query: 178 TGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSGPIP 228
                     L++L  ++  NN+L+  +  L++L  L+D+ + NN  +   P
Sbjct: 59  KS--IDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP 107

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 78.6 bits (194), Expect = 7e-16
 Identities = 40/138 (28%), Positives = 59/138 (42%), Gaps = 15/138 (10%)

Query: 101 DLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDA 160
             S+  +  SIPS L   V++  LS N++T      L R   L  L L +N +N    D+
Sbjct: 37  KGSSGSLN-SIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS 95

Query: 161 FHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS-----GTLNVLEDLHLI 214
           F     L + DLS N L+  L  S  + LSSL  L+L  N           + L  L ++
Sbjct: 96  FSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154

Query: 215 DL-------NIENNLFSG 225
            +        I+   F+G
Sbjct: 155 RVGNMDTFTKIQRKDFAG 172

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 29/194 (14%), Positives = 70/194 (36%), Gaps = 20/194 (10%)

Query: 69  VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN---FSLS 125
           +   V  + L+   +  +    L    ++  + L++N I  +I  +   ++ +     LS
Sbjct: 50  LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLS 108

Query: 126 GNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPD--AFHQFTGLINFDLSANNLTGQLP 182
            N L+ ++  S    L+ L  L+L  N     + +   F   T L    +   +   ++ 
Sbjct: 109 YNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQ 166

Query: 183 PST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLN------IENNLFSGPIPEKL 231
                 L+ L  L +  + L      +L  ++++  + L+      +           + 
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226

Query: 232 LSIPNFRKDGNPFN 245
           L + +   D   F+
Sbjct: 227 LELRDTDLDTFHFS 240

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 37/176 (21%), Positives = 73/176 (41%), Gaps = 19/176 (10%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS----NLPVTV 119
                   N+  + LT   +  +  D+   L S+ ++DLS N++  ++ S     L  ++
Sbjct: 69  NSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLS-SL 126

Query: 120 RNFSLSGNQLTGSIPES--LSRLTQLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLSANN 176
              +L GN    ++ E+   S LT+L  L + N      I    F   T L   ++ A++
Sbjct: 127 TFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185

Query: 177 LTGQLPPST-RNLSSLYSLHLQNNKLS-------GTLNVLEDLHLIDLNIENNLFS 224
           L     P + +++ ++  L L   +            + +E L L D +++   FS
Sbjct: 186 LQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS 240

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 27/179 (15%), Positives = 56/179 (31%), Gaps = 19/179 (10%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHI----GGSIPSNLPVTVR 120
             F    ++  + L+   L  + +     L S+  ++L  N        S+ S+L     
Sbjct: 94  DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQI 153

Query: 121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
               + +  T    +  + LT L +L ++ + L    P +      + +  L        
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-L 212

Query: 181 LPPST-RNLSSLYSLHLQNNKLSG------------TLNVLEDLHLIDLNIENNLFSGP 226
           L        SS+  L L++  L              +L        + +    +LF   
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD-ESLFQVM 270

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 23/147 (15%), Positives = 49/147 (33%), Gaps = 21/147 (14%)

Query: 88  ADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVRNFSLSGNQLTGSIPE-SLSRLTQ 142
                 L  +  +++  + +  S       ++   V +  L   Q    + E  +   + 
Sbjct: 167 RKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQ-NVSHLILHMKQHI-LLLEIFVDVTSS 223

Query: 143 LLDLSLNNNHLNG--------GIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSL 194
           +  L L +  L+         G  ++  +     N  ++  +L  Q+      +S L  L
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLEL 282

Query: 195 HLQNNKLS----GTLNVLEDLHLIDLN 217
               N+L     G  + L  L  I L+
Sbjct: 283 EFSRNQLKSVPDGIFDRLTSLQKIWLH 309

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 24/149 (16%), Positives = 51/149 (34%), Gaps = 15/149 (10%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP---VTVRN 121
             F   + + E+ +   +L      +L  +++V ++ L        +         +V  
Sbjct: 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVEC 226

Query: 122 FSLSGNQLTG----SIPE----SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLS 173
             L    L       +      SL +     ++ + +  L   +    +Q +GL+  + S
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFS 285

Query: 174 ANNLTGQLPPST-RNLSSLYSLHLQNNKL 201
            N L   +P      L+SL  + L  N  
Sbjct: 286 RNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 57.1 bits (138), Expect = 7e-09
 Identities = 25/125 (20%), Positives = 45/125 (36%), Gaps = 13/125 (10%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTV----- 119
                  NV+ + L       +L   +    SV  ++L +  +     S L         
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251

Query: 120 -----RNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLS 173
                RN  ++   L   + + L++++ LL+L  + N L   +PD  F + T L    L 
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLH 309

Query: 174 ANNLT 178
            N   
Sbjct: 310 TNPWD 314

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 77.3 bits (191), Expect = 8e-16
 Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 20/212 (9%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGN 499
           F  G  +G+G  G+VY A E     +LA+K L    + +   + +        S LRH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L    +   KF            A AL Y  
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH 126

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS---GAP 616
                 ++H + K  N+LL     ++++D G        S +  S       G+     P
Sbjct: 127 SKR---VIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTDLCGTLDYLPP 176

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
           E  E   +  + D++SLGV+  E L G+ P++
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 37/265 (13%), Positives = 73/265 (27%), Gaps = 54/265 (20%)

Query: 448 IGEGLLGSVYKAE---LPGGKLLAVKKL-SNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
            G       ++A    L   + +A+  +    V      +E L     +SR+    +  +
Sbjct: 39  HGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           +   +     L+V ++    +L ++  +             IR     A A         
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG------AIRAMQSLAAAADAAHRA-- 148

Query: 564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSY 623
             +       S +         VS  G                +L    +          
Sbjct: 149 -GVALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA------ 179

Query: 624 SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAY 683
           + Q D+  +G  +  LL  R P   +  R   S +  A             +D  +    
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVR---SGLAPAERDTAGQPIEPADIDRDIPFQ- 235

Query: 684 LAKSLSRFADIISRCVQWEPGFRPP 708
                   + + +R VQ + G R  
Sbjct: 236 -------ISAVAARSVQGDGGIRSA 253

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 77.3 bits (191), Expect = 9e-16
 Identities = 31/125 (24%), Positives = 48/125 (38%), Gaps = 7/125 (5%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN 169
            IP NLP + +N  LS N L      S     +L  L L+   +      A+   + L  
Sbjct: 21  KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80

Query: 170 FDLSANNLTGQLPPST-RNLSSLYSLHLQNNKL----SGTLNVLEDLHLIDLNIENNLFS 224
             L+ N +   L       LSSL  L      L    +  +  L+ L  +++   N + S
Sbjct: 81  LILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA-HNLIQS 138

Query: 225 GPIPE 229
             +PE
Sbjct: 139 FKLPE 143

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 34/170 (20%), Positives = 64/170 (37%), Gaps = 18/170 (10%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL---PVTVRN 121
           G +   S+++ + LTG  +  +       L S+  +     ++  S+ +       T++ 
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKE 128

Query: 122 FSLSGNQLTGSIPES--LSRLTQLLDLSLNNNHLNGGIPDAFHQFTGL----INFDLSAN 175
            +++ N +  S       S LT L  L L++N +             +    ++ DLS N
Sbjct: 129 LNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187

Query: 176 NLTGQLPPSTRNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENN 221
            +   + P       L  L L  N+L     G  + L  L  I L+   N
Sbjct: 188 PMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLH--TN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 28/136 (20%), Positives = 46/136 (33%), Gaps = 21/136 (15%)

Query: 101 DLSNNHIGGSIPSNLPVTV-------RNFSLSGNQLTGSIPESL-SRLTQLLDLSLNNNH 152
           DLS   I       +               L+GN +  S+     S L+ L  L     +
Sbjct: 58  DLSRCEI-----QTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETN 111

Query: 153 LNGGIPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNV 207
           L             L   +++ N +     P    NL++L  L L +NK+       L V
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171

Query: 208 LEDL--HLIDLNIENN 221
           L  +    + L++  N
Sbjct: 172 LHQMPLLNLSLDLSLN 187

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 56/296 (18%), Positives = 119/296 (40%), Gaps = 49/296 (16%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIG 505
           + EG    VY+A+ +  G+  A+K+L    ++ + +   ++    + +L  H NIV+   
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 506 YC--------NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
                         + LL+ +      L + L    E+    S +  +++     RA+Q+
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKG-QLVEFLKK-MESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-------PLLFSGSTNELSEGLLTA 610
           +    +PPI+H + K  N+LL  +  +++ D G A          +S     L E  +T 
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 611 HGS---GAPE-FESGS---YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP 663
           + +     PE  +  S      + D+++LG ++  L   + P++        +  +++IP
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN-GKYSIP 269

Query: 664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM 719
                              +  +  + F  +I   +Q  P  R  ++E+V  L  +
Sbjct: 270 ------------------PHDTQY-TVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 47/278 (16%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG+G  G+VY A ++  G+ +A+++++  + Q+   E  +     +   ++ NIV  +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD- 84

Query: 507 CNEHGQHL-LVYDY--GGNCTLHDLLHSD--EEAHKKFSWNIRIRVALGAARALQYLQEV 561
               G  L +V +Y  GG+ T  D++     +E        I   V     +AL++L   
Sbjct: 85  SYLVGDELWVVMEYLAGGSLT--DVVTETCMDEGQ------IAA-VCRECLQALEFLHSN 135

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APEF 618
               ++H + KS NILL     V+++D G     F            T  G+    APE 
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFG-----FCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 619 -ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAIPRLHDIDALSRMVD 676
               +Y  + D++SLG++ +E++ G  PY    P R    +     P L + + LS    
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA--- 244

Query: 677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                         F D ++RC++ +   R    E++Q
Sbjct: 245 -------------IFRDFLNRCLEMDVEKRGSAKELLQ 269

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 66/310 (21%), Positives = 123/310 (39%), Gaps = 41/310 (13%)

Query: 417 SPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLS-N 474
               + + ++  +F   S   +++ +     +G+G  G V    +   G+  AVK +S  
Sbjct: 3   GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62

Query: 475 TVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSD 532
            V Q+   E  L     + +L H NI++L  +  + G   LV +   GG   L D +   
Sbjct: 63  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE--LFDEI--- 117

Query: 533 EEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDC 589
             + K+FS     R+       + Y+ +     IVH + K  N+LL    +   +R+ D 
Sbjct: 118 -ISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDF 173

Query: 590 GLAPLLFSGSTNELSEGLLTAHGSG---APEFESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           GL+    +       + +    G+    APE   G+Y  + DV+S GV++  LL+G  P+
Sbjct: 174 GLSTHFEAS------KKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPF 227

Query: 647 DRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFA-DIISRCVQWEPGF 705
           + +        V                   + +     K +S  A D+I + + + P  
Sbjct: 228 NGANEYDILKKVEKG--------------KYTFELPQW-KKVSESAKDLIRKMLTYVPSM 272

Query: 706 RPPMSEIVQD 715
           R    + +  
Sbjct: 273 RISARDALDH 282

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 56/257 (21%), Positives = 95/257 (36%), Gaps = 35/257 (13%)

Query: 409 PAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLL 467
               + R +     I+ +  ++      +   S+ +   +G G  G V    E  G    
Sbjct: 5   HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64

Query: 468 AVKKLS--------NTVSQRQTDEEFLELASTIS---RLRHGNIVELIGYCNEHGQHLLV 516
           A+K +          +   +  ++   E+ + IS    L H NI++L     +     LV
Sbjct: 65  AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLV 124

Query: 517 YDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSS 574
            ++  GG   L + +        KF       +       + YL +     IVH + K  
Sbjct: 125 TEFYEGGE--LFEQI----INRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPE 175

Query: 575 NILL---DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APEFESGSYSCQSD 628
           NILL   +  L +++ D GL+              L    G+    APE     Y+ + D
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDYK------LRDRLGTAYYIAPEVLKKKYNEKCD 229

Query: 629 VYSLGVVMLELLTGRKP 645
           V+S GV+M  LL G  P
Sbjct: 230 VWSCGVIMYILLCGYPP 246

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 66/287 (22%), Positives = 121/287 (42%), Gaps = 66/287 (22%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG+G  G V+K  +    K++A+K +    ++ + ++   E+ + +S+     + +  G 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYG- 87

Query: 507 CNEHGQHL-LVYDY--GGNCTLHDLLHSD--EEAHKKFSWNIRIRVALGAARALQYLQEV 561
                  L ++ +Y  GG+    DLL     +E        I   +     + L YL   
Sbjct: 88  SYLKDTKLWIIMEYLGGGSAL--DLLEPGPLDETQ------IAT-ILREILKGLDYLHSE 138

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS------G- 614
                +H + K++N+LL E   V+++D G+A             G LT          G 
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVA-------------GQLTDTQIKRNTFVGT 182

Query: 615 ----APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAIPRLHDI 668
               APE  +  +Y  ++D++SLG+  +EL  G  P+    P +     V + IP     
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLFLIP----- 232

Query: 669 DALSRMVDPSLDGAYLAKSLSR-FADIISRCVQWEPGFRPPMSEIVQ 714
               +   P+L+G Y     S+   + +  C+  EP FRP   E+++
Sbjct: 233 ----KNNPPTLEGNY-----SKPLKEFVEACLNKEPSFRPTAKELLK 270

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 65/262 (24%), Positives = 109/262 (41%), Gaps = 46/262 (17%)

Query: 445 GNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEE---FLELASTISRLRHGNI 500
           G+ +GEG  G V +          AVK L     +R  + E     E+   + RLRH N+
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEI-QLLRRLRHKNV 68

Query: 501 VELIG-YCNEHGQHL-LVYDY--GGNCTLHDLLH----SDEEAHKKFSWNIRIRVALGAA 552
           ++L+    NE  Q + +V +Y   G   + D +        +AH  F   I         
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-------- 120

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             L+YL       IVH + K  N+LL     +++S  G+A  L   + ++      T+ G
Sbjct: 121 -GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT---CRTSQG 173

Query: 613 S---GAPEFESGS--YS-CQSDVYSLGVVMLELLTGRKPYD--------RSRPRGEQSLV 658
           S     PE  +G   +S  + D++S GV +  + TG  P++         +  +G  ++ 
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP 233

Query: 659 RWAIPRLHDIDALSRM--VDPS 678
               P L D+  L  M   +P+
Sbjct: 234 GDCGPPLSDL--LKGMLEYEPA 253

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 53/322 (16%), Positives = 108/322 (33%), Gaps = 63/322 (19%)

Query: 432 IASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELAS 490
           + S     + +   + +G+G   +V++      G L A+K  +N    R  D +  E   
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE- 59

Query: 491 TISRLRHGNIVELIG-YCNEHGQHL-LVYDY--GGNCTLHDLLHS-------DEEAHKKF 539
            + +L H NIV+L         +H  L+ ++   G+  L+ +L          E      
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS--LYTVLEEPSNAYGLPESEFLIV 117

Query: 540 SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCGLAPLL 595
             ++           + +L+E     IVH N K  NI+     D + + +++D G A   
Sbjct: 118 LRDV--------VGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA--- 163

Query: 596 FSGSTNELSEG--LLTAHGS---GAPE---------FESGSYSCQSDVYSLGVVMLELLT 641
                 EL +    ++ +G+     P+              Y    D++S+GV      T
Sbjct: 164 -----RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

Query: 642 GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADI------- 694
           G  P+           V + I       A+S +          +  +     +       
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL 278

Query: 695 ----ISRCVQWEPGFRPPMSEI 712
               ++  ++ +        + 
Sbjct: 279 LTPVLANILEADQEKCWGFDQF 300

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 71/328 (21%), Positives = 120/328 (36%), Gaps = 76/328 (23%)

Query: 419 STNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVS 477
           +++  + S+    +++L+     F     +G G  G VYK   +  G+L A+K +     
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV--- 59

Query: 478 QRQTDEEFLELASTISRLR----HGNIVELIG-----YCNEHGQHL-LVYDY--GGNCTL 525
              T +E  E+   I+ L+    H NI    G             L LV ++   G+ T 
Sbjct: 60  ---TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT- 115

Query: 526 HDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR 585
            DL+ + +    K  W I   +     R L +L +     ++H + K  N+LL E   V+
Sbjct: 116 -DLIKNTKGNTLKEEW-IAY-ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169

Query: 586 VSDCGLAPLLFSGSTNELSEGLLTAHGS------G-----APE------FESGSYSCQSD 628
           + D G++               L           G     APE          +Y  +SD
Sbjct: 170 LVDFGVS-------------AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSD 216

Query: 629 VYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKS 687
           ++SLG+  +E+  G  P     P R    + R   PRL                    K 
Sbjct: 217 LWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS------------------KK 258

Query: 688 LSR-FADIISRCVQWEPGFRPPMSEIVQ 714
            S+ F   I  C+      RP   ++++
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPATEQLMK 286

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 77.9 bits (192), Expect = 5e-15
 Identities = 42/192 (21%), Positives = 70/192 (36%), Gaps = 17/192 (8%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIG----GSIPSNLPVTVRNF 122
                ++ +I L+G  L  +    L    +   I LS N +           +P  ++  
Sbjct: 377 IHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVP-HLQIL 431

Query: 123 SLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGI-----PDAFHQFTGLINFDLSANN 176
            L+ N+ +    +   S    L  L L  N L          D F   + L    L+ N 
Sbjct: 432 ILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491

Query: 177 LTGQLPPST-RNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIP 235
           L   LPP    +L++L  L L +N+L+   +     +L  L+I  N    P P+  +S+ 
Sbjct: 492 LN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLS 550

Query: 236 NFRKDGNPFNTT 247
                 N F   
Sbjct: 551 VLDITHNKFICE 562

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 76.4 bits (188), Expect = 2e-14
 Identities = 43/219 (19%), Positives = 85/219 (38%), Gaps = 13/219 (5%)

Query: 34  MALNSLYISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGD 93
           M L  L +S N   ++   +F              +  ++        N+     +T   
Sbjct: 204 MVLEILDVSGNGWTVDITGNFSNAISKSQAF-SLILAHHIMGAGFGFHNIKDPDQNTFAG 262

Query: 94  LE--SVINIDLSNNHIGGSIP----SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLS 147
           L   SV ++DLS+  +  S+       L   ++  +L+ N++     E+   L  L  L+
Sbjct: 263 LARSSVRHLDLSHGFVF-SLNSRVFETLK-DLKVLNLAYNKINKIADEAFYGLDNLQVLN 320

Query: 148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV 207
           L+ N L       F+    +   DL  N++      + + L  L +L L++N L+ T++ 
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHF 379

Query: 208 LEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNT 246
           +  +  I L+  N L +  +P+  L+        N    
Sbjct: 380 IPSIPDIFLS-GNKLVT--LPKINLTANLIHLSENRLEN 415

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 72.1 bits (177), Expect = 3e-13
 Identities = 33/144 (22%), Positives = 52/144 (36%), Gaps = 16/144 (11%)

Query: 93  DLESVINIDLSNNHIGGSIP----SNLPVTVRNFSLSGNQLTGSI-PESLSRLTQLLDLS 147
            L +   + LS N+I  ++       L   ++   L       +I  E+   L  L  L 
Sbjct: 22  VLNTTERLLLSFNYIR-TVTASSFPFLE-QLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79

Query: 148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLT-GQLPPST-RNLSSLYSLHLQNNKLS--- 202
           L ++ +    PDAF     L    L    L+   L     RNL +L  L L  N++    
Sbjct: 80  LGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139

Query: 203 --GTLNVLEDLHLIDLNIENNLFS 224
              +   L  L  ID +  +N   
Sbjct: 140 LHPSFGKLNSLKSIDFS--SNQIF 161

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 66.8 bits (163), Expect = 2e-11
 Identities = 31/190 (16%), Positives = 61/190 (32%), Gaps = 15/190 (7%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHI-----GGSIPSNLPVTV 119
             F    N+  + L    +  +  D    L  +  + L    +           NL   +
Sbjct: 67  EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK-AL 125

Query: 120 RNFSLSGNQLTG-SIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTG--LINFDLSANN 176
               LS NQ+    +  S  +L  L  +  ++N +            G  L  F L+AN+
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS 185

Query: 177 LTGQLPPSTRN-LSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIP 235
           L  ++       ++   ++ L+   +SG         +      +N  S      L+   
Sbjct: 186 LYSRVSVDWGKCMNPFRNMVLEILDVSGNG-----WTVDITGNFSNAISKSQAFSLILAH 240

Query: 236 NFRKDGNPFN 245
           +    G  F+
Sbjct: 241 HIMGAGFGFH 250

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 28/147 (19%), Positives = 54/147 (36%), Gaps = 7/147 (4%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSL 124
            VF   S++  + L    L  +       L ++  + L++N +     ++LP  +    +
Sbjct: 474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDI 533

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIP-DAFHQFTGLINFDLS--ANNLTGQL 181
           S NQL    P+    L+ L    + +N          F  +    N  ++    ++    
Sbjct: 534 SRNQLLAPNPDVFVSLSVLD---ITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVY 590

Query: 182 PPSTRNLSSLYSLHLQNNKLSGTLNVL 208
           P S   + SL+SL  +       L  L
Sbjct: 591 PDSFSGV-SLFSLSTEGCDEEEVLKSL 616

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 47/278 (16%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IGEG  G V  A E   G+ +AVK + +   Q++ +  F E+   +   +H N+VE+   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEV-VIMRDYQHFNVVEMYK- 109

Query: 507 CNEHGQHL-LVYDY--GGNCTLHDLLHSD--EEAHKKFSWNIRIRVALGAARALQYLQEV 561
               G+ L ++ ++  GG  T  D++      E        I   V     +AL YL   
Sbjct: 110 SYLVGEELWVLMEFLQGGALT--DIVSQVRLNEEQ------IAT-VCEAVLQALAYLHA- 159

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APEF 618
               ++H + KS +ILL     V++SD G     F    ++      +  G+    APE 
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFG-----FCAQISKDVPKRKSLVGTPYWMAPEV 212

Query: 619 ESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAIPRLHDIDALSRMVD 676
            S S Y+ + D++SLG++++E++ G  PY    P +  + L     P+L +   +S    
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSP--- 269

Query: 677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
                           D + R +  +P  R    E++ 
Sbjct: 270 -------------VLRDFLERMLVRDPQERATAQELLD 294

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 35/151 (23%), Positives = 59/151 (39%), Gaps = 19/151 (12%)

Query: 88  ADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLS 147
              +     V   +    ++  ++P +LP       LS N L      +L   T+L  L+
Sbjct: 6   VSKVASHLEV---NCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL-- 205
           L+   L   +         L   DLS N L   LP   + L +L  L +  N+L+ +L  
Sbjct: 62  LDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL 117

Query: 206 NVLEDL-HLIDLNIENNLFSGPIPEKLLSIP 235
             L  L  L +L ++ N        +L ++P
Sbjct: 118 GALRGLGELQELYLKGN--------ELKTLP 140

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 44/164 (26%), Positives = 66/164 (40%), Gaps = 14/164 (8%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLA-DTLGDLESVINIDLSNNHIGGSIPS---NLPVTVR 120
                ++ +T++ L    L  +    TL  L ++   DLS+N +  S+P     LP    
Sbjct: 49  ATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL---DLSHNQLQ-SLPLLGQTLPAL-T 103

Query: 121 NFSLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG 179
              +S N+LT S+P      L +L +L L  N L    P        L    L+ NNLT 
Sbjct: 104 VLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT- 161

Query: 180 QLPPST-RNLSSLYSLHLQNNKL-SGTLNVLEDLHLIDLNIENN 221
           +LP      L +L +L LQ N L +          L    +  N
Sbjct: 162 ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 25/157 (15%), Positives = 55/157 (35%), Gaps = 14/157 (8%)

Query: 87  LADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRN------FSLSGNQLTGSIPESLSRL 140
            +     L ++ ++ L    I      +LP ++ N        +  + L+ ++  ++  L
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGI-----RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL 228

Query: 141 TQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNK 200
            +L +L L         P  F     L    L   +    LP     L+ L  L L+   
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288

Query: 201 LSGTL-NVLEDL-HLIDLNIENNLFSGPIPEKLLSIP 235
               L +++  L     + +  +L +     + ++ P
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 69.6 bits (171), Expect = 6e-13
 Identities = 27/150 (18%), Positives = 49/150 (32%), Gaps = 30/150 (20%)

Query: 87  LADTLGDL--ESVINIDLSNNHIGGSIPSNLPVTVRNFS------LSGNQLTGSIPESLS 138
            AD L D      + ++L +  +        P      S      +    L   +P+++ 
Sbjct: 71  TADLLEDATQPGRVALELRSVPL-----PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ 124

Query: 139 RLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS---------TRNLS 189
           +   L  L+L  N L   +P +      L    + A     +LP            + L 
Sbjct: 125 QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV 183

Query: 190 SLYSLHLQNNKLS------GTLNVLEDLHL 213
           +L SL L+   +         L  L+ L +
Sbjct: 184 NLQSLRLEWTGIRSLPASIANLQNLKSLKI 213

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 47.6 bits (114), Expect = 8e-06
 Identities = 19/121 (15%), Positives = 29/121 (23%), Gaps = 28/121 (23%)

Query: 120 RNFSLSGNQLTGSIPESLSRLTQL-------------------LDLSLNNNHLNGGIPDA 160
            N    G+       + LS+  +                      +            D 
Sbjct: 15  ENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADL 74

Query: 161 FHQFT--GLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS------GTLNVLEDLH 212
               T  G +  +L +  L  Q P     LS L  + +    L            LE L 
Sbjct: 75  LEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLT 133

Query: 213 L 213
           L
Sbjct: 134 L 134

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 45.7 bits (109), Expect = 3e-05
 Identities = 18/117 (15%), Positives = 31/117 (26%), Gaps = 25/117 (21%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLT 130
             + E+ L G           G    +  + L +                      + L 
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC---------------------SNLL 267

Query: 131 GSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSAN---NLTGQLPPS 184
            ++P  + RLTQL  L L        +P    Q        +  +    L    P +
Sbjct: 268 -TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVA 323

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 75.5 bits (186), Expect = 9e-15
 Identities = 74/334 (22%), Positives = 129/334 (38%), Gaps = 67/334 (20%)

Query: 403 TVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-EL 461
           T        +    +           V  +         FS+   IG G  G+VY A ++
Sbjct: 17  TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDV 76

Query: 462 PGGKLLAVKKLSNTVSQRQTDEEFLELASTI---SRLRHGNIVELIGYCNEHGQHL-LVY 517
              +++A+KK+S   S +Q++E++ ++   +    +LRH N ++  G C        LV 
Sbjct: 77  RNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHTAWLVM 133

Query: 518 DY-GGNCTLHDLLHSDE----EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFK 572
           +Y  G+ +  DLL   +    E        I   V  GA + L YL       ++H + K
Sbjct: 134 EYCLGSAS--DLLEVHKKPLQEVE------IAA-VTHGALQGLAYLHSH---NMIHRDVK 181

Query: 573 SSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS--G-----APE----FESG 621
           + NILL E  +V++ D G A              ++    S  G     APE     + G
Sbjct: 182 AGNILLSEPGLVKLGDFGSA-------------SIMAPANSFVGTPYWMAPEVILAMDEG 228

Query: 622 SYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAIPRLHDIDALSRMVDPSLD 680
            Y  + DV+SLG+  +EL   + P               + I          +   P+L 
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIA---------QNESPALQ 274

Query: 681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
             + ++    F + +  C+Q  P  RP    +++
Sbjct: 275 SGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLK 305

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 30/214 (14%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFL--ELASTISRLRHGNIV 501
           G  +G+G  G+VY A E     ++A+K L  +  +++  E  L  E+    S LRH NI+
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI-EIQSHLRHPNIL 77

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIRVALGAARALQY 557
            +  Y ++  +  L+ ++     L+  L      DE+    F   +        A AL Y
Sbjct: 78  RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL--------ADALHY 129

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS---G 614
             E     ++H + K  N+L+  K  ++++D G +    S           T  G+    
Sbjct: 130 CHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-------TMCGTLDYL 179

Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
            PE  E  ++  + D++  GV+  E L G  P+D
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 28/140 (20%), Positives = 45/140 (32%), Gaps = 16/140 (11%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIP 158
                + +   IPS+LP           +L   I + + S    L  + ++ N +   I 
Sbjct: 14  FLCQESKVT-EIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIE 71

Query: 159 -DAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS-------GTLNVLE 209
            D F     L    +   N    + P   +NL +L  L + N  +               
Sbjct: 72  ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 131

Query: 210 DLHLIDLN----IENNLFSG 225
            L + D      IE N F G
Sbjct: 132 LLDIQDNINIHTIERNSFVG 151

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 69.5 bits (170), Expect = 8e-13
 Identities = 38/160 (23%), Positives = 60/160 (37%), Gaps = 10/160 (6%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLS-NNHIGGSIPSN----LPVTV 119
             F    N+  + ++   +  +           + +D+  N +I  +I  N    L    
Sbjct: 98  EAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFES 156

Query: 120 RNFSLSGNQLTGSIPESLSRLTQLLDLSL-NNNHLNGGIPDAFHQFTGLINFDLSANNLT 178
               L+ N +   I  S    TQL +L+L +NN+L     D FH  +G +  D+S   + 
Sbjct: 157 VILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215

Query: 179 GQLPPST-RNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLN 217
             LP     NL  L +    N K   TL  L  L    L 
Sbjct: 216 -SLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASLT 254

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 34/174 (19%), Positives = 57/174 (32%), Gaps = 18/174 (10%)

Query: 69  VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP----SNLPVTVRNFSL 124
           +  N  E+R     L  +          +  I++S N +   I     SNLP        
Sbjct: 28  LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLSANNLTGQLPP 183
             N L    PE+   L  L  L ++N  +   +PD         +  D+  N     +  
Sbjct: 88  KANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146

Query: 184 ST-RNLSS-LYSLHLQNNKLS----GTLNVLEDLHLIDLN------IENNLFSG 225
           ++   LS     L L  N +        N  +   L   +      + N++F G
Sbjct: 147 NSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG 200

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 17/103 (16%), Positives = 29/103 (28%), Gaps = 8/103 (7%)

Query: 100 IDLSNNHIGGSIPS---NLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGG 156
           + L+ N I   I +   N            N L     +     +  + L ++   ++  
Sbjct: 159 LWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217

Query: 157 IPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNN 199
                     L     S  NL  +LP     L +L    L   
Sbjct: 218 PSYGLENLKKLRA--RSTYNLK-KLPTLE-KLVALMEASLTYP 256

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 74.9 bits (184), Expect = 3e-14
 Identities = 31/161 (19%), Positives = 54/161 (33%), Gaps = 26/161 (16%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD 159
           +D S N +   +P +L       ++S N ++      +  L++L  L +++N +      
Sbjct: 5   VDRSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63

Query: 160 AFHQFTGLINFDLSANNLTG--------------------QLPPSTR--NLSSLYSLHLQ 197
            F     L   DLS N L                       LP      N+S L  L L 
Sbjct: 64  VFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123

Query: 198 NNKL-SGTLNVLEDLHL--IDLNIENNLFSGPIPEKLLSIP 235
              L   ++  +  L++  + L +         PE L    
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 31/173 (17%), Positives = 58/173 (33%), Gaps = 24/173 (13%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNF-- 122
                 S    +  +   L   + +  G L  +  + L  N +       L         
Sbjct: 318 LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-----KELSKIAEMTTQ 372

Query: 123 -------SLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSA 174
                   +S N ++    +   S    LL L++++N L   I         +   DL +
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHS 430

Query: 175 NNLTGQLPPSTRNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENNLF 223
           N +   +P     L +L  L++ +N+L     G  + L  L  I L+   N +
Sbjct: 431 NKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLH--TNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 36/175 (20%), Positives = 65/175 (37%), Gaps = 33/175 (18%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSL 124
            ++ +FSN+                       + N  +S   +   +  +      +   
Sbjct: 294 YIYEIFSNMN----------------------IKNFTVSGTRMVHMLCPSKISPFLHLDF 331

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLN--GGIPDAFHQFTGLINFDLSANNLTGQLP 182
           S N LT ++ E+   LT+L  L L  N L     I +   Q   L   D+S N+++    
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391

Query: 183 PST-RNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPN 236
                   SL SL++ +N L+ T+       +  L++ +N        K+ SIP 
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSN--------KIKSIPK 438

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 26/184 (14%), Positives = 55/184 (29%), Gaps = 13/184 (7%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSL 124
                 S +  + ++   +  +        + +  +DLS+N +   I  +  V +++  L
Sbjct: 39  SDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHLDL 97

Query: 125 SGNQLTGSIPES--LSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP 182
           S N    ++P       ++QL  L L+  HL                  +       +  
Sbjct: 98  SFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED 156

Query: 183 PSTRNLSSLYSLHLQNNKLSGTL-------NVLEDLHLIDLNIENNLFSGPIPEKLLSIP 235
           P    L    +  L     +          +V    +L   NI+  L        L  + 
Sbjct: 157 PE--GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA 214

Query: 236 NFRK 239
             + 
Sbjct: 215 KLQT 218

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 16/114 (14%), Positives = 36/114 (31%), Gaps = 7/114 (6%)

Query: 96  SVINIDLSNNHIGGSIPSNLPVTVRNF-------SLSGNQLTGSIPESLSRLTQLLDLSL 148
           +V    +SN  + G +                   +  +             + +   + 
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307

Query: 149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS 202
             +           + +  ++ D S N LT  +  +  +L+ L +L LQ N+L 
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 56/326 (17%), Positives = 111/326 (34%), Gaps = 63/326 (19%)

Query: 432 IASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELAS 490
           + S     + +   + +G+G   +V++      G L A+K  +N    R  D +  E   
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF-E 59

Query: 491 TISRLRHGNIVELIGY--CNEHGQHLLVYDY--GGNCTLHDLLHS-------DEEAHKKF 539
            + +L H NIV+L            +L+ ++   G+  L+ +L          E      
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS--LYTVLEEPSNAYGLPESEFLIV 117

Query: 540 SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCGLAPLL 595
             ++           + +L+E     IVH N K  NI+     D + + +++D G A   
Sbjct: 118 LRDV--------VGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA--- 163

Query: 596 FSGSTNELSEG--LLTAHGS---GAPE---------FESGSYSCQSDVYSLGVVMLELLT 641
                 EL +    ++ +G+     P+              Y    D++S+GV      T
Sbjct: 164 -----RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

Query: 642 GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAK------SLSRFA--- 692
           G  P+           V + I       A+S +          +       SLSR     
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL 278

Query: 693 --DIISRCVQWEPGFRPPMSEIVQDL 716
              +++  ++ +        +   + 
Sbjct: 279 LTPVLANILEADQEKCWGFDQFFAET 304

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 60/292 (20%), Positives = 110/292 (37%), Gaps = 66/292 (22%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI---SRLRHGNIVEL 503
           +G+G  G VYKA     G L A K +       +++EE  +    I   +   H  IV+L
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYIVEIEILATCDHPYIVKL 81

Query: 504 IGYCNEHGQHL-LVYDY--GGNCTLHDLLHSDE----EAHKKFSWNIRIRVALGAARALQ 556
           +G    H   L ++ ++  GG      ++   +    E        I++ V      AL 
Sbjct: 82  LG-AYYHDGKLWIMIEFCPGGAVD--AIMLELDRGLTEPQ------IQV-VCRQMLEALN 131

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS-G- 614
           +L       I+H + K+ N+L+  +  +R++D G      S    +  + L       G 
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG-----VSA---KNLKTLQKRDSFIGT 180

Query: 615 ----APE------FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAIP 663
               APE       +   Y  ++D++SLG+ ++E+     P+    P R    + +   P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP 240

Query: 664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
            L      S                  F D +   +   P  RP  +++++ 
Sbjct: 241 TLLTPSKWSV----------------EFRDFLKIALDKNPETRPSAAQLLEH 276

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 31/170 (18%), Positives = 62/170 (36%), Gaps = 15/170 (8%)

Query: 68  CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSI-------PSNLPVTVR 120
            +   +  + +   +      + +    ++  +DLS+N   G         P   P T++
Sbjct: 146 WLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP-TLQ 204

Query: 121 NFSLSGNQLT---GSIPESLSRLTQLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLSANN 176
             +L    +    G      +   QL  L L++N L       +    + L + +LS   
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

Query: 177 LTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGP 226
           L  Q+P      + L  L L  N+L    +  E   + +L+++ N F   
Sbjct: 265 LK-QVPKGL--PAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 35/188 (18%), Positives = 61/188 (32%), Gaps = 20/188 (10%)

Query: 63  WQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVIN-----IDLSNNHIGGSIPSNLPV 117
              +     ++  + L  ++     A  L +L+  +      + ++  H   +       
Sbjct: 113 PPLLEATGPDLNILNLRNVSWATRDAW-LAELQQWLKPGLKVLSIAQAHSL-NFSCEQVR 170

Query: 118 TVRNFS---LSGNQLTGSIPESLS----RLTQLLDLSLNNNHLN---GGIPDAFHQFTGL 167
                S   LS N   G      +    +   L  L+L N  +    G           L
Sbjct: 171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQL 230

Query: 168 INFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLSG-TLNVLEDLHLIDLNIENNLFSG 225
              DLS N+L       +    S L SL+L    L      +   L ++DL+  N L   
Sbjct: 231 QGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLS-YNRLDRN 289

Query: 226 PIPEKLLS 233
           P P++L  
Sbjct: 290 PSPDELPQ 297

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 35/182 (19%), Positives = 55/182 (30%), Gaps = 21/182 (11%)

Query: 72  NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPV----TVRNFSLSGN 127
            V   R+    L G L   +  +  +  + L N  + G+ P  L       +   +L   
Sbjct: 74  TVRAARIPSRILFGALR--VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131

Query: 128 QLTGSIPESLSRLTQLLD-----LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP 182
                    L+ L Q L      LS+   H      +    F  L   DLS N   G+  
Sbjct: 132 SWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

Query: 183 PST----RNLSSLYSLHLQNNKLSGTLNVLEDL-----HLIDLNIENNLFSGPIPEKLLS 233
             +        +L  L L+N  +     V   L      L  L++ +N            
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250

Query: 234 IP 235
            P
Sbjct: 251 WP 252

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 72.3 bits (178), Expect = 8e-14
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 73/292 (25%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVK-----KLSNTVSQRQTDEEFLELASTISRLRHGNIV 501
           IG+G    V  A  +  G+ +A+K     +L+ T  Q+   E        +  L H NIV
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE-----VRIMKILNHPNIV 77

Query: 502 EL---IGYCNEHGQHL-LVYDYGGNCTLHDLLH-----SDEEAHKKFSWNIRIRVALGAA 552
           +L   I    E  + L L+ +Y     + D L       ++EA  KF   I         
Sbjct: 78  KLFEVI----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-RQI--------V 124

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG--LLTA 610
            A+QY  +     IVH + K+ N+LLD  + ++++D G +        NE + G  L   
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS--------NEFTVGGKLDAF 173

Query: 611 HGS---GAPEFESG-SYS-CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL 665
            G+    APE   G  Y   + DV+SLGV++  L++G  P+D                  
Sbjct: 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ---------------- 217

Query: 666 HDIDALSRMVDPSLDGAY-LAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
            ++  L   V   L G Y +   +S    +++ R +   P  R  + +I++D
Sbjct: 218 -NLKELRERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 61/292 (20%), Positives = 118/292 (40%), Gaps = 63/292 (21%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI---SRLRH 497
           F     +GEG  GSVYKA     G+++A+K++         + +  E+   I    +   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-------VESDLQEIIKEISIMQQCDS 83

Query: 498 GNIVELIGYCNEHGQHL-LVYDY--GGNCTLHDLLHSDE----EAHKKFSWNIRIRVALG 550
            ++V+  G        L +V +Y   G+ +  D++        E        I   +   
Sbjct: 84  PHVVKYYG-SYFKNTDLWIVMEYCGAGSVS--DIIRLRNKTLTEDE------IAT-ILQS 133

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
             + L+YL  +     +H + K+ NILL+ +   +++D G      +G   +L++ +   
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG-----VAG---QLTDTMAKR 182

Query: 611 H---GSG---APEF-ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP-RGEQSLVRWAI 662
           +   G+    APE  +   Y+C +D++SLG+  +E+  G+ PY    P R    +     
Sbjct: 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP 242

Query: 663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ 714
           P     +  S                  F D + +C+   P  R   ++++Q
Sbjct: 243 PTFRKPELWSD----------------NFTDFVKQCLVKSPEQRATATQLLQ 278

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 14/163 (8%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL---PVTVRN 121
             F   + +  + L    L  + A    +L+++  + +++N +  ++P  +    V +  
Sbjct: 55  KAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAE 113

Query: 122 FSLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLSANNLTG 179
             L  NQL  S+P  +   LT+L  LSL  N L   +P   F + T L    L  N L  
Sbjct: 114 LRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK- 170

Query: 180 QLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLN 217
           ++P      L+ L +L L NN+L     G  + LE L ++ L 
Sbjct: 171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 40/136 (29%), Positives = 60/136 (44%), Gaps = 16/136 (11%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN 169
           +IPSN+P   +   L  N+L+    ++  RLT+L  L LN+N L       F +   L  
Sbjct: 30  AIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLET 89

Query: 170 FDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLSGTL--NVLEDL-HLIDLNIENNLFSG 225
             ++ N L   LP      L +L  L L  N+L  +L   V + L  L  L++  N    
Sbjct: 90  LWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN---- 143

Query: 226 PIPEKLLSIPN--FRK 239
               +L S+P   F K
Sbjct: 144 ----ELQSLPKGVFDK 155

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 15/156 (9%)

Query: 101 DLSNNHIGGSIPSNLP---VTVRNFSLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGG 156
            L++N +  ++P+ +      +    ++ N+L  ++P  +  +L  L +L L+ N L   
Sbjct: 67  YLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSL 124

Query: 157 IPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDL 211
            P  F   T L    L  N L   LP      L+SL  L L NN+L     G  + L +L
Sbjct: 125 PPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTEL 183

Query: 212 HLIDLNIENNLFSGP--IPEKLLSIPNFRKDGNPFN 245
             + L+  N L   P    + L  +   +   NP++
Sbjct: 184 KTLKLD-NNQLKRVPEGAFDSLEKLKMLQLQENPWD 218

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 6/139 (4%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP---VTVRN 121
           G+F    N+  + +T   L  +       L ++  + L  N +  S+P  +      +  
Sbjct: 79  GIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTY 137

Query: 122 FSLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
            SL  N+L  S+P+ +  +LT L +L L NN L      AF + T L    L  N L   
Sbjct: 138 LSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRV 196

Query: 181 LPPSTRNLSSLYSLHLQNN 199
              +  +L  L  L LQ N
Sbjct: 197 PEGAFDSLEKLKMLQLQEN 215

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 71.5 bits (175), Expect = 4e-13
 Identities = 23/121 (19%), Positives = 43/121 (35%), Gaps = 10/121 (8%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD 159
           +++  + +  ++P  LP  +    +  N LT S+P     L     L ++ N L   +P 
Sbjct: 45  LNVGESGLT-TLPDCLPAHITTLVIPDNNLT-SLPALPPELRT---LEVSGNQLT-SLPV 98

Query: 160 AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIE 219
                  L  F     +L          L  L+    Q   L      L++L + D  + 
Sbjct: 99  LPPGLLELSIFSNPLTHLPALPS----GLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA 154

Query: 220 N 220
           +
Sbjct: 155 S 155

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 33/168 (19%), Positives = 61/168 (36%), Gaps = 29/168 (17%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQL 129
              +  + ++G  L   L      L  +        H+  ++PS L        + GNQL
Sbjct: 80  PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGL----CKLWIFGNQL 133

Query: 130 TGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQ-----------------FTGLINFDL 172
           T S+P     L +   LS+++N L   +P    +                  +GL    +
Sbjct: 134 T-SLPVLPPGLQE---LSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSV 188

Query: 173 SANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIEN 220
           S N L   LP     L  L++ + +   L    + L++L +    + +
Sbjct: 189 SDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS 235

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 69.2 bits (169), Expect = 3e-12
 Identities = 41/178 (23%), Positives = 67/178 (37%), Gaps = 19/178 (10%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQL 129
            S + ++      L   L      L+    + +S+N +  S+P+     +       N+L
Sbjct: 160 PSELCKLWAYNNQLT-SLPMLPSGLQE---LSVSDNQLA-SLPTLPS-ELYKLWAYNNRL 213

Query: 130 TGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLS 189
           T S+P   S L +L    ++ N L   +P    +   L    +S N LT  LP      S
Sbjct: 214 T-SLPALPSGLKEL---IVSGNRLTS-LPVLPSE---LKELMVSGNRLT-SLPML---PS 261

Query: 190 SLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNT 246
            L SL +  N+L+     L  L     +N+E N  S    + L  I +      P   
Sbjct: 262 GLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 64.5 bits (157), Expect = 7e-11
 Identities = 26/139 (18%), Positives = 46/139 (33%), Gaps = 23/139 (16%)

Query: 123 SLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP 182
           ++  + LT ++P+ L     +  L + +N+L   +P        L   ++S N LT  LP
Sbjct: 46  NVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALP---PELRTLEVSGNQLT-SLP 97

Query: 183 PSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGN 242
                L  L         L    + L  L +      N L S  +P     +       N
Sbjct: 98  VLPPGLLELSIFSNPLTHLPALPSGLCKLWIFG----NQLTS--LPVLPPGLQELSVSDN 151

Query: 243 PFNTTVIALPPTAIPPSIA 261
                       ++P   +
Sbjct: 152 QL---------ASLPALPS 161

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 61.4 bits (149), Expect = 6e-10
 Identities = 39/173 (22%), Positives = 68/173 (39%), Gaps = 12/173 (6%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLT 130
           S + E+ ++G N    L     +L+    + +S N +  S+P      + + S+  NQLT
Sbjct: 221 SGLKELIVSG-NRLTSLPVLPSELK---ELMVSGNRLT-SLPMLPS-GLLSLSVYRNQLT 274

Query: 131 GSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFD---LSANNLTGQLPPSTRN 187
             +PESL  L+    ++L  N L+     A  + T    +    +  +      P  TR 
Sbjct: 275 -RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRA 333

Query: 188 LSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKD 240
           L    +  L   +  G     +  H+       + FS    ++L    NF KD
Sbjct: 334 LHLAAADWLVPARE-GEPAPADRWHMFGQEDNADAFSL-FLDRLSETENFIKD 384

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 28/155 (18%), Positives = 63/155 (40%), Gaps = 12/155 (7%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQL 129
            + +T +     ++  +    +  L  +  +  ++N+I  ++  +    +   +   N+L
Sbjct: 41  LATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TLDLSQNTNLTYLACDSNKL 97

Query: 130 TGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLS 189
           T ++   ++ LT+L  L+ + N L   +     Q   L   + + N LT ++  S  + +
Sbjct: 98  T-NLD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLT-EIDVS--HNT 148

Query: 190 SLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFS 224
            L  L    NK    L+V     L  L+   N  +
Sbjct: 149 QLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT 183

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 30/160 (18%), Positives = 58/160 (36%), Gaps = 14/160 (8%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP--SNLPVTVRNFSLSGNQ 128
            N          +      +   L ++ ++D  N+ I   +     L   +     + N 
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-TDMTGIEKLT-GLTKLICTSNN 75

Query: 129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNL 188
           +T ++   LS+ T L  L+ ++N L   +       T L   +   N LT +L  S    
Sbjct: 76  IT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVS--QN 126

Query: 189 SSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIP 228
             L  L+   N L+  ++V  +  L +L+   N     + 
Sbjct: 127 PLLTYLNCARNTLT-EIDVSHNTQLTELDCHLNKKITKLD 165

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 26/135 (19%), Positives = 51/135 (37%), Gaps = 13/135 (9%)

Query: 90  TLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
            +     +  +D   N     +       +     S N++T  +   +S+   L  L+ +
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCD 199

Query: 150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS----GTL 205
            N++   +    +Q   L   D S+N LT ++  +   L+ L       N L+     TL
Sbjct: 200 TNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVT--PLTQLTYFDCSVNPLTELDVSTL 253

Query: 206 NVLEDLHLIDLNIEN 220
           + L  LH I  ++  
Sbjct: 254 SKLTTLHCIQTDLLE 268

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 30/176 (17%), Positives = 49/176 (27%), Gaps = 29/176 (16%)

Query: 91  LGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN 150
           +  L  +  ++   N +     S  P  +   + + N LT  I   +S  TQL +L  + 
Sbjct: 102 VTPLTKLTYLNCDTNKLTKLDVSQNP-LLTYLNCARNTLT-EID--VSHNTQLTELDCHL 157

Query: 151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS----GTLN 206
           N             T L   D S N +T +L  S      L  L+   N ++        
Sbjct: 158 NKKIT--KLDVTPQTQLTTLDCSFNKIT-ELDVS--QNKLLNRLNCDTNNITKLDLNQNI 212

Query: 207 VLEDL----------------HLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNT 246
            L  L                 L   +   N  +      L  +            
Sbjct: 213 QLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLE 268

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 64.3 bits (157), Expect = 5e-11
 Identities = 36/176 (20%), Positives = 55/176 (31%), Gaps = 33/176 (18%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQL 129
            + +TE+          L   +     +  +D S N I     S     +   +   N +
Sbjct: 147 NTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELDVSQNK-LLNRLNCDTNNI 203

Query: 130 TGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLS 189
           T  +   L++  QL  L  ++N L   I       T L  FD S N LT +L  S   LS
Sbjct: 204 T-KLD--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLT-ELDVS--TLS 254

Query: 190 SLYSLHLQNNKLS----GTLNVLEDL-----------------HLIDLNIENNLFS 224
            L +LH     L          L                     L  L+ +    +
Sbjct: 255 KLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 29/185 (15%), Positives = 57/185 (30%), Gaps = 16/185 (8%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQ 128
            + +   +  G      L   +     +  +D     I   +  S  P  +    L+  +
Sbjct: 274 NTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELDLSQNP-KLVYLYLNNTE 329

Query: 129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNL 188
           LT  +   +S  T+L  LS  N H+      +  +   L N   +       +P  T   
Sbjct: 330 LT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTI-TMPKETLTN 383

Query: 189 SSLYSLHLQNNKLSGTLNVL----EDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPF 244
           +SL ++ +  + L    N +     D  + D       +     +       F  +    
Sbjct: 384 NSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAI 442

Query: 245 NTTVI 249
             TV 
Sbjct: 443 VGTVT 447

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 70.9 bits (174), Expect = 5e-13
 Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 31/228 (13%)

Query: 438 YTNSFSE----GNFIGEGLLGSVYKA-ELPGGKLLAVKKLS-NTVSQRQTDEEFLELAST 491
           +  +F+E       +G+G  G V K  +    +  AVK ++  +   + T     E+   
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE-L 74

Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
           + +L H NI++L     +     +V +   GG   L D +       K+FS +   R+  
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE--LFDEI----IKRKRFSEHDAARIIK 128

Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSEG 606
                + Y+ +     IVH + K  NILL   ++   +++ D GL+              
Sbjct: 129 QVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN------TK 179

Query: 607 LLTAHGSG---APEFESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSR 650
           +    G+    APE   G+Y  + DV+S GV++  LL+G  P Y ++ 
Sbjct: 180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE 227

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 55/349 (15%), Positives = 109/349 (31%), Gaps = 97/349 (27%)

Query: 438 YTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKL---SNTVSQRQTDEEFLELAS--- 490
           Y   F     +G G  G V++A+        A+K++   +  +++ +   E   LA    
Sbjct: 4   YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 63

Query: 491 -----------------------------------------------TISRLRHGNIVEL 503
                                                           I R+   +    
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123

Query: 504 IGYCNEHGQHLLVY---DYGGNCTLHDLLH---SDEEAHKKFSWNIRIRVALGAARALQY 557
           +G        + +Y          L D ++   S E+       +I I++A      +++
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEF 179

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG---STNELSEGLLTAHGSG 614
           L       ++H + K SNI      +V+V D GL   +       T          H   
Sbjct: 180 LHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236

Query: 615 -------APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH 666
                  +PE     +YS + D++SLG+++ ELL                     + R+ 
Sbjct: 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST---------------QMERVR 281

Query: 667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
            I  +  +  P L      +   +   ++   +   P  RP  ++I+++
Sbjct: 282 IITDVRNLKFPLL----FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 25/142 (17%), Positives = 52/142 (36%), Gaps = 18/142 (12%)

Query: 99  NIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPE-SLSRLTQLLDLSLNNNHLNGGI 157
           +  ++   I   IPS LP + +   L    L  +IP  + S L  +  + ++ +     +
Sbjct: 15  DFRVTCKDIQ-RIPS-LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQL 71

Query: 158 P-DAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS--------GTLNV 207
              +F+  + + + ++        + P   + L  L  L + N  L          + ++
Sbjct: 72  ESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDI 131

Query: 208 LEDLHLIDLN----IENNLFSG 225
              L + D      I  N F G
Sbjct: 132 FFILEITDNPYMTSIPVNAFQG 153

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 61.9 bits (151), Expect = 7e-11
 Identities = 26/163 (15%), Positives = 59/163 (36%), Gaps = 16/163 (9%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLS-NNHIGGSIP----SNLPVTVRNFSLS 125
            +   ++L   +L  + +    +L ++  I +S +  +   +      NL   V +  + 
Sbjct: 31  PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTL-QQLESHSFYNLS-KVTHIEIR 88

Query: 126 GNQLTGSIP-ESLSRLTQLLDLSLNNNHLNGGIPD--AFHQFTGLINFDLSANNLTGQLP 182
             +    I  ++L  L  L  L + N  L    PD    +        +++ N     +P
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147

Query: 183 PST-RNLSS-LYSLHLQNNKLSGTL--NVLEDLHLIDLNIENN 221
            +  + L +   +L L NN  + ++         L  + +  N
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 36/169 (21%), Positives = 56/169 (33%), Gaps = 18/169 (10%)

Query: 65  GVFCVFSNVTEIRLTG-MNLGGVLADTLGDLESVINIDLSNNHIGGSIPS----NLPVTV 119
             F   S VT I +    NL  +  D L +L  +  + + N  +    P           
Sbjct: 74  HSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIF 132

Query: 120 RNFSLSGNQLTGSIPE-SLSRLT-QLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLSANN 176
               ++ N    SIP  +   L  + L L L NN     +   AF+  T L    L+ N 
Sbjct: 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNG-TKLDAVYLNKNK 190

Query: 177 LTGQLPPST-RNL-SSLYSLHLQNNKLSGTL--NVLEDLHLIDLNIENN 221
               +       + S    L +    ++  L    LE L   +L   N 
Sbjct: 191 YLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLK--ELIARNT 236

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 70.4 bits (173), Expect = 8e-13
 Identities = 33/130 (25%), Positives = 54/130 (41%), Gaps = 9/130 (6%)

Query: 91  LGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN 150
           L +L  +  I   NN +   +P +LP+++ +     N L   +PE L  L  L  +  +N
Sbjct: 191 LQNLPFLTAIYADNNSLK-KLP-DLPLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADN 246

Query: 151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLED 210
           N L   +PD       L   ++  N LT  LP   ++L+ L       + LS     L  
Sbjct: 247 NLLKT-LPD---LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYY 301

Query: 211 LHLIDLNIEN 220
           L+     I +
Sbjct: 302 LNASSNEIRS 311

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 69.6 bits (171), Expect = 1e-12
 Identities = 42/196 (21%), Positives = 75/196 (38%), Gaps = 35/196 (17%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLT 130
            ++  +  +  +L   L +    L+S++  + +   +     S+LP  +    +S NQL 
Sbjct: 91  PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL-----SDLPPLLEYLGVSNNQLE 144

Query: 131 GSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSS 190
             +PE L   + L  + ++NN L   +PD       L       N L     P  +NL  
Sbjct: 145 -KLPE-LQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLEE--LPELQNLPF 196

Query: 191 LYSLHLQNNKLS------GTL-------NVLEDL-------HLIDLNIENNLFSGPIPEK 230
           L +++  NN L        +L       N+LE+L        L  +  +NNL    +P+ 
Sbjct: 197 LTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDL 255

Query: 231 LLSIPNFRKDGNPFNT 246
             S+       N    
Sbjct: 256 PPSLEALNVRDNYLTD 271

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 61.9 bits (151), Expect = 3e-10
 Identities = 35/154 (22%), Positives = 56/154 (36%), Gaps = 20/154 (12%)

Query: 87  LADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDL 146
           L D    LE    +++SNN +   +P+  P  +     S N L   +PE    L QL   
Sbjct: 312 LCDLPPSLEE---LNVSNNKLI-ELPALPP-RLERLIASFNHLA-EVPELPQNLKQL--- 362

Query: 147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN 206
            +  N L    PD           DL  N+   ++P       +L  LH++ N L    +
Sbjct: 363 HVEYNPLRE-FPDIPESVE-----DLRMNSHLAEVPEL---PQNLKQLHVETNPLREFPD 413

Query: 207 VLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKD 240
           + E   + DL + +     P      +      D
Sbjct: 414 IPE--SVEDLRMNSERVVDPYEFAHETTDKLEDD 445

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 58.1 bits (141), Expect = 5e-09
 Identities = 25/135 (18%), Positives = 50/135 (37%), Gaps = 21/135 (15%)

Query: 101 DLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRL-------------TQLLD 145
              ++++   +P       +   +  + ++   + P                    Q  +
Sbjct: 17  LRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHE 75

Query: 146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL 205
           L LNN  L+  +P+       L +   S N+LT +LP   ++L SL   +     LS   
Sbjct: 76  LELNNLGLSS-LPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP 130

Query: 206 NVLEDLHLIDLNIEN 220
            +LE L + +  +E 
Sbjct: 131 PLLEYLGVSNNQLEK 145

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 16/130 (12%), Positives = 35/130 (26%), Gaps = 26/130 (20%)

Query: 89  DTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLL---- 144
                LE    +  S NH+   +P      ++   +  N L    P+    +  L     
Sbjct: 334 ALPPRLE---RLIASFNHLA-EVPELPQ-NLKQLHVEYNPLR-EFPDIPESVEDLRMNSH 387

Query: 145 ------------DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLY 192
                        L +  N L    PD       + +  +++  +      +      L 
Sbjct: 388 LAEVPELPQNLKQLHVETNPLRE-FPDIPES---VEDLRMNSERVVDPYEFAHETTDKLE 443

Query: 193 SLHLQNNKLS 202
               +++   
Sbjct: 444 DDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 20/124 (16%), Positives = 37/124 (29%), Gaps = 13/124 (10%)

Query: 133 IPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLY 192
           I       T L +   ++++L   +P           +  + +      PP       + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 193 SLHLQNNKLSG--TLNV----LEDL-----HLIDLNIENNLFSGPIPEKLLSIPNFRKDG 241
              L++        L +    L  L     HL  L    N  +  +PE   S+ +   D 
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDN 120

Query: 242 NPFN 245
           N   
Sbjct: 121 NNLK 124

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 33/162 (20%), Positives = 68/162 (41%), Gaps = 10/162 (6%)

Query: 89  DTLGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLS 147
             +  L+S+  +DL++  I    P + L   ++   L  NQ+T +I   L+ LT L  LS
Sbjct: 101 SAIAGLQSIKTLDLTSTQITDVTPLAGLS-NLQVLYLDLNQIT-NI-SPLAGLTNLQYLS 157

Query: 148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV 207
           + N  ++          + L       N ++  + P   +L +L  +HL+NN++S  ++ 
Sbjct: 158 IGNAQVSD--LTPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSP 212

Query: 208 LEDL-HLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTV 248
           L +  +L  + + N   +        ++        P    +
Sbjct: 213 LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 35/155 (22%), Positives = 63/155 (40%), Gaps = 14/155 (9%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP--SNLPVTVRNFSLSGN 127
            +N  +I     N+      T  DL+ +  +      +  +I     L   +    L  N
Sbjct: 18  LANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGV-TTIEGVQYLN-NLIGLELKDN 73

Query: 128 QLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRN 187
           Q+T  +   L  LT++ +L L+ N L      A      +   DL++  +T         
Sbjct: 74  QIT-DLAP-LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDV--TPLAG 127

Query: 188 LSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENN 221
           LS+L  L+L  N+++  ++ L  L +L  L+I N 
Sbjct: 128 LSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNA 161

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 28/133 (21%), Positives = 56/133 (42%), Gaps = 10/133 (7%)

Query: 91  LGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
              L + I I    +++  ++  ++L   +   S  G  +T +I E +  L  L+ L L 
Sbjct: 15  DPALANAIKIAAGKSNVTDTVTQADLD-GITTLSAFGTGVT-TI-EGVQYLNNLIGLELK 71

Query: 150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLE 209
           +N +           T +   +LS N L   +      L S+ +L L + +++  +  L 
Sbjct: 72  DNQITD--LAPLKNLTKITELELSGNPLK-NVSAIA-GLQSIKTLDLTSTQIT-DVTPLA 126

Query: 210 DL-HLIDLNIENN 221
            L +L  L ++ N
Sbjct: 127 GLSNLQVLYLDLN 139

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 24/137 (17%), Positives = 49/137 (35%), Gaps = 6/137 (4%)

Query: 91  LGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
           L  L ++  + + N  +    P +NL   +       N+++  I   L+ L  L+++ L 
Sbjct: 147 LAGLTNLQYLSIGNAQVSDLTPLANLS-KLTTLKADDNKIS-DIS-PLASLPNLIEVHLK 203

Query: 150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLE 209
           NN ++          + L    L+   +T Q      NL     +   +        + +
Sbjct: 204 NNQISD--VSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISD 261

Query: 210 DLHLIDLNIENNLFSGP 226
           +      N+  NL S  
Sbjct: 262 NGTYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 13/88 (14%), Positives = 36/88 (40%), Gaps = 6/88 (6%)

Query: 135 ESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSL 194
                L   + ++   +++   +        G+         +T  +    + L++L  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68

Query: 195 HLQNNKLSGTLNVLEDL-HLIDLNIENN 221
            L++N+++  L  L++L  + +L +  N
Sbjct: 69  ELKDNQIT-DLAPLKNLTKITELELSGN 95

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 61/301 (20%), Positives = 101/301 (33%), Gaps = 47/301 (15%)

Query: 378 MVSSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQ 437
           M+S+ + Q   +P P    P       +P  PA     + P              + LQ 
Sbjct: 1   MLSNSQGQSPPVPFPAPAPP------PQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQI 54

Query: 438 YTNSFSE-----GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELAST 491
             N+  +        +G G+ G V +       +  A+K L +    R+  E        
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA--- 111

Query: 492 ISRLRHGNIVELIGYC----NEHGQHLLVYDY--GGNCTLHDLLHS-DEEAHKKFSWNIR 544
               +  +IV ++             L+V +   GG     +L     +   + F+    
Sbjct: 112 ---SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREA 163

Query: 545 IRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTN 601
             +      A+QYL  +    I H + K  N+L        I++++D G A    S    
Sbjct: 164 SEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--- 217

Query: 602 ELSEGLLTAHGSG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPRGEQS 656
                L T   +    APE      Y    D++SLGV+M  LL G  P Y          
Sbjct: 218 ---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 274

Query: 657 L 657
           +
Sbjct: 275 M 275

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 31/94 (32%), Positives = 44/94 (46%), Gaps = 3/94 (3%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN 169
            +P  +P  V    L GNQ T  +P+ LS    L  + L+NN ++     +F   T L+ 
Sbjct: 24  VLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLT 82

Query: 170 FDLSANNLTGQLPP-STRNLSSLYSLHLQNNKLS 202
             LS N L   +PP +   L SL  L L  N +S
Sbjct: 83  LILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS 115

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 69.8 bits (170), Expect = 2e-12
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 14/155 (9%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP--SNLPVTVRNFSLSGN 127
           F+   +  L   ++      T  +L S+  I  +N+ I  S+     LP  V    L+GN
Sbjct: 20  FAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDI-KSVQGIQYLP-NVTKLFLNGN 75

Query: 128 QLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRN 187
           +LT  I + L+ L  L  L L+ N +   +  +      L +  L  N ++  +     +
Sbjct: 76  KLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVH 129

Query: 188 LSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENN 221
           L  L SL+L NNK++  + VL  L  L  L++E+N
Sbjct: 130 LPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDN 163

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 64.7 bits (157), Expect = 6e-11
 Identities = 29/132 (21%), Positives = 50/132 (37%), Gaps = 8/132 (6%)

Query: 91  LGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN 150
                  I  +L    +  ++  N   ++     + + +  S+ + +  L  +  L LN 
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74

Query: 151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLED 210
           N L   I         L    L  N +   L    ++L  L SL L++N +S  +N L  
Sbjct: 75  NKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSSL-KDLKKLKSLSLEHNGIS-DINGLVH 129

Query: 211 L-HLIDLNIENN 221
           L  L  L + NN
Sbjct: 130 LPQLESLYLGNN 141

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 26/211 (12%), Positives = 55/211 (26%), Gaps = 7/211 (3%)

Query: 89  DTLGDLESVINIDLSNNHIGGSIP--SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDL 146
             L  L  +  + L +N I   I   + L   ++N  LS N ++  +  +L+ L  L  L
Sbjct: 147 TVLSRLTKLDTLSLEDNQIS-DIVPLAGLT-KLQNLYLSKNHIS-DL-RALAGLKNLDVL 202

Query: 147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN 206
            L +        +             +  +L      S        ++     + +  ++
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS 262

Query: 207 VLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTAIPPSIAPAPTF 266
                  + +      F G + + L  +     D +           T I     P    
Sbjct: 263 -FIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQG 321

Query: 267 QAPGDQADAPSAFEMTNSAKAKKFWTTKRVI 297
                     +     N            + 
Sbjct: 322 YVFKGWYTEKNGGHEWNFNTDYMSGNDFTLY 352

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 45.9 bits (108), Expect = 5e-05
 Identities = 23/119 (19%), Positives = 39/119 (32%), Gaps = 26/119 (21%)

Query: 124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIP--------------------DAFHQ 163
                +   I        + +  +L    +   +                          
Sbjct: 6   TVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQY 63

Query: 164 FTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENN 221
              +    L+ N LT  + P T NL +L  L L  NK+   L+ L+DL  L  L++E+N
Sbjct: 64  LPNVTKLFLNGNKLT-DIKPLT-NLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHN 119

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 55/232 (23%), Positives = 98/232 (42%), Gaps = 41/232 (17%)

Query: 438 YTNSFSE----GNFIGEGLLGSVYKA-ELPGGKLLAVKKLS-NTVSQRQTDEEFLELAST 491
           +  +F+E       +G+G  G V K  +    +  AVK ++  +   + T     E+   
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE-L 74

Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDE-EAHKKFSWNIRIRVA 548
           + +L H NI++L     +     +V +   GG     +L   DE    K+FS       A
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGG-----ELF--DEIIKRKRFSE----HDA 123

Query: 549 LGAAR----ALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTN 601
               +     + Y+ +     IVH + K  NILL   ++   +++ D GL+      +  
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179

Query: 602 ELSEGLLTAHGSG---APEFESGSYSCQSDVYSLGVVMLELLTGRKP-YDRS 649
                +    G+    APE   G+Y  + DV+S GV++  LL+G  P Y ++
Sbjct: 180 -----MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 68.8 bits (168), Expect = 3e-12
 Identities = 44/205 (21%), Positives = 80/205 (39%), Gaps = 42/205 (20%)

Query: 68  CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGN 127
           C+ +  +E++L  +NL   L D L     +  ++++ N +  S+P  LP ++       N
Sbjct: 56  CLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLP-ELPASLEYLDACDN 110

Query: 128 QLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRN 187
           +L+ ++PE  + L  L    ++NN L   +P+       L   +   N LT  LP    +
Sbjct: 111 RLS-TLPELPASLKHL---DVDNNQLTM-LPE---LPALLEYINADNNQLT-MLPELPTS 161

Query: 188 LSSLY-----------------SLHLQNNKLS------GTLNVLEDLHLIDLNIENNLFS 224
           L  L                  +L +  N L          +  E+   I      N  +
Sbjct: 162 LEVLSVRNNQLTFLPELPESLEALDVSTNLLESLPAVPVRNHHSEET-EIFFRCRENRIT 220

Query: 225 GPIPEKLLSIPNFRK---DGNPFNT 246
             IPE +LS+        + NP ++
Sbjct: 221 H-IPENILSLDPTCTIILEDNPLSS 244

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 61.1 bits (148), Expect = 7e-10
 Identities = 34/149 (22%), Positives = 56/149 (37%), Gaps = 18/149 (12%)

Query: 87  LADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDL 146
                   E       + N     +   L        L+   L+ S+P++L    Q+  L
Sbjct: 29  YFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNL--PPQITVL 85

Query: 147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN 206
            +  N L   +P+       L   D   N L+  LP      +SL  L + NN+L+    
Sbjct: 86  EITQNAL-ISLPELPASLEYL---DACDNRLS-TLPEL---PASLKHLDVDNNQLT---- 133

Query: 207 VLEDL--HLIDLNIENNLFSGPIPEKLLS 233
           +L +L   L  +N +NN  +  +PE   S
Sbjct: 134 MLPELPALLEYINADNNQLTM-LPELPTS 161

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 31/176 (17%), Positives = 63/176 (35%), Gaps = 13/176 (7%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS------NLPVTVRNFSL 124
           +++  + +    L   L +    LE+   +D+S N +  S+P+      +   T   F  
Sbjct: 160 TSLEVLSVRNNQLT-FLPELPESLEA---LDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS 184
             N++T  IPE++  L     + L +N L+  I ++  Q T   ++       +      
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

Query: 185 TRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKD 240
                 L          +   +V +  H  +     N FS    ++L    + R  
Sbjct: 274 NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSA-FLDRLSDTVSARNT 328

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 63/311 (20%), Positives = 103/311 (33%), Gaps = 60/311 (19%)

Query: 377 RMVSSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQ 436
           R + +   +  +  +  L     +   +   A      +   + N+   S+         
Sbjct: 27  RHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDW 86

Query: 437 QYTNSFSE----GNFIGEGLLGSVYKA-ELPGGKLLAVK-----KLSNTVSQRQTDEEFL 486
                F +     + IG G+   V +      G   AVK         +  Q +   E  
Sbjct: 87  AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146

Query: 487 ELASTISRLR----HGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLH--------SD 532
                   LR    H +I+ LI          LV+D    G     +L          S+
Sbjct: 147 R--RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG-----ELFDYLTEKVALSE 199

Query: 533 EEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA 592
           +E           R  L A   + +L       IVH + K  NILLD+ + +R+SD G +
Sbjct: 200 KETRSIM------RSLLEA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS 247

Query: 593 PLLFSGSTNELSEGLLTAHGSG---APE-------FESGSYSCQSDVYSLGVVMLELLTG 642
             L  G      E L    G+    APE            Y  + D+++ GV++  LL G
Sbjct: 248 CHLEPG------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

Query: 643 RKP-YDRSRPR 652
             P + R +  
Sbjct: 302 SPPFWHRRQIL 312

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 52/245 (21%), Positives = 89/245 (36%), Gaps = 58/245 (23%)

Query: 488 LASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRV 547
           + S+ S    G + E      E  +      Y    TL  L+         +S+ +    
Sbjct: 156 ITSSQSSASSGFVEEKSLSDVEEEEAP-EDLYKDFLTLEHLI--------CYSFQV---- 202

Query: 548 ALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL 607
               A+ +++L        +H +  + NILL EK +V++ D GLA  ++           
Sbjct: 203 ----AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY------ 249

Query: 608 LTAHGSG-------APE-FESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLV 658
               G         APE      Y+ QSDV+S GV++ E+ + G  PY            
Sbjct: 250 -VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------------ 296

Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAK---SLSRFADIISRCVQWEPGFRPPMSEIVQD 715
               P +   +   R +    +G  +     +       +  C   EP  RP  SE+V+ 
Sbjct: 297 ----PGVKIDEEFCRRLK---EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

Query: 716 LLCMI 720
           L  ++
Sbjct: 350 LGNLL 354

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 28/96 (29%), Positives = 40/96 (41%), Gaps = 11/96 (11%)

Query: 445 GNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           G  +G G  G V +A+  G       + +AVK L    +  +      EL   I    H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 499 NIVELIGYCNEHGQHLLV---YDYGGNCTLHDLLHS 531
           N+V L+G C + G  L+V   +   GN  L   L S
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGN--LSTYLRS 120

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 22/215 (10%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
              +G G  G V+   E   G    +K ++   SQ   ++   E+   +  L H NI+++
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE-VLKSLDHPNIIKI 85

Query: 504 IGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
                ++    +V +   GG   L + + S +   K  S      +      AL Y    
Sbjct: 86  FEVFEDYHNMYIVMETCEGGE--LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143

Query: 562 CEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---A 615
               +VH + K  NIL         +++ D GLA L  S            A G+    A
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH------STNAAGTALYMA 194

Query: 616 PEFESGSYSCQSDVYSLGVVMLELLTGRKP-YDRS 649
           PE      + + D++S GVVM  LLTG  P    S
Sbjct: 195 PEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 67.6 bits (165), Expect = 7e-12
 Identities = 34/157 (21%), Positives = 57/157 (36%), Gaps = 28/157 (17%)

Query: 95  ESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLN 154
           E    +D SN ++   +P +LP   +  SLS N ++      +S L++L  L L++N + 
Sbjct: 31  ELESMVDYSNRNLT-HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR 89

Query: 155 GGIPDA----------------------FHQFTGLINFDLSANNLTGQLPPST--RNLSS 190
             +                               L + DLS N+    LP      NL+ 
Sbjct: 90  -SLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTK 147

Query: 191 LYSLHLQNNKL-SGTLNVLEDLHLIDLNIENNLFSGP 226
           L  L L   K     L  +  LHL  + ++   +   
Sbjct: 148 LTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 64.1 bits (156), Expect = 9e-11
 Identities = 31/190 (16%), Positives = 64/190 (33%), Gaps = 34/190 (17%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNF 122
            ++ VF+ +    L+  +   +         S   ++ + N    S+         ++  
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382

Query: 123 SLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTG----LINFDLSANNLT 178
            L  N L  +  +       +  L   +  LN     A+ +       ++  +LS+N LT
Sbjct: 383 ILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441

Query: 179 G---------------------QLPPSTRNLSSLYSLHLQNNKLS----GTLNVLEDLHL 213
           G                      +P    +L +L  L++ +N+L     G  + L  L  
Sbjct: 442 GSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQY 501

Query: 214 IDLNIENNLF 223
           I L   +N +
Sbjct: 502 IWL--HDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 58.3 bits (141), Expect = 6e-09
 Identities = 33/145 (22%), Positives = 57/145 (39%), Gaps = 10/145 (6%)

Query: 61  DSWQGVFCVFSNVTEIRLTGMNLGGV--LADTLGDLESVINIDLSNNHIGGSIPSNL--- 115
           DS          +  + L    L     +A    ++ S+  +D+S N +           
Sbjct: 367 DSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW 426

Query: 116 PVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSAN 175
             ++   +LS N LTGS+   L    ++LDL   NN +   IP        L   ++++N
Sbjct: 427 AESILVLNLSSNMLTGSVFRCLPPKVKVLDLH--NNRIM-SIPKDVTHLQALQELNVASN 483

Query: 176 NLTGQLPPST-RNLSSLYSLHLQNN 199
            L   +P      L+SL  + L +N
Sbjct: 484 QLKS-VPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 23/195 (11%), Positives = 56/195 (28%), Gaps = 19/195 (9%)

Query: 50  KWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVIN-----IDLSN 104
             +    + C      +  +    T + +T  ++      ++   +         +++ N
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285

Query: 105 NHIGGSIPSNLPV-------TVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGI 157
             I   I             ++    +       S     S   ++    L+ +      
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH 345

Query: 158 PDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKL------SGTLNVLEDL 211
                  +     + + N  T  +      L  L +L LQ N L      +     +  L
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSL 405

Query: 212 HLIDLNIENNLFSGP 226
             +D+++ N+L S  
Sbjct: 406 ETLDVSL-NSLNSHA 419

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 54/271 (19%), Positives = 94/271 (34%), Gaps = 54/271 (19%)

Query: 436 QQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELA----- 489
            +Y+  +S  + +G G  G V+ A      K + VK +           E  +L      
Sbjct: 20  GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79

Query: 490 -STISRLRHGNIVELIGYCNEHGQHLLV----------YDYGGNCTLHDLLHSDEEAHKK 538
            + +SR+ H NI++++      G   LV          + +      H  L  +  A   
Sbjct: 80  IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAF---IDRHPRL-DEPLASYI 135

Query: 539 FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG 598
           F   +          A+ YL+      I+H + K  NI++ E   +++ D G A      
Sbjct: 136 F-RQL--------VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA------ 177

Query: 599 STNELSEG--LLTAHGS---GAPEFESG-SYSC-QSDVYSLGVVMLELLTGRKPYD--RS 649
               L  G    T  G+    APE   G  Y   + +++SLGV +  L+    P+     
Sbjct: 178 --AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235

Query: 650 RPRGEQSLVRWAIPRLHDIDALSRM--VDPS 678
                          L  +  +S +    P 
Sbjct: 236 TVEAAIHPPYLVSKELMSL--VSGLLQPVPE 264

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 14/155 (9%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIP--SNLPVTVRNFSLSGN 127
           F+   +  L   ++      T  +L S+  I  +N+ I  S+     LP  V    L+GN
Sbjct: 23  FAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDI-KSVQGIQYLP-NVTKLFLNGN 78

Query: 128 QLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRN 187
           +LT  I + L+ L  L  L L+ N +      +      L +  L  N ++  +     +
Sbjct: 79  KLT-DI-KPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGIS-DINGLV-H 132

Query: 188 LSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENN 221
           L  L SL+L NNK++  + VL  L  L  L++E+N
Sbjct: 133 LPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDN 166

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 12/161 (7%)

Query: 91  LGDLESVINIDLSNNHIGGSIP--SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL 148
           L +L+++  + L  N +   +    +L   +++ SL  N ++  I   L  L QL  L L
Sbjct: 86  LANLKNLGWLFLDENKVK-DLSSLKDLK-KLKSLSLEHNGIS-DI-NGLVHLPQLESLYL 141

Query: 149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVL 208
            NN +         + T L    L  N ++  + P    L+ L +L+L  N +S  L  L
Sbjct: 142 GNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVPLA-GLTKLQNLYLSKNHIS-DLRAL 196

Query: 209 EDL-HLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTV 248
             L +L  L + +            ++       N   + V
Sbjct: 197 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 29/132 (21%), Positives = 49/132 (37%), Gaps = 8/132 (6%)

Query: 91  LGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN 150
                  I  +L    +  ++  N   ++     + + +  S+ + +  L  +  L LN 
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77

Query: 151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLED 210
           N L    P        L    L  N +   L     +L  L SL L++N +S  +N L  
Sbjct: 78  NKLTDIKP--LANLKNLGWLFLDENKVK-DLSSLK-DLKKLKSLSLEHNGIS-DINGLVH 132

Query: 211 L-HLIDLNIENN 221
           L  L  L + NN
Sbjct: 133 LPQLESLYLGNN 144

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 32/135 (23%), Positives = 55/135 (40%), Gaps = 10/135 (7%)

Query: 91  LGDLESVINIDLSNNHIGG-SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
           L  L  + ++ L NN I   ++ S L   +   SL  NQ++  I   L+ LT+L +L L+
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLT-KLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLS 186

Query: 150 NNHLNGGIPD--AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV 207
            NH    I D  A      L   +L +     +      NL    ++   +  L     +
Sbjct: 187 KNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 242

Query: 208 LEDLHLIDLNIENNL 222
            +D      N++ +L
Sbjct: 243 SDDGDYEKPNVKWHL 257

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 13/88 (14%), Positives = 35/88 (39%), Gaps = 6/88 (6%)

Query: 135 ESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSL 194
            S     + +  +L    +   +    ++   +     + +++   +    + L ++  L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73

Query: 195 HLQNNKLSGTLNVLEDL-HLIDLNIENN 221
            L  NKL+  +  L +L +L  L ++ N
Sbjct: 74  FLNGNKLT-DIKPLANLKNLGWLFLDEN 100

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 58/260 (22%), Positives = 106/260 (40%), Gaps = 52/260 (20%)

Query: 408 APAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLL 467
           AP    + +          V      + +Q   +++    IG G  G V++A+L     +
Sbjct: 8   APLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV 67

Query: 468 AVKKLSNTVSQRQTDEEFL--ELASTISRLRHGNIVELIGYCNEHGQHL------LVYDY 519
           A+KK+       Q D+ F   EL   +  ++H N+V+L  +   +G         LV +Y
Sbjct: 68  AIKKV------LQ-DKRFKNREL-QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119

Query: 520 GGNCTLHDLLHS--------DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNF 571
               T++                  K + + +         R+L Y+  +    I H + 
Sbjct: 120 VP-ETVYRASRHYAKLKQTMPMLLIKLYMYQL--------LRSLAYIHSIG---ICHRDI 167

Query: 572 KSSNILLD-EKLIVRVSDCGLAPLLFSG--STNELSEGLLTAHGSG---APE--FESGSY 623
           K  N+LLD    ++++ D G A +L +G  + + +         S    APE  F + +Y
Sbjct: 168 KPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--------SRYYRAPELIFGATNY 219

Query: 624 SCQSDVYSLGVVMLELLTGR 643
           +   D++S G VM EL+ G+
Sbjct: 220 TTNIDIWSTGCVMAELMQGQ 239

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 47/278 (16%), Positives = 88/278 (31%), Gaps = 47/278 (16%)

Query: 421 NVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQR 479
           +        F   SL +    +     IG+G  G V  A E     + A+K ++    ++
Sbjct: 7   HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66

Query: 480 QTDEEFLELASTIS---RLRHGNIVELIGYCNEHGQHLLVYDY--GG------------- 521
              ++   + + +    +L H NI  L     +     LV +   GG             
Sbjct: 67  INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126

Query: 522 -----------NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE------- 563
                              + +        +   +            ++++         
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186

Query: 564 PPIVHGNFKSSNILL--DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE- 617
             I H + K  N L   ++   +++ D GL+   F    N    G+ T  G+    APE 
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLS-KEFYKLNNGEYYGMTTKAGTPYFVAPEV 245

Query: 618 --FESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPR 652
               + SY  + D +S GV++  LL G  P    +   
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD 283

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 53/332 (15%), Positives = 112/332 (33%), Gaps = 72/332 (21%)

Query: 408 APAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKL 466
           +   V R S  +      +  +      +   + +  G  +G G  GSVY    +     
Sbjct: 11  SSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLP 70

Query: 467 LAVK-----KLSNTVSQRQTDEEFLELASTISRLRHG--NIVELIGYCNEHGQHLLVYDY 519
           +A+K     ++S+           +E+   + ++  G   ++ L+ +       +L+ + 
Sbjct: 71  VAIKHVEKDRISDWGELPNGTRVPMEVV-LLKKVSSGFSGVIRLLDWFERPDSFVLILER 129

Query: 520 GGNC-------TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFK 572
                      T    L  +E A   F W +          A+++        ++H + K
Sbjct: 130 PEPVQDLFDFITERGAL-QEELARSFF-WQV--------LEAVRHC---HNCGVLHRDIK 176

Query: 573 SSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLL-TAHGS---GAPEFESG-SYS-C 625
             NIL+D  +  +++ D G            L + +     G+     PE+     Y   
Sbjct: 177 DENILIDLNRGELKLIDFGSG--------ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 228

Query: 626 QSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAY-L 684
            + V+SLG+++ +++ G  P++                   +I          + G    
Sbjct: 229 SAAVWSLGILLYDMVCGDIPFEHDE----------------EI----------IRGQVFF 262

Query: 685 AKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
            + +S     +I  C+   P  RP   EI   
Sbjct: 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 63.4 bits (155), Expect = 4e-11
 Identities = 58/260 (22%), Positives = 96/260 (36%), Gaps = 52/260 (20%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-------LRHGN 499
           +GEG  G V  A      + +AVK +          +  ++    I +       L H N
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM--------KRAVDCPENIKKEICINKMLNHEN 66

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD-----EEAHKKFSWNIRIRVALGAARA 554
           +V+  G+  E     L  +Y     L D +  D      +A + F   +           
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AG 117

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS- 613
           + YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   L    G+ 
Sbjct: 118 VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL---LNKMCGTL 171

Query: 614 --GAPEFESG-SYS-CQSDVYSLGVVMLELLTGRKPYD---------RSRPRGEQSLVRW 660
              APE      +     DV+S G+V+  +L G  P+D               +  L  W
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231

Query: 661 AIPRLHDIDALSRM--VDPS 678
                  +  L ++   +PS
Sbjct: 232 KKIDSAPLALLHKILVENPS 251

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 64.0 bits (156), Expect = 6e-11
 Identities = 67/258 (25%), Positives = 113/258 (43%), Gaps = 41/258 (15%)

Query: 405 KPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAEL-PG 463
           +P A   +        + +++ V+       +    S+++   IG G  G VY+A+L   
Sbjct: 19  QPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDS 78

Query: 464 GKLLAVKKLSNTVSQRQTDEEFL--ELASTISRLRHGNIVELIGYCNEHGQHL------L 515
           G+L+A+KK    V Q   D+ F   EL   + +L H NIV L  +    G+        L
Sbjct: 79  GELVAIKK----VLQ---DKRFKNREL-QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130

Query: 516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL-GAARALQYL--QEVCEPPIVHGNFK 572
           V DY    T++ +      A +     I +++ +    R+L Y+    +C     H + K
Sbjct: 131 VLDYVP-ETVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSFGIC-----HRDIK 183

Query: 573 SSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----APE--FESGSYSC 625
             N+LLD +  ++++ D G A  L  G  N        ++       APE  F +  Y+ 
Sbjct: 184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-------VSYICSRYYRAPELIFGATDYTS 236

Query: 626 QSDVYSLGVVMLELLTGR 643
             DV+S G V+ ELL G+
Sbjct: 237 SIDVWSAGCVLAELLLGQ 254

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 63.0 bits (154), Expect = 6e-11
 Identities = 60/238 (25%), Positives = 91/238 (38%), Gaps = 53/238 (22%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR----LR--- 496
              +G G+   V +    P  K  AVK +  T     + EE  EL     +    LR   
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 497 -HGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLH--------SDEEAHKKFSWNIRI 545
            H NI++L      +    LV+D    G     +L          S++E  K        
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKG-----ELFDYLTEKVTLSEKETRKIM------ 130

Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
           R  L     +  L ++    IVH + K  NILLD+ + ++++D G +  L  G      E
Sbjct: 131 RALLEV---ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------E 178

Query: 606 GLLTAHGSG---APE-------FESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPR 652
            L    G+    APE            Y  + D++S GV+M  LL G  P + R +  
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 31/118 (26%), Positives = 53/118 (44%), Gaps = 9/118 (7%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLI 168
            IP ++P+      L+ N+L     + L  RL  L+ L L  N L G  P+AF   + + 
Sbjct: 22  EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ 81

Query: 169 NFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENN 221
              L  N +  ++       L  L +L+L +N++S    G+   L  L  ++L   +N
Sbjct: 82  ELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA--SN 136

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 40/137 (29%), Positives = 54/137 (39%), Gaps = 18/137 (13%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN 169
           S+PS +P       L    L      +   LT+L  L+L+ N L       F   T L  
Sbjct: 28  SVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGT 87

Query: 170 FDLSANNLTGQLPPST-RNLSSLYSLHLQNNKL----SGTLNVLEDLHLIDLNIENNLFS 224
             L+ N L   LP     +L+ L  L+L  N+L    SG  + L  L  + LN   N   
Sbjct: 88  LGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLN--TN--- 141

Query: 225 GPIPEKLLSIPN--FRK 239
                +L SIP   F K
Sbjct: 142 -----QLQSIPAGAFDK 153

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 42/140 (30%), Positives = 61/140 (43%), Gaps = 8/140 (5%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP---VTVRN 121
             F   + +T + L    L  + A    DL  +  + L+NN +  S+P  +      +  
Sbjct: 53  ATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDK 111

Query: 122 FSLSGNQLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLSANNLTG 179
             L GNQL  S+P  +  RLT+L +L LN N L   IP  AF + T L    LS N L  
Sbjct: 112 LYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQS 169

Query: 180 QLPPSTRNLSSLYSLHLQNN 199
               +   L  L ++ L  N
Sbjct: 170 VPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 14/160 (8%)

Query: 71  SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL---PVTVRNFSLSGN 127
           ++  ++ L    L  +   T   L  +  ++L  N +  ++ + +      +    L+ N
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93

Query: 128 QLTGSIPESL-SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST- 185
           QL  S+P  +   LTQL  L L  N L       F + T L    L+ N L   +P    
Sbjct: 94  QLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151

Query: 186 RNLSSLYSLHLQNNKLS----GTLNVLEDLHLIDLNIENN 221
             L++L +L L  N+L     G  + L  L  I L    N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF--GN 189

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 51/242 (21%), Positives = 95/242 (39%), Gaps = 53/242 (21%)

Query: 436 QQYTNSFSE----GNFIGEGLLGSVYKA-ELPGGKLLAVK-----KLSNTVSQRQTDEEF 485
             Y  +  +       +G G  G V  A E    K +A++     K +   ++       
Sbjct: 127 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALN 186

Query: 486 LELASTI-SRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLL-------HSDEEA 535
           +E    I  +L H  I+++  + +    + +V +   GG     +L           E  
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGG-----ELFDKVVGNKRLKEAT 240

Query: 536 HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLA 592
            K + + +          A+QYL E     I+H + K  N+LL   +E  +++++D G +
Sbjct: 241 CKLYFYQM--------LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289

Query: 593 PLLFSGSTNELSEGLLTAHGS---GAPE----FESGSYSCQSDVYSLGVVMLELLTGRKP 645
            +L   S       + T  G+    APE      +  Y+   D +SLGV++   L+G  P
Sbjct: 290 KILGETSL------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

Query: 646 YD 647
           + 
Sbjct: 344 FS 345

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 65/288 (22%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEE--FLELASTISRLRHGNIVEL- 503
           +GEG  G V  A      + +A+K +S  + ++         E+ S +  LRH +I++L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI-SYLKLLRHPHIIKLY 75

Query: 504 --IGYCNEHGQHL-LVYDY-GGNCTLHDLL-----HSDEEAHKKFSWNIRIRVALGAARA 554
             I         + +V +Y GG   L D +      +++E  + F   I          A
Sbjct: 76  DVI----TTPTDIVMVIEYAGGE--LFDYIVEKKRMTEDEGRRFFQQIIC---------A 120

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS- 613
           ++Y        IVH + K  N+LLD+ L V+++D GL+ ++  G        L T+ GS 
Sbjct: 121 IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG------NFLKTSCGSP 171

Query: 614 --GAPEFESG-SYS-CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID 669
              APE  +G  Y+  + DV+S G+V+  +L GR P+D                    I 
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE-----------------FIP 214

Query: 670 ALSRMVDPSLDGAY-LAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
            L + V       Y +   LS  A  +I R +  +P  R  + EI +D
Sbjct: 215 NLFKKV---NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 46/223 (20%), Positives = 86/223 (38%), Gaps = 44/223 (19%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR---- 494
             +     +GEG  G V K      G+++A+KK           ++   +     R    
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKL 77

Query: 495 ---LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS-----DEEAHKKFSWNIRIR 546
              LRH N+V L+  C +  +  LV+++  + T+ D L       D +  +K+ + I   
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQI--- 133

Query: 547 VALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEG 606
                   + +        I+H + K  NIL+ +  +V++ D G A    +       + 
Sbjct: 134 -----INGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYDDE 184

Query: 607 LLTAHGSG----APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
           + T         APE       Y    DV+++G ++ E+  G 
Sbjct: 185 VAT-----RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 58/260 (22%), Positives = 96/260 (36%), Gaps = 52/260 (20%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-------LRHGN 499
           +GEG  G V  A      + +AVK +          +  ++    I +       L H N
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM--------KRAVDCPENIKKEICINKMLNHEN 66

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSD-----EEAHKKFSWNIRIRVALGAARA 554
           +V+  G+  E     L  +Y     L D +  D      +A + F   +           
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------G 117

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS- 613
           + YL  +    I H + K  N+LLDE+  +++SD GLA +    +   L   L    G+ 
Sbjct: 118 VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL---LNKMCGTL 171

Query: 614 --GAPEFESG-SYS-CQSDVYSLGVVMLELLTGRKPYD---------RSRPRGEQSLVRW 660
              APE      +     DV+S G+V+  +L G  P+D               +  L  W
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231

Query: 661 AIPRLHDIDALSRM--VDPS 678
                  +  L ++   +PS
Sbjct: 232 KKIDSAPLALLHKILVENPS 251

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 55/292 (18%), Positives = 106/292 (36%), Gaps = 70/292 (23%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLR-------HG 498
           +G+G  G+V+    L     +A+K +  N V       + +     ++ L        H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCT-LHDLLH-----SDEEAHKKFSWNIRIRVALGAA 552
            ++ L+ +       +LV +       L D +       +  +   F   +         
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF-GQV--------V 149

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLL-TA 610
            A+Q+        +VH + K  NIL+D  +   ++ D       F GS   L +      
Sbjct: 150 AAIQHC---HSRGVVHRDIKDENILIDLRRGCAKLID-------F-GSGALLHDEPYTDF 198

Query: 611 HGS---GAPEFESG-SYS-CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL 665
            G+     PE+ S   Y    + V+SLG+++ +++ G  P++R +               
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------------- 243

Query: 666 HDIDALSRMVDPSLDGAY-LAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
            +I          L+        +S     +I RC+  +P  RP + EI+ D
Sbjct: 244 -EI----------LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 19/157 (12%)

Query: 70  FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHI----GGSIPSNLPVTVRNFSLS 125
            +N  +  L   ++  +   +  +L  V N +  N++I    G    +NL    +   LS
Sbjct: 18  LANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQSLAGMQFFTNL----KELHLS 71

Query: 126 GNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST 185
            NQ++  +   L  LT+L +LS+N N L   +         L    L  N L      S 
Sbjct: 72  HNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLN--GIPSACLSRLFLDNNELRD--TDSL 124

Query: 186 RNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENN 221
            +L +L  L ++NNKL  ++ +L  L  L  L++  N
Sbjct: 125 IHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGN 160

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 32/135 (23%), Positives = 53/135 (39%), Gaps = 15/135 (11%)

Query: 91  LGDLESVINIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
              L + +  +L    +   +    L   V+NF+   + +  S+   +   T L +L L+
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVSQKELS-GVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLS 71

Query: 150 NNHLNGGIPD--AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV 207
           +N     I D       T L    ++ N L   L       + L  L L NN+L    + 
Sbjct: 72  HNQ----ISDLSPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELR-DTDS 123

Query: 208 LEDL-HLIDLNIENN 221
           L  L +L  L+I NN
Sbjct: 124 LIHLKNLEILSIRNN 138

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 20/125 (16%), Positives = 42/125 (33%), Gaps = 6/125 (4%)

Query: 99  NIDLSNNHIGGSIP-SNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGI 157
            + L NN +  +    +L   +   S+  N+L  SI   L  L++L  L L+ N +    
Sbjct: 110 RLFLDNNELRDTDSLIHLK-NLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITN-- 164

Query: 158 PDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLN 217
                +   +   DL+      +       L    ++   + +      +      +D  
Sbjct: 165 TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC 224

Query: 218 IENNL 222
           +   L
Sbjct: 225 VLWEL 229

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 20/99 (20%), Positives = 43/99 (43%), Gaps = 8/99 (8%)

Query: 124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPP 183
                +   +      L   +  +L    +      +  + +G+ NF+   +N+   L  
Sbjct: 4   QRPTPIN-QV-FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLAG 58

Query: 184 STRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENN 221
             +  ++L  LHL +N++S  L+ L+DL  L +L++  N
Sbjct: 59  -MQFFTNLKELHLSHNQIS-DLSPLKDLTKLEELSVNRN 95

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 34/227 (14%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-NTVSQRQTDEEFLELA-----STISRLRHGNI 500
           IG G  G VY       GK+ A+K L    +  +    E L L      S +S      I
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFI 254

Query: 501 VELIGYCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR---A 554
           V +  Y       L  + D   GG+      LH     H  FS      +   AA     
Sbjct: 255 VCMS-YAFHTPDKLSFILDLMNGGD------LHYHLSQHGVFSEA---DMRFYAAEIILG 304

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+++       +V+ + K +NILLDE   VR+SD GLA        +      +  HG  
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYM 357

Query: 615 APE--FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR 659
           APE   +  +Y   +D +SLG ++ +LL G  P+ + + + +  + R
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.5 bits (151), Expect = 3e-10
 Identities = 32/123 (26%), Positives = 48/123 (39%), Gaps = 10/123 (8%)

Query: 103 SNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFH 162
           S   +  S+       VR   L+   LT  +   L +L  +  L L++N L   +P A  
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALA 483

Query: 163 QFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL----HLIDLNI 218
               L     S N L   +     NL  L  L L NN+L      ++ L     L+ LN+
Sbjct: 484 ALRCLEVLQASDNALE-NVDGV-ANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNL 540

Query: 219 ENN 221
           + N
Sbjct: 541 QGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 57.1 bits (137), Expect = 1e-08
 Identities = 25/107 (23%), Positives = 44/107 (41%), Gaps = 10/107 (9%)

Query: 100 IDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGI 157
           + L++  +  ++  +L   + V +  LS N+L  ++P +L+ L  L  L  ++N L   +
Sbjct: 446 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501

Query: 158 PDAFHQFTGLINFDLSANNLTGQLP--PSTRNLSSLYSLHLQNNKLS 202
                    L    L  N L  Q        +   L  L+LQ N L 
Sbjct: 502 DG-VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 28/138 (20%), Positives = 53/138 (38%), Gaps = 11/138 (7%)

Query: 58  PCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP- 116
                   +   +++V  + L   +L  +    L  L  V ++DLS+N +  ++P  L  
Sbjct: 428 KFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRL-RALPPALAA 484

Query: 117 -VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFH--QFTGLINFDLS 173
              +     S N L  ++   ++ L +L +L L NN L               L+  +L 
Sbjct: 485 LRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQ 541

Query: 174 ANNLTGQLPPSTRNLSSL 191
            N+L  Q       L+ +
Sbjct: 542 GNSLC-QEEGIQERLAEM 558

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 60.3 bits (147), Expect = 4e-10
 Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 62/287 (21%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEE--FLELASTISRLRHGNIVEL- 503
           +G G  G V   E    G  +AVK L+    +          E+   +   RH +I++L 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI-QNLKLFRHPHIIKLY 77

Query: 504 --IGYCNEHGQHL-LVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIRIRVALGAARAL 555
             I           +V +Y     L D +       + EA + F   I          A+
Sbjct: 78  QVI----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF-QQI--------LSAV 124

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS-- 613
            Y        +VH + K  N+LLD  +  +++D GL+ ++  G      E L T+ GS  
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRTSCGSPN 175

Query: 614 -GAPEFESG-SYS-CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
             APE  SG  Y+  + D++S GV++  LL G  P+D                    +  
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-----------------EHVPT 218

Query: 671 LSRMVDPSLDGAY-LAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
           L + +     G + + + L+R    ++   +Q +P  R  + +I + 
Sbjct: 219 LFKKI---RGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.6 bits (151), Expect = 4e-10
 Identities = 65/372 (17%), Positives = 108/372 (29%), Gaps = 107/372 (28%)

Query: 398 LVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFT---------IASLQQYTNSFSEGNFI 448
           L+  +  +   P+ +TR      + + +   VF             L+Q          +
Sbjct: 94  LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153

Query: 449 G-EGLLGSVYKAELPGGK-LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL-IG 505
             +G+LGS        GK  +A+    +   Q + D                 I  L + 
Sbjct: 154 LIDGVLGS--------GKTWVALDVCLSYKVQCKMD---------------FKIFWLNLK 190

Query: 506 YCNEHGQHL-----LVYDYGGN-CTLHDLLHSDEEAHKKFSWNIRIRVALGA---ARALQ 556
            CN     L     L+Y    N  +  D  HS     +  S    +R  L +      L 
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSD--HSSNIKLRIHSIQAELRRLLKSKPYENCLL 248

Query: 557 YLQEVCEPPIVHG-NFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
            L  V      +  N          K+++      +   L + +T  +S   L  H    
Sbjct: 249 VLLNVQNAKAWNAFNLSC-------KILLTTRFKQVTDFLSAATTTHIS---LDHHSMTL 298

Query: 616 PEFESGSYSCQSDVYSLGVVMLELL---TGRKPYDRSR------PR-----GE---QSLV 658
              E                   LL      +P D  R      PR      E     L 
Sbjct: 299 TPDEV----------------KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA 342

Query: 659 RWAIPRLHDIDALSRMVDPSLD--------GAYLAKSLSRF---ADIISR--CVQW-EPG 704
            W   +  + D L+ +++ SL+          +    LS F   A I +    + W +  
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF--DRLSVFPPSAHIPTILLSLIWFDVI 400

Query: 705 FRPPMSEIVQDL 716
               M  +V  L
Sbjct: 401 KSDVM-VVVNKL 411

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 8e-07
 Identities = 96/652 (14%), Positives = 177/652 (27%), Gaps = 212/652 (32%)

Query: 93  DLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQ-LTGSI------------PESLSR 139
           D E           I   +       V NF     Q +  SI             +++S 
Sbjct: 8   DFE-TGEHQYQYKDI---LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSG 63

Query: 140 LTQLLDLSLNNNHLNGGIPDAFHQFTGLI---NFDLSANNLTGQLPPSTRNLSSLYSLHL 196
             +L    L+         +   +F   +   N+      L   +    R  S +  +++
Sbjct: 64  TLRLFWTLLSKQE------EMVQKFVEEVLRINYKF----LMSPIKTEQRQPSMMTRMYI 113

Query: 197 -QNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALPPTA 255
            Q ++L     V    ++               +  L +   R+          AL    
Sbjct: 114 EQRDRLYNDNQVFAKYNV------------SRLQPYLKL---RQ----------ALL--- 145

Query: 256 IPPSIAPAPTFQAPGDQADAPSAFEMTNSAKAKKFWTTKRVIWVALSAA---AILCALGC 312
               + PA      G          +  S K           WVAL       + C +  
Sbjct: 146 ---ELRPAKNVLIDG----------VLGSGKT----------WVALDVCLSYKVQCKMDF 182

Query: 313 SLFMW---RYCKT--------RRVNRDAEKNTGTYKGHGEKP------------------ 343
            +F W   + C +        +++    + N  +   H                      
Sbjct: 183 KIF-WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241

Query: 344 NYKNSPLQPSGQV-EEVSKEPVVK-----------SQDGHGVDS--------RRMVSSPR 383
            Y+N  L     V   V                  ++     D           +     
Sbjct: 242 PYENCLL-----VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSM 296

Query: 384 P--QDEKLPL-------PPLPLPLVEKVTVKPLA----PAEVTRRSSPST---------- 420
               DE   L        P  LP  E +T  P         +  R   +T          
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLP-REVLTTNPRRLSIIAESI--RDGLATWDNWKHVNCD 353

Query: 421 ---NVISSSVSVFTIASLQQYTNS---FSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSN 474
               +I SS++V   A  ++  +    F     I   LL  ++   +    ++ V KL  
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413

Query: 475 -TVSQRQTDEE-------FLELASTISRLR--HGNIVE----LIGYCNEH---------- 510
            ++ ++Q  E        +LEL   +      H +IV+       + ++           
Sbjct: 414 YSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF 473

Query: 511 ----GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSW-NIRIRVALGAARALQYLQEVCEPP 565
               G HL   ++    TL  ++  D      F +   +IR    A  A   +    +  
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMVFLD------FRFLEQKIRHDSTAWNASGSILNTLQQL 527

Query: 566 IVHGNFKSSNILLDEKLIVRVSD----CGLAPLLFSGSTNELSEGLLTAHGS 613
             +  +   N    E+L+  + D         L+ S  T+ L   L+    +
Sbjct: 528 KFYKPYICDNDPKYERLVNAILDFLPKIE-ENLICSKYTDLLRIALMAEDEA 578

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 2e-05
 Identities = 49/287 (17%), Positives = 77/287 (26%), Gaps = 102/287 (35%)

Query: 27  VTDPRDVMALNSLYISLNFPPLEKWLSFGGDP-CGDSWQGVFCVFSNVTEIRLTG----M 81
           V+  +  + L    + L   P  K +   G    G +W  +    S   + ++      +
Sbjct: 131 VSRLQPYLKLRQALLELR--P-AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL 187

Query: 82  NLGGVL--ADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSR 139
           NL         L  L+ ++     N        SN+                SI   L R
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK-----------LRIHSIQAELRR 236

Query: 140 LTQ-------LLDLS--LNNNHLNGGIPDAFH---------QFTGLINF----------- 170
           L +       LL L    N         +AF+         +F  + +F           
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKAW-----NAFNLSCKILLTTRFKQVTDFLSAATTTHISL 291

Query: 171 -------------DLSANNL---TGQLPPSTRNLSSL-----------------YSLHLQ 197
                         L    L      LP      +                      H+ 
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351

Query: 198 NNKLSGT----LNVLEDL----HLIDLNIENNLF--SGPIPEKLLSI 234
            +KL+      LNVLE          L++    F  S  IP  LLS+
Sbjct: 352 CDKLTTIIESSLNVLEPAEYRKMFDRLSV----FPPSAHIPTILLSL 394

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 60.7 bits (148), Expect = 4e-10
 Identities = 58/305 (19%), Positives = 113/305 (37%), Gaps = 67/305 (21%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR---- 494
             + +   IGEG  G V+K      G+++A+KK           E+   +     R    
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRM 55

Query: 495 ---LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGA 551
              L+H N+V L+       +  LV++Y   C  H +LH  +   +    ++   +    
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEY---CD-HTVLHELDRYQRGVPEHLVKSITWQT 111

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
            +A+ +  +      +H + K  NIL+ +  ++++ D G A  L +G ++   + + T  
Sbjct: 112 LQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDEVAT-- 165

Query: 612 GSG----APE--FESGSYSCQSDVYSLGVVMLELLTGR--------------------KP 645
                  +PE       Y    DV+++G V  ELL+G                       
Sbjct: 166 ---RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL 222

Query: 646 YDRSRPRGEQSLVRWA---IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWE 702
             R +     +   ++   IP   D++ L     P++    L         ++  C+  +
Sbjct: 223 IPRHQQ-VFSTNQYFSGVKIPDPEDMEPLELKF-PNISYPAL--------GLLKGCLHMD 272

Query: 703 PGFRP 707
           P  R 
Sbjct: 273 PTERL 277

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 33/228 (14%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGNIVELIG 505
           +G G  G V+  ++   GKL A KKL+    +++   +   +   I +++    IV L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 506 YCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR---ALQYLQ 559
           Y  E    L LV     GG+   H  +++ +E +  F      R     A+    L++L 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYH--IYNVDEDNPGFQEP---RAIFYTAQIVSGLEHLH 306

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS-GAPEF 618
           +     I++ + K  N+LLD+   VR+SD GLA         EL  G     G  G P F
Sbjct: 307 QRN---IIYRDLKPENVLLDDDGNVRISDLGLA--------VELKAGQTKTKGYAGTPGF 355

Query: 619 ------ESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPRGEQSLVR 659
                     Y    D ++LGV + E++  R P   R      + L +
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 403

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 59.9 bits (146), Expect = 6e-10
 Identities = 49/220 (22%), Positives = 78/220 (35%), Gaps = 31/220 (14%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGNIVE 502
            N IG G  G V  A +       A KK+         D +  +    I   L H NI+ 
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIP---KYFVEDVDRFKQEIEIMKSLDHPNIIR 70

Query: 503 LIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDE-EAHKKFSWNIRIRVALGAARALQYLQ 559
           L     ++    LV +   GG     +L   +     + F  +   R+      A+ Y  
Sbjct: 71  LYETFEDNTDIYLVMELCTGG-----ELF--ERVVHKRVFRESDAARIMKDVLSAVAYCH 123

Query: 560 EVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG-- 614
           ++    + H + K  N L         +++ D GLA     G        + T  G+   
Sbjct: 124 KL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM------MRTKVGTPYY 174

Query: 615 -APEFESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPR 652
            +P+   G Y  + D +S GV+M  LL G  P    +   
Sbjct: 175 VSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE 214

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 51/245 (20%), Positives = 97/245 (39%), Gaps = 41/245 (16%)

Query: 415 RSSPSTNVISSSV--SVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKK 471
           RS    N  S  +  S FT+         +     IG G  G V  A +    + +A+KK
Sbjct: 4   RSKRDNNFYSVEIGDSTFTV------LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK 57

Query: 472 LS----NTVSQRQTDEEFLELASTISRLRHGNIVELI-----GYCNEHGQHL-LVYDYGG 521
           LS    N    ++   E + +      + H NI+ L+         E  Q + +V +   
Sbjct: 58  LSRPFQNQTHAKRAYRELVLM----KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD 113

Query: 522 NCTLHDLLHSD-EEAHKK-FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD 579
              L  ++  + +        + +           +++L       I+H + K SNI++ 
Sbjct: 114 -ANLCQVIQMELDHERMSYLLYQM--------LCGIKHLHSAG---IIHRDLKPSNIVVK 161

Query: 580 EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLE 638
               +++ D GLA     G++  ++  ++T +   APE      Y    D++S+G +M E
Sbjct: 162 SDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR-APEVILGMGYKENVDIWSVGCIMGE 218

Query: 639 LLTGR 643
           ++ G 
Sbjct: 219 MIKGG 223

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 60.4 bits (147), Expect = 7e-10
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 31/218 (14%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVK--KLSNTVSQRQTDEEFLELASTI-SRLRHGNI 500
              IG+G    V +      G+  AVK   ++   S      E L+  ++I   L+H +I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 501 VELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR----A 554
           VEL+   +  G   +V+++  G +  L   +    +A   +S      VA    R    A
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGAD--LCFEIVKRADAGFVYSE----AVASHYMRQILEA 142

Query: 555 LQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           L+Y  +     I+H + K   +LL   +    V++   G+A  L      E         
Sbjct: 143 LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-----ESGLVAGGRV 194

Query: 612 GSG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKP 645
           G+    APE  +   Y    DV+  GV++  LL+G  P
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 62/311 (19%), Positives = 112/311 (36%), Gaps = 81/311 (26%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLS-----------------NTVSQRQTDEEFLELA 489
           IG+G  G V  A         A+K LS                  T        +     
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 490 STISR-------LRHGNIVEL---IGYCNEHGQHL-LVYDY--GGNCTLHDLLH----SD 532
             + +       L H N+V+L   +   NE   HL +V++    G   + ++      S+
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNED--HLYMVFELVNQGP--VMEVPTLKPLSE 136

Query: 533 EEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA 592
           ++A   F   I         + ++YL       I+H + K SN+L+ E   ++++D G++
Sbjct: 137 DQARFYFQDLI---------KGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 593 PLLFSGSTNELSEGLL-TAHGS---GAPEFESGS---YS-CQSDVYSLGVVMLELLTGRK 644
                    + S+ LL    G+    APE  S +   +S    DV+++GV +   + G+ 
Sbjct: 185 NEF------KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

Query: 645 PYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPG 704
           P+   R     S ++       D   ++                    D+I+R +   P 
Sbjct: 239 PFMDERIMCLHSKIKSQALEFPDQPDIA----------------EDLKDLITRMLDKNPE 282

Query: 705 FRPPMSEIVQD 715
            R  + EI   
Sbjct: 283 SRIVVPEIKLH 293

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 60.0 bits (146), Expect = 9e-10
 Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 31/208 (14%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR----HGNIVE 502
           +G G    V++A  +   + + VK L     ++   E        I  L       NI+ 
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE--------IKILENLRGGPNIIT 95

Query: 503 L--IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           L  I          LV+++  N     L  +  +   +F     +   L   +AL Y   
Sbjct: 96  LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY----MYEIL---KALDYCHS 148

Query: 561 VCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-- 617
           +    I+H + K  N+++D E   +R+ D GLA   F     E +  + + +    PE  
Sbjct: 149 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGPELL 202

Query: 618 FESGSYSCQSDVYSLGVVMLELLTGRKP 645
            +   Y    D++SLG ++  ++  ++P
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 34/117 (29%), Positives = 47/117 (40%), Gaps = 8/117 (6%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN 169
           S+P+ +P +     L  N+L         +LTQL  LSL+ N +       F + T L  
Sbjct: 21  SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTI 80

Query: 170 FDLSANNLTGQLPPST-RNLSSLYSLHLQNNKL----SGTLNVLEDLHLIDLNIENN 221
             L  N L   LP      L+ L  L L  N+L     G  + L  L  I L+   N
Sbjct: 81  LYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLH--TN 134

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 11/129 (8%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN 169
           S+P+ +P   +   L  NQ+T   P     L  L +L L +N L       F   T L  
Sbjct: 33  SVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV 92

Query: 170 FDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSGPI 227
            DL  N LT  LP +    L  L  L +  NKL+     +E L HL  L ++ N      
Sbjct: 93  LDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQN------ 145

Query: 228 PEKLLSIPN 236
             +L SIP+
Sbjct: 146 --QLKSIPH 152

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 59/248 (23%), Positives = 93/248 (37%), Gaps = 52/248 (20%)

Query: 434 SLQQYTNSFSE----GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLEL 488
            L + +  F++       IG G      +          AVK +    S+R   EE    
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK--SKRDPTEE---- 65

Query: 489 ASTISRLR----HGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDE-EAHKKFSW 541
              I  L     H NI+ L    ++     +V +   GG     +LL  D+    K FS 
Sbjct: 66  ---IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG-----ELL--DKILRQKFFSE 115

Query: 542 NIRIRVALGAAR----ALQYLQEVCEPPIVHGNFKSSNILLDEK----LIVRVSDCGLAP 593
               R A          ++YL       +VH + K SNIL  ++      +R+ D G A 
Sbjct: 116 ----REASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 594 LLFSGSTNELSEGLLTAHGSG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRS 649
            L + +       L+T   +    APE  E   Y    D++SLGV++  +LTG  P+   
Sbjct: 169 QLRAEN-----GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223

Query: 650 RPRGEQSL 657
                + +
Sbjct: 224 PDDTPEEI 231

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 36/133 (27%), Positives = 53/133 (39%), Gaps = 15/133 (11%)

Query: 93  DLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLT-GSIPESLSRLTQLLDLSLNNN 151
           D++  I+++L N           P  VR   L   +   G I    +    L  LSL N 
Sbjct: 9   DMKRRIHLELRNRT---------PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV 59

Query: 152 HLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS--GTLNVLE 209
            L   + +   +   L   +LS N + G L      L +L  L+L  NKL    TL  L+
Sbjct: 60  GLIS-VSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLK 117

Query: 210 DL-HLIDLNIENN 221
            L  L  L++ N 
Sbjct: 118 KLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 33/128 (25%), Positives = 50/128 (39%), Gaps = 10/128 (7%)

Query: 79  TGMNLGGVLADTLG--DLESVINIDLSNNHIGGSIPSNLPVTVRNF---SLSGNQLTGSI 133
           +GM++   +   L      +V  + L N          L     N    SL    L  S+
Sbjct: 6   SGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV 64

Query: 134 PESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT--GQLPPSTRNLSSL 191
             +L +L +L  L L+ N + GG+     +   L + +LS N L     L P  + L  L
Sbjct: 65  -SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECL 122

Query: 192 YSLHLQNN 199
            SL L N 
Sbjct: 123 KSLDLFNC 130

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 47/220 (21%), Positives = 93/220 (42%), Gaps = 36/220 (16%)

Query: 439 TNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTIS 493
             ++     +G G  GSV  A +   G+ +A+KKLS    + +  ++   E L L     
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL----K 78

Query: 494 RLRHGNIVELI-----GYCNEHGQHL-LVYDYGGNCTLHDLLHSD-EEAHKK-FSWNIRI 545
            ++H N++ L+          +     LV  +     L  ++     E   +   + +  
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQM-- 135

Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
                  + L+Y+       +VH + K  N+ ++E   +++ D GLA      +  E++ 
Sbjct: 136 ------LKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMTG 182

Query: 606 GLLTAHGSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
            ++T     APE       Y+   D++S+G +M E+LTG+
Sbjct: 183 YVVTRWYR-APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 48/218 (22%), Positives = 79/218 (36%), Gaps = 36/218 (16%)

Query: 447 FIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEF--LELASTISR-------LRH 497
           FI  G  G+V       G  +A+K++ NTVS  +T        L   + R         H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 498 GNIVEL----IGYCNEHGQHL-LVYDYGGNCTLHDLLHSD----EEAHKK-FSWNIRIRV 547
            NI+ L    + +       L LV +      L  ++H         H + F ++I    
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHI---- 143

Query: 548 ALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL 607
                  L  L E     +VH +    NILL +   + + D  LA      +    +  +
Sbjct: 144 ----LLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARE--DTADANKTHYV 194

Query: 608 LTAHGSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
                  APE   +   ++   D++S G VM E+   +
Sbjct: 195 THRWYR-APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 47/233 (20%)

Query: 436 QQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDE--EFLELASTI 492
           ++  + F      G+G  G+V    E   G  +A+KK    V Q       E   +   +
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----VIQDPRFRNRELQIM-QDL 73

Query: 493 SRLRHGNIVELI------GYCNEHGQHL-LVYDYGGNCTLHDLLHS--------DEEAHK 537
           + L H NIV+L       G  +    +L +V +Y    TLH    +             K
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIK 132

Query: 538 KFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-LIVRVSDCGLAPLLF 596
            F + +         R++  L       + H + K  N+L++E    +++ D G A  L 
Sbjct: 133 VFLFQL--------IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

Query: 597 SGSTNELSEGLLTAHGSG----APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
               N        A+       APE  F +  Y+   D++S+G +  E++ G 
Sbjct: 184 PSEPN-------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 1e-09
 Identities = 26/95 (27%), Positives = 36/95 (37%), Gaps = 4/95 (4%)

Query: 110 SIPSNLP--VTVRNFSLSGNQLTGSIP-ESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTG 166
               +LP    +    +   Q    +    L  L +L +L++  + L    PDAFH    
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 167 LINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKL 201
           L   +LS N L   L   T    SL  L L  N L
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 7e-06
 Identities = 19/106 (17%), Positives = 32/106 (30%), Gaps = 13/106 (12%)

Query: 148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLS---- 202
             +  L+            L    +        L     R L  L +L +  + L     
Sbjct: 16  TRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73

Query: 203 GTLNVLEDLHLIDLNIENNLFSGPIPEKL---LSIPNFRKDGNPFN 245
              +    L  ++L+  N L S  +  K    LS+      GNP +
Sbjct: 74  DAFHFTPRLSRLNLS-FNALES--LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.7 bits (110), Expect = 1e-05
 Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 7/115 (6%)

Query: 68  CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS----NLPVTVRNFS 123
           C     + +R T       L   L   E++  + + N      +       L   +RN +
Sbjct: 5   CCPHGSSGLRCTRDGALDSL-HHLPGAENLTELYIENQQHLQHLELRDLRGLG-ELRNLT 62

Query: 124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT 178
           +  + L    P++     +L  L+L+ N L           + L    LS N L 
Sbjct: 63  IVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 37/225 (16%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGNIVE 502
              +G+G    V +  ++  G+  A   + NT      D + LE  + I   L+H NIV 
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMII-NTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 503 LIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDE-EAHKKFSWNIRIRVALGAAR----AL 555
           L    +E G H L++D   GG     +L   ++  A + +S       A    +    A+
Sbjct: 75  LHDSISEEGHHYLIFDLVTGG-----ELF--EDIVAREYYSE----ADASHCIQQILEAV 123

Query: 556 QYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
            +  ++    +VH N K  N+LL    +   V+++D GLA  +         +      G
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-----QQAWFGFAG 175

Query: 613 SG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPR 652
           +    +PE      Y    D+++ GV++  LL G  P +D  + R
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 57/273 (20%), Positives = 96/273 (35%), Gaps = 54/273 (19%)

Query: 414 RRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKL 472
             SS   N+    +    +     Y       + IG G  G VY A +    K +A+KK+
Sbjct: 6   HHSSGRENLYFQGIKNVHV--PDNYIIK----HLIGRGSYGYVYLAYDKNTEKNVAIKKV 59

Query: 473 SNTVSQRQTDEE--FLELASTISRLRHGNIVEL----IGYCNEHGQHL-LVYDYGGNCTL 525
           +  + +   D +    E+   ++RL+   I+ L    I         L +V +      L
Sbjct: 60  NR-MFEDLIDCKRILREIT-ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDL 116

Query: 526 HDLLHSD---EEAHKK-FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK 581
             L  +     E H K   +N+     L       ++ E     I+H + K +N LL++ 
Sbjct: 117 KKLFKTPIFLTEEHIKTILYNL-----L---LGENFIHES---GIIHRDLKPANCLLNQD 165

Query: 582 LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG--------------------APE--FE 619
             V+V D GLA  + S     +   L      G                    APE    
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225

Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR 652
             +Y+   D++S G +  ELL   + +      
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 59/283 (20%), Positives = 110/283 (38%), Gaps = 54/283 (19%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEE--FLELASTISRLRHGNIVELI 504
           +G G  G V   +    G  +AVK L+    +          E+   +   RH +I++L 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREI-QNLKLFRHPHIIKLY 82

Query: 505 GYCNEHGQHLLVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
              +      +V +Y     L D +       ++E+ + F   +           + Y  
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS---------GVDYCH 133

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS---GAP 616
                 +VH + K  N+LLD  +  +++D GL+ ++  G        L T+ GS    AP
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF------LRTSCGSPNYAAP 184

Query: 617 EFESG-SYS-CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM 674
           E  SG  Y+  + D++S GV++  LL G  P+D                    +  L + 
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD-----------------HVPTLFKK 227

Query: 675 VDPSLDGAY-LAKSLSRFA-DIISRCVQWEPGFRPPMSEIVQD 715
           +    DG +   + L+     ++   +Q +P  R  + +I + 
Sbjct: 228 I---CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 29/126 (23%), Positives = 43/126 (34%), Gaps = 10/126 (7%)

Query: 101 DLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLN--GGIP 158
            L+   I  +      V  R   L G ++   I    + L Q   +  ++N +    G P
Sbjct: 3   KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP 61

Query: 159 DAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS--GTLNVLEDL-HLID 215
                   L    ++ N +        + L  L  L L NN L   G L+ L  L  L  
Sbjct: 62  ----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117

Query: 216 LNIENN 221
           L I  N
Sbjct: 118 LCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 27/114 (23%), Positives = 42/114 (36%), Gaps = 10/114 (8%)

Query: 91  LGDLESVINIDLSNNHIGGSIPSNLPVTVRNF---SLSGNQLTGSIPESLSRLTQLLDLS 147
             +      +DL    I   +  NL  T+  F     S N++   + +    L +L  L 
Sbjct: 15  YTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70

Query: 148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLT--GQLPPSTRNLSSLYSLHLQNN 199
           +NNN +             L    L+ N+L   G L P   +L SL  L +  N
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN 123

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 57.9 bits (141), Expect = 3e-09
 Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 44/224 (19%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEF----LELASTISRLR 496
           + +   IGEG  G+V+KA      +++A+K+    V     DE      L     +  L+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKR----VRLDDDDEGVPSSALREICLLKELK 59

Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDL---LHS-----DEEAHKKFSWNIRIRVA 548
           H NIV L    +   +  LV+++   C   DL     S     D E  K F + +     
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEF---CD-QDLKKYFDSCNGDLDPEIVKSFLFQL----- 110

Query: 549 LGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
               + L +        ++H + K  N+L++    +++++ GLA   F       S  ++
Sbjct: 111 ---LKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV 163

Query: 609 TAHGSG----APE--FESGSYSCQSDVYSLGVVMLELLTGRKPY 646
           T          P+  F +  YS   D++S G +  EL    +P 
Sbjct: 164 T-----LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 51/250 (20%), Positives = 85/250 (34%), Gaps = 63/250 (25%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR-------LRHGN 499
           IG G  G V +A +    +++A+KK+   V +   D         I R       L H +
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILR-VFEDLID------CKRILREIAILNRLNHDH 113

Query: 500 IVEL----IGYCNEHGQHL-LVYDYGGNCTLHDLLHSD---EEAHKK-FSWNIRIRVALG 550
           +V++    I    E    L +V +         L  +     E H K   +N+       
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNL------- 165

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA----------PLLFSGST 600
               ++Y+       I+H + K +N L+++   V+V D GLA            L     
Sbjct: 166 -LVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

Query: 601 NELSEGLLTAHGSG---------------APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
            +    +   H                  APE      +Y+   DV+S+G +  ELL   
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281

Query: 644 KPYDRSRPRG 653
           K         
Sbjct: 282 KENVAYHADR 291

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 56/222 (25%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIG 505
           +GEG      K       +  AVK     +S+R       E+   +     H NIV+L  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVK----IISKRMEANTQKEIT-ALKLCEGHPNIVKLHE 73

Query: 506 YCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALG------AAR---- 553
             ++     LV +   GG     +L               RI           A+     
Sbjct: 74  VFHDQLHTFLVMELLNGG-----ELFE-------------RI-KKKKHFSETEASYIMRK 114

Query: 554 ---ALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSEGL 607
              A+ ++ +V    +VH + K  N+L    ++ L +++ D G A L    +     + L
Sbjct: 115 LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-----QPL 166

Query: 608 LTAHGSG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKP 645
            T   +    APE      Y    D++SLGV++  +L+G+ P
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 40/143 (27%), Positives = 56/143 (39%), Gaps = 9/143 (6%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN 169
           S+P+ +P       L  N L          LT L  L L  N L       F++ T L  
Sbjct: 21  SVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80

Query: 170 FDLSANNLTGQLPPST-RNLSSLYSLHLQNNKL----SGTLNVLEDLHLIDLNIENNLFS 224
            +LS N L   LP      L+ L  L L  N+L     G  + L  L  + L   N L S
Sbjct: 81  LNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQ-NQLKS 138

Query: 225 GP--IPEKLLSIPNFRKDGNPFN 245
            P  + ++L S+       NP++
Sbjct: 139 VPDGVFDRLTSLQYIWLHDNPWD 161

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 57.2 bits (139), Expect = 5e-09
 Identities = 51/229 (22%), Positives = 91/229 (39%), Gaps = 52/229 (22%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELAST----IS- 493
           + F +   +G G   +VYK      G  +A+K++      +   EE     ST    IS 
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEE--GTPSTAIREISL 56

Query: 494 --RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDL-----LHSDEEAHKKFSWNIRIR 546
              L+H NIV L    +   +  LV+++      +DL       +     +    N+   
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEF---MD-NDLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 547 VALGAARALQYLQEVCEPPIVHGNF------KSSNILLDEKLIVRVSDCGLAPLLFSGST 600
                 + L +          H N       K  N+L++++  +++ D GLA   F    
Sbjct: 113 FQWQLLQGLAFC---------HENKILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPV 162

Query: 601 NELSEGLLTAHGSG----APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
           N  S  ++T         AP+    S +YS   D++S G ++ E++TG+
Sbjct: 163 NTFSSEVVT-----LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 57.3 bits (139), Expect = 6e-09
 Identities = 61/256 (23%), Positives = 104/256 (40%), Gaps = 38/256 (14%)

Query: 414 RRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKL 472
             +S +        S F + +  ++++++     +G+G    V +      G   A K +
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 473 SNTVSQRQTDEEFLELASTI-SRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLL 529
            NT      D + LE  + I  +L+H NIV L     E   H LV+D   GG     +L 
Sbjct: 63  -NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG-----ELF 116

Query: 530 HSDE-EAHKKFSWNIRIRVALGAAR----ALQYLQEVCEPPIVHGNFKSSNILL---DEK 581
             ++  A + +S       A    +    ++ Y        IVH N K  N+LL    + 
Sbjct: 117 --EDIVAREFYSE----ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKG 167

Query: 582 LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE-FESGSYSCQSDVYSLGVVML 637
             V+++D GLA  +         E      G+    +PE  +   YS   D+++ GV++ 
Sbjct: 168 AAVKLADFGLAIEVNDS------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 221

Query: 638 ELLTGRKP-YDRSRPR 652
            LL G  P +D  + R
Sbjct: 222 ILLVGYPPFWDEDQHR 237

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 57.3 bits (139), Expect = 7e-09
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 37/216 (17%)

Query: 446 NFIGEGLLGSVYKA-ELPGGKLLAVKKLS---NTVSQRQTDEEFLELASTISRLRHGNIV 501
           ++IGEG  G V  A +      +A+KK+S   +    ++T  E   L     R RH NI+
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL----LRFRHENII 88

Query: 502 ELI-----GYCNEHGQHLLVYDYGGNCTLHDLLHSD--EEAHKK-FSWNIRIRVALGAAR 553
            +          +     +V D      L+ LL +      H   F + I         R
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQI--------LR 139

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
            L+Y+       ++H + K SN+LL+    +++ D GLA        +    G LT + +
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR---VADPDHDHTGFLTEYVA 193

Query: 614 G----APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
                APE    S  Y+   D++S+G ++ E+L+ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 53/237 (22%), Positives = 89/237 (37%), Gaps = 65/237 (27%)

Query: 444 EGNFIGEGLLGSVYKA---ELPGGKLLAVKKLSNTV----SQRQTDEEFLELASTISRLR 496
           EG  +G G  G VYKA   +    K  A+K++  T     + R+         + +  L+
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE--------IALLRELK 76

Query: 497 HGNIVELIGYCNEHGQHL--LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA-- 552
           H N++ L      H      L++DY      HDL H  +      +    +++  G    
Sbjct: 77  HPNVISLQKVFLSHADRKVWLLFDY---AE-HDLWHIIKFHRASKANKKPVQLPRGMVKS 132

Query: 553 ------RALQYLQEVCEPPIVHGNF------KSSNILL----DEKLIVRVSDCGLAPLLF 596
                   + YL         H N+      K +NIL+     E+  V+++D G A L F
Sbjct: 133 LLYQILDGIHYL---------HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-F 182

Query: 597 SGSTNELSEGLLTAHGSG--------APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
           +     L+                  APE    +  Y+   D++++G +  ELLT  
Sbjct: 183 NSPLKPLA------DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 56.8 bits (138), Expect = 9e-09
 Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 47/224 (20%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEF----LELASTISRL 495
             + +   +GEG  G VYKA+   G+++A+K+    +     DE      +   S +  L
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKR----IRLDAEDEGIPSTAIREISLLKEL 76

Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            H NIV LI   +      LV+++       DL        KK     +  +     +  
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEF---ME-KDL--------KKVLDENKTGLQDSQIKIY 124

Query: 556 --QYLQEV--CEPPIVHGNF------KSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE 605
             Q L+ V  C     H +       K  N+L++    ++++D GLA   F       + 
Sbjct: 125 LYQLLRGVAHC-----HQHRILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTH 178

Query: 606 GLLTAHGSG----APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
            ++T         AP+    S  YS   D++S+G +  E++TG+
Sbjct: 179 EVVT-----LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 56.4 bits (137), Expect = 9e-09
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 45/221 (20%)

Query: 442 FSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLE-LAST----IS--- 493
           +     IGEG  G VYKA+   G+  A+KK+      R   E+  E + ST    IS   
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKI------RLEKED--EGIPSTTIREISILK 55

Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
            L+H NIV+L    +   + +LV+++       DL        KK        +    A+
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEH---LD-QDL--------KKLLDVCEGGLESVTAK 103

Query: 554 AL--QYLQEVC---EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
           +   Q L  +    +  ++H + K  N+L++ +  ++++D GLA   F     + +  ++
Sbjct: 104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEIV 162

Query: 609 TAHGSG----APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
           T         AP+    S  YS   D++S+G +  E++ G 
Sbjct: 163 T-----LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.9 bits (130), Expect = 9e-09
 Identities = 27/112 (24%), Positives = 45/112 (40%), Gaps = 10/112 (8%)

Query: 116 PVTVRNFSLSGNQLT-GSIPESLSRLTQLLDLSLNNNHLN--GGIPDAFHQFTGLINFDL 172
           P  V+   L  ++   G +        +L  LS  N  L     +P    +   L   +L
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLEL 71

Query: 173 SANNLTGQLPPSTRNLSSLYSLHLQNNKLS--GTLNVLEDL-HLIDLNIENN 221
           S N ++G L        +L  L+L  NK+    T+  L+ L +L  L++ N 
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.6 bits (124), Expect = 6e-08
 Identities = 28/112 (25%), Positives = 47/112 (41%), Gaps = 8/112 (7%)

Query: 93  DLESVINIDLSNNHIG-GSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
               V  + L N+    G +         +   S     LT SI  +L +L +L  L L+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 150 NNHLNGGIPDAFHQFTGLINFDLSANNLT--GQLPPSTRNLSSLYSLHLQNN 199
           +N ++GG+     +   L + +LS N +     + P  + L +L SL L N 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNC 123

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 57.5 bits (139), Expect = 9e-09
 Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 36/228 (15%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGNIVELIG 505
           +G+G  G V   ++   GK+ A KKL     +++  E        I  ++    +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250

Query: 506 YCNEHGQHL-LVYDY--GGNCTLHDLL-HSDEEAHKKFSWNIRIRVALGAAR---ALQYL 558
           Y  E    L LV     GG     DL  H        F      R    AA     L+ L
Sbjct: 251 YAYETKDALCLVLTLMNGG-----DLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDL 302

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF 618
                  IV+ + K  NILLD+   +R+SD GLA          + EG       G   +
Sbjct: 303 HRER---IVYRDLKPENILLDDHGHIRISDLGLA--------VHVPEGQTIKGRVGTVGY 351

Query: 619 ------ESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPRGEQSLVR 659
                 ++  Y+   D ++LG ++ E++ G+ P   R +    + + R
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 46/212 (21%), Positives = 92/212 (43%), Gaps = 37/212 (17%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G G  G+V  A +   G  +A+KKL     + +  ++   E   L      +RH N++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL----KHMRHENVIG 88

Query: 503 LI------GYCNEHGQHLLVYDYGGNCTLHDLLHSD--EEAHKK-FSWNIRIRVALGAAR 553
           L+         ++     LV  + G   L  L+  +   E   +   + +         +
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQFLVYQM--------LK 139

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
            L+Y+       I+H + K  N+ ++E   +++ D GLA      + +E++  ++T    
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMTGYVVTRWYR 192

Query: 614 GAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
            APE       Y+   D++S+G +M E++TG+
Sbjct: 193 -APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 55/289 (19%), Positives = 105/289 (36%), Gaps = 47/289 (16%)

Query: 380 SSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPST--NVISSSVSVFTIASLQQ 437
           S P      + +P           V         + +  S   N +      +    ++ 
Sbjct: 91  SKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEI 150

Query: 438 YTNSFSE----GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLEL-AST 491
             +   +       +G G  G V++  E   G   A K +    +  ++D+E +     T
Sbjct: 151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM---TPHESDKETVRKEIQT 207

Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
           +S LRH  +V L     +  + +++Y++  GG     +L          F         +
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG-----EL----------FEKVADEHNKM 252

Query: 550 GAARALQYLQEVCEP-------PIVHGNFKSSNILLDEKL--IVRVSDCGLAPLLFSGST 600
               A++Y+++VC+          VH + K  NI+   K    +++ D GL   L     
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310

Query: 601 NELSEGLLTAHGSG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKP 645
               + +    G+    APE  E       +D++S+GV+   LL+G  P
Sbjct: 311 ----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 56.0 bits (136), Expect = 1e-08
 Identities = 51/241 (21%), Positives = 83/241 (34%), Gaps = 70/241 (29%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELAST----ISR 494
           + +     IG G  G+VYKA +   G  +A+K     V           L  +    ++ 
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKS----VRVPNGGGGGGGLPISTVREVAL 64

Query: 495 LR------HGNIVELI----GYCNEHGQHL-LVYDYGGNCTLHDL---------LHSDEE 534
           LR      H N+V L+        +    + LV+++       DL              E
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH---VD-QDLRTYLDKAPPPGLPAE 120

Query: 535 AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-- 592
             K               R L +L   C   IVH + K  NIL+     V+++D GLA  
Sbjct: 121 TIKDLMRQF--------LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

Query: 593 ---PLLFSGSTNEL-------SEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTG 642
               +     T  +        E LL    S        +Y+   D++S+G +  E+   
Sbjct: 170 YSYQMAL---TPVVVTLWYRAPEVLL---QS--------TYATPVDMWSVGCIFAEMFRR 215

Query: 643 R 643
           +
Sbjct: 216 K 216

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 31/216 (14%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEE-----FLELASTIS 493
            ++ + + +GEG   +VYK +      L+A+K++      R   EE      +   S + 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLK 55

Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
            L+H NIV L    +      LV++Y       DL    ++     + +          R
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEY---LD-KDLKQYLDDCGNIINMHNVKLFLFQLLR 111

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
            L Y        ++H + K  N+L++E+  ++++D GLA    S  T      ++T    
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYDNEVVT---- 163

Query: 614 G----APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
                 P+    S  YS Q D++ +G +  E+ TGR
Sbjct: 164 -LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 56/232 (24%), Positives = 89/232 (38%), Gaps = 55/232 (23%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
              +G G    V+   +   GKL A+K +    S    D       + + +++H NIV L
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKK--SPAFRDSSLENEIAVLKKIKHENIVTL 71

Query: 504 IGYCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALG------AAR-- 553
                    + LV     GG     +L               RI +  G      A+   
Sbjct: 72  EDIYESTTHYYLVMQLVSGG-----ELFD-------------RI-LERGVYTEKDASLVI 112

Query: 554 -----ALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSE 605
                A++YL E     IVH + K  N+L    +E   + ++D GL+ +  +G       
Sbjct: 113 QQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI------ 163

Query: 606 GLLTAHGS---GAPE-FESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPR 652
            + TA G+    APE      YS   D +S+GV+   LL G  P Y+ +  +
Sbjct: 164 -MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK 214

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 49/263 (18%), Positives = 92/263 (34%), Gaps = 42/263 (15%)

Query: 418 PSTNVISSSVSVFTIASLQQYTNSFSE-----GNFIGEGLLGSVYKA-ELPGGKLLAVKK 471
              +   SS         +    + ++        +G G+ G V +      G+  A+K 
Sbjct: 2   AHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL 61

Query: 472 LSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC----NEHGQHLLVYDY--GGNCTL 525
           L ++   RQ  +   +           +IV ++       +     L++ +   GG    
Sbjct: 62  LYDSPKARQEVDHHWQA------SGGPHIVCILDVYENMHHGKRCLLIIMECMEGG---- 111

Query: 526 HDLLHS-DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEK 581
            +L     E   + F+      +      A+Q+L       I H + K  N+L    ++ 
Sbjct: 112 -ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKD 167

Query: 582 LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE-FESGSYSCQSDVYSLGVVML 637
            +++++D G A      +       L T   +    APE      Y    D++SLGV+M 
Sbjct: 168 AVLKLTDFGFAKETTQNA-------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220

Query: 638 ELLTGRKP-YDRSRPRGEQSLVR 659
            LL G  P Y  +       + R
Sbjct: 221 ILLCGFPPFYSNTGQAISPGMKR 243

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 51/238 (21%), Positives = 88/238 (36%), Gaps = 71/238 (29%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLE-LAST----IS 493
             + + +F+GEG   +VYKA +    +++A+KK+     +     E  + +  T    I 
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-----KLGHRSEAKDGINRTALREIK 64

Query: 494 ---RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDL--------LHSDEEAHKKFSWN 542
               L H NI+ L+          LV+D+       DL        L       K +   
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDF----METDLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 543 IRIRVALGAARALQYLQEVCEPPIVHGNF------KSSNILLDEKLIVRVSDCGLAPLLF 596
                     + L+YL         H ++      K +N+LLDE  +++++D GLA   F
Sbjct: 121 T--------LQGLEYL---------HQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SF 162

Query: 597 SGSTNELS-----------EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGR 643
                  +           E L      GA       Y    D++++G ++ ELL   
Sbjct: 163 GSPNRAYTHQVVTRWYRAPELLF-----GARM-----YGVGVDMWAVGCILAELLLRV 210

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 55/232 (23%), Positives = 101/232 (43%), Gaps = 43/232 (18%)

Query: 428 SVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTD 482
           +++ +         +   + +G G  GSV  A +   G  +AVKKLS    + +  ++T 
Sbjct: 23  TIWEV------PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 76

Query: 483 EEFLELASTISRLRHGNIVELI-----GYCNEHGQHL-LVYDYGGNCTLHDLLHSD--EE 534
            E   L      ++H N++ L+         E    + LV    G   L++++      +
Sbjct: 77  RELRLL----KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTD 131

Query: 535 AHKK-FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP 593
            H +   + I         R L+Y+       I+H + K SN+ ++E   +++ D GLA 
Sbjct: 132 DHVQFLIYQI--------LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA- 179

Query: 594 LLFSGSTNELSEGLLTAHGSGAPE--FESGSYSCQSDVYSLGVVMLELLTGR 643
                + +E++  + T     APE       Y+   D++S+G +M ELLTGR
Sbjct: 180 ---RHTADEMTGYVATRWYR-APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 54.9 bits (133), Expect = 3e-08
 Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 42/235 (17%)

Query: 439 TNSFSE----GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI- 492
           +  FS+       +G+G    V +      G   A K + NT      D + LE  + I 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARIC 59

Query: 493 SRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDE-EAHKKFSWNIRIRVAL 549
            +L+H NIV L     E   H LV+D   GG     +L   ++  A + +S       A 
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGG-----ELF--EDIVAREFYSE----ADAS 108

Query: 550 GAAR----ALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNE 602
              +    ++ Y        IVH N K  N+LL    +   V+++D GLA  +       
Sbjct: 109 HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---- 161

Query: 603 LSEGLLTAHGSG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPR 652
             E      G+    +PE  +   YS   D+++ GV++  LL G  P +D  + R
Sbjct: 162 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 55.7 bits (135), Expect = 3e-08
 Identities = 32/187 (17%), Positives = 61/187 (32%), Gaps = 31/187 (16%)

Query: 69  VFSNVTEIRLTGMNLG----GVLADTLGDLESVINIDLSNNHIGGS-------IPSNLPV 117
           +      +RL    L       ++  L    ++  ++L +N +G                
Sbjct: 26  LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSC 85

Query: 118 TVRNFSLSGNQLT----GSIPESLSRLTQLLDLSLNNNHLNGG----IPDAF-HQFTGLI 168
            ++  SL    LT    G +  +L  L  L +L L++N L       + +        L 
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145

Query: 169 NFDLSANNLTGQ----LPPSTRNLSSLYSLHLQNNKLS--GTLNVLEDL-----HLIDLN 217
              L   +L+      L    R       L + NN ++  G   + + L      L  L 
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

Query: 218 IENNLFS 224
           +E+   +
Sbjct: 206 LESCGVT 212

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 34/193 (17%), Positives = 67/193 (34%), Gaps = 33/193 (17%)

Query: 64  QGVFCVFSNVTEIRLTGMNLGGV----LADTLGDLESVINIDLSNNHIGGS--------I 111
            G+    S +  + +    +       L   L   ES+  + L+ N +G          +
Sbjct: 249 PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETL 308

Query: 112 PSNLPVTVRNFSLSGNQLTG----SIPESLSRLTQLLDLSLNNNHL-NGGIP---DAF-H 162
                  + +  +     T          L++   LL+L ++NN L + G+         
Sbjct: 309 LEPGC-QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQ 367

Query: 163 QFTGLINFDLSANNLTGQ----LPPSTRNLSSLYSLHLQNNKL--SGTLNVLEDL----- 211
             + L    L+  +++      L  +     SL  L L NN L  +G L ++E +     
Sbjct: 368 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 427

Query: 212 HLIDLNIENNLFS 224
            L  L + +  +S
Sbjct: 428 LLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.7 bits (109), Expect = 3e-05
 Identities = 35/186 (18%), Positives = 62/186 (33%), Gaps = 35/186 (18%)

Query: 72  NVTEIRLTGMNLG----GVLADTLGDLESVINIDLSNNHIGGS---------IPSNLPVT 118
            + ++ L    L     GVL+ TL  L ++  + LS+N +G +         +       
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC--R 143

Query: 119 VRNFSLSGNQLT----GSIPESLSRLTQLLDLSLNNNHLNGG----IPDAFHQFT-GLIN 169
           +    L    L+      +   L       +L+++NN +N      +          L  
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203

Query: 170 FDLSANNLTGQ----LPPSTRNLSSLYSLHLQNNKL--SGTLNVLEDL-----HLIDLNI 218
             L +  +T      L     + +SL  L L +NKL   G   +   L      L  L I
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263

Query: 219 ENNLFS 224
                +
Sbjct: 264 WECGIT 269

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 54.9 bits (133), Expect = 3e-08
 Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 44/229 (19%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELAST----IS- 493
           + + +   IG+G  G V+KA     G+ +A+KK+         + E      T    I  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-------LMENEKEGFPITALREIKI 69

Query: 494 --RLRHGNIVELIGYCNEHGQHL--------LVYDYGGNCTLHDLLHSDEEAHKKFSWNI 543
              L+H N+V LI  C               LV+D+   C  HDL         KF+ + 
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF---CE-HDLAGLLSNVLVKFTLSE 125

Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
             RV       L Y+       I+H + K++N+L+    +++++D GLA   FS + N  
Sbjct: 126 IKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNS- 180

Query: 604 SEGLLTAHGSG-------APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
                T   +         PE       Y    D++  G +M E+ T  
Sbjct: 181 QPNRYT---NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 54.9 bits (133), Expect = 4e-08
 Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 50/228 (21%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLE-LAST----IS 493
           + +     +GEG  G VYKA +    + +A+K++      R   EE  E +  T    +S
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI------RLEHEE--EGVPGTAIREVS 85

Query: 494 ---RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS----DEEAHKKFSWNIRIR 546
               L+H NI+EL    + + +  L+++Y     L   +           K F + +   
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQL--- 141

Query: 547 VALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR-----VSDCGLAPLLFSGSTN 601
                   + +         +H + K  N+LL            + D GLA   F     
Sbjct: 142 -----INGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIR 192

Query: 602 ELSEGLLTAHGSG----APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
           + +  ++T          PE    S  YS   D++S+  +  E+L   
Sbjct: 193 QFTHEIIT-----LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 54.5 bits (132), Expect = 4e-08
 Identities = 40/215 (18%), Positives = 78/215 (36%), Gaps = 36/215 (16%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLEL-ASTISRLRHGNIVE 502
              +G G  G V++  E    K    K     V  + TD+  ++   S ++  RH NI+ 
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAK----FVKVKGTDQVLVKKEISILNIARHRNILH 65

Query: 503 LIGYCNEHGQHLLVYDY--GG----NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
           L        + ++++++  G              ++ E    +     +     A + L 
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI-VSY-----VHQVCEALQFLH 119

Query: 557 YLQEVCEPPIVHGNFKSSNILL--DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
                    I H + +  NI+        +++ + G A  L  G      +       + 
Sbjct: 120 SHN------IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG------DNFRLLFTAP 167

Query: 615 ---APE-FESGSYSCQSDVYSLGVVMLELLTGRKP 645
              APE  +    S  +D++SLG ++  LL+G  P
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 57/233 (24%), Positives = 102/233 (43%), Gaps = 58/233 (24%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTD------EEFLELASTISRLR---- 496
           +G+G  G V+K+ +   G+++AVKK+ +   Q  TD      E        I  L     
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFRE--------IMILTELSG 67

Query: 497 HGNIVELIG-YCNEHGQHL-LVYDYGGNCTLHDLLHSD--EEAHKK-FSWNIRIRVALGA 551
           H NIV L+     ++ + + LV+DY     LH ++ ++  E  HK+   + +     +  
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQL-----I-- 119

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
            + ++YL       ++H + K SNILL+ +  V+V+D GL+    +      +  L    
Sbjct: 120 -KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 612 GSG-------------------APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
            +                    APE    S  Y+   D++SLG ++ E+L G+
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 46/191 (24%), Positives = 68/191 (35%), Gaps = 52/191 (27%)

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           AL YLQ      I+H + K  NILLDE   V ++D  +A          L         +
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA--------AMLPRETQITTMA 175

Query: 614 G-----APE----FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-- 662
           G     APE     +   YS   D +SLGV   ELL GR+PY        + +V      
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH-TFET 234

Query: 663 ------PRLHD--IDALSRM--VDPSLDGAYLAKSLSRFADIIS----RCVQWE------ 702
                        +  L ++   +P        +  S+ +D+ +      + W+      
Sbjct: 235 TVVTYPSAWSQEMVSLLKKLLEPNPD-------QRFSQLSDVQNFPYMNDINWDAVFQKR 287

Query: 703 --PGFRPPMSE 711
             PGF P    
Sbjct: 288 LIPGFIPNKGR 298

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 51/231 (22%), Positives = 97/231 (41%), Gaps = 41/231 (17%)

Query: 428 SVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSN-----TVSQRQT 481
           S FT+  L++Y N       IG G  G V  A +    + +A+KKLS      T ++R  
Sbjct: 56  STFTV--LKRYQNL----KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-A 108

Query: 482 DEEFLELASTISRLRHGNIVELI-----GYCNEHGQHL-LVYDYGGNCTLHDLLHSD-EE 534
             E + +      + H NI+ L+         E  Q + LV +      L  ++  + + 
Sbjct: 109 YRELVLM----KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDH 163

Query: 535 AHKK-FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP 593
                  + +           +++L       I+H + K SNI++     +++ D GLA 
Sbjct: 164 ERMSYLLYQM--------LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212

Query: 594 LLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGR 643
               G++  ++  ++T +   APE      Y    D++S+G +M E++  +
Sbjct: 213 TA--GTSFMMTPYVVTRYYR-APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 53.7 bits (130), Expect = 6e-08
 Identities = 52/217 (23%), Positives = 83/217 (38%), Gaps = 38/217 (17%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVK---KLSNTVSQRQTDEEFLELASTI-SRLRHGNIVE 502
           +G G    V K  +   GK  A K   K   + S+R    E +E    I   +RH NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 503 LIGYCNEHGQHLLVYDY--GGNCTLHDLLHSD----EEAHKKFSWNIRIRVALGAARALQ 556
           L          +L+ +   GG   L D L       E+   +F     ++  L     + 
Sbjct: 73  LHDIFENKTDVVLILELVSGGE--LFDFLAEKESLTEDEATQF-----LKQILDG---VH 122

Query: 557 YLQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           YL       I H + K  NI+L         +++ D G+A  + +G             G
Sbjct: 123 YLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG------NEFKNIFG 173

Query: 613 SG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKP 645
           +    APE         ++D++S+GV+   LL+G  P
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 49/226 (21%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVK-----KLSNTVSQRQTDEEFLELASTI-SRLRHGNI 500
           +G G  G V  A E    K +A+K     K +   ++       +E    I  +L H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 501 VELIGYCNEHGQHLLVYDY--GGNCTLHDLL-------HSDEEAHKKFSWNIRIRVALGA 551
           +++  + +    + +V +   GG     +L           E   K +         L A
Sbjct: 78  IKIKNFFDAE-DYYIVLELMEGG-----ELFDKVVGNKRLKEATCKLY-----FYQMLLA 126

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSEGLL 608
              +QYL E     I+H + K  N+LL   +E  +++++D G + +L   S       + 
Sbjct: 127 ---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL------MR 174

Query: 609 TAHGS---GAPE----FESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
           T  G+    APE      +  Y+   D +SLGV++   L+G  P+ 
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 38/218 (17%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS---NTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           +GEG  G V  A   P G+++A+KK+      +   +T  E   L       +H NI+ +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL----KHFKHENIITI 74

Query: 504 I----GYCNEHGQHL-LVYDYGGNCTLHDLLHSD--EEAHKK-FSWNIRIRVALGAARAL 555
                    E+   + ++ +      LH ++ +    + H + F +       L   RA+
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQT-----L---RAV 125

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG- 614
           + L       ++H + K SN+L++    ++V D GLA ++   + +        +     
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 615 -------APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
                  APE    S  YS   DV+S G ++ EL   R
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 45/229 (19%), Positives = 76/229 (33%), Gaps = 57/229 (24%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
              +G G+ G V +       +  A+K L +    R+      E+       +  +IV +
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------EVELHWRASQCPHIVRI 76

Query: 504 IGYC----NEHGQHLLVYDY--GGNCTLHDLLHS-DEEAHKKFSWNIRIRVALGAAR--- 553
           +             L+V +   GG     +L     +   + F+     R A    +   
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTE----REASEIMKSIG 127

Query: 554 -ALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
            A+QYL  +    I H + K  N+L        I++++D G A                 
Sbjct: 128 EAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---------------- 168

Query: 610 AHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPRGEQSL 657
                  E     Y    D++SLGV+M  LL G  P Y          +
Sbjct: 169 -------ETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 210

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 53/217 (24%), Positives = 81/217 (37%), Gaps = 38/217 (17%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVK---KLSNTVSQRQTDEEFLEL-ASTISRLRHGNIVE 502
           +G G    V K  E   G   A K   K  +  S+R    E +E   S + ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 503 LIGYCNEHGQHLLVYDY--GGNCTLHDLLHSD----EEAHKKFSWNIRIRVALGAARALQ 556
           L          +L+ +   GG   L D L       EE    F     I+  L     + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGE--LFDFLAQKESLSEEEATSF-----IKQILD---GVN 129

Query: 557 YLQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           YL       I H + K  NI+L         +++ D GLA  +  G             G
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG------VEFKNIFG 180

Query: 613 SG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKP 645
           +    APE         ++D++S+GV+   LL+G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 56/262 (21%), Positives = 103/262 (39%), Gaps = 50/262 (19%)

Query: 404 VKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSE----GNFIGEGLLGSVYKA 459
           +   + + VT  ++P T  +     +          ++ S+     + +G G    VY+ 
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWI-----DGSNRDALSDFFEVESELGRGATSIVYRC 72

Query: 460 -ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGNIVELIGYCNEHGQHLLVY 517
            +    K  A+K L      +  D++ +     +  RL H NI++L        +  LV 
Sbjct: 73  KQKGTQKPYALKVLK-----KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127

Query: 518 DY--GGNCTLHDLLHSDE-EAHKKFSWNIRIRVALGAAR----ALQYLQEVCEPPIVHGN 570
           +   GG     +L   D       +S     R A  A +    A+ YL E     IVH +
Sbjct: 128 ELVTGG-----ELF--DRIVEKGYYSE----RDAADAVKQILEAVAYLHENG---IVHRD 173

Query: 571 FKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE-FESGSY 623
            K  N+L         ++++D GL+ ++           + T  G+    APE     +Y
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVL------MKTVCGTPGYCAPEILRGCAY 227

Query: 624 SCQSDVYSLGVVMLELLTGRKP 645
             + D++S+G++   LL G +P
Sbjct: 228 GPEVDMWSVGIITYILLCGFEP 249

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 34/94 (36%), Positives = 43/94 (45%), Gaps = 8/94 (8%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN 169
           S+P+ +P T +   L  NQ+T   P    RLTQL  L L+NN L       F + T L  
Sbjct: 23  SVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQ 82

Query: 170 FDLSANNLTGQLPPSTR----NLSSLYSLHLQNN 199
             L+ N    QL    R    NL SL  + L NN
Sbjct: 83  LSLNDN----QLKSIPRGAFDNLKSLTHIWLLNN 112

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 47/259 (18%), Positives = 96/259 (37%), Gaps = 39/259 (15%)

Query: 405 KPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSE----GNFIGEGLLGSVYKA- 459
             +       + +            +    ++    S  +       +G G  G V++  
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 460 ELPGGKLLAVKKLSNTVSQRQTDEEFLEL-ASTISRLRHGNIVELIGYCNEHGQHLLVYD 518
           E   G++   K ++   +    D+  ++   S +++L H  ++ L     +  + +L+ +
Sbjct: 72  EKATGRVFVAKFIN---TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128

Query: 519 Y--GG----NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFK 572
           +  GG         D   S+ E          +R A      L+++ E     IVH + K
Sbjct: 129 FLSGGELFDRIAAEDYKMSEAEVIN------YMRQACE---GLKHMHEH---SIVHLDIK 176

Query: 573 SSNILLDEK--LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS---GAPE-FESGSYSCQ 626
             NI+ + K    V++ D GLA  L         E +     +    APE  +       
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPD------EIVKVTTATAEFAAPEIVDREPVGFY 230

Query: 627 SDVYSLGVVMLELLTGRKP 645
           +D++++GV+   LL+G  P
Sbjct: 231 TDMWAIGVLGYVLLSGLSP 249

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 54/217 (24%), Positives = 82/217 (37%), Gaps = 38/217 (17%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVK---KLSNTVSQRQTDEEFLELASTI-SRLRHGNIVE 502
           +G G    V K  E   G   A K   K     S+R    E +E   +I   ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 503 LIGYCNEHGQHLLVYDY--GGNCTLHDLLHSD----EEAHKKFSWNIRIRVALGAARALQ 556
           L          +L+ +   GG   L D L       EE   +F     ++  L     L 
Sbjct: 79  LHEVYENKTDVILILELVAGGE--LFDFLAEKESLTEEEATEF-----LKQILNGVYYLH 131

Query: 557 YLQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
            LQ      I H + K  NI+L      K  +++ D GLA  +  G             G
Sbjct: 132 SLQ------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG------NEFKNIFG 179

Query: 613 SG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKP 645
           +    APE         ++D++S+GV+   LL+G  P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 55/240 (22%), Positives = 86/240 (35%), Gaps = 30/240 (12%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIG 505
           +GEG    V     L   +  AVK +                   + + + H N++ELI 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 506 YCNEHGQHLLVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           +  E  +  LV++   GG      +L S     + F+      V    A AL +L     
Sbjct: 79  FFEEEDRFYLVFEKMRGG-----SIL-SHIHKRRHFNELEASVVVQDVASALDFLHNKG- 131

Query: 564 PPIVHGNFKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSEG--LLTAHGSG---A 615
             I H + K  NIL    ++   V++ D  L   +             LLT  GS    A
Sbjct: 132 --IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 616 PE------FESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSRPRGEQSLVRWAIPRLHDI 668
           PE       E+  Y  + D++SLGV++  LL+G  P   R                 + +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 48/358 (13%), Positives = 102/358 (28%), Gaps = 100/358 (27%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-----HGNIV 501
           +G G   +V+ +  + G K +A+K + +     +T  + + L  ++            +V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 502 ELIG---YCNEHGQHL-LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
           +L+        +G H+ +V++  G   L   +      ++        ++     + L Y
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDY 161

Query: 558 LQEVCEPPIVHGNFKSSNILL-------------------------DEKLIVRVSDCGLA 592
           L   C   I+H + K  NILL                             +         
Sbjct: 162 LHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219

Query: 593 PLLFSGSTNELSEGLLTAHGSG-------------------APE--FESGSYSCQSDVYS 631
            L+         +  +     G                   + E    SG Y+  +D++S
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG-YNTPADIWS 278

Query: 632 LGVVMLELLTGRKPYDRSRPRGEQS-------------------LVRW------------ 660
              +  EL TG   ++                            +V              
Sbjct: 279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338

Query: 661 --AIPRLHDIDALSRMVD-PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
              I +L        +V+          +  + F D +   ++  P  R   +E ++ 
Sbjct: 339 LKHITKLKPWGLFEVLVEKYEWSQ----EEAAGFTDFLLPMLELIPEKRATAAECLRH 392

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 50.3 bits (121), Expect = 3e-07
 Identities = 29/94 (30%), Positives = 40/94 (42%), Gaps = 8/94 (8%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN 169
           S+P+ +P   +   L+ NQ+T   P     L  L  L  N+N L       F + T L  
Sbjct: 26  SVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQ 85

Query: 170 FDLSANNLTGQLPPSTR----NLSSLYSLHLQNN 199
            DL+ N     L    R    NL SL  ++L NN
Sbjct: 86  LDLNDN----HLKSIPRGAFDNLKSLTHIYLYNN 115

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 52.2 bits (126), Expect = 3e-07
 Identities = 51/242 (21%), Positives = 87/242 (35%), Gaps = 74/242 (30%)

Query: 440 NSFSEGNFIGEGLLGSVYKA--ELPGGKLLAVKKLSNTVSQRQTDEEFLELAST----IS 493
             +     IGEG  G V+KA     GG+ +A+K+    V  +  +E       +    ++
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKR----VRVQTGEEGM---PLSTIREVA 63

Query: 494 RLR------HGNIVELI----GYCNEHGQHL-LVYDYGGNCTLHDL---------LHSDE 533
            LR      H N+V L         +    L LV+++       DL              
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH---VD-QDLTTYLDKVPEPGVPT 119

Query: 534 EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA- 592
           E  K   + +         R L +L       +VH + K  NIL+     ++++D GLA 
Sbjct: 120 ETIKDMMFQL--------LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

Query: 593 ----PLLFSGSTNELS-------EGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLT 641
                +     T+ +        E LL    S        SY+   D++S+G +  E+  
Sbjct: 169 IYSFQMAL---TSVVVTLWYRAPEVLL---QS--------SYATPVDLWSVGCIFAEMFR 214

Query: 642 GR 643
            +
Sbjct: 215 RK 216

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 54/217 (24%), Positives = 81/217 (37%), Gaps = 38/217 (17%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVK---KLSNTVSQRQTDEEFLEL-ASTISRLRHGNIVE 502
           +G G    V K  E   G   A K   K  +  S+R    E +E   S + ++ H NI+ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 503 LIGYCNEHGQHLLVYDY--GGNCTLHDLLHSD----EEAHKKFSWNIRIRVALGAARALQ 556
           L          +L+ +   GG   L D L       EE    F     I+  L     + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGE--LFDFLAQKESLSEEEATSF-----IKQILD---GVN 129

Query: 557 YLQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           YL       I H + K  NI+L         +++ D GLA  +  G             G
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG------VEFKNIFG 180

Query: 613 SG---APE-FESGSYSCQSDVYSLGVVMLELLTGRKP 645
           +    APE         ++D++S+GV+   LL+G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 42/217 (19%), Positives = 91/217 (41%), Gaps = 32/217 (14%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQT--DE-EFLELASTISRLRHG----- 498
           +G G   +V+ A+ +     +A+K +       +   DE + L+  +     +       
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86

Query: 499 NIVELIG---YCNEHGQHL-LVYD-YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           +I++L+    +   +G H+ +V++  G N  L  L+   E  H+        +++     
Sbjct: 87  HILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALIKKYE--HRGIPLIYVKQISKQLLL 142

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDE------KLIVRVSDCGLAPLLFSGSTNELSEGL 607
            L Y+   C   I+H + K  N+L++        + ++++D G A           +  +
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSI 196

Query: 608 LTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTGR 643
            T     +PE   G  + C +D++S   ++ EL+TG 
Sbjct: 197 QTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 32/198 (16%), Positives = 65/198 (32%), Gaps = 44/198 (22%)

Query: 71  SNVTEIRLTGMNLGG----VLADTLGDLESVINIDLSNNHIGGSIPSNLPV--------- 117
            +V EI L+G  +G      L++ +   + +   + S+   G                  
Sbjct: 32  DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALL 91

Query: 118 ---TVRNFSLSGNQLTG----SIPESLSRLTQLLDLSLNNNHL-------------NGGI 157
               +    LS N         + + LS+ T L  L L+NN L                +
Sbjct: 92  KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151

Query: 158 PDAFHQFTGLINFDLSANNLTGQ----LPPSTRNLSSLYSLHLQNNKLS--GTLNVLEDL 211
                    L +     N L          + ++   L+++ +  N +   G  ++L + 
Sbjct: 152 NKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211

Query: 212 -----HLIDLNIENNLFS 224
                 L  L++++N F+
Sbjct: 212 LAYCQELKVLDLQDNTFT 229

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 30/196 (15%), Positives = 56/196 (28%), Gaps = 44/196 (22%)

Query: 71  SNVTEIRLTGMNLG----------GVLADTLGDLESVINIDLSNNHIGGSIPSNL----- 115
            ++     + +  G           +L   L     +  + LS+N  G +    L     
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 116 -PVTVRNFSLSGNQLT-------------GSIPESLSRLTQLLDLSLNNNHL-NGG---I 157
               + +  L  N L               ++ +       L  +    N L NG     
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179

Query: 158 PDAFHQFTGLINFDLSANNLTGQ-----LPPSTRNLSSLYSLHLQNNKLS--GTL---NV 207
              F     L    +  N +  +     L         L  L LQ+N  +  G+      
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239

Query: 208 LEDL-HLIDLNIENNL 222
           L+   +L +L + + L
Sbjct: 240 LKSWPNLRELGLNDCL 255

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 25/138 (18%), Positives = 41/138 (29%), Gaps = 22/138 (15%)

Query: 87  LADTLGDLESVINIDLSNNHIG-----GSIPSNLPV--TVRNFSLSGNQLTG----SIPE 135
            A T      +  + +  N I        +   L     ++   L  N  T     ++  
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238

Query: 136 SLSRLTQLLDLSLNNNHL-NGGIPD-----AFHQFTGLINFDLSANNLTGQ----LPPS- 184
           +L     L +L LN+  L   G        +  +  GL    L  N +       L    
Sbjct: 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 298

Query: 185 TRNLSSLYSLHLQNNKLS 202
              +  L  L L  N+ S
Sbjct: 299 DEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 27/148 (18%), Positives = 47/148 (31%), Gaps = 33/148 (22%)

Query: 87  LADTLGDLESVINIDLSNNHIGG----SIPSNLPV--TVRNFSLSGNQL----------T 130
           +   L + +SV  I LS N IG      +  N+     +     S               
Sbjct: 24  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83

Query: 131 GSIPESLSRLTQLLDLSLNNNHL--NGGIP--DAFHQFTGLINFDLSANNLT-------- 178
             + ++L +  +L  + L++N        P  D   + T L +  L  N L         
Sbjct: 84  RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143

Query: 179 -----GQLPPSTRNLSSLYSLHLQNNKL 201
                  +    +N   L S+    N+L
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRL 171

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 51.1 bits (123), Expect = 5e-07
 Identities = 47/223 (21%), Positives = 91/223 (40%), Gaps = 46/223 (20%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLS--NTVSQRQTDEEFLELASTISRLRHGNIVELI 504
           +G G  G V+ A +    K +A+KK+   +  S +    E   +     RL H NIV++ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKII----RRLDHDNIVKVF 74

Query: 505 -------GYCNEHGQHL-------LVYDYGGNCTLHDLLHSD--EEAHKK-FSWNIRIRV 547
                      +    L       +V +Y     L ++L      E H + F + +    
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQL---- 129

Query: 548 ALGAARALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEG 606
                R L+Y+       ++H + K +N+ ++ E L++++ D GLA        +   +G
Sbjct: 130 ----LRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLAR---IMDPHYSHKG 179

Query: 607 LLTAHGSG----APE--FESGSYSCQSDVYSLGVVMLELLTGR 643
            L+         +P       +Y+   D+++ G +  E+LTG+
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 82/354 (23%), Positives = 133/354 (37%), Gaps = 63/354 (17%)

Query: 331 KNTGTYKGHGEKPNYKNSPLQPSG-------QVEEVSKEP----VVKSQDGHGVDSRRM- 378
           KN GT+ G+ E+P   +    P         Q+ +  +      +++      V  R   
Sbjct: 30  KNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFH 89

Query: 379 VSSPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQY 438
           V +P  ++E        +  V     K  A     R  SPS N  +  + V       + 
Sbjct: 90  VETPEEREEWTTA----IQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRV 145

Query: 439 T-NSFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLS-NTVSQRQTDEEFLELASTIS-- 493
           T N F     +G+G  G V   +    G+  A+K L    +  +       E+A T++  
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD------EVAHTLTEN 199

Query: 494 ----RLRHGNIVELIGYCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIR 546
                 RH  +  L  Y  +    L  V +Y  GG    H  L  +    + FS +   R
Sbjct: 200 RVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFH--LSRE----RVFSED---R 249

Query: 547 VALGAAR---ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
                A    AL YL    E  +V+ + K  N++LD+   ++++D GL           +
Sbjct: 250 ARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGL-------CKEGI 300

Query: 604 SEGLLTAHGSGAPEF------ESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSR 650
            +G       G PE+      E   Y    D + LGVVM E++ GR P Y++  
Sbjct: 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 48/245 (19%), Positives = 88/245 (35%), Gaps = 69/245 (28%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V +  ++  GK  A+KK+      R  + E   +      L H NI++L+ Y
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQ--DPRYKNRELDIM----KVLDHVNIIKLVDY 68

Query: 507 CNEHGQHL--------------------------------------LVYDYGGNCTLHDL 528
               G                                         ++ +Y    TLH +
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKV 127

Query: 529 LHSDEEAHKKFSWNIRIRVAL-GAARALQYL--QEVCEPPIVHGNFKSSNILLD-EKLIV 584
           L S   + +       I + +    RA+ ++    +C     H + K  N+L++ +   +
Sbjct: 128 LKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLGIC-----HRDIKPQNLLVNSKDNTL 181

Query: 585 RVSDCGLAPLLFSGSTNELSEGLLTAHGSG----APE--FESGSYSCQSDVYSLGVVMLE 638
           ++ D G A  L     +        A+       APE    +  Y+   D++S+G V  E
Sbjct: 182 KLCDFGSAKKLIPSEPS-------VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234

Query: 639 LLTGR 643
           L+ G+
Sbjct: 235 LILGK 239

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 49.9 bits (120), Expect = 1e-06
 Identities = 53/256 (20%), Positives = 94/256 (36%), Gaps = 45/256 (17%)

Query: 416 SSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLS- 473
           + P     S   +       ++    F  G  +GEG   +V  A EL   +  A+K L  
Sbjct: 6   AEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK 65

Query: 474 -NTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLH 530
            + + + +      E    +SRL H   V+L     +  +      Y   G     +LL 
Sbjct: 66  RHIIKENKVPYVTRE-RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG-----ELLK 119

Query: 531 SDEEAH----KKFSWNIRIR-----VALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK 581
                +      F      R     +      AL+YL       I+H + K  NILL+E 
Sbjct: 120 -----YIRKIGSFD-ETCTRFYTAEIVS----ALEYLHGK---GIIHRDLKPENILLNED 166

Query: 582 LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF------ESGSYSCQSDVYSLGVV 635
           + ++++D G A +L   S    +   +     G  ++         S    SD+++LG +
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFV-----GTAQYVSPELLTEKSACKSSDLWALGCI 221

Query: 636 MLELLTGRKP-YDRSR 650
           + +L+ G  P    + 
Sbjct: 222 IYQLVAGLPPFRAGNE 237

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 70/322 (21%), Positives = 113/322 (35%), Gaps = 65/322 (20%)

Query: 338 GHGEKPNYKNSPLQPSGQVEEVSKEPVVKSQDGHGVDSRRMVSSPRPQDEKLPLPPLPLP 397
            +    + KNS  Q S      +KE          +  R  V S R     + +P  P  
Sbjct: 17  ENLYFQSMKNSGDQDSRSGHNEAKEV----WSNADLTERMPVKSKRTSALAVDIPAPP-- 70

Query: 398 LVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTNSFSEGNFIGEGLLGSVY 457
                   P     VT +     +                YT   S+   +G G  G V+
Sbjct: 71  -------APFDHRIVTAKQGAVNSF---------------YT--VSKTEILGGGRFGQVH 106

Query: 458 KA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV 516
           K  E   G  LA K +       +  EE     S +++L H N+++L          +LV
Sbjct: 107 KCEETATGLKLAAKIIK--TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164

Query: 517 YDY--GG----NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGN 570
            +Y  GG             ++ +    F     ++        ++++ ++    I+H +
Sbjct: 165 MEYVDGGELFDRIIDESYNLTELDT-ILF-----MKQICE---GIRHMHQM---YILHLD 212

Query: 571 FKSSNILL---DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE-FESGSY 623
            K  NIL    D K I ++ D GLA            E L    G+    APE       
Sbjct: 213 LKPENILCVNRDAKQI-KIIDFGLARRYKPR------EKLKVNFGTPEFLAPEVVNYDFV 265

Query: 624 SCQSDVYSLGVVMLELLTGRKP 645
           S  +D++S+GV+   LL+G  P
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSP 287

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 49.9 bits (118), Expect = 2e-06
 Identities = 36/247 (14%), Positives = 68/247 (27%), Gaps = 56/247 (22%)

Query: 439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKL-------SNTVSQRQTDEEFLELA-- 489
           T        IGEG+ G V++       + A+K +        N   Q+  +E   E+   
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 490 ------STISRLRHGNIVELI------GYCNEHGQHLLVYDYGGNCTLHDLLHS------ 531
                 S     R    + L       G           +      + +D          
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 532 -------------DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL 578
                        ++   K  S      +      +L   +        H +    N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLL 195

Query: 579 DEKLIVRVSD-----------CGLAPLL--FSGSTNELSEGLLTAHGSGAPEFESGSYSC 625
            +  + ++             CGL   +  ++ S  E    ++    S   +  +G    
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDY 255

Query: 626 QSDVYSL 632
           Q D+Y L
Sbjct: 256 QFDIYRL 262

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 58/260 (22%), Positives = 91/260 (35%), Gaps = 52/260 (20%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVELIG 505
           IG G  G           +L+AVK +            E          LRH NIV    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREI----INHRSLRHPNIVRFKE 83

Query: 506 YCNEHGQHL-LVYDYGGNCTLHDLL-----HSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
                  HL ++ +Y     L++ +      S++EA   F   +           + Y  
Sbjct: 84  VI-LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS---------GVSYCH 133

Query: 560 EVCEPPIVHGNFKSSNILLDEKLI--VRVSDCGLAPLLFSGSTNELSEGLLTAHGS---G 614
            +    I H + K  N LLD      +++ D G +      S         +  G+    
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ------PKSTVGTPAYI 184

Query: 615 APEFESG-SYS-CQSDVYSLGVVMLELLTGRKPY-DRSRPRGEQSL------VRWAIPRL 665
           APE      Y    +DV+S GV +  +L G  P+ D   PR  +        V+++IP  
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244

Query: 666 HDI-----DALSRM--VDPS 678
             I       +SR+   DP+
Sbjct: 245 IRISPECCHLISRIFVADPA 264

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 15/45 (33%), Positives = 18/45 (40%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLN 154
           S+P+  PV      L+GN LT   P  L  L  L    L  N   
Sbjct: 24  SLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 42/246 (17%), Positives = 83/246 (33%), Gaps = 45/246 (18%)

Query: 424 SSSVSVFTIASLQQYTNSFSE-----GNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVS 477
           SS V + T     Q   +F+         +G G    V +      G+  A K L     
Sbjct: 8   SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL-KKRR 66

Query: 478 QRQTDEEFLELASTI-SRLRHG-NIVELIGYCNEHGQHLLVYDY--GGNCTLHDLLHSDE 533
           + Q     +     +    +    ++ L        + +L+ +Y  GG   +  L   + 
Sbjct: 67  RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG--EIFSLCLPEL 124

Query: 534 EAHKKFSWNIRIRVALGAARALQYLQEVCE-------PPIVHGNFKSSNILL---DEKLI 583
                          +     ++ ++++ E         IVH + K  NILL        
Sbjct: 125 AEM------------VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGD 172

Query: 584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APE-FESGSYSCQSDVYSLGVVMLEL 639
           +++ D G++  +           L    G+    APE       +  +D++++G++   L
Sbjct: 173 IKIVDFGMSRKIGHA------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML 226

Query: 640 LTGRKP 645
           LT   P
Sbjct: 227 LTHTSP 232

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 35/118 (29%), Positives = 53/118 (44%), Gaps = 11/118 (9%)

Query: 89  DTLGDLESVINIDLSNNHIGGSIPSNL---PVTVRNFSLSGNQLTGSIPESL-SRLTQLL 144
             L +L  +    L+ N +  S+P+ +      ++   L  NQL  S+P+ +  +LT L 
Sbjct: 82  KELTNLTYL---ILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLT 136

Query: 145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKL 201
            L+L +N L       F + T L   DLS N L   LP      L+ L  L L  N+L
Sbjct: 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 31/143 (21%), Positives = 48/143 (33%), Gaps = 31/143 (21%)

Query: 110 SIPSNLPVTVRNFSLSGNQLTGSIP---------------------ESLSRLTQLLDLSL 148
             P +        +L    +T                         + +  L  +  L+L
Sbjct: 12  IFPDDAFAETIKANLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLAL 70

Query: 149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKL----SG 203
             N L+  I  A  + T L    L+ N L   LP      L++L  L L  N+L     G
Sbjct: 71  GGNKLH-DIS-ALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDG 127

Query: 204 TLNVLEDLHLIDLNIENNLFSGP 226
             + L +L  ++L   N L S P
Sbjct: 128 VFDKLTNLTYLNLA-HNQLQSLP 149

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 44/226 (19%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVELIG 505
           IG G  G V   +L    K+ A+K L+   + +R     F E    +       I  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140

Query: 506 YCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIR-----VALGAARALQY 557
           Y  +   +L LV DY  GG     DLL    +   +       R     + +    A+  
Sbjct: 141 YAFQDDNNLYLVMDYYVGG-----DLLTLLSKFEDRLP-EEMARFYLAEMVI----AIDS 190

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS-G-- 614
           + ++     VH + K  NIL+D    +R++D G    L       + +G + +  + G  
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL-------MEDGTVQSSVAVGTP 240

Query: 615 ---APE------FESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSR 650
              +PE         G Y  + D +SLGV M E+L G  P Y  S 
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 38/224 (16%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVELIG 505
           IG G    V   ++   G++ A+K ++   + +R     F E    +       I +L  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127

Query: 506 YCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIR-----VALGAARALQY 557
           +  +   +L LV +Y  GG     DLL    +  ++       R     + +    A+  
Sbjct: 128 FAFQDENYLYLVMEYYVGG-----DLLTLLSKFGERIPAE-MARFYLAEIVM----AIDS 177

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL----------FSGSTNELSEGL 607
           +  +     VH + K  NILLD    +R++D G    L            G+ + LS  +
Sbjct: 178 VHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234

Query: 608 LTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSR 650
           L A G G      GSY  + D ++LGV   E+  G+ P Y  S 
Sbjct: 235 LQAVGGGPGT---GSYGPECDWWALGVFAYEMFYGQTPFYADST 275

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 44.9 bits (107), Expect = 5e-05
 Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 47/221 (21%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-------NTVSQRQTDEEFLELASTISRLRHGN 499
           IG G    V    L    ++ A+K +          +   QT++   E AS      H  
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPF 71

Query: 500 IVELIGYCNEHGQHL-LVYDY--GGNCTLHDLL-HSDEEAHKKFSWNIRIRVALGAAR-- 553
           +V L   C +    L  V +Y  GG     DL+ H   +  +K            +A   
Sbjct: 72  LVGLH-SCFQTESRLFFVIEYVNGG-----DLMFHMQRQ--RKLPEE---HARFYSAEIS 120

Query: 554 -ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
            AL YL E     I++ + K  N+LLD +  ++++D G+           L  G  T+  
Sbjct: 121 LALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM-------CKEGLRPGDTTSTF 170

Query: 613 SGAPEF------ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
            G P +          Y    D ++LGV+M E++ GR P+D
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 54/291 (18%), Positives = 104/291 (35%), Gaps = 48/291 (16%)

Query: 381 SPRPQDEKLPLPPLPLPLVEKVTVKPLAPAEVTRRSSPSTNVISSSVSVFTIASLQQYTN 440
               Q+E         P   +   +     E  +    +      + +  +        +
Sbjct: 277 KLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRD 336

Query: 441 SFSEGNF-----IGEGLLGSVYKAELPG-GKLLAVKKLS-------NTVSQRQTDEEFLE 487
                +F     +G+G  G V  +E  G  +L AVK L        + V     ++  L 
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396

Query: 488 LASTISRLRHGNIVELIGYCNEHGQHL-LVYDY--GGNCTLHDLLHSD--EEAHKKFSWN 542
           L       +   + +L   C +    L  V +Y  GG+   H +      +E H  F   
Sbjct: 397 LPG-----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYH-IQQVGRFKEPHAVF--- 446

Query: 543 IRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE 602
                A   A  L +LQ      I++ + K  N++LD +  ++++D G+           
Sbjct: 447 ----YAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM-------CKEN 492

Query: 603 LSEGLLTAHGSGAPEF------ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
           + +G+ T    G P++          Y    D ++ GV++ E+L G+ P++
Sbjct: 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 54/222 (24%), Positives = 87/222 (39%), Gaps = 49/222 (22%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-------NTVSQRQTDEEFLELASTISRLRHGN 499
           IG G    V    L    ++ A++ +          +   QT++   E AS      H  
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPF 114

Query: 500 IVELIGYCNEHGQHL-LVYDY--GGNCTLHDLLHSD---EEAHKKFSWNIRIRVALGA-- 551
           +V L   C +    L  V +Y  GG+   H  +       E H +F           A  
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFH--MQRQRKLPEEHARF---------YSAEI 162

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           + AL YL E     I++ + K  N+LLD +  ++++D G+           L  G  T+ 
Sbjct: 163 SLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM-------CKEGLRPGDTTST 212

Query: 612 GSGAPEF------ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
             G P +          Y    D ++LGV+M E++ GR P+D
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 32/213 (15%)

Query: 446 NFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVS-QRQTDEE--FLELASTISRLRHGNIV 501
           + IG+G  G V KA      + +A+K + N  +   Q   E   LEL +         IV
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 502 ELIGYCNEHGQHL-LVYD-YGGNCTLHDLLHSDEEAHKKFSWN------IRIRVALGAAR 553
            L  +      HL LV++    N  L+DLL       +  ++        R + A     
Sbjct: 120 HLKRHF-MFRNHLCLVFEMLSYN--LYDLL-------RNTNFRGVSLNLTR-KFAQQMCT 168

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILL--DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
           AL +L    E  I+H + K  NILL   ++  +++ D G +          + + + +  
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF 223

Query: 612 GSGAPEFESG-SYSCQSDVYSLGVVMLELLTGR 643
              +PE   G  Y    D++SLG +++E+ TG 
Sbjct: 224 YR-SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 37/189 (19%), Positives = 61/189 (32%), Gaps = 41/189 (21%)

Query: 71  SNVTEIRLTGMNLG--GV--LADTLGDL-ESVINIDLSNNHIG-------GSIPSNLPVT 118
           +NV  + L G NL       LA  L  +  SV ++DLS N +G         I S++P  
Sbjct: 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNH 226

Query: 119 VRNFSLSGNQLTGS----IPESLSRLTQLLDLSLNNNHLNG-------GIPDAFHQFTGL 167
           V + +L  N L G     +      L  L  + L+ + +          +  AF     +
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286

Query: 168 INFDLSANNLTGQLPPSTRNLS--------SLYSLHLQNNKLSGTLNVLEDL-------H 212
           I  D +   +    P  +  +S              L N  L        ++        
Sbjct: 287 ILVDKNGKEIH---PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDE 343

Query: 213 LIDLNIENN 221
           L +      
Sbjct: 344 LRESIQTCK 352

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 32/170 (18%), Positives = 66/170 (38%), Gaps = 35/170 (20%)

Query: 87  LADTLGDLESVINIDLSNNHIG-------GSIPSNLPVTVRNFSLSGNQLTGSIPESLSR 139
           + +       V ++DLS N++            +N P +V + +LSGN L     + L +
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73

Query: 140 L-----TQLLDLSLNNNHLNG----GIPDAF-HQFTGLINFDLSANNLTGQLPPSTRNLS 189
           +       +  L+L+ N L+      +          +   DL  N+ + +   S+    
Sbjct: 74  ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSK---SSSEFK 130

Query: 190 --------SLYSLHLQNNKLS--GTLNVLEDL-----HLIDLNIENNLFS 224
                   S+ SL+L+ N L    +  +++ L     ++  LN+  N  +
Sbjct: 131 QAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 52/228 (22%), Positives = 82/228 (35%), Gaps = 34/228 (14%)

Query: 445 GNFIGEGLLGSVYKAE---------LPGGKLLAVK------KLSN--TVSQRQTDEEFLE 487
            +F      G +Y+A           P  +  ++K      +L N     QR      + 
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 488 LASTISRLRHGNIVELIGYCNEHGQH-LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIR 546
               +       I   +G+     ++  LV    G  +L   L  D       S    ++
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLG-RSLQSAL--DVSPKHVLSERSVLQ 163

Query: 547 VALGAARALQYLQEVCEPPIVHGNFKSSNILL--DEKLIVRVSDCGLAPLLFSGSTN-EL 603
           VA     AL++L E      VHGN  + NI +  +++  V ++  G A        +   
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220

Query: 604 SEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKP 645
            EG  + H  G  EF S         S +SD+ SLG  ML+ L G  P
Sbjct: 221 VEGSRSPH-EGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 43.7 bits (104), Expect = 1e-04
 Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 49/225 (21%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-NTVSQRQTDEEFLELASTIS------RLRHGN 499
           +G+G  G V        G+  A+K L    +  +       E+A T++        RH  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD------EVAHTVTESRVLQNTRHPF 66

Query: 500 IVELIGYCNEHGQHL-LVYDY--GGNCTLHDLL-HSDEEAHKKFSWNIRIRVALGAAR-- 553
           +  L  Y  +    L  V +Y  GG     +L  H   E  + F+     R     A   
Sbjct: 67  LTALK-YAFQTHDRLCFVMEYANGG-----ELFFHLSRE--RVFTEE---RARFYGAEIV 115

Query: 554 -ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
            AL+YL       +V+ + K  N++LD+   ++++D GL           +S+G      
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGL-------CKEGISDGATMKTF 165

Query: 613 SGAPEF------ESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSR 650
            G PE+      E   Y    D + LGVVM E++ GR P Y++  
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 25/129 (19%), Positives = 47/129 (36%), Gaps = 14/129 (10%)

Query: 123 SLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIP--DAFHQFTGLINFDLSANNLTGQ 180
                 +   +  +LS L     L+L+ N     I    +      L    L  N +  +
Sbjct: 31  HGMIPPIEK-MDATLSTLKACKHLALSTN----NIEKISSLSGMENLRILSLGRNLIK-K 84

Query: 181 LPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGPIP-EKLLSIPNFR 238
           +        +L  L +  N+++ +L+ +E L  L  L + NN  +     +KL ++    
Sbjct: 85  IENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143

Query: 239 K---DGNPF 244
                GNP 
Sbjct: 144 DLLLAGNPL 152

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 62/314 (19%), Positives = 108/314 (34%), Gaps = 61/314 (19%)

Query: 447 FIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVS-QRQTDEE--FLELASTISRLRHGNIVE 502
            IG+G  G V KA      + +A+K + N     RQ  EE   LE      +    N++ 
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 503 LIGYCNEHGQHL-LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
           ++        H+ + ++      L++L+  ++   + FS  +  + A    + L  L + 
Sbjct: 164 MLENF-TFRNHICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN 219

Query: 562 CEPPIVHGNFKSSNILLDE--KLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
               I+H + K  NILL +  +  ++V D G +          +   + +     APE  
Sbjct: 220 R---IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRFYR-APEVI 271

Query: 620 SG-SYSCQSDVYSLGVVMLELLTG------------------------------------ 642
            G  Y    D++SLG ++ ELLTG                                    
Sbjct: 272 LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331

Query: 643 ---RKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSR--FADIISR 697
               K Y R       S     +          R    S +     K      F D + +
Sbjct: 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ 391

Query: 698 CVQWEPGFRPPMSE 711
           C++W+P  R    +
Sbjct: 392 CLEWDPAVRMTPGQ 405

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 53/225 (23%), Positives = 85/225 (37%), Gaps = 45/225 (20%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVELIG 505
           IG G  G V         K+ A+K LS   + +R     F E    ++      +V+L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135

Query: 506 YCNEHGQHL-LVYDY--GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR--------A 554
           Y  +  ++L +V +Y  GG     DL           +      V    AR        A
Sbjct: 136 YAFQDDRYLYMVMEYMPGG-----DL----------VNLMSNYDVPEKWARFYTAEVVLA 180

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L  +  +     +H + K  N+LLD+   ++++D G    +             TA G+ 
Sbjct: 181 LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD----TAVGTP 233

Query: 615 ---APEF-----ESGSYSCQSDVYSLGVVMLELLTGRKP-YDRSR 650
              +PE        G Y  + D +S+GV + E+L G  P Y  S 
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 42.2 bits (100), Expect = 5e-04
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 47/221 (21%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-------NTVSQRQTDEEFLELASTISRLRHGN 499
           +G+G  G V  A +   G L AVK L        + V    T++  L LA       H  
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHPF 85

Query: 500 IVELIGYCNEHGQHL-LVYDY--GGNCTLHDL-LHSDEEAHKKFSWNIRIRVALGAAR-- 553
           + +L   C +    L  V ++  GG     DL  H  +   ++F      R    AA   
Sbjct: 86  LTQLF-CCFQTPDRLFFVMEFVNGG-----DLMFHIQKS--RRFDEA---RARFYAAEII 134

Query: 554 -ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
            AL +L +     I++ + K  N+LLD +   +++D G+           +  G+ TA  
Sbjct: 135 SALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM-------CKEGICNGVTTATF 184

Query: 613 SGAPEF------ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
            G P++      +   Y    D +++GV++ E+L G  P++
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 21/132 (15%), Positives = 45/132 (34%), Gaps = 25/132 (18%)

Query: 71  SNVTEIRLTGMNLGGV-----LADTLGDLESVINIDLSNNHIGGS--------IPSNLPV 117
            ++ E+ L  +    V      A+ L     V    +                +  N   
Sbjct: 36  PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVN--N 93

Query: 118 TVRNFSLSGNQLTG----SIPESLSRLTQLLDLSLNNNHLNGG------IPDAFHQFTGL 167
           T+++ ++  N ++G    ++ E+L   T L++L ++N     G      I +   + T L
Sbjct: 94  TLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTL 153

Query: 168 INFDLSANNLTG 179
           + F         
Sbjct: 154 LKFGYHFTQQGP 165

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 41.4 bits (98), Expect = 6e-04
 Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 47/221 (21%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLS-------NTVSQRQTDEEFLELASTISRLRHGN 499
           +G+G  G V  +E  G  +L AVK L        + V     ++  L L       +   
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPPF 82

Query: 500 IVELIGYCNEHGQHL-LVYDY--GGNCTLHDL-LHSDEEAHKKFSWNIRIRVALGAAR-- 553
           + +L   C +    L  V +Y  GG     DL  H  +    +F           AA   
Sbjct: 83  LTQLH-SCFQTMDRLYFVMEYVNGG-----DLMYHIQQV--GRFKEP---HAVFYAAEIA 131

Query: 554 -ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             L +LQ      I++ + K  N++LD +  ++++D G+           + +G+ T   
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM-------CKENIWDGVTTKTF 181

Query: 613 SGAPEF------ESGSYSCQSDVYSLGVVMLELLTGRKPYD 647
            G P++          Y    D ++ GV++ E+L G+ P++
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	720
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.94
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.94
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.94
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.9
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.89
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.86
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.85
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.84
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.84
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.83
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.83
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.82
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.82
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.81
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.81
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.81
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.81
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.81
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.8
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.8
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.8
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.8
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.8
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.8
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.8
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.8
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.8
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.79
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.79
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.79
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.79
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.79
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.79
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.79
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.78
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.78
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.78
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.78
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.78
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.78
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.78
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.78
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.78
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.78
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.77
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.77
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.77
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.77
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.77
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.76
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.76
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.76
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.76
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.76
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.75
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.75
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.75
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.74
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.74
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.74
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.74
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.74
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.73
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.73
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.73
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.73
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.73
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.72
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.71
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.71
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.71
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.71
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.7
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.69
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.68
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.68
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.68
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.68
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.67
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.67
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.67
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.66
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.66
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.66
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.66
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.65
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.65
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.65
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.63
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.63
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.63
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.63
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.62
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.62
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.62
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.62
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.62
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.62
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.61
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.61
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.61
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.6
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.6
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.59
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.58
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.58
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.58
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.55
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.55
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.54
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.54
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.53
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.51
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.49
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.49
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.47
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.43
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.42
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.41
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.39
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.31
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.28
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.19
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.03
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.98
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.9
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.9
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.86
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.83
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.71
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.6
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.59
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.57
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.54
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.5
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.49
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.46
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.36
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.36
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.34
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.3
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.3
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.23
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.16
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.9
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.89
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.68
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.63
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.53
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.4
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.34
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.28
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.27
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.16
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.08
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.07
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	96.95
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.89
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.75
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.75
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.75
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	96.73
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.73
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.72
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.68
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	96.67
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.62
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.6
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	96.32
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.27
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.18
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.95
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.68
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.37
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.79
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	87.9
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.33
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.09
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.67
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	84.56
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.99

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-53  Score=442.89  Aligned_cols=259  Identities=28%  Similarity=0.400  Sum_probs=202.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +++...+.||+|+||+||+|++.+  .||||+++.........+.|.+|++++++++|||||+++|+|.+ +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            456677899999999999998754  59999997554445556789999999999999999999999865 468999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      |++|+|.++++..   ...++|.++.+|+.|+|+||+|||+.   +||||||||+|||+++++++||+|||+|+......
T Consensus       113 ~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          113 CEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999643   34699999999999999999999987   89999999999999999999999999998775443


Q ss_pred             CcccccCccccccCCCCccCC----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          600 TNELSEGLLTAHGSGAPEFES----GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      .........||+.|+|||++.    +.|+.++|||||||+||||+||+.||.........  ....         .....
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~~~---------~~~~~  255 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IFMV---------GRGYA  255 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHH---------HTTCC
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HHHH---------hcCCC
Confidence            333344567999999999872    35899999999999999999999999754332111  1000         00111


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .|.+. ..+..+++++.+|+.+||+.||++||||.||+++|+.+
T Consensus       256 ~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          256 SPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             CCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             CCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11111 12223456789999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5e-54  Score=447.86  Aligned_cols=256  Identities=25%  Similarity=0.346  Sum_probs=209.1

Q ss_pred             CCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          443 SEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       443 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ...+.||+|+||+||+|.+.      +++.||||+++... .....++|.+|++++++++|||||+++|+|.+.+..++|
T Consensus        29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            34578999999999999762      46899999997543 344567899999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccc------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCe
Q 004994          517 YDYGGNCTLHDLLHSDE------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIV  584 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  584 (720)
                      ||||++|+|.++++...            .....++|..+.+|+.|+|+||+|||+.   +||||||||+|||+++++++
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence            99999999999996432            1235689999999999999999999997   89999999999999999999


Q ss_pred             EEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcc
Q 004994          585 RVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       585 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      ||+|||+|+.+.............+|+.|+|||.+ .+.|+.++|||||||+||||+| |+.||......+   +.... 
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~i-  260 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEMI-  260 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHHH-
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-
Confidence            99999999977554444444556789999999988 6789999999999999999999 899997643221   11111 


Q ss_pred             cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                                  .... ....+..++.++.+|+.+||+.||++||||+||+++|+.+
T Consensus       261 ------------~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          261 ------------RNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ------------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ------------HcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                        1100 0011234456789999999999999999999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.4e-54  Score=448.30  Aligned_cols=258  Identities=23%  Similarity=0.384  Sum_probs=209.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ++|...+.||+|+||+||+|++.      ++..||||+++..  .....++|.+|++++++++|||||+++|+|.+.+..
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            45667789999999999999763      4789999999753  234567899999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccc---------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCe
Q 004994          514 LLVYDYGGNCTLHDLLHSDE---------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIV  584 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  584 (720)
                      ++|||||++|+|.++++...         .....++|.++.+|+.|+|+||+|||+.   +||||||||+|||+++++++
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence            99999999999999997532         1235799999999999999999999987   89999999999999999999


Q ss_pred             EEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcc
Q 004994          585 RVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       585 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      ||+|||+|+...............+|+.|+|||.+ .+.|+.++|||||||++|||+| |+.||......+   +...  
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~--  242 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC--  242 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH--
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH--
Confidence            99999999876544333344456689999999998 6789999999999999999999 999997643221   1111  


Q ss_pred             cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                                 +.... ....+..+++++.+|+.+||+.||++||||+||++.|+++
T Consensus       243 -----------i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          243 -----------ITQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             -----------HHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                       00000 0011223456789999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.3e-54  Score=450.06  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=201.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ++|...+.||+|+||+||+|++.      +++.||||+++..  .....++|.+|+++|++++|||||+++|+|.+.+..
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            34556688999999999999764      4789999999753  244567899999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccch-----------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEE-----------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL  582 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  582 (720)
                      +||||||++|+|.++++....           ....++|.++++|+.|+|+||+|||+.   +||||||||+|||+++++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence            999999999999999975321           234689999999999999999999987   899999999999999999


Q ss_pred             CeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhh
Q 004994          583 IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRW  660 (720)
Q Consensus       583 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~  660 (720)
                      ++||+|||+|+.+.............+|+.|+|||++ .+.|+.++|||||||++|||+| |+.||........   ...
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~  272 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDC  272 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence            9999999999987554444444456789999999998 5679999999999999999999 9999975432211   111


Q ss_pred             cccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          661 AIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       661 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .          .+-..+.    .+..+++++.+|+.+||+.||++||||+||+++|+.|
T Consensus       273 i----------~~g~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          273 I----------TQGRELE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             H----------HHTCCCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             H----------HcCCCCC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            0          0000111    1223456789999999999999999999999999976

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.7e-52  Score=426.84  Aligned_cols=249  Identities=23%  Similarity=0.341  Sum_probs=200.0

Q ss_pred             CCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc----CCeEEEEE
Q 004994          443 SEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE----HGQHLLVY  517 (720)
Q Consensus       443 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~  517 (720)
                      ...+.||+|+||+||+|.. .++..||||++..........+.|.+|++++++++|||||+++++|.+    .+..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            3346799999999999965 568999999997655455566789999999999999999999999864    34689999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-CCCeEEccccCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KLIVRVSDCGLAPLLF  596 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~  596 (720)
                      |||++|+|.+++..    ...+++.....++.|++.||+|||+. .++||||||||+|||++. ++++||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999953    45789999999999999999999986 224999999999999984 7999999999998653


Q ss_pred             CCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..    ......||+.|+|||.+.+.|+.++|||||||++|||+||+.||........  +.             ..+..
T Consensus       184 ~~----~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~-------------~~i~~  244 (290)
T 3fpq_A          184 AS----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY-------------RRVTS  244 (290)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH-------------HHHTT
T ss_pred             CC----ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HH-------------HHHHc
Confidence            22    2334679999999999988899999999999999999999999965332111  11             11111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .......+...++++.+|+.+||+.||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111111222334578899999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.8e-52  Score=438.77  Aligned_cols=252  Identities=21%  Similarity=0.322  Sum_probs=201.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++.+........+.|.+|++++++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5788899999999999999965 579999999997665445566789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      ||++|+|.+++...  ....+++.....++.|++.||+|||+.   +||||||||+|||++.++++||+|||+|+.+...
T Consensus       104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999632  234578888999999999999999997   9999999999999999999999999999876422


Q ss_pred             CCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                        ........||+.|+|||.+. ..|+.++|||||||++|||+||+.||.........                .++...
T Consensus       179 --~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~----------------~~i~~~  240 (350)
T 4b9d_A          179 --VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV----------------LKIISG  240 (350)
T ss_dssp             --HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----------------HHHHHT
T ss_pred             --cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH----------------HHHHcC
Confidence              12233467999999999984 46999999999999999999999999754322111                111110


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ... ..+...+.++.+|+.+||++||++|||++|++++
T Consensus       241 ~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          241 SFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             CCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCC-CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000 0111234678899999999999999999999874

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.8e-52  Score=439.36  Aligned_cols=266  Identities=24%  Similarity=0.375  Sum_probs=212.8

Q ss_pred             HHHHhcCCCCCCeeccCCCceEEEEEeCC------CcEEEEEEecccccccccHHHHHHHHHHHHccCC-CceeEEEeEe
Q 004994          435 LQQYTNSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH-GNIVELIGYC  507 (720)
Q Consensus       435 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~  507 (720)
                      .+...++|+..+.||+|+||+||+|.+..      ++.||||++..... ....++|.+|+++|++++| ||||+++|+|
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            33345778889999999999999996532      46899999975432 3445789999999999965 8999999999


Q ss_pred             cc-CCeEEEEEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 004994          508 NE-HGQHLLVYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSS  574 (720)
Q Consensus       508 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~  574 (720)
                      .+ .+..++|||||++|+|.++++....            ....++|..+..++.|||+||+|||+.   +||||||||+
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~  214 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR  214 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcc
Confidence            76 4578999999999999999975322            134589999999999999999999997   8999999999


Q ss_pred             CeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCc
Q 004994          575 NILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR  652 (720)
Q Consensus       575 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~  652 (720)
                      |||+++++++||+|||+|+.+.............+|+.|+|||.+ .+.|+.++|||||||+||||+| |+.||......
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999987655444444556789999999998 6789999999999999999998 99999754322


Q ss_pred             cccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ..  +...          +.+-..+.    .+..+++++.+++.+||+.||++|||++||+++|+++|
T Consensus       295 ~~--~~~~----------i~~g~~~~----~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          295 EE--FCRR----------LKEGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             HH--HHHH----------HHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH--HHHH----------HHcCCCCC----CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            11  1110          00000111    12223467889999999999999999999999999874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.1e-51  Score=430.17  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=205.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      +.|+..+.||+|+||+||+|.. .+|+.||||++....  ....+.+.+|+++|++++|||||+++++|.+.+..|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4688889999999999999965 579999999996432  2334568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      ||++|+|.+++..     ..+++.....++.|++.||+|||+.   +||||||||+|||++.++++||+|||+|+.+...
T Consensus       152 y~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          152 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             CCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            9999999998852     4589999999999999999999997   9999999999999999999999999999876433


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .  .......||+.|+|||.+ ...|+.++|||||||++|||+||+.||...........+             .....+
T Consensus       224 ~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------------~~~~~~  288 (346)
T 4fih_A          224 V--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLPP  288 (346)
T ss_dssp             S--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHSSCC
T ss_pred             C--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------HcCCCC
Confidence            2  223456899999999998 457999999999999999999999999754322111111             111111


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+.  .....++++.+|+.+||++||++|||++|+++|
T Consensus       289 ~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          289 RLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111  122344678899999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.9e-51  Score=426.22  Aligned_cols=268  Identities=22%  Similarity=0.246  Sum_probs=199.9

Q ss_pred             CCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC----eEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG----QHLLV  516 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv  516 (720)
                      +|...+.||+|+||+||+|++ +|+.||||++....   .....+..|+..+.+++|||||+++|+|.+.+    ..+||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            456678999999999999987 58999999996431   11222334556667889999999999997653    68999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV-----CEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      ||||++|+|.++++.     ..++|..+.+++.|+|+||+|||+.     +.++||||||||+|||+|.++++||+|||+
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            999999999999953     4689999999999999999999975     356899999999999999999999999999


Q ss_pred             CCCCCCCCCcc--cccCccccccCCCCccCCC-------CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 004994          592 APLLFSGSTNE--LSEGLLTAHGSGAPEFESG-------SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       592 a~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-------~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      |+.........  ......||++|+|||++.+       .|+.++|||||||++|||+||+.||......... ...+..
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-~~~~~~  233 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLVP  233 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTSC
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-chhccc
Confidence            98765433211  2234578999999998844       3677999999999999999999887543221110 000000


Q ss_pred             cccCchhh-----hhhhcCCCCCchh-hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          663 PRLHDIDA-----LSRMVDPSLDGAY-LAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       663 ~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       .-...+.     ..+..+|.++... ..+++..+.+|+.+||+.||++||||.||++.|++|
T Consensus       234 -~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          234 -SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             -SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             -ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence             0001111     1122234443332 235667889999999999999999999999999876

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.8e-51  Score=429.34  Aligned_cols=251  Identities=20%  Similarity=0.192  Sum_probs=200.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      +.|...++||+|+||+||+|+. .+|+.||||+++....       +.+|++++++++|||||++++++.+.+..|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            3566678899999999999965 5799999999975422       2468999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-CeEEccccCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPLLFS  597 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~  597 (720)
                      ||++|+|.++++.    ...+++.....++.|++.||+|||+.   +||||||||+|||++.++ ++||+|||+|+.+..
T Consensus       131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            9999999999953    35689999999999999999999987   999999999999999988 699999999987754


Q ss_pred             CCCc---ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          598 GSTN---ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       598 ~~~~---~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ....   .......||+.|+|||.+ ...|+.++|||||||++|||+||+.||...........+....+      ... 
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------~~~-  276 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP------PIR-  276 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC------GGG-
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC------Cch-
Confidence            3221   122345799999999998 45699999999999999999999999976443221111110000      000 


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                              ..+..+++++.+++.+||++||++|||+.|++++|...
T Consensus       277 --------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          277 --------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             --------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                    11223346788999999999999999999999998764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-51  Score=425.80  Aligned_cols=249  Identities=20%  Similarity=0.281  Sum_probs=206.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++.+.. ......+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4688899999999999999965 679999999997542 23345678999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||+.   +||||||||+|||++.++++||+|||+|+.+..
T Consensus       112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            99999999999953    35689999999999999999999997   999999999999999999999999999998765


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...........||+.|+|||.+ ...|+.++||||+||++|||+||+.||...+.......+.            .  .+
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------------~--~~  250 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII------------K--LE  250 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------H--TC
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------c--CC
Confidence            4444445567899999999998 5579999999999999999999999997543221111000            0  00


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIV  713 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  713 (720)
                      ..+    +...++++.+|+.+||++||++|||++|++
T Consensus       251 ~~~----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 YDF----PEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCC----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCC----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            111    122345788999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.8e-50  Score=409.31  Aligned_cols=247  Identities=26%  Similarity=0.344  Sum_probs=188.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++.+... .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999965 5799999999975432 2344567999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+ +|+|.+++..    ...+++.....++.|++.||+|||+.   +||||||||+|||+++++++||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 5799998853    35689999999999999999999997   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccCCC-CC-CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG-SY-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~-~~-~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ..   ......||+.|+|||.+.+ .| +.++||||+||++|||+||+.||...........+...              
T Consensus       165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--------------  227 (275)
T 3hyh_A          165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--------------  227 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------
T ss_pred             CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------------
Confidence            22   2334679999999999854 44 68999999999999999999999753321111101000              


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...+    +...++++.+|+.+||+.||++|||++|+++|
T Consensus       228 ~~~~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          228 VYTL----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             CCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             CCCC----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            0111    11234678899999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.8e-50  Score=431.42  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .+.|+..+.||+|+||+||+|.. .+|+.||||++....  ....+.+.+|+++|++++|||||+++++|.+.+.+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            35688889999999999999965 579999999997442  233457889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      |||++|+|.+++..     ..+++.....++.|++.||+|||+.   +||||||||+||||+.++++||+|||+|+.+..
T Consensus       228 Ey~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          228 EFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             ECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             eCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            99999999999852     3589999999999999999999997   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..  .......||++|||||.+ ...|+.++|||||||++|||++|+.||...........+             .....
T Consensus       300 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------------~~~~~  364 (423)
T 4fie_A          300 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLP  364 (423)
T ss_dssp             SC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHSCC
T ss_pred             CC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------HcCCC
Confidence            32  233457899999999998 457999999999999999999999999754322211111             11111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +.+.  .....++++.+|+.+||++||++|||++|+++|
T Consensus       365 ~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          365 PRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111  112234678899999999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-50  Score=418.43  Aligned_cols=249  Identities=21%  Similarity=0.258  Sum_probs=196.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe----CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL----PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|+..+.||+|+||+||+|+.    .+++.||||++.+..........+.+|++++++++|||||++++++.+.+..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4688889999999999999965    247899999997654444444578899999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++|+|.+++..    ...+++.....++.|++.||+|||+.   +||||||||+|||++.++++||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999953    35689999999999999999999997   9999999999999999999999999999875


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ....  .......||+.|+|||.+ ...|+.++|||||||++|||+||+.||...+.......+                
T Consensus       177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i----------------  238 (304)
T 3ubd_A          177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI----------------  238 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----------------
T ss_pred             cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH----------------
Confidence            4322  223346799999999998 567999999999999999999999999754322111111                


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                      .....  ..+...++++.+|+.+||++||++|||     ++|+++|
T Consensus       239 ~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          239 LKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             HcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            10000  011223467889999999999999998     4677753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.6e-48  Score=402.59  Aligned_cols=253  Identities=19%  Similarity=0.311  Sum_probs=188.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC------
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG------  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------  511 (720)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++.... .....+.+.+|++++++++|||||++++++.+.+      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            34688889999999999999965 579999999996432 2344567999999999999999999999986433      


Q ss_pred             ------eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeE
Q 004994          512 ------QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR  585 (720)
Q Consensus       512 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  585 (720)
                            ..|+||||+++|+|.+++.... ......+.....++.|+++||+|||+.   +||||||||+|||++.++++|
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence                  4789999999999999997532 223456777889999999999999997   999999999999999999999


Q ss_pred             EccccCCCCCCCCCCcc----------cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 004994          586 VSDCGLAPLLFSGSTNE----------LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE  654 (720)
Q Consensus       586 l~DFGla~~~~~~~~~~----------~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~  654 (720)
                      |+|||+|+.+.......          ......||+.|+|||.+ ...|+.++|||||||++|||++   ||.....  .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~  233 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--R  233 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--H
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--H
Confidence            99999998875432111          12235699999999998 4579999999999999999996   7753110  0


Q ss_pred             cchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          655 QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       655 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                   ...+..+.....+. ......+.+.+|+.+||+.||++|||+.|++++
T Consensus       234 -------------~~~~~~~~~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          234 -------------VRTLTDVRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             -------------HHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------------HHHHHHHhcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                         00111111112211 122334567789999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-47  Score=408.36  Aligned_cols=268  Identities=19%  Similarity=0.311  Sum_probs=203.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc------CCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE------HGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~  512 (720)
                      ++|...+.||+|+||+||+|.. .+|+.||||++++........+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5788899999999999999965 679999999998665545556788999999999999999999998753      467


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .|+|||||+ |+|.+++..    ...+++.....++.|++.||+|||+.   +||||||||+|||++.++.+||+|||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999996 689998854    35789999999999999999999997   9999999999999999999999999999


Q ss_pred             CCCCCCC--CcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc-
Q 004994          593 PLLFSGS--TNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD-  667 (720)
Q Consensus       593 ~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-  667 (720)
                      +.+....  .........||++|+|||.+.+  .|+.++||||+||++|||+||+.||...+.......+......... 
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            8774332  1223345789999999998743  4799999999999999999999999765432221111100000000 


Q ss_pred             ---------hhhhhhhcCCCCCc---hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 ---------IDALSRMVDPSLDG---AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ---------~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                               .........+....   ........++.+|+.+||+.||++|||++|+++|
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                     00000001111000   0011124578899999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-45  Score=390.59  Aligned_cols=283  Identities=33%  Similarity=0.555  Sum_probs=233.8

Q ss_pred             CHHHHHHHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC
Q 004994          431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH  510 (720)
Q Consensus       431 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~  510 (720)
                      ...++...+++|...+.||+|+||+||+|...+|+.||||++....  ....+.+.+|++++++++||||+++++++.+.
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            3445556788999999999999999999998889999999987542  34457899999999999999999999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                      +..++||||+++|+|.+++.........++|..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999976544445689999999999999999999997   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      +++...............++..|+|||.. .+.++.++|||||||++|||+||+.||....+........|..... ...
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~  263 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNG  263 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TTT
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-ccc
Confidence            99865433333333445688999999988 6679999999999999999999999998765554444444432111 112


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .+...+++........+.+..+.+++.+||+.||++|||++|++++|+.+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            23444555555555667888999999999999999999999999999975

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-45  Score=394.43  Aligned_cols=200  Identities=24%  Similarity=0.323  Sum_probs=169.2

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEeC----CCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCC
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHG  511 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  511 (720)
                      ...+.|+..+.||+|+||+||+|+.+    +++.||||++.+.    .....+.+|+++++.+ +|||||++++++.+.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            45678999999999999999999642    4789999998653    3345688999999998 6999999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC-CCeEEcccc
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-LIVRVSDCG  590 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFG  590 (720)
                      +.|+||||+++|+|.+++.       .+++.....++.|++.||+|||+.   +||||||||+|||++.+ +.+||+|||
T Consensus        94 ~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            9999999999999999883       378889999999999999999997   99999999999999877 799999999


Q ss_pred             CCCCCCCCCCc--------------------------ccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhC
Q 004994          591 LAPLLFSGSTN--------------------------ELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTG  642 (720)
Q Consensus       591 la~~~~~~~~~--------------------------~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG  642 (720)
                      +|+........                          .......||++|+|||.+.+  .|+.++||||+||++|||+||
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            99865432111                          11123468999999998843  489999999999999999999


Q ss_pred             CCCCCCCC
Q 004994          643 RKPYDRSR  650 (720)
Q Consensus       643 ~~Pf~~~~  650 (720)
                      +.||....
T Consensus       244 ~~Pf~~~~  251 (361)
T 4f9c_A          244 RYPFYKAS  251 (361)
T ss_dssp             CSSSSCCS
T ss_pred             CCCCCCCC
Confidence            99996543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.5e-45  Score=385.23  Aligned_cols=289  Identities=35%  Similarity=0.591  Sum_probs=238.5

Q ss_pred             ccccCHHHHHHHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeE
Q 004994          427 VSVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY  506 (720)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~  506 (720)
                      ...++.+++....++|...+.||+|+||+||+|...+|+.||||++...... .....+.+|++++++++||||++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEE
Confidence            4568899999999999999999999999999998888999999999754322 222368999999999999999999999


Q ss_pred             eccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEE
Q 004994          507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRV  586 (720)
Q Consensus       507 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  586 (720)
                      +.+.+..++||||+++|+|.+++.........++|..+..++.+++.||+|||+.+.++|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            99999999999999999999999876555667999999999999999999999987779999999999999999999999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCC--Cccccchhhhccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSR--PRGEQSLVRWAIP  663 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~--~~~~~~~~~~~~~  663 (720)
                      +|||+++....... .......++..|+|||.. .+.++.++|||||||++|||+||+.||....  .........|...
T Consensus       176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            99999987643322 223345589999999988 5678999999999999999999999996311  1112233334332


Q ss_pred             ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      ... ......+.+......+....+..+.+++.+||+.||++|||++||+++|++
T Consensus       255 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          255 LLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             Hhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            222 233455566666666777888899999999999999999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7e-45  Score=408.20  Aligned_cols=250  Identities=25%  Similarity=0.303  Sum_probs=198.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHH---HHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEF---LELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~---~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ++|...++||+|+||+||+|+. .+|+.||||++.+... ........   ..++++++.++|||||+++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            5788899999999999999965 5799999999975422 12222233   34466777889999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||++||+|.+++..    ...+++.....++.||+.||+|||+.   +||||||||+||||+.+|++||+|||+|+.
T Consensus       269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999953    35689999999999999999999987   999999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +....    .....||+.|+|||++ .+ .|+.++||||+||++|||++|+.||..........+....         ..
T Consensus       342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---------~~  408 (689)
T 3v5w_A          342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------LT  408 (689)
T ss_dssp             CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---------HH
T ss_pred             cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---------cC
Confidence            64432    2346799999999998 34 6999999999999999999999999653322211111100         00


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                        ....    ++...++++.+|+.+||++||++|++     ++||++|
T Consensus       409 --~~~~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          409 --MAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             --CCCC----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             --CCCC----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence              0111    11223467889999999999999998     6888754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.5e-44  Score=406.91  Aligned_cols=252  Identities=20%  Similarity=0.279  Sum_probs=205.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++....  ....+.+.+|+++|+.++|||||+++++|.+.+..|+||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            35788899999999999999965 579999999996532  334567889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC--CCeEEccccCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK--LIVRVSDCGLAPLL  595 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~--~~~kl~DFGla~~~  595 (720)
                      |||++|+|.+++...   ...+++.....++.|+++||+|||+.   +|+||||||+|||++.+  +.+||+|||+|+.+
T Consensus       234 E~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          234 EFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             ECCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             eecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999999999998532   34688999999999999999999997   99999999999999854  89999999999987


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ....   ......||+.|+|||.+ ...|+.++||||+||++|||++|+.||...........+..              
T Consensus       308 ~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~--------------  370 (573)
T 3uto_A          308 DPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS--------------  370 (573)
T ss_dssp             CTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT--------------
T ss_pred             cCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh--------------
Confidence            5432   22345789999999998 45699999999999999999999999976433221111110              


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+...........++++.+|+.+||+.||++|||++|+++|
T Consensus       371 ~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          371 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             TCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            01111112222344678899999999999999999999985

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.2e-42  Score=362.99  Aligned_cols=284  Identities=30%  Similarity=0.461  Sum_probs=229.9

Q ss_pred             ccccCHHHHHHHhcCCCCC------CeeccCCCceEEEEEeCCCcEEEEEEecccc--cccccHHHHHHHHHHHHccCCC
Q 004994          427 VSVFTIASLQQYTNSFSEG------NFIGEGLLGSVYKAELPGGKLLAVKKLSNTV--SQRQTDEEFLELASTISRLRHG  498 (720)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~~~e~~~l~~l~H~  498 (720)
                      ...|+..++..++++|...      +.||+|+||+||+|.. +++.||||++....  ......+.+.+|++++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3568999999999999887      8999999999999986 67899999987532  2234457899999999999999


Q ss_pred             ceeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE
Q 004994          499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       499 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl  578 (720)
                      ||+++++++.+.+..++||||+++++|.+++.... ....+++..+..++.++++||.|||+.   +|+||||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence            99999999999999999999999999999986532 245689999999999999999999997   99999999999999


Q ss_pred             cCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-ch
Q 004994          579 DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SL  657 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~  657 (720)
                      +.++.+||+|||+++...............++..|+|||...+.++.++||||||+++|||+||+.||......... .+
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence            99999999999999876543333333445688999999998888999999999999999999999999764332211 11


Q ss_pred             hhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       658 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ....   ......+...+++.+.. .....+..+.+++.+||+.||.+|||++||+++|+++
T Consensus       247 ~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          247 KEEI---EDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHH---HTTSCCHHHHSCSSCSC-CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHh---hhhhhhhhhhccccccc-cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            1100   01111233344444322 3445677899999999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.8e-43  Score=372.51  Aligned_cols=270  Identities=22%  Similarity=0.299  Sum_probs=207.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC----eEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG----QHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~l  515 (720)
                      ++|...+.||+|+||+||+|+.. ++.||||++...   ......+..|+.++++++|||||++++++.+..    ..++
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            57888899999999999999775 789999999643   233445667888999999999999999997643    4799


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhc-------CCCCeeecCCCCCCeEEcCCCCeEEcc
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV-------CEPPIVHGNFKSSNILLDEKLIVRVSD  588 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-------~~~~ivHrDlkp~NiLl~~~~~~kl~D  588 (720)
                      ||||+++|+|.+++..     ..+++..+..++.++++||+|||+.       |.++|+||||||+|||++.++.+||+|
T Consensus       100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            9999999999999953     3589999999999999999999975       345899999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccCCC------CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG------SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      ||+++.+.............++..|+|||.+.+      .++.++|||||||++|||+||+.||................
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            999987654433333344678999999998854      35678999999999999999999997644322221111111


Q ss_pred             cccCchhhhhh-----hcCCCCCch-hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          663 PRLHDIDALSR-----MVDPSLDGA-YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       663 ~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       .........+     ...+.+... .....+.++.+++.+||+.||++|||++||++.|++|
T Consensus       255 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          255 -QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             -SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             0111111111     112222221 1234567799999999999999999999999999976

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.7e-43  Score=377.76  Aligned_cols=261  Identities=23%  Similarity=0.382  Sum_probs=208.8

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe--------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEecc
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL--------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNE  509 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~  509 (720)
                      .++|...+.||+|+||+||+|..        .++..||||+++... .....+.+.+|+++++++ +||||++++++|.+
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            35677889999999999999964        245689999997543 234457899999999999 89999999999999


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNIL  577 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiL  577 (720)
                      .+..++||||+++|+|.+++.....            ....+++..+..++.|+++||+|||+.   +||||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence            9999999999999999999964321            123578999999999999999999997   9999999999999


Q ss_pred             EcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCcccc
Q 004994          578 LDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQ  655 (720)
Q Consensus       578 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  655 (720)
                      ++.++.+||+|||+++.+.............++..|+|||.+ ...++.++|||||||++|||+| |+.||.........
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            999999999999999876543332233334567889999988 6679999999999999999999 99999754322111


Q ss_pred             chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ..+             ..-..+.    .+..++.++.+++.+||+.||++|||+.|++++|++++
T Consensus       316 ~~~-------------~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          316 KLL-------------KEGHRMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             HHH-------------HTTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH-------------hcCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            100             0000011    11223467889999999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.4e-43  Score=368.56  Aligned_cols=260  Identities=31%  Similarity=0.378  Sum_probs=202.2

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ..++|...+.||+|+||+||+|+. +|+.||||++..........+++.+|++++++++||||+++++++.+.+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356788889999999999999976 6889999999765544555678999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP--IVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~--ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||+++|+|.+++.... ....+++..+..++.++++||+|||+.   +  |+||||||+|||++.++.+||+|||+++..
T Consensus       114 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             ECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             ecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            9999999999997532 234589999999999999999999987   6  999999999999999999999999999765


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ....  .......++..|+|||.+ ...++.++|||||||++|||+||+.||...........+....            
T Consensus       190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~------------  255 (309)
T 3p86_A          190 ASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC------------  255 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC------------
T ss_pred             cccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------
Confidence            3321  122345688999999998 4568999999999999999999999997543221111110000            


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ....    .+...+.++.+++.+||+.||++|||++|+++.|+.++
T Consensus       256 ~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          256 KRLE----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0001    11223357889999999999999999999999998763

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.2e-42  Score=365.99  Aligned_cols=249  Identities=22%  Similarity=0.329  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.+........+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46788899999999999999966 68999999999765544555677899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.|+++||+|||+.   +|+||||||+|||++.++++||+|||+++....
T Consensus        94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            99999999999853    35688999999999999999999997   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSY-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~-~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ..   ......++++|+|||.+ ...+ +.++|||||||++|||+||+.||...........+...              
T Consensus       167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--------------  229 (328)
T 3fe3_A          167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--------------  229 (328)
T ss_dssp             SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred             CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence            32   23345689999999998 4444 57999999999999999999999764322111111000              


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....    +...+.++.+++.+||+.||.+|||++|++++
T Consensus       230 ~~~~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          230 KYRI----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CCCC----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCC----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0001    11123567899999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.1e-42  Score=357.36  Aligned_cols=250  Identities=22%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            46899999999999999999964 679999999986432  344577899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..     ..+++.....++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        97 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             ECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            99999999999853     3588899999999999999999997   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...  ......++..|+|||.+ ...++.++|||||||++|||+||+.||.............             ....
T Consensus       169 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-------------~~~~  233 (297)
T 3fxz_A          169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-------------TNGT  233 (297)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------------HHCS
T ss_pred             ccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------hCCC
Confidence            322  23345689999999998 5678999999999999999999999997543221111000             0000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +..  ..+...+..+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          234 PEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCC--CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            011  1122334678899999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-42  Score=375.81  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=205.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||+||+|... +++.||||+++... .....+.|.+|++++++++|||||++++++.+.+..++|||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            46777899999999999999775 78999999997542 23344578899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++..   ....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            9999999999963   234688999999999999999999997   8999999999999999999999999999865332


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..........++..|+|||.+ .+.++.++|||||||++|||+| |+.||...........+.                 
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-----------------  329 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-----------------  329 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-----------------
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----------------
Confidence            211111223356789999988 5678999999999999999998 999997543211111110                 


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .......+..++.++.+++.+||+.||++|||++++++.|+++
T Consensus       330 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            0000011122346788999999999999999999999999876

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=356.46  Aligned_cols=257  Identities=25%  Similarity=0.401  Sum_probs=205.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||+||+|.. .+++.||+|++...  .....+.|.+|++++++++||||+++++++.+.+..++|||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            4677789999999999999965 56999999998542  34556789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           88 YIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             CCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             ecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            99999999999642   35689999999999999999999997   8999999999999999999999999999876433


Q ss_pred             CCcc------------cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          599 STNE------------LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       599 ~~~~------------~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      ....            ......++..|+|||.+ ...++.++|||||||++|||++|..||............       
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-------  234 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-------  234 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-------
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-------
Confidence            2111            11135688999999998 557899999999999999999999998654332211000       


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...........+        .++.++.+++.+||+.||++|||++|+++.|+++
T Consensus       235 ~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          235 NVRGFLDRYCPP--------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             CHHHHHHHTCCT--------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhccccccCCC--------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            000111111111        1234678999999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-42  Score=373.67  Aligned_cols=270  Identities=23%  Similarity=0.365  Sum_probs=211.9

Q ss_pred             CHHHHHHHhcCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEE
Q 004994          431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVEL  503 (720)
Q Consensus       431 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l  503 (720)
                      ...+.....++|...+.||+|+||.||+|.+      .+++.||||++.... .....+.+.+|+++++++ +|||||++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            3444455667899999999999999999963      346899999997543 233456799999999999 89999999


Q ss_pred             EeEeccCC-eEEEEEeeCCCCCHHHHhhccchh-----------------------------------------------
Q 004994          504 IGYCNEHG-QHLLVYDYGGNCTLHDLLHSDEEA-----------------------------------------------  535 (720)
Q Consensus       504 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------  535 (720)
                      +++|.+.+ ..++||||+++|+|.+++......                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998754 589999999999999999754321                                               


Q ss_pred             ---------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          536 ---------------HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       536 ---------------~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                                     ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           12288999999999999999999997   999999999999999999999999999987654443


Q ss_pred             cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          601 NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      ........++..|+|||.. ...++.++|||||||++|||+| |+.||.........  ..          .+..-....
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~----------~~~~~~~~~  316 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CR----------RLKEGTRMR  316 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HH----------HHHHTCCCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HH----------HHHcCCCCC
Confidence            3344456678899999988 6679999999999999999999 99999754322110  00          000000011


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .    +...++++.+++.+||+.||++|||++|++++|++++
T Consensus       317 ~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          317 A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            1    1122357889999999999999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.6e-42  Score=370.27  Aligned_cols=257  Identities=24%  Similarity=0.378  Sum_probs=195.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      .++|...+.||+|+||+||+|...    ++..||||+++... .....++|.+|++++++++||||+++++++.+.+..+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            357889999999999999999764    57789999997543 2345578999999999999999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++|+|.++++..   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            999999999999999642   34689999999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCcc-cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          595 LFSGSTNE-LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       595 ~~~~~~~~-~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ........ ......++..|+|||.. .+.++.++|||||||++|||++ |+.||.......   .....          
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i----------  263 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAV----------  263 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHH----------
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----------
Confidence            64332111 11222346789999998 5679999999999999999998 999996543211   11100          


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                          ........+..++.++.+++.+||+.||++||+++||++.|+++
T Consensus       264 ----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          264 ----DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             ----HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                00000001112346788999999999999999999999999876

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=357.38  Aligned_cols=248  Identities=21%  Similarity=0.230  Sum_probs=197.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|+..+.||+|+||+||+|... +|+.||||++............+..|+..+.++ +||||++++++|.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            457888899999999999999764 799999999875544444445556666666555 999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+ +++|.+++..   ....++|..+..++.+++.||+|||+.   +||||||||+|||++.++.+||+|||+++...
T Consensus       136 ~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          136 TELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             Eecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            9999 5688888753   235699999999999999999999997   89999999999999999999999999997764


Q ss_pred             CCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...   ......++.+|+|||.+.+.++.++|||||||++|||++|..|+....                   ....+..
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-------------------~~~~~~~  266 (311)
T 3p1a_A          209 TAG---AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE-------------------GWQQLRQ  266 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH-------------------HHHHHTT
T ss_pred             cCC---CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------------------HHHHHhc
Confidence            322   223355889999999998889999999999999999999977664311                   0111111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...........++++.+++.+||+.||++|||++|++++
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            112222233345678999999999999999999999874

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.4e-42  Score=362.99  Aligned_cols=257  Identities=26%  Similarity=0.374  Sum_probs=203.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|...+.||+|+||+||+|...    .+..||||++.... .....+.|.+|++++++++||||+++++++.+.+..++
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            56778899999999999999763    35569999997543 23445789999999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++|+|.+++...   ...+++..+..++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       128 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999543   34689999999999999999999997   9999999999999999999999999999876


Q ss_pred             CCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          596 FSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       596 ~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ...... .......++..|+|||.+ ...++.++|||||||++|||++ |+.||...........+             .
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------------~  268 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-------------E  268 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------------H
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-------------H
Confidence            443221 122233456789999998 4678999999999999999999 99999654322111000             0


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .....    ..+..++.++.+++.+||+.||++|||+.||++.|+.++
T Consensus       269 ~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          269 EGYRL----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             TTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCC----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            00000    011223467889999999999999999999999999863

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9e-42  Score=351.23  Aligned_cols=253  Identities=24%  Similarity=0.402  Sum_probs=206.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|...+.||+|+||+||+|...+++.||+|++....   ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            4677789999999999999998888999999997542   3456799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        87 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           87 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999642   34688999999999999999999987   89999999999999999999999999998663321


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                       ........++..|+|||.. ...++.++||||||+++|||++ |+.||...........+             ......
T Consensus       161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~-------------~~~~~~  226 (269)
T 4hcu_A          161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------STGFRL  226 (269)
T ss_dssp             -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------------HTTCCC
T ss_pred             -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------------hcCccC
Confidence             1122234456789999998 5679999999999999999999 99999754322111000             000001


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..    +...+.++.+++.+||+.||++|||++|++++|+++
T Consensus       227 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          227 YK----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC----CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            11    111235688999999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=369.29  Aligned_cols=261  Identities=23%  Similarity=0.366  Sum_probs=209.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe--------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEecc
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL--------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNE  509 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~  509 (720)
                      .++|...+.||+|+||+||+|..        ..+..||||++.... .....+.+.+|+++++++ +|||||++++++.+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            35677889999999999999964        224689999997543 234457889999999999 99999999999999


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNIL  577 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiL  577 (720)
                      .+..++||||+++|+|.+++.....            ....+++..+..++.++++||+|||+.   +|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence            9999999999999999999964321            124589999999999999999999997   9999999999999


Q ss_pred             EcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCcccc
Q 004994          578 LDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQ  655 (720)
Q Consensus       578 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  655 (720)
                      ++.++.+||+|||+++...............++..|+|||.+ ...++.++|||||||++|||+| |+.||........ 
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~-  302 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-  302 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            999999999999999877544333333445567889999988 6678999999999999999999 9999975432111 


Q ss_pred             chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                        ....          .......    .+..++.++.+++.+||+.||++|||++||+++|++++
T Consensus       303 --~~~~----------~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          303 --FKLL----------KEGHRMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             --HHHH----------HTTCCCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHH----------HcCCCCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              1100          0000011    11123467889999999999999999999999999863

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-41  Score=357.12  Aligned_cols=269  Identities=18%  Similarity=0.269  Sum_probs=202.4

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      +.++|...+.||+|+||+||+|...+|+.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            45678889999999999999998888999999999765444455678899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++ +|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        99 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           99 EFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             ECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             cCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99985 788877532   34588999999999999999999997   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhh-cc-cccCch---hh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW-AI-PRLHDI---DA  670 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~-~~-~~~~~~---~~  670 (720)
                      ...  ......++..|+|||.+.  ..++.++|||||||++|||++|+.||...........+.. .. +.....   ..
T Consensus       172 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          172 PVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             CCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred             Ccc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence            221  222346789999999873  4589999999999999999999999976543322111100 00 000000   00


Q ss_pred             hhhhcC---CCCC----chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          671 LSRMVD---PSLD----GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       671 ~~~~~~---~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +..+.+   ....    ........+++.+|+.+||+.||++|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            000000   0000    01111233578899999999999999999999974

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.5e-42  Score=359.95  Aligned_cols=261  Identities=25%  Similarity=0.394  Sum_probs=208.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  512 (720)
                      .++|...+.||+|+||.||+|..      .+++.||||++.... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            45677889999999999999964      345899999997543 23445788999999999999999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccch--------------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEE--------------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFK  572 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlk  572 (720)
                      .++||||+++|+|.+++.....                    ....+++..+..++.++++||+|||+.   +|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence            9999999999999999965322                    123488999999999999999999997   99999999


Q ss_pred             CCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 004994          573 SSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSR  650 (720)
Q Consensus       573 p~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~  650 (720)
                      |+|||++.++.+||+|||+++...............++..|+|||.. ...++.++|||||||++|||+| |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876543332233334567789999988 5568999999999999999999 999997543


Q ss_pred             CccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          651 PRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .......+.             ....+.    .+...++++.+++.+||+.||++|||++|++++|++++
T Consensus       258 ~~~~~~~~~-------------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          258 PERLFNLLK-------------TGHRME----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             GGGHHHHHH-------------TTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhh-------------cCCcCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            221111110             000011    11223467889999999999999999999999999874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.5e-41  Score=357.81  Aligned_cols=249  Identities=20%  Similarity=0.281  Sum_probs=202.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|+. .+|+.||||++++... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            5678889999999999999966 4699999999975421 2345577899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +|+||||||+|||++.++++||+|||+++....
T Consensus        85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999998853    35688999999999999999999997   999999999999999999999999999986432


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..  .......||+.|+|||.+ ...++.++|||||||++|||++|+.||...........+.            ..  .
T Consensus       158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------------~~--~  221 (337)
T 1o6l_A          158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------------ME--E  221 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------HC--C
T ss_pred             CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH------------cC--C
Confidence            21  223346789999999998 5578999999999999999999999997533211110000            00  0


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      ..    ++...+.++.+++.+||+.||++||     +++|+++|
T Consensus       222 ~~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CC----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            01    1112345788999999999999999     89999865

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.1e-41  Score=362.82  Aligned_cols=252  Identities=21%  Similarity=0.279  Sum_probs=205.2

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc----ccHHHHHHHHHHHHccCCCceeEEEeEeccCCe
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR----QTDEEFLELASTISRLRHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  512 (720)
                      +.+.|...+.||+|+||+||+|.. .+|+.||+|.+.+.....    ...+.+.+|++++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            456788899999999999999965 469999999997543221    245789999999999999999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC----CeEEcc
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL----IVRVSD  588 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~D  588 (720)
                      .++||||+++|+|.+++..    ...+++.....++.+++.||.|||+.   +|+||||||+|||++.++    .+||+|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            9999999999999999853    34689999999999999999999997   999999999999998877    799999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      ||+++.+....   ......|+++|+|||.+ ...++.++|||||||++|||++|+.||.........            
T Consensus       163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~------------  227 (361)
T 2yab_A          163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------  227 (361)
T ss_dssp             CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------------
T ss_pred             cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH------------
Confidence            99998764432   22345689999999998 457999999999999999999999999754321111            


Q ss_pred             hhhhhhhcC--CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDALSRMVD--PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                          ..+..  ...........+.++.+++.+||+.||++|||++|+++|
T Consensus       228 ----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          228 ----ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             ----HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ----HHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                11111  111112222344678899999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2e-41  Score=348.33  Aligned_cols=254  Identities=23%  Similarity=0.337  Sum_probs=206.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|...+.||+|+||+||+|+..++..||||++....   ...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            35678889999999999999998888899999997542   345679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++..   ....+++..+..++.++++||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           84 YISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             ccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            9999999999853   234689999999999999999999997   9999999999999999999999999999876443


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .. .......++..|+|||.. ...++.++||||||+++|||+| |+.||...........+.             ....
T Consensus       158 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------------~~~~  223 (268)
T 3sxs_A          158 QY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-------------QGHR  223 (268)
T ss_dssp             CE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------------TTCC
T ss_pred             hh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-------------cCCC
Confidence            22 122334456779999998 4578999999999999999999 999997543221110000             0000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...    +...++++.+++.+||+.||++|||++|++++|+++
T Consensus       224 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          224 LYR----PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             CCC----CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             CCC----CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            000    111235688999999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=370.17  Aligned_cols=260  Identities=21%  Similarity=0.318  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  512 (720)
                      .++|...+.||+|+||+||+|.+.      +++.||||++.... .......+.+|+.++++++|||||++++++.+.+.
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            356788899999999999999742      46789999997542 23445678999999999999999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccc---hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC---CeEE
Q 004994          513 HLLVYDYGGNCTLHDLLHSDE---EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL---IVRV  586 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl  586 (720)
                      .++||||+++|+|.+++....   .....+++..+..++.++++||+|||+.   +|+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999996432   1224589999999999999999999997   999999999999999554   5999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                      +|||+|+.+.............++..|+|||.+ .+.++.++|||||||++|||+| |+.||........   ...    
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~---~~~----  298 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEF----  298 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHH----
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----
Confidence            999999765332222233345568899999988 6679999999999999999998 9999975432111   110    


Q ss_pred             cCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                               +... .....+..++..+.+++.+||+.||++|||++||+++|+.+
T Consensus       299 ---------i~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          299 ---------VTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             ---------HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------HHcC-CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                     0000 00001112345688999999999999999999999999865

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.6e-41  Score=354.57  Aligned_cols=260  Identities=23%  Similarity=0.307  Sum_probs=208.7

Q ss_pred             ccCHHHHHHHhcC----------CCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCC
Q 004994          429 VFTIASLQQYTNS----------FSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH  497 (720)
Q Consensus       429 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H  497 (720)
                      .++.+++..+++.          |...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|++++++++|
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCC
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCC
Confidence            3567777766654          555678999999999999765 79999999997542  3456778999999999999


Q ss_pred             CceeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 004994          498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNIL  577 (720)
Q Consensus       498 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiL  577 (720)
                      |||+++++++...+..++||||+++++|.+++..     ..+++..+..++.++++||.|||+.   +|+||||||+|||
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  173 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL  173 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence            9999999999999999999999999999998853     3589999999999999999999997   9999999999999


Q ss_pred             EcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc
Q 004994          578 LDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS  656 (720)
Q Consensus       578 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~  656 (720)
                      ++.++.+||+|||+++.......  ......++..|+|||.. .+.++.++|||||||++|||++|+.||......... 
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~-  250 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-  250 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-
T ss_pred             ECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence            99999999999999987643221  22345689999999998 556899999999999999999999999754321111 


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        .          .+.....+...  .....+.++.+++.+||+.||++|||++|++++
T Consensus       251 --~----------~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 --K----------RLRDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             --H----------HHHHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --H----------HHhcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0          11111111111  112234578899999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-42  Score=363.85  Aligned_cols=263  Identities=24%  Similarity=0.360  Sum_probs=208.8

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH  510 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~  510 (720)
                      ...++|...+.||+|+||.||+|...      +++.||||+++... .....+.|.+|++++++++||||+++++++.+.
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            34578889999999999999999763      35899999997543 234457899999999999999999999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccch--------------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEE--------------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGN  570 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrD  570 (720)
                      +..++||||+++|+|.+++.....                    ....+++..+..++.++++||.|||+.   +|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            999999999999999999965321                    125689999999999999999999997   999999


Q ss_pred             CCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 004994          571 FKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDR  648 (720)
Q Consensus       571 lkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~  648 (720)
                      |||+|||++.++.+||+|||+++...............++..|+|||.. .+.++.++|||||||++|||+| |+.||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            9999999999999999999999765433222223345567889999987 5679999999999999999999 9999965


Q ss_pred             CCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          649 SRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ......   ..             .+.+.... ..+...+.++.+++.+||+.||++|||+.|++++|++++
T Consensus       280 ~~~~~~---~~-------------~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          280 MAHEEV---IY-------------YVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             SCHHHH---HH-------------HHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CChHHH---HH-------------HHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            332111   10             01110000 011223457889999999999999999999999999874

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.9e-42  Score=360.59  Aligned_cols=255  Identities=22%  Similarity=0.272  Sum_probs=201.7

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.++|...+.||+|+||+||+|.. .+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            346788899999999999999965 4799999999864322 22346788999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++|+|.+++..    ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            999999999998853    34589999999999999999999987   99999999999999999999999999998764


Q ss_pred             CCCCcccccCccccccCCCCccC-CCC-CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~-~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ............++..|+|||.+ ... ++.++|||||||++|||+||+.||........ ....+..            
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~------------  223 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE------------  223 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT------------
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc------------
Confidence            43333334456789999999998 334 47799999999999999999999975432211 1111110            


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ...........+.++.+++.+||+.||++|||++|++++
T Consensus       224 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          224 --KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             --TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence              000000112234567899999999999999999999865

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=372.00  Aligned_cols=256  Identities=20%  Similarity=0.262  Sum_probs=204.9

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      .+.++|...+.||+|+||+||+|.. .+|+.||+|++..........+.+.+|++++++++|||||++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            3567888999999999999999954 679999999997655444556788999999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc---CCCCeEEccccCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLA  592 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla  592 (720)
                      ||||+.+|+|.+.+..    ...+++.....++.++++||.|||+.   +|+||||||+|||++   +++.+||+|||+|
T Consensus        88 v~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            9999999999998853    35689999999999999999999997   999999999999998   4678999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      +......  .......|+++|+|||.+. ..|+.++|||||||++|||++|+.||...........+....         
T Consensus       161 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------  229 (444)
T 3soa_A          161 IEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA---------  229 (444)
T ss_dssp             BCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC---------
T ss_pred             EEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC---------
Confidence            8764332  2223467899999999984 479999999999999999999999996543211111111000         


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         .  ..........++++.+++.+||+.||++|||++|++++
T Consensus       230 ---~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          230 ---Y--DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ---C--CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---C--CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence               0  00001111234678899999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=363.25  Aligned_cols=253  Identities=20%  Similarity=0.313  Sum_probs=198.8

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCC--CceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH--GNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv  516 (720)
                      .+.|...+.||+|+||+||+|...+++.||||++..........+.+.+|++++++++|  +||+++++++.+.+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            35688889999999999999988889999999997654445556789999999999987  9999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      || +.+++|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+|||++ ++.+||+|||+++.+.
T Consensus        88 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             Ee-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            99 567899999853    35688999999999999999999997   999999999999997 5789999999998775


Q ss_pred             CCCCcccccCccccccCCCCccCC------------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFES------------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~------------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                      ............++++|+|||.+.            +.++.++|||||||++|||++|+.||......            
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------  226 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------------  226 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------------
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------------
Confidence            443333344567899999999872            56889999999999999999999999643211            


Q ss_pred             cCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         ...+..++++......+...+.++.+++.+||+.||.+|||+.|++++
T Consensus       227 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          227 ---ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ---HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence               111222222222222222233568899999999999999999999876

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9e-42  Score=361.07  Aligned_cols=263  Identities=22%  Similarity=0.359  Sum_probs=192.1

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeCC-Cc---EEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELPG-GK---LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~---~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ..++|...+.||+|+||+||+|.... +.   .||||++..........+.+.+|++++++++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            35678889999999999999997643 32   799999986554455668899999999999999999999999876654


Q ss_pred             ------EEEEeeCCCCCHHHHhhccch--hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeE
Q 004994          514 ------LLVYDYGGNCTLHDLLHSDEE--AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR  585 (720)
Q Consensus       514 ------~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  585 (720)
                            ++||||+++|+|.+++.....  ....+++..+..++.++++||+|||+.   +|+||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence                  999999999999999864321  122589999999999999999999997   999999999999999999999


Q ss_pred             EccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhccc
Q 004994          586 VSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       586 l~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      |+|||+++...............++..|+|||.. ...++.++|||||||++|||+| |+.||...........+     
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-----  252 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-----  252 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH-----
Confidence            9999999876544333333344567789999988 5678999999999999999999 99999754322111100     


Q ss_pred             ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                                 .... ....+...+.++.+++.+||+.||++|||+.|+++.|++++
T Consensus       253 -----------~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          253 -----------IGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             -----------HTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------hcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                       0000 00011123357889999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.9e-42  Score=354.35  Aligned_cols=255  Identities=21%  Similarity=0.380  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|...+.||+|+||+||+|...++..||||++....   ...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            45677889999999999999998888999999997542   345679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A          100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            99999999999642   34689999999999999999999997   9999999999999999999999999999866332


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      . ........++..|+|||.. ...++.++||||||+++|||+| |+.||...........+             .....
T Consensus       174 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-------------~~~~~  239 (283)
T 3gen_A          174 E-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------AQGLR  239 (283)
T ss_dssp             H-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------------HTTCC
T ss_pred             c-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-------------hcccC
Confidence            1 1122234456789999998 5679999999999999999998 99999754322111100             00001


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ...    +...++.+.+++.+||+.||++|||++|++++|++++
T Consensus       240 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          240 LYR----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            111    1112356889999999999999999999999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.8e-42  Score=362.22  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=196.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcE----EEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKL----LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~----vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ++|+..+.||+|+||+||+|.. .+++.    ||+|.+.... .....++|.+|++++++++||||++++++|.+.. .+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            4678889999999999999975 34544    5888776432 2345678999999999999999999999998764 78


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +|+||+.+|+|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            999999999999998642   35689999999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +.............++..|+|||.+ .+.++.++|||||||++|||+| |+.||...........+..            
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------------  234 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------  234 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT------------
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc------------
Confidence            6544333333344567789999988 6679999999999999999999 9999975432221111110            


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                           ......+..++.++.+++.+||+.||++|||+.|++++|+++
T Consensus       235 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          235 -----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             -----TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                 000001112335788999999999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.5e-41  Score=352.75  Aligned_cols=261  Identities=22%  Similarity=0.304  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||.||+|.. .+++.||+|++..... .....+.|.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46788899999999999999965 5789999999864322 234457889999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999999853    34689999999999999999999997   99999999999999999999999999998764


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      .... .......+++.|+|||.. ...++.++|||||||++|||+||+.||........  ...........        
T Consensus       163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~--------  231 (294)
T 4eqm_A          163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVPN--------  231 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHSSCCCC--------
T ss_pred             cccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhhccCCC--------
Confidence            3221 122345689999999988 55789999999999999999999999975432110  00000000000        


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhC
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-PMSEIVQDLLCMI  720 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~  720 (720)
                         .........++.+.+++.+||+.||++|| +++++.+.|+.++
T Consensus       232 ---~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          232 ---VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             ---HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             ---cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence               00011122346788999999999999998 9999999998753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.9e-41  Score=362.79  Aligned_cols=256  Identities=21%  Similarity=0.296  Sum_probs=203.8

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc---ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS---QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      +.+.|...+.||+|+||+||+|.. .+|+.||||++.....   .....+.+.+|+++++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            345788889999999999999965 5799999999864321   122467899999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC---eEEcccc
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI---VRVSDCG  590 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFG  590 (720)
                      ++||||+++++|.+.+.........+++.....++.|+++||+|||+.   +|+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            999999999999988865433345689999999999999999999997   9999999999999987654   9999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      +++......  .......+++.|+|||.+ ...++.++|||||||++|||++|+.||.....    ...           
T Consensus       179 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~-----------  241 (351)
T 3c0i_A          179 VAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF-----------  241 (351)
T ss_dssp             TCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH-----------
T ss_pred             ceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH-----------
Confidence            998764322  223345689999999998 45689999999999999999999999965321    000           


Q ss_pred             hhhhhcCC--CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDP--SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ..+...  ..........+.++.+++.+||+.||++|||+.|++++
T Consensus       242 --~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          242 --EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              000000  01111112234678899999999999999999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.7e-41  Score=368.11  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=198.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC--CCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR--HGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~  517 (720)
                      +.|...+.||+|+||+||+|...+++.||||++..........+.+.+|++++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458888999999999999998878999999999765444555678999999999996  599999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      | +.+++|.+++..    ...+++..+..++.++++||.|||+.   +||||||||+|||++ ++.+||+|||+++.+..
T Consensus       136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9 577899999853    34678889999999999999999987   999999999999996 57999999999987754


Q ss_pred             CCCcccccCccccccCCCCccCCC------------CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG------------SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~------------~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      ...........++++|+|||++.+            .++.++|||||||++|||++|+.||......             
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------------  273 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------------  273 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------------
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------------
Confidence            433333345678999999998732            6899999999999999999999999643211             


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ...+..++++......+...+.++.+++.+||+.||++|||+.|++++
T Consensus       274 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          274 --ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             --HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence              011222222222111111223568899999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-41  Score=361.93  Aligned_cols=262  Identities=23%  Similarity=0.379  Sum_probs=207.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHG  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  511 (720)
                      .++|...+.||+|+||+||+|..      .++..||||++.... .....+.+.+|+++++++ +||||+++++++...+
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            46788889999999999999975      246789999997543 233446889999999999 9999999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchh-------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEA-------------------HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFK  572 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlk  572 (720)
                      ..++||||+++|+|.+++......                   ...+++..+..++.++++||+|||+.   +|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence            999999999999999999753211                   13478999999999999999999997   99999999


Q ss_pred             CCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 004994          573 SSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSR  650 (720)
Q Consensus       573 p~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~  650 (720)
                      |+|||++.++.+||+|||+++...............++..|+|||.. .+.++.++|||||||++|||+| |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999999877544433334455677889999987 6679999999999999999998 999997543


Q ss_pred             CccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          651 PRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ....  ....          +..-..+.    .+...+.++.+++.+||+.||.+|||+.|++++|+.++
T Consensus       280 ~~~~--~~~~----------~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          280 VDAN--FYKL----------IQNGFKMD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             CSHH--HHHH----------HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cHHH--HHHH----------HhcCCCCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            2211  0000          00000111    11123467889999999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.5e-41  Score=363.06  Aligned_cols=255  Identities=20%  Similarity=0.260  Sum_probs=205.0

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      .+.++|...+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|++++++++|||||++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3456788999999999999999965 468999999997654444455778999999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC---CCeEEccccCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK---LIVRVSDCGLA  592 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGla  592 (720)
                      ||||+++|+|.+.+..    ...+++.....++.++++||.|||+.   +|+||||||+|||++.+   +.+||+|||++
T Consensus       106 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            9999999999998853    34688999999999999999999997   99999999999999865   45999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      +......   ......++++|+|||.+ ...++.++|||||||++|||++|+.||...........+...          
T Consensus       179 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~----------  245 (362)
T 2bdw_A          179 IEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------  245 (362)
T ss_dssp             BCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----------
T ss_pred             eEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC----------
Confidence            8764332   22345689999999998 447999999999999999999999999754321111100000          


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                          ............+.++.+++.+||+.||++|||+.|++++
T Consensus       246 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          246 ----AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0000111112334678899999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.8e-41  Score=356.80  Aligned_cols=262  Identities=24%  Similarity=0.348  Sum_probs=209.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHG  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  511 (720)
                      .++|...+.||+|+||.||+|..      .+++.||||++..... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            35678889999999999999964      3578999999975432 33457899999999999 9999999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccch--------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEE--------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNIL  577 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiL  577 (720)
                      ..++||||+++|+|.+++.....              ....+++..+..++.++++||+|||+.   +|+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence            99999999999999999964321              123589999999999999999999997   9999999999999


Q ss_pred             EcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCcccc
Q 004994          578 LDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQ  655 (720)
Q Consensus       578 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  655 (720)
                      ++.++.+||+|||+++...............++..|+|||.. ...++.++|||||||++|||+| |+.||.........
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            999999999999999877554433334445677889999987 6679999999999999999999 99999754322110


Q ss_pred             chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                        ..          ..........    +...+.++.+++.+||+.||.+|||++|++++|++++
T Consensus       258 --~~----------~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          258 --YK----------MIKEGFRMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             --HH----------HHHHTCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HH----------HhccCCCCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence              00          0011111111    1123457889999999999999999999999999863

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.4e-41  Score=354.94  Aligned_cols=253  Identities=20%  Similarity=0.303  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc----cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ----RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      .+.|...+.||+|+||+||+|.. .+|+.||+|++......    ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            45688889999999999999965 46899999999754322    12467899999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC----CeEEccc
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL----IVRVSDC  589 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DF  589 (720)
                      ++||||+++++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+|||++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999853    34689999999999999999999987   999999999999999887    8999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      |+++......   ......+++.|+|||.+ ...++.++|||||||++|||++|+.||...........+..        
T Consensus       163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--------  231 (326)
T 2y0a_A          163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA--------  231 (326)
T ss_dssp             TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH--------
T ss_pred             CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh--------
Confidence            9998764322   12335689999999998 45799999999999999999999999965332111100000        


Q ss_pred             hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            .............+..+.+++.+||+.||++|||++|++++
T Consensus       232 ------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          232 ------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ------TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ------cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  01111112222334678899999999999999999999975

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.4e-41  Score=378.29  Aligned_cols=256  Identities=25%  Similarity=0.406  Sum_probs=207.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|...+.||+|+||+||+|.+. ++..||||+++...   ...++|.+|++++++++|||||+++++|.+.+..++||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            345777889999999999999775 48899999997542   34678999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++...  ....+++..+..++.|+++||+|||+.   +||||||||+|||++.++.+||+|||+++....
T Consensus       296 E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          296 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            999999999999643  234688999999999999999999997   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      .. ........++..|+|||.+ .+.++.++|||||||++|||+| |+.||...........+             .   
T Consensus       371 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-------------~---  433 (495)
T 1opk_A          371 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------------E---  433 (495)
T ss_dssp             CC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-------------H---
T ss_pred             Cc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------H---
Confidence            22 1222334456789999998 5678999999999999999999 99999754322111100             0   


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                       .......+..++.++.+++.+||+.||++|||+.||++.|++++
T Consensus       434 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          434 -KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence             01111112233467889999999999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.6e-41  Score=350.05  Aligned_cols=263  Identities=21%  Similarity=0.298  Sum_probs=199.9

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHc--cCCCceeEEEeEecc----CC
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR--LRHGNIVELIGYCNE----HG  511 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~----~~  511 (720)
                      ..++|...+.||+|+||+||+|.. +|+.||||++...     ....+..|.+++..  ++||||+++++++.+    ..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            356788899999999999999987 6899999998642     34556667777766  799999999998643    35


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeEEcCCCCeEE
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV-----CEPPIVHGNFKSSNILLDEKLIVRV  586 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivHrDlkp~NiLl~~~~~~kl  586 (720)
                      ..++||||+++|+|.++++.     ..+++..+.+++.++++||+|||..     +.++|+||||||+|||++.++.+||
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             eeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence            68999999999999999953     4689999999999999999999921     1349999999999999999999999


Q ss_pred             ccccCCCCCCCCCCcc--cccCccccccCCCCccCCCC-------CCCccchHhHHHHHHHHHhC----------CCCCC
Q 004994          587 SDCGLAPLLFSGSTNE--LSEGLLTAHGSGAPEFESGS-------YSCQSDVYSLGVVMLELLTG----------RKPYD  647 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-------~~~~~Dv~S~Gvvl~elltG----------~~Pf~  647 (720)
                      +|||+|+.........  ......++..|+|||.+.+.       ++.++|||||||++|||+||          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999997664332211  12234688999999988442       44789999999999999999          77775


Q ss_pred             CCCCcccc-chhhhcccccCchhhhhhhcCCCCC-chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          648 RSRPRGEQ-SLVRWAIPRLHDIDALSRMVDPSLD-GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       648 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ........ ......        .......+... .......+.++.+++.+||+.||++|||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKV--------VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCCHHHHHHH--------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcchhhhhHH--------HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            43222111 000000        00001111222 123445678899999999999999999999999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.3e-41  Score=374.83  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|...+.||+|+||+||+|...++..||||+++...   ...+.|.+|++++++++|||||++++++. .+..++|||
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            45677789999999999999999888999999997542   35678999999999999999999999987 557899999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.++++...  ...+++..+..++.++++||+|||+.   +||||||||+|||++.++.+||+|||+++.....
T Consensus       263 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             CCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             ecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            999999999997432  34578889999999999999999997   8999999999999999999999999999876432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      . ........++..|+|||.+ .+.++.++|||||||++|||+| |+.||...........+             ..-..
T Consensus       338 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------------~~~~~  403 (454)
T 1qcf_A          338 E-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------------ERGYR  403 (454)
T ss_dssp             H-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------------HHTCC
T ss_pred             c-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------HcCCC
Confidence            1 1112234456789999998 5779999999999999999999 99999754321111000             00000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .    ..+..+++++.+++.+||+.||++|||+++|++.|+++.
T Consensus       404 ~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          404 M----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            0    011233467889999999999999999999999999863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.8e-41  Score=352.76  Aligned_cols=267  Identities=20%  Similarity=0.293  Sum_probs=200.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|...+.||+|+||+||+|...+|+.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46778899999999999999888899999999975544444457788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++ +|.+++...   ...+++.....++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            986 898888543   34688899999999999999999997   99999999999999999999999999997653221


Q ss_pred             CcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhc-ccccCchhhhhh--
Q 004994          600 TNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWA-IPRLHDIDALSR--  673 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~-~~~~~~~~~~~~--  673 (720)
                        .......++..|+|||.+.  ..++.++|||||||++|||+||+.||.......... +.+.. .+....+....+  
T Consensus       155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          155 --RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence              1122345788999999874  358999999999999999999999997543221111 00000 000000000000  


Q ss_pred             hcCCCC-------CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSL-------DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..++..       ........++++.+++.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            001100       011112234678899999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.1e-41  Score=347.10  Aligned_cols=253  Identities=28%  Similarity=0.403  Sum_probs=200.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccccc-----HHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQT-----DEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~-----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ++|...+.||+|+||+||+|.. .+++.||||++.........     .+.+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5677889999999999999965 57899999998654322221     167899999999999999999999997765  


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEEcCCCC-----eEE
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP--IVHGNFKSSNILLDEKLI-----VRV  586 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~--ivHrDlkp~NiLl~~~~~-----~kl  586 (720)
                      ++||||+++|+|.+.+...   ...+++..+..++.++++||+|||+.   +  |+||||||+|||++.++.     +||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            6999999999999888543   35689999999999999999999987   6  999999999999988776     999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccCC---CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES---GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      +|||+++.....     .....++..|+|||.+.   ..++.++|||||||++|||++|+.||.......... ..    
T Consensus       171 ~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~----  240 (287)
T 4f0f_A          171 ADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-IN----  240 (287)
T ss_dssp             CCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HH----
T ss_pred             CCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HH----
Confidence            999999754321     23356789999999872   347889999999999999999999997543221100 00    


Q ss_pred             ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                               .+.........+...++++.+++.+||+.||++|||++|+++.|++|
T Consensus       241 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          241 ---------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ---------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ---------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                     00000111111223346788999999999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=350.33  Aligned_cols=272  Identities=17%  Similarity=0.225  Sum_probs=207.5

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC--eEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG--QHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~l  515 (720)
                      .++|...+.||+|+||+||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++.+.+  ..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            356888899999999999999664 589999999975432 334577889999999999999999999987654  7899


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE----cCCCCeEEccccC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCGL  591 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFGl  591 (720)
                      ||||+++++|.+++.... ....+++..+..++.++++||+|||+.   +|+||||||+|||+    +.++.+||+|||+
T Consensus        87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            999999999999997542 223489999999999999999999997   99999999999999    8888899999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccC---------CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc-cchhhhc
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFE---------SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE-QSLVRWA  661 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~---------~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~-~~~~~~~  661 (720)
                      ++.......   .....++..|+|||.+         ...++.++|||||||++|||+||+.||........ .......
T Consensus       163 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          163 ARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             ceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            987644322   2235688999999986         35689999999999999999999999964332111 1111000


Q ss_pred             c-cccC-chhhhhhh------cCCC--CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 004994          662 I-PRLH-DIDALSRM------VDPS--LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLC  718 (720)
Q Consensus       662 ~-~~~~-~~~~~~~~------~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  718 (720)
                      . .... ....+...      ..+.  ............+.+++.+||+.||++|||++|++++..+
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            0 0000 00000000      0000  1112345667789999999999999999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.8e-41  Score=348.97  Aligned_cols=255  Identities=22%  Similarity=0.284  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .+.|...+.||+|+||+||+|.. .++..||+|++..... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            45678889999999999999965 5689999999975432 345678999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE---cCCCCeEEccccCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAPL  594 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~  594 (720)
                      ||+++|+|.+++.........+++..+..++.++++||+|||+.   +|+||||||+|||+   +.++.+||+|||+++.
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999999999865544456799999999999999999999997   99999999999999   4567899999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      .....   ......++..|+|||.+.+.++.++|||||||++|||++|+.||...............             
T Consensus       177 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-------------  240 (285)
T 3is5_A          177 FKSDE---HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-------------  240 (285)
T ss_dssp             -------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred             cCCcc---cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-------------
Confidence            64322   22345678999999999888999999999999999999999999754322111111110             


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       .+.... .....++++.+++.+||+.||++|||++|++++
T Consensus       241 -~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          241 -EPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             -CCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             -Cccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000000 000123567899999999999999999999874

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-41  Score=358.99  Aligned_cols=256  Identities=26%  Similarity=0.374  Sum_probs=199.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcE----EEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKL----LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~----vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ++|...+.||+|+||+||+|.. .+++.    ||+|.+.... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ   90 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence            4677789999999999999965 44554    7888775432 12333467789999999999999999999864 5689


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++|+|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence            999999999999998643   34688899999999999999999997   899999999999999999999999999988


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +.............++.+|+|||.+ .+.++.++|||||||++|||+| |+.||...........+....          
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------  234 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE----------  234 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC----------
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------
Confidence            7554444344456678899999998 5679999999999999999999 999997644322111111100          


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ...       .+..++.++.+++.+||+.||++|||++|++++|+++.
T Consensus       235 ~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          235 RLA-------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             BCC-------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             CCC-------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            000       01112235679999999999999999999999998763

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.1e-41  Score=350.01  Aligned_cols=251  Identities=21%  Similarity=0.273  Sum_probs=193.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc------------------------ccHHHHHHHHHHHH
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR------------------------QTDEEFLELASTIS  493 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~------------------------~~~~~~~~e~~~l~  493 (720)
                      .++|...+.||+|+||+||+|.. .+++.||||++.......                        ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            35788889999999999999965 578999999996542111                        12356899999999


Q ss_pred             ccCCCceeEEEeEecc--CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 004994          494 RLRHGNIVELIGYCNE--HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNF  571 (720)
Q Consensus       494 ~l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDl  571 (720)
                      +++||||+++++++.+  .+..++||||+++++|.+++.     ...+++..+..++.|+++||+|||+.   +|+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            9999999999999976  568999999999999987653     24689999999999999999999997   9999999


Q ss_pred             CCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccCCCC----CCCccchHhHHHHHHHHHhCCCCCC
Q 004994          572 KSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS----YSCQSDVYSLGVVMLELLTGRKPYD  647 (720)
Q Consensus       572 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~Dv~S~Gvvl~elltG~~Pf~  647 (720)
                      ||+|||++.++.+||+|||+++......  .......++..|+|||...+.    ++.++|||||||++|||++|+.||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            9999999999999999999998764322  122345688999999998543    3778999999999999999999997


Q ss_pred             CCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          648 RSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..........+.            .......    .....++++.+++.+||+.||++|||++|++++
T Consensus       242 ~~~~~~~~~~~~------------~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          242 DERIMCLHSKIK------------SQALEFP----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             CSSHHHHHHHHH------------HCCCCCC----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CccHHHHHHHHh------------cccCCCC----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            532211100000            0000000    001223568899999999999999999999865

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.4e-41  Score=348.27  Aligned_cols=261  Identities=30%  Similarity=0.451  Sum_probs=195.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|...+.||+|+||+||+|....  .||||+++.........+.|.+|++++++++||||+++++++. .+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence            4578888999999999999997643  5999999765555556678999999999999999999999764 456899999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++...   ...+++..+..++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A          100 WCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             ecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999998643   35689999999999999999999997   9999999999999999999999999999866433


Q ss_pred             CCcccccCccccccCCCCccC----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFE----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ..........++..|+|||.+    ...++.++||||||+++|||++|+.||........  ......         ...
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~---------~~~  242 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVG---------RGS  242 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHH---------HTS
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhc---------ccc
Confidence            222233345688999999987    34578899999999999999999999975432211  111000         000


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ..+... .....++.++.+++.+||+.||++|||++|+++.|+++.
T Consensus       243 ~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          243 LSPDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCCCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cCcchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            111110 011223467899999999999999999999999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.4e-41  Score=345.14  Aligned_cols=254  Identities=29%  Similarity=0.403  Sum_probs=192.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccc--cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQ--RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||.||+|... |+.||||++......  ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            56778899999999999999864 889999998754322  234578899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC--------CCCeEEccc
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE--------KLIVRVSDC  589 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~--------~~~~kl~DF  589 (720)
                      ||+++++|.+++.     ...+++..+..++.++++||+|||+....+|+||||||+|||++.        ++.+||+||
T Consensus        86 e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999885     246889999999999999999999973233999999999999986        778999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      |+++......    .....++..|+|||.. ...++.++||||||+++|||+||+.||..........            
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------------  224 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------------  224 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------------
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence            9998664322    1234678899999988 5678999999999999999999999997543211100            


Q ss_pred             hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                          ...........+...++++.+++.+||+.||++|||+.|++++|++|
T Consensus       225 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 ----GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ----HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ----hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                00000111111122346788999999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-41  Score=353.50  Aligned_cols=269  Identities=21%  Similarity=0.274  Sum_probs=201.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-----CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--CC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-----PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--HG  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~  511 (720)
                      .++|+..+.||+|+||+||+|++     .+++.||||++...  .....+.+.+|++++++++||||+++++++..  ..
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            35678889999999999999974     36899999999743  23445688999999999999999999999854  35


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      ..++||||+++|+|.+++...   ...+++..+..++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             ceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            689999999999999999643   34589999999999999999999987   999999999999999999999999999


Q ss_pred             CCCCCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch-
Q 004994          592 APLLFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI-  668 (720)
Q Consensus       592 a~~~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-  668 (720)
                      ++........ .......++..|+|||.. ...++.++||||||+++|||+||..||......    ............ 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~  236 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQM  236 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccch
Confidence            9876443221 122234466779999988 567999999999999999999999998642110    000000000000 


Q ss_pred             --hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          669 --DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       669 --~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                        ....+.+........+..++.++.+++.+||+.||++|||++|+++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              001111111111111223456789999999999999999999999999886

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.1e-41  Score=355.05  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.+... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35788889999999999999965 6799999999864322 122345788999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+ +|+|.+++..    ...+++.....++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++...
T Consensus        88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 6789888853    35689999999999999999999998   99999999999999999999999999998764


Q ss_pred             CCCCcccccCccccccCCCCccCCCC-C-CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFESGS-Y-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~-~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ...   ......+++.|+|||.+.+. + +.++|||||||++|||++|+.||...........+....            
T Consensus       160 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~------------  224 (336)
T 3h4j_B          160 DGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV------------  224 (336)
T ss_dssp             TSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC------------
T ss_pred             CCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC------------
Confidence            332   23345689999999998553 3 789999999999999999999997543222111110000            


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ..    .+...+.++.+++.+||+.||.+|||++|++++
T Consensus       225 --~~----~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          225 --YV----MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             --CC----CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             --CC----CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence              00    011123567899999999999999999999865

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.7e-41  Score=349.12  Aligned_cols=267  Identities=18%  Similarity=0.259  Sum_probs=200.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++..........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            4678889999999999999965 568999999998655555556788999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++ ++.+.+..   ....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9986 55555532   235689999999999999999999997   9999999999999999999999999999876432


Q ss_pred             CCcccccCccccccCCCCccCC-C-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccc-cc-hhhhc-ccccCchhhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFES-G-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE-QS-LVRWA-IPRLHDIDALSR  673 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~-~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~-~~-~~~~~-~~~~~~~~~~~~  673 (720)
                      .  .......++..|+|||... . .++.++|||||||++|||+||..||........ .. +.+.. .+....+.....
T Consensus       155 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             c--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence            1  2223456788999999873 3 389999999999999999999888643322111 00 00000 000000000111


Q ss_pred             hcCC---------CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDP---------SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~---------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+.         ............++.+++.+||+.||++|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000         00001112234678899999999999999999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-41  Score=356.00  Aligned_cols=250  Identities=19%  Similarity=0.234  Sum_probs=203.3

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.++|...+.||+|+||+||+|.. .+++.||+|.+...   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            356788899999999999999965 46899999998643   23456788999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC--CCCeEEccccCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE--KLIVRVSDCGLAPL  594 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~  594 (720)
                      |||+++|+|.+++...   ...+++..+..++.|+++||.|||+.   +|+||||||+|||++.  ++.+||+|||+++.
T Consensus        80 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           80 FEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             ECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            9999999999998542   34688999999999999999999997   9999999999999987  78999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      +....   ......+++.|+|||...+ .++.++|||||||++|||++|+.||.........                ..
T Consensus       154 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------------~~  214 (321)
T 1tki_A          154 LKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII----------------EN  214 (321)
T ss_dssp             CCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HH
T ss_pred             CCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH----------------HH
Confidence            64432   2233567899999999854 5799999999999999999999999754321111                11


Q ss_pred             hcCC--CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDP--SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +...  ..........+.++.+++.+||+.||++|||++|++++
T Consensus       215 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1110  11111122334678899999999999999999999985

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.6e-41  Score=360.02  Aligned_cols=250  Identities=20%  Similarity=0.263  Sum_probs=197.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      .++|...+.||+|+||+||+|+. .+|+.||||++++.. ......+.+.+|.++++.+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            46788899999999999999965 468999999997542 2234556788999999988 79999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +||||||||+|||++.++++||+|||+|+..
T Consensus       102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999853    35689999999999999999999997   9999999999999999999999999999864


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ...  ........||+.|+|||.+ ...|+.++|||||||++|||++|+.||..........                .+
T Consensus       175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~----------------~i  236 (353)
T 3txo_A          175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE----------------AI  236 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------HH
T ss_pred             ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH----------------HH
Confidence            322  1223346789999999998 4468999999999999999999999997543221111                11


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCH------HHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPM------SEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  715 (720)
                      .....  .++.....++.+++.+||+.||++||++      +|+++|
T Consensus       237 ~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          237 LNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             HcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            11000  0111123567899999999999999998      777754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=349.77  Aligned_cols=252  Identities=26%  Similarity=0.435  Sum_probs=194.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|...+.||+|+||+||+|... ++.||||++...    ...+.|.+|++++++++||||+++++++.+  ..++||||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            46777899999999999999874 788999998642    345789999999999999999999999874  47899999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC-eEEccccCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI-VRVSDCGLAPLLFSG  598 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~-~kl~DFGla~~~~~~  598 (720)
                      +++|+|.+++.... ....+++..+..++.++++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            99999999997542 2345788899999999999999999965569999999999999998886 799999999765322


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                           .....++..|+|||.. ...++.++|||||||++|||+||+.||........ . ..+.         ......+
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~-~~~~---------~~~~~~~  223 (307)
T 2eva_A          160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-R-IMWA---------VHNGTRP  223 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-H-HHHH---------HHTTCCC
T ss_pred             -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-H-HHHH---------HhcCCCC
Confidence                 1224578999999998 45789999999999999999999999975322110 0 0000         0000011


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..    ....+..+.+++.+||+.||++|||++|+++.|+.+
T Consensus       224 ~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          224 PL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             CC----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Cc----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11    112345688999999999999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.1e-41  Score=359.97  Aligned_cols=250  Identities=24%  Similarity=0.304  Sum_probs=201.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|.. .+++.||+|++.+.. ......+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            5688889999999999999965 468999999996532 23345578899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+.+|+|.+++..    ...+++..+..++.+++.||.|||+.   +||||||||+|||++.++.+||+|||+|+.+..
T Consensus        95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999853    34689999999999999999999997   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccCC----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES----GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ..   ......||+.|+|||.+.    ..|+.++|||||||++|||+||+.||................          .
T Consensus       168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----------~  234 (384)
T 4fr4_A          168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----------T  234 (384)
T ss_dssp             TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----------H
T ss_pred             CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----------h
Confidence            22   233467899999999983    248999999999999999999999997543322111111100          0


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-MSEIVQ  714 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~  714 (720)
                       ....    ++...+.++.+++.+||+.||++||+ ++++++
T Consensus       235 -~~~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 -TVVT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -CCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -cccC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence             0000    11123467889999999999999998 777764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.7e-41  Score=356.15  Aligned_cols=261  Identities=23%  Similarity=0.386  Sum_probs=205.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe--------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEecc
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL--------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNE  509 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~  509 (720)
                      .++|...+.||+|+||+||+|..        .++..||||++.... .....+.+.+|+++++++ +||||+++++++.+
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            35677889999999999999975        346789999997543 234456789999999999 99999999999999


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNIL  577 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiL  577 (720)
                      .+..++||||+++|+|.+++.....            ....+++..+..++.++++||.|||+.   +|+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence            9999999999999999999975421            123488999999999999999999997   9999999999999


Q ss_pred             EcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCcccc
Q 004994          578 LDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQ  655 (720)
Q Consensus       578 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~  655 (720)
                      ++.++.+||+|||+++...............++..|+|||.. ...++.++|||||||++|||+| |+.||........ 
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  268 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-  268 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence            999999999999999876543322223334567789999988 5668999999999999999999 9999975432111 


Q ss_pred             chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                        ...          +........    +...+.++.+++.+||+.||.+|||++|++++|++++
T Consensus       269 --~~~----------~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          269 --FKL----------LKEGHRMDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             --HHH----------HHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHH----------HhcCCCCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              100          000000111    1123457889999999999999999999999999863

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.8e-40  Score=352.16  Aligned_cols=254  Identities=18%  Similarity=0.297  Sum_probs=198.6

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC-----
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG-----  511 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----  511 (720)
                      +.++|+..+.||+|+||.||+|... +|+.||||++.... .....+.+.+|++++++++|||||+++++|.+..     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            4567888899999999999999765 79999999997543 2345678999999999999999999999885433     


Q ss_pred             ----------------------------------------------------eEEEEEeeCCCCCHHHHhhccchhcccc
Q 004994          512 ----------------------------------------------------QHLLVYDYGGNCTLHDLLHSDEEAHKKF  539 (720)
Q Consensus       512 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~  539 (720)
                                                                          ..++||||+++++|.+++.... .....
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~  161 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDR  161 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGS
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccch
Confidence                                                                3899999999999999997643 23456


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCc----------ccccCccc
Q 004994          540 SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN----------ELSEGLLT  609 (720)
Q Consensus       540 ~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~~  609 (720)
                      .+..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++........          .......+
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            7778899999999999999987   9999999999999999999999999999877543211          12234568


Q ss_pred             cccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHH
Q 004994          610 AHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSL  688 (720)
Q Consensus       610 ~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  688 (720)
                      +..|+|||.+ ...++.++|||||||++|||++|..|+...     .             ............ .......
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~-------------~~~~~~~~~~~~-~~~~~~~  299 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----V-------------RIITDVRNLKFP-LLFTQKY  299 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----H-------------HHHHHHHTTCCC-HHHHHHC
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----H-------------HHHHHhhccCCC-cccccCC
Confidence            9999999998 567999999999999999999987765210     0             011111111111 1223444


Q ss_pred             HHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          689 SRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       689 ~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +++.+++.+||+.||++|||++|++++
T Consensus       300 ~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          300 PQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            677899999999999999999999975

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.8e-41  Score=344.15  Aligned_cols=253  Identities=21%  Similarity=0.295  Sum_probs=202.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC--CeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|... ++.||||++..........+.|.+|++++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            46778899999999999999874 88999999986554455567899999999999999999999999876  7889999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++....  ...+++..+..++.++++||+|||+. .++|+||||||+|||++.++.++|+|||++.....
T Consensus        89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999999999997532  23589999999999999999999986 12399999999999999999999999998754321


Q ss_pred             CCCcccccCccccccCCCCccCCC-CC---CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG-SY---SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~-~~---~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                             ....++..|+|||.+.+ .+   +.++|||||||++|||+||+.||...........            ....
T Consensus       166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------------~~~~  226 (271)
T 3kmu_A          166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK------------VALE  226 (271)
T ss_dssp             -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH------------HHHS
T ss_pred             -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH------------HHhc
Confidence                   22457889999999843 33   3489999999999999999999975432111000            0000


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...+..    +...+.++.+++.+||+.||++|||++|+++.|+++
T Consensus       227 ~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          227 GLRPTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             CCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            011111    122345788999999999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4e-41  Score=355.88  Aligned_cols=266  Identities=21%  Similarity=0.326  Sum_probs=210.0

Q ss_pred             HHHHHhcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEe
Q 004994          434 SLQQYTNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC  507 (720)
Q Consensus       434 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~  507 (720)
                      +.....++|...+.||+|+||.||+|...      +++.||||++.... .......+.+|++++++++||||+++++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            33445678888999999999999999653      37889999997543 233456789999999999999999999999


Q ss_pred             ccCCeEEEEEeeCCCCCHHHHhhccchh------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC
Q 004994          508 NEHGQHLLVYDYGGNCTLHDLLHSDEEA------HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK  581 (720)
Q Consensus       508 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~  581 (720)
                      .+.+..++||||+++|+|.+++......      ...+++..+.+++.++++||+|||+.   +|+||||||+|||++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence            9999999999999999999998643211      14568899999999999999999997   99999999999999999


Q ss_pred             CCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhh
Q 004994          582 LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVR  659 (720)
Q Consensus       582 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~  659 (720)
                      +.+||+|||+++...............++..|+|||.. .+.++.++|||||||++|||+| |+.||........   ..
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~  251 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LR  251 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---HH
Confidence            99999999999866433222222334567889999998 5678999999999999999999 8999965332111   11


Q ss_pred             hcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                                   .+...... ..+...+..+.+++.+||+.||++|||+.|++++|++++
T Consensus       252 -------------~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          252 -------------FVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             -------------HHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             -------------HHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence                         00010000 011123457889999999999999999999999998864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-40  Score=350.16  Aligned_cols=246  Identities=22%  Similarity=0.316  Sum_probs=200.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|.. .+|+.||+|++.+... .....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            5678889999999999999966 4799999999975422 2244567889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +|+||||||+|||++.++++||+|||+++....
T Consensus        86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999853    34688999999999999999999987   999999999999999999999999999987532


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .     .....+|+.|+|||.+ ...++.++|||||||++|||++|+.||.........                ..+..
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------------~~i~~  217 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY----------------EKILN  217 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HHHHH
T ss_pred             c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHh
Confidence            2     2235689999999998 456899999999999999999999999754321111                11111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      ....  ++...+.++.+++.+||+.||++||     +++|+++|
T Consensus       218 ~~~~--~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          218 AELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CCCC--CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCC--CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            0000  1112235788999999999999999     89998864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-40  Score=367.95  Aligned_cols=249  Identities=26%  Similarity=0.394  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC-eEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG-QHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~  517 (720)
                      .++|...+.||+|+||+||+|... |+.||||+++...    ..+.|.+|++++++++|||||++++++.+.+ ..++||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            356777899999999999999875 7899999997542    3468999999999999999999999987654 799999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++...  ....+++..+..++.++++||+|||+.   +||||||||+|||++.++.+||+|||+++....
T Consensus       267 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             ECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999999642  223478899999999999999999997   999999999999999999999999999985432


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ..     ....++..|+|||.+ .+.++.++|||||||++|||+| |+.||...........+             ..-.
T Consensus       342 ~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------------~~~~  403 (450)
T 1k9a_A          342 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------------EKGY  403 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-------------HTTC
T ss_pred             cc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------HcCC
Confidence            11     112456789999998 6679999999999999999998 99999754332211111             0000


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..    ..+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       404 ~~----~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          404 KM----DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            00    11223446788999999999999999999999999876

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.2e-41  Score=369.58  Aligned_cols=255  Identities=27%  Similarity=0.406  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|...+.||+|+||+||+|...++..||||+++...   ...++|.+|++++++++||||+++++++.+ +..++|||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            34577788999999999999998888889999997542   345789999999999999999999999976 67899999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++...  ....+++..+..++.|+++||+|||+.   +||||||||+|||++.++.+||+|||+++.....
T Consensus       259 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          259 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            99999999999632  234588999999999999999999997   9999999999999999999999999999876432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .. .......++..|+|||.+ .+.++.++|||||||++|||+| |+.||...........+             ..-..
T Consensus       334 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------------~~~~~  399 (452)
T 1fmk_A          334 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------------ERGYR  399 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------------HTTCC
T ss_pred             ce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------HcCCC
Confidence            21 122234456789999988 5789999999999999999999 99999754321111000             00000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .    ..+..+++.+.+++.+||+.||++|||++++++.|++++
T Consensus       400 ~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          400 M----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            0    111233467889999999999999999999999999863

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.8e-41  Score=351.84  Aligned_cols=263  Identities=24%  Similarity=0.349  Sum_probs=197.0

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC--
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG--  511 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--  511 (720)
                      ..++|...+.||+|+||.||+|...    ++..||||++..........+.+.+|++++++++||||+++++++.+.+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3467788899999999999999653    3558999999765444455678999999999999999999999997654  


Q ss_pred             ---eEEEEEeeCCCCCHHHHhhccc--hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEE
Q 004994          512 ---QHLLVYDYGGNCTLHDLLHSDE--EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRV  586 (720)
Q Consensus       512 ---~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl  586 (720)
                         ..++||||+++|+|.+++....  .....+++..+..++.++++||.|||+.   +|+||||||+|||++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence               3599999999999999985322  2345689999999999999999999987   9999999999999999999999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                      +|||+++...............++..|+|||.. ...++.++||||||+++|||+| |+.||............      
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------  262 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL------  262 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH------
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH------
Confidence            999999876543322223334567789999998 6678999999999999999999 99999754322111000      


Q ss_pred             cCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                             .....+.    .+...+.++.+++.+||+.||++|||+.+++++|++++
T Consensus       263 -------~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          263 -------LHGHRLK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             -------HTTCCCC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------HcCCCCC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                   0000001    11223467889999999999999999999999999863

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.3e-40  Score=351.12  Aligned_cols=270  Identities=19%  Similarity=0.296  Sum_probs=188.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            35788899999999999999965 468999999997543 2334467889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccch--hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEE--AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~--~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||++ |+|.+++.....  ....+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9999 599998854321  124588999999999999999999997   9999999999999999999999999999876


Q ss_pred             CCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh-hhcc-cccCchhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWAI-PRLHDIDAL  671 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~-~~~~~~~~~  671 (720)
                      ....  .......++..|+|||.+.  ..++.++|||||||++|||+||+.||...........+ .... +.-..+...
T Consensus       159 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          159 GIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             TSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            4321  1223346789999999884  35899999999999999999999999764432211111 0000 000000000


Q ss_pred             hhh--cCCCC----C--------chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRM--VDPSL----D--------GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~--~~~~~----~--------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...  ..+..    .        .......+.++.+++.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            000  00000    0        00001223578899999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-40  Score=358.89  Aligned_cols=257  Identities=18%  Similarity=0.264  Sum_probs=198.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ++|...++||+|+||+||+|+. .+++.||||++++.... ....+.+..|..++.++ +|||||++++++.+.+..++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            5688889999999999999976 46889999999764322 22334577888998887 899999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +||||||||+|||++.++++||+|||+|+...
T Consensus       132 ~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999998853    35689999999999999999999997   99999999999999999999999999998632


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh-hhhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-ALSRM  674 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  674 (720)
                      ..  ........||+.|+|||.+ ...++.++|||||||++|||++|+.||...........        ...+ ....+
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~--------~~~~~~~~~i  274 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQVI  274 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHHH
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch--------hhHHHHHHHH
Confidence            22  1233456789999999998 45789999999999999999999999964322111000        0000 00111


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCH------HHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPM------SEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  715 (720)
                      .....  ..+...+.++.+++.+||+.||++||++      +|+++|
T Consensus       275 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          275 LEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             hcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            11110  0112234578899999999999999985      677654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-40  Score=352.90  Aligned_cols=259  Identities=14%  Similarity=0.128  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.....    .+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            45788889999999999999965 6799999999864322    23578999999999 999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC-----eEEccccC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI-----VRVSDCGL  591 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~-----~kl~DFGl  591 (720)
                      |||+ +++|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.     +||+|||+
T Consensus        84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           84 LELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            9999 89999998642   35789999999999999999999997   9999999999999998887     99999999


Q ss_pred             CCCCCCCCCcc-----cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          592 APLLFSGSTNE-----LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       592 a~~~~~~~~~~-----~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      ++.+.......     ......||..|+|||.. ...++.++|||||||++|||++|+.||...............    
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i----  232 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI----  232 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH----
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH----
Confidence            98764432211     12346789999999998 556899999999999999999999999764332211111100    


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .   .......   ........+ ++.+++.+||+.||.+||++++|++.|+++
T Consensus       233 ~---~~~~~~~---~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          233 G---DTKRATP---IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             H---HHHHHSC---HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             H---hhhccCC---HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            0   0000000   000011123 789999999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6e-41  Score=353.38  Aligned_cols=268  Identities=23%  Similarity=0.371  Sum_probs=210.4

Q ss_pred             HHHHHHhcCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEe
Q 004994          433 ASLQQYTNSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIG  505 (720)
Q Consensus       433 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~  505 (720)
                      .......++|...+.||+|+||+||+|..      .+++.||||++..... ....+.+.+|+++++++ +||||+++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-cHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            33444567888999999999999999963      3568999999975432 33456789999999999 7999999999


Q ss_pred             EeccCC-eEEEEEeeCCCCCHHHHhhccchh------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 004994          506 YCNEHG-QHLLVYDYGGNCTLHDLLHSDEEA------------HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFK  572 (720)
Q Consensus       506 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlk  572 (720)
                      ++...+ ..++||||+++|+|.+++......            ...+++..+..++.++++||.|||+.   +|+|||||
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik  175 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  175 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence            987654 589999999999999999754321            12378999999999999999999997   99999999


Q ss_pred             CCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCC
Q 004994          573 SSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSR  650 (720)
Q Consensus       573 p~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~  650 (720)
                      |+||+++.++.+||+|||+++...............++..|+|||.. ...++.++|||||||++|||+| |+.||....
T Consensus       176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            99999999999999999999877544333334445678899999988 6678999999999999999998 999997543


Q ss_pred             CccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          651 PRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .....  ..          .+........    +...+.++.+++.+||+.||++|||++|++++|++++
T Consensus       256 ~~~~~--~~----------~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          256 IDEEF--CR----------RLKEGTRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CSHHH--HH----------HHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHH--HH----------HhccCccCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            22110  00          0000000111    1112357889999999999999999999999999863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.8e-40  Score=347.43  Aligned_cols=261  Identities=17%  Similarity=0.284  Sum_probs=196.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccc-ccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||.||+|.. .+|+.||||++... .......+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4688889999999999999965 57999999999743 223345578899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++.........+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999875444456789999999999999999999997   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..  .......++..|+|||.. ...++.++||||||+++|||++|+.||....... .....             .+..
T Consensus       189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-------------~~~~  252 (310)
T 2wqm_A          189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK-------------KIEQ  252 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHH-------------HHHT
T ss_pred             CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHH-------------Hhhc
Confidence            22  122235678899999988 5578999999999999999999999996432111 00110             0000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...........+.++.+++.+||+.||++|||++||++.|++|
T Consensus       253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0000000112335788999999999999999999999999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.8e-41  Score=355.90  Aligned_cols=261  Identities=24%  Similarity=0.348  Sum_probs=207.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CC-----cEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GG-----KLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHG  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g-----~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  511 (720)
                      .++|...+.||+|+||+||+|... ++     ..||+|.+.... .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            457788899999999999999753 23     489999997543 233457789999999999 8999999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchh----------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEA----------HKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK  581 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~  581 (720)
                      ..++||||+++|+|.+++......          ...+++..+..++.+++.||+|||+.   +|+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence            999999999999999998643211          24578999999999999999999997   99999999999999999


Q ss_pred             CCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhh
Q 004994          582 LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVR  659 (720)
Q Consensus       582 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~  659 (720)
                      +.+||+|||+++...............++..|+|||.. ...++.++|||||||++|||+| |+.||.........  ..
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~~  278 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--YK  278 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--HH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--HH
Confidence            99999999999876544333333445667889999987 5679999999999999999999 99999754322110  00


Q ss_pred             hcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                                ..........    +...+..+.+++.+||+.||.+|||++|++++|+++
T Consensus       279 ----------~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          279 ----------LVKDGYQMAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             ----------HHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------HHhcCCCCCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence                      0000001111    111235788999999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-40  Score=344.82  Aligned_cols=256  Identities=23%  Similarity=0.334  Sum_probs=193.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      .++|...+.||+|+||.||+|...    .+..||+|++.... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   91 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW   91 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccE
Confidence            457788899999999999999653    25679999987542 23445789999999999999999999999854 5689


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++++|.+++...   ...+++..+..++.++++||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence            999999999999998632   34688999999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ....... ......++..|+|||.. ...++.++|||||||++|||++ |+.||...........+.             
T Consensus       166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-------------  231 (281)
T 1mp8_A          166 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------------  231 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------------
T ss_pred             cCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-------------
Confidence            6433211 12223456789999988 5678999999999999999997 999997543221111000             


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ......    .+...+.++.+++.+||+.||++|||+.|++++|++++
T Consensus       232 ~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          232 NGERLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             TTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            000000    11223467889999999999999999999999999863

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-40  Score=355.99  Aligned_cols=252  Identities=20%  Similarity=0.253  Sum_probs=190.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|...+.||+|+||+||++... +++.||||++....   ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            357888899999999999999664 79999999997542   23357889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC--eEEccccCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI--VRVSDCGLAPLL  595 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~DFGla~~~  595 (720)
                      ||+++|+|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.  +||+|||+++..
T Consensus        96 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           96 EYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            99999999998853    34689999999999999999999987   9999999999999987765  999999999754


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCc-cchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQ-SDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~-~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ...   .......+++.|+|||.+ ...++.+ +|||||||++|||++|+.||..........            ..+..
T Consensus       169 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------------~~~~~  233 (361)
T 3uc3_A          169 VLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR------------KTIQR  233 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH------------HHHHH
T ss_pred             ccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH------------HHHHH
Confidence            222   122335689999999988 4556555 899999999999999999997543221110            01111


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +.............+.++.+|+.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            111111000011123578899999999999999999999976

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.9e-40  Score=345.14  Aligned_cols=260  Identities=17%  Similarity=0.150  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++....    ..+.+.+|+++++++ +|+|++++++++.+....++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            45788899999999999999964 679999999986432    223577899999999 899999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC-----eEEccccC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI-----VRVSDCGL  591 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~-----~kl~DFGl  591 (720)
                      |||+ +++|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.     +||+|||+
T Consensus        85 ~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            9999 89999999632   34589999999999999999999987   9999999999999987776     99999999


Q ss_pred             CCCCCCCCCc-----ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          592 APLLFSGSTN-----ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       592 a~~~~~~~~~-----~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      ++........     .......++..|+|||.. ...++.++|||||||++|||++|+.||................   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---  234 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG---  234 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH---
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH---
Confidence            9876543221     123345688999999998 4568999999999999999999999997643322111111000   


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       ..     ... ..........++++.+++.+||+.||++|||+++|++.|+++
T Consensus       235 -~~-----~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          235 -EK-----KQS-TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             -HH-----HHH-SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             -hh-----ccC-ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence             00     000 000001112346789999999999999999999999999886

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1e-40  Score=355.10  Aligned_cols=249  Identities=22%  Similarity=0.291  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      .++|...+.||+|+||+||+|+. .+|+.||||++++... .....+.+..|.+++..+ +||||+++++++.+.+..++
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            46788899999999999999976 4689999999975421 233456778889999877 99999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +||||||||+|||++.++++||+|||+++..
T Consensus        96 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999853    35688999999999999999999997   9999999999999999999999999999865


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ....  .......||+.|+|||.+ ...++.++|||||||++|||++|+.||...........+..              
T Consensus       169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--------------  232 (345)
T 1xjd_A          169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--------------  232 (345)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred             ccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--------------
Confidence            3222  123346789999999998 45689999999999999999999999975432111111100              


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMS-EIVQ  714 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  714 (720)
                      ..+..    +...+.++.+++.+||+.||++||++. |+++
T Consensus       233 ~~~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          233 DNPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             CCCCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            01111    112235788999999999999999997 6654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.3e-40  Score=342.63  Aligned_cols=251  Identities=23%  Similarity=0.337  Sum_probs=199.8

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc----CCeEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE----HGQHLL  515 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~l  515 (720)
                      .|...+.||+|+||+||+|.. .++..||+|++..........+.+.+|++++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            355667899999999999965 568899999997655455566789999999999999999999998864    456899


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc-CCCCeEEccccCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPL  594 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~  594 (720)
                      ||||+++++|.+++..    ...+++..+..++.+++.||.|||+. .++|+||||||+|||++ +++.+||+|||++..
T Consensus       107 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999953    35688999999999999999999987 12399999999999998 789999999999975


Q ss_pred             CCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ....    ......++..|+|||...+.++.++|||||||++|||++|+.||........  ..             ..+
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~-------------~~~  242 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY-------------RRV  242 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH-------------HHH
T ss_pred             cccc----ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HH-------------HHH
Confidence            5322    2223467899999999988899999999999999999999999965332111  01             111


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .............++++.+++.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            11111111222233578899999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-40  Score=340.54  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=205.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|...+.||+|+||.||+|...+++.||+|++....   ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            4677788999999999999988888999999997543   3346899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++++|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999998532   34688999999999999999999997   89999999999999999999999999998653221


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                       ........++..|+|||.. ...++.++||||||+++|||++ |+.||........   ...          +..-...
T Consensus       159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~----------i~~~~~~  224 (267)
T 3t9t_A          159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VED----------ISTGFRL  224 (267)
T ss_dssp             -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----------HHTTCCC
T ss_pred             -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HHH----------HhcCCcC
Confidence             1112234456789999998 5678999999999999999999 8999975432111   100          0000000


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..    +...+..+.+++.+||+.||++|||++|++++|+++
T Consensus       225 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          225 YK----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC----CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00    111235688999999999999999999999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=348.82  Aligned_cols=267  Identities=21%  Similarity=0.347  Sum_probs=200.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||+||+|.. .+|+.||||++..........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            5788889999999999999966 469999999997655444556778899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999988753    34588999999999999999999997   9999999999999999999999999999876432


Q ss_pred             CCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch--------
Q 004994          599 STNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI--------  668 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------  668 (720)
                      .  .......++.+|+|||.+.  ..++.++|||||||++|||+||+.||...........+..........        
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 S--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             c--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            2  1223456788999999883  468999999999999999999999997654322211111110000000        


Q ss_pred             hhhh--hhcCCCCCch---hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALS--RMVDPSLDGA---YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~--~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....  .+.++.....   .....+.++.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000  0001100000   011234568899999999999999999999865

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.3e-40  Score=352.34  Aligned_cols=246  Identities=20%  Similarity=0.274  Sum_probs=201.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|.. .+|+.||||++.+.. ......+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            5678889999999999999976 479999999996542 22345577899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999999853    34688999999999999999999987   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .     .....||+.|+|||.+ ...++.++|||||||++|||++|+.||.........                ..+..
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----------------~~i~~  252 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----------------EKIVS  252 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHH
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH----------------HHHHc
Confidence            2     2235789999999988 557899999999999999999999999754321111                11110


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                      ...  ..+...+.++.+++.+||+.||++||+     ++|+++|
T Consensus       253 ~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          253 GKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            000  011123457889999999999999998     8888764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.2e-40  Score=360.50  Aligned_cols=250  Identities=19%  Similarity=0.240  Sum_probs=187.6

Q ss_pred             cCCCCC-CeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHH-ccCCCceeEEEeEecc----CCe
Q 004994          440 NSFSEG-NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTIS-RLRHGNIVELIGYCNE----HGQ  512 (720)
Q Consensus       440 ~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~----~~~  512 (720)
                      ++|... ++||+|+||+||+|.. .+|+.||||++...       ..+.+|++++. ..+||||+++++++..    .+.
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            455554 6899999999999965 57899999998532       35667888774 4589999999998864    567


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---CCCeEEccc
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIVRVSDC  589 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DF  589 (720)
                      .++||||+++|+|.+++...  ....+++..+..++.+++.||.|||+.   +||||||||+|||++.   ++.+||+||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence            89999999999999999653  234689999999999999999999997   9999999999999997   789999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcccccCc
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAIPRLHD  667 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~  667 (720)
                      |+++......   ......+|.+|+|||++ .+.|+.++|||||||++|||++|+.||.......... ....       
T Consensus       209 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-------  278 (400)
T 1nxk_A          209 GFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-------  278 (400)
T ss_dssp             TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH-------
T ss_pred             ccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH-------
Confidence            9998654321   12345678999999998 5679999999999999999999999997543322100 0000       


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         +. ..............+.++.+|+.+||+.||++|||++|++++
T Consensus       279 ---i~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          279 ---IR-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ---HH-HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---HH-cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               00 000000101112234678899999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-40  Score=361.63  Aligned_cols=269  Identities=20%  Similarity=0.326  Sum_probs=193.5

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccC--Ce
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEH--GQ  512 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~  512 (720)
                      ...++|...+.||+|+||+||+|.. .+|+.||||++.+........+.+.+|+.+++++. ||||+++++++...  ..
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3567899999999999999999964 57999999999765555556677889999999997 99999999999654  37


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .|+||||++ ++|.+++..     ..+++..+..++.|+++||+|||+.   +||||||||+|||++.++.+||+|||+|
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            899999998 589888853     4688889999999999999999997   9999999999999999999999999999


Q ss_pred             CCCCCCC-------------------CcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 004994          593 PLLFSGS-------------------TNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRP  651 (720)
Q Consensus       593 ~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~  651 (720)
                      +.+....                   .........+|++|+|||.+.  ..|+.++|||||||++|||++|+.||.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8653211                   011223356899999999873  4689999999999999999999999976543


Q ss_pred             ccccchhhhcccccCchhhhhhhcC------------------CCCCchhh------------HHHHHHHHHHHHHHhcc
Q 004994          652 RGEQSLVRWAIPRLHDIDALSRMVD------------------PSLDGAYL------------AKSLSRFADIISRCVQW  701 (720)
Q Consensus       652 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~------------~~~~~~l~~l~~~cl~~  701 (720)
                      ......+.... .....+.+..+..                  ......++            ...++++.+|+.+||+.
T Consensus       237 ~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          237 MNQLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            22111111000 0011111100000                  00000000            02245788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 004994          702 EPGFRPPMSEIVQD  715 (720)
Q Consensus       702 dP~~RPt~~evl~~  715 (720)
                      ||++|||++|+++|
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=352.32  Aligned_cols=256  Identities=24%  Similarity=0.360  Sum_probs=195.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcE----EEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKL----LAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~----vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      .++|...+.||+|+||+||+|.. .+++.    ||+|.+.... .....+.+.+|++++++++||||+++++++.... .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            35788889999999999999965 45554    5777765432 3455678999999999999999999999998764 7


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++|+||+.+|+|.+++...   ...+++..+..++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             eEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            8999999999999998642   35688999999999999999999997   99999999999999999999999999998


Q ss_pred             CCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ...............++..|+|||.. ...++.++|||||||++|||++ |+.||...........+..           
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-----------  234 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-----------  234 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----------
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-----------
Confidence            77544333333344567789999988 5679999999999999999999 9999976433221111100           


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                            ......+...+.++.+++.+||+.||++|||++|+++.|+++
T Consensus       235 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          235 ------GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             ------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  000001112335688999999999999999999999999876

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-40  Score=344.74  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=208.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|...+.||+|+||+||+|... ++..||+|++...   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            456788899999999999999764 5889999999753   334578999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++...  ....+++..+..++.+++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        89 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             ECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999999642  235689999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      .. ........++..|+|||.. ...++.++||||||+++|||++ |+.||...........+             ....
T Consensus       164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-------------~~~~  229 (288)
T 3kfa_A          164 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------------EKDY  229 (288)
T ss_dssp             SS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-------------HTTC
T ss_pred             Cc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------hccC
Confidence            32 2233345567789999988 5678999999999999999999 99999754322111111             1111


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...    .+...++++.+++.+||+.||++|||++|+++.|+++
T Consensus       230 ~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          230 RME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            111    1122346788999999999999999999999999876

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.6e-40  Score=342.01  Aligned_cols=254  Identities=20%  Similarity=0.265  Sum_probs=203.8

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.++|...+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            457888999999999999999965 5689999999976544445557789999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC---eEEccccCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI---VRVSDCGLAP  593 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFGla~  593 (720)
                      |||+++++|.+.+..    ...+++..+..++.+++.||.|||+.   +|+||||||+||+++.++.   +||+|||++.
T Consensus        84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            999999999988853    35688999999999999999999997   9999999999999987655   9999999997


Q ss_pred             CCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ......   ......++..|+|||.. ...++.++||||||+++|||++|+.||...........+....          
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------  223 (284)
T 3kk8_A          157 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA----------  223 (284)
T ss_dssp             ECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------
T ss_pred             EcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc----------
Confidence            664322   22345688999999998 5568999999999999999999999996543221111111000          


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ..  .........++++.+++.+||+.||++|||++|++++
T Consensus       224 --~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          224 --YD--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             --CC--CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --cc--CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              00  0000111233578899999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-40  Score=349.04  Aligned_cols=270  Identities=19%  Similarity=0.302  Sum_probs=204.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-----CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC--Ce
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-----PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH--GQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~  512 (720)
                      +.|+..+.||+|+||.||+|.+     .+++.||||++.... .....+.+.+|++++++++||||+++++++.+.  ..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            3467789999999999999973     468999999997543 234557899999999999999999999999876  66


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||+++++|.+++..   ....+++..+..++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence            8999999999999999853   235689999999999999999999997   9999999999999999999999999999


Q ss_pred             CCCCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC--ch
Q 004994          593 PLLFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH--DI  668 (720)
Q Consensus       593 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~  668 (720)
                      +........ .......++..|+|||.. ...++.++||||||+++|||+||+.|+.....    .......+...  ..
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTV  249 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCH
Confidence            876543221 223345577789999988 56688999999999999999999998643210    00000000000  00


Q ss_pred             hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ..+...+........+...++++.+++.+||+.||++|||++|+++.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0111111111111112234467889999999999999999999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.1e-40  Score=348.90  Aligned_cols=249  Identities=20%  Similarity=0.272  Sum_probs=190.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEe----CCCcEEEEEEeccccc--ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL----PGGKLLAVKKLSNTVS--QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ++|...+.||+|+||+||+|+.    .+|+.||+|++++...  .......+.+|++++++++||||+++++++.+.+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            5688889999999999999976    4789999999976432  123345678999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++||||+++++|.+++..    ...+++.....++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           97 YLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999853    34678889999999999999999997   99999999999999999999999999997


Q ss_pred             CCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ......  .......++..|+|||.+ ...++.++|||||||++|||++|+.||.........                .
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----------------~  231 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI----------------D  231 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----------------H
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH----------------H
Confidence            643221  123345688999999998 556899999999999999999999999754321110                0


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      .+.....  ..+...+.++.+++.+||+.||++||     +++|+++|
T Consensus       232 ~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          232 KILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             HHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             HHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            0100000  01112235788999999999999999     78888865

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.6e-40  Score=354.83  Aligned_cols=247  Identities=26%  Similarity=0.379  Sum_probs=198.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      +.|...+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4577789999999999999965 6799999999975422 2233467899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+. |+|.+++..   ....+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9998 588887742   245689999999999999999999997   899999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      .      ....+++.|+|||.+    .+.++.++|||||||++|||+||+.||.........  ..           +..
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~-----------~~~  267 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YH-----------IAQ  267 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HH-----------HHH
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HH-----------HHh
Confidence            2      235688999999986    456899999999999999999999999654321110  00           000


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...+...   ....+..+.+++.+||+.||++|||++|++++
T Consensus       268 ~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          268 NESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             SCCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             cCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0011111   11223568899999999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.3e-40  Score=357.55  Aligned_cols=272  Identities=20%  Similarity=0.270  Sum_probs=203.7

Q ss_pred             hcCCCCCCeeccC--CCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          439 TNSFSEGNFIGEG--LLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      .++|+..+.||+|  +||+||+|... +|+.||||++..........+.+.+|++++++++|||||++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3568888999999  99999999764 79999999998665445556788899999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++|+|.+++....  ...+++..+..++.|+++||+|||+.   +||||||||+|||++.++.+||+|||.+...
T Consensus       104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999986431  24588999999999999999999997   9999999999999999999999999998654


Q ss_pred             CCCCC-----cccccCccccccCCCCccCCC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhcccccC
Q 004994          596 FSGST-----NELSEGLLTAHGSGAPEFESG---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIPRLH  666 (720)
Q Consensus       596 ~~~~~-----~~~~~~~~~~~~~~aPE~~~~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~  666 (720)
                      .....     ........++..|+|||.+.+   .++.++|||||||++|||++|+.||......... .......+.+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            32211     111223467888999999843   6899999999999999999999999764332211 00000000000


Q ss_pred             chh-----h-------------hhhhcC---C------CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 DID-----A-------------LSRMVD---P------SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 ~~~-----~-------------~~~~~~---~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +..     .             ......   +      ..........++++.+|+.+||+.||++|||++|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            000     0             000000   0      00001122334678999999999999999999999865

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-40  Score=353.25  Aligned_cols=263  Identities=19%  Similarity=0.195  Sum_probs=202.3

Q ss_pred             HHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc---ccccHHHHHHHHHHHHccCCCceeEEEeEecc
Q 004994          434 SLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS---QRQTDEEFLELASTISRLRHGNIVELIGYCNE  509 (720)
Q Consensus       434 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~  509 (720)
                      ++..+.++|...+.||+|+||+||+|.. .+++.||+|++.....   .....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3456778899999999999999999965 5788999999865321   23455789999999999999999999999999


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccch------------------------------------hccccCHHHHHHHHHHHHH
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEE------------------------------------AHKKFSWNIRIRVALGAAR  553 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------~~~~~~~~~~~~i~~~ia~  553 (720)
                      .+..++||||+++|+|.+++.....                                    ....+++.....++.++++
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            9999999999999999999852110                                    0123456778889999999


Q ss_pred             HHHHHHhcCCCCeeecCCCCCCeEEcCCC--CeEEccccCCCCCCCCCCc--ccccCccccccCCCCccCC---CCCCCc
Q 004994          554 ALQYLQEVCEPPIVHGNFKSSNILLDEKL--IVRVSDCGLAPLLFSGSTN--ELSEGLLTAHGSGAPEFES---GSYSCQ  626 (720)
Q Consensus       554 ~L~~LH~~~~~~ivHrDlkp~NiLl~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~~~~~~~aPE~~~---~~~~~~  626 (720)
                      ||+|||+.   +|+||||||+|||++.++  .+||+|||+++.+......  .......+++.|+|||.+.   +.++.+
T Consensus       180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999997   899999999999998776  8999999999865432211  1223456889999999873   568999


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC--CCchhhHHHHHHHHHHHHHHhccCCC
Q 004994          627 SDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS--LDGAYLAKSLSRFADIISRCVQWEPG  704 (720)
Q Consensus       627 ~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~  704 (720)
                      +|||||||++|||++|+.||.........                ..+....  .........+.++.+++.+||+.||+
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADTI----------------SQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHHH----------------HHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence            99999999999999999999754322111                1111111  01111122346788999999999999


Q ss_pred             CCCCHHHHHHH
Q 004994          705 FRPPMSEIVQD  715 (720)
Q Consensus       705 ~RPt~~evl~~  715 (720)
                      +|||+.|++++
T Consensus       321 ~Rps~~~~l~h  331 (345)
T 3hko_A          321 ERFDAMRALQH  331 (345)
T ss_dssp             TSCCHHHHHHS
T ss_pred             HCCCHHHHhcC
Confidence            99999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-40  Score=365.50  Aligned_cols=196  Identities=20%  Similarity=0.314  Sum_probs=155.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEec-----cCCe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN-----EHGQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-----~~~~  512 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++..........+.+.+|++++++++|||||++++++.     ....
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36788899999999999999964 57899999999765555556678999999999999999999999984     3357


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .|+||||++ ++|.+++..    ...+++..+..++.|+++||.|||+.   +||||||||+|||++.++++||+|||+|
T Consensus       132 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            899999985 689988853    35689999999999999999999997   9999999999999999999999999999


Q ss_pred             CCCCCCCCc-------------------------ccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhC
Q 004994          593 PLLFSGSTN-------------------------ELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTG  642 (720)
Q Consensus       593 ~~~~~~~~~-------------------------~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG  642 (720)
                      +........                         .......+|++|+|||.+  ...|+.++|||||||++|||+||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            876432211                         112345679999999965  45699999999999999999993

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.4e-40  Score=363.33  Aligned_cols=262  Identities=19%  Similarity=0.233  Sum_probs=196.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC------C
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH------G  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~  511 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.+........+.+.+|+++++.++|||||++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46788899999999999999954 5799999999986554455667889999999999999999999999644      4


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      ..++||||++++ +.+.+.      ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            679999999874 665553      2478889999999999999999997   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh-hhcc-------
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWAI-------  662 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~-------  662 (720)
                      |+.....   .......+|++|+|||.+ ...|+.++|||||||++|||++|+.||...+..+....+ +...       
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9876432   223346789999999998 557999999999999999999999999764422111100 0000       


Q ss_pred             cccCchhhhhhhcC---------------CCC---CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 PRLHDIDALSRMVD---------------PSL---DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 ~~~~~~~~~~~~~~---------------~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+.  ......+.               ...   ..........++.+|+.+||+.||++|||++|+++|
T Consensus       288 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          288 KKLQ--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TTSC--HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHcc--hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000  00000000               000   011122335678999999999999999999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.5e-40  Score=348.16  Aligned_cols=249  Identities=20%  Similarity=0.292  Sum_probs=180.8

Q ss_pred             CCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEEEeeCC
Q 004994          444 EGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLVYDYGG  521 (720)
Q Consensus       444 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~  521 (720)
                      ..+.||+|+||+||+|.. .+|+.||||++.+.     ....+.+|+++++++. ||||+++++++.+.+..++||||++
T Consensus        15 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~   89 (325)
T 3kn6_A           15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN   89 (325)
T ss_dssp             TSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence            358899999999999966 46899999998642     3457789999999997 9999999999999999999999999


Q ss_pred             CCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC---CeEEccccCCCCCCCC
Q 004994          522 NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL---IVRVSDCGLAPLLFSG  598 (720)
Q Consensus       522 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~~~~~  598 (720)
                      +|+|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++   .+||+|||+++.....
T Consensus        90 ~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           90 GGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             SCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9999999853    35689999999999999999999987   999999999999997765   8999999999865432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      ..  ......++..|+|||.+ ...++.++|||||||++|||++|+.||...........         ..+....+...
T Consensus       163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---------~~~~~~~i~~~  231 (325)
T 3kn6_A          163 NQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS---------AVEIMKKIKKG  231 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC---------HHHHHHHHTTT
T ss_pred             CC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc---------HHHHHHHHHcC
Confidence            21  22334578999999998 55799999999999999999999999975432111000         01111122211


Q ss_pred             C--CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          678 S--LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       678 ~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .  .........++++.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            1  1222223345788999999999999999999998754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.3e-40  Score=339.48  Aligned_cols=252  Identities=19%  Similarity=0.242  Sum_probs=204.1

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.++|...+.||+|+||+||+|.. .++..||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            456788889999999999999965 457899999997543  24467899999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE---cCCCCeEEccccCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAP  593 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~  593 (720)
                      |||+++++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+|||+   +.++.+||+|||++.
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           85 MELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            999999999998853    35689999999999999999999997   99999999999999   788999999999998


Q ss_pred             CCCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ......   ......++..|+|||...+.++.++||||||+++|||+||+.||...........+...            
T Consensus       158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------  222 (277)
T 3f3z_A          158 RFKPGK---MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG------------  222 (277)
T ss_dssp             ECCTTS---CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred             eccCcc---chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------------
Confidence            764332   22345688999999999888999999999999999999999999754321111100000            


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ............+.++.+++.+||+.||++|||+.|++++
T Consensus       223 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          223 --TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             --CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             --CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0011111111234678899999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=345.90  Aligned_cols=269  Identities=19%  Similarity=0.233  Sum_probs=196.8

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc---ccccHHHHHHHHHHHHcc---CCCceeEEEeEeccC
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS---QRQTDEEFLELASTISRL---RHGNIVELIGYCNEH  510 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~  510 (720)
                      ..++|...+.||+|+||+||+|.. .+|+.||||++.....   .......+.+|+++++++   +||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999975 5789999999864321   112234566777776666   499999999999765


Q ss_pred             C-----eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeE
Q 004994          511 G-----QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR  585 (720)
Q Consensus       511 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~k  585 (720)
                      .     ..++||||++ ++|.+++....  ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence            4     5799999998 59999986432  23489999999999999999999997   899999999999999999999


Q ss_pred             EccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 004994          586 VSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       586 l~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                      |+|||+++......   ......++..|+|||.+ .+.++.++|||||||++|||++|+.||...........+......
T Consensus       161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999998764322   22345679999999998 667999999999999999999999999764432211111000000


Q ss_pred             cCc--hh---h-hhhhcCCCCC---chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          665 LHD--ID---A-LSRMVDPSLD---GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       665 ~~~--~~---~-~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...  +.   . ....+.+...   .....+..+++.+++.+||+.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            000  00   0 0000000000   01111234678899999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-39  Score=343.96  Aligned_cols=269  Identities=22%  Similarity=0.312  Sum_probs=199.7

Q ss_pred             HHHHHHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHcc--CCCceeEEEeEeccC
Q 004994          433 ASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL--RHGNIVELIGYCNEH  510 (720)
Q Consensus       433 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l--~H~niv~l~~~~~~~  510 (720)
                      .......++|...+.||+|+||+||+|... |+.||||++...     ....+..|.+++...  +||||+++++++...
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            334455678999999999999999999875 899999998532     234455566666554  999999999999776


Q ss_pred             ----CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeEEcCC
Q 004994          511 ----GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV-----CEPPIVHGNFKSSNILLDEK  581 (720)
Q Consensus       511 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivHrDlkp~NiLl~~~  581 (720)
                          ...++||||+++|+|.+++..     ..+++..+..++.+++.||+|||+.     +.++||||||||+|||++.+
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN  178 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence                789999999999999999953     3588999999999999999999975     24489999999999999999


Q ss_pred             CCeEEccccCCCCCCCCCCcc--cccCccccccCCCCccCCC-CCCCc------cchHhHHHHHHHHHhC----------
Q 004994          582 LIVRVSDCGLAPLLFSGSTNE--LSEGLLTAHGSGAPEFESG-SYSCQ------SDVYSLGVVMLELLTG----------  642 (720)
Q Consensus       582 ~~~kl~DFGla~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~------~Dv~S~Gvvl~elltG----------  642 (720)
                      +.+||+|||+++.+.......  ......++..|+|||.+.+ .++.+      +|||||||++|||+||          
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999999997664332211  1224568899999999844 34443      9999999999999999          


Q ss_pred             CCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch-hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          643 RKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA-YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       643 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      +.||.......... ...     .. ........+..... ....++.++.+++.+||+.||++|||+.||+++|+++
T Consensus       259 ~~p~~~~~~~~~~~-~~~-----~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          259 QLPYHDLVPSDPSY-EDM-----RE-IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             CCTTTTTSCSSCCH-HHH-----HH-HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccHhhhcCCCCch-hhh-----HH-HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            55554322111100 000     00 00001112222221 2236778899999999999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.3e-40  Score=355.83  Aligned_cols=273  Identities=21%  Similarity=0.295  Sum_probs=207.5

Q ss_pred             cccCHHHHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-----CCcee
Q 004994          428 SVFTIASLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-----HGNIV  501 (720)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv  501 (720)
                      ..++..+...+.++|...+.||+|+||+||+|.. .+++.||||++...   ....+.+..|++++++++     ||||+
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            3455556666788999999999999999999966 57899999999642   344567788999999986     99999


Q ss_pred             EEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-
Q 004994          502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-  580 (720)
Q Consensus       502 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-  580 (720)
                      ++++++...+..++||||+ +++|.+++....  ...+++..+..++.|++.||+|||+.   +||||||||+|||++. 
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP  173 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence            9999999999999999999 889999986432  24588999999999999999999987   9999999999999975 


Q ss_pred             ------------------------CCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHH
Q 004994          581 ------------------------KLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVV  635 (720)
Q Consensus       581 ------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvv  635 (720)
                                              ++.+||+|||+|+.....     .....++..|+|||.+ ...++.++|||||||+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                                    789999999999865322     2235678999999988 5579999999999999


Q ss_pred             HHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh--------c---------CCCCC------------chhhHH
Q 004994          636 MLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM--------V---------DPSLD------------GAYLAK  686 (720)
Q Consensus       636 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~---------~~~~~------------~~~~~~  686 (720)
                      +|||+||+.||...........+.......... .....        .         .....            ......
T Consensus       249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  327 (360)
T 3llt_A          249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKN-MLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII  327 (360)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHH-HHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred             HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHH-HHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence            999999999997644322111111111111100 00000        0         00000            000111


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          687 SLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       687 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+.+.+|+.+||+.||++|||++|++++
T Consensus       328 ~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          328 KHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            12568899999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.2e-40  Score=339.88  Aligned_cols=254  Identities=24%  Similarity=0.368  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|...+.||+|+||.||+|...+++.||||++....   ...+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence            35677889999999999999998888899999997542   345789999999999999999999999874 45899999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.+++...  ....+++..+..++.++++||+|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus        88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             cCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999642  223688999999999999999999997   9999999999999999999999999999876433


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .. .......++..|+|||.. .+.++.++||||||+++|||+| |+.||........   ...          +.+-..
T Consensus       163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~----------~~~~~~  228 (279)
T 1qpc_A          163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQN----------LERGYR  228 (279)
T ss_dssp             CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHH----------HHTTCC
T ss_pred             cc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHH----------HhcccC
Confidence            21 122334457789999998 4678999999999999999999 9999975332111   110          000000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..    .+...+.++.+++.+||+.||++|||++++++.|+++
T Consensus       229 ~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          229 MV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            11    1112346788999999999999999999999999876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.9e-40  Score=357.01  Aligned_cols=268  Identities=19%  Similarity=0.241  Sum_probs=198.8

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCC------CcEEEEEEeccccccc---------ccHHHHHHHHHHHHccCCCceeEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQR---------QTDEEFLELASTISRLRHGNIVEL  503 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~---------~~~~~~~~e~~~l~~l~H~niv~l  503 (720)
                      .++|...+.||+|+||+||+|....      ++.||||++.......         .....+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578888999999999999997654      4789999986542110         111234556667788899999999


Q ss_pred             EeEeccC----CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc
Q 004994          504 IGYCNEH----GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD  579 (720)
Q Consensus       504 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~  579 (720)
                      ++++...    ...++||||+ +++|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            9998654    4589999999 9999999863   235689999999999999999999997   999999999999999


Q ss_pred             --CCCCeEEccccCCCCCCCCCCcc-----cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCC
Q 004994          580 --EKLIVRVSDCGLAPLLFSGSTNE-----LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP  651 (720)
Q Consensus       580 --~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~  651 (720)
                        .++.+||+|||+|+.+.......     ......+|..|+|||.+ ...++.++|||||||++|||+||+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999998764322111     11234589999999998 44699999999999999999999999974322


Q ss_pred             ccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          652 RGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ...  .........  ...+..++++.+.   ....+.++.+++.+||+.||++||++++|++.|++++
T Consensus       267 ~~~--~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          267 DPK--YVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             CHH--HHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CHH--HHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            111  111100000  0111111111110   0122467889999999999999999999999998763

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=352.80  Aligned_cols=249  Identities=22%  Similarity=0.298  Sum_probs=186.8

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.+.|...+.||+|+||+||+|... +++.||||++....    ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            4567888999999999999999765 68899999997542    345688999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---CCCeEEccccCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIVRVSDCGLAP  593 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla~  593 (720)
                      |||+++|+|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+|||++.   ++.+||+|||+++
T Consensus       127 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          127 LELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             ECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            999999999999853    34588999999999999999999997   9999999999999975   8899999999998


Q ss_pred             CCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ......   ......++..|+|||.+ ...++.++|||||||++|||++|+.||........  ..             .
T Consensus       200 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~-------------~  261 (349)
T 2w4o_A          200 IVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF-------------R  261 (349)
T ss_dssp             ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH-------------H
T ss_pred             ccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH-------------H
Confidence            764321   22345688999999998 45789999999999999999999999965432210  00             0


Q ss_pred             hhcCCC--CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPS--LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+....  .........+.++.+++.+||+.||++|||+.|++++
T Consensus       262 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          262 RILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             HHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            011100  0001112234678899999999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.6e-40  Score=351.26  Aligned_cols=250  Identities=20%  Similarity=0.242  Sum_probs=201.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEeccccc-ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVS-QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      .++|...+.||+|+||+||+|+.. +|+.||||++.+... .....+.+..|.+++..+ +||||+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467888999999999999999765 588999999975422 234556788999999888 89999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +||||||||+|||++.++++||+|||+++..
T Consensus        99 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999853    34688999999999999999999997   9999999999999999999999999999864


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ....  .......||+.|+|||.+ ...++.++|||||||++|||++|+.||.........                ..+
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~----------------~~i  233 (353)
T 2i0e_A          172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----------------QSI  233 (353)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHH
T ss_pred             ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH----------------HHH
Confidence            3221  223346789999999998 557899999999999999999999999754321111                111


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                      .....  .++...+.++.+++.+||+.||++||+     ++|+++|
T Consensus       234 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          234 MEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             HhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11000  011123467889999999999999995     5777654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.4e-40  Score=366.69  Aligned_cols=254  Identities=21%  Similarity=0.323  Sum_probs=205.3

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.++|...+.||+|+||+||+|.. .+++.||||++.+..........+.+|++++++++|||||++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            456788899999999999999965 4799999999975544445567899999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc---CCCCeEEccccCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAP  593 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~  593 (720)
                      |||+.+|+|.+.+..    ...+++.....++.+++.||.|||+.   +||||||||+|||++   .++.+||+|||+++
T Consensus       100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999998853    35689999999999999999999997   999999999999995   46689999999998


Q ss_pred             CCCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ......   ......++++|+|||.+.+.|+.++|||||||++|||++|+.||...........+...            
T Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------------  237 (486)
T 3mwu_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG------------  237 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred             ECCCCC---ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence            764322   22345689999999999888999999999999999999999999754322111111000            


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ............++++.+++.+||+.||++|||+.|++++
T Consensus       238 --~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          238 --KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             --CCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             --CCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000111122334678899999999999999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.3e-40  Score=362.03  Aligned_cols=260  Identities=18%  Similarity=0.213  Sum_probs=204.0

Q ss_pred             HHHHHHhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccC
Q 004994          433 ASLQQYTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEH  510 (720)
Q Consensus       433 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~  510 (720)
                      .++....++|...+.||+|+||+||+|+.. +++.||+|++.+.. ......+.+.+|+++++.++|||||+++++|.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344445678999999999999999999764 68999999996532 1222334588999999999999999999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                      +..|+||||+++|+|.+++..     ..+++.....++.+++.||+|||+.   +||||||||+|||++.++++||+|||
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence            999999999999999998852     3588889999999999999999997   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccCC-CC----CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFES-GS----YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~----~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      +|+.+.... ........||+.|+|||++. ..    |+.++|||||||++|||+||+.||...........+.      
T Consensus       214 ~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~------  286 (410)
T 3v8s_A          214 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM------  286 (410)
T ss_dssp             TCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------
T ss_pred             eeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH------
Confidence            998764332 11233467899999999873 22    7899999999999999999999997543221111000      


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGF--RPPMSEIVQD  715 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  715 (720)
                       ...  ....-+.     ....+.++.+|+.+||+.+|.+  ||+++||++|
T Consensus       287 -~~~--~~~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          287 -NHK--NSLTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             -THH--HHCCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             -hcc--ccccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence             000  0000010     0112357889999999999988  9999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-40  Score=373.86  Aligned_cols=255  Identities=27%  Similarity=0.406  Sum_probs=205.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|...+.||+|+||+||+|.+.++..||||+++...   ...++|.+|++++++++|||||++++++.+ +..++|||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            35577788999999999999998888889999997542   345789999999999999999999999976 67899999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++...  ....+++..+..++.++++||+|||+.   +||||||||+|||++.++.+||+|||+++.+...
T Consensus       342 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          342 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             hhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            99999999999632  234588999999999999999999997   8999999999999999999999999999876432


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      . ........++..|+|||.+ .+.++.++|||||||++|||+| |+.||...........+             .+-..
T Consensus       417 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-------------~~~~~  482 (535)
T 2h8h_A          417 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------------ERGYR  482 (535)
T ss_dssp             H-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-------------HTTCC
T ss_pred             c-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------HcCCC
Confidence            1 1112234456789999988 6679999999999999999999 99999754321111100             00000


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .    ..+..++.++.+|+.+||+.||++|||+++|++.|++++
T Consensus       483 ~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          483 M----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            0    011233467889999999999999999999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.2e-41  Score=345.47  Aligned_cols=260  Identities=21%  Similarity=0.305  Sum_probs=202.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEe--ccCCeEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC--NEHGQHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~--~~~~~~~l  515 (720)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|++++++++||||+++++++  ...+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            35678889999999999999966 4789999999976544445567899999999999999999999987  44678999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC--EPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ||||+++++|.+++.........+++..+..++.++++||+|||+..  ..+|+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999754444456899999999999999999999982  1129999999999999999999999999997


Q ss_pred             CCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ......  .......++..|+|||.. ...++.++||||||+++|||+||+.||.......   ....          +.
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----------i~  229 (279)
T 2w5a_A          165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGK----------IR  229 (279)
T ss_dssp             HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----------HH
T ss_pred             eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHH----------Hh
Confidence            664321  112234578899999998 5578999999999999999999999997543211   1100          00


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL  717 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  717 (720)
                      .-..+.+.    ...+.++.+++.+||+.||++|||++|+++++.
T Consensus       230 ~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          230 EGKFRRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HTCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             hcccccCC----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            00001111    123357889999999999999999999998764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.8e-41  Score=368.12  Aligned_cols=263  Identities=21%  Similarity=0.251  Sum_probs=206.8

Q ss_pred             HHHHHHHhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEecc
Q 004994          432 IASLQQYTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNE  509 (720)
Q Consensus       432 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~  509 (720)
                      ..++....++|...++||+|+||+||+|+.. +++.||||++.+... .....+.+.+|.+++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4455556788999999999999999999765 589999999975321 12223458899999999999999999999999


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                      .+..++||||+++|+|.+++...   ...+++.....++.+++.||.|||+.   +||||||||+|||++.++++||+||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999999999642   35689999999999999999999997   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcc
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAI  662 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~  662 (720)
                      |+|+....... .......||++|+|||++.      +.|+.++|||||||++|||+||+.||.......... +..+. 
T Consensus       220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-  297 (437)
T 4aw2_A          220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-  297 (437)
T ss_dssp             TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-
T ss_pred             hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc-
Confidence            99976643322 2233457899999999873      458999999999999999999999997543222111 11000 


Q ss_pred             cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 004994          663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGF--RPPMSEIVQD  715 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  715 (720)
                               .+..-|..    ....++++.+|+.+||..+|++  ||+++|+++|
T Consensus       298 ---------~~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          298 ---------ERFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ---------HHCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ---------ccccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence                     00000111    0112357889999999998888  9999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.9e-40  Score=348.43  Aligned_cols=258  Identities=18%  Similarity=0.252  Sum_probs=199.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ++|...+.||+|+||+||+|+. .+++.||||++.+... .....+.+.+|.++++++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            4678889999999999999976 4689999999975432 233456688999999888 899999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++|+|.+++..    ...+++..+..++.+++.||+|||+.   +|+||||||+|||++.++++||+|||+++...
T Consensus        89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            999999999998853    34689999999999999999999997   99999999999999999999999999998643


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ...  .......+|+.|+|||.+ ...++.++|||||||++|||++|+.||............       ........+.
T Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------~~~~~~~~i~  232 (345)
T 3a8x_A          162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-------TEDYLFQVIL  232 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHHHHHHH
T ss_pred             CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc-------cHHHHHHHHH
Confidence            221  223346789999999998 457899999999999999999999999643211100000       0000001111


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCH------HHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPM------SEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  715 (720)
                      .....  .+...+.++.+++.+||+.||++||++      +|+++|
T Consensus       233 ~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          233 EKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HCCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             cCCCC--CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            11100  112234578899999999999999995      677653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.3e-40  Score=343.13  Aligned_cols=249  Identities=24%  Similarity=0.390  Sum_probs=197.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CC-------cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GG-------KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH  510 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g-------~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~  510 (720)
                      .++|...+.||+|+||+||+|... ++       ..||+|++...  .....+.+.+|++++++++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            356778899999999999999543 34       57999998643  245567899999999999999999999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC-------
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI-------  583 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~-------  583 (720)
                      +..++||||+++|+|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.       
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence            9999999999999999999642   34488999999999999999999997   8999999999999998887       


Q ss_pred             -eEEccccCCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCC-CCCCCCCCccccchhh
Q 004994          584 -VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGR-KPYDRSRPRGEQSLVR  659 (720)
Q Consensus       584 -~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~-~Pf~~~~~~~~~~~~~  659 (720)
                       +||+|||++......      ....++..|+|||...  ..++.++|||||||++|||+||. .||.............
T Consensus       159 ~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~  232 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE  232 (289)
T ss_dssp             EEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             eeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence             999999999765321      2245678899999883  56899999999999999999955 4443322111000000


Q ss_pred             hcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .               ......    ..+.++.+++.+||+.||++|||++|++++|++++
T Consensus       233 ~---------------~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          233 D---------------RHQLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             T---------------TCCCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             c---------------cCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            0               000000    01235779999999999999999999999999875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-40  Score=356.34  Aligned_cols=252  Identities=20%  Similarity=0.264  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .+.|...+.||+|+||+||+|.. .+|+.||+|++....  ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            45788899999999999999965 578999999987542  234467899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC--CCCeEEccccCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE--KLIVRVSDCGLAPLL  595 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~~  595 (720)
                      ||+++|+|.+++...   ...+++..+..++.+++.||+|||+.   +|+||||||+|||++.  ++.+||+|||+++.+
T Consensus       128 E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          128 EFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             ECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence            999999999998642   34689999999999999999999997   9999999999999974  578999999999876


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ....   ......++..|+|||.+ ...++.++|||||||++|||+||+.||...........+..              
T Consensus       202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~--------------  264 (387)
T 1kob_A          202 NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR--------------  264 (387)
T ss_dssp             CTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH--------------
T ss_pred             CCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Confidence            4332   22234688999999998 45689999999999999999999999975432111100000              


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .............+.++.+++.+||+.||++|||++|++++
T Consensus       265 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          265 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            00001111112234678899999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.9e-40  Score=337.82  Aligned_cols=255  Identities=22%  Similarity=0.273  Sum_probs=203.5

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.++|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            4467888899999999999999664 789999999864432 23457889999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            999999999998853    34688999999999999999999997   99999999999999999999999999998664


Q ss_pred             CCCCcccccCccccccCCCCccCCC-C-CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFESG-S-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~~-~-~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ............++..|+|||...+ . ++.++||||||+++|||++|+.||........ ....+...           
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-----------  224 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK-----------  224 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT-----------
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc-----------
Confidence            3332223344567899999999844 4 47799999999999999999999975432211 11111110           


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         ..........+..+.+++.+||+.||++|||++|++++
T Consensus       225 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          225 ---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence               00000111234578899999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-40  Score=347.66  Aligned_cols=256  Identities=26%  Similarity=0.397  Sum_probs=196.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC-----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG-----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ++|...+.||+|+||+||+|....     +..||||++.... .......+.+|++++++++||||+++++++.+.+..+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            456667899999999999996532     3469999997543 2344567899999999999999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++|+|.+++..   ....+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999853   235689999999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCcc-cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          595 LFSGSTNE-LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       595 ~~~~~~~~-~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ........ ......++..|+|||.. ...++.++|||||||++|||+| |+.||.......   ...            
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~------------  261 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMK------------  261 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH------------
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHH------------
Confidence            64332111 11223346789999998 5679999999999999999999 999996533211   111            


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       .+.+. .....+...+.++.+++.+||+.||++||++.|+++.|+++
T Consensus       262 -~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          262 -AINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             -HHHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -HHHCC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             00000 00001112346788999999999999999999999999876

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.4e-40  Score=365.98  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=192.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|.. .+|+.||||++.+.. ........+.+|+++++.++||||++++++|.+.+..++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            5688889999999999999965 579999999997542 22334467788999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE-VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      ||+++|+|.+++..    ...+++..+..++.++++||+|||+ .   +||||||||+|||++.++.+||+|||+|+...
T Consensus       228 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          228 EYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             CCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             eeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999998853    3568999999999999999999997 5   89999999999999999999999999998643


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ...  .......||++|+|||.+ ...|+.++|||||||++|||++|+.||...........+...              
T Consensus       301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------------  364 (446)
T 4ejn_A          301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------------  364 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred             CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--------------
Confidence            222  223346789999999998 667999999999999999999999999654321111111000              


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      ...    ++...+.++.+++.+||+.||.+||     +++|+++|
T Consensus       365 ~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          365 EIR----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             CCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCC----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            000    1112235788999999999999999     99999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.5e-40  Score=350.60  Aligned_cols=271  Identities=22%  Similarity=0.255  Sum_probs=206.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-----CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEec--cCCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-----PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN--EHGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~  512 (720)
                      ++|...+.||+|+||.||+|.+     .+++.||||++...  .....+.+.+|++++++++||||+++++++.  +...
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            5677889999999999999974     46889999999754  2344567999999999999999999999886  4567


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||+++++|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             EEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence            89999999999999999632   34689999999999999999999997   9999999999999999999999999999


Q ss_pred             CCCCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhh
Q 004994          593 PLLFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       593 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      +........ .......++..|+|||.. ...++.++|||||||++|||++|+.||......... ...+ .........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~  252 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGC-ERDVPALSR  252 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC-----CCHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hccc-ccccccHHH
Confidence            876443221 122334567789999988 556899999999999999999999998542211000 0000 000111111


Q ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       671 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      +.+.+........+...++++.+++.+||+.||++|||++|++++|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111111111222334567899999999999999999999999999763

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.4e-40  Score=376.94  Aligned_cols=249  Identities=24%  Similarity=0.338  Sum_probs=197.7

Q ss_pred             CeeccCCCceEEEEEe---CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||+||+|.+   .+++.||||+++.........++|.+|++++++++|||||+++++|.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954   346899999998665555567889999999999999999999999965 458899999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCc-
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN-  601 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~-  601 (720)
                      |+|.+++..    ...+++..+..++.+++.||+|||+.   +||||||||+|||++.++.+||+|||+|+.+...... 
T Consensus       454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999953    35689999999999999999999997   9999999999999999999999999999876443221 


Q ss_pred             ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCC
Q 004994          602 ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL  679 (720)
Q Consensus       602 ~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  679 (720)
                      .......++..|+|||.+ ...++.++|||||||++|||+| |+.||...........+                 ....
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-----------------~~~~  589 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----------------EKGE  589 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-----------------HTTC
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----------------HcCC
Confidence            112223456789999998 5679999999999999999998 99999754322111111                 0000


Q ss_pred             CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       680 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ....+..++.++.+++.+||+.||++|||+++|++.|+++
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1111223446789999999999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.6e-40  Score=344.04  Aligned_cols=256  Identities=23%  Similarity=0.341  Sum_probs=189.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|+..+.||+|+||+||+|.. .+|+.||||++..........+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            45788889999999999999965 57999999999765443444455566666788899999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++ +|.+++.........+++..+..++.+++.||+|||+.  .+|+||||||+||+++.++.+||+|||+++....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            99984 88888765444456799999999999999999999984  2899999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ..   ......++..|+|||.+     ...++.++|||||||++|||+||+.||........ .              +.
T Consensus       163 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~--------------~~  224 (290)
T 3fme_A          163 DV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-Q--------------LK  224 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-H--------------HH
T ss_pred             cc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-H--------------HH
Confidence            22   12234678899999984     34588999999999999999999999964321110 0              00


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...............+.++.+++.+||+.||++|||++|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            0110000000111234578899999999999999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.1e-40  Score=342.25  Aligned_cols=255  Identities=24%  Similarity=0.326  Sum_probs=198.9

Q ss_pred             cCCCCCC-eeccCCCceEEEEEe---CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGN-FIGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~-~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|...+ .||+|+||+||+|..   .+++.||||++..........+++.+|+++++.++||||+++++++ +.+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4556566 899999999999953   3478999999976544444567899999999999999999999999 5567899


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++++|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        95 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            9999999999999953    34588999999999999999999997   9999999999999999999999999999876


Q ss_pred             CCCCCcc-cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          596 FSGSTNE-LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       596 ~~~~~~~-~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ....... ......++..|+|||.. ...++.++||||||+++|||+| |+.||...........+             .
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------------~  234 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------------E  234 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------------H
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------------H
Confidence            4432211 11123346789999998 5568899999999999999999 99999754321111100             0


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ....+.    .+...+.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       235 ~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          235 KGERMG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             TTCCCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            000011    1122346788999999999999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=354.64  Aligned_cols=246  Identities=21%  Similarity=0.252  Sum_probs=192.5

Q ss_pred             CCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          445 GNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      .+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            56799999999999965 579999999997532  244578999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE--cCCCCeEEccccCCCCCCCCCCc
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL--DEKLIVRVSDCGLAPLLFSGSTN  601 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl--~~~~~~kl~DFGla~~~~~~~~~  601 (720)
                      +|.+++..   ....+++..+..++.|+++||+|||+.   +|+||||||+|||+  +.++.+||+|||+++.+..... 
T Consensus       172 ~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-  244 (373)
T 2x4f_A          172 ELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-  244 (373)
T ss_dssp             EEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred             cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence            99998853   234688999999999999999999997   89999999999999  5678999999999987643322 


Q ss_pred             ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCC
Q 004994          602 ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD  680 (720)
Q Consensus       602 ~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  680 (720)
                        .....++++|+|||.+ .+.++.++|||||||++|||+||+.||...........+.            ..  .....
T Consensus       245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~------------~~--~~~~~  308 (373)
T 2x4f_A          245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL------------AC--RWDLE  308 (373)
T ss_dssp             --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------------HT--CCCSC
T ss_pred             --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------hc--cCCCC
Confidence              2234688999999988 4568999999999999999999999997543221110000            00  00011


Q ss_pred             chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       681 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .......++++.+|+.+||+.||++|||++|++++
T Consensus       309 ~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11112234678899999999999999999999974

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.7e-40  Score=341.39  Aligned_cols=249  Identities=19%  Similarity=0.277  Sum_probs=201.0

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      +.++|...+.||+|+||+||+|... +++.||||++...........++.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4567888999999999999999664 799999999986554455667888999999999 99999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---------------
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---------------  580 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---------------  580 (720)
                      ||||+++++|.+++.........+++..+..++.|+++||+|||+.   +|+||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999975444446789999999999999999999997   9999999999999984               


Q ss_pred             ----CCCeEEccccCCCCCCCCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 004994          581 ----KLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE  654 (720)
Q Consensus       581 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~  654 (720)
                          ...+||+|||++.......      ...++..|+|||...+  .++.++|||||||++|||++|+.|+.....   
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                4489999999998764322      2347889999999844  456799999999999999999977643210   


Q ss_pred             cchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          655 QSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       655 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ...           +.....+...    ...+.++.+++.+||+.||++|||++|++++
T Consensus       237 --~~~-----------~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 --WHE-----------IRQGRLPRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             --HHH-----------HHTTCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --HHH-----------HHcCCCCCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence              000           0000011111    1223578899999999999999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-39  Score=344.53  Aligned_cols=253  Identities=21%  Similarity=0.277  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc----ccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR----QTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      .+.|...+.||+|+||.||+|.. .+|+.||||++.......    ...+.+.+|++++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            45688889999999999999965 468999999997543221    2467899999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC----CeEEccc
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL----IVRVSDC  589 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DF  589 (720)
                      ++||||+++++|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            999999999999999953    34688999999999999999999997   999999999999999888    7999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      |+++......   ......++..|+|||.. ...++.++|||||||++|||+||+.||...........+..        
T Consensus       164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~--------  232 (321)
T 2a2a_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS--------  232 (321)
T ss_dssp             TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT--------
T ss_pred             ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------
Confidence            9998764332   12335688999999998 45789999999999999999999999965332111100000        


Q ss_pred             hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            .............+..+.+++.+||+.||++|||++|++++
T Consensus       233 ------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          233 ------VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ------TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ------cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  00111111122334678899999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.8e-39  Score=355.71  Aligned_cols=255  Identities=20%  Similarity=0.261  Sum_probs=192.7

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc------cccHHHHHHHHHHHHccCCCceeEEEeEecc
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ------RQTDEEFLELASTISRLRHGNIVELIGYCNE  509 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~  509 (720)
                      ...++|...+.||+|+||+||+|.. .+++.||||++.+....      ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4567899999999999999999955 56899999998754211      1122357899999999999999999999854


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC---CCeEE
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK---LIVRV  586 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl  586 (720)
                       +..++||||+++|+|.+++..    ...+++.....++.|+++||+|||+.   +|+||||||+|||++.+   +.+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence             458999999999999998853    34689999999999999999999987   89999999999999754   45999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccCC----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES----GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      +|||+|+.....   .......++++|+|||++.    ..++.++|||||||++|||+||+.||........  ..... 
T Consensus       284 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i-  357 (419)
T 3i6u_A          284 TDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI-  357 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH-
T ss_pred             eecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH-
Confidence            999999876432   2233466899999999873    4688899999999999999999999975332211  00000 


Q ss_pred             cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                               .. .............++++.+++.+||+.||++|||++|++++
T Consensus       358 ---------~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          358 ---------TS-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             ---------HT-TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---------hc-CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                     00 00001111122334678899999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.6e-40  Score=367.22  Aligned_cols=254  Identities=20%  Similarity=0.288  Sum_probs=199.8

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.+.|...+.||+|+||+||+|.. .++..||||++.+..........+.+|+++++.++|||||+++++|.+.+..++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            345688889999999999999966 4789999999986544444567889999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---CCCeEEccccCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIVRVSDCGLAP  593 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla~  593 (720)
                      |||+++|+|.+.+..    ...+++..+..++.++++||+|||+.   +||||||||+|||++.   ++.+||+|||+++
T Consensus       115 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          115 MECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            999999999988853    35688999999999999999999997   9999999999999976   4559999999998


Q ss_pred             CCCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ......   ......++++|+|||.+.+.|+.++|||||||++|||++|+.||...........+....           
T Consensus       188 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-----------  253 (494)
T 3lij_A          188 VFENQK---KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK-----------  253 (494)
T ss_dssp             ECBTTB---CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------
T ss_pred             ECCCCc---cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            764322   223456899999999998889999999999999999999999997543221111111000           


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         ...........+.++.+++.+||+.||.+|||++|++++
T Consensus       254 ---~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          254 ---YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             ---CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ---CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence               000111112234678899999999999999999999865

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.3e-40  Score=348.18  Aligned_cols=257  Identities=24%  Similarity=0.352  Sum_probs=199.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEE--EEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLL--AVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~v--avK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|...+.||+|+||.||+|.. .++..+  |+|++.... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            5678889999999999999965 456654  999987432 234456789999999999 99999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccc------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDE------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI  583 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  583 (720)
                      ||||+++|+|.+++....            .....+++..+..++.++++||+|||+.   +|+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence            999999999999997543            1234689999999999999999999997   9999999999999999999


Q ss_pred             eEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhc
Q 004994          584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWA  661 (720)
Q Consensus       584 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~  661 (720)
                      +||+|||+++.....   .......++..|+|||.. ...++.++|||||||++|||+| |+.||........   ....
T Consensus       181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~~~  254 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKL  254 (327)
T ss_dssp             EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHG
T ss_pred             EEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH---HHHh
Confidence            999999998754221   111223456789999988 4568999999999999999998 9999975432111   1100


Q ss_pred             ccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                                .......    .+...+.++.+++.+||+.||++|||++|++++|++++
T Consensus       255 ----------~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          255 ----------PQGYRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             ----------GGTCCCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------hcCCCCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                      0000011    11123357889999999999999999999999998863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-40  Score=340.94  Aligned_cols=254  Identities=23%  Similarity=0.330  Sum_probs=201.6

Q ss_pred             CCCCCC-eeccCCCceEEEEEeC---CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          441 SFSEGN-FIGEGLLGSVYKAELP---GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       441 ~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +|...+ .||+|+||.||+|...   ++..||||++.... .....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            344444 8999999999999653   57889999997542 234567899999999999999999999999 45568999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++...   ...+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999998632   34689999999999999999999997   99999999999999999999999999998764


Q ss_pred             CCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          597 SGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       597 ~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ..... .......++..|+|||.. ...++.++||||||+++|||+| |+.||...........+             ..
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i-------------~~  228 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------------EQ  228 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-------------HT
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-------------hc
Confidence            33221 112233457889999998 4678999999999999999999 99999754322111100             00


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...+.    .+...+.++.+++.+||+.||++||++.|++++|+++
T Consensus       229 ~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          229 GKRME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             TCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcCC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            00011    1123346788999999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.4e-40  Score=352.82  Aligned_cols=268  Identities=18%  Similarity=0.253  Sum_probs=192.7

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ..++|...+.||+|+||+||+|.. .+++.||||++..........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            456788999999999999999964 5799999999976544444556788999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE-----cCCCCeEEccccC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL-----DEKLIVRVSDCGL  591 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl-----~~~~~~kl~DFGl  591 (720)
                      |||+++ +|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+|||+     +.++.+||+|||+
T Consensus       112 ~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999985 99998853    34588999999999999999999997   99999999999999     4555699999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhc--ccc---
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA--IPR---  664 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~--~~~---  664 (720)
                      ++......  .......++..|+|||.+.+  .++.++|||||||++|||++|+.||...........+...  .+.   
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            97653221  12233456889999998843  5899999999999999999999999764322111100000  000   


Q ss_pred             cCchhhhhhh-------cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          665 LHDIDALSRM-------VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       665 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .........+       ....+..........++.+|+.+||+.||++|||++|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            0000000000       00000111112234678899999999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.9e-40  Score=338.23  Aligned_cols=248  Identities=24%  Similarity=0.348  Sum_probs=198.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||+||+|.. .+++.||||++.... ......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            45788889999999999999965 467899999986432 1223456789999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..    ...+++..+..++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999998853    35688999999999999999999987   99999999999999999999999999986553


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ...    .....++..|+|||.. ...++.++||||||+++|||++|+.||...........+..              .
T Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------~  222 (279)
T 3fdn_A          161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--------------V  222 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------------T
T ss_pred             ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--------------C
Confidence            221    2235678899999988 45688999999999999999999999975332111111100              0


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....    +...+..+.+++.+||+.||++|||++|++++
T Consensus       223 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          223 EFTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCCC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1111    11123567899999999999999999999976

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-39  Score=360.51  Aligned_cols=248  Identities=21%  Similarity=0.328  Sum_probs=201.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|... +|+.||||++.+... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888899999999999999764 799999999975322 2234567899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        96 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           96 EYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             ECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999853    34689999999999999999999987   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccCCC-CC-CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESG-SY-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~-~~-~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ..   ......+++.|+|||.+.+ .+ +.++|||||||++|||++|+.||........                ...+.
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~----------------~~~i~  229 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL----------------FKKIC  229 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH----------------HHHHH
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH----------------HHHHh
Confidence            32   2234568899999999854 33 7899999999999999999999975432111                11111


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +....  .+...+.++.+++.+||+.||++|||++|++++
T Consensus       230 ~~~~~--~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          230 DGIFY--TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             TTCCC--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             cCCcC--CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            11100  011123568899999999999999999999974

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.5e-40  Score=374.00  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=196.2

Q ss_pred             eeccCCCceEEEEEeC---CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          447 FIGEGLLGSVYKAELP---GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       447 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      .||+|+||+||+|.+.   ++..||||+++... .....++|.+|++++++++|||||+++++|.+ +..++||||+++|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence            7999999999999653   46789999997642 34456789999999999999999999999976 5689999999999


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc-
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE-  602 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~-  602 (720)
                      +|.+++...   ...+++..+..++.++++||+|||+.   +||||||||+|||++.++.+||+|||+++.+....... 
T Consensus       421 ~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  494 (613)
T 2ozo_A          421 PLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  494 (613)
T ss_dssp             BHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred             cHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence            999999643   35689999999999999999999997   99999999999999999999999999998764332211 


Q ss_pred             cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCC
Q 004994          603 LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD  680 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  680 (720)
                      ......++..|+|||.+ .+.++.++|||||||++|||+| |+.||...........+.                 ....
T Consensus       495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-----------------~~~~  557 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-----------------QGKR  557 (613)
T ss_dssp             -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-----------------TTCC
T ss_pred             eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----------------cCCC
Confidence            11122345789999998 5789999999999999999998 999997644322111110                 0000


Q ss_pred             chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          681 GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       681 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...+..++.++.+++.+||+.||++||++++|++.|+++
T Consensus       558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            011223446789999999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.8e-40  Score=347.80  Aligned_cols=267  Identities=22%  Similarity=0.312  Sum_probs=203.4

Q ss_pred             CCCCCeeccCCCceEEEEEeC-----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--CCeEE
Q 004994          442 FSEGNFIGEGLLGSVYKAELP-----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--HGQHL  514 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~  514 (720)
                      |...+.||+|+||+||++.+.     +++.||||++.... .....+.+.+|++++++++||||+++++++.+  ....+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            377899999999999988542     68899999997543 23445779999999999999999999999976  46789


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++|+|.+++..     ..+++..+..++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       112 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence            99999999999999853     3488999999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ....... .......++..|+|||.. ...++.++||||||+++|||+||+.||....... .....+..... ....+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~  261 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQM-TVLRLT  261 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHH-HHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccch-hHHHHH
Confidence            7543221 122334567789999998 5568899999999999999999999986421100 00000000000 001111


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      +.+........+..++.++.+++.+||+.||++|||++|+++.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11111111112233456789999999999999999999999999876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-40  Score=355.50  Aligned_cols=254  Identities=25%  Similarity=0.405  Sum_probs=190.2

Q ss_pred             CCCCCeeccCCCceEEEEEeC--CC--cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc-CCeEEEE
Q 004994          442 FSEGNFIGEGLLGSVYKAELP--GG--KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-HGQHLLV  516 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv  516 (720)
                      |...+.||+|+||+||+|...  ++  ..||||.+... ......+.|.+|++++++++||||++++++|.+ .+..++|
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            455688999999999999653  32  46899998653 233456789999999999999999999998754 5678999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++|+|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999642   34578899999999999999999997   99999999999999999999999999998764


Q ss_pred             CCCCcc--cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          597 SGSTNE--LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       597 ~~~~~~--~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ......  ......++..|+|||.. .+.++.++|||||||++|||+| |..||...........+...          .
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~----------~  313 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----------R  313 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT----------C
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC----------C
Confidence            332111  12234467789999988 5679999999999999999999 77888654332211111000          0


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ....       +..++..+.+++.+||+.||++|||++|++++|+++
T Consensus       314 ~~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          314 RLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0001       112335788999999999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.5e-40  Score=351.24  Aligned_cols=267  Identities=19%  Similarity=0.357  Sum_probs=199.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||.||+|.. .+|+.||||++..........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            5678889999999999999966 458999999987654444556778899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++++|.++...    ...+++..+..++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus       105 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          105 FVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             CCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             cCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999887643    34588999999999999999999997   9999999999999999999999999999866432


Q ss_pred             CCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccch-hhhcccccCc-------h
Q 004994          599 STNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL-VRWAIPRLHD-------I  668 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~-~~~~~~~~~~-------~  668 (720)
                      .  .......++.+|+|||.+.+  .++.++|||||||++|||++|+.||........... ..........       .
T Consensus       178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  12234567889999998843  689999999999999999999999976443221110 0000000000       0


Q ss_pred             hhhhhhcCCCCC-----chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLD-----GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ........+...     .......++++.+++.+||+.||++|||++|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000000111111     01111235678999999999999999999999865

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.9e-40  Score=351.91  Aligned_cols=251  Identities=14%  Similarity=0.168  Sum_probs=200.5

Q ss_pred             hcCCCCCCeeccCCCceEEEEE------eCCCcEEEEEEecccccccccHHHHHHHHHHHHccC---CCceeEEEeEecc
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAE------LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR---HGNIVELIGYCNE  509 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~  509 (720)
                      .++|...+.||+|+||+||+|.      ..+++.||||++...     ...++..|++++++++   |+||+.+++++..
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            4568888999999999999993      456899999999643     3457788888888887   9999999999999


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccch-hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC--------
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEE-AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE--------  580 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~--------  580 (720)
                      .+..++||||+++|+|.+++..... ....+++..+..++.|+++||+|||+.   +||||||||+|||++.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999964322 245699999999999999999999987   8999999999999998        


Q ss_pred             ---CCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc
Q 004994          581 ---KLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS  656 (720)
Q Consensus       581 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~  656 (720)
                         ++.+||+|||+|+.+.............||.+|+|||++ ...++.++|||||||++|||+||+.||.......   
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---  292 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---  292 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence               899999999999765433333334456789999999998 4468999999999999999999999995322110   


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCC-CCHHHHHHHHHhh
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFR-PPMSEIVQDLLCM  719 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~evl~~L~~~  719 (720)
                         +.         ....+... .      ..+.+.+++.+|++.+|.+| |+++++.+.|+++
T Consensus       293 ---~~---------~~~~~~~~-~------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          293 ---CK---------PEGLFRRL-P------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             ---EE---------ECSCCTTC-S------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ---ee---------echhcccc-C------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence               00         00000000 0      12456789999999999999 6888888888765

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.2e-40  Score=348.58  Aligned_cols=257  Identities=23%  Similarity=0.318  Sum_probs=192.9

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCC----
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHG----  511 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----  511 (720)
                      +.++|...+.||+|+||+||+|.. .+++.||||++..... .....+.+.+|++++++++||||+++++++...+    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            346788899999999999999965 6799999999975432 2234467899999999999999999999986543    


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      ..++||||+++++|.+++..    ...+++.....++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence            34999999999999999853    34689999999999999999999997   999999999999999999999999999


Q ss_pred             CCCCCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          592 APLLFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       592 a~~~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      ++.+...... .......++..|+|||.. ...++.++|||||||++|||+||+.||.........  ......      
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~------  234 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQHVRE------  234 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHC------
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhcC------
Confidence            9876443221 122335689999999998 557899999999999999999999999754321110  000000      


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            .+..........+.++.+++.+||+.||++||++.+++++
T Consensus       235 ------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          235 ------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             ------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence                  0000001111234678899999999999999977766643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=335.98  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=183.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5688889999999999999965 5799999999964321 2234577899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++...   ...+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999998642   35689999999999999999999997   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...  ......++..|+|||.. ...++.++||||||+++|||++|+.||...........+  ..   .         +
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~---~---------~  228 (278)
T 3cok_A          165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VL---A---------D  228 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--CS---S---------C
T ss_pred             CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--hh---c---------c
Confidence            221  12235678899999998 456899999999999999999999999754322111000  00   0         0


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...    +...+.++.+++.+||+.||++|||++|++++
T Consensus       229 ~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          229 YEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            001    11123568899999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.2e-40  Score=355.96  Aligned_cols=274  Identities=16%  Similarity=0.230  Sum_probs=208.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC--eEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG--QHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~l  515 (720)
                      .++|...++||+|+||+||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++.+.+  ..++
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            356888899999999999999664 599999999975432 344577889999999999999999999987654  7899


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE----cCCCCeEEccccC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL----DEKLIVRVSDCGL  591 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFGl  591 (720)
                      ||||+++|+|.+++.... ....+++..+..++.+++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+
T Consensus        87 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            999999999999997542 223489999999999999999999997   99999999999999    7888899999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccCC---------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCcc-ccchhh-h
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFES---------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRG-EQSLVR-W  660 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~-~~~~~~-~  660 (720)
                      ++......   ......++..|+|||.+.         ..++.++|||||||++|||+||+.||....... ...... .
T Consensus       163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             CEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             ceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            98764322   223456889999999873         357889999999999999999999996432211 111110 0


Q ss_pred             cccccC-chhhhhhhc--------CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          661 AIPRLH-DIDALSRMV--------DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       661 ~~~~~~-~~~~~~~~~--------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ...... .........        +..............+.+++.+||+.||++|||+.|+++.+++++
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            000000 000000000        000111233566778899999999999999999999999998864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-39  Score=339.64  Aligned_cols=255  Identities=24%  Similarity=0.326  Sum_probs=197.3

Q ss_pred             CCCCCeeccCCCceEEEEEeC-CC---cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE-EEE
Q 004994          442 FSEGNFIGEGLLGSVYKAELP-GG---KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH-LLV  516 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~lv  516 (720)
                      |...++||+|+||+||+|... ++   ..||+|.+.... .....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            445688999999999999642 33   379999997532 234557889999999999999999999999766554 999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+.+|+|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999642   35678999999999999999999997   99999999999999999999999999998664


Q ss_pred             CCCC--cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCC-CCCCCccccchhhhcccccCchhhhh
Q 004994          597 SGST--NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPY-DRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       597 ~~~~--~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ....  ........++..|+|||.. ...++.++||||||+++|||+||..|+ ...........+.             
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-------------  242 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-------------  242 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-------------
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-------------
Confidence            3221  1122334567889999998 457899999999999999999965554 3322211111000             


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ......    .+...+..+.+++.+||+.||.+|||++|+++.|++++
T Consensus       243 ~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          243 QGRRLP----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             TTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCC----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            000000    11122357889999999999999999999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.7e-39  Score=341.29  Aligned_cols=271  Identities=24%  Similarity=0.313  Sum_probs=207.2

Q ss_pred             CHHHHHHHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHc--cCCCceeEEEeEec
Q 004994          431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISR--LRHGNIVELIGYCN  508 (720)
Q Consensus       431 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~  508 (720)
                      .........++|...+.||+|+||+||+|.. +|+.||||++...     ....+.+|.+++..  ++||||+++++++.
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            3344455678899999999999999999987 5899999998632     34567888888887  79999999999998


Q ss_pred             cCC----eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeEEc
Q 004994          509 EHG----QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV-----CEPPIVHGNFKSSNILLD  579 (720)
Q Consensus       509 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivHrDlkp~NiLl~  579 (720)
                      ..+    ..++||||+++|+|.+++..     ..+++..+..++.++++||+|||..     +..+|+||||||+|||++
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  181 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence            765    78999999999999999953     3588999999999999999999931     123899999999999999


Q ss_pred             CCCCeEEccccCCCCCCCCCCcc--cccCccccccCCCCccCCCC-------CCCccchHhHHHHHHHHHhC--------
Q 004994          580 EKLIVRVSDCGLAPLLFSGSTNE--LSEGLLTAHGSGAPEFESGS-------YSCQSDVYSLGVVMLELLTG--------  642 (720)
Q Consensus       580 ~~~~~kl~DFGla~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-------~~~~~Dv~S~Gvvl~elltG--------  642 (720)
                      .++++||+|||+++.........  ......++..|+|||...+.       ++.++|||||||++|||+||        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            99999999999997764432211  22345688999999998543       23689999999999999999        


Q ss_pred             --CCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCch-hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          643 --RKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGA-YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       643 --~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                        +.||......... ...+..      ........+.+... ...+.+..+.+++.+||+.||++|||++||+++|+++
T Consensus       262 ~~~~p~~~~~~~~~~-~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPS-VEEMRK------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCCCTTTTTSCSSCC-HHHHHH------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCccccCcCccc-HHHHHH------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence              6777543221110 000000      00011122222222 1235677899999999999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=361.88  Aligned_cols=263  Identities=20%  Similarity=0.220  Sum_probs=205.3

Q ss_pred             CHHHHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEec
Q 004994          431 TIASLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCN  508 (720)
Q Consensus       431 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~  508 (720)
                      .+++.....++|...+.||+|+||+||+|+. .+|+.||||++.+.. ......+.+.+|.+++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            3445555668899999999999999999976 479999999996432 12223345889999999999999999999999


Q ss_pred             cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcc
Q 004994          509 EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSD  588 (720)
Q Consensus       509 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  588 (720)
                      +.+..|+||||+++|+|.+++...   ...+++.....++.+++.||+|||+.   +||||||||+|||++.++++||+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence            999999999999999999999532   24688999999999999999999997   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccCC--------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhh
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFES--------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVR  659 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~  659 (720)
                      ||+++.+..... .......||+.|+|||++.        +.|+.++|||||||++|||++|+.||.......... +..
T Consensus       206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  284 (412)
T 2vd5_A          206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH  284 (412)
T ss_dssp             CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            999987643322 1223457899999999873        358999999999999999999999997543221111 111


Q ss_pred             hcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCC---CCHHHHHHH
Q 004994          660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFR---PPMSEIVQD  715 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~evl~~  715 (720)
                      +.          ....-+.    .....+.++.+++.+||. +|++|   |+++|+++|
T Consensus       285 ~~----------~~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          285 YK----------EHLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HH----------HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             cc----------cCcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            00          0000011    011234678899999999 99998   699999865

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.2e-39  Score=337.49  Aligned_cols=255  Identities=21%  Similarity=0.314  Sum_probs=199.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCC----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPG----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      .++|...+.||+|+||+||+|...+    +..||+|.+.... .....+.+.+|++++++++||||+++++++.+. ..+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            3567788999999999999996532    3469999997543 234457899999999999999999999998754 568


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++++|.+++..   ....+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        89 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            99999999999999853   234688999999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ...... .......++..|+|||.. ...++.++||||||+++|||+| |+.||...........+.             
T Consensus       163 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-------------  228 (281)
T 3cc6_A          163 IEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-------------  228 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-------------
T ss_pred             cccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-------------
Confidence            643221 112234457789999988 5678999999999999999998 999996543222111110             


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .......    +...++.+.+++.+||+.||++|||+.|++++|+++
T Consensus       229 ~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          229 KGDRLPK----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             HTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            0000000    112235688999999999999999999999999876

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.7e-40  Score=348.83  Aligned_cols=245  Identities=22%  Similarity=0.327  Sum_probs=199.2

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc------ccHHHHHHHHHHHHccCCCceeEEEeEecc
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR------QTDEEFLELASTISRLRHGNIVELIGYCNE  509 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~  509 (720)
                      .+.++|...+.||+|+||+||+|.. .+++.||||++.......      ...+.+.+|++++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            3567899999999999999999964 679999999997543211      133457789999999999999999999999


Q ss_pred             CCeEEEEEeeCCCC-CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcc
Q 004994          510 HGQHLLVYDYGGNC-TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSD  588 (720)
Q Consensus       510 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  588 (720)
                      .+..++||||+.+| +|.+++..    ...+++..+..++.+++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEee
Confidence            99999999999777 99998853    34689999999999999999999997   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccCC-CCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFES-GSY-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH  666 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~-~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  666 (720)
                      ||+++......   ......++..|+|||.+. ..+ +.++|||||||++|||++|+.||......     .        
T Consensus       174 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~--------  237 (335)
T 3dls_A          174 FGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----V--------  237 (335)
T ss_dssp             CTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----T--------
T ss_pred             cccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----H--------
Confidence            99998764332   223356889999999884 344 78999999999999999999999642110     0        


Q ss_pred             chhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                           .....+      +...+.++.+++.+||+.||++|||++|++++
T Consensus       238 -----~~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 -----EAAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----TTCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----hhccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000000      00123568899999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.6e-40  Score=347.95  Aligned_cols=260  Identities=22%  Similarity=0.333  Sum_probs=201.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  512 (720)
                      .++|...+.||+|+||.||+|..      .+++.||||++.... ......++.+|+.++++++||||+++++++.+.+.
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            46788899999999999999973      357789999996432 23455678999999999999999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccch---hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---CCCeEE
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEE---AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIVRV  586 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl  586 (720)
                      .++||||+++++|.+++.....   ....+++..+..++.++++||.|||+.   +|+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999965321   124588999999999999999999997   9999999999999984   456999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                      +|||+++...............++..|+|||.. .+.++.++||||||+++|||+| |+.||.......   ......  
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~--  259 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVT--  259 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH--
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHHHh--
Confidence            999998765433322223345567899999988 6678999999999999999998 999997543211   111100  


Q ss_pred             cCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                              ....+.    .+...+..+.+++.+||+.||.+|||+.|++++|+.+
T Consensus       260 --------~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          260 --------SGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             --------TTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------cCCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                    000000    1112335788999999999999999999999999865

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-39  Score=341.71  Aligned_cols=259  Identities=19%  Similarity=0.223  Sum_probs=197.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            46788899999999999999975 47899999999754322 23347789999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999853    34689999999999999999999997   99999999999999999999999999997664


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      .... .......++..|+|||.. ...++.++||||||+++|||+||+.||.......   ...........        
T Consensus       186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~--------  253 (309)
T 2h34_A          186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MGAHINQAIPR--------  253 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HHHHHHSCCCC--------
T ss_pred             cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HHHHhccCCCC--------
Confidence            3221 122235678899999998 5578999999999999999999999997532110   00000000000        


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhC
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-PMSEIVQDLLCMI  720 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~  720 (720)
                          ........+.++.+++.+||+.||++|| +++++++.|++.+
T Consensus       254 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          254 ----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             ----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             ----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence                0011122335688999999999999999 9999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.7e-39  Score=364.74  Aligned_cols=254  Identities=22%  Similarity=0.267  Sum_probs=202.3

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc-----------ccHHHHHHHHHHHHccCCCceeEEEe
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR-----------QTDEEFLELASTISRLRHGNIVELIG  505 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-----------~~~~~~~~e~~~l~~l~H~niv~l~~  505 (720)
                      ..++|...+.||+|+||+||+|.. .+++.||||++.+.....           ...+.+.+|++++++++|||||++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            457899999999999999999965 468999999997543221           34578899999999999999999999


Q ss_pred             EeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC---
Q 004994          506 YCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL---  582 (720)
Q Consensus       506 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---  582 (720)
                      ++.+.+..++||||+++|+|.+++..    ...+++..+..++.+++.||+|||+.   +|+||||||+|||++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            99999999999999999999998853    35689999999999999999999997   999999999999998776   


Q ss_pred             CeEEccccCCCCCCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 004994          583 IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       583 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      .+||+|||+++......   ......+++.|+|||.+.+.++.++|||||||++|||++|+.||...........+... 
T Consensus       187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-  262 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG-  262 (504)
T ss_dssp             SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-
T ss_pred             cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-
Confidence            69999999998764322   22345689999999999888999999999999999999999999754322111111100 


Q ss_pred             cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                   ............+.++.+++.+||+.||.+|||++|++++
T Consensus       263 -------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          263 -------------KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             -------------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------------CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                         0001111112234678999999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=345.85  Aligned_cols=270  Identities=22%  Similarity=0.300  Sum_probs=194.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHH--HHccCCCceeEEEeEec-----cCCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELAST--ISRLRHGNIVELIGYCN-----EHGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~-----~~~~  512 (720)
                      ++|...+.||+|+||+||+|+. +++.||||++...     ....+..|.++  +..++||||+++++++.     ....
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            5788889999999999999976 6899999998633     23344445444  44589999999998543     2346


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCeEEcCCCCeEE
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC------EPPIVHGNFKSSNILLDEKLIVRV  586 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~------~~~ivHrDlkp~NiLl~~~~~~kl  586 (720)
                      .++||||+++|+|.+++..     ...++..+.+++.++++||+|||+.+      .++||||||||+|||++.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            7899999999999999953     34588899999999999999999863      338999999999999999999999


Q ss_pred             ccccCCCCCCCCCC------cccccCccccccCCCCccCCC--------CCCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 004994          587 SDCGLAPLLFSGST------NELSEGLLTAHGSGAPEFESG--------SYSCQSDVYSLGVVMLELLTGRKPYDRSRPR  652 (720)
Q Consensus       587 ~DFGla~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~--------~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~  652 (720)
                      +|||+++.+.....      ........++..|+|||.+.+        .++.++|||||||++|||+||..||......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999987643211      111223468899999998854        3567899999999999999998776443222


Q ss_pred             ccc-chhhhcccccCchhhhhhh-----cCCCCCch--hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          653 GEQ-SLVRWAIPRLHDIDALSRM-----VDPSLDGA--YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       653 ~~~-~~~~~~~~~~~~~~~~~~~-----~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ... .............+.....     ..+.+...  .....+.++.+++.+||+.||++|||++|+++.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            111 1110000011111111111     11111111  12235668999999999999999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-39  Score=364.86  Aligned_cols=256  Identities=23%  Similarity=0.310  Sum_probs=204.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...++||+|+||+||+|+. .+|+.||||++.+... .....+.+..|++++++++||||+++++++.+.+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            5678889999999999999976 4699999999975422 2244567899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++.........+++.....++.+++.||.|||+.   +||||||||+|||++.++++||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999875544455789999999999999999999997   999999999999999999999999999987644


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...  ......||+.|+|||.+ ...|+.++|||||||++|||+||+.||...........            ....+..
T Consensus       342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~------------~~~~i~~  407 (543)
T 3c4z_A          342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE------------LKQRVLE  407 (543)
T ss_dssp             TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH------------HHHHHHH
T ss_pred             CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH------------HHHHHhh
Confidence            322  22345789999999998 45699999999999999999999999976432111100            0011111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPM-----SEIVQ  714 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~  714 (720)
                      ...  .++...+.++.+++.+||+.||++||++     +|+++
T Consensus       408 ~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          408 QAV--TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ccc--CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            100  0112234678899999999999999975     66664

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.7e-39  Score=337.29  Aligned_cols=262  Identities=19%  Similarity=0.263  Sum_probs=198.9

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEe-ccCCeEE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC-NEHGQHL  514 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~  514 (720)
                      ...++|...+.||+|+||+||+|.. .+++.||||++.....    .+.+.+|+++++.++|++++..++++ .+.+..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            3457899999999999999999965 6799999998754322    23578899999999988877766655 6677889


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE---cCCCCeEEccccC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGL  591 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGl  591 (720)
                      +||||+ +++|.+++..   ....+++..+..++.+++.||+|||+.   +|+||||||+|||+   +.++.+||+|||+
T Consensus        82 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             EEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            999999 8999999853   234689999999999999999999997   99999999999999   7899999999999


Q ss_pred             CCCCCCCCCc-----ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          592 APLLFSGSTN-----ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       592 a~~~~~~~~~-----~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      ++........     .......++..|+|||.. ...++.++|||||||++|||++|+.||................   
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---  231 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---  231 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH---
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh---
Confidence            9876543221     122345688999999998 4578999999999999999999999997644322211111000   


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       .    .....+  ........+.++.+++.+||+.||++|||++|+++.|+++
T Consensus       232 -~----~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          232 -E----KKMSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -H----HHHHSC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -c----ccccch--hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence             0    000000  0001112246789999999999999999999999999886

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-39  Score=336.61  Aligned_cols=249  Identities=26%  Similarity=0.411  Sum_probs=194.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-CeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-GQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~  517 (720)
                      .++|...+.||+|+||+||+|.. .|+.||||++...    ...+.+.+|++++++++||||+++++++.+. +..++||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            35678889999999999999977 4889999999743    2456789999999999999999999997554 5789999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++...  ....+++..+..++.++++||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        95 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           95 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            999999999998642  223478899999999999999999997   999999999999999999999999999976532


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ..     ....++..|+|||.. ...++.++||||||+++|||+| |+.||........   ...          +....
T Consensus       170 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~----------~~~~~  231 (278)
T 1byg_A          170 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR----------VEKGY  231 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHH----------HTTTC
T ss_pred             cc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----------HhcCC
Confidence            21     123457789999998 5678999999999999999998 9999975432111   110          00000


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...    .+...+.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       232 ~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          232 KMD----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            111    1122346788999999999999999999999999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.4e-39  Score=341.22  Aligned_cols=264  Identities=19%  Similarity=0.249  Sum_probs=196.3

Q ss_pred             hcCCCC-CCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          439 TNSFSE-GNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       439 ~~~~~~-~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      .+.|.. .+.||+|+||+||+|.. .+++.||||++....  ....+.+.+|++++.++ +||||+++++++.+.+..++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            456766 47899999999999964 579999999997542  34567889999999885 79999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC---eEEccccCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI---VRVSDCGLA  592 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFGla  592 (720)
                      ||||+++|+|.+++..    ...+++.....++.|+++||+|||+.   +|+||||||+|||++.++.   +||+|||++
T Consensus        89 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             EEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            9999999999999853    35688999999999999999999997   9999999999999998776   999999999


Q ss_pred             CCCCCCCC-----cccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhc
Q 004994          593 PLLFSGST-----NELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA  661 (720)
Q Consensus       593 ~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~  661 (720)
                      +.......     ........++..|+|||.+.      ..++.++|||||||++|||+||+.||.........    |.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~~  237 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG----WD  237 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC----C-
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc----cc
Confidence            76532211     01112345789999999873      35889999999999999999999999764432210    10


Q ss_pred             ccccC---chhhhhhhcCC--CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          662 IPRLH---DIDALSRMVDP--SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       662 ~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .....   .......+...  ..........+.++.+++.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             ---CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00000   00001111111  11111112234678999999999999999999999975

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1e-39  Score=351.04  Aligned_cols=248  Identities=21%  Similarity=0.242  Sum_probs=188.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEeccccc-ccccHHHHHHHHHH-HHccCCCceeEEEeEeccCCeEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVS-QRQTDEEFLELAST-ISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ++|...+.||+|+||+||+|+.. +++.||||++.+... .....+.+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            56888899999999999999764 688999999975432 22333456666665 5778999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +|+||||||+|||++.++++||+|||+++...
T Consensus       118 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          118 LDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999853    34678888999999999999999997   99999999999999999999999999998643


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ...  .......||+.|+|||.+ ...++.++|||||||++|||++|+.||.........                ..+.
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~----------------~~i~  252 (373)
T 2r5t_A          191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY----------------DNIL  252 (373)
T ss_dssp             CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH----------------HHHH
T ss_pred             cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH----------------HHHH
Confidence            221  223446789999999998 456899999999999999999999999653321111                1111


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                      .....  ++...+.++.+++.+||+.||.+||++.+.++
T Consensus       253 ~~~~~--~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          253 NKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             HSCCC--CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred             hcccC--CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence            10000  01122356889999999999999999854333

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.2e-40  Score=345.93  Aligned_cols=255  Identities=20%  Similarity=0.296  Sum_probs=198.2

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC--CCceeEEEeEeccCCeEE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR--HGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~  514 (720)
                      ...++|...+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++  |+||+++++++.+.+..+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            345678889999999999999998888999999999765444455678999999999997  599999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||| +.+++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+|||+++ +.+||+|||+++.
T Consensus       105 lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             EEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccc
Confidence            9999 567899999853    34688999999999999999999997   9999999999999965 8999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccCCC------------CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFESG------------SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~~~------------~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      +.............++..|+|||...+            .++.++|||||||++|||++|+.||.......         
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---------  246 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---------  246 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---------
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---------
Confidence            754433323334568899999998743            68889999999999999999999996532111         


Q ss_pred             cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            ..+..++++......+...+.++.+++.+||+.||++|||++|++++
T Consensus       247 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          247 ------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                  11112222221111112223578899999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=348.17  Aligned_cols=263  Identities=18%  Similarity=0.189  Sum_probs=194.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC----CCcEEEEEEeccccccc---------ccHHHHHHHHHHHHccCCCceeEEEeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQR---------QTDEEFLELASTISRLRHGNIVELIGY  506 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~---------~~~~~~~~e~~~l~~l~H~niv~l~~~  506 (720)
                      ++|...+.||+|+||+||+|...    ++..||||++.......         ...+.+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            56888899999999999999764    57889999987542211         122357788899999999999999999


Q ss_pred             ecc----CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC
Q 004994          507 CNE----HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL  582 (720)
Q Consensus       507 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~  582 (720)
                      +..    ....++||||+ +++|.+++...    ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            877    67899999999 99999998532    3789999999999999999999997   999999999999999887


Q ss_pred             --CeEEccccCCCCCCCCCCc-----ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccc
Q 004994          583 --IVRVSDCGLAPLLFSGSTN-----ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE  654 (720)
Q Consensus       583 --~~kl~DFGla~~~~~~~~~-----~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~  654 (720)
                        .+||+|||+++.+......     .......++..|+|||.. ...++.++|||||||++|||+||+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876432211     111345688999999998 55689999999999999999999999954221111


Q ss_pred             c--chhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          655 Q--SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       655 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .  .........+..  .+.....       ....+.++.+++.+||+.||++|||+++|++.|+++
T Consensus       269 ~~~~~~~~~~~~~~~--~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          269 AVQTAKTNLLDELPQ--SVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHHTTTH--HHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHHhhcccccH--HHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            0  000000000000  0000000       002345789999999999999999999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=349.80  Aligned_cols=263  Identities=19%  Similarity=0.277  Sum_probs=195.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC------C
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH------G  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~  511 (720)
                      .+.|...+.||+|+||.||+|.. .+|+.||||++..........+.+.+|++++++++||||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            45788889999999999999965 5799999999976544455567889999999999999999999999765      3


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      ..++||||+ +++|.+++..     ..+++.....++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence            469999999 7799998853     4588899999999999999999997   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccC-C-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc------
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFE-S-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP------  663 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~------  663 (720)
                      ++.....     .....++.+|+|||.+ . ..++.++|||||||++|||++|+.||...........+.....      
T Consensus       175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9875322     2235678999999987 3 5799999999999999999999999976443221111100000      


Q ss_pred             --ccCchh--hhhhhcCCCCC---chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 --RLHDID--ALSRMVDPSLD---GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 --~~~~~~--~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        .+....  .....+.....   .......++.+.+|+.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence              000000  00000000000   01112234678899999999999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.9e-40  Score=347.98  Aligned_cols=252  Identities=23%  Similarity=0.299  Sum_probs=196.5

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      +.++|...+.||+|+||+||+|.. .+|+.||||++.+...      .+.+|++++.++ +||||+++++++.+.+..++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            556788899999999999999965 4689999999975432      234677888877 79999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC----CCeEEccccC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK----LIVRVSDCGL  591 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~DFGl  591 (720)
                      ||||+++|+|.+++..    ...+++.....++.+++.||+|||+.   +|+||||||+|||+.++    +.+||+|||+
T Consensus        94 v~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           94 VTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            9999999999998853    34689999999999999999999997   99999999999998543    3599999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhh
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      ++.......  ......++..|+|||.+. ..|+.++|||||||++|||++|+.||..........+.....        
T Consensus       167 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~--------  236 (342)
T 2qr7_A          167 AKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG--------  236 (342)
T ss_dssp             CEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH--------
T ss_pred             cccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc--------
Confidence            987643321  223356789999999984 458999999999999999999999997532211111111000        


Q ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       671 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       .  -.......+....+.++.+++.+||+.||++|||++|++++
T Consensus       237 -~--~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          237 -S--GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             -H--CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -c--CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0  00111111222344678899999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.5e-39  Score=357.82  Aligned_cols=201  Identities=21%  Similarity=0.287  Sum_probs=168.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-----Ce
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-----GQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  512 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++..........+.+.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46788899999999999999965 5689999999986555555667899999999999999999999999765     57


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .|+||||++ ++|.+++..    ...+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+|
T Consensus       105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999987 599998853    34689999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCc--------------------ccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCC
Q 004994          593 PLLFSGSTN--------------------ELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYD  647 (720)
Q Consensus       593 ~~~~~~~~~--------------------~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~  647 (720)
                      +........                    .......+|++|+|||.+  ...|+.++|||||||++|||++|..||.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            876432211                    112446689999999975  4569999999999999999999666553

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.1e-40  Score=366.46  Aligned_cols=255  Identities=23%  Similarity=0.313  Sum_probs=204.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...++||+|+||+||+|.. .+|+.||||++.+.. ........+.+|++++++++|||||++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            35688889999999999999966 479999999997542 2234456788999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++|+|.+++....  ...+++..+..++.+++.||+|||+.   +||||||||+|||++.++++||+|||+|+.+.
T Consensus       263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99999999999986432  34589999999999999999999997   99999999999999999999999999998764


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ....   .....||+.|+|||.+ ...|+.++|||||||++|||++|+.||...........+..         .+. ..
T Consensus       338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~---------~i~-~~  404 (576)
T 2acx_A          338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---------LVK-EV  404 (576)
T ss_dssp             TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH---------HHH-HC
T ss_pred             cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH---------Hhh-cc
Confidence            3321   2235789999999998 44689999999999999999999999976432211110100         000 00


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      ...    ++...+.++.+++.+||+.||++||     +++||++|
T Consensus       405 ~~~----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 PEE----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ccc----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            111    1122346788999999999999999     78998865

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-39  Score=339.30  Aligned_cols=257  Identities=24%  Similarity=0.359  Sum_probs=198.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEec-cCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN-EHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~  514 (720)
                      ..|...+.||+|+||+||+|...+    ...||+|.+.... .....+.+.+|++++++++||||+++++++. ..+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            356777899999999999997532    2368999987532 3345578999999999999999999999864 456889


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++|+|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence            999999999999999642   35678899999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCc--ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhh
Q 004994          595 LFSGSTN--ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       595 ~~~~~~~--~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      .......  .......++..|+|||.. ...++.++||||||+++|||++ |.+||.............           
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-----------  246 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-----------  246 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-----------
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-----------
Confidence            6433211  112234567789999988 5678999999999999999999 566665433221110000           


Q ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       671 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                        .......    +...+..+.+++.+||+.||++|||++|+++.|++++
T Consensus       247 --~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          247 --QGRRLLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             --TTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --cCCCCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              0000000    1112356889999999999999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=346.51  Aligned_cols=261  Identities=21%  Similarity=0.265  Sum_probs=200.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEec----cCCeE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN----EHGQH  513 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~----~~~~~  513 (720)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|++++++++||||+++++++.    .....
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            46788899999999999999965 67999999998643  2345678899999999999999999999986    34478


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++||||+++|+|.+++.........+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            999999999999999975433456789999999999999999999997   99999999999999999999999999987


Q ss_pred             CCCCCCCcc-------cccCccccccCCCCccCCCC----CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 004994          594 LLFSGSTNE-------LSEGLLTAHGSGAPEFESGS----YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       594 ~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~----~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      .........       ......++..|+|||.+.+.    ++.++|||||||++|||++|+.||........ .....  
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~--  259 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA--  259 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH--
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH--
Confidence            653211000       00123458899999998432    68899999999999999999999953111000 00000  


Q ss_pred             cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                              ........    .....+.++.+++.+||+.||.+|||++|++++|+.+
T Consensus       260 --------~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          260 --------VQNQLSIP----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             --------HHCC--CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             --------hhccCCCC----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence                    00000000    0112235788999999999999999999999999875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-39  Score=344.89  Aligned_cols=263  Identities=17%  Similarity=0.226  Sum_probs=206.1

Q ss_pred             CHHHHHHHhcCCCCC-CeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEe
Q 004994          431 TIASLQQYTNSFSEG-NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYC  507 (720)
Q Consensus       431 ~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~  507 (720)
                      -+.....+.+.|... +.||+|+||+||+|.. .+|+.||||++............+.+|+.+++++ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344455667777776 8899999999999965 4699999999986655556678899999999999 569999999999


Q ss_pred             ccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---CCCe
Q 004994          508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIV  584 (720)
Q Consensus       508 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~  584 (720)
                      .+.+..++||||+++|+|.+++...  ....+++..+..++.+++.||+|||+.   +|+||||||+|||++.   ++.+
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence            9999999999999999999988542  235689999999999999999999997   9999999999999998   7899


Q ss_pred             EEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 004994          585 RVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       585 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      ||+|||+++......   ......+++.|+|||.+ ...++.++|||||||++|||+||+.||...........+...  
T Consensus       174 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--  248 (327)
T 3lm5_A          174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--  248 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--
T ss_pred             EEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--
Confidence            999999998764322   12335688999999998 457899999999999999999999999754322111101000  


Q ss_pred             ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                  ............+..+.+++.+||+.||++|||++|++++
T Consensus       249 ------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          249 ------------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ------------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                        0001111112234678899999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.5e-39  Score=334.32  Aligned_cols=253  Identities=21%  Similarity=0.308  Sum_probs=200.5

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccc----cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQ----RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      .++|...+.||+|+||.||+|... +|+.||+|++......    ....+.+.+|++++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356788899999999999999765 6899999998754322    12467899999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC----CeEEccc
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL----IVRVSDC  589 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DF  589 (720)
                      ++||||+++++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+||+++.++    .+||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence            999999999999999853    35689999999999999999999997   999999999999998877    8999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      |++.......   ......++..|+|||.. .+.++.++||||||+++|||++|+.||...........+..        
T Consensus       157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------  225 (283)
T 3bhy_A          157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA--------  225 (283)
T ss_dssp             TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--------
T ss_pred             ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh--------
Confidence            9998664322   12234578899999988 45789999999999999999999999975432111100000        


Q ss_pred             hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            .............+..+.+++.+||+.||++|||+.|++++
T Consensus       226 ------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          226 ------VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             ------TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             ------cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence                  01111111222334678899999999999999999999974

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.7e-39  Score=346.27  Aligned_cols=264  Identities=17%  Similarity=0.223  Sum_probs=193.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC------
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG------  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------  511 (720)
                      .++|...+.||+|+||.||+|.. .+++.||||++..........+.+.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46788899999999999999964 57899999999765444455678899999999999999999999997654      


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      ..++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence            78999999985 7877774      3478889999999999999999997   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcc-------
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAI-------  662 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~-------  662 (720)
                      ++.....   .......++..|+|||.+ ...++.++|||||||++|||++|+.||.......... +.....       
T Consensus       174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9866322   122335678999999998 4568999999999999999999999997643221110 000000       


Q ss_pred             cccCch-------------hhhhhhcCCC---CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 PRLHDI-------------DALSRMVDPS---LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 ~~~~~~-------------~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+...             ..........   ...........++.+|+.+||+.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            000000             0000000000   0111223346789999999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.1e-40  Score=365.45  Aligned_cols=254  Identities=23%  Similarity=0.350  Sum_probs=205.8

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      +.++|...+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|++++++++|||||++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            346788889999999999999966 4799999999965432 24456789999999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE---cCCCCeEEccccCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLA  592 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla  592 (720)
                      ||||+.+|+|.+.+..    ...+++..+..++.+++.||.|||+.   +|+||||||+|||+   +.++.+||+|||++
T Consensus       104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            9999999999998854    34689999999999999999999997   99999999999999   56789999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +.+....   ......++++|+|||.+.+.|+.++|||||||++|||++|+.||...........+...           
T Consensus       177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-----------  242 (484)
T 3nyv_A          177 THFEASK---KMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-----------  242 (484)
T ss_dssp             HHBCCCC---SHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             EEccccc---ccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-----------
Confidence            8764332   12235688999999999888999999999999999999999999754322111111000           


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         ............++++.+++.+||+.||++|||++|+++|
T Consensus       243 ---~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          243 ---KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             ---CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence               0000111122344678899999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.3e-39  Score=336.63  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            356778899999999999999664 688999999875432 234457789999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            999999999998742    35689999999999999999999997   99999999999999999999999999998764


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ....  ......++..|+|||.. ...++.++||||||+++|||+||+.||..........                .+.
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----------------~~~  228 (294)
T 2rku_A          167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL----------------RIK  228 (294)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----------------HHH
T ss_pred             cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------HHh
Confidence            3221  22335678899999998 4468999999999999999999999997543211110                000


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .....  .+......+.+++.+||+.||++|||++|++++
T Consensus       229 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          229 KNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             TTCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hccCC--CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000  011223567899999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.7e-39  Score=335.56  Aligned_cols=261  Identities=20%  Similarity=0.260  Sum_probs=201.9

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEe-ccCCeEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC-NEHGQHLL  515 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~l  515 (720)
                      ..++|...+.||+|+||+||+|.. .+|+.||||++.....    .+.+.+|+++++.++|++++..++++ .+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            356788899999999999999965 6799999999864322    23688999999999998876666655 56778899


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE---cCCCCeEEccccCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLA  592 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla  592 (720)
                      ||||+ +++|.+++..   ....+++..+..++.++++||+|||+.   +|+||||||+|||+   ++++.+||+|||++
T Consensus        83 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            99999 8899999853   234689999999999999999999997   99999999999999   58899999999999


Q ss_pred             CCCCCCCCcc-----cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC
Q 004994          593 PLLFSGSTNE-----LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH  666 (720)
Q Consensus       593 ~~~~~~~~~~-----~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  666 (720)
                      +.........     ......++..|+|||.. ...++.++|||||||++|||+||+.||................    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----  231 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS----  231 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH----
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc----
Confidence            8765433211     12345688999999998 4578999999999999999999999997643322111111000    


Q ss_pred             chhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       667 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      . ..   ...+  ........++++.+++.+||+.||++|||++|+++.|+++
T Consensus       232 ~-~~---~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          232 E-KK---MSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             H-HH---HHSC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             c-cc---cCCc--hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            0 00   0000  0001112346788999999999999999999999999876

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.7e-39  Score=343.18  Aligned_cols=269  Identities=20%  Similarity=0.292  Sum_probs=200.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--------C
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--------H  510 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~  510 (720)
                      ++|...+.||+|+||+||+|.. .+|+.||||++............+.+|++++++++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5688889999999999999966 679999999997655444555678899999999999999999999876        4


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                      +..++||||+++ +|.+.+...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            568999999986 777776532   34589999999999999999999997   99999999999999999999999999


Q ss_pred             CCCCCCCCCC--cccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc-
Q 004994          591 LAPLLFSGST--NELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL-  665 (720)
Q Consensus       591 la~~~~~~~~--~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~-  665 (720)
                      +++.+.....  ........++.+|+|||.+.  ..++.++|||||||++|||+||+.||...........+....... 
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9987643221  11223456789999999874  358999999999999999999999997644322111111100000 


Q ss_pred             ----Cchh---hhhhhcCCCC-CchhhHH-----HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          666 ----HDID---ALSRMVDPSL-DGAYLAK-----SLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       666 ----~~~~---~~~~~~~~~~-~~~~~~~-----~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                          ....   ....+..... .......     ..+.+.+|+.+||+.||++|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence                0000   0000000000 0000000     13568899999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.1e-39  Score=343.47  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=202.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||.||++.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            35688889999999999999966 4688999999875432 234557789999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            999999999998743    35689999999999999999999997   99999999999999999999999999998764


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ....  ......++..|+|||.+ ...++.++|||||||++|||++|+.||...........+..              .
T Consensus       193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------------~  256 (335)
T 2owb_A          193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--------------N  256 (335)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------------T
T ss_pred             cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc--------------C
Confidence            3221  22345678899999998 55689999999999999999999999975332111100000              0


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...+.    .....++.+++.+||+.||++|||++|++++
T Consensus       257 ~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 EYSIP----KHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCCCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00111    1123567899999999999999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.1e-39  Score=345.06  Aligned_cols=260  Identities=24%  Similarity=0.332  Sum_probs=205.6

Q ss_pred             HHHHHHHhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccc------cccHHHHHHHHHHHHcc-CCCceeEE
Q 004994          432 IASLQQYTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQ------RQTDEEFLELASTISRL-RHGNIVEL  503 (720)
Q Consensus       432 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~~~e~~~l~~l-~H~niv~l  503 (720)
                      ......+.++|...+.||+|+||.||+|... +|+.||||++......      ....+.+.+|+++++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444566788999999999999999999764 7999999998754321      11245688999999999 89999999


Q ss_pred             EeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC
Q 004994          504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI  583 (720)
Q Consensus       504 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  583 (720)
                      ++++...+..++||||+++++|.+++..    ...+++..+..++.+++.||.|||+.   +|+||||||+|||++.++.
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence            9999999999999999999999999852    35689999999999999999999997   9999999999999999999


Q ss_pred             eEEccccCCCCCCCCCCcccccCccccccCCCCccCC-------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc
Q 004994          584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES-------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS  656 (720)
Q Consensus       584 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~  656 (720)
                      +||+|||++..+....   ......+++.|+|||++.       ..++.++|||||||++|||+||+.||..........
T Consensus       239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  315 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR  315 (365)
T ss_dssp             EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999998764332   223456889999999862       247889999999999999999999996532211100


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+..            .  ............+..+.+++.+||+.||++|||++|++++
T Consensus       316 ~i~~------------~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          316 MIME------------G--QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHH------------T--CCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHh------------C--CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0000            0  0000000111223568899999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-39  Score=350.42  Aligned_cols=266  Identities=20%  Similarity=0.338  Sum_probs=201.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|...+.||+|+||+||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            356888899999999999999664 78999999997543 2344578899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++..    ...+++.....++.+++.||+|||+.+  +|+||||||+|||++.++.+||+|||+++....
T Consensus       111 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          111 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             ECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999853    346889999999999999999999842  799999999999999999999999999865422


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc--------------
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI--------------  662 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~--------------  662 (720)
                      .    ......++..|+|||.. ...++.++|||||||++|||+||+.||................              
T Consensus       185 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          185 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             H----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             c----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence            1    22335678999999998 4568999999999999999999999997543221110000000              


Q ss_pred             ------------cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 ------------PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                  +.....+....+.............+.++.+|+.+||+.||++|||++|+++|
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                        00000000000000000000011234578899999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.2e-40  Score=358.23  Aligned_cols=245  Identities=14%  Similarity=0.185  Sum_probs=187.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHH---HHHHccCCCceeEEE-------eE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELA---STISRLRHGNIVELI-------GY  506 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~---~~l~~l~H~niv~l~-------~~  506 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.... ......+.+.+|+   +++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35677789999999999999975 579999999997432 2234557888999   556666899999998       55


Q ss_pred             eccCC-----------------eEEEEEeeCCCCCHHHHhhccch---hccccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 004994          507 CNEHG-----------------QHLLVYDYGGNCTLHDLLHSDEE---AHKKFSWNIRIRVALGAARALQYLQEVCEPPI  566 (720)
Q Consensus       507 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~i  566 (720)
                      +.+.+                 ..++||||+ +|+|.+++.....   ....+++..+..++.|+++||+|||+.   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            55443                 278999999 5799999964321   112355688889999999999999997   99


Q ss_pred             eecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CC-----------CCCCccchHhHHH
Q 004994          567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SG-----------SYSCQSDVYSLGV  634 (720)
Q Consensus       567 vHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~-----------~~~~~~Dv~S~Gv  634 (720)
                      |||||||+|||++.++.+||+|||+|+....     ......| ..|+|||.+ ..           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986422     1223456 899999998 33           5899999999999


Q ss_pred             HHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          635 VMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       635 vl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                      ++|||+||+.||..........   .             +... .     ...++++.+++.+||+.||++|||+.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~---~-------------~~~~-~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSE---W-------------IFRS-C-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCSG---G-------------GGSS-C-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccchh---h-------------hhhh-c-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999996543221111   0             0000 0     012356889999999999999999999986


Q ss_pred             H
Q 004994          715 D  715 (720)
Q Consensus       715 ~  715 (720)
                      +
T Consensus       360 h  360 (377)
T 3byv_A          360 T  360 (377)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-39  Score=352.77  Aligned_cols=264  Identities=22%  Similarity=0.304  Sum_probs=195.8

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc------
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE------  509 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------  509 (720)
                      ...++|...+.||+|+||+||+|.. .+|+.||||++.....      ...+|+++++.++|||||++++++..      
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            4567899999999999999999965 6799999999864421      22368999999999999999999843      


Q ss_pred             --------------------------------CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHH
Q 004994          510 --------------------------------HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY  557 (720)
Q Consensus       510 --------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~  557 (720)
                                                      ....++||||++ |+|.+.+.........+++..+..++.|+++||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            334889999999 48888876544445679999999999999999999


Q ss_pred             HHhcCCCCeeecCCCCCCeEEc-CCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccCCC--CCCCccchHhHHH
Q 004994          558 LQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGV  634 (720)
Q Consensus       558 LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gv  634 (720)
                      ||+.   +|+||||||+|||++ .++.+||+|||+|+.+....   ......++..|+|||.+.+  .++.++|||||||
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            9987   999999999999998 68899999999998764332   2233567889999998733  5899999999999


Q ss_pred             HHHHHHhCCCCCCCCCCccccc-hhhhcccccCchhhhhhh-------cCCCCC-----chhhHHHHHHHHHHHHHHhcc
Q 004994          635 VMLELLTGRKPYDRSRPRGEQS-LVRWAIPRLHDIDALSRM-------VDPSLD-----GAYLAKSLSRFADIISRCVQW  701 (720)
Q Consensus       635 vl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-------~~~~~~-----~~~~~~~~~~l~~l~~~cl~~  701 (720)
                      ++|||++|+.||......+... ++....  ....+....+       .-+...     ...+...+.++.+|+.+||+.
T Consensus       231 il~ell~g~~pf~~~~~~~~~~~i~~~~g--~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQLVRIIQIMG--TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHC--CCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhC--CCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            9999999999997644322111 111000  0000000000       000000     011222346788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 004994          702 EPGFRPPMSEIVQD  715 (720)
Q Consensus       702 dP~~RPt~~evl~~  715 (720)
                      ||++|||+.|+++|
T Consensus       309 dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          309 EPDLRINPYEAMAH  322 (383)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=346.45  Aligned_cols=254  Identities=19%  Similarity=0.283  Sum_probs=183.8

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEe--------c
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYC--------N  508 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~--------~  508 (720)
                      ..+|...+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++++. ||||+++++++        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            45788889999999999999975 57899999998543  2344567899999999996 99999999998        3


Q ss_pred             cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEEcCCCCeEE
Q 004994          509 EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPP--IVHGNFKSSNILLDEKLIVRV  586 (720)
Q Consensus       509 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~--ivHrDlkp~NiLl~~~~~~kl  586 (720)
                      .....++||||+. |+|.+++.... ....+++..+..++.+++.||+|||+.   +  |+||||||+|||++.++.+||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence            3456899999996 69998886422 234689999999999999999999987   6  999999999999999999999


Q ss_pred             ccccCCCCCCCCCCcc----------cccCccccccCCCCccC----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCc
Q 004994          587 SDCGLAPLLFSGSTNE----------LSEGLLTAHGSGAPEFE----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR  652 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~----------~~~~~~~~~~~~aPE~~----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~  652 (720)
                      +|||+++.........          ......++..|+|||.+    ...++.++|||||||++|||+||+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998765432211          11134578899999987    335788999999999999999999999653221


Q ss_pred             cccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      .   .....             .....    .......+.+++.+||+.||++|||++|++++|+++
T Consensus       260 ~---~~~~~-------------~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          260 R---IVNGK-------------YSIPP----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             ----------------------CCCCT----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             H---hhcCc-------------ccCCc----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1   00000             00000    001113467999999999999999999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.7e-39  Score=333.06  Aligned_cols=247  Identities=22%  Similarity=0.352  Sum_probs=200.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||.||+|... +++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56788899999999999999664 688999999864321 2234567899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++..    ...+++.....++.++++||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999853    34688999999999999999999987   999999999999999999999999999876532


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..    .....++..|+|||.. ...++.++||||||+++|||++|+.||.........                ..+..
T Consensus       167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------------~~~~~  226 (284)
T 2vgo_A          167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH----------------RRIVN  226 (284)
T ss_dssp             SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HHHHT
T ss_pred             cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH----------------HHHhc
Confidence            21    2335678899999998 456899999999999999999999999753321110                01111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...  ..+...+.++.+++.+||+.||.+|||++|++++
T Consensus       227 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          227 VDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             TCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ccc--CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            000  0111223568899999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.6e-39  Score=335.27  Aligned_cols=246  Identities=21%  Similarity=0.316  Sum_probs=199.4

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc-------
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-------  509 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-------  509 (720)
                      +.++|...+.||+|+||.||+|... +|+.||+|++....      +.+.+|++++++++||||+++++++..       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            4567888999999999999999764 79999999996432      356789999999999999999998854       


Q ss_pred             ---------CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC
Q 004994          510 ---------HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE  580 (720)
Q Consensus       510 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~  580 (720)
                               ....++||||+++++|.+++...  ....+++..+..++.++++||.|||+.   +|+||||||+|||++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                     34589999999999999999642  235689999999999999999999997   9999999999999999


Q ss_pred             CCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh
Q 004994          581 KLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR  659 (720)
Q Consensus       581 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  659 (720)
                      ++.+||+|||+++.......   .....++..|+|||.. ...++.++||||||+++|||++|..|+....     .   
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~---  226 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----K---  226 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----H---
T ss_pred             CCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----H---
Confidence            99999999999987644321   2234578899999998 5678999999999999999999998874210     0   


Q ss_pred             hcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                                ............    ..+..+.+++.+||+.||++|||+.|++++|+.+
T Consensus       227 ----------~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          227 ----------FFTDLRDGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             ----------HHHHHHTTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------HHHHhhcccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                      000111111111    1224678999999999999999999999999865

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-38  Score=329.41  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=193.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||.||+|... +|+.||||++.... ......+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            357888899999999999999765 79999999986432 1234456889999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            999999999999853    34688999999999999999999998   99999999999999999999999999998764


Q ss_pred             CCCCcccccCccccccCCCCccCCCC-C-CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFESGS-Y-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~-~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ...   ......++..|+|||...+. + +.++||||||+++|||++|+.||...........+.             .-
T Consensus       163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------------~~  226 (276)
T 2h6d_A          163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR-------------GG  226 (276)
T ss_dssp             C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------------HC
T ss_pred             CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh-------------cC
Confidence            322   12234578899999998543 3 689999999999999999999996532211100000             00


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       ....    +...+.++.+++.+||+.||++|||++|++++
T Consensus       227 -~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          227 -VFYI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -cccC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             0001    11123568899999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-39  Score=344.46  Aligned_cols=269  Identities=21%  Similarity=0.306  Sum_probs=195.6

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc---ccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR---QTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ..++|...+.||+|+||.||+|.. .+|+.||||++.......   ...+.+.+|++++++++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            456899999999999999999976 468999999997432211   1224688999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++||||+++ +|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999996 888887532   34678888999999999999999997   89999999999999999999999999998


Q ss_pred             CCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhh-cccc---cC
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRW-AIPR---LH  666 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~-~~~~---~~  666 (720)
                      .+....  .......++..|+|||.+.  ..++.++|||||||++|||++|..||.......... +... ..+.   ..
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            764322  1223456789999999873  348999999999999999999999997643221111 0000 0000   00


Q ss_pred             chhhhhhhcCC-CCCc----hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 DIDALSRMVDP-SLDG----AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 ~~~~~~~~~~~-~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +.....+.+.. ....    ......+.++.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00000000000 0000    0112234678999999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.9e-39  Score=347.48  Aligned_cols=276  Identities=21%  Similarity=0.250  Sum_probs=201.0

Q ss_pred             cCHHHHHHHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccc---------cccHHHHHHHHHHHHccCCCce
Q 004994          430 FTIASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQ---------RQTDEEFLELASTISRLRHGNI  500 (720)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------~~~~~~~~~e~~~l~~l~H~ni  500 (720)
                      ...+++..+.++|...+.||+|+||.||+|...+|+.||||++......         ....+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            3467788899999999999999999999998888999999998653221         1123789999999999999999


Q ss_pred             eEEEeEec-----cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 004994          501 VELIGYCN-----EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSN  575 (720)
Q Consensus       501 v~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~N  575 (720)
                      +++++++.     .....++||||++ |+|.+.+...   ...+++..+..++.+++.||.|||+.   +|+||||||+|
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  164 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN  164 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence            99999983     3447899999998 5888887632   34689999999999999999999997   99999999999


Q ss_pred             eEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 004994          576 ILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRG  653 (720)
Q Consensus       576 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~  653 (720)
                      ||++.++.+||+|||+++......   ......++..|+|||...  ..++.++|||||||++|||++|+.||.......
T Consensus       165 Il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  241 (362)
T 3pg1_A          165 ILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN  241 (362)
T ss_dssp             EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999997543222   223356788999999873  568999999999999999999999997643222


Q ss_pred             ccc-hhhhcc-cccCc-----hhhhhhhcCCCC---C----chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          654 EQS-LVRWAI-PRLHD-----IDALSRMVDPSL---D----GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       654 ~~~-~~~~~~-~~~~~-----~~~~~~~~~~~~---~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ... +..... +...+     .......+....   .    ........+.+.+++.+||+.||++|||++|++++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            111 111000 00000     000000110000   0    01111234678899999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.3e-39  Score=339.09  Aligned_cols=254  Identities=20%  Similarity=0.264  Sum_probs=194.9

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc------ccccHHHHHHHHHHHHccCCCceeEEEeEeccC
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS------QRQTDEEFLELASTISRLRHGNIVELIGYCNEH  510 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~  510 (720)
                      ..++|...+.||+|+||.||+|.. .+++.||||++.....      .......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            456788899999999999999965 5689999999875321      112234588999999999999999999999766


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC---eEEc
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI---VRVS  587 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~  587 (720)
                      + .++||||+++++|.+++..    ...+++.....++.++++||.|||+.   +|+||||||+|||++.++.   +||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence            5 8999999999999998853    35688999999999999999999987   9999999999999987654   9999


Q ss_pred             cccCCCCCCCCCCcccccCccccccCCCCccC----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 004994          588 DCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       588 DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      |||+++.....   .......++..|+|||.+    ...++.++|||||||++|||++|+.||........  +...   
T Consensus       160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~---  231 (322)
T 2ycf_A          160 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ---  231 (322)
T ss_dssp             CCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHH---
T ss_pred             cCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHH---
Confidence            99999876322   112234578999999985    45689999999999999999999999975432211  0000   


Q ss_pred             ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                             +... ............+.++.+++.+||+.||++|||++|++++
T Consensus       232 -------~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          232 -------ITSG-KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             -------HHHT-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------HHhC-ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence                   0000 0000111112234678899999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=333.06  Aligned_cols=254  Identities=21%  Similarity=0.304  Sum_probs=197.2

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc--cccHHHHHHHHHHHHccCCCceeEEEeEe--ccCCe
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ--RQTDEEFLELASTISRLRHGNIVELIGYC--NEHGQ  512 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~--~~~~~  512 (720)
                      ..++|...+.||+|+||.||+|.. .+++.||+|++......  ....+.+.+|++++++++||||+++++++  .+.+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            357899999999999999999976 56899999999754221  23457899999999999999999999998  44568


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||++++ |.+++...  ....+++..+..++.++++||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccc
Confidence            89999999986 77766532  235688999999999999999999997   9999999999999999999999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCCC-C--CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFESG-S--YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~--~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      ................++..|+|||...+ .  ++.++||||||+++|||++|+.||...........+           
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-----------  225 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI-----------  225 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-----------
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH-----------
Confidence            87654333333334568899999998844 2  477999999999999999999999753221110000           


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ... .....    ...+..+.+++.+||+.||++|||++|++++
T Consensus       226 --~~~-~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          226 --GKG-SYAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             --HHC-CCCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --hcC-CCCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              000 00111    1223568899999999999999999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.2e-40  Score=346.20  Aligned_cols=266  Identities=20%  Similarity=0.286  Sum_probs=192.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||+||+|... +++.||||++..... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            46778899999999999999764 789999999964322 1111245578999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |++ |+|.+++...   ...+++..+..++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           81 YLD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             CCS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             ccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            998 4888888532   34688999999999999999999987   9999999999999999999999999999765322


Q ss_pred             CCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc--------cccCch
Q 004994          599 STNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI--------PRLHDI  668 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~~  668 (720)
                      .  .......++.+|+|||.+.  ..++.++|||||||++|||+||+.||...........+....        +.....
T Consensus       154 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          154 T--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             c--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            1  1223346788999999873  468999999999999999999999997644322111111000        000000


Q ss_pred             hhhhhhcCCCCCc----hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDG----AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ........+....    ........++.+|+.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0011111111000    0111234578899999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.3e-39  Score=334.97  Aligned_cols=257  Identities=22%  Similarity=0.324  Sum_probs=193.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC--CCc--EEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP--GGK--LLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ++|...+.||+|+||+||+|.+.  +++  .||||++..... .....+.+.+|++++++++||||+++++++.+.. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            56888899999999999999753  333  689999875432 2345578999999999999999999999998765 88


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++++|.+++...   ...+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        97 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence            999999999999998632   35688999999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCcc-cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          595 LFSGSTNE-LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       595 ~~~~~~~~-~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ........ ......++..|+|||.. ...++.++||||||+++|||++ |+.||........   ..            
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~------------  235 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LH------------  235 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH------------
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---HH------------
Confidence            64432211 22234567789999998 5568999999999999999999 9999975432111   11            


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       .+.............+.++.+++.+||+.||++|||+.++++.|+++
T Consensus       236 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          236 -KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             -HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence             00000000001112346788999999999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.8e-38  Score=351.94  Aligned_cols=260  Identities=20%  Similarity=0.216  Sum_probs=202.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCC-CceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH-GNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||+||+|.. .+++.||||++.....    ..++..|+++++.++| ++|..+..++.+.+..++|
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            46899999999999999999965 6799999998764322    2357889999999977 5666677777788899999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE---cCCCCeEEccccCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAP  593 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~  593 (720)
                      |||+ +++|.+++...   ...+++..+..|+.|++.||.|||+.   +||||||||+|||+   +.++.+||+|||+++
T Consensus        82 me~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            9999 88999999632   35689999999999999999999997   99999999999999   688999999999998


Q ss_pred             CCCCCCCcc-----cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc
Q 004994          594 LLFSGSTNE-----LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       594 ~~~~~~~~~-----~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      .+.......     ......++..|+|||.+ ...++.++|||||||++|||++|+.||................    .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~----~  230 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS----E  230 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH----H
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh----h
Confidence            775433221     12256789999999998 5578999999999999999999999997644322211111000    0


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                           ..+.. .........+.++.+++.+||+.||++||++++|++.|+++
T Consensus       231 -----~~~~~-~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          231 -----KKVAT-SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             -----HHHHS-CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             -----ccccc-cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                 00000 00011122346789999999999999999999999999876

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.7e-39  Score=334.77  Aligned_cols=251  Identities=21%  Similarity=0.298  Sum_probs=198.5

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ..++|...+.||+|+||+||+|.. .+|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            346788889999999999999966 479999999997532  22345788999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE---cCCCCeEEccccCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL---DEKLIVRVSDCGLAP  593 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~  593 (720)
                      |||+++++|.+++..    ...+++.....++.+++.||.|||+.   +|+||||||+||++   +.++.+||+|||+++
T Consensus        85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           85 MQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             ECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            999999999998853    34688999999999999999999997   99999999999999   788999999999997


Q ss_pred             CCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      .....    ......++..|+|||.. ...++.++|||||||++|||++|+.||...........+..            
T Consensus       158 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~------------  221 (304)
T 2jam_A          158 MEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE------------  221 (304)
T ss_dssp             CCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------
T ss_pred             ecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc------------
Confidence            65321    12234578899999998 55689999999999999999999999965432111000000            


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...  ..........+.++.+++.+||+.||++|||++|++++
T Consensus       222 ~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          222 GYY--EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CCC--CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCC--CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000  00011112234678899999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.8e-39  Score=369.36  Aligned_cols=250  Identities=20%  Similarity=0.247  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      .++|...++||+|+||+||+|.. .+++.||||++++.. ......+.+..|.+++..+ +||||+.+++++.+.+..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46788899999999999999965 568999999997542 2233456788899999887 79999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++|+|.+++..    ...+++..+..++.+++.||+|||+.   +||||||||+|||++.++++||+|||+|+..
T Consensus       420 V~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999853    34689999999999999999999997   9999999999999999999999999999864


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ....  .......||+.|+|||++ ...|+.++|||||||++|||++|+.||...+....                ...+
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~----------------~~~i  554 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----------------FQSI  554 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHH
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH----------------HHHH
Confidence            3222  223456789999999998 56799999999999999999999999975432211                1111


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPM-----SEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  715 (720)
                      .....  .++...+.++.+|+.+||+.||++||++     +||++|
T Consensus       555 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          555 MEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             HSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             HhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            11111  1122234678899999999999999998     777653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.3e-39  Score=338.92  Aligned_cols=258  Identities=16%  Similarity=0.244  Sum_probs=196.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEecc--CCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNE--HGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~l  515 (720)
                      ++|+..+.||+|+||+||+|.. .+++.||||++..     ...+.+.+|++++++++ ||||+++++++.+  ....++
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            5788889999999999999964 6799999999863     23467899999999997 9999999999987  667899


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-CeEEccccCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPL  594 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~  594 (720)
                      ||||+++++|.+++.       .+++..+..++.++++||+|||+.   +|+||||||+|||++.++ .+||+|||+++.
T Consensus       111 v~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            999999999998873       378888999999999999999987   999999999999999776 899999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc--chhhhcc--------
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ--SLVRWAI--------  662 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~--~~~~~~~--------  662 (720)
                      ......   .....++..|+|||...  ..++.++|||||||++|||++|+.||.........  .+.....        
T Consensus       181 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          181 YHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             CCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             cCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence            643322   23356788999999873  46899999999999999999999999543321110  0000000        


Q ss_pred             --cccCchhhhhhhcCCC--------CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 --PRLHDIDALSRMVDPS--------LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 --~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ................        .........+.++.+|+.+||+.||++|||++|+++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              0000000000000000        0011112235678999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.6e-39  Score=350.79  Aligned_cols=255  Identities=15%  Similarity=0.080  Sum_probs=178.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHcc--CCCceeEEE-------eEec
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRL--RHGNIVELI-------GYCN  508 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l--~H~niv~l~-------~~~~  508 (720)
                      ..|...+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|+++++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            3477789999999999999975 5799999999986533 234456677775444444  699988865       3332


Q ss_pred             cC-----------------CeEEEEEeeCCCCCHHHHhhccchhccccCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 004994          509 EH-----------------GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIR------IRVALGAARALQYLQEVCEPP  565 (720)
Q Consensus       509 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~------~~i~~~ia~~L~~LH~~~~~~  565 (720)
                      ..                 ...++||||++ |+|.+++...   ...+.+..+      ..++.|+++||+|||+.   +
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            22                 34799999999 8999999643   223455556      78889999999999987   9


Q ss_pred             eeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccCC---CCCCCccchHhHHHHHHHHHhC
Q 004994          566 IVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES---GSYSCQSDVYSLGVVMLELLTG  642 (720)
Q Consensus       566 ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~Dv~S~Gvvl~elltG  642 (720)
                      ||||||||+|||++.++.+||+|||+|+.....     .....++..|+|||.+.   ..++.++|||||||++|||+||
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999865321     11244568999999984   3689999999999999999999


Q ss_pred             CCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          643 RKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       643 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +.||....+.........   ....      ..............+..+.+++.+||+.||++|||+.|++++
T Consensus       290 ~~Pf~~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWKRP---SLRV------PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             SCSTTBCCTTCTTCCCBC---CTTS------CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCCCcCcccccchhhh---hhhh------ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            999976543221111000   0000      000000000111234678899999999999999999999753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-39  Score=348.00  Aligned_cols=255  Identities=25%  Similarity=0.308  Sum_probs=199.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEe----CCCcEEEEEEeccccc--ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL----PGGKLLAVKKLSNTVS--QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~  512 (720)
                      ++|...+.||+|+||+||+|+.    .+|+.||||++++...  .....+.+.+|+++++++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5688889999999999999976    4789999999975321  123345677899999999 69999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||+++|+|.+++..    ...+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999853    34688999999999999999999987   8999999999999999999999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCCC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFESG---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      +.+..... .......++..|+|||.+.+   .++.++|||||||++|||+||+.||...........+..         
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------  276 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------  276 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---------
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH---------
Confidence            86533221 12234568999999999853   478999999999999999999999975432221110000         


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQDL  716 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~L  716 (720)
                      .... ..+.    ++...+..+.+++.+||+.||.+||     |++|++++.
T Consensus       277 ~~~~-~~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          277 RILK-SEPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHH-CCCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHhc-cCCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            0000 0111    1122335678999999999999999     999998764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8e-39  Score=335.22  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .+.|...+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            34677889999999999999965 5789999999975432 344678999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++..     ..+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus       100 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             ECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            99999999999853     4688999999999999999999997   999999999999999999999999999977643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..  .......++..|+|||.. ...++.++||||||+++|||++|+.||...........             +.....
T Consensus       172 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~  236 (303)
T 3a7i_A          172 TQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-------------IPKNNP  236 (303)
T ss_dssp             TB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHHSCC
T ss_pred             cc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------------hhcCCC
Confidence            22  122345678899999998 55689999999999999999999999975332111100             000111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL  716 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  716 (720)
                      +....    ..+..+.+++.+||+.||++|||++|++++.
T Consensus       237 ~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          237 PTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             CCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            11111    1235688999999999999999999998753

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=344.13  Aligned_cols=258  Identities=21%  Similarity=0.281  Sum_probs=198.6

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ...++|...+.||+|+||.||+|...+  .||+|++..........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345788899999999999999998754  499999975543344445678899999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++ ++.+||+|||+++...
T Consensus       108 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             CBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             eecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            9999999999999642   34688999999999999999999997   999999999999998 6799999999987653


Q ss_pred             CCCC---cccccCccccccCCCCccCCC----------CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccc
Q 004994          597 SGST---NELSEGLLTAHGSGAPEFESG----------SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP  663 (720)
Q Consensus       597 ~~~~---~~~~~~~~~~~~~~aPE~~~~----------~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~  663 (720)
                      ....   ........++..|+|||...+          .++.++|||||||++|||+||+.||...........+     
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-----  255 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-----  255 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH-----
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-----
Confidence            2111   112223457889999998742          4788999999999999999999999754321110000     


Q ss_pred             ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                              .....+....   ...+.++.+++.+||+.||++|||++|+++.|+++
T Consensus       256 --------~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l  300 (319)
T 2y4i_B          256 --------GTGMKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL  300 (319)
T ss_dssp             --------HTTCCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred             --------ccCCCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                    0001111110   01224578999999999999999999999999876

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.8e-38  Score=348.65  Aligned_cols=198  Identities=22%  Similarity=0.294  Sum_probs=168.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc------CCCceeEEEeEeccCC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL------RHGNIVELIGYCNEHG  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~~~~~~~~  511 (720)
                      ..+|...+.||+|+||+||+|.. .+++.||||++...   ....+++.+|+++++.+      +|+||+++++++...+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            45688889999999999999955 56899999999753   23445677888888777      5679999999999999


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC--eEEccc
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI--VRVSDC  589 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~DF  589 (720)
                      ..++||||++ ++|.+++...  ....+++..+..++.++++||+|||+.   +||||||||+|||++.++.  +||+||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             eEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence            9999999997 5899888643  234589999999999999999999998   9999999999999999987  999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSR  650 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~  650 (720)
                      |+|+.....     .....+++.|+|||.+ ...++.++|||||||++|||+||+.||....
T Consensus       247 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          247 GSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999765322     2235678999999998 5579999999999999999999999997654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=342.12  Aligned_cols=268  Identities=21%  Similarity=0.291  Sum_probs=202.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-----CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC--e
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-----PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG--Q  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~  512 (720)
                      ++|...+.||+|+||.||+|..     .+|+.||||++...  .....+.+.+|++++++++||||+++++++...+  .
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            4577789999999999999973     46899999999753  2344578999999999999999999999987644  7


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||+++++|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence            89999999999999999642   34589999999999999999999997   9999999999999999999999999999


Q ss_pred             CCCCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc---
Q 004994          593 PLLFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD---  667 (720)
Q Consensus       593 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---  667 (720)
                      +........ .......++..|+|||.. ...++.++||||||+++|||+||+.||.....    ...+........   
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMI  268 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhh
Confidence            876443221 112234456779999988 55689999999999999999999999853210    000000000000   


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...+.+.+........+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0001111111100111223446789999999999999999999999999876

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.2e-38  Score=331.12  Aligned_cols=255  Identities=21%  Similarity=0.322  Sum_probs=205.0

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      .+.++|...+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34578899999999999999999764 78999999997655445567789999999999999999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC---CCeEEccccCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK---LIVRVSDCGLA  592 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGla  592 (720)
                      ||||+++++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+||+++.+   +.+||+|||++
T Consensus        99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999988853    34688999999999999999999997   99999999999999754   47999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      .......   ......++..|+|||...+.++.++||||||+++|||++|+.||...........+..            
T Consensus       172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------  236 (287)
T 2wei_A          172 TCFQQNT---KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------  236 (287)
T ss_dssp             GTBCCCS---SCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------
T ss_pred             eeecCCC---ccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------------
Confidence            8664322   1223457889999999988899999999999999999999999975432111100000            


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....  .........+.++.+++.+||+.||++|||++|++++
T Consensus       237 ~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          237 GKYA--FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCCC--CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCCC--CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            0000  0000111234678899999999999999999999974

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-39  Score=347.52  Aligned_cols=262  Identities=19%  Similarity=0.282  Sum_probs=184.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC------C
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH------G  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~  511 (720)
                      .++|...+.||+|+||.||+|. ..+|+.||||++..........+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            4678889999999999999996 46799999999976544445567889999999999999999999998653      5


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                      ..++|+||+ +++|.+++..     ..+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            689999998 5789888753     4688999999999999999999997   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc-------
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-------  662 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-------  662 (720)
                      ++.....     .....++.+|+|||.+.  ..++.++|||||||++|||++|+.||...........+....       
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9865322     22356789999999874  468999999999999999999999997644322111110000       


Q ss_pred             -cccCchhhhhhh---cCCCCCc---hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 -PRLHDIDALSRM---VDPSLDG---AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 -~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       ..+... ....+   +......   .......+.+.+|+.+||+.||++|||++|++++
T Consensus       254 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          254 LKKISSE-SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HTTCCCH-HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhhhH-HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence             000000 00000   0000000   0011224578899999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=332.73  Aligned_cols=252  Identities=21%  Similarity=0.303  Sum_probs=195.2

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      +|....+||+|+||.||+|.. .+++.||||.+....  ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            455556999999999999965 578999999987542  34457899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-CCCeEEccccCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~  598 (720)
                      +++++|.+++.... ....+++..+..++.++++||.|||+.   +|+||||||+||+++. ++.+||+|||+++.....
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          101 VPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             CCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            99999999986431 223567888899999999999999997   9999999999999987 899999999999876432


Q ss_pred             CCcccccCccccccCCCCccCCC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          599 STNELSEGLLTAHGSGAPEFESG---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      .  .......++..|+|||...+   .++.++||||||+++|||+||+.||......... ...          ......
T Consensus       177 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~----------~~~~~~  243 (295)
T 2clq_A          177 N--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK----------VGMFKV  243 (295)
T ss_dssp             ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH----------HHHHCC
T ss_pred             C--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh----------hccccc
Confidence            1  12234567889999998832   3889999999999999999999999642211100 000          000001


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+.+.    ...+.++.+++.+||+.||++|||++|++++
T Consensus       244 ~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          244 HPEIP----ESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCCCC----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ccccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11111    1234578899999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.5e-39  Score=337.67  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=184.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|...+.||+|+||.||+|.. .+++.||||++..... ....+++.+|++++++++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            46788899999999999999965 4789999999864422 234567889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccc----hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          518 DYGGNCTLHDLLHSDE----EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~----~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ||+++++|.+++....    .....+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            9999999999986321    1234589999999999999999999997   99999999999999999999999999987


Q ss_pred             CCCCCCC---cccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh-hhcccccCc
Q 004994          594 LLFSGST---NELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWAIPRLHD  667 (720)
Q Consensus       594 ~~~~~~~---~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~  667 (720)
                      .......   ........++..|+|||...  ..++.++|||||||++|||+||+.||............ ....+....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  249 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET  249 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence            6543221   11223356788999999883  46899999999999999999999999764332111000 000000000


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                           ...++...    ...+.++.+++.+||+.||++|||++|++++
T Consensus       250 -----~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          250 -----GVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             ----------CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -----ccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                 00011111    1223568899999999999999999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=341.55  Aligned_cols=257  Identities=24%  Similarity=0.377  Sum_probs=196.8

Q ss_pred             HHHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEecc-
Q 004994          433 ASLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNE-  509 (720)
Q Consensus       433 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~-  509 (720)
                      .++....++|...+.||+|+||.||+|.. .+|+.||||++....   ...+.+.+|+++++++ +||||+++++++.. 
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            33444567888999999999999999976 578999999986432   3346788999999999 89999999999876 


Q ss_pred             -----CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCe
Q 004994          510 -----HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIV  584 (720)
Q Consensus       510 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~  584 (720)
                           .+..++||||+++++|.+++....  ...+++.....++.+++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence                 468899999999999999996432  35688899999999999999999997   99999999999999999999


Q ss_pred             EEccccCCCCCCCCCCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh
Q 004994          585 RVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV  658 (720)
Q Consensus       585 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~  658 (720)
                      ||+|||++.......  .......++..|+|||.+.      ..++.++|||||||++|||+||+.||...........+
T Consensus       169 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  246 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             EEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            999999998764321  1123356788999999873      45899999999999999999999999653321111000


Q ss_pred             hhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       659 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                   .+...+...   ....+..+.+++.+||+.||++|||++|++++
T Consensus       247 -------------~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          247 -------------PRNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             -------------HHSCCCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -------------hcCccccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                         000011110   11123578899999999999999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.4e-39  Score=351.38  Aligned_cols=261  Identities=24%  Similarity=0.338  Sum_probs=192.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc----C--Ce
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE----H--GQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~--~~  512 (720)
                      .+|...+.||+|+||+||+|.. .+|+.||||++.....      .+.+|++++++++|||||+++++|..    .  ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            3577789999999999999976 4699999999864321      23468999999999999999998843    1  24


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC-CCeEEccccC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-LIVRVSDCGL  591 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGl  591 (720)
                      .++||||+++ ++.+.+.........+++..+..++.|+++||+|||+.   +|+||||||+|||++.+ +.+||+|||+
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence            6799999986 66666654333456789999999999999999999987   99999999999999965 5789999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhhcccccCch
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIPRLHDI  668 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~  668 (720)
                      |+.+.....   .....++.+|+|||.+.+  .|+.++|||||||++|||++|+.||......... .+++.. . ....
T Consensus       204 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~l-g-~p~~  278 (420)
T 1j1b_A          204 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-G-TPTR  278 (420)
T ss_dssp             CEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-C-SCCH
T ss_pred             hhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-C-CCCH
Confidence            987643322   223567899999998733  6899999999999999999999999764322111 111100 0 0000


Q ss_pred             hhhhhhc-------CCCCCc-----hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMV-------DPSLDG-----AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~-------~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +.+..+-       -+....     .+....+.++.+|+.+||+.||++|||+.|+++|
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            1111110       011100     0112234678999999999999999999999865

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=345.76  Aligned_cols=261  Identities=18%  Similarity=0.229  Sum_probs=198.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC---------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeE--------
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP---------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVE--------  502 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~---------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~--------  502 (720)
                      ++|...+.||+|+||+||+|...         +++.||||++...       +.+.+|++++++++||||++        
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            57888899999999999999765         3789999998643       36789999999999999987        


Q ss_pred             -------EEeEecc-CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 004994          503 -------LIGYCNE-HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSS  574 (720)
Q Consensus       503 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~  574 (720)
                             +++++.. .+..++||||+ +++|.+++...  ....+++..+..++.|+++||+|||+.   +|+||||||+
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~  188 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE  188 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence                   5677765 67899999999 99999999643  135789999999999999999999997   9999999999


Q ss_pred             CeEEcCCC--CeEEccccCCCCCCCCCCc-----ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCC
Q 004994          575 NILLDEKL--IVRVSDCGLAPLLFSGSTN-----ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPY  646 (720)
Q Consensus       575 NiLl~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf  646 (720)
                      |||++.++  .+||+|||+++.+......     .......++..|+|||.. ...++.++|||||||++|||+||+.||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  9999999999876432211     111334688999999998 447899999999999999999999999


Q ss_pred             CCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          647 DRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ........ .+..... .+  ........+....   ....+.++.+++.+||+.||++|||++|+++.|++++
T Consensus       269 ~~~~~~~~-~~~~~~~-~~--~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          269 TNCLPNTE-DIMKQKQ-KF--VDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             GGGTTCHH-HHHHHHH-HH--HHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccCCcCHH-HHHHHHH-hc--cCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            75432111 0110000 00  0000001110000   0112367889999999999999999999999998863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.4e-39  Score=342.83  Aligned_cols=265  Identities=17%  Similarity=0.224  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccc---------------cHHHHHHHHHHHHccCCCceeEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQ---------------TDEEFLELASTISRLRHGNIVEL  503 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~---------------~~~~~~~e~~~l~~l~H~niv~l  503 (720)
                      .++|...+.||+|+||.||+|.. +|+.||||++........               ..+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788899999999999999987 899999999874322111               12789999999999999999999


Q ss_pred             EeEeccCCeEEEEEeeCCCCCHHHH------hhccchhccccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCe
Q 004994          504 IGYCNEHGQHLLVYDYGGNCTLHDL------LHSDEEAHKKFSWNIRIRVALGAARALQYLQE-VCEPPIVHGNFKSSNI  576 (720)
Q Consensus       504 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDlkp~Ni  576 (720)
                      ++++.+.+..++||||+++++|.++      +..  .....+++..+..++.++++||.|||+ .   +|+||||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence            9999999999999999999999998      432  124678999999999999999999998 6   999999999999


Q ss_pred             EEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccCCC--CCCC-ccchHhHHHHHHHHHhCCCCCCCCCCcc
Q 004994          577 LLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG--SYSC-QSDVYSLGVVMLELLTGRKPYDRSRPRG  653 (720)
Q Consensus       577 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~-~~Dv~S~Gvvl~elltG~~Pf~~~~~~~  653 (720)
                      +++.++.+||+|||++......    ......++..|+|||...+  .++. ++|||||||++|||++|+.||.......
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            9999999999999999876332    2234567889999999844  4555 9999999999999999999997644311


Q ss_pred             -ccchhhhcccccCchhhhhhhcCCCCC---chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          654 -EQSLVRWAIPRLHDIDALSRMVDPSLD---GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       654 -~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       ....+.........  .......+...   .......+.++.+++.+||+.||++|||++|++++
T Consensus       260 ~~~~~i~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          260 ELFNNIRTKNIEYPL--DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHHHTSCCCCCCC--SSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhccCcCCcc--chhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             11111000000000  00000000000   00112234678899999999999999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-38  Score=332.89  Aligned_cols=251  Identities=22%  Similarity=0.374  Sum_probs=196.6

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ..+.|...+.||+|+||.||+|... +|+.||||++...    ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            4567888899999999999999664 6999999999753    2346788999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..   ....+++..+..++.+++.||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            999999999999852   245689999999999999999999997   99999999999999999999999999997664


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ...  .......++..|+|||.. ...++.++||||||+++|||++|+.||...........             .....
T Consensus       177 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~  241 (314)
T 3com_A          177 DTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-------------IPTNP  241 (314)
T ss_dssp             TTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHHSC
T ss_pred             hhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------HhcCC
Confidence            321  122335678899999998 45689999999999999999999999975332111000             00000


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+...  .+...+..+.+++.+||+.||.+|||+.|++++
T Consensus       242 ~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          242 PPTFR--KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             CCCCS--SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CcccC--CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11111  112234678899999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-38  Score=335.66  Aligned_cols=269  Identities=19%  Similarity=0.297  Sum_probs=198.0

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe--CCCcEEEEEEecccccccccHHHHHHHHHHHHcc---CCCceeEEEeEec----
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL--PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL---RHGNIVELIGYCN----  508 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~----  508 (720)
                      +.++|...+.||+|+||.||+|..  .+|+.||||++............+.+|+++++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457889999999999999999976  4689999999875433222233556677766665   8999999999986    


Q ss_pred             -cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEc
Q 004994          509 -EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVS  587 (720)
Q Consensus       509 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  587 (720)
                       .....++||||++ |+|.+++....  ...+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             5567899999998 59999886432  23588999999999999999999997   99999999999999999999999


Q ss_pred             cccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhc-ccc
Q 004994          588 DCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWA-IPR  664 (720)
Q Consensus       588 DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~-~~~  664 (720)
                      |||+++.....   .......++..|+|||.. .+.++.++|||||||++|||+||+.||.......... +.... .+.
T Consensus       163 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          163 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999876322   122345678899999988 5578999999999999999999999997643221111 10000 000


Q ss_pred             cCchh----hhhhhcC---CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          665 LHDID----ALSRMVD---PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       665 ~~~~~----~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..++.    .......   ...........+..+.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00000    0000000   000011112234678899999999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.3e-39  Score=349.10  Aligned_cols=262  Identities=21%  Similarity=0.337  Sum_probs=192.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC------e
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG------Q  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~  512 (720)
                      ..+|...+.||+|+||+||+|....+..||+|++.....      ...+|+++++.++||||+++++++...+      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            346888899999999999999887777799998864321      1236899999999999999999985432      3


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc-CCCCeEEccccC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGL  591 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGl  591 (720)
                      .++||||++++.+ +.+.........+++..+..++.|+++||+|||+.   +|+||||||+|||++ .++.+||+|||+
T Consensus       113 ~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          113 LNLVLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            7899999997544 33332223356789999999999999999999997   999999999999999 799999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcccccCch
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAIPRLHDI  668 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~  668 (720)
                      |+.+.....   .....++++|+|||.+.+  .++.++|||||||++|||++|+.||.......... +++...  ....
T Consensus       189 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g--~p~~  263 (394)
T 4e7w_A          189 AKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG--TPSR  263 (394)
T ss_dssp             CEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC--CCCH
T ss_pred             cccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC--CCCH
Confidence            987643322   223567889999998733  58999999999999999999999997644221111 111000  0000


Q ss_pred             hhhhh----hcC---CCCC-----chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSR----MVD---PSLD-----GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~----~~~---~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +.+..    ...   +...     ..+....++++.+|+.+||+.||++|||+.|+++|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00000    000   0000     01111234678999999999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.7e-38  Score=342.51  Aligned_cols=263  Identities=19%  Similarity=0.300  Sum_probs=197.2

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE---
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH---  513 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~---  513 (720)
                      ..++|...+.||+|+||+||+|.. .+|+.||||++..........+.+.+|+++++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            346788889999999999999965 5799999999986554455567889999999999999999999999876654   


Q ss_pred             ---EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          514 ---LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       514 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                         ++||||+. ++|.+++.      ..+++..+..++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence               99999998 58887763      3488999999999999999999997   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh-hhcc-----
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWAI-----  662 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~-----  662 (720)
                      +++.....     .....++.+|+|||.+.  ..++.++|||||||++|||+||+.||...........+ ....     
T Consensus       190 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  264 (371)
T 4exu_A          190 LARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE  264 (371)
T ss_dssp             CC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence            99865322     22356789999999874  47899999999999999999999999764322111100 0000     


Q ss_pred             --cccCch--hhhhhhcCCCCCch---hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 --PRLHDI--DALSRMVDPSLDGA---YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 --~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ..+.+.  ....+.+.......   .....+.++.+|+.+||+.||++|||++|++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence              000000  00000001000000   111234678999999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.9e-38  Score=330.03  Aligned_cols=255  Identities=22%  Similarity=0.302  Sum_probs=201.6

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc-------cccHHHHHHHHHHHHccC-CCceeEEEeEe
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-------RQTDEEFLELASTISRLR-HGNIVELIGYC  507 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-------~~~~~~~~~e~~~l~~l~-H~niv~l~~~~  507 (720)
                      .+.++|...+.||+|+||.||+|.. .+|+.||||++......       ....+.+.+|+++++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3467888899999999999999966 46899999999643211       123467889999999995 99999999999


Q ss_pred             ccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEc
Q 004994          508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVS  587 (720)
Q Consensus       508 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  587 (720)
                      .+.+..++||||+++++|.+++..    ...+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence            999999999999999999999853    35688999999999999999999997   99999999999999999999999


Q ss_pred             cccCCCCCCCCCCcccccCccccccCCCCccC-------CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhh
Q 004994          588 DCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-------SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW  660 (720)
Q Consensus       588 DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-------~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  660 (720)
                      |||++.......   ......++..|+|||..       ...++.++||||||+++|||++|+.||...........+. 
T Consensus       167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-  242 (298)
T 1phk_A          167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-  242 (298)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-
T ss_pred             cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh-
Confidence            999998764332   22335678899999986       2457899999999999999999999996533211100000 


Q ss_pred             cccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          661 AIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       661 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                 ...  ...........+.++.+++.+||+.||++|||++|++++
T Consensus       243 -----------~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          243 -----------SGN--YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             -----------HTC--CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -----------cCC--cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence                       000  000001112234678899999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.1e-38  Score=340.51  Aligned_cols=272  Identities=21%  Similarity=0.271  Sum_probs=188.8

Q ss_pred             HHHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC
Q 004994          433 ASLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG  511 (720)
Q Consensus       433 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  511 (720)
                      .......++|...+.||+|+||+||+|.. .+|+.||||++....   .....+.++++.++.++||||+++++++...+
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~   92 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG   92 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence            34556678999999999999999999976 568999999986432   22345677888889999999999999985433


Q ss_pred             -------eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-CCC
Q 004994          512 -------QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KLI  583 (720)
Q Consensus       512 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~  583 (720)
                             ..++||||+++ +|.+.+.........+++.....++.+++.||.|||. |..+|+||||||+|||++. ++.
T Consensus        93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTE
T ss_pred             cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCc
Confidence                   37899999997 5555444322345678889999999999999999992 2349999999999999997 899


Q ss_pred             eEEccccCCCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhh
Q 004994          584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRW  660 (720)
Q Consensus       584 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~  660 (720)
                      +||+|||+++.+.....   .....++..|+|||.+.  ..++.++|||||||++|||+||+.||.......... +.+.
T Consensus       171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  247 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV  247 (360)
T ss_dssp             EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence            99999999987643322   22356788999999873  348999999999999999999999997644322111 1110


Q ss_pred             cccccCchhhhhhhcCCCCC----------------chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          661 AIPRLHDIDALSRMVDPSLD----------------GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       661 ~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..  ....+.+..+ ++...                .......+.++.+|+.+||+.||.+|||+.|+++|
T Consensus       248 ~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          248 LG--CPSREVLRKL-NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HC--CCCHHHHHHH-CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cC--CCCHHHHHhc-ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00  0000011100 00000                00011135678999999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.4e-38  Score=333.09  Aligned_cols=253  Identities=20%  Similarity=0.328  Sum_probs=196.3

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ..+.|+..+.||+|+||+||+|... +++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            3467888899999999999999764 6899999998643  234567899999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++..   ....+++..+..++.++++||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        95 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999998853   235689999999999999999999997   99999999999999999999999999875321


Q ss_pred             CCCCcccccCccccccCCCCccC------CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE------SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~------~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      ..  ........++..|+|||..      ...++.++||||||+++|||++|+.||.........  ....         
T Consensus       169 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~---------  235 (302)
T 2j7t_A          169 KT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKIA---------  235 (302)
T ss_dssp             HH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHH---------
T ss_pred             cc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--HHHh---------
Confidence            11  1112234678899999986      456899999999999999999999999754321110  0000         


Q ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       671 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ....+..  ..+...+.++.+++.+||+.||++|||++|++++
T Consensus       236 --~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          236 --KSDPPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             --HSCCCCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             --ccCCccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              0000000  0112234578899999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3e-38  Score=339.78  Aligned_cols=266  Identities=20%  Similarity=0.278  Sum_probs=200.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-----Ce
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-----GQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  512 (720)
                      .++|...+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++...     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            45788899999999999999965 578999999997432 234457789999999999999999999998654     47


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||+++ +|.+++..     ..+++..+..++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~iv~e~~~~-~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEcccCc-CHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence            8999999985 89988842     4588999999999999999999997   9999999999999999999999999999


Q ss_pred             CCCCCCCCc-ccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          593 PLLFSGSTN-ELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       593 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      +........ .......++++|+|||.+  ...++.++|||||||++|||+||+.||...........+....... ..+
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~  254 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP-SQE  254 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC-CHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC-CHH
Confidence            876432211 122345789999999976  3458999999999999999999999997654332211111000000 000


Q ss_pred             hhhh------------hcCCCCC--chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSR------------MVDPSLD--GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~------------~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....            ...+...  .........++.+|+.+||+.||++|||++|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000            0000000  00111234678899999999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.1e-38  Score=342.45  Aligned_cols=267  Identities=21%  Similarity=0.309  Sum_probs=180.5

Q ss_pred             CCCC-CCeeccCCCceEEEEEeC---CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEe--ccCCeEE
Q 004994          441 SFSE-GNFIGEGLLGSVYKAELP---GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC--NEHGQHL  514 (720)
Q Consensus       441 ~~~~-~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~--~~~~~~~  514 (720)
                      .|.. +++||+|+||+||+|...   +++.||||++....    ..+.+.+|++++++++|||||++++++  ......+
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            3544 568999999999999764   57899999997432    234688999999999999999999999  4577899


Q ss_pred             EEEeeCCCCCHHHHhhccch-----hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE----cCCCCeE
Q 004994          515 LVYDYGGNCTLHDLLHSDEE-----AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL----DEKLIVR  585 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl----~~~~~~k  585 (720)
                      +||||+++ +|.+++.....     ....+++..+..++.+++.||+|||+.   +||||||||+|||+    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999985 78877753221     122489999999999999999999997   89999999999999    7789999


Q ss_pred             EccccCCCCCCCCCC-cccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc------c
Q 004994          586 VSDCGLAPLLFSGST-NELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ------S  656 (720)
Q Consensus       586 l~DFGla~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~------~  656 (720)
                      |+|||+|+.+..... ........+|.+|+|||.+.+  .++.++|||||||++|||+||+.||.........      .
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999999987643211 122234568999999998743  5899999999999999999999999654321100      0


Q ss_pred             hhhh-----cccccCchhhhhhh---------cC-CCCCchh--------hHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 004994          657 LVRW-----AIPRLHDIDALSRM---------VD-PSLDGAY--------LAKSLSRFADIISRCVQWEPGFRPPMSEIV  713 (720)
Q Consensus       657 ~~~~-----~~~~~~~~~~~~~~---------~~-~~~~~~~--------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  713 (720)
                      ....     ..+....+..+..+         +. .......        .......+.+|+.+||+.||++|||++|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            0000     00000000000000         00 0000000        000135678999999999999999999999


Q ss_pred             HH
Q 004994          714 QD  715 (720)
Q Consensus       714 ~~  715 (720)
                      +|
T Consensus       333 ~h  334 (405)
T 3rgf_A          333 QD  334 (405)
T ss_dssp             TS
T ss_pred             cC
Confidence            75

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-38  Score=340.25  Aligned_cols=267  Identities=21%  Similarity=0.314  Sum_probs=197.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccC-----Ce
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEH-----GQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  512 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.... .......+.+|++++++++||||+++++++...     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            46788889999999999999976 469999999996432 234456788999999999999999999988653     67


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++||||+. ++|.+++..     ..+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            899999998 589888852     4688999999999999999999997   9999999999999999999999999999


Q ss_pred             CCCCCCCCcc--------cccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 004994          593 PLLFSGSTNE--------LSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       593 ~~~~~~~~~~--------~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      +.........        ......++..|+|||.+  ...++.++|||||||++|||++|+.||...........+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  239 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII  239 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            8764322110        11234678899999976  3578999999999999999999999997643221111000000


Q ss_pred             cccC--------chhhhhhhcC--CCC----CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 PRLH--------DIDALSRMVD--PSL----DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 ~~~~--------~~~~~~~~~~--~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....        ......+.+.  +..    ........+.++.+++.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000        0000000000  000    000112234678899999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.3e-38  Score=334.35  Aligned_cols=257  Identities=25%  Similarity=0.358  Sum_probs=178.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHH-HHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELAS-TISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||.||+|.. .+|+.||||++...... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            5788889999999999999976 47999999999755332 23344555555 778889999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccch-hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEE-AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      ||+++ +|.+++..... ....+++..+..++.++++||.|||+.  .+|+||||||+|||++.++.+||+|||+++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            99986 78777753211 245688999999999999999999984  279999999999999999999999999998764


Q ss_pred             CCCCcccccCccccccCCCCccC-----CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-----SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-----~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ...   ......++..|+|||.+     ...++.++|||||||++|||++|+.||......... ....    ...    
T Consensus       178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~----~~~----  245 (327)
T 3aln_A          178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-LTQV----VKG----  245 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCC----CCS----
T ss_pred             ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-HHHH----hcC----
Confidence            322   12223678899999997     235899999999999999999999999753211100 0000    000    


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         ..+.+........+.++.+++.+||+.||++|||+.|++++
T Consensus       246 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          246 ---DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             ---CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ---CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence               00111111111233578899999999999999999999864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.3e-38  Score=362.47  Aligned_cols=256  Identities=23%  Similarity=0.338  Sum_probs=200.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC----CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP----GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      .++|...+.||+|+||+||+|...    .+..||||++.... .....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            456788899999999999999763    25679999987532 23445789999999999999999999999854 5689


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++|+|.+++...   ...+++..+..++.++++||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       467 lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             EEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence            999999999999999632   34688999999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ....... ......++..|+|||.+ ...++.++|||||||++|||++ |+.||........   ...          +.
T Consensus       541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~----------i~  606 (656)
T 2j0j_A          541 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR----------IE  606 (656)
T ss_dssp             CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----------HH
T ss_pred             cCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----------HH
Confidence            6433221 22233456789999998 5679999999999999999997 9999975432111   100          00


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ......    .+..++..+.+++.+||+.||++|||+.|+++.|++++
T Consensus       607 ~~~~~~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          607 NGERLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             HTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCC----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            000000    11223467889999999999999999999999999863

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.3e-38  Score=332.46  Aligned_cols=263  Identities=19%  Similarity=0.323  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe--CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCc------eeEEEeEeccC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL--PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN------IVELIGYCNEH  510 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~  510 (720)
                      .++|...+.||+|+||+||+|..  .+++.||||++...   ....+.+.+|+++++.++|++      ++++++++.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            46788899999999999999965  46899999999643   234567889999998887664      99999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC----------
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE----------  580 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~----------  580 (720)
                      +..++||||+ +++|.+++...  ....+++..+..++.|+++||+|||+.   +|+||||||+|||++.          
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            9999999999 78999988643  224688999999999999999999997   9999999999999987          


Q ss_pred             ---------CCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 004994          581 ---------KLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSR  650 (720)
Q Consensus       581 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~  650 (720)
                               ++.+||+|||+++.....     .....++..|+|||.. ...++.++|||||||++|||+||+.||....
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                     678999999999765322     2235678999999998 4578999999999999999999999997644


Q ss_pred             CccccchhhhcccccCch-------------------------hhhhhhcCCCCC-chhhHHHHHHHHHHHHHHhccCCC
Q 004994          651 PRGEQSLVRWAIPRLHDI-------------------------DALSRMVDPSLD-GAYLAKSLSRFADIISRCVQWEPG  704 (720)
Q Consensus       651 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~  704 (720)
                      .......+......+...                         ....+...+... .......++++.+++.+||+.||+
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            322111111111000000                         000000000000 001224567889999999999999


Q ss_pred             CCCCHHHHHHH
Q 004994          705 FRPPMSEIVQD  715 (720)
Q Consensus       705 ~RPt~~evl~~  715 (720)
                      +|||++|++++
T Consensus       319 ~Rpt~~ell~h  329 (339)
T 1z57_A          319 KRITLREALKH  329 (339)
T ss_dssp             TSCCHHHHTTS
T ss_pred             cccCHHHHhcC
Confidence            99999999865

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5e-38  Score=331.47  Aligned_cols=265  Identities=21%  Similarity=0.322  Sum_probs=191.9

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEec---------
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCN---------  508 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~---------  508 (720)
                      .++|...+.||+|+||.||+|... +|+.||||++...  .....+.+.+|++++++++||||+++++++.         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            467888899999999999999765 5999999998643  2345578899999999999999999999873         


Q ss_pred             -----cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc-CCC
Q 004994          509 -----EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD-EKL  582 (720)
Q Consensus       509 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~  582 (720)
                           +....++||||++ |+|.+++..     ..+++.....++.++++||+|||+.   +|+||||||+|||++ +++
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence                 3467899999998 599998853     4578899999999999999999997   999999999999997 567


Q ss_pred             CeEEccccCCCCCCCCCC-cccccCccccccCCCCccC-C-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh
Q 004994          583 IVRVSDCGLAPLLFSGST-NELSEGLLTAHGSGAPEFE-S-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR  659 (720)
Q Consensus       583 ~~kl~DFGla~~~~~~~~-~~~~~~~~~~~~~~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  659 (720)
                      .+||+|||+++....... ........++..|+|||.. . ..++.++|||||||++|||+||+.||...........+.
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999987643211 1112234568889999987 3 578999999999999999999999997644322111111


Q ss_pred             hcccccCchhhhhhhc------------CCCCC-chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          660 WAIPRLHDIDALSRMV------------DPSLD-GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       660 ~~~~~~~~~~~~~~~~------------~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...+.... +...++.            .+... .......+.++.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          239 ESIPVVHE-EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHSCCCCH-HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhcCCCch-hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            11111100 0000000            01000 01112235678999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.9e-38  Score=328.65  Aligned_cols=253  Identities=24%  Similarity=0.370  Sum_probs=190.9

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc-------
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-------  509 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-------  509 (720)
                      +.++|+..+.||+|+||.||+|.. .+|+.||||++...   ....+.+.+|++++++++||||+++++++.+       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            456788889999999999999975 57999999999642   3345778999999999999999999998754       


Q ss_pred             ------CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC
Q 004994          510 ------HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI  583 (720)
Q Consensus       510 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  583 (720)
                            .+..++||||+++|+|.+++...   ...+++..+..++.++++||+|||+.   +|+||||||+|||++.++.
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence                  35789999999999999999632   34577888999999999999999997   9999999999999999999


Q ss_pred             eEEccccCCCCCCCCCC------------cccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 004994          584 VRVSDCGLAPLLFSGST------------NELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRS  649 (720)
Q Consensus       584 ~kl~DFGla~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~  649 (720)
                      +||+|||+++.......            ........++..|+|||...  +.++.++|||||||++|||++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            99999999987642210            11122345788999999984  368999999999999999998   55321


Q ss_pred             CCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          650 RPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..  .......          +.. .............+..+.+++.+||+.||++|||++|++++
T Consensus       232 ~~--~~~~~~~----------~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          232 ME--RVNILKK----------LRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HH--HHHHHHH----------HHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hh--HHHHHHh----------ccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            10  0000000          000 01111112222334568899999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=335.94  Aligned_cols=261  Identities=19%  Similarity=0.308  Sum_probs=195.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe-----
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ-----  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----  512 (720)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            35788889999999999999965 579999999997654444556788999999999999999999999977653     


Q ss_pred             -EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          513 -HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       513 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                       .++||||+. ++|.+++.      ..+++..+..++.++++||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence             599999998 58877763      3488999999999999999999997   999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc-------
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI-------  662 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~-------  662 (720)
                      ++.....     .....++..|+|||.+.  ..++.++|||||||++|||++|+.||...........+....       
T Consensus       173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  247 (353)
T 3coi_A          173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  247 (353)
T ss_dssp             TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred             ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9865322     22356788999999873  468999999999999999999999997643221110000000       


Q ss_pred             -cccCchh--hhhhhc----CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 -PRLHDID--ALSRMV----DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 -~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       ..+.+..  ...+.+    .+.+. ......+.++.+++.+||+.||++|||++|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             0000000  000000    00000 0112334678999999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7e-38  Score=340.87  Aligned_cols=264  Identities=17%  Similarity=0.240  Sum_probs=197.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC--------CCceeEEEeEec-
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR--------HGNIVELIGYCN-  508 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~~~~~-  508 (720)
                      .++|...+.||+|+||+||+|.. .+++.||||++...   ....+.+.+|++++++++        |+||+++++++. 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            46788899999999999999964 57899999999743   334567889999999986        788999999987 


Q ss_pred             ---cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC---
Q 004994          509 ---EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL---  582 (720)
Q Consensus       509 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~---  582 (720)
                         +....++||||+. +++.+.+...  ....+++..+..++.|+++||+|||+.+  +||||||||+|||++.++   
T Consensus       113 ~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          113 SGVNGTHICMVFEVLG-HHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EETTEEEEEEEECCCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred             cCCCCceEEEEEeccC-ccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence               5568999999995 5666655422  2356899999999999999999999853  799999999999999775   


Q ss_pred             ----------------------------------------------CeEEccccCCCCCCCCCCcccccCccccccCCCC
Q 004994          583 ----------------------------------------------IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP  616 (720)
Q Consensus       583 ----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aP  616 (720)
                                                                    .+||+|||+|+.....     .....+|..|+||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP  262 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence                                                          8999999999876432     2234678999999


Q ss_pred             ccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc---hhhh---cccccC---------------chhhhhhh
Q 004994          617 EFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS---LVRW---AIPRLH---------------DIDALSRM  674 (720)
Q Consensus       617 E~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~---~~~~---~~~~~~---------------~~~~~~~~  674 (720)
                      |.+ ...++.++|||||||++|||+||+.||..........   ....   ......               .......+
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            998 5569999999999999999999999997543322110   0000   000000               00000000


Q ss_pred             cCCCCC---------chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLD---------GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~---------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+....         .........++.+|+.+||+.||++|||++|+++|
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            000000         01234566789999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-37  Score=343.12  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=185.4

Q ss_pred             CCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEee
Q 004994          441 SFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      .|...++||+|+||+||.+...+|+.||||++...     ..+.+.+|+++++++ +|||||++++++.+.+..++||||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            34446889999999998877778999999998643     235678899999886 899999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhcccc---CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC-------------CC
Q 004994          520 GGNCTLHDLLHSDEEAHKKF---SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK-------------LI  583 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~---~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~-------------~~  583 (720)
                      ++ |+|.+++..........   .+.....++.|++.||+|||+.   +||||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence            96 69999997543222111   2334578999999999999987   99999999999999754             48


Q ss_pred             eEEccccCCCCCCCCCCc--ccccCccccccCCCCccCC--------CCCCCccchHhHHHHHHHHHh-CCCCCCCCCCc
Q 004994          584 VRVSDCGLAPLLFSGSTN--ELSEGLLTAHGSGAPEFES--------GSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPR  652 (720)
Q Consensus       584 ~kl~DFGla~~~~~~~~~--~~~~~~~~~~~~~aPE~~~--------~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~  652 (720)
                      +||+|||+++.+......  .......++.+|+|||.+.        +.++.++|||||||++|||+| |+.||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            999999999877543221  1123456899999999873        458999999999999999999 99999653321


Q ss_pred             cccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          653 GEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      . ..+..... ..           +..........+.++.+++.+||+.||++|||+.||+++
T Consensus       247 ~-~~i~~~~~-~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          247 E-SNIIRGIF-SL-----------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             H-HHHHHTCC-CC-----------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             H-HHHhcCCC-Cc-----------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            1 11111000 00           011111223456788999999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.1e-37  Score=335.53  Aligned_cols=201  Identities=23%  Similarity=0.314  Sum_probs=168.0

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CC-----ceeEEEeEeccC
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HG-----NIVELIGYCNEH  510 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~  510 (720)
                      +.++|...+.||+|+||+||+|.. .+++.||||++...   .....++..|+++++.++ |+     +|+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            467888999999999999999965 47899999999743   234466778888888875 55     499999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc--CCCCeEEcc
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD--EKLIVRVSD  588 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~--~~~~~kl~D  588 (720)
                      +..++||||+++ +|.+++....  ...+++..+..++.+++.||.|||.. ..+||||||||+|||++  .++.+||+|
T Consensus       129 ~~~~lv~e~~~~-~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          129 NHLCLVFEMLSY-NLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             TEEEEEEECCCC-BHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             CceEEEEecCCC-CHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            999999999975 9999986432  24589999999999999999999952 34899999999999994  578899999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSR  650 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~  650 (720)
                      ||+|+.....     .....+++.|+|||.+ ...++.++|||||||++|||+||+.||....
T Consensus       205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999876332     2235678899999998 4579999999999999999999999997644

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-37  Score=331.02  Aligned_cols=253  Identities=17%  Similarity=0.233  Sum_probs=172.4

Q ss_pred             HhcCCCCC-CeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc----CC
Q 004994          438 YTNSFSEG-NFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE----HG  511 (720)
Q Consensus       438 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~  511 (720)
                      ..++|... ++||+|+||+||+|... +|+.||||++...      .....+....++.++||||+++++++..    ..
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            34677774 47999999999999664 7999999998642      1222333344667799999999999865    44


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---CCCeEEcc
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIVRVSD  588 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~D  588 (720)
                      ..++||||+++|+|.+++...  ....+++..+..++.++++||.|||+.   +|+||||||+|||++.   ++.+||+|
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             eEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence            689999999999999999643  234689999999999999999999997   9999999999999976   45699999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      ||+++.....    ......++..|+|||.+ ...++.++|||||||++|||++|+.||.............   ..+..
T Consensus       175 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~  247 (336)
T 3fhr_A          175 FGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRL  247 (336)
T ss_dssp             CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             cccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhc
Confidence            9999765322    12234578899999998 5568999999999999999999999996543221100000   00000


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                             .............+.++.+++.+||+.||++|||++|++++
T Consensus       248 -------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          248 -------GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -------cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                   00000001112234678899999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=325.36  Aligned_cols=254  Identities=22%  Similarity=0.358  Sum_probs=180.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..........+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            35677789999999999999976 47999999999765433334445566666788899999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+ ++.+..+..   .....+++..+..++.++++||.|||+.+  +|+||||||+||+++.++.+||+|||+++....
T Consensus       104 e~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 445555443   22356889999999999999999999832  899999999999999999999999999976643


Q ss_pred             CCCcccccCccccccCCCCccCC------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ..   ......++..|+|||.+.      ..++.++|||||||++|||++|+.||........  ....          .
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~----------~  242 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLTK----------V  242 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHH----------H
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHHH----------H
Confidence            22   122346788999999873      3588999999999999999999999975322110  0000          0


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .....+....  ....+.++.+++.+||+.||.+|||++|++++
T Consensus       243 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          243 LQEEPPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HHSCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             hccCCCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0000011110  01123568899999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=327.69  Aligned_cols=247  Identities=19%  Similarity=0.331  Sum_probs=187.8

Q ss_pred             HHHHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc----ccHHHHHHHHHHHHcc----CCCceeEEE
Q 004994          434 SLQQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR----QTDEEFLELASTISRL----RHGNIVELI  504 (720)
Q Consensus       434 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l----~H~niv~l~  504 (720)
                      +...+.++|...+.||+|+||.||+|.. .+++.||||++.......    .....+.+|+++++++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3445678899999999999999999965 578999999996543211    1223456788888888    899999999


Q ss_pred             eEeccCCeEEEEEee-CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc-CCC
Q 004994          505 GYCNEHGQHLLVYDY-GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD-EKL  582 (720)
Q Consensus       505 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~  582 (720)
                      +++.+.+..++|||| +.+++|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+||+++ .++
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence            999999999999999 789999999853    34689999999999999999999998   999999999999999 889


Q ss_pred             CeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhh
Q 004994          583 IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSY-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW  660 (720)
Q Consensus       583 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~-~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~  660 (720)
                      .+||+|||+++......    .....++..|+|||.. ...+ +.++|||||||++|||++|+.||....     .... 
T Consensus       178 ~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~-  247 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILE-  247 (312)
T ss_dssp             EEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-
T ss_pred             eEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHhh-
Confidence            99999999998764322    2235578899999987 3344 558999999999999999999996421     0000 


Q ss_pred             cccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          661 AIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       661 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                  .  ....    +...+.++.+++.+||+.||++|||++|++++
T Consensus       248 ------------~--~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          248 ------------A--ELHF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ------------T--CCCC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ------------h--ccCC----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        0  0000    11123567899999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-37  Score=329.25  Aligned_cols=245  Identities=17%  Similarity=0.324  Sum_probs=196.0

Q ss_pred             HHHhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc----ccHHHHHHHHHHHHccC--CCceeEEEeEec
Q 004994          436 QQYTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR----QTDEEFLELASTISRLR--HGNIVELIGYCN  508 (720)
Q Consensus       436 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~--H~niv~l~~~~~  508 (720)
                      ....++|...+.||+|+||.||+|.. .+++.||||++.......    ...+.+.+|++++++++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34567888999999999999999964 678999999997543221    12245678899999996  599999999999


Q ss_pred             cCCeEEEEEeeCCC-CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc-CCCCeEE
Q 004994          509 EHGQHLLVYDYGGN-CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRV  586 (720)
Q Consensus       509 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl  586 (720)
                      +.+..++||||+.+ ++|.+++..    ...+++..+..++.++++||+|||+.   +|+||||||+|||++ +++.+||
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence            99999999999976 899999853    35688999999999999999999997   999999999999999 7899999


Q ss_pred             ccccCCCCCCCCCCcccccCccccccCCCCccC-CCC-CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccc
Q 004994          587 SDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR  664 (720)
Q Consensus       587 ~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~-~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~  664 (720)
                      +|||+++......    .....++..|+|||.. ... ++.++|||||||++|||+||+.||....     .....   .
T Consensus       192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~---~  259 (320)
T 3a99_A          192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRG---Q  259 (320)
T ss_dssp             CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHHC---C
T ss_pred             eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhhcc---c
Confidence            9999998764321    2235678899999987 334 4788999999999999999999996421     00000   0


Q ss_pred             cCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          665 LHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       665 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .        ...        ...+.++.+++.+||+.||++|||++|++++
T Consensus       260 ~--------~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          260 V--------FFR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             C--------CCS--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             c--------ccc--------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0        001        1123568899999999999999999999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.9e-37  Score=329.56  Aligned_cols=263  Identities=17%  Similarity=0.280  Sum_probs=196.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCC-cEEEEEEecccccccccHHHHHHHHHHHHccCCCc------eeEEEeEeccC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGG-KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN------IVELIGYCNEH  510 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g-~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~  510 (720)
                      .++|...+.||+|+||+||+|.. .++ +.||||+++..   ....+.+.+|++++++++|++      ++.+++++...
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            46788899999999999999965 344 78999999743   234567888999999998766      99999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE------------
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL------------  578 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl------------  578 (720)
                      +..++||||+ ++++.+.+...  ....+++..+..++.|+++||+|||+.   +|+||||||+|||+            
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence            9999999999 55676666432  224689999999999999999999987   99999999999999            


Q ss_pred             -------cCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCC
Q 004994          579 -------DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSR  650 (720)
Q Consensus       579 -------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~  650 (720)
                             +.++.+||+|||+++.....     .....++..|+|||.+ ...++.++|||||||++|||+||+.||....
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                   67889999999999865332     2235688999999998 5579999999999999999999999997643


Q ss_pred             CccccchhhhcccccCch-------------------------hhhhhhcCCCCC-chhhHHHHHHHHHHHHHHhccCCC
Q 004994          651 PRGEQSLVRWAIPRLHDI-------------------------DALSRMVDPSLD-GAYLAKSLSRFADIISRCVQWEPG  704 (720)
Q Consensus       651 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~  704 (720)
                      .......+..........                         ........+... .........++.+|+.+||+.||+
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            222111111100000000                         000000000000 001123456789999999999999


Q ss_pred             CCCCHHHHHHH
Q 004994          705 FRPPMSEIVQD  715 (720)
Q Consensus       705 ~RPt~~evl~~  715 (720)
                      +|||++|++++
T Consensus       324 ~Rpt~~e~l~h  334 (355)
T 2eu9_A          324 QRITLAEALLH  334 (355)
T ss_dssp             TSCCHHHHTTS
T ss_pred             hCcCHHHHhcC
Confidence            99999999864

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2e-36  Score=313.97  Aligned_cols=231  Identities=14%  Similarity=0.075  Sum_probs=183.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||.||+|... +|+.||||++...... ....+.|.+|++++++++||||+++++++.+.+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            356888899999999999999664 5999999999765332 33447899999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++++|.+++...      .......+++.|+++||+|||+.   +|+||||||+|||++.++.+||+++|.     
T Consensus       110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~-----  175 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT-----  175 (286)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccc-----
Confidence            9999999999998431      24456788999999999999997   999999999999999999999985542     


Q ss_pred             CCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  675 (720)
                                       ++      .++.++|||||||++|||+||+.||.......... ............       
T Consensus       176 -----------------~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------  225 (286)
T 3uqc_A          176 -----------------MP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP-------  225 (286)
T ss_dssp             -----------------CT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH-------
T ss_pred             -----------------cC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh-------
Confidence                             22      36889999999999999999999998654322110 000000000000       


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                           .......+.++.+++.+||+.||++| |++|+++.|+++
T Consensus       226 -----~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          226 -----ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             -----HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             -----hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence                 01112234678899999999999999 999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-37  Score=338.39  Aligned_cols=249  Identities=20%  Similarity=0.272  Sum_probs=183.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .+|...++||+|+||+||.....+|+.||||++......     .+.+|+++++++ +|||||++++++.+.+..++|||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            457778999999999977666668899999999754321     245789999999 89999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-----CCCeEEccccCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-----KLIVRVSDCGLAP  593 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-----~~~~kl~DFGla~  593 (720)
                      |++ |+|.+++....   ..+.+.....++.|+++||+|||+.   +||||||||+|||++.     ...+||+|||+|+
T Consensus        99 ~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           99 LCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             CCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             CCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            997 59999986432   2233445678999999999999997   8999999999999943     3368899999998


Q ss_pred             CCCCCCCc-ccccCccccccCCCCccCC----CCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCc
Q 004994          594 LLFSGSTN-ELSEGLLTAHGSGAPEFES----GSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       594 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~----~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      .+...... .......+|++|+|||.+.    ..++.++|||||||++|||+| |+.||.............    ... 
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~----~~~-  246 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG----ACS-  246 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT----CCC-
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc----cCC-
Confidence            76533211 2233456899999999984    357789999999999999999 999995432211100000    000 


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                              .....  ........+.+++.+||+.||++|||++||++|
T Consensus       247 --------~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          247 --------LDCLH--PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             --------CTTSC--TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------ccccC--ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                    00000  112234567899999999999999999999854

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.8e-37  Score=334.81  Aligned_cols=263  Identities=17%  Similarity=0.294  Sum_probs=193.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-----------CCceeEEEeEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-----------HGNIVELIGYC  507 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~  507 (720)
                      ++|...+.||+|+||+||+|.. .+++.||||++...   ....+.+.+|++++++++           |+||+++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            5788889999999999999965 67999999999743   234567888999998886           89999999998


Q ss_pred             ccCC----eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc----
Q 004994          508 NEHG----QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD----  579 (720)
Q Consensus       508 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~----  579 (720)
                      ...+    ..++||||+ +++|.+++....  ...+++..+..++.|++.||+|||+.+  +|+||||||+|||++    
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence            7543    789999999 889999986432  345889999999999999999999842  799999999999994    


Q ss_pred             --CCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-
Q 004994          580 --EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-  655 (720)
Q Consensus       580 --~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-  655 (720)
                        ..+.+||+|||+++.....     .....++..|+|||.+ ...++.++|||||||++|||+||+.||......... 
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence              4458999999999876432     2234678999999998 557899999999999999999999999754321100 


Q ss_pred             ---chhh--hcccccCch-----hhhhhhcCC----------CC---------CchhhHHHHHHHHHHHHHHhccCCCCC
Q 004994          656 ---SLVR--WAIPRLHDI-----DALSRMVDP----------SL---------DGAYLAKSLSRFADIISRCVQWEPGFR  706 (720)
Q Consensus       656 ---~~~~--~~~~~~~~~-----~~~~~~~~~----------~~---------~~~~~~~~~~~l~~l~~~cl~~dP~~R  706 (720)
                         .+..  .....+...     .....++..          ..         ....+...+.++.+|+.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence               0000  000000000     000000000          00         001234567789999999999999999


Q ss_pred             CCHHHHHHH
Q 004994          707 PPMSEIVQD  715 (720)
Q Consensus       707 Pt~~evl~~  715 (720)
                      ||++|++++
T Consensus       326 pt~~ell~h  334 (373)
T 1q8y_A          326 ADAGGLVNH  334 (373)
T ss_dssp             BCHHHHHTC
T ss_pred             CCHHHHhhC
Confidence            999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-36  Score=342.58  Aligned_cols=260  Identities=20%  Similarity=0.256  Sum_probs=195.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc------CCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE------HGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~  512 (720)
                      ++|...+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|++++++++||||+++++++..      .+.
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            6799999999999999999965 568999999987543 23455779999999999999999999999865      667


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC---eEEccc
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI---VRVSDC  589 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DF  589 (720)
                      .++||||+++|+|.+++.... ....+++..+..++.+++.||+|||+.   +|+||||||+||+++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            899999999999999997532 223588889999999999999999997   9999999999999997765   999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc---
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL---  665 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~---  665 (720)
                      |+++......   ......++.+|+|||.+ .+.++.++|||||||++|||+||+.||......     ..|.....   
T Consensus       169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~  240 (676)
T 3qa8_A          169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKS  240 (676)
T ss_dssp             CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC---
T ss_pred             cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhccc
Confidence            9998764432   22345788999999998 567999999999999999999999999653211     01100000   


Q ss_pred             ----Cchhhhhhh--cCCC--CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHH
Q 004994          666 ----HDIDALSRM--VDPS--LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI  712 (720)
Q Consensus       666 ----~~~~~~~~~--~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev  712 (720)
                          ...+.....  ....  .........+..+.+++.+||+.||++|||++|+
T Consensus       241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence                000000000  0000  0111233456788999999999999999999884

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.4e-36  Score=312.58  Aligned_cols=231  Identities=19%  Similarity=0.274  Sum_probs=177.1

Q ss_pred             cCCCCC-CeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHH-HccCCCceeEEEeEecc----CCe
Q 004994          440 NSFSEG-NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTI-SRLRHGNIVELIGYCNE----HGQ  512 (720)
Q Consensus       440 ~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~  512 (720)
                      ++|... ++||+|+||.||+|.. .+++.||||++...       ..+.+|++++ +..+||||+++++++..    ...
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            456555 7899999999999965 57899999998532       3567788887 66699999999999876    667


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---CCCeEEccc
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIVRVSDC  589 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DF  589 (720)
                      .++||||+++|+|.+++...  ....+++..+..++.+++.||+|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            89999999999999999642  234689999999999999999999997   9999999999999998   789999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      |++....                       ...++.++|||||||++|||+||+.||.............   ..+..  
T Consensus       165 g~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~---~~~~~--  216 (299)
T 3m2w_A          165 GFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRM--  216 (299)
T ss_dssp             TTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---CSSCT--
T ss_pred             ccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---HHHhh--
Confidence            9986442                       1346789999999999999999999996543221100000   00000  


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                           .............+.++.+++.+||+.||++|||++|++++
T Consensus       217 -----~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          217 -----GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             -----TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                 00011111112234678999999999999999999999975

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-36  Score=350.25  Aligned_cols=239  Identities=20%  Similarity=0.292  Sum_probs=191.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC--CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCe----
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP--GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQ----  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----  512 (720)
                      .++|...+.||+|+||+||+|...  +|+.||||++.... .....+.+.+|++++++++|||||++++++.+.+.    
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            467888999999999999999764  68999999986532 23445678999999999999999999999976554    


Q ss_pred             -EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccC
Q 004994          513 -HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGL  591 (720)
Q Consensus       513 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl  591 (720)
                       .|+||||+++++|.+++.      ..+++..+..++.++++||.|||+.   +||||||||+|||++.+ .+||+|||+
T Consensus       158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence             799999999999988763      2689999999999999999999997   89999999999999986 899999999


Q ss_pred             CCCCCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          592 APLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       592 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      ++.....      ....+|++|+|||.+.+.++.++|||||||++|||++|..||......           .+..    
T Consensus       228 a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~~----  286 (681)
T 2pzi_A          228 VSRINSF------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLPE----  286 (681)
T ss_dssp             CEETTCC------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCCT----
T ss_pred             chhcccC------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc-----------cccc----
Confidence            9876432      335689999999998666789999999999999999999888532100           0000    


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHHHHh
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-MSEIVQDLLC  718 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~L~~  718 (720)
                               ..........+.+++.+||+.||++||+ ++++.+.|..
T Consensus       287 ---------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          287 ---------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ---------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ---------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                     0011123457889999999999999995 6666666654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-35  Score=324.80  Aligned_cols=244  Identities=14%  Similarity=0.150  Sum_probs=176.4

Q ss_pred             cCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCC-Ccee---------------
Q 004994          440 NSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRH-GNIV---------------  501 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H-~niv---------------  501 (720)
                      ..|...++||+|+||+||+|. ..+|+.||||++.... ......+.|.+|+.+++.++| +|..               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            346667899999999999996 5679999999987322 222345779999999999987 3211               


Q ss_pred             E------EEeEecc-----CCeEEEEEeeCCCCCHHHHhhcc---chhccccCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 004994          502 E------LIGYCNE-----HGQHLLVYDYGGNCTLHDLLHSD---EEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV  567 (720)
Q Consensus       502 ~------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~iv  567 (720)
                      .      +..++..     ....+++|++ .+++|.+++...   ......+++..+..++.|+++||+|||+.   +||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            1      1111111     1235566665 457999888422   12245678889999999999999999987   999


Q ss_pred             ecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC----------CC-CCCCccchHhHHHHH
Q 004994          568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE----------SG-SYSCQSDVYSLGVVM  636 (720)
Q Consensus       568 HrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~-~~~~~~Dv~S~Gvvl  636 (720)
                      ||||||+|||++.++.+||+|||+++.....     .....+ ..|+|||.+          .+ .++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999765322     233456 899999987          22 378899999999999


Q ss_pred             HHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          637 LELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       637 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      |||+||+.||..........                .++...      ...++++.+++.+||+.||++|||+.|++++
T Consensus       308 ~elltg~~Pf~~~~~~~~~~----------------~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSE----------------WIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSG----------------GGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHCCCCCCCcchhhhHH----------------HHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            99999999997543211110                011100      0112568899999999999999999888653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.4e-35  Score=313.52  Aligned_cols=245  Identities=17%  Similarity=0.187  Sum_probs=186.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEeccccc------ccccHHHHHHHHHHHHccC---------CCceeEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVS------QRQTDEEFLELASTISRLR---------HGNIVEL  503 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~------~~~~~~~~~~e~~~l~~l~---------H~niv~l  503 (720)
                      .++|...+.||+|+||+||+|.. +|+.||||++.....      .....+.+.+|++++++++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35677889999999999999977 789999999975432      2334478899999998886         7777777


Q ss_pred             EeEe-----------------cc-------------CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHH
Q 004994          504 IGYC-----------------NE-------------HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR  553 (720)
Q Consensus       504 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~  553 (720)
                      .+++                 .+             .+..++||||+++|++.+.+..     ..+++.....++.|++.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            6653                 22             6789999999999976666532     45789999999999999


Q ss_pred             HHHHHH-hcCCCCeeecCCCCCCeEEcCCC--------------------CeEEccccCCCCCCCCCCcccccCcccccc
Q 004994          554 ALQYLQ-EVCEPPIVHGNFKSSNILLDEKL--------------------IVRVSDCGLAPLLFSGSTNELSEGLLTAHG  612 (720)
Q Consensus       554 ~L~~LH-~~~~~~ivHrDlkp~NiLl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~  612 (720)
                      ||+||| +.   +||||||||+|||++.++                    .+||+|||+|+.....       ...+|..
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence            999999 77   899999999999999887                    8999999999876422       2468899


Q ss_pred             CCCCccCCCCCCCccchHhHHHH-HHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh-hcCCCCCchhhHHHHHH
Q 004994          613 SGAPEFESGSYSCQSDVYSLGVV-MLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR-MVDPSLDGAYLAKSLSR  690 (720)
Q Consensus       613 ~~aPE~~~~~~~~~~Dv~S~Gvv-l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  690 (720)
                      |+|||.+.+..+.++||||+|++ .+++++|..||......  .....         ..... ..............+++
T Consensus       243 y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~---------~~~~~~~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          243 SMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTD---------KMLKQMTFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             TTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHH---------HHHHTCCCSSCCCSHHHHHHHHH
T ss_pred             ccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhh--hHHHH---------hhhhhhccCcccchhhhhhcCHH
Confidence            99999997777999999998777 78889999998421000  00000         00000 01111122334567788


Q ss_pred             HHHHHHHHhccCCCCCCCHHHHH-HH
Q 004994          691 FADIISRCVQWEPGFRPPMSEIV-QD  715 (720)
Q Consensus       691 l~~l~~~cl~~dP~~RPt~~evl-~~  715 (720)
                      +.+|+.+||+.|     |++|++ +|
T Consensus       312 ~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHHhccC-----CHHHHHhcC
Confidence            999999999976     999998 64

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.97  E-value=9.7e-32  Score=282.54  Aligned_cols=220  Identities=25%  Similarity=0.487  Sum_probs=201.0

Q ss_pred             CCCHHHHHHHHHHHHhcCCC-CCCCccCCCCCCCCCCCceeEeec----CceeEEEecCCcccc--cCCcCcCCCCCccE
Q 004994           27 VTDPRDVMALNSLYISLNFP-PLEKWLSFGGDPCGDSWQGVFCVF----SNVTEIRLTGMNLGG--VLADTLGDLESVIN   99 (720)
Q Consensus        27 ~~~~~~~~al~~~~~~l~~~-~~~~w~~~~~~~c~~~w~gv~c~~----~~l~~l~L~~n~l~~--~~~~~~~~l~~L~~   99 (720)
                      .|.++|+.||++||+++++| .+.+|.. +.|||.+.|.||.|..    .+|+.|+|++|+++|  .+|+.|+.+++|++
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~   80 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF   80 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred             CCCHHHHHHHHHHHHhcCCcccccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence            58999999999999999887 5789965 6788855699999975    689999999999999  89999999999999


Q ss_pred             EeccC-CcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCc
Q 004994          100 IDLSN-NHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANN  176 (720)
Q Consensus       100 L~L~~-N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~  176 (720)
                      |+|++ |++.+.+|..+.  .+|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|++|+
T Consensus        81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  160 (313)
T 1ogq_A           81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR  160 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred             eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence            99995 999999999887  799999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCC-CCceeeccccccccccc-cccccccceEEccCCcCcccCCcccCCCccccccCccCCCc
Q 004994          177 LTGQLPPSTRNLS-SLYSLHLQNNKLSGTLN-VLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTT  247 (720)
Q Consensus       177 l~g~~p~~~~~l~-~L~~L~l~~N~l~~~~~-~~~~~~l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~~  247 (720)
                      ++|.+|..+..++ +|+.|+|++|++++.++ .+..+.|+.|++++|.+++.+|..+..+++|+..+...|..
T Consensus       161 l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  233 (313)
T 1ogq_A          161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL  233 (313)
T ss_dssp             CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred             ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCce
Confidence            9999999999998 99999999999997664 56777799999999999999999988888877666655544

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.3e-29  Score=286.53  Aligned_cols=187  Identities=13%  Similarity=0.054  Sum_probs=130.6

Q ss_pred             eccCCCceEEEE-EeCCCcEEEEEEeccccc--------ccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEEEE
Q 004994          448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVS--------QRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       448 lg~G~~g~Vy~~-~~~~g~~vavK~l~~~~~--------~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .+.|+.|.++.+ +...|+.||||++.+...        .....++|.+|+++|+++ .|+||++++++++++++.||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            456666666665 344688999999975421        112346799999999999 7999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||++|++|.+++...    ..++..   +|+.||+.||+|+|+.   +||||||||+|||+++++++||+|||+|+....
T Consensus       322 Eyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999643    345443   5899999999999998   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPY  646 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf  646 (720)
                      ...  ......||++|+|||.+.+.+..++|+||+|++++++.++..|+
T Consensus       392 ~~~--~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          392 DCS--WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --C--CSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred             CCc--cccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence            322  23346789999999999888899999999999998877665443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.94  E-value=6.9e-28  Score=283.08  Aligned_cols=218  Identities=18%  Similarity=0.247  Sum_probs=165.1

Q ss_pred             cCCCCCHHHHHHHHHHHHhcCCCCCCCccCCC----CCCCCCCC------------ceeEeec-CceeEEEecCCccccc
Q 004994           24 CAGVTDPRDVMALNSLYISLNFPPLEKWLSFG----GDPCGDSW------------QGVFCVF-SNVTEIRLTGMNLGGV   86 (720)
Q Consensus        24 ~~~~~~~~~~~al~~~~~~l~~~~~~~w~~~~----~~~c~~~w------------~gv~c~~-~~l~~l~L~~n~l~~~   86 (720)
                      .++.+..+|+.||++||+++++|   +|...+    .+||+|.|            .||.|+. .+|+.|+|++|+|.|.
T Consensus       262 ~~~~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~  338 (876)
T 4ecn_A          262 KETAEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR  338 (876)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEE
T ss_pred             cccccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCc
Confidence            34556678999999999999877   887544    47855599            9999985 7899999999999999


Q ss_pred             CCcCcCCCCCccEEec-cCCccccc-------------------------------------------------------
Q 004994           87 LADTLGDLESVINIDL-SNNHIGGS-------------------------------------------------------  110 (720)
Q Consensus        87 ~~~~~~~l~~L~~L~L-~~N~l~g~-------------------------------------------------------  110 (720)
                      +|+.|++|++|+.|+| ++|.++|.                                                       
T Consensus       339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~  418 (876)
T 4ecn_A          339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK  418 (876)
T ss_dssp             ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred             CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence            9999999999999999 88877766                                                       


Q ss_pred             ---------------------CCCCcc--ccCcEEEecCCcCCC-----------------CCcchhh--cccccccccc
Q 004994          111 ---------------------IPSNLP--VTVRNFSLSGNQLTG-----------------SIPESLS--RLTQLLDLSL  148 (720)
Q Consensus       111 ---------------------ip~~~~--~~L~~L~Ls~N~l~g-----------------~~p~~l~--~l~~L~~L~l  148 (720)
                                           ||..+.  .+|+.|+|++|+|+|                 .+|..++  ++++|+.|+|
T Consensus       419 ~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L  498 (876)
T 4ecn_A          419 KDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL  498 (876)
T ss_dssp             CCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred             cccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence                                 555554  577777777777776                 3777766  7777777777


Q ss_pred             cccccCCCCCchhcCCCCCceEeccCCc-ccc-cCCCCCCCCC-------CCceeeccccccccccc--cccccc-cceE
Q 004994          149 NNNHLNGGIPDAFHQFTGLINFDLSANN-LTG-QLPPSTRNLS-------SLYSLHLQNNKLSGTLN--VLEDLH-LIDL  216 (720)
Q Consensus       149 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~-l~g-~~p~~~~~l~-------~L~~L~l~~N~l~~~~~--~~~~~~-l~~l  216 (720)
                      ++|++.+.+|..|+++++|+.|+|++|+ |+| .+|..+++++       +|+.|+|++|+|+..+.  .+..+. |+.|
T Consensus       499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L  578 (876)
T 4ecn_A          499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLL  578 (876)
T ss_dssp             ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEE
T ss_pred             cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEE
Confidence            7777777777777777777777777777 776 6666554444       77777777777774444  455554 7777


Q ss_pred             EccCCcCcccCCcccCCCccccccCccCCC
Q 004994          217 NIENNLFSGPIPEKLLSIPNFRKDGNPFNT  246 (720)
Q Consensus       217 ~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~  246 (720)
                      +|++|+|+ .+| .+..+++|+..+...|.
T Consensus       579 ~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~  606 (876)
T 4ecn_A          579 DCVHNKVR-HLE-AFGTNVKLTDLKLDYNQ  606 (876)
T ss_dssp             ECTTSCCC-BCC-CCCTTSEESEEECCSSC
T ss_pred             ECCCCCcc-cch-hhcCCCcceEEECcCCc
Confidence            77777777 677 66666666655444443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.94  E-value=7.1e-27  Score=275.51  Aligned_cols=220  Identities=24%  Similarity=0.285  Sum_probs=165.5

Q ss_pred             CCCCCHHHHHHHHHHHHhcCCC-CCCCccCCCCCCCCCCCceeEeecCceeEEEecCCccccc---CC------------
Q 004994           25 AGVTDPRDVMALNSLYISLNFP-PLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGV---LA------------   88 (720)
Q Consensus        25 ~~~~~~~~~~al~~~~~~l~~~-~~~~w~~~~~~~c~~~w~gv~c~~~~l~~l~L~~n~l~~~---~~------------   88 (720)
                      +++..++|+.||++||+++.|| .+.+|.. +.|||  .|.||.|+.++|+.|+|+++.+.|.   +|            
T Consensus         6 ~~~~~~~~~~all~~k~~~~~~~~l~~W~~-~~~~C--~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l   82 (768)
T 3rgz_A            6 PSQSLYREIHQLISFKDVLPDKNLLPDWSS-NKNPC--TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL   82 (768)
T ss_dssp             --CCHHHHHHHHHHHHTTCSCTTSSTTCCT-TSCGG--GSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred             cccCCHHHHHHHHHHHhhCCCcccccCCCC-CCCCc--CCcceEECCCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence            3455788999999999999887 6899973 56777  8999999988999999999999987   54            


Q ss_pred             -----------cCcCCCCCccEEeccCCcccccCCC--Ccc--ccCcEEEecCCcCCCCCcchh-hcccccccccccccc
Q 004994           89 -----------DTLGDLESVINIDLSNNHIGGSIPS--NLP--VTVRNFSLSGNQLTGSIPESL-SRLTQLLDLSLNNNH  152 (720)
Q Consensus        89 -----------~~~~~l~~L~~L~L~~N~l~g~ip~--~~~--~~L~~L~Ls~N~l~g~~p~~l-~~l~~L~~L~l~~N~  152 (720)
                                 +.|+.+++|++|||++|+++|.+|.  .+.  .+|++|+|++|.+++.+|..+ .++++|++|+|++|+
T Consensus        83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  162 (768)
T 3rgz_A           83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS  162 (768)
T ss_dssp             ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred             CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence                       4666777777777777777777776  555  577777777777777777665 677777777777777


Q ss_pred             cCCCCCch---hcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcCcccCC
Q 004994          153 LNGGIPDA---FHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGPIP  228 (720)
Q Consensus       153 l~g~~p~~---~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g~~p  228 (720)
                      +++..|..   +.++++|++|+|++|.+++.+|.  .++++|+.|+|++|++++.++.+..+. |++|++++|+++|.+|
T Consensus       163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~  240 (768)
T 3rgz_A          163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFS  240 (768)
T ss_dssp             CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCHH
T ss_pred             cCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCcCCCccc
Confidence            77666665   66777777777777777765543  677788888888888877776666554 8888888888888888


Q ss_pred             cccCCCccccccCccCCCccc
Q 004994          229 EKLLSIPNFRKDGNPFNTTVI  249 (720)
Q Consensus       229 ~~~~~l~~l~~~~n~~~~~~~  249 (720)
                      ..+..+++|+..+...|...+
T Consensus       241 ~~l~~l~~L~~L~Ls~n~l~~  261 (768)
T 3rgz_A          241 RAISTCTELKLLNISSNQFVG  261 (768)
T ss_dssp             HHTTTCSSCCEEECCSSCCEE
T ss_pred             HHHhcCCCCCEEECCCCcccC
Confidence            877777777665555554433

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.94  E-value=2.1e-27  Score=273.82  Aligned_cols=216  Identities=20%  Similarity=0.291  Sum_probs=174.5

Q ss_pred             CCCCCHHHHHHHHHHHHhcCCC----------CCCCccCCCCCCCCCCC---ceeEeec-CceeEEEecCCcccccCCcC
Q 004994           25 AGVTDPRDVMALNSLYISLNFP----------PLEKWLSFGGDPCGDSW---QGVFCVF-SNVTEIRLTGMNLGGVLADT   90 (720)
Q Consensus        25 ~~~~~~~~~~al~~~~~~l~~~----------~~~~w~~~~~~~c~~~w---~gv~c~~-~~l~~l~L~~n~l~~~~~~~   90 (720)
                      ++.....|+.||.++|.+++.+          ...+|.. +.++|  .|   .||.|+. .+|+.|+|++|+++|.+|+.
T Consensus        24 ~~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c--~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~  100 (636)
T 4eco_A           24 RTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELD--MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDA  100 (636)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGG--GTTCCTTEEECTTCCEEEEECTTSCCEEEECGG
T ss_pred             hhhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcc--cccCCCCeEEcCCCCEEEEEecCcccCCcCChH
Confidence            3445567999999999998654          1337874 56777  89   9999965 59999999999999999999


Q ss_pred             cCCCCCccEEeccCCc----------------------------------------------------------------
Q 004994           91 LGDLESVINIDLSNNH----------------------------------------------------------------  106 (720)
Q Consensus        91 ~~~l~~L~~L~L~~N~----------------------------------------------------------------  106 (720)
                      |++|++|++|+|++|.                                                                
T Consensus       101 l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~  180 (636)
T 4eco_A          101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR  180 (636)
T ss_dssp             GGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCC
T ss_pred             HhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccc
Confidence            9999999999999984                                                                


Q ss_pred             --------------ccccCCCCcc--ccCcEEEecCCcCCCC-----------------Ccchhh--ccccccccccccc
Q 004994          107 --------------IGGSIPSNLP--VTVRNFSLSGNQLTGS-----------------IPESLS--RLTQLLDLSLNNN  151 (720)
Q Consensus       107 --------------l~g~ip~~~~--~~L~~L~Ls~N~l~g~-----------------~p~~l~--~l~~L~~L~l~~N  151 (720)
                                    |+| ||..+.  ++|++|+|++|+|+|.                 +|..++  ++++|++|+|++|
T Consensus       181 ~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n  259 (636)
T 4eco_A          181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC  259 (636)
T ss_dssp             CCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred             cchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence                          444 777775  6888888888888875                 888888  8888888888888


Q ss_pred             ccCCCCCchhcCCCCCceEeccCCc-ccc-cCCCCCCCC------CCCceeeccccccccccc--cccccc-cceEEccC
Q 004994          152 HLNGGIPDAFHQFTGLINFDLSANN-LTG-QLPPSTRNL------SSLYSLHLQNNKLSGTLN--VLEDLH-LIDLNIEN  220 (720)
Q Consensus       152 ~l~g~~p~~~~~l~~L~~L~ls~N~-l~g-~~p~~~~~l------~~L~~L~l~~N~l~~~~~--~~~~~~-l~~l~l~~  220 (720)
                      ++.|.+|..|+++++|+.|+|++|+ ++| .+|..++++      ++|+.|+|++|+|+..+.  .+..+. |+.|++++
T Consensus       260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~  339 (636)
T 4eco_A          260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY  339 (636)
T ss_dssp             TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCS
T ss_pred             cCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcC
Confidence            8888888888888888888888888 887 788877776      888888888888885555  566665 88888888


Q ss_pred             CcCcccCCcccCCCccccccCccCC
Q 004994          221 NLFSGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       221 N~l~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      |+++|.+| .+..+++|+..+...|
T Consensus       340 N~l~g~ip-~~~~l~~L~~L~L~~N  363 (636)
T 4eco_A          340 NQLEGKLP-AFGSEIKLASLNLAYN  363 (636)
T ss_dssp             CCCEEECC-CCEEEEEESEEECCSS
T ss_pred             CcCccchh-hhCCCCCCCEEECCCC
Confidence            88888888 7776666665544444

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.93  E-value=2e-26  Score=243.54  Aligned_cols=220  Identities=17%  Similarity=0.203  Sum_probs=191.5

Q ss_pred             CCCHHHHHHHHHHHHhc-CCC--CCCCcc---CCCCCCCCCCCceeEee----------cCceeEEEecCCcccccCCcC
Q 004994           27 VTDPRDVMALNSLYISL-NFP--PLEKWL---SFGGDPCGDSWQGVFCV----------FSNVTEIRLTGMNLGGVLADT   90 (720)
Q Consensus        27 ~~~~~~~~al~~~~~~l-~~~--~~~~w~---~~~~~~c~~~w~gv~c~----------~~~l~~l~L~~n~l~~~~~~~   90 (720)
                      ....+|+.||++||+++ .++  .+..|.   ....++|  .|.|+.|.          .++|+.|+|++|+++ .+|+.
T Consensus        23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~--~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~   99 (328)
T 4fcg_A           23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE--TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ   99 (328)
T ss_dssp             CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC--CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred             ccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc--ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence            44567999999999988 344  256784   3345566  79999995          378999999999999 78889


Q ss_pred             cCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcC-----
Q 004994           91 LGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQ-----  163 (720)
Q Consensus        91 ~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~-----  163 (720)
                      ++.+++|++|+|++|+|+ .+|..+.  .+|++|+|++|+|+ .+|..|+++++|++|+|++|++.+.+|..+..     
T Consensus       100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~  177 (328)
T 4fcg_A          100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG  177 (328)
T ss_dssp             GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CC
T ss_pred             hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchh
Confidence            999999999999999999 9999887  79999999999999 88999999999999999999999999988765     


Q ss_pred             ----CCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcCcccCCcccCCCcccc
Q 004994          164 ----FTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGPIPEKLLSIPNFR  238 (720)
Q Consensus       164 ----l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g~~p~~~~~l~~l~  238 (720)
                          +++|+.|+|++|+|+ .+|..+.++++|+.|+|++|++++.++.+..+. |+.|+|++|++.+.+|..+..+++|+
T Consensus       178 ~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~  256 (328)
T 4fcg_A          178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK  256 (328)
T ss_dssp             CEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred             hhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence                999999999999999 899999999999999999999999887777665 99999999999999999998888888


Q ss_pred             ccCccCCCcccCCC
Q 004994          239 KDGNPFNTTVIALP  252 (720)
Q Consensus       239 ~~~n~~~~~~~~~~  252 (720)
                      ..+...|......|
T Consensus       257 ~L~L~~n~~~~~~p  270 (328)
T 4fcg_A          257 RLILKDCSNLLTLP  270 (328)
T ss_dssp             EEECTTCTTCCBCC
T ss_pred             EEECCCCCchhhcc
Confidence            76666554444333

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=7.9e-26  Score=254.17  Aligned_cols=186  Identities=13%  Similarity=0.187  Sum_probs=143.4

Q ss_pred             CCCeeccCCCceEEEEEeCCCcEEEEEEecccccc------cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          444 EGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQ------RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       444 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ..+.||+|+||+||+|.. .++.+|+|+.......      ....+.+.+|++++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            357899999999999954 5678899986543211      112356899999999999999995555555666779999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++++|.+++..            +..++.|+++||+|||+.   +|+||||||+|||++.  ++||+|||+|+....
T Consensus       419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            99999999999853            457999999999999987   9999999999999999  999999999988743


Q ss_pred             CCCcc-----cccCccccccCCCCccCC---CCCCCccchHhHHHHHHHHHhCCCCCC
Q 004994          598 GSTNE-----LSEGLLTAHGSGAPEFES---GSYSCQSDVYSLGVVMLELLTGRKPYD  647 (720)
Q Consensus       598 ~~~~~-----~~~~~~~~~~~~aPE~~~---~~~~~~~Dv~S~Gvvl~elltG~~Pf~  647 (720)
                      .....     ......+|+.|+|||++.   ..|+..+|+||..+-.++-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            22111     123467899999999984   357888999999999999998887773

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.90  E-value=5.1e-24  Score=223.63  Aligned_cols=187  Identities=25%  Similarity=0.457  Sum_probs=123.2

Q ss_pred             eEeecCceeEEEecC-CcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccc
Q 004994           66 VFCVFSNVTEIRLTG-MNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        66 v~c~~~~l~~l~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      .++.+++|+.|+|++ |++.+.+|..|+.+++|++|+|++|+|++.+|..+.  .+|++|+|++|++++.+|..|.++++
T Consensus        71 ~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  150 (313)
T 1ogq_A           71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN  150 (313)
T ss_dssp             GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTT
T ss_pred             hHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCC
Confidence            445567777777774 777777777777777777777777777777776665  56777777777777777777777777


Q ss_pred             cccccccccccCCCCCchhcCCC-CCceEeccCCcccccCCCC-----------------------CCCCCCCceeeccc
Q 004994          143 LLDLSLNNNHLNGGIPDAFHQFT-GLINFDLSANNLTGQLPPS-----------------------TRNLSSLYSLHLQN  198 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~~l~-~L~~L~ls~N~l~g~~p~~-----------------------~~~l~~L~~L~l~~  198 (720)
                      |++|+|++|+++|.+|..++.++ +|+.|+|++|++++.+|..                       +..+++|+.|+|++
T Consensus       151 L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  230 (313)
T 1ogq_A          151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK  230 (313)
T ss_dssp             CCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCS
T ss_pred             CCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCC
Confidence            77777777777766776666665 6666666666666555544                       44555555555555


Q ss_pred             cccccccccccccc-cceEEccCCcCcccCCcccCCCccccccCccCCCcccCCC
Q 004994          199 NKLSGTLNVLEDLH-LIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALP  252 (720)
Q Consensus       199 N~l~~~~~~~~~~~-l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~~~~~~~  252 (720)
                      |++++.++.+..+. |++|+|++|+|+|.+|..+..+++|+..+...|...+.+|
T Consensus       231 N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  285 (313)
T 1ogq_A          231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             SEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             CceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence            55555554444433 7777777777777777777666666655555554443333

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.89  E-value=1.7e-23  Score=246.76  Aligned_cols=190  Identities=27%  Similarity=0.411  Sum_probs=139.8

Q ss_pred             eeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccc
Q 004994           65 GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      ..++.+++|+.|+|++|+++|.+|..++.+++|++|+|++|+++|.+|..+.  ++|+.|+|++|+++|.+|..++++++
T Consensus       460 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  539 (768)
T 3rgz_A          460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS  539 (768)
T ss_dssp             GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTT
T ss_pred             HHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCC
Confidence            3444566777777777777777777777777777777777777777777665  57777777777777777777777777


Q ss_pred             cccccccccccCCCCCchhc------------------------------------------------------------
Q 004994          143 LLDLSLNNNHLNGGIPDAFH------------------------------------------------------------  162 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~------------------------------------------------------------  162 (720)
                      |+.|+|++|+++|.+|..+.                                                            
T Consensus       540 L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  619 (768)
T 3rgz_A          540 LIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV  619 (768)
T ss_dssp             CCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCE
T ss_pred             CCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccce
Confidence            77777777777776665443                                                            


Q ss_pred             ----------CCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCcccCCcc
Q 004994          163 ----------QFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSGPIPEK  230 (720)
Q Consensus       163 ----------~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g~~p~~  230 (720)
                                ++++|+.|||++|+|+|.+|..++++++|+.|+|++|+|+|.+| .+..+. |+.|||++|+++|.+|..
T Consensus       620 ~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~  699 (768)
T 3rgz_A          620 YGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA  699 (768)
T ss_dssp             EEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGG
T ss_pred             ecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChH
Confidence                      24567778888888888888888888888888888888887664 455555 888888888888888888


Q ss_pred             cCCCccccccCccCCCcccCCCCC
Q 004994          231 LLSIPNFRKDGNPFNTTVIALPPT  254 (720)
Q Consensus       231 ~~~l~~l~~~~n~~~~~~~~~~~~  254 (720)
                      +.+++.|+..+.++|...+.+|..
T Consensus       700 l~~l~~L~~L~ls~N~l~g~iP~~  723 (768)
T 3rgz_A          700 MSALTMLTEIDLSNNNLSGPIPEM  723 (768)
T ss_dssp             GGGCCCCSEEECCSSEEEEECCSS
T ss_pred             HhCCCCCCEEECcCCcccccCCCc
Confidence            877777777777777666666543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.88  E-value=5.1e-22  Score=203.77  Aligned_cols=175  Identities=22%  Similarity=0.326  Sum_probs=105.0

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCc-c--ccCcEEEecCCcCCCCCcchhhcccccccccc
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL-P--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL  148 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~-~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l  148 (720)
                      +++.|+|++|++++..+..|..+++|++|+|++|+|+ .+|..+ .  .+|++|+|++|++++..+..|.++++|+.|+|
T Consensus        38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  116 (270)
T 2o6q_A           38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL  116 (270)
T ss_dssp             TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred             CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence            3566666666666655556666666666666666666 444332 2  56666666666666555555666666666666


Q ss_pred             cccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccc-cccc-ccceEEccCCcCccc
Q 004994          149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV-LEDL-HLIDLNIENNLFSGP  226 (720)
Q Consensus       149 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~-~l~~l~l~~N~l~g~  226 (720)
                      ++|++++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++++.++. +..+ .|+.|+|++|++++.
T Consensus       117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  196 (270)
T 2o6q_A          117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRV  196 (270)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcC
Confidence            66666655555666666666666666666644444466666666666666666665542 3333 366666666666644


Q ss_pred             CCcccCCCc---cccccCccCCCc
Q 004994          227 IPEKLLSIP---NFRKDGNPFNTT  247 (720)
Q Consensus       227 ~p~~~~~l~---~l~~~~n~~~~~  247 (720)
                      .+..+..++   .|.+.+|+|.|.
T Consensus       197 ~~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          197 PEGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCBCCS
T ss_pred             CHHHhccccCCCEEEecCCCeeCC
Confidence            443343333   344455555443

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=2e-22  Score=198.33  Aligned_cols=175  Identities=24%  Similarity=0.244  Sum_probs=150.9

Q ss_pred             CCCCCCCceeEeec-----------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEE
Q 004994           57 DPCGDSWQGVFCVF-----------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFS  123 (720)
Q Consensus        57 ~~c~~~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~  123 (720)
                      +.|.|.|.++.|..           ++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..+.  .+|++|+
T Consensus         3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~   82 (208)
T 2o6s_A            3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN   82 (208)
T ss_dssp             TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence            46777899999963           3689999999999988778899999999999999999954444444  7899999


Q ss_pred             ecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccc
Q 004994          124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG  203 (720)
Q Consensus       124 Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~  203 (720)
                      |++|+|++..+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|.+.+
T Consensus        83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  162 (208)
T 2o6s_A           83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  162 (208)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred             CCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence            99999997777778999999999999999997777778999999999999999996666668999999999999999887


Q ss_pred             ccccccccccceEEccCCcCcccCCcccCCCcc
Q 004994          204 TLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPN  236 (720)
Q Consensus       204 ~~~~~~~~~l~~l~l~~N~l~g~~p~~~~~l~~  236 (720)
                      ..+     .|+.|+++.|+++|.+|..++.++.
T Consensus       163 ~~~-----~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          163 TCP-----GIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CTT-----TTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             CCC-----CHHHHHHHHHhCCceeeccCccccC
Confidence            554     3678889999999999998887653

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.86  E-value=7.7e-22  Score=208.32  Aligned_cols=182  Identities=18%  Similarity=0.282  Sum_probs=127.0

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhc-----
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSR-----  139 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~-----  139 (720)
                      +..+++|+.|+|++|+++ .+|..++.+++|++|+|++|+|+ .+|..+.  .+|+.|+|++|++.+.+|..+..     
T Consensus       100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~  177 (328)
T 4fcg_A          100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG  177 (328)
T ss_dssp             GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CC
T ss_pred             hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchh
Confidence            334677777788777777 67777777777777777777777 6776665  57777777777777777776654     


Q ss_pred             ----ccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-c
Q 004994          140 ----LTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-L  213 (720)
Q Consensus       140 ----l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l  213 (720)
                          +++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+++ .+|..+..+++|+.|+|++|++.+.++ .+..+. |
T Consensus       178 ~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L  255 (328)
T 4fcg_A          178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL  255 (328)
T ss_dssp             CEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCC
T ss_pred             hhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCC
Confidence                777777777777777 67777777777777777777777 466667777777777777777766654 344443 7


Q ss_pred             ceEEccCCcCcccCCcccCCCccccccCccCCCcccCCC
Q 004994          214 IDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALP  252 (720)
Q Consensus       214 ~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~~~~~~~  252 (720)
                      +.|+|++|++.+.+|..+.++++|+..+...|...+..|
T Consensus       256 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP  294 (328)
T 4fcg_A          256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP  294 (328)
T ss_dssp             CEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCC
T ss_pred             CEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhcc
Confidence            777777777777777766666666655555544444433

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=2.5e-22  Score=207.00  Aligned_cols=145  Identities=12%  Similarity=0.037  Sum_probs=113.6

Q ss_pred             HHHHHHHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEeccccccc----------------ccHHHHHHHHHHHHcc
Q 004994          432 IASLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQR----------------QTDEEFLELASTISRL  495 (720)
Q Consensus       432 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----------------~~~~~~~~e~~~l~~l  495 (720)
                      +..+......|...+.||+|+||.||+|...+|+.||||.++......                .....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            344445556676779999999999999977789999999996432111                1346789999999999


Q ss_pred             CCCceeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 004994          496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSN  575 (720)
Q Consensus       496 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~N  575 (720)
                      +|   +++.+++.. +..++||||+++++|.+ +..          .....++.++++||.|||+.   +||||||||+|
T Consensus       162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N  223 (282)
T 1zar_A          162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN  223 (282)
T ss_dssp             TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             cC---CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence            84   555554433 45699999999999988 421          11336999999999999987   99999999999


Q ss_pred             eEEcCCCCeEEccccCCCCC
Q 004994          576 ILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       576 iLl~~~~~~kl~DFGla~~~  595 (720)
                      ||++ ++.+||+|||+|+..
T Consensus       224 ILl~-~~~vkl~DFG~a~~~  242 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVEV  242 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEET
T ss_pred             EEEE-CCcEEEEECCCCeEC
Confidence            9999 999999999998643

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.86  E-value=2.2e-21  Score=196.74  Aligned_cols=181  Identities=21%  Similarity=0.262  Sum_probs=152.6

Q ss_pred             CCceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhc
Q 004994           62 SWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSR  139 (720)
Q Consensus        62 ~w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~  139 (720)
                      .|.|..|. .+.+.+++++++++. +|..+.  ++|+.|+|++|++++..|..+.  .+|+.|+|++|+|++..|..|.+
T Consensus         6 ~~~gC~C~-~~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (251)
T 3m19_A            6 TVTGCTCN-EGKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD   81 (251)
T ss_dssp             HHHSSEEE-GGGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred             CCCceEcC-CCCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhcc
Confidence            68898885 456789999999984 666655  6899999999999977777776  78999999999999888888999


Q ss_pred             ccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEE
Q 004994          140 LTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLN  217 (720)
Q Consensus       140 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~  217 (720)
                      +++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|++.++ .+..+. |+.|+
T Consensus        82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  161 (251)
T 3m19_A           82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS  161 (251)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEE
Confidence            9999999999999998777889999999999999999996666668999999999999999998886 465554 99999


Q ss_pred             ccCCcCcccCCcccCCCccc---cccCccCCC
Q 004994          218 IENNLFSGPIPEKLLSIPNF---RKDGNPFNT  246 (720)
Q Consensus       218 l~~N~l~g~~p~~~~~l~~l---~~~~n~~~~  246 (720)
                      |++|+|++..|..+..+++|   .+.+|++.|
T Consensus       162 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          162 LSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             CCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            99999997777667665554   456666653

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.85  E-value=7.9e-21  Score=196.84  Aligned_cols=176  Identities=23%  Similarity=0.200  Sum_probs=151.2

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN  150 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~  150 (720)
                      ++++.|+|++|++++..+..|..+++|+.|+|++|+|++..+..-..+|+.|+|++|+|+ .+|..+.++++|+.|+|++
T Consensus        31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~  109 (290)
T 1p9a_G           31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF  109 (290)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred             CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCC
Confidence            578999999999999888999999999999999999995444333378999999999999 8898999999999999999


Q ss_pred             cccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccc-ccccc-cceEEccCCcCcccCC
Q 004994          151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV-LEDLH-LIDLNIENNLFSGPIP  228 (720)
Q Consensus       151 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-l~~l~l~~N~l~g~~p  228 (720)
                      |+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. +..+. |+.|+|++|+|+ .+|
T Consensus       110 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip  188 (290)
T 1p9a_G          110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP  188 (290)
T ss_dssp             SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred             CcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccC
Confidence            999987778899999999999999999976667788999999999999999988754 45454 999999999999 788


Q ss_pred             cccCCCc---cccccCccCCCcc
Q 004994          229 EKLLSIP---NFRKDGNPFNTTV  248 (720)
Q Consensus       229 ~~~~~l~---~l~~~~n~~~~~~  248 (720)
                      ..+..+.   .+.+.+|+|.|.|
T Consensus       189 ~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          189 KGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             TTTTTTCCCSEEECCSCCBCCSG
T ss_pred             hhhcccccCCeEEeCCCCccCcC
Confidence            8776544   4556788887654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.84  E-value=1.2e-20  Score=195.26  Aligned_cols=176  Identities=21%  Similarity=0.223  Sum_probs=154.1

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCc-CCCCCcchhhccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQ-LTGSIPESLSRLTQLLDLS  147 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~-l~g~~p~~l~~l~~L~~L~  147 (720)
                      ++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..+.  .+|++|+|++|. ++...|..|.++++|++|+
T Consensus        32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~  111 (285)
T 1ozn_A           32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (285)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence            4789999999999998888899999999999999999977788776  789999999997 8866688899999999999


Q ss_pred             ccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccc-ccccc-cceEEccCCcCcc
Q 004994          148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV-LEDLH-LIDLNIENNLFSG  225 (720)
Q Consensus       148 l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-l~~l~l~~N~l~g  225 (720)
                      |++|.+++..|..|.++++|++|+|++|++++..+..+..+++|+.|+|++|+|++.++. +..+. |+.|++++|.+++
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence            999999988888899999999999999999966666789999999999999999987753 55554 9999999999999


Q ss_pred             cCCcccCCCccccccCccCCC
Q 004994          226 PIPEKLLSIPNFRKDGNPFNT  246 (720)
Q Consensus       226 ~~p~~~~~l~~l~~~~n~~~~  246 (720)
                      ..|..+..+++|+..+...|.
T Consensus       192 ~~~~~~~~l~~L~~L~l~~n~  212 (285)
T 1ozn_A          192 VHPHAFRDLGRLMTLYLFANN  212 (285)
T ss_dssp             ECTTTTTTCTTCCEEECCSSC
T ss_pred             cCHhHccCcccccEeeCCCCc
Confidence            889988887777766555543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.84  E-value=6.2e-21  Score=197.32  Aligned_cols=183  Identities=24%  Similarity=0.289  Sum_probs=157.6

Q ss_pred             eEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCc-ccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccc
Q 004994           66 VFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNH-IGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        66 v~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      .+..+++|+.|+|++|++++..|..|..+++|++|+|++|+ +.+..|..+.  .+|++|+|++|++++..|..|.++++
T Consensus        51 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  130 (285)
T 1ozn_A           51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA  130 (285)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT
T ss_pred             HcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcC
Confidence            34567899999999999999889999999999999999998 7755577775  79999999999999888999999999


Q ss_pred             cccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccc-ccccccc-cceEEccC
Q 004994          143 LLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL-NVLEDLH-LIDLNIEN  220 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~-l~~l~l~~  220 (720)
                      |++|+|++|++++..+..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|.+++.. ..+..+. |+.|++++
T Consensus       131 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  210 (285)
T 1ozn_A          131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA  210 (285)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCC
Confidence            999999999999777777999999999999999999666667999999999999999999885 4555554 99999999


Q ss_pred             CcCcccCCcccCCCcc---ccccCccCCCcc
Q 004994          221 NLFSGPIPEKLLSIPN---FRKDGNPFNTTV  248 (720)
Q Consensus       221 N~l~g~~p~~~~~l~~---l~~~~n~~~~~~  248 (720)
                      |++++..|..+..+++   |.+.+|++.|.+
T Consensus       211 n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~  241 (285)
T 1ozn_A          211 NNLSALPTEALAPLRALQYLRLNDNPWVCDC  241 (285)
T ss_dssp             SCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred             CcCCcCCHHHcccCcccCEEeccCCCccCCC
Confidence            9999766665665555   556777776544

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.83  E-value=2.5e-20  Score=188.97  Aligned_cols=158  Identities=22%  Similarity=0.278  Sum_probs=142.3

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL  148 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l  148 (720)
                      .+++.|+|++|++++..+..|..+++|++|+|++|+|++..|..+.  .+|+.|+|++|+|++..+..|.++++|+.|+|
T Consensus        35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  114 (251)
T 3m19_A           35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL  114 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence            4689999999999999999999999999999999999977776665  79999999999999887788999999999999


Q ss_pred             cccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCccc
Q 004994          149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSGP  226 (720)
Q Consensus       149 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g~  226 (720)
                      ++|+|++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|+|++.++ .+..+. |+.|+|++|.+++.
T Consensus       115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            9999997777778999999999999999996666689999999999999999998875 455554 99999999999976


Q ss_pred             CC
Q 004994          227 IP  228 (720)
Q Consensus       227 ~p  228 (720)
                      ..
T Consensus       195 ~~  196 (251)
T 3m19_A          195 RC  196 (251)
T ss_dssp             ST
T ss_pred             cc
Confidence            33

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.83  E-value=7.3e-21  Score=198.91  Aligned_cols=188  Identities=19%  Similarity=0.246  Sum_probs=143.5

Q ss_pred             CCCCCCCceeEeec-----------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCccccc--CCCCcc--ccCcE
Q 004994           57 DPCGDSWQGVFCVF-----------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGS--IPSNLP--VTVRN  121 (720)
Q Consensus        57 ~~c~~~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~--ip~~~~--~~L~~  121 (720)
                      ++|.|.|.++.|..           ++++.|+|++|+++...+..|..+++|++|+|++|+++..  +|..+.  .+|++
T Consensus         3 ~~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~   82 (306)
T 2z66_A            3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY   82 (306)
T ss_dssp             TTCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred             CCCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence            46777899999963           3689999999999976666689999999999999999832  233332  67888


Q ss_pred             EEecCCcCCCCCcchhhcccccccccccccccCCCCC-chhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccc
Q 004994          122 FSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIP-DAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNK  200 (720)
Q Consensus       122 L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  200 (720)
                      |+|++|.++ .+|..+.++++|+.|+|++|++++..+ ..+..+++|++|++++|.+++..|..+.++++|+.|+|++|.
T Consensus        83 L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  161 (306)
T 2z66_A           83 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS  161 (306)
T ss_dssp             EECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred             EECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence            888888888 567778888888888888888876544 567888888888888888887777778888888888888888


Q ss_pred             ccc--ccccccccc-cceEEccCCcCcccCCcccCCCccccccCccCC
Q 004994          201 LSG--TLNVLEDLH-LIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       201 l~~--~~~~~~~~~-l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      +++  .+..+..+. |+.|++++|++++..|..+..+++|+..+...|
T Consensus       162 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N  209 (306)
T 2z66_A          162 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN  209 (306)
T ss_dssp             EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCC
Confidence            876  334455554 888888888888777777776666655444433

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.82  E-value=2.6e-20  Score=191.69  Aligned_cols=158  Identities=20%  Similarity=0.204  Sum_probs=121.4

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccccccc
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN  149 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~  149 (720)
                      +|+.|+|++|++++..+..|.++++|++|+|++|++++..+..+.  .+|++|+|++|++++..|..|.++++|+.|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            588888888888887777888888888888888888865555565  678888888888887777788888888888888


Q ss_pred             ccccCCCCCchhcCCCCCceEeccCCcccc-cCCCCCCCCCCCceeeccccccccccc-cccccc-cc----eEEccCCc
Q 004994          150 NNHLNGGIPDAFHQFTGLINFDLSANNLTG-QLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LI----DLNIENNL  222 (720)
Q Consensus       150 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~----~l~l~~N~  222 (720)
                      +|++++..+..+.++++|++|+|++|++++ .+|..+.++++|+.|+|++|++++.++ .+..+. ++    .|++++|.
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            888887666678888888888888888875 368888888888888888888877653 232221 32    67777777


Q ss_pred             CcccCCc
Q 004994          223 FSGPIPE  229 (720)
Q Consensus       223 l~g~~p~  229 (720)
                      +++..+.
T Consensus       189 l~~~~~~  195 (276)
T 2z62_A          189 MNFIQPG  195 (276)
T ss_dssp             CCEECTT
T ss_pred             ccccCcc
Confidence            7754443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.82  E-value=5.8e-20  Score=218.76  Aligned_cols=91  Identities=23%  Similarity=0.246  Sum_probs=73.5

Q ss_pred             hhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCcCcccCCcccCCCccccc
Q 004994          160 AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRK  239 (720)
Q Consensus       160 ~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~g~~p~~~~~l~~l~~  239 (720)
                      .|.++++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.++......|+.|+|++|+|++.+|..+.++..|.+
T Consensus       475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l  554 (844)
T 3j0a_A          475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDI  554 (844)
T ss_dssp             CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEE
T ss_pred             hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEe
Confidence            35566777777777777777677778888888888888888887775443456899999999999999999999999999


Q ss_pred             cCccCCCcccC
Q 004994          240 DGNPFNTTVIA  250 (720)
Q Consensus       240 ~~n~~~~~~~~  250 (720)
                      .+|+|.|.|..
T Consensus       555 ~~Np~~C~c~~  565 (844)
T 3j0a_A          555 THNKFICECEL  565 (844)
T ss_dssp             EEECCCCSSSC
T ss_pred             cCCCccccccc
Confidence            99999997753

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.81  E-value=1.1e-19  Score=200.74  Aligned_cols=185  Identities=21%  Similarity=0.224  Sum_probs=146.2

Q ss_pred             CCceeEeec-----------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCc
Q 004994           62 SWQGVFCVF-----------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQ  128 (720)
Q Consensus        62 ~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~  128 (720)
                      .|..+.|..           ++++.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..+.  .+|++|+|++|+
T Consensus        55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~  134 (452)
T 3zyi_A           55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW  134 (452)
T ss_dssp             SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence            367788853           3689999999999999999999999999999999999977777776  789999999999


Q ss_pred             CCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCC-CCCCCCCCCceeecccccccccccc
Q 004994          129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP-PSTRNLSSLYSLHLQNNKLSGTLNV  207 (720)
Q Consensus       129 l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~  207 (720)
                      |++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+..+.+| ..+.++++|+.|+|++|+|++.+..
T Consensus       135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~  214 (452)
T 3zyi_A          135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNL  214 (452)
T ss_dssp             CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCC
T ss_pred             CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccccc
Confidence            997777779999999999999999997666678888888888888843333444 4577888888888888888776432


Q ss_pred             ccccccceEEccCCcCcccCCcccCCCccccccCccCCC
Q 004994          208 LEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNT  246 (720)
Q Consensus       208 ~~~~~l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~  246 (720)
                      .....|+.|+|++|+|++..|..|..+++|+..+...|.
T Consensus       215 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~  253 (452)
T 3zyi_A          215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ  253 (452)
T ss_dssp             TTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSC
T ss_pred             cccccccEEECcCCcCcccCcccccCccCCCEEEeCCCc
Confidence            222347788888888887777777766666655444443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.81  E-value=3.3e-20  Score=190.44  Aligned_cols=172  Identities=23%  Similarity=0.286  Sum_probs=146.9

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      +..+++|+.|+|++|++++.  +.+..+++|++|+|++|+|++..|..+.  .+|++|+|++|++++..|..|.++++|+
T Consensus        59 l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  136 (272)
T 3rfs_A           59 IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT  136 (272)
T ss_dssp             GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence            45678999999999999974  4899999999999999999966665554  7899999999999988888899999999


Q ss_pred             cccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccc-ccccc-cceEEccCCc
Q 004994          145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV-LEDLH-LIDLNIENNL  222 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-l~~l~l~~N~  222 (720)
                      .|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|+|++.++. +..+. |+.|++++|.
T Consensus       137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  216 (272)
T 3rfs_A          137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP  216 (272)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence            999999999987777789999999999999999977777789999999999999999998764 45554 9999999999


Q ss_pred             CcccCCcccCCCccccccCccC
Q 004994          223 FSGPIPEKLLSIPNFRKDGNPF  244 (720)
Q Consensus       223 l~g~~p~~~~~l~~l~~~~n~~  244 (720)
                      +.+..|    ++..+....|.+
T Consensus       217 ~~~~~~----~l~~l~~~~n~~  234 (272)
T 3rfs_A          217 WDCTCP----GIRYLSEWINKH  234 (272)
T ss_dssp             BCCCTT----TTHHHHHHHHHT
T ss_pred             ccccCc----HHHHHHHHHHhC
Confidence            998766    234444444443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.81  E-value=1.6e-19  Score=198.87  Aligned_cols=184  Identities=21%  Similarity=0.234  Sum_probs=140.1

Q ss_pred             CCceeEeec-----------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCc
Q 004994           62 SWQGVFCVF-----------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQ  128 (720)
Q Consensus        62 ~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~  128 (720)
                      .|..+.|..           .+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..+.  .+|++|+|++|+
T Consensus        44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~  123 (440)
T 3zyj_A           44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR  123 (440)
T ss_dssp             TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence            466778853           4578899999999988888999999999999999999866666665  789999999999


Q ss_pred             CCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCC-CCCCCCCCCceeecccccccccccc
Q 004994          129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP-PSTRNLSSLYSLHLQNNKLSGTLNV  207 (720)
Q Consensus       129 l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~~  207 (720)
                      |++..+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+..+.++ ..|.++++|+.|+|++|+|+..+..
T Consensus       124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~  203 (440)
T 3zyj_A          124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNL  203 (440)
T ss_dssp             CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCC
T ss_pred             CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccccc
Confidence            996666678899999999999999987666678888888888888844333444 4677888888888888888765432


Q ss_pred             ccccccceEEccCCcCcccCCcccCCCccccccCccCC
Q 004994          208 LEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       208 ~~~~~l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      .....|+.|+|++|+|++..|..|..+++|+..+...|
T Consensus       204 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  241 (440)
T 3zyj_A          204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS  241 (440)
T ss_dssp             TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             CCCcccCEEECCCCccCccChhhhccCccCCEEECCCC
Confidence            22234778888888887777777776666655444443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.81  E-value=5.3e-20  Score=192.34  Aligned_cols=180  Identities=19%  Similarity=0.229  Sum_probs=107.9

Q ss_pred             eeEeecCceeEEEecCCcccc--cCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCc-chhhc
Q 004994           65 GVFCVFSNVTEIRLTGMNLGG--VLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIP-ESLSR  139 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p-~~l~~  139 (720)
                      +++..+++|+.|+|++|+++.  ..+..+..+++|++|+|++|++. .+|..+.  .+|+.|+|++|++++..+ ..+.+
T Consensus        46 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  124 (306)
T 2z66_A           46 GVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS  124 (306)
T ss_dssp             TTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTT
T ss_pred             hHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhh
Confidence            344556667777777777662  23455556666666666666666 4554443  566666666666664433 45666


Q ss_pred             ccccccccccccccCCCCCchhcCCCCCceEeccCCcccc-cCCCCCCCCCCCceeeccccccccccc-cccccc-cceE
Q 004994          140 LTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG-QLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDL  216 (720)
Q Consensus       140 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l  216 (720)
                      +++|+.|+|++|.+++..|..|.++++|+.|+|++|.+++ .+|..+..+++|+.|+|++|++++.++ .+..+. |+.|
T Consensus       125 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  204 (306)
T 2z66_A          125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  204 (306)
T ss_dssp             CTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             ccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence            6666666666666666666666666666666666666664 456666666666666666666666542 333333 6666


Q ss_pred             EccCCcCcccCCcccCCCccccccCccCC
Q 004994          217 NIENNLFSGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       217 ~l~~N~l~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      +|++|++++..+..+..+++|+..+...|
T Consensus       205 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  233 (306)
T 2z66_A          205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLN  233 (306)
T ss_dssp             ECTTSCCSBCCSGGGTTCTTCCEEECTTS
T ss_pred             ECCCCccCccChhhccCcccCCEeECCCC
Confidence            66666666555545555555444444433

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.81  E-value=1.1e-19  Score=187.01  Aligned_cols=183  Identities=17%  Similarity=0.259  Sum_probs=155.2

Q ss_pred             eEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccc
Q 004994           66 VFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQL  143 (720)
Q Consensus        66 v~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L  143 (720)
                      .+..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..+.  .+|++|+|++|++++..+..+.++++|
T Consensus        47 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  126 (276)
T 2z62_A           47 SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL  126 (276)
T ss_dssp             TTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTC
T ss_pred             HhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCC
Confidence            445678999999999999988888999999999999999999977777776  799999999999998777789999999


Q ss_pred             ccccccccccCCC-CCchhcCCCCCceEeccCCcccccCCCCCCCCCCCc----eeecccccccccccc-ccccccceEE
Q 004994          144 LDLSLNNNHLNGG-IPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLY----SLHLQNNKLSGTLNV-LEDLHLIDLN  217 (720)
Q Consensus       144 ~~L~l~~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~----~L~l~~N~l~~~~~~-~~~~~l~~l~  217 (720)
                      +.|+|++|++++. +|..|.++++|+.|+|++|++++..+..+..+.+|+    .|+|++|.+++.++. +....|+.|+
T Consensus       127 ~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~  206 (276)
T 2z62_A          127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELA  206 (276)
T ss_dssp             CEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEE
T ss_pred             CEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEE
Confidence            9999999999873 699999999999999999999977777888777777    899999999988754 4445799999


Q ss_pred             ccCCcCcccCCcccCCCcc---ccccCccCCCcc
Q 004994          218 IENNLFSGPIPEKLLSIPN---FRKDGNPFNTTV  248 (720)
Q Consensus       218 l~~N~l~g~~p~~~~~l~~---l~~~~n~~~~~~  248 (720)
                      +++|++++..+..+..+++   |.+.+|++.|.|
T Consensus       207 L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  240 (276)
T 2z62_A          207 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  240 (276)
T ss_dssp             CCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred             CCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence            9999999666655555554   556777776543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.80  E-value=3.3e-19  Score=182.94  Aligned_cols=173  Identities=23%  Similarity=0.317  Sum_probs=148.8

Q ss_pred             ecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      .+.+|+.|++++|.++..  +.+..+++|++|+|++|++++ ++ .+.  .+|++|+|++|++++..|..|.++++|++|
T Consensus        39 ~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  114 (272)
T 3rfs_A           39 ELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-IS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL  114 (272)
T ss_dssp             HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             cccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEE
Confidence            467899999999999853  468999999999999999995 44 444  789999999999998888889999999999


Q ss_pred             cccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccc-cccc-ccceEEccCCcCc
Q 004994          147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV-LEDL-HLIDLNIENNLFS  224 (720)
Q Consensus       147 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~-~l~~l~l~~N~l~  224 (720)
                      +|++|++++..|..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|+|++.++. +..+ .|+.|++++|+++
T Consensus       115 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  194 (272)
T 3rfs_A          115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK  194 (272)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence            9999999988888899999999999999999977777789999999999999999988764 4555 4999999999999


Q ss_pred             ccCCcccCCCcccc---ccCccCC
Q 004994          225 GPIPEKLLSIPNFR---KDGNPFN  245 (720)
Q Consensus       225 g~~p~~~~~l~~l~---~~~n~~~  245 (720)
                      +..|..+..+++|+   +.+|++.
T Consensus       195 ~~~~~~~~~l~~L~~L~l~~N~~~  218 (272)
T 3rfs_A          195 SVPDGVFDRLTSLQYIWLHDNPWD  218 (272)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ccCHHHHhCCcCCCEEEccCCCcc
Confidence            88887776666655   4556554

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.80  E-value=4.3e-20  Score=212.70  Aligned_cols=180  Identities=15%  Similarity=0.229  Sum_probs=159.3

Q ss_pred             EeecCceeEEEecCCccccc-----------------CCcCcC--CCCCccEEeccCCcccccCCCCcc--ccCcEEEec
Q 004994           67 FCVFSNVTEIRLTGMNLGGV-----------------LADTLG--DLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLS  125 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls  125 (720)
                      +..+++|+.|+|++|+|+|.                 +|+.++  ++++|++|+|++|++.|.+|..+.  .+|+.|+|+
T Consensus       202 l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls  281 (636)
T 4eco_A          202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA  281 (636)
T ss_dssp             GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECT
T ss_pred             HhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECc
Confidence            44578999999999999996                 999999  999999999999999999999987  799999999


Q ss_pred             CCc-CCC-CCcchhhcc------cccccccccccccCCCCCc--hhcCCCCCceEeccCCcccccCCCCCCCCCCCceee
Q 004994          126 GNQ-LTG-SIPESLSRL------TQLLDLSLNNNHLNGGIPD--AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLH  195 (720)
Q Consensus       126 ~N~-l~g-~~p~~l~~l------~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~  195 (720)
                      +|+ ++| .+|..++++      ++|+.|+|++|+++ .+|.  .|+++++|+.|+|++|+++|.+| .+.++++|+.|+
T Consensus       282 ~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~  359 (636)
T 4eco_A          282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN  359 (636)
T ss_dssp             TCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEE
T ss_pred             CCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEE
Confidence            999 999 899999987      99999999999999 8998  99999999999999999999999 999999999999


Q ss_pred             cccccccccccccccc-c-cceEEccCCcCcccCCcccCCCc--cccccCccCCCccc
Q 004994          196 LQNNKLSGTLNVLEDL-H-LIDLNIENNLFSGPIPEKLLSIP--NFRKDGNPFNTTVI  249 (720)
Q Consensus       196 l~~N~l~~~~~~~~~~-~-l~~l~l~~N~l~g~~p~~~~~l~--~l~~~~n~~~~~~~  249 (720)
                      |++|+++..+..+..+ . |+.|++++|+++ .+|..+..+.  +|+..+...|...+
T Consensus       360 L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~  416 (636)
T 4eco_A          360 LAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGS  416 (636)
T ss_dssp             CCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTT
T ss_pred             CCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCC
Confidence            9999999666556554 5 999999999999 8998876543  55555554444433

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.80  E-value=1.5e-19  Score=198.96  Aligned_cols=179  Identities=17%  Similarity=0.208  Sum_probs=129.6

Q ss_pred             eeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccc
Q 004994           65 GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      ..+..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..+.  .+|+.|+|++|+|++..+..|.++++
T Consensus        82 ~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  161 (440)
T 3zyj_A           82 NSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPS  161 (440)
T ss_dssp             TTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTT
T ss_pred             HHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcc
Confidence            4456678899999999999988888999999999999999999944444454  78999999999998766667888888


Q ss_pred             cccccccccccCCCC-CchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEcc
Q 004994          143 LLDLSLNNNHLNGGI-PDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIE  219 (720)
Q Consensus       143 L~~L~l~~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~  219 (720)
                      |+.|+|++|+..+.+ +..|.++++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++..+ .+..+. |+.|+|+
T Consensus       162 L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  239 (440)
T 3zyj_A          162 LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI  239 (440)
T ss_dssp             CCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred             cCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECC
Confidence            888888874433334 345777777777777777776 555 36777777777777777776643 344443 6777777


Q ss_pred             CCcCcccCCcccCCCccccccCccCC
Q 004994          220 NNLFSGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       220 ~N~l~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      +|++++..|..|..+++|+..+...|
T Consensus       240 ~n~l~~~~~~~~~~l~~L~~L~L~~N  265 (440)
T 3zyj_A          240 QSQIQVIERNAFDNLQSLVEINLAHN  265 (440)
T ss_dssp             TCCCCEECTTSSTTCTTCCEEECTTS
T ss_pred             CCceeEEChhhhcCCCCCCEEECCCC
Confidence            77777666666666655555444444

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.80  E-value=1.5e-19  Score=201.15  Aligned_cols=184  Identities=17%  Similarity=0.210  Sum_probs=162.8

Q ss_pred             CCceeEeec-----------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCc
Q 004994           62 SWQGVFCVF-----------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQ  128 (720)
Q Consensus        62 ~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~  128 (720)
                      .|..+.|..           .+++.|+|++|+|++..+..|..+++|++|+|++|++++..|..+.  .+|++|+|++|+
T Consensus        12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~   91 (477)
T 2id5_A           12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR   91 (477)
T ss_dssp             TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence            467888853           3688999999999999899999999999999999999988888886  799999999999


Q ss_pred             CCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-c
Q 004994          129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-V  207 (720)
Q Consensus       129 l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~  207 (720)
                      +++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|.+++..|..|.++++|+.|+|++|++++.++ .
T Consensus        92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  171 (477)
T 2id5_A           92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA  171 (477)
T ss_dssp             CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred             CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence            996666678999999999999999999889999999999999999999998888999999999999999999998775 3


Q ss_pred             ccccc-cceEEccCCcCcccCCcccCCCccccccCccCC
Q 004994          208 LEDLH-LIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       208 ~~~~~-l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      +..+. |+.|+|++|.+++..+..+..+++|+..+...+
T Consensus       172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~  210 (477)
T 2id5_A          172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW  210 (477)
T ss_dssp             HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECC
T ss_pred             hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCC
Confidence            55554 999999999999888878887777776555443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.80  E-value=3e-19  Score=188.92  Aligned_cols=165  Identities=23%  Similarity=0.347  Sum_probs=77.3

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccccccccccccc
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNN  151 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N  151 (720)
                      +|+.|+|++|++++..|..|+.+++|++|+|++|+++ .+|..+..+|++|+|++|++++..+..|.++++|+.|++++|
T Consensus        79 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n  157 (332)
T 2ft3_A           79 HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN  157 (332)
T ss_dssp             TCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSC
T ss_pred             CCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCC
Confidence            3444444444444433444444444444444444444 444444445555555555555444444566666666666666


Q ss_pred             ccC--CCCCchhcCC--------------------CCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cc
Q 004994          152 HLN--GGIPDAFHQF--------------------TGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VL  208 (720)
Q Consensus       152 ~l~--g~~p~~~~~l--------------------~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~  208 (720)
                      .++  +..|..|..+                    ++|+.|+|++|.+++..|..+..+++|+.|+|++|++++.++ .+
T Consensus       158 ~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~  237 (332)
T 2ft3_A          158 PLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSL  237 (332)
T ss_dssp             CCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGG
T ss_pred             ccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHh
Confidence            653  2444444443                    233333333344443333444445555555555555544443 23


Q ss_pred             cccc-cceEEccCCcCcccCCcccCCCcccc
Q 004994          209 EDLH-LIDLNIENNLFSGPIPEKLLSIPNFR  238 (720)
Q Consensus       209 ~~~~-l~~l~l~~N~l~g~~p~~~~~l~~l~  238 (720)
                      ..+. |+.|++++|+++ .+|..+..+++|+
T Consensus       238 ~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~  267 (332)
T 2ft3_A          238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ  267 (332)
T ss_dssp             GGCTTCCEEECCSSCCC-BCCTTGGGCTTCC
T ss_pred             hCCCCCCEEECCCCcCe-ecChhhhcCccCC
Confidence            3322 555555555555 4554444444433

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.80  E-value=3.6e-19  Score=188.18  Aligned_cols=195  Identities=19%  Similarity=0.285  Sum_probs=153.7

Q ss_pred             CCCccCCCCCCCCCCCceeEeec-----------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc
Q 004994           48 LEKWLSFGGDPCGDSWQGVFCVF-----------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP  116 (720)
Q Consensus        48 ~~~w~~~~~~~c~~~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~  116 (720)
                      ...|...-...|.+.|..+.|..           ++++.|+|++|++++..+..|+++++|++|+|++|++++..|..+.
T Consensus        18 i~~~~~~cp~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   97 (330)
T 1xku_A           18 IEPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA   97 (330)
T ss_dssp             ----CCCCCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTT
T ss_pred             cccccCCCCCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhc
Confidence            44554333445666788888852           4688999999999988888899999999999999999977788886


Q ss_pred             --ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccc--cCCCCCCCCCCCc
Q 004994          117 --VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG--QLPPSTRNLSSLY  192 (720)
Q Consensus       117 --~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~~L~  192 (720)
                        .+|++|+|++|+++ .+|..+.  ++|+.|++++|++++..+..|.++++|+.|+|++|.++.  ..+..+.++++|+
T Consensus        98 ~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~  174 (330)
T 1xku_A           98 PLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS  174 (330)
T ss_dssp             TCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCC
T ss_pred             CCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcC
Confidence              68999999999998 6776665  789999999999987777778899999999999999853  6777888899999


Q ss_pred             eeeccccccccccccccccccceEEccCCcCcccCCcccCCCccccccCccCCC
Q 004994          193 SLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNT  246 (720)
Q Consensus       193 ~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~  246 (720)
                      .|++++|.++..+..+. ..|+.|++++|++++..|..+..+++|+..+...|.
T Consensus       175 ~L~l~~n~l~~l~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  227 (330)
T 1xku_A          175 YIRIADTNITTIPQGLP-PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS  227 (330)
T ss_dssp             EEECCSSCCCSCCSSCC-TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSC
T ss_pred             EEECCCCccccCCcccc-ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCc
Confidence            99999998887654433 458888999998888778888777777766555553

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.80  E-value=1.8e-19  Score=206.29  Aligned_cols=134  Identities=20%  Similarity=0.229  Sum_probs=100.3

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL  148 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l  148 (720)
                      .+++.|++++|.+....+..|..+++|++|+|++|+|++..|..+.  .+|+.|+|++|.|++..|..|+++++|++|+|
T Consensus        51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  130 (597)
T 3oja_B           51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  130 (597)
T ss_dssp             CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence            4567778888887766666677778888888888888766666665  67888888888888777777778888888888


Q ss_pred             cccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccc
Q 004994          149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT  204 (720)
Q Consensus       149 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~  204 (720)
                      ++|.|++..+..|+++++|+.|+|++|.|++..|..|.++++|+.|+|++|.|++.
T Consensus       131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  186 (597)
T 3oja_B          131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  186 (597)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence            88888754455567788888888888888777777777788888888877777653

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.80  E-value=2.2e-19  Score=180.59  Aligned_cols=174  Identities=15%  Similarity=0.159  Sum_probs=147.1

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCc-ccccCCCCcc--ccCcEEEecC-CcCCCCCcchhhcccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNH-IGGSIPSNLP--VTVRNFSLSG-NQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~g~ip~~~~--~~L~~L~Ls~-N~l~g~~p~~l~~l~~L~~L  146 (720)
                      .+++.|+|++|++++..+..|..+++|++|+|++|+ +++..+..+.  .+|+.|+|++ |++++..+..|.++++|+.|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            579999999999999888899999999999999997 8844444665  7999999999 99997777889999999999


Q ss_pred             cccccccCCCCCchhcCCCCCc---eEeccCC-cccccCCCCCCCCCCCc-eeecccccccccccc-ccccccceEEccC
Q 004994          147 SLNNNHLNGGIPDAFHQFTGLI---NFDLSAN-NLTGQLPPSTRNLSSLY-SLHLQNNKLSGTLNV-LEDLHLIDLNIEN  220 (720)
Q Consensus       147 ~l~~N~l~g~~p~~~~~l~~L~---~L~ls~N-~l~g~~p~~~~~l~~L~-~L~l~~N~l~~~~~~-~~~~~l~~l~l~~  220 (720)
                      +|++|++++ +|. |..+++|+   .|++++| ++++..+..|.++++|+ .|+|++|+++..+.. +....|+.|++++
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~  188 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNK  188 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTT
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCC
Confidence            999999996 776 88999998   9999999 99966667799999999 999999999966543 3445699999999


Q ss_pred             Cc-CcccCCcccCCC-ccccccCccCCC
Q 004994          221 NL-FSGPIPEKLLSI-PNFRKDGNPFNT  246 (720)
Q Consensus       221 N~-l~g~~p~~~~~l-~~l~~~~n~~~~  246 (720)
                      |+ +++..+..|..+ ++|+..+...|.
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~  216 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTS  216 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCC
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCc
Confidence            95 996666777777 776655554443

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.80  E-value=5.5e-19  Score=186.72  Aligned_cols=177  Identities=23%  Similarity=0.328  Sum_probs=143.1

Q ss_pred             ceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccccc
Q 004994           64 QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQL  143 (720)
Q Consensus        64 ~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L  143 (720)
                      .+.+..+++|+.|+|++|++++..|..|+.+++|++|+|++|+|+ .+|..+..+|+.|+|++|++++..+..|.++++|
T Consensus        69 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L  147 (330)
T 1xku_A           69 DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM  147 (330)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTC
T ss_pred             hhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhcccccEEECCCCcccccCHhHhcCCccc
Confidence            345667899999999999999988999999999999999999999 8998888999999999999998888889999999


Q ss_pred             ccccccccccCC--CCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccc-ccccccc-cceEEcc
Q 004994          144 LDLSLNNNHLNG--GIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL-NVLEDLH-LIDLNIE  219 (720)
Q Consensus       144 ~~L~l~~N~l~g--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~-l~~l~l~  219 (720)
                      +.|+|++|.+..  ..+..|.++++|+.|++++|.++ .+|..+.  ++|+.|+|++|++++.. ..+..+. |+.|+++
T Consensus       148 ~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls  224 (330)
T 1xku_A          148 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLS  224 (330)
T ss_dssp             CEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECC
T ss_pred             cEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECC
Confidence            999999999963  67888999999999888888887 5666554  67778888888777764 3444443 7777777


Q ss_pred             CCcCcccCCcccCCCccccccCccC
Q 004994          220 NNLFSGPIPEKLLSIPNFRKDGNPF  244 (720)
Q Consensus       220 ~N~l~g~~p~~~~~l~~l~~~~n~~  244 (720)
                      +|.+++..|..+..+++|+..+...
T Consensus       225 ~n~l~~~~~~~~~~l~~L~~L~L~~  249 (330)
T 1xku_A          225 FNSISAVDNGSLANTPHLRELHLNN  249 (330)
T ss_dssp             SSCCCEECTTTGGGSTTCCEEECCS
T ss_pred             CCcCceeChhhccCCCCCCEEECCC
Confidence            7777766666665555554443333

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.79  E-value=1.9e-19  Score=199.13  Aligned_cols=108  Identities=20%  Similarity=0.264  Sum_probs=88.5

Q ss_pred             cccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEc
Q 004994          141 TQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNI  218 (720)
Q Consensus       141 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l  218 (720)
                      ++|+.|+|++|++++.+|..|.++++|+.|+|++|++++..|..+.++++|+.|+|++|++++.++ .+..+. |+.|+|
T Consensus       275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL  354 (455)
T ss_dssp             SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence            356666677777777788899999999999999999998888899999999999999999988764 455554 999999


Q ss_pred             cCCcCcccCCcccCCCccccccCccCCCcc
Q 004994          219 ENNLFSGPIPEKLLSIPNFRKDGNPFNTTV  248 (720)
Q Consensus       219 ~~N~l~g~~p~~~~~l~~l~~~~n~~~~~~  248 (720)
                      ++|++++..|..+..+++|+..+...|...
T Consensus       355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  384 (455)
T 3v47_A          355 SYNHIRALGDQSFLGLPNLKELALDTNQLK  384 (455)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCCcccccChhhccccccccEEECCCCccc
Confidence            999999888988888877776655555443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.79  E-value=5.3e-19  Score=176.44  Aligned_cols=157  Identities=23%  Similarity=0.274  Sum_probs=93.0

Q ss_pred             CCCCCCCCCceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCC
Q 004994           55 GGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGS  132 (720)
Q Consensus        55 ~~~~c~~~w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~  132 (720)
                      +.+.|  +|.++.|..          ++++ .+|..+.  ++|++|+|++|+|++..|..+.  .+|+.|+|++|+|++.
T Consensus        15 ~~~~C--s~~~v~c~~----------~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i   79 (229)
T 3e6j_A           15 SQCSC--SGTTVDCRS----------KRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL   79 (229)
T ss_dssp             TTCEE--ETTEEECTT----------SCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCCEE--eCCEeEccC----------CCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc
Confidence            45666  899988853          3333 2333332  5566666666666655555553  4566666666666544


Q ss_pred             CcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-ccccc
Q 004994          133 IPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDL  211 (720)
Q Consensus       133 ~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~  211 (720)
                      .+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++ .+..+
T Consensus        80 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  158 (229)
T 3e6j_A           80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL  158 (229)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTC
T ss_pred             ChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCC
Confidence            4444566666666666666666554555566666666666666666 566666666666666666666665553 23333


Q ss_pred             c-cceEEccCCcCcccC
Q 004994          212 H-LIDLNIENNLFSGPI  227 (720)
Q Consensus       212 ~-l~~l~l~~N~l~g~~  227 (720)
                      . |+.|+|++|.+++..
T Consensus       159 ~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A          159 SSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             TTCCEEECTTSCBCTTB
T ss_pred             CCCCEEEeeCCCccCCc
Confidence            3 666666666666443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.79  E-value=7.9e-20  Score=191.59  Aligned_cols=173  Identities=17%  Similarity=0.184  Sum_probs=131.7

Q ss_pred             cCceeEEEecCCcccccCCcCc--CCCCCccEEeccCCcccccCCCCcc-------ccCcEEEecCCcCCCCCcchhhcc
Q 004994           70 FSNVTEIRLTGMNLGGVLADTL--GDLESVINIDLSNNHIGGSIPSNLP-------VTVRNFSLSGNQLTGSIPESLSRL  140 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~g~ip~~~~-------~~L~~L~Ls~N~l~g~~p~~l~~l  140 (720)
                      +++|+.|+|++|++++.+|..+  +.+++|++|+|++|+|++. |..+.       .+|++|+|++|++++..|..|+++
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  172 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF  172 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence            6788999999999998888876  8889999999999999865 66543       678999999999988777888899


Q ss_pred             cccccccccccccCCC--CCchh--cCCCCCceEeccCCcccc--cCC-CCCCCCCCCceeeccccccccccc--ccccc
Q 004994          141 TQLLDLSLNNNHLNGG--IPDAF--HQFTGLINFDLSANNLTG--QLP-PSTRNLSSLYSLHLQNNKLSGTLN--VLEDL  211 (720)
Q Consensus       141 ~~L~~L~l~~N~l~g~--~p~~~--~~l~~L~~L~ls~N~l~g--~~p-~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~  211 (720)
                      ++|+.|+|++|++.+.  +|..+  .++++|++|+|++|+|++  .++ ..+.++++|+.|+|++|+|++.++  .+..+
T Consensus       173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l  252 (312)
T 1wwl_A          173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP  252 (312)
T ss_dssp             SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred             CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence            9999999999988765  34444  788888888888888873  222 234567888888888888888663  33333


Q ss_pred             -ccceEEccCCcCcccCCcccC-CCccccccCccC
Q 004994          212 -HLIDLNIENNLFSGPIPEKLL-SIPNFRKDGNPF  244 (720)
Q Consensus       212 -~l~~l~l~~N~l~g~~p~~~~-~l~~l~~~~n~~  244 (720)
                       .|+.|+|++|+|+ .+|..+. ++..|.+.+|..
T Consensus       253 ~~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N~l  286 (312)
T 1wwl_A          253 SQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNRL  286 (312)
T ss_dssp             TTCCEEECTTSCCS-SCCSSCCSEEEEEECCSSCC
T ss_pred             CCCCEEECCCCccC-hhhhhccCCceEEECCCCCC
Confidence             4888888888888 7787765 334444444444

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.79  E-value=1e-19  Score=204.49  Aligned_cols=161  Identities=28%  Similarity=0.461  Sum_probs=118.7

Q ss_pred             CCCccCCCCCCCCC---CCcee-EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEE
Q 004994           48 LEKWLSFGGDPCGD---SWQGV-FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFS  123 (720)
Q Consensus        48 ~~~w~~~~~~~c~~---~w~gv-~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~  123 (720)
                      +.+|.. +.+||..   .|.|+ .|..++|+.|+|++|+|++ +|..+.  ++|+.|+|++|+|+ .+| .+..+|+.|+
T Consensus        33 l~~W~~-~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip-~~l~~L~~L~  106 (571)
T 3cvr_A           33 WDKWEK-QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP-ELPASLEYLD  106 (571)
T ss_dssp             HHHHHT-TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC-CCCTTCCEEE
T ss_pred             HHHHhc-cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc-cccCCCCEEE
Confidence            446754 6778854   59999 7888899999999999997 676553  78888888888888 788 5567888888


Q ss_pred             ecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccc
Q 004994          124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG  203 (720)
Q Consensus       124 Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~  203 (720)
                      |++|+|++ +|. +.+  +|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++
T Consensus       107 Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~  174 (571)
T 3cvr_A          107 ACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF  174 (571)
T ss_dssp             CCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred             ccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC
Confidence            88888885 676 654  78888888888875 665   56777777777777774 665   45677777777777776


Q ss_pred             ccccccccccceEEccCCcCcccCCc
Q 004994          204 TLNVLEDLHLIDLNIENNLFSGPIPE  229 (720)
Q Consensus       204 ~~~~~~~~~l~~l~l~~N~l~g~~p~  229 (720)
                      .+. +. ..|+.|+|++|+|+ .+|.
T Consensus       175 lp~-l~-~~L~~L~Ls~N~L~-~lp~  197 (571)
T 3cvr_A          175 LPE-LP-ESLEALDVSTNLLE-SLPA  197 (571)
T ss_dssp             CCC-CC-TTCCEEECCSSCCS-SCCC
T ss_pred             cch-hh-CCCCEEECcCCCCC-chhh
Confidence            444 33 44666777777666 5555

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.79  E-value=8.1e-20  Score=191.52  Aligned_cols=173  Identities=17%  Similarity=0.202  Sum_probs=134.7

Q ss_pred             ceeEEEecCCcc-cccCCcCcC-------CCCCccEEeccCCcccccCCCCc--c--ccCcEEEecCCcCCCCCcchhhc
Q 004994           72 NVTEIRLTGMNL-GGVLADTLG-------DLESVINIDLSNNHIGGSIPSNL--P--VTVRNFSLSGNQLTGSIPESLSR  139 (720)
Q Consensus        72 ~l~~l~L~~n~l-~~~~~~~~~-------~l~~L~~L~L~~N~l~g~ip~~~--~--~~L~~L~Ls~N~l~g~~p~~l~~  139 (720)
                      .++.|+|++|++ .+.+|..+.       ++++|++|+|++|++++.+|..+  .  .+|+.|+|++|++++. |..++.
T Consensus        64 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~  142 (312)
T 1wwl_A           64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE  142 (312)
T ss_dssp             HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH
T ss_pred             HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH
Confidence            388889999998 456777665       78999999999999998898876  3  7899999999999976 888888


Q ss_pred             c-----cccccccccccccCCCCCchhcCCCCCceEeccCCccccc--CCCCC--CCCCCCceeeccccccccccc---c
Q 004994          140 L-----TQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ--LPPST--RNLSSLYSLHLQNNKLSGTLN---V  207 (720)
Q Consensus       140 l-----~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~--~p~~~--~~l~~L~~L~l~~N~l~~~~~---~  207 (720)
                      +     ++|++|+|++|++++..|..|+++++|++|+|++|++.|.  +|..+  ..+++|+.|+|++|+|++...   .
T Consensus       143 l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  222 (312)
T 1wwl_A          143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA  222 (312)
T ss_dssp             HHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHH
T ss_pred             HHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHH
Confidence            7     8999999999999988888899999999999999998765  33344  888999999999999985432   2


Q ss_pred             -cccc-ccceEEccCCcCcccCC-cccCCCccccccCccCC
Q 004994          208 -LEDL-HLIDLNIENNLFSGPIP-EKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       208 -~~~~-~l~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~~  245 (720)
                       +..+ .|+.|++++|++++.+| ..+..+++|+..+...|
T Consensus       223 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N  263 (312)
T 1wwl_A          223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT  263 (312)
T ss_dssp             HHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTS
T ss_pred             HHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCC
Confidence             2233 58999999999998776 33444444444433333

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.79  E-value=4.8e-19  Score=175.55  Aligned_cols=147  Identities=24%  Similarity=0.316  Sum_probs=97.4

Q ss_pred             EEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccccccccccc
Q 004994           76 IRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHL  153 (720)
Q Consensus        76 l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l  153 (720)
                      +++++++|+. +|..+.  ++|+.|+|++|+|++..|..+.  .+|+.|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus        16 v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l   92 (220)
T 2v9t_B           16 VDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI   92 (220)
T ss_dssp             EECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred             EEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence            4445566653 444443  5677777777777744444554  5677777777777766677777777777777777777


Q ss_pred             CCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCcc
Q 004994          154 NGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSG  225 (720)
Q Consensus       154 ~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g  225 (720)
                      +...+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++ .+..+. |+.|+|++|.+..
T Consensus        93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            75444456677777777777777776666677777777777777777776664 244443 7777777777653

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.79  E-value=4.2e-19  Score=192.18  Aligned_cols=133  Identities=20%  Similarity=0.231  Sum_probs=101.6

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL  148 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l  148 (720)
                      .+++.|++++|.++...+..|..+++|++|+|++|++++..|..+.  .+|++|+|++|++++..|..|+++++|++|+|
T Consensus        45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  124 (390)
T 3o6n_A           45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  124 (390)
T ss_dssp             CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence            5677888888888765555577788888888888888865555665  67888888888888777777888888888888


Q ss_pred             cccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccc
Q 004994          149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG  203 (720)
Q Consensus       149 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~  203 (720)
                      ++|+++...+..|.++++|++|+|++|++++..|..+.++++|+.|+|++|++++
T Consensus       125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  179 (390)
T 3o6n_A          125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH  179 (390)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred             CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence            8888874333446778888888888888886667778888888888888887765

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.78  E-value=4.8e-19  Score=175.58  Aligned_cols=151  Identities=20%  Similarity=0.253  Sum_probs=126.7

Q ss_pred             EEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCC-cc--ccCcEEEecCCcCCCCCcchhhccccccccccccc
Q 004994           75 EIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN-LP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNN  151 (720)
Q Consensus        75 ~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~-~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N  151 (720)
                      .+++++|+|+. +|..+.  ..++.|+|++|+|++..|.. +.  .+|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus        15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            67888888885 566553  45689999999999765654 43  68999999999999887778999999999999999


Q ss_pred             ccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCcccCC
Q 004994          152 HLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSGPIP  228 (720)
Q Consensus       152 ~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g~~p  228 (720)
                      +|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.++ .+..+. |+.|+|++|.+++..+
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            9998878889999999999999999998888899999999999999999998854 556554 8999999999987554

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.78  E-value=1.9e-19  Score=211.55  Aligned_cols=177  Identities=15%  Similarity=0.219  Sum_probs=155.9

Q ss_pred             EeecCceeEEEecCCcccc-----------------cCCcCcC--CCCCccEEeccCCcccccCCCCcc--ccCcEEEec
Q 004994           67 FCVFSNVTEIRLTGMNLGG-----------------VLADTLG--DLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLS  125 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls  125 (720)
                      +..+++|+.|+|++|+|+|                 .+|+.++  ++++|++|+|++|++.|.+|..+.  ++|+.|+|+
T Consensus       444 l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls  523 (876)
T 4ecn_A          444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA  523 (876)
T ss_dssp             GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECT
T ss_pred             HhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECc
Confidence            4567899999999999999                 4899988  999999999999999999998887  799999999


Q ss_pred             CCc-CCC-CCcchhhccc-------ccccccccccccCCCCCc--hhcCCCCCceEeccCCcccccCCCCCCCCCCCcee
Q 004994          126 GNQ-LTG-SIPESLSRLT-------QLLDLSLNNNHLNGGIPD--AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSL  194 (720)
Q Consensus       126 ~N~-l~g-~~p~~l~~l~-------~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L  194 (720)
                      +|+ |+| .+|..+++++       +|+.|+|++|+|+ .+|.  .|+++++|+.|+|++|+|+ .+| .++++++|+.|
T Consensus       524 ~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L  600 (876)
T 4ecn_A          524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDL  600 (876)
T ss_dssp             TCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEE
T ss_pred             CCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEE
Confidence            998 999 8999998887       9999999999999 8998  9999999999999999999 899 99999999999


Q ss_pred             ecccccccccccccccc-c-cceEEccCCcCcccCCcccCCCcc--ccccCccCCCc
Q 004994          195 HLQNNKLSGTLNVLEDL-H-LIDLNIENNLFSGPIPEKLLSIPN--FRKDGNPFNTT  247 (720)
Q Consensus       195 ~l~~N~l~~~~~~~~~~-~-l~~l~l~~N~l~g~~p~~~~~l~~--l~~~~n~~~~~  247 (720)
                      +|++|+|+..+..+..+ . |+.|+|++|+|+ .+|..+..++.  |+..+...|..
T Consensus       601 ~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l  656 (876)
T 4ecn_A          601 KLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKI  656 (876)
T ss_dssp             ECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCT
T ss_pred             ECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcC
Confidence            99999999655556554 4 999999999999 89988776543  55444444433

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.78  E-value=4.4e-19  Score=196.13  Aligned_cols=181  Identities=17%  Similarity=0.259  Sum_probs=114.3

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCC--cc--ccCcEEEecCCcCCCCCcch-hhccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN--LP--VTVRNFSLSGNQLTGSIPES-LSRLT  141 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~--~~--~~L~~L~Ls~N~l~g~~p~~-l~~l~  141 (720)
                      +..+++|+.|+|++|++++..|..|+.+++|++|+|++|++++.+|..  +.  .+|+.|+|++|++++..|.. +.+++
T Consensus        75 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~  154 (455)
T 3v47_A           75 FRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMR  154 (455)
T ss_dssp             TTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCT
T ss_pred             ccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCC
Confidence            444566777777777776666666777777777777777776544433  33  56777777777777665655 66677


Q ss_pred             ccccccccccccCCCCCchhcCC----------------------------------C----------------------
Q 004994          142 QLLDLSLNNNHLNGGIPDAFHQF----------------------------------T----------------------  165 (720)
Q Consensus       142 ~L~~L~l~~N~l~g~~p~~~~~l----------------------------------~----------------------  165 (720)
                      +|++|+|++|++++..|..+..+                                  +                      
T Consensus       155 ~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~  234 (455)
T 3v47_A          155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD  234 (455)
T ss_dssp             TCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHH
T ss_pred             cccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhc
Confidence            77777777777766555544332                                  2                      


Q ss_pred             -----------------------------------------CCceEeccCCcccccCCCCCCCCCCCceeeccccccccc
Q 004994          166 -----------------------------------------GLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT  204 (720)
Q Consensus       166 -----------------------------------------~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~  204 (720)
                                                               +|+.|+|++|++++.+|..+.++++|+.|+|++|++++.
T Consensus       235 ~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~  314 (455)
T 3v47_A          235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI  314 (455)
T ss_dssp             HTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred             cccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccccc
Confidence                                                     344444444444444566677777777777777777766


Q ss_pred             cc-cccccc-cceEEccCCcCcccCCcccCCCccccccCccCCCc
Q 004994          205 LN-VLEDLH-LIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTT  247 (720)
Q Consensus       205 ~~-~~~~~~-l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~~  247 (720)
                      ++ .+..+. |+.|+|++|.+++..|..+..+++|+..+...|..
T Consensus       315 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  359 (455)
T 3v47_A          315 DDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI  359 (455)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCC
T ss_pred             ChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcc
Confidence            54 444443 77777777777766677766666666555554443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.78  E-value=1.2e-18  Score=172.61  Aligned_cols=149  Identities=23%  Similarity=0.263  Sum_probs=110.3

Q ss_pred             CCCCCCCceeEeec-----------CceeEEEecCCcccccCC-cCcCCCCCccEEeccCCcccccCCCCcc--ccCcEE
Q 004994           57 DPCGDSWQGVFCVF-----------SNVTEIRLTGMNLGGVLA-DTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNF  122 (720)
Q Consensus        57 ~~c~~~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L  122 (720)
                      ..|.|.|..+.|..           ..++.|+|++|+|++..+ ..|..+++|+.|+|++|+|++..|..+.  .+|+.|
T Consensus         7 ~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L   86 (220)
T 2v70_A            7 EKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI   86 (220)
T ss_dssp             TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence            34555677777742           246678888888877654 4577788888888888888765555555  678888


Q ss_pred             EecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccc
Q 004994          123 SLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS  202 (720)
Q Consensus       123 ~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  202 (720)
                      +|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.++
T Consensus        87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  166 (220)
T 2v70_A           87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN  166 (220)
T ss_dssp             ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred             ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence            88888888776677777888888888888888777777888888888888888887766777888888888888888777


Q ss_pred             ccc
Q 004994          203 GTL  205 (720)
Q Consensus       203 ~~~  205 (720)
                      +..
T Consensus       167 c~c  169 (220)
T 2v70_A          167 CNC  169 (220)
T ss_dssp             CSG
T ss_pred             CCC
Confidence            544

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.78  E-value=1e-18  Score=184.89  Aligned_cols=186  Identities=22%  Similarity=0.307  Sum_probs=156.5

Q ss_pred             CCCCCCCceeEeec-----------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEE
Q 004994           57 DPCGDSWQGVFCVF-----------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFS  123 (720)
Q Consensus        57 ~~c~~~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~  123 (720)
                      ..|.|.|..+.|..           ++++.|+|++|++++..|..|..+++|++|+|++|++++..|..+.  .+|++|+
T Consensus        29 ~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  108 (332)
T 2ft3_A           29 FGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY  108 (332)
T ss_dssp             SSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred             CCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence            44555788888852           4689999999999988888999999999999999999977787776  7899999


Q ss_pred             ecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCccc--ccCCCCCCCCCCCceeecccccc
Q 004994          124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT--GQLPPSTRNLSSLYSLHLQNNKL  201 (720)
Q Consensus       124 Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~--g~~p~~~~~l~~L~~L~l~~N~l  201 (720)
                      |++|+++ .+|..+.  ++|++|+|++|++++..+..|.++++|+.|++++|.++  +..|..+..+ +|+.|++++|++
T Consensus       109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l  184 (332)
T 2ft3_A          109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL  184 (332)
T ss_dssp             CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred             CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence            9999999 7777665  89999999999999776777999999999999999996  4678888888 999999999999


Q ss_pred             ccccccccccccceEEccCCcCcccCCcccCCCccccccCccCCCc
Q 004994          202 SGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTT  247 (720)
Q Consensus       202 ~~~~~~~~~~~l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~~  247 (720)
                      ++.+..+. ..|+.|++++|.+++..|..+..+++|+..+...|..
T Consensus       185 ~~l~~~~~-~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l  229 (332)
T 2ft3_A          185 TGIPKDLP-ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI  229 (332)
T ss_dssp             SSCCSSSC-SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCC
T ss_pred             CccCcccc-CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcC
Confidence            98665433 4588999999999988888888877777666655543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.78  E-value=2.5e-19  Score=191.19  Aligned_cols=181  Identities=16%  Similarity=0.173  Sum_probs=150.2

Q ss_pred             CCceeEeec-------------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecC
Q 004994           62 SWQGVFCVF-------------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSG  126 (720)
Q Consensus        62 ~w~gv~c~~-------------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~  126 (720)
                      .|.|+ |..             ++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..+.  .+|++|+|++
T Consensus        31 ~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  109 (353)
T 2z80_A           31 DRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY  109 (353)
T ss_dssp             CTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence            78777 653             3799999999999988777999999999999999999977777776  7899999999


Q ss_pred             CcCCCCCcchhhcccccccccccccccCCCCCc--hhcCCCCCceEeccCC-cccccCCCCCCCCCCCceeecccccccc
Q 004994          127 NQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD--AFHQFTGLINFDLSAN-NLTGQLPPSTRNLSSLYSLHLQNNKLSG  203 (720)
Q Consensus       127 N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~ls~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~~  203 (720)
                      |++++..+..|.++++|++|+|++|++++ +|.  .|.++++|+.|++++| .+++..|..+.++++|+.|+|++|++++
T Consensus       110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~  188 (353)
T 2z80_A          110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS  188 (353)
T ss_dssp             SCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred             CcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCc
Confidence            99996555559999999999999999995 554  7999999999999999 5776667889999999999999999998


Q ss_pred             cc-ccccccc-cceEEccCCcCcccCCcc----cCCCccccccCccCC
Q 004994          204 TL-NVLEDLH-LIDLNIENNLFSGPIPEK----LLSIPNFRKDGNPFN  245 (720)
Q Consensus       204 ~~-~~~~~~~-l~~l~l~~N~l~g~~p~~----~~~l~~l~~~~n~~~  245 (720)
                      .. ..+..+. |+.|++++|.++ .+|..    +.++..|.+.+|...
T Consensus       189 ~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~  235 (353)
T 2z80_A          189 YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLD  235 (353)
T ss_dssp             ECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCT
T ss_pred             cCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccc
Confidence            85 4566655 999999999996 55543    344555555666543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.78  E-value=3.9e-19  Score=203.37  Aligned_cols=158  Identities=19%  Similarity=0.243  Sum_probs=88.7

Q ss_pred             eEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCC-cc--ccCcEEEecCCcCCCCCcchhhcccc
Q 004994           66 VFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN-LP--VTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        66 v~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~-~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      .++.+++|+.|+|++|.|++..|..|+.+++|++|+|++|+|+ .+|.. +.  .+|+.|+|++|.|++..|..|+++++
T Consensus        94 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  172 (597)
T 3oja_B           94 AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS  172 (597)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTT
T ss_pred             HhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCc
Confidence            3444556666666666666655555666666666666666666 33333 22  45666666666666555555666666


Q ss_pred             cccccccccccCCCC-----------------------------------------------------------CchhcC
Q 004994          143 LLDLSLNNNHLNGGI-----------------------------------------------------------PDAFHQ  163 (720)
Q Consensus       143 L~~L~l~~N~l~g~~-----------------------------------------------------------p~~~~~  163 (720)
                      |+.|+|++|.|++..                                                           +..+..
T Consensus       173 L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~~~~l~~  252 (597)
T 3oja_B          173 LQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLN  252 (597)
T ss_dssp             CCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCCCGGGGG
T ss_pred             CcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCCChhhcc
Confidence            665555555554311                                                           122445


Q ss_pred             CCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcCc
Q 004994          164 FTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFS  224 (720)
Q Consensus       164 l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l~  224 (720)
                      +++|+.|+|++|.|++.+|..+.++++|+.|+|++|.|++.+.....+ .|+.|+|++|.++
T Consensus       253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~  314 (597)
T 3oja_B          253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL  314 (597)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC
T ss_pred             CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC
Confidence            556666666666666655666666666666666666666544333322 2555555555555

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.78  E-value=2.4e-19  Score=199.55  Aligned_cols=176  Identities=16%  Similarity=0.076  Sum_probs=128.1

Q ss_pred             CCceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccc
Q 004994           62 SWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLT  141 (720)
Q Consensus        62 ~w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~  141 (720)
                      ...+.++.+++|+.|+|++|.+++..|  |+.+++|++|+|++|+|++. |..  ++|+.|+|++|+|++..+.   .++
T Consensus        49 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~~~--~~L~~L~L~~N~l~~~~~~---~l~  120 (487)
T 3oja_A           49 ISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-LVG--PSIETLHAANNNISRVSCS---RGQ  120 (487)
T ss_dssp             CCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEE-EEC--TTCCEEECCSSCCCCEEEC---CCS
T ss_pred             CCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCC-CCC--CCcCEEECcCCcCCCCCcc---ccC
Confidence            344566778889999999999987765  88888999999999888843 322  5777788888877755543   346


Q ss_pred             ccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCC-CCCCCceeeccccccccccccccccccceEEccC
Q 004994          142 QLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTR-NLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIEN  220 (720)
Q Consensus       142 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~  220 (720)
                      +|+.|+|++|.|++..|..|+++++|+.|+|++|.|++.+|..+. .+++|+.|+|++|.|++.++......|+.|+|++
T Consensus       121 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~  200 (487)
T 3oja_A          121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSS  200 (487)
T ss_dssp             SCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCS
T ss_pred             CCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCC
Confidence            788888888888877777788888888888888888877777765 6788888888888887775544444588888888


Q ss_pred             CcCcccCCcccCCCccccccCccCCC
Q 004994          221 NLFSGPIPEKLLSIPNFRKDGNPFNT  246 (720)
Q Consensus       221 N~l~g~~p~~~~~l~~l~~~~n~~~~  246 (720)
                      |.|++. |..+..+++|+..+...|.
T Consensus       201 N~l~~~-~~~~~~l~~L~~L~Ls~N~  225 (487)
T 3oja_A          201 NKLAFM-GPEFQSAAGVTWISLRNNK  225 (487)
T ss_dssp             SCCCEE-CGGGGGGTTCSEEECTTSC
T ss_pred             CCCCCC-CHhHcCCCCccEEEecCCc
Confidence            888864 4446555555554444443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=4.9e-19  Score=171.59  Aligned_cols=159  Identities=21%  Similarity=0.275  Sum_probs=122.7

Q ss_pred             eEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCC-cc--ccCcEEEecCCcCCCCCcchhhcccccccccccc
Q 004994           74 TEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN-LP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN  150 (720)
Q Consensus        74 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~-~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~  150 (720)
                      +.|++++|+|+ .+|..+..  +|++|+|++|+|++..|.. +.  .+|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            46788888886 56766644  8999999999998655543 54  7899999999999988899999999999999999


Q ss_pred             cccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcCcccCCc
Q 004994          151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGPIPE  229 (720)
Q Consensus       151 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g~~p~  229 (720)
                      |+|++..|..|.++++|+.|+|++|+|++.+|..+..+++|+.|+|++|.|++..+...... +....+..+......|.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~  167 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence            99998888889999999999999999998889999999999999999999987654211111 22223344444445555


Q ss_pred             ccCCCc
Q 004994          230 KLLSIP  235 (720)
Q Consensus       230 ~~~~l~  235 (720)
                      .+....
T Consensus       168 ~l~~~~  173 (192)
T 1w8a_A          168 KVRDVQ  173 (192)
T ss_dssp             TTTTSB
T ss_pred             HHcCCC
Confidence            554443

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.78  E-value=6.7e-19  Score=188.43  Aligned_cols=173  Identities=21%  Similarity=0.221  Sum_probs=144.9

Q ss_pred             eEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc---ccCcEEEecCCcCCCCCcchhhcccccccccccc
Q 004994           74 TEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP---VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN  150 (720)
Q Consensus        74 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~  150 (720)
                      +.+++++++|+. +|..+.  ..|+.|+|++|+|++..+..+.   .+|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            468889999985 666554  4689999999999966666553   6899999999999988888899999999999999


Q ss_pred             cccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccc----ccc-ccceEEccCCcCcc
Q 004994          151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVL----EDL-HLIDLNIENNLFSG  225 (720)
Q Consensus       151 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~----~~~-~l~~l~l~~N~l~g  225 (720)
                      |+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+...    ..+ .|+.|+|++|+|++
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            9999877788999999999999999999888899999999999999999999877543    334 49999999999995


Q ss_pred             cCCcccCCCc-----cccccCccCCCccc
Q 004994          226 PIPEKLLSIP-----NFRKDGNPFNTTVI  249 (720)
Q Consensus       226 ~~p~~~~~l~-----~l~~~~n~~~~~~~  249 (720)
                      ..+..+..++     .|.+.+|+|.|.|.
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             cCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            5445565554     46788999988763

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.78  E-value=3.3e-19  Score=204.65  Aligned_cols=172  Identities=17%  Similarity=0.164  Sum_probs=97.1

Q ss_pred             ecCceeEEEecCCccccc--CCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCc-chhhccccc
Q 004994           69 VFSNVTEIRLTGMNLGGV--LADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIP-ESLSRLTQL  143 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~--~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p-~~l~~l~~L  143 (720)
                      .+++|+.|+|++|++++.  +|..+..+++|+.|+|++|+++ .+|..+.  .+|+.|+|++|++++..| ..+.++++|
T Consensus       348 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  426 (606)
T 3vq2_A          348 ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL  426 (606)
T ss_dssp             CCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC
T ss_pred             cCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccC
Confidence            455666666666666654  2555566666666666666655 3444443  456666666666655555 455556666


Q ss_pred             ccccccccccCCCCCchhcCCCCCceEeccCCcccc-cCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccC
Q 004994          144 LDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG-QLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIEN  220 (720)
Q Consensus       144 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~  220 (720)
                      +.|+|++|.+++.+|..|.++++|+.|+|++|++++ .+|..+..+++|+.|+|++|++++.++ .+..+. |+.|++++
T Consensus       427 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~  506 (606)
T 3vq2_A          427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH  506 (606)
T ss_dssp             CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCC
Confidence            666666666655555555566666666666666654 245555556666666666666555543 233333 55566666


Q ss_pred             CcCcccCCcccCCCccccccC
Q 004994          221 NLFSGPIPEKLLSIPNFRKDG  241 (720)
Q Consensus       221 N~l~g~~p~~~~~l~~l~~~~  241 (720)
                      |++++.+|..+..+++|+..+
T Consensus       507 N~l~~~~~~~~~~l~~L~~L~  527 (606)
T 3vq2_A          507 NNLLFLDSSHYNQLYSLSTLD  527 (606)
T ss_dssp             SCCSCEEGGGTTTCTTCCEEE
T ss_pred             CcCCCcCHHHccCCCcCCEEE
Confidence            666555555555544444333

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.78  E-value=1.2e-18  Score=192.41  Aligned_cols=181  Identities=17%  Similarity=0.202  Sum_probs=150.8

Q ss_pred             eeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccc
Q 004994           65 GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      +.+..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..+.  .+|++|+|++|+|++..+..|.++++
T Consensus        93 ~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  172 (452)
T 3zyi_A           93 DTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPS  172 (452)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTT
T ss_pred             HHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCc
Confidence            4456788999999999999999999999999999999999999954444454  79999999999999777778999999


Q ss_pred             ccccccccc-ccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEcc
Q 004994          143 LLDLSLNNN-HLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIE  219 (720)
Q Consensus       143 L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~  219 (720)
                      |+.|+|++| .+....+..|.++++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++..+ .+..+. |+.|+|+
T Consensus       173 L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  250 (452)
T 3zyi_A          173 LMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM  250 (452)
T ss_dssp             CCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECT
T ss_pred             ccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeC
Confidence            999999984 555334456899999999999999998 455 58889999999999999998864 455554 9999999


Q ss_pred             CCcCcccCCcccCCCccccccCccCCCc
Q 004994          220 NNLFSGPIPEKLLSIPNFRKDGNPFNTT  247 (720)
Q Consensus       220 ~N~l~g~~p~~~~~l~~l~~~~n~~~~~  247 (720)
                      +|++++..|..|..+++|+..+...|..
T Consensus       251 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l  278 (452)
T 3zyi_A          251 NSQVSLIERNAFDGLASLVELNLAHNNL  278 (452)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             CCcCceECHHHhcCCCCCCEEECCCCcC
Confidence            9999988888888777777666555543

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.77  E-value=3.4e-19  Score=186.59  Aligned_cols=159  Identities=18%  Similarity=0.180  Sum_probs=93.8

Q ss_pred             CceeEEEecCCcccccCCcCc--CCCCCccEEeccCCcccccCCCC----c--cccCcEEEecCCcCCCCCcchhhcccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTL--GDLESVINIDLSNNHIGGSIPSN----L--PVTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~g~ip~~----~--~~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      ++|++|+|++|++++..|..+  ..+++|++|+|++|++++..|..    +  .++|+.|+|++|++++..|..|+++++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            457777777777777766666  66777777777777776544411    1  146677777777776666666666777


Q ss_pred             cccccccccccCCC--C--CchhcCCCCCceEeccCCcccccCCC----CCCCCCCCceeecccccccccc-cccccc--
Q 004994          143 LLDLSLNNNHLNGG--I--PDAFHQFTGLINFDLSANNLTGQLPP----STRNLSSLYSLHLQNNKLSGTL-NVLEDL--  211 (720)
Q Consensus       143 L~~L~l~~N~l~g~--~--p~~~~~l~~L~~L~ls~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~~~~-~~~~~~--  211 (720)
                      |++|+|++|++.+.  +  +..+..+++|++|+|++|+|+ .+|.    .+.++++|+.|+|++|+|++.. +.+..+  
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  249 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW  249 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence            77777777766431  1  122345666666666666665 2222    1345566666666666666552 222222  


Q ss_pred             --ccceEEccCCcCcccCCccc
Q 004994          212 --HLIDLNIENNLFSGPIPEKL  231 (720)
Q Consensus       212 --~l~~l~l~~N~l~g~~p~~~  231 (720)
                        .|+.|+|++|+|+ .+|..+
T Consensus       250 ~~~L~~L~Ls~N~l~-~lp~~~  270 (310)
T 4glp_A          250 SSALNSLNLSFAGLE-QVPKGL  270 (310)
T ss_dssp             CTTCCCEECCSSCCC-SCCSCC
T ss_pred             cCcCCEEECCCCCCC-chhhhh
Confidence              3666666666666 455544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.77  E-value=5.7e-19  Score=202.66  Aligned_cols=170  Identities=18%  Similarity=0.187  Sum_probs=82.4

Q ss_pred             eecCceeEEEecCCcccccC--CcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcch-hhcccc
Q 004994           68 CVFSNVTEIRLTGMNLGGVL--ADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPES-LSRLTQ  142 (720)
Q Consensus        68 c~~~~l~~l~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~-l~~l~~  142 (720)
                      ..+++|+.|+|++|++++..  +..+..+++|+.|+|++|++.+..|..+.  .+|+.|+|++|++++..|.. +.++++
T Consensus       347 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~  426 (606)
T 3t6q_A          347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL  426 (606)
T ss_dssp             TTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTT
T ss_pred             hccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCccc
Confidence            34445555555555555443  44455555555555555555544444443  44555555555555443332 445555


Q ss_pred             cccccccccccCCCCCchhcCCCCCceEeccCCccccc---CCCCCCCCCCCceeeccccccccccc-cccccc-cceEE
Q 004994          143 LLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ---LPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLN  217 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~---~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~  217 (720)
                      |+.|+|++|.+++..|..|.++++|++|+|++|++++.   .+..+..+++|+.|+|++|++++.++ .+..+. |+.|+
T Consensus       427 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  506 (606)
T 3t6q_A          427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD  506 (606)
T ss_dssp             CCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEE
Confidence            55555555555544444455555555555555555431   12334445555555555555544432 233332 45555


Q ss_pred             ccCCcCcccCCcccCCCccc
Q 004994          218 IENNLFSGPIPEKLLSIPNF  237 (720)
Q Consensus       218 l~~N~l~g~~p~~~~~l~~l  237 (720)
                      |++|++++..|..+.+++.|
T Consensus       507 Ls~N~l~~~~~~~l~~l~~L  526 (606)
T 3t6q_A          507 LSHNRLTSSSIEALSHLKGI  526 (606)
T ss_dssp             CCSSCCCGGGGGGGTTCCSC
T ss_pred             CCCCccCcCChhHhCccccc
Confidence            55555555444444444443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.77  E-value=1.8e-18  Score=177.19  Aligned_cols=163  Identities=23%  Similarity=0.286  Sum_probs=142.3

Q ss_pred             eeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccc
Q 004994           65 GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      +.+..+++|+.|+|++|+++...+..|..+++|++|+|++|++++..+..+.  .+|+.|+|++|++++..|..|.++++
T Consensus        55 ~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  134 (270)
T 2o6q_A           55 KAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK  134 (270)
T ss_dssp             TSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             HHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcC
Confidence            4566788999999999999987777789999999999999999954444444  78999999999999888888999999


Q ss_pred             cccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccc-ccccc-cceEEccC
Q 004994          143 LLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV-LEDLH-LIDLNIEN  220 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-l~~l~l~~  220 (720)
                      |+.|+|++|+|++..+..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|+|++.++. +..+. |+.|+|++
T Consensus       135 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  214 (270)
T 2o6q_A          135 LTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE  214 (270)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecC
Confidence            99999999999976667799999999999999999976666799999999999999999987753 55554 99999999


Q ss_pred             CcCcccC
Q 004994          221 NLFSGPI  227 (720)
Q Consensus       221 N~l~g~~  227 (720)
                      |.+...-
T Consensus       215 N~~~c~c  221 (270)
T 2o6q_A          215 NPWDCTC  221 (270)
T ss_dssp             SCBCCSS
T ss_pred             CCeeCCC
Confidence            9997543

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.77  E-value=2.6e-18  Score=171.37  Aligned_cols=151  Identities=25%  Similarity=0.301  Sum_probs=130.5

Q ss_pred             ccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCc
Q 004994           97 VINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANN  176 (720)
Q Consensus        97 L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~  176 (720)
                      .+.+++++|++. .+|..++.+|+.|+|++|+|++..|..|.++++|+.|+|++|+|+...+..|.++++|+.|+|++|+
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~   99 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ   99 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCEeEccCCCcC-ccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence            457899999998 9999999999999999999999889999999999999999999986666778999999999999999


Q ss_pred             ccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcCcccCCcccCCCcc---ccccCccCCCcc
Q 004994          177 LTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGPIPEKLLSIPN---FRKDGNPFNTTV  248 (720)
Q Consensus       177 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g~~p~~~~~l~~---l~~~~n~~~~~~  248 (720)
                      |++..+..+..+++|+.|+|++|+|+..+..+..+. |+.|+|++|+|++..+..+..+++   |.+.+|++.|.|
T Consensus       100 l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A          100 LTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred             CCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence            997666778999999999999999997776666655 999999999999766666665555   456777776543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.77  E-value=1.5e-18  Score=171.95  Aligned_cols=150  Identities=26%  Similarity=0.327  Sum_probs=131.3

Q ss_pred             cEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcc
Q 004994           98 INIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL  177 (720)
Q Consensus        98 ~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l  177 (720)
                      +.+++++|+++ .+|..++.+|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l   92 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI   92 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred             CEEEcCCCCcC-cCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence            57999999999 89999999999999999999987778899999999999999999988899999999999999999999


Q ss_pred             cccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCcccCCcccCCCcc---ccccCccCCCcc
Q 004994          178 TGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSGPIPEKLLSIPN---FRKDGNPFNTTV  248 (720)
Q Consensus       178 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g~~p~~~~~l~~---l~~~~n~~~~~~  248 (720)
                      +...+..|.++++|+.|+|++|+|++..+ .+..+. |+.|+|++|+|++..+..+..+++   |.+.+|+|.|.|
T Consensus        93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  168 (220)
T 2v9t_B           93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC  168 (220)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence            95555567899999999999999999864 455554 999999999999877776765554   556788887654

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.76  E-value=2.4e-18  Score=178.19  Aligned_cols=158  Identities=25%  Similarity=0.236  Sum_probs=138.8

Q ss_pred             eeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccc
Q 004994           65 GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      +.+..+++|+.|+|++|+|++..+.  +.+++|++|+|++|+|+ .+|..+.  .+|+.|+|++|+|++..|..|.++++
T Consensus        49 ~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~  125 (290)
T 1p9a_G           49 ATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE  125 (290)
T ss_dssp             GGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTT
T ss_pred             HHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCC
Confidence            4456788999999999999976443  88999999999999999 8888775  78999999999999877788999999


Q ss_pred             cccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccc-cccceEEccCC
Q 004994          143 LLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLED-LHLIDLNIENN  221 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~l~~l~l~~N  221 (720)
                      |+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+..+..+.. ..|+.|+|++|
T Consensus       126 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~N  205 (290)
T 1p9a_G          126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN  205 (290)
T ss_dssp             CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSC
T ss_pred             CCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCC
Confidence            99999999999987777889999999999999999955555678899999999999999987765544 45999999999


Q ss_pred             cCcc
Q 004994          222 LFSG  225 (720)
Q Consensus       222 ~l~g  225 (720)
                      .+..
T Consensus       206 p~~C  209 (290)
T 1p9a_G          206 PWLC  209 (290)
T ss_dssp             CBCC
T ss_pred             CccC
Confidence            9873

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.76  E-value=5.8e-19  Score=200.07  Aligned_cols=182  Identities=16%  Similarity=0.180  Sum_probs=151.8

Q ss_pred             CCceeEeec-------------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecC
Q 004994           62 SWQGVFCVF-------------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSG  126 (720)
Q Consensus        62 ~w~gv~c~~-------------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~  126 (720)
                      .|.|+ |+.             ++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..+.  .+|++|+|++
T Consensus         5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~   83 (549)
T 2z81_A            5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD   83 (549)
T ss_dssp             CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence            78887 764             3799999999999998899999999999999999999987777776  7899999999


Q ss_pred             CcCCCCCcchhhcccccccccccccccCC-CCCchhcCCCCCceEeccCCcccccCC-CCCCCCCCCceeeccccccccc
Q 004994          127 NQLTGSIPESLSRLTQLLDLSLNNNHLNG-GIPDAFHQFTGLINFDLSANNLTGQLP-PSTRNLSSLYSLHLQNNKLSGT  204 (720)
Q Consensus       127 N~l~g~~p~~l~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~  204 (720)
                      |++++..|..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++.+.+| ..+.++++|+.|+|++|.+++.
T Consensus        84 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~  163 (549)
T 2z81_A           84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY  163 (549)
T ss_dssp             SCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred             CccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccccc
Confidence            99998888789999999999999999986 467889999999999999999555665 5799999999999999999986


Q ss_pred             cc-cccccc-cceEEccCCcCcccCCcc----cCCCccccccCccCC
Q 004994          205 LN-VLEDLH-LIDLNIENNLFSGPIPEK----LLSIPNFRKDGNPFN  245 (720)
Q Consensus       205 ~~-~~~~~~-l~~l~l~~N~l~g~~p~~----~~~l~~l~~~~n~~~  245 (720)
                      ++ .+..+. |+.|++++|.+. .+|..    +.++..|.+.+|.+.
T Consensus       164 ~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~  209 (549)
T 2z81_A          164 QSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLA  209 (549)
T ss_dssp             CTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCT
T ss_pred             ChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccc
Confidence            54 455555 899999999886 45543    345555556666543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.76  E-value=2.2e-18  Score=200.59  Aligned_cols=168  Identities=23%  Similarity=0.269  Sum_probs=149.8

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL  148 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l  148 (720)
                      ++++.|+|++|++++..+..|+++++|++|+|++|++++..|..+.  .+|++|+|++|++++..+..|+++++|++|+|
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            4799999999999998888999999999999999999987787776  79999999999999655567999999999999


Q ss_pred             cccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccc-c---cccccceEEccCCcCc
Q 004994          149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV-L---EDLHLIDLNIENNLFS  224 (720)
Q Consensus       149 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~---~~~~l~~l~l~~N~l~  224 (720)
                      ++|++++..|..|+++++|++|+|++|.+++..|..+.++++|+.|+|++|++++.++. +   ....|+.|++++|.++
T Consensus       105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~  184 (680)
T 1ziw_A          105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK  184 (680)
T ss_dssp             CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred             CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence            99999987788999999999999999999988899999999999999999999988753 2   2345999999999999


Q ss_pred             ccCCcccCCCcccc
Q 004994          225 GPIPEKLLSIPNFR  238 (720)
Q Consensus       225 g~~p~~~~~l~~l~  238 (720)
                      +..|..+..+++|+
T Consensus       185 ~~~~~~~~~l~~L~  198 (680)
T 1ziw_A          185 EFSPGCFHAIGRLF  198 (680)
T ss_dssp             CBCTTGGGGSSEEC
T ss_pred             ccChhhhhhhhhhh
Confidence            98888776655543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.76  E-value=1.7e-18  Score=187.47  Aligned_cols=169  Identities=18%  Similarity=0.228  Sum_probs=110.1

Q ss_pred             eEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCc-c--ccCcEEEecCCcCCCCCcchhhcccc
Q 004994           66 VFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL-P--VTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        66 v~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~-~--~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      .+..+++|+.|+|++|++++..|..|+.+++|++|+|++|+|+ .+|..+ .  .+|+.|+|++|++++..|..|.++++
T Consensus        88 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  166 (390)
T 3o6n_A           88 AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS  166 (390)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTT
T ss_pred             hccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCC
Confidence            3445566777777777777666666777777777777777776 455443 2  56777777777776666666666666


Q ss_pred             cccccccccccCCCC-----------------------------------------------------------CchhcC
Q 004994          143 LLDLSLNNNHLNGGI-----------------------------------------------------------PDAFHQ  163 (720)
Q Consensus       143 L~~L~l~~N~l~g~~-----------------------------------------------------------p~~~~~  163 (720)
                      |+.|+|++|++++..                                                           +..+..
T Consensus       167 L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~~~l~~  246 (390)
T 3o6n_A          167 LQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLN  246 (390)
T ss_dssp             CCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCCGGGGG
T ss_pred             CCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCcccHHHcC
Confidence            666666666655321                                                           123455


Q ss_pred             CCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcCcccCCcccCCCcc
Q 004994          164 FTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSGPIPEKLLSIPN  236 (720)
Q Consensus       164 l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l~g~~p~~~~~l~~  236 (720)
                      +++|+.|+|++|.+++..|..+..+++|+.|+|++|++++.+.....+ .|+.|+|++|+++ .+|..+..+++
T Consensus       247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~  319 (390)
T 3o6n_A          247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR  319 (390)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTT
T ss_pred             CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCc
Confidence            677777788888877766777777888888888888877765444433 3777777777777 45554433333

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=1.9e-19  Score=209.68  Aligned_cols=202  Identities=23%  Similarity=0.198  Sum_probs=120.7

Q ss_pred             CCCHHHHHHHHHHHHhcCC---CCCCCccCCCCCCCCCCCceeEeecCceeEEEecCCccc------------------c
Q 004994           27 VTDPRDVMALNSLYISLNF---PPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLG------------------G   85 (720)
Q Consensus        27 ~~~~~~~~al~~~~~~l~~---~~~~~w~~~~~~~c~~~w~gv~c~~~~l~~l~L~~n~l~------------------~   85 (720)
                      +....++.+|++++.++..   .....|... ..++. .|.++.++.++++.|+|.+|.+.                  +
T Consensus       128 s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~  205 (727)
T 4b8c_D          128 SLVDCTKQALMEMADTLTDSKTAKKQQPTGD-STPSG-TATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDE  205 (727)
T ss_dssp             ----CCCHHHHHHHHHHHHHHTTC--------------------------------------------------------
T ss_pred             hccccchhhhhhhhhhcccccCcccCCCcCC-CCccc-cCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccC
Confidence            3455688999999877732   234456432 23332 68888777666666655444433                  2


Q ss_pred             ---------cCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccC
Q 004994           86 ---------VLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLN  154 (720)
Q Consensus        86 ---------~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~  154 (720)
                               ..+..+..+++|+.|+|++|+|. .+|..+.  .+|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|+
T Consensus       206 ~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~  283 (727)
T 4b8c_D          206 DDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT  283 (727)
T ss_dssp             ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred             ccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence                     23566778888888888888888 7777665  67888888888888 88888888888888888888888


Q ss_pred             CCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccc-ccccc--cceEEccCCcCcccCCccc
Q 004994          155 GGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV-LEDLH--LIDLNIENNLFSGPIPEKL  231 (720)
Q Consensus       155 g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~--l~~l~l~~N~l~g~~p~~~  231 (720)
                       .+|..|++|++|++|+|++|.|+ .+|..|++|++|+.|+|++|.|++.++. +....  +..|+|++|.++|.+|..+
T Consensus       284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l  361 (727)
T 4b8c_D          284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER  361 (727)
T ss_dssp             -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred             -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc
Confidence             77888888888888888888887 7888888888888888888888877653 33222  3456788888888888766


Q ss_pred             CCC
Q 004994          232 LSI  234 (720)
Q Consensus       232 ~~l  234 (720)
                      ..+
T Consensus       362 ~~l  364 (727)
T 4b8c_D          362 RFI  364 (727)
T ss_dssp             ---
T ss_pred             cee
Confidence            543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.76  E-value=1.3e-18  Score=174.97  Aligned_cols=175  Identities=16%  Similarity=0.185  Sum_probs=146.8

Q ss_pred             eeEeecCceeEEEecCCc-ccccCCcCcCCCCCccEEeccC-CcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcc
Q 004994           65 GVFCVFSNVTEIRLTGMN-LGGVLADTLGDLESVINIDLSN-NHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRL  140 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l  140 (720)
                      +.+..+++|+.|+|++|+ +++..+..|..+++|++|+|++ |+|++..|..+.  .+|+.|+|++|++++ +|. |.++
T Consensus        49 ~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l  126 (239)
T 2xwt_C           49 HAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKV  126 (239)
T ss_dssp             TTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTC
T ss_pred             HHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccc
Confidence            345567899999999997 8887778999999999999999 999955555664  689999999999995 776 8889


Q ss_pred             cccc---ccccccc-ccCCCCCchhcCCCCCc-eEeccCCcccccCCCCCCCCCCCceeeccccc-cccccc-ccccc--
Q 004994          141 TQLL---DLSLNNN-HLNGGIPDAFHQFTGLI-NFDLSANNLTGQLPPSTRNLSSLYSLHLQNNK-LSGTLN-VLEDL--  211 (720)
Q Consensus       141 ~~L~---~L~l~~N-~l~g~~p~~~~~l~~L~-~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~-~~~~~--  211 (720)
                      ++|+   .|++++| ++++..+..|.++++|+ .|++++|+++ .+|......++|+.|+|++|+ +++.++ .+..+  
T Consensus       127 ~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~  205 (239)
T 2xwt_C          127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS  205 (239)
T ss_dssp             CBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSB
T ss_pred             cccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhcccc
Confidence            9988   9999999 99977777899999999 9999999999 777665555899999999995 998764 45665  


Q ss_pred             ccceEEccCCcCcccCCcccCCCccccccCc
Q 004994          212 HLIDLNIENNLFSGPIPEKLLSIPNFRKDGN  242 (720)
Q Consensus       212 ~l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n  242 (720)
                      .|+.|++++|+|++..+..+.+++.|.+.++
T Consensus       206 ~L~~L~l~~N~l~~l~~~~~~~L~~L~l~~~  236 (239)
T 2xwt_C          206 GPSLLDVSQTSVTALPSKGLEHLKELIARNT  236 (239)
T ss_dssp             CCSEEECTTCCCCCCCCTTCTTCSEEECTTC
T ss_pred             CCcEEECCCCccccCChhHhccCceeeccCc
Confidence            5999999999999655555777777766544

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.76  E-value=6.2e-19  Score=196.21  Aligned_cols=168  Identities=20%  Similarity=0.171  Sum_probs=137.1

Q ss_pred             cCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccccccccccc
Q 004994           70 FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN  149 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~  149 (720)
                      .++|+.|+|++|++++..|..|+.+++|++|+|++|+|++.+|-.-..+|+.|+|++|.|++..     ..++|+.|+|+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~  107 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA  107 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEECTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcccccCCCCCEEEecCCcCCCCC-----CCCCcCEEECc
Confidence            3489999999999999888999999999999999999998777222279999999999999543     23899999999


Q ss_pred             ccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-ccc-cc-ccceEEccCCcCccc
Q 004994          150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLE-DL-HLIDLNIENNLFSGP  226 (720)
Q Consensus       150 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~-~~-~l~~l~l~~N~l~g~  226 (720)
                      +|.|++..+.   .+++|+.|+|++|.|++..|..++++++|+.|+|++|.|++.++ .+. .+ .|+.|+|++|.|++.
T Consensus       108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~  184 (487)
T 3oja_A          108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV  184 (487)
T ss_dssp             SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred             CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence            9999976554   46889999999999998889999999999999999999999764 343 34 499999999999976


Q ss_pred             CCcc-cCCCccccccCccCC
Q 004994          227 IPEK-LLSIPNFRKDGNPFN  245 (720)
Q Consensus       227 ~p~~-~~~l~~l~~~~n~~~  245 (720)
                      .+.. +.+|..|.+.+|.+.
T Consensus       185 ~~~~~l~~L~~L~Ls~N~l~  204 (487)
T 3oja_A          185 KGQVVFAKLKTLDLSSNKLA  204 (487)
T ss_dssp             ECCCCCTTCCEEECCSSCCC
T ss_pred             cccccCCCCCEEECCCCCCC
Confidence            4322 334444445555443

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=1.2e-18  Score=177.16  Aligned_cols=138  Identities=21%  Similarity=0.184  Sum_probs=105.1

Q ss_pred             CCCCCeeccCCCceEEEEEe-CCCcE--EEEEEeccccccc----------------------ccHHHHHHHHHHHHccC
Q 004994          442 FSEGNFIGEGLLGSVYKAEL-PGGKL--LAVKKLSNTVSQR----------------------QTDEEFLELASTISRLR  496 (720)
Q Consensus       442 ~~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~~~----------------------~~~~~~~~e~~~l~~l~  496 (720)
                      |...+.||+|+||.||+|.. .+|+.  ||||+++......                      .....+.+|++.+.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999976 78988  9999975431110                      11236789999999998


Q ss_pred             CCce--eEEEeEeccCCeEEEEEeeCCC-C----CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHH-hcCCCCeee
Q 004994          497 HGNI--VELIGYCNEHGQHLLVYDYGGN-C----TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ-EVCEPPIVH  568 (720)
Q Consensus       497 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH  568 (720)
                      |+++  ..++++    +..++||||+++ |    +|.++...       .++.....++.+++.||.||| ..   +|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8754  444443    356899999952 4    66665421       123456789999999999999 66   9999


Q ss_pred             cCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          569 GNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       569 rDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      |||||+|||+++  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999754

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.75  E-value=3.1e-18  Score=194.63  Aligned_cols=174  Identities=18%  Similarity=0.217  Sum_probs=110.3

Q ss_pred             ceeEEEecCCcccccCCcCc-----CCCCC--------------------------ccEEeccCCcccccCCCCccccCc
Q 004994           72 NVTEIRLTGMNLGGVLADTL-----GDLES--------------------------VINIDLSNNHIGGSIPSNLPVTVR  120 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~-----~~l~~--------------------------L~~L~L~~N~l~g~ip~~~~~~L~  120 (720)
                      +|+.|++++|+++|.+|..+     ..++.                          |+.|++++|++.......-..+|+
T Consensus       277 ~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~  356 (562)
T 3a79_B          277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT  356 (562)
T ss_dssp             SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCC
T ss_pred             cccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCce
Confidence            78888888888888888776     44433                          344444444443111001125677


Q ss_pred             EEEecCCcCCCCCcchhhcccccccccccccccCCC--CCchhcCCCCCceEeccCCcccccCCC-CCCCCCCCceeecc
Q 004994          121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGG--IPDAFHQFTGLINFDLSANNLTGQLPP-STRNLSSLYSLHLQ  197 (720)
Q Consensus       121 ~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~l~  197 (720)
                      .|+|++|++++.+|..++++++|+.|+|++|++++.  +|..|.++++|+.|+|++|++++.+|. .+..+++|+.|+|+
T Consensus       357 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~  436 (562)
T 3a79_B          357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS  436 (562)
T ss_dssp             EEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECC
T ss_pred             EEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECC
Confidence            777777777777777777777777777777777752  245567777777777777777764554 36667777777777


Q ss_pred             ccccccccccccccccceEEccCCcCcccCCcccCCCccccccCccCCC
Q 004994          198 NNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNT  246 (720)
Q Consensus       198 ~N~l~~~~~~~~~~~l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~  246 (720)
                      +|+|++.++..-...|+.|+|++|+|+ .+|..+..+++|+..+...|.
T Consensus       437 ~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~  484 (562)
T 3a79_B          437 SNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ  484 (562)
T ss_dssp             SSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSC
T ss_pred             CCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCC
Confidence            777766543211134777777777777 666666566655554444443

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.75  E-value=2.2e-18  Score=193.91  Aligned_cols=174  Identities=21%  Similarity=0.247  Sum_probs=133.8

Q ss_pred             CceeEEEecCCcccccCCcCc-----CCCCCccEEeccCCcccccCCC----------------------------Cccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTL-----GDLESVINIDLSNNHIGGSIPS----------------------------NLPV  117 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~g~ip~----------------------------~~~~  117 (720)
                      ++|+.|+|++|+++|.+|..+     +.+++|+.+++++|.+  .+|.                            .-..
T Consensus       247 ~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~  324 (520)
T 2z7x_B          247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS  324 (520)
T ss_dssp             SSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCC
T ss_pred             CcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCC
Confidence            378888888888888888877     7777777777777766  3441                            1225


Q ss_pred             cCcEEEecCCcCCCCCcchhhcccccccccccccccCC--CCCchhcCCCCCceEeccCCcccccCCCC-CCCCCCCcee
Q 004994          118 TVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNG--GIPDAFHQFTGLINFDLSANNLTGQLPPS-TRNLSSLYSL  194 (720)
Q Consensus       118 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~~L  194 (720)
                      +|+.|+|++|++++.+|..++++++|+.|+|++|++++  .+|..|.++++|+.|+|++|++++.+|.. +..+++|+.|
T Consensus       325 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L  404 (520)
T 2z7x_B          325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL  404 (520)
T ss_dssp             CCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEE
T ss_pred             cccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEE
Confidence            78899999999998888888899999999999999986  56677888999999999999998757654 7788899999


Q ss_pred             eccccccccccccccccccceEEccCCcCcccCCcccCCCccccccCccCCCc
Q 004994          195 HLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTT  247 (720)
Q Consensus       195 ~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~~  247 (720)
                      +|++|++++..+..-...|+.|++++|+|+ .+|..+..+++|+..+...|..
T Consensus       405 ~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l  456 (520)
T 2z7x_B          405 NMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL  456 (520)
T ss_dssp             ECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCC
T ss_pred             ECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcC
Confidence            999999887654322245888999999988 7888776776666555544433

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.75  E-value=3.1e-18  Score=199.33  Aligned_cols=183  Identities=22%  Similarity=0.268  Sum_probs=117.7

Q ss_pred             eEeecCceeEEEecCCcccccCC-cCcCCCCCccEEeccCCccccc--------------------------CCCCcc--
Q 004994           66 VFCVFSNVTEIRLTGMNLGGVLA-DTLGDLESVINIDLSNNHIGGS--------------------------IPSNLP--  116 (720)
Q Consensus        66 v~c~~~~l~~l~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~g~--------------------------ip~~~~--  116 (720)
                      .++.+++|+.|+|++|.+++.+| ..|..+++|++|+|++|++.+.                          +|..+.  
T Consensus       400 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l  479 (680)
T 1ziw_A          400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL  479 (680)
T ss_dssp             TTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTC
T ss_pred             hhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccC
Confidence            34456677777777777776555 5677777777777777776543                          344443  


Q ss_pred             ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCC--------CchhcCCCCCceEeccCCcccccCCC-CCCC
Q 004994          117 VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGI--------PDAFHQFTGLINFDLSANNLTGQLPP-STRN  187 (720)
Q Consensus       117 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~--------p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~  187 (720)
                      .+|+.|+|++|++++..|..|.++++|+.|+|++|++++..        +..|.++++|+.|+|++|+|+ .+|. .|.+
T Consensus       480 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~  558 (680)
T 1ziw_A          480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKD  558 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTT
T ss_pred             CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHccc
Confidence            45666666666666555555666666777777777665421        122566677777777777776 4443 4677


Q ss_pred             CCCCceeecccccccccccc-cccc-ccceEEccCCcCcccCCc----ccCCCccccccCccCCCccc
Q 004994          188 LSSLYSLHLQNNKLSGTLNV-LEDL-HLIDLNIENNLFSGPIPE----KLLSIPNFRKDGNPFNTTVI  249 (720)
Q Consensus       188 l~~L~~L~l~~N~l~~~~~~-~~~~-~l~~l~l~~N~l~g~~p~----~~~~l~~l~~~~n~~~~~~~  249 (720)
                      +++|+.|+|++|+|++.++. +..+ .|+.|+|++|+|++..|.    .+.++..+.+.+|+|.|.|.
T Consensus       559 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence            77777777777777766543 3343 377777777777765554    24456666677777777664

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.74  E-value=2.6e-18  Score=183.84  Aligned_cols=167  Identities=26%  Similarity=0.245  Sum_probs=142.2

Q ss_pred             CCCCCCceeEeec-----------CceeEEEecCCcccccCCcCcC-CCCCccEEeccCCcccccCCCCcc--ccCcEEE
Q 004994           58 PCGDSWQGVFCVF-----------SNVTEIRLTGMNLGGVLADTLG-DLESVINIDLSNNHIGGSIPSNLP--VTVRNFS  123 (720)
Q Consensus        58 ~c~~~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~  123 (720)
                      .|.|.+..+.|..           ..++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..|..|.  .+|+.|+
T Consensus        15 ~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~   94 (361)
T 2xot_A           15 NCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLD   94 (361)
T ss_dssp             TCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEE
Confidence            3656677788853           3478999999999998888888 999999999999999966666675  7899999


Q ss_pred             ecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCC-C---CCCCCCceeecccc
Q 004994          124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPS-T---RNLSSLYSLHLQNN  199 (720)
Q Consensus       124 Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~---~~l~~L~~L~l~~N  199 (720)
                      |++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+ .+|.. +   ..+++|+.|+|++|
T Consensus        95 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N  173 (361)
T 2xot_A           95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSN  173 (361)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSS
T ss_pred             CCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCC
Confidence            9999999877788999999999999999999888999999999999999999999 46654 4   67999999999999


Q ss_pred             ccccccc-cccccc---cceEEccCCcCcc
Q 004994          200 KLSGTLN-VLEDLH---LIDLNIENNLFSG  225 (720)
Q Consensus       200 ~l~~~~~-~~~~~~---l~~l~l~~N~l~g  225 (720)
                      +|++.+. .+..+.   ++.|+|++|.+..
T Consensus       174 ~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          174 KLKKLPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             CCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             CCCccCHHHhhhccHhhcceEEecCCCccC
Confidence            9998763 344443   5889999999873

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.74  E-value=4e-18  Score=202.90  Aligned_cols=175  Identities=19%  Similarity=0.202  Sum_probs=152.7

Q ss_pred             CCCceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccC-CCCcc--ccCcEEEecCCcCCCCCcchh
Q 004994           61 DSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSI-PSNLP--VTVRNFSLSGNQLTGSIPESL  137 (720)
Q Consensus        61 ~~w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~i-p~~~~--~~L~~L~Ls~N~l~g~~p~~l  137 (720)
                      ..|..|-+..++|+.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..+.  .+|++|+|++|++++..|..|
T Consensus        14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~   93 (844)
T 3j0a_A           14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF   93 (844)
T ss_dssp             CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred             CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence            357777774578999999999999999999999999999999999887788 56665  789999999999999999999


Q ss_pred             hcccccccccccccccCCCCCch--hcCCCCCceEeccCCcccccCC-CCCCCCCCCceeeccccccccccc-cccc---
Q 004994          138 SRLTQLLDLSLNNNHLNGGIPDA--FHQFTGLINFDLSANNLTGQLP-PSTRNLSSLYSLHLQNNKLSGTLN-VLED---  210 (720)
Q Consensus       138 ~~l~~L~~L~l~~N~l~g~~p~~--~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~~-~~~~---  210 (720)
                      +++++|++|+|++|.+++.+|..  |.++++|++|+|++|.+++..+ ..|+++++|+.|+|++|.+++..+ .+..   
T Consensus        94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~  173 (844)
T 3j0a_A           94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG  173 (844)
T ss_dssp             CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHH
T ss_pred             cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccC
Confidence            99999999999999999877766  9999999999999999997655 579999999999999999988653 3433   


Q ss_pred             cccceEEccCCcCcccCCcccCCCc
Q 004994          211 LHLIDLNIENNLFSGPIPEKLLSIP  235 (720)
Q Consensus       211 ~~l~~l~l~~N~l~g~~p~~~~~l~  235 (720)
                      ..|+.|++++|.+.+.+|..+..+.
T Consensus       174 ~~L~~L~L~~n~l~~~~~~~~~~~~  198 (844)
T 3j0a_A          174 KTLSFFSLAANSLYSRVSVDWGKCM  198 (844)
T ss_dssp             CSSCCCEECCSBSCCCCCCCCCSSS
T ss_pred             CccceEECCCCccccccccchhhcC
Confidence            4599999999999998887765543

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.74  E-value=1.9e-18  Score=181.49  Aligned_cols=173  Identities=15%  Similarity=0.082  Sum_probs=112.7

Q ss_pred             CceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccc
Q 004994           63 WQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        63 w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      ....++.+++|+.|+|++|++++..+  +..+++|++|+|++|+|++ +|..  .+|+.|+|++|++++..+..   +++
T Consensus        50 ~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~~~--~~L~~L~l~~n~l~~~~~~~---~~~  121 (317)
T 3o53_A           50 SAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LLVG--PSIETLHAANNNISRVSCSR---GQG  121 (317)
T ss_dssp             CHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EEEC--TTCCEEECCSSCCSEEEECC---CSS
T ss_pred             CHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-ccCC--CCcCEEECCCCccCCcCccc---cCC
Confidence            33556778889999999999987665  8889999999999999884 3321  56777777777776444332   456


Q ss_pred             cccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCC-CCCCCCceeeccccccccccccccccccceEEccCC
Q 004994          143 LLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENN  221 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N  221 (720)
                      |+.|+|++|++++..|..|..+++|+.|+|++|.+++..|..+ ..+++|+.|+|++|.|++.........|+.|+|++|
T Consensus       122 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N  201 (317)
T 3o53_A          122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN  201 (317)
T ss_dssp             CEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSS
T ss_pred             CCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCC
Confidence            6777777777766556666667777777777777765555554 356677777777777666543333334667777777


Q ss_pred             cCcccCCcccCCCccccccCccC
Q 004994          222 LFSGPIPEKLLSIPNFRKDGNPF  244 (720)
Q Consensus       222 ~l~g~~p~~~~~l~~l~~~~n~~  244 (720)
                      ++++ +|..+..+++|+..+...
T Consensus       202 ~l~~-l~~~~~~l~~L~~L~L~~  223 (317)
T 3o53_A          202 KLAF-MGPEFQSAAGVTWISLRN  223 (317)
T ss_dssp             CCCE-ECGGGGGGTTCSEEECTT
T ss_pred             cCCc-chhhhcccCcccEEECcC
Confidence            7764 344455544444433333

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.74  E-value=2.3e-18  Score=197.56  Aligned_cols=167  Identities=19%  Similarity=0.171  Sum_probs=76.0

Q ss_pred             cCceeEEEecCCcccccCCcCcCCCCCccEEeccCCccccc--CCCCcc--ccCcEEEecCCcCCCCCcchhhccccccc
Q 004994           70 FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGS--IPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLD  145 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~--ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~  145 (720)
                      +++|+.|+|++|...+.+  .+..+++|++|+|++|++++.  +|..+.  .+|+.|+|++|.++ .+|..+.++++|+.
T Consensus       327 l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~  403 (606)
T 3vq2_A          327 LPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQH  403 (606)
T ss_dssp             CSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCE
T ss_pred             CCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCe
Confidence            344455555554333322  344445555555555554433  132222  34555555555544 23344444555555


Q ss_pred             ccccccccCCCCC-chhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccc--cccccccc-cceEEccCC
Q 004994          146 LSLNNNHLNGGIP-DAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT--LNVLEDLH-LIDLNIENN  221 (720)
Q Consensus       146 L~l~~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~-l~~l~l~~N  221 (720)
                      |+|++|++.+..| ..|.++++|+.|++++|.+++.+|..+.++++|+.|+|++|++++.  +..+..+. |+.|++++|
T Consensus       404 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n  483 (606)
T 3vq2_A          404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC  483 (606)
T ss_dssp             EECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred             eECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCC
Confidence            5555555544444 3444455555555555555444444445555555555555554441  12233332 445555555


Q ss_pred             cCcccCCcccCCCccccc
Q 004994          222 LFSGPIPEKLLSIPNFRK  239 (720)
Q Consensus       222 ~l~g~~p~~~~~l~~l~~  239 (720)
                      ++++..|..+..+++|+.
T Consensus       484 ~l~~~~~~~~~~l~~L~~  501 (606)
T 3vq2_A          484 QLEQISWGVFDTLHRLQL  501 (606)
T ss_dssp             CCCEECTTTTTTCTTCCE
T ss_pred             cCCccChhhhcccccCCE
Confidence            555444444444444333

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.74  E-value=5.6e-18  Score=194.36  Aligned_cols=184  Identities=22%  Similarity=0.165  Sum_probs=158.1

Q ss_pred             eeEeecCceeEEEecCCcccccCCcC-cCCCCCccEEeccCCcccccC--CCCcc--ccCcEEEecCCcCCCCCcchhhc
Q 004994           65 GVFCVFSNVTEIRLTGMNLGGVLADT-LGDLESVINIDLSNNHIGGSI--PSNLP--VTVRNFSLSGNQLTGSIPESLSR  139 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~g~i--p~~~~--~~L~~L~Ls~N~l~g~~p~~l~~  139 (720)
                      ..+..+++|+.|+|++|.+.+.+|.. +..+++|++|+|++|++++..  |..+.  .+|+.|+|++|++++..|..|.+
T Consensus       319 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  398 (606)
T 3t6q_A          319 ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE  398 (606)
T ss_dssp             GCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTT
T ss_pred             hhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcC
Confidence            45667889999999999999877654 999999999999999999765  66665  78999999999999999999999


Q ss_pred             ccccccccccccccCCCCCch-hcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccc----ccccccc-c
Q 004994          140 LTQLLDLSLNNNHLNGGIPDA-FHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL----NVLEDLH-L  213 (720)
Q Consensus       140 l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~~-l  213 (720)
                      +++|+.|+|++|++++..|.. |.++++|+.|+|++|.+++..|..+..+++|+.|+|++|++++..    ..+..+. |
T Consensus       399 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L  478 (606)
T 3t6q_A          399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL  478 (606)
T ss_dssp             CTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTC
T ss_pred             CccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCc
Confidence            999999999999999877654 899999999999999999888999999999999999999998732    2355554 9


Q ss_pred             ceEEccCCcCcccCCcccCCCccccccCccCCCcc
Q 004994          214 IDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTV  248 (720)
Q Consensus       214 ~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~~~  248 (720)
                      +.|++++|++++..|..+..+++|+..+.+.|...
T Consensus       479 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  513 (606)
T 3t6q_A          479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT  513 (606)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             cEEECCCCccCccChhhhccccCCCEEECCCCccC
Confidence            99999999999998998888888776665555443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.73  E-value=8.3e-19  Score=187.20  Aligned_cols=160  Identities=20%  Similarity=0.247  Sum_probs=139.0

Q ss_pred             eEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCC-cc--ccCcEEEecCCcCCCCCcc--hhhcc
Q 004994           66 VFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN-LP--VTVRNFSLSGNQLTGSIPE--SLSRL  140 (720)
Q Consensus        66 v~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~-~~--~~L~~L~Ls~N~l~g~~p~--~l~~l  140 (720)
                      .+..+++|+.|+|++|++++..+..|+.+++|++|+|++|+|+ .+|.. +.  .+|++|+|++|+++ .+|.  .+.++
T Consensus        71 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l  148 (353)
T 2z80_A           71 DLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHL  148 (353)
T ss_dssp             TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTC
T ss_pred             HhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccC
Confidence            4566789999999999999988999999999999999999999 55554 44  78999999999999 4554  79999


Q ss_pred             ccccccccccc-ccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccc-ccc-ccceEE
Q 004994          141 TQLLDLSLNNN-HLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVL-EDL-HLIDLN  217 (720)
Q Consensus       141 ~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~-~l~~l~  217 (720)
                      ++|+.|++++| .+++..|..|.++++|+.|++++|++++..|..+.++++|+.|+|++|+++..+..+ ..+ .|+.|+
T Consensus       149 ~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~  228 (353)
T 2z80_A          149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLE  228 (353)
T ss_dssp             TTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEE
T ss_pred             CCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEE
Confidence            99999999999 577666788999999999999999999888999999999999999999997666433 333 489999


Q ss_pred             ccCCcCcccC
Q 004994          218 IENNLFSGPI  227 (720)
Q Consensus       218 l~~N~l~g~~  227 (720)
                      +++|.+++..
T Consensus       229 L~~n~l~~~~  238 (353)
T 2z80_A          229 LRDTDLDTFH  238 (353)
T ss_dssp             EESCBCTTCC
T ss_pred             CCCCcccccc
Confidence            9999998743

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.73  E-value=6.8e-18  Score=187.82  Aligned_cols=160  Identities=21%  Similarity=0.257  Sum_probs=121.4

Q ss_pred             eeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccc
Q 004994           65 GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      +.+..+++|+.|+|++|++++..+..|..+++|++|+|++|++.+..|..+.  .+|+.|+|++|++++..|..|.++++
T Consensus        74 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  153 (477)
T 2id5_A           74 GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS  153 (477)
T ss_dssp             TTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTT
T ss_pred             hhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCC
Confidence            4466778899999999999877777788899999999999999877777775  68889999999888888888888888


Q ss_pred             cccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc--cccccccceEEccC
Q 004994          143 LLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN--VLEDLHLIDLNIEN  220 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~l~~l~l~~  220 (720)
                      |+.|+|++|++++..+..|.++++|+.|+|++|.+++..+..+..+++|+.|+|++|.+.+.++  .+....|+.|+|++
T Consensus       154 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~  233 (477)
T 2id5_A          154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH  233 (477)
T ss_dssp             CCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEES
T ss_pred             CCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcC
Confidence            8888888888886666678888888888888888887666677777777777777765544332  11222344444444


Q ss_pred             CcCc
Q 004994          221 NLFS  224 (720)
Q Consensus       221 N~l~  224 (720)
                      |+++
T Consensus       234 n~l~  237 (477)
T 2id5_A          234 CNLT  237 (477)
T ss_dssp             SCCC
T ss_pred             Cccc
Confidence            4444

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.73  E-value=1.8e-17  Score=162.75  Aligned_cols=165  Identities=20%  Similarity=0.243  Sum_probs=135.2

Q ss_pred             eEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccccccccc
Q 004994           74 TEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNN  151 (720)
Q Consensus        74 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N  151 (720)
                      +.++.++++++. +|..+  .++|++|+|++|+|++..+..+.  .+|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus        10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            578899999985 45444  46899999999999955554554  78999999999999776677899999999999999


Q ss_pred             ccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccc-cccc-ccceEEccCCcCcccCCc
Q 004994          152 HLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV-LEDL-HLIDLNIENNLFSGPIPE  229 (720)
Q Consensus       152 ~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~-~l~~l~l~~N~l~g~~p~  229 (720)
                      +|++..+..|.++++|++|+|++|+|++..+..+.++++|+.|+|++|+|++.++. +..+ .|+.|++++|.+.+..| 
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-  165 (208)
T 2o6s_A           87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-  165 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT-
T ss_pred             cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC-
Confidence            99977777789999999999999999976666789999999999999999988764 5555 49999999999987655 


Q ss_pred             ccCCCccccccCccCC
Q 004994          230 KLLSIPNFRKDGNPFN  245 (720)
Q Consensus       230 ~~~~l~~l~~~~n~~~  245 (720)
                         ++..|....|.+.
T Consensus       166 ---~l~~L~~~~n~~~  178 (208)
T 2o6s_A          166 ---GIRYLSEWINKHS  178 (208)
T ss_dssp             ---TTHHHHHHHHHCT
T ss_pred             ---CHHHHHHHHHhCC
Confidence               3444444555443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.73  E-value=1.3e-18  Score=182.15  Aligned_cols=175  Identities=21%  Similarity=0.229  Sum_probs=84.3

Q ss_pred             eecCceeEEEecCCcccccCC----cCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCC--Cc--chh
Q 004994           68 CVFSNVTEIRLTGMNLGGVLA----DTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGS--IP--ESL  137 (720)
Q Consensus        68 c~~~~l~~l~L~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~--~p--~~l  137 (720)
                      ..+++|+.|+|++|++++..+    ..+..+++|++|+|++|++.+..|..+.  .+|++|+|++|++.+.  ++  ..+
T Consensus       114 ~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  193 (310)
T 4glp_A          114 ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCP  193 (310)
T ss_dssp             CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCT
T ss_pred             ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhh
Confidence            334455555555555554333    2233455555555555555544444443  4555555555555431  11  112


Q ss_pred             hcccccccccccccccCCCCCc----hhcCCCCCceEeccCCcccccCCCCCCCC---CCCceeeccccccccccccccc
Q 004994          138 SRLTQLLDLSLNNNHLNGGIPD----AFHQFTGLINFDLSANNLTGQLPPSTRNL---SSLYSLHLQNNKLSGTLNVLED  210 (720)
Q Consensus       138 ~~l~~L~~L~l~~N~l~g~~p~----~~~~l~~L~~L~ls~N~l~g~~p~~~~~l---~~L~~L~l~~N~l~~~~~~~~~  210 (720)
                      .++++|++|+|++|+|+ .+|.    .+.++++|++|+|++|+|++.+|..+..+   ++|+.|+|++|+|+..+..+. 
T Consensus       194 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~-  271 (310)
T 4glp_A          194 HKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP-  271 (310)
T ss_dssp             TSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC-
T ss_pred             hcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc-
Confidence            44555555555555554 2222    13445555555555555554445554444   355555555555554333222 


Q ss_pred             cccceEEccCCcCcc-cCCcccCCCccccccCccC
Q 004994          211 LHLIDLNIENNLFSG-PIPEKLLSIPNFRKDGNPF  244 (720)
Q Consensus       211 ~~l~~l~l~~N~l~g-~~p~~~~~l~~l~~~~n~~  244 (720)
                      ..|+.|+|++|+|++ .++..+.++..|.+.+|++
T Consensus       272 ~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l  306 (310)
T 4glp_A          272 AKLRVLDLSSNRLNRAPQPDELPEVDNLTLDGNPF  306 (310)
T ss_dssp             SCCSCEECCSCCCCSCCCTTSCCCCSCEECSSTTT
T ss_pred             CCCCEEECCCCcCCCCchhhhCCCccEEECcCCCC
Confidence            235555555555554 2333333444444444443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.73  E-value=5.7e-18  Score=192.70  Aligned_cols=176  Identities=18%  Similarity=0.199  Sum_probs=99.7

Q ss_pred             cCceeEEEecCCcccccC--CcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCc-chhhcccccc
Q 004994           70 FSNVTEIRLTGMNLGGVL--ADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIP-ESLSRLTQLL  144 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p-~~l~~l~~L~  144 (720)
                      +++|+.|+|++|++++..  +..+..+++|++|+|++|++.+. |..+.  .+|+.|+|++|++++..| ..+.++++|+
T Consensus       346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~  424 (570)
T 2z63_A          346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI  424 (570)
T ss_dssp             CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred             CCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence            445555555555555432  44555556666666666665532 22233  456666666666665544 3456666666


Q ss_pred             cccccccccCCCCCchhcCCCCCceEeccCCccc-ccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCC
Q 004994          145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT-GQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENN  221 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N  221 (720)
                      .|+|++|.+++.+|..|.++++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++.++ .+..+. |+.|++++|
T Consensus       425 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  504 (570)
T 2z63_A          425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN  504 (570)
T ss_dssp             EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence            6666666666666666666666666666666665 4566666666666666666666665532 344433 666666666


Q ss_pred             cCcccCCcccCCCccc---cccCccCCC
Q 004994          222 LFSGPIPEKLLSIPNF---RKDGNPFNT  246 (720)
Q Consensus       222 ~l~g~~p~~~~~l~~l---~~~~n~~~~  246 (720)
                      ++++..|..+..+++|   .+.+|++.|
T Consensus       505 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~  532 (570)
T 2z63_A          505 QLKSVPDGIFDRLTSLQKIWLHTNPWDC  532 (570)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cCCCCCHHHhhcccCCcEEEecCCcccC
Confidence            6665555544444333   344454443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.73  E-value=6.4e-18  Score=164.43  Aligned_cols=151  Identities=21%  Similarity=0.294  Sum_probs=128.7

Q ss_pred             eecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccc
Q 004994           68 CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLD  145 (720)
Q Consensus        68 c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~  145 (720)
                      ..+++|+.|+|++|+++ .+| .+..+++|++|+|++|.++ .++ .+.  ++|+.|+|++|++++..|..|+.+++|+.
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            34678999999999999 455 6999999999999999876 333 444  78999999999999888999999999999


Q ss_pred             ccccccccCCCCCchhcCCCCCceEeccCCc-ccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcC
Q 004994          146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANN-LTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLF  223 (720)
Q Consensus       146 L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l  223 (720)
                      |+|++|++++..|..|..+++|++|+|++|. ++ .+| .+..+++|+.|+|++|++++.. .+..+ .|+.|++++|++
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i  193 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTI  193 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC--
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCccc
Confidence            9999999998889999999999999999998 65 677 6899999999999999999865 44444 499999999998


Q ss_pred             cc
Q 004994          224 SG  225 (720)
Q Consensus       224 ~g  225 (720)
                      .+
T Consensus       194 ~~  195 (197)
T 4ezg_A          194 GG  195 (197)
T ss_dssp             --
T ss_pred             CC
Confidence            64

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.72  E-value=1.5e-17  Score=173.78  Aligned_cols=166  Identities=22%  Similarity=0.362  Sum_probs=133.0

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      ++.+++|+.|+|++|++++..+  +..+++|++|+|++|++++ +| .+.  .+|+.|+|++|++++ +|. +.++++|+
T Consensus        59 ~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~  132 (308)
T 1h6u_A           59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQ  132 (308)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCC
T ss_pred             hhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCC
Confidence            4567899999999999987554  9999999999999999984 44 343  689999999999985 454 89999999


Q ss_pred             cccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCcCc
Q 004994          145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFS  224 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~  224 (720)
                      .|+|++|++++. +. +..+++|+.|+|++|++++ ++. +..+++|+.|+|++|++++..+......|+.|+|++|+++
T Consensus       133 ~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~  208 (308)
T 1h6u_A          133 VLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQIS  208 (308)
T ss_dssp             EEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred             EEECCCCccCcC-cc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccC
Confidence            999999999854 43 8899999999999999984 554 8899999999999999988766333334999999999999


Q ss_pred             ccCCcccCCCcccc---ccCccC
Q 004994          225 GPIPEKLLSIPNFR---KDGNPF  244 (720)
Q Consensus       225 g~~p~~~~~l~~l~---~~~n~~  244 (720)
                      +..|  +..+++|+   +.+|++
T Consensus       209 ~~~~--l~~l~~L~~L~l~~N~i  229 (308)
T 1h6u_A          209 DVSP--LANTSNLFIVTLTNQTI  229 (308)
T ss_dssp             BCGG--GTTCTTCCEEEEEEEEE
T ss_pred             cccc--ccCCCCCCEEEccCCee
Confidence            6554  55555554   455554

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.72  E-value=1.3e-17  Score=187.70  Aligned_cols=111  Identities=18%  Similarity=0.230  Sum_probs=86.5

Q ss_pred             CceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCC-CCcchhhccc
Q 004994           63 WQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTG-SIPESLSRLT  141 (720)
Q Consensus        63 w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g-~~p~~l~~l~  141 (720)
                      ..+.+..+++|+.|+|++|++++..|..|+.+++|++|+|++|+|+ .+|..-..+|++|+|++|++++ .+|..|++++
T Consensus        37 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~l~~L~~L~L~~N~l~~~~~p~~~~~l~  115 (520)
T 2z7x_B           37 WTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHLDLSFNAFDALPICKEFGNMS  115 (520)
T ss_dssp             CHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECCCCCCCSEEECCSSCCSSCCCCGGGGGCT
T ss_pred             ChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCccccCCccEEeccCCccccccchhhhccCC
Confidence            3355677889999999999999988999999999999999999998 6777733789999999999987 5788999999


Q ss_pred             ccccccccccccCCCCCchhcCCCCC--ceEeccCCcc
Q 004994          142 QLLDLSLNNNHLNGGIPDAFHQFTGL--INFDLSANNL  177 (720)
Q Consensus       142 ~L~~L~l~~N~l~g~~p~~~~~l~~L--~~L~ls~N~l  177 (720)
                      +|++|+|++|.|++   ..|..+++|  +.|+|++|.+
T Consensus       116 ~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l  150 (520)
T 2z7x_B          116 QLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGET  150 (520)
T ss_dssp             TCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTT
T ss_pred             cceEEEecCcccch---hhccccccceeeEEEeecccc
Confidence            99999988888754   233333334  4444444444

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.71  E-value=2.7e-17  Score=159.31  Aligned_cols=130  Identities=25%  Similarity=0.412  Sum_probs=118.9

Q ss_pred             cEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcc-hhhcccccccccccccccCCCCCchhcCCCCCceEeccCCc
Q 004994           98 INIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPE-SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANN  176 (720)
Q Consensus        98 ~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~-~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~  176 (720)
                      +.|++++|+|+ .+|..++.+|+.|+|++|+|++..+. .|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~   89 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK   89 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             CEEEcCCCCcC-cCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence            78999999997 89999999999999999999976664 48999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCcccCC
Q 004994          177 LTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSGPIP  228 (720)
Q Consensus       177 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g~~p  228 (720)
                      |++..|..|.++++|+.|+|++|+|++.++ .+..+. |+.|+|++|.+++..+
T Consensus        90 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            998888889999999999999999999865 455554 9999999999998765

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.71  E-value=2.6e-17  Score=189.53  Aligned_cols=162  Identities=18%  Similarity=0.188  Sum_probs=136.7

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccccccc
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN  149 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~  149 (720)
                      +++.|+|++|+|++..+..|.++++|++|||++|+|++..|..|.  .+|++|+|++|+|++..+..|.++++|++|+|+
T Consensus        53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls  132 (635)
T 4g8a_A           53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  132 (635)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred             CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence            689999999999988888999999999999999999965566665  789999999999997777789999999999999


Q ss_pred             ccccCCCCCchhcCCCCCceEeccCCcccc-cCCCCCCCCCCCceeeccccccccccc-ccc---ccc--cceEEccCCc
Q 004994          150 NNHLNGGIPDAFHQFTGLINFDLSANNLTG-QLPPSTRNLSSLYSLHLQNNKLSGTLN-VLE---DLH--LIDLNIENNL  222 (720)
Q Consensus       150 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~---~~~--l~~l~l~~N~  222 (720)
                      +|+|++..+..|+++++|++|+|++|.+++ .+|..+..+++|+.|+|++|+|++..+ .+.   .+.  ...++++.|.
T Consensus       133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~  212 (635)
T 4g8a_A          133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  212 (635)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred             CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence            999997777789999999999999999975 467888999999999999999988763 232   222  5578899999


Q ss_pred             CcccCCcccCC
Q 004994          223 FSGPIPEKLLS  233 (720)
Q Consensus       223 l~g~~p~~~~~  233 (720)
                      ++...|..+..
T Consensus       213 l~~i~~~~~~~  223 (635)
T 4g8a_A          213 MNFIQPGAFKE  223 (635)
T ss_dssp             CCEECTTTTTT
T ss_pred             ccccCcccccc
Confidence            98655554443

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.71  E-value=3.1e-17  Score=186.40  Aligned_cols=120  Identities=17%  Similarity=0.140  Sum_probs=81.7

Q ss_pred             ceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCC-CCcchhhcccc
Q 004994           64 QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTG-SIPESLSRLTQ  142 (720)
Q Consensus        64 ~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g-~~p~~l~~l~~  142 (720)
                      .+.+..+++|+.|+|++|++++..|..|+.+++|++|+|++|+|+ .+|..-..+|+.|+|++|++++ .+|..|+++++
T Consensus        69 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~  147 (562)
T 3a79_B           69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTK  147 (562)
T ss_dssp             GGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSCCCTTCSEEECCSSCCSBCCCCGGGGGCTT
T ss_pred             hhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCccccccCCEEECCCCCccccCchHhhcccCc
Confidence            345566777888888888888777777888888888888888887 6666633678888888888875 34577888888


Q ss_pred             cccccccccccCCCCCchhcCCCCC--ceEeccCCcc--cccCCCCCCC
Q 004994          143 LLDLSLNNNHLNGGIPDAFHQFTGL--INFDLSANNL--TGQLPPSTRN  187 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~~l~~L--~~L~ls~N~l--~g~~p~~~~~  187 (720)
                      |++|+|++|++++.   .+..+++|  +.|+|++|.+  ++..|..+..
T Consensus       148 L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~  193 (562)
T 3a79_B          148 LTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQI  193 (562)
T ss_dssp             CCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEE
T ss_pred             ccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccc
Confidence            88888888777642   23333444  5666666655  4444544443

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.71  E-value=5.6e-18  Score=177.90  Aligned_cols=168  Identities=20%  Similarity=0.173  Sum_probs=136.9

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      +...++|+.|+|++|++++..|..|..+++|++|+|++|++++..|  +.  .+|++|+|++|++++. |    .+++|+
T Consensus        30 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l-~----~~~~L~  102 (317)
T 3o53_A           30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-L----VGPSIE  102 (317)
T ss_dssp             HTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEE-E----ECTTCC
T ss_pred             hccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccc-c----CCCCcC
Confidence            3345689999999999999888999999999999999999997665  43  7899999999999843 3    448999


Q ss_pred             cccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cc-ccc-ccceEEccCC
Q 004994          145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VL-EDL-HLIDLNIENN  221 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~-~~~-~l~~l~l~~N  221 (720)
                      .|++++|++++..+.   .+++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..+ .+ ..+ .|+.|+|++|
T Consensus       103 ~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N  179 (317)
T 3o53_A          103 TLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN  179 (317)
T ss_dssp             EEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred             EEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCC
Confidence            999999999975544   36789999999999998778899999999999999999998764 33 233 4999999999


Q ss_pred             cCcccCCcc--cCCCccccccCccCC
Q 004994          222 LFSGPIPEK--LLSIPNFRKDGNPFN  245 (720)
Q Consensus       222 ~l~g~~p~~--~~~l~~l~~~~n~~~  245 (720)
                      .+++. |..  +.++..|.+.+|...
T Consensus       180 ~l~~~-~~~~~l~~L~~L~Ls~N~l~  204 (317)
T 3o53_A          180 FIYDV-KGQVVFAKLKTLDLSSNKLA  204 (317)
T ss_dssp             CCCEE-ECCCCCTTCCEEECCSSCCC
T ss_pred             cCccc-ccccccccCCEEECCCCcCC
Confidence            99965 332  334445555555543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.70  E-value=3.8e-17  Score=185.94  Aligned_cols=164  Identities=20%  Similarity=0.209  Sum_probs=145.0

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL  148 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l  148 (720)
                      .+++.|+|++|++++..+..|..+++|++|+|++|++++..|..+.  .+|++|+|++|++++..|..|+++++|++|+|
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence            4799999999999998889999999999999999999976677776  79999999999999888899999999999999


Q ss_pred             cccccCCCCCchhcCCCCCceEeccCCcccc-cCCCCCCCCCCCceeeccccccccccc-cccccc-c----ceEEccCC
Q 004994          149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTG-QLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-L----IDLNIENN  221 (720)
Q Consensus       149 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l----~~l~l~~N  221 (720)
                      ++|++++..+..|+++++|++|+|++|.+++ .+|..++++++|+.|++++|++++.++ .+..+. |    ..|++++|
T Consensus       108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n  187 (570)
T 2z63_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  187 (570)
T ss_dssp             TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred             cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence            9999997666679999999999999999986 479999999999999999999998764 343332 4    78999999


Q ss_pred             cCcccCCcccCCC
Q 004994          222 LFSGPIPEKLLSI  234 (720)
Q Consensus       222 ~l~g~~p~~~~~l  234 (720)
                      .+++..|..+..+
T Consensus       188 ~l~~~~~~~~~~~  200 (570)
T 2z63_A          188 PMNFIQPGAFKEI  200 (570)
T ss_dssp             CCCEECTTTTTTC
T ss_pred             CceecCHHHhccC
Confidence            9998888776653

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.69  E-value=4.9e-17  Score=168.40  Aligned_cols=161  Identities=23%  Similarity=0.342  Sum_probs=120.6

Q ss_pred             ecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      .+++|+.|++++|++...  +.+..+++|+.|+|++|++++..|  +.  .+|+.|+|++|++++ +| .+.++++|+.|
T Consensus        44 ~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L  117 (291)
T 1h6t_A           44 ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL  117 (291)
T ss_dssp             HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred             hcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence            456788888888888754  347888888888888888885443  43  678888888888884 44 48888888888


Q ss_pred             cccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcCcc
Q 004994          147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSG  225 (720)
Q Consensus       147 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l~g  225 (720)
                      +|++|++++ + +.+..+++|+.|+|++|++++ + ..+..+++|+.|+|++|++++..+ +..+ .|+.|++++|.+++
T Consensus       118 ~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~  192 (291)
T 1h6t_A          118 SLEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD  192 (291)
T ss_dssp             ECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB
T ss_pred             ECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCC
Confidence            888888875 3 468888888888888888884 3 567888888888888888887766 4444 48888888888885


Q ss_pred             cCCcccCCCccccccCc
Q 004994          226 PIPEKLLSIPNFRKDGN  242 (720)
Q Consensus       226 ~~p~~~~~l~~l~~~~n  242 (720)
                       +|. +..+++|+..+.
T Consensus       193 -l~~-l~~l~~L~~L~l  207 (291)
T 1h6t_A          193 -LRA-LAGLKNLDVLEL  207 (291)
T ss_dssp             -CGG-GTTCTTCSEEEE
T ss_pred             -Chh-hccCCCCCEEEC
Confidence             443 555555554433

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.68  E-value=8.8e-17  Score=182.10  Aligned_cols=173  Identities=20%  Similarity=0.216  Sum_probs=147.9

Q ss_pred             eecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccc
Q 004994           68 CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLD  145 (720)
Q Consensus        68 c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~  145 (720)
                      |.-..+  .++++|+++. +|..+.  ++|++|+|++|++++..|..+.  .+|++|+|++|++++..|..|+++++|++
T Consensus         4 C~~~~~--c~~~~~~l~~-ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   78 (549)
T 2z81_A            4 CDASGV--CDGRSRSFTS-IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEH   78 (549)
T ss_dssp             ECTTSE--EECTTSCCSS-CCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             CCCCce--EECCCCcccc-ccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCE
Confidence            544444  7899999984 666554  7999999999999988888886  79999999999999988899999999999


Q ss_pred             ccccccccCCCCCchhcCCCCCceEeccCCcccc-cCCCCCCCCCCCceeeccccccccccc--cccccc-cceEEccCC
Q 004994          146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTG-QLPPSTRNLSSLYSLHLQNNKLSGTLN--VLEDLH-LIDLNIENN  221 (720)
Q Consensus       146 L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~-l~~l~l~~N  221 (720)
                      |+|++|++++..|..|+++++|++|+|++|.+++ .+|..+.++++|+.|+|++|.+.+.++  .+..+. |++|++++|
T Consensus        79 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n  158 (549)
T 2z81_A           79 LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL  158 (549)
T ss_dssp             EECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred             EECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCC
Confidence            9999999998878789999999999999999986 467889999999999999999554442  456665 999999999


Q ss_pred             cCcccCCcccCCCccccccCccCC
Q 004994          222 LFSGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       222 ~l~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      .+++.+|..+..+++|+..+...|
T Consensus       159 ~l~~~~~~~l~~l~~L~~L~l~~n  182 (549)
T 2z81_A          159 SLRNYQSQSLKSIRDIHHLTLHLS  182 (549)
T ss_dssp             TCCEECTTTTTTCSEEEEEEEECS
T ss_pred             cccccChhhhhccccCceEecccC
Confidence            999999999988887775544433

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.68  E-value=1.6e-16  Score=153.82  Aligned_cols=124  Identities=26%  Similarity=0.325  Sum_probs=57.2

Q ss_pred             EEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccc
Q 004994           75 EIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNH  152 (720)
Q Consensus        75 ~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~  152 (720)
                      .+++++|+|+. +|..+.  ++|+.|+|++|+|+ .+|..+.  .+|+.|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus        14 ~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            34555555552 333322  34555555555554 4443333  344444444444444444444444444444444444


Q ss_pred             cCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccc
Q 004994          153 LNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS  202 (720)
Q Consensus       153 l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  202 (720)
                      |++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            44444444444444444444444444322233444444444444444443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.68  E-value=4.7e-17  Score=182.89  Aligned_cols=156  Identities=26%  Similarity=0.296  Sum_probs=131.4

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN  150 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~  150 (720)
                      ++|+.|+|++|+|+ .+|   ..+++|+.|+|++|+|++ +|. ++.+|+.|+|++|+|++ +|.   .+++|+.|+|++
T Consensus        80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~  149 (571)
T 3cvr_A           80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPASLKHLDVDNNQLTM-LPE---LPALLEYINADN  149 (571)
T ss_dssp             TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred             CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhcCCCEEECCCCcCCC-CCC---cCccccEEeCCC
Confidence            68999999999999 566   568999999999999996 888 77899999999999996 776   689999999999


Q ss_pred             cccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccccc-------ceEEccCCcC
Q 004994          151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHL-------IDLNIENNLF  223 (720)
Q Consensus       151 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l-------~~l~l~~N~l  223 (720)
                      |+|++ +|.   .+++|+.|+|++|+|++ +|. +.  ++|+.|+|++|+|+..+. +.. .|       +.|+|++|+|
T Consensus       150 N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~-~L~~~~~~L~~L~Ls~N~l  219 (571)
T 3cvr_A          150 NQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV-RNHHSEETEIFFRCRENRI  219 (571)
T ss_dssp             SCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC---------CCEEEECCSSCC
T ss_pred             CccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH-hhhcccccceEEecCCCcc
Confidence            99996 776   67899999999999995 887 66  899999999999996666 443 56       9999999999


Q ss_pred             cccCCcccCCCccccccCccCCCc
Q 004994          224 SGPIPEKLLSIPNFRKDGNPFNTT  247 (720)
Q Consensus       224 ~g~~p~~~~~l~~l~~~~n~~~~~  247 (720)
                      + .+|..+..+++|+..+...|..
T Consensus       220 ~-~lp~~l~~l~~L~~L~L~~N~l  242 (571)
T 3cvr_A          220 T-HIPENILSLDPTCTIILEDNPL  242 (571)
T ss_dssp             C-CCCGGGGGSCTTEEEECCSSSC
T ss_pred             e-ecCHHHhcCCCCCEEEeeCCcC
Confidence            9 6898887777766554444433

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.68  E-value=1.6e-16  Score=183.04  Aligned_cols=162  Identities=19%  Similarity=0.215  Sum_probs=136.8

Q ss_pred             CcCcCCCCCccEEeccCCcccccCCCCcc---ccCcEEEecCCcCCCCCcchhhccccccccccccccc-CCCCCchhcC
Q 004994           88 ADTLGDLESVINIDLSNNHIGGSIPSNLP---VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHL-NGGIPDAFHQ  163 (720)
Q Consensus        88 ~~~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l-~g~~p~~~~~  163 (720)
                      +..+..+++|+.++++.|++....+....   .+++.++++.|++++..|..+..+++|+.|+|++|++ .+.+|..|..
T Consensus       413 ~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~  492 (635)
T 4g8a_A          413 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE  492 (635)
T ss_dssp             CSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred             cccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhh
Confidence            44566777888888887777755554432   6899999999999999999999999999999999985 4457888999


Q ss_pred             CCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCcccCCcccCC----Cccc
Q 004994          164 FTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSGPIPEKLLS----IPNF  237 (720)
Q Consensus       164 l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g~~p~~~~~----l~~l  237 (720)
                      +++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++ .+..+. |+.|+|++|+|++..|..+..    +..|
T Consensus       493 l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L  572 (635)
T 4g8a_A          493 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL  572 (635)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEE
T ss_pred             ccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEE
Confidence            9999999999999998889999999999999999999999875 456665 999999999999999988764    4556


Q ss_pred             cccCccCCCccc
Q 004994          238 RKDGNPFNTTVI  249 (720)
Q Consensus       238 ~~~~n~~~~~~~  249 (720)
                      .+.+|+|.|+|.
T Consensus       573 ~L~~Np~~C~C~  584 (635)
T 4g8a_A          573 NLTQNDFACTCE  584 (635)
T ss_dssp             ECTTCCBCCSGG
T ss_pred             EeeCCCCcccCC
Confidence            788999988763

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.67  E-value=2.1e-16  Score=150.81  Aligned_cols=137  Identities=22%  Similarity=0.269  Sum_probs=94.4

Q ss_pred             CCCCCCCceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCc
Q 004994           57 DPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIP  134 (720)
Q Consensus        57 ~~c~~~w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p  134 (720)
                      +.|.|.|.++.|          ++|+++. +|..+  .++|+.|+|++|+|++..+..+.  .+|++|+|++|+|++..+
T Consensus         3 ~~C~C~~~~l~~----------~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~   69 (177)
T 2o6r_A            3 SRCSCSGTEIRC----------NSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD   69 (177)
T ss_dssp             TTCEEETTEEEC----------CSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred             CCCEeCCCEEEe----------cCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence            456556666555          4555553 34333  36788888888888754444444  678888888888876555


Q ss_pred             chhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc
Q 004994          135 ESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN  206 (720)
Q Consensus       135 ~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~  206 (720)
                      ..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|.+++..+
T Consensus        70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            667778888888888888876666667778888888888888875444445777788888888777776554

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.67  E-value=1.2e-16  Score=166.79  Aligned_cols=164  Identities=23%  Similarity=0.396  Sum_probs=136.3

Q ss_pred             ecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      .+++|+.|++++|+++. ++ .+..+++|++|+|++|++++ +|. +.  .+|+.|+|++|++++ +| .+.++++|+.|
T Consensus        39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L  112 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTL  112 (308)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEE
T ss_pred             HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEE
Confidence            46789999999999986 44 68999999999999999995 444 54  789999999999995 44 69999999999


Q ss_pred             cccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcCcc
Q 004994          147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSG  225 (720)
Q Consensus       147 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l~g  225 (720)
                      +|++|++++ +|. +..+++|+.|+|++|++++ ++. +..+++|+.|+|++|++++..+ +..+ .|+.|++++|++++
T Consensus       113 ~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~  187 (308)
T 1h6u_A          113 DLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD  187 (308)
T ss_dssp             ECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC
T ss_pred             ECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCc
Confidence            999999986 453 9999999999999999985 444 8999999999999999998766 5555 49999999999996


Q ss_pred             cCCcccCCCccccccCccCC
Q 004994          226 PIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       226 ~~p~~~~~l~~l~~~~n~~~  245 (720)
                      ..|  +..+++|+..+...|
T Consensus       188 ~~~--l~~l~~L~~L~L~~N  205 (308)
T 1h6u_A          188 ISP--LASLPNLIEVHLKNN  205 (308)
T ss_dssp             CGG--GGGCTTCCEEECTTS
T ss_pred             Chh--hcCCCCCCEEEccCC
Confidence            544  555555554444433

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.67  E-value=1.1e-16  Score=151.23  Aligned_cols=132  Identities=21%  Similarity=0.256  Sum_probs=95.2

Q ss_pred             CceeEEEecCCccc-ccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccccc
Q 004994           71 SNVTEIRLTGMNLG-GVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLS  147 (720)
Q Consensus        71 ~~l~~l~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~  147 (720)
                      ++|+.|+|++|+++ +.+|..+..+++|++|+|++|+|++.  ..+.  .+|+.|+|++|++++.+|..+.++++|+.|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            56778888888887 67777777788888888888887744  4443  5777777777777766777777777777777


Q ss_pred             ccccccCCCC-CchhcCCCCCceEeccCCcccccCCC----CCCCCCCCceeecccccccccc
Q 004994          148 LNNNHLNGGI-PDAFHQFTGLINFDLSANNLTGQLPP----STRNLSSLYSLHLQNNKLSGTL  205 (720)
Q Consensus       148 l~~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~~~~  205 (720)
                      |++|+|++.. +..+..+++|+.|+|++|.+++ +|.    .+..+++|+.|++++|.+...+
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~~n~~~~~~  163 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYLDGYDREDQEAP  163 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGT-STTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcc-hHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence            7777777432 2567777777777777777773 443    6677777777777777765544

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.67  E-value=4.8e-16  Score=171.23  Aligned_cols=160  Identities=25%  Similarity=0.318  Sum_probs=110.0

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN  150 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~  150 (720)
                      ++|+.|+|++|++++ +| .|+.+++|++|+|++|++++ +|..+ .+|++|+|++|++++ +| .++++++|+.|++++
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~-~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~  204 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP-PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADN  204 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC-TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc-ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCC
Confidence            467777777777775 55 47777777777777777773 66544 477777777777775 55 577777777777777


Q ss_pred             cccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCcCcccCCcc
Q 004994          151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEK  230 (720)
Q Consensus       151 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~g~~p~~  230 (720)
                      |++++ +|...   ++|+.|++++|.++ .+| .++.+++|+.|++++|++++.+...  ..|+.|++++|++++ +|..
T Consensus       205 N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~~~--~~L~~L~l~~N~l~~-l~~~  275 (454)
T 1jl5_A          205 NSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPDLP--PSLEALNVRDNYLTD-LPEL  275 (454)
T ss_dssp             SCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCSCC--TTCCEEECCSSCCSC-CCCC
T ss_pred             CcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCcccccc--cccCEEECCCCcccc-cCcc
Confidence            77774 44432   46777777777777 666 3777778888888888777654322  347777777777775 6666


Q ss_pred             cCCCccccccCccCC
Q 004994          231 LLSIPNFRKDGNPFN  245 (720)
Q Consensus       231 ~~~l~~l~~~~n~~~  245 (720)
                      +.++..|.+.+|.+.
T Consensus       276 ~~~L~~L~ls~N~l~  290 (454)
T 1jl5_A          276 PQSLTFLDVSENIFS  290 (454)
T ss_dssp             CTTCCEEECCSSCCS
T ss_pred             cCcCCEEECcCCccC
Confidence            666666666666544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.66  E-value=1.5e-16  Score=164.67  Aligned_cols=148  Identities=26%  Similarity=0.352  Sum_probs=129.4

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      +..+++|+.|+|++|++++..+  +..+++|+.|+|++|++++ +|. +.  .+|+.|+|++|++++ + +.+.++++|+
T Consensus        64 ~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~  137 (291)
T 1h6t_A           64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLE  137 (291)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCC
T ss_pred             HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCCC-C-hhhcCCCCCC
Confidence            5668899999999999998655  9999999999999999985 554 44  789999999999995 4 4699999999


Q ss_pred             cccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcC
Q 004994          145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLF  223 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l  223 (720)
                      .|+|++|++++.  ..+..+++|+.|+|++|++++..|  +..+++|+.|+|++|.|++... +..+ .|+.|++++|++
T Consensus       138 ~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~~-l~~l~~L~~L~l~~n~i  212 (291)
T 1h6t_A          138 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRA-LAGLKNLDVLELFSQEC  212 (291)
T ss_dssp             EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGG-GTTCTTCSEEEEEEEEE
T ss_pred             EEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCChh-hccCCCCCEEECcCCcc
Confidence            999999999964  679999999999999999996444  9999999999999999998654 5555 499999999999


Q ss_pred             cc
Q 004994          224 SG  225 (720)
Q Consensus       224 ~g  225 (720)
                      +.
T Consensus       213 ~~  214 (291)
T 1h6t_A          213 LN  214 (291)
T ss_dssp             EC
T ss_pred             cC
Confidence            85

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.66  E-value=3.7e-16  Score=177.44  Aligned_cols=155  Identities=25%  Similarity=0.320  Sum_probs=121.9

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      +..+++|+.|+|++|+|++..+  +..+++|+.|+|++|+|++ +| .+.  .+|+.|+|++|+|++ + +.+.+|++|+
T Consensus        61 l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~  134 (605)
T 1m9s_A           61 IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLE  134 (605)
T ss_dssp             GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCS
T ss_pred             HccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccC
Confidence            4567888999999999887654  8888999999999998884 44 443  688999999999885 4 3588888999


Q ss_pred             cccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcC
Q 004994          145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLF  223 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l  223 (720)
                      .|+|++|+|++.  ..|..|++|+.|+|++|.|++..|  +..+++|+.|+|++|+|++. +.+..+. |+.|+|++|.+
T Consensus       135 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l  209 (605)
T 1m9s_A          135 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC  209 (605)
T ss_dssp             EEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEE
T ss_pred             EEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcC
Confidence            999999998864  578888999999999999986555  88888999999999988876 3455544 88899999988


Q ss_pred             cccCCcccC
Q 004994          224 SGPIPEKLL  232 (720)
Q Consensus       224 ~g~~p~~~~  232 (720)
                      ++.....+.
T Consensus       210 ~~~p~~~~~  218 (605)
T 1m9s_A          210 LNKPINHQS  218 (605)
T ss_dssp             ECCCCCCCS
T ss_pred             cCCcccccc
Confidence            864333333

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.66  E-value=3.7e-16  Score=149.06  Aligned_cols=131  Identities=24%  Similarity=0.333  Sum_probs=117.3

Q ss_pred             ccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCc
Q 004994           97 VINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANN  176 (720)
Q Consensus        97 L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~  176 (720)
                      .+.+++++|+++ .+|..++.+|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   87 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK   87 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCEEEecCCCCc-cCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence            578999999999 8898888999999999999997777778999999999999999997777778999999999999999


Q ss_pred             ccccCCCCCCCCCCCceeecccccccccccc-cccc-ccceEEccCCcCcccCC
Q 004994          177 LTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV-LEDL-HLIDLNIENNLFSGPIP  228 (720)
Q Consensus       177 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~-~l~~l~l~~N~l~g~~p  228 (720)
                      |++..+..+..+++|+.|+|++|+|++.++. +..+ .|+.|++++|.+++..|
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            9976677789999999999999999988764 3545 49999999999998766

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.66  E-value=2.1e-16  Score=179.42  Aligned_cols=164  Identities=23%  Similarity=0.298  Sum_probs=138.2

Q ss_pred             eecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccc
Q 004994           68 CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLD  145 (720)
Q Consensus        68 c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~  145 (720)
                      ..+.+|+.|+|++|.+... + .|..|++|+.|+|++|+|++..|  +.  .+|+.|+|++|+|++ +| .|..+++|+.
T Consensus        40 ~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~  113 (605)
T 1m9s_A           40 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKS  113 (605)
T ss_dssp             HHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCE
T ss_pred             hcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCE
Confidence            3578899999999999864 3 69999999999999999996554  54  789999999999995 44 7999999999


Q ss_pred             ccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcCc
Q 004994          146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFS  224 (720)
Q Consensus       146 L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l~  224 (720)
                      |+|++|+|++ + +.+..|++|+.|+|++|.|++.  ..+..|++|+.|+|++|.|++.++ +..+ .|+.|+|++|+|+
T Consensus       114 L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~  188 (605)
T 1m9s_A          114 LSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS  188 (605)
T ss_dssp             EECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred             EEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCC
Confidence            9999999985 4 4699999999999999999954  678999999999999999999887 5555 4999999999999


Q ss_pred             ccCCcccCCCccccccCccC
Q 004994          225 GPIPEKLLSIPNFRKDGNPF  244 (720)
Q Consensus       225 g~~p~~~~~l~~l~~~~n~~  244 (720)
                      +. | .+..+++|+.++...
T Consensus       189 ~l-~-~l~~l~~L~~L~L~~  206 (605)
T 1m9s_A          189 DL-R-ALAGLKNLDVLELFS  206 (605)
T ss_dssp             BC-G-GGTTCTTCSEEECCS
T ss_pred             CC-h-HHccCCCCCEEEccC
Confidence            64 4 466666665444433

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=3.1e-16  Score=148.22  Aligned_cols=133  Identities=25%  Similarity=0.312  Sum_probs=115.5

Q ss_pred             CCCCccEEeccCCccc-ccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCce
Q 004994           93 DLESVINIDLSNNHIG-GSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLIN  169 (720)
Q Consensus        93 ~l~~L~~L~L~~N~l~-g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  169 (720)
                      ..++|+.|+|++|+++ +.+|..+.  .+|+.|+|++|.+++.  ..+..+++|++|+|++|++++.+|..+.++++|+.
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   99 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH   99 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence            3478999999999998 88998875  7899999999999965  78999999999999999999888888888999999


Q ss_pred             EeccCCcccccCC--CCCCCCCCCceeeccccccccccc----cccccc-cceEEccCCcCcccCCc
Q 004994          170 FDLSANNLTGQLP--PSTRNLSSLYSLHLQNNKLSGTLN----VLEDLH-LIDLNIENNLFSGPIPE  229 (720)
Q Consensus       170 L~ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~-l~~l~l~~N~l~g~~p~  229 (720)
                      |+|++|+|++ +|  ..+..+++|+.|+|++|.+++.++    .+..+. |+.|++++|.+. .+|+
T Consensus       100 L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~  164 (168)
T 2ell_A          100 LNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD  164 (168)
T ss_dssp             EECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred             EeccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence            9999999985 44  688999999999999999998876    555554 999999999887 5554

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.65  E-value=6.3e-16  Score=149.63  Aligned_cols=126  Identities=30%  Similarity=0.396  Sum_probs=116.6

Q ss_pred             cEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcc
Q 004994           98 INIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL  177 (720)
Q Consensus        98 ~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l  177 (720)
                      +.+++++|+|+ .+|..++.+|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l   90 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL   90 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CEEEcCCCCCC-cCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence            58999999999 899999999999999999999 8889999999999999999999988888999999999999999999


Q ss_pred             cccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCcc
Q 004994          178 TGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSG  225 (720)
Q Consensus       178 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g  225 (720)
                      ++..|..|.++++|+.|+|++|+|++.++ .+..+. |+.|+|++|.+..
T Consensus        91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            98778889999999999999999998876 355554 9999999999975

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.65  E-value=4.7e-16  Score=165.53  Aligned_cols=186  Identities=18%  Similarity=0.141  Sum_probs=141.4

Q ss_pred             CCCCCceeEeec-----------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc---ccC-cEEE
Q 004994           59 CGDSWQGVFCVF-----------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP---VTV-RNFS  123 (720)
Q Consensus        59 c~~~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~---~~L-~~L~  123 (720)
                      |.|+|..|.|..           .++++|+|++|+|+...+..|.++++|++|+|++|++.+.+|....   .++ +.+.
T Consensus         7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~   86 (350)
T 4ay9_X            7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI   86 (350)
T ss_dssp             SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred             cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence            767899999963           3689999999999977777899999999999999999878886543   344 4577


Q ss_pred             ecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccC-CcccccCCCCCCCCC-CCceeecccccc
Q 004994          124 LSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSA-NNLTGQLPPSTRNLS-SLYSLHLQNNKL  201 (720)
Q Consensus       124 Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~-~L~~L~l~~N~l  201 (720)
                      +++|+++...|..|.++++|++|++++|+|++..+..+....++..|++++ |++....+..+..+. .|+.|+|++|+|
T Consensus        87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i  166 (350)
T 4ay9_X           87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI  166 (350)
T ss_dssp             EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred             ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence            889999988888999999999999999999977666777777788888855 567644445566654 578888888888


Q ss_pred             cccccc-ccccccceEEccC-CcCcccCCc-ccCCCccccccCccCC
Q 004994          202 SGTLNV-LEDLHLIDLNIEN-NLFSGPIPE-KLLSIPNFRKDGNPFN  245 (720)
Q Consensus       202 ~~~~~~-~~~~~l~~l~l~~-N~l~g~~p~-~~~~l~~l~~~~n~~~  245 (720)
                      +..++. +...+++.|++++ |.++ .+|. .|..+++|+..+.+.|
T Consensus       167 ~~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N  212 (350)
T 4ay9_X          167 QEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRT  212 (350)
T ss_dssp             CEECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTS
T ss_pred             cCCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCC
Confidence            876643 3445588888875 4444 5664 4566666555444444

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.65  E-value=1.2e-16  Score=147.89  Aligned_cols=127  Identities=20%  Similarity=0.259  Sum_probs=103.0

Q ss_pred             cCceeEEEecCCccc-ccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           70 FSNVTEIRLTGMNLG-GVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      .++++.|+|++|+++ +.+|..+..+++|+.|+|++|++++.  ..+.  .+|+.|+|++|++++.+|..+.++++|+.|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            357899999999998 78888889999999999999999854  4444  688888888888887788888888888888


Q ss_pred             cccccccCCC-CCchhcCCCCCceEeccCCcccccCC---CCCCCCCCCceeeccc
Q 004994          147 SLNNNHLNGG-IPDAFHQFTGLINFDLSANNLTGQLP---PSTRNLSSLYSLHLQN  198 (720)
Q Consensus       147 ~l~~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~~p---~~~~~l~~L~~L~l~~  198 (720)
                      +|++|++++. .|..+..+++|+.|++++|.+++..+   ..+..+++|+.|++++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            8888888863 34778888888888888888885443   3678888888888763

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.65  E-value=1.7e-17  Score=193.14  Aligned_cols=177  Identities=16%  Similarity=0.162  Sum_probs=124.3

Q ss_pred             ceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccc
Q 004994           64 QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLT  141 (720)
Q Consensus        64 ~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~  141 (720)
                      .+.+..+.+|+.|+|++|++. .+|..+..+++|++|+|++|+|+ .+|..|.  .+|+.|+|++|+|+ .+|..|++|+
T Consensus       217 ~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~  293 (727)
T 4b8c_D          217 KDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCF  293 (727)
T ss_dssp             -----CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGT
T ss_pred             hhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCC
Confidence            566778899999999999998 67888889999999999999999 9998886  79999999999999 8899999999


Q ss_pred             ccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCC-CceeeccccccccccccccccccceEEccC
Q 004994          142 QLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSS-LYSLHLQNNKLSGTLNVLEDLHLIDLNIEN  220 (720)
Q Consensus       142 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~  220 (720)
                      +|++|+|++|.|+ .+|..|++|++|+.|+|++|.|++.+|..+..+.. +..|+|++|.++|.++.    .|..|++++
T Consensus       294 ~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~----~l~~l~l~~  368 (727)
T 4b8c_D          294 QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH----ERRFIEINT  368 (727)
T ss_dssp             TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC----C--------
T ss_pred             CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc----ccceeEeec
Confidence            9999999999997 88999999999999999999999999988766532 33588999999988753    244566666


Q ss_pred             C--------cCcccCCcccCCCccccccCccCCCcc
Q 004994          221 N--------LFSGPIPEKLLSIPNFRKDGNPFNTTV  248 (720)
Q Consensus       221 N--------~l~g~~p~~~~~l~~l~~~~n~~~~~~  248 (720)
                      |        .|.+.++..+.++..+.+....+|..+
T Consensus       369 n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          369 DGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             ---------------------------------CCC
T ss_pred             ccccccccCCccccccchhhcccccceeeeeccccc
Confidence            6        344444444555555555555566543

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.63  E-value=6.5e-16  Score=171.24  Aligned_cols=164  Identities=27%  Similarity=0.356  Sum_probs=104.7

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      ++.+++|+.|+|++|.+++..|  ++.+++|+.|+|++|++++ ++ .+.  .+|+.|+|++|++++..|  +..+++|+
T Consensus       195 l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~  268 (466)
T 1o6v_A          195 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLT  268 (466)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred             hccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-ch-hhhcCCCCCEEECCCCccccchh--hhcCCCCC
Confidence            4556778888888888876554  6667777777777777763 33 232  567777777777775443  66777777


Q ss_pred             cccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCcCc
Q 004994          145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFS  224 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~  224 (720)
                      .|+|++|.+++..|  +..+++|+.|+|++|++++..|  +..+++|+.|+|++|++++..+......|+.|++++|+++
T Consensus       269 ~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~  344 (466)
T 1o6v_A          269 ELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVS  344 (466)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCC
T ss_pred             EEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccC
Confidence            77777777764333  6677777777777777764332  6667777777777777766655222223666777777666


Q ss_pred             ccCCcccCCCccccccCc
Q 004994          225 GPIPEKLLSIPNFRKDGN  242 (720)
Q Consensus       225 g~~p~~~~~l~~l~~~~n  242 (720)
                      +.  ..+..+++|+..+.
T Consensus       345 ~~--~~l~~l~~L~~L~l  360 (466)
T 1o6v_A          345 DV--SSLANLTNINWLSA  360 (466)
T ss_dssp             CC--GGGTTCTTCCEEEC
T ss_pred             Cc--hhhccCCCCCEEeC
Confidence            53  24444444444333

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.63  E-value=2.3e-15  Score=165.86  Aligned_cols=144  Identities=19%  Similarity=0.202  Sum_probs=102.0

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      ++.+++|+.|+|++|++++. |  ++.+++|++|+|++|+|++ +|  +.  .+|++|+|++|++++ +|  ++++++|+
T Consensus        60 l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~  130 (457)
T 3bz5_A           60 IEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLT  130 (457)
T ss_dssp             GGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCC
T ss_pred             hcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCC
Confidence            45677888888888888874 3  8888888888888888885 44  43  678888888888885 44  78888888


Q ss_pred             cccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcC
Q 004994          145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLF  223 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l  223 (720)
                      .|++++|+|++ ++  ++++++|++|++++|+..+.+  .+..+++|+.|+|++|+|++.+  +..+ .|+.|++++|++
T Consensus       131 ~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~--l~~l~~L~~L~l~~N~l  203 (457)
T 3bz5_A          131 YLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD--VSQNKLLNRLNCDTNNI  203 (457)
T ss_dssp             EEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC--CTTCTTCCEEECCSSCC
T ss_pred             EEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec--cccCCCCCEEECcCCcC
Confidence            88888888876 33  667777777777777555555  3666677777777777766643  2222 256666666666


Q ss_pred             ccc
Q 004994          224 SGP  226 (720)
Q Consensus       224 ~g~  226 (720)
                      ++.
T Consensus       204 ~~~  206 (457)
T 3bz5_A          204 TKL  206 (457)
T ss_dssp             SCC
T ss_pred             Cee
Confidence            543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.63  E-value=3.5e-16  Score=152.09  Aligned_cols=147  Identities=16%  Similarity=0.248  Sum_probs=122.2

Q ss_pred             cCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCc
Q 004994           91 LGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLI  168 (720)
Q Consensus        91 ~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~  168 (720)
                      .+.+++|+.|+|++|+++ .+| .+.  .+|+.|+|++|.++ . ++.+..+++|++|+|++|++++..|..|+.+++|+
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            366889999999999999 777 554  79999999999776 3 34799999999999999999988899999999999


Q ss_pred             eEeccCCcccccCCCCCCCCCCCceeeccccc-cccccccccccc-cceEEccCCcCcccCCcccCCCcccc---ccCcc
Q 004994          169 NFDLSANNLTGQLPPSTRNLSSLYSLHLQNNK-LSGTLNVLEDLH-LIDLNIENNLFSGPIPEKLLSIPNFR---KDGNP  243 (720)
Q Consensus       169 ~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~-l~~l~l~~N~l~g~~p~~~~~l~~l~---~~~n~  243 (720)
                      +|+|++|++++..|..+..+++|+.|+|++|. ++.. +.+..+. |+.|++++|.+++ ++ .+..+++|+   +.+|+
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-GGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-HhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence            99999999998888889999999999999998 5554 4555554 9999999999996 44 455555544   45554


Q ss_pred             C
Q 004994          244 F  244 (720)
Q Consensus       244 ~  244 (720)
                      +
T Consensus       193 i  193 (197)
T 4ezg_A          193 I  193 (197)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.63  E-value=2e-15  Score=166.47  Aligned_cols=162  Identities=19%  Similarity=0.201  Sum_probs=129.5

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      ++.+++|+.|+|++|+|++. +  ++.+++|++|+|++|+|++ +|-.-..+|+.|+|++|+|++ ++  ++++++|+.|
T Consensus        81 ~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L  153 (457)
T 3bz5_A           81 LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LDVSQNPLLTYLNCARNTLTE-ID--VSHNTQLTEL  153 (457)
T ss_dssp             CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CCCTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEE
T ss_pred             cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ecCCCCCcCCEEECCCCccce-ec--cccCCcCCEE
Confidence            45678999999999999985 3  8999999999999999995 662222789999999999996 44  8889999999


Q ss_pred             cccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcCcc
Q 004994          147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSG  225 (720)
Q Consensus       147 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l~g  225 (720)
                      ++++|+..+.+  .+..+++|+.|++++|+|++ +|  +..+++|+.|++++|+|++. + +..+ .|+.|++++|+|++
T Consensus       154 ~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~-l~~l~~L~~L~Ls~N~l~~  226 (457)
T 3bz5_A          154 DCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D-LNQNIQLTFLDCSSNKLTE  226 (457)
T ss_dssp             ECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSC
T ss_pred             ECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-c-cccCCCCCEEECcCCcccc
Confidence            99999766666  47888999999999999985 66  78889999999999998886 2 4444 48889999999987


Q ss_pred             cCCcccCCCccccccCccCC
Q 004994          226 PIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       226 ~~p~~~~~l~~l~~~~n~~~  245 (720)
                       +|  +..+++|+..+...|
T Consensus       227 -ip--~~~l~~L~~L~l~~N  243 (457)
T 3bz5_A          227 -ID--VTPLTQLTYFDCSVN  243 (457)
T ss_dssp             -CC--CTTCTTCSEEECCSS
T ss_pred             -cC--ccccCCCCEEEeeCC
Confidence             56  555555554444443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.62  E-value=2.2e-16  Score=160.91  Aligned_cols=148  Identities=22%  Similarity=0.266  Sum_probs=113.4

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      +..+++|+.|+|++|+++. ++ .+..+++|+.|+|++|+|++..|  +.  .+|+.|+|++|++++ +|.. .. ++|+
T Consensus        37 ~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~  109 (263)
T 1xeu_A           37 QKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLS  109 (263)
T ss_dssp             HHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCC
T ss_pred             hhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-Cccc
Confidence            3456788888888888885 44 68888888888888888885433  44  678888888888884 4543 33 8888


Q ss_pred             cccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcC
Q 004994          145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLF  223 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l  223 (720)
                      .|+|++|+|++ +| .+..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|++++. ..+..+. |+.|++++|.+
T Consensus       110 ~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~  184 (263)
T 1xeu_A          110 RLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKC  184 (263)
T ss_dssp             EEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEE
T ss_pred             EEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcc
Confidence            88888888885 33 58888888888888888884 44 678888888888888888877 4444444 88888888888


Q ss_pred             ccc
Q 004994          224 SGP  226 (720)
Q Consensus       224 ~g~  226 (720)
                      ++.
T Consensus       185 ~~~  187 (263)
T 1xeu_A          185 VNE  187 (263)
T ss_dssp             ECC
T ss_pred             cCC
Confidence            754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=1.7e-16  Score=167.51  Aligned_cols=144  Identities=15%  Similarity=0.113  Sum_probs=101.1

Q ss_pred             HHHHHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccc------------cccHHH--------HHHHHHHHH
Q 004994          434 SLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQ------------RQTDEE--------FLELASTIS  493 (720)
Q Consensus       434 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------------~~~~~~--------~~~e~~~l~  493 (720)
                      .+..-..-|.+++.||+|++|.||+|...+|+.||||+++.....            ......        ..+|...|.
T Consensus        89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~  168 (397)
T 4gyi_A           89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK  168 (397)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence            333333448889999999999999998889999999997642110            001111        234556666


Q ss_pred             ccCCCcee--EEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 004994          494 RLRHGNIV--ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNF  571 (720)
Q Consensus       494 ~l~H~niv--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDl  571 (720)
                      ++.+.++.  ..+++.    ..++||||++++.|.++....          ....++.+++.+|.|||..   +||||||
T Consensus       169 rL~~~gv~vp~p~~~~----~~~LVME~i~G~~L~~l~~~~----------~~~~l~~qll~~l~~lH~~---gIVHrDL  231 (397)
T 4gyi_A          169 ALYEEGFPVPEPIAQS----RHTIVMSLVDALPMRQVSSVP----------DPASLYADLIALILRLAKH---GLIHGDF  231 (397)
T ss_dssp             HHHHTTCSCCCEEEEE----TTEEEEECCSCEEGGGCCCCS----------CHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             HHHhcCCCCCeeeecc----CceEEEEecCCccHhhhcccH----------HHHHHHHHHHHHHHHHHHC---CCcCCCC
Confidence            66444332  223221    237999999998887654211          1245788999999999987   8999999


Q ss_pred             CCCCeEEcCCCC----------eEEccccCCCC
Q 004994          572 KSSNILLDEKLI----------VRVSDCGLAPL  594 (720)
Q Consensus       572 kp~NiLl~~~~~----------~kl~DFGla~~  594 (720)
                      ||.|||+++++.          +.|+||+-+-.
T Consensus       232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             STTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            999999988773          89999997754

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.62  E-value=7.1e-16  Score=157.07  Aligned_cols=160  Identities=25%  Similarity=0.334  Sum_probs=104.5

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL  148 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l  148 (720)
                      .+++.++|.+|++++..  .+..+++|+.|+|++|+|+ .+| .+.  .+|+.|+|++|+|++. |. +.++++|+.|+|
T Consensus        19 ~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L   92 (263)
T 1xeu_A           19 ANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSV   92 (263)
T ss_dssp             HHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEEC
T ss_pred             HHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEEC
Confidence            34556667777776543  4667777777777777777 555 343  5777777777777743 33 777777777777


Q ss_pred             cccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcCcccC
Q 004994          149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGPI  227 (720)
Q Consensus       149 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g~~  227 (720)
                      ++|++++ +|.. .. ++|+.|+|++|+|++ ++ .+..+++|+.|+|++|+|++.. .+..+. |+.|++++|++++. 
T Consensus        93 ~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~~~-  165 (263)
T 1xeu_A           93 NRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNT-  165 (263)
T ss_dssp             CSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCCCBC-
T ss_pred             CCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcCcch-
Confidence            7777774 4432 22 777777777777774 43 4777777777777777777654 344443 77777777777755 


Q ss_pred             CcccCCCcccc---ccCccC
Q 004994          228 PEKLLSIPNFR---KDGNPF  244 (720)
Q Consensus       228 p~~~~~l~~l~---~~~n~~  244 (720)
                       ..+..+++|+   +.+|++
T Consensus       166 -~~l~~l~~L~~L~l~~N~~  184 (263)
T 1xeu_A          166 -GGLTRLKKVNWIDLTGQKC  184 (263)
T ss_dssp             -TTSTTCCCCCEEEEEEEEE
T ss_pred             -HHhccCCCCCEEeCCCCcc
Confidence             4444444444   444443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.62  E-value=1.2e-15  Score=169.20  Aligned_cols=171  Identities=25%  Similarity=0.374  Sum_probs=138.0

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      +..+++|+.|+|++|.+++.  +.+..+++|+.|+|++|++++..|-....+|+.|+|++|++++ + +.+..+++|+.|
T Consensus       173 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L  248 (466)
T 1o6v_A          173 LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD-I-GTLASLTNLTDL  248 (466)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred             hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccccccccccCCCCEEECCCCCccc-c-hhhhcCCCCCEE
Confidence            44568899999999999865  3588999999999999999977663334799999999999995 4 468999999999


Q ss_pred             cccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCcCccc
Q 004994          147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGP  226 (720)
Q Consensus       147 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~g~  226 (720)
                      ++++|.+++..|  +..+++|+.|++++|.+++ +|. +..+++|+.|+|++|++++.++......|+.|++++|++++.
T Consensus       249 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~  324 (466)
T 1o6v_A          249 DLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI  324 (466)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCC
T ss_pred             ECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCc
Confidence            999999996554  8999999999999999995 444 889999999999999999877633333499999999999987


Q ss_pred             CCc-ccCCCccccccCccCC
Q 004994          227 IPE-KLLSIPNFRKDGNPFN  245 (720)
Q Consensus       227 ~p~-~~~~l~~l~~~~n~~~  245 (720)
                      .|- .+.++..|.+.+|...
T Consensus       325 ~~~~~l~~L~~L~l~~n~l~  344 (466)
T 1o6v_A          325 SPVSSLTKLQRLFFYNNKVS  344 (466)
T ss_dssp             GGGGGCTTCCEEECCSSCCC
T ss_pred             hhhccCccCCEeECCCCccC
Confidence            761 2334444445555543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.62  E-value=1.1e-15  Score=162.38  Aligned_cols=168  Identities=21%  Similarity=0.355  Sum_probs=125.1

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      +..+++|+.|++++|.+.+..+  +..+++|+.|+|++|++.+ ++. +.  .+|+.|++++|.+++..+  +..+++|+
T Consensus       151 ~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~  224 (347)
T 4fmz_A          151 LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLN  224 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCC
T ss_pred             hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCch--hhcCCcCC
Confidence            4566788899999988886544  8888889999999998884 433 33  678888888888885443  78888888


Q ss_pred             cccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcC
Q 004994          145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLF  223 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l  223 (720)
                      .|+|++|++++ +|. +..+++|++|++++|.+++ + +.+..+++|+.|++++|++++. +.+..+ .|+.|++++|.+
T Consensus       225 ~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l  299 (347)
T 4fmz_A          225 SLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQL  299 (347)
T ss_dssp             EEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCC
T ss_pred             EEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcC
Confidence            88888888875 343 7888888888888888874 4 3577888888888888888776 334444 488888888888


Q ss_pred             cccCCcccCCCccccccCccCC
Q 004994          224 SGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       224 ~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      ++..|..+..+++|+..+...|
T Consensus       300 ~~~~~~~l~~l~~L~~L~L~~n  321 (347)
T 4fmz_A          300 GNEDMEVIGGLTNLTTLFLSQN  321 (347)
T ss_dssp             CGGGHHHHHTCTTCSEEECCSS
T ss_pred             CCcChhHhhccccCCEEEccCC
Confidence            8777777666666554444433

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.62  E-value=2.6e-17  Score=185.79  Aligned_cols=153  Identities=24%  Similarity=0.249  Sum_probs=122.2

Q ss_pred             cCceeEEEecCCcccccCCcCcCCCCCccEEeccCCc-------------ccccCCCCcc--------------------
Q 004994           70 FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNH-------------IGGSIPSNLP--------------------  116 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~g~ip~~~~--------------------  116 (720)
                      .++|+.|+|++|+|+ .+|+.++++++|+.|++++|.             +.+.+|..+.                    
T Consensus       348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~  426 (567)
T 1dce_A          348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLR  426 (567)
T ss_dssp             TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHH
T ss_pred             CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhh
Confidence            356778899999997 679999999999999997775             3444442211                    


Q ss_pred             --------------ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCC
Q 004994          117 --------------VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP  182 (720)
Q Consensus       117 --------------~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p  182 (720)
                                    ..|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +|
T Consensus       427 ~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp  502 (567)
T 1dce_A          427 SKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD  502 (567)
T ss_dssp             HHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG
T ss_pred             hhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc
Confidence                          257788899998885 676 888888999999999888 788888888899999999999885 77


Q ss_pred             CCCCCCCCCceeeccccccccc--cccccccc-cceEEccCCcCcccCC
Q 004994          183 PSTRNLSSLYSLHLQNNKLSGT--LNVLEDLH-LIDLNIENNLFSGPIP  228 (720)
Q Consensus       183 ~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~-l~~l~l~~N~l~g~~p  228 (720)
                       .++++++|+.|+|++|+|++.  +..+..+. |+.|+|++|+|++.+|
T Consensus       503 -~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          503 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             -GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             -ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence             788888899999999988888  55666665 8889999998887655

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.62  E-value=3.7e-15  Score=164.14  Aligned_cols=158  Identities=25%  Similarity=0.335  Sum_probs=124.9

Q ss_pred             cCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccccccccccc
Q 004994           70 FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN  149 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~  149 (720)
                      .++|+.|+|++|++++ +|..   +++|+.|+|++|++++ +|. ++.+|++|+|++|++++ +| .|+++++|++|+++
T Consensus        90 ~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~-~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~  161 (454)
T 1jl5_A           90 PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSD-LPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVD  161 (454)
T ss_dssp             CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCS-CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred             cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccC-CCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECC
Confidence            4688999999999987 6653   4789999999999984 553 33689999999999995 77 59999999999999


Q ss_pred             ccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCcCcccCCc
Q 004994          150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPE  229 (720)
Q Consensus       150 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~g~~p~  229 (720)
                      +|++++ +|..+   .+|++|++++|++++ +| .++++++|+.|++++|++++.+...  ..|+.|++++|.++ .+|.
T Consensus       162 ~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~--~~L~~L~l~~n~l~-~lp~  232 (454)
T 1jl5_A          162 NNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLP--LSLESIVAGNNILE-ELPE  232 (454)
T ss_dssp             SSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCC--TTCCEEECCSSCCS-SCCC
T ss_pred             CCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCc--CcccEEECcCCcCC-cccc
Confidence            999985 66543   589999999999985 67 6899999999999999998855432  25888999999988 7774


Q ss_pred             ccCCCccccccCccCC
Q 004994          230 KLLSIPNFRKDGNPFN  245 (720)
Q Consensus       230 ~~~~l~~l~~~~n~~~  245 (720)
                       +..+++|+..+...|
T Consensus       233 -~~~l~~L~~L~l~~N  247 (454)
T 1jl5_A          233 -LQNLPFLTTIYADNN  247 (454)
T ss_dssp             -CTTCTTCCEEECCSS
T ss_pred             -cCCCCCCCEEECCCC
Confidence             767666665544444

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.61  E-value=1.1e-15  Score=162.40  Aligned_cols=163  Identities=23%  Similarity=0.317  Sum_probs=120.2

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      +..+++|+.|++++|.....++. +..+++|++|++++|++.+..+  +.  .+|+.|++++|.+++ ++. +..+++|+
T Consensus       128 ~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~  202 (347)
T 4fmz_A          128 LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSLH  202 (347)
T ss_dssp             GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTTCC
T ss_pred             hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-ccc-ccCCCccc
Confidence            45667888888888866554443 8888888888888888874433  33  688888888888884 444 88888888


Q ss_pred             cccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcC
Q 004994          145 DLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLF  223 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l  223 (720)
                      .|++++|.+++..+  +..+++|+.|+|++|++++ ++. +..+++|+.|+|++|.+++. +.+..+ .|+.|++++|++
T Consensus       203 ~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l  277 (347)
T 4fmz_A          203 YFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQI  277 (347)
T ss_dssp             EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCC
T ss_pred             eeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCcc
Confidence            88888888885443  7888888888888888884 444 78888888888888888875 344444 488888888888


Q ss_pred             cccCCcccCCCccccccC
Q 004994          224 SGPIPEKLLSIPNFRKDG  241 (720)
Q Consensus       224 ~g~~p~~~~~l~~l~~~~  241 (720)
                      ++. | .+..+++|+..+
T Consensus       278 ~~~-~-~~~~l~~L~~L~  293 (347)
T 4fmz_A          278 SDI-S-VLNNLSQLNSLF  293 (347)
T ss_dssp             CCC-G-GGGGCTTCSEEE
T ss_pred             CCC-h-hhcCCCCCCEEE
Confidence            853 3 344444444433

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.61  E-value=1.4e-17  Score=180.03  Aligned_cols=163  Identities=20%  Similarity=0.297  Sum_probs=95.2

Q ss_pred             ecCceeEEEecCCcccc----cCCcCcCCCCCccEEeccCCcccccCCCCcc---------------ccCcEEEecCCcC
Q 004994           69 VFSNVTEIRLTGMNLGG----VLADTLGDLESVINIDLSNNHIGGSIPSNLP---------------VTVRNFSLSGNQL  129 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~---------------~~L~~L~Ls~N~l  129 (720)
                      .+++|+.|+|++|.+++    .++..+..+++|++|+|++|+|++..+..++               ++|+.|+|++|++
T Consensus        92 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l  171 (386)
T 2ca6_A           92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL  171 (386)
T ss_dssp             TCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCC
T ss_pred             hCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCC
Confidence            34566666666666665    3555666666666666666666533332222               3566666666666


Q ss_pred             C-CCCc---chhhcccccccccccccccC--C---CCCchhcCCCCCceEeccCCccc----ccCCCCCCCCCCCceeec
Q 004994          130 T-GSIP---ESLSRLTQLLDLSLNNNHLN--G---GIPDAFHQFTGLINFDLSANNLT----GQLPPSTRNLSSLYSLHL  196 (720)
Q Consensus       130 ~-g~~p---~~l~~l~~L~~L~l~~N~l~--g---~~p~~~~~l~~L~~L~ls~N~l~----g~~p~~~~~l~~L~~L~l  196 (720)
                      + +.+|   ..+.++++|+.|+|++|+|+  |   .+|..+..+++|+.|+|++|.|+    +.+|..+..+++|+.|+|
T Consensus       172 ~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L  251 (386)
T 2ca6_A          172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL  251 (386)
T ss_dssp             TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred             CcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEEC
Confidence            5 3444   34556666666666666665  2   23335666666666666666664    455666666666666666


Q ss_pred             cccccccc----c-cccc---ccccceEEccCCcCcc----cCCccc
Q 004994          197 QNNKLSGT----L-NVLE---DLHLIDLNIENNLFSG----PIPEKL  231 (720)
Q Consensus       197 ~~N~l~~~----~-~~~~---~~~l~~l~l~~N~l~g----~~p~~~  231 (720)
                      ++|.|++.    + ..+.   ...|+.|+|++|.+++    .+|..+
T Consensus       252 ~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l  298 (386)
T 2ca6_A          252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI  298 (386)
T ss_dssp             TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHH
T ss_pred             CCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHH
Confidence            66666543    1 2221   2336666666666665    355544

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.61  E-value=1.5e-15  Score=172.74  Aligned_cols=138  Identities=30%  Similarity=0.435  Sum_probs=93.5

Q ss_pred             eecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccccccccc
Q 004994           68 CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLS  147 (720)
Q Consensus        68 c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~  147 (720)
                      |...+++.|++++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|. ...+|+.|+|++|+|+ .+|.   .+++|++|+
T Consensus        37 c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~-~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~  107 (622)
T 3g06_A           37 CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA-LPPELRTLEVSGNQLT-SLPV---LPPGLLELS  107 (622)
T ss_dssp             HHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC-CCTTCCEEEECSCCCS-CCCC---CCTTCCEEE
T ss_pred             ccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC-cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEE
Confidence            33456888888888888 5666665  78888888888888 6776 4467888888888887 5665   567788888


Q ss_pred             ccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCcCc
Q 004994          148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFS  224 (720)
Q Consensus       148 l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~  224 (720)
                      |++|+|++ +|.   .+++|+.|+|++|+|+ .+|..   +++|+.|+|++|+|++.+..+  ..|+.|++++|+|+
T Consensus       108 Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~l~~~~--~~L~~L~L~~N~l~  174 (622)
T 3g06_A          108 IFSNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLPALP--SELCKLWAYNNQLT  174 (622)
T ss_dssp             ECSCCCCC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSCCCCCC--TTCCEEECCSSCCS
T ss_pred             CcCCcCCC-CCC---CCCCcCEEECCCCCCC-cCCCC---CCCCCEEECcCCcCCCcCCcc--CCCCEEECCCCCCC
Confidence            88888874 454   4567777777777777 45553   366777777777776644321  12444444444444

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.60  E-value=5.5e-15  Score=168.07  Aligned_cols=162  Identities=23%  Similarity=0.347  Sum_probs=90.5

Q ss_pred             ecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccc
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL  148 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l  148 (720)
                      .+++|+.|+|++|+|++ +|.   .+++|++|+|++|+|+ .+|. ...+|+.|+|++|+|+ .+|..   +++|++|+|
T Consensus        79 ~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~l~~-~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~L  148 (622)
T 3g06_A           79 LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLT-HLPA-LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSV  148 (622)
T ss_dssp             CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCC-CCCC-CCTTCCEEECCSSCCS-CCCCC---CTTCCEEEC
T ss_pred             cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCC-CCCC-CCCCcCEEECCCCCCC-cCCCC---CCCCCEEEC
Confidence            45678888888888874 444   5677777777777776 3554 3345555555555555 24432   244555555


Q ss_pred             cccccCCCCCchh---cC--------------CCCCceEeccCCcccccCCCCCCC-----------------CCCCcee
Q 004994          149 NNNHLNGGIPDAF---HQ--------------FTGLINFDLSANNLTGQLPPSTRN-----------------LSSLYSL  194 (720)
Q Consensus       149 ~~N~l~g~~p~~~---~~--------------l~~L~~L~ls~N~l~g~~p~~~~~-----------------l~~L~~L  194 (720)
                      ++|+|++ +|..+   ..              +++|+.|+|++|+|++ +|..+.+                 +++|+.|
T Consensus       149 s~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L  226 (622)
T 3g06_A          149 SDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKEL  226 (622)
T ss_dssp             CSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCCTTCCEE
T ss_pred             cCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCccchhhEEECcCCcccccCCCCCCCCEE
Confidence            5555543 22211   11              1555666666666653 3332211                 2566777


Q ss_pred             eccccccccccccccccccceEEccCCcCcccCCcccCCCccccccCccCC
Q 004994          195 HLQNNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       195 ~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      +|++|+|++.+..  ...|+.|+|++|+|+ .+|..+.+|..|.+.+|.+.
T Consensus       227 ~Ls~N~L~~lp~~--l~~L~~L~Ls~N~L~-~lp~~~~~L~~L~Ls~N~L~  274 (622)
T 3g06_A          227 IVSGNRLTSLPVL--PSELKELMVSGNRLT-SLPMLPSGLLSLSVYRNQLT  274 (622)
T ss_dssp             ECCSSCCSCCCCC--CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCC
T ss_pred             EccCCccCcCCCC--CCcCcEEECCCCCCC-cCCcccccCcEEeCCCCCCC
Confidence            7777777664411  123677777777777 45655555555555555443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.60  E-value=2.5e-15  Score=142.22  Aligned_cols=108  Identities=31%  Similarity=0.410  Sum_probs=93.5

Q ss_pred             cEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcc
Q 004994           98 INIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL  177 (720)
Q Consensus        98 ~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l  177 (720)
                      +.|++++|+|+ .+|..++.+|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|
T Consensus        12 ~~l~~s~n~l~-~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l   90 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL   90 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CEEEeCCCCcC-ccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence            56777777777 67777778888999999999988888899999999999999999977777789999999999999999


Q ss_pred             cccCCCCCCCCCCCceeeccccccccccc
Q 004994          178 TGQLPPSTRNLSSLYSLHLQNNKLSGTLN  206 (720)
Q Consensus       178 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~~  206 (720)
                      ++..+..|.++++|+.|+|++|.++...+
T Consensus        91 ~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           91 KSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            96666679999999999999999987654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.59  E-value=7.5e-16  Score=142.42  Aligned_cols=124  Identities=23%  Similarity=0.281  Sum_probs=95.1

Q ss_pred             CCCccEEeccCCccc-ccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceE
Q 004994           94 LESVINIDLSNNHIG-GSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINF  170 (720)
Q Consensus        94 l~~L~~L~L~~N~l~-g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L  170 (720)
                      .++|+.|+|++|+++ +.+|..+.  .+|+.|+|++|++++.  ..++++++|+.|+|++|++++.+|..+..+++|+.|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            467888888888887 77887665  6788888888888855  678888888888888888887778777778888888


Q ss_pred             eccCCccccc-CCCCCCCCCCCceeeccccccccccc----cccccc-cceEEcc
Q 004994          171 DLSANNLTGQ-LPPSTRNLSSLYSLHLQNNKLSGTLN----VLEDLH-LIDLNIE  219 (720)
Q Consensus       171 ~ls~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~~-l~~l~l~  219 (720)
                      ++++|++++. .+..+..+++|+.|++++|.+++.++    .+..+. |+.|+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            8888888752 34678888888888888888877665    344443 6777665

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.58  E-value=7.5e-17  Score=170.59  Aligned_cols=174  Identities=18%  Similarity=0.257  Sum_probs=139.5

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCccccc-CCCCcc--ccCcEEEecCCcCCCCCcchhhccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGS-IPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLS  147 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~-ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~  147 (720)
                      .+++.|++++|.+.+..+. +..+++|++|+|++|++++. +|..+.  ++|+.|+|++|++++..|..++++++|++|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            7889999999999887665 56789999999999998865 665554  6899999999999988888899999999999


Q ss_pred             cccc-ccCC-CCCchhcCCCCCceEeccCC-ccccc-CCCCCCCCC-CCceeecccc--ccc-c-cccccccc-ccceEE
Q 004994          148 LNNN-HLNG-GIPDAFHQFTGLINFDLSAN-NLTGQ-LPPSTRNLS-SLYSLHLQNN--KLS-G-TLNVLEDL-HLIDLN  217 (720)
Q Consensus       148 l~~N-~l~g-~~p~~~~~l~~L~~L~ls~N-~l~g~-~p~~~~~l~-~L~~L~l~~N--~l~-~-~~~~~~~~-~l~~l~  217 (720)
                      |++| .+++ .+|..+.++++|++|+|++| .+++. ++..+..++ +|+.|+|++|  .++ + .+..+..+ .|+.|+
T Consensus       149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~  228 (336)
T 2ast_B          149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD  228 (336)
T ss_dssp             CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence            9999 6775 36777888999999999999 88864 677788889 9999999999  454 2 23344444 499999


Q ss_pred             ccCCc-CcccCCcccCCCccccccCccCC
Q 004994          218 IENNL-FSGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       218 l~~N~-l~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      +++|. +++..+..+..+++|+..+...|
T Consensus       229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~  257 (336)
T 2ast_B          229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRC  257 (336)
T ss_dssp             CTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred             CCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence            99998 77777777777777776655544

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.58  E-value=5.2e-15  Score=140.57  Aligned_cols=108  Identities=27%  Similarity=0.359  Sum_probs=92.3

Q ss_pred             cEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcc
Q 004994           98 INIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL  177 (720)
Q Consensus        98 ~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l  177 (720)
                      +.+++++|+|+ .+|..++.+|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l   93 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL   93 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             cEEEeCCCCCC-ccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcc
Confidence            46777777775 77877778888999999999988888999999999999999999976666689999999999999999


Q ss_pred             cccCCCCCCCCCCCceeeccccccccccc
Q 004994          178 TGQLPPSTRNLSSLYSLHLQNNKLSGTLN  206 (720)
Q Consensus       178 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~~  206 (720)
                      ++..+..|..+++|+.|+|++|.|.....
T Consensus        94 ~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           94 KSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             CCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             ceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            95555569999999999999999987654

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.58  E-value=9.7e-17  Score=173.33  Aligned_cols=170  Identities=24%  Similarity=0.323  Sum_probs=87.6

Q ss_pred             cCceeEEEecCCccccc----CCcCcCCCCCccEEeccCC---cccccCCCCc-------c--ccCcEEEecCCcCCC--
Q 004994           70 FSNVTEIRLTGMNLGGV----LADTLGDLESVINIDLSNN---HIGGSIPSNL-------P--VTVRNFSLSGNQLTG--  131 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N---~l~g~ip~~~-------~--~~L~~L~Ls~N~l~g--  131 (720)
                      +++|+.|+|++|++++.    ++..|..+++|++|+|++|   ++++.+|..+       .  .+|+.|+|++|+|++  
T Consensus        31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~  110 (386)
T 2ca6_A           31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA  110 (386)
T ss_dssp             CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred             CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHH
Confidence            34566666666666544    2233555666666666653   3444444433       1  456666666666654  


Q ss_pred             --CCcchhhcccccccccccccccCCCCCchh----cCC---------CCCceEeccCCccc-ccCC---CCCCCCCCCc
Q 004994          132 --SIPESLSRLTQLLDLSLNNNHLNGGIPDAF----HQF---------TGLINFDLSANNLT-GQLP---PSTRNLSSLY  192 (720)
Q Consensus       132 --~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~----~~l---------~~L~~L~ls~N~l~-g~~p---~~~~~l~~L~  192 (720)
                        .+|..+.++++|+.|+|++|.|++..+..+    ..+         ++|++|+|++|+|+ +.+|   ..+..+++|+
T Consensus       111 ~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~  190 (386)
T 2ca6_A          111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH  190 (386)
T ss_dssp             HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCC
T ss_pred             HHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcC
Confidence              355555666666666666666543222222    222         56666666666664 2333   2444555666


Q ss_pred             eeeccccccc--c---ccc-ccccc-ccceEEccCCcCc----ccCCcccCCCccccc
Q 004994          193 SLHLQNNKLS--G---TLN-VLEDL-HLIDLNIENNLFS----GPIPEKLLSIPNFRK  239 (720)
Q Consensus       193 ~L~l~~N~l~--~---~~~-~~~~~-~l~~l~l~~N~l~----g~~p~~~~~l~~l~~  239 (720)
                      .|+|++|+|+  |   ..+ .+..+ .|+.|+|++|.|+    +.+|..+..+++|+.
T Consensus       191 ~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~  248 (386)
T 2ca6_A          191 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE  248 (386)
T ss_dssp             EEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred             EEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCE
Confidence            6666666655  2   122 33333 2566666666664    445554444444443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.55  E-value=4.1e-15  Score=141.68  Aligned_cols=130  Identities=21%  Similarity=0.243  Sum_probs=88.0

Q ss_pred             eecCceeEEEecCCcccccCCcCcCCCC-CccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccc
Q 004994           68 CVFSNVTEIRLTGMNLGGVLADTLGDLE-SVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLL  144 (720)
Q Consensus        68 c~~~~l~~l~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~  144 (720)
                      ....+|+.|+|++|+++. +|. +..+. +|++|+|++|+|++.  ..+.  .+|+.|+|++|+|++..|..+..+++|+
T Consensus        16 ~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             CCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            344577778888887774 343 44444 777888887777743  3443  5777777777777754444457777777


Q ss_pred             cccccccccCCCCCc--hhcCCCCCceEeccCCcccccCCCC----CCCCCCCceeecccccccc
Q 004994          145 DLSLNNNHLNGGIPD--AFHQFTGLINFDLSANNLTGQLPPS----TRNLSSLYSLHLQNNKLSG  203 (720)
Q Consensus       145 ~L~l~~N~l~g~~p~--~~~~l~~L~~L~ls~N~l~g~~p~~----~~~l~~L~~L~l~~N~l~~  203 (720)
                      .|+|++|+|+ .+|.  .+..+++|+.|+|++|.++ .+|..    +..+++|+.||+++|.+..
T Consensus        92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            7777777775 4555  6777777777777777776 55653    6677777777777776653

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.55  E-value=2.7e-16  Score=166.25  Aligned_cols=175  Identities=19%  Similarity=0.223  Sum_probs=139.5

Q ss_pred             ecCceeEEEecCCccccc-CCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCC-cCCCC-Ccchhhccccc
Q 004994           69 VFSNVTEIRLTGMNLGGV-LADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGN-QLTGS-IPESLSRLTQL  143 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N-~l~g~-~p~~l~~l~~L  143 (720)
                      .+++|+.|+|++|.+++. ++..+..+++|++|+|++|++++.+|..+.  ++|+.|+|++| .+++. +|..+.++++|
T Consensus        91 ~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L  170 (336)
T 2ast_B           91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL  170 (336)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred             cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCC
Confidence            468899999999999876 888899999999999999999987777665  78999999999 78863 77778999999


Q ss_pred             cccccccc-ccCCC-CCchhcCCC-CCceEeccCC--ccc-ccCCCCCCCCCCCceeeccccc-cccc-cccccccc-cc
Q 004994          144 LDLSLNNN-HLNGG-IPDAFHQFT-GLINFDLSAN--NLT-GQLPPSTRNLSSLYSLHLQNNK-LSGT-LNVLEDLH-LI  214 (720)
Q Consensus       144 ~~L~l~~N-~l~g~-~p~~~~~l~-~L~~L~ls~N--~l~-g~~p~~~~~l~~L~~L~l~~N~-l~~~-~~~~~~~~-l~  214 (720)
                      +.|+|++| .+++. ++..+..++ +|+.|+|++|  .++ +.+|..+.++++|+.|+|++|. +++. +..+..+. |+
T Consensus       171 ~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~  250 (336)
T 2ast_B          171 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ  250 (336)
T ss_dssp             CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred             CEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCC
Confidence            99999999 99864 677789999 9999999999  555 4677778889999999999999 6643 44555554 99


Q ss_pred             eEEccCCc-CcccCCcccCCCccccccCcc
Q 004994          215 DLNIENNL-FSGPIPEKLLSIPNFRKDGNP  243 (720)
Q Consensus       215 ~l~l~~N~-l~g~~p~~~~~l~~l~~~~n~  243 (720)
                      .|++++|. +.......+.++++|+..+..
T Consensus       251 ~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~  280 (336)
T 2ast_B          251 HLSLSRCYDIIPETLLELGEIPTLKTLQVF  280 (336)
T ss_dssp             EEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred             EeeCCCCCCCCHHHHHHHhcCCCCCEEecc
Confidence            99999995 322211245556666554444

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.54  E-value=1.5e-14  Score=153.84  Aligned_cols=180  Identities=16%  Similarity=0.166  Sum_probs=145.5

Q ss_pred             CceeEeecCceeEEEecCCcccccCC-cCcCCCCCccE-EeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhh
Q 004994           63 WQGVFCVFSNVTEIRLTGMNLGGVLA-DTLGDLESVIN-IDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLS  138 (720)
Q Consensus        63 w~gv~c~~~~l~~l~L~~n~l~~~~~-~~~~~l~~L~~-L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~  138 (720)
                      ..++|..+++|+.|+|++|++.+.+| ..|.++++|+. ++++.|+|+...|..+.  .+|+.|++++|++++..+..+.
T Consensus        46 ~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~  125 (350)
T 4ay9_X           46 QKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI  125 (350)
T ss_dssp             CTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTC
T ss_pred             CHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhc
Confidence            56778889999999999999987766 57889998775 67778999966666665  7899999999999977777777


Q ss_pred             cccccccccccc-cccCCCCCchhcCCC-CCceEeccCCcccccCCCCCCCCCCCceeeccc-cccccccc-cccccc-c
Q 004994          139 RLTQLLDLSLNN-NHLNGGIPDAFHQFT-GLINFDLSANNLTGQLPPSTRNLSSLYSLHLQN-NKLSGTLN-VLEDLH-L  213 (720)
Q Consensus       139 ~l~~L~~L~l~~-N~l~g~~p~~~~~l~-~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~~~-~~~~~~-l  213 (720)
                      ...++..|++.+ |++....+..|..+. .++.|+|++|+|+ .+|.......+|+.|++++ |.++..++ .+..+. |
T Consensus       126 ~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L  204 (350)
T 4ay9_X          126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGP  204 (350)
T ss_dssp             CBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECC
T ss_pred             ccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCccc
Confidence            888899999965 677755556677764 6899999999998 6777777788999999985 66776664 355554 9


Q ss_pred             ceEEccCCcCcccCCcccCCCccccccCcc
Q 004994          214 IDLNIENNLFSGPIPEKLLSIPNFRKDGNP  243 (720)
Q Consensus       214 ~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~  243 (720)
                      +.|+|++|+|+...+..+.+++.|+..++.
T Consensus       205 ~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~  234 (350)
T 4ay9_X          205 VILDISRTRIHSLPSYGLENLKKLRARSTY  234 (350)
T ss_dssp             SEEECTTSCCCCCCSSSCTTCCEEECTTCT
T ss_pred             chhhcCCCCcCccChhhhccchHhhhccCC
Confidence            999999999995445568889888887764

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.54  E-value=4.7e-17  Score=158.41  Aligned_cols=130  Identities=23%  Similarity=0.295  Sum_probs=92.3

Q ss_pred             cCceeEEEecCCcccccCCc------CcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccc
Q 004994           70 FSNVTEIRLTGMNLGGVLAD------TLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLT  141 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~------~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~  141 (720)
                      ..+++.++|+.+.+.|.+|.      .+..+++|++|+|++|+|++ +| .+.  .+|+.|+|++|+++ .+|..+..++
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~   93 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD   93 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence            34556666666777766665      77778888888888888874 66 554  67777777777777 6677777777


Q ss_pred             ccccccccccccCCCCCchhcCCCCCceEeccCCcccccCC--CCCCCCCCCceeecccccccccc
Q 004994          142 QLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP--PSTRNLSSLYSLHLQNNKLSGTL  205 (720)
Q Consensus       142 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~  205 (720)
                      +|+.|+|++|+|++ +| .+..+++|+.|+|++|++++ +|  ..+..+++|+.|++++|.+++.+
T Consensus        94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~  156 (198)
T 1ds9_A           94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDY  156 (198)
T ss_dssp             HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred             cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc-hhHHHHHhcCCCCCEEEecCCcccccc
Confidence            77777777777774 44 57777777777777777763 33  35667777777777777776654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.53  E-value=4.7e-15  Score=141.29  Aligned_cols=132  Identities=17%  Similarity=0.165  Sum_probs=109.9

Q ss_pred             cCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCC
Q 004994           89 DTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTG  166 (720)
Q Consensus        89 ~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~  166 (720)
                      +.+.++.+|+.|+|++|+++ .+|....  ++|+.|+|++|+|++.  ..|.++++|+.|+|++|+|++..|..|..+++
T Consensus        13 ~~~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             HhcCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            45677899999999999999 5665332  4899999999999965  67999999999999999999655566699999


Q ss_pred             CceEeccCCcccccCCC--CCCCCCCCceeecccccccccccc----ccccc-cceEEccCCcCc
Q 004994          167 LINFDLSANNLTGQLPP--STRNLSSLYSLHLQNNKLSGTLNV----LEDLH-LIDLNIENNLFS  224 (720)
Q Consensus       167 L~~L~ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~-l~~l~l~~N~l~  224 (720)
                      |+.|+|++|+|+ .+|.  .+..+++|+.|+|++|.++..+..    +..+. |+.||+++|.+.
T Consensus        90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            999999999996 6776  788999999999999999876653    45444 889999888775

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.51  E-value=9.4e-16  Score=164.05  Aligned_cols=155  Identities=23%  Similarity=0.325  Sum_probs=87.2

Q ss_pred             ceeEEEecCCcccccCCcCcCCC-----CCccEEeccCCcccccCCCCcc-------ccCcEEEecCCcCCCCCcchhhc
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDL-----ESVINIDLSNNHIGGSIPSNLP-------VTVRNFSLSGNQLTGSIPESLSR  139 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~g~ip~~~~-------~~L~~L~Ls~N~l~g~~p~~l~~  139 (720)
                      +|+.|+|++|++++..+..+..+     ++|++|+|++|+|++..+..+.       .+|+.|+|++|+|++..+..+..
T Consensus        52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  131 (362)
T 3goz_A           52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ  131 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence            56666666666666555555443     6666666666666654443221       35666666666666555544433


Q ss_pred             -----ccccccccccccccCCCC----CchhcCCC-CCceEeccCCcccccCCCCC----CCC-CCCceeeccccccccc
Q 004994          140 -----LTQLLDLSLNNNHLNGGI----PDAFHQFT-GLINFDLSANNLTGQLPPST----RNL-SSLYSLHLQNNKLSGT  204 (720)
Q Consensus       140 -----l~~L~~L~l~~N~l~g~~----p~~~~~l~-~L~~L~ls~N~l~g~~p~~~----~~l-~~L~~L~l~~N~l~~~  204 (720)
                           .++|++|+|++|.|++.-    +..+..++ +|++|+|++|+|++..+..+    ..+ ++|+.|+|++|.|+..
T Consensus       132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~  211 (362)
T 3goz_A          132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLK  211 (362)
T ss_dssp             HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred             HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChh
Confidence                 246666666666666432    23334443 66666666666665444322    233 4666677777666652


Q ss_pred             -----cccccc--cccceEEccCCcCccc
Q 004994          205 -----LNVLED--LHLIDLNIENNLFSGP  226 (720)
Q Consensus       205 -----~~~~~~--~~l~~l~l~~N~l~g~  226 (720)
                           ...+..  ..|+.|+|++|.+++.
T Consensus       212 ~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~  240 (362)
T 3goz_A          212 SYAELAYIFSSIPNHVVSLNLCLNCLHGP  240 (362)
T ss_dssp             CHHHHHHHHHHSCTTCCEEECCSSCCCCC
T ss_pred             HHHHHHHHHhcCCCCceEEECcCCCCCcH
Confidence                 222322  2466677777766653

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.49  E-value=2.2e-15  Score=161.10  Aligned_cols=156  Identities=24%  Similarity=0.305  Sum_probs=104.3

Q ss_pred             cCceeEEEecCCcccccCC----cCcCCCC-CccEEeccCCcccccCCCCcc-------ccCcEEEecCCcCCCCCcchh
Q 004994           70 FSNVTEIRLTGMNLGGVLA----DTLGDLE-SVINIDLSNNHIGGSIPSNLP-------VTVRNFSLSGNQLTGSIPESL  137 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~g~ip~~~~-------~~L~~L~Ls~N~l~g~~p~~l  137 (720)
                      ..+|+.|+|++|++++..+    ..|..++ +|++|+|++|+|++..+..+.       .+|++|+|++|++++..+..+
T Consensus        21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l  100 (362)
T 3goz_A           21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL  100 (362)
T ss_dssp             CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred             CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence            3457788888888776655    6667777 788888888887765554442       467888888888877666655


Q ss_pred             hcc-----cccccccccccccCCCCCchhcC-----CCCCceEeccCCccccc----CCCCCCCCC-CCceeeccccccc
Q 004994          138 SRL-----TQLLDLSLNNNHLNGGIPDAFHQ-----FTGLINFDLSANNLTGQ----LPPSTRNLS-SLYSLHLQNNKLS  202 (720)
Q Consensus       138 ~~l-----~~L~~L~l~~N~l~g~~p~~~~~-----l~~L~~L~ls~N~l~g~----~p~~~~~l~-~L~~L~l~~N~l~  202 (720)
                      ...     ++|+.|+|++|+|++..+..+..     .++|++|+|++|.|+..    ++..+..++ +|+.|+|++|+|+
T Consensus       101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~  180 (362)
T 3goz_A          101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA  180 (362)
T ss_dssp             HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred             HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence            443     67888888888887655544433     35788888888887742    233334444 7888888888777


Q ss_pred             cccc-----cccc--cccceEEccCCcCcc
Q 004994          203 GTLN-----VLED--LHLIDLNIENNLFSG  225 (720)
Q Consensus       203 ~~~~-----~~~~--~~l~~l~l~~N~l~g  225 (720)
                      +...     .+..  ..|+.|+|++|.|++
T Consensus       181 ~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~  210 (362)
T 3goz_A          181 SKNCAELAKFLASIPASVTSLDLSANLLGL  210 (362)
T ss_dssp             GSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred             hhhHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence            6542     2222  257788888888775

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.49  E-value=4.5e-14  Score=159.36  Aligned_cols=118  Identities=23%  Similarity=0.279  Sum_probs=97.9

Q ss_pred             CccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEecc
Q 004994           96 SVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLS  173 (720)
Q Consensus        96 ~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls  173 (720)
                      .|+.|+|++|+|++ +|. +.  .+|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|+++++|+.|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            48889999999984 776 65  68999999999998 888899999999999999999986 67 78999999999999


Q ss_pred             CCcccccC-CCCCCCCCCCceeeccccccccccccccc----c-ccceEEc
Q 004994          174 ANNLTGQL-PPSTRNLSSLYSLHLQNNKLSGTLNVLED----L-HLIDLNI  218 (720)
Q Consensus       174 ~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~----~-~l~~l~l  218 (720)
                      +|+|++.. |..++.+++|+.|+|++|+|++.++....    + .|+.|++
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            99998766 88899999999999999999888764322    2 3666653

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.47  E-value=2.4e-16  Score=153.44  Aligned_cols=145  Identities=27%  Similarity=0.340  Sum_probs=124.1

Q ss_pred             cCCCCCccEEeccCCcccccCCC------Ccc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhc
Q 004994           91 LGDLESVINIDLSNNHIGGSIPS------NLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFH  162 (720)
Q Consensus        91 ~~~l~~L~~L~L~~N~l~g~ip~------~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~  162 (720)
                      +.....++.++|+.|.|+|.+|.      .+.  .+|+.|+|++|++++ +| .+.++++|+.|+|++|+|+ .+|..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            45567889999999999999887      554  689999999999996 77 8999999999999999998 7898888


Q ss_pred             CCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc--cccccc-cceEEccCCcCcccCCcc---------
Q 004994          163 QFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN--VLEDLH-LIDLNIENNLFSGPIPEK---------  230 (720)
Q Consensus       163 ~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~-l~~l~l~~N~l~g~~p~~---------  230 (720)
                      .+++|+.|+|++|+|++ +| .+..+++|+.|+|++|++++...  .+..+. |+.|++++|.+++.+|..         
T Consensus        91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~  168 (198)
T 1ds9_A           91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE  168 (198)
T ss_dssp             HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred             cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence            89999999999999995 66 68899999999999999997543  555554 999999999999887753         


Q ss_pred             -cCCCcccccc
Q 004994          231 -LLSIPNFRKD  240 (720)
Q Consensus       231 -~~~l~~l~~~  240 (720)
                       +..+++|+..
T Consensus       169 ~~~~l~~L~~L  179 (198)
T 1ds9_A          169 VVKRLPNLKKL  179 (198)
T ss_dssp             HHHHCSSCSEE
T ss_pred             HHHhCCCcEEE
Confidence             6666776654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.43  E-value=3.4e-13  Score=127.45  Aligned_cols=108  Identities=26%  Similarity=0.343  Sum_probs=95.0

Q ss_pred             cCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecc
Q 004994          118 TVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQ  197 (720)
Q Consensus       118 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  197 (720)
                      ..+.|++++|+|+ .+|..+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            4688999999999 6887774  899999999999998889999999999999999999997666678999999999999


Q ss_pred             cccccccccc-ccccc-cceEEccCCcCcccCC
Q 004994          198 NNKLSGTLNV-LEDLH-LIDLNIENNLFSGPIP  228 (720)
Q Consensus       198 ~N~l~~~~~~-~~~~~-l~~l~l~~N~l~g~~p  228 (720)
                      +|+|++.++. +..+. |+.|+|++|.++...+
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            9999998864 66654 9999999999986543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.42  E-value=6.3e-13  Score=126.11  Aligned_cols=106  Identities=25%  Similarity=0.286  Sum_probs=92.6

Q ss_pred             eEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccccccccc
Q 004994           74 TEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNN  151 (720)
Q Consensus        74 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N  151 (720)
                      +.+++++|+|+ .+|..+.  ++|++|+|++|+|++..|..+.  .+|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            68999999997 5677664  8999999999999987787776  79999999999999766666899999999999999


Q ss_pred             ccCCCCCchhcCCCCCceEeccCCcccccCCC
Q 004994          152 HLNGGIPDAFHQFTGLINFDLSANNLTGQLPP  183 (720)
Q Consensus       152 ~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~  183 (720)
                      +|++..+..|..+++|+.|+|++|.+. ..+.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~  122 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD-CECR  122 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC-TTBG
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc-cccc
Confidence            999766667999999999999999998 4443

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.41  E-value=9.2e-15  Score=161.57  Aligned_cols=175  Identities=18%  Similarity=0.177  Sum_probs=133.8

Q ss_pred             cCceeEEEecCCccccc----CCcCcCCCCCccEEeccCCcccccCC----CCc---cccCcEEEecCCcCCCC----Cc
Q 004994           70 FSNVTEIRLTGMNLGGV----LADTLGDLESVINIDLSNNHIGGSIP----SNL---PVTVRNFSLSGNQLTGS----IP  134 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~g~ip----~~~---~~~L~~L~Ls~N~l~g~----~p  134 (720)
                      .++|+.|+|++|++++.    ++..+..+++|+.|+|++|++++.-.    ..+   ..+|+.|+|++|++++.    ++
T Consensus       198 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~  277 (461)
T 1z7x_W          198 PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC  277 (461)
T ss_dssp             CCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred             CCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence            45899999999999873    57778889999999999999875321    111   25899999999999864    67


Q ss_pred             chhhcccccccccccccccCCCCCchhcC-----CCCCceEeccCCccccc----CCCCCCCCCCCceeecccccccccc
Q 004994          135 ESLSRLTQLLDLSLNNNHLNGGIPDAFHQ-----FTGLINFDLSANNLTGQ----LPPSTRNLSSLYSLHLQNNKLSGTL  205 (720)
Q Consensus       135 ~~l~~l~~L~~L~l~~N~l~g~~p~~~~~-----l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~  205 (720)
                      ..+.++++|+.|+|++|.+++..+..+..     .++|+.|+|++|.+++.    ++..+..+++|+.|+|++|.+++..
T Consensus       278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~  357 (461)
T 1z7x_W          278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG  357 (461)
T ss_dssp             HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred             HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence            78888999999999999987554444443     36899999999999864    5667778899999999999987653


Q ss_pred             -ccc----c--ccccceEEccCCcCcc----cCCcccCCCcccc---ccCccC
Q 004994          206 -NVL----E--DLHLIDLNIENNLFSG----PIPEKLLSIPNFR---KDGNPF  244 (720)
Q Consensus       206 -~~~----~--~~~l~~l~l~~N~l~g----~~p~~~~~l~~l~---~~~n~~  244 (720)
                       ..+    .  ...|+.|++++|.+++    .+|..+..+++|+   +.+|.+
T Consensus       358 ~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i  410 (461)
T 1z7x_W          358 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL  410 (461)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred             HHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCC
Confidence             222    2  3369999999999986    7787765555544   455544

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.39  E-value=8.1e-15  Score=162.03  Aligned_cols=174  Identities=21%  Similarity=0.209  Sum_probs=133.5

Q ss_pred             ceeEEEecCCcccc----cCCcCcCCCCCccEEeccCCcccccCCCCcc-------ccCcEEEecCCcCCCC----Ccch
Q 004994           72 NVTEIRLTGMNLGG----VLADTLGDLESVINIDLSNNHIGGSIPSNLP-------VTVRNFSLSGNQLTGS----IPES  136 (720)
Q Consensus        72 ~l~~l~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~-------~~L~~L~Ls~N~l~g~----~p~~  136 (720)
                      +|+.|+|++|+++.    .++..+..+++|++|+|++|++++..+..+.       .+|+.|+|++|++++.    ++..
T Consensus        86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~  165 (461)
T 1z7x_W           86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV  165 (461)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred             ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence            69999999999984    6788899999999999999999865444332       3699999999999874    4666


Q ss_pred             hhcccccccccccccccCCCCCchhc-----CCCCCceEeccCCccccc----CCCCCCCCCCCceeecccccccccc--
Q 004994          137 LSRLTQLLDLSLNNNHLNGGIPDAFH-----QFTGLINFDLSANNLTGQ----LPPSTRNLSSLYSLHLQNNKLSGTL--  205 (720)
Q Consensus       137 l~~l~~L~~L~l~~N~l~g~~p~~~~-----~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~--  205 (720)
                      +..+++|+.|+|++|.++...+..+.     .+++|+.|+|++|.+++.    ++..+..+++|+.|+|++|.++...  
T Consensus       166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~  245 (461)
T 1z7x_W          166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA  245 (461)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred             HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence            77889999999999998765444444     367999999999999863    5777888999999999999987642  


Q ss_pred             ---ccc-c-ccccceEEccCCcCccc----CCcccCCCccccccCccCC
Q 004994          206 ---NVL-E-DLHLIDLNIENNLFSGP----IPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       206 ---~~~-~-~~~l~~l~l~~N~l~g~----~p~~~~~l~~l~~~~n~~~  245 (720)
                         +.+ . ...|+.|++++|.++..    +|..+..+++|+..+...|
T Consensus       246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n  294 (461)
T 1z7x_W          246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN  294 (461)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTC
T ss_pred             HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCC
Confidence               222 1 33599999999999864    6666555555554444433

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.31  E-value=2.2e-12  Score=136.88  Aligned_cols=101  Identities=29%  Similarity=0.302  Sum_probs=70.9

Q ss_pred             cCC-cccccCCcCcCCCCCccEEeccC-CcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccccccCCC
Q 004994           79 TGM-NLGGVLADTLGDLESVINIDLSN-NHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGG  156 (720)
Q Consensus        79 ~~n-~l~~~~~~~~~~l~~L~~L~L~~-N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~  156 (720)
                      +++ +|++ +|. |..+++|+.|+|++ |+|+                      +..|..|.+|++|+.|+|++|+|++.
T Consensus        16 ~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~----------------------~~~~~~~~~l~~L~~L~l~~N~l~~~   71 (347)
T 2ifg_A           16 TRDGALDS-LHH-LPGAENLTELYIENQQHLQ----------------------HLELRDLRGLGELRNLTIVKSGLRFV   71 (347)
T ss_dssp             CSSCCCTT-TTT-SCSCSCCSEEECCSCSSCC----------------------EECGGGSCSCCCCSEEECCSSCCCEE
T ss_pred             CCCCCCCc-cCC-CCCCCCeeEEEccCCCCCC----------------------CcChhHhccccCCCEEECCCCcccee
Confidence            444 5664 555 66666666666664 5555                      44556677888888888888888877


Q ss_pred             CCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccc
Q 004994          157 IPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT  204 (720)
Q Consensus       157 ~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~  204 (720)
                      .|..|.+|++|+.|+|++|+|++..+..+..++ |+.|+|++|.|...
T Consensus        72 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS  118 (347)
T ss_dssp             CTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred             CHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence            777888888888888888888854444444454 88888888887653

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.28  E-value=3.3e-12  Score=135.50  Aligned_cols=103  Identities=20%  Similarity=0.213  Sum_probs=91.6

Q ss_pred             EEEecCC-cCCCCCcchhhcccccccccccc-cccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccc
Q 004994          121 NFSLSGN-QLTGSIPESLSRLTQLLDLSLNN-NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQN  198 (720)
Q Consensus       121 ~L~Ls~N-~l~g~~p~~l~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  198 (720)
                      .+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4577776 777 6788 99999999999996 999988888999999999999999999998888999999999999999


Q ss_pred             ccccccccc-ccccccceEEccCCcCcc
Q 004994          199 NKLSGTLNV-LEDLHLIDLNIENNLFSG  225 (720)
Q Consensus       199 N~l~~~~~~-~~~~~l~~l~l~~N~l~g  225 (720)
                      |+|++.++. +..+.|+.|+|++|.|..
T Consensus        90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c  117 (347)
T 2ifg_A           90 NALESLSWKTVQGLSLQELVLSGNPLHC  117 (347)
T ss_dssp             SCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred             CccceeCHHHcccCCceEEEeeCCCccC
Confidence            999998854 555669999999999974

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.21  E-value=4.3e-11  Score=121.47  Aligned_cols=145  Identities=12%  Similarity=0.086  Sum_probs=110.8

Q ss_pred             HHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEE
Q 004994          437 QYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       437 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l  515 (720)
                      .....|.....++.|+.+.||++... ++.+++|+......  .....+.+|+++++.+. |..+.++++++.+.+..|+
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            34456766677888888999999754 67899999864321  12235788999998884 6778899999988889999


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC---------------------------------  562 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~---------------------------------  562 (720)
                      ||||++|.+|.+....         ......++.+++++|..||...                                 
T Consensus        88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999999998875311         1123367888999999999821                                 


Q ss_pred             -----------------------CCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          563 -----------------------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       563 -----------------------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                                             ...++|+|++|.|||++++..+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   1458999999999999876667799999763

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.19  E-value=4.6e-13  Score=143.08  Aligned_cols=160  Identities=19%  Similarity=0.213  Sum_probs=120.6

Q ss_pred             cCceeEEEecCCcccccCCcC----cCC-CCCccEEeccCCcccccCCCCcc---ccCcEEEecCCcCCCCCcchhh---
Q 004994           70 FSNVTEIRLTGMNLGGVLADT----LGD-LESVINIDLSNNHIGGSIPSNLP---VTVRNFSLSGNQLTGSIPESLS---  138 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~----~~~-l~~L~~L~L~~N~l~g~ip~~~~---~~L~~L~Ls~N~l~g~~p~~l~---  138 (720)
                      .++|+.|+|++|+|+......    +.. .++|+.|+|++|+|+..-...+.   .+|+.|+|++|+|+..-...+.   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            467999999999998643333    332 37999999999999754333332   5899999999999855444443   


Q ss_pred             --cccccccccccccccCC----CCCchhcCCCCCceEeccCCcccc----cCCCCCCCCCCCceeecccccccccc---
Q 004994          139 --RLTQLLDLSLNNNHLNG----GIPDAFHQFTGLINFDLSANNLTG----QLPPSTRNLSSLYSLHLQNNKLSGTL---  205 (720)
Q Consensus       139 --~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~~---  205 (720)
                        ..++|+.|+|++|.|+.    .++..+..+++|++|+|++|.|+.    .++..+..+++|+.|+|++|.|+...   
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence              35789999999999974    355566889999999999999974    24556777889999999999997532   


Q ss_pred             --cccc-ccccceEEccCCcCcccCCc
Q 004994          206 --NVLE-DLHLIDLNIENNLFSGPIPE  229 (720)
Q Consensus       206 --~~~~-~~~l~~l~l~~N~l~g~~p~  229 (720)
                        ..+. ...|+.|+|++|.|+..-..
T Consensus       231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~  257 (372)
T 3un9_A          231 LARAAREHPSLELLHLYFNELSSEGRQ  257 (372)
T ss_dssp             HHHHHHHCSSCCEEECTTSSCCHHHHH
T ss_pred             HHHHHHhCCCCCEEeccCCCCCHHHHH
Confidence              2232 34599999999999854333

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.11  E-value=8.6e-11  Score=118.92  Aligned_cols=128  Identities=18%  Similarity=0.177  Sum_probs=94.8

Q ss_pred             ccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCc--eeEEEeEeccCCeEEEEEeeCCCCCHH
Q 004994          449 GEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN--IVELIGYCNEHGQHLLVYDYGGNCTLH  526 (720)
Q Consensus       449 g~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~  526 (720)
                      +.|..+.||++...+|+.+++|.....     ....+..|+++++.+.+.+  +.+++++..+.+..++||||+++.++.
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            355669999998777888999997643     1235678888888885544  556888888888899999999998774


Q ss_pred             HHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 004994          527 DLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC--------------------------------------------  562 (720)
Q Consensus       527 ~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------------  562 (720)
                        ...       .+   ...++.++++.|..||...                                            
T Consensus       104 --~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (264)
T 1nd4_A          104 --SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  171 (264)
T ss_dssp             --TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             --cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence              211       01   1246667777777777642                                            


Q ss_pred             -----------CCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          563 -----------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       563 -----------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                                 ...++|+|++|.|||++++..+.|+|||.+.
T Consensus       172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                       1239999999999999887667899999874

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.03  E-value=6.9e-10  Score=116.61  Aligned_cols=173  Identities=11%  Similarity=0.073  Sum_probs=124.4

Q ss_pred             CceeEee--------cCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCC-CccccCcEEEecCCc--C--
Q 004994           63 WQGVFCV--------FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS-NLPVTVRNFSLSGNQ--L--  129 (720)
Q Consensus        63 w~gv~c~--------~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~-~~~~~L~~L~Ls~N~--l--  129 (720)
                      ..+.|..        +.+|+.|+|.+ +++.+-+.+|.++++|+.|+|++|.+. .|+. .|...+..+.+..+.  .  
T Consensus        85 ~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~~~~~~  162 (329)
T 3sb4_A           85 PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLGSSDAYR  162 (329)
T ss_dssp             CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTTCTHHHH
T ss_pred             CHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCcchhhhh
Confidence            3466777        89999999999 898877889999999999999999987 4443 343333333333222  0  


Q ss_pred             --C----------------------CCCcchh----------------------------hcccccccccccccccCCCC
Q 004994          130 --T----------------------GSIPESL----------------------------SRLTQLLDLSLNNNHLNGGI  157 (720)
Q Consensus       130 --~----------------------g~~p~~l----------------------------~~l~~L~~L~l~~N~l~g~~  157 (720)
                        .                      +.++..+                            ..+++|+.|+|++|+++...
T Consensus       163 ~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~  242 (329)
T 3sb4_A          163 FKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIP  242 (329)
T ss_dssp             TSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEEC
T ss_pred             ccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceec
Confidence              0                      0111110                            13788999999999998655


Q ss_pred             CchhcCCCCCceEeccCCcccccCCCCCCCCCCCc-eeecccccccccc-ccccccc-cceEEccCCcCcccCCcccCCC
Q 004994          158 PDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLY-SLHLQNNKLSGTL-NVLEDLH-LIDLNIENNLFSGPIPEKLLSI  234 (720)
Q Consensus       158 p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~~~~-~~~~~~~-l~~l~l~~N~l~g~~p~~~~~l  234 (720)
                      +.+|.+|.+|+.|+|.+| ++..-+.+|.+|.+|+ .|+|.+ .++... ..+..+. |+.+++++|+++..-+..|.++
T Consensus       243 ~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~  320 (329)
T 3sb4_A          243 DFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNG  320 (329)
T ss_dssp             TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTT
T ss_pred             HhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCC
Confidence            667999999999999998 7755566789999999 999988 666554 3455554 9999999999985555677777


Q ss_pred             ccccc
Q 004994          235 PNFRK  239 (720)
Q Consensus       235 ~~l~~  239 (720)
                      ++|+.
T Consensus       321 ~~L~~  325 (329)
T 3sb4_A          321 VPSKL  325 (329)
T ss_dssp             CCCCE
T ss_pred             cchhh
Confidence            77664

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.98  E-value=2e-09  Score=114.56  Aligned_cols=142  Identities=15%  Similarity=0.237  Sum_probs=105.5

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEec--ccccccccHHHHHHHHHHHHccC--CCceeEEEeEeccC---CeEEEEE
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLS--NTVSQRQTDEEFLELASTISRLR--HGNIVELIGYCNEH---GQHLLVY  517 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~--~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~  517 (720)
                      .+.++.|.++.||++...+ ..+++|+..  .... ......+.+|+++++.+.  +..+.++++++.+.   +..++||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4678999999999998765 578888875  3221 122356788999999887  45688899998776   5689999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC-----------------------------------  562 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~-----------------------------------  562 (720)
                      ||+++..+.+..      ...++...+..++.++++.|+.||...                                   
T Consensus       121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999997764311      233567778889999999999999831                                   


Q ss_pred             --------------------CCCeeecCCCCCCeEEcCCCC--eEEccccCCCC
Q 004994          563 --------------------EPPIVHGNFKSSNILLDEKLI--VRVSDCGLAPL  594 (720)
Q Consensus       563 --------------------~~~ivHrDlkp~NiLl~~~~~--~kl~DFGla~~  594 (720)
                                          ...++|+|+++.|||+++++.  +.|.||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                246999999999999997753  68999998864

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.95  E-value=1.5e-11  Score=131.26  Aligned_cols=134  Identities=25%  Similarity=0.272  Sum_probs=105.2

Q ss_pred             CceeEEEecCCcccccCCcC-cCCCCCccEEeccCCcccccCCCCc-------cccCcEEEecCCcCCC----CCcchhh
Q 004994           71 SNVTEIRLTGMNLGGVLADT-LGDLESVINIDLSNNHIGGSIPSNL-------PVTVRNFSLSGNQLTG----SIPESLS  138 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~g~ip~~~-------~~~L~~L~Ls~N~l~g----~~p~~l~  138 (720)
                      .+|+.|+|++|.|+..-... ...+++|+.|+|++|+|+..-...+       ..+|+.|+|++|.|+.    .++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            68999999999997543323 3346789999999999975433332       1579999999999974    2455567


Q ss_pred             cccccccccccccccCC----CCCchhcCCCCCceEeccCCcccc----cCCCCCCCCCCCceeeccccccccc
Q 004994          139 RLTQLLDLSLNNNHLNG----GIPDAFHQFTGLINFDLSANNLTG----QLPPSTRNLSSLYSLHLQNNKLSGT  204 (720)
Q Consensus       139 ~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~  204 (720)
                      .+++|++|+|++|.|+.    .++..+..+++|+.|+|++|.|+.    .++..+..+++|+.|+|++|.|+..
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~  254 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE  254 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence            88999999999999974    245667888999999999999975    2445566778999999999999754

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.90  E-value=2.5e-10  Score=130.13  Aligned_cols=128  Identities=9%  Similarity=0.115  Sum_probs=66.2

Q ss_pred             ecCceeEEEecCCcccccCCcCcCCC--CCccEEeccCCc-ccc-cCCCCc--cccCcEEEecCCcCCCC----Ccchhh
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLGDL--ESVINIDLSNNH-IGG-SIPSNL--PVTVRNFSLSGNQLTGS----IPESLS  138 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~~l--~~L~~L~L~~N~-l~g-~ip~~~--~~~L~~L~Ls~N~l~g~----~p~~l~  138 (720)
                      .+++|+.|+|++|.+++..+..+..+  .+|++|+|++|. ++. .++...  .++|++|+|++|.+++.    ++..+.
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~  189 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ  189 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence            45778888888887776554444442  236666666554 110 011000  04566666666665544    333344


Q ss_pred             cccccccccccccccCC----CCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecc
Q 004994          139 RLTQLLDLSLNNNHLNG----GIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQ  197 (720)
Q Consensus       139 ~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  197 (720)
                      ++++|+.|+|++|.+++    .++..+.++++|+.|+|++|.+.+ +|..+.++++|+.|+++
T Consensus       190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~  251 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGG  251 (592)
T ss_dssp             HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEEC
T ss_pred             cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhccc
Confidence            55566666666666542    233334455566666666665552 33444444444444444

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.90  E-value=1.1e-10  Score=133.08  Aligned_cols=167  Identities=9%  Similarity=0.050  Sum_probs=113.1

Q ss_pred             ceeEEEecCCc-ccc-cCCcCcCCCCCccEEeccCCcccccCCCCc----c--ccCcEEEecCCcCC----CCCcchhhc
Q 004994           72 NVTEIRLTGMN-LGG-VLADTLGDLESVINIDLSNNHIGGSIPSNL----P--VTVRNFSLSGNQLT----GSIPESLSR  139 (720)
Q Consensus        72 ~l~~l~L~~n~-l~~-~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~----~--~~L~~L~Ls~N~l~----g~~p~~l~~  139 (720)
                      +|+.|+|++|. ++. .++..+..+++|++|+|++|.+++.-+..+    .  ++|+.|+|++|.++    +.++..+.+
T Consensus       139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~  218 (592)
T 3ogk_B          139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN  218 (592)
T ss_dssp             GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred             cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence            49999999887 221 123334578899999999998875522211    1  68999999999997    344555678


Q ss_pred             ccccccccccccccCCCCCchhcCCCCCceEeccCCccc---ccCCCCCCCCCCCceeeccccccccccccccccc-cce
Q 004994          140 LTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT---GQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LID  215 (720)
Q Consensus       140 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~---g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~  215 (720)
                      +++|+.|+|++|.+.+ +|..+.++++|+.|+++.+...   +..+..+..+++|+.|+++++.....+..+..+. |+.
T Consensus       219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~  297 (592)
T 3ogk_B          219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRK  297 (592)
T ss_dssp             CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCE
T ss_pred             CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcE
Confidence            8999999999999885 7788888999999998764333   2344566777788888887765444444444443 778


Q ss_pred             EEccCCcCcccCC-cccCCCccccc
Q 004994          216 LNIENNLFSGPIP-EKLLSIPNFRK  239 (720)
Q Consensus       216 l~l~~N~l~g~~p-~~~~~l~~l~~  239 (720)
                      |+|++|.+++... ..+..+++|+.
T Consensus       298 L~Ls~~~l~~~~~~~~~~~~~~L~~  322 (592)
T 3ogk_B          298 LDLLYALLETEDHCTLIQKCPNLEV  322 (592)
T ss_dssp             EEETTCCCCHHHHHHHHTTCTTCCE
T ss_pred             EecCCCcCCHHHHHHHHHhCcCCCE
Confidence            8888877765433 22344444443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.86  E-value=3.8e-09  Score=110.91  Aligned_cols=169  Identities=16%  Similarity=0.202  Sum_probs=121.1

Q ss_pred             cCceeEEEecCCccc--------------------ccCCcCcCC--------CCCccEEeccCCcccccCCC-Ccc--cc
Q 004994           70 FSNVTEIRLTGMNLG--------------------GVLADTLGD--------LESVINIDLSNNHIGGSIPS-NLP--VT  118 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~--------------------~~~~~~~~~--------l~~L~~L~L~~N~l~g~ip~-~~~--~~  118 (720)
                      +++|+.|||++|++.                    ...+..|.+        +++|+.|+|++ +++ .|+. .|.  .+
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~  125 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIK-NIEDAAFKGCDN  125 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCC-EECTTTTTTCTT
T ss_pred             hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-ccc-chhHHHhhcCcc
Confidence            678999999999988                    222345667        89999999998 887 5554 443  68


Q ss_pred             CcEEEecCCcCCCCCcchhhccccccccccccccc----CC----------------------CCCchh-----------
Q 004994          119 VRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHL----NG----------------------GIPDAF-----------  161 (720)
Q Consensus       119 L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l----~g----------------------~~p~~~-----------  161 (720)
                      |+.|+|++|.++...+..|.++.++..+.+..+..    ..                      .++..+           
T Consensus       126 L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~  205 (329)
T 3sb4_A          126 LKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDIN  205 (329)
T ss_dssp             CCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCS
T ss_pred             cceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccc
Confidence            99999999998866667788888777777655321    00                      000000           


Q ss_pred             -----------------cCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccc-ccccccc-cc-eEEccCC
Q 004994          162 -----------------HQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL-NVLEDLH-LI-DLNIENN  221 (720)
Q Consensus       162 -----------------~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~-l~-~l~l~~N  221 (720)
                                       ..+++|+.|+|++|+++..-+..|.+|.+|+.|+|.+| ++... ..+..+. |+ .+++.+ 
T Consensus       206 ~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-  283 (329)
T 3sb4_A          206 FLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-  283 (329)
T ss_dssp             EEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-
T ss_pred             eEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-
Confidence                             13789999999999998555567999999999999998 66554 3466665 88 999988 


Q ss_pred             cCcccCCcccCCCccccccCc
Q 004994          222 LFSGPIPEKLLSIPNFRKDGN  242 (720)
Q Consensus       222 ~l~g~~p~~~~~l~~l~~~~n  242 (720)
                      .++..-+..|.++++|+....
T Consensus       284 ~l~~I~~~aF~~c~~L~~l~l  304 (329)
T 3sb4_A          284 SVTAIEFGAFMGCDNLRYVLA  304 (329)
T ss_dssp             TCCEECTTTTTTCTTEEEEEE
T ss_pred             cceEEchhhhhCCccCCEEEe
Confidence            677445567888877776543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.83  E-value=1.3e-09  Score=113.23  Aligned_cols=187  Identities=18%  Similarity=0.206  Sum_probs=119.3

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCc--eeEEEeEeccCC---eEEEEEe
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGN--IVELIGYCNEHG---QHLLVYD  518 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e  518 (720)
                      .+.++.|.+..||++.    ..+++|+....    .....+.+|.++++.+. +..  +.+++.+....+   ..|+||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            4678999999999863    45888886432    33467889999998884 332  445555544333   4589999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV-------------------------------------  561 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-------------------------------------  561 (720)
                      +++|..+.+...      ..++..++..++.++++.|+.||..                                     
T Consensus        97 ~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           97 KIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             CCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             ccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            999977764321      2345566667777777777777751                                     


Q ss_pred             ------------------CCCCeeecCCCCCCeEEcC--CCCeEEccccCCCCCCCCCCc-cc-------c----cCccc
Q 004994          562 ------------------CEPPIVHGNFKSSNILLDE--KLIVRVSDCGLAPLLFSGSTN-EL-------S----EGLLT  609 (720)
Q Consensus       562 ------------------~~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~~~~~~~~-~~-------~----~~~~~  609 (720)
                                        ..+.++|+|++|.||++++  +..+.|+||+.+..-.....- ..       .    .....
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence                              1235899999999999998  456789999987543211000 00       0    00001


Q ss_pred             cccCCC-CccCCCCCCCccchHhHHHHHHHHHhCCCCC
Q 004994          610 AHGSGA-PEFESGSYSCQSDVYSLGVVMLELLTGRKPY  646 (720)
Q Consensus       610 ~~~~~a-PE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf  646 (720)
                      .++... |+... ......+.|+++.++|++.+|+.+|
T Consensus       251 ~Y~~~~~~~~~~-r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLE-KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHH-HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHH-HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111111 11110 0122368999999999999998776

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.71  E-value=4.7e-10  Score=112.80  Aligned_cols=81  Identities=23%  Similarity=0.342  Sum_probs=50.1

Q ss_pred             EEecCCcCCCCCcc----hhhcccccccccccccccCC--CCCchhcCCCCCceEeccCCcccccCCCCCCCCC--CCce
Q 004994          122 FSLSGNQLTGSIPE----SLSRLTQLLDLSLNNNHLNG--GIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLS--SLYS  193 (720)
Q Consensus       122 L~Ls~N~l~g~~p~----~l~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~--~L~~  193 (720)
                      ++++.|+.. .++.    ...++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|+.
T Consensus       148 l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~  224 (267)
T 3rw6_A          148 IDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEE  224 (267)
T ss_dssp             CCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSE
T ss_pred             ccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcce
Confidence            556666433 2222    22456777777777777776  4456666777777777777777743  2333343  7777


Q ss_pred             eecccccccccc
Q 004994          194 LHLQNNKLSGTL  205 (720)
Q Consensus       194 L~l~~N~l~~~~  205 (720)
                      |+|++|.+++.+
T Consensus       225 L~L~~Npl~~~~  236 (267)
T 3rw6_A          225 LWLDGNSLCDTF  236 (267)
T ss_dssp             EECTTSTTGGGC
T ss_pred             EEccCCcCcccc
Confidence            777777777643

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.60  E-value=2.2e-09  Score=122.23  Aligned_cols=130  Identities=15%  Similarity=0.174  Sum_probs=92.7

Q ss_pred             ecCceeEEEecCCcccccCCcCcC-CCCCccEEeccCC-ccccc-CCCCcc--ccCcEEEecCCcCCCCCcchhh----c
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLG-DLESVINIDLSNN-HIGGS-IPSNLP--VTVRNFSLSGNQLTGSIPESLS----R  139 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N-~l~g~-ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~----~  139 (720)
                      .+++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.  ++|++|+|++|.+++..+..+.    .
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            467899999999999887666665 6889999999988 55532 332221  6899999999998876665554    5


Q ss_pred             ccccccccccccc--cCC-CCCchhcCCCCCceEeccCC-cccccCCCCCCCCCCCceeecccc
Q 004994          140 LTQLLDLSLNNNH--LNG-GIPDAFHQFTGLINFDLSAN-NLTGQLPPSTRNLSSLYSLHLQNN  199 (720)
Q Consensus       140 l~~L~~L~l~~N~--l~g-~~p~~~~~l~~L~~L~ls~N-~l~g~~p~~~~~l~~L~~L~l~~N  199 (720)
                      +++|+.|+|++|.  ++. .++.-+.++++|+.|+|++| .++ .+|..+.++++|+.|+++.+
T Consensus       183 ~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~  245 (594)
T 2p1m_B          183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGY  245 (594)
T ss_dssp             CCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBC
T ss_pred             CCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccc
Confidence            6689999999887  221 11122345789999999988 444 36666777777777775544

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.59  E-value=1.7e-09  Score=123.11  Aligned_cols=155  Identities=16%  Similarity=0.198  Sum_probs=110.6

Q ss_pred             eEeecCceeEEEecCCcccc---cCCcC------------cCCCCCccEEeccCCcccccCCCCcc---ccCcEEEecCC
Q 004994           66 VFCVFSNVTEIRLTGMNLGG---VLADT------------LGDLESVINIDLSNNHIGGSIPSNLP---VTVRNFSLSGN  127 (720)
Q Consensus        66 v~c~~~~l~~l~L~~n~l~~---~~~~~------------~~~l~~L~~L~L~~N~l~g~ip~~~~---~~L~~L~Ls~N  127 (720)
                      ++..+++|+.|+|+++....   ..|..            ...+++|+.|+|++|.+++..+..+.   ++|+.|+|++|
T Consensus        61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~  140 (594)
T 2p1m_B           61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC  140 (594)
T ss_dssp             HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred             HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence            44568899999999986432   22222            34688999999999999877666663   69999999999


Q ss_pred             -cCCCC-CcchhhcccccccccccccccCCCCCchhc----CCCCCceEeccCCc--ccc-cCCCCCCCCCCCceeeccc
Q 004994          128 -QLTGS-IPESLSRLTQLLDLSLNNNHLNGGIPDAFH----QFTGLINFDLSANN--LTG-QLPPSTRNLSSLYSLHLQN  198 (720)
Q Consensus       128 -~l~g~-~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~----~l~~L~~L~ls~N~--l~g-~~p~~~~~l~~L~~L~l~~  198 (720)
                       .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|+.|+|++|.  ++. .++..+.++++|+.|+|++
T Consensus       141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~  220 (594)
T 2p1m_B          141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNR  220 (594)
T ss_dssp             EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCT
T ss_pred             CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCC
Confidence             56532 555566899999999999999876555554    66799999999997  221 1222234579999999999


Q ss_pred             c-cccccccccccc-ccceEEccC
Q 004994          199 N-KLSGTLNVLEDL-HLIDLNIEN  220 (720)
Q Consensus       199 N-~l~~~~~~~~~~-~l~~l~l~~  220 (720)
                      | .+.+.+..+..+ .|++|+++.
T Consensus       221 ~~~~~~l~~~~~~~~~L~~L~l~~  244 (594)
T 2p1m_B          221 AVPLEKLATLLQRAPQLEELGTGG  244 (594)
T ss_dssp             TSCHHHHHHHHHHCTTCSEEECSB
T ss_pred             CCcHHHHHHHHhcCCcceEccccc
Confidence            8 455533334443 378887543

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.57  E-value=2.3e-07  Score=99.81  Aligned_cols=167  Identities=13%  Similarity=0.142  Sum_probs=110.5

Q ss_pred             ceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCC-Ccc--ccCcEEEecCCcCCCCCcchhhcc
Q 004994           64 QGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS-NLP--VTVRNFSLSGNQLTGSIPESLSRL  140 (720)
Q Consensus        64 ~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~-~~~--~~L~~L~Ls~N~l~g~~p~~l~~l  140 (720)
                      .+.|..+.+|+.++|.+|+++......|. ..+|+.+.|.+| +. .|+. .|.  .+|+.|+|..| ++..-...|.+ 
T Consensus       173 ~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-  247 (401)
T 4fdw_A          173 EDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-  247 (401)
T ss_dssp             SSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-
T ss_pred             HHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-
Confidence            35666778999999999999866666666 588999998854 66 4444 333  57888888875 55344455666 


Q ss_pred             cccccccccccccCCCCCchhcCCCCCceEeccCCccc-----ccCCCCCCCCCCCceeecccccccccc-cccccc-cc
Q 004994          141 TQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT-----GQLPPSTRNLSSLYSLHLQNNKLSGTL-NVLEDL-HL  213 (720)
Q Consensus       141 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~-~l  213 (720)
                      .+|+.+.| .|.++..-..+|.+|++|+.+++.+|.+.     ..-+..|.+|++|+.++|.+ .++... ..+..+ .|
T Consensus       248 ~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L  325 (401)
T 4fdw_A          248 SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKV  325 (401)
T ss_dssp             CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSC
T ss_pred             CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCc
Confidence            67888888 44565445667888888888888877764     23456778888888888874 455443 234443 47


Q ss_pred             ceEEccCCcCcccCCcccCCCccccc
Q 004994          214 IDLNIENNLFSGPIPEKLLSIPNFRK  239 (720)
Q Consensus       214 ~~l~l~~N~l~g~~p~~~~~l~~l~~  239 (720)
                      +.++|.+| ++..-+..|.++ +|+.
T Consensus       326 ~~l~lp~~-l~~I~~~aF~~~-~L~~  349 (401)
T 4fdw_A          326 TQLTIPAN-VTQINFSAFNNT-GIKE  349 (401)
T ss_dssp             CEEEECTT-CCEECTTSSSSS-CCCE
T ss_pred             cEEEECcc-ccEEcHHhCCCC-CCCE
Confidence            78888554 553333455554 4443

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.54  E-value=2.4e-08  Score=105.60  Aligned_cols=156  Identities=15%  Similarity=0.199  Sum_probs=100.7

Q ss_pred             ecCceeEEEecCCccc---------ccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhh-
Q 004994           69 VFSNVTEIRLTGMNLG---------GVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLS-  138 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~---------~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~-  138 (720)
                      .+++|+.|.+.++...         +.+...+..+++|+.|+|++|.-. .+|..-..+|+.|+|..|.++...-..+. 
T Consensus       137 ~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~~~~~~L~~L~L~~~~l~~~~l~~l~~  215 (362)
T 2ra8_A          137 KFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGKKPRPNLKSLEIISGGLPDSVVEDILG  215 (362)
T ss_dssp             HHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCSCBCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred             hcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eeccccCCCCcEEEEecCCCChHHHHHHHH
Confidence            4578889988765431         224455677889999999887311 34442136899999988887644434454 


Q ss_pred             -cccccccccccc--cccCCC-----CCchh--cCCCCCceEeccCCcccccCCCCC---CCCCCCceeecccccccccc
Q 004994          139 -RLTQLLDLSLNN--NHLNGG-----IPDAF--HQFTGLINFDLSANNLTGQLPPST---RNLSSLYSLHLQNNKLSGTL  205 (720)
Q Consensus       139 -~l~~L~~L~l~~--N~l~g~-----~p~~~--~~l~~L~~L~ls~N~l~g~~p~~~---~~l~~L~~L~l~~N~l~~~~  205 (720)
                       .+++|+.|+|+.  |...+.     +...+  ..+++|+.|+|++|.+....+..+   ..+++|+.|+|+.|.|+..-
T Consensus       216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G  295 (362)
T 2ra8_A          216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG  295 (362)
T ss_dssp             SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHH
T ss_pred             ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHH
Confidence             688999998853  332221     11122  247889999999888874332222   35788999999999887531


Q ss_pred             -----cccccc-ccceEEccCCcCcc
Q 004994          206 -----NVLEDL-HLIDLNIENNLFSG  225 (720)
Q Consensus       206 -----~~~~~~-~l~~l~l~~N~l~g  225 (720)
                           ..+..+ +|+.|+|++|.++.
T Consensus       296 ~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          296 ARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             HHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             HHHHHhhcccCCcceEEECCCCcCCH
Confidence                 222333 48889999888764

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.50  E-value=4.6e-07  Score=97.43  Aligned_cols=163  Identities=17%  Similarity=0.141  Sum_probs=109.9

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccccccc
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN  149 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~  149 (720)
                      +|+.+.|.+ ++...-+.+|.++++|+.++|++|+++ .||....  .+|+.+.|.+| ++..-...|.+|++|+.|+|.
T Consensus       158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~  234 (401)
T 4fdw_A          158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP  234 (401)
T ss_dssp             CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred             CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence            477777775 666666677888888888888888887 5554432  67888888744 664555668888888888887


Q ss_pred             ccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccc-----ccc-cccccc-ccceEEccCCc
Q 004994          150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS-----GTL-NVLEDL-HLIDLNIENNL  222 (720)
Q Consensus       150 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-----~~~-~~~~~~-~l~~l~l~~N~  222 (720)
                      +| ++..-..+|.+ .+|+.+.| .|+++..-+.+|.+|++|+.+++.+|.+.     ... ..+..+ .|+.++|.+ .
T Consensus       235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~  310 (401)
T 4fdw_A          235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-S  310 (401)
T ss_dssp             TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-T
T ss_pred             CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-c
Confidence            75 44344556666 67888888 45566445667888888888888888775     111 234444 488888874 4


Q ss_pred             CcccCCcccCCCccccccC
Q 004994          223 FSGPIPEKLLSIPNFRKDG  241 (720)
Q Consensus       223 l~g~~p~~~~~l~~l~~~~  241 (720)
                      ++-.-...|.++.+|+...
T Consensus       311 i~~I~~~aF~~c~~L~~l~  329 (401)
T 4fdw_A          311 IRILGQGLLGGNRKVTQLT  329 (401)
T ss_dssp             CCEECTTTTTTCCSCCEEE
T ss_pred             eEEEhhhhhcCCCCccEEE
Confidence            6633334565656655443

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.46  E-value=1.7e-08  Score=101.35  Aligned_cols=106  Identities=18%  Similarity=0.260  Sum_probs=79.7

Q ss_pred             hhccccccc--ccccccccC---CCCCchhcCCCCCceEeccCCcccc--cCCCCCCCCCCCceeeccccccccc--ccc
Q 004994          137 LSRLTQLLD--LSLNNNHLN---GGIPDAFHQFTGLINFDLSANNLTG--QLPPSTRNLSSLYSLHLQNNKLSGT--LNV  207 (720)
Q Consensus       137 l~~l~~L~~--L~l~~N~l~---g~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~--~~~  207 (720)
                      |...+.|..  ++++.|+..   +.++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  +..
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~  216 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK  216 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhh
Confidence            555566665  778888543   2233333578999999999999997  5667778999999999999999985  344


Q ss_pred             ccccccceEEccCCcCcccCCc-------ccCCCccccccCc
Q 004994          208 LEDLHLIDLNIENNLFSGPIPE-------KLLSIPNFRKDGN  242 (720)
Q Consensus       208 ~~~~~l~~l~l~~N~l~g~~p~-------~~~~l~~l~~~~n  242 (720)
                      +..+.|++|+|++|.+++.+|.       .+..+++|+.++.
T Consensus       217 l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LDg  258 (267)
T 3rw6_A          217 IKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDG  258 (267)
T ss_dssp             GTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEESS
T ss_pred             cccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeECC
Confidence            5555799999999999998873       2556677765543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.36  E-value=6e-08  Score=102.60  Aligned_cols=155  Identities=14%  Similarity=0.199  Sum_probs=106.0

Q ss_pred             eeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc----ccCcEEEecC--CcCCCC-----C
Q 004994           65 GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP----VTVRNFSLSG--NQLTGS-----I  133 (720)
Q Consensus        65 gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~----~~L~~L~Ls~--N~l~g~-----~  133 (720)
                      .+...+++|+.|+|++|.-. .++. +. +++|+.|+|..|.++...-..+.    ++|+.|+|+.  |...|.     +
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l  242 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF  242 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred             HHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence            33445689999999988311 2343 43 89999999999888643222221    5899999863  332222     1


Q ss_pred             cchh--hcccccccccccccccCCCCCchhc---CCCCCceEeccCCccccc----CCCCCCCCCCCceeeccccccccc
Q 004994          134 PESL--SRLTQLLDLSLNNNHLNGGIPDAFH---QFTGLINFDLSANNLTGQ----LPPSTRNLSSLYSLHLQNNKLSGT  204 (720)
Q Consensus       134 p~~l--~~l~~L~~L~l~~N~l~g~~p~~~~---~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~  204 (720)
                      ...+  ..+++|+.|+|++|.+.+..+..+.   .+++|+.|+|+.|.|++.    ++..+.++++|+.|+|++|.++..
T Consensus       243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~  322 (362)
T 2ra8_A          243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE  322 (362)
T ss_dssp             GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred             HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence            1122  2478999999999998754444443   478999999999999863    555667789999999999998754


Q ss_pred             c-ccccccccceEEccCCc
Q 004994          205 L-NVLEDLHLIDLNIENNL  222 (720)
Q Consensus       205 ~-~~~~~~~l~~l~l~~N~  222 (720)
                      . ..+...-...+++++|+
T Consensus       323 ~~~~l~~alg~~~~~~~~~  341 (362)
T 2ra8_A          323 MKKELQKSLPMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHHHCCSEEECCSBC
T ss_pred             HHHHHHHHcCCEEEecCCc
Confidence            2 22332114568888876

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.36  E-value=2e-08  Score=95.92  Aligned_cols=63  Identities=16%  Similarity=0.279  Sum_probs=27.9

Q ss_pred             cccccccccccccccCCC----CCchhcCCCCCceEec--cCCccccc----CCCCCCCCCCCceeecccccc
Q 004994          139 RLTQLLDLSLNNNHLNGG----IPDAFHQFTGLINFDL--SANNLTGQ----LPPSTRNLSSLYSLHLQNNKL  201 (720)
Q Consensus       139 ~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l--s~N~l~g~----~p~~~~~l~~L~~L~l~~N~l  201 (720)
                      ..++|++|+|++|.|+..    +...+...++|++|+|  ++|.|+..    +...+...++|+.|+|++|.+
T Consensus        91 ~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i  163 (185)
T 1io0_A           91 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  163 (185)
T ss_dssp             HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             hCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence            334455555555554421    2233444445555555  44555421    222233334455555555544

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.34  E-value=4.4e-08  Score=93.49  Aligned_cols=110  Identities=19%  Similarity=0.312  Sum_probs=86.9

Q ss_pred             ecCceeEEEecCC-cccc----cCCcCcCCCCCccEEeccCCcccccC----CCCcc--ccCcEEEecCCcCCCC----C
Q 004994           69 VFSNVTEIRLTGM-NLGG----VLADTLGDLESVINIDLSNNHIGGSI----PSNLP--VTVRNFSLSGNQLTGS----I  133 (720)
Q Consensus        69 ~~~~l~~l~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~g~i----p~~~~--~~L~~L~Ls~N~l~g~----~  133 (720)
                      ..++|++|+|++| .+..    .+...+...++|++|+|++|+|...-    ...+.  .+|++|+|++|.|+..    +
T Consensus        34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l  113 (185)
T 1io0_A           34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL  113 (185)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred             cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence            3568999999999 8874    24566778899999999999997432    22222  5799999999999853    4


Q ss_pred             cchhhcccccccccc--cccccCCC----CCchhcCCCCCceEeccCCccc
Q 004994          134 PESLSRLTQLLDLSL--NNNHLNGG----IPDAFHQFTGLINFDLSANNLT  178 (720)
Q Consensus       134 p~~l~~l~~L~~L~l--~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~  178 (720)
                      ...+...++|+.|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus       114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            566777889999999  88999743    4455667799999999999985

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.30  E-value=4e-06  Score=86.66  Aligned_cols=135  Identities=17%  Similarity=0.181  Sum_probs=88.4

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCC---ceeEEEeEec-cCCeEEEEEeeCC
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG---NIVELIGYCN-EHGQHLLVYDYGG  521 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~  521 (720)
                      +.++.|....||+.    |..+++|+-..    ......+..|.++++.+.+.   .+.+++.++. ..+..++||||++
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            56788888899998    56688887532    23346788999999999753   3566777764 4567889999999


Q ss_pred             CCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 004994          522 NCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV----------------------------------------  561 (720)
Q Consensus       522 ~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~----------------------------------------  561 (720)
                      |..+.+...      ..++...+..++.++++.|..||..                                        
T Consensus        97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            977765211      0112222222333333333333321                                        


Q ss_pred             -----------------CCCCeeecCCCCCCeEEcC---CCC-eEEccccCCCC
Q 004994          562 -----------------CEPPIVHGNFKSSNILLDE---KLI-VRVSDCGLAPL  594 (720)
Q Consensus       562 -----------------~~~~ivHrDlkp~NiLl~~---~~~-~kl~DFGla~~  594 (720)
                                       ..+.++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             3346799999999999987   455 48999998743

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.30  E-value=3.2e-06  Score=85.60  Aligned_cols=134  Identities=15%  Similarity=0.165  Sum_probs=92.7

Q ss_pred             eeccCCCc-eEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          447 FIGEGLLG-SVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       447 ~lg~G~~g-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      .+..|..+ .||+.... ++..+++|+-..     .....+.+|.+.|+.+. +--+.++++++.+.+..++|||++++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            45566666 58998654 567889998643     23456788999988884 334678899998889999999999998


Q ss_pred             CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 004994          524 TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC-----------------------------------------  562 (720)
Q Consensus       524 sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~-----------------------------------------  562 (720)
                      ++.+......        .....+..++++.|.-||...                                         
T Consensus       106 ~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          106 TAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             EHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             cccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            8776542111        112234444444444444321                                         


Q ss_pred             --------------CCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          563 --------------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       563 --------------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                                    ...++|+|+.+.|||+++++.+-|.||+.+.
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                          1237999999999999988777899999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.90  E-value=5.1e-05  Score=79.45  Aligned_cols=141  Identities=18%  Similarity=0.239  Sum_probs=77.8

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC--CCceeEEEe------EeccCCeEEEEE
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR--HGNIVELIG------YCNEHGQHLLVY  517 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~------~~~~~~~~~lv~  517 (720)
                      +.|+.|..+.||++...+| .+++|+....      ......|.++++.+.  .-.+.+++.      +....+..++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            3455577899999987665 4899998642      122333444444432  112333333      112456789999


Q ss_pred             eeCCCCCHH--------------HHhhccchh---c-------cccCHHHHH----------------------------
Q 004994          518 DYGGNCTLH--------------DLLHSDEEA---H-------KKFSWNIRI----------------------------  545 (720)
Q Consensus       518 e~~~~gsL~--------------~~l~~~~~~---~-------~~~~~~~~~----------------------------  545 (720)
                      +|++|..+.              ..+|.....   .       ..-.|....                            
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            999985432              011111000   0       011232110                            


Q ss_pred             ---HHHHHHHHHHHHHHh----------cCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          546 ---RVALGAARALQYLQE----------VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       546 ---~i~~~ia~~L~~LH~----------~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                         .+...+.+++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence               011123345666663          124689999999999999888899999999763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.89  E-value=5.1e-05  Score=80.08  Aligned_cols=81  Identities=7%  Similarity=-0.035  Sum_probs=54.3

Q ss_pred             Cee-ccCCCceEEEEEeC-------CCcEEEEEEeccccc-ccccHHHHHHHHHHHHccC-C--CceeEEEeEeccC---
Q 004994          446 NFI-GEGLLGSVYKAELP-------GGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLR-H--GNIVELIGYCNEH---  510 (720)
Q Consensus       446 ~~l-g~G~~g~Vy~~~~~-------~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~---  510 (720)
                      +.| +.|....+|+....       +++.+++|+...... .......+.+|+++++.+. +  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78889999998664       267889998654320 0001134667777777774 2  3577788887665   


Q ss_pred             CeEEEEEeeCCCCCHH
Q 004994          511 GQHLLVYDYGGNCTLH  526 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~  526 (720)
                      +..++||||+++..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            4678999999986654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.68  E-value=9.7e-05  Score=79.24  Aligned_cols=77  Identities=14%  Similarity=0.024  Sum_probs=49.4

Q ss_pred             CCeeccCCCceEEEEEeC-CCcEEEEEEeccccc--c---cccHHHHHHHHHHHHccCC--C-ceeEEEeEeccCCeEEE
Q 004994          445 GNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVS--Q---RQTDEEFLELASTISRLRH--G-NIVELIGYCNEHGQHLL  515 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~---~~~~~~~~~e~~~l~~l~H--~-niv~l~~~~~~~~~~~l  515 (720)
                      .+.+|.|.++.||++... +++.|+||.......  .   ......+..|.++++.+..  + .+.+++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            357899999999999654 468899998753221  0   1123456778888887732  3 445666553  334689


Q ss_pred             EEeeCCCC
Q 004994          516 VYDYGGNC  523 (720)
Q Consensus       516 v~e~~~~g  523 (720)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.63  E-value=0.00031  Score=72.37  Aligned_cols=138  Identities=17%  Similarity=0.187  Sum_probs=90.4

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC---CCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR---HGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.|+.|....+|+... ++..+++|+....     ....+..|.+.|+.+.   ...+.++++++...+..++||||+++
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            5689999999999976 4667888987532     3567888888888873   35688899988888899999999998


Q ss_pred             CCHH--------H---Hhhccch-h-------------c----cccCHHHHH---HHHH--H--------------HH-H
Q 004994          523 CTLH--------D---LLHSDEE-A-------------H----KKFSWNIRI---RVAL--G--------------AA-R  553 (720)
Q Consensus       523 gsL~--------~---~l~~~~~-~-------------~----~~~~~~~~~---~i~~--~--------------ia-~  553 (720)
                      ..+.        +   .+|.... .             .    -.-+|....   ++..  +              +. +
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7542        1   1222110 0             0    012454321   1111  1              11 1


Q ss_pred             HHHHHHh-cCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          554 ALQYLQE-VCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       554 ~L~~LH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                      ....|.. ...+.+||+|+.+.|++++.++ +.|.||.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1223321 2256799999999999999887 8899974

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.53  E-value=9.5e-05  Score=65.54  Aligned_cols=56  Identities=29%  Similarity=0.428  Sum_probs=40.0

Q ss_pred             EEeccCCccc-ccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccccccC
Q 004994           99 NIDLSNNHIG-GSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLN  154 (720)
Q Consensus        99 ~L~L~~N~l~-g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~  154 (720)
                      .++.++++|+ ..+|..++.+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5677777775 4677777778888888888888544455677777777777777664

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.40  E-value=0.00062  Score=69.35  Aligned_cols=75  Identities=20%  Similarity=0.236  Sum_probs=54.2

Q ss_pred             CCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCC---CceeEEEeEeccCCeEEEEEeeC
Q 004994          444 EGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH---GNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       444 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H---~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      ..+.+|.|..+.||+.+..||+.|++|+-....  ......|..|.+.|+.+.-   --+.+++++..    .++||||+
T Consensus        19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~lv~e~l   92 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RTLAMEWV   92 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TEEEEECC
T ss_pred             EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEeccC----ceEEEEee
Confidence            346789999999999999999999999875432  2223467889888888742   23555666532    37899998


Q ss_pred             CCCC
Q 004994          521 GNCT  524 (720)
Q Consensus       521 ~~gs  524 (720)
                      +.+.
T Consensus        93 ~~~~   96 (288)
T 3f7w_A           93 DERP   96 (288)
T ss_dssp             CCCC
T ss_pred             cccC
Confidence            7754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.34  E-value=0.0008  Score=72.63  Aligned_cols=75  Identities=15%  Similarity=0.128  Sum_probs=45.4

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEeccccc---cc----ccHHHHHHHHHHH-HccCCCceeEEEeEeccCCeEEEE
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVS---QR----QTDEEFLELASTI-SRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---~~----~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      .+.||.|....||++.. +++.++||.......   ..    .....+..|+..+ ....+..+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            35789999999999964 467899995332110   00    1222333333222 222335677777776  4567899


Q ss_pred             EeeC-CC
Q 004994          517 YDYG-GN  522 (720)
Q Consensus       517 ~e~~-~~  522 (720)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.28  E-value=0.0011  Score=68.94  Aligned_cols=142  Identities=15%  Similarity=0.126  Sum_probs=73.0

Q ss_pred             CeeccCCCce-EEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC--CCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGS-VYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR--HGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.|+.|.... +|+....+|..+++|.......     +.+..|+++++.+.  .-.+.+++.+..+.+  +++||++++
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~   96 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD   96 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence            3455555444 6787665467777876543210     12234455555553  224566777755554  689999987


Q ss_pred             CCHHHHhhccch----------------------hccccCHHHHH--------------------HHHHHHHHHHHHHHh
Q 004994          523 CTLHDLLHSDEE----------------------AHKKFSWNIRI--------------------RVALGAARALQYLQE  560 (720)
Q Consensus       523 gsL~~~l~~~~~----------------------~~~~~~~~~~~--------------------~i~~~ia~~L~~LH~  560 (720)
                      ..+.+++.....                      ....++.....                    .....+.+.+..+..
T Consensus        97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~  176 (333)
T 3csv_A           97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS  176 (333)
T ss_dssp             CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred             cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence            776554421100                      00111111000                    000111122222311


Q ss_pred             ---cCCCCeeecCCCCCCeEEcCC----CCeEEccccCCCC
Q 004994          561 ---VCEPPIVHGNFKSSNILLDEK----LIVRVSDCGLAPL  594 (720)
Q Consensus       561 ---~~~~~ivHrDlkp~NiLl~~~----~~~kl~DFGla~~  594 (720)
                         ...+.++|+|+.+.|||++.+    ..+.|.||+.+..
T Consensus       177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence               124579999999999999875    6789999998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.27  E-value=0.00047  Score=71.40  Aligned_cols=159  Identities=13%  Similarity=0.153  Sum_probs=87.6

Q ss_pred             cCHHHHHHHhcCCCCC-----CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCc--eeE
Q 004994          430 FTIASLQQYTNSFSEG-----NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN--IVE  502 (720)
Q Consensus       430 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~  502 (720)
                      ++.+++..+...|...     +.|+.|....+|+....+| .+++|......    ..+.+..|+++++.+....  +.+
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCc
Confidence            4556666666667653     3456688889999987666 57899886421    1123445666666653222  333


Q ss_pred             EEeEe------ccCCeEEEEEeeCCCCCHHH--------------Hhhcc----chh----ccccCHHHHHH--------
Q 004994          503 LIGYC------NEHGQHLLVYDYGGNCTLHD--------------LLHSD----EEA----HKKFSWNIRIR--------  546 (720)
Q Consensus       503 l~~~~------~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~----~~~~~~~~~~~--------  546 (720)
                      ++...      ...+..+++|+|++|..+..              .+|..    ...    .....|.....        
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            33211      12356789999998754311              01110    000    00112332111        


Q ss_pred             ----HHHHHHHHHHHHHhc----CCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          547 ----VALGAARALQYLQEV----CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       547 ----i~~~ia~~L~~LH~~----~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                          +...+.+.+.+++..    ....++|+|+++.|||++++..+.|+||+.+.
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                011244556666543    13469999999999999987666899999763

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.16  E-value=0.003  Score=65.37  Aligned_cols=142  Identities=15%  Similarity=0.155  Sum_probs=81.7

Q ss_pred             CeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCC--ceeEEEeE-----eccCCeEEEEEe
Q 004994          446 NFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG--NIVELIGY-----CNEHGQHLLVYD  518 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~-----~~~~~~~~lv~e  518 (720)
                      ..++ |....||++...+|+.+++|......   ...+.+..|..+++.+...  .+++++..     ....+..+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            3466 88889999987778789999986432   2344566777777776422  24444443     112456789999


Q ss_pred             eCCCCCHH-----HH---------hhccch-----hccccCHHHH----HHH---------------HHHHHHHHHHHHh
Q 004994          519 YGGNCTLH-----DL---------LHSDEE-----AHKKFSWNIR----IRV---------------ALGAARALQYLQE  560 (720)
Q Consensus       519 ~~~~gsL~-----~~---------l~~~~~-----~~~~~~~~~~----~~i---------------~~~ia~~L~~LH~  560 (720)
                      |++|..+.     .+         +|....     ....+++...    ..+               ...+.+.+..+..
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            99874432     11         111000     0011222111    000               1111223333433


Q ss_pred             c----CCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          561 V----CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       561 ~----~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      .    ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            2    234689999999999999 4 89999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.08  E-value=0.0047  Score=63.19  Aligned_cols=71  Identities=15%  Similarity=0.085  Sum_probs=42.2

Q ss_pred             CCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCce-eEEEeEeccCCeEEEEEeeC-CC
Q 004994          445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI-VELIGYCNEHGQHLLVYDYG-GN  522 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~-~~  522 (720)
                      .+.|+.|....+|++     ..+++|+..........   ...|.+.++.+....+ .++++++.+.  -++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~---r~~E~~~l~~l~~~g~~P~~~~~~~~~--~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYIN---RANEAVAAREAAKAGVSPEVLHVDPAT--GVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CCC---HHHHHHHHHHHHHTTSSCCEEEECTTT--CCEEEECCTTC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccceeC---HHHHHHHHHHHHHcCCCCceEEEECCC--CEEEEeecCCC
Confidence            577889999999998     45888887643211111   2346666655532222 4666655433  46899999 55


Q ss_pred             CCH
Q 004994          523 CTL  525 (720)
Q Consensus       523 gsL  525 (720)
                      -.+
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            333

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.07  E-value=9e-05  Score=70.26  Aligned_cols=62  Identities=13%  Similarity=0.148  Sum_probs=29.9

Q ss_pred             ccccccccccccccCCC----CCchhcCCCCCceEeccCC---cccc----cCCCCCCCCCCCceeecccccc
Q 004994          140 LTQLLDLSLNNNHLNGG----IPDAFHQFTGLINFDLSAN---NLTG----QLPPSTRNLSSLYSLHLQNNKL  201 (720)
Q Consensus       140 l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~ls~N---~l~g----~~p~~~~~l~~L~~L~l~~N~l  201 (720)
                      -+.|+.|+|++|.|+..    +-.++..-+.|++|+|++|   .+..    .+-..+..-+.|..|+|+.|.+
T Consensus        97 N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A           97 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             CCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            34455555555555421    2223334455666666654   2221    1223344445667777766654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=96.95  E-value=0.0019  Score=68.90  Aligned_cols=124  Identities=15%  Similarity=0.057  Sum_probs=58.2

Q ss_pred             ecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCC-cc--ccCcEEEecCCcCCCCCcchhhccccccc
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN-LP--VTVRNFSLSGNQLTGSIPESLSRLTQLLD  145 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~-~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~  145 (720)
                      +..+|+++.|.. +++.+-..+|.++++|+.++|.+| ++ .|+.. +.  .+|+.+.+..+ +...-...|.++..+..
T Consensus        69 ~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~  144 (394)
T 4fs7_A           69 GCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEI  144 (394)
T ss_dssp             TCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEE
T ss_pred             CCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecceeeeccccccc
Confidence            456788888863 466555667888888888888654 43 33322 21  34444443322 11122222333222222


Q ss_pred             ccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccc
Q 004994          146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNN  199 (720)
Q Consensus       146 L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N  199 (720)
                      ....+...  .-..+|.++++|+.+.+.++..+ .-...|.++.+|+.+++..|
T Consensus       145 ~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~  195 (394)
T 4fs7_A          145 TIPEGVTV--IGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN  195 (394)
T ss_dssp             ECCTTCCE--ECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT
T ss_pred             ccCccccc--cchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC
Confidence            21111111  11234555555665555544322 33344555555555555444

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.89  E-value=0.0012  Score=70.56  Aligned_cols=145  Identities=10%  Similarity=0.180  Sum_probs=92.2

Q ss_pred             eeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCC-Ccc--ccCcEEEecCCcCCCCCcchhhccccccccccc
Q 004994           73 VTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS-NLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN  149 (720)
Q Consensus        73 l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~-~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~  149 (720)
                      +..+.+. +.+...-..+|.++.+|+.+.+.++..+  |.. .+.  .+|+.+.+. +.++..-...|.+|.+|+.++|.
T Consensus       244 ~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~--I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp  319 (394)
T 4gt6_A          244 DPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS--IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIP  319 (394)
T ss_dssp             CSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE--ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECC
T ss_pred             cceEEcC-CcceEcccceeeecccccEEecccccce--ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeC
Confidence            3344443 3444445567889999999999776543  333 332  679999996 45664555678999999999998


Q ss_pred             ccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccccceEEccCCcCc
Q 004994          150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENNLFS  224 (720)
Q Consensus       150 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~l~l~~N~l~  224 (720)
                      .| ++..-..+|.+|.+|+.+.|..+ ++..-..+|.+|.+|+.+++.+|..... .......|+.+.+..|.+.
T Consensus       320 ~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~~-~~~~~~~L~~i~i~~~~~~  391 (394)
T 4gt6_A          320 EG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQWN-AISTDSGLQNLPVAPGSID  391 (394)
T ss_dssp             TT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHHH-TCBCCCCC-----------
T ss_pred             Cc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeehh-hhhccCCCCEEEeCCCCEE
Confidence            65 55344568999999999999755 6633356799999999999998864321 1222334777777666543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.75  E-value=0.0025  Score=68.06  Aligned_cols=104  Identities=9%  Similarity=0.136  Sum_probs=78.6

Q ss_pred             ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeec
Q 004994          117 VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHL  196 (720)
Q Consensus       117 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  196 (720)
                      .+|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-..+|.++.+|+.++|..| ++..-..+|.+|.+|+.+.|
T Consensus       265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i  341 (394)
T 4gt6_A          265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI  341 (394)
T ss_dssp             SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred             ccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence            57899999877654 556678999999999996 4555444567999999999999865 66344668999999999999


Q ss_pred             ccccccccc-cccccc-ccceEEccCCcCc
Q 004994          197 QNNKLSGTL-NVLEDL-HLIDLNIENNLFS  224 (720)
Q Consensus       197 ~~N~l~~~~-~~~~~~-~l~~l~l~~N~l~  224 (720)
                      ..+ ++..- ..+.+. .|+.+++.+|...
T Consensus       342 p~s-v~~I~~~aF~~C~~L~~i~~~~~~~~  370 (394)
T 4gt6_A          342 PSS-VTKIPESAFSNCTALNNIEYSGSRSQ  370 (394)
T ss_dssp             CTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred             Ccc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence            755 55443 345554 4999999987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.75  E-value=0.0028  Score=68.46  Aligned_cols=70  Identities=13%  Similarity=0.139  Sum_probs=48.1

Q ss_pred             CeeccCCCceEEEEEeCC--------CcEEEEEEecccccccccHHHHHHHHHHHHccCCCc-eeEEEeEeccCCeEEEE
Q 004994          446 NFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN-IVELIGYCNEHGQHLLV  516 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv  516 (720)
                      +.|+.|....+|++...+        ++.+++|+....    ...+.+..|..+++.+...+ ..++++.+.+    .+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            567888889999998753        578999987431    11134557888888774333 3677777653    289


Q ss_pred             EeeCCCC
Q 004994          517 YDYGGNC  523 (720)
Q Consensus       517 ~e~~~~g  523 (720)
                      |||+++-
T Consensus       151 ~e~l~G~  157 (429)
T 1nw1_A          151 EEYIPSR  157 (429)
T ss_dssp             ECCCCEE
T ss_pred             EEEeCCc
Confidence            9999863

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.75  E-value=0.0045  Score=65.38  Aligned_cols=141  Identities=16%  Similarity=0.150  Sum_probs=80.7

Q ss_pred             CeeccCCCceEEEEEeC--------CCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEE
Q 004994          446 NFIGEGLLGSVYKAELP--------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.|..|-...+|++...        +++.|++|+....   ........+|.++++.+. +.-..++++++.+.    +|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cE
Confidence            56777888999999764        2478999986332   123455668888887773 33346677777652    99


Q ss_pred             EeeCCCCCHHHH-----------------hhccc-hhccccC--HHHHHHHHHHHH-------------------HHHHH
Q 004994          517 YDYGGNCTLHDL-----------------LHSDE-EAHKKFS--WNIRIRVALGAA-------------------RALQY  557 (720)
Q Consensus       517 ~e~~~~gsL~~~-----------------l~~~~-~~~~~~~--~~~~~~i~~~ia-------------------~~L~~  557 (720)
                      |||+++..+..-                 +|... ...+...  |.+..++..++.                   +.+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            999987544210                 11110 0011122  333333333221                   12333


Q ss_pred             HHh----c-CCCCeeecCCCCCCeEEcCC----CCeEEccccCCC
Q 004994          558 LQE----V-CEPPIVHGNFKSSNILLDEK----LIVRVSDCGLAP  593 (720)
Q Consensus       558 LH~----~-~~~~ivHrDlkp~NiLl~~~----~~~kl~DFGla~  593 (720)
                      |..    . ....++|+|+.+.||+++.+    +.+.++||..|.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            322    1 23368999999999999876    789999998774

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=96.73  E-value=0.0035  Score=66.83  Aligned_cols=158  Identities=14%  Similarity=0.152  Sum_probs=102.4

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSL  148 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l  148 (720)
                      .+|+.+.+.. .++..-...+..+..|+.+.+..|... .-...+.  ..++.+.+..+.+.   ...|..+.+|+.+.+
T Consensus       230 ~~l~~i~ip~-~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l  304 (394)
T 4fs7_A          230 TGVKNIIIPD-SFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKL  304 (394)
T ss_dssp             CCCCEEEECT-TCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEE
T ss_pred             CCCceEEECC-CceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---ccccccccccccccc
Confidence            4677777764 344444567888899999999877554 2222332  56777777766533   345778888888888


Q ss_pred             cccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccc-cccccc-ccceEEccCCcCccc
Q 004994          149 NNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL-NVLEDL-HLIDLNIENNLFSGP  226 (720)
Q Consensus       149 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~-~l~~l~l~~N~l~g~  226 (720)
                      .+| ++..-..+|.++.+|+.++|.++ ++..-..+|.+|.+|+.++|..| ++..- ..+.+. .|+.+++..| ++ .
T Consensus       305 ~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~  379 (394)
T 4fs7_A          305 LDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-Q  379 (394)
T ss_dssp             CTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-G
T ss_pred             ccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-E
Confidence            765 55344567888899999988754 66344567888899999988776 55433 345554 4888888654 22 2


Q ss_pred             CCcccCCCcccc
Q 004994          227 IPEKLLSIPNFR  238 (720)
Q Consensus       227 ~p~~~~~l~~l~  238 (720)
                      +...|.+.++|+
T Consensus       380 ~~~~F~~c~~L~  391 (394)
T 4fs7_A          380 YRYDFEDTTKFK  391 (394)
T ss_dssp             GGGGBCTTCEEE
T ss_pred             hhheecCCCCCc
Confidence            233454444443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.73  E-value=0.0015  Score=57.62  Aligned_cols=56  Identities=27%  Similarity=0.337  Sum_probs=36.1

Q ss_pred             cccccccccC-CCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccc
Q 004994          145 DLSLNNNHLN-GGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS  202 (720)
Q Consensus       145 ~L~l~~N~l~-g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  202 (720)
                      .++.+++.|+ ..+|..+.  .+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            4566666664 24454322  35777888888887444445677788888888888764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.72  E-value=0.00024  Score=66.04  Aligned_cols=83  Identities=11%  Similarity=0.196  Sum_probs=49.2

Q ss_pred             cCcEEEecCCcCCCCCcchhhcccccccccccccc-cCCCCCchhcCC----CCCceEeccCCc-ccccCCCCCCCCCCC
Q 004994          118 TVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNH-LNGGIPDAFHQF----TGLINFDLSANN-LTGQLPPSTRNLSSL  191 (720)
Q Consensus       118 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~L~ls~N~-l~g~~p~~~~~l~~L  191 (720)
                      +|+.|||+++.++..--..+.++++|+.|+|+++. ++..-=..++.+    ++|++|+|+++. +|..-=..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45555555555543333446677788888888774 543211224443    368888888764 653211235667888


Q ss_pred             ceeeccccc
Q 004994          192 YSLHLQNNK  200 (720)
Q Consensus       192 ~~L~l~~N~  200 (720)
                      +.|+|++..
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            888888764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.68  E-value=0.00016  Score=68.63  Aligned_cols=87  Identities=20%  Similarity=0.255  Sum_probs=46.2

Q ss_pred             hcccccccccccccccCC----CCCchhcCCCCCceEeccCCcccc----cCCCCCCCCCCCceeecccc---ccccc--
Q 004994          138 SRLTQLLDLSLNNNHLNG----GIPDAFHQFTGLINFDLSANNLTG----QLPPSTRNLSSLYSLHLQNN---KLSGT--  204 (720)
Q Consensus       138 ~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g----~~p~~~~~l~~L~~L~l~~N---~l~~~--  204 (720)
                      ..-+.|+.|+|++|+|..    .+-..+..-+.|+.|+|++|.|+.    .+-..+..-+.|+.|+|++|   .+...  
T Consensus        67 ~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~  146 (197)
T 1pgv_A           67 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE  146 (197)
T ss_dssp             TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred             hhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHH
Confidence            333455555555555542    233344455677777777777763    13334455556777777754   33211  


Q ss_pred             --c-ccc-cccccceEEccCCcCc
Q 004994          205 --L-NVL-EDLHLIDLNIENNLFS  224 (720)
Q Consensus       205 --~-~~~-~~~~l~~l~l~~N~l~  224 (720)
                        + ..+ .+..|..|+++.|.+.
T Consensus       147 ~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          147 MDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHHHhCCCcCeEeccCCCcc
Confidence              1 112 2334777777766543

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=96.67  E-value=0.0037  Score=66.21  Aligned_cols=129  Identities=12%  Similarity=0.091  Sum_probs=80.3

Q ss_pred             cCCcCcCCCCCccEEeccCCcccccCCC-Ccc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhc
Q 004994           86 VLADTLGDLESVINIDLSNNHIGGSIPS-NLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFH  162 (720)
Q Consensus        86 ~~~~~~~~l~~L~~L~L~~N~l~g~ip~-~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~  162 (720)
                      .....+....+|+.+.+..+ +. .+.. .+.  .+|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-..+|.
T Consensus       208 i~~~~f~~~~~l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~  283 (379)
T 4h09_A          208 VTAYGFSYGKNLKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCS  283 (379)
T ss_dssp             ECTTTTTTCSSCSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTT
T ss_pred             Eeecccccccccceeeeccc-ee-EEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccc
Confidence            34456667777888877654 33 2322 222  56788888765 54344556777888888877654 4433345678


Q ss_pred             CCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccc-cccccc-ccceEEcc
Q 004994          163 QFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTL-NVLEDL-HLIDLNIE  219 (720)
Q Consensus       163 ~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~-~l~~l~l~  219 (720)
                      ++.+|+.+.+.+|.++..-..+|.++.+|+.+.|..+ ++..- ..+.+. .|+.+.+.
T Consensus       284 ~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip  341 (379)
T 4h09_A          284 GCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP  341 (379)
T ss_dssp             TCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             cccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence            8888888888888777444567788888888888654 44332 234443 36665543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.62  E-value=0.0092  Score=64.75  Aligned_cols=72  Identities=8%  Similarity=0.039  Sum_probs=46.0

Q ss_pred             CeeccCCCceEEEEEeCC-CcEEEEEEecccccccccHHHHHHHHHHHHccCCCce-eEEEeEeccCCeEEEEEeeCCCC
Q 004994          446 NFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI-VELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      +.|+.|-...+|++...+ +..+++|+..........   -..|..+++.+...++ .++++++..    .+||||+++-
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~  186 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGY  186 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCc
Confidence            567888889999998765 578889987543211111   1467778887754444 567777742    2599999874


Q ss_pred             C
Q 004994          524 T  524 (720)
Q Consensus       524 s  524 (720)
                      .
T Consensus       187 ~  187 (458)
T 2qg7_A          187 A  187 (458)
T ss_dssp             E
T ss_pred             c
Confidence            3

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.60  E-value=0.00062  Score=63.22  Aligned_cols=37  Identities=24%  Similarity=0.269  Sum_probs=27.3

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCc-cc
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNH-IG  108 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~  108 (720)
                      +|++|||+++.++..--..+..+++|+.|+|+++. |+
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~It   99 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIE   99 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccC
Confidence            68889998888765433456778888888888774 55

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=96.32  E-value=0.006  Score=64.56  Aligned_cols=126  Identities=15%  Similarity=0.167  Sum_probs=95.0

Q ss_pred             ecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCC-cc--ccCcEEEecCCcCCCCCcchhhccccccc
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN-LP--VTVRNFSLSGNQLTGSIPESLSRLTQLLD  145 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~-~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~  145 (720)
                      ...+++.+.+..+ +...-...+.++..|+.+.+..+ ++ .|... +.  .+|+.+.+..+ ++..-...|.+|++|+.
T Consensus       215 ~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~  290 (379)
T 4h09_A          215 YGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTK  290 (379)
T ss_dssp             TCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCE
T ss_pred             cccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceecccccccccccccc
Confidence            3456777877644 55455678889999999999876 54 44433 32  57999999755 55344567899999999


Q ss_pred             ccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccc
Q 004994          146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNN  199 (720)
Q Consensus       146 L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N  199 (720)
                      +.+.+|.++..-..+|.++.+|+.+.|.++ ++..-..+|.+|.+|+.+.+..|
T Consensus       291 i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          291 VVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             EEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             ccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            999999888555678999999999999765 66344567999999999998655

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.27  E-value=0.016  Score=61.05  Aligned_cols=72  Identities=10%  Similarity=0.050  Sum_probs=41.6

Q ss_pred             CeeccCCCceEEEEEeCC---------CcEEEEEEecccccccccHHHHHHHHHHHHccCCCc-eeEEEeEeccCCeEEE
Q 004994          446 NFIGEGLLGSVYKAELPG---------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN-IVELIGYCNEHGQHLL  515 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~l  515 (720)
                      +.++.|....+|++...+         ++.+++|+.........   ....|.++++.+...+ +.++++...    -++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~---~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~  111 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELY---NTISEFEVYKTMSKYKIAPQLLNTFN----GGR  111 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTS---CHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcccee---cHHHHHHHHHHHHhcCCCCceEEecC----CcE
Confidence            457778888999997654         26888888754321111   1245666666663223 446666542    268


Q ss_pred             EEeeCCCCC
Q 004994          516 VYDYGGNCT  524 (720)
Q Consensus       516 v~e~~~~gs  524 (720)
                      ||||+++..
T Consensus       112 v~e~i~G~~  120 (369)
T 3c5i_A          112 IEEWLYGDP  120 (369)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEecCCc
Confidence            999998743

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.18  E-value=0.018  Score=59.94  Aligned_cols=31  Identities=16%  Similarity=0.275  Sum_probs=27.3

Q ss_pred             CCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          564 PPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       564 ~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      ..++|+|+.+.||++++++.+.|.||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999987643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.95  E-value=0.043  Score=52.21  Aligned_cols=100  Identities=13%  Similarity=0.082  Sum_probs=64.6

Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      -+|.++|..   ...+++..+...++.|.+++|.-+-.... + ..+=+-|..|++..+|.|...+ +.+.         
T Consensus        33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence            378888863   45789999999999999888766522101 1 1223346899999999988764 2110         


Q ss_pred             cccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhC
Q 004994          603 LSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTG  642 (720)
Q Consensus       603 ~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG  642 (720)
                           .....+.+||......+.+.=|||+|+++|.-+--
T Consensus        98 -----~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 -----AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             --------------CCSSSSSCHHHHHHHHHHHHHHHHTT
T ss_pred             -----ccccCCCChhhccccchHHHHHHHHHHHHHHHhhc
Confidence                 01123557887655567889999999999998853

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.37  E-value=0.33  Score=51.78  Aligned_cols=72  Identities=10%  Similarity=0.006  Sum_probs=45.2

Q ss_pred             CeeccCCCceEEEEEeCC--------CcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEE
Q 004994          446 NFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.+..|-...+|+....+        ++.|++|+.........+   -.+|.++++.+. +.-..++++.+..    ++|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~id---R~~E~~~l~~L~~~gi~P~l~~~~~~----~~I  148 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYD---SKVELDVFRYLSNINIAPNIIADFPE----GRI  148 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCC---HHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcC---HHHHHHHHHHHHhcCCCCCEEEEcCC----CEE
Confidence            457778889999997753        578999986543211112   235666666653 2224566665432    689


Q ss_pred             EeeCCCCC
Q 004994          517 YDYGGNCT  524 (720)
Q Consensus       517 ~e~~~~gs  524 (720)
                      |||+++..
T Consensus       149 ~efI~G~~  156 (424)
T 3mes_A          149 EEFIDGEP  156 (424)
T ss_dssp             EECCCSEE
T ss_pred             EEEeCCcc
Confidence            99999854

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.79  E-value=0.57  Score=31.85  Aligned_cols=24  Identities=8%  Similarity=0.184  Sum_probs=9.8

Q ss_pred             HHHHHHHHHHHHHHHHHHHHhhcc
Q 004994          302 SAAAILCALGCSLFMWRYCKTRRV  325 (720)
Q Consensus       302 i~~~~~~~l~~~~~~~~~~~~r~~  325 (720)
                      +++++++++++++..|++.|+|++
T Consensus        16 VVgGv~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A           16 VIGGLFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             ehHHHHHHHHHHHHHHHHhhhhhh
Confidence            333333333333344444544433

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=87.90  E-value=0.56  Score=31.97  Aligned_cols=12  Identities=17%  Similarity=0.229  Sum_probs=5.2

Q ss_pred             HHHHHHHHHhhc
Q 004994          313 SLFMWRYCKTRR  324 (720)
Q Consensus       313 ~~~~~~~~~~r~  324 (720)
                      ++.+|++.|+|+
T Consensus        28 ~~~~~~~~RRr~   39 (44)
T 2ks1_B           28 ALGIGLFMRRRH   39 (44)
T ss_dssp             HHHHHHHHHTTT
T ss_pred             HHHHHHHhhhhH
Confidence            333344444443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.33  E-value=1.8  Score=45.81  Aligned_cols=28  Identities=29%  Similarity=0.418  Sum_probs=23.9

Q ss_pred             eeecCCCCCCeEE------cCCCCeEEccccCCC
Q 004994          566 IVHGNFKSSNILL------DEKLIVRVSDCGLAP  593 (720)
Q Consensus       566 ivHrDlkp~NiLl------~~~~~~kl~DFGla~  593 (720)
                      ++|+|+.+.|||+      +++..++++||-.|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      456779999998874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.09  E-value=0.95  Score=42.94  Aligned_cols=116  Identities=11%  Similarity=0.139  Sum_probs=78.7

Q ss_pred             cCCCceeEEEeEeccCCeEEEEEeeCCCC-CHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 004994          495 LRHGNIVELIGYCNEHGQHLLVYDYGGNC-TLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKS  573 (720)
Q Consensus       495 l~H~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp  573 (720)
                      ..||+.+.. .+-.+.+.+.+.|+.-+.+ ++..        -+.++...+++++..++....+++.     -+|--|.|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~--------ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P  107 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN--------IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP  107 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG--------GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH--------HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence            368988876 4555666666666654422 2221        3456778899999998887766554     37889999


Q ss_pred             CCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCC
Q 004994          574 SNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYD  647 (720)
Q Consensus       574 ~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~  647 (720)
                      +||++|.++.+++.-.|+-..+.                   |.    ..+...=+-.+=+++..+++++..|+
T Consensus       108 ~NL~f~~~~~p~i~~RGik~~l~-------------------P~----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQNVVD-------------------PL----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGEEECTTSCEEESCCEETTTBS-------------------CC----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             ceEEEcCCCCEEEEEccCccCCC-------------------CC----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999999888754332                   21    11212223346678888999998884

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.67  E-value=1.9  Score=41.03  Aligned_cols=114  Identities=14%  Similarity=0.128  Sum_probs=74.2

Q ss_pred             CCCceeEEEeEeccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHH-HHHhcCCCCeeecCCCCC
Q 004994          496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ-YLQEVCEPPIVHGNFKSS  574 (720)
Q Consensus       496 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~-~LH~~~~~~ivHrDlkp~  574 (720)
                      .||++  -...-.+.+.+.+.|+.-+++.=...+       +.++...+++++..++.... +++     .-+|--+.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence            68888  333446667777777765443222222       34667788888888776555 443     4588899999


Q ss_pred             CeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccCCCCCCCccc-hHhHHHHHHHHHhCCCCCC
Q 004994          575 NILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSD-VYSLGVVMLELLTGRKPYD  647 (720)
Q Consensus       575 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~D-v~S~Gvvl~elltG~~Pf~  647 (720)
                      ||++|.++.+++.-.|+-..+                   +|.-    .+ ..| +-.+=+++..++.++..|+
T Consensus       114 NL~f~~~~~p~i~hRGi~~~l-------------------pP~e----~~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESL-------------------PPDE----WD-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTB-------------------SSCS----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCcccC-------------------CCCC----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999988875433                   2211    11 122 2245677778888887774

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=84.56  E-value=2.2  Score=28.92  Aligned_cols=6  Identities=33%  Similarity=0.451  Sum_probs=2.6

Q ss_pred             HHHhhc
Q 004994          319 YCKTRR  324 (720)
Q Consensus       319 ~~~~r~  324 (720)
                      |.|||+
T Consensus        34 ~~RRR~   39 (44)
T 2jwa_A           34 LIKRRQ   39 (44)
T ss_dssp             HHHHHC
T ss_pred             heehhh
Confidence            444443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.99  E-value=0.11  Score=56.24  Aligned_cols=60  Identities=3%  Similarity=-0.038  Sum_probs=16.0

Q ss_pred             CCeeccCCCceEEEEEeCC-CcEEEE------EEecccccccccHHHHHHHHHHHHccCCCceeEEEeEe
Q 004994          445 GNFIGEGLLGSVYKAELPG-GKLLAV------KKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC  507 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~-g~~vav------K~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~  507 (720)
                      .+.+|   ||+||+|.+.. ...|||      |..+...........|.+|..+++.++|||+++.+++.
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            35565   99999997754 467888      77664433344456788899999999999999987764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	720
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-50
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-49
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-48
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-46
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-44
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-44
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-44
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-42
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-38
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-38
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-37
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-35
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-34
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-31
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-23
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.001
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.002
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.003
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 1e-58
 Identities = 76/281 (27%), Positives = 122/281 (43%), Gaps = 25/281 (8%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
              + G  IG G  G+VYK +  G   +AVK L+ T    Q  + F      + + RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+  +GY     Q  +V  +    +L+  LH  E    KF     I +A   A+ + YL 
Sbjct: 66  ILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYL- 120

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF- 618
                 I+H + KS+NI L E L V++ D GLA +    S +   E L  +    APE  
Sbjct: 121 --HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 619 ---ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
              +   YS QSDVY+ G+V+ EL+TG+ PY     R +   +        D+  +    
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
             ++              +++ C++ +   RP   +I+  +
Sbjct: 239 PKAM------------KRLMAECLKKKRDERPLFPQILASI 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 6e-55
 Identities = 62/277 (22%), Positives = 112/277 (40%), Gaps = 25/277 (9%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           +  +    IG G  G V+         +A+K +        ++E+F+E A  + +L H  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPK 61

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           +V+L G C E     LV+++  +  L D L +       F+    + + L     + YL 
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYL- 117

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
              E  ++H +  + N L+ E  +++VSD G+   +        +        +    F 
Sbjct: 118 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
              YS +SDV+S GV+M E+ +  K    +R   E          + DI    R+  P L
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGFRLYKPRL 226

Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                    +    I++ C +  P  RP  S +++ L
Sbjct: 227 AS-------THVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 6e-53
 Identities = 54/277 (19%), Positives = 107/277 (38%), Gaps = 25/277 (9%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
            +      +G G  G V+     G   +AVK L        + + FL  A+ + +L+H  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQR 69

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           +V L           ++ +Y  N +L D L +      K + N  + +A   A  + ++ 
Sbjct: 70  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFI- 125

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
              E   +H + +++NIL+ + L  +++D GLA L+                 +      
Sbjct: 126 --EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
            G+++ +SDV+S G+++ E++T  +         E          + +++   RMV P  
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---------IQNLERGYRMVRPD- 233

Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                         ++  C +  P  RP    +   L
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (450), Expect = 5e-51
 Identities = 64/308 (20%), Positives = 120/308 (38%), Gaps = 42/308 (13%)

Query: 427 VSVFTIASLQQYTNSFSE---------GNFIGEGLLGSVYKAELPG----GKLLAVKKLS 473
           +  FT     +    F++            IG G  G V    L         +A+K L 
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63

Query: 474 NTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDE 533
           +  +++Q   +FL  AS + +  H N++ L G   +    +++ ++  N +L   L  + 
Sbjct: 64  SGYTEKQR-RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN- 121

Query: 534 EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP 593
               +F+    + +  G A  ++YL    +   VH +  + NIL++  L+ +VSD GL+ 
Sbjct: 122 --DGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176

Query: 594 LLFSGSTNELSEGLLTAHGS---GAPEF-ESGSYSCQSDVYSLGVVMLELLT-GRKPYDR 648
            L   +++      L         APE  +   ++  SDV+S G+VM E+++ G +PY  
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236

Query: 649 SRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP 708
                                 +   ++            S    ++  C Q +   RP 
Sbjct: 237 MTN-----------------QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 279

Query: 709 MSEIVQDL 716
             +IV  L
Sbjct: 280 FGQIVNTL 287

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 6e-51
 Identities = 55/279 (19%), Positives = 106/279 (37%), Gaps = 27/279 (9%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
              +    +G G  G V   +  G   +A+K +        +++EF+E A  +  L H  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEK 60

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           +V+L G C +     ++ +Y  N  L + L        +F     + +      A++YL 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYL- 116

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF- 618
                  +H +  + N L++++ +V+VSD GL+  +                 S  PE  
Sbjct: 117 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS-PPEVL 173

Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
               +S +SD+++ GV+M E+ +  K         E             I    R+  P 
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---------AEHIAQGLRLYRPH 224

Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
           L       +  +   I+  C   +   RP    ++ ++L
Sbjct: 225 L-------ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-50
 Identities = 62/292 (21%), Positives = 109/292 (37%), Gaps = 33/292 (11%)

Query: 448 IGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC 507
           IG+G  G V++ +  G + +AVK  S   S+ +              LRH NI+  I   
Sbjct: 11  IGKGRFGEVWRGKWRG-EEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 508 NEHGQHL----LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC- 562
           N+         LV DY  + +L D L+         +    I++AL  A  L +L     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 563 ----EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG--STNELSEGLLTAHGSGAP 616
               +P I H + KS NIL+ +     ++D GLA    S   + +      +      AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 617 EF-------ESGSYSCQSDVYSLGVVMLELLTGRKPY----DRSRPRGEQSLVRWAIPRL 665
           E        +      ++D+Y++G+V  E+           D   P  +      ++  +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 666 HDIDALSRMVDPSLDGAYLAKSLSR-FADIISRCVQWEPGFRPPMSEIVQDL 716
             +    + + P++   + +    R  A I+  C       R     I + L
Sbjct: 242 RKV-VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 6e-50
 Identities = 64/284 (22%), Positives = 113/284 (39%), Gaps = 30/284 (10%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGG-----KLLAVKKLSNTVSQRQTDEEFLELASTISR 494
           +  +    IG G  G VYK  L          +A+K L    +++Q   +FL  A  + +
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLGEAGIMGQ 65

Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
             H NI+ L G  +++   +++ +Y  N  L   L        +FS    + +  G A  
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAG 122

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSE-GLLTAHGS 613
           ++Y   +     VH +  + NIL++  L+ +VSD GL+ +L        +  G       
Sbjct: 123 MKY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 614 GAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
            APE      ++  SDV+S G+VM E++T  +         E                + 
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VM 223

Query: 673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           + ++            S    ++ +C Q E   RP  ++IV  L
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-49
 Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 25/277 (9%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
            S      +G+G  G V+     G   +A+K L        + E FL+ A  + +LRH  
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEK 73

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           +V+L           +V +Y    +L D L  +    K       + +A   A  + Y+ 
Sbjct: 74  LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYV- 129

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
                  VH + +++NIL+ E L+ +V+D GLA L+                 +      
Sbjct: 130 --ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
            G ++ +SDV+S G+++ EL T  +         E          L  ++   RM  P  
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------LDQVERGYRMPCPP- 237

Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                 +      D++ +C + EP  RP    +   L
Sbjct: 238 ------ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  171 bits (435), Expect = 6e-49
 Identities = 62/279 (22%), Positives = 116/279 (41%), Gaps = 27/279 (9%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
              +  + +G G  G VY+         +AVK L     +    EEFL+ A+ +  ++H 
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHP 73

Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           N+V+L+G C       ++ ++     L D L   E   ++ S  + + +A   + A++YL
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP-E 617
               +   +H +  + N L+ E  +V+V+D GL+ L+ +G T     G        AP  
Sbjct: 132 ---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 187

Query: 618 FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP 677
                +S +SDV++ GV++ E+ T                         D+  +  +++ 
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEK 231

Query: 678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                       +  +++  C QW P  RP  +EI Q  
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 4e-48
 Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 33/279 (11%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
                   IG+G  G V   +  G   +AVK + N      T + FL  AS +++LRH N
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKN----DATAQAFLAEASVMTQLRHSN 61

Query: 500 IVELIGYCNEHGQHL-LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           +V+L+G   E    L +V +Y    +L D L S          +  ++ +L    A++YL
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE- 617
                   VH +  + N+L+ E  + +VSD GL     S                 APE 
Sbjct: 120 ---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEA 171

Query: 618 FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP 677
                +S +SDV+S G+++ E+ +  +      P  +   V   + + + +DA       
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYKMDAPDGCPP- 227

Query: 678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                          +++  C   +   RP   ++ + L
Sbjct: 228 ------------AVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 9e-48
 Identities = 67/336 (19%), Positives = 120/336 (35%), Gaps = 57/336 (16%)

Query: 422 VISSSVSVFTIASLQQYT---------NSFSEGNFIGEGLLGSVYKAELPG------GKL 466
           V  SS + +     ++Y           +   G  +G G  G V  A   G         
Sbjct: 10  VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 69

Query: 467 LAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLLVYDYGGNCTL 525
           +AVK L       +  E  +     +++L  H NIV L+G C   G   L+++Y     L
Sbjct: 70  VAVKMLKEKADSSE-REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128

Query: 526 HDLLHS-------------------DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
            + L S                   +EE     ++   +  A   A+ +++L+       
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSC 185

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF-ESGSYSC 625
           VH +  + N+L+    +V++ D GLA  + S S   +           APE    G Y+ 
Sbjct: 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245

Query: 626 QSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
           +SDV+S G+++ E+ + G  PY                P +       +++         
Sbjct: 246 KSDVWSYGILLWEIFSLGVNPY----------------PGIPVDANFYKLIQNGFKMDQP 289

Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
             +      I+  C  ++   RP    +   L C +
Sbjct: 290 FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-47
 Identities = 57/308 (18%), Positives = 117/308 (37%), Gaps = 39/308 (12%)

Query: 435 LQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTIS 493
           ++   + F + + +G G  G V+K    P G ++A K +   +       + +     + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-RNQIIRELQVLH 59

Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
                 IV   G     G+  +  ++    +L  +L        +    I  +V++   +
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIK 115

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
            L YL+E     I+H + K SNIL++ +  +++ D G++  L     N      +     
Sbjct: 116 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSY 169

Query: 614 GAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYD------------------------- 647
            +PE  +   YS QSD++S+G+ ++E+  GR P                           
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229

Query: 648 -RSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFR 706
            R+  R   S    + P +   + L  +V+              F D +++C+   P  R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289

Query: 707 PPMSEIVQ 714
             + +++ 
Sbjct: 290 ADLKQLMV 297

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-47
 Identities = 62/280 (22%), Positives = 111/280 (39%), Gaps = 31/280 (11%)

Query: 445 GNFIGEGLLGSVYKAELPGGK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
              IG G  G VY   L          AVK L+      +   +FL     +    H N+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 90

Query: 501 VELIGYCNEH-GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           + L+G C    G  L+V  Y  +  L + + ++       +    I   L  A+ +++  
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKF-- 145

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL--SEGLLTAHGSGAPE 617
            +     VH +  + N +LDEK  V+V+D GLA  ++    + +    G        A E
Sbjct: 146 -LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 618 -FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
             ++  ++ +SDV+S GV++ EL+T   P     P  + +     +  L       R++ 
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQG----RRLLQ 255

Query: 677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
           P               +++ +C   +   RP  SE+V  +
Sbjct: 256 PE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-47
 Identities = 56/280 (20%), Positives = 104/280 (37%), Gaps = 25/280 (8%)

Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           +     IG G  G   K      GK+L  K+L          +  +   + +  L+H NI
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 501 VELIGYC-NEHGQHL-LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           V       +     L +V +Y     L  ++    +  +       +RV      AL+  
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 559 --QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
             +      ++H + K +N+ LD K  V++ D GLA +L        ++  +      +P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSP 183

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
           E     SY+ +SD++SLG ++ EL     P+     +     +R           +    
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-----KFRRIPYRY 238

Query: 676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
              L             +II+R +  +   RP + EI+++
Sbjct: 239 SDEL------------NEIITRMLNLKDYHRPSVEEILEN 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (420), Expect = 9e-47
 Identities = 64/312 (20%), Positives = 116/312 (37%), Gaps = 47/312 (15%)

Query: 432 IASLQQYTNSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEF 485
           + SL+   N+      IGEG  G V++A  PG        ++AVK L    S      +F
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-QADF 63

Query: 486 LELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS-------------- 531
              A+ ++   + NIV+L+G C       L+++Y     L++ L S              
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 532 ------DEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVR 585
                         S   ++ +A   A  + YL    E   VH +  + N L+ E ++V+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVK 180

Query: 586 VSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGS-YSCQSDVYSLGVVMLELLTGRK 644
           ++D GL+  ++S    +             PE    + Y+ +SDV++ GVV+ E+ +   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 645 PYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPG 704
                    E          ++ +   + +  P               +++  C    P 
Sbjct: 241 QPYYGMAHEEV---------IYYVRDGNILACPE-------NCPLELYNLMRLCWSKLPA 284

Query: 705 FRPPMSEIVQDL 716
            RP    I + L
Sbjct: 285 DRPSFCSIHRIL 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-46
 Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 31/279 (11%)

Query: 444 EGNFIGEGLLGSVYKAELPG---GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           E   +G G  G+V K         K +AVK L N  +     +E L  A+ + +L +  I
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           V +IG C E    +LV +      L+  L      ++       I +    +  ++YL  
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL-- 123

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG-STNELSEGLLTAHGSGAPE-F 618
             E   VH +  + N+LL  +   ++SD GL+  L +  +  +            APE  
Sbjct: 124 -EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 619 ESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP 677
               +S +SDV+S GV+M E  + G+KPY   +     +++     R+       R    
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPR---- 237

Query: 678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                          D+++ C  ++   RP  + +   L
Sbjct: 238 ------------EMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 6e-46
 Identities = 65/303 (21%), Positives = 107/303 (35%), Gaps = 41/303 (13%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTIS 493
           N  S G  +G G  G V +A   G         +AVK L  +    +  E  +     +S
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLS 81

Query: 494 RL-RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHS--------------DEEAHKK 538
            L  H NIV L+G C   G  L++ +Y     L + L                 E+    
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 539 FSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG 598
                 +  +   A+ + +L        +H +  + NILL    I ++ D GLA  + + 
Sbjct: 142 LDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 599 STNELSEGLLTAHGSGAPEF-ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSL 657
           S   +           APE   +  Y+ +SDV+S G+ + EL +         P   +  
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256

Query: 658 VRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
                          +M+           + +   DI+  C   +P  RP   +IVQ + 
Sbjct: 257 -------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

Query: 718 CMI 720
             I
Sbjct: 304 KQI 306

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (415), Expect = 7e-46
 Identities = 62/280 (22%), Positives = 114/280 (40%), Gaps = 35/280 (12%)

Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTD-EEFLELASTISRLRHGN 499
           FS+   IG G  G+VY A  +   +++A+KK+S +  Q     ++ ++    + +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
            ++  G         LV +Y        L        K         V  GA + L YL 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH 132

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-- 617
                 ++H + K+ NILL E  +V++ D G A ++   ++   +   +      APE  
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWM------APEVI 183

Query: 618 --FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
              + G Y  + DV+SLG+  +EL   + P                      +  +++  
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------LYHIAQNE 230

Query: 676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
            P+L   + ++    F + +  C+Q  P  RP    +++ 
Sbjct: 231 SPALQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLKH 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 3e-45
 Identities = 59/293 (20%), Positives = 103/293 (35%), Gaps = 38/293 (12%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLL---AVKKLSNTVSQRQTDEEFLELASTISRL- 495
           N     + IGEG  G V KA +    L    A+K++    S+     +F      + +L 
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLG 68

Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLH------------SDEEAHKKFSWNI 543
            H NI+ L+G C   G   L  +Y  +  L D L                      S   
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 544 RIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNEL 603
            +  A   AR + YL    +   +H +  + NIL+ E  + +++D GL+          +
Sbjct: 129 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185

Query: 604 SEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIP 663
                              Y+  SDV+S GV++ E+++         P    +       
Sbjct: 186 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAEL--- 235

Query: 664 RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
               +    R+  P               D++ +C + +P  RP  ++I+  L
Sbjct: 236 -YEKLPQGYRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 8e-45
 Identities = 58/281 (20%), Positives = 98/281 (34%), Gaps = 28/281 (9%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPG----GKLLAVKKLSNTVSQRQTDEEFLELASTISRL 495
                G  IGEG  G V++            +A+K   N  S     E+FL+ A T+ + 
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQF 65

Query: 496 RHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            H +IV+LIG   E+    ++ +      L   L               I  A   + AL
Sbjct: 66  DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTAL 121

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGA 615
            YL        VH +  + N+L+     V++ D GL+  +   +  + S+G L       
Sbjct: 122 AYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 616 PEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
                  ++  SDV+  GV M E+L       +     +         RL          
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP--- 235

Query: 676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                             ++++C  ++P  RP  +E+   L
Sbjct: 236 -------------PTLYSLMTKCWAYDPSRRPRFTELKAQL 263

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-44
 Identities = 58/277 (20%), Positives = 96/277 (34%), Gaps = 36/277 (12%)

Query: 448 IGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           IG G   +VYK         +A  +L +    +   + F E A  +  L+H NIV     
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 507 C----NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
                      +LV +   + TL   L       K     +         + LQ+L    
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-R 131

Query: 563 EPPIVHGNFKSSNILL-DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---APEF 618
            PPI+H + K  NI +      V++ D GLA L  +              G+    APE 
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-------AVIGTPEFMAPEM 184

Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
               Y    DVY+ G+ MLE+ T   PY   +   +                  R+    
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---------------IYRRVTSGV 229

Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
              ++   ++    +II  C++     R  + +++  
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-44
 Identities = 58/288 (20%), Positives = 117/288 (40%), Gaps = 31/288 (10%)

Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELA 489
           +I S+      ++    IG+G  G+VY A ++  G+ +A+++++  + Q+   E  +   
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEI 68

Query: 490 STISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVAL 549
             +   ++ NIV  +       +  +V +Y    +L D++                 V  
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCR 123

Query: 550 GAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLT 609
              +AL++L       ++H + KS NILL     V+++D G    +           ++ 
Sbjct: 124 ECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVG 178

Query: 610 AHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE-QSLVRWAIPRLHD 667
                APE     +Y  + D++SLG++ +E++ G  PY    P      +     P L +
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238

Query: 668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
            + LS                + F D ++RC+  +   R    E++Q 
Sbjct: 239 PEKLS----------------AIFRDFLNRCLDMDVEKRGSAKELLQH 270

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-44
 Identities = 61/284 (21%), Positives = 108/284 (38%), Gaps = 28/284 (9%)

Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVK---KLSNTVSQRQTDEEFLELASTISRLRH 497
           F +   +G G  G+VYK   +P G+ + +    K     +  + ++E L+ A  ++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            ++  L+G C      L+       C    LL    E          +   +  A+ + Y
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGC----LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L    +  +VH +  + N+L+     V+++D GLA LL +      +EG        A E
Sbjct: 127 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 618 -FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD 676
                 Y+ QSDV+S GV + EL+T         P  E S +     RL      +    
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI--- 240

Query: 677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI 720
                            I+ +C   +   RP   E++ +   M 
Sbjct: 241 -------------DVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-44
 Identities = 60/285 (21%), Positives = 107/285 (37%), Gaps = 32/285 (11%)

Query: 439 TNSFSEGNF-IGEGLLGSVYKAEL---PGGKLLAVKKLSNTVSQRQTDEEFLELASTISR 494
            ++    +  +G G  GSV +           +A+K L     +  T EE +  A  + +
Sbjct: 7   RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQ 65

Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           L +  IV LIG C +    +LV +  G   LH  L       ++   +    +    +  
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMG 121

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST--NELSEGLLTAHG 612
           ++YL    E   VH +  + N+LL  +   ++SD GL+  L +  +     S G      
Sbjct: 122 MKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 613 SGAPEFESGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL 671
                     +S +SDV+S GV M E L+ G+KPY + +     + +     R+      
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPEC 237

Query: 672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                                 ++S C  ++   RP    + Q +
Sbjct: 238 P----------------PELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 8e-44
 Identities = 62/277 (22%), Positives = 106/277 (38%), Gaps = 32/277 (11%)

Query: 442 FSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNT-VSQRQTDEEFLELASTISRLRHGN 499
           F  G  +G+G  G+VY A       +LA+K L    + +   + +        S LRH N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           I+ L GY ++  +  L+ +Y    T++  L        KF            A AL Y  
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH 123

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-F 618
                 ++H + K  N+LL     ++++D G +    S         L        PE  
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEMI 176

Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
           E   +  + D++SLGV+  E L G+ P++ +  +     +        D       V   
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF------VTEG 230

Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
                         D+ISR ++  P  RP + E+++ 
Sbjct: 231 A------------RDLISRLLKHNPSQRPMLREVLEH 255

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 1e-43
 Identities = 53/276 (19%), Positives = 106/276 (38%), Gaps = 34/276 (12%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G+G  G VYKA+      L A K +       +  E+++     ++   H NIV+L+  
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
                   ++ ++     +  ++    E  +  + +    V      AL YL    +  I
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKI 131

Query: 567 VHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE------FES 620
           +H + K+ NIL      ++++D G++       T +  +  +      APE       + 
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGE-QSLVRWAIPRLHDIDALSRMVDPSL 679
             Y  ++DV+SLG+ ++E+     P+    P      + +   P L      S       
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS------- 242

Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
                    S F D + +C++     R   S+++Q 
Sbjct: 243 ---------SNFKDFLKKCLEKNVDARWTTSQLLQH 269

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 4e-43
 Identities = 57/278 (20%), Positives = 105/278 (37%), Gaps = 31/278 (11%)

Query: 448 IGEGLLGSVYKAELPG----GKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGNIVE 502
           +G+G  G V + E          +AVK L  + +SQ +  ++F+   + +  L H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 503 LIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           L G         +V +      L  LL    +    F      R A+  A  + YL    
Sbjct: 76  LYGVV-LTPPMKMVTEL---APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---E 128

Query: 563 EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTN-ELSEGLLTAHGSGAPE-FES 620
               +H +  + N+LL  + +V++ D GL   L     +  + E         APE  ++
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188

Query: 621 GSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL 679
            ++S  SD +  GV + E+ T G++P+           +     RL   +   +      
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ------ 242

Query: 680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLL 717
                        +++ +C   +P  RP    +   LL
Sbjct: 243 ----------DIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  154 bits (389), Expect = 1e-42
 Identities = 52/287 (18%), Positives = 105/287 (36%), Gaps = 18/287 (6%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
             +     IGEG  G VYKA+   G+  A+KK+             +   S +  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           IV+L    +   + +LV+++        L                    L     + Y  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYC- 116

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE 619
              +  ++H + K  N+L++ +  ++++D GLA            E +   + +      
Sbjct: 117 --HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 620 SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPR----------GEQSLVRWA-IPRLHDI 668
           S  YS   D++S+G +  E++ G   +                G  +   W  +  L   
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           D    + +P    ++L        D++S+ ++ +P  R    + ++ 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-42
 Identities = 56/278 (20%), Positives = 97/278 (34%), Gaps = 28/278 (10%)

Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           +     +GEG  G V  A      + +AVK +          E   +       L H N+
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENV 65

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           V+  G+  E     L  +Y     L D +                R        + YL  
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYL-- 119

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES 620
                I H + K  N+LLDE+  +++SD GLA +    +   L   +       APE   
Sbjct: 120 -HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 621 GS--YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRWAIPRLHDIDALSRMVDP 677
               ++   DV+S G+V+  +L G  P+D+     ++ S  +     L+    +      
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID----- 233

Query: 678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
                      S    ++ + +   P  R  + +I +D
Sbjct: 234 -----------SAPLALLHKILVENPSARITIPDIKKD 260

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 4e-42
 Identities = 56/290 (19%), Positives = 107/290 (36%), Gaps = 33/290 (11%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTIS 493
              +    +G+G  G VY+    G         +A+K ++   S R+   EFL  AS + 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASVMK 78

Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLH------SDEEAHKKFSWNIRIRV 547
                ++V L+G  ++    L++ +      L   L       ++       S +  I++
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 548 ALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGL 607
           A   A  + YL        VH +  + N ++ E   V++ D G+   ++           
Sbjct: 139 AGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 608 LTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH 666
           L      +PE  + G ++  SDV+S GVV+ E+ T  +   +     +          L 
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---------LR 246

Query: 667 DIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
            +     +  P               +++  C Q+ P  RP   EI+  +
Sbjct: 247 FVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 6e-42
 Identities = 60/298 (20%), Positives = 112/298 (37%), Gaps = 40/298 (13%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELAST 491
           +    G  +GEG  G V  AE  G           +AVK L +  +++   +   E+   
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLH------------SDEEAHKKF 539
               +H NI+ L+G C + G   ++ +Y     L + L                   ++ 
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 540 SWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS 599
           S    +  A   AR ++YL        +H +  + N+L+ E  +++++D GLA  +    
Sbjct: 133 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 600 TNELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV 658
             + +          APE      Y+ QSDV+S GV++ E+ T         P       
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------- 242

Query: 659 RWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                    ++ L +++         +   +    ++  C    P  RP   ++V+DL
Sbjct: 243 ---------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 5e-41
 Identities = 65/297 (21%), Positives = 108/297 (36%), Gaps = 38/297 (12%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPG------GKLLAVKKLSNTVSQRQTDEEFLELASTIS 493
           +    G  +G G  G V +A+  G       + +AVK L    +  +      EL   I 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 494 RLRHGNIVELIGYCNEHGQHL-LVYDYGGNCTLHDLLHS------------DEEAHKKFS 540
              H N+V L+G C + G  L ++ ++     L   L S            ++      +
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 541 WNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST 600
               I  +   A+ +++L        +H +  + NILL EK +V++ D GLA  ++    
Sbjct: 133 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 601 NELSEGLLTAHGSGA-PEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR 659
                         A        Y+ QSDV+S GV++ E+ +         P     +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244

Query: 660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
               RL +     RM  P         +       +  C   EP  RP  SE+V+ L
Sbjct: 245 EFCRRLKEGT---RMRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 7e-40
 Identities = 52/274 (18%), Positives = 99/274 (36%), Gaps = 28/274 (10%)

Query: 442 FSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLS-NTVSQRQTDEEFLELASTISRLRHGN 499
           F  G  +GEG   +V  A EL   +  A+K L    + +             +SRL H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 500 IVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
            V+L     +  +      Y  N  L   +         F            A  +  L+
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDET---CTRFYTAEIVSALE 122

Query: 560 EVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-F 618
            +    I+H + K  NILL+E + ++++D G A +L   S    +   +      +PE  
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 619 ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS 678
              S    SD+++LG ++ +L+ G  P+                   ++     +++   
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAG----------------NEYLIFQKIIKLE 226

Query: 679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI 712
            D  +  K   +  D++ + +  +   R    E+
Sbjct: 227 YD--FPEKFFPKARDLVEKLLVLDATKRLGCEEM 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  145 bits (366), Expect = 8e-39
 Identities = 54/282 (19%), Positives = 108/282 (38%), Gaps = 33/282 (11%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           + +     +G G  G V++  E   G   A K +          E   +   T+S LRH 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 83

Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
            +V L     +  + +++Y++     L + +    + H K S +  +       + L ++
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 559 QEVCEPPIVHGNFKSSNILLDEKL--IVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
               E   VH + K  NI+   K    +++ D GL   L    + +++ G        AP
Sbjct: 141 ---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAP 194

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
           E  E       +D++S+GV+   LL+G  P+                   +D + L  + 
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPF----------------GGENDDETLRNVK 238

Query: 676 --DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
             D ++D +  +       D I + +  +P  R  + + ++ 
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 1e-38
 Identities = 48/286 (16%), Positives = 103/286 (36%), Gaps = 18/286 (6%)

Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI 500
           F +   IGEG  G VYKA     G+++A+KK+             +   S +  L H NI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 501 VELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQE 560
           V+L+   +   +  LV+++        +  S           +         + L +   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFC-- 118

Query: 561 VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFES 620
                ++H + K  N+L++ +  ++++D GLA            E +   + +       
Sbjct: 119 -HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 621 GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLD 680
             YS   D++SLG +  E++T R  +       +   +   +    ++        P   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 681 GAYLAKSLSRFA-----------DIISRCVQWEPGFRPPMSEIVQD 715
            ++   +   F+            ++S+ + ++P  R      +  
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  142 bits (358), Expect = 1e-38
 Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 34/290 (11%)

Query: 439 TNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTD-EEFLELASTISRLR 496
           ++ +  G  +G G +  V+ A  L   + +AVK L   +++  +    F   A   + L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 497 HGNIVELIGYC----NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           H  IV +               +V +Y    TL D++H+        +    I V   A 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 121

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA-PLLFSGSTNELSEGLLTAH 611
           +AL +     +  I+H + K +NI++     V+V D G+A  +  SG++   +  ++   
Sbjct: 122 QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 612 GSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRG--EQSLVRWAIPRLHDI 668
              +PE     S   +SDVYSLG V+ E+LTG  P+    P     Q +    IP     
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-MSEIVQDLL 717
           + LS                +    ++ + +   P  R    +E+  DL+
Sbjct: 239 EGLS----------------ADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  142 bits (360), Expect = 6e-38
 Identities = 61/285 (21%), Positives = 104/285 (36%), Gaps = 32/285 (11%)

Query: 440 NSFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNT-VSQRQTDEEFLE---LASTISR 494
           N FS    IG G  G VY       GK+ A+K L    +  +Q +   L    + S +S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 495 LRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
                IV +    +   +   + D      LH  L      H  FS       A      
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILG 119

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L+++       +V+ + K +NILLDE   VR+SD GLA        +       T     
Sbjct: 120 LEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG---THGYMA 173

Query: 615 APEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
               + G +Y   +D +SLG ++ +LL G  P+ + + + +  + R  +    ++     
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---D 230

Query: 674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-PMSEIVQDLL 717
              P L              ++   +Q +   R   +    Q++ 
Sbjct: 231 SFSPEL------------RSLLEGLLQRDVNRRLGCLGRGAQEVK 263

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (355), Expect = 9e-38
 Identities = 54/282 (19%), Positives = 95/282 (33%), Gaps = 30/282 (10%)

Query: 439 TNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH 497
            + +   + +G G    V  AE     KL+A+K ++    + + +       + + +++H
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKH 66

Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            NIV L       G   L+        L D +         ++     R+      A++Y
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKY 122

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS---G 614
           L ++                LDE   + +SD GL+ +   GS       L TA G+    
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV------LSTACGTPGYV 176

Query: 615 AP-EFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
           AP       YS   D +S+GV+   LL G  P+                     +     
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------------AKLFEQIL 222

Query: 674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
             +   D  Y         D I   ++ +P  R    + +Q 
Sbjct: 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  141 bits (356), Expect = 2e-37
 Identities = 54/274 (19%), Positives = 106/274 (38%), Gaps = 33/274 (12%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V++  E   G++   K ++      +         S +++L H  ++ L   
Sbjct: 37  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLHHPKLINLHDA 94

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
             +  + +L+ ++     L D + ++     K S    I     A   L+++    E  I
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHM---HEHSI 148

Query: 567 VHGNFKSSNILLDEK--LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE-FESGSY 623
           VH + K  NI+ + K    V++ D GLA  L   + +E+ +         APE  +    
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPV 205

Query: 624 SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV--DPSLDG 681
              +D++++GV+   LL+G  P+                    D++ L  +   D   D 
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPF----------------AGEDDLETLQNVKRCDWEFDE 249

Query: 682 AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
              +       D I   +Q EP  R  + + ++ 
Sbjct: 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 4e-37
 Identities = 44/271 (16%), Positives = 93/271 (34%), Gaps = 28/271 (10%)

Query: 448 IGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G  G V++  E    K    K +     +        +  S ++  RH NI+ L   
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 507 CNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPI 566
                + ++++++     + + +++      + +    +        ALQ+L       I
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFL---HSHNI 123

Query: 567 VHGNFKSSNILLDEK--LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYS 624
            H + +  NI+   +    +++ + G A  L  G    L               +    S
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDVVS 181

Query: 625 CQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYL 684
             +D++SLG ++  LL+G  P+     +     +  A              + + D    
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA--------------EYTFDEEAF 227

Query: 685 AKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
            +      D + R +  E   R   SE +Q 
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQH 258

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  136 bits (344), Expect = 1e-36
 Identities = 57/287 (19%), Positives = 99/287 (34%), Gaps = 34/287 (11%)

Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLEL-------ASTIS 493
           +     +G G+   V +    P  K  AVK +  T     + EE  EL          + 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 494 RLR-HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAA 552
           ++  H NI++L      +    LV+D      L D L          S     ++     
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALL 120

Query: 553 RALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
             +  L ++    IVH + K  NILLD+ + ++++D G +  L  G       G  +   
Sbjct: 121 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177

Query: 613 ----SGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI 668
                 +       Y  + D++S GV+M  LL G  P+   +      ++     +    
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG-- 235

Query: 669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
                   P  D            D++SR +  +P  R    E +  
Sbjct: 236 -------SPEWDDYS-----DTVKDLVSRFLVVQPQKRYTAEEALAH 270

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 3e-35
 Identities = 50/293 (17%), Positives = 98/293 (33%), Gaps = 21/293 (7%)

Query: 439 TNSFSEGNFIGEGLLGSVYKAE--LPGGKLLAVKKLSNTVSQRQTDEEFL---ELASTIS 493
              +     IGEG  G V+KA     GG+ +A+K++     +       +    +   + 
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 494 RLRHGNIVELIGYC--NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGA 551
              H N+V L   C  +   +   +     +       + D+             +    
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
            R L +L       +VH + K  NIL+     ++++D GLA +              T  
Sbjct: 126 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLW 180

Query: 612 GSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID-- 669
                     SY+   D++S+G +  E+   +  +  S    +   +   I    + D  
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240

Query: 670 ---ALSRMVDPSLDGAYLAKSLSR----FADIISRCVQWEPGFRPPMSEIVQD 715
              AL R    S     + K ++       D++ +C+ + P  R      +  
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 8e-35
 Identities = 55/270 (20%), Positives = 91/270 (33%), Gaps = 31/270 (11%)

Query: 442 FSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEE--FLELASTISRLRHG 498
           F     +G+G  G V+ AE     +  A+K L   V     D E   +E         H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
            +  +            V +Y     L   + S      KF  +     A      LQ+L
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFL 119

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEF 618
                  IV+ + K  NILLD+   ++++D G+     +   +  +          APE 
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEI 174

Query: 619 ESGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP 677
             G  Y+   D +S GV++ E+L G+ P+           +R   P         R ++ 
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF------YPRWLEK 228

Query: 678 SLDGAYLAKSLSRFADIISRCVQWEPGFRP 707
                          D++ +    EP  R 
Sbjct: 229 EA------------KDLLVKLFVREPEKRL 246

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 9e-35
 Identities = 60/294 (20%), Positives = 103/294 (35%), Gaps = 30/294 (10%)

Query: 441 SFSEGNFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGN 499
           S+++   IG G  G VY+A+L   G+L+A+KK+       Q           + +L H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCN 74

Query: 500 IVELIGYCNEHGQH------LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
           IV L  +    G+        LV DY          H      +               R
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-KQTLPVIYVKLYMYQLFR 133

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEK-LIVRVSDCGLAPLLFSGSTNELSEGLLTAHG 612
           +L Y+       I H + K  N+LLD    ++++ D G A  L  G  N  S      + 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYR 189

Query: 613 SGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-----------RWA 661
           +    F +  Y+   DV+S G V+ ELL G+  +       +   +              
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           +   +      ++        +  ++      + SR +++ P  R    E    
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (330), Expect = 2e-34
 Identities = 50/284 (17%), Positives = 95/284 (33%), Gaps = 34/284 (11%)

Query: 445 GNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           G  IG G  G +Y    +  G+ +A+K        +    +    +     ++ G  +  
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIPT 67

Query: 504 IGYCNEHGQHL-LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC 562
           I +C   G +  +V +  G      L        +KFS    + +A      ++Y+    
Sbjct: 68  IRWCGAEGDYNVMVMELLG----PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---H 120

Query: 563 EPPIVHGNFKSSNIL---LDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG----- 614
               +H + K  N L     +  +V + D GLA       T++        + +G     
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 615 APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR 673
           +         S + D+ SLG V++    G  P+   +   ++        +        +
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--------K 232

Query: 674 MVDPSLDGAYLAKSLSR-FADIISRCVQWEPGFRPPMSEIVQDL 716
           M  P      L K     FA  ++ C       +P  S + Q  
Sbjct: 233 MSTPIEV---LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-34
 Identities = 53/295 (17%), Positives = 102/295 (34%), Gaps = 34/295 (11%)

Query: 431 TIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTD----EEF 485
           T+   +   + +  G  +G G    V K  E   G   A K +    ++        E+ 
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60

Query: 486 LELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRI 545
               S +  ++H N++ L          +L+ +      L D L       +  +     
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEAT 116

Query: 546 RVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE----KLIVRVSDCGLAPLLFSGSTN 601
                    + Y   +    I H + K  NI+L +    K  +++ D GLA  +  G+  
Sbjct: 117 EFLKQILNGVYY---LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173

Query: 602 ELSEGLLTAHGSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW 660
           +   G        APE         ++D++S+GV+   LL+G  P+              
Sbjct: 174 KNIFG---TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------- 221

Query: 661 AIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
                 +  A    V+   +  Y + + +   D I R +  +P  R  + + +Q 
Sbjct: 222 -----QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-34
 Identities = 54/309 (17%), Positives = 112/309 (36%), Gaps = 36/309 (11%)

Query: 428 SVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFL 486
            VF +         ++  ++IGEG  G V  A +      +A+KK+S    Q    +  L
Sbjct: 2   QVFDV------GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTL 54

Query: 487 ELASTISRLRHGNIVELIGYCN----EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWN 542
                + R RH NI+ +         E  + + +  +     L+ LL       +  S +
Sbjct: 55  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSND 109

Query: 543 IRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE 602
                     R L+Y+       ++H + K SN+LL+    +++ D GLA +      + 
Sbjct: 110 HICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166

Query: 603 LSEGLLTAH-GSGAPE--FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR 659
                  A     APE    S  Y+   D++S+G ++ E+L+ R  +       + + + 
Sbjct: 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226

Query: 660 WAIPRLHDIDALSRMVDPSLDGAYLAKSLSR-------------FADIISRCVQWEPGFR 706
             +      D    +   + +        ++               D++ + + + P  R
Sbjct: 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 286

Query: 707 PPMSEIVQD 715
             + + +  
Sbjct: 287 IEVEQALAH 295

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 3e-34
 Identities = 57/286 (19%), Positives = 107/286 (37%), Gaps = 25/286 (8%)

Query: 446 NFIGEGLLGSVYKAELPG-GKLLAVKKLSNTVSQRQTD---EEFLELASTISRLRHGNIV 501
           +F+GEG   +VYKA      +++A+KK+         D      L     +  L H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 502 ELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV 561
            L+          LV+D+        +  +        + +      L   + L+YL   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYL--- 116

Query: 562 CEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG 621
            +  I+H + K +N+LLDE  +++++D GLA     GS N      +      APE   G
Sbjct: 117 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFG 174

Query: 622 --SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI--PRLHDIDALSRMVDP 677
              Y    D++++G ++ ELL             + + +   +  P       +  + D 
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 678 SLDGAYLAKSLSR--------FADIISRCVQWEPGFRPPMSEIVQD 715
               ++    L            D+I     + P  R   ++ ++ 
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  130 bits (328), Expect = 4e-34
 Identities = 56/288 (19%), Positives = 102/288 (35%), Gaps = 38/288 (13%)

Query: 434 SLQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTD-EEFLELAST 491
           SLQ +         +G G  G V+       G+  A+K L   +  R    E   +    
Sbjct: 2   SLQDFQ----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM 57

Query: 492 ISRLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGA 551
           +S + H  I+ + G   +  Q  ++ DY     L  LL   +      +      V L  
Sbjct: 58  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-- 115

Query: 552 ARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAH 611
                 L+ +    I++ + K  NILLD+   ++++D G A  +   +       L    
Sbjct: 116 -----ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTP 165

Query: 612 GSGAPE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA 670
              APE   +  Y+   D +S G+++ E+L G  P+  S        +  A  R      
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-- 223

Query: 671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-MSEIVQDLL 717
                +  +             D++SR +  +   R   +    +D+ 
Sbjct: 224 ----FNEDV------------KDLLSRLITRDLSQRLGNLQNGTEDVK 255

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  129 bits (325), Expect = 7e-34
 Identities = 46/284 (16%), Positives = 85/284 (29%), Gaps = 32/284 (11%)

Query: 445 GNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
           G  IGEG  G +++   L   + +A+K       +R    +  +   T   L     +  
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAGCTGIPN 65

Query: 504 IGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCE 563
           + Y  + G H ++       +L DLL       +KFS       A      +Q +    E
Sbjct: 66  VYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSI---HE 119

Query: 564 PPIVHGNFKSSNILLDEKLI-----VRVSDCGLAPLLFSGSTNELSEGLLTAHGSG---- 614
             +V+ + K  N L+          + V D G+        T +        + SG    
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 615 -APE-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
            +         S + D+ +LG V +  L G  P+   +    +             + + 
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----------QKYERIG 229

Query: 673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDL 716
                +      A     F   +           P    +    
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 9e-33
 Identities = 49/294 (16%), Positives = 102/294 (34%), Gaps = 24/294 (8%)

Query: 435 LQQYTNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTIS 493
           +Q+Y     +   IGEG  G+V+KA+     +++A+K++             L     + 
Sbjct: 1   MQKYE----KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK 56

Query: 494 RLRHGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAAR 553
            L+H NIV L    +   +  LV+++                +      I         +
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLK 112

Query: 554 ALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
            L +        ++H + K  N+L++    +++++ GLA           +E +   +  
Sbjct: 113 GLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169

Query: 614 GAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ------------SLVRWA 661
               F +  YS   D++S G +  EL    +P        +Q                 +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229

Query: 662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
           + +L D          +     + K  +   D++   ++  P  R    E +Q 
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (313), Expect = 4e-32
 Identities = 56/306 (18%), Positives = 109/306 (35%), Gaps = 40/306 (13%)

Query: 440 NSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
           + + +   IG+G  G V+KA     G+ +A+KK+     +       L     +  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 499 NIVELIGYCNEH--------GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALG 550
           N+V LI  C           G   LV+D+      HDL         KF+ +   RV   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQM 125

Query: 551 AARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTA 610
               L Y+       I+H + K++N+L+    +++++D GLA      S  + S+     
Sbjct: 126 LLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAF---SLAKNSQPNRYT 179

Query: 611 HGSGAPEF-------ESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRP--------RGEQ 655
           +      +           Y    D++  G +M E+ T       +          +   
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 656 SLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFA------DIISRCVQWEPGFRPPM 709
           S+     P + + +   ++         +   L  +       D+I + +  +P  R   
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

Query: 710 SEIVQD 715
            + +  
Sbjct: 300 DDALNH 305

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 2e-31
 Identities = 41/281 (14%), Positives = 91/281 (32%), Gaps = 44/281 (15%)

Query: 445 GNFIGEGLLGSVYKA-ELPGGKLLAVKKLS----NTVSQRQTDEEFLELASTISRLRHG- 498
           G  +G G  GSVY    +     +A+K +     +   +             + ++  G 
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 499 -NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
             ++ L+ +       +L+ +          L             +          A+++
Sbjct: 69  SGVIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 558 LQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
                   ++H + K  NIL+D  +  +++ D G   LL      +             P
Sbjct: 126 C---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRVYSPP 178

Query: 617 EFESGS--YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM 674
           E+      +   + V+SLG+++ +++ G  P++      ++ ++R  +     +      
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQVFFRQRVS----- 228

Query: 675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
                         S    +I  C+   P  RP   EI   
Sbjct: 229 --------------SECQHLIRWCLALRPSDRPTFEEIQNH 255

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 3e-31
 Identities = 50/280 (17%), Positives = 94/280 (33%), Gaps = 33/280 (11%)

Query: 445 GNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVEL 503
              +G G+ G V +       +  A+K L +    R+      E+       +  +IV +
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------EVELHWRASQCPHIVRI 70

Query: 504 IGYC----NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQ 559
           +             L+V +      L   +   +   + F+      +      A+QYL 
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 560 EVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
            +    I H + K  N+L        I++++D G A    S ++              AP
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAP 182

Query: 617 E-FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV 675
           E      Y    D++SLGV+M  LL G  P+  +            +     +    RM 
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----------LAISPGMKTRIRMG 232

Query: 676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
                    ++       +I   ++ EP  R  ++E +  
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 1e-30
 Identities = 49/292 (16%), Positives = 100/292 (34%), Gaps = 24/292 (8%)

Query: 440 NSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHG 498
             + +   +G G  G+V  A +   G  +A+KKL          +        +  +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 499 NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYL 558
           N++ L+             D+                H+K   +    +     + L+Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 559 QEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE- 617
                  I+H + K  N+ ++E   +++ D GLA        +    G +      APE 
Sbjct: 138 ---HAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEV 189

Query: 618 -FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI--PRLHDIDALSRM 674
                 Y+   D++S+G +M E++TG+  +  S    +   +      P    +  L   
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 675 VD-------PSLDGAYLAKSLSR----FADIISRCVQWEPGFRPPMSEIVQD 715
                    P L+    A  L+       +++ + +  +   R    E +  
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 5e-30
 Identities = 51/281 (18%), Positives = 95/281 (33%), Gaps = 29/281 (10%)

Query: 440 NSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTD-EEFLELASTISRLRH 497
           N F     +G+G  G V        G+  A+K L   V   + +    +  +  +   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
             +  L      H +   V +Y     L   L       + F+     R     A  +  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEE---RARFYGAEIVSA 117

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L+ +    +V+ + K  N++LD+   ++++D GL     S     +     T        
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176

Query: 618 FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP 677
            E   Y    D + LGVVM E++ GR P+          L+     R        R + P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------FPRTLSP 230

Query: 678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEI-VQDLL 717
                           +++  ++ +P  R        ++++
Sbjct: 231 EA------------KSLLAGLLKKDPKQRLGGGPSDAKEVM 259

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-28
 Identities = 59/286 (20%), Positives = 100/286 (34%), Gaps = 31/286 (10%)

Query: 442 FSEGNFIGEGLLGSVYKAELPG----GKLLAVKKL--SNTVSQRQTDEEFLELASTISRL 495
           F     +G G  G V+          GKL A+K L  +  V + +T E        +  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 496 RHG-NIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
           R    +V L        +  L+ DY     L   L       ++F+ +           A
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLA 141

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
           L++L    +  I++ + K  NILLD    V ++D GL+    +  T    +   T     
Sbjct: 142 LEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198

Query: 615 APEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS 672
                 G   +    D +SLGV+M ELLTG  P+     +  Q+ +   I +        
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYP 256

Query: 673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMS-EIVQDLL 717
           + +                 D+I R +  +P  R         ++ 
Sbjct: 257 QEMSALA------------KDLIQRLLMKDPKKRLGCGPRDADEIK 290

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  110 bits (276), Expect = 6e-27
 Identities = 47/281 (16%), Positives = 92/281 (32%), Gaps = 32/281 (11%)

Query: 440 NSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTD-EEFLELASTISRLRH 497
           + F     +G G  G V   +    G   A+K L      +    E  L     +  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
             +V+L     ++    +V +Y     +   L        +FS       A       +Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEY 156

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           L  +    +++ + K  N+L+D++  ++V+D G A  +   +         T        
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG----TPEALAPEI 209

Query: 618 FESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP 677
             S  Y+   D ++LGV++ E+  G  P+   +P      +     R             
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS------HFSS 263

Query: 678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPP-MSEIVQDLL 717
            L             D++   +Q +   R   +   V D+ 
Sbjct: 264 DLK------------DLLRNLLQVDLTKRFGNLKNGVNDIK 292

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 2e-26
 Identities = 55/294 (18%), Positives = 108/294 (36%), Gaps = 26/294 (8%)

Query: 439 TNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH 497
              +   + +G G  GSV  A     G  +AVKKLS         +        +  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 498 GNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQY 557
            N++ L+             D      L     ++    +K + +    +     R L+Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 558 LQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPE 617
           +       I+H + K SN+ ++E   +++ D GLA       T++   G +      APE
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 188

Query: 618 --FESGSYSCQSDVYSLGVVMLELLTGRKPYD--------------RSRPRGEQSLVRWA 661
                  Y+   D++S+G +M ELLTGR  +                  P  E      +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248

Query: 662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD 715
               + I +L++M   +    ++  +     D++ + +  +   R   ++ +  
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGAN-PLAVDLLEKMLVLDSDKRITAAQALAH 301

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  104 bits (261), Expect = 3e-25
 Identities = 48/304 (15%), Positives = 105/304 (34%), Gaps = 47/304 (15%)

Query: 440 NSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-H 497
           + +     +G G    V++A  +   + + VK L     ++   E        +  LR  
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-----IKILENLRGG 89

Query: 498 GNIVELIGYCNEHGQHL--LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARAL 555
            NI+ L     +       LV+++  N     L       ++  +            +AL
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-------YQTLTDYDIRFYMYEILKAL 142

Query: 556 QYLQEVCEPPIVHGNFKSSNILLDEK-LIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSG 614
            Y   +    I+H + K  N+++D +   +R+ D GLA     G    +     + +  G
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKG 197

Query: 615 APEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ---------SLVRWAIPR 664
                    Y    D++SLG ++  ++  ++P+       +Q         +   +    
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 665 LHDIDALSRMVDPSLDGAYLAKSLSRFA-------------DIISRCVQWEPGFRPPMSE 711
            ++I+   R     + G +  K   RF              D + + ++++   R    E
Sbjct: 258 KYNIELDPRF--NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315

Query: 712 IVQD 715
            ++ 
Sbjct: 316 AMEH 319

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 99.7 bits (247), Expect = 3e-23
 Identities = 43/313 (13%), Positives = 98/313 (31%), Gaps = 50/313 (15%)

Query: 448 IGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGY 506
           +G G   +V+ A+ +     +A+K +      +   E   +    + R+   +  +    
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 507 CNEHGQHLLVYDYGGN------------CTLHDLLHSDEEAHKKFSWNIRIRVALGAARA 554
              H   LL +                    + L    +  H+        +++      
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 555 LQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGS 613
           L Y+       I+H + K  N+L++       +    +A L  +   +E     +     
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 614 GAPEFESGS-YSCQSDVYSLGVVMLELLTGRKPYD------------------------- 647
            +PE   G+ + C +D++S   ++ EL+TG   ++                         
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255

Query: 648 ----RSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSR-FADIISRCVQWE 702
               R+            + R         + D   +    +K  ++  +D +S  +Q +
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315

Query: 703 PGFRPPMSEIVQD 715
           P  R     +V  
Sbjct: 316 PRKRADAGGLVNH 328

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.9 bits (245), Expect = 6e-23
 Identities = 54/319 (16%), Positives = 113/319 (35%), Gaps = 49/319 (15%)

Query: 428 SVFTIASLQQYTNSFSEGNFIGEGLLGSVYKA-ELPGGKLLAVKKLSNTVSQRQTDEEFL 486
           S FT+  L++Y         IG G  G V  A +    + +A+KKLS     +   +   
Sbjct: 11  STFTV--LKRYQ----NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY 64

Query: 487 ELASTISRLRHGNIVELIGYC------NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFS 540
                +  + H NI+ L+          E     LV +         +    +       
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE----- 119

Query: 541 WNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST 600
                R++    + L  ++ +    I+H + K SNI++     +++ D GLA    +G++
Sbjct: 120 -----RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTS 172

Query: 601 NELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYD------------- 647
             ++  ++T +           Y    D++S+G +M E++  +  +              
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

Query: 648 ---RSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSR--------FADIIS 696
                 P   + L       + +    + +  P L    L  + S           D++S
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292

Query: 697 RCVQWEPGFRPPMSEIVQD 715
           + +  +P  R  + + +Q 
Sbjct: 293 KMLVIDPAKRISVDDALQH 311

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 2e-18
 Identities = 38/202 (18%), Positives = 65/202 (32%), Gaps = 23/202 (11%)

Query: 445 GNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVS--------QRQTDEEFLELASTISRLR 496
           G  +GEG   +V+           VK      +        +   D  F  LA   +R  
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 497 HGNIVELIGYCNEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQ 556
              + +L G          VY + GN  L +L+ + E    +        V       + 
Sbjct: 65  FRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKE--LYRVRVENPDEVLDMILEEVA 117

Query: 557 YLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAP 616
                    IVHG+    N+L+ E+ I  + D   +         E    +L        
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVSEEGIW-IIDFPQS----VEVGEEGWREILERDVRNII 169

Query: 617 EFESGSYSCQSDVYSLGVVMLE 638
            + S +Y  + D+ S    +L+
Sbjct: 170 TYFSRTYRTEKDINSAIDRILQ 191

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 73.9 bits (180), Expect = 1e-14
 Identities = 35/175 (20%), Positives = 67/175 (38%), Gaps = 26/175 (14%)

Query: 67  FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSG 126
             + +N+ E+ L G  L  +   TL  L ++ ++DL+NN I    P +    +    L  
Sbjct: 215 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGA 272

Query: 127 NQLTGSIP--------------------ESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTG 166
           NQ++   P                      +S L  L  L+L  N+++   P      T 
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330

Query: 167 LINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLNIENN 221
           L     + N ++     S  NL+++  L   +N++S    +     +  L + + 
Sbjct: 331 LQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 60.4 bits (145), Expect = 3e-10
 Identities = 40/153 (26%), Positives = 56/153 (36%), Gaps = 24/153 (15%)

Query: 94  LESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHL 153
           L ++ ++  +NN I    P  +   +   SL+GNQL      +L+ LT L DL L NN +
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253

Query: 154 NGGIPDAFHQFTGLINFDLSANNLTGQLP--------------------PSTRNLSSLYS 193
           +   P      T L    L AN ++   P                        NL +L  
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTY 311

Query: 194 LHLQNNKLSGTLNVLEDLHLIDLNIENNLFSGP 226
           L L  N +S    V     L  L   NN  S  
Sbjct: 312 LTLYFNNISDISPVSSLTKLQRLFFANNKVSDV 344

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 3e-05
 Identities = 25/100 (25%), Positives = 40/100 (40%), Gaps = 4/100 (4%)

Query: 138 SRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQ 197
           ++LT L  L   NN ++   P      T L    L+ N L      +  +L++L  L L 
Sbjct: 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 198 NNKLSGTLNVLEDLHLIDLNIENNLFSGPIPEKLLSIPNF 237
           NN++S    +     L +L +  N  S   P   L+    
Sbjct: 250 NNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTN 289

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 2e-04
 Identities = 29/113 (25%), Positives = 50/113 (44%), Gaps = 6/113 (5%)

Query: 91  LGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN 150
           L +L ++  +D+S+N +           + +   + NQ++   P  +   T L +LSLN 
Sbjct: 171 LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNG 228

Query: 151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG 203
           N L           T L + DL+ N ++   P S   L+ L  L L  N++S 
Sbjct: 229 NQLKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISN 277

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 0.001
 Identities = 11/66 (16%), Positives = 22/66 (33%), Gaps = 2/66 (3%)

Query: 93  DLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNH 152
            L   +   L   ++  ++       V         +  SI + +  L  L  ++ +NN 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 77

Query: 153 LNGGIP 158
           L    P
Sbjct: 78  LTDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.002
 Identities = 16/78 (20%), Positives = 30/78 (38%), Gaps = 6/78 (7%)

Query: 157 IPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLID 215
             D        +   L   N+T     S  +L  + +L      +  +++ +E L +L  
Sbjct: 16  FTDT--ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQ 70

Query: 216 LNIENNLFSGPIPEKLLS 233
           +N  NN  +   P K L+
Sbjct: 71  INFSNNQLTDITPLKNLT 88

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.6 bits (171), Expect = 9e-14
 Identities = 55/184 (29%), Positives = 81/184 (44%), Gaps = 27/184 (14%)

Query: 29  DPRDVMALNSLYISLNFPP-LEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVL 87
           +P+D  AL  +   L  P  L  W     D C  +W GV C                   
Sbjct: 4   NPQDKQALLQIKKDLGNPTTLSSW-LPTTDCCNRTWLGVLC------------------- 43

Query: 88  ADTLGDLESVINIDLSNNHIGGSIP-----SNLPVTVRNFSLSGNQLTGSIPESLSRLTQ 142
            DT      V N+DLS  ++    P     +NLP     +    N L G IP ++++LTQ
Sbjct: 44  -DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102

Query: 143 LLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS 202
           L  L + + +++G IPD   Q   L+  D S N L+G LPPS  +L +L  +    N++S
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162

Query: 203 GTLN 206
           G + 
Sbjct: 163 GAIP 166

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 57.1 bits (136), Expect = 2e-09
 Identities = 19/68 (27%), Positives = 31/68 (45%), Gaps = 3/68 (4%)

Query: 120 RNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANN-LT 178
               L  N++ G++P+ L++L  L  L+++ N+L G IP              + N  L 
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLC 305

Query: 179 G-QLPPST 185
           G  LP  T
Sbjct: 306 GSPLPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 56.7 bits (135), Expect = 3e-09
 Identities = 18/54 (33%), Positives = 25/54 (46%), Gaps = 1/54 (1%)

Query: 148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKL 201
           L NN + G +P    Q   L + ++S NNL G++P    NL         NNK 
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 53.6 bits (127), Expect = 3e-08
 Identities = 20/71 (28%), Positives = 27/71 (38%), Gaps = 3/71 (4%)

Query: 161 FHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIE 219
                 L   DL  N + G LP     L  L+SL++  N L G +    +L         
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA 299

Query: 220 NN--LFSGPIP 228
           NN  L   P+P
Sbjct: 300 NNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.9 bits (107), Expect = 8e-06
 Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 3/86 (3%)

Query: 51  WLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGS 110
                         G   +  N+  + L    + G L   L  L+ + ++++S N++ G 
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283

Query: 111 IPS--NLPVTVRNFSLSGNQLTGSIP 134
           IP   NL       + + N+     P
Sbjct: 284 IPQGGNLQ-RFDVSAYANNKCLCGSP 308

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 70.1 bits (170), Expect = 1e-13
 Identities = 29/147 (19%), Positives = 46/147 (31%), Gaps = 2/147 (1%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD 159
           +  S+  +   +P +LP       L  N++T         L  L  L L NN ++   P 
Sbjct: 15  VQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73

Query: 160 AFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKL-SGTLNVLEDLHLIDLNI 218
           AF     L    LS N L        + L  L     +  K+     N L  + +++L  
Sbjct: 74  AFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 133

Query: 219 ENNLFSGPIPEKLLSIPNFRKDGNPFN 245
                SG        +           
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADT 160

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 65.8 bits (159), Expect = 3e-12
 Identities = 34/191 (17%), Positives = 69/191 (36%), Gaps = 12/191 (6%)

Query: 41  ISLNFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLG--GVLADTLGDLESVI 98
           +    P   + L    +      + VF   + +  + L    L   G+       ++ + 
Sbjct: 94  LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 153

Query: 99  NIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIP 158
            I +++ +I  +IP  LP ++    L GN++T     SL  L  L  L L+ N ++    
Sbjct: 154 YIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 212

Query: 159 DAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS--------GTLNVLED 210
            +      L    L+ N L    P    +   +  ++L NN +S              + 
Sbjct: 213 GSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 271

Query: 211 LHLIDLNIENN 221
                +++ +N
Sbjct: 272 ASYSGVSLFSN 282

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 64.7 bits (156), Expect = 7e-12
 Identities = 34/162 (20%), Positives = 62/162 (38%), Gaps = 6/162 (3%)

Query: 44  NFPPLEKWLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLS 103
           + PP    L    +   +   G F    N+  + L    +  +       L  +  + LS
Sbjct: 28  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87

Query: 104 NNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQ--LLDLSLNNNHLNGGIPDAF 161
            N +   +P  +P T++   +  N++T       + L Q  +++L  N    +G    AF
Sbjct: 88  KNQL-KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146

Query: 162 HQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSG 203
                L    ++  N+T  +P       SL  LHL  NK++ 
Sbjct: 147 QGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLDGNKITK 185

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 49.3 bits (116), Expect = 7e-07
 Identities = 36/193 (18%), Positives = 60/193 (31%), Gaps = 20/193 (10%)

Query: 40  YISLNFPPLEKWLSFGGDPCGDS--WQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESV 97
               N       +  G +P   S    G F     ++ IR+   N+  +       L   
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE- 175

Query: 98  INIDLSNNHIGGSIPSNLPVTVRNFSL--SGNQLTGSIPESLSRLTQLLDLSLNNNHLNG 155
             + L  N I     ++L        L  S N ++     SL+    L +L LNNN L  
Sbjct: 176 --LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 232

Query: 156 GIPDAFHQFTGLINFDLSANNLTG------QLPPSTRNLSSLYSLHLQNNKLS------G 203
            +P        +    L  NN++         P      +S   + L +N +        
Sbjct: 233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292

Query: 204 TLNVLEDLHLIDL 216
           T   +     + L
Sbjct: 293 TFRCVYVRAAVQL 305

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.0 bits (133), Expect = 4e-09
 Identities = 31/175 (17%), Positives = 57/175 (32%), Gaps = 3/175 (1%)

Query: 60  GDSWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--V 117
                  F     +  + L    L  +       L ++  + L +N +            
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 118 TVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNL 177
            + +  L GN+++     +   L  L  L L+ N +    P AF     L+   L ANNL
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 178 TGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSGPIPEKL 231
           +     +   L +L  L L +N              L      ++     +P++L
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.6 bits (119), Expect = 3e-07
 Identities = 33/141 (23%), Positives = 49/141 (34%), Gaps = 6/141 (4%)

Query: 65  GVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPV--TVRNF 122
             F    N+T + L G  +  V       L S+  + L  N +    P        +   
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206

Query: 123 SLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP 182
            L  N L+    E+L+ L  L  L LN+N        A   +  L  F  S++ +   LP
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP 265

Query: 183 PSTRNLSSLYSLHLQNNKLSG 203
                L+      L  N L G
Sbjct: 266 Q---RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.4 bits (116), Expect = 6e-07
 Identities = 33/187 (17%), Positives = 55/187 (29%), Gaps = 28/187 (14%)

Query: 95  ESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLN 154
           E  +        +  ++P  +P   +   L GN+++     S      L  L L++N L 
Sbjct: 11  EPKVTTSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69

Query: 155 GGI-------------------------PDAFHQFTGLINFDLSANNLTGQLPPSTRNLS 189
                                       P  FH    L    L    L    P   R L+
Sbjct: 70  RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA 129

Query: 190 SLYSLHLQNNKLSGTLN--VLEDLHLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTT 247
           +L  L+LQ+N L    +    +  +L  L +  N  S         + +  +     N  
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

Query: 248 VIALPPT 254
               P  
Sbjct: 190 AHVHPHA 196

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.4 bits (103), Expect = 2e-05
 Identities = 33/165 (20%), Positives = 53/165 (32%), Gaps = 7/165 (4%)

Query: 69  VFSNVTEIRLTGMNLGGVLADTLG---DLESVINIDLSNNHIGGSIPSNLPVTVRNFSLS 125
           + +    I L G  +  V A +     +L  +         I  +  + L +  +     
Sbjct: 30  IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89

Query: 126 GNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPST 185
             QL    P +   L +L  L L+   L    P  F     L    L  N L      + 
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149

Query: 186 RNLSSLYSLHLQNNKLSG----TLNVLEDLHLIDLNIENNLFSGP 226
           R+L +L  L L  N++S         L  L  + L+        P
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (122), Expect = 9e-08
 Identities = 13/63 (20%), Positives = 27/63 (42%), Gaps = 1/63 (1%)

Query: 90  TLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN 149
            +  + S + ++    ++  ++P +LP       LS N L      +L   T+L  L+L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 150 NNH 152
              
Sbjct: 64  RAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.003
 Identities = 11/65 (16%), Positives = 24/65 (36%), Gaps = 3/65 (4%)

Query: 136 SLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLH 195
            +S++   L+++ +  +L   +P             LS N L      +    + L  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 196 LQNNK 200
           L   +
Sbjct: 62  LDRAE 66

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.9 bits (116), Expect = 1e-07
 Identities = 25/115 (21%), Positives = 42/115 (36%), Gaps = 8/115 (6%)

Query: 100 IDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGI 157
           + L++  +  ++  +L   + V +  LS N+L   +P +L+ L  L  L    +      
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVL--QASDNALEN 57

Query: 158 PDAFHQFTGLINFDLSANNLTG-QLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL 211
            D       L    L  N L          +   L  L+LQ N L     + E L
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERL 112

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.5 bits (94), Expect = 9e-05
 Identities = 24/105 (22%), Positives = 40/105 (38%), Gaps = 2/105 (1%)

Query: 91  LGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN 150
           L  L  V ++DLS+N +    P+ L        L  +       + ++ L +L +L L N
Sbjct: 16  LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQELLLCN 74

Query: 151 NHLNGG-IPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSL 194
           N L              L+  +L  N+L  +     R    L S+
Sbjct: 75  NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (122), Expect = 1e-07
 Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 3/98 (3%)

Query: 100 IDLSNNHIGGSIPSNL-PVTVRNFSLSGNQLTGSIPESLSRLT-QLLDLSLNNNHLNGGI 157
           +DL+  ++   +   L    V  F    + +   + E  S    Q +DLS N+      +
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLS-NSVIEVSTL 63

Query: 158 PDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLH 195
                Q + L N  L    L+  +  +    S+L  L+
Sbjct: 64  HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 2e-06
 Identities = 20/97 (20%), Positives = 38/97 (39%), Gaps = 8/97 (8%)

Query: 121 NFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
                 N  +  I         L +L+++NN L   +P    +   L     S N+L  +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-E 318

Query: 181 LPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLHLIDLN 217
           +P       +L  LH++ N L    ++ E +  + +N
Sbjct: 319 VPEL---PQNLKQLHVEYNPLREFPDIPESVEDLRMN 352

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 3e-06
 Identities = 16/90 (17%), Positives = 29/90 (32%), Gaps = 5/90 (5%)

Query: 119 VRNFSLSGNQLTGS-IPESLSRLTQLLDLSLNNNHLNG----GIPDAFHQFTGLINFDLS 173
           +++  +   +L+ +   E L  L Q   + L++  L       I  A      L   +L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 174 ANNLTGQLPPSTRNLSSLYSLHLQNNKLSG 203
           +N L               S  +Q   L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 5e-06
 Identities = 22/114 (19%), Positives = 37/114 (32%), Gaps = 17/114 (14%)

Query: 51  WLSFGGDPCGDSWQGVFCVFSNVTEIRLTGMNLGGV----LADTLGDLESVINIDLSNNH 106
                     +  QG+    S +  + L   ++       LA TL    S+  +DLSNN 
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408

Query: 107 IGGSIPSNLPVTVRNFS-------LSGNQLTGSIPESLSRLTQLLDLSLNNNHL 153
           +G +    L  +VR          L     +  + + L        L  +   L
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQ------ALEKDKPSL 456

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 2e-05
 Identities = 16/95 (16%), Positives = 32/95 (33%), Gaps = 10/95 (10%)

Query: 93  DLESVINIDLSNNHIGGSIPSNLPVTVRN---FSLSGNQLTG----SIPESLSRLTQLLD 145
           D++S   +D+    +  +  + L   ++      L    LT      I  +L     L +
Sbjct: 3   DIQS---LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 146 LSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ 180
           L+L +N L         Q     +  +   +L   
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 10/99 (10%), Positives = 28/99 (28%), Gaps = 7/99 (7%)

Query: 72  NVTEIRLTGMNLGGV-LADTLGDLESVINIDLSNNHIGGSIPSNLP------VTVRNFSL 124
           ++  + +    L     A+ L  L+    + L +  +  +   ++         +   +L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQ 163
             N+L       + +  Q     +    L          
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 13/80 (16%), Positives = 25/80 (31%), Gaps = 9/80 (11%)

Query: 118 TVRNFSLSGNQLTG----SIPESLSRLTQLLDLSLNNNHLNGGIPDAF-----HQFTGLI 168
            +R   L+   ++     S+  +L     L +L L+NN L                  L 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 169 NFDLSANNLTGQLPPSTRNL 188
              L     + ++    + L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 17/85 (20%), Positives = 34/85 (40%), Gaps = 11/85 (12%)

Query: 161 FHQFTGLINFDLSANNLTGQ----LPPSTRNLSSLYSLHLQNNKLS--GTLNVLEDL--- 211
               + L    L+  +++      L  +     SL  L L NN L   G L ++E +   
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 212 --HLIDLNIENNLFSGPIPEKLLSI 234
              L  L + +  +S  + ++L ++
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (96), Expect = 9e-05
 Identities = 21/101 (20%), Positives = 34/101 (33%), Gaps = 3/101 (2%)

Query: 102 LSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAF 161
           L+   I  +      V  R   L G ++   I    + L Q   +  ++N +     D F
Sbjct: 3   LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGF 59

Query: 162 HQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS 202
                L    ++ N +        + L  L  L L NN L 
Sbjct: 60  PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (96), Expect = 1e-04
 Identities = 10/65 (15%), Positives = 19/65 (29%), Gaps = 1/65 (1%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD 159
                + +   IPS+LP           +L      + S    L  + ++ N +   I  
Sbjct: 13  FLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71

Query: 160 AFHQF 164
                
Sbjct: 72  DVFSN 76

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.004
 Identities = 13/45 (28%), Positives = 18/45 (40%), Gaps = 2/45 (4%)

Query: 157 IPDAFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNK 200
             D FH  +G +  D+S   +   LP     NL  L +    N K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARSTYNLK 236

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.6 bits (94), Expect = 2e-04
 Identities = 23/106 (21%), Positives = 37/106 (34%), Gaps = 5/106 (4%)

Query: 101 DLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNG--GIP 158
           DL       S P  +   +       + +  ++      + +LL L+L+NN L     + 
Sbjct: 28  DLKGLR---SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMS 84

Query: 159 DAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT 204
               +   L   +LS N L  +          L  L L  N LS T
Sbjct: 85  SIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.6 bits (93), Expect = 3e-04
 Identities = 19/105 (18%), Positives = 37/105 (35%), Gaps = 2/105 (1%)

Query: 100 IDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD 159
           +D +   +   IP ++P+      L+ N+L     + L      L       +   GI  
Sbjct: 13  VDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71

Query: 160 AFHQFTGLINFDLSANNLTGQLPPST-RNLSSLYSLHLQNNKLSG 203
              +    I       N   ++       L  L +L+L +N++S 
Sbjct: 72  NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC 116

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.002
 Identities = 15/87 (17%), Positives = 28/87 (32%), Gaps = 12/87 (13%)

Query: 148 LNNNHLNGGIPDA------FHQFTGLINFDLSANNLTGQLPPS-----TRNLSSLYSLHL 196
           LN+  L+     A        +  GL    L  N +      +        +  L  L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 197 QNNKLSGTLNVLEDLH-LIDLNIENNL 222
             N+ S   +V++++  +        L
Sbjct: 310 NGNRFSEEDDVVDEIREVFSTRGRGEL 336

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	720
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.84
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.83
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.78
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.77
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.71
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.7
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.68
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.65
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.6
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.6
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.6
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.51
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.5
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.49
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.48
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.48
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.45
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.45
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.43
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.43
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.42
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.37
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.32
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.23
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.22
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.21
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.19
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.18
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.15
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.79
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.77
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.75
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.51
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.31
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.3
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.29
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.28
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.08
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.9
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.47
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.36
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.12
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.11
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.58
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.29
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.18
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.39

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=421.65  Aligned_cols=260  Identities=29%  Similarity=0.431  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .++|...+.||+|+||+||+|++++  .||||+++.........+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            3578889999999999999998643  59999997655555667889999999999999999999999865 46899999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++...   ...+++..+..++.|+|+||+|||+.   +||||||||+|||++.++++||+|||+|+.....
T Consensus        84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            99999999999643   34689999999999999999999987   9999999999999999999999999999887544


Q ss_pred             CCcccccCccccccCCCCccCC----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFES----GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ..........+|+.|+|||.+.    +.|+.++|||||||++|||+||+.||..............           ...
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~-----------~~~  226 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----------RGY  226 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH-----------HTS
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh-----------cCC
Confidence            4333444567899999999873    3589999999999999999999999976433221110000           001


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ..+.. ......+++++.+++.+||+.||++||||+||+++|+.|
T Consensus       227 ~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         227 LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             CCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11111 111223446789999999999999999999999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=416.15  Aligned_cols=253  Identities=24%  Similarity=0.404  Sum_probs=196.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|+..+.||+|+||+||+|.+.+++.||||+++..   ....++|.+|++++++++|||||+++|+|.+.+..++||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            356777899999999999999988999999999754   33457899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++|+|.+++...   ...++|..+.+++.|+|+||+|||+.   +|+||||||+|||+|+++++||+|||+|+.+....
T Consensus        82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            9999999998642   45688999999999999999999997   89999999999999999999999999998775432


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhC-CCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTG-RKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      . .......++..|+|||.+ .+.|+.++|||||||++|||+|+ ++||.......   +.....       .-.+... 
T Consensus       156 ~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i~-------~~~~~~~-  223 (263)
T d1sm2a_         156 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIS-------TGFRLYK-  223 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHHH-------HTCCCCC-
T ss_pred             c-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHHH-------hcCCCCC-
Confidence            2 223345678999999998 56799999999999999999995 55554322111   111100       0000111 


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                            +..+++++.+++.+||+.||++||||+||+++|++|
T Consensus       224 ------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         224 ------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                  112345788999999999999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.8e-51  Score=421.00  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=194.8

Q ss_pred             CCCCCCeeccCCCceEEEEEeC-CC---cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          441 SFSEGNFIGEGLLGSVYKAELP-GG---KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +|...++||+|+||+||+|.+. ++   ..||||++..... ....++|.+|++++++++|||||+++|+|.+.+..++|
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            3445679999999999999764 33   3689999875432 34557899999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++|+|.+++...   ...++|.++.+++.|+|+||+|||+.   +||||||||+|||++.++++||+|||+|+.+.
T Consensus       106 ~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999988642   34689999999999999999999987   99999999999999999999999999998875


Q ss_pred             CCCCccc---ccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          597 SGSTNEL---SEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       597 ~~~~~~~---~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      .......   .....++..|+|||.. .+.|+.++|||||||++|||+| |+.||.......   +.....         
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~---------  247 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIE---------  247 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH---------
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHH---------
Confidence            4332211   1234568899999998 6789999999999999999998 899997543221   111110         


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                          . ......+..++.++.+++.+||+.||++||||+||++.|++++
T Consensus       248 ----~-~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         248 ----Q-DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             ----T-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----c-CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                0 0000112234567889999999999999999999999999874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-51  Score=415.07  Aligned_cols=254  Identities=22%  Similarity=0.283  Sum_probs=203.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|+..+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            45788899999999999999965 5799999999975432 233467899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.|+++||+|||+.   +||||||||+|||+++++++||+|||+|+.+..
T Consensus        83 Ey~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          83 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             eccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            99999999999853    34689999999999999999999997   999999999999999999999999999988755


Q ss_pred             CCCcccccCccccccCCCCccC-CCCC-CCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSY-SCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~-~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ...........||+.|+|||.+ ...+ +.++|||||||++|||+||+.||......... ....              .
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~--------------~  220 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW--------------K  220 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHH--------------H
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHH--------------h
Confidence            4433444557799999999998 4444 67899999999999999999999754322111 0000              0


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ............++++.+|+.+||+.||++|||++|+++|
T Consensus       221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0000001112234677899999999999999999999874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-50  Score=405.35  Aligned_cols=253  Identities=22%  Similarity=0.381  Sum_probs=210.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|+..+.||+|+||+||+|++++++.||||++++.   ....++|.+|++++++++|||||+++|+|.+.+..++||||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~---~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS---SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC---cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            578899999999999999999988999999999754   23457899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++|+|.+++...   ...+++..+.+++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             cCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            9999999987543   45688999999999999999999987   99999999999999999999999999998775433


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      .. ......++..|+|||.+ .+.++.++|||||||++|||+| |+.||......+....+..          ..+..  
T Consensus       155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~----------~~~~~--  221 (258)
T d1k2pa_         155 YT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ----------GLRLY--  221 (258)
T ss_dssp             CC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT----------TCCCC--
T ss_pred             ce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh----------CCCCC--
Confidence            22 23345678899999998 5789999999999999999998 8999975432221111110          00011  


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                           .+...++++.+|+.+||+.||++|||++|++++|.++
T Consensus       222 -----~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         222 -----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -----CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                 1122346788999999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-50  Score=415.58  Aligned_cols=256  Identities=23%  Similarity=0.372  Sum_probs=208.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|+||+||+|.+. +|+.||||+++..   ....++|.+|++++++++|||||+++|+|.+.+..++|||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            46777789999999999999764 6899999999754   2345789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++...  ....+++..+..++.|+++||+|||+.   +||||||||+|||+++++++||+|||+|+.....
T Consensus        94 ~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          94 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             cccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            99999999998643  245789999999999999999999997   8999999999999999999999999999977543


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDP  677 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  677 (720)
                      . ........++..|+|||.+ .+.|+.++|||||||++|||++|..||.......  .+              .+.+..
T Consensus       169 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~--------------~~~i~~  231 (287)
T d1opja_         169 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV--------------YELLEK  231 (287)
T ss_dssp             S-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH--------------HHHHHT
T ss_pred             C-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HH--------------HHHHhc
Confidence            2 2233445678899999987 6789999999999999999999777664322111  11              111111


Q ss_pred             CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          678 SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       678 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      ......+..+++++.+|+.+||+.||++||||+||++.|+.++
T Consensus       232 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1111122234467899999999999999999999999998763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=411.96  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=204.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|+..+.||+|+||+||+|.+++++.||||+++..   ....++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC---cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            467778899999999999999988899999999754   2345789999999999999999999998865 457899999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++|+|.+++...  ....++|..+.+|+.|+++||+|||+.   +||||||||+|||+++++.+||+|||+|+.+....
T Consensus        89 ~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999999988643  234689999999999999999999987   89999999999999999999999999999875432


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      . .......++..|+|||.+ .+.|+.++|||||||++|||+||..|+......  ......          +.....+.
T Consensus       164 ~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~----------i~~~~~~~  230 (272)
T d1qpca_         164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQN----------LERGYRMV  230 (272)
T ss_dssp             E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----------HHTTCCCC
T ss_pred             c-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHH----------HHhcCCCC
Confidence            2 233445678899999988 567999999999999999999965554322211  111111          00001111


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                          .+..+++++.+|+.+||+.||++||||+||++.|+++
T Consensus       231 ----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         231 ----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                1122346788999999999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=415.95  Aligned_cols=257  Identities=21%  Similarity=0.300  Sum_probs=196.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--CCeEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--HGQHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv  516 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++..........+.+.+|++++++++|||||++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5688889999999999999965 579999999997655445556789999999999999999999998864  4568999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC--EPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      |||+++|+|.+++.........+++..+..++.|++.||+|||+..  ..+||||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999999765555677999999999999999999999863  23599999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      +....  .......+|++|+|||.+ ...|+.++|||||||++|||+||+.||...........+             ..
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i-------------~~  228 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------------RE  228 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------------HH
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH-------------Hc
Confidence            64322  223346789999999998 557999999999999999999999999753321111000             00


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...+.+    +...++++.+|+.+||+.||++|||++|+++|
T Consensus       229 ~~~~~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         229 GKFRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             TCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            000111    11234578899999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=406.80  Aligned_cols=247  Identities=24%  Similarity=0.350  Sum_probs=203.8

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++.+.. ......+.+.+|++++++++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4688889999999999999966 578999999986432 23345678899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.|+++||+|||+.   +||||||||+|||++.++++||+|||+|+....
T Consensus        86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            99999999999853    35689999999999999999999997   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..    .....||+.|+|||.+. ..|+.++|||||||++|||+||+.||...........+                ..
T Consensus       159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----------------~~  218 (263)
T d2j4za1         159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------SR  218 (263)
T ss_dssp             CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----------------HT
T ss_pred             Cc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH----------------Hc
Confidence            22    23356899999999984 46899999999999999999999999754322111111                11


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ...  ..+...++++.+|+.+||+.||++|||++|+++|
T Consensus       219 ~~~--~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         219 VEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             TCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            000  0111234678899999999999999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=406.07  Aligned_cols=249  Identities=23%  Similarity=0.341  Sum_probs=199.2

Q ss_pred             CCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc----CCeEEEEE
Q 004994          443 SEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE----HGQHLLVY  517 (720)
Q Consensus       443 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~  517 (720)
                      ...+.||+|+||+||+|.. .+++.||+|++..........+.|.+|++++++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            3346799999999999965 568999999997654445556789999999999999999999999854    34689999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc-CCCCeEEccccCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD-EKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~~  596 (720)
                      ||+++|+|.+++..    ...+++..+..++.|+++||+|||+. .++||||||||+|||++ +++.+||+|||+|+...
T Consensus        92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999853    35689999999999999999999986 22499999999999996 57899999999998653


Q ss_pred             CCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..    ......||+.|+|||.+.+.|+.++|||||||++|||+||+.||........  +.             ..+..
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~-------------~~i~~  227 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY-------------RRVTS  227 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH-------------HHHTT
T ss_pred             CC----ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HH-------------HHHHc
Confidence            22    2234678999999999988899999999999999999999999965332111  11             11111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .......+...++++.+++.+||+.||++|||++|+++|
T Consensus       228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            111111222334578899999999999999999999874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=406.11  Aligned_cols=248  Identities=22%  Similarity=0.342  Sum_probs=204.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++....  ....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            4799999999999999999965 579999999987442  3345789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++..     ..+++.....++.|++.||+|||+.   +||||||||+|||++.++++||+|||+|+.+...
T Consensus        98 y~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            9999999998742     4588999999999999999999997   9999999999999999999999999999877443


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc-hhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS-LVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .  .......||+.|+|||.+ .+.|+.++|||||||++|||+||+.||.......... +....              .
T Consensus       170 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--------------~  233 (293)
T d1yhwa1         170 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG--------------T  233 (293)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC--------------S
T ss_pred             c--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------------C
Confidence            2  223446789999999998 5568999999999999999999999997543221110 00000              0


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +..  ..+...++++.+|+.+||+.||++|||++|+++|
T Consensus       234 ~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         234 PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             CCC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCC--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111  1122334678899999999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=407.69  Aligned_cols=258  Identities=25%  Similarity=0.360  Sum_probs=197.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC-C----cEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG-G----KLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g----~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      +.|+..++||+|+||+||+|.+.+ +    ..||||++..... .....+|.+|++++++++|||||+++|+|.+.+..+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            356677899999999999997643 2    4799999975433 334567999999999999999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+.++++.+++..   ....++|..+.+++.|+++||+|||+.   +||||||||+|||++.++.+||+|||+|+.
T Consensus        86 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          86 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence            99999999999988753   345789999999999999999999997   899999999999999999999999999988


Q ss_pred             CCCCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +...... .......+|..|+|||++ .+.++.++|||||||++|||+||..|+......  ..+.+.            
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~------------  225 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKA------------  225 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH------------
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHH------------
Confidence            7543322 223345678899999988 678999999999999999999976665432211  111111            


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                       + ........+..++.++.+|+.+||+.||++||||.||++.|++++
T Consensus       226 -i-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         226 -I-NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             -H-HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -H-hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence             1 111111122234467899999999999999999999999998763

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=406.37  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=196.9

Q ss_pred             CeeccCCCceEEEEEeC---CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeCCC
Q 004994          446 NFIGEGLLGSVYKAELP---GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYGGN  522 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  522 (720)
                      +.||+|+||+||+|.+.   .++.||||+++.........++|.+|++++++++|||||+++|+|.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999653   357899999976554455567899999999999999999999999654 57899999999


Q ss_pred             CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcc
Q 004994          523 CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNE  602 (720)
Q Consensus       523 gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~  602 (720)
                      |+|.++++.    ...++|..+.+++.|+++||+|||+.   +||||||||+|||++.++.+||+|||+|+.+.......
T Consensus        92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999853    45689999999999999999999987   89999999999999999999999999998775443222


Q ss_pred             -cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcCCCC
Q 004994          603 -LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSL  679 (720)
Q Consensus       603 -~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  679 (720)
                       ......+|+.|+|||.+ .+.++.++|||||||++|||+| |+.||...........+.                 ...
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-----------------~~~  227 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-----------------KGE  227 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-----------------TTC
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-----------------cCC
Confidence             22345678899999988 6679999999999999999998 899997543221111110                 000


Q ss_pred             CchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          680 DGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       680 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ....+..++.++.+|+.+||+.||++|||++||++.|+..
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            0011223446788999999999999999999999888763

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=417.32  Aligned_cols=260  Identities=23%  Similarity=0.392  Sum_probs=205.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC-C-----cEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG-G-----KLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~  512 (720)
                      ++|+..+.||+|+||+||+|+... +     ..||||++..... ......|.+|+++++++ +|||||+++++|.+.+.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            567788999999999999996532 2     3699999875432 33446789999999998 89999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccch-------------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEE-------------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKS  573 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp  573 (720)
                      .++||||+++|+|.++++....                   ....++|..+..++.|+++||+|||+.   +||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence            9999999999999999975421                   124589999999999999999999997   999999999


Q ss_pred             CCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCC
Q 004994          574 SNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRP  651 (720)
Q Consensus       574 ~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~  651 (720)
                      +|||++.++++||+|||+|+...............+|+.|+|||.+ .+.|+.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999887655444444456689999999988 6789999999999999999998 8999975432


Q ss_pred             ccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          652 RGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ....  .              +++........+..+++++.+|+.+||+.||++|||++||+++|...
T Consensus       273 ~~~~--~--------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~~  324 (325)
T d1rjba_         273 DANF--Y--------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  324 (325)
T ss_dssp             SHHH--H--------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH--H--------------HHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhCC
Confidence            2111  1              11111111111223346789999999999999999999999999754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=416.49  Aligned_cols=266  Identities=20%  Similarity=0.330  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .++|+..+.||+|+||+||+|.. .+|+.||+|+++... .....+.+.+|++++++++|||||+++++|.+.++.++||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46788899999999999999965 579999999997543 2344578999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++..+..++.|+++||.|||+.+  +||||||||+|||+++++++||+|||+|+.+..
T Consensus        84 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999953    346899999999999999999999742  799999999999999999999999999986632


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhh-ccc------------
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRW-AIP------------  663 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~-~~~------------  663 (720)
                      .    ......||++|+|||++ ...|+.++||||+||++|||+||+.||.............. ...            
T Consensus       158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            2    22346799999999998 56799999999999999999999999976432211000000 000            


Q ss_pred             -------------ccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 -------------RLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                   .....+....+.............+.++.+|+.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                         0000000000000000000001123578899999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=406.38  Aligned_cols=254  Identities=23%  Similarity=0.336  Sum_probs=203.0

Q ss_pred             CCCCCCe-eccCCCceEEEEEeC---CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          441 SFSEGNF-IGEGLLGSVYKAELP---GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       441 ~~~~~~~-lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +|...+. ||+|+||+||+|.+.   ++..||||+++... .....++|.+|++++++++|||||+++|+|.+ +..++|
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4445564 999999999999653   35689999997543 34456789999999999999999999999975 468999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++|+|.+++...   ...+++..+.+++.|+++||+|||+.   +||||||||+|||++.++.+||+|||+|+.+.
T Consensus        87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence            9999999999987532   35689999999999999999999997   99999999999999999999999999998875


Q ss_pred             CCCCc-ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          597 SGSTN-ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       597 ~~~~~-~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ..... .......++..|+|||.+ .+.++.++|||||||++|||+| |+.||......+....+.             .
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-------------~  227 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------------Q  227 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------------T
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------------c
Confidence            43322 222344578899999998 5679999999999999999998 999997643321111111             0


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      -..+.    .+..+++++.+|+.+||+.||++||||.+|++.|+.+
T Consensus       228 ~~~~~----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         228 GKRME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             TCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCC----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            00011    1223446788999999999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=405.04  Aligned_cols=251  Identities=20%  Similarity=0.308  Sum_probs=202.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      +.|+..+.||+|+||+||+|.. .+|+.||||++....  ....+.|.+|++++++++|||||++++++.+.+..++|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            4577789999999999999965 579999999997542  3345678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++..   ....+++..+..++.|+++||+|||+.   +||||||||+|||++.++++||+|||+|+.....
T Consensus        90 y~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          90 FCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            9999999998753   235689999999999999999999997   9999999999999999999999999999765321


Q ss_pred             CCcccccCccccccCCCCccC------CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFE------SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~------~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                        ........||+.|+|||.+      ...|+.++|||||||++|||+||+.||...........+.             
T Consensus       164 --~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~-------------  228 (288)
T d2jfla1         164 --IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------------  228 (288)
T ss_dssp             --HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-------------
T ss_pred             --cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH-------------
Confidence              1122346789999999986      2348999999999999999999999997644322111000             


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..-.+.+  ..+...++++.+|+.+||+.||++|||++|+++|
T Consensus       229 ~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         229 KSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             HSCCCCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cCCCCCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000111  1122345678999999999999999999999874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=407.03  Aligned_cols=250  Identities=20%  Similarity=0.288  Sum_probs=201.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++.+.. ......+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4688899999999999999965 579999999997532 22345578999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++.    ....+++.....++.|++.||+|||+.   +||||||||+|||+++++.+||+|||+|+.+..
T Consensus        88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999999885    345789999999999999999999997   999999999999999999999999999988754


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ...........||+.|+|||.+ ...|+.++|||||||++|||+||+.||...+.....                ..+..
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----------------~~i~~  224 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----------------QKIIK  224 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHT
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH----------------HHHHc
Confidence            4333334456789999999998 567999999999999999999999999754321111                11111


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQ  714 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  714 (720)
                      ...  ..+...++++.+|+.+||+.||++|||++|+++
T Consensus       225 ~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         225 LEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             TCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            000  011223457889999999999999999998754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=400.39  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=199.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|+..+.||+|+||+||+|..++++.||||++....   ...+.|.+|+.++++++|||||+++|+|.+ +..++||||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            4678889999999999999998888899999997542   345789999999999999999999999965 567899999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++|+|.+++...  ....++|..++.++.++++||+|||+.   +|+||||||+|||+|+++++||+|||+|+.+....
T Consensus        93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            9999999988643  345699999999999999999999997   89999999999999999999999999998764432


Q ss_pred             CcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcCCC
Q 004994          600 TNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPS  678 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  678 (720)
                      . .......++..|+|||++ .+.++.++|||||||++|||+||..|+......  ..+.....          +...+ 
T Consensus       168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~----------~~~~~-  233 (285)
T d1fmka3         168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVE----------RGYRM-  233 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----------TTCCC-
T ss_pred             c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHH----------hcCCC-
Confidence            2 223335678999999998 678999999999999999999976665432211  11111110          00011 


Q ss_pred             CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          679 LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       679 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                         ..+..+++++.+++.+||+.||++||||++|++.|++.
T Consensus       234 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         234 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             ---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence               11223446789999999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.4e-49  Score=406.80  Aligned_cols=246  Identities=25%  Similarity=0.354  Sum_probs=199.5

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      .|+..+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            477889999999999999964 6799999999975432 23344678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+.+|+|..++.    ....+++..+..++.|++.||.|||+.   +||||||||+|||++.++++||+|||+|+.....
T Consensus        96 ~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          96 YCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             CCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            999999876653    245789999999999999999999997   9999999999999999999999999999876332


Q ss_pred             CCcccccCccccccCCCCccCC----CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFES----GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                            ....||+.|+|||.+.    +.|+.++|||||||++|||++|+.||..........  .           ....
T Consensus       169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~--~-----------i~~~  229 (309)
T d1u5ra_         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--H-----------IAQN  229 (309)
T ss_dssp             ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--H-----------HHHS
T ss_pred             ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH--H-----------HHhC
Confidence                  2356899999999873    458999999999999999999999997543211100  0           0000


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+...   ....++++.+|+.+||+.||++|||++|+++|
T Consensus       230 ~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         230 ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             CCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            011111   11224678899999999999999999999864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.4e-49  Score=406.98  Aligned_cols=266  Identities=24%  Similarity=0.347  Sum_probs=210.9

Q ss_pred             HHHHHhcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEe
Q 004994          434 SLQQYTNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYC  507 (720)
Q Consensus       434 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~  507 (720)
                      +++..+++|+..+.||+|+||+||+|+..      +++.||||++.... .....++|.+|++++++++||||++++++|
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            34445678999999999999999999753      46789999997543 234467899999999999999999999999


Q ss_pred             ccCCeEEEEEeeCCCCCHHHHhhccc--------------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 004994          508 NEHGQHLLVYDYGGNCTLHDLLHSDE--------------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIV  567 (720)
Q Consensus       508 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~iv  567 (720)
                      .+.+..++||||+++|+|.+++....                    .....+++..++.|+.|++.||+|||+.   +||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence            99999999999999999999986421                    1234589999999999999999999987   999


Q ss_pred             ecCCCCCCeEEcCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCC-CC
Q 004994          568 HGNFKSSNILLDEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGR-KP  645 (720)
Q Consensus       568 HrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~-~P  645 (720)
                      ||||||+|||+|.++++||+|||+|+.+.............+++.|+|||.+ ...|+.++|||||||++|||++|. .|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            9999999999999999999999999876544333333445678899999988 668999999999999999999985 56


Q ss_pred             CCCCCCccccchhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          646 YDRSRPRGEQSLVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       646 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      |......+..   .             .+.+... ...+..+++++.+|+.+||+.||++||||.||+++|++|.
T Consensus       243 ~~~~~~~e~~---~-------------~v~~~~~-~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         243 YYGMAHEEVI---Y-------------YVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTSCHHHHH---H-------------HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCHHHHH---H-------------HHHcCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            7654322211   1             1111110 0112233467889999999999999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-48  Score=402.40  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=189.0

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.+.|+..+.||+|+||+||+|.. .+|+.||||++.+.... ...+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            356688899999999999999965 57999999999754332 2345688999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc---CCCCeEEccccCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAP  593 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~  593 (720)
                      |||+++|+|.+++..    ...+++.....++.|++.||+|||+.   +||||||||+|||++   +++.+||+|||+|+
T Consensus        86 mE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          86 MQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             ECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence            999999999999953    35689999999999999999999987   999999999999994   57899999999998


Q ss_pred             CCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          594 LLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       594 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      ......   ......||+.|+|||.+ .+.|+.++|||||||++|||+||+.||...........+...           
T Consensus       159 ~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-----------  224 (307)
T d1a06a_         159 MEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-----------  224 (307)
T ss_dssp             -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT-----------
T ss_pred             EccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------
Confidence            764332   22346789999999998 456999999999999999999999999754322111100000           


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         +...........++++.+|+.+||+.||++|||++|+++|
T Consensus       225 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         225 ---EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ---CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ---CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence               0011111122334678899999999999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=392.37  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=194.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc-CCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-HGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e  518 (720)
                      ++|+..+.||+|+||.||+|++ .|+.||||++++.    ...++|.+|++++++++|||||+++|+|.+ .+..++|||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            3566678999999999999988 4788999999653    344689999999999999999999999865 466899999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+++|+|.+++...  ....++|..+++|+.|++.||+|||+.   +||||||||+|||++.++++||+|||+++.....
T Consensus        82 y~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          82 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999999642  234689999999999999999999987   9999999999999999999999999999876332


Q ss_pred             CCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          599 STNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                           .....++..|+|||++ .+.++.++|||||||++|||+| |+.||.......   +......          -..
T Consensus       157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~----------~~~  218 (262)
T d1byga_         157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK----------GYK  218 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTT----------TCC
T ss_pred             -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc----------CCC
Confidence                 1224567899999988 6789999999999999999998 788886543222   1111110          001


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      +.    .+...++++.+|+.+||+.||++||||.|++++|++|
T Consensus       219 ~~----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         219 MD----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            11    1223346788999999999999999999999999876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-48  Score=403.67  Aligned_cols=255  Identities=24%  Similarity=0.359  Sum_probs=199.5

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCc----EEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGK----LLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      .+|+..++||+|+||+||+|.+ .+|+    .||+|+++... .....++|.+|++++++++|||||+++|+|.++ ..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            3688889999999999999965 3454    58899886543 334567899999999999999999999999875 567


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +++||+.+|+|.+.+..   ....+++..+.+++.|+|+||+|||+.   +||||||||+|||++.++++||+|||+|+.
T Consensus        87 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          87 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             EEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence            88999999999988753   346789999999999999999999997   899999999999999999999999999998


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +.............+|..|+|||.+ .+.|+.++|||||||++|||+| |+.||...........+..            
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~------------  228 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------  228 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH------------
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------------
Confidence            7655444444455688999999987 6789999999999999999999 8999975432221111110            


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       -..+    ..+..+++++.+++.+||+.||++|||+.||+++|+.+
T Consensus       229 -~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         229 -GERL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             -TCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCC----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence             0000    11122346788999999999999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=395.82  Aligned_cols=253  Identities=20%  Similarity=0.307  Sum_probs=205.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc----cccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ----RQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      .+.|...+.||+|+||+||+|.. .+|+.||||++.+....    ....+.|.+|++++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45788999999999999999975 57999999999754321    23467899999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC----CeEEccc
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL----IVRVSDC  589 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DF  589 (720)
                      ++||||+++|+|.+++..    ...+++.....++.|++.||+|||+.   +||||||||+|||++.++    .+||+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            999999999999999853    35689999999999999999999997   999999999999998776    5999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI  668 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  668 (720)
                      |+|+......   ......+++.|+|||.+. ..++.++|||||||++|||+||+.||...........+..        
T Consensus       162 G~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--------  230 (293)
T d1jksa_         162 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA--------  230 (293)
T ss_dssp             TTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT--------
T ss_pred             hhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh--------
Confidence            9998764332   223456788999999984 5699999999999999999999999975432211110000        


Q ss_pred             hhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            .............+.++.+|+.+||+.||++|||++|+++|
T Consensus       231 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         231 ------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ------TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  01111122223345678899999999999999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-48  Score=399.55  Aligned_cols=262  Identities=23%  Similarity=0.366  Sum_probs=197.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccC-
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEH-  510 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-  510 (720)
                      .++|+..+.||+|+||+||+|...      +++.||||+++.... ....+.+.+|.+.+.++ +|+|||.+++++.+. 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            367888899999999999999642      357899999975432 34456778888888777 689999999988654 


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl  578 (720)
                      +..++||||+++|+|.++++....            ....+++..+..++.|+++||+|||+.   +||||||||+|||+
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeE
Confidence            578999999999999999965322            134589999999999999999999987   99999999999999


Q ss_pred             cCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhC-CCCCCCCCCccccc
Q 004994          579 DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTG-RKPYDRSRPRGEQS  656 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG-~~Pf~~~~~~~~~~  656 (720)
                      +.++++||+|||+|+...............||+.|+|||.+ .+.++.++|||||||++|||+|| +.||........  
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--  245 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--  245 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            99999999999999877655444444556789999999988 66799999999999999999996 567764332111  


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      +..          .+.+-..+.    .+...++++.+++.+||+.||++|||++||+++|+++|
T Consensus       246 ~~~----------~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         246 FCR----------RLKEGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             HHH----------HHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH----------HHhcCCCCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            000          001101111    11223467889999999999999999999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=392.24  Aligned_cols=255  Identities=23%  Similarity=0.336  Sum_probs=194.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|+..+.||+|+||+||+|.+..    +..||||+++... .....+.|.+|++++++++|||||+++|++.+ +..++
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            567788999999999999997532    4578999986433 34445789999999999999999999999964 57899


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLL  595 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~  595 (720)
                      ||||+++|+|.+++..   ....+++..+..++.|+++||+|||+.   +||||||||+||+++.++.+||+|||+|+.+
T Consensus        85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999998753   345689999999999999999999997   9999999999999999999999999999876


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      ..... .......+|+.|+|||.+ .+.|+.++|||||||++|||+| |+.||...........+.             .
T Consensus       159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-------------~  224 (273)
T d1mp8a_         159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------------N  224 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------------T
T ss_pred             cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-------------c
Confidence            43322 223345578899999998 6789999999999999999998 899997654322111110             0


Q ss_pred             hcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          674 MVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       674 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      -..+    ..+..+++++.+|+.+||+.||++|||++||+++|++|+
T Consensus       225 ~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         225 GERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            0000    012233467899999999999999999999999999874

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.1e-47  Score=403.35  Aligned_cols=251  Identities=20%  Similarity=0.278  Sum_probs=204.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|...+.||+|+||+||+|.. .+|+.||||++....  ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5788899999999999999965 579999999997542  3445778999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC--CCCeEEccccCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE--KLIVRVSDCGLAPLLF  596 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~~~  596 (720)
                      |+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +||||||||+|||++.  ++.+||+|||+|+.+.
T Consensus       104 ~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         104 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             CCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             cCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            99999999998532   34689999999999999999999997   9999999999999964  6789999999998764


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ...   ......||+.|+|||.+ ...|+.++|||||||++|||+||+.||...........+..              .
T Consensus       178 ~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~--------------~  240 (350)
T d1koaa2         178 PKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS--------------C  240 (350)
T ss_dssp             TTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------T
T ss_pred             ccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------C
Confidence            332   22345789999999998 55789999999999999999999999975432211111100              0


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +...........++++.+|+.+||+.||++|||++|+++|
T Consensus       241 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111111222334678899999999999999999999985

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=395.80  Aligned_cols=260  Identities=23%  Similarity=0.377  Sum_probs=205.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCC--------CcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccC
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPG--------GKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEH  510 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~  510 (720)
                      ++|...+.||+|+||.||+|+...        +..||||++++... .....++.+|...+.++ +|||||+++++|.+.
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            467778999999999999996422        34799999976543 34456788888888888 899999999999999


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccch------------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEE------------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl  578 (720)
                      +..++||||+++|+|.+++.....            ....+++.++++++.|++.||+|||+.   +||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence            999999999999999999965421            235689999999999999999999998   99999999999999


Q ss_pred             cCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccc
Q 004994          579 DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQS  656 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  656 (720)
                      +.++.+||+|||+++...............+++.|+|||.+ .+.|+.++|||||||++|||+| |+.||........  
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~--  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH--
Confidence            99999999999999987655544445556788999999988 6789999999999999999998 7888865432211  


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                       ....          ..-..+.    .+...++++.+|+.+||+.||++|||+.||++.|++|+
T Consensus       247 -~~~i----------~~~~~~~----~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         247 -FKLL----------KEGHRMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             -HHHH----------HTTCCCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHH----------HcCCCCC----CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence             1110          0000111    11223467889999999999999999999999999874

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=395.23  Aligned_cols=249  Identities=20%  Similarity=0.277  Sum_probs=204.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|...+.||+|+||+||+|+. .+|+.||||++.+... .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            4688899999999999999965 6799999999975432 2345678899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||+.   +||||||||+|||++.++++||+|||+|+....
T Consensus        85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999998853    45688888999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..  .......||+.|+|||.+ ...|+.++||||+||++|||+||+.||...+.......+..              -.
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--------------~~  221 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------EE  221 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------CC
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc--------------CC
Confidence            22  233456799999999998 55799999999999999999999999976432211111100              00


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                      ..    ++...++++.+|+.+||++||++||+     ++|+++|
T Consensus       222 ~~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CC----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            11    11223467889999999999999994     8888864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=389.91  Aligned_cols=257  Identities=22%  Similarity=0.317  Sum_probs=194.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC--CC--cEEEEEEeccccc-ccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP--GG--KLLAVKKLSNTVS-QRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ++|+..+.||+|+||+||+|++.  ++  ..||||++.+... .....++|.+|++++++++|||||+++|+|.+. ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            46778899999999999999653  23  3789999875433 234457899999999999999999999999764 678


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++|++.+.+..   ....+++..+.+++.|+|+||.|||+.   +|+||||||+|||++.++++||+|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            99999999999988753   345699999999999999999999997   999999999999999999999999999998


Q ss_pred             CCCCCCcc-cccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccchhhhcccccCchhhh
Q 004994          595 LFSGSTNE-LSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQSLVRWAIPRLHDIDAL  671 (720)
Q Consensus       595 ~~~~~~~~-~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  671 (720)
                      +....... ......++..|+|||.+ ...++.++|||||||++|||+| |+.||.......   ...+           
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~-----------  226 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHK-----------  226 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH-----------
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHH-----------
Confidence            75543322 23344567899999998 5678999999999999999998 899997543221   1111           


Q ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          672 SRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                        +.........+...+.++.+++.+||+.||++||||+||++.|++.
T Consensus       227 --i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         227 --IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             --HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              1111111111123346788999999999999999999999999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=396.86  Aligned_cols=261  Identities=25%  Similarity=0.370  Sum_probs=209.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEe------CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL------PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~  512 (720)
                      ++|+..+.||+|+||+||+|++      .+++.||||+++... ......+|.+|+.+++++ +|||||+++|+|.+.+.
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            5677788999999999999964      346799999997643 234556899999999999 69999999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccc--------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEE
Q 004994          513 HLLVYDYGGNCTLHDLLHSDE--------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILL  578 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl  578 (720)
                      .++||||+++|+|.++++...              .....+++..+.+++.|+++||+|||+.   +||||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence            999999999999999986432              1234689999999999999999999997   89999999999999


Q ss_pred             cCCCCeEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHh-CCCCCCCCCCccccc
Q 004994          579 DEKLIVRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLT-GRKPYDRSRPRGEQS  656 (720)
Q Consensus       579 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~ellt-G~~Pf~~~~~~~~~~  656 (720)
                      +.++.+|++|||+++...............+++.|+|||.+ .+.++.++|||||||++|||+| |++||........  
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            99999999999999987665555555567789999999988 6789999999999999999999 5555544322111  


Q ss_pred             hhhhcccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          657 LVRWAIPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                                    +.+++........+...+.++.+|+.+||+.||++||||+||++.|+++|
T Consensus       257 --------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         257 --------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             --------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence                          11111101111111223467889999999999999999999999999764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.8e-47  Score=401.67  Aligned_cols=252  Identities=20%  Similarity=0.263  Sum_probs=204.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      .+.|+..+.||+|+||+||+|.. .+|+.||||++....  ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35688899999999999999965 579999999997543  234567889999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc--CCCCeEEccccCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD--EKLIVRVSDCGLAPLL  595 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~--~~~~~kl~DFGla~~~  595 (720)
                      ||+++|+|.+.+..   ....+++.....++.|++.||+|||+.   +||||||||+|||++  .++.+||+|||+|+.+
T Consensus       106 E~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         106 EFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             ECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence            99999999988753   234689999999999999999999987   999999999999998  6789999999999887


Q ss_pred             CCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhh
Q 004994          596 FSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRM  674 (720)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (720)
                      ....   ......+++.|+|||.+ ...|+.++|||||||++|||+||+.||...........+..              
T Consensus       180 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--------------  242 (352)
T d1koba_         180 NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR--------------  242 (352)
T ss_dssp             CTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH--------------
T ss_pred             CCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Confidence            5432   22335678999999998 45699999999999999999999999975432211111100              


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          675 VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       675 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .+...........+.++.+|+.+||+.||.+|||++|+++|
T Consensus       243 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            01111111122334678899999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-46  Score=393.01  Aligned_cols=246  Identities=22%  Similarity=0.317  Sum_probs=202.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++.+.. ......+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4688889999999999999975 579999999997543 23345678999999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||+.   +||||||||+|||++.++++||+|||+|+....
T Consensus        84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            99999999988853    45678888889999999999999987   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .     .....||+.|+|||.+. ..|+.++|||||||++|||+||+.||..........                ++..
T Consensus       157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----------------~i~~  215 (316)
T d1fota_         157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE----------------KILN  215 (316)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----------------HHHH
T ss_pred             c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH----------------HHHc
Confidence            2     22367899999999984 469999999999999999999999997543221111                1110


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      ...  ..+...++++.+++.+||+.||.+|+     |++|+++|
T Consensus       216 ~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         216 AEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            000  01112235688999999999999996     89999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-47  Score=391.46  Aligned_cols=268  Identities=23%  Similarity=0.269  Sum_probs=199.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHH--HHHHHHccCCCceeEEEeEeccCC----eE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLE--LASTISRLRHGNIVELIGYCNEHG----QH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~--e~~~l~~l~H~niv~l~~~~~~~~----~~  513 (720)
                      ++|...+.||+|+||+||+|++ +|+.||||++...     ..+++..  |+..+..++|||||+++++|.+.+    ..
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            3455668899999999999986 6889999998643     2233444  444556789999999999997543    68


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeEEcCCCCeEEcc
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEV-----CEPPIVHGNFKSSNILLDEKLIVRVSD  588 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivHrDlkp~NiLl~~~~~~kl~D  588 (720)
                      ++||||+++|+|.++++.     ..++|..+.+++.++|.||+|+|+.     +.++||||||||+|||+++++++||+|
T Consensus        77 ~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence            999999999999999963     3589999999999999999999974     356999999999999999999999999


Q ss_pred             ccCCCCCCCCCCc--ccccCccccccCCCCccCCCC-------CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhh
Q 004994          589 CGLAPLLFSGSTN--ELSEGLLTAHGSGAPEFESGS-------YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVR  659 (720)
Q Consensus       589 FGla~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-------~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~  659 (720)
                      ||+++........  .......||++|+|||++.+.       ++.++|||||||++|||+||..||......... ...
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~  230 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYD  230 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTT
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhh
Confidence            9999877543321  123346789999999987543       577899999999999999999888543221111 000


Q ss_pred             hcccccCchhh----hhhhcCCCCCchh-hHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          660 WAIPRLHDIDA----LSRMVDPSLDGAY-LAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       660 ~~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                      ...........    ..+..+|.+.... ..+.+..+.+++.+||+.||++||||.||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            00000000011    1112223333322 335667799999999999999999999999999876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=395.47  Aligned_cols=257  Identities=24%  Similarity=0.339  Sum_probs=200.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC-CCc--EEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEeccCCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP-GGK--LLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNEHGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  515 (720)
                      ++|+..+.||+|+||+||+|.+. +|.  .||||++..... ....++|.+|+++++++ +|||||+++|+|.+.+..++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            56777899999999999999664 454  478888764322 33456799999999998 79999999999999999999


Q ss_pred             EEeeCCCCCHHHHhhccc------------hhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDE------------EAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI  583 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~  583 (720)
                      ||||+++|+|.++++...            .....++|..+.+++.|+|+||.|||+.   +||||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence            999999999999997542            2245789999999999999999999997   9999999999999999999


Q ss_pred             eEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCC-CCCCCCCCccccchhhhc
Q 004994          584 VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGR-KPYDRSRPRGEQSLVRWA  661 (720)
Q Consensus       584 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~-~Pf~~~~~~~~~~~~~~~  661 (720)
                      +||+|||+|+......   ......++..|+|||.+ .+.|+.++|||||||++|||++|. .||.......   +....
T Consensus       166 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i  239 (309)
T d1fvra_         166 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL  239 (309)
T ss_dssp             EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHG
T ss_pred             eEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence            9999999998654322   22234578899999998 667999999999999999999975 5675432211   11111


Q ss_pred             ccccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          662 IPRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                      .          +-..+.    .+..+++++.+|+.+||+.||++||||+||+++|++++
T Consensus       240 ~----------~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         240 P----------QGYRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             G----------GTCCCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----------hcCCCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            0          000011    11223467899999999999999999999999998863

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-47  Score=393.06  Aligned_cols=260  Identities=22%  Similarity=0.323  Sum_probs=209.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEeC------CCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELP------GGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQH  513 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  513 (720)
                      ++|...+.||+|+||+||+|.+.      +++.||||++++.. .......|.+|++++++++|||||+++|+|...+..
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            56777899999999999999653      35789999997543 334556799999999999999999999999999999


Q ss_pred             EEEEeeCCCCCHHHHhhccch------hccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEc
Q 004994          514 LLVYDYGGNCTLHDLLHSDEE------AHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVS  587 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  587 (720)
                      ++||||+++|+|.+++.....      ....+++..+.+++.++|+||.|||+.   +||||||||+|||+|+++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence            999999999999999864321      123468999999999999999999997   89999999999999999999999


Q ss_pred             cccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCC-CCCCCCCCccccchhhhccccc
Q 004994          588 DCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGR-KPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       588 DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      |||+|+.+.............+++.|+|||.+ .+.++.++|||||||++|||+||. .||........           
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~-----------  244 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-----------  244 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-----------
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH-----------
Confidence            99999987554444444455688999999988 667999999999999999999984 77754322111           


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhC
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCMI  720 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~  720 (720)
                           +..+.+.... ..+..++..+.+++.+||+.||++||||+||+++|++.+
T Consensus       245 -----~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         245 -----LRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             -----HHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             -----HHHHHhCCCC-CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                 1111111110 011223467899999999999999999999999999764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=389.30  Aligned_cols=252  Identities=24%  Similarity=0.389  Sum_probs=199.0

Q ss_pred             CCeeccCCCceEEEEEeCC----CcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc-CCeEEEEEee
Q 004994          445 GNFIGEGLLGSVYKAELPG----GKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-HGQHLLVYDY  519 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~  519 (720)
                      .++||+|+||+||+|.+.+    ...||||++++. ......++|.+|++++++++|||||+++|+|.+ ++..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            3689999999999997643    236899999753 234556789999999999999999999999865 5689999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +++|+|.++++..   ...+++..+++++.|+++||.|+|+.   +|+||||||+|||+++++.+||+|||+++.+....
T Consensus       111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             eecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999998643   45677888999999999999999987   89999999999999999999999999998875433


Q ss_pred             Cc--ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          600 TN--ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       600 ~~--~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      ..  .......++..|+|||.. .+.++.++||||||+++|||+||..||......  ..+..+....       .+...
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~g-------~~~~~  255 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQG-------RRLLQ  255 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTT-------CCCCC
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcC-------CCCCC
Confidence            22  122345678899999987 678999999999999999999988887543211  1111111000       00011


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                             +..+++++.+++.+||+.||++||||.||+++|+++
T Consensus       256 -------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                   112345788999999999999999999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.9e-46  Score=383.35  Aligned_cols=253  Identities=22%  Similarity=0.297  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc-------ccHHHHHHHHHHHHccC-CCceeEEEeEecc
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR-------QTDEEFLELASTISRLR-HGNIVELIGYCNE  509 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-------~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~  509 (720)
                      .++|+..+.||+|+||+||+|+. .+|+.||||++.+.....       ...+.+.+|++++++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            46788899999999999999965 679999999997543221       22356889999999997 9999999999999


Q ss_pred             CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccc
Q 004994          510 HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDC  589 (720)
Q Consensus       510 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF  589 (720)
                      ++..|+||||+++|+|.+++..    ...+++.....++.|+++||+|||+.   +||||||||+|||++.++.+||+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence            9999999999999999999953    45689999999999999999999987   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccCC-------CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFES-------GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI  662 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~  662 (720)
                      |+|+.+....   ......||..|+|||+..       ..++.++||||+||++|||+||+.||...........+... 
T Consensus       155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~-  230 (277)
T d1phka_         155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-  230 (277)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-
T ss_pred             hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC-
Confidence            9998774432   223467899999999862       24788999999999999999999999764322211111000 


Q ss_pred             cccCchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          663 PRLHDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                                   ............++++.+++.+||+.||++|||++||++|
T Consensus       231 -------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         231 -------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             -------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                         0001111122344678999999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.3e-46  Score=384.32  Aligned_cols=260  Identities=23%  Similarity=0.327  Sum_probs=199.7

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccc-cccHHHHHHHHHHHHccCCCceeEEEeEeccCC----e
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQ-RQTDEEFLELASTISRLRHGNIVELIGYCNEHG----Q  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~  512 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++++.... ....+.|.+|++++++++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46788899999999999999964 67999999999765432 334567999999999999999999999986543    4


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .|+||||+++++|.+++.    ....+++.+...++.|+++||+|||+.   +||||||||+|||++.++..+|+|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence            889999999999998874    345789999999999999999999987   9999999999999999999999999998


Q ss_pred             CCCCCCCC-cccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhh
Q 004994          593 PLLFSGST-NELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       593 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      +....... ........||+.|+|||.+ ...|+.++|||||||++|||+||+.||..........  ..          
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~--~~----------  226 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--QH----------  226 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HH----------
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH--HH----------
Confidence            76543322 2233446789999999998 4569999999999999999999999997543221100  00          


Q ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhh
Q 004994          671 LSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-PMSEIVQDLLCM  719 (720)
Q Consensus       671 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~  719 (720)
                      +..  ++..........++++.+++.+||+.||++|| |++|+++.|.++
T Consensus       227 ~~~--~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         227 VRE--DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             HHC--CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             Hhc--CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            000  00111111122346788999999999999999 899999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.6e-46  Score=396.37  Aligned_cols=250  Identities=25%  Similarity=0.308  Sum_probs=197.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccc-ccccHHHHH---HHHHHHHccCCCceeEEEeEeccCCeEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVS-QRQTDEEFL---ELASTISRLRHGNIVELIGYCNEHGQHL  514 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~~---~e~~~l~~l~H~niv~l~~~~~~~~~~~  514 (720)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++.+... .......+.   +++++++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5788889999999999999965 5799999999864321 122233344   4467777888999999999999999999


Q ss_pred             EEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCC
Q 004994          515 LVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPL  594 (720)
Q Consensus       515 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~  594 (720)
                      +||||+++|+|.+++..    ...+++.....++.|++.||.|||+.   +||||||||+|||++.++.+||+|||+|+.
T Consensus        84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999853    35678889999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALS  672 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  672 (720)
                      +....    .....||+.|+|||.+ .+ .|+.++|||||||++|||+||+.||..........+.+....         
T Consensus       157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~---------  223 (364)
T d1omwa3         157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------  223 (364)
T ss_dssp             CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS---------
T ss_pred             cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------
Confidence            64332    2345789999999987 34 589999999999999999999999976443222111111100         


Q ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 004994          673 RMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPP-----MSEIVQD  715 (720)
Q Consensus       673 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  715 (720)
                        ....    .+...++++.+|+.+||+.||++|||     ++|+++|
T Consensus       224 --~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         224 --MAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             --CCCC----CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             --CCCC----CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence              0001    11123457889999999999999999     6888764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.9e-46  Score=392.56  Aligned_cols=246  Identities=20%  Similarity=0.255  Sum_probs=202.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++.+.. ......+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4688889999999999999965 579999999996432 23345578899999999999999999999999999999999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFS  597 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~  597 (720)
                      ||+.+|+|.+++..    ...+++.....++.|++.||.|||+.   +||||||||+|||++.++++||+|||+|+.+..
T Consensus       121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999998853    34689999999999999999999987   999999999999999999999999999987643


Q ss_pred             CCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhcC
Q 004994          598 GSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMVD  676 (720)
Q Consensus       598 ~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  676 (720)
                      .     .....||+.|+|||.+ ...|+.++|||||||++|||+||+.||...........+...              .
T Consensus       194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--------------~  254 (350)
T d1rdqe_         194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--------------K  254 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------C
T ss_pred             c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--------------C
Confidence            2     2346789999999998 456899999999999999999999999754321111101000              0


Q ss_pred             CCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          677 PSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       677 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                      +.    .+...++++.+++.+||+.||.+|+     |++|+++|
T Consensus       255 ~~----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         255 VR----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CC----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            00    1112345788999999999999994     89999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=385.92  Aligned_cols=268  Identities=19%  Similarity=0.263  Sum_probs=198.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            4788889999999999999965 679999999997554434455789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+.++.+. ++..  .....+++..+..++.|++.||+|||+.   +||||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~~~~-~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKK-FMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHH-HHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhh-hhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99865444 4322  2245689999999999999999999987   8999999999999999999999999999866432


Q ss_pred             CCcccccCccccccCCCCccC-C-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh-hhc-c------cccCch
Q 004994          599 STNELSEGLLTAHGSGAPEFE-S-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWA-I------PRLHDI  668 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~-~------~~~~~~  668 (720)
                        ........+++.|+|||.. . ..++.++|||||||++|||++|+.||...+.......+ ... .      ......
T Consensus       156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence              2233446789999999976 3 34688999999999999999999999754322111000 000 0      000000


Q ss_pred             hhhhhhcCCCCCch---hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 DALSRMVDPSLDGA---YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..............   .....+.++.+|+.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000000000100   011223578899999999999999999999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-46  Score=390.13  Aligned_cols=250  Identities=19%  Similarity=0.237  Sum_probs=202.9

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEE
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.++|...+.||+|+||+||+|.. .+|+.||||+++...   .....+.+|+++|++++|||||++++++.+.+..|+|
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            356788899999999999999965 579999999997542   3345688999999999999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCC--CCeEEccccCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEK--LIVRVSDCGLAPL  594 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~--~~~kl~DFGla~~  594 (720)
                      |||+++|+|.+++...   ...+++.+...++.|+++||+|||+.   +||||||||+|||++.+  ..+||+|||+++.
T Consensus        80 mE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          80 FEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             ECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence            9999999999999642   24689999999999999999999987   99999999999999854  5899999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhh
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSR  673 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (720)
                      .....   ......+++.|+|||.. ...|+.++|||||||++|||++|+.||........                +..
T Consensus       154 ~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~----------------~~~  214 (321)
T d1tkia_         154 LKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----------------IEN  214 (321)
T ss_dssp             CCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHH
T ss_pred             cccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH----------------HHH
Confidence            64322   22335678899999988 45689999999999999999999999976432211                111


Q ss_pred             hcC--CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVD--PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +..  ...........+.++.+|+.+||+.||++|||++|+++|
T Consensus       215 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111  111111222334678899999999999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-46  Score=386.62  Aligned_cols=262  Identities=21%  Similarity=0.284  Sum_probs=193.1

Q ss_pred             CCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc---ccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEeeC
Q 004994          445 GNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR---QTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDYG  520 (720)
Q Consensus       445 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  520 (720)
                      .++||+|+||+||+|.. .+|+.||||+++......   ...+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            47899999999999965 579999999997543221   12356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCCC
Q 004994          521 GNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGST  600 (720)
Q Consensus       521 ~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~  600 (720)
                      .++++..+..    ....+++..+..++.|++.||+|||+.   +||||||||+|||++.++.+||+|||+|+...... 
T Consensus        83 ~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-  154 (299)
T d1ua2a_          83 ETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-  154 (299)
T ss_dssp             SEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred             cchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc-
Confidence            9987776653    235678888999999999999999997   99999999999999999999999999998764432 


Q ss_pred             cccccCccccccCCCCccC-C-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcc--c---ccCchhhhhh
Q 004994          601 NELSEGLLTAHGSGAPEFE-S-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAI--P---RLHDIDALSR  673 (720)
Q Consensus       601 ~~~~~~~~~~~~~~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~--~---~~~~~~~~~~  673 (720)
                       .......+|+.|+|||.+ . ..|+.++|||||||++|||+||+.||......+....+....  +   ...+......
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence             222345689999999987 3 358999999999999999999999997543322111110000  0   0000000000


Q ss_pred             hcC-CCCCc----hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVD-PSLDG----AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~-~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ... .....    .......+++.+|+.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            000 00000    0011224678899999999999999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-46  Score=387.29  Aligned_cols=248  Identities=22%  Similarity=0.298  Sum_probs=199.2

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccc-cccccHHHHHHHHHHHH-ccCCCceeEEEeEeccCCeEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTV-SQRQTDEEFLELASTIS-RLRHGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lv  516 (720)
                      ++|...+.||+|+||+||+|.. .+|+.||||++++.. ......+.+..|..++. .++|||||++++++.+.+..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            4688889999999999999965 579999999997542 12334456667777665 68999999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLF  596 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~  596 (720)
                      |||+++|+|.+++..    ...+++.....++.|++.||+|||+.   +||||||||+|||+++++++||+|||+|+...
T Consensus        82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            999999999999853    35688889999999999999999997   89999999999999999999999999998764


Q ss_pred             CCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhhhhhhc
Q 004994          597 SGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDALSRMV  675 (720)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  675 (720)
                      ...  .......||+.|+|||.+ .+.|+.++|||||||++|||+||+.||...........+...              
T Consensus       155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--------------  218 (320)
T d1xjda_         155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--------------  218 (320)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred             ccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence            322  223346789999999998 557999999999999999999999999754322211111110              


Q ss_pred             CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 004994          676 DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMS-EIVQ  714 (720)
Q Consensus       676 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  714 (720)
                      .+..    +...+.++.+|+.+||+.||++|||+. |+++
T Consensus       219 ~~~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 NPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1111    112345788999999999999999995 6764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=386.32  Aligned_cols=252  Identities=19%  Similarity=0.248  Sum_probs=195.6

Q ss_pred             hcCCCCC-CeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHcc-CCCceeEEEeEecc----CC
Q 004994          439 TNSFSEG-NFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRL-RHGNIVELIGYCNE----HG  511 (720)
Q Consensus       439 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~  511 (720)
                      .++|.+. ++||+|+||+||+|.. .+|+.||||++++.       +.+.+|++++.++ +|||||+++++|.+    ..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            3567765 5699999999999965 67999999998632       3567889887655 89999999999864    45


Q ss_pred             eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC---CCCeEEcc
Q 004994          512 QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE---KLIVRVSD  588 (720)
Q Consensus       512 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~D  588 (720)
                      ..|+|||||++|+|.+++...  ....+++.+...++.|++.||+|||+.   +|+||||||+|||+++   ++.+||+|
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence            789999999999999999642  235689999999999999999999987   9999999999999985   56799999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccCCC-CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFESG-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      ||+|+......   ......||+.|+|||.+.+ .|+.++|||||||++|||+||+.||..............   .+. 
T Consensus       158 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~---~i~-  230 (335)
T d2ozaa1         158 FGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---RIR-  230 (335)
T ss_dssp             CTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC-
T ss_pred             cceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH---HHh-
Confidence            99998764432   2234578999999999854 699999999999999999999999965432211110000   000 


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            ......+.......++++.+|+.+||+.||++|||+.|+++|
T Consensus       231 ------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         231 ------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                  000111112233455788999999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-45  Score=381.24  Aligned_cols=267  Identities=19%  Similarity=0.255  Sum_probs=201.9

Q ss_pred             cCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEee
Q 004994          440 NSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYDY  519 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  519 (720)
                      ++|...+.||+|+||+||+|+..+|+.||||++..........+.+.+|++++++++|||||++++++.+.+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            46888899999999999999888999999999976544445567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCCC
Q 004994          520 GGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSGS  599 (720)
Q Consensus       520 ~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~  599 (720)
                      +.++.+..+...    ...+++.....++.|++.||+|||+.   +||||||||+|||++.++.+|++|||+|.......
T Consensus        82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            998777766532    35689999999999999999999987   99999999999999999999999999997764322


Q ss_pred             CcccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhc--cccc---Cchhhhh
Q 004994          600 TNELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWA--IPRL---HDIDALS  672 (720)
Q Consensus       600 ~~~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~--~~~~---~~~~~~~  672 (720)
                        .......+++.|+|||.+.  ..++.++|||||||++|||++|+.||......+....+...  .+..   .+.....
T Consensus       155 --~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         155 --RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence              2233456788999999873  35799999999999999999999999754322111110000  0000   0000000


Q ss_pred             hh------cCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          673 RM------VDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       673 ~~------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      +.      ..+..........++.+.+|+.+||+.||++|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00      00000011122234678899999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=377.74  Aligned_cols=268  Identities=19%  Similarity=0.264  Sum_probs=196.6

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CC-CcEEEEEEecccccccccHHHHHHHHHHHHcc---CCCceeEEEeEec-----
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PG-GKLLAVKKLSNTVSQRQTDEEFLELASTISRL---RHGNIVELIGYCN-----  508 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~-----  508 (720)
                      .++|+..+.||+|+||+||+|.. .+ ++.||||+++...........+.+|+++++.+   +|||||+++++|.     
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999975 44 67899999975443333334556677766655   8999999999984     


Q ss_pred             cCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcc
Q 004994          509 EHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSD  588 (720)
Q Consensus       509 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D  588 (720)
                      .....+++|||++++.+......   ....+++.....++.|++.||+|||+.   +||||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence            23478999999998877654432   345688899999999999999999997   999999999999999999999999


Q ss_pred             ccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccc---
Q 004994          589 CGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPR---  664 (720)
Q Consensus       589 FGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~---  664 (720)
                      ||+++....   ........||+.|+|||.+ ...|+.++||||+||++|||+||+.||...........+......   
T Consensus       160 fg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         160 FGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  236 (305)
T ss_dssp             CCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             hhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence            999986532   2233456789999999987 667999999999999999999999999765432211111000000   


Q ss_pred             --cCchhhh-hhhc---CCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          665 --LHDIDAL-SRMV---DPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       665 --~~~~~~~-~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                        ....... ....   ............++.+.+|+.+||+.||++|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              0000000 0000   0000011122234678899999999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-45  Score=372.61  Aligned_cols=242  Identities=17%  Similarity=0.323  Sum_probs=193.8

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEeccccccc----ccHHHHHHHHHHHHccC--CCceeEEEeEeccCC
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQR----QTDEEFLELASTISRLR--HGNIVELIGYCNEHG  511 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~----~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~  511 (720)
                      .++|...+.||+|+||+||+|.. .+|+.||||++.+.....    ....++.+|++++++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            45788899999999999999965 579999999997543211    11234678999999996  899999999999999


Q ss_pred             eEEEEEeeCCC-CCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-CCCeEEccc
Q 004994          512 QHLLVYDYGGN-CTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-KLIVRVSDC  589 (720)
Q Consensus       512 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DF  589 (720)
                      ..++||||+.+ +++.+++.    ....+++.....++.|+++||+|||+.   +||||||||+|||++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            99999999975 67777774    245789999999999999999999997   9999999999999985 479999999


Q ss_pred             cCCCCCCCCCCcccccCccccccCCCCccC-CCC-CCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCc
Q 004994          590 GLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGS-YSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHD  667 (720)
Q Consensus       590 Gla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~-~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  667 (720)
                      |+|+.....    ......||+.|+|||++ ... ++.++|||||||++|||+||+.||....     .+.+..   .  
T Consensus       156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~~~---~--  221 (273)
T d1xwsa_         156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQ---V--  221 (273)
T ss_dssp             TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHHCC---C--
T ss_pred             ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHhhcc---c--
Confidence            999865332    22346789999999988 334 4678999999999999999999996421     111100   0  


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            .+.+        ..++++.+|+.+||+.||++|||++|+++|
T Consensus       222 ------~~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 ------FFRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ------CCSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------CCCC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                  0111        123578899999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-43  Score=369.00  Aligned_cols=269  Identities=19%  Similarity=0.263  Sum_probs=196.1

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc--------C
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE--------H  510 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~  510 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++..........+++.+|+++|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5788889999999999999965 679999999987655445566788999999999999999999998854        3


Q ss_pred             CeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          511 GQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       511 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                      +..++||||+.++.+.....    ....++......++.|+++||.|||+.   +||||||||+|||++.++.+||+|||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            46899999999877665442    245678888999999999999999987   99999999999999999999999999


Q ss_pred             CCCCCCCCCCc--ccccCccccccCCCCccCC--CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC
Q 004994          591 LAPLLFSGSTN--ELSEGLLTAHGSGAPEFES--GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH  666 (720)
Q Consensus       591 la~~~~~~~~~--~~~~~~~~~~~~~aPE~~~--~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  666 (720)
                      +++.+......  .......+|++|+|||.+.  ..|+.++|||||||++|||+||+.||...........+........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99776433221  2223456899999999873  3589999999999999999999999976443222111111110000


Q ss_pred             --------chhhhhhhcCCCCCchhh------HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 --------DIDALSRMVDPSLDGAYL------AKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 --------~~~~~~~~~~~~~~~~~~------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                              ..................      ....+.+.+|+.+||+.||++|||++|+++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence                    000000000000000000      1123467899999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=373.06  Aligned_cols=264  Identities=18%  Similarity=0.272  Sum_probs=194.6

Q ss_pred             HhcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC-----
Q 004994          438 YTNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG-----  511 (720)
Q Consensus       438 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----  511 (720)
                      +.+.|+..+.||+|+||+||+|.. .+|+.||||++++........+.+.+|+++|++++|||||+++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            356788889999999999999964 57999999999866555556678999999999999999999999997554     


Q ss_pred             -eEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEcccc
Q 004994          512 -QHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCG  590 (720)
Q Consensus       512 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG  590 (720)
                       +.++||||+ +.+|..+.+     ...+++.....++.|++.||+|||+.   +||||||||+|||++.++.+|++|||
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence             579999999 457777663     34689999999999999999999987   99999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccCccccccCCCCccC-C-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc---
Q 004994          591 LAPLLFSGSTNELSEGLLTAHGSGAPEFE-S-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL---  665 (720)
Q Consensus       591 la~~~~~~~~~~~~~~~~~~~~~~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~---  665 (720)
                      +|+.....     .....+++.|+|||.+ . ..++.++||||+||++|||++|+.||...................   
T Consensus       167 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (346)
T d1cm8a_         167 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE  241 (346)
T ss_dssp             TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence            99876432     2335688999999987 3 357899999999999999999999997653222111110000000   


Q ss_pred             -----C--chhhhhhhcCCCCC---chhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          666 -----H--DIDALSRMVDPSLD---GAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       666 -----~--~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                           .  ..............   ........+++.+|+.+||+.||++|||++|+++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                 0  00000000000000   00111223567899999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-43  Score=373.44  Aligned_cols=261  Identities=23%  Similarity=0.312  Sum_probs=190.9

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc------CCeE
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE------HGQH  513 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~  513 (720)
                      +|+..++||+|+||+||+|+. .+|+.||||++.+...      .+.+|++++++++|||||+++++|..      ..+.
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            467778999999999999965 5799999999975422      22478999999999999999999843      3357


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-CeEEccccCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLA  592 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla  592 (720)
                      ++||||++++.+..+. ........+++..+..++.|+++||+|||+.   +||||||||+|||++.++ .+||+|||++
T Consensus        95 ~lv~Ey~~~~~~~~l~-~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          95 NLVLDYVPETVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEECCSEEHHHHHH-HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEeccCCccHHHHH-hhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            8999999876444433 2223456789999999999999999999987   999999999999999775 8999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchhh
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDIDA  670 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  670 (720)
                      +.+....   ......++..|+|||..  ...|+.++||||+||++|||++|+.||......+....+....... ..+.
T Consensus       171 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~-~~~~  246 (350)
T d1q5ka_         171 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP-TREQ  246 (350)
T ss_dssp             EECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC-CHHH
T ss_pred             hhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC-hHHh
Confidence            8764332   22345688899999976  3468999999999999999999999997543222111110000000 0000


Q ss_pred             hhhhc----C---CC-----CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          671 LSRMV----D---PS-----LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       671 ~~~~~----~---~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      .....    +   +.     .........++++.+|+.+||+.||++|||++|+++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000    0   00     0000111234578899999999999999999999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=358.28  Aligned_cols=267  Identities=17%  Similarity=0.226  Sum_probs=203.7

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCCeEEEEEe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHGQHLLVYD  518 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  518 (720)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++.........+.+.+|+++++.++|||||+++++|.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4688889999999999999965 679999999997655555567889999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCCCCCCC
Q 004994          519 YGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAPLLFSG  598 (720)
Q Consensus       519 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~  598 (720)
                      |+.++++..++..    ...+++..+..++.|+++||+|||+.   +||||||||+|||++.++++||+|||.|+.....
T Consensus        82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999998887743    35678889999999999999999997   9999999999999999999999999999876443


Q ss_pred             CCcccccCccccccCCCCccCC-C-CCCCccchHhHHHHHHHHHhCCCCCCCCCCcccc-chhhh--cccccCchhhhhh
Q 004994          599 STNELSEGLLTAHGSGAPEFES-G-SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQ-SLVRW--AIPRLHDIDALSR  673 (720)
Q Consensus       599 ~~~~~~~~~~~~~~~~aPE~~~-~-~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~--~~~~~~~~~~~~~  673 (720)
                      ..  ......++..|+|||.+. . .++.++|||||||++|||++|+.||......... ..+..  ..+.-........
T Consensus       155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence            22  222345677899999873 3 4789999999999999999999997543322211 00000  0000000000000


Q ss_pred             hcCC---------CCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          674 MVDP---------SLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       674 ~~~~---------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ..+.         ...........+++.+|+.+||+.||.+|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000         00001112234578899999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-43  Score=369.48  Aligned_cols=268  Identities=19%  Similarity=0.268  Sum_probs=196.4

Q ss_pred             hcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEeccCC----eE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNEHG----QH  513 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~  513 (720)
                      +.+|...+.||+|+||+||+|. ..+|+.||||++.+.. .....+.+.+|+++|++++|||||++++++....    ..
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            4568888999999999999995 4689999999997532 2445568899999999999999999999986543    34


Q ss_pred             EEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          514 LLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       514 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      +++++|+.+|+|.+++..     ..+++.....++.|+++||+|||+.   +||||||||+|||++.++.+||+|||+|+
T Consensus        86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            556677788999999852     3689999999999999999999987   99999999999999999999999999998


Q ss_pred             CCCCCCC-cccccCccccccCCCCccC--CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCch--
Q 004994          594 LLFSGST-NELSEGLLTAHGSGAPEFE--SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDI--  668 (720)
Q Consensus       594 ~~~~~~~-~~~~~~~~~~~~~~aPE~~--~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--  668 (720)
                      ....... ........+++.|+|||.+  ...++.++||||+||++|||++|+.||......................  
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            7644322 2223446688999999987  3457899999999999999999999997644322111110000000000  


Q ss_pred             ------hhhhhh-cCCCCCc----hhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          669 ------DALSRM-VDPSLDG----AYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       669 ------~~~~~~-~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                            ...... ..+....    ........++.+|+.+||+.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  000000 0000000    0011123568899999999999999999999976

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-41  Score=353.13  Aligned_cols=258  Identities=20%  Similarity=0.248  Sum_probs=193.3

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCcee-EEEeEeccCCeEEEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV-ELIGYCNEHGQHLLVY  517 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lv~  517 (720)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++.....    .+++..|++++++++|+|+| .+.+++.+.+..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            4688899999999999999965 6799999999865322    23578899999999877655 5555667788899999


Q ss_pred             eeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEc---CCCCeEEccccCCCC
Q 004994          518 DYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLD---EKLIVRVSDCGLAPL  594 (720)
Q Consensus       518 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~~  594 (720)
                      ||+++ ++.+.+..   ....+++..+..++.|+++||+|||+.   +||||||||+|||++   .+..+||+|||+|+.
T Consensus        83 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          83 ELLGP-SLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             ECCCC-BHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEcCC-chhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            99865 66655532   245689999999999999999999997   999999999999985   456799999999988


Q ss_pred             CCCCCCc-----ccccCccccccCCCCccCC-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh-hhcccccCc
Q 004994          595 LFSGSTN-----ELSEGLLTAHGSGAPEFES-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWAIPRLHD  667 (720)
Q Consensus       595 ~~~~~~~-----~~~~~~~~~~~~~aPE~~~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~~~~~~  667 (720)
                      +......     .......||+.|+|||... ..++.++|||||||++|||+||+.||............ .+...    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~----  231 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----  231 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH----
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc----
Confidence            7543322     1233467899999999984 46999999999999999999999999764432221111 11000    


Q ss_pred             hhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          668 IDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       668 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                           ....+  ........++++.+++.+||+.+|++||+++++.+.|+++
T Consensus       232 -----~~~~~--~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         232 -----KMSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             -----HHHSC--HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             -----cCCCC--hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                 00000  0001112346789999999999999999999998888764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-41  Score=351.89  Aligned_cols=260  Identities=17%  Similarity=0.163  Sum_probs=201.1

Q ss_pred             hcCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCC-CceeEEEeEeccCCeEEEE
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH-GNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv  516 (720)
                      .++|...+.||+|+||+||+|+. .+|+.||||++.....    .+.+.+|++.++.+.| +|++.+++++.+....++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            35788899999999999999965 5799999999864322    2346778888888865 8999999999999999999


Q ss_pred             EeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcC-----CCCeEEccccC
Q 004994          517 YDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDE-----KLIVRVSDCGL  591 (720)
Q Consensus       517 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~-----~~~~kl~DFGl  591 (720)
                      |||+ +++|.+++..   ....+++.....++.+++.||+|||+.   +||||||||+|||++.     ++.+||+|||+
T Consensus        80 me~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          80 IDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence            9998 5799988853   235689999999999999999999987   9999999999999974     57899999999


Q ss_pred             CCCCCCCCCc-----ccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhccccc
Q 004994          592 APLLFSGSTN-----ELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRL  665 (720)
Q Consensus       592 a~~~~~~~~~-----~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~  665 (720)
                      |+.+......     .......||+.|+|||.. ...++.++|||||||++|||+||+.||................   
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~---  229 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG---  229 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH---
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH---
Confidence            9876543221     122345789999999988 4569999999999999999999999997544332211111000   


Q ss_pred             CchhhhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 004994          666 HDIDALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQDLLCM  719 (720)
Q Consensus       666 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~  719 (720)
                       ..   ....   .........++++.+++..|+..+|++||+++.+.+.|+++
T Consensus       230 -~~---~~~~---~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         230 -EK---KQST---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             -HH---HHHS---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             -hc---cCCC---ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence             00   0000   00001112346788999999999999999999999888875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.3e-42  Score=359.78  Aligned_cols=258  Identities=16%  Similarity=0.254  Sum_probs=194.6

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEecc--CCeEEE
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNE--HGQHLL  515 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~l  515 (720)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++..     ..+++.+|+++|++++ ||||+++++++..  ....++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            5788899999999999999965 67999999998642     3467889999999995 9999999999864  457899


Q ss_pred             EEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCC-CeEEccccCCCC
Q 004994          516 VYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKL-IVRVSDCGLAPL  594 (720)
Q Consensus       516 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~  594 (720)
                      ||||+++++|.++.       +.+++.....++.|+++||.|||+.   +||||||||+|||++.++ .+||+|||+|+.
T Consensus       110 v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         110 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence            99999999987654       3588889999999999999999997   999999999999998655 689999999987


Q ss_pred             CCCCCCcccccCccccccCCCCccCCC--CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc--hhh---------hc
Q 004994          595 LFSGSTNELSEGLLTAHGSGAPEFESG--SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS--LVR---------WA  661 (720)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~--~~~---------~~  661 (720)
                      .....   ......+|..|+|||...+  .++.++||||+||++|||++|+.||..........  +..         +.
T Consensus       180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  256 (328)
T d3bqca1         180 YHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  256 (328)
T ss_dssp             CCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             ccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence            64432   2234567889999998733  48999999999999999999999997543321100  000         00


Q ss_pred             -ccccCchhhhhhhcCCC--------CCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          662 -IPRLHDIDALSRMVDPS--------LDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       662 -~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                       .................        ..........+++.+|+.+||+.||++|||++|+++|
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00000000000000000        0001112234678899999999999999999999974

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=360.22  Aligned_cols=263  Identities=17%  Similarity=0.203  Sum_probs=191.0

Q ss_pred             cCCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc------CCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE------HGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~  512 (720)
                      ++|.+.+.||+|+||+||+|.. .+|+.||||++.+..........+.+|++++++++|||||+++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6788899999999999999965 579999999998665555556778999999999999999999999953      368


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .|+||||+.++.+. .+.      ..+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence            89999999875444 332      3578899999999999999999998   9999999999999999999999999998


Q ss_pred             CCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchh-hhcc-------c
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLV-RWAI-------P  663 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~-~~~~-------~  663 (720)
                      +......   ......+|+.|+|||.+ ...++.++||||+||++|||++|+.||...........+ ....       .
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            8664322   22345678999999998 457899999999999999999999999754321110000 0000       0


Q ss_pred             ccCc-------------hhhhhhhcC---CCCCchhhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          664 RLHD-------------IDALSRMVD---PSLDGAYLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       664 ~~~~-------------~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                      ....             .........   ...........+.++.+|+.+||+.||++|||++|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000             000000010   011112334456789999999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-42  Score=361.00  Aligned_cols=254  Identities=25%  Similarity=0.306  Sum_probs=198.4

Q ss_pred             cCCCCCCeeccCCCceEEEEEe----CCCcEEEEEEeccccc--ccccHHHHHHHHHHHHccCC-CceeEEEeEeccCCe
Q 004994          440 NSFSEGNFIGEGLLGSVYKAEL----PGGKLLAVKKLSNTVS--QRQTDEEFLELASTISRLRH-GNIVELIGYCNEHGQ  512 (720)
Q Consensus       440 ~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~  512 (720)
                      ++|+..+.||+|+||+||+|..    .+|+.||||++.+...  .....+.+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5688899999999999999964    2588999999975432  22344678899999999976 899999999999999


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .+++|||+.+|+|.+++..    ...+.......++.|++.||+|+|+.   +||||||||+|||++.++.+||+|||+|
T Consensus       104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence            9999999999999999853    34567778888999999999999997   8999999999999999999999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccCCC---CCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccCchh
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFESG---SYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLHDID  669 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  669 (720)
                      +.+..... .......+++.|++||...+   .++.++|||||||+||||+||+.||...........+.          
T Consensus       177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~----------  245 (322)
T d1vzoa_         177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS----------  245 (322)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH----------
T ss_pred             hhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence            87643322 22334668889999998732   47889999999999999999999997654332211110          


Q ss_pred             hhhhhcCCCCCchhhHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 004994          670 ALSRMVDPSLDGAYLAKSLSRFADIISRCVQWEPGFRP-----PMSEIVQD  715 (720)
Q Consensus       670 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  715 (720)
                        ........  ..+...++++.+++.+||+.||++||     |++|+++|
T Consensus       246 --~~~~~~~~--~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         246 --RRILKSEP--PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             --HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             --HhcccCCC--CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence              00000000  01122346788999999999999999     58999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=361.77  Aligned_cols=264  Identities=19%  Similarity=0.267  Sum_probs=196.3

Q ss_pred             hcCCCCCCeeccCCCceEEEEE-eCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCceeEEEeEecc-----CCe
Q 004994          439 TNSFSEGNFIGEGLLGSVYKAE-LPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIVELIGYCNE-----HGQ  512 (720)
Q Consensus       439 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~  512 (720)
                      .++|+..+.||+|+||+||+|. ..+|+.||||++.+........+.+.+|++++++++|||||++++++..     ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4678889999999999999996 4679999999998665555566788999999999999999999999853     334


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEccccCC
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVSDCGLA  592 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla  592 (720)
                      .++++||+.+|+|.+++..     ..+++.....++.|++.||+|||+.   +||||||||+|||++.++.+|++|||+|
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            5677888899999999853     3589999999999999999999987   9999999999999999999999999999


Q ss_pred             CCCCCCCCcccccCccccccCCCCccC-C-CCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccchhhhcccccC----
Q 004994          593 PLLFSGSTNELSEGLLTAHGSGAPEFE-S-GSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQSLVRWAIPRLH----  666 (720)
Q Consensus       593 ~~~~~~~~~~~~~~~~~~~~~~aPE~~-~-~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----  666 (720)
                      .....     ......++..|+|||.. . ..++.++|||||||++|||++|+.||...+.......+........    
T Consensus       169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            76522     23345688899999976 3 3468999999999999999999999976432221111110000000    


Q ss_pred             ---chhhhhhhcC--CCCCch----hhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 004994          667 ---DIDALSRMVD--PSLDGA----YLAKSLSRFADIISRCVQWEPGFRPPMSEIVQD  715 (720)
Q Consensus       667 ---~~~~~~~~~~--~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  715 (720)
                         ..........  ......    ......+++.+|+.+||+.||++|||++|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence               0000000000  000000    011234578899999999999999999999974

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-36  Score=322.03  Aligned_cols=264  Identities=15%  Similarity=0.195  Sum_probs=185.6

Q ss_pred             CCCCCCeeccCCCceEEEEEe-CCCcEEEEEEecccccccccHHHHHHHHHHHHccC-----------CCceeEEEeEec
Q 004994          441 SFSEGNFIGEGLLGSVYKAEL-PGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-----------HGNIVELIGYCN  508 (720)
Q Consensus       441 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~  508 (720)
                      +|+..+.||+|+||+||+|+. .+|+.||||++++.   ....+.+.+|++++++++           |+|||++++++.
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            488899999999999999965 67999999999754   233467788888888775           578999998875


Q ss_pred             c--CCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCC---
Q 004994          509 E--HGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLI---  583 (720)
Q Consensus       509 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~---  583 (720)
                      .  ....+++++++..+........ ......+++..+..++.+++.||+|||+.  .+|+||||||+|||++.++.   
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred             eccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccc
Confidence            4  3566777777655443322211 12345678888999999999999999983  28999999999999987653   


Q ss_pred             ---eEEccccCCCCCCCCCCcccccCccccccCCCCccC-CCCCCCccchHhHHHHHHHHHhCCCCCCCCCCccccc---
Q 004994          584 ---VRVSDCGLAPLLFSGSTNELSEGLLTAHGSGAPEFE-SGSYSCQSDVYSLGVVMLELLTGRKPYDRSRPRGEQS---  656 (720)
Q Consensus       584 ---~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~Dv~S~Gvvl~elltG~~Pf~~~~~~~~~~---  656 (720)
                         +|++|||.|.....     ......+++.|+|||.. ...++.++||||+||+++||++|+.||..........   
T Consensus       168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence               99999999976532     22345688999999987 6679999999999999999999999996533211110   


Q ss_pred             -hhh--hcccccCchh-----hhhhhcC---------CCC----------CchhhHHHHHHHHHHHHHHhccCCCCCCCH
Q 004994          657 -LVR--WAIPRLHDID-----ALSRMVD---------PSL----------DGAYLAKSLSRFADIISRCVQWEPGFRPPM  709 (720)
Q Consensus       657 -~~~--~~~~~~~~~~-----~~~~~~~---------~~~----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  709 (720)
                       ...  +.........     ......+         ...          ........+.++.+|+.+||+.||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence             000  0000000000     0000000         000          011234566789999999999999999999


Q ss_pred             HHHHHH
Q 004994          710 SEIVQD  715 (720)
Q Consensus       710 ~evl~~  715 (720)
                      +|+++|
T Consensus       323 ~e~L~H  328 (362)
T d1q8ya_         323 GGLVNH  328 (362)
T ss_dssp             HHHHTC
T ss_pred             HHHhcC
Confidence            999986

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=1e-31  Score=280.13  Aligned_cols=225  Identities=26%  Similarity=0.522  Sum_probs=188.3

Q ss_pred             CCCHHHHHHHHHHHHhcCCC-CCCCccCCCCCCCCCCCceeEeecC----ceeEEEecCCcccc--cCCcCcCCCCCccE
Q 004994           27 VTDPRDVMALNSLYISLNFP-PLEKWLSFGGDPCGDSWQGVFCVFS----NVTEIRLTGMNLGG--VLADTLGDLESVIN   99 (720)
Q Consensus        27 ~~~~~~~~al~~~~~~l~~~-~~~~w~~~~~~~c~~~w~gv~c~~~----~l~~l~L~~n~l~~--~~~~~~~~l~~L~~   99 (720)
                      .|.|+|++||++||+++.+| .+.+|.. ++|||.+.|.||.|+..    +|+.|+|++|+++|  .+|+.+++|++|++
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~   80 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF   80 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred             CCCHHHHHHHHHHHHHCCCCCcCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence            48999999999999999888 6889975 78999778999999753    69999999999998  58899999999999


Q ss_pred             EeccC-CcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCc
Q 004994          100 IDLSN-NHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANN  176 (720)
Q Consensus       100 L~L~~-N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~  176 (720)
                      |+|++ |+|+|.+|..+.  .+|++|+|++|+|.+..|..+..+..|+.+++++|++.+.+|..|.+++.|+.+++++|.
T Consensus        81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~  160 (313)
T d1ogqa_          81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR  160 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred             cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence            99996 999999999997  799999999999998888888888889999999998888888888888888888888888


Q ss_pred             ccccCCCCCCCCCCC-ceeecccccccc-----------------------------------------------ccccc
Q 004994          177 LTGQLPPSTRNLSSL-YSLHLQNNKLSG-----------------------------------------------TLNVL  208 (720)
Q Consensus       177 l~g~~p~~~~~l~~L-~~L~l~~N~l~~-----------------------------------------------~~~~~  208 (720)
                      ++|.+|..+..+.+| +.+++++|++++                                               .++.+
T Consensus       161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~  240 (313)
T d1ogqa_         161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV  240 (313)
T ss_dssp             CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            888888777666654 566666665543                                               22222


Q ss_pred             ccc-ccceEEccCCcCcccCCcccCCCccccccCccCCCcccCCC
Q 004994          209 EDL-HLIDLNIENNLFSGPIPEKLLSIPNFRKDGNPFNTTVIALP  252 (720)
Q Consensus       209 ~~~-~l~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~~~~~~~  252 (720)
                      ... .++.|+|++|+|+|.+|..|.++++|+..+...|...+.+|
T Consensus       241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP  285 (313)
T d1ogqa_         241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC
Confidence            222 37789999999999999999988888887777776665555

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1.1e-23  Score=202.01  Aligned_cols=170  Identities=14%  Similarity=0.068  Sum_probs=120.1

Q ss_pred             CCCeeccCCCceEEEEEeCCCcEEEEEEecccccc----------------cccHHHHHHHHHHHHccCCCceeEEEeEe
Q 004994          444 EGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQ----------------RQTDEEFLELASTISRLRHGNIVELIGYC  507 (720)
Q Consensus       444 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----------------~~~~~~~~~e~~~l~~l~H~niv~l~~~~  507 (720)
                      .++.||+|+||+||+|...+|+.||||+++.....                .........|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            46889999999999998888999999987532110                01123456688899999999999988764


Q ss_pred             ccCCeEEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEEcCCCCeEEc
Q 004994          508 NEHGQHLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVCEPPIVHGNFKSSNILLDEKLIVRVS  587 (720)
Q Consensus       508 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~  587 (720)
                      .    .+++|||+++..+.+           ++.....+++.+++++++|||+.   +|+||||||+|||++++ .++|+
T Consensus        84 ~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          84 G----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             T----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             C----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence            3    379999998865433           22333457899999999999997   99999999999999976 48999


Q ss_pred             cccCCCCCCCCCCcccccCccccccCCCCccCCCCCCCccchHhHHHHH
Q 004994          588 DCGLAPLLFSGSTNELSEGLLTAHGSGAPEFESGSYSCQSDVYSLGVVM  636 (720)
Q Consensus       588 DFGla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~Dv~S~Gvvl  636 (720)
                      |||.|..................    -.+++.+.|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~~~l~rd~~~----~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWREILERDVRN----IITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHHHHHH----HHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHHHHHH----HHHHHcCCCCCcccHHHHHHHH
Confidence            99999765432211100000000    0123345678899999965433

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.84  E-value=2.1e-21  Score=201.17  Aligned_cols=176  Identities=27%  Similarity=0.459  Sum_probs=136.7

Q ss_pred             EeecCceeEEEecC-CcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccc
Q 004994           67 FCVFSNVTEIRLTG-MNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQL  143 (720)
Q Consensus        67 ~c~~~~l~~l~L~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L  143 (720)
                      ++.+++|+.|+|++ |+++|.+|+.|++|++|++|+|++|+|.+..|..+.  .+|+.+++++|++.+.+|..++++++|
T Consensus        72 l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L  151 (313)
T d1ogqa_          72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL  151 (313)
T ss_dssp             GGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC
T ss_pred             HhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccc
Confidence            34578999999997 899999999999999999999999999987776555  568888888888888888888888888


Q ss_pred             ccccccccccCCCCCchhcCCCC------------------------------------------------CceEeccCC
Q 004994          144 LDLSLNNNHLNGGIPDAFHQFTG------------------------------------------------LINFDLSAN  175 (720)
Q Consensus       144 ~~L~l~~N~l~g~~p~~~~~l~~------------------------------------------------L~~L~ls~N  175 (720)
                      +.+++++|.++|.+|..+..+.+                                                |+.|++++|
T Consensus       152 ~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~  231 (313)
T d1ogqa_         152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN  231 (313)
T ss_dssp             CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSS
T ss_pred             ceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            88888887777777765554444                                                344445555


Q ss_pred             cccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCcccCCcccCCCcccc---ccCccC
Q 004994          176 NLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSGPIPEKLLSIPNFR---KDGNPF  244 (720)
Q Consensus       176 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g~~p~~~~~l~~l~---~~~n~~  244 (720)
                      .+++.+| .++.+++|+.|+|++|+|+|.+| .+..+. |+.|+|++|+|+|.+|. ++++++|+   +.+|+.
T Consensus       232 ~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~  303 (313)
T d1ogqa_         232 SLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC  303 (313)
T ss_dssp             EECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSE
T ss_pred             ccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCcc
Confidence            5554433 46677899999999999998765 577766 99999999999999996 45555555   455543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=2.2e-20  Score=188.63  Aligned_cols=175  Identities=23%  Similarity=0.220  Sum_probs=153.2

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCC-ccccCcEEEecCCcCCCCCcchhhccccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN-LPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN  149 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~-~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~  149 (720)
                      ++++.|+|++|+|++..+..|.++++|++|+|++|+|+ .+|.. ..++|+.|+|++|+++ .+|..+.++++|+.|+++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~  108 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS  108 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred             cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccccccccccccccccccccc-cccccccccccccccccc
Confidence            47999999999999887889999999999999999998 56643 2378999999999999 567789999999999999


Q ss_pred             ccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccc-ccccc-cceEEccCCcCcccC
Q 004994          150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNV-LEDLH-LIDLNIENNLFSGPI  227 (720)
Q Consensus       150 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~-l~~l~l~~N~l~g~~  227 (720)
                      +|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|++.++. +..+. |+.|+|++|+|+ .+
T Consensus       109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l  187 (266)
T d1p9ag_         109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI  187 (266)
T ss_dssp             SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred             ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-cc
Confidence            9999988888899999999999999999966677788999999999999999988753 55554 999999999999 89


Q ss_pred             CcccCCCcc---ccccCccCCCcc
Q 004994          228 PEKLLSIPN---FRKDGNPFNTTV  248 (720)
Q Consensus       228 p~~~~~l~~---l~~~~n~~~~~~  248 (720)
                      |+.+..++.   |.+.||||.|.|
T Consensus       188 p~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         188 PKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             ChhHCCCCCCCEEEecCCCCCCCc
Confidence            987766554   557899998765

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.78  E-value=3.7e-19  Score=170.06  Aligned_cols=170  Identities=20%  Similarity=0.254  Sum_probs=140.3

Q ss_pred             EEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCc-c--ccCcEEEecCCcCCCCCcchhhccccccccccccc
Q 004994           75 EIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNL-P--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNN  151 (720)
Q Consensus        75 ~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~-~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N  151 (720)
                      .++.++++|+ .+|..+.  +++++|+|++|+|++.++... .  .+|+.|+|++|++.+..+..+..+++|+.|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            5677788888 5676653  689999999999987675544 3  78999999999999999999999999999999999


Q ss_pred             ccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcCcccCCcc
Q 004994          152 HLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSGPIPEK  230 (720)
Q Consensus       152 ~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l~g~~p~~  230 (720)
                      +|+...|.+|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.......... .+..+.+..|.+....|..
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~  168 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK  168 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChh
Confidence            999888888999999999999999999877888999999999999999998765432211 2556677888888888888


Q ss_pred             cCCCccccccCccCCCc
Q 004994          231 LLSIPNFRKDGNPFNTT  247 (720)
Q Consensus       231 ~~~l~~l~~~~n~~~~~  247 (720)
                      +.+++-+.+..|.+.|.
T Consensus       169 l~~~~l~~L~~n~l~C~  185 (192)
T d1w8aa_         169 VRDVQIKDLPHSEFKCS  185 (192)
T ss_dssp             TTTSBGGGSCTTTCCCC
T ss_pred             hcCCEeeecCHhhCcCC
Confidence            87776666666666543

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=2.1e-18  Score=175.63  Aligned_cols=175  Identities=22%  Similarity=0.247  Sum_probs=100.3

Q ss_pred             ceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc---------------------------ccCcEEEe
Q 004994           72 NVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP---------------------------VTVRNFSL  124 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~---------------------------~~L~~L~L  124 (720)
                      .++.|+|++|+|+...+..|.++++|++|++++|+|.+..+..+.                           ++|++|+|
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l  112 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence            578999999999987778899999999999999999754433222                           34555555


Q ss_pred             cCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccc
Q 004994          125 SGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGT  204 (720)
Q Consensus       125 s~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~  204 (720)
                      ++|.+.+..+..+..+.+|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.+++++|++++.
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i  192 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV  192 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence            55555544444444555555555555555544444455555555555555555544444555555555555555555544


Q ss_pred             cc-cccccc-cceEEccCCcCcccCCcccCCCc---cccccCccCCC
Q 004994          205 LN-VLEDLH-LIDLNIENNLFSGPIPEKLLSIP---NFRKDGNPFNT  246 (720)
Q Consensus       205 ~~-~~~~~~-l~~l~l~~N~l~g~~p~~~~~l~---~l~~~~n~~~~  246 (720)
                      .+ .+..+. |+.|++++|++++..|..|..++   .|.+.+|+|.|
T Consensus       193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence            32 233332 55555555555544444443322   23334444443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=2.8e-17  Score=165.44  Aligned_cols=159  Identities=24%  Similarity=0.213  Sum_probs=139.3

Q ss_pred             CceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcc
Q 004994           63 WQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRL  140 (720)
Q Consensus        63 w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l  140 (720)
                      ..+.|..+++|+.|+|++|+|+.. + .++.+++|++|+|++|+|+ .+|..+.  .+|+.|++++|.+.+..+..+..+
T Consensus        47 ~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l  123 (266)
T d1p9ag_          47 SLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL  123 (266)
T ss_dssp             EGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTC
T ss_pred             CHHHhhcccccccccccccccccc-c-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccc
Confidence            346677889999999999999854 3 4688999999999999999 4555554  789999999999998888889999


Q ss_pred             cccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEcc
Q 004994          141 TQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIE  219 (720)
Q Consensus       141 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~  219 (720)
                      .+|+.|++++|.++...+..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|+..+..+..+ .|+.|+|+
T Consensus       124 ~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~  203 (266)
T d1p9ag_         124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLH  203 (266)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECC
T ss_pred             cccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEec
Confidence            99999999999999777788889999999999999999777788999999999999999999776555544 49999999


Q ss_pred             CCcCc
Q 004994          220 NNLFS  224 (720)
Q Consensus       220 ~N~l~  224 (720)
                      +|.+.
T Consensus       204 ~Np~~  208 (266)
T d1p9ag_         204 GNPWL  208 (266)
T ss_dssp             SCCBC
T ss_pred             CCCCC
Confidence            99886

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.70  E-value=5.7e-17  Score=166.66  Aligned_cols=183  Identities=22%  Similarity=0.319  Sum_probs=110.0

Q ss_pred             CCCCCCceeEeec-----------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEe
Q 004994           58 PCGDSWQGVFCVF-----------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSL  124 (720)
Q Consensus        58 ~c~~~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~L  124 (720)
                      .|.|.|.++.|+.           ++++.|+|++|+|+...+..|.++++|++|++++|.+....|..|.  .+|+.|+|
T Consensus         7 ~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_           7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             TCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence            3555677777742           3466677777777765555677777777777777777744455554  45666666


Q ss_pred             cCCcCCCCCc------------------------------------------------chhhcccccccccccccccCCC
Q 004994          125 SGNQLTGSIP------------------------------------------------ESLSRLTQLLDLSLNNNHLNGG  156 (720)
Q Consensus       125 s~N~l~g~~p------------------------------------------------~~l~~l~~L~~L~l~~N~l~g~  156 (720)
                      ++|+++ .+|                                                ..+..+++|+.+++++|.++ .
T Consensus        87 ~~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~  164 (305)
T d1xkua_          87 SKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T  164 (305)
T ss_dssp             CSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-S
T ss_pred             cCCccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-c
Confidence            666554 222                                                12223344555555555554 3


Q ss_pred             CCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-ccccc-ccceEEccCCcCcccCCcccCCC
Q 004994          157 IPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDL-HLIDLNIENNLFSGPIPEKLLSI  234 (720)
Q Consensus       157 ~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~-~l~~l~l~~N~l~g~~p~~~~~l  234 (720)
                      +|..+  +++|+.|++++|.+++..+..+.+++.++.|++++|.+++..+ .+..+ .|++|+|++|+|+ .+|..+.++
T Consensus       165 l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l  241 (305)
T d1xkua_         165 IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH  241 (305)
T ss_dssp             CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred             cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccc
Confidence            33322  4566666676666666666677777777777777777766543 33333 3777777777776 566666666


Q ss_pred             ccccccCccCC
Q 004994          235 PNFRKDGNPFN  245 (720)
Q Consensus       235 ~~l~~~~n~~~  245 (720)
                      ++|+..+.+.|
T Consensus       242 ~~L~~L~Ls~N  252 (305)
T d1xkua_         242 KYIQVVYLHNN  252 (305)
T ss_dssp             SSCCEEECCSS
T ss_pred             cCCCEEECCCC
Confidence            66655444443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.68  E-value=5.6e-17  Score=154.67  Aligned_cols=130  Identities=25%  Similarity=0.395  Sum_probs=116.9

Q ss_pred             ccEEeccCCcccccCCCCccccCcEEEecCCcCCCCC-cchhhcccccccccccccccCCCCCchhcCCCCCceEeccCC
Q 004994           97 VINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSI-PESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSAN  175 (720)
Q Consensus        97 L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~-p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N  175 (720)
                      .+.++.++|+|+ .||..++.++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|++|+|++|
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CCEEEEeCCCcC-ccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            357999999999 999999999999999999998755 566899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccCCcCcccC
Q 004994          176 NLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIENNLFSGPI  227 (720)
Q Consensus       176 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~N~l~g~~  227 (720)
                      +|++..|..|.++++|+.|+|++|+|++.++ .+..+. |++|+|++|.+....
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~  142 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence            9997778889999999999999999999875 455554 999999999987543

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=4.1e-17  Score=165.98  Aligned_cols=163  Identities=21%  Similarity=0.254  Sum_probs=138.4

Q ss_pred             eEeecCceeEEEe-cCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccc
Q 004994           66 VFCVFSNVTEIRL-TGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQ  142 (720)
Q Consensus        66 v~c~~~~l~~l~L-~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~  142 (720)
                      .++....+..+.. ..|.++...+..|.++++|++|+|++|.+.+..+..+.  .+|+.+++++|+|++..+..|..+++
T Consensus        75 ~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~  154 (284)
T d1ozna_          75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN  154 (284)
T ss_dssp             TTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             cccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccc
Confidence            3444566777765 46677777788899999999999999999855554454  68999999999999777788999999


Q ss_pred             cccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccc-cccccc-cceEEccC
Q 004994          143 LLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLN-VLEDLH-LIDLNIEN  220 (720)
Q Consensus       143 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~-l~~l~l~~  220 (720)
                      |+.|+|++|+|++..|.+|.++++|+.+++++|++++..|..|.++++|+.|++++|++++.++ .+..+. |+.|+|++
T Consensus       155 L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~  234 (284)
T d1ozna_         155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND  234 (284)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCS
T ss_pred             hhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecC
Confidence            9999999999998888899999999999999999998889999999999999999999998875 455554 99999999


Q ss_pred             CcCcccCC
Q 004994          221 NLFSGPIP  228 (720)
Q Consensus       221 N~l~g~~p  228 (720)
                      |.+.+.-+
T Consensus       235 N~l~C~C~  242 (284)
T d1ozna_         235 NPWVCDCR  242 (284)
T ss_dssp             SCEECSGG
T ss_pred             CCCCCCcc
Confidence            99986543

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.60  E-value=2.1e-15  Score=144.41  Aligned_cols=157  Identities=27%  Similarity=0.444  Sum_probs=130.0

Q ss_pred             ecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      .+.+++.|++++|+++..  +.+..+++|++|+|++|+|++..|  +.  ++|+.|++++|.+. .++ .+.++++|+.|
T Consensus        38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L  111 (199)
T d2omxa2          38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGL  111 (199)
T ss_dssp             HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEE
T ss_pred             HhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccc
Confidence            357899999999999853  358889999999999999995433  43  68999999999998 555 48999999999


Q ss_pred             cccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcCcc
Q 004994          147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSG  225 (720)
Q Consensus       147 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l~g  225 (720)
                      ++++|.+...  ..+..+++|+.|++++|++. .++ .+..+++|+.|++++|++++..+ +..+ .|+.|++++|+++.
T Consensus       112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~i~~  186 (199)
T d2omxa2         112 TLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNKVSD  186 (199)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC
T ss_pred             cccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCCcc-ccCCCCCCEEECCCCCCCC
Confidence            9999999743  35889999999999999997 454 58899999999999999988654 4444 49999999999985


Q ss_pred             cCCcccCCCcccc
Q 004994          226 PIPEKLLSIPNFR  238 (720)
Q Consensus       226 ~~p~~~~~l~~l~  238 (720)
                       +| .+..+++|+
T Consensus       187 -i~-~l~~L~~L~  197 (199)
T d2omxa2         187 -IS-VLAKLTNLE  197 (199)
T ss_dssp             -CG-GGGGCTTCS
T ss_pred             -Cc-cccCCCCCC
Confidence             44 466666665

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.60  E-value=2.6e-15  Score=154.00  Aligned_cols=180  Identities=22%  Similarity=0.295  Sum_probs=149.6

Q ss_pred             CceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCC----------------------------
Q 004994           63 WQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN----------------------------  114 (720)
Q Consensus        63 w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~----------------------------  114 (720)
                      ..+.|..+++|+.|++++|.+....|..|..+++|+.|+|++|+|+ .+|..                            
T Consensus        47 ~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~  125 (305)
T d1xkua_          47 KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ  125 (305)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTT
T ss_pred             ChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccchhhhhhhhhccccchhhhhhhhhhcccc
Confidence            4456777889999999999999888889999999999999999987 44420                            


Q ss_pred             --------------------cc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEec
Q 004994          115 --------------------LP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDL  172 (720)
Q Consensus       115 --------------------~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  172 (720)
                                          +.  .+|+.+++++|+++ .+|..+  +++|+.|++++|.+++..+..|.+++.++.|++
T Consensus       126 ~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~  202 (305)
T d1xkua_         126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL  202 (305)
T ss_dssp             CCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEEC
T ss_pred             ccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccc
Confidence                                01  36788899999998 667554  589999999999999999999999999999999


Q ss_pred             cCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcCcccCCc-cc---------CCCccccccC
Q 004994          173 SANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGPIPE-KL---------LSIPNFRKDG  241 (720)
Q Consensus       173 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g~~p~-~~---------~~l~~l~~~~  241 (720)
                      ++|.+++..+..+.++++|+.|+|++|+|+..+..+..+. |+.|+|++|+|+ .++. .|         .++..|.+.+
T Consensus       203 s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~  281 (305)
T d1xkua_         203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFS  281 (305)
T ss_dssp             CSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCS
T ss_pred             ccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCC
Confidence            9999998888899999999999999999998877777665 999999999999 4443 22         3355566888


Q ss_pred             ccCCCc
Q 004994          242 NPFNTT  247 (720)
Q Consensus       242 n~~~~~  247 (720)
                      |+++..
T Consensus       282 N~~~~~  287 (305)
T d1xkua_         282 NPVQYW  287 (305)
T ss_dssp             SSSCGG
T ss_pred             CcCccC
Confidence            988754

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.60  E-value=2.2e-15  Score=145.62  Aligned_cols=161  Identities=22%  Similarity=0.310  Sum_probs=131.4

Q ss_pred             cCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccccccccccc
Q 004994           70 FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN  149 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~  149 (720)
                      +.+|+.|++++|.++...  .+..+++|++|+|++|+|++..|-.-..+|+.|++++|+++ .+| .+.++++|+.|+++
T Consensus        45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~  120 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE  120 (210)
T ss_dssp             HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred             hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCccccccCcccccccccccccc-ccc-cccccccccccccc
Confidence            568999999999998643  48889999999999999995433222378999999999999 455 58999999999999


Q ss_pred             ccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcCcccCC
Q 004994          150 NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSGPIP  228 (720)
Q Consensus       150 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l~g~~p  228 (720)
                      +|.+. .+ ..+.++++|+.+++++|.+++  +..+..+++|+.+++++|++++..+ +..+ .|+.|+|++|+++ .+|
T Consensus       121 ~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i~-~l~  194 (210)
T d1h6ta2         121 HNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS-DLR  194 (210)
T ss_dssp             TSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-BCG
T ss_pred             ccccc-cc-ccccccccccccccccccccc--ccccccccccccccccccccccccc-ccCCCCCCEEECCCCCCC-CCh
Confidence            99987 34 468899999999999999974  3357889999999999999987654 5555 4999999999998 465


Q ss_pred             cccCCCccccccC
Q 004994          229 EKLLSIPNFRKDG  241 (720)
Q Consensus       229 ~~~~~l~~l~~~~  241 (720)
                       .+.++++|+..+
T Consensus       195 -~l~~l~~L~~L~  206 (210)
T d1h6ta2         195 -ALAGLKNLDVLE  206 (210)
T ss_dssp             -GGTTCTTCSEEE
T ss_pred             -hhcCCCCCCEEE
Confidence             577787777654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.51  E-value=2.5e-14  Score=139.89  Aligned_cols=160  Identities=23%  Similarity=0.361  Sum_probs=88.8

Q ss_pred             ecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc-ccCcEEEecCCcCCCCCcchhhccccccccc
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP-VTVRNFSLSGNQLTGSIPESLSRLTQLLDLS  147 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~-~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~  147 (720)
                      .+++|+.|+|++|++++..|  +..+++|++|++++|.++ .++.-.. .+|+.|++++|...+..  .+...+.+..+.
T Consensus        61 ~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~  135 (227)
T d1h6ua2          61 YLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLY  135 (227)
T ss_dssp             GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEE
T ss_pred             cCCCCcEeecCCceeecccc--cccccccccccccccccc-ccccccccccccccccccccccccc--hhccccchhhhh
Confidence            34455555555555544322  445555555555555444 2321111 34555555555544221  233444555555


Q ss_pred             ccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCcCccc
Q 004994          148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNLFSGP  226 (720)
Q Consensus       148 l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~l~g~  226 (720)
                      ++++.+...  ..+.++++|+.|++++|.++. ++ .+.++++|+.|+|++|++++..+ +..+ .|++|+|++|++++ 
T Consensus       136 ~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~-  209 (227)
T d1h6ua2         136 LDLNQITNI--SPLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISD-  209 (227)
T ss_dssp             CCSSCCCCC--GGGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCB-
T ss_pred             chhhhhchh--hhhcccccccccccccccccc-ch-hhcccccceecccCCCccCCChh-hcCCCCCCEEECcCCcCCC-
Confidence            555555422  235667778888888888763 22 36778888888888888876543 4443 48888888888874 


Q ss_pred             CCcccCCCcccccc
Q 004994          227 IPEKLLSIPNFRKD  240 (720)
Q Consensus       227 ~p~~~~~l~~l~~~  240 (720)
                      +|. +.++++|+..
T Consensus       210 i~~-l~~l~~L~~L  222 (227)
T d1h6ua2         210 VSP-LANTSNLFIV  222 (227)
T ss_dssp             CGG-GTTCTTCCEE
T ss_pred             Ccc-cccCCCCCEE
Confidence            332 5566665544

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=5.6e-14  Score=138.66  Aligned_cols=185  Identities=18%  Similarity=0.170  Sum_probs=121.0

Q ss_pred             CCCCCCceeEeec-----------CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCC-cc--ccCcEEE
Q 004994           58 PCGDSWQGVFCVF-----------SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSN-LP--VTVRNFS  123 (720)
Q Consensus        58 ~c~~~w~gv~c~~-----------~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~-~~--~~L~~L~  123 (720)
                      +|.|....+.|..           .++++|+|++|+|+...+..|.++++|++|+|++|.+...+|.. +.  .++++|+
T Consensus         5 ~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~   84 (242)
T d1xwdc1           5 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR   84 (242)
T ss_dssp             SEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred             cCCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccc
Confidence            4666788888852           36899999999999777778999999999999999998777654 33  6788888


Q ss_pred             ec-CCcCCCCCcchhhcccccccccccccccCCCCCc-hhcCCCCCceEeccCCcccccCCCCCCCCC-CCceeeccccc
Q 004994          124 LS-GNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPD-AFHQFTGLINFDLSANNLTGQLPPSTRNLS-SLYSLHLQNNK  200 (720)
Q Consensus       124 Ls-~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~-~L~~L~l~~N~  200 (720)
                      +. .|++....+..|.++++|+.|++++|.+....+. .+..+..+..+..+++.+...-+..+..++ .++.|++++|+
T Consensus        85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~  164 (242)
T d1xwdc1          85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG  164 (242)
T ss_dssp             EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred             ccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccc
Confidence            75 5788877788899999999999999998743322 233344555555566666533344444443 56666666666


Q ss_pred             ccccccc-ccccccceE-EccCCcCcccCCc-ccCCCccccccCcc
Q 004994          201 LSGTLNV-LEDLHLIDL-NIENNLFSGPIPE-KLLSIPNFRKDGNP  243 (720)
Q Consensus       201 l~~~~~~-~~~~~l~~l-~l~~N~l~g~~p~-~~~~l~~l~~~~n~  243 (720)
                      ++..... +....+..+ ++++|+++ .+|. .|..+++|+..+.+
T Consensus       165 l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls  209 (242)
T d1xwdc1         165 IQEIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDIS  209 (242)
T ss_dssp             CCEECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECT
T ss_pred             ccccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECC
Confidence            6654432 222333333 34555555 3332 34444444443333

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.49  E-value=5.6e-14  Score=135.51  Aligned_cols=146  Identities=28%  Similarity=0.397  Sum_probs=122.1

Q ss_pred             CceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcc
Q 004994           63 WQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRL  140 (720)
Q Consensus        63 w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l  140 (720)
                      ..|+ ..+++|++|+|++|++++..  .++.+++|++|+|++|+|+ .+|. +.  ++|+.|++++|.+. .++ .+.++
T Consensus        61 l~~l-~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~~-l~~l~~L~~L~l~~~~~~-~~~-~l~~l  133 (210)
T d1h6ta2          61 VQGI-QYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DIN-GLVHL  133 (210)
T ss_dssp             CTTG-GGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGGG-GTTCTTCCEEECTTSCCC-CCG-GGGGC
T ss_pred             chhH-hhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc-cccc-cccccccccccccccccc-ccc-ccccc
Confidence            4453 45789999999999999753  4789999999999999998 4653 33  78999999999997 444 68999


Q ss_pred             cccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEcc
Q 004994          141 TQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIE  219 (720)
Q Consensus       141 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~  219 (720)
                      ++|+.+++++|.+++  +..+..+++|+.+++++|++++ +++ +.++++|+.|+|++|+|+.. +.+..+. |+.|+|+
T Consensus       134 ~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         134 PQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELF  208 (210)
T ss_dssp             TTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEE
T ss_pred             ccccccccccccccc--cccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCCCC-hhhcCCCCCCEEEcc
Confidence            999999999999974  3468889999999999999984 543 88999999999999999865 4566654 9999987


Q ss_pred             C
Q 004994          220 N  220 (720)
Q Consensus       220 ~  220 (720)
                      +
T Consensus       209 ~  209 (210)
T d1h6ta2         209 S  209 (210)
T ss_dssp             E
T ss_pred             C
Confidence            5

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.48  E-value=4.6e-14  Score=123.46  Aligned_cols=81  Identities=28%  Similarity=0.354  Sum_probs=38.1

Q ss_pred             cCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCC--CCCCCCCCCceee
Q 004994          118 TVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLP--PSTRNLSSLYSLH  195 (720)
Q Consensus       118 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p--~~~~~l~~L~~L~  195 (720)
                      +|++|+|++|+|+ .+|+.++.+++|+.|++++|+|++ +| .++.+++|+.|++++|+|+ .+|  ..+..+++|+.|+
T Consensus        21 ~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L~   96 (124)
T d1dcea3          21 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLN   96 (124)
T ss_dssp             TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccC-CCCCchhhcCCCCCCEEE
Confidence            3444444444443 344445555555555555555542 33 2455555555555555554 222  2344455555555


Q ss_pred             ccccccc
Q 004994          196 LQNNKLS  202 (720)
Q Consensus       196 l~~N~l~  202 (720)
                      +++|+++
T Consensus        97 l~~N~i~  103 (124)
T d1dcea3          97 LQGNSLC  103 (124)
T ss_dssp             CTTSGGG
T ss_pred             CCCCcCC
Confidence            5555544

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.48  E-value=6.6e-14  Score=147.91  Aligned_cols=157  Identities=28%  Similarity=0.422  Sum_probs=91.8

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN  150 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~  150 (720)
                      .+++.|++++|.++..  +.+..+++|+.|++++|++++..|-...++|+.|++++|++++..  .+.+++.++.+++++
T Consensus       219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~  294 (384)
T d2omza2         219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNE  294 (384)
T ss_dssp             TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCS
T ss_pred             CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCcccccccCCEeeccCcccCCCC--ccccccccccccccc
Confidence            4455555555555532  245555666666666666654333222245666666666665332  255555666666666


Q ss_pred             cccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccCCcCcccCCc
Q 004994          151 NHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIENNLFSGPIPE  229 (720)
Q Consensus       151 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~N~l~g~~p~  229 (720)
                      |++++  ...+..+.+++.|++++|++++ ++ .+..+++|+.|+|++|+|++.. .+..+. |+.|++++|+|++..| 
T Consensus       295 n~l~~--~~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~l~-~l~~l~~L~~L~l~~N~l~~l~~-  368 (384)
T d2omza2         295 NQLED--ISPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGHNQISDLTP-  368 (384)
T ss_dssp             SCCSC--CGGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCBCGG-
T ss_pred             ccccc--ccccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCCCh-hHcCCCCCCEEECCCCcCCCChh-
Confidence            66653  2346667777777777777774 33 2677777777777777777643 344443 7777777777776544 


Q ss_pred             ccCCCcccc
Q 004994          230 KLLSIPNFR  238 (720)
Q Consensus       230 ~~~~l~~l~  238 (720)
                       +.++++|+
T Consensus       369 -l~~l~~L~  376 (384)
T d2omza2         369 -LANLTRIT  376 (384)
T ss_dssp             -GTTCTTCS
T ss_pred             -hccCCCCC
Confidence             44444444

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.45  E-value=1e-13  Score=121.17  Aligned_cols=101  Identities=29%  Similarity=0.377  Sum_probs=87.7

Q ss_pred             cEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccc
Q 004994          120 RNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNN  199 (720)
Q Consensus       120 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N  199 (720)
                      +.|+|++|+++ .++ .+.++++|++|++++|+|+ .+|+.|+.+++|+.|++++|.|+ .+| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            46888888888 666 4899999999999999998 68889999999999999999998 566 4899999999999999


Q ss_pred             cccccc--cccccc-ccceEEccCCcCcc
Q 004994          200 KLSGTL--NVLEDL-HLIDLNIENNLFSG  225 (720)
Q Consensus       200 ~l~~~~--~~~~~~-~l~~l~l~~N~l~g  225 (720)
                      +|+...  ..+..+ .|+.|++++|+++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            998765  345555 49999999999974

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=5.3e-14  Score=129.39  Aligned_cols=121  Identities=19%  Similarity=0.245  Sum_probs=67.5

Q ss_pred             cCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccccccc
Q 004994           70 FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLS  147 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~  147 (720)
                      ..++++|+|++|+|+. ++..+..+++|+.|||++|+|+ .++. +.  ++|+.|+|++|+++...+..+..+++|+.|+
T Consensus        17 ~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~   93 (162)
T d1a9na_          17 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI   93 (162)
T ss_dssp             TTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EECC-CCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred             cCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccCC-cccCcchhhhhcccccccCCCccccccccccccce
Confidence            3456666666666664 3444555666666666666666 4432 32  4566666666666643333445566666666


Q ss_pred             ccccccCCCCC--chhcCCCCCceEeccCCcccccCCC----CCCCCCCCceee
Q 004994          148 LNNNHLNGGIP--DAFHQFTGLINFDLSANNLTGQLPP----STRNLSSLYSLH  195 (720)
Q Consensus       148 l~~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~g~~p~----~~~~l~~L~~L~  195 (720)
                      |++|+|+. ++  ..+..+++|++|++++|.++ ..|.    .+..+++|+.||
T Consensus        94 L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          94 LTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             eccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            66666652 22  24555666666666666665 3332    244555555554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.43  E-value=2.8e-13  Score=129.27  Aligned_cols=143  Identities=32%  Similarity=0.482  Sum_probs=116.9

Q ss_pred             CCceeEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhc
Q 004994           62 SWQGVFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSR  139 (720)
Q Consensus        62 ~w~gv~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~  139 (720)
                      .+.|+ +.+++|+.|+|++|++++..+  ++.+++|+.|++++|.+. .+|. +.  .+|+.|++++|.+...  ..+..
T Consensus        54 ~l~~l-~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~~--~~~~~  126 (199)
T d2omxa2          54 SIDGV-EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITDI--DPLKN  126 (199)
T ss_dssp             CCTTG-GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCCC--GGGTT
T ss_pred             Ccccc-ccCCCcCcCccccccccCccc--ccCCcccccccccccccc-cccc-cccccccccccccccccccc--cccch
Confidence            35553 568999999999999997543  999999999999999998 5553 33  7899999999999843  34889


Q ss_pred             ccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceE
Q 004994          140 LTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDL  216 (720)
Q Consensus       140 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l  216 (720)
                      +++|+.|++++|++. .++ .+..+++|+.|++++|++++ ++ .+.++++|+.|+|++|+++... .+..+. |+.|
T Consensus       127 l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~~i~-~l~~L~~L~~L  199 (199)
T d2omxa2         127 LTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVSDIS-VLAKLTNLESL  199 (199)
T ss_dssp             CTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCG-GGGGCTTCSEE
T ss_pred             hhhhHHhhhhhhhhc-ccc-cccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCCCCc-cccCCCCCCcC
Confidence            999999999999997 344 68999999999999999984 54 4899999999999999998743 344443 5443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=4.3e-14  Score=129.99  Aligned_cols=111  Identities=20%  Similarity=0.195  Sum_probs=70.3

Q ss_pred             CcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCCCCC
Q 004994           90 TLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGL  167 (720)
Q Consensus        90 ~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L  167 (720)
                      .+.+...|+.|||++|+|+ .||..+.  .+|+.|+|++|+|+ .++ .|..+++|+.|+|++|+++...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            3556667778888888877 5554332  46777777777776 443 36666777777777777764444445566777


Q ss_pred             ceEeccCCcccccCC--CCCCCCCCCceeeccccccccc
Q 004994          168 INFDLSANNLTGQLP--PSTRNLSSLYSLHLQNNKLSGT  204 (720)
Q Consensus       168 ~~L~ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~  204 (720)
                      +.|+|++|+|+ .++  ..+..+++|+.|++++|.++..
T Consensus        90 ~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~  127 (162)
T d1a9na_          90 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK  127 (162)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred             ccceecccccc-ccccccccccccccchhhcCCCccccc
Confidence            77777777765 333  2455666666666666666543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.42  E-value=2.3e-13  Score=143.63  Aligned_cols=146  Identities=23%  Similarity=0.352  Sum_probs=123.6

Q ss_pred             eecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccccccccc
Q 004994           68 CVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLS  147 (720)
Q Consensus        68 c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~  147 (720)
                      -.+++++.|++.+|.+++..+  ++.+++|+.|++++|++++..|-.-...++.++++.|++++ + ..+..+++++.|+
T Consensus       238 ~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~  313 (384)
T d2omza2         238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED-I-SPISNLKNLTYLT  313 (384)
T ss_dssp             GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEE
T ss_pred             hcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccccccccc-c-cccchhcccCeEE
Confidence            346789999999999997653  88899999999999999954432222689999999999995 3 3588999999999


Q ss_pred             ccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecccccccccccccccc-ccceEEccCCc
Q 004994          148 LNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDL-HLIDLNIENNL  222 (720)
Q Consensus       148 l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~l~~l~l~~N~  222 (720)
                      +++|++++. + .+..+++|+.|+|++|+|+ .++ .+.++++|+.|+|++|+|++.++ +..+ +|+.|+|++|.
T Consensus       314 ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         314 LYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQA  384 (384)
T ss_dssp             CCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCEE
T ss_pred             CCCCCCCCC-c-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCCc
Confidence            999999964 3 3899999999999999998 455 68999999999999999998876 5555 59999999983

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.37  E-value=1.1e-12  Score=127.90  Aligned_cols=145  Identities=24%  Similarity=0.386  Sum_probs=119.8

Q ss_pred             EeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccc
Q 004994           67 FCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDL  146 (720)
Q Consensus        67 ~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L  146 (720)
                      +..+.+++.+++++|.++. + +.+..+++|+.|++++|...+..+-.....+..+.++++.+....  .+.++++|+.|
T Consensus        81 l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L  156 (227)
T d1h6ua2          81 LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYL  156 (227)
T ss_dssp             GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEE
T ss_pred             ccccccccccccccccccc-c-ccccccccccccccccccccccchhccccchhhhhchhhhhchhh--hhccccccccc
Confidence            4556789999999999985 3 358899999999999999885544344478999999999998543  47889999999


Q ss_pred             cccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccccccccccccc-cceEEccC
Q 004994          147 SLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLSGTLNVLEDLH-LIDLNIEN  220 (720)
Q Consensus       147 ~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-l~~l~l~~  220 (720)
                      ++++|.+++..  .++++++|+.|+|++|+++ .++. +.++++|+.|+|++|+|++..+ +..+. |+.|++++
T Consensus       157 ~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         157 SIGNAQVSDLT--PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTN  226 (227)
T ss_dssp             ECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEE
T ss_pred             cccccccccch--hhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEeeC
Confidence            99999997432  4899999999999999998 4554 8899999999999999997665 55554 99999874

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.32  E-value=1.7e-12  Score=118.21  Aligned_cols=73  Identities=33%  Similarity=0.284  Sum_probs=59.0

Q ss_pred             CCCCCcchhhcccccccccccccccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeeccccccc
Q 004994          129 LTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQNNKLS  202 (720)
Q Consensus       129 l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  202 (720)
                      |+...+..|.++++|+.|+|++|+|+...|.+|..+++|+.|+|++|+|+ .+|.......+|+.|+|++|.|.
T Consensus        44 l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          44 LQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             ccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence            44344566888899999999999998777888999999999999999998 66666555557999999999885

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.23  E-value=9.1e-14  Score=132.38  Aligned_cols=112  Identities=24%  Similarity=0.311  Sum_probs=68.0

Q ss_pred             CCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhcccccccccccccccCCCCCchhcCC
Q 004994           87 LADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNNHLNGGIPDAFHQF  164 (720)
Q Consensus        87 ~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N~l~g~~p~~~~~l  164 (720)
                      ++..+..|++|++|+|++|+|+ .++ .+.  .+|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+. + +.+.++
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred             hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence            3445666677777777777776 444 343  56666666666666 555555555566666676666663 3 235666


Q ss_pred             CCCceEeccCCcccccCC--CCCCCCCCCceeeccccccccc
Q 004994          165 TGLINFDLSANNLTGQLP--PSTRNLSSLYSLHLQNNKLSGT  204 (720)
Q Consensus       165 ~~L~~L~ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~  204 (720)
                      ++|+.|+|++|+|+ .++  ..+..+++|+.|+|++|.+...
T Consensus       115 ~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~  155 (198)
T d1m9la_         115 VNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             HHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred             ccccccccccchhc-cccccccccCCCccceeecCCCccccC
Confidence            66666666666665 333  2456666666666666665543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.22  E-value=5.9e-11  Score=122.92  Aligned_cols=167  Identities=22%  Similarity=0.249  Sum_probs=112.6

Q ss_pred             cCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccccccccccc
Q 004994           70 FSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLN  149 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~  149 (720)
                      .++|+.|+|++|+|+ .+|..+   .+|+.|++++|+++ .++ .++..|++|+|++|.++ .+|. ++++++|+.|+++
T Consensus        57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~-~lp~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~  128 (353)
T d1jl5a_          57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALS-DLPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVD  128 (353)
T ss_dssp             CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCC-SCCTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECC
T ss_pred             CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhh-hhccccccccccccccc-cccc-hhhhccceeeccc
Confidence            467899999999998 566553   57888899999888 665 35567999999999998 6664 6788999999998


Q ss_pred             ccccCCCCC------------------chhcCCCCCceEeccCCccccc------------------CCCCCCCCCCCce
Q 004994          150 NNHLNGGIP------------------DAFHQFTGLINFDLSANNLTGQ------------------LPPSTRNLSSLYS  193 (720)
Q Consensus       150 ~N~l~g~~p------------------~~~~~l~~L~~L~ls~N~l~g~------------------~p~~~~~l~~L~~  193 (720)
                      +|.+....+                  ..+..++.++.|++++|.+...                  ....+..++.|+.
T Consensus       129 ~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~  208 (353)
T d1jl5a_         129 NNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTT  208 (353)
T ss_dssp             SSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCE
T ss_pred             cccccccccccccccchhhccccccccccccccccceecccccccccccccccccccccccccccccccccccccccccc
Confidence            887763221                  2234556666677666655421                  0112344566666


Q ss_pred             eecccccccccc-----------------------cc-------------c---------------------cc-cccce
Q 004994          194 LHLQNNKLSGTL-----------------------NV-------------L---------------------ED-LHLID  215 (720)
Q Consensus       194 L~l~~N~l~~~~-----------------------~~-------------~---------------------~~-~~l~~  215 (720)
                      +++++|.....+                       ..             +                     .. ..|++
T Consensus       209 l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~  288 (353)
T d1jl5a_         209 IYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEE  288 (353)
T ss_dssp             EECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhcccccccCccccccccCCCCCE
Confidence            666665432100                       00             0                     00 13788


Q ss_pred             EEccCCcCcccCCcccCCCccccccCccCC
Q 004994          216 LNIENNLFSGPIPEKLLSIPNFRKDGNPFN  245 (720)
Q Consensus       216 l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~  245 (720)
                      |+|++|+|+ .+|..+.+|..|.+.+|...
T Consensus       289 L~Ls~N~l~-~lp~~~~~L~~L~L~~N~L~  317 (353)
T d1jl5a_         289 LNVSNNKLI-ELPALPPRLERLIASFNHLA  317 (353)
T ss_dssp             EECCSSCCS-CCCCCCTTCCEEECCSSCCS
T ss_pred             EECCCCccC-ccccccCCCCEEECCCCcCC
Confidence            999999998 78888888888887777654

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.21  E-value=1.5e-13  Score=130.80  Aligned_cols=124  Identities=21%  Similarity=0.307  Sum_probs=102.5

Q ss_pred             eEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecCCcCCCCCcchhhccccc
Q 004994           66 VFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSGNQLTGSIPESLSRLTQL  143 (720)
Q Consensus        66 v~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L  143 (720)
                      .+..+.+|+.|+|++|+|+. ++ .|..+++|+.|+|++|+|+ .+|....  .+|+.|++++|+++ .++ .+.++++|
T Consensus        43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L  117 (198)
T d1m9la_          43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHS
T ss_pred             HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccc
Confidence            35568899999999999985 44 5899999999999999998 7775443  57999999999999 444 58999999


Q ss_pred             ccccccccccCCCCC--chhcCCCCCceEeccCCcccccCCCC----------CCCCCCCceee
Q 004994          144 LDLSLNNNHLNGGIP--DAFHQFTGLINFDLSANNLTGQLPPS----------TRNLSSLYSLH  195 (720)
Q Consensus       144 ~~L~l~~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~g~~p~~----------~~~l~~L~~L~  195 (720)
                      +.|+|++|+|+. ++  ..+..+++|+.|+|++|.++...+..          +..+++|+.||
T Consensus       118 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         118 RVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             SEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             cccccccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            999999999984 44  46899999999999999998554433          45677888775

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.19  E-value=1.4e-11  Score=112.07  Aligned_cols=105  Identities=18%  Similarity=0.165  Sum_probs=86.7

Q ss_pred             CcEEEecCCcCCCCCcchhhccccccccccccc-ccCCCCCchhcCCCCCceEeccCCcccccCCCCCCCCCCCceeecc
Q 004994          119 VRNFSLSGNQLTGSIPESLSRLTQLLDLSLNNN-HLNGGIPDAFHQFTGLINFDLSANNLTGQLPPSTRNLSSLYSLHLQ  197 (720)
Q Consensus       119 L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  197 (720)
                      .+.+++++|++. .+|..+..+++|+.|+|++| .|+...+.+|.++++|+.|+|++|+|+...|..|..+++|+.|+|+
T Consensus        10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls   88 (156)
T d2ifga3          10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (156)
T ss_dssp             SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence            345677777776 67778888999999999766 5886666789999999999999999997667889999999999999


Q ss_pred             cccccccccc-ccccccceEEccCCcCc
Q 004994          198 NNKLSGTLNV-LEDLHLIDLNIENNLFS  224 (720)
Q Consensus       198 ~N~l~~~~~~-~~~~~l~~l~l~~N~l~  224 (720)
                      +|+|+..++. +..+.|+.|+|++|.|.
T Consensus        89 ~N~l~~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          89 FNALESLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             SSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred             CCCCcccChhhhccccccccccCCCccc
Confidence            9999977653 55566888888888774

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.18  E-value=5.7e-11  Score=116.58  Aligned_cols=166  Identities=15%  Similarity=0.172  Sum_probs=124.3

Q ss_pred             eEeecCceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCC-Ccc--ccCcEEEecCCcCCCCCc-chhhccc
Q 004994           66 VFCVFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPS-NLP--VTVRNFSLSGNQLTGSIP-ESLSRLT  141 (720)
Q Consensus        66 v~c~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~-~~~--~~L~~L~Ls~N~l~g~~p-~~l~~l~  141 (720)
                      ..|.... +.++.++++|+ .+|+.+.  +++++|||++|+|+ .+|. .|.  .+|++|+|++|.+...+| ..|.+++
T Consensus         4 ~~C~C~~-~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~   78 (242)
T d1xwdc1           4 RICHCSN-RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP   78 (242)
T ss_dssp             SSEEECS-SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCT
T ss_pred             CcCCCcC-CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccc
Confidence            3465543 57899999998 5776653  58999999999998 5665 454  789999999999986654 4688899


Q ss_pred             cccccccc-ccccCCCCCchhcCCCCCceEeccCCcccccCCC-CCCCCCCCceeeccccccccccc-ccccc--ccceE
Q 004994          142 QLLDLSLN-NNHLNGGIPDAFHQFTGLINFDLSANNLTGQLPP-STRNLSSLYSLHLQNNKLSGTLN-VLEDL--HLIDL  216 (720)
Q Consensus       142 ~L~~L~l~-~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~~~~~-~~~~~--~l~~l  216 (720)
                      +++.|.+. .|++....+..|.++++|+.|++++|+++...+. .+..+..|..+..+++.+..... .+..+  .+..|
T Consensus        79 ~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L  158 (242)
T d1xwdc1          79 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL  158 (242)
T ss_dssp             TCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEE
T ss_pred             ccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceee
Confidence            99999876 4788877888899999999999999999743222 34456667777777888876543 33333  48889


Q ss_pred             EccCCcCcccCCcccCCCccc
Q 004994          217 NIENNLFSGPIPEKLLSIPNF  237 (720)
Q Consensus       217 ~l~~N~l~g~~p~~~~~l~~l  237 (720)
                      ++++|+++ .++....+...+
T Consensus       159 ~l~~n~l~-~i~~~~~~~~~l  178 (242)
T d1xwdc1         159 WLNKNGIQ-EIHNCAFNGTQL  178 (242)
T ss_dssp             ECCSSCCC-EECTTTTTTCCE
T ss_pred             eccccccc-ccccccccchhh
Confidence            99999999 455554444443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.15  E-value=1.6e-10  Score=119.56  Aligned_cols=97  Identities=20%  Similarity=0.322  Sum_probs=82.0

Q ss_pred             CceeEEEecCCcccccCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhcccccccccccc
Q 004994           71 SNVTEIRLTGMNLGGVLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLDLSLNN  150 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~l~~  150 (720)
                      .+++.|+|++|+|+. +|+.   +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.-   .+.|++|+|++
T Consensus        38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~-~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~  107 (353)
T d1jl5a_          38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP-QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN  107 (353)
T ss_dssp             HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC-TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred             cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch-hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence            578999999999984 6754   568999999999999 888765 58999999999998 55532   14699999999


Q ss_pred             cccCCCCCchhcCCCCCceEeccCCcccc
Q 004994          151 NHLNGGIPDAFHQFTGLINFDLSANNLTG  179 (720)
Q Consensus       151 N~l~g~~p~~~~~l~~L~~L~ls~N~l~g  179 (720)
                      |.+. .+|. ++.+++|+.|++++|.++.
T Consensus       108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~  134 (353)
T d1jl5a_         108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKK  134 (353)
T ss_dssp             SCCS-SCCC-CTTCTTCCEEECCSSCCSC
T ss_pred             cccc-cccc-hhhhccceeeccccccccc
Confidence            9998 5774 6889999999999999873

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.79  E-value=1.5e-10  Score=120.06  Aligned_cols=156  Identities=20%  Similarity=0.266  Sum_probs=105.6

Q ss_pred             cCceeEEEecCCccccc----CCcCcCCCCCccEEeccCCcccccCCCC----c-----------cccCcEEEecCCcCC
Q 004994           70 FSNVTEIRLTGMNLGGV----LADTLGDLESVINIDLSNNHIGGSIPSN----L-----------PVTVRNFSLSGNQLT  130 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~g~ip~~----~-----------~~~L~~L~Ls~N~l~  130 (720)
                      .++|+.|+|++|.++..    +...+...++|+.|+|++|.+...-...    +           ...|+.|++++|+++
T Consensus        92 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~  171 (344)
T d2ca6a1          92 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE  171 (344)
T ss_dssp             CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred             CCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccc
Confidence            35788888888887653    3344556778888888888775211100    0           146788888888876


Q ss_pred             CC----CcchhhcccccccccccccccCCC-----CCchhcCCCCCceEeccCCccccc----CCCCCCCCCCCceeecc
Q 004994          131 GS----IPESLSRLTQLLDLSLNNNHLNGG-----IPDAFHQFTGLINFDLSANNLTGQ----LPPSTRNLSSLYSLHLQ  197 (720)
Q Consensus       131 g~----~p~~l~~l~~L~~L~l~~N~l~g~-----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~  197 (720)
                      ..    +...+..++.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..+++|+.|+|+
T Consensus       172 ~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls  251 (344)
T d2ca6a1         172 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN  251 (344)
T ss_dssp             GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred             ccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhh
Confidence            22    233355677888899988887631     334466788889999999888532    44556778888999999


Q ss_pred             cccccccc-----ccc---cccccceEEccCCcCcc
Q 004994          198 NNKLSGTL-----NVL---EDLHLIDLNIENNLFSG  225 (720)
Q Consensus       198 ~N~l~~~~-----~~~---~~~~l~~l~l~~N~l~g  225 (720)
                      +|.|++.-     ..+   ....|++|++++|+++.
T Consensus       252 ~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~  287 (344)
T d2ca6a1         252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL  287 (344)
T ss_dssp             TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             cCccCchhhHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence            99887531     122   23458889999998864

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.77  E-value=5.8e-10  Score=112.08  Aligned_cols=172  Identities=19%  Similarity=0.230  Sum_probs=106.6

Q ss_pred             CceeEEEecCCccccc-CCcCcCCCCCccEEeccCCcccccCCCCcc--ccCcEEEecC-CcCCCC-Ccchhhccccccc
Q 004994           71 SNVTEIRLTGMNLGGV-LADTLGDLESVINIDLSNNHIGGSIPSNLP--VTVRNFSLSG-NQLTGS-IPESLSRLTQLLD  145 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~--~~L~~L~Ls~-N~l~g~-~p~~l~~l~~L~~  145 (720)
                      .+|+.|+|+++.++.. +...+..+++|++|+|+++.+++..+..+.  ++|+.|+|++ +.++.. +..-+.++++|++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~  125 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  125 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence            4788888888887643 445577788888888888888766655554  5788888888 455521 2222456788888


Q ss_pred             cccccc-ccCC-CCCchhcC-CCCCceEeccCC--cccc-cCCCCCCCCCCCceeecccc-ccccc-cccccccc-cceE
Q 004994          146 LSLNNN-HLNG-GIPDAFHQ-FTGLINFDLSAN--NLTG-QLPPSTRNLSSLYSLHLQNN-KLSGT-LNVLEDLH-LIDL  216 (720)
Q Consensus       146 L~l~~N-~l~g-~~p~~~~~-l~~L~~L~ls~N--~l~g-~~p~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~~-l~~l  216 (720)
                      |+|+++ .++. .+...+.. .++|+.|++++.  .++. .+...+.++++|+.|+|++| .+++. +..+..++ |++|
T Consensus       126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L  205 (284)
T d2astb2         126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL  205 (284)
T ss_dssp             EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred             cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence            888874 4432 12222333 367888887753  3332 12223355777888888775 35533 23444443 7788


Q ss_pred             EccC-CcCcccCCcccCCCccccccCc
Q 004994          217 NIEN-NLFSGPIPEKLLSIPNFRKDGN  242 (720)
Q Consensus       217 ~l~~-N~l~g~~p~~~~~l~~l~~~~n  242 (720)
                      ++++ +.++......+.++++|+..+.
T Consensus       206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l  232 (284)
T d2astb2         206 SLSRCYDIIPETLLELGEIPTLKTLQV  232 (284)
T ss_dssp             ECTTCTTCCGGGGGGGGGCTTCCEEEC
T ss_pred             ECCCCCCCChHHHHHHhcCCCCCEEee
Confidence            8877 5666655555666666554443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.75  E-value=3.2e-10  Score=114.04  Aligned_cols=172  Identities=17%  Similarity=0.250  Sum_probs=101.3

Q ss_pred             ecCceeEEEecCCcccccCCcCcCCCCCccEEeccC-Cccccc-CCCCc--cccCcEEEecCC-cCCCC-Ccchhhc-cc
Q 004994           69 VFSNVTEIRLTGMNLGGVLADTLGDLESVINIDLSN-NHIGGS-IPSNL--PVTVRNFSLSGN-QLTGS-IPESLSR-LT  141 (720)
Q Consensus        69 ~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~g~-ip~~~--~~~L~~L~Ls~N-~l~g~-~p~~l~~-l~  141 (720)
                      ..++|+.|+|+++.+++..+..++.+++|+.|+|++ +.++.. +..-.  .++|++|+|+++ .++.. +...+.. ++
T Consensus        69 ~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~  148 (284)
T d2astb2          69 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSE  148 (284)
T ss_dssp             TBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCT
T ss_pred             hCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccc
Confidence            456788888888887776677777788888888877 355421 11101  157888888774 44321 2223333 35


Q ss_pred             cccccccccc--ccCC-CCCchhcCCCCCceEeccCC-cccccCCCCCCCCCCCceeeccc-ccccccc-cccccc-ccc
Q 004994          142 QLLDLSLNNN--HLNG-GIPDAFHQFTGLINFDLSAN-NLTGQLPPSTRNLSSLYSLHLQN-NKLSGTL-NVLEDL-HLI  214 (720)
Q Consensus       142 ~L~~L~l~~N--~l~g-~~p~~~~~l~~L~~L~ls~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~~~~-~~~~~~-~l~  214 (720)
                      +|+.|++++.  .++. .+...+.++++|++|+|++| .+++.....+.++++|++|+|++ +.++... ..+..+ .|+
T Consensus       149 ~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~  228 (284)
T d2astb2         149 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK  228 (284)
T ss_dssp             TCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred             ccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCC
Confidence            7788887753  3332 12233456778888888774 46666666777788888888887 3565332 233333 377


Q ss_pred             eEEccCCcCcccCCcccCCCcccccc
Q 004994          215 DLNIENNLFSGPIPEKLLSIPNFRKD  240 (720)
Q Consensus       215 ~l~l~~N~l~g~~p~~~~~l~~l~~~  240 (720)
                      .|+++++--.+.++.-...+++|++.
T Consensus       229 ~L~l~~~~~d~~l~~l~~~lp~L~i~  254 (284)
T d2astb2         229 TLQVFGIVPDGTLQLLKEALPHLQIN  254 (284)
T ss_dssp             EEECTTSSCTTCHHHHHHHSTTSEES
T ss_pred             EEeeeCCCCHHHHHHHHHhCcccccc
Confidence            88877662222233223345566553

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.51  E-value=7.5e-09  Score=106.81  Aligned_cols=83  Identities=29%  Similarity=0.398  Sum_probs=39.6

Q ss_pred             CceeEEEecCCcccc----cCCcCcCCCCCccEEeccCCcccc---cCCCCc-------c--ccCcEEEecCCcCCCC--
Q 004994           71 SNVTEIRLTGMNLGG----VLADTLGDLESVINIDLSNNHIGG---SIPSNL-------P--VTVRNFSLSGNQLTGS--  132 (720)
Q Consensus        71 ~~l~~l~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~g---~ip~~~-------~--~~L~~L~Ls~N~l~g~--  132 (720)
                      ..|+.|+|++|.++.    .+...+...++|+.|+|+++.+..   ..|..+       .  ++|+.|+|++|.++..  
T Consensus        31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  110 (344)
T d2ca6a1          31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ  110 (344)
T ss_dssp             SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred             CCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccc
Confidence            445566666665532    123345555566666665554321   111111       0  3456666666655532  


Q ss_pred             --Ccchhhccccccccccccccc
Q 004994          133 --IPESLSRLTQLLDLSLNNNHL  153 (720)
Q Consensus       133 --~p~~l~~l~~L~~L~l~~N~l  153 (720)
                        +...+..+++|+.|++++|.+
T Consensus       111 ~~l~~~l~~~~~L~~L~l~~n~l  133 (344)
T d2ca6a1         111 EPLIDFLSKHTPLEHLYLHNNGL  133 (344)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSCC
T ss_pred             cchhhhhcccccchheecccccc
Confidence              222333455566666665554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.31  E-value=2.6e-08  Score=90.54  Aligned_cols=104  Identities=17%  Similarity=0.207  Sum_probs=60.5

Q ss_pred             hhcccccccccccccccCCCCCchhcCCCCCceEeccCCccccc--CCCCCCCCCCCceeeccccccccccc--cccccc
Q 004994          137 LSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLTGQ--LPPSTRNLSSLYSLHLQNNKLSGTLN--VLEDLH  212 (720)
Q Consensus       137 l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~--~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~  212 (720)
                      +..+..+..|++.+|... .++..+.++++|++|+|++|+|+..  ++..+..+++|+.|+|++|.++....  .+..+.
T Consensus        38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~  116 (162)
T d1koha1          38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK  116 (162)
T ss_dssp             TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred             hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence            444444555555555443 3444455667777777777777632  12334566777777777777765442  334455


Q ss_pred             cceEEccCCcCcccCCcc-------cCCCccccccC
Q 004994          213 LIDLNIENNLFSGPIPEK-------LLSIPNFRKDG  241 (720)
Q Consensus       213 l~~l~l~~N~l~g~~p~~-------~~~l~~l~~~~  241 (720)
                      |+.|++++|.++......       +..+|+|+..+
T Consensus       117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1         117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            777777777777554422       44566666543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.30  E-value=1.5e-08  Score=108.26  Aligned_cols=156  Identities=21%  Similarity=0.196  Sum_probs=82.6

Q ss_pred             cCceeEEEecCCcccc-----cCCcCcCCCCCccEEeccCCcccccCCC----Ccc--ccCcEEEecCCcCCCCCcchhh
Q 004994           70 FSNVTEIRLTGMNLGG-----VLADTLGDLESVINIDLSNNHIGGSIPS----NLP--VTVRNFSLSGNQLTGSIPESLS  138 (720)
Q Consensus        70 ~~~l~~l~L~~n~l~~-----~~~~~~~~l~~L~~L~L~~N~l~g~ip~----~~~--~~L~~L~Ls~N~l~g~~p~~l~  138 (720)
                      ...++.+++.+|.+..     .+.........|+.|++++|.+......    .+.  ..++.+++++|.++......+.
T Consensus       225 ~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~  304 (460)
T d1z7xw1         225 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC  304 (460)
T ss_dssp             CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred             cccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence            3566777777776532     2233344566677777777766532111    111  4566777777766532222221


Q ss_pred             -----cccccccccccccccCCCCC----chhcCCCCCceEeccCCccccc----CCCCCC-CCCCCceeeccccccccc
Q 004994          139 -----RLTQLLDLSLNNNHLNGGIP----DAFHQFTGLINFDLSANNLTGQ----LPPSTR-NLSSLYSLHLQNNKLSGT  204 (720)
Q Consensus       139 -----~l~~L~~L~l~~N~l~g~~p----~~~~~l~~L~~L~ls~N~l~g~----~p~~~~-~l~~L~~L~l~~N~l~~~  204 (720)
                           ....|+.+++++|.++..-.    ..+....+|++|+|++|+|+..    ++..+. ..+.|+.|+|++|.|+..
T Consensus       305 ~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~  384 (460)
T d1z7xw1         305 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS  384 (460)
T ss_dssp             HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred             ccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChH
Confidence                 22456677777776654322    2233445677777777776531    222222 345577777777776532


Q ss_pred             ----c-ccccc-cccceEEccCCcCcc
Q 004994          205 ----L-NVLED-LHLIDLNIENNLFSG  225 (720)
Q Consensus       205 ----~-~~~~~-~~l~~l~l~~N~l~g  225 (720)
                          + ..+.. ..|++|+|++|+|+.
T Consensus       385 ~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         385 SCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             HHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             HHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence                1 11222 236677777777653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.29  E-value=1.3e-06  Score=85.72  Aligned_cols=148  Identities=13%  Similarity=0.114  Sum_probs=93.1

Q ss_pred             HHHHHhcCCCCCCeeccCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCe
Q 004994          434 SLQQYTNSFSEGNFIGEGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQ  512 (720)
Q Consensus       434 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~  512 (720)
                      ++...-+.|...+..+-++...||+... +++.+++|+......  .....+.+|...++.+. +--+.++++++.+.+.
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            4555555665444333344568999865 455677888754321  22234567777777663 4346778888888889


Q ss_pred             EEEEEeeCCCCCHHHHhhccchhccccCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 004994          513 HLLVYDYGGNCTLHDLLHSDEEAHKKFSWNIRIRVALGAARALQYLQEVC------------------------------  562 (720)
Q Consensus       513 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~------------------------------  562 (720)
                      .++||+++++..+.+......         ....++.++++.+..||+..                              
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~~---------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDEQ---------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTCS---------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             eEEEEEecccccccccccccc---------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            999999999987765432110         01123333344444444311                              


Q ss_pred             --------------------------CCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          563 --------------------------EPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       563 --------------------------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                                                ...++|+|+.|.|||+++++..-|.||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                      1237999999999999987767799999763

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.28  E-value=1.8e-08  Score=91.64  Aligned_cols=42  Identities=21%  Similarity=0.134  Sum_probs=19.1

Q ss_pred             hhcccccccccccccccCCCCCchhcCCCCCceEeccCCccc
Q 004994          137 LSRLTQLLDLSLNNNHLNGGIPDAFHQFTGLINFDLSANNLT  178 (720)
Q Consensus       137 l~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~  178 (720)
                      +..+++|+.|+|++|.|+..-+-.+.....|+.|++++|.++
T Consensus        87 ~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          87 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             HhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            444555555555555554221212222334555555555554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.08  E-value=1.1e-07  Score=101.27  Aligned_cols=37  Identities=14%  Similarity=0.215  Sum_probs=17.8

Q ss_pred             ceeEEEecCCccccc-CCcCcCCCCCccEEeccCCccc
Q 004994           72 NVTEIRLTGMNLGGV-LADTLGDLESVINIDLSNNHIG  108 (720)
Q Consensus        72 ~l~~l~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~  108 (720)
                      +|+.|||++|++++. +...+..+++|+.|+|++|+|+
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~   40 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT   40 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCC
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCC
Confidence            455555555555532 1223334455555555555444

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.90  E-value=9.4e-06  Score=78.85  Aligned_cols=142  Identities=21%  Similarity=0.216  Sum_probs=83.5

Q ss_pred             eeccCCC-ceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCC--CceeEEEeEeccCCeEEEEEeeCCCC
Q 004994          447 FIGEGLL-GSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRH--GNIVELIGYCNEHGQHLLVYDYGGNC  523 (720)
Q Consensus       447 ~lg~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g  523 (720)
                      .+..|.. +.||+...+++..+++|.-....     ...+..|.+.++.+..  --+.++++++.+.+..++||+|+++.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            3445554 57899988888889999865432     1235566666666633  33667888888888899999999875


Q ss_pred             CHHHH-----------------hhccchhcccc--CHHHHHHHHH--------------------HHHHHHHHHHhcC--
Q 004994          524 TLHDL-----------------LHSDEEAHKKF--SWNIRIRVAL--------------------GAARALQYLQEVC--  562 (720)
Q Consensus       524 sL~~~-----------------l~~~~~~~~~~--~~~~~~~i~~--------------------~ia~~L~~LH~~~--  562 (720)
                      .+.+.                 +|........+  .+.....-..                    .....+..+....  
T Consensus        92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  171 (255)
T d1nd4a_          92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD  171 (255)
T ss_dssp             ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred             ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence            54321                 01000000000  0110000000                    0112233333321  


Q ss_pred             --CCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          563 --EPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       563 --~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                        ...++|+|+.|.|||++++..+-|+||+.+.
T Consensus       172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             SCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence              2237999999999999988777899999763

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.47  E-value=1.3e-05  Score=72.38  Aligned_cols=65  Identities=11%  Similarity=0.134  Sum_probs=33.5

Q ss_pred             hhcccccccccccccccCCC----CCchhcCCCCCceEeccCCcccc-------cCCCCCCCCCCCceeecccccc
Q 004994          137 LSRLTQLLDLSLNNNHLNGG----IPDAFHQFTGLINFDLSANNLTG-------QLPPSTRNLSSLYSLHLQNNKL  201 (720)
Q Consensus       137 l~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g-------~~p~~~~~l~~L~~L~l~~N~l  201 (720)
                      +...+.|+.|+|++|.|+..    +-.++...++|++|+|++|.+..       .+...+...++|+.|+++.+..
T Consensus        68 L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          68 IETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             hhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            33445555555555555421    11234445566777776665441       1223334456677777766543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.36  E-value=1.1e-05  Score=73.02  Aligned_cols=87  Identities=20%  Similarity=0.206  Sum_probs=47.4

Q ss_pred             hhcccccccccccccccCC----CCCchhcCCCCCceEeccCCccccc----CCCCCCCCCCCceeecccccccccc---
Q 004994          137 LSRLTQLLDLSLNNNHLNG----GIPDAFHQFTGLINFDLSANNLTGQ----LPPSTRNLSSLYSLHLQNNKLSGTL---  205 (720)
Q Consensus       137 l~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~---  205 (720)
                      +...++|+.|+|++|.+..    .+...+...+.|+.|+|++|.|+..    +-..+...++|+.|+|++|.+...-   
T Consensus        40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~  119 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV  119 (167)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred             HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence            3344556666666665542    1223344556777777777777631    2234555667777777777654211   


Q ss_pred             -----ccc-cccccceEEccCCcC
Q 004994          206 -----NVL-EDLHLIDLNIENNLF  223 (720)
Q Consensus       206 -----~~~-~~~~l~~l~l~~N~l  223 (720)
                           ..+ .+..|+.|+++.+..
T Consensus       120 ~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_         120 EMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHHHhCCCccEeeCcCCCc
Confidence                 111 123467777765543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.12  E-value=0.00053  Score=70.65  Aligned_cols=77  Identities=17%  Similarity=0.079  Sum_probs=47.8

Q ss_pred             CeeccCCCceEEEEEeC-CCcEEEEEEeccccc-----ccccHHHHHHHHHHHHcc-CC--CceeEEEeEeccCCeEEEE
Q 004994          446 NFIGEGLLGSVYKAELP-GGKLLAVKKLSNTVS-----QRQTDEEFLELASTISRL-RH--GNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~~~e~~~l~~l-~H--~niv~l~~~~~~~~~~~lv  516 (720)
                      +.||.|....||++... +++.|+||.-.....     ..........|.+.++.+ .+  ..+.+++.+..+  ..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~--~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--MAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--TTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC--CCEEE
Confidence            46899999999999764 467899997543211     011222344577777655 22  456677776544  45789


Q ss_pred             EeeCCCCC
Q 004994          517 YDYGGNCT  524 (720)
Q Consensus       517 ~e~~~~gs  524 (720)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99998644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.11  E-value=0.00064  Score=68.11  Aligned_cols=135  Identities=16%  Similarity=0.176  Sum_probs=77.9

Q ss_pred             ceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCcee--EEEe-----EeccCCeEEEEEeeCCCCCHH
Q 004994          454 GSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNIV--ELIG-----YCNEHGQHLLVYDYGGNCTLH  526 (720)
Q Consensus       454 g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~niv--~l~~-----~~~~~~~~~lv~e~~~~gsL~  526 (720)
                      -.||++..++|+.|++|+.+...   ...+++.+|.+.+..|....+.  ..+.     .+...+..+.++++++|..+.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            47999999999999999987542   3456777888888777533221  1111     223456788999998863321


Q ss_pred             -----HH---------hhc----cc-hhccccCHH-------------------HHHHHHHHHHHHHHHHHhc----CCC
Q 004994          527 -----DL---------LHS----DE-EAHKKFSWN-------------------IRIRVALGAARALQYLQEV----CEP  564 (720)
Q Consensus       527 -----~~---------l~~----~~-~~~~~~~~~-------------------~~~~i~~~ia~~L~~LH~~----~~~  564 (720)
                           .+         +|.    .. ......++.                   .+..+...+.+.+..+...    ...
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                 11         010    00 000111111                   1111222233334444332    234


Q ss_pred             CeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          565 PIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       565 ~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ++||+|+.+.|||++++  ..+.||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhcc
Confidence            68999999999999754  4589999775

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.58  E-value=0.00014  Score=65.37  Aligned_cols=113  Identities=17%  Similarity=0.278  Sum_probs=52.0

Q ss_pred             CceeEEEecC-Ccccc----cCCcCcCCCCCccEEeccCCcccccCCCCccccCcEEEecCCcCCCCCcchhhccccccc
Q 004994           71 SNVTEIRLTG-MNLGG----VLADTLGDLESVINIDLSNNHIGGSIPSNLPVTVRNFSLSGNQLTGSIPESLSRLTQLLD  145 (720)
Q Consensus        71 ~~l~~l~L~~-n~l~~----~~~~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~  145 (720)
                      +.|++|+|++ +.++.    .+-..+...++|+.|+|++|.++..--..                  +-..+...+.|+.
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~------------------L~~~l~~~~~l~~   78 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA------------------LAEMLKVNNTLKS   78 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH------------------HHHHHHHCSSCCE
T ss_pred             CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHH------------------HHHHHhhcccchh
Confidence            4556666665 33431    12233445556666666666554221111                  1112333445555


Q ss_pred             ccccccccCCC----CCchhcCCCCCceEec--cCCcccc----cCCCCCCCCCCCceeecccccc
Q 004994          146 LSLNNNHLNGG----IPDAFHQFTGLINFDL--SANNLTG----QLPPSTRNLSSLYSLHLQNNKL  201 (720)
Q Consensus       146 L~l~~N~l~g~----~p~~~~~l~~L~~L~l--s~N~l~g----~~p~~~~~l~~L~~L~l~~N~l  201 (720)
                      |++++|.++..    +-..+...++|+.++|  ++|.+..    .+...+...++|+.|+++.|..
T Consensus        79 l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          79 LNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             EECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             hhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            55555554321    1233445555654333  4455532    2333344566677777666544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.29  E-value=0.015  Score=57.36  Aligned_cols=159  Identities=11%  Similarity=0.084  Sum_probs=82.1

Q ss_pred             cCHHHHHHHhcCCCCCCeec-----cCCCceEEEEEeCCCcEEEEEEecccccccccHHHHHHHHHHHHccCCCce--eE
Q 004994          430 FTIASLQQYTNSFSEGNFIG-----EGLLGSVYKAELPGGKLLAVKKLSNTVSQRQTDEEFLELASTISRLRHGNI--VE  502 (720)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~  502 (720)
                      .+.++++.+..+|..+++..     .|---+.|+.+.++|+ +++|+...... .   ++...|++++..+.+.++  ..
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~-~---~~l~~~~~~l~~L~~~g~pvp~   77 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE-K---NDLPFFLGLMQHLAAKGLSCPL   77 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC-H---HHHHHHHHHHHhhhhccccccc
Confidence            46778888888898766554     4555678999887765 89998864321 1   233345556655533222  11


Q ss_pred             EEe------EeccCCeEEEEEeeCCCCCHHHH--------------hhcc------chhcc-----------------cc
Q 004994          503 LIG------YCNEHGQHLLVYDYGGNCTLHDL--------------LHSD------EEAHK-----------------KF  539 (720)
Q Consensus       503 l~~------~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~------~~~~~-----------------~~  539 (720)
                      .+.      +..-.+....++.+..+......              ++..      .....                 ..
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            111      11123456667777665322110              0000      00000                 00


Q ss_pred             CHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEEcCCCCeEEccccCCC
Q 004994          540 SWNIRIRVALGAARALQYLQE-VCEPPIVHGNFKSSNILLDEKLIVRVSDCGLAP  593 (720)
Q Consensus       540 ~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~  593 (720)
                      ........+......+.-.+. ....++||+|+.++||+++.+...-|.||+.+.
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            000111112222222222211 124579999999999999998877899999773

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.18  E-value=0.00016  Score=64.96  Aligned_cols=88  Identities=18%  Similarity=0.279  Sum_probs=58.8

Q ss_pred             hhcccccccccccccccCCC----CCchhcCCCCCceEeccCCccccc----CCCCCCCCCCCceeec--ccccccccc-
Q 004994          137 LSRLTQLLDLSLNNNHLNGG----IPDAFHQFTGLINFDLSANNLTGQ----LPPSTRNLSSLYSLHL--QNNKLSGTL-  205 (720)
Q Consensus       137 l~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l--~~N~l~~~~-  205 (720)
                      +...++|+.|+|++|.++..    +-..+...++|+.|++++|.++..    +-..+...++|+.++|  ++|.+.... 
T Consensus        42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~  121 (166)
T d1io0a_          42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE  121 (166)
T ss_dssp             HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH
T ss_pred             HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH
Confidence            44567777888888877532    223456678999999999998642    3356677888987555  567775321 


Q ss_pred             ----ccc-cccccceEEccCCcCc
Q 004994          206 ----NVL-EDLHLIDLNIENNLFS  224 (720)
Q Consensus       206 ----~~~-~~~~l~~l~l~~N~l~  224 (720)
                          ..+ .+..|+.|+++.|...
T Consensus       122 ~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_         122 MEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             HHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHhCCCcCEEeCcCCCCc
Confidence                223 2345999999877653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.39  E-value=0.029  Score=57.06  Aligned_cols=71  Identities=13%  Similarity=0.109  Sum_probs=46.4

Q ss_pred             CeeccCCCceEEEEEeCCC--------cEEEEEEecccccccccHHHHHHHHHHHHccC-CCceeEEEeEeccCCeEEEE
Q 004994          446 NFIGEGLLGSVYKAELPGG--------KLLAVKKLSNTVSQRQTDEEFLELASTISRLR-HGNIVELIGYCNEHGQHLLV  516 (720)
Q Consensus       446 ~~lg~G~~g~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv  516 (720)
                      +.|+-|-.-.+|++...++        +.|.+++....    .......+|.++++.+. +.-..++++++.+    .+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            5677888889999976543        45666665421    11233456777777774 4334578888764    589


Q ss_pred             EeeCCCCC
Q 004994          517 YDYGGNCT  524 (720)
Q Consensus       517 ~e~~~~gs  524 (720)
                      +||+++-.
T Consensus       120 ~efi~g~~  127 (395)
T d1nw1a_         120 EEYIPSRP  127 (395)
T ss_dssp             ECCCCEEE
T ss_pred             EEEecccc
Confidence            99998643